Citrus Sinensis ID: 001494
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1067 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LP24 | 1120 | Probable leucine-rich rep | yes | no | 0.986 | 0.940 | 0.489 | 0.0 | |
| Q8VZG8 | 1045 | Probable LRR receptor-lik | no | no | 0.836 | 0.854 | 0.472 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.955 | 0.925 | 0.381 | 1e-180 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.962 | 0.931 | 0.373 | 1e-177 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.910 | 0.778 | 0.368 | 1e-167 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.924 | 0.877 | 0.374 | 1e-162 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.959 | 0.817 | 0.343 | 1e-158 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.932 | 0.876 | 0.361 | 1e-156 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.920 | 0.860 | 0.351 | 1e-154 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.942 | 0.843 | 0.346 | 1e-148 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 951 bits (2459), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 536/1095 (48%), Positives = 717/1095 (65%), Gaps = 42/1095 (3%)
Query: 1 MEEAHALLRWKTSLQNHNNGSPLSSWTF--NNVTKIGSCAWVGIHCNHGGRVNSINLTSI 58
+ EA+ALL+WK++ N S LSSW N T +W G+ CN G + +NLT+
Sbjct: 31 IAEANALLKWKSTFTN---SSKLSSWVHDANTNTSFSCTSWYGVSCNSRGSIEELNLTNT 87
Query: 59 GLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIG 118
G++GT DF F S +LAY+DL N L G IPPQ GN+SKL Y DLS+N +G I P +G
Sbjct: 88 GIEGTFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLG 147
Query: 119 HLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYN 178
+L L L+L +N L+ IP E+G + S+ +LAL N L IP SLGNL NL+ L LY
Sbjct: 148 NLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYE 207
Query: 179 NLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELG 238
N L+G IP E+GN++ + DL L N+L GSIP +LGNL NL +L L N L G IP E+G
Sbjct: 208 NYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIG 267
Query: 239 NLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSY 298
N++ +++L L+ NKL GSIP SL NL NL +L ++ N L+G IP ++GN++ + + LS
Sbjct: 268 NMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSN 327
Query: 299 NKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLG 358
NK +G IP SLGNL N+ L+L N L G+IP EL N++S+ L+L NNKL GSIP G
Sbjct: 328 NKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFG 387
Query: 359 NLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYK 418
NL NL+ L++Y N L+G IP E+GN++S+ L+L+ NKLT S+P S N T L L
Sbjct: 388 NLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRV 447
Query: 419 NSLSGAIPKEYRNLVKLTKLFLGDNQF------------------------QGPIP-NLK 453
N LSGAIP N LT L L N F +GPIP +L+
Sbjct: 448 NHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLR 507
Query: 454 NLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSK 513
+ SL+R N T +I E+F IYP+L FID S+N +GEISS+W + PKLGAL S
Sbjct: 508 DCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSN 567
Query: 514 NNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLG 573
NNITG IP +I +QL LDLS+N++ G++P +G L+ L +L L NQLSG++ L
Sbjct: 568 NNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLS 627
Query: 574 LLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSY 633
L LE LDLSSNN S+ IP++ + +KLH +NLS N+F IP +L +L L++LDLS+
Sbjct: 628 FLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSH 686
Query: 634 NFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTA 693
N L IPSQ+ +QSL+KL+LSHN+LSG+IP FE M AL +DIS N+L GP+P++
Sbjct: 687 NQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPT 746
Query: 694 FRDAPIKALQGNKGLCGDF--KGLPSCKALKS-NKQASRKIWIVVLFPLLGIVALLISLI 750
FR A AL+ N GLC + + L C+ LK K + +WI+V P+LG++ +L S+
Sbjct: 747 FRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILV--PILGVLVIL-SIC 803
Query: 751 GLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQG 810
F + RK K Q +++ T S+ + +GK Y++II +TN+FD H IG GG
Sbjct: 804 ANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYS 863
Query: 811 SVYKVELASGEIIAVKKFHSPLPGEMT---FQQEFLNEVKALTEIRHRNIVKFYGFCSHA 867
VY+ L IIAVK+ H + E++ +QEFLNEVKALTEIRHRN+VK +GFCSH
Sbjct: 864 KVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHR 922
Query: 868 QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDI 927
+H+F++YEY+E GSL +L+ND A+ L WT+R++V+KG+A ALSY+H+D PIVHRDI
Sbjct: 923 RHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDI 982
Query: 928 SSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSF 987
SS N+LLD A++SDFG AK LK DSSNW+ +AGTYGYVAPE AYTMKVTEKCDVYSF
Sbjct: 983 SSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSF 1042
Query: 988 GVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISC 1047
GVL LE+I GKHPGD +S +SSS ++L I D R+ P +EKL+ VE+A+ C
Sbjct: 1043 GVLILELIIGKHPGDLVSSLSSSP-GEALSLRSISDERVLEPRGQNREKLLKMVEMALLC 1101
Query: 1048 LDESPESRPTMQKVS 1062
L +PESRPTM +S
Sbjct: 1102 LQANPESRPTMLSIS 1116
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 798 bits (2060), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/927 (47%), Positives = 594/927 (64%), Gaps = 34/927 (3%)
Query: 168 LTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSN 227
L NL + L N SG+I G L +L N+L G IP LG+LSNL L+L N
Sbjct: 117 LPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVEN 176
Query: 228 SLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGN 287
L GSIPSE+G L ++++ + DN L G IP S NLT LV LY++ NSLSG IPSEIGN
Sbjct: 177 KLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGN 236
Query: 288 LKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNN 347
L L ++ L N +G IP S GNL N+ L + N L G IP E+ N+ +L L L N
Sbjct: 237 LPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTN 296
Query: 348 KLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSN 407
KL G IP LGN+ L+VL +Y N L+GSIP E+G ++S+ L ++ NKLT +P S
Sbjct: 297 KLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGK 356
Query: 408 LTNLSVLSFYKNSLSGAIPKEYRNLVKLT------------------------KLFLGDN 443
LT L L N LSG IP N +LT L L DN
Sbjct: 357 LTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDN 416
Query: 444 QFQGPIP-NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGR 502
F+GP+P +L++ SL+RV N + +ISE+F +YP L FIDLS NN +G++S++W +
Sbjct: 417 HFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQ 476
Query: 503 CPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQN 562
KL A S N+ITG IPP+I +QL LDLSSN + G++P + ++ + KL L N
Sbjct: 477 SQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGN 536
Query: 563 QLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEE 622
+LSG++ + LL LE+LDLSSN S+ IP +L NL +L+Y+NLS N IP L +
Sbjct: 537 RLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTK 596
Query: 623 LIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYN 682
L L LDLSYN L I SQ +Q+LE+L+LSHN+LSG IP F++M AL +D+S+N
Sbjct: 597 LSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHN 656
Query: 683 ELRGPIPNSTAFRDAPIKALQGNKGLCGDF---KGLPSCKALKSNK-QASRKIWIVVLFP 738
L+GPIP++ AFR+AP A +GNK LCG +GL C S K R + I +L P
Sbjct: 657 NLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVP 716
Query: 739 LLGIVALLISLIGLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDF 798
++G + +L G+F F++R + + S L S+ +F+GK+ Y+EII+AT +F
Sbjct: 717 IIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETL-SIFSFDGKVRYQEIIKATGEF 775
Query: 799 DDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMT---FQQEFLNEVKALTEIRHR 855
D ++ IG GG G VYK +L + I+AVKK + ++ +QEFLNE++ALTEIRHR
Sbjct: 776 DPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHR 834
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
N+VK +GFCSH +++F+VYEY+E GSL +L ND A+ L+W +R++V+KG+A ALSY+H
Sbjct: 835 NVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMH 894
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 975
+D P IVHRDISS N+LL EA++SDFG AK LKPDSSNW+ +AGTYGYVAPELAY
Sbjct: 895 HDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYA 954
Query: 976 MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035
MKVTEKCDVYSFGVL LEVIKG+HPGD +S +SSS + ++L I D RLP P+ ++E
Sbjct: 955 MKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKE 1014
Query: 1036 KLISFVEVAISCLDESPESRPTMQKVS 1062
+++ ++VA+ CL P++RPTM +S
Sbjct: 1015 EVLEILKVALLCLHSDPQARPTMLSIS 1041
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 632 bits (1631), Expect = e-180, Method: Compositional matrix adjust.
Identities = 417/1092 (38%), Positives = 580/1092 (53%), Gaps = 73/1092 (6%)
Query: 2 EEAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLK 61
EE LL +K L N +NG L+SW N C W GI C H V S++L + L
Sbjct: 26 EEGRVLLEFKAFL-NDSNGY-LASW---NQLDSNPCNWTGIACTHLRTVTSVDLNGMNLS 80
Query: 62 GTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLS 121
GTL L L++ +N + G IP + L+ LDL +N F G IP Q+ +
Sbjct: 81 GTLSPL-ICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMII 139
Query: 122 YLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLL 181
LK L+L +N L GSIP ++G LSSL L +YSN L +IP S+ L L + N
Sbjct: 140 TLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGF 199
Query: 182 SGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLK 241
SG IPSEI + L L L N L GS+P+ L L NL L L N L G IP +GN+
Sbjct: 200 SGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNIS 259
Query: 242 YLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKF 301
L L L +N GSIP + LT + LY+Y N L+G IP EIGNL ++I S N+
Sbjct: 260 RLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQL 319
Query: 302 SGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLT 361
+G IP G++ N+ L L N L G IP EL L L L+L N+L G+IP L L
Sbjct: 320 TGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLP 379
Query: 362 NLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL 421
L L +++N L G IP IG + S L+++ N L+ IP L +LS N L
Sbjct: 380 YLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKL 439
Query: 422 SGAIPKEYRNLVKLTKLFLGDNQFQGPIP----NLKNLTSLVRVHLDRNYLTSNISESFY 477
SG IP++ + LTKL LGDNQ G +P NL+NLT+L
Sbjct: 440 SGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTAL------------------- 480
Query: 478 IYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSS 537
+L N L G IS+D G+ L L + NN TG IPP+IG +++ ++SS
Sbjct: 481 --------ELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISS 532
Query: 538 NHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLG 597
N + G IP ELG + +L L+ N+ SG ++ +LG LV LE L LS N L+ IP S G
Sbjct: 533 NQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFG 592
Query: 598 NLVKLHYLNLSNNQFSWEIPIKLEELIHLS-ELDLSYNFLGRAIPSQICIMQSLEKLNLS 656
+L +L L L N S IP++L +L L L++S+N L IP + +Q LE L L+
Sbjct: 593 DLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLN 652
Query: 657 HNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLP 716
N LSG IP + +L +IS N L G +P++ F+ GN GLC +
Sbjct: 653 DNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRS-- 710
Query: 717 SCKALKSNKQ---------ASRKIWIVVLFPLLGIVALLISLIGLFFKFQRRKN-----K 762
C+ L + + R+ + + ++G V LI+ +GL + +RR+ +
Sbjct: 711 HCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSV-FLITFLGLCWTIKRREPAFVALE 769
Query: 763 SQTKQSSPRNTPGLRSMLTFEGK-IVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGE 821
QTK P + F K Y+ ++ AT +F ++ +G+G G+VYK E++ GE
Sbjct: 770 DQTK-------PDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGE 822
Query: 822 IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGS 881
+IAVKK +S G + F E+ L +IRHRNIVK YGFC H + ++YEY+ GS
Sbjct: 823 VIAVKKLNSRGEGASS-DNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGS 881
Query: 882 LAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEAR 941
L L L+W R + G A+ L YLH+DC P IVHRDI S N+LLD + +A
Sbjct: 882 LGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAH 941
Query: 942 VSDFGIAKFLKPD-SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
V DFG+AK + S + + +AG+YGY+APE AYTMKVTEKCD+YSFGV+ LE+I GK P
Sbjct: 942 VGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPP 1001
Query: 1001 -------GDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPE 1053
GD ++ + S N+ I E+ D RL ++ +++A+ C SP
Sbjct: 1002 VQPLEQGGDLVNWVRRSIRNM-IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPA 1060
Query: 1054 SRPTMQKVSQLL 1065
SRPTM++V ++
Sbjct: 1061 SRPTMREVVAMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 621 bits (1602), Expect = e-177, Method: Compositional matrix adjust.
Identities = 405/1085 (37%), Positives = 586/1085 (54%), Gaps = 58/1085 (5%)
Query: 3 EAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCNH---GGRVNSINLTSIG 59
E LL K+ + L +W N+ C W G+ C++ V S+NL+S+
Sbjct: 30 EGQYLLEIKSKFVDAKQN--LRNWNSNDSVP---CGWTGVMCSNYSSDPEVLSLNLSSMV 84
Query: 60 LKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGH 119
L G L S HL LDL N L G IP +IGN S L+ L L++N F G IP +IG
Sbjct: 85 LSGKLSP-SIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGK 143
Query: 120 LSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
L L+ L ++ N++SGS+P+E+G L SL+ L YSN + +P S+GNL L + N
Sbjct: 144 LVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQN 203
Query: 180 LLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGN 239
++SGS+PSEIG + L+ L L N+L+G +P+ +G L L+ + L N G IP E+ N
Sbjct: 204 MISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISN 263
Query: 240 LKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYN 299
L L L N+L G IP L +L +L LY+Y N L+G IP EIGNL + +I S N
Sbjct: 264 CTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSEN 323
Query: 300 KFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGN 359
+G IP LGN+ + L+L N L G IP EL LK+LS L+L N L G IP
Sbjct: 324 ALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQY 383
Query: 360 LTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKN 419
L L +L ++ NSLSG+IP ++G L L+++ N L+ IP L +N+ +L+ N
Sbjct: 384 LRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTN 443
Query: 420 SLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIY 479
+LSG IP + +LV++ L RN L +
Sbjct: 444 NLSGNIPT-----------------------GITTCKTLVQLRLARNNLVGRFPSNLCKQ 480
Query: 480 PNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNH 539
N+T I+L N G I + G C L L + N TG +P +IG SQL L++SSN
Sbjct: 481 VNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNK 540
Query: 540 VVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNL 599
+ G++P+E+ L +L + N SG L ++G L QLE L LS+NNLS IP +LGNL
Sbjct: 541 LTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNL 600
Query: 600 VKLHYLNLSNNQFSWEIPIKLEELIHLS-ELDLSYNFLGRAIPSQICIMQSLEKLNLSHN 658
+L L + N F+ IP +L L L L+LSYN L IP ++ + LE L L++N
Sbjct: 601 SRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNN 660
Query: 659 SLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCG-------- 710
+LSG IP F + +L + SYN L GPIP R+ + + GN+GLCG
Sbjct: 661 NLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQ 717
Query: 711 DFKGLPSCKALKSNKQASRKIWIVVLFPLLGIVALLISLIGLFFKFQRRKNKSQTKQSSP 770
PS K S KI + + G+ +LI+LI + R S + P
Sbjct: 718 TQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQP 777
Query: 771 RNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHS 830
L + +++++ AT++FD+ +G+G G+VYK L +G +AVKK S
Sbjct: 778 SEM-SLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLAS 836
Query: 831 PLPG--EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSN 888
G F E+ L IRHRNIVK +GFC+H + ++YEY+ GSL IL +
Sbjct: 837 NHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHD 896
Query: 889 DAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948
+ +L+W++R + G A L+YLH+DC P I HRDI S N+LLD K EA V DFG+A
Sbjct: 897 PSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 954
Query: 949 KFLK-PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP------- 1000
K + P S + + +AG+YGY+APE AYTMKVTEK D+YS+GV+ LE++ GK P
Sbjct: 955 KVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQG 1014
Query: 1001 GDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQK 1060
GD ++ + S + + +LD RL + + +++ +++A+ C SP +RP+M++
Sbjct: 1015 GDVVNWV-RSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQ 1073
Query: 1061 VSQLL 1065
V +L
Sbjct: 1074 VVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 591 bits (1523), Expect = e-167, Method: Compositional matrix adjust.
Identities = 385/1044 (36%), Positives = 558/1044 (53%), Gaps = 72/1044 (6%)
Query: 80 LWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPL 139
L N L G IP ++GN S L + N+ +G IP ++G L L+ L+L N L+G IP
Sbjct: 198 LQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPS 257
Query: 140 EVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLN 199
++G +S L L+L +N L+ +IP SL +L NL TL L N L+G IP E N+ LLDL
Sbjct: 258 QLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLV 317
Query: 200 LYNNELNGSIPQSL-GNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIP 258
L NN L+GS+P+S+ N +NL L LS L G IP EL + L L L++N L GSIP
Sbjct: 318 LANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIP 377
Query: 259 HSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFL 318
+L L L LY++NN+L G + I NL L + L +N G +P + L + L
Sbjct: 378 EALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVL 437
Query: 319 FLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIP 378
FL N G IP E+ N SL ++++ N G IP +G L L++L + N L G +P
Sbjct: 438 FLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLP 497
Query: 379 CEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKL 438
+GN L+ L+LA N+L+ SIP S L L L Y NSL G +P +L LT++
Sbjct: 498 ASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRI 557
Query: 439 FLGDNQ-----------------------FQGPIP-NLKNLTSLVRVHLDRNYLTSNISE 474
L N+ F+ IP L N +L R+ L +N LT I
Sbjct: 558 NLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPW 617
Query: 475 SFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLD 534
+ L+ +D+S N L G I C KL +D + N ++G IPP +G SQL L
Sbjct: 618 TLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELK 677
Query: 535 LSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPE 594
LSSN V +P EL + L+ L L N L+G + ++G L L L+L N S ++P+
Sbjct: 678 LSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQ 737
Query: 595 SLGNLVKLHYLNLSNNQFSWEIPIKLEELIHL-SELDLSYNFLGRAIPSQICIMQSLEKL 653
++G L KL+ L LS N + EIP+++ +L L S LDLSYN IPS I + LE L
Sbjct: 738 AMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETL 797
Query: 654 NLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFK 713
+LSHN L+G +P +M +L +++S+N L G + F P + GN GLCG
Sbjct: 798 DLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL--KKQFSRWPADSFLGNTGLCG--S 853
Query: 714 GLPSCKALKSNKQ----ASRKIWIVVLFPLLGIVALLISLIGLFFKFQRRKNKSQTKQSS 769
L C ++SN + ++R + I+ L + L+I +I LFFK QR + S
Sbjct: 854 PLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFK-QRHDFFKKVGHGS 912
Query: 770 PRNT-----------PGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELA 818
T P R+ + + I +E+I+ AT++ +E IG GG G VYK EL
Sbjct: 913 TAYTSSSSSSQATHKPLFRNGAS-KSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELE 971
Query: 819 SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH--SFIVYEY 876
+GE +AVKK ++ + F EVK L IRHR++VK G+CS + ++YEY
Sbjct: 972 NGETVAVKKIL--WKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEY 1029
Query: 877 LEMGSLAMILSNDAAAED-----LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKN 931
++ GS+ L D + L+W R+ + G+A + YLH+DC PPIVHRDI S N
Sbjct: 1030 MKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSN 1089
Query: 932 VLLDFKNEARVSDFGIAKFLKP------DSSNWTELAGTYGYVAPELAYTMKVTEKCDVY 985
VLLD EA + DFG+AK L DS+ W A +YGY+APE AY++K TEK DVY
Sbjct: 1090 VLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTW--FACSYGYIAPEYAYSLKATEKSDVY 1147
Query: 986 SFGVLALEVIKGKHPGDFI-----SLISSSSLNLNI---ALDEILDPRLPIPSHNVQEKL 1037
S G++ +E++ GK P D + ++ +L + A D+++DP+L ++
Sbjct: 1148 SMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAA 1207
Query: 1038 ISFVEVAISCLDESPESRPTMQKV 1061
+E+A+ C SP+ RP+ ++
Sbjct: 1208 CQVLEIALQCTKTSPQERPSSRQA 1231
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 574 bits (1480), Expect = e-162, Method: Compositional matrix adjust.
Identities = 379/1012 (37%), Positives = 543/1012 (53%), Gaps = 26/1012 (2%)
Query: 78 LDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSI 137
LDL S L G + P IG + L YL+L+ N +G IP +IG+ S L+ + L NQ GSI
Sbjct: 90 LDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSI 149
Query: 138 PLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLD 197
P+E+ LS L + + +N L +P +G+L NL L Y N L+G +P +GNL L
Sbjct: 150 PVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTT 209
Query: 198 LNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSI 257
N+ +G+IP +G NL +L L+ N + G +P E+G L L ++ L NK +G I
Sbjct: 210 FRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFI 269
Query: 258 PHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAF 317
P + NLT+L L +Y NSL G IPSEIGN+K L K+ L N+ +G IP LG LS +
Sbjct: 270 PKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVME 329
Query: 318 LFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSI 377
+ N L G IP EL + L +L L NKL G IP+ L L NL+ L + NSL+G I
Sbjct: 330 IDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPI 389
Query: 378 PCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTK 437
P NL S+ L L N L+ IP L + L V+ F +N LSG IP L
Sbjct: 390 PPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLIL 449
Query: 438 LFLGDNQFQGPI-PNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEI 496
L LG N+ G I P + SL+++ + N LT NL+ I+L N G +
Sbjct: 450 LNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPL 509
Query: 497 SSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIK 556
+ G C KL L + N + N+P +I S L ++SSN + G IP+E+ L +
Sbjct: 510 PPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQR 569
Query: 557 LILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEI 616
L L++N G L P+LG L QLE L LS N S IP ++GNL L L + N FS I
Sbjct: 570 LDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSI 629
Query: 617 PIKLEELIHLS-ELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQ 675
P +L L L ++LSYN IP +I + L L+L++N LSG IP FE + +L
Sbjct: 630 PPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLL 689
Query: 676 CIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCG--------DFKGLPSCKALKSNKQA 727
+ SYN L G +P++ F++ + + GNKGLCG P +LK+
Sbjct: 690 GCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSAR 749
Query: 728 SRKIWIVVLFPLLGIVALLISLIGLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIV 787
+I I+V + GI LLI+++ F + P + E +
Sbjct: 750 RGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKE-RFT 808
Query: 788 YEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFH----SPLPGEMTFQQEFL 843
++I+ AT F D + +G+G G+VYK + SG+ IAVKK F
Sbjct: 809 VKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFR 868
Query: 844 NEVKALTEIRHRNIVKFYGFCSH--AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRM 901
E+ L +IRHRNIV+ Y FC H + + ++YEY+ GSL +L + + ++W R
Sbjct: 869 AEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELL-HGGKSHSMDWPTRF 927
Query: 902 SVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK-PDSSNWTE 960
++ G A+ L+YLH+DC P I+HRDI S N+L+D EA V DFG+AK + P S + +
Sbjct: 928 AIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSA 987
Query: 961 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP------GDFISLISSSSLNL 1014
+AG+YGY+APE AYTMKVTEKCD+YSFGV+ LE++ GK P G ++ + + +
Sbjct: 988 VAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRD 1047
Query: 1015 NIALDEILDPRL-PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+ EILDP L + + +I+ ++A+ C SP RPTM++V +L
Sbjct: 1048 HSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 560 bits (1442), Expect = e-158, Method: Compositional matrix adjust.
Identities = 416/1211 (34%), Positives = 591/1211 (48%), Gaps = 187/1211 (15%)
Query: 14 LQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGR-VNSINLTSIGLKGTLHDFSFSSF 72
L++ N+GSP C W G+ C GGR + +NL+ +GL G++ S F
Sbjct: 50 LRDWNSGSP------------SYCNWTGVTC--GGREIIGLNLSGLGLTGSISP-SIGRF 94
Query: 73 PHLAYLDLWSNQLFG-------------------------NIPPQIGNISKLKYLDLSSN 107
+L ++DL SN+L G +IP Q+G++ LK L L N
Sbjct: 95 NNLIHIDLSSNRLVGPIPTTLSNLSSSLESLHLFSNLLSGDIPSQLGSLVNLKSLKLGDN 154
Query: 108 LFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGN 167
+G IP G+L L+ L L +L+G IP G L L L L N LE IP +GN
Sbjct: 155 ELNGTIPETFGNLVNLQMLALASCRLTGLIPSRFGRLVQLQTLILQDNELEGPIPAEIGN 214
Query: 168 LT------------------------NLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNN 203
T NL TL L +N SG IPS++G+L + LNL N
Sbjct: 215 CTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGN 274
Query: 204 ELNGSIPQSLGNLSNLAMLNLSSNSLFG-------------------------------- 231
+L G IP+ L L+NL L+LSSN+L G
Sbjct: 275 QLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICS 334
Query: 232 -----------------SIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYN 274
IP+E+ N + L L L++N L G IP SL L L LY+ N
Sbjct: 335 NNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNN 394
Query: 275 NSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELR 334
NSL G + S I NL L + L +N G +P +G L + ++L N G +P E+
Sbjct: 395 NSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIG 454
Query: 335 NLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAF 394
N L ++ N+L G IP +G L +L+ L + N L G+IP +GN ++ ++LA
Sbjct: 455 NCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLAD 514
Query: 395 NKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKL------FLG------- 441
N+L+ SIP S LT L + Y NSL G +P NL LT++ F G
Sbjct: 515 NQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCG 574
Query: 442 ----------DNQFQGPIP-NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYN 490
+N F+G IP L T+L R+ L +N T I +F L+ +D+S N
Sbjct: 575 SSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRN 634
Query: 491 NLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGK 550
+L G I + G C KL +D + N ++G IP +G L L LSSN VG +P E+
Sbjct: 635 SLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFS 694
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
L+ ++ L L N L+G + ++G L L L+L N LS +P ++G L KL L LS N
Sbjct: 695 LTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRN 754
Query: 611 QFSWEIPIKLEELIHL-SELDLSY-NFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCF 668
+ EIP+++ +L L S LDLSY NF GR IPS I + LE L+LSHN L G +P
Sbjct: 755 ALTGEIPVEIGQLQDLQSALDLSYNNFTGR-IPSTISTLPKLESLDLSHNQLVGEVPGQI 813
Query: 669 EEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLPSCKALKSNKQAS 728
+M +L +++SYN L G + F A GN GLCG L C S Q S
Sbjct: 814 GDMKSLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAGLCG--SPLSHCNRAGSKNQRS 869
Query: 729 ---RKIWIVVLFPLLGIVALLISLIGLFFK-----FQR-RKNKSQTKQSSPRNTPGLRSM 779
+ + I+ L +AL++ +I LFFK F++ R S +S + L S
Sbjct: 870 LSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSN 929
Query: 780 LTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQ 839
+ I +++I+ AT+ ++E IG GG G VYK EL +GE IAVKK ++
Sbjct: 930 GGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKIL--WKDDLMSN 987
Query: 840 QEFLNEVKALTEIRHRNIVKFYGFCSHAQH--SFIVYEYLEMGSLAMIL---SNDAAAED 894
+ F EVK L IRHR++VK G+CS + ++YEY+ GS+ L N E
Sbjct: 988 KSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEV 1047
Query: 895 LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954
L W R+ + G+A + YLH DC PPIVHRDI S NVLLD EA + DFG+AK L +
Sbjct: 1048 LGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGN 1107
Query: 955 SSNWTE----LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSS 1010
TE AG+YGY+APE AY++K TEK DVYS G++ +E++ GK P + +
Sbjct: 1108 YDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTE---AMFDE 1164
Query: 1011 SLNLNIALDEILDPRLPIPSHNVQEKLI----------------SFVEVAISCLDESPES 1054
++ ++ +LD P +EKLI +E+A+ C P+
Sbjct: 1165 ETDMVRWVETVLDTP---PGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQE 1221
Query: 1055 RPTMQKVSQLL 1065
RP+ ++ S+ L
Sbjct: 1222 RPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 553 bits (1426), Expect = e-156, Method: Compositional matrix adjust.
Identities = 395/1093 (36%), Positives = 574/1093 (52%), Gaps = 98/1093 (8%)
Query: 3 EAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGR--VNSINLTSIGL 60
E AL+ W S +N P S ++ N + C W I C+ V IN+ S+ L
Sbjct: 39 EVSALISWLHS----SNSPPPSVFSGWNPSDSDPCQWPYITCSSSDNKLVTEINVVSVQL 94
Query: 61 KGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHL 120
+ SSF L L + + L G I +IG+ S+L +DLSSN G IP +G L
Sbjct: 95 ALPFPP-NISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKL 153
Query: 121 SYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTL-CLYNN 179
L+ L L N L+G IP E+G SL NL ++ NYL + +P LG ++ L ++ N+
Sbjct: 154 KNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNS 213
Query: 180 LLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGN 239
LSG IP EIGN + L L L +++GS+P SLG LS L L++ S L G IP ELGN
Sbjct: 214 ELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGN 273
Query: 240 LKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYN 299
L +L L DN L+G++P L L NL + ++ N+L G IP EIG +K L+ I LS N
Sbjct: 274 CSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMN 333
Query: 300 KFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGN 359
FSG IP S GNLSN+ L L SN++ G IPS L N L ++ N++ G IP +G
Sbjct: 334 YFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGL 393
Query: 360 LTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKN 419
L L++ + N L G+IP E+ ++L L+L+ N LT S+P L L NL+ L N
Sbjct: 394 LKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISN 453
Query: 420 SLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIY 479
++SG IP E N L +L L +N+ G IP +
Sbjct: 454 AISGVIPLEIGNCTSLVRLRLVNNRITGEIP-----------------------KGIGFL 490
Query: 480 PNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNH 539
NL+F+DLS NNL G + + C +L L+ S N + G +P + ++L+VLD+SSN
Sbjct: 491 QNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSND 550
Query: 540 VVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNL 599
+ G IP LG L L +LIL++N +G++ LG L+ LDLSSNN+S IPE L ++
Sbjct: 551 LTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDI 610
Query: 600 VKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNS 659
L L+LS+N L IP +I + L L++SHN
Sbjct: 611 QDLDI-----------------------ALNLSWNSLDGFIPERISALNRLSVLDISHNM 647
Query: 660 LSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLPSCK 719
LSG + + L ++IS+N G +P+S FR ++GN GLC KG SC
Sbjct: 648 LSGDL-SALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCS--KGFRSCF 704
Query: 720 ALKSNKQASR--------KIWIVVLFPLLGIVALLISLIGLFFK-FQRRKNKSQTKQS-- 768
S++ ++ +I I +L + ++A+L L + K R N S+T ++
Sbjct: 705 VSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLW 764
Query: 769 SPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKF 828
+ + TP + L F + V + ++ + IGKG G VYK E+ + E+IAVKK
Sbjct: 765 TWQFTPFQK--LNFTVEHVLKCLVEG-------NVIGKGCSGIVYKAEMPNREVIAVKKL 815
Query: 829 HS---PLPGEMT----FQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGS 881
P E T + F EVK L IRH+NIV+F G C + ++Y+Y+ GS
Sbjct: 816 WPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGS 875
Query: 882 LAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEAR 941
L +L + L W R +I G A L+YLH+DC PPIVHRDI + N+L+ E
Sbjct: 876 LGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPY 935
Query: 942 VSDFGIAKFLK----PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG 997
+ DFG+AK + SSN +AG+YGY+APE Y+MK+TEK DVYS+GV+ LEV+ G
Sbjct: 936 IGDFGLAKLVDDGDFARSSN--TIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTG 993
Query: 998 KHP-----GDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESP 1052
K P D + ++ +I +++D L + E+++ + VA+ C++ P
Sbjct: 994 KQPIDPTIPDGLHIVDWVKKIRDI---QVIDQGLQARPESEVEEMMQTLGVALLCINPIP 1050
Query: 1053 ESRPTMQKVSQLL 1065
E RPTM+ V+ +L
Sbjct: 1051 EDRPTMKDVAAML 1063
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 546 bits (1406), Expect = e-154, Method: Compositional matrix adjust.
Identities = 374/1065 (35%), Positives = 557/1065 (52%), Gaps = 83/1065 (7%)
Query: 26 WTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQL 85
+ +N++ W I C+ G + I++ S+ L+ +L + +F L L + L
Sbjct: 59 FNWNSIDNTPCNNWTFITCSSQGFITDIDIESVPLQLSLPK-NLPAFRSLQKLTISGANL 117
Query: 86 FGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLS 145
G +P +G+ LK LDLSSN G IP + L L+TL L NQL+G IP ++ S
Sbjct: 118 TGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCS 177
Query: 146 SLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNL-YNNE 204
L +L L++NLL+GSIP+E+G L L + + N E
Sbjct: 178 KLK------------------------SLILFDNLLTGSIPTELGKLSGLEVIRIGGNKE 213
Query: 205 LNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNL 264
++G IP +G+ SNL +L L+ S+ G++PS LG LK L L + ++G IP L N
Sbjct: 214 ISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNC 273
Query: 265 TNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNS 324
+ LV L++Y NSLSG IP EIG L L ++ L N G IP +GN SN+ + L N
Sbjct: 274 SELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNL 333
Query: 325 LFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNL 384
L G IPS + L L + +NK GSIP + N ++L L + N +SG IP E+G L
Sbjct: 334 LSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTL 393
Query: 385 KSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQ 444
L+ N+L SIP L++ T+L L +NSL+G IP L LTKL L N
Sbjct: 394 TKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNS 453
Query: 445 FQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRC 503
G IP + N +SLVR+ L N +T I + F+D S N L+G++ + G C
Sbjct: 454 LSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSC 513
Query: 504 PKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQ 563
+L +D S N++ G++P + S L+VLD+S+N G IPA LG+L L KLIL++N
Sbjct: 514 SELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNL 573
Query: 564 LSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHY-LNLSNNQFSWEIPIKLEE 622
SG + LG+ L+ LDL SN LS IP LG++ L LNLS+N+ + +IP K+
Sbjct: 574 FSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIAS 633
Query: 623 LIHLSELDLSYNFL-GRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISY 681
L LS LDLS+N L G P + +++L LN+S+NS SG
Sbjct: 634 LNKLSILDLSHNMLEGDLAP--LANIENLVSLNISYNSFSGY------------------ 673
Query: 682 NELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLPSC-------KALKSNKQASRKIWIV 734
+P++ FR + L+GNK LC + SC L + ASR +
Sbjct: 674 ------LPDNKLFRQLSPQDLEGNKKLCSSTQD--SCFLTYRKGNGLGDDGDASRTRKLR 725
Query: 735 VLFPLLGIVALLISLIGLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRA 794
+ LL + +++ ++G + R+N + S T + + ++IIR
Sbjct: 726 LTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRC 785
Query: 795 TNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPL------PGEMTFQQEFLNEVKA 848
+ + IGKG G VY+ ++ +GE+IAVKK + + F EVK
Sbjct: 786 ---LVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKT 842
Query: 849 LTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIA 908
L IRH+NIV+F G C + ++Y+Y+ GSL +L ++ L+W R ++ G A
Sbjct: 843 LGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL-HERRGSSLDWDLRYRILLGAA 901
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE--LAGTYG 966
L+YLH+DC PPIVHRDI + N+L+ E ++DFG+AK + +AG+YG
Sbjct: 902 QGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYG 961
Query: 967 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGD-----FISLISSSSLNLNIALDEI 1021
Y+APE Y+MK+TEK DVYS+GV+ LEV+ GK P D I L+ + N E+
Sbjct: 962 YIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLV--DWVRQNRGSLEV 1019
Query: 1022 LDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
LD L + ++++ + A+ C++ SP+ RPTM+ V+ +LK
Sbjct: 1020 LDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLK 1064
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 526 bits (1356), Expect = e-148, Method: Compositional matrix adjust.
Identities = 402/1160 (34%), Positives = 577/1160 (49%), Gaps = 154/1160 (13%)
Query: 37 CAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNI 96
C WVG+ C G RVNS++L S+ L+G + SS +L L L NQ G IPP+I N+
Sbjct: 55 CDWVGVTCLLG-RVNSLSLPSLSLRGQIPK-EISSLKNLRELCLAGNQFSGKIPPEIWNL 112
Query: 97 SKLK------------------------YLDLSSNLFSGAIPPQIG-HLSYLKTLHLFKN 131
L+ YLDLS N FSG++PP L L +L + N
Sbjct: 113 KHLQTLDLSGNSLTGLLPRLLSELPQLLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNN 172
Query: 132 QLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGN 191
LSG IP E+G LS+L+NL + N IP +GN++ L + +G +P EI
Sbjct: 173 SLSGEIPPEIGKLSNLSNLYMGLNSFSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISK 232
Query: 192 LKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADN 251
LK+L L+L N L SIP+S G L NL++LNL S L G IP ELGN K L L L+ N
Sbjct: 233 LKHLAKLDLSYNPLKCSIPKSFGELHNLSILNLVSAELIGLIPPELGNCKSLKSLMLSFN 292
Query: 252 KLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGN 311
L+G +P L + L+ N LSG +PS +G K L + L+ N+FSG IPH + +
Sbjct: 293 SLSGPLPLELSEIP-LLTFSAERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIED 351
Query: 312 LSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNN 371
+ L L SN L G IP EL SL ++L N L G+I ++L L + NN
Sbjct: 352 CPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNN 411
Query: 372 SLSGSIP-----------------------------------------------CEIGNL 384
++GSIP EIGN
Sbjct: 412 QINGSIPEDLWKLPLMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNA 471
Query: 385 KSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQ 444
SL L L+ N+LT IP + LT+LSVL+ N G IP E + LT L LG N
Sbjct: 472 ASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNN 531
Query: 445 FQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIY------PNLTFI------DLSYNN 491
QG IP+ + L L + L N L+ +I Y P+L+F+ DLSYN
Sbjct: 532 LQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNR 591
Query: 492 LYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKL 551
L G I + G C L + S N+++G IP + + L +LDLS N + G IP E+G
Sbjct: 592 LSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNS 651
Query: 552 SFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQ 611
L L LA NQL+G + GLL L L+L+ N L +P SLGNL +L +++LS N
Sbjct: 652 LKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNN 711
Query: 612 FSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEM 671
S E+ +L + L L + N IPS++ + LE L++S N LSG IP +
Sbjct: 712 LSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGL 771
Query: 672 HALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLPSCKALKSNKQASRKI 731
L+ ++++ N LRG +P+ +D L GNK LCG G CK ++ K R
Sbjct: 772 PNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVG-SDCK-IEGTKL--RSA 827
Query: 732 WIVVLFPLLGIVALLI--SLIGLFFKFQRRKNKSQTKQSSPRNTP--------------- 774
W GI L++ ++I F F R+ + TK+ R+ P
Sbjct: 828 W--------GIAGLMLGFTIIVFVFVFSLRR-WAMTKRVKQRDDPERMEESRLKGFVDQN 878
Query: 775 -----GLRS-------MLTFEG---KIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELAS 819
G RS + FE K+ +I+ AT+ F ++ IG GG G+VYK L
Sbjct: 879 LYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPG 938
Query: 820 GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879
+ +AVKK + +EF+ E++ L +++H N+V G+CS ++ +VYEY+
Sbjct: 939 EKTVAVKKLSE---AKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVN 995
Query: 880 GSLAMILSNDAAA-EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN 938
GSL L N E L+W++R+ + G A L++LH+ P I+HRDI + N+LLD
Sbjct: 996 GSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDF 1055
Query: 939 EARVSDFGIAKFLKP-DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG 997
E +V+DFG+A+ + +S T +AGT+GY+ PE + + T K DVYSFGV+ LE++ G
Sbjct: 1056 EPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTG 1115
Query: 998 KHP----------GDFISLISSSSLNLNIALDEILDPRL-PIPSHNVQEKLISFVEVAIS 1046
K P G+ + + +N A+D ++DP L + N Q +L+ ++A+
Sbjct: 1116 KEPTGPDFKESEGGNLVGW-AIQKINQGKAVD-VIDPLLVSVALKNSQLRLL---QIAML 1170
Query: 1047 CLDESPESRPTMQKVSQLLK 1066
CL E+P RP M V + LK
Sbjct: 1171 CLAETPAKRPNMLDVLKALK 1190
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1067 | ||||||
| 297846638 | 1123 | hypothetical protein ARALYDRAFT_473694 [ | 0.989 | 0.940 | 0.494 | 0.0 | |
| 15219699 | 1120 | putative leucine-rich repeat receptor-li | 0.986 | 0.940 | 0.489 | 0.0 | |
| 357439013 | 1131 | Receptor protein kinase-like protein [Me | 0.989 | 0.933 | 0.476 | 0.0 | |
| 356577797 | 1204 | PREDICTED: probable LRR receptor-like se | 0.986 | 0.874 | 0.458 | 0.0 | |
| 147767326 | 1032 | hypothetical protein VITISV_008862 [Viti | 0.842 | 0.871 | 0.538 | 0.0 | |
| 224145445 | 1163 | predicted protein [Populus trichocarpa] | 0.990 | 0.908 | 0.475 | 0.0 | |
| 359484864 | 1091 | PREDICTED: probable LRR receptor-like se | 0.940 | 0.920 | 0.473 | 0.0 | |
| 359491509 | 1032 | PREDICTED: probable LRR receptor-like se | 0.842 | 0.871 | 0.533 | 0.0 | |
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.841 | 0.865 | 0.526 | 0.0 | |
| 147772402 | 996 | hypothetical protein VITISV_022117 [Viti | 0.831 | 0.890 | 0.529 | 0.0 |
| >gi|297846638|ref|XP_002891200.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] gi|297337042|gb|EFH67459.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 989 bits (2557), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 542/1095 (49%), Positives = 720/1095 (65%), Gaps = 39/1095 (3%)
Query: 1 MEEAHALLRWKTSLQNHNNGSPLSSWTFN-NVTKIGSC-AWVGIHCNHGGRVNSINLTSI 58
+ EA+ALL+WK++ N ++ S LSSW + N SC +W G+ CN G + +NLT
Sbjct: 31 IAEANALLKWKSTFTNQSHSSKLSSWVNDANTNPSFSCTSWYGVFCNSRGSIEKLNLTDN 90
Query: 59 GLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIG 118
++GT DF FSS P+LA +DL N+ G IPPQ GN+SKL Y DLS+N + IPP +G
Sbjct: 91 AIEGTFQDFPFSSLPNLASIDLSMNRFSGTIPPQFGNLSKLIYFDLSTNHLTREIPPSLG 150
Query: 119 HLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYN 178
+L L L L N L+G IP ++G + S+ L L N L IP SLGNL NL L LY
Sbjct: 151 NLKNLTVLDLHHNYLTGVIPPDLGNMESMTYLELSHNKLTGSIPSSLGNLKNLTVLYLYQ 210
Query: 179 NLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELG 238
N L+G IP E+GN++ ++DL L N+L GSIP SLGNL NL +L L N L G IP ELG
Sbjct: 211 NYLTGVIPPELGNMESMIDLELSTNKLTGSIPSSLGNLKNLTVLYLHHNYLTGVIPPELG 270
Query: 239 NLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSY 298
N++ + DL+L+DNKL GSIP SL NL NL +LY+Y N L+G+IP E+GN++ ++ + LS
Sbjct: 271 NMESMIDLELSDNKLTGSIPSSLGNLKNLTVLYLYKNYLTGVIPPELGNMESMTYLDLSE 330
Query: 299 NKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLG 358
NK +G IP SLGNL N+ L+L N L G+IP EL NL+S+ LEL +NKL GSIP LG
Sbjct: 331 NKLTGSIPSSLGNLKNLTVLYLHHNYLTGVIPPELGNLESMIDLELSDNKLTGSIPSSLG 390
Query: 359 NLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYK 418
NL NL+VL++++N L+G IP E+GN++S+ L L+ N LT SIP S N T L L
Sbjct: 391 NLKNLTVLYLHHNYLTGVIPPELGNMESMIDLALSQNNLTGSIPSSFGNFTKLESLYLRD 450
Query: 419 NSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIP-------------------------NLK 453
N LSG IP+ N +LT+L L N F G +P +L+
Sbjct: 451 NHLSGTIPRGVANSSELTELLLDINNFTGFLPENICKGGKLQNFSLDYNHLEGHIPKSLR 510
Query: 454 NLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSK 513
+ SL+R N NISE+F +YP+L FIDLS+N GEISS+W + PKLGAL S
Sbjct: 511 DCKSLIRAKFVGNKFIGNISEAFGVYPDLDFIDLSHNKFNGEISSNWQKSPKLGALIMSN 570
Query: 514 NNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLG 573
NNITG IPP+I QL LDLS+N++ G++P +G L+ L KL+L N+LSG++ L
Sbjct: 571 NNITGAIPPEIWNMKQLGELDLSTNNLTGELPEAIGNLTGLSKLLLNGNKLSGRVPTGLS 630
Query: 574 LLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSY 633
L LE LDLSSN S+ IP++ + +KLH +NLS N F IP L +L L+ LDLS+
Sbjct: 631 FLTNLESLDLSSNRFSSQIPQTFDSFLKLHEMNLSKNNFDGRIP-GLTKLTQLTHLDLSH 689
Query: 634 NFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTA 693
N L IPSQ+ +QSL+KLNLSHN+LSG IP FE M AL IDIS N+L GP+P++ A
Sbjct: 690 NQLDGEIPSQLSSLQSLDKLNLSHNNLSGFIPTTFESMKALTFIDISNNKLEGPLPDNPA 749
Query: 694 FRDAPIKALQGNKGLCGDF--KGLPSCKAL-KSNKQASRKIWIVVLFPLLGIVALLISLI 750
F++A AL+GN+GLC + + L SC+ K K + +WI+V P+LG + +L S+
Sbjct: 750 FQNATSDALEGNRGLCSNIPKQRLKSCRGFQKPKKNGNLLVWILV--PILGALVIL-SIC 806
Query: 751 GLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQG 810
F + RK K +++ T S+ + +GK Y++II +TN+FD + IG GG
Sbjct: 807 AGAFTYYIRKRKPHNGRNTDSETGENMSIFSVDGKFKYQDIIESTNEFDQRYLIGSGGYS 866
Query: 811 SVYKVELASGEIIAVKKFHSPLPGEMT---FQQEFLNEVKALTEIRHRNIVKFYGFCSHA 867
VYK L I+AVK+ H + E++ +QEFLNEV+ALTEIRHRN+VK +GFCSH
Sbjct: 867 KVYKANLPDA-IVAVKRLHDTIDEEISKPVVKQEFLNEVRALTEIRHRNVVKLFGFCSHR 925
Query: 868 QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDI 927
+H+F++YEY+E GSL +L+N+ A+ L WT+R++++KG+A ALSY+H+D PIVHRDI
Sbjct: 926 RHTFLIYEYMEKGSLNKLLANEEEAKRLTWTKRINIVKGVAHALSYMHHDRSTPIVHRDI 985
Query: 928 SSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSF 987
SS N+LLD A++SDFG AK LK DSSNW+ +AGTYGYVAPE AYTMKVTEKCDVYSF
Sbjct: 986 SSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSF 1045
Query: 988 GVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISC 1047
GVL LEVI GKHPGD ++ +SSS ++L I D R+ P +EKLI VEVA+SC
Sbjct: 1046 GVLILEVIMGKHPGDLVASLSSSP-GETLSLRSISDERILEPRGQNREKLIKMVEVALSC 1104
Query: 1048 LDESPESRPTMQKVS 1062
L P+SRPTM +S
Sbjct: 1105 LQADPQSRPTMLSIS 1119
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15219699|ref|NP_174809.1| putative leucine-rich repeat receptor-like protein [Arabidopsis thaliana] gi|75175345|sp|Q9LP24.1|Y1571_ARATH RecName: Full=Probable leucine-rich repeat receptor-like protein kinase At1g35710; Flags: Precursor gi|8778966|gb|AAF79881.1|AC021198_1 Contains similarity to receptor protein kinase-like protein from Arabidopsis thaliana gb|AL161513. It contains a eukaryotic protein kinase domain PF|00069. EST gb|AI997574 comes from this gene [Arabidopsis thaliana] gi|332193703|gb|AEE31824.1| putative leucine-rich repeat receptor-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2459), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 536/1095 (48%), Positives = 717/1095 (65%), Gaps = 42/1095 (3%)
Query: 1 MEEAHALLRWKTSLQNHNNGSPLSSWTF--NNVTKIGSCAWVGIHCNHGGRVNSINLTSI 58
+ EA+ALL+WK++ N S LSSW N T +W G+ CN G + +NLT+
Sbjct: 31 IAEANALLKWKSTFTN---SSKLSSWVHDANTNTSFSCTSWYGVSCNSRGSIEELNLTNT 87
Query: 59 GLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIG 118
G++GT DF F S +LAY+DL N L G IPPQ GN+SKL Y DLS+N +G I P +G
Sbjct: 88 GIEGTFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLG 147
Query: 119 HLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYN 178
+L L L+L +N L+ IP E+G + S+ +LAL N L IP SLGNL NL+ L LY
Sbjct: 148 NLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYE 207
Query: 179 NLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELG 238
N L+G IP E+GN++ + DL L N+L GSIP +LGNL NL +L L N L G IP E+G
Sbjct: 208 NYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIG 267
Query: 239 NLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSY 298
N++ +++L L+ NKL GSIP SL NL NL +L ++ N L+G IP ++GN++ + + LS
Sbjct: 268 NMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSN 327
Query: 299 NKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLG 358
NK +G IP SLGNL N+ L+L N L G+IP EL N++S+ L+L NNKL GSIP G
Sbjct: 328 NKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFG 387
Query: 359 NLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYK 418
NL NL+ L++Y N L+G IP E+GN++S+ L+L+ NKLT S+P S N T L L
Sbjct: 388 NLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRV 447
Query: 419 NSLSGAIPKEYRNLVKLTKLFLGDNQF------------------------QGPIP-NLK 453
N LSGAIP N LT L L N F +GPIP +L+
Sbjct: 448 NHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLR 507
Query: 454 NLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSK 513
+ SL+R N T +I E+F IYP+L FID S+N +GEISS+W + PKLGAL S
Sbjct: 508 DCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSN 567
Query: 514 NNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLG 573
NNITG IP +I +QL LDLS+N++ G++P +G L+ L +L L NQLSG++ L
Sbjct: 568 NNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLS 627
Query: 574 LLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSY 633
L LE LDLSSNN S+ IP++ + +KLH +NLS N+F IP +L +L L++LDLS+
Sbjct: 628 FLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSH 686
Query: 634 NFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTA 693
N L IPSQ+ +QSL+KL+LSHN+LSG+IP FE M AL +DIS N+L GP+P++
Sbjct: 687 NQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPT 746
Query: 694 FRDAPIKALQGNKGLCGDF--KGLPSCKALKS-NKQASRKIWIVVLFPLLGIVALLISLI 750
FR A AL+ N GLC + + L C+ LK K + +WI+V P+LG++ +L S+
Sbjct: 747 FRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILV--PILGVLVIL-SIC 803
Query: 751 GLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQG 810
F + RK K Q +++ T S+ + +GK Y++II +TN+FD H IG GG
Sbjct: 804 ANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYS 863
Query: 811 SVYKVELASGEIIAVKKFHSPLPGEMT---FQQEFLNEVKALTEIRHRNIVKFYGFCSHA 867
VY+ L IIAVK+ H + E++ +QEFLNEVKALTEIRHRN+VK +GFCSH
Sbjct: 864 KVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHR 922
Query: 868 QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDI 927
+H+F++YEY+E GSL +L+ND A+ L WT+R++V+KG+A ALSY+H+D PIVHRDI
Sbjct: 923 RHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDI 982
Query: 928 SSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSF 987
SS N+LLD A++SDFG AK LK DSSNW+ +AGTYGYVAPE AYTMKVTEKCDVYSF
Sbjct: 983 SSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSF 1042
Query: 988 GVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISC 1047
GVL LE+I GKHPGD +S +SSS ++L I D R+ P +EKL+ VE+A+ C
Sbjct: 1043 GVLILELIIGKHPGDLVSSLSSSP-GEALSLRSISDERVLEPRGQNREKLLKMVEMALLC 1101
Query: 1048 LDESPESRPTMQKVS 1062
L +PESRPTM +S
Sbjct: 1102 LQANPESRPTMLSIS 1116
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357439013|ref|XP_003589783.1| Receptor protein kinase-like protein [Medicago truncatula] gi|355478831|gb|AES60034.1| Receptor protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 929 bits (2402), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/1096 (47%), Positives = 712/1096 (64%), Gaps = 40/1096 (3%)
Query: 3 EAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGR-VNSINLTSIGLK 61
EA ALL+WK SL NH+N + LSSW NN +W GI C++ + +N +NLT IGLK
Sbjct: 36 EADALLKWKASLDNHSN-ALLSSWIGNNPCS----SWEGITCDYKSKSINKVNLTDIGLK 90
Query: 62 GTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLS 121
GTL +FSS + L L +N L+G +P IG +S LK LDLS N SG IP IG+LS
Sbjct: 91 GTLQSLNFSSLTKIHTLVLTNNFLYGVVPHHIGEMSSLKTLDLSVNNLSGTIPNSIGNLS 150
Query: 122 YLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLL 181
+ L L N L+G IP E+ L SL L++ +N L IP +GNL NL L + N L
Sbjct: 151 KISYLDLSFNYLTGIIPFEITQLVSLYFLSMATNQLIGHIPREIGNLVNLERLDIQLNNL 210
Query: 182 SGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLK 241
+GS+P EIG L L +L+L N L+G+IP ++GNLSNL L L N L GSIPSE+GNL
Sbjct: 211 TGSVPQEIGFLTKLAELDLSANYLSGTIPSTIGNLSNLHWLYLYQNHLMGSIPSEVGNLY 270
Query: 242 YLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKF 301
L ++L N L+G IP S+ NL NL + + +N LSG IP IG L L I LS NK
Sbjct: 271 SLFTIQLLGNHLSGPIPSSIGNLVNLNSIRLDHNDLSGEIPISIGKLVNLDTIDLSDNKI 330
Query: 302 SGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLT 361
SG +P ++GNL+ + L+L SN+L G IP + NL +L ++L NKL IP +GNLT
Sbjct: 331 SGPLPSTIGNLTKLTVLYLSSNALTGQIPPSIGNLVNLDTIDLSENKLSRPIPSTVGNLT 390
Query: 362 NLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL 421
+S+L +++N+L+G +P IGN+ +L + L+ NKL+ IP ++ NLT L+ LS + NSL
Sbjct: 391 KVSILSLHSNALTGQLPPSIGNMVNLDTIYLSENKLSGPIPSTIGNLTKLNSLSLFSNSL 450
Query: 422 SGAIPKEYRNLV------------------------KLTKLFLGDNQFQGPIP-NLKNLT 456
+G IPK N+ KLTK +NQF GPIP +LK +
Sbjct: 451 TGNIPKVMNNIANLESLQLASNNFTGHLPLNICAGRKLTKFSASNNQFTGPIPKSLKKCS 510
Query: 457 SLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNI 516
SL+RV L +N +T NI+++F +YPNL +++LS NN YG IS +WG+C L +L S NN+
Sbjct: 511 SLIRVRLQQNQITDNITDAFGVYPNLDYMELSDNNFYGHISPNWGKCKNLTSLQISNNNL 570
Query: 517 TGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLV 576
TG+IP ++G ++QL+ L+LSSNH+ G IP ELG LS LIKL ++ N L G++ ++ L
Sbjct: 571 TGSIPQELGGATQLQELNLSSNHLTGKIPEELGNLSLLIKLSISNNNLLGEVPVQIASLQ 630
Query: 577 QLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFL 636
L L+L NNLS IP LG L +L +LNLS N+F IP++ ++L + +LDLS N +
Sbjct: 631 ALTALELEKNNLSGFIPRRLGRLSELIHLNLSQNKFEGNIPVEFDQLKVIEDLDLSENVM 690
Query: 637 GRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRD 696
IPS + + L+ LNLSHN+LSG IP + EM +L +DISYN+L GPIP+ TAF+
Sbjct: 691 SGTIPSMLGQLNHLQTLNLSHNNLSGTIPLSYGEMLSLTIVDISYNQLEGPIPSITAFQK 750
Query: 697 APIKALQGNKGLCGDFKGLPSCKALKSNKQASRKIWIVVLFPLLGIVALLISLI--GLFF 754
API+AL+ NKGLCG+ GL C N + + I+VL L + LL++ G+ +
Sbjct: 751 APIEALRNNKGLCGNVSGLVCCSTSGGNFHSHKTSNILVLVLPLTLGTLLLAFFAYGISY 810
Query: 755 KFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYK 814
F + + + + T L ++ +F+GK+VYE II AT DFD++H IG GG GSVYK
Sbjct: 811 LFCQTSSTKEDNHAEEFQTENLFAIWSFDGKMVYETIIEATEDFDNKHLIGVGGHGSVYK 870
Query: 815 VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874
EL +G+++AVKK HS EM+ + F NE+ AL EIRHRNIVK YGFCSH HSF+VY
Sbjct: 871 AELPTGQVVAVKKLHSLQNEEMSNLKAFTNEIHALKEIRHRNIVKLYGFCSHRLHSFLVY 930
Query: 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLL 934
E+LE GS+ IL ++ A + +W +R++VIK IA+AL YLH+DC PPIVHRDISSKNV+L
Sbjct: 931 EFLEKGSMDNILKDNEQAAEFDWNRRVNVIKDIANALCYLHHDCSPPIVHRDISSKNVIL 990
Query: 935 DFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 994
D + A VSDFG +KFL P+SSN T AGT+GY APELAYTM+V EKCDVYSFG+L LE+
Sbjct: 991 DLEYVAHVSDFGTSKFLNPNSSNMTSFAGTFGYAAPELAYTMEVNEKCDVYSFGILTLEI 1050
Query: 995 IKGKHPGDFISLI--SSSSLNLNIALD-----EILDPRLPIPSHNVQEKLISFVEVAISC 1047
+ GKHPGD ++ + S +++ LD E LD RLP P++ + +++ S V +A++C
Sbjct: 1051 LFGKHPGDVVTSLWKQPSQSVIDVTLDTMPLIERLDQRLPHPTNTIVQEVASVVRIAVAC 1110
Query: 1048 LDESPESRPTMQKVSQ 1063
L ES SRPTM+ V +
Sbjct: 1111 LAESLRSRPTMEHVCK 1126
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356577797|ref|XP_003557009.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 912 bits (2356), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 536/1170 (45%), Positives = 724/1170 (61%), Gaps = 117/1170 (10%)
Query: 3 EAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLKG 62
EA+ALL+WK+SL N + S LSSW+ NN C W+GI C+ V++INLT++GL+G
Sbjct: 36 EANALLKWKSSLDNQSRAS-LSSWSGNN-----PCIWLGIACDEFNSVSNINLTNVGLRG 89
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSY 122
TL + +FS P++ L++ N L G IPPQIG++SKL LDLS N SG IP IG+LS
Sbjct: 90 TLQNLNFSLLPNILTLNMSHNSLNGTIPPQIGSLSKLARLDLSDNFLSGEIPSTIGNLSN 149
Query: 123 L------------------------KTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLE 158
L ++ L KN+LSGSIP +G LS L+ L++YSN L
Sbjct: 150 LYYLSFYDNSLSGAIPSSIGNLVNLDSMILHKNKLSGSIPFIIGNLSKLSVLSIYSNELT 209
Query: 159 DIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDL-------------------- 198
IP S+GNL N+ +L LY N LSGSIP IGNL L L
Sbjct: 210 GPIPTSIGNLVNMDSLLLYENKLSGSIPFTIGNLSKLSGLYISLNELTGPIPASIGNLVN 269
Query: 199 ----NLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLN 254
L+ N+L+GSIP ++GNLS L+ L++ SN L G IP+ +GNL L + L NKL+
Sbjct: 270 LEAMRLFKNKLSGSIPFNIGNLSKLSKLSIHSNELTGPIPASIGNLVNLDSMILHKNKLS 329
Query: 255 GSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSN 314
GSIP + NL+ +L I N L+G IP+ IGNL L + L NK SG IP ++GNLS
Sbjct: 330 GSIPFIIGNLSKFSVLSISFNELTGPIPASIGNLVHLDSLLLEENKLSGSIPFTIGNLSK 389
Query: 315 IAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLS 374
++ L++ N L G IP+ + NL +L + L NKL GSIP +GNL+ LS L I++N L+
Sbjct: 390 LSGLYISLNELTGPIPASIGNLVNLEAMRLFKNKLSGSIPFTIGNLSKLSKLSIHSNELT 449
Query: 375 GSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVK 434
G IP IGNL L L L NKL+ SIP ++ NL+ LSVLS N L+G+IP NL
Sbjct: 450 GPIPASIGNLVHLDSLLLEENKLSGSIPFTIGNLSKLSVLSISLNELTGSIPSTIGNLSN 509
Query: 435 LTKLFL------------------------------------------------GDNQFQ 446
+ +LF GDN F
Sbjct: 510 VRELFFIGNELGGKIPIEMSMLTALESLQLADNNFIGHLPQNICIGGTLKNFTAGDNNFI 569
Query: 447 GPIP-NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPK 505
GPIP +LKN +SL+RV L RN LT +I+++F + PNL +I+LS NN YG++S +WG+
Sbjct: 570 GPIPVSLKNCSSLIRVRLQRNQLTGDITDAFGVLPNLDYIELSDNNFYGQLSPNWGKFRS 629
Query: 506 LGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLS 565
L +L S NN++G IPP++ +++L+ L LSSNH+ G+IP +L L L L L N L+
Sbjct: 630 LTSLRISNNNLSGVIPPELAGATKLQRLQLSSNHLTGNIPHDLCNLP-LFDLSLDNNNLT 688
Query: 566 GQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIH 625
G + ++ + +L+ L L SN LS IP+ LGNL+ L ++LS N F IP +L +L
Sbjct: 689 GNVPKEIASMQKLQILKLGSNKLSGLIPKQLGNLLNLWNMSLSQNNFQGNIPSELGKLKS 748
Query: 626 LSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
L+ LDL N L IPS ++SLE LNLSHN+LSG + F++M +L IDISYN+
Sbjct: 749 LTSLDLGGNSLRGTIPSMFGELKSLETLNLSHNNLSGNL-SSFDDMTSLTSIDISYNQFE 807
Query: 686 GPIPNSTAFRDAPIKALQGNKGLCGDFKGLPSCK--ALKSNKQASRKIWIVVLFPLLGIV 743
GP+PN AF +A I+AL+ NKGLCG+ GL C + KS+ +K+ IV+L LGI+
Sbjct: 808 GPLPNILAFHNAKIEALRNNKGLCGNVTGLEPCSTSSGKSHNHMRKKVMIVILPLTLGIL 867
Query: 744 ALLISLIGLFFKF-QRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEH 802
L + G+++ Q NK Q++ TP + ++ +F+GK+V+E II AT DFDD+H
Sbjct: 868 ILALFAFGVWYHLCQTSTNKED--QATSIQTPNIFAIWSFDGKMVFENIIEATEDFDDKH 925
Query: 803 CIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG GGQG VYK L +G+++AVKK HS GEM + F E++ALTEIRHRNIVK YG
Sbjct: 926 LIGVGGQGCVYKAVLPTGQVVAVKKLHSVPNGEMLNLKAFTCEIQALTEIRHRNIVKLYG 985
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
FCSH+Q SF+V E+LE GS+ L +D A +W +R++V+K +A+AL Y+H++C P I
Sbjct: 986 FCSHSQFSFLVCEFLENGSVEKTLKDDGQAMAFDWYKRVNVVKDVANALCYMHHECSPRI 1045
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 982
VHRDISSKNVLLD + A VSDFG AKFL PDSSNWT GT+GY APELAYTM+V EKC
Sbjct: 1046 VHRDISSKNVLLDSEYVAHVSDFGTAKFLNPDSSNWTSFVGTFGYAAPELAYTMEVNEKC 1105
Query: 983 DVYSFGVLALEVIKGKHPGDFI-SLISSSSLNL------NIALDEILDPRLPIPSHNVQE 1035
DVYSFGVLA E++ GKHPGD I SL+ SS L ++AL + LDPRLP P+ + +
Sbjct: 1106 DVYSFGVLAWEILVGKHPGDDISSLLGSSPSTLVASTLDHMALMDKLDPRLPHPTKPIGK 1165
Query: 1036 KLISFVEVAISCLDESPESRPTMQKVSQLL 1065
++ S ++A++CL ESP SRPTM++V+ L
Sbjct: 1166 EVASIAKIAMACLTESPRSRPTMEQVANEL 1195
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 906 bits (2341), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/927 (53%), Positives = 640/927 (69%), Gaps = 28/927 (3%)
Query: 164 SLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLN 223
S + NL + N LSG IP +IG L L L+L N+ +G IP +G L+NL +L+
Sbjct: 105 SFSSFPNLAYFDINMNKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLH 164
Query: 224 LSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPS 283
L N L GSIP E+G LK L DL L NKL GSIP SL NL+NL LY+ N LSGLIP
Sbjct: 165 LVENQLNGSIPHEIGQLKSLCDLSLYTNKLEGSIPASLGNLSNLTNLYLDENKLSGLIPP 224
Query: 284 EIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILE 343
E+GNL L ++ L+ N +G IP +LGNL ++ L L +N L G IP+E+ NLK L L
Sbjct: 225 EMGNLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLS 284
Query: 344 LGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPI 403
L +N L G IP LG+L+ L L +++N LSG IP E+GNL+SL L ++ N+L SIP
Sbjct: 285 LSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPT 344
Query: 404 SLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG---------------- 447
SL NL NL +L N LS +IP E L KL +L + NQ G
Sbjct: 345 SLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFT 404
Query: 448 --------PIP-NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISS 498
PIP +LKN SL R L RN LT NISE+F + PNL I+LS N YGE+S
Sbjct: 405 VFDNFLIGPIPESLKNCPSLARARLQRNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQ 464
Query: 499 DWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLI 558
+WGRC KL LD + NNITG+IP G S+QL VL+LSSNH+VG+IP +LG +S L KLI
Sbjct: 465 NWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLI 524
Query: 559 LAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPI 618
L N+LSG + P+LG L L +LDLS N L+ +IPE LGN + L+YLNLSNN+ S IP+
Sbjct: 525 LNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPV 584
Query: 619 KLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCID 678
++ +L HLS LDLS+N L IPSQI +QSLEKLNLSHN+LSG+IP+ FE+MH L +D
Sbjct: 585 QMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVD 644
Query: 679 ISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLPSCKALKSNKQASRKIWIVVLFP 738
ISYN+L+G IPNS AF++ I+ LQGNKGLCG KGL C+ + K + ++I++ F
Sbjct: 645 ISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKAVFIII-FS 703
Query: 739 LLGIVALLISLIGLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDF 798
LLG + +L + IG+ Q R+N ++ +++ T L S+ TF+G+ YE II AT DF
Sbjct: 704 LLGALLILSAFIGISLISQGRRN-AKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDF 762
Query: 799 DDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 858
D +CIG+GG GSVYK EL SG I+AVKK H +M Q++F+NE++ALTEI+HRNIV
Sbjct: 763 DPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR-FDIDMAHQKDFMNEIRALTEIKHRNIV 821
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
K GFCSH++HSF+VYEYLE GSL ILS + A+++ W R+++IKG+A ALSYLH+DC
Sbjct: 822 KLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVAHALSYLHHDC 881
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 978
PPIVHRDISS NVLLD K EA VSDFG AKFLK DSSNW+ LAGTYGYVAPELAYTMKV
Sbjct: 882 VPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKV 941
Query: 979 TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLI 1038
TEKCDVYSFGVLALEV++G+HPGD IS +S+S N+ L ++LDPRLP P+ + +++
Sbjct: 942 TEKCDVYSFGVLALEVMRGRHPGDLISSLSASPGKDNVVLKDVLDPRLPPPTLRDEAEVM 1001
Query: 1039 SFVEVAISCLDESPESRPTMQKVSQLL 1065
S +++A +CL+ SP+SRPTMQ VSQ+L
Sbjct: 1002 SVIQLATACLNGSPQSRPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224145445|ref|XP_002325645.1| predicted protein [Populus trichocarpa] gi|222862520|gb|EEF00027.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 903 bits (2333), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/1080 (47%), Positives = 712/1080 (65%), Gaps = 23/1080 (2%)
Query: 3 EAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCA-WVGIHCNHGGRVNSINLTSIGLK 61
EA ALL+WK SL N + S LSSW I C W GI C+ G V +++L GL+
Sbjct: 61 EAEALLKWKASLDNQSQ-SLLSSWF-----GISPCINWTGITCDSSGSVTNLSLPHFGLR 114
Query: 62 GTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLS 121
GTL+D +FSSFP+L L+L N + G +P I N+ K+ L+L N +G+IP +IG +
Sbjct: 115 GTLYDLNFSSFPNLFSLNLQRNSIHGTVPSGIDNLPKITELNLCDNNLTGSIPSKIGLMK 174
Query: 122 YLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLL 181
L L+L N LSGSIP E+G L+SL+ L+L +N L +IP S+GNLTNL L L+ N L
Sbjct: 175 SLNILYLCGNILSGSIPCEIGKLTSLSLLSLSANNLTGVIPFSIGNLTNLSLLHLFQNQL 234
Query: 182 SGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLK 241
SG IPS IGN+ +L+DL L N L G IP S+GNL +L++L L N L GSIP E+G L+
Sbjct: 235 SGPIPSSIGNMSFLIDLQLQQNNLTGFIPSSVGNLRSLSILYLWGNKLSGSIPGEIGLLE 294
Query: 242 YLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKF 301
L+DL + N L G+IP+S+ NLTNL +++ N LSG IP+ IGN+ L + L N
Sbjct: 295 SLNDLDFSSNNLTGAIPNSIGNLTNLSFFHLFQNQLSGPIPTSIGNMIMLIDVELGQNNL 354
Query: 302 SGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILE---LGNNKLCGSIPHFLG 358
G IP S+GNL ++ +L N L G IP E+ L+SL+ L+ L N L G IP +G
Sbjct: 355 IGSIPTSVGNLRKLSIFYLWRNKLSGFIPQEIGLLESLNDLDFSKLDENNLNGLIPSSIG 414
Query: 359 NLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYK 418
NL NLS L++ N+L G +P EIG LKSL L NKL S+P+ ++NLT+L L
Sbjct: 415 NLKNLSFLYLGENNLYGYVPSEIGKLKSLEKLTFGENKLRGSLPLKMNNLTHLKFLDLSY 474
Query: 419 NSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIP-NLKNLTSLVRVHLDRNYLTSNISESFY 477
N +G +P+E + L + +N F G IP +LKN T L R+ LDRN LT NISE F
Sbjct: 475 NEFTGHLPQELCHGEVLERFIACNNYFSGSIPKSLKNCTGLHRLRLDRNQLTGNISEDFG 534
Query: 478 IYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSS 537
IYP+L ++DLSYNN YGE+S WG + +L S NN++G IP ++G ++QL+++DLSS
Sbjct: 535 IYPHLNYVDLSYNNFYGELSLKWGDYRNITSLKISNNNVSGEIPAELGKATQLQLIDLSS 594
Query: 538 NHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLG 597
NH+ G IP ELG L L L L+ N LSG + + +L L+ LDL+SNNLS +IP+ LG
Sbjct: 595 NHLEGTIPKELGGLKLLYNLTLSNNHLSGAIPSDIKMLSSLKILDLASNNLSGSIPKQLG 654
Query: 598 NLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSH 657
L LNLSNN+F+ IP ++ L L +LDLS NFL + IP Q+ +Q LE LN+SH
Sbjct: 655 ECSNLLLLNLSNNKFTNSIPQEMGFLRSLQDLDLSCNFLAQEIPWQLGQLQMLETLNVSH 714
Query: 658 NSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLPS 717
N LSG+IPR F+++ +L +DISYNEL GPIP++ AF +A +AL+ N G+CG+ GL
Sbjct: 715 NMLSGLIPRTFKDLLSLTVVDISYNELHGPIPDTKAFHNASFEALRDNMGICGNASGLKP 774
Query: 718 C---KALKSNKQASRKIWIVVLFPLLGIVALLISLIGLFFKFQRRKNKSQTKQSSPRNTP 774
C K+ ++ K+ S K+ I+++ PLLG + L++ +IG F ++R K + + +
Sbjct: 775 CNLPKSSRTVKRKSNKLVILIVLPLLGSLLLVLVVIGALFILRQRARKRKAEPGNIEQDR 834
Query: 775 GLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPG 834
L ++L +GK++YE II AT +F+ +CIG+GG G+VYK + + +++AVKK H
Sbjct: 835 NLFTILGHDGKLLYENIIAATEEFNSNYCIGEGGYGTVYKAVMPAEQVVAVKKLHRSQTD 894
Query: 835 EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAED 894
+++ + F EV L IRHRNIVK YGFCSHA+HSF+VYE++E GSL I++++ A +
Sbjct: 895 KLSDFKAFETEVCVLANIRHRNIVKLYGFCSHAKHSFLVYEFIERGSLRKIITSEEQAIE 954
Query: 895 LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954
L+W +R++V+KG+A ALSYLH+ C PPI+HRDI+S NVLLD + EA VSDFG A+ L PD
Sbjct: 955 LDWMKRLNVVKGMAGALSYLHHSCSPPIIHRDITSNNVLLDLEYEAHVSDFGTARLLMPD 1014
Query: 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL 1014
SSNWT AGT+GY APELAYTMKVTEKCDVYSFGV+ +EV+ G+HPGD IS ISS + +
Sbjct: 1015 SSNWTSFAGTFGYTAPELAYTMKVTEKCDVYSFGVVTMEVMMGRHPGDLISTISSQASSS 1074
Query: 1015 ---------NIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
L ++LD R+ +P E ++ +++A++CL +P+SRPTM ++S L
Sbjct: 1075 SSSKPPISQQTLLKDVLDQRISLPKKGAVEGVVHIMKIALACLHPNPQSRPTMGRISSEL 1134
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484864|ref|XP_002273966.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2318), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/1074 (47%), Positives = 680/1074 (63%), Gaps = 70/1074 (6%)
Query: 2 EEAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCA-WVGIHCNHGGRVNSINLTSIGL 60
+EA ALL WK+SL + S LSSW+ + C W G+ C+ V+S+NL S GL
Sbjct: 56 KEALALLTWKSSLHIRSQ-SFLSSWS-----GVSPCNNWFGVTCHKSKSVSSLNLESCGL 109
Query: 61 KGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHL 120
+GTL++ +F S P+L LDL++N L G+IP +IG + L L LS+N SG IPP IG+L
Sbjct: 110 RGTLYNLNFLSLPNLVTLDLYNNSLSGSIPQEIGLLRSLNNLKLSTNNLSGPIPPSIGNL 169
Query: 121 SYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNL 180
L TL+L N+LSGSIP E+G L SLN+L L +N L IP S+GNL NL TL L+ N
Sbjct: 170 RNLTTLYLHTNKLSGSIPQEIGLLRSLNDLELSANNLSGPIPPSIGNLRNLTTLYLHTNK 229
Query: 181 LSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNL 240
LSGSIP EIG L+ L DL L N LNG IP S+GNL NL L L +N L GSIP E+G L
Sbjct: 230 LSGSIPQEIGLLRSLNDLELSTNNLNGPIPPSIGNLRNLTTLYLHTNKLSGSIPKEIGML 289
Query: 241 KYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNK 300
+ L+DL+L+ N LNG IP S+ L NL LY++NN LSG IP EIG L+ L ++LS N
Sbjct: 290 RSLNDLELSTNNLNGPIPPSIGKLRNLTTLYLHNNKLSGSIPLEIGLLRSLFNLSLSTNN 349
Query: 301 FSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNL 360
SG IP +GNL N+ L+LD+N G IP E+ L+SL L L NKL G IP + NL
Sbjct: 350 LSGPIPPFIGNLRNLTKLYLDNNRFSGSIPREIGLLRSLHDLALATNKLSGPIPQEIDNL 409
Query: 361 TNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNS 420
+L L + N+ +G +P ++ + +L N T + N
Sbjct: 410 IHLKSLHLEENNFTGHLPQQM------------------CLGGALENFTAMG------NH 445
Query: 421 LSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYP 480
+G IP RN L ++ L NQ +G NI+E F +YP
Sbjct: 446 FTGPIPMSLRNCTSLFRVRLERNQLEG-----------------------NITEVFGVYP 482
Query: 481 NLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHV 540
NL F+DLS NNLYGE+S WG+C L +L+ S NN++G IPP++G + QL LDLSSNH+
Sbjct: 483 NLNFMDLSSNNLYGELSHKWGQCGSLTSLNISHNNLSGIIPPQLGEAIQLHRLDLSSNHL 542
Query: 541 VGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLV 600
+G IP ELGKL+ + L+L+ NQLSG + ++G L LEHL L+SNNLS +IP+ LG L
Sbjct: 543 LGKIPRELGKLTSMFHLVLSNNQLSGNIPLEVGNLFNLEHLSLTSNNLSGSIPKQLGMLS 602
Query: 601 KLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSL 660
KL +LNLS N+F IP ++ + L LDLS N L IP Q+ +Q LE LNLSHN L
Sbjct: 603 KLFFLNLSKNKFGESIPDEIGNMHSLQNLDLSQNMLNGKIPQQLGELQRLETLNLSHNEL 662
Query: 661 SGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLPSCKA 720
SG IP FE+M +L +DIS N+L GP+P+ AF++AP +A N GLCG+ GL C
Sbjct: 663 SGSIPSTFEDMLSLTSVDISSNQLEGPLPDIKAFQEAPFEAFMSNGGLCGNATGLKPCIP 722
Query: 721 LKSNKQASRKIWIVVLFPLLGIVALLISLIGLFFK-FQRRKNKSQTKQSSPRNTPGLRSM 779
K I I+ V LL +G++F + R +N+ +P L ++
Sbjct: 723 FTQKKNKRSMILIIS-----STVFLLCISMGIYFTLYWRARNRKGKSSETP--CEDLFAI 775
Query: 780 LTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQ 839
+G I+Y++II T +F+ ++CIG GGQG+VYK EL +G ++AVKK H P GEM+
Sbjct: 776 WDHDGGILYQDIIEVTEEFNSKYCIGSGGQGTVYKAELPTGRVVAVKKLHPPQDGEMSSL 835
Query: 840 QEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQ 899
+ F +E++ALTEIRHRNIVKFYG+CSHA+HSF+VY+ +E GSL ILSN+ A L+W +
Sbjct: 836 KAFTSEIRALTEIRHRNIVKFYGYCSHARHSFLVYKLMEKGSLRNILSNEEEAIGLDWIR 895
Query: 900 RMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD-SSNW 958
R++++KG+A+ALSY+H+DC PPI+HRDISS NVLLD + EA VSDFG A+ LKPD SSNW
Sbjct: 896 RLNIVKGVAEALSYMHHDCSPPIIHRDISSNNVLLDSEYEAHVSDFGTARLLKPDSSSNW 955
Query: 959 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISS-------SS 1011
T AGT+GY APELAYT +V K DVYS+GV+ LEVI GKHPGD IS +SS ++
Sbjct: 956 TSFAGTFGYSAPELAYTTQVNNKTDVYSYGVVTLEVIMGKHPGDLISSLSSASSSSSVTA 1015
Query: 1012 LNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+ ++ L + +D RL P H + E++ V++A +C +P RPTM++VSQ L
Sbjct: 1016 VADSLLLKDAIDQRLSPPIHQISEEVAFAVKLAFACQHVNPHCRPTMRQVSQAL 1069
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2313), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/927 (53%), Positives = 636/927 (68%), Gaps = 28/927 (3%)
Query: 164 SLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLN 223
S + NL + N LSG IP +IG L L L+L N+ +G IP +G L+NL +L+
Sbjct: 105 SFSSFPNLAYFDINMNKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLH 164
Query: 224 LSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPS 283
L N L GSIP E+G LK L DL L NKL G+IP SL NL+NL LY+ N LSGLIP
Sbjct: 165 LVENQLNGSIPHEIGQLKSLCDLSLYTNKLEGTIPASLGNLSNLTNLYLDENKLSGLIPP 224
Query: 284 EIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILE 343
E+GNL L ++ L+ N +G IP +LGNL ++ L L +N L G IP+E+ NLK L L
Sbjct: 225 EMGNLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLS 284
Query: 344 LGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPI 403
L +N L G IP LG+L+ L L +++N LSG IP E+GNL+SL L ++ N+L SIP
Sbjct: 285 LSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPT 344
Query: 404 SLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG---------------- 447
L NL NL +L N LS +IP E L KL +L + NQ G
Sbjct: 345 LLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFT 404
Query: 448 --------PIP-NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISS 498
PIP +LKN SL R L N LT NISE+F + PNL I+LS N YGE+S
Sbjct: 405 VFDNFLIGPIPESLKNCPSLARARLQGNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQ 464
Query: 499 DWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLI 558
+WGRC KL LD + NNITG+IP G S+QL VL+LSSNH+VG+IP +LG +S L KLI
Sbjct: 465 NWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLI 524
Query: 559 LAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPI 618
L N+LSG + P+LG L L +LDLS N L+ +IPE LGN + L+YLNLSNN+ S IP+
Sbjct: 525 LNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPV 584
Query: 619 KLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCID 678
++ +L HLS LDLS+N L IPSQI +QSLEKLNLSHN+LSG+IP+ FE+MH L +D
Sbjct: 585 QMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVD 644
Query: 679 ISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLPSCKALKSNKQASRKIWIVVLFP 738
ISYN+L+G IPNS AF++ I+ LQGNKGLCG KGL C+ + K + ++I++ F
Sbjct: 645 ISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQPCENRSATKGTHKAVFIII-FS 703
Query: 739 LLGIVALLISLIGLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDF 798
LLG + +L + IG+ Q R+N ++ +++ T L S+ TF+G+ YE II AT DF
Sbjct: 704 LLGALLILSAFIGISLISQGRRN-AKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDF 762
Query: 799 DDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 858
D +CIG+GG GSVYK EL SG I+AVKK H +M Q++F+NE++ALTEI+HRNIV
Sbjct: 763 DPMYCIGEGGHGSVYKAELPSGNIVAVKKLHR-FDIDMAHQKDFVNEIRALTEIKHRNIV 821
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
K GFCSH++HSF+VYEYLE GSL ILS + A+++ W R+++IKG++ ALSYLH+DC
Sbjct: 822 KLLGFCSHSRHSFLVYEYLERGSLGTILSKELQAKEVGWGTRVNIIKGVSHALSYLHHDC 881
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 978
PPIVHRDISS NVLLD K EA VSDFG AKFLK DSSNW+ LAGTYGYVAPELAYTMKV
Sbjct: 882 VPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKV 941
Query: 979 TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLI 1038
TEKCDVYSFGVLALEV++G+HPGD IS +S S N+ L ++LDPRLP P+ + ++
Sbjct: 942 TEKCDVYSFGVLALEVMRGRHPGDLISSLSDSPGKDNVVLKDVLDPRLPPPTFRDEAEVT 1001
Query: 1039 SFVEVAISCLDESPESRPTMQKVSQLL 1065
S +++A +CL+ SP+SRPTMQ VSQ+L
Sbjct: 1002 SVIQLATACLNGSPQSRPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 891 bits (2303), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 490/931 (52%), Positives = 633/931 (67%), Gaps = 33/931 (3%)
Query: 164 SLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLN 223
S + NL + + N LSG IP +IG L L L+L N+ +G IP +G L+NL +L+
Sbjct: 108 SFSSFPNLAYVDISMNNLSGPIPPQIGLLFELKYLDLSINQFSGGIPSEIGLLTNLEVLH 167
Query: 224 LSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPS 283
L N L GSIP E+G L L +L L N+L GSIP SL NL+NL LY+Y N LSG IP
Sbjct: 168 LVQNQLNGSIPHEIGQLASLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPP 227
Query: 284 EIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILE 343
E+GNL L +I + N +G IP + GNL + L+L +NSL G IP E+ NLKSL L
Sbjct: 228 EMGNLTNLVEIYSNNNNLTGPIPSTFGNLKRLTVLYLFNNSLSGPIPPEIGNLKSLQELS 287
Query: 344 LGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPI 403
L N L G IP L +L+ L++L +Y N LSG IP EIGNLKSL L L+ N+L SIP
Sbjct: 288 LYENNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPT 347
Query: 404 SLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLT------------------------KLF 439
SL NLTNL +L N LSG IP+E L KL +
Sbjct: 348 SLGNLTNLEILFLRDNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQAGSLVRFA 407
Query: 440 LGDNQFQGPIP-NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISS 498
+ DN GPIP +LKN +L R N LT NISE PNL FIDLSYN +GE+S
Sbjct: 408 VSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNISEVVGDCPNLEFIDLSYNRFHGELSH 467
Query: 499 DWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLI 558
+WGRCP+L L+ + NNITG+IP G S+ L +LDLSSNH+VG+IP ++G L+ L+ LI
Sbjct: 468 NWGRCPQLQRLEIAGNNITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLGLI 527
Query: 559 LAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPI 618
L NQLSG + P+LG L LE+LDLS+N L+ +IPE LG+ + LHYLNLSNN+ S IP+
Sbjct: 528 LNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPV 587
Query: 619 KLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCID 678
++ +L HLS+LDLS+N L IP QI +QSLE L+LSHN+L G IP+ FE+M AL +D
Sbjct: 588 QMGKLSHLSQLDLSHNLLAGGIPPQIQGLQSLEMLDLSHNNLCGFIPKAFEDMPALSYVD 647
Query: 679 ISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLPSCK-ALKSNKQ---ASRKIWIV 734
ISYN+L+GPIP+S AFR+A I+ L+GNK LCG+ KGL CK ++Q S K+ +
Sbjct: 648 ISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFI 707
Query: 735 VLFPLLGIVALLISLIGLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRA 794
++FPLLG + LL + IG+F +RR+ + ++ +N L S+ F+G+ +YEEII+A
Sbjct: 708 IIFPLLGALVLLFAFIGIFLIAERRERTPEIEEGDVQND--LFSISNFDGRTMYEEIIKA 765
Query: 795 TNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
T DFD +CIGKGG GSVYK EL S I+AVKK H P EM Q++FLNE++ALTEI+H
Sbjct: 766 TKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH-PSDTEMANQKDFLNEIRALTEIKH 824
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
RNIVK GFCSH +H F+VYEYLE GSLA ILS + A + L W R+++IKG+A AL+Y+
Sbjct: 825 RNIVKLLGFCSHPRHKFLVYEYLERGSLATILSREEAKK-LGWATRVNIIKGVAHALAYM 883
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
H+DC PPIVHRD+SS N+LLD + EA +SDFG AK LK DSSN + LAGT+GY+APELAY
Sbjct: 884 HHDCSPPIVHRDVSSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAY 943
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034
TMKVTEK DV+SFGV+ALEVIKG+HPGD I +S S NIAL+++LDPRLP + +
Sbjct: 944 TMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKDNIALEDMLDPRLPPLTPQDE 1003
Query: 1035 EKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
++I+ ++ AI CL +P+SRPTMQ VSQ+L
Sbjct: 1004 GEVIAILKQAIECLKANPQSRPTMQTVSQML 1034
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2280), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 487/920 (52%), Positives = 620/920 (67%), Gaps = 33/920 (3%)
Query: 175 CLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIP 234
C N LSG IP +IG L L L+L N+ +G IP +G L+NL +L+L N L GSIP
Sbjct: 77 CKCMNNLSGPIPPQIGLLSELKYLDLSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIP 136
Query: 235 SELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKI 294
E+G L L +L L N+L GSIP SL NL+NL LY+Y N LS IP E+GNL L +I
Sbjct: 137 HEIGQLASLYELALYTNQLEGSIPASLGNLSNLAYLYLYENQLSDSIPPEMGNLTNLVEI 196
Query: 295 ALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIP 354
N G IP + GNL + L+L +N L G IP E+ NLKSL L L N L G IP
Sbjct: 197 YSDTNNLIGPIPSTFGNLKRLTVLYLFNNRLSGHIPPEIGNLKSLQGLSLYENNLSGPIP 256
Query: 355 HFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVL 414
LG+L+ L++L +Y N LSG IP EIGNLKSL L L+ N+L SIP SL NLTNL L
Sbjct: 257 ASLGDLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLETL 316
Query: 415 SFYKNSLSGAIPKEYRNLVKLT------------------------KLFLGDNQFQGPIP 450
N LSG IP+E L KL + + DN GPIP
Sbjct: 317 FLRDNQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIP 376
Query: 451 -NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGAL 509
+LKN +L R N LT NISE PNL +I++SYN+ +GE+S +WGR P+L L
Sbjct: 377 KSLKNCKNLTRALFGGNQLTGNISEVVGDCPNLEYINVSYNSFHGELSHNWGRYPRLQRL 436
Query: 510 DFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLS 569
+ + NNITG+IP G S+ L +LDLSSNH+ G+IP ++G ++ L KLIL NQLSG +
Sbjct: 437 EMAWNNITGSIPEDFGISTDLTLLDLSSNHLFGEIPKKMGSVTSLWKLILNDNQLSGNIP 496
Query: 570 PKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSEL 629
P+LG L L +LDLS+N L+ +IPE LG+ + L+YLNLSNN+ S IP+++ +L HLS+L
Sbjct: 497 PELGSLADLGYLDLSANRLNGSIPEHLGDCLGLNYLNLSNNKLSHGIPVQMGKLGHLSQL 556
Query: 630 DLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIP 689
DLS+N L IP QI +QSLE LNLSHN+LSG IP+ FEEM L +DISYN+L+GPIP
Sbjct: 557 DLSHNLLTGDIPPQIEGLQSLENLNLSHNNLSGFIPKAFEEMLGLSDVDISYNQLQGPIP 616
Query: 690 NSTAFRDAPIKALQGNKGLCGDFKGLPSCKALKSNKQ----ASRKIWIVVLFPLLGIVAL 745
NS AFRDA I+AL+GNKGLCG+ K L CK Q S K+ +++FPLLG + L
Sbjct: 617 NSKAFRDATIEALKGNKGLCGNVKRLRPCKYGSGVDQQPVKKSHKVVFIIIFPLLGALVL 676
Query: 746 LISLIGLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIG 805
L + IG+F RR+ + K+ +N L S+ TF+G+ +YEEII+AT DFD +CIG
Sbjct: 677 LFAFIGIFLIAARRERTPEIKEGEVQND--LFSISTFDGRTMYEEIIKATKDFDPMYCIG 734
Query: 806 KGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCS 865
KGG GSVYK EL S I+AVKK H P EM Q++FLNE++ALTEI+HRNIVK GFCS
Sbjct: 735 KGGHGSVYKAELPSSNIVAVKKLH-PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCS 793
Query: 866 HAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHR 925
H +H F+VYEYLE GSLA ILS + A + L W R+++IKG+A AL+Y+H+DC PPIVHR
Sbjct: 794 HPRHKFLVYEYLERGSLATILSREEAKK-LGWATRVNIIKGVAHALAYMHHDCSPPIVHR 852
Query: 926 DISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVY 985
DISS N+LLD + EA +SDFG AK LK DSSN + LAGT+GY+APELAYTMKVTEK DV+
Sbjct: 853 DISSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVF 912
Query: 986 SFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAI 1045
SFGV+ALEVIKG+HPGD I +S S NIAL+++LDPRLP + + ++I+ ++ A
Sbjct: 913 SFGVIALEVIKGRHPGDQILSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEVIAIIKQAT 972
Query: 1046 SCLDESPESRPTMQKVSQLL 1065
CL +P+SRPTMQ VSQ+L
Sbjct: 973 ECLKANPQSRPTMQTVSQML 992
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1067 | ||||||
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.940 | 0.895 | 0.442 | 7.8e-213 | |
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.838 | 0.856 | 0.445 | 1.9e-195 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.940 | 0.911 | 0.362 | 3.6e-153 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.949 | 0.901 | 0.345 | 1.4e-149 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.919 | 0.891 | 0.353 | 3.9e-147 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.946 | 0.808 | 0.345 | 1.2e-143 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.910 | 0.776 | 0.349 | 3.5e-139 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.773 | 0.692 | 0.323 | 8.2e-138 | |
| UNIPROTKB|P93194 | 1109 | INRPK1 "Receptor-like protein | 0.969 | 0.932 | 0.326 | 3.8e-133 | |
| TAIR|locus:2032697 | 1123 | PEPR1 "PEP1 receptor 1" [Arabi | 0.971 | 0.923 | 0.315 | 4.4e-132 |
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2057 (729.2 bits), Expect = 7.8e-213, P = 7.8e-213
Identities = 450/1017 (44%), Positives = 612/1017 (60%)
Query: 53 INLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGA 112
++L+ L GT+ F + L Y DL +N L G I P +GN+ L L L N +
Sbjct: 107 VDLSMNLLSGTIPP-QFGNLSKLIYFDLSTNHLTGEISPSLGNLKNLTVLYLHQNYLTSV 165
Query: 113 IPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGXXXXXXXXXXXXXXEDIIPHSLGNLTNLV 172
IP ++G++ + L L +N+L+GSIP +G +IP LGN+ ++
Sbjct: 166 IPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMT 225
Query: 173 TLCLYNNLLSGSIPSEIGXXXXXXXXXXXXXXXXGSIPQXXXXXXXXXXXXXXXXXXFGS 232
L L N L+GSIPS +G G IP GS
Sbjct: 226 DLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGS 285
Query: 233 IPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLS 292
IPS LGNLK L+ L L N L G IP L N+ +++ L + NN L+G IPS +GNLK L+
Sbjct: 286 IPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLT 345
Query: 293 KIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGS 352
+ L N +G+IP LGN+ ++ L L++N L G IPS NLK+L+ L L N L G
Sbjct: 346 ILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGV 405
Query: 353 IPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPIXXXXXXXXX 412
IP LGN+ ++ L + N L+GS+P GN L L L N L+ +IP
Sbjct: 406 IPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLT 465
Query: 413 XXXFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIP-NLKNLTSLVRVHLDRNYLTSN 471
N+ +G P+ KL + L N +GPIP +L++ SL+R N T +
Sbjct: 466 TLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGD 525
Query: 472 ISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLE 531
I E+F IYP+L FID S+N +GEISS+W + PKLGAL S NNITG IP +I +QL
Sbjct: 526 IFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLV 585
Query: 532 VLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNA 591
LDLS+N++ G++P +G L+ L +L L NQLSG++ L L LE LDLSSNN S+
Sbjct: 586 ELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSE 645
Query: 592 IPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLE 651
IP++ + +KLH +NLS N+F IP +L +L L++LDLS+N L IPSQ+ +QSL+
Sbjct: 646 IPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLD 704
Query: 652 KLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCGD 711
KL+LSHN+LSG+IP FE M AL +DIS N+L GP+P++ FR A AL+ N GLC +
Sbjct: 705 KLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSN 764
Query: 712 F--KGLPSCKALKS-NKQASRKIWIVVLFPLLGIVALLISLIGLFFKFQRRKNKSQTKQS 768
+ L C+ LK K + +WI+V P+LG++ +L S+ F + RK K Q ++
Sbjct: 765 IPKQRLKPCRELKKPKKNGNLVVWILV--PILGVLVIL-SICANTFTYCIRKRKLQNGRN 821
Query: 769 SPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKF 828
+ T S+ + +GK Y++II +TN+FD H IG GG VY+ L IIAVK+
Sbjct: 822 TDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRL 880
Query: 829 HSPLPGEMT---FQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMI 885
H + E++ +QEFLNEVKALTEIRHRN+VK +GFCSH +H+F++YEY+E GSL +
Sbjct: 881 HDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKL 940
Query: 886 LSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDF 945
L+ND A+ L WT+R++V+KG+A ALSY+H+D PIVHRDISS N+LLD A++SDF
Sbjct: 941 LANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDF 1000
Query: 946 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFXX 1005
G AK LK DSSNW+ +AGTYGYVAPE AYTMKVTEKCDVYSFGVL LE+I GKHPGD
Sbjct: 1001 GTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVS 1060
Query: 1006 XXXXXXXXXXXALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVS 1062
+L I D R+ P +EKL+ VE+A+ CL +PESRPTM +S
Sbjct: 1061 SLSSSPGEAL-SLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116
|
|
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1893 (671.4 bits), Expect = 1.9e-195, P = 1.9e-195
Identities = 403/905 (44%), Positives = 556/905 (61%)
Query: 166 GNLTNLVTLCLYNNLLSGSIPSEIGXXXXXXXXXXXXXXXXGSIPQXXXXXXXXXXXXXX 225
G + L L N L G IP E+G GSIP
Sbjct: 139 GRFSKLEYFDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIY 198
Query: 226 XXXXFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEI 285
G IPS GNL L +L L N L+GSIP + NL NL L + N+L+G IPS
Sbjct: 199 DNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSF 258
Query: 286 GNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELG 345
GNLK ++ + + N+ SG IP +GN++ + L L +N L G IPS L N+K+L++L L
Sbjct: 259 GNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLY 318
Query: 346 NNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPIXX 405
N+L GSIP LG + ++ L I N L+G +P G L +L +L L N+L+ IP
Sbjct: 319 LNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGI 378
Query: 406 XXXXXXXXXXFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIP-NLKNLTSLVRVHLD 464
N+ +G +P KL L L DN F+GP+P +L++ SL+RV
Sbjct: 379 ANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFK 438
Query: 465 RNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKI 524
N + +ISE+F +YP L FIDLS NN +G++S++W + KL A S N+ITG IPP+I
Sbjct: 439 GNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEI 498
Query: 525 GYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLS 584
+QL LDLSSN + G++P + ++ + KL L N+LSG++ + LL LE+LDLS
Sbjct: 499 WNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLS 558
Query: 585 SNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQI 644
SN S+ IP +L NL +L+Y+NLS N IP L +L L LDLSYN L I SQ
Sbjct: 559 SNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQF 618
Query: 645 CIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQG 704
+Q+LE+L+LSHN+LSG IP F++M AL +D+S+N L+GPIP++ AFR+AP A +G
Sbjct: 619 RSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEG 678
Query: 705 NKGLCGDF---KGLPSCKALKSNKQ-ASRKIWIVVLFPLLGIVALLISLIGLFFKFQRRK 760
NK LCG +GL C S K R + I +L P++G + +L G+F F++R
Sbjct: 679 NKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRT 738
Query: 761 NKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASG 820
+ + S L S+ +F+GK+ Y+EII+AT +FD ++ IG GG G VYK +L +
Sbjct: 739 KQIEEHTDSESGGETL-SIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA 797
Query: 821 EIIAVKKFHSPLPGEMT---FQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYL 877
I+AVKK + ++ +QEFLNE++ALTEIRHRN+VK +GFCSH +++F+VYEY+
Sbjct: 798 -IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYM 856
Query: 878 EMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK 937
E GSL +L ND A+ L+W +R++V+KG+A ALSY+H+D P IVHRDISS N+LL
Sbjct: 857 ERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGED 916
Query: 938 NEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG 997
EA++SDFG AK LKPDSSNW+ +AGTYGYVAPELAY MKVTEKCDVYSFGVL LEVIKG
Sbjct: 917 YEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKG 976
Query: 998 KHPGDFXXXXXXXXXXXXXALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPT 1057
+HPGD +L I D RLP P+ ++E+++ ++VA+ CL P++RPT
Sbjct: 977 EHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPT 1036
Query: 1058 MQKVS 1062
M +S
Sbjct: 1037 MLSIS 1041
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1494 (531.0 bits), Expect = 3.6e-153, P = 3.6e-153
Identities = 376/1038 (36%), Positives = 535/1038 (51%)
Query: 51 NSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFS 110
NS + G G + ++SS P + L+L S L G + P IG + LK LDLS N S
Sbjct: 52 NSNDSVPCGWTGVMCS-NYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLS 110
Query: 111 GAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGXXXXXXXXXXXXXXEDIIPHSLGNLTN 170
G IP +IG+ S L+ L L NQ G IP+E+G +P +GNL +
Sbjct: 111 GKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLS 170
Query: 171 LVTLCLYNNLLSGSIPSEIGXXXXXXXXXXXXXXXXGSIPQXXXXXXXXXXXXXXXXXXF 230
L L Y+N +SG +P IG GS+P
Sbjct: 171 LSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLS 230
Query: 231 GSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKF 290
G +P E+G LK LS + L +N+ +G IP + N T+L L +Y N L G IP E+G+L+
Sbjct: 231 GELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQS 290
Query: 291 LSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLC 350
L + L N +G IP +GNLS + N+L G IP EL N++ L +L L N+L
Sbjct: 291 LEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLT 350
Query: 351 GSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPIXXXXXXX 410
G+IP L L NLS L + N+L+G IP L+ L L L N L+ +IP
Sbjct: 351 GTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSD 410
Query: 411 XXXXXFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLT 469
N LSG IP + L LG N G IP + +LV++ L RN L
Sbjct: 411 LWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLV 470
Query: 470 SNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQ 529
+ N+T I+L N G I + G C L L + N TG +P +IG SQ
Sbjct: 471 GRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQ 530
Query: 530 LEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLS 589
L L++SSN + G++P+E+ L +L + N SG L ++G L QLE L LS+NNLS
Sbjct: 531 LGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLS 590
Query: 590 NAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLS-ELDLSYNFLGRAIPSQICIMQ 648
IP +LGNL +L L + N F+ IP +L L L L+LSYN L IP ++ +
Sbjct: 591 GTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLV 650
Query: 649 SLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGL 708
LE L L++N+LSG IP F + +L + SYN L GPIP R+ + + GN+GL
Sbjct: 651 MLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGL 707
Query: 709 CGDFKG--------LPSCKALKSNKQASRKIWIVVLFPLLGIVALLISLIGLFFKFQRRK 760
CG PS K S KI I + ++G V+L+ LI L RR
Sbjct: 708 CGPPLNQCIQTQPFAPSQSTGKPGGMRSSKI-IAITAAVIGGVSLM--LIALIVYLMRRP 764
Query: 761 NKSQTKQSSPRNTPGLRSM-LTFEGK--IVYEEIIRATNDFDDEHCIGKGGQGSVYKVEL 817
++ S+ P S+ + F K +++++ AT++FD+ +G+G G+VYK L
Sbjct: 765 VRT-VASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVL 823
Query: 818 ASGEIIAVKKFHSPLPG--EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875
+G +AVKK S G F E+ L IRHRNIVK +GFC+H + ++YE
Sbjct: 824 PAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYE 883
Query: 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD 935
Y+ GSL IL + + +L+W++R + G A L+YLH+DC P I HRDI S N+LLD
Sbjct: 884 YMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLD 941
Query: 936 FKNEARVSDFGIAKFLK-PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 994
K EA V DFG+AK + P S + + +AG+YGY+APE AYTMKVTEK D+YS+GV+ LE+
Sbjct: 942 DKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLEL 1001
Query: 995 IKGKHP-------GDFXXXXXXXXXXXXXALDEILDPRLPIPSHNVQEKLISFVEVAISC 1047
+ GK P GD + +LD RL + + +++ +++A+ C
Sbjct: 1002 LTGKAPVQPIDQGGDVVNWVRSYIRRDALS-SGVLDARLTLEDERIVSHMLTVLKIALLC 1060
Query: 1048 LDESPESRPTMQKVSQLL 1065
SP +RP+M++V +L
Sbjct: 1061 TSVSPVARPSMRQVVLML 1078
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1460 (519.0 bits), Expect = 1.4e-149, P = 1.4e-149
Identities = 371/1075 (34%), Positives = 539/1075 (50%)
Query: 23 LSSWTFNNVTKIGSCAWVGIHCNHGGR--------VNSINLTSIGLKGTLHDFSFSSFPH 74
L +W N + + C W+G++C+ G V S++L+S+ L G + S +
Sbjct: 55 LHNW--NGIDET-PCNWIGVNCSSQGSSSSSNSLVVTSLDLSSMNLSGIVSP-SIGGLVN 110
Query: 75 LAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLS 134
L YL+L N L G+IP +IGN SKL+ + L++N F G+IP +I LS L++ ++ N+LS
Sbjct: 111 LVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLS 170
Query: 135 GSIPLEVGGXXXXXXXXXXXXXXEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGXXXX 194
G +P E+G +P SLGNL L T N SG+IP+EIG
Sbjct: 171 GPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLN 230
Query: 195 XXXXXXXXXXXXGSIPQXXXXXXXXXXXXXXXXXXFGSIPSELGNLKYLSDLKLADNKLN 254
G +P+ G IP ++GNL L L L N L
Sbjct: 231 LKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLV 290
Query: 255 GSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSN 314
G IP + N+ +L LY+Y N L+G IP E+G L + +I S N SG IP L +S
Sbjct: 291 GPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISE 350
Query: 315 IAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLS 374
+ L+L N L G+IP+EL L++L+ L+L N L G IP NLT++ L +++NSLS
Sbjct: 351 LRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLS 410
Query: 375 GSIPCEIGNLKSLSYLNLAFNKLTSSIPIXXXXXXXXXXXXFYKNSLSGAIPKEYRNLVK 434
G IP +G L ++ + N+L+ IP N + G IP
Sbjct: 411 GVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKS 470
Query: 435 LTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYG 494
L +L + N+ G P L LV NL+ I+L N G
Sbjct: 471 LLQLRVVGNRLTGQFPT--ELCKLV---------------------NLSAIELDQNRFSG 507
Query: 495 EISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFL 554
+ + G C KL L + N + N+P +I S L ++SSN + G IP+E+ L
Sbjct: 508 PLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKML 567
Query: 555 IKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSW 614
+L L++N G L P+LG L QLE L LS N S IP ++GNL L L + N FS
Sbjct: 568 QRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSG 627
Query: 615 EIPIKLEELIHLS-ELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHA 673
IP +L L L ++LSYN IP +I + L L+L++N LSG IP FE + +
Sbjct: 628 SIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSS 687
Query: 674 LQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCG--------DFKGLPSCKALKSNK 725
L + SYN L G +P++ F++ + + GNKGLCG P +LK+
Sbjct: 688 LLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGS 747
Query: 726 QASRKIWIVVLFPLLGIVALLISLIGLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGK 785
+I I+V + GI LLI+++ F + P + E +
Sbjct: 748 ARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKE-R 806
Query: 786 IVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMT----FQQE 841
++I+ AT F D + +G+G G+VYK + SG+ IAVKK S G
Sbjct: 807 FTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNS 866
Query: 842 FLNEVKALTEIRHRNIVKFYGFCSH--AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQ 899
F E+ L +IRHRNIV+ Y FC H + + ++YEY+ GSL +L + + ++W
Sbjct: 867 FRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELL-HGGKSHSMDWPT 925
Query: 900 RMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK-PDSSNW 958
R ++ G A+ L+YLH+DC P I+HRDI S N+L+D EA V DFG+AK + P S +
Sbjct: 926 RFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSV 985
Query: 959 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-------GDFXXXXXXXX 1011
+ +AG+YGY+APE AYTMKVTEKCD+YSFGV+ LE++ GK P GD
Sbjct: 986 SAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHI 1045
Query: 1012 XXXXXALDEILDPRLP-IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
EILDP L + + +I+ ++A+ C SP RPTM++V +L
Sbjct: 1046 RDHSLT-SEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1437 (510.9 bits), Expect = 3.9e-147, P = 3.9e-147
Identities = 356/1008 (35%), Positives = 517/1008 (51%)
Query: 78 LDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSI 137
+DL L G + P I + L+ L++S+N SG IP + L+ L L N+ G I
Sbjct: 72 VDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVI 131
Query: 138 PLEVGGXXXXXXXXXXXXXXEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGXXXXXXX 197
P+++ IP +GNL++L L +Y+N L+G IP +
Sbjct: 132 PIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRI 191
Query: 198 XXXXXXXXXGSIPQXXXXXXXXXXXXXXXXXXFGSIPSELGNLKYLSDLKLADNKLNGSI 257
G IP GS+P +L L+ L+DL L N+L+G I
Sbjct: 192 IRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEI 251
Query: 258 PHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAF 317
P S+ N++ L +L ++ N +G IP EIG L + ++ L N+ +G IP +GNL + A
Sbjct: 252 PPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAE 311
Query: 318 LFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSI 377
+ N L G IP E ++ +L +L L N L G IP LG LT L L + N L+G+I
Sbjct: 312 IDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTI 371
Query: 378 PCEIGNLKSLSYLNLAFNKLTSSIPIXXXXXXXXXXXXFYKNSLSGAIPKEYRNLVKLTK 437
P E+ L L L L N+L IP NSLSG IP + L
Sbjct: 372 PQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLIL 431
Query: 438 LFLGDNQFQGPIP-NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEI 496
L LG N+ G IP +LK SL ++ L N LT ++ + NLT ++L N L G I
Sbjct: 432 LSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNI 491
Query: 497 SSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIK 556
S+D G+ L L + NN TG IPP+IG +++ ++SSN + G IP ELG + +
Sbjct: 492 SADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQR 551
Query: 557 LILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEI 616
L L+ N+ SG ++ +LG LV LE L LS N L+ IP S G+L +L L L N S I
Sbjct: 552 LDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENI 611
Query: 617 PIKLEELIHLS-ELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQ 675
P++L +L L L++S+N L IP + +Q LE L L+ N LSG IP + +L
Sbjct: 612 PVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLL 671
Query: 676 CIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLPSCKALKSNKQASRKIWIV- 734
+IS N L G +P++ F+ GN GLC + C+ L + S+ W++
Sbjct: 672 ICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRS--HCQPLVPHSD-SKLNWLIN 728
Query: 735 -----VLFPLLGIV---ALLISLIGLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGK- 785
+ + IV LI+ +GL + +RR+ + + P + F K
Sbjct: 729 GSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTK--PDVMDSYYFPKKG 786
Query: 786 IVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNE 845
Y+ ++ AT +F ++ +G+G G+VYK E++ GE+IAVKK +S G + F E
Sbjct: 787 FTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASS-DNSFRAE 845
Query: 846 VKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIK 905
+ L +IRHRNIVK YGFC H + ++YEY+ GSL L L+W R +
Sbjct: 846 ISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIAL 905
Query: 906 GIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD-SSNWTELAGT 964
G A+ L YLH+DC P IVHRDI S N+LLD + +A V DFG+AK + S + + +AG+
Sbjct: 906 GAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGS 965
Query: 965 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-------GDFXXXXXXXXXXXXXA 1017
YGY+APE AYTMKVTEKCD+YSFGV+ LE+I GK P GD
Sbjct: 966 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPT 1025
Query: 1018 LDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+ E+ D RL ++ +++A+ C SP SRPTM++V ++
Sbjct: 1026 I-EMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1404 (499.3 bits), Expect = 1.2e-143, P = 1.2e-143
Identities = 365/1056 (34%), Positives = 530/1056 (50%)
Query: 49 RVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNL 108
RV S+ L L+G + + L N L G IP ++G + L+ L+L++N
Sbjct: 192 RVQSLILQDNYLEGPI-PAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNS 250
Query: 109 FSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGXXXXXXXXXXXXXXEDIIPHSLGNL 168
+G IP Q+G +S L+ L L NQL G IP + IP N+
Sbjct: 251 LTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNM 310
Query: 169 TNLVTLCLYNNLLSGSIPSEI-GXXXXXXXXXXXXXXXXGSIPQXXXXXXXXXXXXXXXX 227
+ L+ L L NN LSGS+P I G IP
Sbjct: 311 SQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNN 370
Query: 228 XXFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGN 287
GSIP L L L+DL L +N L G++ S+ NLTNL L +Y+N+L G +P EI
Sbjct: 371 SLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISA 430
Query: 288 LKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNN 347
L+ L + L N+FSG IP +GN +++ + + N G IP + LK L++L L N
Sbjct: 431 LRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQN 490
Query: 348 KLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPIXXXX 407
+L G +P LGN L++L + +N LSGSIP G LK L L L N L ++P
Sbjct: 491 ELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLIS 550
Query: 408 XXXXXXXXFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIP-NLKNLTSLVRVHLDRN 466
N L+G I + L+ + +N F+ IP L N +L R+ L +N
Sbjct: 551 LRNLTRINLSHNRLNGTIHPLCGSSSYLS-FDVTNNGFEDEIPLELGNSQNLDRLRLGKN 609
Query: 467 YLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGY 526
LT I + L+ +D+S N L G I C KL +D + N ++G IPP +G
Sbjct: 610 QLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGK 669
Query: 527 SSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSN 586
SQL L LSSN V +P EL + L+ L L N L+G + ++G L L L+L N
Sbjct: 670 LSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKN 729
Query: 587 NLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHL-SELDLSYNFLGRAIPSQIC 645
S ++P+++G L KL+ L LS N + EIP+++ +L L S LDLSYN IPS I
Sbjct: 730 QFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIG 789
Query: 646 IMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGN 705
+ LE L+LSHN L+G +P +M +L +++S+N L G + F P + GN
Sbjct: 790 TLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGN 847
Query: 706 KGLCGDFKGLPSCKALKSNKQ--ASRKIWIVVLFPLLGIVALLISLIGLFFK-----FQR 758
GLCG + + +Q ++R + I+ L + L+I +I LFFK F++
Sbjct: 848 TGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKK 907
Query: 759 RKNKSQTKQSSPRNTPGLRSMLTFEGK----IVYEEIIRATNDFDDEHCIGKGGQGSVYK 814
+ S SS ++ L G I +E+I+ AT++ +E IG GG G VYK
Sbjct: 908 VGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYK 967
Query: 815 VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH--SFI 872
EL +GE +AVKK ++ + F EVK L IRHR++VK G+CS + +
Sbjct: 968 AELENGETVAVKKIL--WKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLL 1025
Query: 873 VYEYLEMGSLAMILSNDAAAED-----LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDI 927
+YEY++ GS+ L D + L+W R+ + G+A + YLH+DC PPIVHRDI
Sbjct: 1026 IYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDI 1085
Query: 928 SSKNVLLDFKNEARVSDFGIAKFL------KPDSSNWTELAGTYGYVAPELAYTMKVTEK 981
S NVLLD EA + DFG+AK L DS+ W A +YGY+APE AY++K TEK
Sbjct: 1086 KSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTW--FACSYGYIAPEYAYSLKATEK 1143
Query: 982 CDVYSFGVLALEVIKGKHPGD--FXXXXX------XXXXXXXXALDEILDPRL-PIPSHN 1032
DVYS G++ +E++ GK P D F A D+++DP+L P+
Sbjct: 1144 SDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFE 1203
Query: 1033 VQEKLISFVEVAISCLDESPESRPTM-QKVSQLLKI 1067
++ +E+A+ C SP+ RP+ Q LL +
Sbjct: 1204 -EDAACQVLEIALQCTKTSPQERPSSRQACDSLLHV 1238
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1362 (484.5 bits), Expect = 3.5e-139, P = 3.5e-139
Identities = 363/1039 (34%), Positives = 516/1039 (49%)
Query: 60 LKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGH 119
L G+L + +L L+L N G IP Q+G++ ++YL+L N G IP ++
Sbjct: 228 LNGSL-PAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTE 286
Query: 120 LSYLKTLHLFKNQLSGSIPLEVGGXXXXXXXXXXXXXXEDIIPHSL-GNLTNLVTLCLYN 178
L+ L+TL L N L+G I E +P ++ N T+L L L
Sbjct: 287 LANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSE 346
Query: 179 NLLSGSIPSEIGXXXXXXXXXXXXXXXXGSIPQXXXXXXXXXXXXXXXXXXFGSIPSELG 238
LSG IP+EI G IP G++ S +
Sbjct: 347 TQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSIS 406
Query: 239 NLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSY 298
NL L + L N L G +P + L L I+Y+Y N SG +P EIGN L +I
Sbjct: 407 NLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYG 466
Query: 299 NKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLG 358
N+ SG IP S+G L ++ L L N L G IP+ L N +++++L +N+L GSIP G
Sbjct: 467 NRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFG 526
Query: 359 NLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSI-PIXXXXXXXXXXXXFY 417
LT L + IYNNSL G++P + NLK+L+ +N + NK SI P+
Sbjct: 527 FLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVT-- 584
Query: 418 KNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFY 477
+N G IP E L +L LG NQF G IP R + ISE
Sbjct: 585 ENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIP--------------RTF--GKISE--- 625
Query: 478 IYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSS 537
L+ +D+S N+L G I + G C KL +D + N ++G IP +G L L LSS
Sbjct: 626 ----LSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSS 681
Query: 538 NHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLG 597
N VG +P E+ L+ ++ L L N L+G + ++G L L L+L N LS +P ++G
Sbjct: 682 NKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIG 741
Query: 598 NLVKLHYLNLSNNQFSWEIPIKLEELIHL-SELDLSYN-FLGRAIPSQICIMQSLEKLNL 655
L KL L LS N + EIP+++ +L L S LDLSYN F GR IPS I + LE L+L
Sbjct: 742 KLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGR-IPSTISTLPKLESLDL 800
Query: 656 SHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGL 715
SHN L G +P +M +L +++SYN L G + F A GN GLCG L
Sbjct: 801 SHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGS--PL 856
Query: 716 PSCKALKSNKQAS---RKIWIVVLFPLLGIVALLISLIGLFFK-----FQRRK--NKSQT 765
C S Q S + + I+ L +AL++ +I LFFK F++ + N + +
Sbjct: 857 SHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFS 916
Query: 766 KQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAV 825
SS P L S + I +++I+ AT+ ++E IG GG G VYK EL +GE IAV
Sbjct: 917 SNSSSSQAP-LFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAV 975
Query: 826 KKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH--SFIVYEYLEMGSLA 883
KK ++ + F EVK L IRHR++VK G+CS + ++YEY+ GS+
Sbjct: 976 KKIL--WKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVW 1033
Query: 884 MIL---SNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA 940
L N E L W R+ + G+A + YLH DC PPIVHRDI S NVLLD EA
Sbjct: 1034 DWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEA 1093
Query: 941 RVSDFGIAKFLKPDSSNWTE----LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK 996
+ DFG+AK L + TE AG+YGY+APE AY++K TEK DVYS G++ +E++
Sbjct: 1094 HLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVT 1153
Query: 997 GKHPGDFXXXXXXXXXX----------XXXALDEILDPRLPIPSHNVQEKLISFVEVAIS 1046
GK P + A ++++D L +E +E+A+
Sbjct: 1154 GKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQ 1213
Query: 1047 CLDESPESRPTMQKVSQLL 1065
C P+ RP+ ++ S+ L
Sbjct: 1214 CTKSYPQERPSSRQASEYL 1232
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 913 (326.5 bits), Expect = 8.2e-138, Sum P(2) = 8.2e-138
Identities = 283/874 (32%), Positives = 405/874 (46%)
Query: 53 INLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGA 112
++L+ G+L F S P L+ LD+ +N L G IPP+IG +S L L + N FSG
Sbjct: 142 LDLSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNLYMGLNSFSGQ 201
Query: 113 IPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGXXXXXXXXXXXXXXEDIIPHSLGNLTNLV 172
IP +IG++S LK +G +P E+ + IP S G L NL
Sbjct: 202 IPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGELHNLS 261
Query: 173 TLCLYNNLLSGSIPSEIGXXXXXXXXXXXXXXXXGSIPQXXXXXXXXXXXXXXXXXXFGS 232
L L + L G IP E+G G +P GS
Sbjct: 262 ILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIPLLTFSAERNQLS-GS 320
Query: 233 IPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLS 292
+PS +G K L L LA+N+ +G IPH + + L L + +N LSG IP E+ L
Sbjct: 321 LPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGSLE 380
Query: 293 KIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGS 352
I LS N SG I S++ L L +N + G IP +L L L L+L +N G
Sbjct: 381 AIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLP-LMALDLDSNNFTGE 439
Query: 353 IPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPIXXXXXXXXX 412
IP L TNL N L G +P EIGN SL L L+ N+LT IP
Sbjct: 440 IPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLS 499
Query: 413 XXXFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLTSN 471
N G IP E + LT L LG N QG IP+ + L L + L N L+ +
Sbjct: 500 VLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGS 559
Query: 472 ISE--SFYIY----PNLTFI------DLSYNNLYGEISSDWGRCPKLGALDFSKNNITGN 519
I S Y + P+L+F+ DLSYN L G I + G C L + S N+++G
Sbjct: 560 IPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGE 619
Query: 520 IPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLE 579
IP + + L +LDLS N + G IP E+G L L LA NQL+G + GLL L
Sbjct: 620 IPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLV 679
Query: 580 HLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYN-FLGR 638
L+L+ N L +P SLGNL +L +++LS N S E+ +L + L L + N F G
Sbjct: 680 KLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGE 739
Query: 639 AIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAP 698
IPS++ + LE L++S N LSG IP + L+ ++++ N LRG +P+ +D P
Sbjct: 740 -IPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQD-P 797
Query: 699 IKAL-QGNKGLCGDFKGLPSCKALKSNKQASRKIWIVVLFPLLG---IVALLISLIGLFF 754
KAL GNK LCG G CK ++ K R W + +LG IV + + + +
Sbjct: 798 SKALLSGNKELCGRVVG-SDCK-IEGTKL--RSAWGIAGL-MLGFTIIVFVFVFSLRRWA 852
Query: 755 KFQRRKNKSQTKQSSPRNTPGL--RSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSV 812
+R K + ++ G +++ G E + + N E + K G +
Sbjct: 853 MTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPL--SINIAMFEQPLLKVRLGDI 910
Query: 813 YKV--ELASGEIIAVKKFHSP----LPGEMTF------------QQEFLNEVKALTEIRH 854
+ + II F + LPGE T +EF+ E++ L +++H
Sbjct: 911 VEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKH 970
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSN 888
N+V G+CS ++ +VYEY+ GSL L N
Sbjct: 971 PNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRN 1004
|
|
| UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)] | Back alignment and assigned GO terms |
|---|
Score = 1305 (464.4 bits), Expect = 3.8e-133, P = 3.8e-133
Identities = 352/1079 (32%), Positives = 529/1079 (49%)
Query: 13 SLQNHNNGSP---LSSWTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSF 69
SL H P SW ++ T C+W+G+ C+ V+++NL+S G+ G
Sbjct: 33 SLTRHWTSIPSDITQSWNASDSTP---CSWLGVECDRRQFVDTLNLSSYGISGEFGP-EI 88
Query: 70 SSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLF 129
S HL + L N FG+IP Q+GN S L+++DLSSN F+G IP +G L L+ L LF
Sbjct: 89 SHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQNLRNLSLF 148
Query: 130 KNQLSGSIPLEVGGXXXXXXXXXXXXXXEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI 189
N L G P + IP ++GN++ L TL L +N SG +PS +
Sbjct: 149 FNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSGPVPSSL 208
Query: 190 GXXXXXXXXXXXXXXXXGSIPQXXXXXXXXXXXXXXXXXXFGSIPSELGNLKYLSDLKLA 249
G G++P G+IP + + K + + L+
Sbjct: 209 GNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFVSCKQIDTISLS 268
Query: 250 DNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSL 309
+N+ G +P L N T+L ++ +LSG IPS G L L + L+ N FSG IP L
Sbjct: 269 NNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHFSGRIPPEL 328
Query: 310 GNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIY 369
G ++ L L N L G IP EL L L L L N L G +P + + +L L +Y
Sbjct: 329 GKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIWKIQSLQSLQLY 388
Query: 370 NNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPIXXXXXXXXXXXXFYKNSLSGAIPKEY 429
N+LSG +P ++ LK L L L N T IP +N +G IP
Sbjct: 389 QNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLTRNMFTGHIPPNL 448
Query: 430 RNLVKLTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLS 488
+ KL +L LG N +G +P+ L ++L R+ L+ N L + + F NL F DLS
Sbjct: 449 CSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGLPD-FVEKQNLLFFDLS 507
Query: 489 YNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAEL 548
NN G I G + A+ S N ++G+IPP++G +LE L+LS N + G +P+EL
Sbjct: 508 GNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEHLNLSHNILKGILPSEL 567
Query: 549 GKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLS 608
L +L + N L+G + LG L +L L L N+ S IP SL KL L L
Sbjct: 568 SNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLFQSNKLLNLQLG 627
Query: 609 NNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCF 668
N + +IP + L L L+LS N L +P + ++ LE+L++SHN+LSG + R
Sbjct: 628 GNLLAGDIP-PVGALQALRSLNLSSNKLNGQLPIDLGKLKMLEELDVSHNNLSGTL-RVL 685
Query: 669 EEMHALQCIDISYNELRGPIPNS-TAFRDAPIKALQGNKGLC----GDFKGLPSCKALKS 723
+ +L I+IS+N GP+P S T F ++ + GN LC D P L+
Sbjct: 686 STIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLCINCPADGLACPESSILRP 745
Query: 724 -NKQASR-KIWIVVLFPLLGIVALLISLIGLF----FKFQRRKNKSQTKQSSPRNTPGLR 777
N Q++ K + L + ++ L+ +I LF F F K Q S + G
Sbjct: 746 CNMQSNTGKGGLSTLGIAMIVLGALLFIICLFLFSAFLFLHCKKSVQEIAISAQEGDG-- 803
Query: 778 SMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMT 837
S+L +++ AT + +D++ IGKG G++YK L+ ++ AVKK G
Sbjct: 804 SLLN--------KVLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKL--VFTGIKN 853
Query: 838 FQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEW 897
+ E++ + ++RHRN++K F ++ I+Y Y+E GSL IL + L+W
Sbjct: 854 GSVSMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNPPKPLDW 913
Query: 898 TQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN 957
+ R ++ G A L+YLH DC P IVHRDI N+LLD E +SDFGIAK L +++
Sbjct: 914 STRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKLLDQSATS 973
Query: 958 WTE--LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGD--FXXXXXX---- 1009
+ GT GY+APE A+T + + DVYS+GV+ LE+I K D F
Sbjct: 974 IPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALDPSFNGETDIVGWV 1033
Query: 1010 -XXXXXXXALDEILDPRL--PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+ +I+DP L + +V E++ + +A+ C ++ + RPTM+ V + L
Sbjct: 1034 RSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEALSLALRCAEKEVDKRPTMRDVVKQL 1092
|
|
| TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1295 (460.9 bits), Expect = 4.4e-132, P = 4.4e-132
Identities = 343/1088 (31%), Positives = 533/1088 (48%)
Query: 13 SLQNHNNGSP---LSSWTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSF 69
SL H + P S+W N ++ C W GI C+ V S+N T + G L
Sbjct: 38 SLLKHLDRVPPQVTSTWKIN-ASEATPCNWFGITCDDSKNVASLNFTRSRVSGQLGP-EI 95
Query: 70 SSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLF 129
L LDL +N G IP +GN +KL LDLS N FS IP + L L+ L+L+
Sbjct: 96 GELKSLQILDLSTNNFSGTIPSTLGNCTKLATLDLSENGFSDKIPDTLDSLKRLEVLYLY 155
Query: 130 KNQLSGSIPLEVGGXXXXXXXXXXXXXXEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI 189
N L+G +P + IP S+G+ LV L +Y N SG+IP I
Sbjct: 156 INFLTGELPESLFRIPKLQVLYLDYNNLTGPIPQSIGDAKELVELSMYANQFSGNIPESI 215
Query: 190 GXXXXXXXXXXXXXXXXGSIPQXXXXXXXXXXXXXXXXXXFGSIPSELGNLKYLSDLKLA 249
G GS+P+ G + N K L L L+
Sbjct: 216 GNSSSLQILYLHRNKLVGSLPESLNLLGNLTTLFVGNNSLQGPVRFGSPNCKNLLTLDLS 275
Query: 250 DNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSL 309
N+ G +P +L N ++L L I + +LSG IPS +G LK L+ + LS N+ SG IP L
Sbjct: 276 YNEFEGGVPPALGNCSSLDALVIVSGNLSGTIPSSLGMLKNLTILNLSENRLSGSIPAEL 335
Query: 310 GNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIY 369
GN S++ L L+ N L G IPS L L+ L LEL N+ G IP + +L+ L +Y
Sbjct: 336 GNCSSLNLLKLNDNQLVGGIPSALGKLRKLESLELFENRFSGEIPIEIWKSQSLTQLLVY 395
Query: 370 NNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPIXXXXXXXXXXXXFYKNSLSGAIPKEY 429
N+L+G +P E+ +K L L N +IP F N L+G IP
Sbjct: 396 QNNLTGELPVEMTEMKKLKIATLFNNSFYGAIPPGLGVNSSLEEVDFIGNKLTGEIPPNL 455
Query: 430 RNLVKLTKLFLGDNQFQGPIP-NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLS 488
+ KL L LG N G IP ++ + ++ R L N L+ + E F +L+F+D +
Sbjct: 456 CHGRKLRILNLGSNLLHGTIPASIGHCKTIRRFILRENNLSGLLPE-FSQDHSLSFLDFN 514
Query: 489 YNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAEL 548
NN G I G C L +++ S+N TG IPP++G L ++LS N + G +PA+L
Sbjct: 515 SNNFEGPIPGSLGSCKNLSSINLSRNRFTGQIPPQLGNLQNLGYMNLSRNLLEGSLPAQL 574
Query: 549 GKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLS 608
L + + N L+G + L L LS N S IP+ L L KL L ++
Sbjct: 575 SNCVSLERFDVGFNSLNGSVPSNFSNWKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIA 634
Query: 609 NNQFSWEIPIKL---EELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIP 665
N F EIP + E+LI+ +LDLS N L IP+++ + L +LN+S+N+L+G +
Sbjct: 635 RNAFGGEIPSSIGLIEDLIY--DLDLSGNGLTGEIPAKLGDLIKLTRLNISNNNLTGSLS 692
Query: 666 RCFEEMHALQCIDISYNELRGPIPNSTAFR--DAPIKALQGNKGLC--GDFKG------- 714
+ + +L +D+S N+ GPIP++ + P + GN LC F
Sbjct: 693 -VLKGLTSLLHVDVSNNQFTGPIPDNLEGQLLSEP-SSFSGNPNLCIPHSFSASNNSRSA 750
Query: 715 LPSCKALKSNKQASRKIWIVVLFPLLGIVALLISLIGLFFKFQRRKNKSQTKQSSPRNTP 774
L CK ++++ W +VL +L + +L+ ++ L F RR+ K + ++ + T
Sbjct: 751 LKYCKDQSKSRKSGLSTWQIVLIAVLSSLLVLVVVLALVFICLRRR-KGRPEKDAYVFTQ 809
Query: 775 GLRSMLTFEG-KIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLP 833
EG ++ +++ AT++ ++++ IG+G G VY+ L SG++ AVK+
Sbjct: 810 E-------EGPSLLLNKVLAATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVKRL--VFA 860
Query: 834 GEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAE 893
+ Q + E+ + ++RHRN++K GF ++Y Y+ GSL +L + E
Sbjct: 861 SHIRANQSMMREIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKE 920
Query: 894 D-LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952
+ L+W+ R +V G+A L+YLH DC PPIVHRDI +N+L+D E + DFG+A+ L
Sbjct: 921 NVLDWSARYNVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLD 980
Query: 953 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH------PG--DFX 1004
+ + + GT GY+APE A+ + DVYS+GV+ LE++ K P D
Sbjct: 981 DSTVSTATVTGTTGYIAPENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSFPESTDIV 1040
Query: 1005 XXXXXXXXXXXXALDE----ILDPRL--PIPSHNVQEKLISFVEVAISCLDESPESRPTM 1058
+++ I+DP L + +++E+++ E+A+SC + P RPTM
Sbjct: 1041 SWVRSALSSSNNNVEDMVTTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPTM 1100
Query: 1059 QKVSQLLK 1066
+ +LL+
Sbjct: 1101 RDAVKLLE 1108
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LP24 | Y1571_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4894 | 0.9868 | 0.9401 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh2_kg.1__3648__AT1G35710.1 | annotation not avaliable (1123 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1067 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-145 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-44 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-07 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-05 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 4e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 460 bits (1184), Expect = e-145
Identities = 321/988 (32%), Positives = 484/988 (48%), Gaps = 121/988 (12%)
Query: 95 NISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYS 154
N S++ +DLS SG I I L Y++T++L NQLSG IP ++ SS
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSS-------- 118
Query: 155 NYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLG 214
+L L L NN +GSIP G++ L L+L NN L+G IP +G
Sbjct: 119 ---------------SLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIG 161
Query: 215 NLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYN 274
+ S+L +L+L N L G IP+ L NL L L LA N+L G IP L + +L +Y+
Sbjct: 162 SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY 221
Query: 275 NSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELR 334
N+LSG IP EIG L L+ + L YN +G IP SLGNL N+ +LFL N L G IP +
Sbjct: 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281
Query: 335 NLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAF 394
+L+ L L+L +N L G IP + L NL +L +++N+ +G IP + +L L L L
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341
Query: 395 NKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIP-NLK 453
NK + IP +L NL+VL N+L+G IP+ + L KL L N +G IP +L
Sbjct: 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLG 401
Query: 454 NLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSK 513
SL RV L N + + F P + F+D+S NNL G I+S P L L ++
Sbjct: 402 ACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR 461
Query: 514 NNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLG 573
N G +P G S +LE LDLS N G +P +LG LS
Sbjct: 462 NKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLS--------------------- 499
Query: 574 LLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSY 633
+L L LS N LS IP+ L + KL L+LS+NQ S +IP E
Sbjct: 500 ---ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSE----------- 545
Query: 634 NFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTA 693
M L +L+LS N LSG IP+ + +L ++IS+N L G +P++ A
Sbjct: 546 -------------MPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592
Query: 694 FRDAPIKALQGNKGLCGDFK--GLPSCKALKSNKQASRKIWIVVLFPLLGIVALLISLIG 751
F A+ GN LCG GLP CK ++ W + LG L+++L+
Sbjct: 593 FLAINASAVAGNIDLCGGDTTSGLPPCKRVRKT-----PSWWFYITCTLG-AFLVLALVA 646
Query: 752 LFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGK----IVYEEIIRATNDFDDEHCIGKG 807
F F R +N + K+ N G + F+ K I +I+ + +E+ I +G
Sbjct: 647 FGFVFIRGRNNLELKRV--ENEDGTWELQFFDSKVSKSITINDILSSLK---EENVISRG 701
Query: 808 GQGSVYKVELASGEI-IAVKKFH--SPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFC 864
+G+ YK + + VK+ + + +P +E+ + +++H NIVK G C
Sbjct: 702 KKGASYKGKSIKNGMQFVVKEINDVNSIP---------SSEIADMGKLQHPNIVKLIGLC 752
Query: 865 SHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVH 924
+ +++++EY+E +L+ +L N L W +R + GIA AL +LH C P +V
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 925 RDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDV 984
++S + +++D K+E + + L D+ + A YVAPE T +TEK D+
Sbjct: 807 GNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA----YVAPETRETKDITEKSDI 861
Query: 985 YSFGVLALEVIKGKHPGDFISLISSSSLNL------NIALDEILDPRLPIPSHNVQEKLI 1038
Y FG++ +E++ GK P D + S + + LD +DP + Q +++
Sbjct: 862 YGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV 921
Query: 1039 SFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ +A+ C P +RP V + L+
Sbjct: 922 EVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-47
Identities = 73/270 (27%), Positives = 123/270 (45%), Gaps = 24/270 (8%)
Query: 798 FDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
++ +G+G G VY + +G+++A+K ++ L E+K L +++H N
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIK--KKKIKKDRERILREIKILKKLKHPN 58
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSLA-MILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
IV+ Y ++V EY E G L ++ +ED ++ I AL YLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR----FYLRQILSALEYLH 114
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 975
+ IVHRD+ +N+LLD +++DFG+A+ L P T GT Y+APE+
Sbjct: 115 SKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLG 170
Query: 976 MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH--NV 1033
+ D++S GV+ E++ GK P F L +I P+ P P ++
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPP--F-----PGDDQLLELFKKIGKPKPPFPPPEWDI 223
Query: 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQ 1063
+ + L + PE R T ++ Q
Sbjct: 224 SPEAKDLIR---KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 79/271 (29%), Positives = 122/271 (45%), Gaps = 17/271 (6%)
Query: 798 FDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
++ +G G G+VYK +G+I+AVK + Q E++ L + H N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
IV+ H ++V EY E G L LS L + + I L YLH+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHS 116
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYT 975
+ I+HRD+ +N+LLD +++DFG+AK L SS+ T GT Y+APE L
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 976 MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035
K DV+S GV+ E++ GK P + L+ + IL P L
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP-----FSGENILDQLQLIRRILGPPLEFDEPKWSS 228
Query: 1036 KLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
++ CL++ P RPT + ++L+
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAE---EILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 65/193 (33%), Positives = 105/193 (54%), Gaps = 10/193 (5%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G+GG G+VY +G+ +A+K + +E L E++ L ++ H NIVK YG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
H ++V EY E GSL +L + L + + ++ I + L YLH++ I
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 923 VHRDISSKNVLLDFKN-EARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTE 980
+HRD+ +N+LLD N + +++DFG++K L D S + GT Y+APE L +E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 981 KCDVYSFGVLALE 993
K D++S GV+ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 4e-44
Identities = 108/289 (37%), Positives = 150/289 (51%), Gaps = 4/289 (1%)
Query: 403 ISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVR 460
I+ +N + + + ++SG I L + + L +NQ GPIP+ +SL
Sbjct: 63 ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 461 VHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNI 520
++L N T +I PNL +DLS N L GEI +D G L LD N + G I
Sbjct: 123 LNLSNNNFTGSIPRGSI--PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 521 PPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEH 580
P + + LE L L+SN +VG IP ELG++ L + L N LSG++ ++G L L H
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 581 LDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAI 640
LDL NNL+ IP SLGNL L YL L N+ S IP + L L LDLS N L I
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 641 PSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIP 689
P + +Q+LE L+L N+ +G IP + LQ + + N+ G IP
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 85/275 (30%), Positives = 132/275 (48%), Gaps = 30/275 (10%)
Query: 797 DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
F+ IGKGG G VYK +G+ +A+K +++ +NE++ L + +H
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE---SKEKKEKIINEIQILKKCKHP 57
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
NIVK+YG +IV E+ GSL +L + + L +Q V K + L YLH
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 975
++ I+HRDI + N+LL E ++ DFG++ L D+ + GT ++APE+
Sbjct: 116 SN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMAPEVING 171
Query: 976 MKVTEKCDVYSFGVLALEVIKGKHP-GDFISLISSSSLNLNIALDEILD---PRLPIPSH 1031
K D++S G+ A+E+ +GK P + + AL +I P L P
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPPYSELPPM---------KALFKIATNGPPGLRNPEK 222
Query: 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
E F + CL ++PE RPT QLLK
Sbjct: 223 WSDE----FKDFLKKCLQKNPEKRPT---AEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 6e-40
Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 42/279 (15%)
Query: 802 HCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFL-NEVKALTEIRHRNIVK 859
+G+G GSVY ++ +GE++AVK L G+ + E L E++ L+ ++H NIV+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKS--VELSGDSEEELEALEREIRILSSLQHPNIVR 63
Query: 860 FYGFCSHAQHSF--IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG----IADALSY 913
+YG + + I EY+ GSL+ +L + VI+ I + L+Y
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAY 116
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE--LAGTYGYVAPE 971
LH++ IVHRDI N+L+D +++DFG AK L + + GT ++APE
Sbjct: 117 LHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 972 LAYTMKVTEKCDVYSFGVLALEVIKGKHP----GDFISLISSSSLNLNIALDEILDPRLP 1027
+ + D++S G +E+ GK P G+ ++ + I
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL------YKIGSSGEPP---E 224
Query: 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
IP H +E F+ CL P+ RPT +LL+
Sbjct: 225 IPEHLSEE-AKDFLR---KCLRRDPKKRPT---ADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 83/275 (30%), Positives = 133/275 (48%), Gaps = 26/275 (9%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+D + +G+G G VYKV +G+I A+KK H + G+ F+++ L E+K L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCES 58
Query: 855 RNIVKFYG-FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRM--SVIKGIADAL 911
+VK YG F + S IV EY++ GSLA D + + + + + + I L
Sbjct: 59 PYVVKCYGAFYKEGEIS-IVLEYMDGGSLA-----DLLKKVGKIPEPVLAYIARQILKGL 112
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 971
YLH I+HRDI N+L++ K E +++DFGI+K L+ GT Y++PE
Sbjct: 113 DYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170
Query: 972 LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD-PRLPIPS 1030
+ D++S G+ LE GK P F+ S L + I D P +P+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFP--FLPPGQPSFFEL---MQAICDGPPPSLPA 225
Query: 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+ F+ +CL + P+ RP+ ++LL
Sbjct: 226 EEFSPEFRDFIS---ACLQKDPKKRPS---AAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 77/283 (27%), Positives = 122/283 (43%), Gaps = 53/283 (18%)
Query: 804 IGKGGQGSVYKVEL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 858
+G+G G VYK +L +AVK + +EFL E + + ++ H N+V
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
K G C+ + +IV EY+E G L L L + +S IA + YL +
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN----------WTELAGTYGYV 968
+HRD++++N L+ ++SDFG+++ L D W
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM--------- 170
Query: 969 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEIL----- 1022
APE K T K DV+SFGVL E+ G+ P ++ +E+L
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP------------YPGMSNEEVLEYLKN 218
Query: 1023 DPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
RLP P + E ++ + C E PE RPT ++ ++L
Sbjct: 219 GYRLPQPPNCPPE----LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 77/283 (27%), Positives = 121/283 (42%), Gaps = 52/283 (18%)
Query: 804 IGKGGQGSVYKVEL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 858
+G+G G VYK L +AVK + +EFL E + + ++ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNIV 64
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
K G C+ + IV EY+ G L L ++L + +S IA + YL +
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN----------WTELAGTYGYV 968
+HRD++++N L+ ++SDFG+++ L D W
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM--------- 171
Query: 969 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILD---- 1023
APE K T K DV+SFGVL E+ G+ P ++ E+L+
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP------------YPGMSNAEVLEYLKK 219
Query: 1024 -PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
RLP P + E ++ + C E PE RPT ++ ++L
Sbjct: 220 GYRLPKPPNCPPE----LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 74/281 (26%), Positives = 116/281 (41%), Gaps = 48/281 (17%)
Query: 804 IGKGGQGSVYK-----VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 858
+G+G G VYK + +AVK E ++EFL E + ++ H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE--REEFLEEASIMKKLSHPNIV 64
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
+ G C+ + +IV EY+ G L L L+ + + IA + YL +
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLESKN 122
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYV-----APELA 973
F VHRD++++N L+ ++SDFG+++ + D G + APE
Sbjct: 123 F---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWMAPESL 176
Query: 974 YTMKVTEKCDVYSFGVLALEVI-------KGKHPGDFISLISSSSLNLNIALDEILDPRL 1026
K T K DV+SFGVL E+ G + + L+ RL
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED-------------GYRL 223
Query: 1027 PIPSHNVQE--KLISFVEVAISCLDESPESRPTMQKVSQLL 1065
P P + E +L+ C PE RPT ++ + L
Sbjct: 224 PRPENCPDELYELML------QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 73/292 (25%), Positives = 124/292 (42%), Gaps = 61/292 (20%)
Query: 804 IGKGGQGSVYKVEL----ASGEIIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRHRNI 857
+G+G G VYK +L +AVK L + + ++ +FL E + + ++ H N+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKT----LKEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSL------AMILSNDAAAEDLEWTQRMSVIKGIADAL 911
V+ G C+ + ++V EY+E G L + + L +S IA +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN-----------WTE 960
YL + VHRD++++N L+ ++SDFG+++ + D W
Sbjct: 119 EYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM- 174
Query: 961 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALD 1019
APE T K DV+SFGVL E+ G P ++ +
Sbjct: 175 --------APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP------------GLSNE 214
Query: 1020 EILDP-----RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
E+L+ RLP P + ++L + SC PE RPT ++ + L+
Sbjct: 215 EVLEYLRKGYRLPKPEY-CPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 72/280 (25%), Positives = 130/280 (46%), Gaps = 42/280 (15%)
Query: 798 FDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQE----FLNEVKALTEI 852
+ + IG+G G VYK + A+G+ +A+KK M +++ +NE+ + +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKK--------MRLRKQNKELIINEILIMKDC 72
Query: 853 RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALS 912
+H NIV +Y ++V EY++ GSL I++ + + Q V + + L
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV--RMNEPQIAYVCREVLQGLE 130
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
YLH+ ++HRDI S N+LL +++DFG A L + S + GT ++APE+
Sbjct: 131 YLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEV 187
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGKHPG-DF-----ISLISSSSLNLNIALDEILDPRL 1026
K D++S G++ +E+ +G+ P + LI++ + P L
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI-----------PPL 236
Query: 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ F+ CL + PE RP+ + +LL+
Sbjct: 237 K-NPEKWSPEFKDFLN---KCLVKDPEKRPSAE---ELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 84/281 (29%), Positives = 126/281 (44%), Gaps = 36/281 (12%)
Query: 797 DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
++ IGKG G VY V + G++ +K+ E +++ LNEVK L ++ H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHP 59
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAA-----ED--LEW-TQRMSVIKGI 907
NI+K+Y IV EY + G L+ + E+ L+W Q +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ-------L 112
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGY 967
AL YLH+ I+HRDI +N+ L ++ DFGI+K L + GT Y
Sbjct: 113 CLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY 169
Query: 968 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD-PRL 1026
++PEL K D++S G + E+ KHP F NL +IL
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP--F------EGENLLELALKILKGQYP 221
Query: 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLKI 1067
PIPS E L + V S L + PE RP+ ++Q+L+
Sbjct: 222 PIPSQYSSE-LRNLVS---SLLQKDPEERPS---IAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 84/279 (30%), Positives = 130/279 (46%), Gaps = 42/279 (15%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQ-------QEFLNEVKALTEIRHR 855
IG G G VY V L +GE++AVK E+ Q +E +E+K L ++H
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVK--------EIRIQDNDPKTIKEIADEMKVLELLKHP 59
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
N+VK+YG H + +I EY G+L +L + D + + + + L+YLH
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYT--LQLLEGLAYLH 116
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE----LAGTYGYVAPE 971
+ IVHRDI N+ LD ++ DFG A LK +++ E LAGT Y+APE
Sbjct: 117 SH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 972 LAYTMKVTEK---CDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028
+ K D++S G + LE+ GK P + L + + ++ + PI
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP--WSELDNEFQIMFHVGAGH----KPPI 227
Query: 1029 PSHNVQEKL-ISFVEVAISCLDESPESRPTMQKVSQLLK 1066
P F++ CL+ P+ RPT S+LL+
Sbjct: 228 PDSLQLSPEGKDFLD---RCLESDPKKRPT---ASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 73/268 (27%), Positives = 121/268 (45%), Gaps = 28/268 (10%)
Query: 803 CIGKGGQGSVYK-VELASGEIIAVKKF--HSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
IG+G G VYK + L +G+ +A+K+ + + + E+ L ++H NIVK
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL---KSIMQEIDLLKNLKHPNIVK 63
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
+ G + +I+ EY E GSL I+ + + + L+YLH
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQ-- 118
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 979
++HRDI + N+L +++DFG+A L S + + GT ++APE+ +
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 980 EKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL-DPRLPIPSHNVQEKLI 1038
D++S G +E++ G P LN AL I+ D P+P + +L
Sbjct: 178 TASDIWSLGCTVIELLTGNPP--------YYDLNPMAALFRIVQDDHPPLPE-GISPELK 228
Query: 1039 SFVEVAISCLDESPESRPTMQKVSQLLK 1066
F+ C + P RPT + QLLK
Sbjct: 229 DFLM---QCFQKDPNLRPTAK---QLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 84/277 (30%), Positives = 129/277 (46%), Gaps = 35/277 (12%)
Query: 803 CIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRHRNIVK 859
IGKG G+V KV + G+I+ K+ G MT + Q+ ++EV L E++H NIV+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDY---GNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 860 FYG-FCSHAQHS-FIVYEYLEMGSLAMILS-----NDAAAEDLEWTQRMSVIKGIADALS 912
+Y + + +IV EY E G LA ++ E+ W ++ + AL
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLALY 119
Query: 913 YLHN--DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAP 970
HN D ++HRD+ N+ LD N ++ DFG+AK L DSS GT Y++P
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP 179
Query: 971 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP-IP 1029
E M EK D++S G L E+ P + + L L + E R+P
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPP-----FTARNQLQLASKIKEGKFRRIPYRY 234
Query: 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
S + E +I S L+ P+ RP+ +LL+
Sbjct: 235 SSELNE-VIK------SMLNVDPDKRPS---TEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 73/269 (27%), Positives = 119/269 (44%), Gaps = 20/269 (7%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+D + +G G G V KV +G+I+AVK L Q++ L E+ L +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNS 58
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
IV FYG + I EY++ GSL IL +++V + L+YL
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYL 116
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
H I+HRD+ N+L++ + + ++ DFG++ L + GT Y+APE
Sbjct: 117 HEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQ 172
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD---PRLPIPSH 1031
+ K D++S G+ +E+ G+ P + L L I++ PRL PS
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL---LQYIVNEPPPRL--PSG 227
Query: 1032 NVQEKLISFVEVAISCLDESPESRPTMQK 1060
FV + CL + P RP+ ++
Sbjct: 228 KFSPDFQDFVNL---CLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 88/278 (31%), Positives = 135/278 (48%), Gaps = 37/278 (13%)
Query: 804 IGKGGQGSVY-KVELASGEIIAVKKFHSPLPGEMTFQQE------FLNEVKALTEIRHRN 856
IG G GSVY + +SGE++AVK+ P + ++ E+ L E++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
IV++ G A H I EY+ GS+A +L+N A E T + ++ I L+YLHN
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQILKGLNYLHN 124
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT------ELAGTYGYVAP 970
I+HRDI N+L+D K ++SDFGI+K L+ +S + L G+ ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 971 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPS 1030
E+ T K D++S G L +E++ GKHP A+ +I + P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP--------FPDCTQLQAIFKIGENASPEIP 233
Query: 1031 HNVQEKLISFVE--VAISCLDESPESRPTMQKVSQLLK 1066
N+ + I F+E I RPT ++LLK
Sbjct: 234 SNISSEAIDFLEKTFEIDH-----NKRPT---AAELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 72/267 (26%), Positives = 122/267 (45%), Gaps = 17/267 (6%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH-RNIVKFYG 862
+G+G G VY +++A+K L + + FL E++ L + H NIVK Y
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
F ++V EY++ GSL +L L ++ + ++ I AL YLH+ I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---I 122
Query: 923 VHRDISSKNVLLDFK-NEARVSDFGIAKFLKPDSSN------WTELAGTYGYVAPELAYT 975
+HRDI +N+LLD ++ DFG+AK L S + GT GY+APE+
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 976 M---KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032
+ + D++S G+ E++ G P + S++S L I L+ S +
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 1033 VQEKLIS-FVEVAISCLDESPESRPTM 1058
E + ++ L + P++R +
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 76/266 (28%), Positives = 125/266 (46%), Gaps = 26/266 (9%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
+G G G V+ + +A+K G M+ + +F+ E K + ++ H N+V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE---GAMS-EDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 864 CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIV 923
C+ + FIV EY+ G L L EW + + + +A+ YL ++ F +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNGF---I 122
Query: 924 HRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 980
HRD++++N L+ N +VSDFG+A+++ D +T GT + PE+ + +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDD--QYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 981 KCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039
K DV+SFGVL EV +GK P + S N + RL P ++
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFS-------NSEVVESVSAGYRLYRP-KLAPTEV-- 230
Query: 1040 FVEVAISCLDESPESRPTMQKVSQLL 1065
+ SC E PE RP +K+ L
Sbjct: 231 -YTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 76/271 (28%), Positives = 123/271 (45%), Gaps = 29/271 (10%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
IGKG G VYK L +AVK S LP ++ +++FL E + L + H NIVK G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL--KRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 864 CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIV 923
C Q +IV E + GSL L L + + + A + YL + +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 924 HRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT----YGYVAPELAYTMKVT 979
HRD++++N L+ N ++SDFG+++ + + +T G + APE + T
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 980 EKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP--RLPIPSHNVQEK 1036
+ DV+S+G+L E G P +S N E ++ R+P P +E
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYPGMS---------NQQTRERIESGYRMPAPQLCPEE- 223
Query: 1037 LISFVEVAISCLDESPESRPTMQKVSQLLKI 1067
+ + C PE+RP+ ++ L+I
Sbjct: 224 ---IYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 81/283 (28%), Positives = 121/283 (42%), Gaps = 48/283 (16%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+ IGKG G V + G+ +AVK L + T Q FL E +T +RH
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKC----LKDDSTAAQAFLAEASVMTTLRHP 60
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
N+V+ G +IV EY+ GSL L + A + Q++ + + + YL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE 119
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK--FLKPDSS----NWTELAGTYGYVA 969
F VHRD++++NVL+ A+VSDFG+AK DS WT A
Sbjct: 120 EKNF---VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT---------A 167
Query: 970 PELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP---- 1024
PE K + K DV+SFG+L E+ G+ P I L +++
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP------------RIPLKDVVPHVEKG 215
Query: 1025 -RLPIPSHNVQEKLISFV-EVAISCLDESPESRPTMQKVSQLL 1065
R+ P E V +V C + P RPT +++ + L
Sbjct: 216 YRMEAP-----EGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 80/278 (28%), Positives = 138/278 (49%), Gaps = 35/278 (12%)
Query: 796 NDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
FD +G+G GSVYK + +G+++A+K P+ ++ QE + E+ L +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDL---QEIIKEISILKQCDS 57
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSL--AMILSNDAAAEDLEWTQRMSVIKGIADALS 912
IVK+YG +IV EY GS+ M ++N E+ + +++ L
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE----EIAAILYQTLKGLE 113
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
YLH++ +HRDI + N+LL+ + +A+++DFG++ L + + GT ++APE+
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032
+ K D++S G+ A+E+ +GK P S ++ A+ I P P P+ +
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPP--------YSDIHPMRAIFMI--PNKPPPTLS 220
Query: 1033 VQEK----LISFVEVAISCLDESPESRPTMQKVSQLLK 1066
EK FV+ CL + PE RP+ QLL+
Sbjct: 221 DPEKWSPEFNDFVK---KCLVKDPEERPS---AIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 76/271 (28%), Positives = 119/271 (43%), Gaps = 24/271 (8%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG G VY L + E +A+K+ L T E EV+A+++ H N+VK+Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRID--LEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
++V YL GSL I+ + L+ +V+K + L YLH++
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQ 123
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW----TELAGTYGYVAPELAYTMK- 977
+HRDI + N+LL +++DFG++ L GT ++APE+ +
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 978 VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKL 1037
K D++SFG+ A+E+ G P + L L + D P L K
Sbjct: 184 YDFKADIWSFGITAIELATGAAP--YSKYPPMKVLMLTLQNDP---PSLE---TGADYKK 235
Query: 1038 IS--FVEVAISCLDESPESRPTMQKVSQLLK 1066
S F ++ CL + P RPT +LLK
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPT---AEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 60/203 (29%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 804 IGKGGQGSVY-KVELASGEIIAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIRHRNI 857
IG+G G+VY +++A+G+ +A+K +M QQ+ +NE+ + E +H NI
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKHPNI 78
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
V + ++V EYL GSL +++ E Q +V + AL +LH++
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN 134
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 977
++HRDI S N+LL +++DFG + P+ S + + GT ++APE+
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 978 VTEKCDVYSFGVLALEVIKGKHP 1000
K D++S G++A+E+++G+ P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 67/232 (28%), Positives = 116/232 (50%), Gaps = 23/232 (9%)
Query: 834 GEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAE 893
G M+ + EF+ E K + ++ H +V+ YG C+ + +IV EY+ G L L +
Sbjct: 39 GSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE--HGK 95
Query: 894 DLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953
+ +Q + + K + + ++YL + F +HRD++++N L+D + +VSDFG+++++
Sbjct: 96 RFQPSQLLEMCKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152
Query: 954 DSSNWTELAGT---YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISS 1009
D +T G+ + PE+ K + K DV++FGVL EV GK P + +
Sbjct: 153 DE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN---- 206
Query: 1010 SSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
N RL P H EK+ + + SC E E RPT Q++
Sbjct: 207 ---NSETVEKVSQGLRLYRP-HLASEKVYA---IMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 72/266 (27%), Positives = 126/266 (47%), Gaps = 41/266 (15%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
+G G G V+ +AVK PG M+ + FL E + + ++RH +V+ Y
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMS-PEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 864 CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIV 923
CS + +IV EY+ GSL L + + L Q + + IA+ ++YL + + +
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRNY---I 125
Query: 924 HRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN----------WTELAGTYGYVAPELA 973
HRD++++N+L+ +++DFG+A+ ++ D WT APE A
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT---------APEAA 176
Query: 974 YTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEI-LDPRLPIPSH 1031
+ T K DV+SFG+L E++ G+ P + L+++ R+P P +
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP--------YPGMTNREVLEQVERGYRMPRPPN 228
Query: 1032 NVQEKLISFVEVAISCLDESPESRPT 1057
+E ++ + C D+ PE RPT
Sbjct: 229 CPEE----LYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 80/284 (28%), Positives = 125/284 (44%), Gaps = 45/284 (15%)
Query: 797 DFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEF---LNEVKALTEI 852
D++ IG G G VYK ++A+GE++A+K ++ +F E+ L E
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI------KLEPGDDFEIIQQEISMLKEC 57
Query: 853 RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALS 912
RH NIV ++G +IV EY GSL I L Q V + L+
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLA 115
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
YLH +HRDI N+LL + +++DFG++ L + GT ++APE+
Sbjct: 116 YLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 973 A---YTMKVTEKCDVYSFGVLALEVIKGK------HPGDFISLISSSSLNLNIALDEILD 1023
A KCD+++ G+ A+E+ + + HP + LIS S+
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN----------FP 222
Query: 1024 PRLPIPSHNVQEK----LISFVEVAISCLDESPESRPTMQKVSQ 1063
P P +EK F++ CL + P+ RPT K+ Q
Sbjct: 223 P----PKLKDKEKWSPVFHDFIKK---CLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 76/276 (27%), Positives = 128/276 (46%), Gaps = 43/276 (15%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH---RNIVK 859
IG+G G+VY+ + +G ++A+K + P + + EV L+++R NI K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV--SDIQREVALLSQLRQSQPPNITK 66
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVI-KGIADALSYLHNDC 918
+YG +I+ EY E GS+ ++ AE + +SVI + + AL Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE-----KYISVIIREVLVALKYIHKV- 120
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----A 973
++HRDI + N+L+ ++ DFG+A L +SS + GT ++APE+
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD---PRLPIPS 1030
Y K D++S G+ E+ G P S ++ A+ I PRL
Sbjct: 179 YDTKA----DIWSLGITIYEMATGNPP--------YSDVDAFRAMMLIPKSKPPRLEDNG 226
Query: 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
++ + E +CLDE P+ R + +LLK
Sbjct: 227 YSKLLR-----EFVAACLDEEPKERLS---AEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 77/276 (27%), Positives = 130/276 (47%), Gaps = 33/276 (11%)
Query: 797 DFDDEHCIGKGGQGSV-YKVELASGEIIAVKKFHSPLPGEMTFQQ--EFL-NEVKALTEI 852
D+ IG+G G V + ++G +AVKK ++ QQ E L NEV + +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM------DLRKQQRRELLFNEVVIMRDY 73
Query: 853 RHRNIVKFYGFCSH--AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADA 910
+H NIV+ Y S+ ++V E+LE G+L I+++ E+ Q +V + A
Sbjct: 74 QHPNIVEMYS--SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLAVLKA 127
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAP 970
LS+LH ++HRDI S ++LL ++SDFG + + L GT ++AP
Sbjct: 128 LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 184
Query: 971 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPS 1030
E+ + + D++S G++ +E++ G+ P + L + + L P+L
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPP-----YFNEPPLQAMKRIRDNLPPKLKNL- 238
Query: 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
H V +L SF++ L P R T +LL
Sbjct: 239 HKVSPRLRSFLD---RMLVRDPAQRATAA---ELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 35/278 (12%)
Query: 796 NDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKF---HSPLPGEMTFQQEFLNEVKALTE 851
F CIGKG G VYK ++ + +++A+K + E+ Q+ E++ L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQ---EIQFLSQ 55
Query: 852 IRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADAL 911
R I K+YG +I+ EY GS +L L+ T +++ + L
Sbjct: 56 CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVLLGL 111
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 971
YLH + +HRDI + N+LL + + +++DFG++ L S GT ++APE
Sbjct: 112 EYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPE 168
Query: 972 LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPS- 1030
+ EK D++S G+ A+E+ KG+ P S L+ L I P+ PS
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPP--------LSDLHPMRVLFLI--PKNNPPSL 218
Query: 1031 --HNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ + FV CL++ P+ RP+ +LLK
Sbjct: 219 EGNKFSKPFKDFVS---LCLNKDPKERPS---AKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 75/265 (28%), Positives = 123/265 (46%), Gaps = 25/265 (9%)
Query: 797 DFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFH-SPLPGEMTFQQEFLNEVKALTEIRH 854
DF+ + IGKG G V+K V A + A+K+ S + ++E ++E + L ++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE--REEAIDEARVLAKLDS 58
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAA---AEDLEWTQRMSVIKGIADAL 911
I+++Y IV EY E G L +L ED W + ++ G L
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 971
++LH+ I+HRDI S N+ LD + ++ D G+AK L +++ + GT Y++PE
Sbjct: 115 AHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171
Query: 972 LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031
L EK DV++ GV+ E GKHP D + N + +I+ P S
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD--------ANNQGALILKIIRGVFPPVSQ 223
Query: 1032 NVQEKLISFVEVAISCLDESPESRP 1056
++L ++ CL + RP
Sbjct: 224 MYSQQLAQLID---QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 76/273 (27%), Positives = 135/273 (49%), Gaps = 34/273 (12%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIRHRNI 857
IG+G G+VY +++A+G+ +A++ +M QQ+ +NE+ + E ++ NI
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
V + ++V EYL GSL +++ E Q +V + AL +LH++
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHSN 135
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 977
++HRDI S N+LL +++DFG + P+ S + + GT ++APE+
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 978 VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKL 1037
K D++S G++A+E+I+G+ P ++ + L + P L P EKL
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP-----YLNENPLRALYLIATNGTPELQNP-----EKL 242
Query: 1038 IS-FVEVAISCLDESPESRPTMQKV--SQLLKI 1067
+ F + CLD E R + +++ Q LKI
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 801 EHCIGKGGQGSVYK--VELASGEII--AVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
E IG G G V + ++L + I A+K + + + +FL E + + H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ--RLDFLTEASIMGQFDHPN 66
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSLAMIL-SNDAAAEDLEWTQRMSVIKGIADALSYLH 915
I++ G + ++ I+ EY+E GSL L ND Q + +++GIA + YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLS 123
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG--YVAPE-L 972
+ VHRD++++N+L++ +VSDFG+++ L+ + +T G + APE +
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 973 AYTMKVTEKCDVYSFGVLALEVI 995
AY K T DV+SFG++ EV+
Sbjct: 181 AYR-KFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 72/269 (26%), Positives = 129/269 (47%), Gaps = 32/269 (11%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
+G G G V+ + + +A+K + G M+ +++F+ E K + ++ H +V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE---GAMS-EEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 864 CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIV 923
C+ + +IV E++E G L L L +S+ + + + + YL + F +
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGK--LSKDMLLSMCQDVCEGMEYLERNSF---I 122
Query: 924 HRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 980
HRD++++N L+ +VSDFG+ +++ D +T +G + PE+ K +
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--YTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 981 KCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIAL---DEILDPRLPIPSHNVQEK 1036
K DV+SFGVL EV +GK P + S+ + + + P+L S V
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFE-----KKSNYEVVEMISRGFRLYRPKL--ASMTV--- 230
Query: 1037 LISFVEVAISCLDESPESRPTMQKVSQLL 1065
EV SC E PE RPT ++ + +
Sbjct: 231 ----YEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 3e-22
Identities = 58/198 (29%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG+G G+V+ +++A+G+ +A+K+ + + ++ +NE+ + E+++ NIV F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQ---KQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
F+V EYL GSL +++ E Q +V + AL +LH + +
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDE----AQIAAVCRECLQALEFLHAN---QV 136
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 982
+HRDI S NVLL +++DFG + P+ S + + GT ++APE+ K
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 983 DVYSFGVLALEVIKGKHP 1000
D++S G++A+E+++G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 3e-22
Identities = 59/203 (29%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQE-----FLNEVKALTEIRHRNI 857
IG+G G+VY +++A+G+ +A+K +M QQ+ +NE+ + E ++ NI
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKNPNI 78
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
V + ++V EYL GSL +++ E Q +V + AL +LH++
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALDFLHSN 134
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 977
++HRDI S N+LL +++DFG + P+ S + + GT ++APE+
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 978 VTEKCDVYSFGVLALEVIKGKHP 1000
K D++S G++A+E+++G+ P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 4e-22
Identities = 78/270 (28%), Positives = 144/270 (53%), Gaps = 30/270 (11%)
Query: 798 FDDEHCIGKGGQGSVY-KVELASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRH 854
F D IG G G+VY ++ + E++A+KK G+ + + Q+ + EV+ L ++RH
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 855 RNIVKFYGFCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
N +++ G C +H+ ++V EY +GS + IL + + L+ + ++ G L+Y
Sbjct: 75 PNTIEYKG-CYLREHTAWLVMEYC-LGSASDIL--EVHKKPLQEVEIAAICHGALQGLAY 130
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
LH+ +HRDI + N+LL +++DFG A + P +S GT ++APE+
Sbjct: 131 LHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVI 183
Query: 974 YTM---KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPS 1030
M + K DV+S G+ +E+ + K P ++ + S+L +IA ++ P L S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSAL-YHIAQND--SPTL--SS 236
Query: 1031 HNVQEKLISFVEVAISCLDESPESRPTMQK 1060
++ + +FV+ SCL + P+ RP+ ++
Sbjct: 237 NDWSDYFRNFVD---SCLQKIPQDRPSSEE 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 75/268 (27%), Positives = 122/268 (45%), Gaps = 31/268 (11%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRHRNIVKF 860
+GKG GSVYKV+ L+ + A+K+ G M+ ++ + +NE++ L + H NI+ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDL---GSMSQKEREDAVNEIRILASVNHPNIISY 64
Query: 861 YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAA-----EDLEWTQRMSVIKGIADALSYLH 915
IV EY G L+ +S E W + +++G L LH
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----LQALH 120
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 975
I+HRD+ S N+LL + ++ D GI+K LK + + T++ GT Y+APE+
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQI-GTPHYMAPEVWKG 175
Query: 976 MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035
+ K D++S G L E+ P + S+ L + PIP Q+
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKV----QRGKYPPIPPIYSQD 228
Query: 1036 KLISFVEVAISCLDESPESRPTMQKVSQ 1063
L +F+ S L P+ RP K+
Sbjct: 229 -LQNFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 12/210 (5%)
Query: 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 861
IGKG G V V+ + ++ A+K + E + LNE + L E+ H +V Y
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 862 GFCSHAQHSFIVYEYLEMGSLAM-ILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
F ++ ++V + L G L + +E+ + + + I AL YLH+
Sbjct: 68 SFQDE-ENMYLVVDLLLGGDLRYHLSQKVKFSEE---QVKFWICE-IVLALEYLHSK--- 119
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 980
I+HRDI N+LLD + ++DF IA + PD+ T +GT GY+APE+ +
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-TSTSGTPGYMAPEVLCRQGYSV 178
Query: 981 KCDVYSFGVLALEVIKGKHPGDFISLISSS 1010
D +S GV A E ++GK P S
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 7e-22
Identities = 70/272 (25%), Positives = 122/272 (44%), Gaps = 25/272 (9%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVK--KFHSPLPGEM-TFQQEFLNEVKALTEIRHRNIVK 859
+G G S Y+ ++ +G ++AVK + E + E++ + + H +I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
G H + E++ GS++ +LS A ++ ++ + + LSYLH +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122
Query: 920 PPIVHRDISSKNVLLDFKNE-ARVSDFGIAKFLKPDSSNWTE----LAGTYGYVAPELAY 974
I+HRD+ N+L+D + R++DFG A L + E L GT ++APE+
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034
+ CDV+S G + +E+ K P + + +L IA P IP H
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA-SATTAP--SIPEHLSP 238
Query: 1035 EKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+V + CL+ PE RP +LLK
Sbjct: 239 ----GLRDVTLRCLELQPEDRP---PSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 8e-22
Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 804 IGKGGQGSVYKVELASG------EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
+G+G G V+ E E++AVK + +++F E + LT +H NI
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA--RKDFEREAELLTNFQHENI 70
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMIL-----------SNDAAAEDLEWTQRMSVIKG 906
VKFYG C+ +V+EY+E G L L S D+ +L +Q + +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT-- 964
IA + YL + F VHRD++++N L+ + ++ DFG+++ + ++++ + G
Sbjct: 131 IASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSRDVY--TTDYYRVGGHTM 185
Query: 965 --YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 1000
++ PE K T + DV+SFGV+ E+ GK P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 72/260 (27%), Positives = 129/260 (49%), Gaps = 25/260 (9%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
+G G G V++ + +AVK PG M ++FL E + + ++RH +++ Y
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 864 CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIV 923
C+ + +IV E ++ GSL L A L+ Q + + +A ++YL + +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQNY---I 125
Query: 924 HRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 982
HRD++++NVL+ N +V+DFG+A+ +K D E A + APE A + + K
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 983 DVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP--RLPIPSHNVQEKLIS 1039
DV+SFG+L E++ G+ P ++ N + + +D R+P P +E
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMT---------NAEVLQQVDQGYRMPCPPGCPKE---- 232
Query: 1040 FVEVAISCLDESPESRPTMQ 1059
++ + C E P+ RPT +
Sbjct: 233 LYDIMLDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 74/277 (26%), Positives = 122/277 (44%), Gaps = 44/277 (15%)
Query: 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG+G G V+ L A +AVK LP ++ + +FL E + L + H NIV+ G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 60
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
C+ Q +IV E ++ G L + L+ + + +++ A + YL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG-----------YVAPE 971
+HRD++++N L+ KN ++SDFG+++ E G Y + APE
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR---------EEEDGVYASTGGMKQIPVKWTAPE 166
Query: 972 LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL-NIALDEILDP--RLPI 1028
+ + + DV+SFG+L E SL + NL N E ++ RLP
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEA---------FSLGAVPYANLSNQQTREAIEQGVRLPC 217
Query: 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
P + + +E C + P RP+ V Q L
Sbjct: 218 PE-LCPDAVYRLME---RCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 73/269 (27%), Positives = 131/269 (48%), Gaps = 25/269 (9%)
Query: 793 RATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 852
R +F E +G G G V++ + +A+K S ++ QQ+F EV+AL +
Sbjct: 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS---DDLLKQQDFQKEVQALKRL 59
Query: 853 RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALS 912
RH++++ + CS + +I+ E +E GSL L + L + + +A+ ++
Sbjct: 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMA 118
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD--SSNWTELAGTYGYVAP 970
YL +HRD++++N+L+ +V+DFG+A+ +K D S+ ++ Y + AP
Sbjct: 119 YLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKWTAP 173
Query: 971 ELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP-RLPI 1028
E A + K DV+SFG+L E+ G+ P +N + D+I R+P
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVP--------YPGMNNHEVYDQITAGYRMPC 225
Query: 1029 PSHNVQEKLISFVEVAISCLDESPESRPT 1057
P+ QE ++ + C PE RP+
Sbjct: 226 PAKCPQE----IYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 38/274 (13%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRHRNIVKF 860
+G G GSVY+ + L G+ AVK+ G+ + ++ E+ L++++H NIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 861 YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
G + +I E + GSLA +L + + I L YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGS---FPEPVIRLYTRQILLGLEYLHDR--- 121
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AYT 975
VHRDI N+L+D +++DFG+AK + + S G+ ++APE+ Y
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 976 MKVTEKCDVYSFGVLALEVIKGKHP-GDF--ISLISSSSLNLNIALDEILDPRLPIPSHN 1032
+ D++S G LE+ GK P ++ + I + L PIP H
Sbjct: 181 LAA----DIWSLGCTVLEMATGKPPWSQLEGVAAV------FKIGRSKELP---PIPDH- 226
Query: 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ ++ F+ + CL P RPT ++LL+
Sbjct: 227 LSDEAKDFI---LKCLQRDPSLRPT---AAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 64/211 (30%), Positives = 110/211 (52%), Gaps = 21/211 (9%)
Query: 801 EHCIGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIRHR 855
+ IG G G V++ L +A+K PG Q Q+FL+E + + H
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK---PGYTEKQRQDFLSEASIMGQFSHH 66
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWT--QRMSVIKGIADALSY 913
NI++ G + + + I+ EY+E G+L L + D E++ Q + +++GIA + Y
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRD----HDGEFSSYQLVGMLRGIAAGMKY 122
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD-SSNWTELAGTYG--YVAP 970
L + + VHRD++++N+L++ E +VSDFG+++ L+ D +T G + AP
Sbjct: 123 LSDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 971 ELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 1000
E K T DV+SFG++ EV+ G+ P
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 16/199 (8%)
Query: 801 EHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
+H +G G G VY+ V +AVK L + +EFL E + EI+H N+V+
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
G C+ +I+ E++ G+L L + +++ + + I+ A+ YL F
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT---YGYVAPE-LAYT 975
+HRD++++N L+ + +V+DFG+++ + D+ +T AG + APE LAY
Sbjct: 126 ---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN 180
Query: 976 MKVTEKCDVYSFGVLALEV 994
K + K DV++FGVL E+
Sbjct: 181 -KFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 4e-21
Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 26/264 (9%)
Query: 804 IGKGGQGSV-YKVELASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIRHRNIVK 859
IG+G G V E +G+ +AVKK ++ QQ NEV + + H N+V
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM------DLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
Y ++V E+LE G+L I+++ E+ T +SV++ ALSYLHN
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR----ALSYLHNQ-- 137
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 979
++HRDI S ++LL ++SDFG + + L GT ++APE+ +
Sbjct: 138 -GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 980 EKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039
+ D++S G++ +E+I G+ P + L + + L PR+ SH V L
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPP-----YFNEPPLQAMRRIRDNLPPRVK-DSHKVSSVLRG 250
Query: 1040 FVEVAISCLDESPESRPTMQKVSQ 1063
F+++ L P R T Q++ Q
Sbjct: 251 FLDLM---LVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 5e-21
Identities = 72/264 (27%), Positives = 123/264 (46%), Gaps = 26/264 (9%)
Query: 804 IGKGGQGSV-YKVELASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIRHRNIVK 859
IG+G G V E SG +AVK ++ QQ NEV + + +H+N+V+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM------DLRKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
Y + +++ E+L+ G+L I+S E+ Q +V + + AL YLH+
Sbjct: 83 MYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEE----QIATVCESVLQALCYLHSQ-- 136
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 979
++HRDI S ++LL ++SDFG + D L GT ++APE+
Sbjct: 137 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 980 EKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039
+ D++S G++ +E++ G+ P S S + L + P+L +H + L
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPP-----YFSDSPVQAMKRLRDSPPPKLK-NAHKISPVLRD 249
Query: 1040 FVEVAISCLDESPESRPTMQKVSQ 1063
F+E L P+ R T Q++
Sbjct: 250 FLE---RMLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 75/284 (26%), Positives = 118/284 (41%), Gaps = 49/284 (17%)
Query: 804 IGKGGQGSVYKVEL-----ASGEIIAVKKF-HSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
+G+G G V +GE +AVK HS GE + +F E++ L + H NI
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS---GEEQHRSDFEREIEILRTLDHENI 68
Query: 858 VKFYGFC--SHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
VK+ G C + ++ EYL GSL L +L + + I + YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL--KRLLLFSSQICKGMDYLG 126
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYV------- 968
+ +HRD++++N+L++ ++ ++SDFG+AK L D Y YV
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD--------YYYVKEPGESP 175
Query: 969 ----APELAYTMKVTEKCDVYSFGVLALEVI----KGKHPGDFISLISSSSLNLNIALD- 1019
APE T K + DV+SFGV E+ + P + + I
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235
Query: 1020 -EILDP--RLPIPSHNVQEKLISFV-EVAISCLDESPESRPTMQ 1059
E+L RLP P V ++ C + P+ RP+
Sbjct: 236 LELLKEGERLPRP-----PSCPDEVYDLMKLCWEAEPQDRPSFA 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 52/283 (18%)
Query: 804 IGKGGQGSVYK--VELASGEII--AVKKFHSPLPGEM-TFQQEFLNEVKALTEIRHRNIV 858
+G G GSV K + SG+ + AVK + ++EFL E + ++ H IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSND---AAAEDLEWTQRMSVIKGIADALSYLH 915
+ G C + +V E +G L L ++ E + +A ++YL
Sbjct: 60 RLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLE 112
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG-----YVAP 970
+ F VHRD++++NVLL +++A++SDFG+++ L S + A T G + AP
Sbjct: 113 SKHF---VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAP 167
Query: 971 ELAYTMKVTEKCDVYSFGVLALEVI-------KGKHPGDFISLISSSSLNLNIALDEILD 1023
E K + K DV+S+GV E + I+++ S
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE------------ 215
Query: 1024 PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
RLP P QE + +SC PE RPT ++ +
Sbjct: 216 -RLPRPEECPQE----IYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 7e-21
Identities = 75/270 (27%), Positives = 130/270 (48%), Gaps = 32/270 (11%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
+G G G V+ +AVK PG M+ + FL E + + ++RH +V+ Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMS-PESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 864 CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIV 923
S + +IV EY+ GSL L D L+ + + +A ++Y+ + +
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMNY---I 124
Query: 924 HRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 980
HRD+ S N+L+ +++DFG+A+ + + + +T G + APE A + T
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 981 KCDVYSFGVLALEVI-KGK--HPGDFISLISSSSLNLNIALDEI-LDPRLPIPSHNVQEK 1036
K DV+SFG+L E++ KG+ +PG +N L+++ R+P P Q+
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPG----------MNNREVLEQVERGYRMPCP----QDC 228
Query: 1037 LISFVEVAISCLDESPESRPTMQKVSQLLK 1066
IS E+ + C + PE RPT + + L+
Sbjct: 229 PISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 9e-21
Identities = 74/272 (27%), Positives = 127/272 (46%), Gaps = 36/272 (13%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
+G+G G V+ +A+K PG M+ + FL E + + ++RH +V+ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 864 CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIV 923
S + +IV EY+ GSL L + L Q + + IA ++Y+ + V
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNY---V 124
Query: 924 HRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 980
HRD+ + N+L+ +V+DFG+A+ + + + +T G + APE A + T
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 981 KCDVYSFGVLALEV-IKGKHPGDFISLISSSSLNLNIALDEILDP-----RLPIPSHNVQ 1034
K DV+SFG+L E+ KG+ P + +++ E+LD R+P P
Sbjct: 183 KSDVWSFGILLTELTTKGRVP--YPGMVNR----------EVLDQVERGYRMPCPP---- 226
Query: 1035 EKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
E S ++ C + PE RPT + + L+
Sbjct: 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG+G G VYK + +GEI+A+KK + L E+K L E+ H NI+K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
H ++V+E+++ +I L + S + + L++ H+ I
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLI---KDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV-TEK 981
+HRD+ +N+L++ + +++DFG+A+ +T T Y APEL K +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 982 CDVYSFGVLALEVIKGK--HPGD 1002
D++S G + E++ + PG
Sbjct: 180 VDIWSVGCIFAELLSRRPLFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 1e-20
Identities = 77/268 (28%), Positives = 134/268 (50%), Gaps = 32/268 (11%)
Query: 798 FDDEHCIGKGGQGSVY-KVELASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRH 854
F D IG G G+VY ++ + E++A+KK G+ + + Q+ + EV+ L ++RH
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 855 RNIVKFYGFCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
N +++ G C +H+ ++V EY +GS + +L + + L+ + +V G L+Y
Sbjct: 75 PNTIQYRG-CYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
LH+ ++HRD+ + N+LL ++ DFG A + P + GT ++APE+
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVI 183
Query: 974 YTMKVTE---KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPI-P 1029
M + K DV+S G+ +E+ + K P ++N AL I P
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP--------LFNMNAMSALYHIAQNESPALQ 235
Query: 1030 SHNVQEKLISFVEVAISCLDESPESRPT 1057
S + E +FV+ SCL + P+ RPT
Sbjct: 236 SGHWSEYFRNFVD---SCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 79/272 (29%), Positives = 123/272 (45%), Gaps = 27/272 (9%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLN---EVKALTEIRHRNIVKF 860
+GKG G+VY G++IAVK+ + ++E+ EV L ++H NIV++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 861 YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
G C I E++ GS++ IL+ + + + K I D ++YLHN+C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE------LAGTYGYVAPELAY 974
+VHRDI NV+L ++ DFG A+ L + T + GT ++APE+
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034
K D++S G E+ GK P ++ + + I L PRLP +
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPP---LASMDRLAAMFYIGAHRGLMPRLP---DSFS 235
Query: 1035 EKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
I FV SCL RP+ QLL+
Sbjct: 236 AAAIDFVT---SCLTRDQHERPS---ALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 79/272 (29%), Positives = 130/272 (47%), Gaps = 36/272 (13%)
Query: 804 IGKGGQGSVY-KVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL-TEIR------HR 855
IGKG G VY + + +GE++AVK+ P + VKAL +EI H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAA-AEDLEWTQRMSVIKGIADALSYL 914
NIV++ GF + ++ I EY+ GS+ L E L V++G L+YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG----LAYL 124
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP--DSSNWTELAGTYGYVAPEL 972
H+ I+HRD+ + N+L+D ++SDFGI+K D+ + G+ ++APE+
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 973 --AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEI--LDPRLPI 1028
+Y+ + K D++S G + LE+ G+ P S A+ ++ PI
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW--------SDEEAIAAMFKLGNKRSAPPI 233
Query: 1029 P---SHNVQEKLISFVEVAISCLDESPESRPT 1057
P S N+ + F+ +C +P++RPT
Sbjct: 234 PPDVSMNLSPVALDFLN---ACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-20
Identities = 77/267 (28%), Positives = 134/267 (50%), Gaps = 30/267 (11%)
Query: 798 FDDEHCIGKGGQGSVY-KVELASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRH 854
F H IG G G+VY + E++AVKK G+ T + Q+ + EVK L +++H
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKM--SYSGKQTNEKWQDIIKEVKFLQQLKH 80
Query: 855 RNIVKFYGFCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
N +++ G C +H+ ++V EY +GS + +L + + L+ + ++ G L+Y
Sbjct: 81 PNTIEYKG-CYLKEHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAY 136
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
LH+ ++HRDI + N+LL + +++DFG A P +S GT ++APE+
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVI 189
Query: 974 YTMKVTE---KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPS 1030
M + K DV+S G+ +E+ + K P ++ + S+L +IA ++ P+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSAL-YHIAQND-------SPT 239
Query: 1031 HNVQEKLISFVEVAISCLDESPESRPT 1057
E SF CL + P+ RP
Sbjct: 240 LQSNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 72/271 (26%), Positives = 111/271 (40%), Gaps = 45/271 (16%)
Query: 804 IGKGGQGSVYK----VELASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 858
+G G G+VYK E +I +A+K + +E L+E + + H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA--NKEILDEAYVMASVDHPHVV 72
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAED----LEWTQRMSVIKGIADALSYL 914
+ G C +Q I + + +G L + N L W + IA +SYL
Sbjct: 73 RLLGICLSSQVQLIT-QLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL 125
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTY--GYVAPEL 972
+VHRD++++NVL+ +++DFG+AK L D + G ++A E
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 973 AYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILD-----PRL 1026
T K DV+S+GV E++ G P + I EI D RL
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYE------------GIPAVEIPDLLEKGERL 230
Query: 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPT 1057
P P I V + C ESRPT
Sbjct: 231 PQP----PICTIDVYMVLVKCWMIDAESRPT 257
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 77/281 (27%), Positives = 128/281 (45%), Gaps = 36/281 (12%)
Query: 808 GQGSVYKVEL--------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
G+G KV L +GE++AVK + T + E+ L + H NIVK
Sbjct: 13 GEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHENIVK 70
Query: 860 FYGFCSHA--QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
+ G CS + ++ EY+ +GSL L L Q + + I + ++YLH+
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA----GTYGYVAPELA 973
+ +HRD++++NVLLD ++ DFG+AK + P+ + + + A E
Sbjct: 127 HY---IHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECL 182
Query: 974 YTMKVTEKCDVYSFGVLALEVI-----KGKHPGDFISLISSSSLNLN-IALDEILD--PR 1025
K + DV+SFGV E++ K P F +I + + L E+L+ R
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242
Query: 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
LP P + QE I + +C + + RPT + + +LK
Sbjct: 243 LPCPKNCPQEVYI----LMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 81/302 (26%), Positives = 131/302 (43%), Gaps = 49/302 (16%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
N ++ +G+G G V K A+GEI+A+KKF E ++ L EVK L ++RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDV-KKTALREVKVLRQLRH 59
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
NIV ++V+EY+E L ++ +A+ L S I + A++Y
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 915 H-NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK-PDSSNWTELAGTYGYVAPEL 972
H ++ I+HRDI +N+L+ ++ DFG A+ L+ +S T+ T Y APEL
Sbjct: 117 HSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172
Query: 973 -----AYTMKVTEKCDVYSFGVLALEVIKGK--HPGD-------------------FISL 1006
Y V DV++ G + E++ G+ PGD L
Sbjct: 173 LVGDTNYGKPV----DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228
Query: 1007 ISSSSLNLNIALDEIL--DPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064
SS+ +A E + V + F++ +CL P+ R T +L
Sbjct: 229 FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLK---ACLRMDPKERLTCD---EL 282
Query: 1065 LK 1066
L+
Sbjct: 283 LQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 6e-20
Identities = 72/242 (29%), Positives = 123/242 (50%), Gaps = 30/242 (12%)
Query: 801 EHCIGKGGQGSVYKVEL---ASGEI-IAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRH 854
E IG G G V + L EI +A+K L T +Q +FL+E + + H
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKT----LKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILS-NDAAAEDLEWTQRMSVIKGIADALSY 913
NI+ G + ++ I+ E++E G+L L ND Q + +++GIA + Y
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKY 121
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG-----YV 968
L + VHRD++++N+L++ +VSDFG+++FL+ D+S+ T + G +
Sbjct: 122 LSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178
Query: 969 APELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLP 1027
APE K T DV+S+G++ EV+ G+ P + + + +N A+++ D RLP
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMSNQDVIN---AIEQ--DYRLP 231
Query: 1028 IP 1029
P
Sbjct: 232 PP 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 76/279 (27%), Positives = 119/279 (42%), Gaps = 47/279 (16%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
+G+G GSV K L + +I K + P Q++ L E++ + IVK+YG
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD-LQKQILRELEINKSCKSPYIVKYYGA 67
Query: 864 CSHAQHS--FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS------VIKGIADALSYLH 915
S I EY E GSL I + + R+ + + + LSYLH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYK-----KVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE---- 971
+ I+HRDI N+LL K + ++ DFG++ L +S GT Y+APE
Sbjct: 123 SR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFTGTSFYMAPERIQG 177
Query: 972 LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD-------P 1024
Y++ DV+S G+ LEV + + P F + E+L P
Sbjct: 178 KPYSI----TSDVWSLGLTLLEVAQNRFP--FP-----PEGEPPLGPIELLSYIVNMPNP 226
Query: 1025 RLP-IPSHNVQ--EKLISFVEVAISCLDESPESRPTMQK 1060
L P + ++ E+ F++ CL++ P RPT
Sbjct: 227 ELKDEPGNGIKWSEEFKDFIKQ---CLEKDPTRRPTPWD 262
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 7e-20
Identities = 79/269 (29%), Positives = 140/269 (52%), Gaps = 26/269 (9%)
Query: 798 FDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
F D IG G G+VY ++ + E++A+KK Q+ + EVK L I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 857 IVKFYGFCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
+++ G C +H+ ++V EY +GS + +L + + L+ + ++ G L+YLH
Sbjct: 87 SIEYKG-CYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 975
+ ++HRDI + N+LL + +++DFG A P +S GT ++APE+
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILA 195
Query: 976 MKVTE---KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032
M + K DV+S G+ +E+ + K P ++ + S+L +IA +E P L S+
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSAL-YHIAQNE--SPTL--QSNE 248
Query: 1033 VQEKLISFVEVAISCLDESPESRPTMQKV 1061
+ +FV+ SCL + P+ RPT +++
Sbjct: 249 WSDYFRNFVD---SCLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG+G G V+K + +GE +A+KK E + L E+KAL +H +VK
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRR-LEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
H +V EY+ L+ +L ++ L Q S ++ + ++Y+H + I
Sbjct: 67 VFPHGSGFVLVMEYM-PSDLSEVLRDEERP--LPEAQVKSYMRMLLKGVAYMHAN---GI 120
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN-WTELAGTYGYVAPELAY-TMKVTE 980
+HRD+ N+L+ +++DFG+A+ + ++ T Y APEL Y K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 981 KCDVYSFGVLALEVIKG 997
D+++ G + E++ G
Sbjct: 181 GVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-20
Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 24/264 (9%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IGKG G V+K ++ + +++A+K L ++ E+ L++ + K+YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
+I+ EYL GS +L A + Q +++K I L YLH++
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KK 122
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 982
+HRDI + NVLL + + +++DFG+A L GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182
Query: 983 DVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVE 1042
D++S G+ A+E+ KG+ P +S ++ L I P+ P+ E F E
Sbjct: 183 DIWSLGITAIELAKGEPP--------NSDMHPMRVLFLI--PKNNPPTL-TGEFSKPFKE 231
Query: 1043 VAISCLDESPESRPTMQKVSQLLK 1066
+CL++ P RPT + +LLK
Sbjct: 232 FIDACLNKDPSFRPTAK---ELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 74/259 (28%), Positives = 122/259 (47%), Gaps = 21/259 (8%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IGKG G V+K ++ + +++A+K L ++ E+ L++ + K+YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
+I+ EYL GS +L L+ TQ ++++ I L YLH++
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---KK 122
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 982
+HRDI + NVLL E +++DFG+A L GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 983 DVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVE 1042
D++S G+ A+E+ KG+ P S L+ L I P N + L FVE
Sbjct: 183 DIWSLGITAIELAKGEPP--------HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 234
Query: 1043 VAISCLDESPESRPTMQKV 1061
+CL++ P RPT +++
Sbjct: 235 ---ACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 70/258 (27%), Positives = 119/258 (46%), Gaps = 26/258 (10%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
IG G G V+ +A+K G M+ +++F+ E + + ++ H +V+ YG
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE---GAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 864 CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIV 923
C+ +V+E++E G L+ L E M + + + ++YL + +
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL--DVCEGMAYLESSNV---I 122
Query: 924 HRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 980
HRD++++N L+ +VSDFG+ +F+ D +T GT + +PE+ K +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 981 KCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039
K DV+SFGVL EV +GK P + S +S + A + PRL
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRS--NSEVVETINAGFRLYKPRL-ASQS-------- 229
Query: 1040 FVEVAISCLDESPESRPT 1057
E+ C E PE RP+
Sbjct: 230 VYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 75/276 (27%), Positives = 130/276 (47%), Gaps = 25/276 (9%)
Query: 801 EHCIGKGGQGSVYKVEL--ASGEIIAVKK--FHSPLPGEMTFQQE-----FLNEVKALTE 851
EH +G G G VYKV ++A+K+ H+P G+ +++ ++EV + E
Sbjct: 6 EH-LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 852 -IRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLA-MILSNDAAAEDLEWTQRMSVIKGIAD 909
+RH NIV++Y +IV + +E L S + + ++ +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVA 969
AL YLH + IVHRD++ N++L ++ ++DFG+AK K S T + GT Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSC 181
Query: 970 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029
PE+ EK DV++FG + ++ + P S++ L+L + E + P+P
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP-----FYSTNMLSLATKIVEAVYE--PLP 234
Query: 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
E + + SCL E+RP + +VS ++
Sbjct: 235 EGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 74/259 (28%), Positives = 123/259 (47%), Gaps = 21/259 (8%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IGKG G VYK ++ + E++A+K L ++ E+ L++ I ++YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
+I+ EYL GS +L LE T ++++ I L YLH++
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSE---RK 122
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 982
+HRDI + NVLL + + +++DFG+A L GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 983 DVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVE 1042
D++S G+ A+E+ KG+ P +S L+ L L P+ P+ Q F E
Sbjct: 183 DIWSLGITAIELAKGEPP--------NSDLHPMRVL--FLIPKNSPPTLEGQYSK-PFKE 231
Query: 1043 VAISCLDESPESRPTMQKV 1061
+CL++ P RPT +++
Sbjct: 232 FVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 17/201 (8%)
Query: 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIRHRNIVK 859
IG+G G V + +SG+++AVKK ++ QQ NEV + + +H N+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
Y ++V E+LE G+L I+++ E+ ++V+K ALS LH
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK----ALSVLHAQ-- 135
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 979
++HRDI S ++LL ++SDFG + + L GT ++APEL +
Sbjct: 136 -GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 980 EKCDVYSFGVLALEVIKGKHP 1000
+ D++S G++ +E++ G+ P
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 70/268 (26%), Positives = 120/268 (44%), Gaps = 37/268 (13%)
Query: 804 IGKGGQGSVYKVELAS--GEII--AVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
+G G G V + E ++ G++I AVK S ++ +FL E + + H N+++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIR 60
Query: 860 FYGFCSHAQHSF-IVYEYLEMGSLAMILSNDAAAEDL-----EWTQRMSVIKGIADALSY 913
YG H +V E +GSL L DA L ++ + IA+ + Y
Sbjct: 61 LYGVV--LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRY 112
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT---ELAGTYGYVAP 970
L + F +HRD++++N+LL ++ ++ DFG+ + L + ++ L + + AP
Sbjct: 113 LESKRF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169
Query: 971 ELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029
E T + DV+ FGV E+ G+ P + L S L +D+ + RL P
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEP--WAGLSGSQILK---KIDKEGE-RLERP 223
Query: 1030 SHNVQEKLISFVEVAISCLDESPESRPT 1057
Q+ V + C +P RPT
Sbjct: 224 EACPQD----IYNVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 7e-19
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 30/228 (13%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-R 853
+DF IG+G +V E + + A+K + + E + LT +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 854 HRNIVKFYGFCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALS 912
H I+K Y + + + + V EY G L + + D + T+ I AL
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTR--FYAAEILLALE 116
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA---------- 962
YLH+ I+HRD+ +N+LLD +++DFG AK L P+SS +
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 963 ----------GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
GT YV+PEL + D+++ G + +++ GK P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 8e-19
Identities = 77/264 (29%), Positives = 131/264 (49%), Gaps = 23/264 (8%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G G GSV KV+ + +G ++A K H + + + +++ L E++ + E R IV FYG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVH--IGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAA-AEDLEWTQRMSVIKGIADALSYLHNDCFPP 921
+ + + E+++ GSL I ++ ++V++G L+YL+N
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEG----LTYLYNV--HR 124
Query: 922 IVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 981
I+HRDI N+L++ + + ++ DFG++ L ++ GT Y++PE K T K
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVGTSTYMSPERIQGGKYTVK 182
Query: 982 CDVYSFGVLALEVIKGKHPGDF---ISLISSSSLNLNIALDEILD---PRLPIPSHNVQE 1035
DV+S G+ +E+ GK P F + + L +I+ PRL PS + E
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL--PSSDFPE 240
Query: 1036 KLISFVEVAISCLDESPESRPTMQ 1059
L FV+ CL + P RPT Q
Sbjct: 241 DLRDFVDA---CLLKDPTERPTPQ 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 72/267 (26%), Positives = 122/267 (45%), Gaps = 37/267 (13%)
Query: 816 ELASGEIIAVKKFHSPLPGEMTFQ-------------QEFLNEVKALTEIRHRNIVKFYG 862
+L GEII +F + L GE T Q Q FL E +T++ H+N+V+ G
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
H +IV E + G+L L A + Q + +A+ + YL + +
Sbjct: 67 VILH-NGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK---KL 121
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 982
VHRD++++N+L+ A+VSDFG+A+ + + ++L + APE K + K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLP--VKWTAPEALKHKKFSSKS 178
Query: 983 DVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP--RLPIPSHNVQEKLIS 1039
DV+S+GVL EV G+ P +SL + + ++P P + +
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSL---KEVKECVEKGYRMEPPEGCPADVYVLMT---- 231
Query: 1040 FVEVAISCLDESPESRPTMQKVSQLLK 1066
SC + P+ RP+ K+ + L+
Sbjct: 232 ------SCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 2e-18
Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK-FY 861
+GKG G V V + +G++ A+K + + L E L+ I H IVK Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 862 GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP 921
F + + ++V EY G L LS E + + I AL YLH+
Sbjct: 61 AFQTE-EKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAA--EIVLALEYLHSL---G 113
Query: 922 IVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----AYTMK 977
I++RD+ +N+LLD +++DFG+AK L + S GT Y+APE+ Y
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 978 VTEKCDVYSFGVLALEVIKGKHP 1000
V D +S GVL E++ GK P
Sbjct: 174 V----DWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 70/269 (26%), Positives = 129/269 (47%), Gaps = 30/269 (11%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
+G+G G V+ +A+K PG M + FL E + + ++RH +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMM-PEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 864 CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIV 923
S + +IV E++ GSL L + + L+ Q + + IAD ++Y+ + +
Sbjct: 70 VSE-EPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMNY---I 124
Query: 924 HRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTE 980
HRD+ + N+L+ +++DFG+A+ + + + +T G + APE A + T
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 981 KCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP--RLPIPSHNVQEKL 1037
K DV+SFG+L E++ KG+ P + +++ L E ++ R+P P +
Sbjct: 183 KSDVWSFGILLTELVTKGRVP--YPGMVNREVL-------EQVERGYRMPCPQGCPE--- 230
Query: 1038 ISFVEVAISCLDESPESRPTMQKVSQLLK 1066
S E+ C + P+ RPT + + L+
Sbjct: 231 -SLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 42/277 (15%)
Query: 804 IGKGGQGSVYKVE------LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
+G G G VYK + A+ +II ++ E+ ++F+ E+ L+E +H NI
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES-----EEEL---EDFMVEIDILSECKHPNI 64
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
V Y + +I+ E+ + G+L I+ L Q V + + +AL++LH+
Sbjct: 65 VGLYEAYFYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY--T 975
++HRD+ + N+LL + +++DFG++ K GT ++APE+ T
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 976 MKVTE---KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD---PRLPIP 1029
K K D++S G+ +E+ + + P LN L +IL P L P
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPP--------HHELNPMRVLLKILKSEPPTLDQP 231
Query: 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
S SF + SCL + P+ RPT ++LLK
Sbjct: 232 SKWSS----SFNDFLKSCLVKDPDDRPT---AAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 68/202 (33%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 804 IGKGGQGSVYKVELAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G GG G V V++ S A+K E Q+ +E + L E H IVK Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
++ +++ EY G L IL D D E+T R I + A YLHN I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILR-DRGLFD-EYTARFY-IACVVLAFEYLHNR---GI 114
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----AYTMKV 978
++RD+ +N+LLD ++ DFG AK LK WT GT YVAPE+ Y V
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILNKGYDFSV 173
Query: 979 TEKCDVYSFGVLALEVIKGKHP 1000
D +S G+L E++ G+ P
Sbjct: 174 ----DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 72/278 (25%), Positives = 127/278 (45%), Gaps = 33/278 (11%)
Query: 804 IGKGGQGSVYK-----VELASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
+G+G G V+ +E GE ++ VK + Q EF E+ ++ H+N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNV 70
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAED------LEWTQRMSVIKGIADAL 911
V+ G C A+ +++ EY ++G L L + ++ L Q++++ IA +
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG---YV 968
+L N F VHRD++++N L+ + E +VS ++K +S + +L ++
Sbjct: 131 DHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRWL 185
Query: 969 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027
APE + K DV+SFGVL EV +G+ P F L LN L LP
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP--FYGLSDEEVLN---RLQA-GKLELP 239
Query: 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+P +L ++ C +P+ RP+ ++ L
Sbjct: 240 VPE-GCPSRL---YKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 25/266 (9%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
+G G G V+ + +AVK PG M+ Q FL E + ++H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTMSVQA-FLEEANLMKTLQHDKLVRLYAV 69
Query: 864 CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIV 923
+ + +I+ EY+ GSL L +D + + + + IA+ ++Y+ + +
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGK-VLLPKLIDFSAQIAEGMAYIERKNY---I 125
Query: 924 HRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 982
HRD+ + NVL+ +++DFG+A+ ++ + E A + APE T K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 983 DVYSFGVLALEVI---KGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039
DV+SFG+L E++ K +PG S+ ++ AL R+P + E
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPG-------MSNSDVMSALQR--GYRMPRMENCPDE---- 232
Query: 1040 FVEVAISCLDESPESRPTMQKVSQLL 1065
++ +C E E RPT + +L
Sbjct: 233 LYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 79/286 (27%), Positives = 131/286 (45%), Gaps = 42/286 (14%)
Query: 795 TNDFDDEHCIGKGGQGSVYKVELASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
++ + +GKG G VY S ++ IA+K+ + + Q E+ + ++
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLK 63
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL-SNDAAAEDLEWTQRMSVIKGIADALS 912
HRNIV++ G S I E + GSL+ +L S +D E T K I + L
Sbjct: 64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT-KQILEGLK 122
Query: 913 YLHNDCFPPIVHRDISSKNVLLD-FKNEARVSDFGIAKFL---KPDSSNWTELAGTYGYV 968
YLH++ IVHRDI NVL++ + ++SDFG +K L P + +T GT Y+
Sbjct: 123 YLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYM 176
Query: 969 APELAYTMKVTEK--------CDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDE 1020
APE V +K D++S G +E+ GK P FI L + + + +
Sbjct: 177 APE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPP--FIELGEPQAAMFKVGMFK 228
Query: 1021 ILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
I P +P ++ + +F+ + C + P+ R + LL+
Sbjct: 229 I-HPEIP---ESLSAEAKNFI---LRCFEPDPDKRAS---AHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 73/277 (26%), Positives = 127/277 (45%), Gaps = 32/277 (11%)
Query: 808 GQGSVYKVELA--------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
G+G KVEL +GE +AVK G + E++ L + H NIVK
Sbjct: 13 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHENIVK 70
Query: 860 FYGFCSHAQHSFI--VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
+ G C+ + I + E+L GSL L + +L+ + +V I + YL +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYLGSR 128
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAY 974
+ VHRD++++NVL++ +++ ++ DFG+ K ++ D +T +L + APE
Sbjct: 129 QY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 975 TMKVTEKCDVYSFGVLALEVI-----KGKHPGDFISLISSSSLNLNIA-LDEILD--PRL 1026
K DV+SFGV E++ + F+ +I + + + L +L+ RL
Sbjct: 186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245
Query: 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063
P P N E++ + C + P R T Q + +
Sbjct: 246 PRPP-NCPEEVYQLMR---KCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 70/276 (25%), Positives = 119/276 (43%), Gaps = 40/276 (14%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
+GKG G V+K L +AVK LP E+ + FL+E + L + H NIVK G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK--FLSEARILKQYDHPNIVKLIGV 60
Query: 864 CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN-DCFPPI 922
C+ Q +IV E + G L ++L+ Q + A ++YL + +C
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESKNC---- 114
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAK----------FLKPDSSNWTELAGTYGYVAPEL 972
+HRD++++N L+ N ++SDFG+++ LK WT APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT---------APEA 165
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP-RLPIPSH 1031
+ + + DV+S+G+L E + + + A +++ R+ P
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFS-------LGVCPYPGMTNQQAREQVEKGYRMSCPQK 218
Query: 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQLLKI 1067
+ +V C D PE+RP ++ + L
Sbjct: 219 CPDD----VYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 5e-18
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG+G G VYK +GE++A+KK + F + E+K L ++RH NIV+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 863 FC-SHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
S + S ++V+EY++ L +L + +Q +K + + L YLH++
Sbjct: 66 IVTSKGKGSIYMVFEYMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSN--- 119
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS-NWTELAGTYGYVAPEL-----AY 974
I+HRDI N+L++ +++DFG+A+ +S ++T T Y PEL Y
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRY 179
Query: 975 TMKVTEKCDVYSFGVLALEVIKGK 998
+V D++S G + E+ GK
Sbjct: 180 GPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 51/296 (17%)
Query: 794 ATNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 852
T F+ IG+G G VYK +G+++A+K E ++E N ++ +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE-YNILRKYSN- 61
Query: 853 RHRNIVKFYG-------FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS--- 902
H NI FYG + Q V E GS+ D + +R+
Sbjct: 62 -HPNIATFYGAFIKKNPPGNDDQLWL-VMELCGGGSVT-----DLVKGLRKKGKRLKEEW 114
Query: 903 ---VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959
+++ L+YLH + ++HRDI +N+LL E ++ DFG++ L
Sbjct: 115 IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171
Query: 960 ELAGTYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL 1014
GT ++APE+ + + + DV+S G+ A+E+ GK P ++
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP--------LCDMHP 223
Query: 1015 NIALDEILDPRLPIP----SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
AL +I PR P P N +K F+ CL ++ E RP M+ +LL+
Sbjct: 224 MRALFKI--PRNPPPTLKSPENWSKKFNDFIS---ECLIKNYEQRPFME---ELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 8e-18
Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 32/221 (14%)
Query: 804 IGKGGQGSVYKVELAS------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
+G+G G V+ E + ++AVK P + +++F E + LT ++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHI 69
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSL----------AMILSND---AAAEDLEWTQRMSVI 904
VKFYG C +V+EY++ G L AMIL + A +L +Q + +
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 905 KGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG- 963
IA + YL + F VHRD++++N L+ ++ DFG+++ + S+++ + G
Sbjct: 130 SQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGGH 184
Query: 964 ---TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 1000
++ PE K T + DV+SFGV+ E+ GK P
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 843 LNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS 902
LNE+ L+ ++H NI+ +Y I EY G+L + + E +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG-QLFEEEMVLW 105
Query: 903 VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA 962
+ I A+SY+H I+HRDI + N+ L ++ DFGI+K L + S +
Sbjct: 106 YLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV 162
Query: 963 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL 1022
GT Y++PEL +K K D+++ G + E++ K D +++ LNL + + +
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD-----ATNPLNLVVKI--VQ 215
Query: 1023 DPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
P+ S E LIS V S L + PE RPT +V
Sbjct: 216 GNYTPVVSVYSSE-LISLVH---SLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 76/286 (26%), Positives = 124/286 (43%), Gaps = 37/286 (12%)
Query: 795 TNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKK---FHSPLPGEMT---FQQEFLNEVK 847
+F E IGKG VYK L G ++A+KK F EM +Q+ L E+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIF------EMMDAKARQDCLKEID 54
Query: 848 ALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAA-----EDLEWTQRMS 902
L ++ H N++K+ IV E + G L+ ++ + E W +
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 903 VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA 962
+ AL ++H+ I+HRDI NV + ++ D G+ +F ++ L
Sbjct: 115 ----LCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 167
Query: 963 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP--GDFISLISSSSLNLNIALDE 1020
GT Y++PE + K D++S G L E+ + P GD ++L SL I +
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKIEKCD 224
Query: 1021 ILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
P+P+ + E+L V C++ PE RP + V Q+ K
Sbjct: 225 Y----PPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 78/312 (25%), Positives = 132/312 (42%), Gaps = 66/312 (21%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVEL---------ASGEIIAVKKFHSPLPGEMTFQQ 840
EI + F +E +G+G G VYK EL S I +K+ P QQ
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-----KVQQ 53
Query: 841 EFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAED------ 894
EF E + +++++H NIV G C+ Q + +++EYL G L L ++ D
Sbjct: 54 EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 895 -------LEWTQRMSVIKGIADALSYL--HNDCFPPIVHRDISSKNVLLDFKNEARVSDF 945
L+ + + + IA + YL H+ VHRD++++N L+ ++SDF
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDF 168
Query: 946 GIAKFLKPDSSNWTELAGT----YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 1000
G+++ + S+++ + ++ PE K T + D++SFGV+ E+ G P
Sbjct: 169 GLSRDIY--SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
Query: 1001 ------GDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPES 1054
+ I +I S L LP P + I C +E P
Sbjct: 227 YYGFSNQEVIEMIRSRQL-------------LPCPEDCPA----RVYALMIECWNEIPAR 269
Query: 1055 RPTMQKVSQLLK 1066
RP + + L+
Sbjct: 270 RPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 804 IGKGGQGSVYKVELAS------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
+G+G G V+ E + ++AVK + +Q+F E + LT ++H++I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTVLQHQHI 69
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSL----------AMIL--SNDAAAEDLEWTQRMSVIK 905
V+FYG C+ + +V+EY+ G L A IL D A L Q +++
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 906 GIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG-- 963
IA + YL + F VHRD++++N L+ ++ DFG+++ + S+++ + G
Sbjct: 130 QIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGRT 184
Query: 964 --TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 1000
++ PE K T + D++SFGV+ E+ GK P
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (206), Expect = 3e-17
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 803 CIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 861
+G+G G VYK + +GEI+A+KK E L E+ L E++H NIVK
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE-GIPSTALREISLLKELKHPNIVKLL 64
Query: 862 GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIA----DALSYLHND 917
+ ++V+EY +M L L L ++IK I L+Y H+
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDK--RPGPLS----PNLIKSIMYQLLRGLAYCHSH 117
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 972
I+HRD+ +N+L++ +++DFG+A+ +T T Y APE+
Sbjct: 118 R---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK 174
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
Y+ V D++S G + E+I GK PGD
Sbjct: 175 HYSTAV----DIWSVGCIFAEMITGKPLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 63/233 (27%), Positives = 119/233 (51%), Gaps = 24/233 (10%)
Query: 839 QQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWT 898
+++FL+E + + H NI+ G + ++ IV EY+E GSL L D ++T
Sbjct: 49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK----HDGQFT 104
Query: 899 --QRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD-S 955
Q + +++GIA + YL + + VHRD++++N+L++ +VSDFG+++ L+ D
Sbjct: 105 VIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161
Query: 956 SNWTELAGTYG--YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSL 1012
+ +T G + APE K T DV+S+G++ EV+ G+ P S+
Sbjct: 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-----YWEMSNQ 216
Query: 1013 NLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
++ A++E RLP P + + ++ + C + RP +++ +L
Sbjct: 217 DVIKAIEE--GYRLPAP----MDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 81/288 (28%), Positives = 129/288 (44%), Gaps = 44/288 (15%)
Query: 798 FDDEHCI-----GKGGQGSVYKVELA--------SGEIIAVKKFHSPLPGEMTFQQEFLN 844
F++ H GKG GSV EL +GE++AVKK ++F
Sbjct: 1 FEERHLKFIQQLGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQ---HSTAEHLRDFER 54
Query: 845 EVKALTEIRHRNIVKFYGFC-SHAQHSF-IVYEYLEMGSLAMILSNDAAAEDLEWTQRMS 902
E++ L ++H NIVK+ G C S + + +V EYL GSL L E L+ + +
Sbjct: 55 EIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLL 112
Query: 903 VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTEL- 961
I + YL + + VHRD++++N+L++ +N ++ DFG+ K L D +
Sbjct: 113 YASQICKGMEYLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVRE 169
Query: 962 ---AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKHP-GDFISLISSSSLN 1013
+ + Y APE K + DV+SFGV+ E+ K P +F+ ++ +
Sbjct: 170 PGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG 228
Query: 1014 LNIA--LDEILDP--RLPIPSHNVQEKLISFVEVAISCLDESPESRPT 1057
I L E+L RLP P E + C + P RP+
Sbjct: 229 QMIVYHLIELLKNNGRLPAPPGCPAE----IYAIMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-17
Identities = 72/258 (27%), Positives = 123/258 (47%), Gaps = 24/258 (9%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G G G+VYK L + I+AVK PL + Q++ ++E++ L + I+ FYG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI--PLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
I E+++ GSL + E + ++V+KG L+YL + I
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRK---IPEHVLGRIAVAVVKG----LTYLWS---LKI 116
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 982
+HRD+ N+L++ + + ++ DFG++ L +S GT Y+APE +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 983 DVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD---PRLPIPSHNVQEKLIS 1039
DV+S G+ +E+ G+ P I S + L + L I+D P LP+ EK +
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVLPV--GQFSEKFVH 231
Query: 1040 FVEVAISCLDESPESRPT 1057
F+ C+ + P+ RP
Sbjct: 232 FI---TQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 32/204 (15%)
Query: 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
IGKG G V + G +AVK + Q FL E +T++RH N+V+
Sbjct: 11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-----QAFLAEASVMTQLRHSNLVQL 64
Query: 861 YGFCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG---------IADA 910
G + +IV EY+ GSL D ++ SV+ G + +A
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLV----------DYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAP 970
+ YL + F VHRD++++NVL+ N A+VSDFG+ K SS + AP
Sbjct: 115 MEYLEANNF---VHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAP 168
Query: 971 ELAYTMKVTEKCDVYSFGVLALEV 994
E K + K DV+SFG+L E+
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 70/275 (25%), Positives = 126/275 (45%), Gaps = 19/275 (6%)
Query: 797 DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+F E IG+G VY+ L G +A+KK + + + + E+ L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDL--EWTQRMSVIKGIADALSY 913
N++K+Y IV E + G L+ ++ + + L E T ++ + AL +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ-LCSALEH 121
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
+H+ ++HRDI NV + ++ D G+ +F ++ L GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGKHP--GDFISLISSSSLNLNIALDEILDPRLPIPSH 1031
+ K D++S G L E+ + P GD ++L S L +++ P P+PS
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-----LCKKIEQCDYP--PLPSD 231
Query: 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ E+L V + C++ PE RP + V + K
Sbjct: 232 HYSEELRQLVNM---CINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 793 RATNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQE-------FLN 844
R+ +F+ + IG+G G VY+ + SGEI+A+KK + E L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKK--------VRMDNERDGIPISSLR 55
Query: 845 EVKALTEIRHRNIVKFYGFC--SHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS 902
E+ L +RH NIV+ H F+V EY E LA +L N +Q
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP--FSESQVKC 112
Query: 903 VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA 962
++ + L YLH + I+HRD+ N+LL K +++DFG+A+ + T
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 963 GTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGK 998
T Y APEL T D+++ G + E++ K
Sbjct: 170 VTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 24/262 (9%)
Query: 803 CIGKGGQGSVYK-VELASGEIIAVKKFH-SPLPGEMTFQQEFL-NEVKALTEIRHRNIVK 859
+G+G G VY ++ +G +AVK+ P E + L E++ L ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
+YG + I EY+ GS+ L A L T + I + + YLH++
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLHSN-- 123
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA---GTYGYVAPELAYTM 976
IVHRDI N+L D ++ DFG +K L+ S+ T + GT +++PE+
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 977 KVTEKCDVYSFGVLALEVIKGKHP-GDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035
K DV+S G +E++ K P +F ++ + IA +P+LP +V
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIATQPT-NPQLPS---HVSP 234
Query: 1036 KLISFVEVAISCLDESPESRPT 1057
+F+ E+ + RP+
Sbjct: 235 DARNFLR---RTFVENAKKRPS 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-16
Identities = 42/111 (37%), Positives = 66/111 (59%), Gaps = 6/111 (5%)
Query: 39 WVGIHC---NHGGR--VNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI 93
W G C + G+ ++ + L + GL+G + + S HL ++L N + GNIPP +
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSL 462
Query: 94 GNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGL 144
G+I+ L+ LDLS N F+G+IP +G L+ L+ L+L N LSG +P +GG
Sbjct: 463 GSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 68/272 (25%), Positives = 115/272 (42%), Gaps = 38/272 (13%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG G G+VYKV +G + A+K + E T +++ E++ L ++ H N+VK +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
H ++ E+++ GSL D V + I ++YLH I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQ-------FLADVARQILSGIAYLHRR---HI 189
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-----LAYTMK 977
VHRDI N+L++ +++DFG+++ L GT Y++PE L +
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAY 249
Query: 978 VTEKCDVYSFGVLALEVIKGKHP------GDFISLISSSSLNLNIALDEILDPRLPIPSH 1031
D++S GV LE G+ P GD+ SL+ + ++ P P
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS---------QP--PEAPA 298
Query: 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063
+ F+ CL P R + ++ Q
Sbjct: 299 TASREFRHFISC---CLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 75/284 (26%), Positives = 132/284 (46%), Gaps = 34/284 (11%)
Query: 790 EIIRAT--NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEV 846
+I+R +D++ +G G G VYK L +GE+ AVK + + Q+ E+
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EI 57
Query: 847 KALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG 906
+ E +H NIV ++G + +I EY GSL I +L Q V +
Sbjct: 58 FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRE 114
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG 966
L+YLH+ +HRDI N+LL + +++DFG+A + + GT
Sbjct: 115 TLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY 171
Query: 967 YVAPELAYTMK---VTEKCDVYSFGVLALEVIKGK------HPGDFISLISSSSLNLNIA 1017
++APE+A K + CD+++ G+ A+E+ + + HP + L+S S+
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL 231
Query: 1018 LDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
D+ + HN FV+++ L ++P+ RPT +++
Sbjct: 232 KDKT---KWSSTFHN-------FVKIS---LTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 76/299 (25%), Positives = 120/299 (40%), Gaps = 64/299 (21%)
Query: 796 NDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
D D IG+G G+V K + SG I+AVK+ S + Q+ L ++ + +R
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVV--MRS 59
Query: 855 RN---IVKFYGFCSHAQHSFIVYEYLE--MGSLAMIL---SNDAAAEDLEWTQRMSVIKG 906
+ IVKFYG +I E ++ + + E++ ++ +K
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK- 118
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG 966
AL+YL + I+HRD+ N+LLD ++ DFGI+ L DS T AG
Sbjct: 119 ---ALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDAGCRP 172
Query: 967 YVAPEL-------AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALD 1019
Y+APE Y + + DV+S G+ EV GK P +
Sbjct: 173 YMAPERIDPSARDGYDV----RSDVWSLGITLYEVATGKFPYP--------------KWN 214
Query: 1020 EILD----------PRLPIPSHNVQ--EKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ D P L S + ++F+ CL + RP K +LL+
Sbjct: 215 SVFDQLTQVVKGDPPILS-NSEEREFSPSFVNFIN---LCLIKDESKRP---KYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 6e-16
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 797 DFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
D + +G G G V+ V + S A+K P + +Q NE + L E+ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG--IADALSY 913
I++ + + +++ EY+ G L L N ++ + I AL Y
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEY 116
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
LH+ IV+RD+ +N+LLD + +++DFG AK L+ WT L GT Y+APE+
Sbjct: 117 LHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWT-LCGTPEYLAPEVI 170
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGKHP 1000
+ + D ++ G+L E++ G P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 9e-16
Identities = 61/244 (25%), Positives = 116/244 (47%), Gaps = 33/244 (13%)
Query: 839 QQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL----------AMILSN 888
+++F E + LT ++H +IVKFYG C +V+EY++ G L A++++
Sbjct: 51 RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAE 110
Query: 889 DAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948
+L +Q + + + IA + YL + F VHRD++++N L+ ++ DFG++
Sbjct: 111 GNRPAELTQSQMLHIAQQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMS 167
Query: 949 KFLKPDSSNWTELAG----TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDF 1003
+ + S+++ + G ++ PE K T + DV+S GV+ E+ GK P
Sbjct: 168 RDVY--STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW-- 223
Query: 1004 ISLISSSSLNLNIALDEILDPR-LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVS 1062
L+ N ++ I R L P +E ++ + C P R ++++
Sbjct: 224 ------YQLSNNEVIECITQGRVLQRPRTCPKE----VYDLMLGCWQREPHMRLNIKEIH 273
Query: 1063 QLLK 1066
LL+
Sbjct: 274 SLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-15
Identities = 40/88 (45%), Positives = 56/88 (63%)
Query: 174 LCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSI 233
L L N L G IP++I L++L +NL N + G+IP SLG++++L +L+LS NS GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 234 PSELGNLKYLSDLKLADNKLNGSIPHSL 261
P LG L L L L N L+G +P +L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-15
Identities = 44/95 (46%), Positives = 59/95 (62%), Gaps = 1/95 (1%)
Query: 193 KYLLD-LNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADN 251
K+ +D L L N L G IP + L +L +NLS NS+ G+IP LG++ L L L+ N
Sbjct: 417 KWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN 476
Query: 252 KLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIG 286
NGSIP SL LT+L IL + NSLSG +P+ +G
Sbjct: 477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 72/274 (26%), Positives = 117/274 (42%), Gaps = 33/274 (12%)
Query: 804 IGKGGQGSVYKVELAS-GEIIAVK--KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
I KG G V+ + S G+I A+K K + + Q L E L++ + +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-MIRKNQVDQ-VLTERDILSQAQSPYVVKL 58
Query: 861 YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
Y ++ ++V EYL G LA +L N + ++ I I AL YLH++
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI---YIAEIVLALEYLHSN--- 112
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKF--------LKPDSSNWTELAGTYGYVAPEL 972
I+HRD+ N+L+D +++DFG++K L D + GT Y+APE+
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGKHP--GDFISLISSSSLNLNIALDEILDPRLPIPS 1030
++ D +S G + E + G P G+ + + NI +I P S
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE-----TPEEIFQNILNGKIEWPEDVEVS 227
Query: 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064
LIS L PE R + + ++
Sbjct: 228 DEAI-DLIS------KLLVPDPEKRLGAKSIEEI 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-15
Identities = 107/362 (29%), Positives = 159/362 (43%), Gaps = 26/362 (7%)
Query: 51 NSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGN--IPPQIGNISKLKYLDLSSNL 108
++N ++ L SS L LDL S + + N+ L LDL+ N
Sbjct: 45 VAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNR 104
Query: 109 FSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNL 168
I + L+ L +L L N ++ PL S+L L L N +E + P L NL
Sbjct: 105 LRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESL-PSPLRNL 162
Query: 169 TNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNS 228
NL L L N LS +P + NL L +L+L N+++ +P + LS L L+LS+NS
Sbjct: 163 PNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220
Query: 229 LFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNL 288
+ + S L NLK LS L+L++NKL +P S+ NL+NL L + NN +S S +G+L
Sbjct: 221 II-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSL 276
Query: 289 KFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNK 348
L ++ LS N S +P L + L +L L L + +IL G
Sbjct: 277 TNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNG--- 333
Query: 349 LCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNL 408
+ LS+L NN + N S LN K ++I L +
Sbjct: 334 -------ETSSPEALSILESLNN------LWTLDNALDESNLNRYIVKNPNAIGSLLDLV 380
Query: 409 TN 410
Sbjct: 381 KK 382
|
Length = 394 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 67/281 (23%), Positives = 129/281 (45%), Gaps = 28/281 (9%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 849
EI R + + + +G G G V+ +AVK PG M+ + FL E +
Sbjct: 2 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEA-FLAEANVM 55
Query: 850 TEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIAD 909
++H +VK + + + +I+ E++ GSL L +D ++ + + IA+
Sbjct: 56 KTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAE 113
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG-TYGYV 968
++++ + +HRD+ + N+L+ +++DFG+A+ ++ + E A +
Sbjct: 114 GMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 170
Query: 969 APELAYTMKVTEKCDVYSFGVLALEVI---KGKHPGDFISLISSSSLNLNIALDEILDPR 1025
APE T K DV+SFG+L +E++ + +PG S+ + AL+ R
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG-------MSNPEVIRALER--GYR 221
Query: 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+P P + +E + + C PE RPT + + +L
Sbjct: 222 MPRPENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLN-----EVKALTEIRHRNI 857
+G+G VYK + +G I+A+KK GE ++ +N E+K L E++H NI
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSND----AAAEDLEWTQRMSVIKGIADALSY 913
+ H + +V+E++E L ++ + A+ + ++G L Y
Sbjct: 65 IGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT--LRG----LEY 117
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
LH+ + I+HRD+ N+L+ +++DFG+A+ + T T Y APEL
Sbjct: 118 LHS-NW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL 174
Query: 974 Y-TMKVTEKCDVYSFGVLALEVIKGKH--PGD 1002
+ D++S G + E++ PGD
Sbjct: 175 FGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-15
Identities = 42/93 (45%), Positives = 55/93 (59%), Gaps = 3/93 (3%)
Query: 484 FID-LSYNN--LYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHV 540
FID L +N L G I +D + L +++ S N+I GNIPP +G + LEVLDLS N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 541 VGDIPAELGKLSFLIKLILAQNQLSGQLSPKLG 573
G IP LG+L+ L L L N LSG++ LG
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-15
Identities = 58/202 (28%), Positives = 80/202 (39%), Gaps = 30/202 (14%)
Query: 581 LDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAI 640
L L + L IP + L L +NLS N IP L + L LDLSYN +I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 641 PSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIK 700
P + + SL LNL+ NSLSG +P + L N T
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA-----------LGGRLLHRASFNFT-------- 523
Query: 701 ALQGNKGLCGDFKGLPSCKALKSNKQASRKIWIVVLFPLLGIVALLISLIGLFFKFQRRK 760
N GLCG GL +C + KI I VA L +I ++RR+
Sbjct: 524 ---DNAGLCG-IPGLRAC---GPHLSVGAKIGIA----FGVSVAFLFLVICAMCWWKRRQ 572
Query: 761 NKSQTKQSSPRNTPGLRSMLTF 782
N + ++ + R P ++ F
Sbjct: 573 NILRAQRIAAREAPYAKARTHF 594
|
Length = 623 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 73/275 (26%), Positives = 119/275 (43%), Gaps = 45/275 (16%)
Query: 803 CIGKGGQGSVYK---VELASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 858
CIG+G G VY+ + + +I +AVK + + ++FL E + + H +IV
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQFDHPHIV 70
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIK---GIADALSYLH 915
K G + +IV E +G L L + S+I ++ AL+YL
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLE 124
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELA 973
+ F VHRDI+++NVL+ + ++ DFG++++L+ D S + G ++APE
Sbjct: 125 SKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESI 180
Query: 974 YTMKVTEKCDVYSFGVLALEVIK-GKHP------GDFISLISSSSLNLNIALDEILDPRL 1026
+ T DV+ FGV E++ G P D I I + RL
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------------RL 227
Query: 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
P+P N L S + C P RP ++
Sbjct: 228 PMPP-NCPPTLYSLMT---KCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 72/279 (25%), Positives = 123/279 (44%), Gaps = 36/279 (12%)
Query: 797 DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGE--MTFQQEFLNEVKALTEIR 853
DF+ IG G G VYK + +GE+ A+K PGE QQE + + + +
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEII----MMKDCK 64
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
H NIV ++G +I E+ GSL I + Q V + L Y
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES---QIAYVSRETLQGLYY 121
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
LH+ +HRDI N+LL +++DFG++ + + GT ++APE+A
Sbjct: 122 LHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178
Query: 974 YTMK---VTEKCDVYSFGVLALEVIKGK------HPGDFISLISSSSLNLNIALDEILDP 1024
+ + CD+++ G+ A+E+ + + HP + L++ S+ D++
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKM--- 235
Query: 1025 RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063
FV++A L ++P+ RPT +K+ Q
Sbjct: 236 -------KWSNSFHHFVKMA---LTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 76/271 (28%), Positives = 121/271 (44%), Gaps = 41/271 (15%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+GKG GSVYKV +G +A+K+ L E F Q + E+ L + IV FYG
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQ-IIMELDILHKAVSPYIVDFYG 66
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL---HNDCF 919
++ EY++ GSL + + A E + + + L +L HN
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--- 123
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-------- 971
I+HRD+ NVL++ + ++ DFG++ L + T + G Y+APE
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK-TNI-GCQSYMAPERIKSGGPN 179
Query: 972 --LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD---PRL 1026
YT+ + DV+S G+ LE+ G++P + N+ L I+D P L
Sbjct: 180 QNPTYTV----QSDVWSLGLSILEMALGRYP-----YPPETYANIFAQLSAIVDGDPPTL 230
Query: 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPT 1057
P ++ + FV CL++ P RPT
Sbjct: 231 P-SGYSDDAQ--DFVA---KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 56/293 (19%)
Query: 798 FDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
F+ +G G G VYK + +G++ A+K E + E +N +K + HRN
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE-INMLKKYSH--HRN 74
Query: 857 IVKFYGF------CSHAQHSFIVYEYLEMGSLAMILSN---DAAAEDLEWTQRMSVIKGI 907
I +YG H ++V E+ GS+ ++ N +A ED W + + I
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED--WIAYIC--REI 130
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGY 967
L++LH ++HRDI +NVLL E ++ DFG++ L GT +
Sbjct: 131 LRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 187
Query: 968 VAPELAYTMKVTE-----KCDVYSFGVLALEVIKGK------HPGDFISLISSSSLNLNI 1016
+APE+ + + + D++S G+ A+E+ +G HP + LI
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI--------- 238
Query: 1017 ALDEILDPRLPIP---SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
PR P P S +K I F+E CL ++ SRP+ + QLLK
Sbjct: 239 -------PRNPPPKLKSKKWSKKFIDFIE---GCLVKNYLSRPSTE---QLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 78/271 (28%), Positives = 131/271 (48%), Gaps = 30/271 (11%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G G G VYK + +G + A K + E+ ++++ E++ L H IVK G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPYIVKLLG 76
Query: 863 FCSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP 921
+I+ E+ G++ A++L D L Q + + + +AL YLH+
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSM---K 130
Query: 922 IVHRDISSKNVLLDFKNEARVSDFGI-AKFLKPDSSNWTELAGTYGYVAPELAY--TMKV 978
I+HRD+ + NVLL + +++DFG+ AK +K GT ++APE+ TMK
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR-DSFIGTPYWMAPEVVMCETMKD 189
Query: 979 TE---KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035
T K D++S G+ +E+ + + P ++ + L IA E P L PS E
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSE--PPTLSQPSKWSME 244
Query: 1036 KLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
F + + LD+ PE+RP+ +QLL+
Sbjct: 245 ----FRDFLKTALDKHPETRPS---AAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 8e-15
Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 40/285 (14%)
Query: 798 FDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
F+ +G G G VYK + +G++ A+K E +QE +N +K + HRN
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE-INMLKKYSH--HRN 64
Query: 857 IVKFYG-FCSHA-----QHSFIVYEYLEMGSLAMILSNDAAAE-DLEWTQRMSVIKGIAD 909
I +YG F ++V E+ GS+ ++ N EW + + I
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILR 122
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVA 969
LS+LH ++HRDI +NVLL E ++ DFG++ L GT ++A
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 179
Query: 970 PELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP 1024
PE+ + + K D++S G+ A+E+ +G P +++ L P
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP----------LCDMHPMRALFLIP 229
Query: 1025 RLPIP---SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
R P P S +K SF+E SCL ++ RPT + QL+K
Sbjct: 230 RNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPTTE---QLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-15
Identities = 51/126 (40%), Positives = 69/126 (54%), Gaps = 2/126 (1%)
Query: 62 GTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLS 121
G L D S L LDL NQ G +P ++G++S+L L LS N SG IP ++
Sbjct: 466 GGLPDSFGSK--RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCK 523
Query: 122 YLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLL 181
L +L L NQLSG IP + L+ L L N L IP +LGN+ +LV + + +N L
Sbjct: 524 KLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583
Query: 182 SGSIPS 187
GS+PS
Sbjct: 584 HGSLPS 589
|
Length = 968 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 68/275 (24%), Positives = 125/275 (45%), Gaps = 19/275 (6%)
Query: 797 DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+F E IG+G VY+ L + +A+KK + +Q+ + E+ L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDL--EWTQRMSVIKGIADALSY 913
N++K+ IV E + G L+ ++ + L E T ++ + A+ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ-LCSAVEH 121
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
+H+ ++HRDI NV + ++ D G+ +F ++ L GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGKHP--GDFISLISSSSLNLNIALDEILDPRLPIPSH 1031
+ K D++S G L E+ + P GD ++L S L +++ P P+P+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS-----LCQKIEQCDYP--PLPTE 231
Query: 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ EKL V + C+ P+ RP + V Q+ K
Sbjct: 232 HYSEKLRELVSM---CIYPDPDQRPDIGYVHQIAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 41/211 (19%)
Query: 808 GQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
G GS +V L SG+ A+K ++ + LNE + L IRH +V YG
Sbjct: 10 GTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGS 69
Query: 864 CSHAQHSFIVYEYLEMGSLAMIL------SNDA----AAEDLEWTQRMSVIKGIADALSY 913
+ ++V EY+ G L L AA+ + AL Y
Sbjct: 70 FQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ-------------VVLALEY 116
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL- 972
LH+ IV+RD+ +N+LLD +++DFG AK +K + +T L GT Y+APE+
Sbjct: 117 LHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT-LCGTPEYLAPEII 170
Query: 973 ---AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
Y V D ++ G+L E++ G P
Sbjct: 171 LSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 20/199 (10%)
Query: 804 IGKGGQGSV----YKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
+G G G+V YK+ S + +AVK + + + E L E + ++ + IV+
Sbjct: 3 LGSGNFGTVKKGMYKM-KKSEKTVAVKILKND-NNDPALKDELLREANVMQQLDNPYIVR 60
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
G C A+ +V E E+G L L + + T+ ++ ++ + YL F
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEETNF 116
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG-----YVAPELAY 974
VHRD++++NVLL ++ A++SDFG++K L D + + A T+G + APE
Sbjct: 117 ---VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMN 171
Query: 975 TMKVTEKCDVYSFGVLALE 993
K + K DV+SFGVL E
Sbjct: 172 YYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 71/286 (24%), Positives = 125/286 (43%), Gaps = 35/286 (12%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G+G G V K + +G+I+A+KKF +M ++ + E++ L ++RH N+V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMV-KKIAMREIRMLKQLRHENLVNLIE 67
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRM--SVIKGIADALSYLHNDCFP 920
+ ++V+E+++ L L D ++ +++GI + H+
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIE----FCHSH--- 119
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVT 979
I+HRDI +N+L+ ++ DFG A+ L +T+ T Y APEL K
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 980 EKCDVYSFGVLALEVIKGK--HPG----DFISLISSSSLNLNIALDEILDP-------RL 1026
D+++ G L E++ G+ PG D + I NL EI RL
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239
Query: 1027 PIPSH--NVQEKLISFVEVAI----SCLDESPESRPTMQKVSQLLK 1066
P ++++ + + CL P+ RP+ SQLL
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS---SSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 25/187 (13%)
Query: 823 IAVKKFHSPLPGE-MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGS 881
+AVK P +++FL EVK L+ + NI + G C+ ++ EY+E G
Sbjct: 49 VAVKV---LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105
Query: 882 LAMILSNDAAAEDLEWTQRMSVIKG--------IADALSYLHNDCFPPIVHRDISSKNVL 933
L L A S+ IA + YL + F VHRD++++N L
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF---VHRDLATRNCL 162
Query: 934 LDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAP------ELAYTMKVTEKCDVYSF 987
+ +++DFG+++ L SS++ + G P E K T K DV++F
Sbjct: 163 VGKNYTIKIADFGMSRNLY--SSDYYRVQGR--APLPIRWMAWESVLLGKFTTKSDVWAF 218
Query: 988 GVLALEV 994
GV E+
Sbjct: 219 GVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-14
Identities = 57/193 (29%), Positives = 87/193 (45%), Gaps = 21/193 (10%)
Query: 819 SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY--GFCSHAQHSFIVYEY 876
+G +A+K + P E + F E + H NIV G F V+EY
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEY 60
Query: 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLL-- 934
+ +L +L+ D A E + M + DAL+ HN IVHRD+ +N+++
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLML---QVLDALACAHNQ---GIVHRDLKPQNIMVSQ 114
Query: 935 -DFKNEARVSDFGIAKFLKPDSSNW--------TELAGTYGYVAPELAYTMKVTEKCDVY 985
+ A+V DFGI L P + TE+ GT Y APE VT D+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 986 SFGVLALEVIKGK 998
++G++ LE + G+
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 25/195 (12%)
Query: 793 RATNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 851
R + FD IG+G G VYK + +GE++A+KK E F + E+K L +
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQ 62
Query: 852 IRHRNIVKFYGFCSHAQHS----------FIVYEYLE---MGSLAMILSNDAAAEDLEWT 898
+ HRNIV + Q + ++V+EY++ MG L ++
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL------ESGLVHFSED 116
Query: 899 QRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN- 957
S +K + + L+Y H F +HRDI N+LL+ K + +++DFG+A+ + S
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 958 WTELAGTYGYVAPEL 972
+T T Y PEL
Sbjct: 174 YTNKVITLWYRPPEL 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 43/285 (15%)
Query: 804 IGKGGQGSVYKVELASGEIIA---VKKFH-SPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
IG G G V E G A VK+ S P E Q FL EV+ E+ H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE---QLLFLQEVQPYRELNHPNVLQ 59
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSND----AAAEDLEWTQRMSVIKGIADALSYLH 915
G C + +V E+ +G L L ++ A + QRM+ +A L +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMAC--EVASGLLWLH 117
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA------KFLKPDSSNWTELAGTYGYVA 969
F +H D++ +N L ++ D+G+A + + L ++A
Sbjct: 118 QADF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLA 170
Query: 970 PELA-------YTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEI 1021
PEL T+K +++S GV E+ P +S + + +
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-------DEQVLKQVV 223
Query: 1022 LDPRLPIPSHNVQEKLIS-FVEVAISCLDESPESRPTMQKVSQLL 1065
+ + +P + K + EV C PE+RPT ++V +LL
Sbjct: 224 REQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 66/269 (24%), Positives = 123/269 (45%), Gaps = 30/269 (11%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
+G G G V+ +A+K G M+ + FL E + +++H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMS-PEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 864 CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIV 923
+ + +I+ EY+E GSL L L + + + IA+ ++++ + +
Sbjct: 70 VTQ-EPIYIITEYMENGSLVDFLKTPEGI-KLTINKLIDMAAQIAEGMAFIERKNY---I 124
Query: 924 HRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG-TYGYVAPELAYTMKVTEKC 982
HRD+ + N+L+ +++DFG+A+ ++ + E A + APE T K
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 983 DVYSFGVLALEVIK-GK--HPGDFISLISSSSLNLNIALDEILDP--RLPIPSHNVQEKL 1037
DV+SFG+L E++ G+ +PG N + + L+ R+P P + +E
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPG-----------MTNPEVIQNLERGYRMPRPDNCPEE-- 231
Query: 1038 ISFVEVAISCLDESPESRPTMQKVSQLLK 1066
E+ C E PE RPT + + +L+
Sbjct: 232 --LYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 80/294 (27%), Positives = 119/294 (40%), Gaps = 59/294 (20%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR- 853
ND ++ IG G G VYK+ +G ++AVK+ T +E + L ++
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR------RTGNKEENKRI--LMDLDV 66
Query: 854 ----HR--NIVKFYGFCSHAQHSFIVYEYLEMGSLA---MILSNDAAAEDLEWTQRMSVI 904
H IVK YG+ FI E M + + ED+ ++++
Sbjct: 67 VLKSHDCPYIVKCYGYFITDSDVFICMEL--MSTCLDKLLKRIQGPIPEDILGKMTVAIV 124
Query: 905 KGIADALSYL---HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTEL 961
K AL YL H ++HRD+ N+LLD ++ DFGI+ L DS T
Sbjct: 125 K----ALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAKTRS 174
Query: 962 AGTYGYVAPELAYTMKVTEK----CDVYSFGVLALEVIKGKHP-----GDFISLISSSSL 1012
AG Y+APE K DV+S G+ +E+ G+ P +F L + L
Sbjct: 175 AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL--TKIL 232
Query: 1013 NLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
P LP P+ SFV+ CL + RP K +LL+
Sbjct: 233 QEEP-------PSLP-PNEGFSPDFCSFVD---LCLTKDHRKRP---KYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 802 HCIGKGGQGSVYKVELASGE------IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
I K G+GS K+ LA + +I E + EV L +++H
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMKHP 59
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
NIV F+ FIV EY + G L M N Q +S I+ L ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDL-MKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 916 NDCFPPIVHRDISSKNVLLDFKNE--ARVSDFGIAKFLKPDSSNWTELA----GTYGYVA 969
+ I+HRDI S+N+ L KN A++ DFGIA+ L ++ ELA GT Y++
Sbjct: 119 DR---KILHRDIKSQNIFLS-KNGMVAKLGDFGIARQL----NDSMELAYTCVGTPYYLS 170
Query: 970 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
PE+ K D++S G + E+ KHP
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 6e-14
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 803 CIGKGGQGSVYK-VELASGEIIAVK----KFHSPLPGEMTFQQEFLN--EVKALTEI-RH 854
+G G GSVY +GE++A+K KF+S +E +N EVK+L ++ H
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--------EECMNLREVKSLRKLNEH 57
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
NIVK + V+EY+E ++ + S+I I L+++
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKP--FSESVIRSIIYQILQGLAHI 115
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-- 972
H F HRD+ +N+L+ +++DFG+A+ ++ +T+ T Y APE+
Sbjct: 116 HKHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYVSTRWYRAPEILL 171
Query: 973 ---AYTMKVTEKCDVYSFGVLALEVIKGK 998
+Y+ V D+++ G + E+ +
Sbjct: 172 RSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 79/301 (26%), Positives = 139/301 (46%), Gaps = 50/301 (16%)
Query: 797 DFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
DF+ +G G G V KV SG I+A K H L + + + + E+K L E
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH--LEIKPAIRNQIIRELKVLHECNSP 59
Query: 856 NIVKFYG-FCSHAQHSFIVYEYLEMGSLAMILSNDAA-AEDLEWTQRMSVIKGIADALSY 913
IV FYG F S + S I E+++ GSL +L E++ ++V++G L+Y
Sbjct: 60 YIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRG----LTY 114
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
L I+HRD+ N+L++ + E ++ DFG++ L +N GT Y++PE
Sbjct: 115 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 170
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGKHP-------------GDFISLISSSSLNLN----- 1015
T + D++S G+ +E+ G++P G +S + +
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230
Query: 1016 ------IALDEILD-------PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVS 1062
+A+ E+LD P+L PS ++ FV+ CL ++P+ R +++++
Sbjct: 231 PDSPRPMAIFELLDYIVNEPPPKL--PSGAFSDEFQDFVD---KCLKKNPKERADLKELT 285
Query: 1063 Q 1063
+
Sbjct: 286 K 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 59/199 (29%), Positives = 87/199 (43%), Gaps = 8/199 (4%)
Query: 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 861
+GKGG G V ++ A+G++ A KK + +Q LNE K L ++ R IV Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 862 GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP 921
F + ++ + G L + N E + I L +LH
Sbjct: 61 AFETKDDLCLVM-TLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQR---R 115
Query: 922 IVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 981
IV+RD+ +NVLLD R+SD G+A L AGT GY+APE+
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 982 CDVYSFGVLALEVIKGKHP 1000
D ++ G E+I G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFH-SPLPGEMTFQQEFLN-EVKALTEIRHRNIVKF 860
+G+G G VY ++ +G +A K+ P E + + L E++ L ++H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 861 YGFC--SHAQHSFIVY-EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
YG C A+ + ++ EY+ GS+ L A L + + I + +SYLH++
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLHSN 125
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAY 974
IVHRDI N+L D ++ DFG +K L+ + T + GT +++PE+
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHP 1000
K DV+S G +E++ K P
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 18/219 (8%)
Query: 845 EVKALTEIRHRNIVKFY-GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSV 903
E + L++++H NIV + + +IV + E G L L + + L Q +
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEW 107
Query: 904 IKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG 963
IA AL YLH I+HRD+ ++NV L N +V D GIA+ L+ + L G
Sbjct: 108 FVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIG 164
Query: 964 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD 1023
T Y++PEL K DV++ G E+ KH + ++ ++N + I++
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKH--------AFNAKDMNSLVYRIIE 216
Query: 1024 PRLP-IPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+LP +P E E+ + L + PE RP+++ +
Sbjct: 217 GKLPPMPKDYSPE----LGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-14
Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 14/208 (6%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+DF+ +G G G V+KV SG I+A K H L + + + + E++ L E
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNS 62
Query: 855 RNIVKFYG-FCSHAQHSFIVYEYLEMGSLAMILSNDAA-AEDLEWTQRMSVIKGIADALS 912
IV FYG F S + S I E+++ GSL +L E + ++VIKG L+
Sbjct: 63 PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 117
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
YL I+HRD+ N+L++ + E ++ DFG++ L +N GT Y++PE
Sbjct: 118 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 173
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
+ + D++S G+ +E+ G++P
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-13
Identities = 61/208 (29%), Positives = 106/208 (50%), Gaps = 14/208 (6%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+DF+ +G G G V KV+ SG I+A K H L + + + + E++ L E
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNS 62
Query: 855 RNIVKFYG-FCSHAQHSFIVYEYLEMGSLAMILSN-DAAAEDLEWTQRMSVIKGIADALS 912
IV FYG F S + S I E+++ GSL +L E++ ++V++G+A
Sbjct: 63 PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA---- 117
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
YL I+HRD+ N+L++ + E ++ DFG++ L +N GT Y++PE
Sbjct: 118 YLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 173
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
+ + D++S G+ +E+ G++P
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 60/243 (24%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 839 QQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAA----E 893
++ ++E+K ++ + H NIV G C+ ++ EY G L L + E
Sbjct: 82 REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE 141
Query: 894 DLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953
DL +S +A +++L +HRD++++NVLL ++ DFG+A+ +
Sbjct: 142 DL-----LSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193
Query: 954 DSSNWTELAGTY---GYVAPELAYTMKVTEKCDVYSFGVLALEVIK---GKHPG-----D 1002
D SN+ ++APE + T + DV+S+G+L E+ +PG
Sbjct: 194 D-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK 252
Query: 1003 FISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVS 1062
F LI R+ P H E ++ +C D P RPT +++
Sbjct: 253 FYKLIKEGY-------------RMAQPEHAPAE----IYDIMKTCWDADPLKRPTFKQIV 295
Query: 1063 QLL 1065
QL+
Sbjct: 296 QLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGE-MTFQQEF--LNEVKALTEIRHRNIVK 859
+G+G G V+ A +++ +K+ +P E MT + NE + L + H NI++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQ----IPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
+Y + IV EY G+LA + L+ + I AL ++H
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 920 PPIVHRDISSKNVLLD-FKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 978
I+HRD+ ++N+LLD K ++ DFGI+K L S +T + GT Y++PEL
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEGKPY 178
Query: 979 TEKCDVYSFGVLALEV 994
+K D+++ G + E+
Sbjct: 179 NQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-13
Identities = 41/111 (36%), Positives = 64/111 (57%), Gaps = 3/111 (2%)
Query: 222 LNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLI 281
L L + L G IP+++ L++L + L+ N + G+IP SL ++T+L +L + NS +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 282 PSEIGNLKFLSKIALSYNKFSGLIPHSLGN--LSNIAFLFLDSNSLFGLIP 330
P +G L L + L+ N SG +P +LG L +F F D+ L G IP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IP 532
|
Length = 623 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVK--KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV-- 858
I +G G VY+ + +GEI+A+K K G F L E+ L +++H NIV
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTV 69
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
K S+ ++V EY+E L ++ + ++ ++ + +++LH++
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNW 126
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMK 977
I+HRD+ + N+LL+ + ++ DFG+A+ +T+L T Y APEL +
Sbjct: 127 ---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 978 VTEKCDVYSFGVLALEVIKGK 998
+ D++S G + E++ K
Sbjct: 184 YSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 80/291 (27%), Positives = 128/291 (43%), Gaps = 32/291 (10%)
Query: 789 EEIIRATNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 847
E + T+ ++ IGKG G VYKV G + AVK + + E+ N ++
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEY-NILQ 73
Query: 848 ALTEIRHRNIVKFYGFCSHAQHS-----FIVYEYLEMGSLAMILSND-AAAEDLEWTQRM 901
+L H N+VKFYG A ++V E GS+ ++ + L+
Sbjct: 74 SLPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 902 SVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTEL 961
++ G L +LHN+ I+HRD+ N+LL + ++ DFG++ L
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 962 AGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNI 1016
GT ++APE+ Y +CDV+S G+ A+E+ G P ++
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP--------LFDMHPVK 240
Query: 1017 ALDEILDPRLPIPSHNVQEKLI-SFVEVAISCLDESPESRPTMQKVSQLLK 1066
L +I PR P P+ EK SF CL + E+RP+ V+ LL+
Sbjct: 241 TLFKI--PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS---VTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 15/213 (7%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
N F+ +G+G G V K + EI+A+KKF E ++ L E+K L ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQ 59
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMI--LSNDAAAEDLEWTQRMSVIKGIADALS 912
NIV+ ++V+EY+E L ++ + N E + S I + A+
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-----SYIYQLIKAIH 114
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS-SNWTELAGTYGYVAPE 971
+ H + IVHRDI +N+L+ + ++ DFG A+ L S +N+TE T Y +PE
Sbjct: 115 WCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 972 LAYTMKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
L + D++S G + E+ G+ PG+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 23/205 (11%)
Query: 803 CIGKGGQGSVYKVELASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 861
C+ KG VYK+ +I +A+K + E + + E + E + + ++ + IV+
Sbjct: 10 CVKKG----VYKMR--KKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 862 GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP 921
G C A+ +V E G L LS +++ + + ++ ++ + YL F
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKNF-- 116
Query: 922 IVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG-----YVAPELAYTM 976
VHRD++++NVLL ++ A++SDFG++K L D S + A + G + APE
Sbjct: 117 -VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--ARSAGKWPLKWYAPECINFR 173
Query: 977 KVTEKCDVYSFGVLALEVIK-GKHP 1000
K + + DV+S+G+ E G+ P
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-13
Identities = 37/89 (41%), Positives = 56/89 (62%)
Query: 150 LALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSI 209
L L + L IP+ + L +L ++ L N + G+IP +G++ L L+L N NGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 210 PQSLGNLSNLAMLNLSSNSLFGSIPSELG 238
P+SLG L++L +LNL+ NSL G +P+ LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLP------GEMTFQQ---EFLNEVKALTEIRH 854
+G G G VY+ G L E +Q +FL E +++ H
Sbjct: 14 LGHGAFGEVYE-----GLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS----VIKGIADA 910
+NIV+ G FI+ E + G L L + + + M + +A
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARV---SDFGIAKFLKPDSSNWTELAGT--- 964
YL + F +HRDI+++N LL K RV +DFG+A+ + +++ G
Sbjct: 129 CKYLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKGGRAML 183
Query: 965 -YGYVAPELAYTMKVTEKCDVYSFGVLALEV 994
++ PE T K DV+SFGVL E+
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 50/288 (17%)
Query: 804 IGKGGQGSVYK-----VELASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
+G+G G VY+ V E +A+K + M + EFLNE + E ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHV 71
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMIL------SNDAAAEDLEWTQRMSVIKG-IADA 910
V+ G S Q + +V E + G L L + + Q+ + IAD
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK------FLKPDSS-----NWT 959
++YL F VHRD++++N ++ ++ DFG+ + + + W
Sbjct: 132 MAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW- 187
Query: 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIAL 1018
+APE T K DV+SFGV+ E+ + P + L + L I
Sbjct: 188 --------MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP--YQGLSNEEVLKFVIDG 237
Query: 1019 DEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ LP N +KL+ + + C +P+ RPT ++ LK
Sbjct: 238 GHL---DLPE---NCPDKLLELMRM---CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 44/300 (14%)
Query: 786 IVYEEIIRATNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLN 844
I+++ ++ ++ IGKG G V+KV +G AVK + + E+ N
Sbjct: 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEY-N 66
Query: 845 EVKALTEIRHRNIVKFYGF-----CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQ 899
+KAL++ H N+VKFYG + ++V E GS+ D L+ +
Sbjct: 67 ILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVT-----DLVKGFLKRGE 119
Query: 900 RMS------VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953
RM ++ L +LH + +HRD+ N+LL + ++ DFG++ L
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176
Query: 954 DSSNWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLIS 1008
GT ++APE+ +CDV+S G+ A+E+ G P
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP-------- 228
Query: 1009 SSSLNLNIALDEILDPRLPIPSHNVQEKLIS--FVEVAISCLDESPESRPTMQKVSQLLK 1066
+ L+ AL +I PR P P+ + Q +L S F + CL + E RPT VS LL+
Sbjct: 229 LADLHPMRALFKI--PRNPPPTLH-QPELWSNEFNDFIRKCLTKDYEKRPT---VSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 69/293 (23%), Positives = 127/293 (43%), Gaps = 49/293 (16%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKF----HSPLPGEMTFQQEFLNEVKALTEIRHRNIV 858
IG+G G V+K +G+I+A+KKF P+ ++ L E++ L +++H N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA-----LREIRMLKQLKHPNLV 63
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH-ND 917
+ +V+EY + L + + + +I A+++ H ++
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 972
C +HRD+ +N+L+ + + ++ DFG A+ L ++T+ T Y APEL
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGKH--PG----DFISLISSSSLNLNIALDEILDP-- 1024
Y V DV++ G + E++ G+ PG D + LI + +L +I
Sbjct: 177 QYGPPV----DVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232
Query: 1025 -----RLPIPSHNV--QEKLISFVEVAIS----CLDESPESRPTMQKVSQLLK 1066
+P P + K + A+S CL P R + +LL+
Sbjct: 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS---CEELLE 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-12
Identities = 80/214 (37%), Positives = 111/214 (51%), Gaps = 7/214 (3%)
Query: 431 NLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYN 490
NL+ L L L N+ + I L LT+L + LD N +T + NL +DLS N
Sbjct: 91 NLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDN 150
Query: 491 NLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGK 550
+ + S P L LD S N+++ ++P + S L LDLS N + D+P E+
Sbjct: 151 KI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK-ISDLPPEIEL 207
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
LS L +L L+ N + +L L L L L+LS+N L + +PES+GNL L L+LSNN
Sbjct: 208 LSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNN 265
Query: 611 QFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQI 644
Q S L L +L ELDLS N L A+P
Sbjct: 266 QIS--SISSLGSLTNLRELDLSGNSLSNALPLIA 297
|
Length = 394 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 804 IGKGGQGSV-YKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IGKG G V ++ +GE +A+KK + ++ L E+K L +RH +IV+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 863 FC-----SHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
+ ++V+E +E +I +ND DL + + AL Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELMESDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHT- 121
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAK--FLK-PDSSNWTELAGTYGYVAPEL-- 972
+ HRD+ KN+L + + ++ DFG+A+ F P + WT+ T Y APEL
Sbjct: 122 --ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGK 998
++ K T D++S G + EV+ GK
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G+G G V+ + S + A+K+ LP + ++ E L +++H NIV F
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIR--LPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAA---AED--LEWTQRMSVIKGIADALSYLHND 917
H +IV EY + G L + ED L+W +M + + ++H
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK 119
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK 977
++HRDI SKN+ L + ++ DFG A+ L + GT YV PE+ M
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176
Query: 978 VTEKCDVYSFGVLALEVIKGKHP 1000
K D++S G + E+ KHP
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 45/221 (20%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQE-------FLNEVKALTEIRHR 855
IG+G G VYK + + E IA+KK + +QE + E+ L E++H
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKK--------IRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRM------SVIKGIAD 909
NIV+ + ++V+EYL+ L + D++ D R+ +++GIA
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIA- 116
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFK-NEARVSDFGIAKFLKPDSSNWTELAGTYGYV 968
Y H+ ++HRD+ +N+L+D + N +++DFG+A+ +T T Y
Sbjct: 117 ---YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 969 APEL-----AYTMKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
APE+ Y+ V D++S G + E++ K PGD
Sbjct: 171 APEILLGSRHYSTPV----DIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
+G G G+V+K + + G+ I + K G TFQ E + + A+ + H IV+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ-EITDHMLAMGSLDHAYIVR 73
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAED----LEWTQRMSVIKGIADALSYLH 915
G C A +V + +GSL + + D L W + IA + YL
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLE 126
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELA 973
+VHR+++++N+LL + +++DFG+A L PD ++E ++A E
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 974 YTMKVTEKCDVYSFGVLALEVIK-GKHP 1000
+ T + DV+S+GV E++ G P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 804 IGKGGQGSVY-KVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IGKGG G VY + +A+KK L ++ FL E K ++ H IV Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSN----DAAAEDLEWTQR----MSVIKGIADALSYL 914
CS + Y+E +L +L + ++ +++L +S+ I + Y+
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD---------------SSNWT 959
H+ ++HRD+ N+LL E + D+G A F K + S+ T
Sbjct: 130 HSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 960 ---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 990
++ GT Y+APE + +E D+Y+ GV+
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220
|
Length = 932 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/257 (22%), Positives = 110/257 (42%), Gaps = 50/257 (19%)
Query: 840 QEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL------------- 886
++ L+E L ++ H +++K YG CS ++ EY + GSL L
Sbjct: 48 RDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGS 107
Query: 887 ------SNDAAAEDLEWTQRM--SVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN 938
S ++ T S I+ + YL +VHRD++++NVL+
Sbjct: 108 DGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGR 164
Query: 939 EARVSDFGIAKFLKPDSSNWTELAG--TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK 996
+ ++SDFG+++ + + S G ++A E + T + DV+SFGVL E++
Sbjct: 165 KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
Query: 997 -------GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLD 1049
G P +L+ + R+ P N E++ + + ++C
Sbjct: 225 LGGNPYPGIAPERLFNLLKTGY-------------RMERPE-NCSEEMYNLM---LTCWK 267
Query: 1050 ESPESRPTMQKVSQLLK 1066
+ P+ RPT +S+ L+
Sbjct: 268 QEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-12
Identities = 38/91 (41%), Positives = 55/91 (60%)
Query: 315 IAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLS 374
I L LD+ L G IP+++ L+ L + L N + G+IP LG++T+L VL + NS +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 375 GSIPCEIGNLKSLSYLNLAFNKLTSSIPISL 405
GSIP +G L SL LNL N L+ +P +L
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-12
Identities = 38/85 (44%), Positives = 47/85 (55%)
Query: 274 NNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSEL 333
N L G IP++I L+ L I LS N G IP SLG+++++ L L NS G IP L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 334 RNLKSLSILELGNNKLCGSIPHFLG 358
L SL IL L N L G +P LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFH-SPLPGEMTFQQEFLN-EVKALTEIRHRNIVKF 860
+G+G G VY + +G +AVK+ P E + + L E++ L + H IV++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 861 YGFCSHAQHSF--IVYEYLEMGSLA-MILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
YG I E++ GS+ + S A E++ T++ + + I + +SYLH++
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV--TRKYT--RQILEGVSYLHSN 125
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP---DSSNWTELAGTYGYVAPELAY 974
IVHRDI N+L D ++ DFG +K L+ + + GT +++PE+
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHP 1000
K D++S G +E++ K P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-12
Identities = 42/106 (39%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 131 NQ-LSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI 189
NQ L G IP ++ L L ++ L N + IP SLG++T+L L L N +GSIP +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 190 GNLKYLLDLNLYNNELNGSIPQSLGN-LSNLAMLNLSSNSLFGSIP 234
G L L LNL N L+G +P +LG L + A N + N+ IP
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 18/168 (10%)
Query: 839 QQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAA---AEDL 895
++E EV L+ ++H NIV++ + +IV +Y E G L ++ ED
Sbjct: 43 REESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED- 101
Query: 896 EWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955
Q + I AL ++H+ I+HRDI S+N+ L ++ DFGIA+ L
Sbjct: 102 ---QILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL---- 151
Query: 956 SNWTELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 999
++ ELA GT Y++PE+ K D+++ G + E+ KH
Sbjct: 152 NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 30/219 (13%)
Query: 804 IGKGGQGSVYKVEL------ASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
+G G G VY+ SG I +AVK + ++EFL E ++ H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAED-----LEWTQRMSVIKGIADAL 911
IVK G C + +I+ E +E G L L DA E L + + + +A
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEAR-----VSDFGIAKFLKPDSSNWTELAG--- 963
YL F +HRD++++N L+ K + DFG+A+ + S++ G
Sbjct: 120 VYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--KSDYYRKEGEGL 174
Query: 964 -TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 1000
++APE K T + DV+SFGVL E++ G+ P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKF-HSPLPGEMTFQQEFLN-EVKALTEIRHRNIVKF 860
+G+G G VY + +G +AVK+ P E + + L E++ L +RH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 861 YGFC--SHAQHSFIVY-EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
YG C + ++ EY+ GS+ L A + T+R + + I +SYLH++
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE-NVTRRYT--RQILQGVSYLHSN 125
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT---ELAGTYGYVAPELAY 974
IVHRDI N+L D ++ DFG +K ++ + T + GT +++PE+
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHP 1000
K DV+S +E++ K P
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-12
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 27/220 (12%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
DFD + +G+G G V V E A+G+I A+K + + QE ++ + +I
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKV----MKKSVLLAQETVSFFEEERDILS 56
Query: 855 RNIVKF-----YGFCSHAQHSFIVYEYLEMGSLAMILS--NDAAAEDLEWTQRMSVIKGI 907
+ + Y F + ++V EY G L +L+ D ED+ + +
Sbjct: 57 ISNSPWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYLAEL 111
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTEL-AGTYG 966
A+ +H + VHRDI +NVL+D +++DFG A L + ++L GT
Sbjct: 112 VLAIHSVHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168
Query: 967 YVAPELAYTMKVTEK------CDVYSFGVLALEVIKGKHP 1000
Y+APE+ TM K CD +S GV+A E+I G+ P
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 35/85 (41%), Positives = 52/85 (61%)
Query: 342 LELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSI 401
L L N L G IP+ + L +L + + NS+ G+IP +G++ SL L+L++N SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 402 PISLSNLTNLSVLSFYKNSLSGAIP 426
P SL LT+L +L+ NSLSG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 35/227 (15%)
Query: 798 FDDEHCIGKGGQGSVYKV---ELASGEIIAVKKFHSPLPGEMT-FQQEFLNEVKALTEIR 853
++ E CIG+G G VYK G+ A+KKF + T Q E+ L E++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD-KEQYTGISQSACREIALLRELK 60
Query: 854 HRNIVKFYG-FCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRM--SVIKGIAD 909
H N+V F HA S +++++Y E L I+ A+ + M S++ I +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLL--DFKNEARV--SDFGIAKFLKPDSSNWTELAG-- 963
+ YLH++ ++HRD+ N+L+ + V D G+A+ +L
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 964 -TYGYVAPELA-----YTMKVTEKCDVYSFG-----VLALEVI-KGK 998
T Y APEL YT + D+++ G +L LE I KG+
Sbjct: 177 VTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLEPIFKGR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 16/177 (9%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEV---KALTEIRHRNIVK 859
IG+G G+VYK +L +G +A+KK PL E L E+ K L H NIV+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 860 FYGFC-----SHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
C +V+E+++ LA LS L +++ + + +L
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK-CPKPGLPPETIKDLMRQLLRGVDFL 123
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 971
H+ IVHRD+ +N+L+ + +++DFG+A+ + + T + T Y APE
Sbjct: 124 HSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 57/231 (24%), Positives = 101/231 (43%), Gaps = 42/231 (18%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFH-SPLPGEMTFQQEF----------LNEVKALTE 851
+G+G G V K +G+I+A+KK + ++T ++ L E+K + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 852 IRHRNIVKFYG-FCSHAQHSFI--VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIA 908
I+H NI+ + + FI V + + L ++ + +Q ++ I
Sbjct: 77 IKHENIMGLVDVYV---EGDFINLVMDIMA-SDLKKVVDRKIRLTE---SQVKCILLQIL 129
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA-KFLKPDSS----------- 956
+ L+ LH F +HRD+S N+ ++ K +++DFG+A ++ P S
Sbjct: 130 NGLNVLHKWYF---MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 957 --NWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
T T Y APEL K D++S G + E++ GK PG+
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237
|
Length = 335 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 64/217 (29%), Positives = 91/217 (41%), Gaps = 34/217 (15%)
Query: 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVK--KFHSPLPGEMTFQQEFLNEVKALTEIR 853
DF+ +G G G V + +GE A+K K L +M Q E L E+
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL--KMKQVQHVAQEKSILMELS 76
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSL------AMILSNDAA----AEDLEWTQRMSV 903
H IV + + E++ G L A ND A AE
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE---------- 126
Query: 904 IKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG 963
+ A YLH+ I++RD+ +N+LLD K +V+DFG AK K +T L G
Sbjct: 127 ---LVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT-LCG 177
Query: 964 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
T Y+APE+ + + D ++ GVL E I G P
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 26/214 (12%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 851
DF +G+GG G V+ LA +GEI+A+K+ L ++ + L E LT
Sbjct: 1 KDFQILTQVGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT 57
Query: 852 IRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADA 910
+ +VK Y F ++ ++ EY+ G +L+N + R + + A
Sbjct: 58 TKSEWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH--ARFYMAEMFE-A 113
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA----GTYG 966
+ LH +HRD+ +N L+D +++DFG+ S A G+
Sbjct: 114 VDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGL-------SKGIVTYANSVVGSPD 163
Query: 967 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
Y+APE+ D +S G + E + G P
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 68/247 (27%), Positives = 105/247 (42%), Gaps = 26/247 (10%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEI 852
+DF+ IG+G G V V++ E I K + EM + E F E L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW--EMLKRAETACFREERNVLVNG 58
Query: 853 RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSN--DAAAEDLEWTQRMSVIKGIADA 910
+ I + + ++V +Y G L +LS D ED+ ++ I +
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-HS 117
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA-GTYGYVA 969
+ LH VHRDI NVLLD R++DFG + D + + +A GT Y++
Sbjct: 118 IHQLH------YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYIS 171
Query: 970 PELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP 1024
PE+ M K +CD +S GV E++ G+ P SL+ + +N +
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN------HEE 225
Query: 1025 RLPIPSH 1031
R PSH
Sbjct: 226 RFQFPSH 232
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 39/107 (36%), Positives = 54/107 (50%), Gaps = 9/107 (8%)
Query: 78 LDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSI 137
L L + L G IP I + L+ ++LS N G IPP +G ++ L+ L L N +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 138 PLEVGGLSSLNNLALYSNYLEDIIPHSLG---------NLTNLVTLC 175
P +G L+SL L L N L +P +LG N T+ LC
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 79/244 (32%), Positives = 108/244 (44%), Gaps = 10/244 (4%)
Query: 481 NLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHV 540
L +DL+ N L IS L +LD NNIT P S L+ LDLS N +
Sbjct: 94 PLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI 152
Query: 541 VGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLV 600
+P+ L L L L L+ N LS L L L L +LDLS N +S+ +P + L
Sbjct: 153 -ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLS 209
Query: 601 KLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSL 660
L L+LSNN E+ L L +LS L+LS N +P I + +LE L+LS+N +
Sbjct: 210 ALEELDLSNNSII-ELLSSLSNLKNLSGLELS-NNKLEDLPESIGNLSNLETLDLSNNQI 267
Query: 661 SGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLPSCKA 720
S + L+ +D+S N L +P L N L L
Sbjct: 268 S--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLL--ELLLNLLLTLKALELKLNSI 323
Query: 721 LKSN 724
L +N
Sbjct: 324 LLNN 327
|
Length = 394 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTE 851
+DF+ IG+G G V V++ +G++ A+K + EM + E F E L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNK---WEMLKRAETACFREERDVLVN 57
Query: 852 IRHRNIVKF-YGFCSHAQHSFIVYEYLEMGSLAMILSN--DAAAEDLEWTQRMSVIKGIA 908
R I Y F + ++V +Y G L +LS D ED+ ++ I
Sbjct: 58 GDRRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI- 115
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA-GTYGY 967
D++ L VHRDI NVLLD R++DFG L D + + +A GT Y
Sbjct: 116 DSVHQLG------YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDY 169
Query: 968 VAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 1000
++PE+ M + +CD +S GV E++ G+ P
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
F +GKGG G V ++ A+G++ A KK + + LNE + L ++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSLAMILS--------------NDAAAEDLEWTQRMS 902
+V + Y Y +L ++L+ +A E+ + +
Sbjct: 62 VVS------------LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE---GRAVF 106
Query: 903 VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA 962
I L LH + IV+RD+ +N+LLD R+SD G+A + P+
Sbjct: 107 YAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV 162
Query: 963 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
GT GY+APE+ + T D ++ G L E+I G+ P
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 42/220 (19%)
Query: 798 FDDEHCIGKGGQGSV-YKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
+ D +G G G+V ++ +G +A+KK + P E+ F + E++ L ++H N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHEN 75
Query: 857 IV-------------KFYGFCSHAQHSFIVYEYLEMGS-LAMILSNDAAAEDLEWTQRMS 902
++ +F+ F ++V + MG+ L ++ ++ +ED
Sbjct: 76 VIGLLDVFTPDLSLDRFHDF-------YLVMPF--MGTDLGKLMKHEKLSEDRIQFLVYQ 126
Query: 903 VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA 962
++KG L Y+H I+HRD+ N+ ++ E ++ DFG+A+ + DS E+
Sbjct: 127 MLKG----LKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDS----EMT 173
Query: 963 G---TYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 998
G T Y APE+ M T+ D++S G + E++ GK
Sbjct: 174 GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 45/140 (32%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 863 FCSHA--QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
FC+ +H F V EYL G L M + D + + I L +LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDL-MFHIQSSGRFDEARARFYAA--EIICGLQFLHKK--- 115
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 980
I++RD+ NVLLD +++DFG+ K + GT Y+APE+ K E
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175
Query: 981 KCDVYSFGVLALEVIKGKHP 1000
D +SFGVL E++ G+ P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 9/221 (4%)
Query: 804 IGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 861
+GKGG G V V++ +G++ A KK + + ++ L E + L ++ IV Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 862 GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP 921
F S H +V + G L + N LE + + I + +LH+
Sbjct: 61 AFESKT-HLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 922 IVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEK 981
IV+RD+ +NVLLD + R+SD G+A L D T+ AGT GY+APE+ +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 982 CDVYSFGVLALEVIKGKHP-GDFISLISSSSLNLNIALDEI 1021
D ++ G E++ G+ P D ++ L DE+
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 24/205 (11%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR-----NI 857
I KG GSVY + ++G+ A+K +M + + N VKA I +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKK---SDMIAKNQVTN-VKAERAIMMIQGESPYV 59
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
K Y + ++V EYL G A ++ +W ++ I + + LH
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQY--IAEVVLGVEDLHQR 116
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYT 975
I+HRDI +N+L+D +++DFG+++ GT Y+APE
Sbjct: 117 ---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILG 167
Query: 976 MKVTEKCDVYSFGVLALEVIKGKHP 1000
+ + D +S G + E + G P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 55/230 (23%), Positives = 103/230 (44%), Gaps = 40/230 (17%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE---LASGE---IIAVKKFHSPLPGEMTFQQEFLNEVKAL 849
N+ + IG+G G V++ L E ++AVK +M Q +F E +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 62
Query: 850 TEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL--------------SNDAAAE-- 893
E H NIVK G C+ + +++EY+ G L L ++ A
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 894 ---DLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGI--- 947
L T+++ + K +A ++YL F VHRD++++N L+ +++DFG+
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 948 ---AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 994
A + K ++ + ++ PE + + T + DV+++GV+ E+
Sbjct: 180 IYSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-11
Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 797 DFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGE-MTFQQEFLNEVKALTEIRH 854
+ + IG+G G V +G +A+KK P E TF Q L E+K L +H
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS---PFEHQTFCQRTLREIKILRRFKH 62
Query: 855 RNIVKFY------GFCSHAQHSFIVYEYLEMGSLAMI----LSNDAAAEDLEWTQRMSVI 904
NI+ F S +IV E +E +I LSND L R
Sbjct: 63 ENIIGILDIIRPPSFESF-NDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILR---- 117
Query: 905 KGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN---WTEL 961
L Y+H+ ++HRD+ N+LL+ + ++ DFG+A+ P+ + TE
Sbjct: 118 -----GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 962 AGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIK------GKHPGDFISLI 1007
T Y APE+ K T+ D++S G + E++ GK ++LI
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 7/200 (3%)
Query: 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 861
+GKGG G V ++ A+G++ A KK + + + + E + L ++ R IV Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 862 GFCSHAQHSFIVYEYLEMGSLAMILSN-DAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
F + +V + G L + N D + I L +LH
Sbjct: 61 AFQTKTDLC-LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 980
I++RD+ +NVLLD R+SD G+A LK S AGT G++APEL +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 981 KCDVYSFGVLALEVIKGKHP 1000
D ++ GV E+I + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-11
Identities = 36/88 (40%), Positives = 50/88 (56%)
Query: 533 LDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAI 592
L L + + G IP ++ KL L + L+ N + G + P LG + LE LDLS N+ + +I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 593 PESLGNLVKLHYLNLSNNQFSWEIPIKL 620
PESLG L L LNL+ N S +P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 47/186 (25%), Positives = 90/186 (48%), Gaps = 20/186 (10%)
Query: 822 IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGS 881
++AVK + + T + +FL E+K ++ +++ NI++ G C ++ EY+E G
Sbjct: 46 LVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 882 LAMILSND------AAAEDLEWTQRMSVI---KGIADALSYLHNDCFPPIVHRDISSKNV 932
L LS A ++ +++ IA + YL + F VHRD++++N
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF---VHRDLATRNC 160
Query: 933 LLDFKNEARVSDFGIAKFLKPDSSNWTELAG----TYGYVAPELAYTMKVTEKCDVYSFG 988
L+ +++DFG+++ L S ++ + G ++A E K T DV++FG
Sbjct: 161 LVGNHYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218
Query: 989 VLALEV 994
V E+
Sbjct: 219 VTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 69/275 (25%), Positives = 117/275 (42%), Gaps = 43/275 (15%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
+G G G+VYK + + GE + + K + G EF++E + + H ++V+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKA-NVEFMDEALIMASMDHPHLVR 73
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMIL----SNDAAAEDLEWTQRMSVIKGIADALSYLH 915
G C +V + + G L + N + L W + IA + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 126
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTY--GYVAPELA 973
+VHRD++++NVL+ N +++DFG+A+ L+ D + G ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 974 YTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILD-----PRLP 1027
+ K T + DV+S+GV E++ G P D I EI D RLP
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD------------GIPTREIPDLLEKGERLP 231
Query: 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVS 1062
P I V + C +SRP ++++
Sbjct: 232 QPPICT----IDVYMVMVKCWMIDADSRPKFKELA 262
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 32/272 (11%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
+G G G VYK + ++A K E ++++ E+ L H NIVK
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHPNIVKLLDA 70
Query: 864 CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEW----TQRMSVIKGIADALSYLHNDCF 919
+ + +I+ E+ G++ DA +LE Q V K +AL+YLH +
Sbjct: 71 FYYENNLWILIEFCAGGAV------DAVMLELERPLTEPQIRVVCKQTLEALNYLHEN-- 122
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 979
I+HRD+ + N+L + +++DFG++ GT ++APE+
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 980 E-----KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034
+ K DV+S G+ +E+ + + P ++ + L IA E P L PS
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSE--PPTLAQPSRWSS 236
Query: 1035 EKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
E F + CL+++ ++R T +QLL+
Sbjct: 237 E----FKDFLKKCLEKNVDARWT---TTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG+G G VYK +GE++A+KK E + E+ L E+ H NIVK
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 66
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADAL--SYLHN---- 916
++V+E+L +DL+ S + GI L SYL
Sbjct: 67 VIHTENKLYLVFEFLH--------------QDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 917 --DCFP-PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
C ++HRD+ +N+L++ + +++DFG+A+ +T T Y APE+
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 974 YTMKV-TEKCDVYSFGVLALEVI--KGKHPGD 1002
K + D++S G + E++ + PGD
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 8e-11
Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 43/231 (18%)
Query: 798 FDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEF-----LNEVKALTE 851
++ IG G G V V+ +G +A+KK F L E+K L
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS------NVFDDLIDAKRILREIKLLRH 55
Query: 852 IRHRNIVKFYG-FCSHAQHSF----IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG 906
+RH NI+ + F IV E +E L ++ + + L +
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSP---QPLTDDHIQYFLYQ 111
Query: 907 IADALSYLH--NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS---NWTEL 961
I L YLH N ++HRD+ N+L++ + ++ DFG+A+ + PD TE
Sbjct: 112 ILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 962 AGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKH--PG-DFI 1004
T Y APEL YT + D++S G + E++ K PG D+I
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKPLFPGRDYI 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH-RNIVKFY 861
+G+G G V K+ + +G I+AVK+ + + Q+ L ++ V FY
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATV--NSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 862 GFCSHAQHSFIVYEYLEMGSL-----AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
G +I E ++ SL + ED+ +S++K AL YLH+
Sbjct: 67 GALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVK----ALEYLHS 121
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 972
++HRD+ NVL++ + ++ DFGI+ +L DS T AG Y+APE
Sbjct: 122 KL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPERINPE 178
Query: 973 ----AYTMKVTEKCDVYSFGVLALEVIKGKHPGD 1002
Y + K DV+S G+ +E+ G+ P D
Sbjct: 179 LNQKGYDV----KSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 43/174 (24%), Positives = 81/174 (46%), Gaps = 27/174 (15%)
Query: 841 EFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILS------------ 887
+ ++E++ + I +H+NI+ G C+ +++ EY G+L L
Sbjct: 66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 888 -NDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946
E + + +S +A + YL + +HRD++++NVL+ N +++DFG
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFG 182
Query: 947 IAKFLKPDSSNWTELAGTYG------YVAPELAYTMKVTEKCDVYSFGVLALEV 994
+A+ D +N T ++APE + T + DV+SFGVL E+
Sbjct: 183 LAR----DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 795 TNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
TN + D +G G G V + +G+ +A+KK P + ++ + E+K L +R
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLR 67
Query: 854 HRNIVKFYG-FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALS 912
H NI+ F S + + V E L L +L+ + LE + I L
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGT-DLHRLLT----SRPLEKQFIQYFLYQILRGLK 122
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
Y+H+ +VHRD+ N+L++ + ++ DFG+A + T T Y APE+
Sbjct: 123 YVHS---AGVVHRDLKPSNILINENCDLKICDFGLA---RIQDPQMTGYVSTRYYRAPEI 176
Query: 973 AYT-MKVTEKCDVYSFGVLALEVIKGK 998
T K + D++S G + E+++GK
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 861
+GKG G V V E ASG+ A+K + L E + L RH + Y
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 862 GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG--IADALSYLHNDCF 919
F + + F++ EY+ G L LS + +++ + G I AL YLH+
Sbjct: 63 SFQTKDRLCFVM-EYVNGGELFFHLSRERV-----FSEDRTRFYGAEIVSALDYLHSG-- 114
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 979
IV+RD+ +N++LD +++DFG+ K D++ GT Y+APE+
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 980 EKCDVYSFGVLALEVIKGKHP 1000
D + GV+ E++ G+ P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 35/89 (39%), Positives = 50/89 (56%)
Query: 102 LDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDII 161
L L + G IP I L +L++++L N + G+IP +G ++SL L L N I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 162 PHSLGNLTNLVTLCLYNNLLSGSIPSEIG 190
P SLG LT+L L L N LSG +P+ +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 6/204 (2%)
Query: 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
F +GKGG G V ++ A+G++ A K+ + + LNE + L ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
+V +V + G L + N E + + I L LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 976
+ V+RD+ +N+LLD R+SD G+A + P+ + GT GY+APE+
Sbjct: 121 E---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGYMAPEVLNNQ 176
Query: 977 KVTEKCDVYSFGVLALEVIKGKHP 1000
+ T D + G L E+I+G+ P
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 73/281 (25%), Positives = 126/281 (44%), Gaps = 42/281 (14%)
Query: 804 IGKGGQGSVYKVELASGEII----AVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
IGKG G VY L + AVK + ++ ++FL E + + H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 860 FYGFCSHAQHS-FIVYEYLEMGSLAMIL---SNDAAAEDLEWTQRMSVIKGIADALSYLH 915
G C ++ S +V Y++ G L + +++ +DL + +A + YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYLA 115
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK------FLKPDSSNWTELAGTYGYVA 969
+ F VHRD++++N +LD +V+DFG+A+ + + +L ++A
Sbjct: 116 SKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP--VKWMA 170
Query: 970 PELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028
E T K T K DV+SFGVL E++ +G P + S ++ + L + RL
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDITVYL--LQGRRLLQ 223
Query: 1029 PSHNVQEKLISFVEVAISCLDESPESRPT----MQKVSQLL 1065
P + EV +SC PE RPT + ++ Q+
Sbjct: 224 PEYCPD----PLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 861
+GKG G V V E A+G A+K + L E + L RH + Y
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 862 GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG--IADALSYLHNDCF 919
F +H + F++ EY G L LS + +++ + G I AL YLH++
Sbjct: 63 SFQTHDRLCFVM-EYANGGELFFHLSRERV-----FSEDRARFYGAEIVSALDYLHSE-- 114
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 979
+V+RD+ +N++LD +++DFG+ K D + GT Y+APE+
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174
Query: 980 EKCDVYSFGVLALEVIKGKHP 1000
D + GV+ E++ G+ P
Sbjct: 175 RAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 16/226 (7%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF-Y 861
+GKG G V V E A+G A+K + + E + L RH + Y
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 862 GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG--IADALSYLHNDCF 919
F +H + F V EY G L LS + +T+ + G I AL YLH+
Sbjct: 63 AFQTHDRLCF-VMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSR-- 114
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 979
+V+RDI +N++LD +++DFG+ K D + GT Y+APE+
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 980 EKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPR 1025
D + GV+ E++ G+ P F + L I ++EI PR
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP--FYNQDHERLFEL-ILMEEIRFPR 216
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 48/205 (23%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 802 HCIGKGGQGSV-YKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
+G G GSV ++ +GE +A+KK P E+ F + E+ L ++H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAYRELTLLKHMQHENVIGL 79
Query: 861 YGFCSHA------QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
+ A Q ++V Y++ L I+ + + + +++ ++ + L Y+
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY-----LVYQMLCGLKYI 133
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
H+ I+HRD+ N+ ++ E ++ DFG+A+ + + + T Y APE+
Sbjct: 134 HS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV---TRWYRAPEVIL 187
Query: 975 T-MKVTEKCDVYSFGVLALEVIKGK 998
M + D++S G + E++ GK
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 797 DFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTEIR 853
DF+ IG+G G V V+L + + + K + EM + E F E L
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNGD 59
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSN--DAAAEDLEWTQRMSVIKGIADAL 911
++ I + + ++V +Y G L +LS D ED+ ++ I D++
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DSV 118
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA-GTYGYVAP 970
LH VHRDI N+L+D R++DFG L D + + +A GT Y++P
Sbjct: 119 HQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172
Query: 971 ELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 1000
E+ M K +CD +S GV E++ G+ P
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 56/243 (23%), Positives = 101/243 (41%), Gaps = 54/243 (22%)
Query: 853 RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILS-------------NDAAAEDLEWTQ 899
+H+NI+ G C+ +++ EY G+L L E L +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 900 RMSVIKGIADALSYLHND-CFPPIVHRDISSKNVLLDFKNEARVSDFGIAK------FLK 952
+S +A + YL + C +HRD++++NVL+ N +++DFG+A+ + K
Sbjct: 136 LVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 953 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK---GKHPGDFISLISS 1009
S+ + ++APE + T + DV+SFG+L E+ +PG
Sbjct: 192 KTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG-------- 239
Query: 1010 SSLNLNIALDEILD-----PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064
I ++E+ R+ PS+ E + E C P RPT +++ +
Sbjct: 240 ------IPVEELFKLLREGHRMDKPSNCTHELYMLMRE----CWHAVPTQRPTFKQLVEA 289
Query: 1065 LKI 1067
L
Sbjct: 290 LDK 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 48/160 (30%), Positives = 81/160 (50%), Gaps = 12/160 (7%)
Query: 844 NEVKALTEIRHRNIVKF-YGFCSHAQHSFIVYEYLEMGSLAMILSNDA--AAEDLEWTQR 900
E L E+ H IVK Y F + + +++ ++L G L LS + ED+++
Sbjct: 47 MERDILAEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKF--- 102
Query: 901 MSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE 960
+ +A AL +LH+ I++RD+ +N+LLD + +++DFG++K
Sbjct: 103 --YLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157
Query: 961 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
GT Y+APE+ T+ D +SFGVL E++ G P
Sbjct: 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 16/204 (7%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEV---KALTEIRHRNIVK 859
IG G G+VYK + SG +A+K E + EV K L H NIV+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQ-TNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 860 FYGFCSHAQHS-----FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
C+ ++ +V+E+++ L L L +++ L +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK-VPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
H +C IVHRD+ +N+L+ + +++DFG+A+ + T + T Y APE+
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVLL 180
Query: 975 TMKVTEKCDVYSFGVLALEVIKGK 998
D++S G + E+ + K
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+GKGG G V ++ A+G++ A KK + + LNE + L ++ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 863 FCSHAQHSF-IVYEYLEMGSLAM---ILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
+ + + +V + G L + N E + G+ D L +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLED----LQRE- 121
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 978
IV+RD+ +N+LLD + R+SD G+A + P+ GT GY+APE+ K
Sbjct: 122 --RIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 979 TEKCDVYSFGVLALEVIKGKHP 1000
T D + G L E+I+G+ P
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 41/225 (18%)
Query: 797 DFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT 850
D E IG+G G V + + + I +K+F S ++F E++ L
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-----NDHRDFAGELEVLC 57
Query: 851 EI-RHRNIVKFYGFCSHAQHSFIVYEYLEMGSL------AMILSNDAA-------AEDLE 896
++ H NI+ G C + + +I EY G+L + +L D A A L
Sbjct: 58 KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 897 WTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956
Q + +A + YL F +HRD++++NVL+ ++++DFG+++
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLSR------G 168
Query: 957 NWTELAGTYG-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVI 995
+ T G ++A E L Y++ T K DV+SFGVL E++
Sbjct: 169 EEVYVKKTMGRLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-10
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 803 CIGKGGQGSVYK-VELASGEIIAVKK----FHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
IG G G V ++ SG+ +A+KK F P T + L E+K L +H NI
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP-----TLAKRTLRELKILRHFKHDNI 66
Query: 858 VK----FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG-IADALS 912
+ + + ++V + +E L I+ +D + L + + + L
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSD---QPLT-EEHIRYFLYQLLRGLK 121
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL--KPD--SSNWTELAGTYGYV 968
Y+H+ ++HRD+ N+L++ E R+ DFG+A+ L P TE T Y
Sbjct: 122 YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 969 APELAYTM-KVTEKCDVYSFGVLALEVI------KGKHPGDFISLI 1007
APEL ++ + T D++S G + E++ GK+ + LI
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLI 224
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 56/219 (25%), Positives = 105/219 (47%), Gaps = 42/219 (19%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQE-------FLNEVKALTEIRHR 855
IG+G G VYK + +GEI+A+KK + + E + E+ L E+ H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKK--------IRLETEDEGVPSTAIREISLLKELNHP 58
Query: 856 NIVKFYGFCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG----IADA 910
NIV+ H+++ ++V+E+L++ L + D++ +IK +
Sbjct: 59 NIVRLLDVV-HSENKLYLVFEFLDL-DLKKYM--DSSPLT---GLDPPLIKSYLYQLLQG 111
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAP 970
++Y H+ ++HRD+ +N+L+D + +++DFG+A+ +T T Y AP
Sbjct: 112 IAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAP 168
Query: 971 EL-----AYTMKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
E+ Y+ V D++S G + E++ + PGD
Sbjct: 169 EILLGSRQYSTPV----DIWSIGCIFAEMVNRRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 65/281 (23%), Positives = 119/281 (42%), Gaps = 36/281 (12%)
Query: 804 IGKGGQGSVYK---VELASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
+G+G G VY+ ++ GE +AVK + + + EFLNE + ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 71
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMIL------SNDAAAEDLEWTQRMSVIKG-IADA 910
V+ G S Q + +V E + G L L + + Q M + IAD
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT----YG 966
++YL+ F VHRD++++N ++ ++ DFG+ + + +++ G
Sbjct: 132 MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 186
Query: 967 YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPR 1025
++APE T D++SFGV+ E+ + P L+ L ++D
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP--------YQGLSNEQVLKFVMDGG 238
Query: 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
N E++ + + C +P+ RPT ++ LLK
Sbjct: 239 YLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 73/284 (25%), Positives = 124/284 (43%), Gaps = 41/284 (14%)
Query: 804 IGKGGQGSVYKVELASG---EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
IG G G V E+ SG + VK+ + Q +FL E + ++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVS--ASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 861 YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAE----DLEWTQRMSVIKGIADALSYLHN 916
G C+ +V E+ +G L L + AE D QRM+ IA L +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLHK 118
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-------FLKPDSSNWTELAGTYGYVA 969
+ F +H D++ +N LL ++ D+G++ ++ PD W L ++A
Sbjct: 119 NNF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL-WVPLR----WIA 170
Query: 970 PELA-------YTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEI 1021
PEL + T++ +V+S GV E+ + G P +S + + ++
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL 230
Query: 1022 LDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
PRL +P + + EV C + PE RP+ ++V LL
Sbjct: 231 PKPRLKLPLSD------RWYEVMQFCWLQ-PEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 73/308 (23%), Positives = 133/308 (43%), Gaps = 58/308 (18%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVEL---ASGE---IIAVKKFHSPLPGEMTFQQEFL 843
EI +T F +E +G+ G VYK L A GE +A+K E ++EF
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFK 56
Query: 844 NEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL-----SNDAAAED---- 894
+E + ++H NIV G + Q +++ Y L L +D + D
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 895 ----LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950
LE + ++ IA + +L + +VH+D++++NVL+ K ++SD G+ F
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL--F 171
Query: 951 LKPDSSNWTELAGT----YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP----- 1000
+ ++++ +L G +++PE K + D++S+GV+ EV G P
Sbjct: 172 REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231
Query: 1001 -GDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFV-EVAISCLDESPESRPTM 1058
D I +I + + LP P + ++V + + C +E P RP
Sbjct: 232 NQDVIEMIRNRQV-------------LPCP-----DDCPAWVYTLMLECWNEFPSRRPRF 273
Query: 1059 QKVSQLLK 1066
+ + L+
Sbjct: 274 KDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 44/134 (32%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 868 QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG-IADALSYLHNDCFPPIVHRD 926
+H F V E+L G L M D DL R + I L +LH+ I++RD
Sbjct: 69 EHLFFVMEFLNGGDL-MFHIQDKGRFDL---YRATFYAAEIVCGLQFLHSK---GIIYRD 121
Query: 927 ISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYS 986
+ NV+LD +++DFG+ K + + GT Y+APE+ +K T D +S
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWS 181
Query: 987 FGVLALEVIKGKHP 1000
FGVL E++ G+ P
Sbjct: 182 FGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASGEI---IAVKKFHSPLPGEMTFQQEFLNEVKALTEI 852
ND + IG+G G V K + + A+K+ ++F E++ L ++
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKL 64
Query: 853 -RHRNIVKFYGFCSHAQHSFIVYEYLEMGSL------AMILSNDAA-------AEDLEWT 898
H NI+ G C H + ++ EY G+L + +L D A A L
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 899 QRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW 958
Q + +A + YL F +HRD++++N+L+ A+++DFG+++
Sbjct: 125 QLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------GQE 175
Query: 959 TELAGTYG-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVI 995
+ T G ++A E L Y++ T DV+S+GVL E++
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIRHRNIVKFY 861
+GKG G V+ EL + + A+K L ++ + +V+ + E R ++ +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKA----LKKDVVLMDD---DVECTMVEKRVLSLAWEH 55
Query: 862 GFCSH-------AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
F +H ++ F V EYL G L + + + + I L +L
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFL 112
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
H+ IV+RD+ N+LLD +++DFG+ K + GT Y+APE+
Sbjct: 113 HSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHP 1000
K D +SFGVL E++ G+ P
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG+G G VYK +G+I+A+KK E + E+ L E++H NIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQD 66
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
++++E+L M L L + + ++ S + I + + H+ +
Sbjct: 67 VLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RV 122
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AYTMK 977
+HRD+ +N+L+D K +++DFG+A+ +T T Y APE+ Y+
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTP 182
Query: 978 VTEKCDVYSFGVLALEVIKGK 998
V D++S G + E+ K
Sbjct: 183 V----DIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+GKGG G V ++ A+G++ A KK + + LNE + L ++ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS--- 64
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILS--NDAAAEDLEW-----------TQRMSVIKG-IA 908
+ Y Y +L ++L+ N DL++ +R I
Sbjct: 65 ---------LAYAYETKDALCLVLTLMNGG---DLKFHIYNMGNPGFDEERAVFYAAEIT 112
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYV 968
L LH + IV+RD+ +N+LLD R+SD G+A + P+ GT GY+
Sbjct: 113 CGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYM 168
Query: 969 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
APE+ + T D + G L E+I+GK P
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 62/240 (25%), Positives = 95/240 (39%), Gaps = 43/240 (17%)
Query: 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQE----FLNEVKAL-TEIRHRNI 857
+GKG G V EL + E+ AVK L ++ Q + + E + L +H +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKV----LKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AAEDLEWTQRMSVIKGI 907
+ + F V EY+ G L + AAE I
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE-------------I 105
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGY 967
L +LH I++RD+ NVLLD + +++DFG+ K + GT Y
Sbjct: 106 VLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDY 162
Query: 968 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP--GDFISLISSSSLNLNIALDEILDPR 1025
+APE+ D ++ GVL E++ G+ P GD L +I DE+ PR
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD-----DEDELFQSILEDEVRYPR 217
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-10
Identities = 67/285 (23%), Positives = 121/285 (42%), Gaps = 38/285 (13%)
Query: 791 IIRATNDFDDEHCIGKGGQGSVYK-VELASGEII----AVKKFHSPLPGEMTFQQEFLNE 845
I++ T +F +G G G+VYK + + GE + A+K+ + +E L+E
Sbjct: 3 ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILDE 59
Query: 846 VKALTEIRHRNIVKFYGFC--SHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSV 903
+ + + ++ + G C S Q ++ + + G L + ++ V
Sbjct: 60 AYVMASVDNPHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 116
Query: 904 IKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG 963
IA ++YL +VHRD++++NVL+ +++DFG+AK L D + G
Sbjct: 117 --QIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171
Query: 964 TY--GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDE 1020
++A E T + DV+S+GV E++ G P D I SS+
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----- 226
Query: 1021 ILDPRLPIPSHNVQEKLISFVEV---AISCLDESPESRPTMQKVS 1062
RLP P I ++V + C +SRP +++
Sbjct: 227 --GERLPQPP-------ICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 9e-10
Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 38/236 (16%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+DF+ IG+G G V+ V + +G++ A+K + E L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 855 RNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
IVK +Y F +H ++V EY+ G L +L + E + I + AL
Sbjct: 61 PWIVKLYYSF-QDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ETARFY--IAELVLALDS 116
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-------------------FLKPD 954
+H F +HRDI N+L+D +++DFG+ K F
Sbjct: 117 VHKLGF---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 955 SSNWTEL----------AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
+ GT Y+APE+ +CD +S GV+ E++ G P
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 51/209 (24%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 804 IGKGGQGSVYKVELASGEI-------IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
+G+G G VY+ +A G + +A+K + M + EFLNE + E +
Sbjct: 14 LGQGSFGMVYE-GIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 70
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSLAMIL------SNDAAAEDLEWTQRMSVIKG-IAD 909
+V+ G S Q + ++ E + G L L + + ++M + G IAD
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT----Y 965
++YL+ + F VHRD++++N ++ ++ DFG+ + + +++ G
Sbjct: 131 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 185
Query: 966 GYVAPELAYTMKVTEKCDVYSFGVLALEV 994
+++PE T DV+SFGV+ E+
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 27/174 (15%)
Query: 841 EFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEMGSL----------AMILSND 889
+ ++E++ + I +H+NI+ G C+ +++ EY G+L M S D
Sbjct: 63 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122
Query: 890 AAA---EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946
E L + +S +A + YL + +HRD++++NVL+ N +++DFG
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFG 179
Query: 947 IAKFLKPDSSNWTELAGTYG------YVAPELAYTMKVTEKCDVYSFGVLALEV 994
+A+ D N T ++APE + T + DV+SFGVL E+
Sbjct: 180 LAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-09
Identities = 31/81 (38%), Positives = 44/81 (54%)
Query: 370 NNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEY 429
N L G IP +I L+ L +NL+ N + +IP SL ++T+L VL NS +G+IP+
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 430 RNLVKLTKLFLGDNQFQGPIP 450
L L L L N G +P
Sbjct: 487 GQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 18/170 (10%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA----LT 850
DF IGKG G V V+ +G+I A+K + L EM F+++ L VKA L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK---TLLKSEM-FKKDQLAHVKAERDVLA 56
Query: 851 EIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSVIKGIAD 909
E +V Y AQ+ +++ E+L G L M++ D +ED+ + I
Sbjct: 57 ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEA 116
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNW 958
+H F +HRDI N+L+D ++SDFG++ F K S +
Sbjct: 117 ----VHKLGF---IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 69/288 (23%), Positives = 125/288 (43%), Gaps = 43/288 (14%)
Query: 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRHRNIV 858
E GK +G +Y + +++A+K L QQ EF E + E+ H NIV
Sbjct: 15 ECAFGKIYKGHLYLPGMDHAQLVAIKT----LKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMIL------SNDAAAEDLEWTQRMSVIKG------ 906
G + Q +++EYL G L L S+ + D + T + S+ G
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 907 --IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT 964
IA + YL + F VH+D++++N+L+ + ++SD G+++ + S+++ +
Sbjct: 131 IQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIY--SADYYRVQPK 185
Query: 965 ----YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALD 1019
++ PE K + D++SFGV+ E+ G P S N +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---------NQEVI 236
Query: 1020 EILDPRLPIP-SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
E++ R +P S + ++ S + C E P RP + + L+
Sbjct: 237 EMVRKRQLLPCSEDCPPRMYSLM---TECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 21/198 (10%)
Query: 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN-DCFPPIVHRDISSKNV 932
Y+ + +LS+D + E L +S +A + +L + +C VHRD++++NV
Sbjct: 214 YKGSNDSEVKNLLSDDGS-EGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNV 268
Query: 933 LLDFKNEARVSDFGIAKFLKPDSSNWTELAGTY---GYVAPELAYTMKVTEKCDVYSFGV 989
LL ++ DFG+A+ + D SN+ T+ ++APE + T DV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 990 LALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCL 1048
L E+ G P + +I S+ I R+ P H QE ++ + C
Sbjct: 328 LLWEIFSLGGTP--YPGMIVDSTFYNKIKSGY----RMAKPDHATQE----VYDIMVKCW 377
Query: 1049 DESPESRPTMQKVSQLLK 1066
+ PE RP+ +S +++
Sbjct: 378 NSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 60/241 (24%), Positives = 104/241 (43%), Gaps = 28/241 (11%)
Query: 788 YEEIIR-------ATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQ 840
YE+I+R D+D IG+G G V V S + + K S EM +
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF--EMIKRS 85
Query: 841 E---FLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEW 897
+ F E + +V+ + ++ ++V EY+ G L ++SN E +W
Sbjct: 86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KW 143
Query: 898 TQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN 957
+ + + AL +H+ ++HRD+ N+LLD +++DFG +K D +
Sbjct: 144 AKFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETG 196
Query: 958 WTEL---AGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPGDFISLISSS 1010
GT Y++PE+ + +CD +S GV E++ G P SL+ +
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY 256
Query: 1011 S 1011
S
Sbjct: 257 S 257
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 24/232 (10%)
Query: 839 QQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWT 898
++ FL E L + H NIV+ G + IV EY+ G+L L L
Sbjct: 50 RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAG 107
Query: 899 QRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN- 957
Q M ++ G+A + YL + VH+ +++ VL++ ++S F L+ D S
Sbjct: 108 QLMGMLPGLASGMKYLSEMGY---VHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEA 161
Query: 958 -WTELAGTYG--YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLN 1013
+T ++G + APE + DV+SFG++ EV+ G+ P S +
Sbjct: 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP-----YWDMSGQD 216
Query: 1014 LNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+ A+++ RLP P + ++ + C + RP ++ +L
Sbjct: 217 VIKAVEDGF--RLPAPRNCPNL----LHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 43/230 (18%)
Query: 799 DDEHCIGKGGQGS---VYK-VELASGEIIAVKKF--HSPLPGEMTFQQEFLNEVKALTEI 852
D +GK G+G+ VYK ++ +G ++A+KK H+ G F L E+K L ++
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKL 64
Query: 853 RHRNIVK----FYGFCSHAQHS----FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVI 904
+H N+V ++ ++V Y++ L+ +L N + L +Q +
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSV--KLTESQIKCYM 121
Query: 905 KGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW------ 958
+ + ++YLH + I+HRDI + N+L+D + +++DFG+A+ N
Sbjct: 122 LQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 959 -----TELAGTYGYVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGK 998
T L T Y PEL YT V D++ G + E+ +
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 10/151 (6%)
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNWTELAGTY 965
I+ AL+YLH I++RD+ NVLLD + +++D+G+ K L+P + + GT
Sbjct: 105 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTP 160
Query: 966 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDE-ILDP 1024
Y+APE+ D ++ GVL E++ G+ P D + + N L + IL+
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220
Query: 1025 RLPIPSHNVQEKLISFVEVAISCLDESPESR 1055
++ IP + + V S L++ P+ R
Sbjct: 221 QIRIP----RSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 54/238 (22%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 777 RSMLTFEGKI-------VYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFH 829
R LTF+ K+ V+ F D+ V ++AVK
Sbjct: 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDF--------SLDVSGNQPVLVAVKMLR 55
Query: 830 SPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSND 889
+ +FL E+K ++ ++ NI++ C + ++ EY+E G L LS
Sbjct: 56 ED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH 113
Query: 890 AAAEDLEWTQRMSVIKG--------IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEAR 941
E E +++ IA + YL + F VHRD++++N L+ +
Sbjct: 114 EPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNCLVGKNYTIK 170
Query: 942 VSDFGIAKFLKPDSSNWTELAG----TYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 995
++DFG+++ L S ++ + G +++ E K T DV++FGV E++
Sbjct: 171 IADFGMSRNLY--SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 49/184 (26%), Positives = 82/184 (44%), Gaps = 39/184 (21%)
Query: 839 QQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILS----------- 887
+ +FL EVK L+ ++ NI++ G C ++ EY+E G L LS
Sbjct: 63 RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122
Query: 888 NDAAAED-----LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARV 942
NDA + ++ + V IA + YL + F VHRD++++N L+ ++
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---VHRDLATRNCLVGENLTIKI 179
Query: 943 SDFGIAKFLKPDSSNWTELAGTY-----------GYVAPELAYTMKVTEKCDVYSFGVLA 991
+DFG+++ L AG Y ++A E K T DV++FGV
Sbjct: 180 ADFGMSRNL---------YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTL 230
Query: 992 LEVI 995
E++
Sbjct: 231 WEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-09
Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 3/105 (2%)
Query: 508 ALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQ 567
L + G IP I L+ ++LS N + G+IP LG ++ L L L+ N +G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 568 LSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLH--YLNLSNN 610
+ LG L L L+L+ N+LS +P +LG + LH N ++N
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRL-LHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 6e-09
Identities = 77/274 (28%), Positives = 130/274 (47%), Gaps = 52/274 (18%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKK----FHSPLPGEMTFQQEFLNEVKALTEIR-HRNI 857
+GKG G V+K ++ + E++A+KK F + + TF+ E+ L E+ H NI
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-----EIMFLQELGDHPNI 69
Query: 858 VKFYGFCSHAQHS---FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
VK A++ ++V+EY+E A+I +N LE + ++ + AL Y+
Sbjct: 70 VKLLNVIK-AENDKDIYLVFEYMETDLHAVIRANI-----LEDVHKRYIMYQLLKALKYI 123
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW-----TELAGTYGYVA 969
H+ ++HRD+ N+LL+ +++DFG+A+ L N T+ T Y A
Sbjct: 124 HSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180
Query: 970 PEL-----AYTMKVTEKCDVYSFGVLALEVIKGK--HPGDFISLISSSSLNLNIALDEIL 1022
PE+ YT V D++S G + E++ GK PG +S+LN L++I+
Sbjct: 181 PEILLGSTRYTKGV----DMWSVGCILGEMLLGKPLFPG-------TSTLN---QLEKII 226
Query: 1023 DPRLPIPSHNVQEKLISFVEVAISCLDESPESRP 1056
+ + PS E + S A + LD P
Sbjct: 227 EV-IGPPSAEDIESIKS--PFAATMLDSLPSRPR 257
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSP-LPGEMTFQQEFLNEVKALTEIR 853
DF+ I G G+VY V + + A+KK + L QQ F+ E LT
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAE 59
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
+ +V + +H +V EY+E G A +L N A ++ RM + + AL Y
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN-IGALPVD-MARMYFAETVL-ALEY 116
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF-LKPDSSNWTE------------ 960
LHN IVHRD+ N+L+ +++DFG++K L ++N E
Sbjct: 117 LHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 961 --LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
+ GT Y+APE+ + D ++ G++ E + G P
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 20/182 (10%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG+G G V+K + +I+A+KK E F L E+K L ++H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIE 78
Query: 863 FCSHAQHS--------FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
C ++V+E+ E LA +LSN L +++ +K + + L Y+
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV--MKMLLNGLYYI 135
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL----KPDSSNWTELAGTYGYVAP 970
H I+HRD+ + N+L+ +++DFG+A+ + +T T Y P
Sbjct: 136 H---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192
Query: 971 EL 972
EL
Sbjct: 193 EL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 46/177 (25%), Positives = 84/177 (47%), Gaps = 30/177 (16%)
Query: 839 QQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEMGSL------AMILSNDAA 891
++F E++ L ++ H NI+ G C H + ++ EY G+L + +L D A
Sbjct: 39 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 98
Query: 892 -------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSD 944
A L Q + +A + YL F +HRD++++N+L+ A+++D
Sbjct: 99 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIAD 155
Query: 945 FGIAKFLKPDSSNWTELAGTYG-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVI 995
FG+++ + T G ++A E L Y++ T DV+S+GVL E++
Sbjct: 156 FGLSR------GQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 59/235 (25%), Positives = 102/235 (43%), Gaps = 34/235 (14%)
Query: 838 FQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEW 897
+ + F ++++ H+++V YG C S +V EY++ GSL L + ++ W
Sbjct: 42 YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW 101
Query: 898 TQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEAR---------VSDFGIA 948
++ V K +A AL +L + + H ++ +KNVLL + E R +SD GI+
Sbjct: 102 --KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLL-IREEDRKTGNPPFIKLSDPGIS 155
Query: 949 KFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDF-ISL 1006
+ P L +V PE + ++ D +SFG E+ G GD +S
Sbjct: 156 ITVLPKEI----LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG---GDKPLSA 208
Query: 1007 ISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+ S L D +LP P K + C+D P+ RP+ + +
Sbjct: 209 LDSQK-KLQFYEDRH---QLPAP------KWTELANLINQCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 23/207 (11%)
Query: 803 CIGKGGQGSV-YKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 861
IG+G G V + E +A+KK + + ++ L E+K L + H N++
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIK 70
Query: 862 GFCSHAQHS-----FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
+IVYE ++ +I S+ ++D + + L Y+H+
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDD----HCQYFLYQLLRGLKYIHS 126
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 972
++HRD+ N+LL+ + ++ DFG+A+ TE T Y APEL
Sbjct: 127 ---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNC 183
Query: 973 -AYTMKVTEKCDVYSFGVLALEVIKGK 998
YT + DV+S G + E++ K
Sbjct: 184 SEYTTAI----DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 65/292 (22%)
Query: 802 HCIGKGGQGSVYKVELASGE------IIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEI- 852
+G+G G V K E + +AVK L + T + + ++E++ + I
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM----LKDDATEKDLSDLVSEMEMMKMIG 73
Query: 853 RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL-SNDAAAEDLEW----------TQR- 900
+H+NI+ G C+ ++V EY G+L L + E TQ+
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 901 -MSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959
+S +A + +L + +HRD++++NVL+ + +++DFG+A+ D +
Sbjct: 134 LVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHID 186
Query: 960 ELAGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK---GKHPGDFISLISSS 1010
T ++APE + T + DV+SFGVL E+ +PG
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG--------- 237
Query: 1011 SLNLNIALDEILD-----PRLPIPSHNVQEKLISFVEVAISCLDESPESRPT 1057
I ++E+ R+ P N ++L + C E P RPT
Sbjct: 238 -----IPVEELFKLLKEGYRMEKP-QNCTQELYHLM---RDCWHEVPSQRPT 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 64/250 (25%), Positives = 105/250 (42%), Gaps = 35/250 (14%)
Query: 772 NTPGLRSMLTFEGKIV-YEEIIRATN-------DFDDEHCIGKGGQGSVYKV-ELASGEI 822
+ P LR + + YE+ DFD IG+G G V V +S ++
Sbjct: 11 DIPALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQV 70
Query: 823 IAVK---KFHSPLPGEMTFQQE---FLNEVKALTEIRHRNIVK-FYGFCSHAQHSFIVYE 875
A+K KF EM + + F E + IV+ Y F ++ ++V E
Sbjct: 71 YAMKLLSKF------EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-QDDKYLYMVME 123
Query: 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD 935
Y+ G L ++SN E W + + AL +H+ F +HRD+ N+LLD
Sbjct: 124 YMPGGDLVNLMSNYDIPEK--WAR--FYTAEVVLALDAIHSMGF---IHRDVKPDNMLLD 176
Query: 936 FKNEARVSDFGIAKFLKPDSSNWTELA-GTYGYVAPELAYTMKVT----EKCDVYSFGVL 990
+++DFG + + + A GT Y++PE+ + +CD +S GV
Sbjct: 177 KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236
Query: 991 ALEVIKGKHP 1000
E++ G P
Sbjct: 237 LYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 42/174 (24%), Positives = 82/174 (47%), Gaps = 27/174 (15%)
Query: 841 EFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILS------------ 887
+ ++E++ + I +H+NI+ G C+ +++ EY G+L L
Sbjct: 69 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128
Query: 888 -NDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946
E L + +S +A + YL + +HRD++++NVL+ N +++DFG
Sbjct: 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFG 185
Query: 947 IAK------FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 994
+A+ + K ++ + ++APE + T + DV+SFGVL E+
Sbjct: 186 LARDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 49/198 (24%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G+G +VYK +GEI+A+K+ H L E + E+ + E++H NIV+ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIH--LDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
+V+EY++ L + L+ S + +++ H + +
Sbjct: 66 VIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNWTELAGTYGYVAPELAYTMKV-TE 980
+HRD+ +N+L++ + E +++DFG+A+ F P ++ E+ T Y AP++ + +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYST 180
Query: 981 KCDVYSFGVLALEVIKGK 998
D++S G + E+I G+
Sbjct: 181 SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQE----FLNEVKALTEIRHRNIV 858
+GKG G V V E A+G+ A+K L E+ ++ L E + L RH +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKI----LKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 859 KF-YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG--IADALSYLH 915
Y F +H + F V EY G L LS + +++ + G I AL YLH
Sbjct: 59 ALKYSFQTHDRLCF-VMEYANGGELFFHLSRERV-----FSEDRARFYGAEIVSALGYLH 112
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 975
+ +V+RD+ +N++LD +++DFG+ K D + GT Y+APE+
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 169
Query: 976 MKVTEKCDVYSFGVLALEVIKGKHP 1000
D + GV+ E++ G+ P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 68/247 (27%), Positives = 107/247 (43%), Gaps = 54/247 (21%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKA----LT 850
+DF+ IG+G G V V+ +G I A+K +M ++E + ++A L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRK---ADM-LEKEQVAHIRAERDILV 56
Query: 851 EIRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSVIKGIA 908
E +VK FY F ++ +++ E+L G + +++ D +E E TQ I
Sbjct: 57 EADGAWVVKMFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLSE--EATQ--FYIAETV 111
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK--------------PD 954
A+ +H F +HRDI N+LLD K ++SDFG+ LK P
Sbjct: 112 LAIDAIHQLGF---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
Query: 955 S-----------------SNWTELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLALE 993
S N +LA GT Y+APE+ + CD +S GV+ E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 994 VIKGKHP 1000
++ G P
Sbjct: 229 MLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 804 IGKGGQGSV-YKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG G QG V + G +AVKK P + T + E+ L + H+NI+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLN 87
Query: 863 FCS------HAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS-VIKGIADALSYLH 915
+ Q ++V E ++ +L ++ + E RMS ++ + + +LH
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHE------RMSYLLYQMLCGIKHLH 140
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELA 973
+ I+HRD+ N+++ ++ DFG+A+ +N+ T T Y APE+
Sbjct: 141 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVI 194
Query: 974 YTMKVTEKCDVYSFGVLALEVIKG 997
M E D++S G + E++KG
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 27/241 (11%)
Query: 804 IGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKA----LTEIRHR 855
+GKGG G V++V +G+I A+K + Q+ KA L ++H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKK---ATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 856 NIVKF-YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
IV Y F + + +++ EYL G L M L + +E T + I+ AL +L
Sbjct: 61 FIVDLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIF--MEDTACF-YLSEISLALEHL 116
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
H I++RD+ +N+LLD + +++DFG+ K + + GT Y+APE+
Sbjct: 117 HQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034
+ D +S G L +++ G P ++ N +D+IL +L +P +
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPP--------FTAENRKKTIDKILKGKLNLPPYLTP 225
Query: 1035 E 1035
E
Sbjct: 226 E 226
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 65/277 (23%), Positives = 119/277 (42%), Gaps = 49/277 (17%)
Query: 804 IGKGGQGSVYK-VELASGE-------IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+G G G+VYK + + GE I +++ SP +E L+E + +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-----KANKEILDEAYVMAGVGSP 69
Query: 856 NIVKFYGFC--SHAQHSFIVYEYLEMGSLAMILSND----AAAEDLEWTQRMSVIKGIAD 909
+ + G C S Q +V + + G L + + + + L W + IA
Sbjct: 70 YVCRLLGICLTSTVQ---LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAK 120
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTY--GY 967
+SYL +VHRD++++NVL+ N +++DFG+A+ L D + + G +
Sbjct: 121 GMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 968 VAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-- 1024
+A E + T + DV+S+GV E++ G P D I + ++L+
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---------IPDLLEKGE 228
Query: 1025 RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
RLP P + + + + C E RP +++
Sbjct: 229 RLPQPPICTIDVYM----IMVKCWMIDSECRPRFREL 261
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 62/263 (23%), Positives = 94/263 (35%), Gaps = 51/263 (19%)
Query: 429 YRNLVKLTKLFLGDNQFQ----GPIPNLKNLTSLVRVHLDRNYL----TSNISESF-YIY 479
L +L L DN G + +L +SL + L+ N L +++ +
Sbjct: 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLP 136
Query: 480 PNLTFIDLSYNNLYGEISSDWGR----CPKLGALDFSKNNITGNIPPKIG----YSSQLE 531
P L + L N L G + L L+ + N I + + LE
Sbjct: 137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLE 196
Query: 532 VLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNA 591
VLDL++N + D A L+ L L LE L+L NNL++A
Sbjct: 197 VLDLNNN-GLTDEGA-------------------SALAETLASLKSLEVLNLGDNNLTDA 236
Query: 592 I-----PESLGNLVKLHYLNLSNNQFSWEIPIKLEELIH----LSELDLSYNFLGRAI-- 640
L + L L+LS N + + L E++ L ELDL N G
Sbjct: 237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQ 296
Query: 641 ---PSQICIMQSLEKLNLSHNSL 660
S + LE L + +S
Sbjct: 297 LLAESLLEPGNELESLWVKDDSF 319
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-08
Identities = 70/259 (27%), Positives = 108/259 (41%), Gaps = 67/259 (25%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA----LT 850
+DF+ IG+G G V V + +G I A+KK EM ++E + V+A L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL---RKSEM-LEKEQVAHVRAERDILA 56
Query: 851 EIRHRNIVKFYGFCSHAQHSFIVYEYL---EMGSLAM---ILSNDAAAEDLEWTQRMSVI 904
E + +VK Y + +++ EYL +M +L M + + R +
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET--------RFYIA 108
Query: 905 KGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK------------ 952
+ I A+ +H + +HRDI N+LLD K ++SDFG+ LK
Sbjct: 109 ETIL-AIDSIHKLGY---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 953 -------------PDSS-----NWTE----LA----GTYGYVAPELAYTMKVTEKCDVYS 986
P SS W LA GT Y+APE+ ++CD +S
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224
Query: 987 FGVLALEVIKGKHPGDFIS 1005
GV+ E++ G P F S
Sbjct: 225 LGVIMYEMLVGYPP--FCS 241
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 66/261 (25%), Positives = 111/261 (42%), Gaps = 25/261 (9%)
Query: 804 IGKGGQGSVYKV---ELASGEIIAVKKFHSPLP-GEMTFQQEFLNEVKA--LTEIRHRNI 857
+GKG G+VY V + + E + V K +P GE+ + +A L+++ H I
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLK---EIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSN-DAAAEDLEWTQRMSVIKGIADALSYLHN 916
VKF+ I+ EY E L L + L Q + + Y+H
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 976
I+HRD+ +KN+ L N ++ DFG+++ L T GT Y++PE
Sbjct: 125 R---RILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 977 KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEK 1036
K D++S G + E+ H + + L++ + + E P LP +
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAH-----AFEGQNFLSVVLRIVEGPTPSLP---ETYSRQ 232
Query: 1037 LISFVEVAISCLDESPESRPT 1057
L S ++ S L++ P RP+
Sbjct: 233 LNSIMQ---SMLNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 804 IGKGGQGSV---YKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
+G G GSV Y L + +AVKK P + ++ + E++ L ++H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGL 79
Query: 861 YGFCSHAQHSFIVYE-YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
+ A E YL + L+N + L +I + L Y+H+
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS--- 136
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKV 978
I+HRD+ NV ++ E R+ DFG+A + T T Y APE+ M
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYRAPEIMLNWMHY 193
Query: 979 TEKCDVYSFGVLALEVIKGK--HPGD 1002
+ D++S G + E++KGK PG+
Sbjct: 194 NQTVDIWSVGCIMAELLKGKALFPGN 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 32/237 (13%)
Query: 804 IGKGGQGSVYKVELA-SGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHRN--- 856
IG+GG G VY A +G++ A+K K + T LNE L+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNERIMLSLVSTGDCPF 58
Query: 857 -IVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS-VIKGIADALSYL 914
+ Y F + + SFI+ + + G L LS + E + +I G L ++
Sbjct: 59 IVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG----LEHM 113
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA---KFLKPDSSNWTELAGTYGYVAPE 971
HN +V+RD+ N+LLD R+SD G+A KP +S GT+GY+APE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPE 165
Query: 972 -LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027
L + D +S G + ++++G P F + ++ + + LP
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEID-RMTLTMAVELP 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG 966
I+ L +LH I++RD+ NV+LD + +++DFG+ K D GT
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD 166
Query: 967 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGD 1002
Y+APE+ + D +++GVL E++ G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNWTELAGTY 965
IA L +LH+ I++RD+ NV+LD + +++DFG+ K + + T GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165
Query: 966 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGD 1002
Y+APE+ + D ++FGVL E++ G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 59/249 (23%), Positives = 104/249 (41%), Gaps = 30/249 (12%)
Query: 754 FKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVY 813
+ ++K+ TK+ +N K+ YE DF+ +G G G V
Sbjct: 7 LQLHKKKDSDSTKEPKRKN------------KMKYE-------DFNFIRTLGTGSFGRVI 47
Query: 814 KVELASGEI--IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871
+ + +A+K+F + +E K L I H V YG + +
Sbjct: 48 LATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107
Query: 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKN 931
+V E++ G L + + + I I + L L+ IV+RD+ +N
Sbjct: 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN------IVYRDLKPEN 161
Query: 932 VLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 991
+LLD +++DFG AK + D+ +T L GT Y+APE+ + + D ++ G+
Sbjct: 162 LLLDKDGFIKMTDFGFAKVV--DTRTYT-LCGTPEYIAPEILLNVGHGKAADWWTLGIFI 218
Query: 992 LEVIKGKHP 1000
E++ G P
Sbjct: 219 YEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 48/199 (24%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 804 IGKGGQGSV-YKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G G GSV + +G +AVKK P + ++ + E++ L ++H N++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 863 FCSHAQHSFIVYE--YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
+ A+ S + YL + L+N + L +I I L Y+H+
Sbjct: 84 VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 139
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVT 979
I+HRD+ N+ ++ E ++ DFG+A+ + + + T Y APE+ M
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 196
Query: 980 EKCDVYSFGVLALEVIKGK 998
+ D++S G + E++ G+
Sbjct: 197 QTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 41/136 (30%), Positives = 64/136 (47%), Gaps = 8/136 (5%)
Query: 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSK 930
F+V EY+ G L + L I AL++LH I++RD+
Sbjct: 72 FLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLD 125
Query: 931 NVLLDFKNEARVSDFGIAK-FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGV 989
NVLLD +++D+G+ K L P + T GT Y+APE+ + D ++ GV
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGEEYGFSVDWWALGV 184
Query: 990 LALEVIKGKHPGDFIS 1005
L E++ G+ P D I+
Sbjct: 185 LMFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 26/237 (10%)
Query: 804 IGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN----IV 858
IG+GG G VY A +G++ A+K + LNE L+ + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
Y F + + FI+ + + G L LS + E R + I L ++HN
Sbjct: 62 MTYAFHTPDKLCFIL-DLMNGGDLHYHLSQHGVFSEKE--MRFYATE-IILGLEHMHNRF 117
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIA---KFLKPDSSNWTELAGTYGYVAPE-LAY 974
+V+RD+ N+LLD R+SD G+A KP +S GT+GY+APE L
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQK 169
Query: 975 TMKVTEKCDVYSFGVLALEVIKG-----KHPGDFISLISSSSLNLNIALDEILDPRL 1026
D +S G + ++++G +H I +L +N+ L + P L
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPEL 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-08
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 808 GQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQE----FLNEVKALTEIR-HRNIV 858
G+GS KV LA SG + AVK L ++ Q + + E + L+ R H +
Sbjct: 4 GKGSFGKVMLARLKESGRLYAVKV----LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
+ Y F V E++ G L M + D + + I AL +LH+
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARFYAA--EITSALMFLHDK- 115
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV 978
I++RD+ NVLLD + +++DFG+ K + + GT Y+APE+ M
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 979 TEKCDVYSFGVLALEVIKGKHP 1000
D ++ GVL E++ G P
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 44/285 (15%)
Query: 804 IGKGGQGSVYKVELASGEIIA---VKKFH-SPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
IG G G V E+ + +A VK+ + E Q EFL + ++H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE---QNEFLQQGDPYRILQHPNILQ 59
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA---AAEDLEWTQRMSVIKGIADALSYLHN 916
G C A +V+EY E+G L LS + L QRM+ IA ++++H
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC--EIAAGVTHMHK 117
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIA------KFLKPDSSNWTELAGTYGYVAP 970
F +H D++ +N L +V D+GI +++ + L ++AP
Sbjct: 118 HNF---LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLAP 170
Query: 971 ELA-------YTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEI- 1021
EL T + T+ +V++ GV E+ + P + L LN I ++
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP--YSHLSDREVLNHVIKDQQVK 228
Query: 1022 -LDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
P+L +P +++ F + SPE R T ++V +LL
Sbjct: 229 LFKPQLELPYSERWYEVLQFCWL-------SPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-08
Identities = 42/151 (27%), Positives = 70/151 (46%), Gaps = 23/151 (15%)
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 980
+HRD++++N+LL N ++ DFG+A+ + PD + ++APE + T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 981 KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP------IPSHNVQ 1034
+ DV+SFGVL E+ SL +S + I DE RL P +
Sbjct: 255 QSDVWSFGVLLWEI---------FSLGASPYPGVQI--DEEFCRRLKEGTRMRAPEYATP 303
Query: 1035 EKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
E + + C +PE RPT ++ ++L
Sbjct: 304 E----IYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 3/96 (3%)
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG 966
IA L +LH+ I++RD+ NV+LD + +++DFG+ K D GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166
Query: 967 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGD 1002
Y+APE+ + D ++FGVL E++ G+ P +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 38/125 (30%), Positives = 67/125 (53%), Gaps = 6/125 (4%)
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNWTELAGTY 965
I+ AL++LH I++RD+ NVLLD + +++D+G+ K ++P + T GT
Sbjct: 105 ISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTP 160
Query: 966 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDE-ILDP 1024
Y+APE+ D ++ GVL E++ G+ P D + + + N L + IL+
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK 220
Query: 1025 RLPIP 1029
++ IP
Sbjct: 221 QIRIP 225
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-08
Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 899 QRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW 958
Q + + K I + L YLH I+HRD+ ++N+ ++ ++ + D G A+F + +
Sbjct: 158 QALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAF 213
Query: 959 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 995
LAGT APE+ K K D++S G++ E++
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-07
Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 15/143 (10%)
Query: 922 IVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVT 979
++HRDI S N+LL ++ DFG +K S+ GT YVAPE+ +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 980 EKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL-PIPSHNVQEKLI 1038
+K D++S GVL E++ K P D N+ + + L R P+P E
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD--------GENMEEVMHKTLAGRYDPLPPSISPE--- 272
Query: 1039 SFVEVAISCLDESPESRPTMQKV 1061
E+ + L P+ RP+ K+
Sbjct: 273 -MQEIVTALLSSDPKRRPSSSKL 294
|
Length = 496 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVA 969
AL LH +++RD+ +N+LLD++ + DFG+ K D GT Y+A
Sbjct: 105 ALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLA 161
Query: 970 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
PEL T+ D ++ GVL E++ G P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 15/226 (6%)
Query: 797 DFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
D++ IG+G G V V S + K S F E + + +
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 857 IVK--FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
V FY F ++ ++V EY+ G L ++SN E +W + + + AL +
Sbjct: 104 WVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KWARFYTA--EVVLALDAI 158
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA-GTYGYVAPELA 973
H+ F +HRD+ N+LLD +++DFG + + + A GT Y++PE+
Sbjct: 159 HSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 215
Query: 974 YTMK----VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN 1015
+ +CD +S GV E++ G P SL+ + S +N
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 36/203 (17%)
Query: 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN-DCFPPIVHRDISSKNVLL 934
Y++ + IL D A D E +S +A +S+L + +C +HRD++++N+LL
Sbjct: 194 YIDQDVTSEILEEDELALDTE--DLLSFSYQVAKGMSFLASKNC----IHRDLAARNILL 247
Query: 935 DFKNEARVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTEKCDVYSFGVLA 991
++ DFG+A+ ++ D SN+ ++APE + T + DV+S+G+L
Sbjct: 248 THGRITKICDFGLARDIRND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILL 306
Query: 992 LEVI---KGKHPG-----DFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEV 1043
E+ +PG F +I R+ P E ++
Sbjct: 307 WEIFSLGSSPYPGMPVDSKFYKMIKEGY-------------RMLSPECAPSE----MYDI 349
Query: 1044 AISCLDESPESRPTMQKVSQLLK 1066
SC D P RPT +++ QL++
Sbjct: 350 MKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 65/246 (26%), Positives = 103/246 (41%), Gaps = 54/246 (21%)
Query: 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKA----LTE 851
DF+ IG+G G V V+ +G + A+K +M ++E + ++A L E
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRK---ADM-LEKEQVGHIRAERDILVE 57
Query: 852 IRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSVIKGIAD 909
+VK FY F + +++ E+L G + +++ D E E TQ I
Sbjct: 58 ADSLWVVKMFYSF-QDKLNLYLIMEFLPGGDMMTLLMKKDTLTE--EETQ--FYIAETVL 112
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP---------------- 953
A+ +H F +HRDI N+LLD K ++SDFG+ LK
Sbjct: 113 AIDSIHQLGF---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 954 -----------DSSNWT----ELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 994
+ W +LA GT Y+APE+ + CD +S GV+ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 995 IKGKHP 1000
+ G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVA 969
AL +LH +++RD+ N+LLD + +++DFG+ K + T GT Y+A
Sbjct: 108 ALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIA 164
Query: 970 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
PE+ ++ D ++ GVL E++ G+ P
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 804 IGKGGQGSVYKVELASGEII---AVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
+G+G GSV + +L + I AVK + + ++FL+E + E H N+++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR-SEMEDFLSEAVCMKEFDHPNVMRL 65
Query: 861 YGFCSHAQHS------FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIK---GIADAL 911
G C S ++ +++ G L L + ++ ++K IA +
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA-KFLKPDSSNWTELAGT-YGYVA 969
YL + F +HRD++++N +L+ V+DFG++ K D +A ++A
Sbjct: 126 EYLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 970 PELAYTMKVTEKCDVYSFGVLALEV-IKGKHP 1000
E T K DV+SFGV E+ +G+ P
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 68/257 (26%), Positives = 109/257 (42%), Gaps = 44/257 (17%)
Query: 803 CIGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFL---NEVKAL------ 849
C+ G+G KV LA +GE+ A+K ++ + +EV++L
Sbjct: 3 CLAVLGRGHFGKVLLAEYKKTGELYAIK----------ALKKGDIIARDEVESLMCEKRI 52
Query: 850 ----TEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIK 905
RH +V + H V EY G L M + D +E V+
Sbjct: 53 FETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL 112
Query: 906 GIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNWTELAGT 964
G L YLH + IV+RD+ N+LLD + +++DFG+ K + T GT
Sbjct: 113 G----LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGT 164
Query: 965 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP--GDFISLISSSSLNLNIALDEIL 1022
++APE+ T D + GVL E++ G+ P GD + S +N DE+
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-----DEVR 219
Query: 1023 DPR-LPIPSHNVQEKLI 1038
PR L + ++ +L+
Sbjct: 220 YPRFLSREAISIMRRLL 236
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 18/229 (7%)
Query: 804 IGKGGQGSVYKVELAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE-IRHRNIVKFY 861
IGKG G V + S G AVK + Q + E L + ++H +V +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 862 GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP 921
A+ + V +Y+ G L L + LE R + +A A+ YLH+
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCF--LEPRARFYAAE-VASAIGYLHS---LN 116
Query: 922 IVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 980
I++RD+ +N+LLD + ++DFG+ K ++P+ + T GT Y+APE+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYDR 175
Query: 981 KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029
D + G + E++ G P S +++ D IL L +P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP--------FYSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 804 IGKGGQGSVYKVELASGEII-AVKKFHSPLPGEMTFQQEFLNEVKALTE-IRHRNIVKFY 861
IGKG G V + E AVK + ++ ++E L + ++H +V +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 862 GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP 921
A + V +Y+ G L L + LE R + IA AL YLH+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCF--LEPRARFYAAE-IASALGYLHS---LN 116
Query: 922 IVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 980
IV+RD+ +N+LLD + ++DFG+ K ++ + + T GT Y+APE+ +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPYDR 175
Query: 981 KCDVYSFGVLALEVIKGKHP 1000
D + G + E++ G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 23/151 (15%)
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 980
+HRD++++N+LL N ++ DFG+A+ + PD + ++APE + T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 981 KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL------DPRLPIPSHNVQ 1034
+ DV+SFGVL E+ SL +S + I DE R+ P +
Sbjct: 261 QSDVWSFGVLLWEI---------FSLGASPYPGVKI--DEEFCRRLKEGTRMRAPDYTTP 309
Query: 1035 EKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
E + + C P RPT ++ + L
Sbjct: 310 E----MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 11/198 (5%)
Query: 808 GQGSVYKVELAS----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE-IRHRNIVKFYG 862
G+GS KV LA G+ AVK + Q+ + E L + ++H +V +
Sbjct: 4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHY 63
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
+ + V +++ G L L + + + + IA AL YLH+ I
Sbjct: 64 SFQTTEKLYFVLDFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLHS---INI 117
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 982
V+RD+ +N+LLD + ++DFG+ K S T GT Y+APE+
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 983 DVYSFGVLALEVIKGKHP 1000
D + G + E++ G P
Sbjct: 178 DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 5e-07
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 40/218 (18%)
Query: 804 IGKGGQGSVYKVELA-SGEIIAVKK----FHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 858
+G G G V +G +A+KK F S + + T++ E++ L + H N++
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-----ELRLLKHMDHENVI 77
Query: 859 KFYG-FC--SHAQHSFIVYEYLE-MGS-LAMILSNDAAAEDLEWTQRMS------VIKGI 907
F S + VY MG+ L I+ Q++S ++ I
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK----------CQKLSDDHIQFLVYQI 127
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGY 967
L Y+H+ I+HRD+ N+ ++ E ++ DFG+A + T T Y
Sbjct: 128 LRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEMTGYVATRWY 181
Query: 968 VAPELAYT-MKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
APE+ M + D++S G + E++ GK PG
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 53/235 (22%), Positives = 94/235 (40%), Gaps = 43/235 (18%)
Query: 842 FLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRM 901
F ++++ H ++ +G C + +V E++E G L + L + + W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 902 SVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT-- 959
+V + +A ALSYL + +VH ++ +KN+LL A G + F+K +
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE----GTSPFIKLSDPGVSFT 173
Query: 960 -----ELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEV-------IKGKHPGDFISL 1006
E ++APE + ++ D +SFG LE+ +K + P +
Sbjct: 174 ALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233
Query: 1007 ISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
RLP PS LIS CL P RP+ + +
Sbjct: 234 YEKKH-------------RLPEPSCKELATLIS------QCLTYEPTQRPSFRTI 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-07
Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 31/199 (15%)
Query: 844 NEVKALTEIRHRNIVKF--------YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDL 895
NE+ AL + H NI+K + ++ F +Y ++ + D L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------DWKDRPL 265
Query: 896 EWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA-KFLKPD 954
R +++K + A+ Y+H+ ++HRDI +N+ L+ + + DFG A F K
Sbjct: 266 LKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321
Query: 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK---------GKHPGDFIS 1005
+ GT +PE+ E D++S G++ L+++ G PG +
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381
Query: 1006 LISSSSLNLNIALDEILDP 1024
I S L++ +E DP
Sbjct: 382 KIIDS---LSVCDEEFPDP 397
|
Length = 501 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 28/102 (27%), Positives = 48/102 (47%), Gaps = 5/102 (4%)
Query: 833 PGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAA 892
P F + ++ H++IV YG C + +V E++E G L + + +
Sbjct: 42 PSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDV 101
Query: 893 EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLL 934
W + V K +A ALSYL + +VH ++ +KN+LL
Sbjct: 102 LTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 66/281 (23%), Positives = 119/281 (42%), Gaps = 35/281 (12%)
Query: 804 IGKGGQGSV----YKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
+GKG GSV K E S + +AVK + + + EFL E + E H N++K
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVIK 65
Query: 860 FYGFCSHAQHS------FIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSV--IKGIADA 910
G ++ ++ +++ G L +L + E + V + IA
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT----YG 966
+ YL + F +HRD++++N +L+ V+DFG++K K S ++
Sbjct: 126 MEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSK--KIYSGDYYRQGCASKLPVK 180
Query: 967 YVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDPR 1025
++A E T DV++FGV E++ +G+ P + + +S N I + + P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP--YAGVENSEIYNYLIKGNRLKQP- 237
Query: 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ L E+ C P+ RP+ Q + L+
Sbjct: 238 --------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 42/160 (26%), Positives = 67/160 (41%), Gaps = 34/160 (21%)
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDL--EWTQRMSVIKGIADALS 912
N+V + + F+V ++ E G L + I E+ W M V AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG------ 966
LH + IV RD++ N+LLD + +++ F W+E+ +
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFS----------RWSEVEDSCDGEAVEN 146
Query: 967 -YVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-----HP 1000
Y APE+ + TE CD +S G + E++ GK HP
Sbjct: 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 71/259 (27%), Positives = 94/259 (36%), Gaps = 38/259 (14%)
Query: 463 LDRNYL-TSNISESFYIYPNLTFIDLSYNNLYGE----ISSDWGRCPKLGALDFSKNNIT 517
L L T +E L + L N L E ++S P L L S N T
Sbjct: 5 LKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNE-T 63
Query: 518 GNIPPKIG-------YSSQLEVLDLSSNHVVGDIPAELGKL---SFLIKLILAQNQLSGQ 567
G IP + L+ LDLS N + D L L S L +L L N L +
Sbjct: 64 GRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDR 123
Query: 568 LSPKLG-----LLVQLEHLDLSSNNLSNAIPESLGNLV----KLHYLNLSNNQFSWE-IP 617
L L LE L L N L A E+L + L LNL+NN I
Sbjct: 124 GLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183
Query: 618 IKLEELIHLSEL---DLSYNFLGRAIPSQICI----MQSLEKLNLSHNSLSGVIPRCF-- 668
E L L DL+ N L S + ++SLE LNL N+L+
Sbjct: 184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALAS 243
Query: 669 ---EEMHALQCIDISYNEL 684
+L + +S N++
Sbjct: 244 ALLSPNISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-07
Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 804 IGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IGKG G VY+V + I A+K L + ++ + I R ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKV----LSKKEIVAKKEVAHTIGERNILVRTLLDESP 56
Query: 863 FCSHAQHSF-------IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSV-IKGIADALSYL 914
F + SF +V +Y+ G L L + + R I + AL +L
Sbjct: 57 FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE----DRAKFYIAELVLALEHL 112
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
H IV+RD+ +N+LLD + DFG++K D+ GT Y+APE+
Sbjct: 113 HKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 975 TMK-VTEKCDVYSFGVLALEVIKGKHP 1000
K T+ D +S GVL E+ G P
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-06
Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 31/200 (15%)
Query: 839 QQEFLNEVKALTEIRHRNIVKFYG-FCSHA-QHSFIVYEYLEMGSLAM-ILSNDAAAEDL 895
+ + + EV + E++H+NIV++ F + A Q +I+ E+ + G L+ I +
Sbjct: 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI 115
Query: 896 EWTQRMSVIKGIADALSYLHNDCFPP----IVHRDISSKNVL-----------------L 934
E + + + + AL+Y HN P ++HRD+ +N+ L
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 935 DFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY--TMKVTEKCDVYSFGVLAL 992
+ + A++ DFG++K + +S + GT Y +PEL T +K D+++ G +
Sbjct: 176 NGRPIAKIGDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 993 EVIKGKHP----GDFISLIS 1008
E+ GK P +F LIS
Sbjct: 235 ELCSGKTPFHKANNFSQLIS 254
|
Length = 1021 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 804 IGKGGQG---SVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVK 859
+G+G G S E + E +A+KK + ++ ++ L E+K L R H+NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA-LRELKLLRHFRGHKNITC 66
Query: 860 FYGF---CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
Y + +YE L L I+ + D + S I I L Y+H+
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHF---QSFIYQILCGLKYIHS 123
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD----SSNWTELAGTYGYVAPEL 972
++HRD+ N+L++ E ++ DFG+A+ + + TE T Y APE+
Sbjct: 124 ---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 973 AYTMK-VTEKCDVYSFGVLALEVIKGK 998
+ + T+ DV+S G + E++ K
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 44/197 (22%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G+G +VYK + +G+++A+K + F + E L ++H NIV +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA--IREASLLKGLKHANIVLLHD 70
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
+ V+EY+ LA + L + + L+Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGG--LHPYNVRLFMFQLLRGLAYIHGQ---HI 124
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEK 981
+HRD+ +N+L+ + E +++DFG+A+ S ++ T Y P+ L +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 982 CDVYSFGVLALEVIKGK 998
D++ G + +E+++G+
Sbjct: 185 LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG+G G+V+K + EI+A+K+ E L E+ L E++H+NIV+ Y
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYD 66
Query: 863 FCSHAQHSF-IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP 921
H+ +V+EY + L D+ D++ S + + L++ H+
Sbjct: 67 VL-HSDKKLTLVFEYCDQ-DLKKYF--DSCNGDIDPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 922 IVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNWTELAGTYGYVAPELAYTMKV-T 979
++HRD+ +N+L++ E +++DFG+A+ F P E+ T Y P++ + K+ +
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 178
Query: 980 EKCDVYSFGVLALEVIKGKHP 1000
D++S G + E+ P
Sbjct: 179 TSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
+ N +K Y + + ++ +Y++ G L +L + L + +I+ + +AL+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALND 124
Query: 914 LHNDCFPPIVHRDISSKNVLLD-FKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
LH I+H DI +NVL D K+ + D+G+ K + S GT Y +PE
Sbjct: 125 LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC----YDGTLDYFSPE- 176
Query: 973 AYTMKVT-EKCDV----YSFGVLALEVIKGKHP 1000
K+ DV ++ GVL E++ GKHP
Sbjct: 177 ----KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 20/215 (9%)
Query: 797 DFDDEHCIGKGGQGSVYKVELASG----EIIAVKKFH-SPLPGEMTFQQEFLNEVKALTE 851
+F+ +G G G V+ V +G ++ A+K + L + + E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 852 IRHRN--IVKFYGFCSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSVIKG-I 907
+R + Y F + A+ I+ +Y+ G + + D +ED + G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLIL-DYVSGGEMFTHLYQRDNFSED-----EVRFYSGEI 114
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNWTELAGTYG 966
AL +LH IV+RDI +N+LLD + ++DFG++K FL + GT
Sbjct: 115 ILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 967 YVAPELAYTMKVTEKC-DVYSFGVLALEVIKGKHP 1000
Y+APE+ K D +S G+L E++ G P
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 2e-06
Identities = 20/60 (33%), Positives = 33/60 (55%)
Query: 625 HLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNEL 684
+L LDLS N L + +L+ L+LS N+L+ + P F + +L+ +D+S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-06
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 34/212 (16%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQ-----QEFLNEVKALTEIRHRNI 857
IG G G V+ V + G+ +A+KK +P FQ + E+K L +H N+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKK----MPN--VFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 858 VKFY-----GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALS 912
+ + ++V E ++ +I+S + D +++G L
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG----LK 117
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS-NWTELAGTYGYVAPE 971
YLH+ I+HRDI N+L++ ++ DFG+A+ +PD S + T+ T Y APE
Sbjct: 118 YLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 972 LA-----YTMKVTEKCDVYSFGVLALEVIKGK 998
+ YT V D++S G + E++ +
Sbjct: 175 ILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 41/144 (28%), Positives = 66/144 (45%), Gaps = 10/144 (6%)
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
Y F + + ++ +Y+ G L L E ++ I I AL +LH
Sbjct: 71 HYAFQTDTK-LHLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ--- 123
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNWTELAGTYGYVAPELAYTMKV 978
I++RDI +N+LLD + ++DFG++K FL + GT Y+APE+
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183
Query: 979 --TEKCDVYSFGVLALEVIKGKHP 1000
+ D +S GVL E++ G P
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 63/306 (20%), Positives = 107/306 (34%), Gaps = 64/306 (20%)
Query: 803 CIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
C + K + + ++AVKK + + + E+ +++H NI+ +
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQ-QEIITSRQLQHPNILPYVT 66
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
++V + GS +L E L ++K + +AL Y+H+ F
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKGF--- 122
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAK------------FLKPDSS----NWTELAGTYG 966
+HR + + ++LL + +S + P SS W
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL------- 175
Query: 967 YVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHP---------------GDFISLISS 1009
+PE+ EK D+YS G+ A E+ G P G L+
Sbjct: 176 --SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK 233
Query: 1010 SSLNLNI-----ALDEILDPRLPIPSHNVQEKLIS-----FVEVAISCLDESPESRPTMQ 1059
S+ L + P + + S FVE+ CL PESRP+
Sbjct: 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL---CLQRDPESRPS-- 288
Query: 1060 KVSQLL 1065
SQLL
Sbjct: 289 -ASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 67/255 (26%), Positives = 113/255 (44%), Gaps = 48/255 (18%)
Query: 839 QQEFLNEVKALTEI-----RHRNIV--KFY-----GFCSHAQHSFIVYEYLEMGSLAMIL 886
+ FLN V AL EI ++NI K Y GF S + Y+EM ++
Sbjct: 137 AETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDT-----YVEMRPVSSSS 191
Query: 887 SNDAAAEDLEWTQRM---------SVIKGIADALSYL-HNDCFPPIVHRDISSKNVLLDF 936
S + ++D E T+ +A + +L +C +HRD++++NVLL
Sbjct: 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTD 247
Query: 937 KNEARVSDFGIAKFLKPDSSNWTELAGT----YGYVAPELAYTMKVTEKCDVYSFGVLAL 992
A++ DFG+A+ + D SN+ + G ++APE + T + DV+S+G+L
Sbjct: 248 GRVAKICDFGLARDIMND-SNYV-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 305
Query: 993 EVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDES 1051
E+ GK P I L++S + ++ P P + C +
Sbjct: 306 EIFSLGKSPYPGI-LVNSKFYKMVKRGYQMSRPDFAPP---------EIYSIMKMCWNLE 355
Query: 1052 PESRPTMQKVSQLLK 1066
P RPT ++SQL++
Sbjct: 356 PTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 37/153 (24%), Positives = 67/153 (43%), Gaps = 27/153 (17%)
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAK--FLKPDSSNWTELAGTYGYVAPELAYTMKVTE 980
+HRD++++N+LL N ++ DFG+A+ + PD ++APE + T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 981 KCDVYSFGVLALEVIK---GKHPG-----DFISLISSSSLNLNIALDEILDPRLPIPSHN 1032
+ DV+SFGVL E+ +PG +F + + R+ P +
Sbjct: 256 QSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-------------RMRAPENA 302
Query: 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
E + ++C P+ RPT + ++L
Sbjct: 303 TPE----IYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 41/185 (22%)
Query: 845 EVKALTEIRHRNIVKFYGFCSHA------------QHSFIVYEYLE-MGSLAMILSNDAA 891
E+ L I HR I+ HA ++ ++ Y++ G L +
Sbjct: 136 EIDILKTISHRAIINLI----HAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPL------- 184
Query: 892 AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951
Q +++ + + +AL+YLH I+HRD+ ++N+ LD A + DFG A L
Sbjct: 185 ------EQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 952 -----KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISL 1006
P W +GT +PEL K D++S G++ E+ +
Sbjct: 236 DAHPDTPQCYGW---SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292
Query: 1007 ISSSS 1011
SSSS
Sbjct: 293 KSSSS 297
|
Length = 392 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG 966
IA AL YLH+ I++RD+ +N+LLD + ++DFG+ K S + GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161
Query: 967 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
Y+APE+ D + G + E++ G P
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 804 IGKGGQGSVYKVELASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG G QG V A E +A+KK P + T + E+ + + H+NI+
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 863 FCS------HAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS-VIKGIADALSYLH 915
+ Q +IV E ++ +L ++ + E RMS ++ + + +LH
Sbjct: 91 VFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHE------RMSYLLYQMLCGIKHLH 143
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 975
+ I+HRD+ N+++ ++ DFG+A+ + Y Y APE+
Sbjct: 144 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILG 199
Query: 976 MKVTEKCDVYSFGVLALEVIKGK--HPG-DFI 1004
M E D++S G + E+IKG PG D I
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 75/300 (25%)
Query: 804 IGKGGQGSVYKVELASGEI----IAVKKF------HSPLPGEMTFQQEFLNEVKALTEIR 853
+G+G GSV + +L+ + +AVK +S + +EFL+E + +
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI-------EEFLSEAACMKDFD 59
Query: 854 HRNIVKFYGFC--SHAQHSF----IVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSV--I 904
H N++K G C + + ++ +++ G L + +L + + + + +
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 905 KGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT 964
IA + YL N F +HRD++++N +L V+DFG++K +G
Sbjct: 120 VDIALGMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSK---------KIYSGD 167
Query: 965 Y-----------GYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGK--HPGDFISLISSS 1010
Y ++A E T K DV++FGV E+ +G+ +PG
Sbjct: 168 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG--------- 218
Query: 1011 SLNLNIALDEILD-----PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+ EI D RL P + E ++ SC P+ RPT K+ ++L
Sbjct: 219 -----VENHEIYDYLRHGNRLKQPEDCLDE----LYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNWTELAGTY 965
I AL +LH I++RDI +N+LLD ++DFG++K F + + GT
Sbjct: 114 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 966 GYVAPELAYTMKV--TEKCDVYSFGVLALEVIKGKHP 1000
Y+AP++ + D +S GVL E++ G P
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-06
Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 4/99 (4%)
Query: 901 MSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF-LKPDSSNWT 959
+++ + + A+ YLH + I+HRDI ++N+ ++ + + DFG A F + +++ +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 998
AGT APEL D++S G++ E+
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-06
Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 798 FDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
+ D +G G G V+ V+ + +AVKK P + + L E+K + + H N
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV---KHALREIKIIRRLDHDN 63
Query: 857 IVKFY--------------GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS 902
IVK Y G + +IV EY+E LA +L +E+
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQ 122
Query: 903 VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA-RVSDFGIAKFLKPDSSN---W 958
+++G L Y+H+ ++HRD+ NV ++ ++ ++ DFG+A+ + P S+
Sbjct: 123 LLRG----LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175
Query: 959 TELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 998
+E T Y +P L + T+ D+++ G + E++ GK
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 33/226 (14%)
Query: 841 EFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQR 900
F ++++ H+++VK YG C + +V EY++ G L + L + L W +
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--K 103
Query: 901 MSVIKGIADALSYLHNDCFPPIVHRDISSKNVLL--DFKNE-----ARVSDFGIAKFLKP 953
+ V K +A AL YL + +VH ++ KN+L+ NE ++SD GI +
Sbjct: 104 LDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160
Query: 954 DSSNWTELAGTYGYVAPELAY--TMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSS 1010
E ++APE +T D +SFG LE+ G+ P +S +SSS
Sbjct: 161 RE----ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP---LSTLSSS 213
Query: 1011 SLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRP 1056
RLP+P LI+ C P RP
Sbjct: 214 EKERFYQDQH----RLPMPDCAELANLIN------QCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 8e-06
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG G QG V + +G+ +A+KK P ++ + E+ + + H+NI+
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGLLN 82
Query: 863 -FC-----SHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS-VIKGIADALSYLH 915
F Q ++V E ++ +L ++ D E RMS ++ + + +LH
Sbjct: 83 VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHE------RMSYLLYQMLCGIKHLH 135
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 975
+ I+HRD+ N+++ ++ DFG+A+ S T T Y APE+
Sbjct: 136 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVILG 191
Query: 976 MKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
M E D++S G + E+I+G PG
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGTVLFPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
I + Q S+YK + + + ++ F G NE+K L I NI+K YGF
Sbjct: 28 IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86
Query: 864 ----CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
++ EY G L +L + +DL + ++ + L L+
Sbjct: 87 IIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN 143
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK-PDSSNWTELAGTYGYVAPELAYTM-- 976
P +++++S + L+ + ++ G+ K L P N + Y + ++ +
Sbjct: 144 KP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFS 197
Query: 977 KVTEKCDVYSFGVLALEVIKGKHP 1000
+ T K D+YS GV+ E+ GK P
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 804 IGKGGQGSV---YKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
IG G QG V Y L +A+KK P + T + E+ + + H+NI+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISL 81
Query: 861 YGFCS------HAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS-VIKGIADALSY 913
+ Q ++V E ++ +L ++ + E RMS ++ + + +
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHE------RMSYLLYQMLCGIKH 134
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
LH+ I+HRD+ N+++ ++ DFG+A+ S T T Y APE+
Sbjct: 135 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGK--HPG-DFI 1004
M E D++S G + E+++ K PG D+I
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 46/196 (23%), Positives = 87/196 (44%), Gaps = 10/196 (5%)
Query: 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G+G +VYK + +G+++A+K L E + E L ++H NIV +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIR--LQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
+ +V+EY+ + D L + + LSY+H I
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKC 982
+HRD+ +N+L+ E +++DFG+A+ S ++ T Y P++ C
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 983 -DVYSFGVLALEVIKG 997
D++ G + +E+I+G
Sbjct: 185 LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 29/169 (17%)
Query: 842 FLNEVKALTEIRHRNIVKFYGFCSH-AQHSFIVYEYLEMGSLAMILSNDAAAEDLEW--- 897
L E L + H+NI+ C + F++Y Y+ G+L + L E
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 898 TQRMSVIKG--IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP-- 953
+ + V IA +SYLH ++H+DI+++N ++D + + +++D +++ L P
Sbjct: 115 STQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
Query: 954 -----DSSN----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 993
D+ N W +A E + + DV+SFGVL E
Sbjct: 172 YHCLGDNENRPVKW---------MALESLVNKEYSSASDVWSFGVLLWE 211
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-05
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 442 DNQ-FQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSD 499
DNQ +G IPN + L L ++L N + NI S +L +DLSYN+ G I
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 500 WGRCPKLGALDFSKNNITGNIPPKIG 525
G+ L L+ + N+++G +P +G
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-05
Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 25/152 (16%)
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTY---GYVAPELAYTMKVT 979
VHRD++++NVL+ ++ DFG+A+ + D SN+ T+ ++APE + T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRD-SNYISKGSTFLPLKWMAPESIFNNLYT 319
Query: 980 EKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-----RLPIPSHNV 1033
DV+SFG+L E+ G P L +N ++ + R+ P+H
Sbjct: 320 TLSDVWSFGILLWEIFTLGGTP--------YPELPMN---EQFYNAIKRGYRMAKPAHAS 368
Query: 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
E E+ C +E E RP ++ L+
Sbjct: 369 DE----IYEIMQKCWEEKFEIRPDFSQLVHLV 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 50/223 (22%), Positives = 87/223 (39%), Gaps = 30/223 (13%)
Query: 801 EHCIGKGGQGSVYKVELASGEII---AVKKFHS---------PLPGEMTFQQEFLNEVKA 848
+ IG GG G VY+ + AS I AV K + L + + + K
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76
Query: 849 LTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRM--SVIKG 906
+ I H I K+YG C + + Y ++ + L + + + +++ +++K
Sbjct: 77 IHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKD 134
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL---------KPDSSN 957
+ L Y+H I H DI +N+++D N + D+GIA + +
Sbjct: 135 MLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKD 191
Query: 958 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
GT Y + VT + D+ S G L+ K P
Sbjct: 192 LHR--GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-05
Identities = 15/44 (34%), Positives = 26/44 (59%), Gaps = 4/44 (9%)
Query: 2 EEAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCN 45
++ ALL +K+SL +G+ LSSW ++ C+W G+ C+
Sbjct: 3 DDRDALLAFKSSLNGDPSGA-LSSWNPSSS---DPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 39/159 (24%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 843 LNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQ--R 900
+ EV L ++H NIV + + +V+EYL+ L L N + +
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFM 109
Query: 901 MSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE 960
+++G LSY H I+HRD+ +N+L++ K E +++DFG+A+ + ++
Sbjct: 110 FQLLRG----LSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162
Query: 961 LAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGK 998
T Y P+ L + + + D++ G + E+ G+
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 46/203 (22%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 804 IGKGGQGSVYKVELASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G+G +V+K E ++A+K+ L E + EV L +++H NIV +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 863 FCSHAQHSFIVYEYLE------MGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
+ +V+EYL+ M I+S L +++G+A Y H
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL-----YQILRGLA----YCHR 122
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYT 975
++HRD+ +N+L++ + E +++DFG+A+ + ++ T Y P+ L +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 976 MKVTEKCDVYSFGVLALEVIKGK 998
+ + + D++ G + E+ G+
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 46/198 (23%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 804 IGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G+G +VYK + ++A+K+ L E + EV L +++H NIV +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 863 FCSHAQHSF-IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP 921
H + S +V+EYL+ L L D + + + L+Y H
Sbjct: 72 II-HTEKSLTLVFEYLDK-DLKQYL--DDCGNSINMHNVKLFLFQLLRGLNYCHRR---K 124
Query: 922 IVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTE 980
++HRD+ +N+L++ + E +++DFG+A+ + ++ T Y P+ L + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
Query: 981 KCDVYSFGVLALEVIKGK 998
+ D++ G + E+ G+
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-04
Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 895 LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954
L Q +V + + A+ Y+H + I+HRDI ++NVL++ + + DFG A F +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313
Query: 955 SSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 993
S +AGT APE+ T D++S G++ E
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 49/207 (23%), Positives = 93/207 (44%), Gaps = 21/207 (10%)
Query: 804 IGKGGQGSVYKVE--LASGEIIAVKKFHSPLPGE-MTFQQEFLNEVKALTEIR---HRNI 857
IG+G G V+K G +A+K+ E M + EV L + H N+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST--IREVAVLRHLETFEHPNV 66
Query: 858 VKFYGFCSHAQHS-----FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS-VIKGIADAL 911
V+ + C+ ++ +V+E+++ L L D E T+ + ++ + L
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQLLRGL 123
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 971
+LH+ +VHRD+ +N+L+ + +++DFG+A+ + T + T Y APE
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPE 179
Query: 972 LAYTMKVTEKCDVYSFGVLALEVIKGK 998
+ D++S G + E+ + K
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN-IVKFY 861
IG+G G VYK + +G+++A+KK + E L E+ L + IV+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLL 67
Query: 862 GFCSHAQHS-----FIVYEYLEMGSLAMILSN-DAAAEDLEWTQRMSVIKGIADALSYLH 915
+ + ++V+EYL+ + SN L S + + +++ H
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 916 NDCFPPIVHRDISSKNVLLD-FKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-- 972
++HRD+ +N+L+D K +++D G+ + ++T T Y APE+
Sbjct: 128 KH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLL 184
Query: 973 ---AYTMKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
Y+ V D++S G + E+ + + PGD
Sbjct: 185 GSTHYSTPV----DIWSVGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 21/58 (36%), Positives = 27/58 (46%)
Query: 577 QLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYN 634
L+ LDLS+N L+ + L L L+LS N + P L L LDLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 844 NEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS- 902
+E+ L H IVK + ++ EY G L + E L + +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQ-RLKEHLPFQEYEVG 172
Query: 903 -VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW--- 958
+ I AL +H+ ++HRD+ S N+ L ++ DFG +K DS +
Sbjct: 173 LLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVA 228
Query: 959 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
+ GT Y+APEL + ++K D++S GV+ E++ P
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-04
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 57/204 (27%)
Query: 846 VKA----LTEIRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQ 899
VKA L E + +VK +Y F F++ +Y+ G + ++++ EDL
Sbjct: 48 VKAERDILAEADNEWVVKLYYSFQDKDNLYFVM-DYIPGGDMMSLLIRLGIFEEDL---A 103
Query: 900 RMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGI---------AKF 950
R I + A+ +H F +HRDI N+L+D +++DFG+ +K+
Sbjct: 104 RF-YIAELTCAIESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 951 LKP------DS----SNWTE------------------------LAGTYGYVAPELAYTM 976
+ DS W+E L GT Y+APE+
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 977 KVTEKCDVYSFGVLALEVIKGKHP 1000
T+ CD +S GV+ E++ G+ P
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 4e-04
Identities = 21/60 (35%), Positives = 29/60 (48%)
Query: 338 SLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKL 397
+L L+L NN+L L NL VL + N+L+ P L SL L+L+ N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 7e-04
Identities = 19/60 (31%), Positives = 28/60 (46%)
Query: 386 SLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQF 445
+L L+L+ N+LT + L NL VL N+L+ P+ + L L L L N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 44/204 (21%), Positives = 81/204 (39%), Gaps = 55/204 (26%)
Query: 845 EVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSV 903
E L E + +V+ Y + + V +Y+ G + ++++ EDL
Sbjct: 51 ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLA----RFY 106
Query: 904 IKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGI---------AKF---- 950
I + A+ +H F +HRDI N+L+D +++DFG+ +K+
Sbjct: 107 IAELTCAVESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG 163
Query: 951 --LKPDSSNWT--------------------------------ELAGTYGYVAPELAYTM 976
++ DS +++ L GT Y+APE+
Sbjct: 164 DHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223
Query: 977 KVTEKCDVYSFGVLALEVIKGKHP 1000
T+ CD +S GV+ E++ G+ P
Sbjct: 224 GYTQLCDWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 30/153 (19%), Positives = 54/153 (35%), Gaps = 26/153 (16%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV--KFY 861
+ G VY + + + +K S G EV L + + + K
Sbjct: 6 LKGGLTNRVYLLGTKDEDYV-LKINPSREKGAD-----REREVAILQLLARKGLPVPKVL 59
Query: 862 GFCSHAQHSFIVYEYLEMGSL--AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
S+++ E++E +L + AE L A+ L+ LH
Sbjct: 60 ASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQL------------AELLAKLHQ--L 105
Query: 920 PPIV--HRDISSKNVLLDFKNEARVSDFGIAKF 950
P +V H D+ N+L+D + D+ A +
Sbjct: 106 PLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 22/59 (37%), Positives = 30/59 (50%)
Query: 554 LIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQF 612
L L L+ N+L+ L L+ LDLS NNL++ PE+ L L L+LS N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 45/204 (22%), Positives = 82/204 (40%), Gaps = 55/204 (26%)
Query: 845 EVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSV 903
E L E + +VK Y + + V +Y+ G + ++++ + E L R +
Sbjct: 51 ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYI 107
Query: 904 IKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGI---------AKF---- 950
+ + A+ +H F +HRDI N+L+D +++DFG+ +K+
Sbjct: 108 AE-LTLAIESVHKMGF---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG 163
Query: 951 --LKPDSSN----WTE----------------------------LAGTYGYVAPELAYTM 976
++ DS W + L GT Y+APE+
Sbjct: 164 SHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK 223
Query: 977 KVTEKCDVYSFGVLALEVIKGKHP 1000
T+ CD +S GV+ E++ G+ P
Sbjct: 224 GYTQLCDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 18/59 (30%), Positives = 27/59 (45%)
Query: 291 LSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKL 349
L + LS N+ + + + L N+ L L N+L + P L SL L+L N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.003
Identities = 21/60 (35%), Positives = 29/60 (48%)
Query: 362 NLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL 421
NL L + NN L+ L +L L+L+ N LTS P + S L +L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.003
Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 82/247 (33%)
Query: 804 IGKGGQGS---VYKV-ELASGEIIAVKK----FHSPLPGEMTFQQEFLNEVKALTEIR-- 853
+GK G+G+ V K +G+ A+K F S L +V L EI+
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS------------LEQVNNLREIQAL 51
Query: 854 -----HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSV---IK 905
H NI++ ++++ G LA++ E ++ M++ IK
Sbjct: 52 RRLSPHPNILRLIE---------VLFDRKT-GRLALVF------ELMD----MNLYELIK 91
Query: 906 G----------------IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK 949
G + +L ++H + I HRDI +N+L+ + +++DFG +
Sbjct: 92 GRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIK-DDILKLADFGSCR 147
Query: 950 --FLKPDSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIK------GKHP 1000
+ KP +TE T Y APE T K D+++ G + E++ G +
Sbjct: 148 GIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204
Query: 1001 GDFISLI 1007
D I+ I
Sbjct: 205 LDQIAKI 211
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 19/60 (31%), Positives = 26/60 (43%)
Query: 218 NLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSL 277
NL L+LS+N L L L L L+ N L P + L +L L + N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1067 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.51 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.25 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.17 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.12 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.12 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.11 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.11 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.01 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.98 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.96 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.72 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.67 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.6 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.57 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.56 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.43 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.41 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.4 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.38 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-114 Score=1113.26 Aligned_cols=910 Identities=36% Similarity=0.552 Sum_probs=565.1
Q ss_pred hHHHHHHHHHhhcccCCCCCCCCCCCCCCCCCcCCcceeeEEcCCCCceeeeeeecccccccccCCcCCCCCCcceEecc
Q 001494 2 EEAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLW 81 (1067)
Q Consensus 2 ~~~~all~~k~~~~~~~~~~~l~sW~~~~~~~~~~c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~~~~~~~l~~L~L~ 81 (1067)
+|++||++||+++.+ +.+.+++|+. ..+||.|.||+|+..++|+.++|.++++.|.++ ..|..+++|++|+|+
T Consensus 29 ~~~~~l~~~~~~~~~--~~~~~~~w~~----~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~-~~~~~l~~L~~L~Ls 101 (968)
T PLN00113 29 EELELLLSFKSSIND--PLKYLSNWNS----SADVCLWQGITCNNSSRVVSIDLSGKNISGKIS-SAIFRLPYIQTINLS 101 (968)
T ss_pred HHHHHHHHHHHhCCC--CcccCCCCCC----CCCCCcCcceecCCCCcEEEEEecCCCccccCC-hHHhCCCCCCEEECC
Confidence 689999999999963 2347899974 357999999999877888887777666666553 245556666666666
Q ss_pred CCccccCCCCccc-ccCccceeecCCCcccCCCCcccccccccceecccccccccCCCCccccccccccccccccccccc
Q 001494 82 SNQLFGNIPPQIG-NISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDI 160 (1067)
Q Consensus 82 ~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 160 (1067)
+|++.|.+|..+. ++++|++|+|++|+++|.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.
T Consensus 102 ~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~ 179 (968)
T PLN00113 102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179 (968)
T ss_pred CCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccccc
Confidence 6666655555443 556666666666666555553 3455555555555555555554444444444444444444444
Q ss_pred cCCCccCCCcccEEEEeccCCcCccCCccccccccceecccccccccccCCCCCcccccceeecccCcCCCCCCcccCCc
Q 001494 161 IPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNL 240 (1067)
Q Consensus 161 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 240 (1067)
+|..++++++|++|+|++|++++.+| ..++++++|++|+|++|++++.+|..++++
T Consensus 180 ~p~~~~~l~~L~~L~L~~n~l~~~~p------------------------~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l 235 (968)
T PLN00113 180 IPNSLTNLTSLEFLTLASNQLVGQIP------------------------RELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235 (968)
T ss_pred CChhhhhCcCCCeeeccCCCCcCcCC------------------------hHHcCcCCccEEECcCCccCCcCChhHhcC
Confidence 44444444444444444444444444 444444444444444444444444444444
Q ss_pred ccCCceEecCcccccccCccccCccceeeEEEecccccccCCCccccCCcccEEEeccccccCCccccccCCccccEEec
Q 001494 241 KYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFL 320 (1067)
Q Consensus 241 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 320 (1067)
++|++|++++|.+++.+|..++++++|+.|++++|++++.+|..+.++++|+.|++++|++.+.+|..+.++++|++|++
T Consensus 236 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l 315 (968)
T PLN00113 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHL 315 (968)
T ss_pred CCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEEC
Confidence 44444444444444444444444444444444444444444444444444444444444444444444444444444444
Q ss_pred cCCCCcCCCCcccccCCCCCeEEecCccccccCCccccCCCCCCeEEccCCcCccccCcccCCCCCCCEEEccCCccccc
Q 001494 321 DSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSS 400 (1067)
Q Consensus 321 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 400 (1067)
++|.+.+..|..+..+++|+.|++++|++++.+|..++.+++|+.|++++|.+++.+|.++..+++|+.|++++|++.+.
T Consensus 316 ~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~ 395 (968)
T PLN00113 316 FSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGE 395 (968)
T ss_pred CCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEeccc
Confidence 44444444444444444444455544444444444444444444444444444444444444444455555555555444
Q ss_pred CCCccccccCCcEEEcccCcCcccCchhhhCcCCCcEEeCCCCcccCCCCCCCCCCcccEEeccCcccccccccccccCC
Q 001494 401 IPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYP 480 (1067)
Q Consensus 401 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 480 (1067)
+|..+..+++|+.|++++|++++..|..|..++.|+.|++++|.+
T Consensus 396 ~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l----------------------------------- 440 (968)
T PLN00113 396 IPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL----------------------------------- 440 (968)
T ss_pred CCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcc-----------------------------------
Confidence 444444444444444444444444444443333333333333333
Q ss_pred ceeEEEcccccccCCCCCCCCCCCCcceEeccCCccCCCCCCcccCCCCCcEEEcCCCcccCcCcccccCCCccceeecc
Q 001494 481 NLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILA 560 (1067)
Q Consensus 481 ~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 560 (1067)
++.++..+..++ +|+.|+|++|++.+..|..+
T Consensus 441 ------------~~~~~~~~~~l~------------------------~L~~L~L~~n~~~~~~p~~~------------ 472 (968)
T PLN00113 441 ------------QGRINSRKWDMP------------------------SLQMLSLARNKFFGGLPDSF------------ 472 (968)
T ss_pred ------------cCccChhhccCC------------------------CCcEEECcCceeeeecCccc------------
Confidence 222222222233 33333333333333222211
Q ss_pred cccccCCccccccccccccEEEccCCCCCCCcccccccccccceecccCcccccccchhhhhccccceeccccccCCCcc
Q 001494 561 QNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAI 640 (1067)
Q Consensus 561 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 640 (1067)
...+|+.||+++|++++..|..|..+++|++|+|++|++++.+|..+..+++|++|+|++|.+++.+
T Consensus 473 -------------~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 539 (968)
T PLN00113 473 -------------GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI 539 (968)
T ss_pred -------------ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccC
Confidence 1134666777777777777777777778888888888888888888888888888888888888888
Q ss_pred hhhhhcccccccccccccccccccccccccCccccEEEcccCcCCCCCCCCCcccCCCcccccCCCCccCCC--CCCCCc
Q 001494 641 PSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDF--KGLPSC 718 (1067)
Q Consensus 641 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~n~~~c~~~--~~~~~c 718 (1067)
|..+..+++|+.|+|++|++++.+|..+..+++|+.+++++|++.|.+|...+|..+...++.|||++|+.. .+.++|
T Consensus 540 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c 619 (968)
T PLN00113 540 PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC 619 (968)
T ss_pred ChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCC
Confidence 888999999999999999999999999999999999999999999999999999999999999999999854 346678
Q ss_pred cccccCccccceEEEeehhHHHHHHHHHHHHhheeeeEEeecccccccCCCCCCCCCCcccc-cccCcccHHHHHHHhcC
Q 001494 719 KALKSNKQASRKIWIVVLFPLLGIVALLISLIGLFFKFQRRKNKSQTKQSSPRNTPGLRSML-TFEGKIVYEEIIRATND 797 (1067)
Q Consensus 719 ~~~~~~~~~~~~~~~iv~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 797 (1067)
... .+....+. +++++++++++++++++++++++++++...++.............. ........++ ....
T Consensus 620 ~~~----~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 691 (968)
T PLN00113 620 KRV----RKTPSWWF-YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND---ILSS 691 (968)
T ss_pred ccc----cccceeee-ehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHH---HHhh
Confidence 532 11223333 3333333333333333333332322221111111000000000000 0001122233 3346
Q ss_pred CCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|...++||+|+||.||+|+. .+++.||||++...... ..+|++.+++++|||||+++|+|.+++..|+||||
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 77888999999999999976 57899999998643211 12468889999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+++|+|.++++ .++|.++.+|+.|+++|++|||.++.++|+||||||+||+++.++.+++. ||.+......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999999994 27899999999999999999997666699999999999999999988875 6665433221
Q ss_pred ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccch------hhhhhhhhccCCCCCCCC
Q 001494 957 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSL------NLNIALDEILDPRLPIPS 1030 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 1030 (1067)
....+|+.|||||++.+..++.++|||||||++|||+||+.||+.......... ........+.++......
T Consensus 836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence 223678999999999999999999999999999999999999853221110000 001112233444443322
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1031 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....++..++.+++.+||+.||++||||+||++.|+
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 949 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence 333456667899999999999999999999999986
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-61 Score=622.01 Aligned_cols=496 Identities=39% Similarity=0.584 Sum_probs=367.6
Q ss_pred ceeeeeeecccccccccCCcCCCCCCcceEeccCCccccCCCCcccccCccceeecCCCcccCCCCcccccccccceecc
Q 001494 49 RVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHL 128 (1067)
Q Consensus 49 ~v~~l~l~~~~l~g~l~~~~~~~~~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 128 (1067)
....++|.++.+.|.++...|..+++|++|+|++|+++|.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|
T Consensus 94 ~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 171 (968)
T PLN00113 94 YIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDL 171 (968)
T ss_pred CCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEEC
Confidence 5677899999999999988888999999999999999999886 57899999999999999999999999999999999
Q ss_pred cccccccCCCCccccccccccccccccccccccCCCccCCCcccEEEEeccCCcCccCCccccccccceecccccccccc
Q 001494 129 FKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGS 208 (1067)
Q Consensus 129 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 208 (1067)
++|.+.+.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|++++.+|..++++++|++|++++|.+++.
T Consensus 172 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 251 (968)
T PLN00113 172 GGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGP 251 (968)
T ss_pred ccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCcccccceeecccCcCCCCCCcccCCcccCCceEecCcccccccCccccCccceeeEEEecccccccCCCccccC
Q 001494 209 IPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNL 288 (1067)
Q Consensus 209 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 288 (1067)
+|..++++++|+.|+|++|++.+.+|..+.++++|+.|++++|.+++.+|..+.++++|+.|++++|.+++.+|..+.++
T Consensus 252 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l 331 (968)
T PLN00113 252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331 (968)
T ss_pred cChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcC
Confidence 99999999999999999999888888888888888888888888888888878888888888888888877777777777
Q ss_pred CcccEEEeccccccCCccccccCCccccEEeccCCCCcCCCCcccccCCCCCeEEecCccccccCCccccCCCCCCeEEc
Q 001494 289 KFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFI 368 (1067)
Q Consensus 289 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 368 (1067)
++|+.|++++|.+.+.+|..++.+++|+.|++++|++.+..|..+..+++|+.|++++|++.+.+|..++.+++|+.|++
T Consensus 332 ~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L 411 (968)
T PLN00113 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRL 411 (968)
T ss_pred CCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEEC
Confidence 77777777777777666666666666666666666666665655555556666666666665555555555555555555
Q ss_pred cCCcCccccCcccCCCCCCCEEEccCCcccccCCCccccccCCcEEEcccCcCcccCchhhhCcCCCcEEeCCCCcccCC
Q 001494 369 YNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGP 448 (1067)
Q Consensus 369 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 448 (1067)
++|.+++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+
T Consensus 412 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~------------------- 472 (968)
T PLN00113 412 QDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF------------------- 472 (968)
T ss_pred cCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-------------------
Confidence 5555555555555555555555555555555544444444444444444444443333322
Q ss_pred CCCCCCCCcccEEeccCcccccccccccccCCceeEEEcccccccCCCCCCCCCCCCcceEeccCCccCCCCCCcccCCC
Q 001494 449 IPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSS 528 (1067)
Q Consensus 449 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~ 528 (1067)
. .++|+.|||++|++++..|..+..+++|+.|++++|.+.+.+|..+..++
T Consensus 473 -----~------------------------~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 523 (968)
T PLN00113 473 -----G------------------------SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCK 523 (968)
T ss_pred -----c------------------------cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCcc
Confidence 1 13345555555555555555555555555666666666555555555566
Q ss_pred CCcEEEcCCCcccCcCcccccCCCccceeecccccccCCccccccccccccEEEccCCCCCCCccc
Q 001494 529 QLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPE 594 (1067)
Q Consensus 529 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 594 (1067)
+|++|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+.+|+.|++++|++++.+|.
T Consensus 524 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~ 589 (968)
T PLN00113 524 KLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589 (968)
T ss_pred CCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCC
Confidence 666666666666666666666666666666666666666666666666666666666666655553
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=429.50 Aligned_cols=280 Identities=41% Similarity=0.693 Sum_probs=235.6
Q ss_pred cCcccHHHHHHHhcCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeE
Q 001494 783 EGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862 (1067)
Q Consensus 783 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 862 (1067)
...+.++++..||++|....+||+|+||.||+|...+|+.||||++....... .++|..|++++.+++|||+|+++|
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEE
Confidence 34688999999999999999999999999999999999999999886543321 466999999999999999999999
Q ss_pred EEeeCC-ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeE
Q 001494 863 FCSHAQ-HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEAR 941 (1067)
Q Consensus 863 ~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~k 941 (1067)
||.+.+ +.++|||||++|+|+++++..... +++|.+|++||.++|+||+|||+.+.|+||||||||+|||+|+++++|
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 999999 599999999999999999765544 799999999999999999999999988999999999999999999999
Q ss_pred EeccccceecCCCCCccccc-cccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccc-------cccchh
Q 001494 942 VSDFGIAKFLKPDSSNWTEL-AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLI-------SSSSLN 1013 (1067)
Q Consensus 942 l~DfG~a~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~-------~~~~~~ 1013 (1067)
|+|||+|+............ .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+..... +.....
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999996544312222222 8999999999999999999999999999999999999987743211 111122
Q ss_pred hhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1014 LNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
......+++|+++........+...++..++.+|++.+|.+||+|.||+++|+
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 22267788888876322211256777999999999999999999999999874
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=392.57 Aligned_cols=251 Identities=29% Similarity=0.447 Sum_probs=213.7
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC-ceeEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ-HSFIVY 874 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 874 (1067)
+.+..+.||+|..|+||+++++ +++.+|+|++... .+...++++.+|+++++..+||+||.++|+|...+ ..+++|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 4566788999999999999765 7899999999543 34556789999999999999999999999999999 499999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN-DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||++|+|++++... +.+++....+|+.++++||.|||+ + +||||||||+|||++..|+|||||||.++.+..
T Consensus 158 EYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 999999999999654 458999999999999999999996 6 999999999999999999999999999987764
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC-CCCCCCcc
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP-RLPIPSHN 1032 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1032 (1067)
. ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||... ..........+..+.+. ....|..
T Consensus 232 S--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv~~ppP~lP~~- 305 (364)
T KOG0581|consen 232 S--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIVDEPPPRLPEG- 305 (364)
T ss_pred h--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHhcCCCCCCCcc-
Confidence 4 446789999999999999999999999999999999999999998643 12223445556666663 3333333
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
..+.+++.|+..|+++||.+|||+.|+++
T Consensus 306 --~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 --EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred --cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 23445999999999999999999999976
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=408.06 Aligned_cols=250 Identities=27% Similarity=0.467 Sum_probs=224.1
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.+|..++.||+|||+.||+++. .+|+.||+|++.+.........+.+.+||++.++++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999976 899999999998765555556788999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
|+|+.++|.++++ ..+++++.++..+++||+.|+.|||++ +|+|||||..|++++++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999995 345699999999999999999999999 9999999999999999999999999999999988
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
..+..+.||||.|.|||++....++..+||||+|||+|-|+.|++||+.. ...+....+...+...|.+...
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--------~vkety~~Ik~~~Y~~P~~ls~ 243 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--------TVKETYNKIKLNEYSMPSHLSA 243 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------hHHHHHHHHHhcCcccccccCH
Confidence 88888999999999999999999999999999999999999999999732 2334445555556666654444
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+ +.++|.++|+.+|.+|||+++|+.
T Consensus 244 ~----A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 244 E----AKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred H----HHHHHHHHhcCCcccCCCHHHHhc
Confidence 4 889999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=393.04 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=218.6
Q ss_pred hcCCCccCccccCCceeEEEE-EECCCcEEEEEEeCCCCCCC----hhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc
Q 001494 795 TNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGE----MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 869 (1067)
.+.|...+.||+|+||.|-+| +.++|+.||||++.+..... ........+|+++|++++|||||+++++|+.++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 356788899999999999998 67799999999997543322 1123345799999999999999999999999999
Q ss_pred eeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC---CCeEEeccc
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK---NEARVSDFG 946 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~---~~~kl~DfG 946 (1067)
.||||||++||+|.+.+-.. +.+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ -.+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999988443 3466777788999999999999999 99999999999999876 569999999
Q ss_pred cceecCCCCCccccccccccccCccccccCCC---CccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccC
Q 001494 947 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKV---TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD 1023 (1067)
Q Consensus 947 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1023 (1067)
+|+..+ ....+.+.||||.|.|||++.+..+ ..++|+||+||++|-+++|.+||..... .....+++..
T Consensus 325 lAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-------~~sl~eQI~~ 396 (475)
T KOG0615|consen 325 LAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-------DPSLKEQILK 396 (475)
T ss_pred hhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC-------CccHHHHHhc
Confidence 999877 5677889999999999999987653 3488999999999999999999874322 2225567888
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1024 PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1024 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+++.+.+..+.+...+..++|.+||..||++|||+.|+++
T Consensus 397 G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 8888888888888899999999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=401.97 Aligned_cols=254 Identities=31% Similarity=0.551 Sum_probs=210.9
Q ss_pred CCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC-ceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ-HSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~ 876 (1067)
+...+.+|+|+||+||+|.++....||||++.....+... .++|.+|+.++++++|||||+++|+|.+.. ..++||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 3445669999999999999985455999999876544444 679999999999999999999999999887 79999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCC-eeecCCCCCceeeCCCC-CeEEeccccceecCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP-IVHRDISSKNVLLDFKN-EARVSDFGIAKFLKPD 954 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivHrDlk~~Nill~~~~-~~kl~DfG~a~~~~~~ 954 (1067)
+++|+|.++++.. ....+++..+++++.+||+||.|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999764 456799999999999999999999999 7 99999999999999998 9999999999876654
Q ss_pred CCccccccccccccCccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcc
Q 001494 955 SSNWTELAGTYGYVAPELAY--TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
...++...||+.|||||++. ...|+.|+||||||+++|||+||+.||......... ...... ..+..+|..
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~----~~v~~~--~~Rp~~p~~- 270 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA----SAVVVG--GLRPPIPKE- 270 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhc--CCCCCCCcc-
Confidence 34555578999999999999 668999999999999999999999999865531110 111111 122222332
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....+..++.+||+.||.+||++.+++..|+
T Consensus 271 ---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 271 ---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred ---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 2334889999999999999999999999886
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=371.72 Aligned_cols=203 Identities=30% Similarity=0.500 Sum_probs=181.3
Q ss_pred hcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
..+|...+.||+|+||+||+|+++ ++..||||.+....- .....+-+..|+++++.++|||||++++++..++..|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 467888899999999999999754 689999999976532 233456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC------CCeEEecccc
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK------NEARVSDFGI 947 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~------~~~kl~DfG~ 947 (1067)
||||.||+|.++++..+ .+++..+..++.|+|.|+++||++ +||||||||+|||++.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999997654 589999999999999999999999 99999999999999875 3589999999
Q ss_pred ceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 001494 948 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFIS 1005 (1067)
Q Consensus 948 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~ 1005 (1067)
|+.+.+ .....+.+|+|-|||||++...+|+.|+|+||+|+++||+++|+.||+...
T Consensus 162 AR~L~~-~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 162 ARFLQP-GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhhCCc-hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 998874 344567899999999999999999999999999999999999999998544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=371.48 Aligned_cols=245 Identities=28% Similarity=0.415 Sum_probs=212.4
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
.++|+..++||+|+||.||.++. .+++.+|+|++++...-+....+...+|..++.+++||.||+++-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 36799999999999999999964 57899999999877665555677889999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
+||+.||.|...+++.+ .+++..+.-++.+|+.||.|||++ ||||||+||+|||+|++|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999996544 488888999999999999999999 999999999999999999999999999997666
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.+....+++||+.|||||++.+..|+.++|.||+|+++|||++|.+||.... .....+.+...+...++...
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--------~~~~~~~I~~~k~~~~p~~l 249 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--------VKKMYDKILKGKLPLPPGYL 249 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--------HHHHHHHHhcCcCCCCCccC
Confidence 6666677899999999999999999999999999999999999999987433 23444555555544444322
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC
Q 001494 1034 QEKLISFVEVAISCLDESPESRP 1056 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rp 1056 (1067)
.. ++++++.+.++.||++|-
T Consensus 250 s~---~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 250 SE---EARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CH---HHHHHHHHHhccCHHHhc
Confidence 22 378999999999999995
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=387.63 Aligned_cols=249 Identities=30% Similarity=0.479 Sum_probs=207.0
Q ss_pred CCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEec
Q 001494 798 FDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYL 877 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 877 (1067)
+...+.||+|-||+||.|++.....||+|.++...- ..+.|.+|+++|++++|++||+++|+|..++..|||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 455688999999999999999888999999976422 2467899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCc
Q 001494 878 EMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN 957 (1067)
Q Consensus 878 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 957 (1067)
+.|+|.++++. .....+...+.+.++.|||+|++||+++ ++|||||.++|||++++..+||+|||+|+...++.+.
T Consensus 284 ~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 284 PKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred ccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 99999999976 3345688899999999999999999999 9999999999999999999999999999955443332
Q ss_pred cc-cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CCCCCCcchH
Q 001494 958 WT-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLPIPSHNVQ 1034 (1067)
Q Consensus 958 ~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1034 (1067)
.. ...-+..|.|||.+..+.++.|||||||||+||||+| |+.||..... .+.+..+..+ +++-|..+.+
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------~ev~~~le~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------EEVLELLERGYRLPRPEGCPD 431 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--------HHHHHHHhccCcCCCCCCCCH
Confidence 22 2223568999999999999999999999999999998 8999875543 2222233222 3333433333
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
+++++|..||+.+|++|||++.+...++
T Consensus 432 ----~vY~lM~~CW~~~P~~RPtF~~L~~~l~ 459 (468)
T KOG0197|consen 432 ----EVYELMKSCWHEDPEDRPTFETLREVLE 459 (468)
T ss_pred ----HHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence 4899999999999999999999887764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=357.15 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=211.2
Q ss_pred cCCCccCccccCCceeEEEE-EECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeE-EEeeCC-ceeE
Q 001494 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG-FCSHAQ-HSFI 872 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~-~~~l 872 (1067)
.+|++.++||+|.||+||++ ...+|+.||.|.+.-..- +....+....|+.++++++|||||++++ .+.++. ..++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 35788899999999999998 577999999999974433 3344677899999999999999999998 444444 4899
Q ss_pred EEEeccCCCHHHHhcccCc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eeecCCCCCceeeCCCCCeEEeccccce
Q 001494 873 VYEYLEMGSLAMILSNDAA-AEDLEWTQRMSVIKGIADALSYLHNDCFPP--IVHRDISSKNVLLDFKNEARVSDFGIAK 949 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrDlk~~Nill~~~~~~kl~DfG~a~ 949 (1067)
||||+++|+|..++++.+. ...+++..+++++.|++.||.++|++.. . |+||||||.||+++.+|.||++|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999976443 3468999999999999999999999533 5 8999999999999999999999999999
Q ss_pred ecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC-C
Q 001494 950 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP-I 1028 (1067)
Q Consensus 950 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 1028 (1067)
.+..........+|||.||+||.+.+.+|+.||||||+||++|||..-+.||.+.. .......+.....+ .
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--------~~~L~~KI~qgd~~~~ 248 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--------LLSLCKKIEQGDYPPL 248 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--------HHHHHHHHHcCCCCCC
Confidence 99887777788999999999999999999999999999999999999999987542 22222333333332 2
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1029 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
| ....+..+.++|..|+.+||+.||+.-.+++
T Consensus 249 p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 249 P---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred c---HHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 2 2456667999999999999999998544443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=352.96 Aligned_cols=261 Identities=21% Similarity=0.353 Sum_probs=207.8
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
+.|+...++|+|+||+||+++.+ +|+.||||++..+.. +....+-.++|++++++++|||+|.++.+|......++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 35777889999999999999765 799999999986543 3444566789999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||++..-|++.-+. ...++...+.+++.|+++|+.|+|++ ++|||||||+|||++.+|.+|+||||+|+.+..+
T Consensus 81 E~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 81 EYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred eecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 99998666655432 23478889999999999999999999 9999999999999999999999999999999878
Q ss_pred CCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh----------------hhh
Q 001494 955 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL----------------NIA 1017 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~----------------~~~ 1017 (1067)
+..++..+.|.+|+|||.+.+ .+|+.++||||+||++.||++|.+-|.+.+......... ...
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 888999999999999998887 679999999999999999999998776544322110000 000
Q ss_pred hhhccCCCCCCCCcc---hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1018 LDEILDPRLPIPSHN---VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1018 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+..+.-|...-+... .+.....+.+++..|++.||++|++.+|++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111111111111 1122235789999999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=398.02 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=211.0
Q ss_pred cCCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 869 (1067)
.+....+.||+|+||.||+|+.. +...||||.++... +...+++|.+|++.++.++|||||+++|+|.+++.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 45566788999999999998643 44679999998653 34467899999999999999999999999999999
Q ss_pred eeEEEEeccCCCHHHHhcccCc-----------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC
Q 001494 870 SFIVYEYLEMGSLAMILSNDAA-----------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN 938 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~ 938 (1067)
.++|+|||..|||.++|..... ..+++..+.+.||.|||.|++||-++ .+|||||..+|+||+++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 9999999999999999953221 22388999999999999999999999 899999999999999999
Q ss_pred CeEEeccccceecCCCCCcc-c-cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhh
Q 001494 939 EARVSDFGIAKFLKPDSSNW-T-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLN 1015 (1067)
Q Consensus 939 ~~kl~DfG~a~~~~~~~~~~-~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~ 1015 (1067)
.|||+|||+++.....++.. . ...-+.+|||||.+..++|+.+||||||||+|||+++ |+.||.+... .
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--------~ 712 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--------Q 712 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------H
Confidence 99999999999765433221 1 2234679999999999999999999999999999998 8999765443 3
Q ss_pred hhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1016 IALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
+.+..+..+++..-++ .++.+++++|..||+..|++||+++||-..|+
T Consensus 713 EVIe~i~~g~lL~~Pe---~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~ 760 (774)
T KOG1026|consen 713 EVIECIRAGQLLSCPE---NCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ 760 (774)
T ss_pred HHHHHHHcCCcccCCC---CCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence 4445555555532222 33446999999999999999999999988875
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=392.99 Aligned_cols=491 Identities=32% Similarity=0.435 Sum_probs=382.4
Q ss_pred cccccccccccccccccCCCccCCCcccEEEEeccCCcCccCCccccccccceecccccccccccCCCCCcccccceeec
Q 001494 145 SSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNL 224 (1067)
Q Consensus 145 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 224 (1067)
.-|+.|.+++|.++.+. +.+.++..|.+|++++|+++ ..|++++.+..++.|+.++|+++ .+|+.++++.+|..|+.
T Consensus 45 v~l~~lils~N~l~~l~-~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~ 121 (565)
T KOG0472|consen 45 VDLQKLILSHNDLEVLR-EDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC 121 (565)
T ss_pred cchhhhhhccCchhhcc-HhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence 45888999999998754 45788999999999999998 88999999999999999999998 89999999999999999
Q ss_pred ccCcCCCCCCcccCCcccCCceEecCcccccccCccccCccceeeEEEecccccccCCCccccCCcccEEEeccccccCC
Q 001494 225 SSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGL 304 (1067)
Q Consensus 225 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 304 (1067)
++|.+. .+|++++.+..|+.|+..+|+++ ..|+.+.++.+|..|++.+|+++...|..+. ++.|++||+..|.+. .
T Consensus 122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 122 SSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-T 197 (565)
T ss_pred ccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-c
Confidence 999998 78888999999999999999998 7888999999999999999999987666555 999999999999887 4
Q ss_pred ccccccCCccccEEeccCCCCcCCCCcccccCCCCCeEEecCccccccCCccc-cCCCCCCeEEccCCcCccccCcccCC
Q 001494 305 IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFL-GNLTNLSVLFIYNNSLSGSIPCEIGN 383 (1067)
Q Consensus 305 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~~~~~ 383 (1067)
+|+.++++.+|..|||.+|+|... | +|.+++.|.+|+++.|.|. .+|... .++.++..||+..|+++ ..|.++.-
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~~l-P-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl 273 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIRFL-P-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL 273 (565)
T ss_pred CChhhcchhhhHHHHhhhcccccC-C-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHH
Confidence 577889999999999999999855 4 8889999999999999998 555544 48889999999999998 78888888
Q ss_pred CCCCCEEEccCCcccccCCCccccccCCcEEEcccCcCcccCchhhhCcC--CCcEEeCCCCcccCCCCCCCCCCcccEE
Q 001494 384 LKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLV--KLTKLFLGDNQFQGPIPNLKNLTSLVRV 461 (1067)
Q Consensus 384 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~l~~l~~L~~L 461 (1067)
+.+|.+||+|+|.|+ ..|.+++++ .|+.|-+.+|++..+-.+.+.+-+ -|++|.= .+..
T Consensus 274 LrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs---~~~~-------------- 334 (565)
T KOG0472|consen 274 LRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS---KIKD-------------- 334 (565)
T ss_pred hhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH---hhcc--------------
Confidence 899999999999998 577888888 888898998888633222221110 0111110 0000
Q ss_pred eccCcccccccccccccCCceeEEEcccccccCCCCCCCCCCCCcceEeccCCccCCCCCCccc--CCCCCcEEEcCCCc
Q 001494 462 HLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIG--YSSQLEVLDLSSNH 539 (1067)
Q Consensus 462 ~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~--~~~~L~~L~Ls~N~ 539 (1067)
-.++.-....-. .-+ .......+.....+.+.|++++-+++.+..+.|. ...-....+++.|+
T Consensus 335 ----dglS~se~~~e~------~~t-----~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNq 399 (565)
T KOG0472|consen 335 ----DGLSQSEGGTET------AMT-----LPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQ 399 (565)
T ss_pred ----CCCCCCcccccc------cCC-----CCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccch
Confidence 000000000000 000 0001111222334566667776666633333332 12236677888888
Q ss_pred ccCcCcccccCCCccc-eeecccccccCCccccccccccccEEEccCCCCCCCcccccccccccceecccCcccccccch
Q 001494 540 VVGDIPAELGKLSFLI-KLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPI 618 (1067)
Q Consensus 540 l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~ 618 (1067)
+. .+|+.+..+..+. .+.+++|.++ -.|..++.+++|..|+|++|.+. .+|..++.+..|++||+|+|++. ..|.
T Consensus 400 L~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~ 475 (565)
T KOG0472|consen 400 LC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPE 475 (565)
T ss_pred Hh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchH
Confidence 87 6677666665544 4566666665 66778899999999999999886 78888999999999999999998 7899
Q ss_pred hhhhccccceeccccccCCCcchhhhhcccccccccccccccccccccccccCccccEEEcccCcCC
Q 001494 619 KLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685 (1067)
Q Consensus 619 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~l~l~~N~l~ 685 (1067)
.+..+..++.+-.++|+++...++.+.+|.+|.+|||.+|.|. .+|..+.+|++|++|++++|+++
T Consensus 476 ~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 476 CLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 9999999999999999999999999999999999999999998 78889999999999999999998
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=388.75 Aligned_cols=495 Identities=31% Similarity=0.404 Sum_probs=367.8
Q ss_pred cccccceecccccccccCCCCccccccccccccccccccccccCCCccCCCcccEEEEeccCCcCccCCcccccccccee
Q 001494 119 HLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDL 198 (1067)
Q Consensus 119 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 198 (1067)
.-.-|+.|++++|.++ .+-+.+.+|..|.+|.+.+|.+.. .|.+++.+..++.|+.++|+++ .+|..++.+.+|+.|
T Consensus 43 ~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~-lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l 119 (565)
T KOG0472|consen 43 EQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQ-LPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKL 119 (565)
T ss_pred hhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhhh-CCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhh
Confidence 3456899999999998 566778999999999999999998 6778999999999999999999 899999999999999
Q ss_pred cccccccccccCCCCCcccccceeecccCcCCCCCCcccCCcccCCceEecCcccccccCccccCccceeeEEEeccccc
Q 001494 199 NLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLS 278 (1067)
Q Consensus 199 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 278 (1067)
+.+.|.+. .+|+.++.+..|+.|+..+|+++ ..|+.++.+.+|..|++.+|++....|..+ +++.|++||.-+|-++
T Consensus 120 ~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~ 196 (565)
T KOG0472|consen 120 DCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE 196 (565)
T ss_pred hcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh
Confidence 99999999 78899999999999999999999 789999999999999999999995545444 5999999999999998
Q ss_pred ccCCCccccCCcccEEEeccccccCCccccccCCccccEEeccCCCCcCCCCcccccCCCCCeEEecCccccccCCcccc
Q 001494 279 GLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLG 358 (1067)
Q Consensus 279 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 358 (1067)
.+|+.++++.+|+.|||.+|++... | .|+++..|++|+++.|+|.-...+...++.++.+|||.+|+++ ..|+.+.
T Consensus 197 -tlP~~lg~l~~L~~LyL~~Nki~~l-P-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c 272 (565)
T KOG0472|consen 197 -TLPPELGGLESLELLYLRRNKIRFL-P-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC 272 (565)
T ss_pred -cCChhhcchhhhHHHHhhhcccccC-C-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHH
Confidence 5688999999999999999999965 4 8999999999999999999665555669999999999999999 7899999
Q ss_pred CCCCCCeEEccCCcCccccCcccCCCCCCCEEEccCCcccccCCCcccccc---CCcEEEcccCcCcccCchhhhCcCCC
Q 001494 359 NLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLT---NLSVLSFYKNSLSGAIPKEYRNLVKL 435 (1067)
Q Consensus 359 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~---~L~~L~L~~N~l~~~~~~~~~~l~~L 435 (1067)
-+++|++||+++|.|+ ..|.+++++ .|+.|.+.+|.+.. +-..+-+.. -|++|. -.++...+..-.+ .+-
T Consensus 273 lLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLr---s~~~~dglS~se~-~~e 345 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLR---SKIKDDGLSQSEG-GTE 345 (565)
T ss_pred HhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHH---HhhccCCCCCCcc-ccc
Confidence 9999999999999999 678899999 99999999999973 222222211 122221 0111111100000 000
Q ss_pred cEEeCCCCcccCCCCCCCCCCcccEEeccCcccccccccccccCCceeEEEcccccccCCCCCCCCCCCCcceEeccCCc
Q 001494 436 TKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNN 515 (1067)
Q Consensus 436 ~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~ 515 (1067)
..-+ ...+..+....+.+.+.|++++-+++.++.+.|.... -.-.+.++++.|+
T Consensus 346 ~~~t----~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~----------------------~~~Vt~VnfskNq 399 (565)
T KOG0472|consen 346 TAMT----LPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAK----------------------SEIVTSVNFSKNQ 399 (565)
T ss_pred ccCC----CCCCcccchhhhhhhhhhcccccccccCCHHHHHHhh----------------------hcceEEEecccch
Confidence 0000 0111222233334455555555555555555553321 1124445555555
Q ss_pred cCCCCCCcccCCCCCcE-EEcCCCcccCcCcccccCCCccceeecccccccCCccccccccccccEEEccCCCCCCCccc
Q 001494 516 ITGNIPPKIGYSSQLEV-LDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPE 594 (1067)
Q Consensus 516 l~~~~~~~~~~~~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 594 (1067)
+. .+|..+..+..+.+ +++++|.+. .+|..++.++.|+.|+|++|-+. .+|..++.+..|+.||+|+|++. ..|.
T Consensus 400 L~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~ 475 (565)
T KOG0472|consen 400 LC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPE 475 (565)
T ss_pred Hh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchH
Confidence 54 44554444444333 333444333 55666666666666666666555 45666666667777777777776 6777
Q ss_pred ccccccccceecccCcccccccchhhhhccccceeccccccCCCcchhhhhcccccccccccccccc
Q 001494 595 SLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLS 661 (1067)
Q Consensus 595 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 661 (1067)
.+..+..|+++-.++|++....|+.+.+|.+|..|||.+|.| ..+|..+++|.+|++|+|++|+|.
T Consensus 476 ~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdl-q~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 476 CLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDL-QQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCch-hhCChhhccccceeEEEecCCccC
Confidence 777777777777777888766666678888888888888887 466777888888888888888887
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=374.77 Aligned_cols=249 Identities=25% Similarity=0.444 Sum_probs=212.3
Q ss_pred cCCCccCccccCCceeEEEE-EECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
..|...++||+|+.|.||.| +..+++.||||++....... .+-+..|+.+|+..+|+|||.+++.|..++..|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 45788899999999999998 46678999999997543322 356789999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
|||+||+|.+++.+.. +++.++..|+.++++||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+...
T Consensus 350 Eym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred eecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999999996543 89999999999999999999999 9999999999999999999999999999998887
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
.......+|||.|||||++....|++|+||||||+|++||+-|.+||-...+... -..+..--.+.+..+..
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA-----lyLIa~ng~P~lk~~~k--- 494 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATNGTPKLKNPEK--- 494 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH-----HHHHhhcCCCCcCCccc---
Confidence 7788889999999999999999999999999999999999999999754332211 11111222233333333
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.+..+.+|+.+||+.||++||+|.|+++
T Consensus 495 -lS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 495 -LSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 3345999999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=364.37 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=217.0
Q ss_pred HHHhcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCc
Q 001494 792 IRATNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 792 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 869 (1067)
.+...+|..++.||+|+|++||+|+ ..+++.||||++.+...-.....+-+..|-.+|.+| .||.|++++-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3445789999999999999999995 568999999998654333222234466788889999 89999999999999999
Q ss_pred eeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccce
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK 949 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~ 949 (1067)
+|+|+||+++|+|.+++++. +.+++.-+..++.+|+.|++|||++ |||||||||+|||+|.+|++||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999999765 4488899999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC-------------ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhh
Q 001494 950 FLKPDSS-------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNI 1016 (1067)
Q Consensus 950 ~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 1016 (1067)
.+.+... ....++||..|.+||++.....++.+|+|+||||+|+|+.|++||.. .+...
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra--------~Neyl 294 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA--------ANEYL 294 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc--------ccHHH
Confidence 7754211 12458999999999999999999999999999999999999999863 33455
Q ss_pred hhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1017 ALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
.++.++.-.+.+|+...+. +.+|+.+.|..||.+|+|++|+.+.
T Consensus 295 iFqkI~~l~y~fp~~fp~~----a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 295 IFQKIQALDYEFPEGFPED----ARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHHhcccCCCCCCHH----HHHHHHHHHccCccccccHHHHhhC
Confidence 6667777677777665544 8899999999999999999998753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=329.83 Aligned_cols=259 Identities=22% Similarity=0.320 Sum_probs=207.9
Q ss_pred cCCCccCccccCCceeEEEE-EECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.+|...+++|+|.||.||+| +..+|+.||||+++.....+ .......+|++.++.++||||+.++++|...+...+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46778899999999999999 46789999999998653322 22345789999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
|||+ .+|+..++. ....++..++..++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+|+.+.+.
T Consensus 81 Efm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred Eecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9997 489998853 344689999999999999999999999 9999999999999999999999999999999887
Q ss_pred CCccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchh-------------------h
Q 001494 955 SSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN-------------------L 1014 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------------------~ 1014 (1067)
....+..+-|.+|+|||.+.|. .|+..+||||.|||+.||+-|.+-|.+....+..... .
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 7776667889999999988775 4999999999999999999998776554332211111 1
Q ss_pred hhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1015 NIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
...+...-.+. .....+.......+++..++..||.+|.|++|++++
T Consensus 235 Y~~~~~~P~~~---~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPP---LNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCc---cccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11111110000 011223334457999999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.01 Aligned_cols=261 Identities=25% Similarity=0.404 Sum_probs=210.0
Q ss_pred hcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
.++|+..+.||.|..++||+|+ ...++.||||++.-..... ..+.+.+|+..|+.++||||+.++..|..+...|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 3678999999999999999995 5678999999997654433 367899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|.||.+|++.++++..... .+++..+..|.+++++||.|||.+ |.||||||+.||||+.+|.|||+|||.+..+..
T Consensus 103 mpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999764443 389999999999999999999999 999999999999999999999999998876654
Q ss_pred CCCc----cccccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC
Q 001494 954 DSSN----WTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 954 ~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
.+.+ ...++||+.|||||++.. ..|+.|+||||||++..||.+|+.||....+.................. .
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~--~ 256 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS--G 256 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc--c
Confidence 4332 245689999999998543 3589999999999999999999999986665432211111111100000 0
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.+.+.......++.+++..|+++||++||||+++++
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111122233457999999999999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=362.65 Aligned_cols=248 Identities=28% Similarity=0.404 Sum_probs=214.2
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|.+.+.||+|.||.||||+. .+.+.||+|.+.+....++ ..+.+.+|++++++++|||||.++++|+...++|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k-~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEK-ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchH-HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 4688888999999999999965 4789999999987655443 3567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+.| +|..++..++ .++++++..|+.+++.||.|||+. +|+|||+||+|||++..|.+|+||||+|+.+...
T Consensus 81 e~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 99987 9999996544 499999999999999999999999 9999999999999999999999999999998877
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
....+...|||-|||||.+.+.+|+..+|.||+||++||+++|++||-..+ ..+.+..+.......|.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d~v~~p~---- 221 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKDPVKPPS---- 221 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcCCCCCcc----
Confidence 777788899999999999999999999999999999999999999975222 23334444444443333
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.....+..++...+.+||.+|.|..+++.
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 34445899999999999999999988764
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=359.66 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=204.5
Q ss_pred hcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--Ccee
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--QHSF 871 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 871 (1067)
.+.|+..++||+|.||.||+|+ ..+|+.||+|++...... ........+||.++++++||||+++.+...+. +.+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3557788999999999999994 678999999999866433 23456678999999999999999999998877 6899
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+|+|||++ ||.-++... .-.+++.++..+++|++.||+|+|++ ||+|||||.+|||||.+|.+||+|||+|+.+
T Consensus 195 lVFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 99999987 666666432 33589999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCC-ccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh--------hhhh---
Q 001494 952 KPDSS-NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL--------NIAL--- 1018 (1067)
Q Consensus 952 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~--------~~~~--- 1018 (1067)
..... .++..+-|.+|+|||.+.+. .|+.++|+||.|||+.||++|++.|.+-...+...... ..+.
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 76543 47888999999999988875 59999999999999999999999986543322111100 0010
Q ss_pred -h--hccCCCCCCCCc---chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1019 -D--EILDPRLPIPSH---NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1019 -~--~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
. ..+.+..+.... .......+..+++..+|..||++|.||.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 001111000000 00111235789999999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=360.96 Aligned_cols=248 Identities=31% Similarity=0.519 Sum_probs=206.6
Q ss_pred cccHHHHHHHhcCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEE
Q 001494 785 KIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFC 864 (1067)
Q Consensus 785 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 864 (1067)
.++|+++.+ .+-||.|+.|.||.|+++ ++.||||+++.- -..+|+-+++|+||||+.|.|+|
T Consensus 120 eiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 120 EIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred cCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeee
Confidence 456766643 466999999999999998 788999998531 13678999999999999999999
Q ss_pred eeCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEec
Q 001494 865 SHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSD 944 (1067)
Q Consensus 865 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~D 944 (1067)
.....++||||||+.|-|+.+++.. ..++......+.++||.|+.|||.+ .|||||+|.-||||+.+..|||+|
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsD 255 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISD 255 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecc
Confidence 9999999999999999999999543 3477788899999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC
Q 001494 945 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP 1024 (1067)
Q Consensus 945 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1024 (1067)
||-++..... ..+..++||..|||||++...+.++|+|||||||+||||+||..||..++..... +. ..... -
T Consensus 256 FGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---wG-VGsNs--L 328 (904)
T KOG4721|consen 256 FGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---WG-VGSNS--L 328 (904)
T ss_pred ccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---Ee-ccCCc--c
Confidence 9999876544 5556789999999999999999999999999999999999999998755431100 00 00011 1
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 001494 1025 RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLKI 1067 (1067)
Q Consensus 1025 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1067 (1067)
.++.|..+. ..++-++++||+..|..||++++++..|+|
T Consensus 329 ~LpvPstcP----~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 329 HLPVPSTCP----DGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cccCcccCc----hHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 334444433 348889999999999999999999999876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=332.71 Aligned_cols=240 Identities=26% Similarity=0.349 Sum_probs=211.1
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||.|+||.|..++.+ +|..+|+|++.....-...+.+....|..+++.+.||.++++++.+.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56888999999999999999755 68899999998655445555667889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||++||.|..++++. +++++..+.-+|.||+.|++|||+. +|++||+||+|||+|++|.+||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999654 3489999999999999999999999 9999999999999999999999999999987633
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
.-+.||||.|+|||.+.+.+|..++|-|||||++|||+.|.+||..... -...+.++...+.+|+....
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~v~fP~~fs~ 266 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGKVKFPSYFSS 266 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCcccCCcccCH
Confidence 4568999999999999999999999999999999999999999863332 34455677777777776665
Q ss_pred HHHHHHHHHHHhccCCCCCCCC
Q 001494 1035 EKLISFVEVAISCLDESPESRP 1056 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rp 1056 (1067)
+ +.+++...+++|-.+|.
T Consensus 267 ~----~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 267 D----AKDLLKKLLQVDLTKRF 284 (355)
T ss_pred H----HHHHHHHHHhhhhHhhh
Confidence 5 88999999999999993
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=371.86 Aligned_cols=363 Identities=24% Similarity=0.224 Sum_probs=308.0
Q ss_pred cccccccccccccCCCccCCCcccEEEEeccCCcCccCCccccccccceecccccccccccCCCCCcccccceeecccCc
Q 001494 149 NLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNS 228 (1067)
Q Consensus 149 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 228 (1067)
.|++++|.+..+-+..|.++++|+++++..|.++ .||...+-..+|+.|+|.+|.|+..-.+.+..++.|+.||||.|.
T Consensus 82 ~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~ 160 (873)
T KOG4194|consen 82 TLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNL 160 (873)
T ss_pred eeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhch
Confidence 4555555555555666777777777777777777 677666666667777777777776666777778888888888888
Q ss_pred CCCCCCcccCCcccCCceEecCcccccccCccccCccceeeEEEecccccccCCCccccCCcccEEEeccccccCCcccc
Q 001494 229 LFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHS 308 (1067)
Q Consensus 229 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 308 (1067)
|+.+.-..|..-.++++|+|++|+|+..-.+.|.++.+|..|.|++|+++.+++..|+++++|+.|+|..|+|.-..--.
T Consensus 161 is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~lt 240 (873)
T KOG4194|consen 161 ISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLT 240 (873)
T ss_pred hhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhh
Confidence 87555556766678888899999988777788999999999999999999888889999999999999999998665678
Q ss_pred ccCCccccEEeccCCCCcCCCCcccccCCCCCeEEecCccccccCCccccCCCCCCeEEccCCcCccccCcccCCCCCCC
Q 001494 309 LGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLS 388 (1067)
Q Consensus 309 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 388 (1067)
|.++++|+.|.|..|.|.....+.|..|.++++|+|+.|+++..-..++.+++.|+.|++++|.|....++.+...++|+
T Consensus 241 FqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~ 320 (873)
T KOG4194|consen 241 FQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLK 320 (873)
T ss_pred hcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccce
Confidence 99999999999999999999999999999999999999999988888999999999999999999988888888899999
Q ss_pred EEEccCCcccccCCCccccccCCcEEEcccCcCcccCchhhhCcCCCcEEeCCCCcccCCCC----CCCCCCcccEEecc
Q 001494 389 YLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIP----NLKNLTSLVRVHLD 464 (1067)
Q Consensus 389 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~l~~l~~L~~L~L~ 464 (1067)
+|+|++|+|+...+.+|..+.+|++|+|++|+|+..--..|..+.+|++|||+.|.+...+. .+.++++|+.|.+.
T Consensus 321 ~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~ 400 (873)
T KOG4194|consen 321 ELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLT 400 (873)
T ss_pred eEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeec
Confidence 99999999998888999999999999999999998888899999999999999999877443 36778888888888
Q ss_pred CcccccccccccccCCceeEEEcccccccCCCCCCCCCCCCcceEeccC
Q 001494 465 RNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSK 513 (1067)
Q Consensus 465 ~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~ 513 (1067)
+|++.+++..+|.++++|++|||.+|.|..+-+.+|..+ .|++|.+..
T Consensus 401 gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS 448 (873)
T KOG4194|consen 401 GNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS 448 (873)
T ss_pred CceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence 888888888888888888888888888888888888877 777776654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=353.62 Aligned_cols=252 Identities=29% Similarity=0.458 Sum_probs=199.6
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC--ceeE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ--HSFI 872 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l 872 (1067)
.++...+.||+|+||+||++... +|+..|||.+..... . ..+.+.+|+.++++++|||||+++|...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--P-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--h-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 45778899999999999999765 499999999875421 1 1567889999999999999999999855554 6899
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC-CCCeEEeccccceec
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF-KNEARVSDFGIAKFL 951 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~-~~~~kl~DfG~a~~~ 951 (1067)
.|||+++|+|.+++.+.+. .+++..+.++++||++||+|||++ |||||||||+|||++. ++.+||+|||+++..
T Consensus 94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 9999999999999976543 599999999999999999999999 9999999999999999 799999999999876
Q ss_pred CCC---CCccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC
Q 001494 952 KPD---SSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 952 ~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
... ........||+.|||||++..+ ...+++||||+||++.||+||+.||... .............. ..| .
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~-~~P--~ 243 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRED-SLP--E 243 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccC-CCC--C
Confidence 631 1223457899999999999853 3446999999999999999999997643 00000011111111 111 2
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
+|.... .+..+++.+|++.+|.+||||.++++.
T Consensus 244 ip~~ls----~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 244 IPDSLS----DEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CCcccC----HHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 333322 348899999999999999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=374.48 Aligned_cols=251 Identities=26% Similarity=0.470 Sum_probs=209.9
Q ss_pred CCccCccccCCceeEEEEEECC----CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 798 FDDEHCIGKGGQGSVYKVELAS----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
..+.++||.|.||.||+|+++. ...||||.++.... ..++.+|+.|+.+|.+++||||+++.|+.......+||
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 3567899999999999998752 35699999986543 34568899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
.|||++|+|+.+++... +++++.+...|.++||.|+.||.+. ++|||||.++|||++.+-.+||+|||+++.+.+
T Consensus 709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999996543 5699999999999999999999999 999999999999999999999999999998866
Q ss_pred CCC-ccccccc--cccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCC
Q 001494 954 DSS-NWTELAG--TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029 (1067)
Q Consensus 954 ~~~-~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1067)
+.. .++...| +.+|.|||.+...+++.+||||||||++||.++ |..||..+.. +..+..+.++. ..|
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--------QdVIkaIe~gy-RLP 854 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVIKAIEQGY-RLP 854 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--------HHHHHHHHhcc-CCC
Confidence 553 3344444 468999999999999999999999999999886 9999865443 23333333332 222
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
++. +++..+.++|..||++|-.+||++.|++..|+
T Consensus 855 pPm--DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lD 889 (996)
T KOG0196|consen 855 PPM--DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLD 889 (996)
T ss_pred CCC--CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHH
Confidence 222 23446999999999999999999999998874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=363.61 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=212.4
Q ss_pred HhcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCC-Ch-hHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCCc
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPG-EM-TFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 869 (1067)
....|..++.||+|+||.|+.|+ ..+++.||+|++...... .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 34679999999999999999995 557899999977653221 11 23455678999999998 9999999999999999
Q ss_pred eeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC-CCeEEeccccc
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK-NEARVSDFGIA 948 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~-~~~kl~DfG~a 948 (1067)
.|+||||+.||+|.+++.. .+++.+..+.++++|++.|++|||++ ||+||||||+||+++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999965 34588899999999999999999999 99999999999999999 99999999999
Q ss_pred eecCCCCCccccccccccccCccccccCC-CC-ccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCC
Q 001494 949 KFLKPDSSNWTELAGTYGYVAPELAYTMK-VT-EKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL 1026 (1067)
Q Consensus 949 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1067)
...........+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+... .......+....+
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRKIRKGEF 240 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcCCc
Confidence 98754455667889999999999999877 75 78999999999999999999998522 1222233555556
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.+|.... ..++..++.+|+..+|.+|+|+.++++
T Consensus 241 ~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 241 KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 6655441 334899999999999999999999974
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.59 Aligned_cols=261 Identities=21% Similarity=0.321 Sum_probs=205.6
Q ss_pred hcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCC-cee
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQ-HSF 871 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~ 871 (1067)
.++|...++||.|.||.||+|+ ..+|+.||||+++..... ..+-.=++|++.++++. |||||++.+++.+.+ .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s--~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc--HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4678899999999999999995 568999999999764332 11223478999999998 999999999998888 999
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+|||||+. +|+++++++ ...+++.++..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 99999975 899999654 67799999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCccccccccccccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccc-------------hhhhhh
Q 001494 952 KPDSSNWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSS-------------LNLNIA 1017 (1067)
Q Consensus 952 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------------~~~~~~ 1017 (1067)
.. ...++..+.|.+|+|||++. .+-|+.+.||||+|||++|+.+-++-|.+........ ......
T Consensus 161 ~S-kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 161 RS-KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cc-CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 64 34568889999999999765 5668999999999999999999887775543321100 000011
Q ss_pred hhhccCCCCCCCCc-----chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1018 LDEILDPRLPIPSH-----NVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1018 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
....+.-+++.-.. .......++.+++.+|+.+||++||||.|+++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111111111 111234568999999999999999999999874
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=366.25 Aligned_cols=362 Identities=26% Similarity=0.250 Sum_probs=244.1
Q ss_pred cEEEeccccccCCccccccCCccccEEeccCCCCcCCCCcccccCCCCCeEEecCccccccCCccccCCCCCCeEEccCC
Q 001494 292 SKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNN 371 (1067)
Q Consensus 292 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 371 (1067)
+.|++++|+++..-+..|.++++|+++++.+|.++.+ |..-....+|+.|+|.+|.|+.+-.+.+..++.|+.|||+.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~I-P~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRI-PRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhhhc-ccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 3455555555555555555555555555555555532 333333344666666666666555566666666777777777
Q ss_pred cCccccCcccCCCCCCCEEEccCCcccccCCCccccccCCcEEEcccCcCcccCchhhhCcCCCcEEeCCCCcccCC-CC
Q 001494 372 SLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGP-IP 450 (1067)
Q Consensus 372 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~ 450 (1067)
.|+...-..|..-.++++|+|++|.|+..-...|.++.+|.+|.|++|+|+...+..|+.+++|+.|+|..|+|.-. .-
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~l 239 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGL 239 (873)
T ss_pred hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhh
Confidence 77644334566667788888888888877777788888888888888888877778888888888888888888754 34
Q ss_pred CCCCCCcccEEeccCcccccccccccccCCceeEEEcccccccCCCCCCCCCCCCcceEeccCCccCCCCCCcccCCCCC
Q 001494 451 NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQL 530 (1067)
Q Consensus 451 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~L 530 (1067)
.|.++++|+.|.|.+|.|..+..++|+.+.++++|+|+.|+++..-..++.++.+|+.|+||+|.|..+.++.....++|
T Consensus 240 tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL 319 (873)
T KOG4194|consen 240 TFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKL 319 (873)
T ss_pred hhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccc
Confidence 67888888888889999888888888888888888888888887777777888888888888888888888888888888
Q ss_pred cEEEcCCCcccCcCcccccCCCccceeecccccccCCccccccccccccEEEccCCCCCCCcc---cccccccccceecc
Q 001494 531 EVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIP---ESLGNLVKLHYLNL 607 (1067)
Q Consensus 531 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~l~~l~~L~~L~L 607 (1067)
+.|+|++|+|+...+..|..++.|++|+|++|.|+.+-..+|..+++|+.|||++|.|+..+. ..|..+++|+.|.|
T Consensus 320 ~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l 399 (873)
T KOG4194|consen 320 KELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRL 399 (873)
T ss_pred eeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheee
Confidence 888888888887666666666666666666666665545555555666666666665553322 23444455555555
Q ss_pred cCcccccccchhhhhccccceeccccccCCCcchhhhhcccccccccc
Q 001494 608 SNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNL 655 (1067)
Q Consensus 608 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 655 (1067)
.+|+|..+.-.+|.++..|++|||.+|.|..+-+.+|..| .|+.|-+
T Consensus 400 ~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~ 446 (873)
T KOG4194|consen 400 TGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVM 446 (873)
T ss_pred cCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhh
Confidence 5555544444444555555555555555544444555444 4444444
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.95 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=217.3
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
.++|+.++.||+|-||.||.|+. +++-.||+|++.+.........+++.+|+++.+.++||||.+++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46799999999999999999964 56788999999876555555677899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
+||.+.|.+...++.. ..+.+++.....++.|+|.|+.|+|.. +|+||||||+|+|++.++..||+|||.+....
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999643 345588888899999999999999999 99999999999999999999999999997543
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.......+||..|.|||+..+..++.++|+|++|++.||++.|.+||+... ......++...+..+|....
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~etYkrI~k~~~~~p~~is 246 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HSETYKRIRKVDLKFPSTIS 246 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------hHHHHHHHHHccccCCcccC
Confidence 556678999999999999999999999999999999999999999987433 23334444444555554444
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
. ++.++|.+|+..+|.+|.+..|+++.
T Consensus 247 ~----~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 247 G----GAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred h----hHHHHHHHHhccCccccccHHHHhhh
Confidence 4 38899999999999999999998763
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=360.91 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=216.0
Q ss_pred cCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.-|+.++-||.|+.|.|..|+ ..+|+.+|||++.....-.......+.+|+.+|+-+.||||+++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 347788999999999999996 4689999999997654333444567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|-|.+++-+ .+++++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|.. ..+
T Consensus 92 Eyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsL-e~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASL-EVP 164 (786)
T ss_pred EecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeec-ccC
Confidence 99999999999954 34589999999999999999999999 999999999999999999999999999975 444
Q ss_pred CCccccccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
+.-..+.||.|.|.|||++.+.+| +.++||||.|||||.|+||+.|||. .+.......+..+.+..|....
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD--------dNir~LLlKV~~G~f~MPs~Is 236 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD--------DNIRVLLLKVQRGVFEMPSNIS 236 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC--------ccHHHHHHHHHcCcccCCCcCC
Confidence 556678899999999999999998 6799999999999999999999983 2334445556666666665444
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
.+ +++++++|+.+||.+|.|++||.+.
T Consensus 237 ~e----aQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 237 SE----AQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HH----HHHHHHHHhccCccccccHHHHhhC
Confidence 44 8999999999999999999999863
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=339.85 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=218.6
Q ss_pred cCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.+|++.+.||+|.||.|-+|. +..|+.||||.+++....+....-.+.+||++|+.++||||+.++.+|+..+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 567888999999999999984 5789999999999877776666667899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||..+|.|++|+.+.+ .+++.++..+++||..|+.|+|.+ +++|||+|.+|||+|+++++||+|||++..+..
T Consensus 133 EYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~- 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD- 205 (668)
T ss_pred EecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence 9999999999997644 499999999999999999999999 999999999999999999999999999987764
Q ss_pred CCccccccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
....+++||+|-|.+||.+.+.+| ++.+|.||+||++|-+..|..|||+.+. ...+.++..+.+..|....
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvrQIs~GaYrEP~~PS 277 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVRQISRGAYREPETPS 277 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHHHhhcccccCCCCCc
Confidence 456688999999999999999998 6789999999999999999999996553 4556666666665543322
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...-+|+.|+.++|++|.|+.+|..
T Consensus 278 -----dA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 278 -----DASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -----hHHHHHHHHHhcCcccchhHHHHhh
Confidence 2567999999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=383.90 Aligned_cols=254 Identities=27% Similarity=0.441 Sum_probs=209.1
Q ss_pred CCCccCccccCCceeEEEEEEC--CCc----EEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCce
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA--SGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 870 (1067)
..+..+.||+|+||.||.|... .|. .||||.+... .+.....+|.+|+.+|+.++|||||+++|+|-+.+..
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4556788999999999999764 343 4899988754 3445578899999999999999999999999999999
Q ss_pred eEEEEeccCCCHHHHhcccCc----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccc
Q 001494 871 FIVYEYLEMGSLAMILSNDAA----AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 946 (1067)
+|++|||++|+|..++++.+. ...++..+.+.++.|||+|+.||+++ ++|||||.++|+|+++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999976422 34688999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCc-cccc-cccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccC
Q 001494 947 IAKFLKPDSSN-WTEL-AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILD 1023 (1067)
Q Consensus 947 ~a~~~~~~~~~-~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1023 (1067)
+|+.+....+. .... .-+.+|||||.+..+.++.|+|||||||++||++| |..||...... .....-...
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-------~v~~~~~~g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-------EVLLDVLEG 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-------HHHHHHHhC
Confidence 99955433222 2222 23568999999999999999999999999999998 89998754432 122223334
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1024 PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1024 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
+++..|+.+.. .++++|..||+.+|++||++..+++.++
T Consensus 921 gRL~~P~~CP~----~ly~lM~~CW~~~pe~RP~F~~i~~q~~ 959 (1025)
T KOG1095|consen 921 GRLDPPSYCPE----KLYQLMLQCWKHDPEDRPSFRTIVEQDP 959 (1025)
T ss_pred CccCCCCCCCh----HHHHHHHHHccCChhhCccHHHHHhhhh
Confidence 56666655544 4889999999999999999999998764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=328.38 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=215.8
Q ss_pred hcCCCccCccccCCceeEEEE-EECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
+++|++.+.||+|+|+.||++ ...+|+.+|+|++....-... ..+++.+|+++-+.++|||||++.+.+.+.+..|+|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456888899999999999996 667899999998864433322 357889999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC---CCeEEecccccee
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK---NEARVSDFGIAKF 950 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~---~~~kl~DfG~a~~ 950 (1067)
+|+|.|++|..-+-.. .-.++..+-..++||++|+.|+|.+ +|||||+||+|+++-.. .-+|++|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999996544221 3367888889999999999999999 99999999999999644 3499999999999
Q ss_pred cCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCC
Q 001494 951 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPS 1030 (1067)
Q Consensus 951 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1067)
+. +...+..++|||+|||||++...+|+..+|||+.||++|-++.|+.||.+.+ .....++++......++
T Consensus 163 l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--------~~rlye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 163 VN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYEQIKAGAYDYPS 233 (355)
T ss_pred eC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--------HHHHHHHHhccccCCCC
Confidence 88 6667788999999999999999999999999999999999999999986432 23445566667777777
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1031 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
..++...++.++++++|+..||.+|.|+.|.++
T Consensus 234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 667777778999999999999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=364.43 Aligned_cols=254 Identities=29% Similarity=0.444 Sum_probs=205.1
Q ss_pred cCCCccCccccCCceeEEEEEECC--C--cE-EEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCce
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELAS--G--EI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 870 (1067)
++....++||+|+||.||+|++.. + .. ||||..+..........++|+.|+++|+.++|||||+++|++..+...
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344556899999999999997543 2 23 899998864434456688999999999999999999999999999999
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
|+|||+|+||+|.++++... +.++..++.+++.++|.||+|||++ +++||||.++|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999996543 2689999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC--CCC
Q 001494 951 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP--RLP 1027 (1067)
Q Consensus 951 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 1027 (1067)
-...........-+.+|+|||.+..+.|++++|||||||++||+++ |..||.+.... +....+... +.+
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGYRMP 383 (474)
T ss_pred CcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCccCC
Confidence 4311111111224678999999999999999999999999999998 88898765543 222233111 122
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+. ..+..+..++.+||..+|++||+|.++.+.++
T Consensus 384 ~~~----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 384 IPS----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred CCC----CCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 222 22234778888999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.00 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=205.5
Q ss_pred HhcCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
..+++.....||+|.||+||+|++. | .||||++........ ..+.|+.|+..+++-+|.||+=+.|||..+.. .||
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred CHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 3345677899999999999999876 4 389999987765544 67889999999999999999999999999887 999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
+.+|+|.+|+.+++-.+ ..++..+.+.||+|||+|+.|||.+ +|||||+|..||++.+++.|||+|||++..-..
T Consensus 466 TqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred ehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 99999999999996433 5688889999999999999999999 999999999999999999999999999975332
Q ss_pred --CCCccccccccccccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCC
Q 001494 954 --DSSNWTELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028 (1067)
Q Consensus 954 --~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1067)
.........|...|||||++... +|++.+||||||+++|||+||..||.. ...+ ....+..+....++...
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~d---qIifmVGrG~l~pd~s~ 616 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRD---QIIFMVGRGYLMPDLSK 616 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChh---heEEEecccccCccchh
Confidence 22233445677889999988754 589999999999999999999999872 2110 00111111111222222
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1029 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
. ......++.+|+..||..++++||.+.+++..|+
T Consensus 617 ~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~ 651 (678)
T KOG0193|consen 617 I---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE 651 (678)
T ss_pred h---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence 2 2334456999999999999999999999999664
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=347.66 Aligned_cols=250 Identities=25% Similarity=0.430 Sum_probs=210.0
Q ss_pred cCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
..|...+.||+|.||.||+|. ..+++.||+|++...... ...+++.+|+.++.+++++||.++++.+..+..+|++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 457777999999999999984 568999999999765433 34578889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+.||++.+.++... .+++..+.-|++++..|+.|+|++ +.+|||||+.||++..+|.+|++|||.+.++...
T Consensus 91 ey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999995433 346777778999999999999999 9999999999999999999999999999998877
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
.....+++|||-|||||++....|+.|+||||+|++.+||.+|.+|+....++... ..+ ++-. |+....
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl---------flI-pk~~-PP~L~~ 233 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL---------FLI-PKSA-PPRLDG 233 (467)
T ss_pred hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE---------Eec-cCCC-CCcccc
Confidence 77778899999999999999889999999999999999999999998654432110 111 1111 111112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
.....+++|+..|++++|+.||+|.++++.
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 444569999999999999999999999863
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=349.26 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=203.9
Q ss_pred hcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
.++|+..++||+||||+||.|+ ..+|+.+|+|++++..--.....+.++.|-.+|...++|+||+++-.|++.+.+|+|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 4689999999999999999996 457999999999876544555667788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||++||++.-++.+. +.+++..+..++.+++-|++.+|.. |+|||||||+|+|||..|++|++|||++.-+..
T Consensus 220 MEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999998543 4589999999999999999999999 999999999999999999999999999853211
Q ss_pred ----------------------CC-C-----c-------------------cccccccccccCccccccCCCCccchhHH
Q 001494 954 ----------------------DS-S-----N-------------------WTELAGTYGYVAPELAYTMKVTEKCDVYS 986 (1067)
Q Consensus 954 ----------------------~~-~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 986 (1067)
.. . . ....+|||.|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 00 0 0 01247999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCC--CCCCCcchHHHHHHHHHHHHhccCCCCCCCCC---HHHH
Q 001494 987 FGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPR--LPIPSHNVQEKLISFVEVAISCLDESPESRPT---MQKV 1061 (1067)
Q Consensus 987 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~ev 1061 (1067)
+|||+|||+.|.+||....+.+ ....++..+ +..|.+. +...++.++|.+|+. ||++|-- +.||
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~--------T~rkI~nwr~~l~fP~~~--~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQE--------TYRKIVNWRETLKFPEEV--DLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHhhhccCCCcC--cccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 9999999999999997544322 222222222 2222221 222458999999999 9999975 5554
Q ss_pred H
Q 001494 1062 S 1062 (1067)
Q Consensus 1062 l 1062 (1067)
.
T Consensus 443 K 443 (550)
T KOG0605|consen 443 K 443 (550)
T ss_pred h
Confidence 3
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=356.89 Aligned_cols=245 Identities=23% Similarity=0.339 Sum_probs=210.5
Q ss_pred hcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 872 (1067)
.++|...++||+|.||.|++++.+ +++.+|||++++...-.....+..+.|.+++... +||.++.++..|...+++|.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 467999999999999999999765 6889999999887655555677888899988777 59999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
||||+.||++..+.+ ...+++..+.-++..|+.||+|||++ ||||||||.+|||+|.+|++||+|||+++..-
T Consensus 447 vmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence 999999999544432 34589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcc
Q 001494 953 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 953 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
-.+...++++|||.|||||++.+..|+.++|.|||||++|||+.|..||.+.+ ..+.++.++......|...
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd--------Eee~FdsI~~d~~~yP~~l 591 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD--------EEEVFDSIVNDEVRYPRFL 591 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHhcCCCCCCCcc
Confidence 45566778999999999999999999999999999999999999999987433 3445556665555555444
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCH
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTM 1058 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~ 1058 (1067)
.. +...++++++.++|++|--+
T Consensus 592 s~----ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 592 SK----EAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred cH----HHHHHHHHHhccCcccccCC
Confidence 43 48899999999999999865
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=359.27 Aligned_cols=256 Identities=23% Similarity=0.422 Sum_probs=200.8
Q ss_pred hcCCCccCccccCCceeEEEEEE------CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeC
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHA 867 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 867 (1067)
.++|++.++||+|+||.||+|.. .+++.||||++.... .....+.+..|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 35789999999999999999863 245689999987432 223346789999999999 899999999988765
Q ss_pred C-ceeEEEEeccCCCHHHHhcccCc-------------------------------------------------------
Q 001494 868 Q-HSFIVYEYLEMGSLAMILSNDAA------------------------------------------------------- 891 (1067)
Q Consensus 868 ~-~~~lv~E~~~~g~L~~~l~~~~~------------------------------------------------------- 891 (1067)
+ ..++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 68999999999999999864221
Q ss_pred ----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC--ccccccccc
Q 001494 892 ----AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS--NWTELAGTY 965 (1067)
Q Consensus 892 ----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~ 965 (1067)
..++++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++....... ......+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 13478889999999999999999999 999999999999999999999999999986543222 112334567
Q ss_pred cccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CCCCCCcchHHHHHHHHHH
Q 001494 966 GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLPIPSHNVQEKLISFVEV 1043 (1067)
Q Consensus 966 ~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l 1043 (1067)
.|+|||++.+..++.++|||||||++|||++ |..||....... .....+... ....+.. ...++.++
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~----~~~~l~~l 309 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFCQRLKDGTRMRAPEN----ATPEIYRI 309 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------HHHHHHhcCCCCCCCCC----CCHHHHHH
Confidence 8999999998889999999999999999997 999987533211 011111111 1111221 22358899
Q ss_pred HHhccCCCCCCCCCHHHHHHHhc
Q 001494 1044 AISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1044 i~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
+.+||+.||++|||+.|+++.|+
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~ 332 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILG 332 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=315.70 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=219.6
Q ss_pred HhcCCCccCccccCCceeEEEE-EECCCcEEEEEEeCCCCCC-----ChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEee
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPG-----EMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH 866 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 866 (1067)
.-..|...+.+|.|..++|.++ ...+|+.+|+|++...... .....++-.+|+.+++++ .||+|+.+.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456888899999999999886 5678899999998543211 223345567899999998 69999999999999
Q ss_pred CCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccc
Q 001494 867 AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 867 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 946 (1067)
+..+++|+|.|+.|.|.|++.... .+++....+|++|+.+|++|||.+ .|||||+||+|||+|++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 999999999999999999996543 489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhh
Q 001494 947 IAKFLKPDSSNWTELAGTYGYVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDE 1020 (1067)
Q Consensus 947 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1020 (1067)
+|+.+.+ +......||||+|.|||.+.. ..|+..+|+|+.|||+|-++.|.+||. ....-.....
T Consensus 169 Fa~~l~~-GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--------HRkQmlMLR~ 239 (411)
T KOG0599|consen 169 FACQLEP-GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--------HRKQMLMLRM 239 (411)
T ss_pred eeeccCC-chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--------HHHHHHHHHH
Confidence 9998875 466788999999999998753 347889999999999999999999975 2233445667
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1021 ILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
++.+.+.+..+.+.+......++|.+|++.||++|.|+.|+++
T Consensus 240 ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 7788888888888888889999999999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=325.02 Aligned_cols=262 Identities=24% Similarity=0.318 Sum_probs=204.2
Q ss_pred hcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEe--eCCcee
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCS--HAQHSF 871 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~ 871 (1067)
.++|+...+|++|.||.||+|+ .++++.||+|+++..... ..+.-.-++||.++.+.+|||||.+-.+.. +-+..|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccccc-CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 3568888999999999999996 458899999999876532 233345689999999999999999988764 445799
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+|||||++ +|...+.... .++...++..++.|+++|++|||++ .|+|||+|++|+|++..|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 99999986 7877775433 5688899999999999999999999 9999999999999999999999999999999
Q ss_pred CCCCCccccccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhh--hhhccCCC---
Q 001494 952 KPDSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIA--LDEILDPR--- 1025 (1067)
Q Consensus 952 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~--- 1025 (1067)
+.+...++..+-|.+|+|||.+.+.+ |+++.|+||+|||+.||+++++-|.+.............. -.+.+.+.
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 98888889999999999999888765 8999999999999999999998876544322111100000 00000000
Q ss_pred ------CCCCC---cc----hHH--HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1026 ------LPIPS---HN----VQE--KLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1026 ------~~~~~---~~----~~~--~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...+. .. ... ....-.+++...+..||.+|.||.|.++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00000 00 000 1235689999999999999999999875
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=356.28 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=200.5
Q ss_pred CccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCC
Q 001494 802 HCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMG 880 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 880 (1067)
+.||+|+||.||+|+. .+|+.||+|++.............+.+|+.++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 578999999987543223333456788999999999999999999999999999999999999
Q ss_pred CHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcccc
Q 001494 881 SLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE 960 (1067)
Q Consensus 881 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 960 (1067)
+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 999888543 3588999999999999999999999 9999999999999999999999999999765433344455
Q ss_pred ccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHH
Q 001494 961 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISF 1040 (1067)
Q Consensus 961 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1040 (1067)
.+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+.... .++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~~~~~~~p~~~~----~~~ 222 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEEIRFPRTLS----PEA 222 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCCCC----HHH
Confidence 6799999999999998999999999999999999999999864322 1112222223333333332 348
Q ss_pred HHHHHhccCCCCCCCC-----CHHHHHH
Q 001494 1041 VEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1041 ~~li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
.+++.+||+.||++|| ++.++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 8999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.30 Aligned_cols=245 Identities=21% Similarity=0.319 Sum_probs=199.4
Q ss_pred cCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee----CCceeEEEEe
Q 001494 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH----AQHSFIVYEY 876 (1067)
Q Consensus 801 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~ 876 (1067)
...+|+|++|.||+|.. +|+.||||++...........+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999988 589999999986544444445778899999999999999999999876 3468999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+++|+|.+++... ..+++..+.+++.+++.|++|||+.. +++||||||+||+++.++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999999643 35889999999999999999999742 78899999999999999999999999998654322
Q ss_pred ccccccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhcc--CCCCCCCCcc
Q 001494 957 NWTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL--DPRLPIPSHN 1032 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 1032 (1067)
....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||+..... .....+. ..+...+..
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~~- 246 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--------EIYDLIINKNNSLKLPLD- 246 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcCCCCCCCCc-
Confidence 23467899999999876 67899999999999999999999998754321 1111111 112222222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
...++.+++.+||+.||++|||+.|+++.|+
T Consensus 247 ---~~~~l~~li~~cl~~dp~~Rps~~ell~~l~ 277 (283)
T PHA02988 247 ---CPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277 (283)
T ss_pred ---CcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 2335899999999999999999999999886
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.95 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=204.6
Q ss_pred HhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCC-----------ChhHHHHHHHHHHHHhcCCCCeeeeee
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPG-----------EMTFQQEFLNEVKALTEIRHRNIVKFY 861 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~niv~l~ 861 (1067)
..++|+..+.||+|.||.|-+|+. .+++.||||++.+.... .....+...+||.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 357899999999999999999964 57999999998643110 111235788999999999999999999
Q ss_pred EEEeeC--CceeEEEEeccCCCHHHHhcccCccCC-CChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC
Q 001494 862 GFCSHA--QHSFIVYEYLEMGSLAMILSNDAAAED-LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN 938 (1067)
Q Consensus 862 ~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~ 938 (1067)
.+..+. +.+|||+|||..|.+... ...++ +++.++++++.++..||+|||.+ |||||||||+|+|++++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 998765 488999999998876532 22333 89999999999999999999999 999999999999999999
Q ss_pred CeEEeccccceecCCC-----CCccccccccccccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCccccccc
Q 001494 939 EARVSDFGIAKFLKPD-----SSNWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPGDFISLISS 1009 (1067)
Q Consensus 939 ~~kl~DfG~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~p~~~~~~~~~ 1009 (1067)
+|||+|||.+...... .......+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~------ 321 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD------ 321 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc------
Confidence 9999999999876322 22234578999999999887743 36789999999999999999999752
Q ss_pred cchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1010 SSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.......+.++...+.+|... +..+.+.++|.++|.+||++|.+..+|..
T Consensus 322 --~~~~~l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 322 --DFELELFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred --chHHHHHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhhee
Confidence 233445566777666666442 34456899999999999999999998864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.60 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=200.4
Q ss_pred cCCCccCccccCCceeEEEEEECC-----------------CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELAS-----------------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 858 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 858 (1067)
.+|+..++||+|+||.||+|..++ +..||+|++.... ......++.+|++++++++||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence 568889999999999999986532 3469999987542 233456799999999999999999
Q ss_pred eeeEEEeeCCceeEEEEeccCCCHHHHhcccC----------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 001494 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922 (1067)
Q Consensus 859 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 922 (1067)
++++++.+.+..++||||+++|+|.+++.... ....+++.++.+++.|++.|++|||+. +|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence 99999999999999999999999999885421 113468889999999999999999999 99
Q ss_pred eecCCCCCceeeCCCCCeEEeccccceecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh--CC
Q 001494 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GK 998 (1067)
Q Consensus 923 vHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~ 998 (1067)
+||||||+||+++.++.+||+|||+++.+...... .....++..|+|||++.+..++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999999865433211 123345788999999988889999999999999999997 55
Q ss_pred CCCCccccccccchhhhhhhhhcc-CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 999 HPGDFISLISSSSLNLNIALDEIL-DPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 999 ~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.||.......... .......... ......++. ....+.+++.+||+.||.+|||+.||.+.|+
T Consensus 240 ~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQVIE-NAGEFFRDQGRQVYLFRPPP----CPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHHHH-HHHHHhhhccccccccCCCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6765432211100 0000000000 001111111 2235899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=334.87 Aligned_cols=258 Identities=27% Similarity=0.439 Sum_probs=199.7
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHh--cCCCCeeeeeeEEEeeCC----c
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT--EIRHRNIVKFYGFCSHAQ----H 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~ 869 (1067)
...+..+++|+|+||.||||++. ++.||||++... ..+.|..|-.+.+ .++|+||++++++-.... .
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 44566788999999999999988 589999998632 3466777777765 458999999999876665 8
Q ss_pred eeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCC------CCCeeecCCCCCceeeCCCCCeEEe
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC------FPPIVHRDISSKNVLLDFKNEARVS 943 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivHrDlk~~Nill~~~~~~kl~ 943 (1067)
+|+|+||.+.|+|.++++.. .++|....+|+..+++||+|||+.. .|+|+|||||++|||+..|+++.|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 99999999999999999654 3899999999999999999999764 3789999999999999999999999
Q ss_pred ccccceecCCCC--CccccccccccccCccccccCC-C-----CccchhHHHHHHHHHHHhCCCCCC--ccc----cc--
Q 001494 944 DFGIAKFLKPDS--SNWTELAGTYGYVAPELAYTMK-V-----TEKCDVYSFGVLALEVIKGKHPGD--FIS----LI-- 1007 (1067)
Q Consensus 944 DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwslGvil~elltg~~p~~--~~~----~~-- 1007 (1067)
|||+|..+.+.. ......+||.+|||||++.+.- + -.+.||||+|.++|||+++..-++ ..+ ++
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 999999887542 2334578999999999987653 2 236999999999999998654332 111 11
Q ss_pred -----cccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1008 -----SSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1008 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
..........+.+..+|.++...... ..+..+.+.+..||+.||+.|-|+.-|.+.+
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 11112222233444445544333333 4456689999999999999999999887765
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=344.53 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=201.9
Q ss_pred CCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|+..+.||+|+||.||+|.. .+|+.||+|++.............+.+|++++++++|++|+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999965 57999999998654322223345678999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..... .
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-E 156 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-C
Confidence 99999988775322 23588999999999999999999999 9999999999999999999999999999875432 2
Q ss_pred ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHH
Q 001494 957 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEK 1036 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1067)
......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .......+.......+.. .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~----~ 228 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVKEDQEEYSEK----F 228 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhhcccccCCcc----C
Confidence 23445789999999999999999999999999999999999999874332110 111111122222222222 2
Q ss_pred HHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 001494 1037 LISFVEVAISCLDESPESRPT-----MQKVSQ 1063 (1067)
Q Consensus 1037 ~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 1063 (1067)
...+.+++.+||+.||++||+ ++++++
T Consensus 229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 234889999999999999997 788765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=349.42 Aligned_cols=247 Identities=26% Similarity=0.335 Sum_probs=203.4
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||.||+|... +++.||+|++...........+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999764 78999999986432222234566889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999998543 3588899999999999999999999 9999999999999999999999999999865432
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+....
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~- 222 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGKLEFPRHLD- 222 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCcCCCccCC-
Confidence 2345789999999999988899999999999999999999999864332 1122223333333333322
Q ss_pred HHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPT-----MQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 1063 (1067)
..+.+++.+||+.||.+||+ +.|+++
T Consensus 223 ---~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 223 ---LYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ---HHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 24889999999999999995 888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=351.41 Aligned_cols=241 Identities=24% Similarity=0.333 Sum_probs=196.8
Q ss_pred cccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCCCH
Q 001494 804 IGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL 882 (1067)
Q Consensus 804 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 882 (1067)
||+|+||.||+|+.. +++.||+|++.............+.+|+.++++++||||+++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999764 6889999998643222333456788999999999999999999999999999999999999999
Q ss_pred HHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcccccc
Q 001494 883 AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA 962 (1067)
Q Consensus 883 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 962 (1067)
.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 9998543 3588999999999999999999999 999999999999999999999999999986544333444567
Q ss_pred ccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHH
Q 001494 963 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVE 1042 (1067)
Q Consensus 963 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1042 (1067)
||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+.... .++.+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~----~~~~~ 222 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKILQEPLRFPDGFD----RDAKD 222 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCCCCCCcCC----HHHHH
Confidence 99999999999998999999999999999999999999864322 1222233333333333222 34889
Q ss_pred HHHhccCCCCCCCCC---HHHHH
Q 001494 1043 VAISCLDESPESRPT---MQKVS 1062 (1067)
Q Consensus 1043 li~~cl~~dP~~Rpt---~~evl 1062 (1067)
++.+||+.||.+||+ +.|++
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHH
Confidence 999999999999985 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=379.83 Aligned_cols=507 Identities=30% Similarity=0.350 Sum_probs=344.3
Q ss_pred eecCCCcccCCCCcccccccccceecccccccccCCCCccccccccccccccccccccccCCCccCCCcccEEEEeccCC
Q 001494 102 LDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLL 181 (1067)
Q Consensus 102 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l 181 (1067)
+|.|+.++. .||..+-.-..|+.|++++|.+- ..|-+| .....+|+.||+++|++
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~-----------------------~~~~v~L~~l~lsnn~~ 57 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEF-----------------------VEKRVKLKSLDLSNNQI 57 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHH-----------------------hhheeeeEEeecccccc
Confidence 566666666 56665544444666666666654 222221 22233477777777777
Q ss_pred cCccCCccccccccceecccccccccccCCCCCcccccceeecccCcCCCCCCcccCCcccCCceEecCcccccccCccc
Q 001494 182 SGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSL 261 (1067)
Q Consensus 182 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 261 (1067)
. .+|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|.|.+|.+. ..|.++..+++|+.|++++|++. .+|..+
T Consensus 58 ~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i 133 (1081)
T KOG0618|consen 58 S-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVI 133 (1081)
T ss_pred c-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhH
Confidence 6 67777777777777777777776 66677777777777777777776 67777777777777777777776 667777
Q ss_pred cCccceeeEEEecccccccCCCccccCCcccEEEeccccccCCccccccCCccccEEeccCCCCcCCCCcccccCCCCCe
Q 001494 262 CNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSI 341 (1067)
Q Consensus 262 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 341 (1067)
..++.++.+..++|......+ ... .+.++|..|.+.+.++..+..+.. .|+|.+|.+. ...+..+.+|+.
T Consensus 134 ~~lt~~~~~~~s~N~~~~~lg----~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~ 203 (1081)
T KOG0618|consen 134 EVLTAEEELAASNNEKIQRLG----QTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEV 203 (1081)
T ss_pred HhhhHHHHHhhhcchhhhhhc----ccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhh
Confidence 777777777777772222222 222 667777777777766666666655 5777777776 234566677777
Q ss_pred EEecCccccccCCccccCCCCCCeEEccCCcCccccCcccCCCCCCCEEEccCCcccccCCCccccccCCcEEEcccCcC
Q 001494 342 LELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL 421 (1067)
Q Consensus 342 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 421 (1067)
|....|++... --.-++|+.|+.++|.++...+.. .-.+|+++++++|+++ .+|.+++.+.+|+.++..+|++
T Consensus 204 l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l 276 (1081)
T KOG0618|consen 204 LHCERNQLSEL----EISGPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRL 276 (1081)
T ss_pred hhhhhcccceE----EecCcchheeeeccCcceeecccc--ccccceeeecchhhhh-cchHHHHhcccceEecccchhH
Confidence 77777777632 223456788888888877333322 2257888888888888 4568888888888888888888
Q ss_pred cccCchhhhCcCCCcEEeCCCCcccCCCCCCCCCCcccEEeccCcccccccccccccCCc-eeEEEcccccccCCCCCCC
Q 001494 422 SGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPN-LTFIDLSYNNLYGEISSDW 500 (1067)
Q Consensus 422 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~-L~~L~Ls~N~l~~~~~~~~ 500 (1067)
+ .+|..+...++|+.|....|.+.-.++.+.+.++|+.|+|..|+|.+.+...|..... |..|..|.|++.......=
T Consensus 277 ~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e 355 (1081)
T KOG0618|consen 277 V-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEE 355 (1081)
T ss_pred H-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccc
Confidence 5 6777778888888888888888888888888888888888888888877765555544 6666666666654331111
Q ss_pred CCCCCcceEeccCCccCCCCCCcccCCCCCcEEEcCCCcccCcCcccccCCCccceeecccccccCCccccccccccccE
Q 001494 501 GRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEH 580 (1067)
Q Consensus 501 ~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 580 (1067)
...+ .|+.|++.+|++++.....+.+..+|+.|+|++|+|.......+..+..|+.
T Consensus 356 ~~~~------------------------~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~Lee 411 (1081)
T KOG0618|consen 356 NNHA------------------------ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEE 411 (1081)
T ss_pred hhhH------------------------HHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHH
Confidence 1223 4555555555555444444555555555555555555444555666667777
Q ss_pred EEccCCCCCCCcccccccccccceecccCcccccccchhhhhccccceeccccccCCCcchhhhhccccccccccccccc
Q 001494 581 LDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSL 660 (1067)
Q Consensus 581 L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 660 (1067)
|+||+|+++ .+|..+..+..|++|....|++. ..| .+..+++|+.+|||.|+|+.........-++|++|||++|.=
T Consensus 412 L~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 412 LNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred Hhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 777777776 66777888888888888888887 455 788888888888888888775444444448899999999975
Q ss_pred ccccccccccCccccEEEcccC
Q 001494 661 SGVIPRCFEEMHALQCIDISYN 682 (1067)
Q Consensus 661 ~~~~~~~l~~l~~L~~l~l~~N 682 (1067)
....-..|..++++..+++.-|
T Consensus 489 l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 489 LVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred cccchhhhHHhhhhhheecccC
Confidence 5566677778888888888777
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=381.89 Aligned_cols=505 Identities=31% Similarity=0.394 Sum_probs=357.6
Q ss_pred EeccCCccccCCCCcccccCccceeecCCCcccCCCCcccccccccceecccccccccCCCCcccccccccccccccccc
Q 001494 78 LDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYL 157 (1067)
Q Consensus 78 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 157 (1067)
+|++..++. .||..+-.-..|..|+++.|.+....-+.+.+.-+|+.|||++|+++ ..|..+..+..|+.|.++.|.|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 566666764 67777766666888888888776332234455666899999998887 7888888889999999999988
Q ss_pred ccccCCCccCCCcccEEEEeccCCcCccCCccccccccceecccccccccccCCCCCcccccceeecccCcCCCCCCccc
Q 001494 158 EDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSEL 237 (1067)
Q Consensus 158 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 237 (1067)
.. .|.+..++.+|++|.|.+|++. ..|.++..+++|++|+++.|.+. .+|..+..++.++.++.++|..... +
T Consensus 81 ~~-vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----l 153 (1081)
T KOG0618|consen 81 RS-VPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----L 153 (1081)
T ss_pred hh-Cchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----h
Confidence 87 5688888999999999999988 88999999999999999999987 8888999999999999999932222 3
Q ss_pred CCcccCCceEecCcccccccCccccCccceeeEEEecccccccCCCccccCCcccEEEeccccccCCccccccCCccccE
Q 001494 238 GNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAF 317 (1067)
Q Consensus 238 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 317 (1067)
+... .+.+++..|.+.+.++..+..++. .|+|.+|.+.. -.+.++.+|+.|....|+++... -.-++|+.
T Consensus 154 g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~---~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~ 223 (1081)
T KOG0618|consen 154 GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV---LDLSNLANLEVLHCERNQLSELE----ISGPSLTA 223 (1081)
T ss_pred cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhhh---hhhhhccchhhhhhhhcccceEE----ecCcchhe
Confidence 3332 788889999998888888877776 79999998882 35677888999999999887542 23467899
Q ss_pred EeccCCCCcCCCCcccccCCCCCeEEecCccccccCCccccCCCCCCeEEccCCcCccccCcccCCCCCCCEEEccCCcc
Q 001494 318 LFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKL 397 (1067)
Q Consensus 318 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 397 (1067)
|+.++|.++...+... -.+|+++++++|++++ +|++++.+.+|+.+...+|+++ .+|..+....+|++|.+.+|.+
T Consensus 224 L~a~~n~l~~~~~~p~--p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel 299 (1081)
T KOG0618|consen 224 LYADHNPLTTLDVHPV--PLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNEL 299 (1081)
T ss_pred eeeccCcceeeccccc--cccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhh
Confidence 9999999885543222 3579999999999984 6699999999999999999997 7888888899999999999999
Q ss_pred cccCCCccccccCCcEEEcccCcCcccCchhhhCcCC-CcEEeCCCCcccCCCC-CCCCCCcccEEeccCcccccccccc
Q 001494 398 TSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVK-LTKLFLGDNQFQGPIP-NLKNLTSLVRVHLDRNYLTSNISES 475 (1067)
Q Consensus 398 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~-~l~~l~~L~~L~L~~N~l~~~~~~~ 475 (1067)
. .+|....++++|++|+|..|+|....+..+..+.. |..|+.+.|++...+. .-...+.|+.|++.+|++++-....
T Consensus 300 ~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~ 378 (1081)
T KOG0618|consen 300 E-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPV 378 (1081)
T ss_pred h-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhh
Confidence 8 67777888999999999999998666655555544 7777777777765432 1123445666666666666655555
Q ss_pred cccCCceeEEEcccccccCCCCCCCCCCCCcceEeccCCccCCCCCCcccCCCCCcEEEcCCCcccCcCcccccCCCccc
Q 001494 476 FYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLI 555 (1067)
Q Consensus 476 ~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 555 (1067)
+.++..|+.|+|++|++.......+.++..|++|+||+|+++ .+|..+..+..|++|...+|++. .+|
T Consensus 379 l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP---------- 446 (1081)
T KOG0618|consen 379 LVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP---------- 446 (1081)
T ss_pred hccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech----------
Confidence 555666666666666665544445555555555555555555 44455555555555555555554 333
Q ss_pred eeecccccccCCccccccccccccEEEccCCCCCCC-cccccccccccceecccCcccccccchhhhhccccceeccccc
Q 001494 556 KLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNA-IPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYN 634 (1067)
Q Consensus 556 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 634 (1067)
.+..+++|+.+|+|.|+|+.. +|..... ++|++|||++|.-....-..|..++++...++.-|
T Consensus 447 ---------------e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 447 ---------------ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred ---------------hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 444455555555555555432 2222222 56666666666532233344445555555555544
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=350.60 Aligned_cols=244 Identities=24% Similarity=0.295 Sum_probs=199.3
Q ss_pred CccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCC
Q 001494 802 HCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMG 880 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 880 (1067)
+.||+|+||.||+++. .+|+.||+|++.............+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999965 578999999987543222333456788999999999999999999999999999999999999
Q ss_pred CHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcccc
Q 001494 881 SLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE 960 (1067)
Q Consensus 881 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 960 (1067)
+|..++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 999888543 3588999999999999999999999 9999999999999999999999999998764433334445
Q ss_pred ccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHH
Q 001494 961 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISF 1040 (1067)
Q Consensus 961 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1040 (1067)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.... .++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~~~~~p~~~~----~~~ 222 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEEIRFPRTLS----PEA 222 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCCCCCCCCC----HHH
Confidence 6799999999999988999999999999999999999999864322 1112222222333333322 347
Q ss_pred HHHHHhccCCCCCCCC-----CHHHHHH
Q 001494 1041 VEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1041 ~~li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
.+++.+||+.||++|| ++.++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 8999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=350.55 Aligned_cols=244 Identities=24% Similarity=0.301 Sum_probs=200.3
Q ss_pred CccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCC
Q 001494 802 HCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMG 880 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 880 (1067)
+.||+|+||.||+++. .+++.||+|++.............+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 578999999997543333334567889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcccc
Q 001494 881 SLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE 960 (1067)
Q Consensus 881 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 960 (1067)
+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 999888543 3588999999999999999999999 9999999999999999999999999999764433333445
Q ss_pred ccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHH
Q 001494 961 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISF 1040 (1067)
Q Consensus 961 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1040 (1067)
..||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+.... .++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~~~~~~~~~~~~p~~~~----~~~ 222 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEDIKFPRTLS----ADA 222 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHHHHHhccCCccCCCCCC----HHH
Confidence 6799999999999988899999999999999999999999864322 1112222222333333332 348
Q ss_pred HHHHHhccCCCCCCCC-----CHHHHHH
Q 001494 1041 VEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1041 ~~li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
.+++.+||+.||.+|| ++.|+++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 8999999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=344.51 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=215.3
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc-eeEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH-SFIV 873 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv 873 (1067)
++|...+++|+|+||.++.++++ +++.|++|++......+.. .+....|+.++++++|||||.+.+.|.+++. .+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 57888999999999999998654 6788999999866554443 3467899999999999999999999999988 9999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|+|++||++.+.+.+.. ...++++++..++.|++.|+.|||++ .|+|||||+.||+++.++.|||+|||+|+.+.+
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999997655 45689999999999999999999988 999999999999999999999999999999988
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCC-CCCCCcc
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPR-LPIPSHN 1032 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1032 (1067)
+.......+||+.||+||.+.+.+|..|+||||+||++|||++-+++|...+. ...+.++.... .+.|..+
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki~~~~~~Plp~~y 230 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKINRGLYSPLPSMY 230 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHHhhccCCCCCccc
Confidence 77667788999999999999999999999999999999999999999875443 22222333222 2233333
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
..++..++..|++.+|..||++.+++..
T Consensus 231 ----s~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 231 ----SSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----cHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 3348999999999999999999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=339.66 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=206.7
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
....++++||+|-||.|..++...+..||||+++.... .....+|.+|+++|.+++|||||+++|+|..++.+++|+|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34567899999999999999999889999999986533 3446899999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
||++|+|..++.+..... ...+.-.+|+.||+.|++||.+. ++||||+.++|+|+|.++++||+|||+++.+....
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999997654322 45566678999999999999999 99999999999999999999999999999665443
Q ss_pred Ccc--ccccccccccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCccccccccchhhhhhhhhccCC-----CC
Q 001494 956 SNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPGDFISLISSSSLNLNIALDEILDP-----RL 1026 (1067)
Q Consensus 956 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 1026 (1067)
+.. ...+-+.+|||||.+.-++++.|+|||+|||++||+++ ...||........ .+...++.+. -+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-----ven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-----VENAGEFFRDQGRQVVL 766 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-----HHhhhhhcCCCCcceec
Confidence 322 23455789999999999999999999999999999875 7889864332111 1111111111 11
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
..|..+ ..++++++.+||..|-.+||+++++...|+
T Consensus 767 ~~P~~c----p~~lyelml~Cw~~es~~RPsFe~lh~~lq 802 (807)
T KOG1094|consen 767 SRPPAC----PQGLYELMLRCWRRESEQRPSFEQLHLFLQ 802 (807)
T ss_pred cCCCcC----cHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence 122222 235889999999999999999999988764
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=352.24 Aligned_cols=247 Identities=26% Similarity=0.313 Sum_probs=203.4
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.+|+..+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56889999999999999999764 68999999986432222233567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999998543 3578889999999999999999999 9999999999999999999999999999876432
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......+....
T Consensus 172 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~~~~p~~~~- 239 (329)
T PTZ00263 172 T---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------RIYEKILAGRLKFPNWFD- 239 (329)
T ss_pred c---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--------HHHHHHhcCCcCCCCCCC-
Confidence 2 2457899999999999988999999999999999999999998643321 122223333333333222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPT-----MQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 1063 (1067)
..+.+++.+||+.||.+||+ +.++++
T Consensus 240 ---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 240 ---GRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 24789999999999999997 577664
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=309.24 Aligned_cols=260 Identities=24% Similarity=0.349 Sum_probs=208.3
Q ss_pred hcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC-----C
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA-----Q 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 868 (1067)
.++|++.+.||+|||+-||.++ ..+++.||+|++.... .+..+..++|++..++++||||++++++...+ .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4679999999999999999996 6788999999997653 33467889999999999999999999887433 3
Q ss_pred ceeEEEEeccCCCHHHHhcccCc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccc
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAA-AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGI 947 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~ 947 (1067)
..|++++|+..|+|.+.+.+... +..+++.+.+.|+.++++||++||+.. |+++||||||.||++++++.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 58999999999999999875443 447999999999999999999999983 3699999999999999999999999999
Q ss_pred ceecCCCCC---------ccccccccccccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh
Q 001494 948 AKFLKPDSS---------NWTELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN 1015 (1067)
Q Consensus 948 a~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 1015 (1067)
++...-.-. .+.....|..|+|||.+.-. ..++++|||||||++|+|+.|..||+.... ....
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgS---- 250 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGS---- 250 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCe----
Confidence 986542211 12334568899999987643 468899999999999999999999975432 1111
Q ss_pred hhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1016 IALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
..-.+..+.+.+|.... .++.+.+++..|+++||.+||++.+++..++
T Consensus 251 -laLAv~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~~d 298 (302)
T KOG2345|consen 251 -LALAVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSKLD 298 (302)
T ss_pred -EEEeeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 11123334444443322 5557899999999999999999999998764
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=343.24 Aligned_cols=253 Identities=26% Similarity=0.342 Sum_probs=221.7
Q ss_pred hcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCCceeE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 872 (1067)
...|+..+.||+|.||.||+++.+ +|+.+|+|++.+.........+.+.+|+.+|+++. |||||.+.++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 356888899999999999999655 59999999998765544334578899999999998 9999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC----CCeEEeccccc
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK----NEARVSDFGIA 948 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~----~~~kl~DfG~a 948 (1067)
|||++.||.|.+.+... .+++.++..++.|++.|++|||+. ||+|||+||+|+|+... +.+|++|||+|
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999998654 289999999999999999999999 99999999999999644 47999999999
Q ss_pred eecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCC
Q 001494 949 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028 (1067)
Q Consensus 949 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1067)
..... .......+||+.|+|||++...+|+.++||||+||++|.|++|..||..... ......+....+.+
T Consensus 187 ~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~--------~~~~~~i~~~~~~f 257 (382)
T KOG0032|consen 187 KFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE--------FEIFLAILRGDFDF 257 (382)
T ss_pred eEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh--------hHHHHHHHcCCCCC
Confidence 98877 6677889999999999999999999999999999999999999999874432 22333666666667
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1029 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+.+.+......+.++++.|+..||.+|+|+.++++
T Consensus 258 ~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 258 TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 77777777788999999999999999999999986
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=350.40 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=202.5
Q ss_pred cCCCccCccccCCceeEEEEEECC--CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELAS--GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
++|+..+.||+|+||.||+|.... +..||+|++...........+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 568899999999999999997543 368999998643222223356788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999998643 3488999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+....
T Consensus 184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~p~~~~ 252 (340)
T PTZ00426 184 R---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKILEGIIYFPKFLD 252 (340)
T ss_pred C---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHhcCCCCCCCCCC
Confidence 2 23467999999999999888999999999999999999999998643321 112223333333333322
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001494 1034 QEKLISFVEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
. .+.+++.+|++.||++|+ +++++++
T Consensus 253 ~----~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 253 N----NCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred H----HHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 2 378999999999999995 8888875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.72 Aligned_cols=262 Identities=23% Similarity=0.357 Sum_probs=203.7
Q ss_pred HhcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee-----C
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH-----A 867 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~ 867 (1067)
....|...+.||+|+||.|+.+. ..+|+.||||++..+.... ...++..+|+++++.++|+||+.+.+++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~-~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ-IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch-HHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34456667899999999999984 5689999999998554433 346778899999999999999999998855 3
Q ss_pred CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccc
Q 001494 868 QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGI 947 (1067)
Q Consensus 868 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~ 947 (1067)
...|+|+|+| +.+|..+++.. ..++..++..++.|+++|+.|+|+. +|+|||+||.|++++.+...||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 4789999999 46999998543 3489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCC--CCCccccccccccccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc-------chhhhhh
Q 001494 948 AKFLKP--DSSNWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSS-------SLNLNIA 1017 (1067)
Q Consensus 948 a~~~~~--~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~ 1017 (1067)
|+.... ....++..+.|.+|+|||.+. ...|+.+.||||.|||+.||++|++-|.+.+..... +......
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 998764 345568889999999999765 456999999999999999999999888664432110 0000111
Q ss_pred --------hhhccCCCCCCCCcc----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1018 --------LDEILDPRLPIPSHN----VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1018 --------~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+..-...+... .+.....+.+++.+||..||.+|+|++|+++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111111111111111 1122245889999999999999999999986
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=350.59 Aligned_cols=257 Identities=25% Similarity=0.423 Sum_probs=201.1
Q ss_pred hcCCCccCccccCCceeEEEEEE------CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeC
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHA 867 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 867 (1067)
.++|+..+.||+|+||.||+|.. .++..||+|++..... ....+.+.+|+++++.+ +|||||++++++.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 35789999999999999999853 2345799999975432 22346788999999999 899999999999999
Q ss_pred CceeEEEEeccCCCHHHHhcccCc--------------------------------------------------------
Q 001494 868 QHSFIVYEYLEMGSLAMILSNDAA-------------------------------------------------------- 891 (1067)
Q Consensus 868 ~~~~lv~E~~~~g~L~~~l~~~~~-------------------------------------------------------- 891 (1067)
+..++||||+++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999998853211
Q ss_pred -----------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCc--c
Q 001494 892 -----------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN--W 958 (1067)
Q Consensus 892 -----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~ 958 (1067)
..++++.++.+++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+++........ .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 12478889999999999999999999 9999999999999999999999999999865433221 1
Q ss_pred ccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHH
Q 001494 959 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKL 1037 (1067)
Q Consensus 959 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1067)
....+++.|||||++.+..++.++|||||||++|||++ |+.||....... .......... ....+... .
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~~~~~~~~~~--~~~~~~~~----~ 341 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----KFYKMVKRGY--QMSRPDFA----P 341 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----HHHHHHHccc--CccCCCCC----C
Confidence 12334668999999988889999999999999999997 999986432211 0011111111 11111111 2
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1038 ISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1038 ~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.++.+++.+||+.||++|||+.++++.|+
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~ 370 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQ 370 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 35889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=349.25 Aligned_cols=244 Identities=24% Similarity=0.295 Sum_probs=199.3
Q ss_pred CccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCC
Q 001494 802 HCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMG 880 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 880 (1067)
+.||+|+||.||+++. .+|+.||+|++.............+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 578999999987543223334566788999999999999999999999999999999999999
Q ss_pred CHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 881 SLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN-DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 881 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
+|..++... ..+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 999888543 358899999999999999999997 6 999999999999999999999999999986544434444
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~~----~~ 222 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEEIRFPRTLS----PE 222 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHHHHHHhcCCCCCCCCCC----HH
Confidence 56799999999999988999999999999999999999999864322 1112222222333333332 24
Q ss_pred HHHHHHhccCCCCCCCC-----CHHHHHH
Q 001494 1040 FVEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
+.+++.+||+.||++|+ ++.++++
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 88999999999999996 8988875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=349.77 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=204.2
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|++.++||+|+||.||+|+.. +++.||+|++...........+.+..|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999765 68999999987543222334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999999543 3578899999999999999999999 999999999999999999999999999986543
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.......... ...........+....+. .
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~---~ 227 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE-NLKYWKETLQRPVYDDPR---F 227 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH-HHHhccccccCCCCCccc---c
Confidence 2345678999999999998899999999999999999999999987543211100 000000001111111000 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
....++.+++.+||+.+|++||++.++++.
T Consensus 228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 228 NLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 123358899999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=346.04 Aligned_cols=244 Identities=25% Similarity=0.367 Sum_probs=199.0
Q ss_pred CccccCCceeEEEEEE----CCCcEEEEEEeCCCCC-CChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 802 HCIGKGGQGSVYKVEL----ASGEIIAVKKFHSPLP-GEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
++||+|+||.||+++. .+++.||+|++..... ........+..|+.+++.++||||+++++++.+++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999865 3678999999864321 1122235577899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+++++|.+++... ..+.+..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999988543 3478888899999999999999999 999999999999999999999999999976544333
Q ss_pred ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHH
Q 001494 957 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEK 1036 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1067)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~--- 224 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILKGKLNLPPYLT--- 224 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCCCC---
Confidence 34456799999999999988899999999999999999999999874332 1223333334444443332
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001494 1037 LISFVEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1037 ~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
.++.+++.+||+.+|++|| ++.++++
T Consensus 225 -~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 225 -PEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -HHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 2488999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=320.71 Aligned_cols=264 Identities=21% Similarity=0.310 Sum_probs=203.8
Q ss_pred cCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCe-eeeeeEEEeeCC-----
Q 001494 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN-IVKFYGFCSHAQ----- 868 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~----- 868 (1067)
..|+..++||+|+||+||+|+ ..+|+.||+|++......+ .......+|+.+++.++|+| ||++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-CCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 456777889999999999995 5688999999998654421 23355689999999999999 999999998877
Q ss_pred -ceeEEEEeccCCCHHHHhcccCcc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccc
Q 001494 869 -HSFIVYEYLEMGSLAMILSNDAAA-EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 869 -~~~lv~E~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 946 (1067)
..++||||++. +|..++...... ..++...+..++.||++|++|||++ +|+||||||+||+++.+|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 78999999974 888888543321 3466688999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh-------hhhh
Q 001494 947 IAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL-------NIAL 1018 (1067)
Q Consensus 947 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------~~~~ 1018 (1067)
+|+...-+...++..++|.+|+|||++.+. .|+...||||+|||++||++++.-|.+........... ....
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 999877666667888999999999998887 69999999999999999999988776544321110000 0000
Q ss_pred hhc--------cCCCCCCCCcchHHHH---HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1019 DEI--------LDPRLPIPSHNVQEKL---ISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1019 ~~~--------~~~~~~~~~~~~~~~~---~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
..+ ..+.+..+........ ....+++.+|++.+|.+|.|+..+++.
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 0111111111111111 257899999999999999999998864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=322.02 Aligned_cols=259 Identities=26% Similarity=0.380 Sum_probs=196.6
Q ss_pred hcCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHH--hcCCCCeeeeeeEEEeeCC----
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL--TEIRHRNIVKFYGFCSHAQ---- 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l--~~l~h~niv~l~~~~~~~~---- 868 (1067)
.++....+.||+|.||+||+|+++ |+.||||++... ++ +.+.+|.++. ..++|+||..+++.-..+.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--dE----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--DE----RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEeccc--ch----hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 457788899999999999999998 999999999743 22 3444555554 4569999999998865443
Q ss_pred ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhC-----CCCCeeecCCCCCceeeCCCCCeEEe
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND-----CFPPIVHRDISSKNVLLDFKNEARVS 943 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivHrDlk~~Nill~~~~~~kl~ 943 (1067)
++|+|.||.+.|+|+|++.+ ..++....++++..+|.||+|||.. ..|.|+|||||+.|||+..++.+.|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 68999999999999999965 3488999999999999999999954 56899999999999999999999999
Q ss_pred ccccceecCCCCC----ccccccccccccCccccccCC----C--CccchhHHHHHHHHHHHhC----------CCCCCc
Q 001494 944 DFGIAKFLKPDSS----NWTELAGTYGYVAPELAYTMK----V--TEKCDVYSFGVLALEVIKG----------KHPGDF 1003 (1067)
Q Consensus 944 DfG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslGvil~elltg----------~~p~~~ 1003 (1067)
|+|+|........ .....+||.+|||||++...- + -..+||||||.++||+..+ +.||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 9999987665432 234578999999999986432 1 2359999999999999863 345543
Q ss_pred cccc-cccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1004 ISLI-SSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1004 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
..+. ............+.++|.++..+. ..+.+..+.++|+.||..+|..|-||-.+.+.+
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~-s~~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWK-SDPALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCcccc-cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 2221 111111111122233343333332 346778899999999999999999998887655
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=336.13 Aligned_cols=249 Identities=24% Similarity=0.293 Sum_probs=198.7
Q ss_pred cccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCCCH
Q 001494 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL 882 (1067)
Q Consensus 804 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 882 (1067)
||+|+||+||++.. .+++.||+|++...........+.+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999865 47899999998643322222345678899999999999999999999999999999999999999
Q ss_pred HHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccccc
Q 001494 883 AMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTEL 961 (1067)
Q Consensus 883 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 961 (1067)
.+.+... .....+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 8877432 2344689999999999999999999999 99999999999999999999999999998765544444456
Q ss_pred cccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHH
Q 001494 962 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFV 1041 (1067)
Q Consensus 962 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1041 (1067)
.||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+.......+.. ....+.
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~----~~~~~~ 229 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRILNDSVTYPDK----FSPASK 229 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHHhhcccCCCCccc----CCHHHH
Confidence 78999999999999999999999999999999999999986432211 1111122222222222222 233588
Q ss_pred HHHHhccCCCCCCCC-----CHHHHHH
Q 001494 1042 EVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1042 ~li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
+++.+||+.||++|| ++.++++
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=349.81 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=200.9
Q ss_pred cCCCccCccccCCceeEEEEEE------CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCC
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQ 868 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 868 (1067)
++|+..++||+|+||.||+|+. .++..||||++..... ....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 4688899999999999999853 3466899999864322 23346788999999999 8999999999999999
Q ss_pred ceeEEEEeccCCCHHHHhcccCc---------------------------------------------------------
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAA--------------------------------------------------------- 891 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~--------------------------------------------------------- 891 (1067)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999998854221
Q ss_pred ---------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 892 ---------------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 892 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
...+++..+.+++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 12478889999999999999999999 999999999999999999999999999987654322
Q ss_pred c--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 957 N--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 957 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
. .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ........-. ....+...
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----~~~~~~~~~~--~~~~~~~~- 342 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----KFYKMIKEGY--RMLSPECA- 342 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----HHHHHHHhCc--cCCCCCCC-
Confidence 1 112334667999999999999999999999999999998 888886432211 0001111110 11111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
..++.+++.+||+.||++||++.|+++.|+
T Consensus 343 ---~~~l~~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 343 ---PSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 235889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=319.44 Aligned_cols=248 Identities=29% Similarity=0.444 Sum_probs=208.6
Q ss_pred CCccCccccCCceeEEEE-EECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|+++++||+|+||.||+| ...+|+.+|||++... ...+++..|+.+|++.+.|+||+++|.|.....+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 567789999999999998 5668999999998653 2368899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
|..|+..++++ ..++++++.++..|.+..++||+|||.. .-+|||||+.|||++-+|.+|++|||.|.++.+.-.
T Consensus 110 CGAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 110 CGAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred cCCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 99999999995 4456899999999999999999999998 789999999999999999999999999988776555
Q ss_pred ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHH
Q 001494 957 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEK 1036 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1067)
......|||-|||||++..-.|+.++||||+|+...||..|++||...-+....- .+..-..|.+.. ..+-
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-----MIPT~PPPTF~K----PE~W 255 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-----MIPTKPPPTFKK----PEEW 255 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-----eccCCCCCCCCC----hHhh
Confidence 5667889999999999999999999999999999999999999987554321110 000011111221 2233
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1037 LISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1037 ~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
+.++-++++.|+-+.|++|.||.++++.
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 3458999999999999999999998763
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=345.69 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=200.1
Q ss_pred CccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
++||+|+||.||+|+.. +++.||+|++...........+.+..|..+++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999654 6889999999754333333445678899999888 799999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 9999888543 3589999999999999999999999 999999999999999999999999999975433333445
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccch-hhhhhhhhccCCCCCCCCcchHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSL-NLNIALDEILDPRLPIPSHNVQEKLI 1038 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1067)
...||+.|+|||++.+..++.++||||+||++|||++|+.||+.......... ........+.......|.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~----~ 230 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS----V 230 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCC----H
Confidence 56899999999999998999999999999999999999999974332111111 111112223333333343332 2
Q ss_pred HHHHHHHhccCCCCCCCCC------HHHHHH
Q 001494 1039 SFVEVAISCLDESPESRPT------MQKVSQ 1063 (1067)
Q Consensus 1039 ~l~~li~~cl~~dP~~Rpt------~~evl~ 1063 (1067)
++.+++.+|++.||.+||+ +.++++
T Consensus 231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 4789999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=345.05 Aligned_cols=239 Identities=24% Similarity=0.360 Sum_probs=194.2
Q ss_pred CccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
+.||+|+||+||+|+.. +++.||+|++...........+.+..|..+++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 6889999998643222222345677888888776 699999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 9999888543 3488999999999999999999999 999999999999999999999999999986543334445
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+.... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~----~~ 222 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDEVVYPTWLS----QD 222 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCCCCCCCCCC----HH
Confidence 56799999999999988899999999999999999999999874332 1122223333333332222 24
Q ss_pred HHHHHHhccCCCCCCCCCH
Q 001494 1040 FVEVAISCLDESPESRPTM 1058 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rpt~ 1058 (1067)
+.+++.+|++.||++||++
T Consensus 223 ~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHcccCHHHCCCC
Confidence 7899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=344.89 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=196.6
Q ss_pred CccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
+.||+|+||.||+|+. .+++.||+|++...........+.+..|+.++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999975 46889999999764333334456678888888776 899999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|..++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 9999888543 3588999999999999999999999 999999999999999999999999999976443333344
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccch-hhhhhhhhccCCCCCCCCcchHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSL-NLNIALDEILDPRLPIPSHNVQEKLI 1038 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1067)
...||+.|+|||++.+..++.++|||||||++|||++|+.||+.......... ........+.......|.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~----~ 230 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS----V 230 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCC----H
Confidence 56799999999999999999999999999999999999999864322111111 111112223333333443332 3
Q ss_pred HHHHHHHhccCCCCCCCCCH
Q 001494 1039 SFVEVAISCLDESPESRPTM 1058 (1067)
Q Consensus 1039 ~l~~li~~cl~~dP~~Rpt~ 1058 (1067)
++.+++.+||+.||++||++
T Consensus 231 ~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 231 KAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHHhcCCHHHcCCC
Confidence 47899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.18 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=201.5
Q ss_pred cCCCccCccccCCceeEEEEEEC----CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCcee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 871 (1067)
.+|++.+.||+|+||.||+|... .+..||+|++..... ....+.+.+|+..+++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 46888999999999999998653 456899999875422 233567899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+||||+++|+|.+++... ...+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+|++|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999998643 24689999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCCc-cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CCCC
Q 001494 952 KPDSSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLPI 1028 (1067)
Q Consensus 952 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1028 (1067)
...... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||....... ....+.+. ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~~~ 229 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--------VIKAVEDGFRLPA 229 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHCCCCCCC
Confidence 322111 112334678999999999999999999999999999875 999986443211 11111111 1122
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1029 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
+.. ....+.+++.+||+.+|++||++.|+.+.|+
T Consensus 230 ~~~----~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~ 263 (266)
T cd05064 230 PRN----CPNLLHQLMLDCWQKERGERPRFSQIHSILS 263 (266)
T ss_pred CCC----CCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence 222 2335889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=344.64 Aligned_cols=244 Identities=22% Similarity=0.333 Sum_probs=197.5
Q ss_pred CccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
++||+|+||.||+|+.. +++.||+|++...........+.+..|.++++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999764 6789999998753222223345677888888766 799999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|...+... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 9999888543 3488899999999999999999999 999999999999999999999999999986544444445
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
...||+.|+|||++.+..++.++||||+||++|||++|+.||+.... ......+.......+.... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~~----~~ 222 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILHDDVLYPVWLS----KE 222 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCCCC----HH
Confidence 56799999999999988899999999999999999999999874432 1222223333333332222 34
Q ss_pred HHHHHHhccCCCCCCCC-------CHHHHHH
Q 001494 1040 FVEVAISCLDESPESRP-------TMQKVSQ 1063 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rp-------t~~evl~ 1063 (1067)
+.+++.+||+.||++|| ++.++++
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 88999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=343.93 Aligned_cols=244 Identities=23% Similarity=0.302 Sum_probs=197.2
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCC-CeeeeeeEEEeeCCceeEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH-RNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 874 (1067)
+|+..+.||+|+||.||+|+.. +++.||+|++...........+.+..|+++++.++| ++|+.+++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999654 678999999875332222334667889999999976 56888999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999888543 3478899999999999999999999 9999999999999999999999999998754333
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
........||+.|+|||++.+..++.++||||+||++|||++|+.||+.... ......+.......+....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~- 225 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHNVSYPKSLS- 225 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCCCCC-
Confidence 3334456799999999999999999999999999999999999999874432 1112222223333333222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTM 1058 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~ 1058 (1067)
.++.+++.+||+.||.+|+++
T Consensus 226 ---~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 226 ---KEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---HHHHHHHHHHhhcCHHHcCCC
Confidence 347899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=344.48 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=196.8
Q ss_pred CCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHH---hcCCCCeeeeeeEEEeeCCceeEE
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL---TEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
|++.+.||+|+||.||+|+. .+++.||||++...........+.+..|++++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56788999999999999965 47899999998743222222345566666654 567899999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+++++|...++. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988743 3589999999999999999999999 999999999999999999999999999876443
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.........|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+.......+....
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~~~~p~~~~ 225 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSIVNDEVRYPRFLS 225 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCCCCC
Confidence 334445567999999999999888999999999999999999999998643321 112222222222332222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001494 1034 QEKLISFVEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
..+.+++.+||+.||.+|| ++.++++
T Consensus 226 ----~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 226 ----REAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 3478999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=332.56 Aligned_cols=248 Identities=27% Similarity=0.451 Sum_probs=202.6
Q ss_pred CCccCccccCCceeEEEEEEC---CCc--EEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeE
Q 001494 798 FDDEHCIGKGGQGSVYKVELA---SGE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 872 (1067)
....++||.|-||.||+|.+- .|+ .||||..+... +....+.|+.|+.+|+.++|||||+++|+|.+ ...|+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 445688999999999998643 333 48888887543 33346889999999999999999999999976 57899
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
|||.++.|.|..+++.. ...++......++.||+.|++|||+. ..|||||..+|||+....-||++|||+++++.
T Consensus 468 vmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 99999999999999643 34588888999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCccc-cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhcc-CCCCCCC
Q 001494 953 PDSSNWT-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEIL-DPRLPIP 1029 (1067)
Q Consensus 953 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1029 (1067)
.+..... ...-+..|||||.+.-.+++.++|||.|||++||++. |..||.+...-.. +..+. ..+++.|
T Consensus 543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------I~~iEnGeRlP~P 614 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------IGHIENGERLPCP 614 (974)
T ss_pred ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------EEEecCCCCCCCC
Confidence 6644322 2223568999999999999999999999999999986 9999986553221 11111 2345555
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
+.+.+ .++.++.+||+.||.+||++.|+...|
T Consensus 615 ~nCPp----~LYslmskcWayeP~kRPrftei~~~l 646 (974)
T KOG4257|consen 615 PNCPP----ALYSLMSKCWAYEPSKRPRFTEIKAIL 646 (974)
T ss_pred CCCCh----HHHHHHHHHhccCcccCCcHHHHHHHH
Confidence 44433 489999999999999999999998776
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=340.34 Aligned_cols=261 Identities=20% Similarity=0.307 Sum_probs=197.9
Q ss_pred hcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
.++|+..++||+|+||.||+|+.. +++.||+|++....... ....+.+|+.+++.++||||+++++++.+++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 467999999999999999999765 78999999987543222 234567899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||++ +++.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred EECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 99996 5676666432 24578899999999999999999999 999999999999999999999999999986544
Q ss_pred CCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhh--------h------
Q 001494 954 DSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIA--------L------ 1018 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~------ 1018 (1067)
.........+++.|+|||++.+ ..++.++||||+||++|||++|+.||................ .
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 4344455678999999998765 457889999999999999999999997543211100000000 0
Q ss_pred hhccCCCCCC-CCcchHH------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1019 DEILDPRLPI-PSHNVQE------KLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1019 ~~~~~~~~~~-~~~~~~~------~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.......... .+..... ....+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000 0000000 1134789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=341.75 Aligned_cols=243 Identities=26% Similarity=0.365 Sum_probs=192.9
Q ss_pred CccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhc-CCCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE-IRHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
+.||+|+||.||+|+. .+++.||+|++...........+.+..|..++.. .+||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999975 4688999999875432222233455666666654 4899999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|.+++... ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 9999888543 3588899999999999999999999 999999999999999999999999999986544434445
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
..+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+.... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~----~~ 222 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSILNDRPHFPRWIS----KE 222 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCCCCC----HH
Confidence 56799999999999988899999999999999999999999874332 1111222222222222222 24
Q ss_pred HHHHHHhccCCCCCCCCCHH-HHH
Q 001494 1040 FVEVAISCLDESPESRPTMQ-KVS 1062 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rpt~~-evl 1062 (1067)
+.+++.+||+.+|++||++. ++.
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHH
Confidence 78999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=353.80 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=206.9
Q ss_pred cCCCccCccccCCceeEEEEEECCC-cEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeE-EEee------
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASG-EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYG-FCSH------ 866 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~------ 866 (1067)
.++++.+.|.+|||+.||.|+...+ ..||+|++... +....+.+.+|+++|+.|+ |||||.++| ....
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 4567889999999999999987766 99999999764 4455788999999999996 999999999 3321
Q ss_pred CCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccc
Q 001494 867 AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 867 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 946 (1067)
..+++|.||||.||.|-+++....... +++.++++|+.++++|+++||.. .|+|||||||-+||||+.+|+.||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 236789999999999999997544434 99999999999999999999987 5689999999999999999999999999
Q ss_pred cceecCCCCCcc---------ccccccccccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh
Q 001494 947 IAKFLKPDSSNW---------TELAGTYGYVAPELA---YTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL 1014 (1067)
Q Consensus 947 ~a~~~~~~~~~~---------~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~ 1014 (1067)
.|+-........ -...-|+-|+|||++ .+.+.++|+|||++||+||-|+.+..||+....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------- 263 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------- 263 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------
Confidence 997443222111 112458999999975 466789999999999999999999999984422
Q ss_pred hhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1015 NIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
-.|+...+.+|+. +.+...+.+||+.||+.||.+||++.+|++++
T Consensus 264 ----laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 264 ----LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred ----eeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 2456666666653 35566799999999999999999999999875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.78 Aligned_cols=260 Identities=19% Similarity=0.274 Sum_probs=198.9
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..++||+|+||.||+|+.. +++.||+|++...... .....+.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 56889999999999999999654 7899999998654322 22356778999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++ +|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 83 EYLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred eCCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 99985 888877432 23478899999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchh-------hhhh---------
Q 001494 955 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN-------LNIA--------- 1017 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~~~~--------- 1017 (1067)
........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||............ ....
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 444445678999999998865 45899999999999999999999998643321110000 0000
Q ss_pred hhhccCCCCCCCC--cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1018 LDEILDPRLPIPS--HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1018 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
......+...... ........++.+++.+|++.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0001111110000 000011235789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=343.19 Aligned_cols=244 Identities=22% Similarity=0.305 Sum_probs=198.3
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
+|+..+.||+|+||.||+|+.. +++.||+|++...........+.+..|..++..+ +||+|+.+++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999655 6789999998754322223345567788888777 5899999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999888543 3488899999999999999999999 9999999999999999999999999999865433
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
........||+.|+|||++.+..++.++|||||||++|||++|+.||+.... ......+.......+....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~s- 225 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPKSMS- 225 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCcCC-
Confidence 3444556799999999999999999999999999999999999999874432 1122223333333333322
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTM 1058 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~ 1058 (1067)
.++.+++.+|++.+|++|+++
T Consensus 226 ---~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 226 ---KEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---HHHHHHHHHHcccCHHhcCCC
Confidence 347899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=319.99 Aligned_cols=254 Identities=22% Similarity=0.272 Sum_probs=212.3
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
+.|+..+.||+|.-|+||.++.+ ++..+|+|++.+..........+...|.+|++.++||.++.+++.++.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 34677789999999999999876 45899999997654444444566778999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC-
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP- 953 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~- 953 (1067)
|||+||+|....+++ ..+.+++..+.-++.+++-||+|||-. |||+||+||+||||.++|++.++||.++.....
T Consensus 157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999888654 456689999999999999999999999 999999999999999999999999998753210
Q ss_pred --------------------------------C-C----------------------CccccccccccccCccccccCCC
Q 001494 954 --------------------------------D-S----------------------SNWTELAGTYGYVAPELAYTMKV 978 (1067)
Q Consensus 954 --------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 978 (1067)
. . .....++||-.|.|||++.+..+
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 01123579999999999999999
Q ss_pred CccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC-
Q 001494 979 TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPT- 1057 (1067)
Q Consensus 979 ~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt- 1057 (1067)
+.++|.|+|||++|||+.|..||.+.. ..+.+..++...+.+|... +.+..++++|++.|.+||.+|..
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~--------~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSN--------NKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCC--------chhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhcc
Confidence 999999999999999999999987433 3555666776666666543 44567899999999999999987
Q ss_pred ---HHHHHH
Q 001494 1058 ---MQKVSQ 1063 (1067)
Q Consensus 1058 ---~~evl~ 1063 (1067)
|+||.+
T Consensus 383 ~rGA~eIK~ 391 (459)
T KOG0610|consen 383 KRGAAEIKR 391 (459)
T ss_pred ccchHHhhc
Confidence 777654
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=345.53 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=194.6
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.+|+..++||+|+||.||+|+.. +++.||||++.... .....+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 45667789999999999999754 78999999986432 2334567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.... ...+..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999986432 245677888999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhcc-CCCCCC
Q 001494 955 SSNWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL-DPRLPI 1028 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1028 (1067)
........||..|+|||++.. ...+.++|||||||++|||++|+.||....... .......+. ......
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~ 296 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASLMCAICMSQPPEA 296 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHhccCCCCC
Confidence 333345679999999998743 224568999999999999999999986322110 011111111 111111
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1029 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
+. ....++.+++.+||+.||++|||+.|+++.
T Consensus 297 ~~----~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 297 PA----TASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CC----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 223358999999999999999999999863
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.73 Aligned_cols=260 Identities=21% Similarity=0.313 Sum_probs=208.4
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|++.+.||+|+||.||+|+. .+++.||||.+.............+.+|+++++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788999999999999999965 478999999886543334444567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccC-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 875 EYLEMGSLAMILSNDA-AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
||+++++|.+++.... ....+++..+..++.|+++|++|||++ +++||||||+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885322 234578899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.........+++.|+|||.+.+..++.++||||+|+++|||++|+.||...... .............+. ...
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-----~~~ 230 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSLCQKIEQCDYPP-----LPT 230 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHHHHHHhcCCCCC-----CCh
Confidence 433334456888999999998888999999999999999999999997532210 001111111111111 111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
......+.+++.+||+.+|++||++.+|++.++
T Consensus 231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~ 263 (267)
T cd08228 231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263 (267)
T ss_pred hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence 223346899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=341.17 Aligned_cols=258 Identities=25% Similarity=0.354 Sum_probs=202.6
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||.||+++.. ++..||+|++.... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 67899999999999999999754 78899999987532 2334567999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++... ..+++..+..++.|++.|++|||+.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 83 EHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999998543 34788999999999999999999862 6999999999999999999999999999765432
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh--------------------
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL-------------------- 1014 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------------------- 1014 (1067)
......|++.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 2234578999999999998889999999999999999999999986432211000000
Q ss_pred ------------------hhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1015 ------------------NIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1015 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
......+..... +.........++.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPP--PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCC--cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 000001123458999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=328.64 Aligned_cols=250 Identities=27% Similarity=0.451 Sum_probs=202.2
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
++|+..+.||+|+||.||+++.+++..+|+|.+..... ..+++..|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 45788899999999999999988888999998764321 24678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++|+|.+++.... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+|++|||.++......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 80 FMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 999999999886432 3588999999999999999999999 99999999999999999999999999998654322
Q ss_pred Cc-cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CCCCCCcc
Q 001494 956 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLPIPSHN 1032 (1067)
Q Consensus 956 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1032 (1067)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+... ....+..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--------~~~~~i~~~~~~~~~~~- 225 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--------EVVEMISRGFRLYRPKL- 225 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCCCCCCCC-
Confidence 21 122345668999999988889999999999999999999 89998643321 111112111 1111211
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
...++.+++.+||+.+|++||++.++++.|.
T Consensus 226 ---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 ---ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1235899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=341.76 Aligned_cols=244 Identities=24% Similarity=0.316 Sum_probs=197.6
Q ss_pred CccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
+.||+|+||.||+|+.. +++.||+|++.............+..|+++++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 6789999998754222223345677888888877 799999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|.+++... ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 9999888543 3589999999999999999999999 999999999999999999999999999976433333334
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
..+|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+... ...
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~~~~~~~~~~----~~~ 222 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILEDEVRYPRWL----SKE 222 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCCCCCcC----CHH
Confidence 567899999999999999999999999999999999999998644321 11122222233333222 234
Q ss_pred HHHHHHhccCCCCCCCCCH-----HHHHH
Q 001494 1040 FVEVAISCLDESPESRPTM-----QKVSQ 1063 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rpt~-----~evl~ 1063 (1067)
+.+++.+||+.||.+||++ .++++
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 8899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.81 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=201.3
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 36889999999999999999765 68899999987543222 23466789999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||++++.+..+... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 80 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 80 EYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred ecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99999877765532 24588999999999999999999999 9999999999999999999999999999876433
Q ss_pred CC-ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh-------hhhhh-------
Q 001494 955 SS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL-------NIALD------- 1019 (1067)
Q Consensus 955 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------~~~~~------- 1019 (1067)
.. ......|++.|+|||++.+..++.++||||+||++|||++|+.||............. .....
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 22 2334578999999999988889999999999999999999999987543211100000 00000
Q ss_pred --hccCCCCCCCCc----chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1020 --EILDPRLPIPSH----NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1020 --~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+....+.. ........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 00112345899999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.91 Aligned_cols=250 Identities=26% Similarity=0.463 Sum_probs=207.1
Q ss_pred CCCccCccccCCceeEEEEE-ECCCc----EEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCcee
Q 001494 797 DFDDEHCIGKGGQGSVYKVE-LASGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~-~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 871 (1067)
+.+..++||+|+||+||+|. ...|+ +||+|++......+ ...++++|+.+|.+++|||+++++|+|.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~--~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK--ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch--hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 34567899999999999974 44454 58999987654333 3578999999999999999999999998766 88
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
||++||+.|.|.++++.. ++.+--...+.|..|||+||.|||++ ++|||||.++|||+....++||+|||+|+.+
T Consensus 774 lvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 999999999999999753 44577788999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCccccccc--cccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCC
Q 001494 952 KPDSSNWTELAG--TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028 (1067)
Q Consensus 952 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1067)
.++...+....| .+.|||-|.+....|+.++|||||||.+||++| |..||+..+..+..... -...++..
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-------e~geRLsq 921 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-------EKGERLSQ 921 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-------hccccCCC
Confidence 877766655444 568999999999999999999999999999998 99999876643211111 01233444
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1029 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
|+....+ ++-++.+||..|++.||+++++.+++
T Consensus 922 PpiCtiD----Vy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 922 PPICTID----VYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred CCCccHH----HHHHHHHHhccCcccCccHHHHHHHH
Confidence 5544444 88999999999999999999998876
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=351.84 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=204.8
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|++.+.||+|+||+||+|+.. +++.||+|++...........+.+..|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36889999999999999999765 78999999987543222234567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++... ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998654 4588999999999999999999998 9999999999999999999999999999876543
Q ss_pred C-----------------------------CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 001494 955 S-----------------------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFIS 1005 (1067)
Q Consensus 955 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~ 1005 (1067)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 3 12234578999999999999999999999999999999999999986443
Q ss_pred cccccchhhhhhhhhccC--CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 001494 1006 LISSSSLNLNIALDEILD--PRLPIPSHNVQEKLISFVEVAISCLDESPESRPT-MQKVSQL 1064 (1067)
Q Consensus 1006 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~evl~~ 1064 (1067)
.. .....+.. .....+... ....++.+++.+|+. ||.+||+ +.|+++.
T Consensus 235 ~~--------~~~~~i~~~~~~~~~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQ--------ETYNKIINWKESLRFPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH--------HHHHHHhccCCcccCCCCC--CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 21 11111111 111222111 123358899999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=331.93 Aligned_cols=254 Identities=27% Similarity=0.459 Sum_probs=204.0
Q ss_pred cCCCccCccccCCceeEEEEEECC------CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELAS------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 869 (1067)
.+|+..+.||+|+||.||+|.... ...||+|.+.... .....+++.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 468889999999999999997542 2579999987432 33345678999999999999999999999999999
Q ss_pred eeEEEEeccCCCHHHHhcccCc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC
Q 001494 870 SFIVYEYLEMGSLAMILSNDAA-------------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF 936 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~ 936 (1067)
.+++|||+++++|.+++..... ...+++.++..++.|++.|++|||++ +++||||||+||+++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence 9999999999999999864321 14578899999999999999999999 9999999999999999
Q ss_pred CCCeEEeccccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchh
Q 001494 937 KNEARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLN 1013 (1067)
Q Consensus 937 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~ 1013 (1067)
++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------ 233 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------ 233 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 99999999999986543321 1233456788999999988889999999999999999998 99998643321
Q ss_pred hhhhhhhccCCCC-CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1014 LNIALDEILDPRL-PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1014 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....+..... ..+. ..+.++.+++.+||+.||.+||+++||++.|+
T Consensus 234 --~~~~~i~~~~~~~~~~----~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 234 --EVIEMIRSRQLLPCPE----DCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred --HHHHHHHcCCcCCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 11111111111 1122 23345899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=348.14 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=195.4
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||+||+|+. .+++.||+|++......+......+..|+.++.+++||+|+++++++.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688999999999999999965 468999999986532222333456888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999998643 3589999999999999999999999 9999999999999999999999999999754321
Q ss_pred CC-----------------------------------ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCC
Q 001494 955 SS-----------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 999 (1067)
Q Consensus 955 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~ 999 (1067)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 0123579999999999999899999999999999999999999
Q ss_pred CCCccccccccchhhhhhhhhccC--CCCCCCCcchHHHHHHHHHHHHhccC--CCCCCCCCHHHHHH
Q 001494 1000 PGDFISLISSSSLNLNIALDEILD--PRLPIPSHNVQEKLISFVEVAISCLD--ESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1000 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~Rpt~~evl~ 1063 (1067)
||....... ....+.. .....+... ....++.+++.+++. .++..||++.|+++
T Consensus 235 Pf~~~~~~~--------~~~~i~~~~~~~~~p~~~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 235 PFCSETPQE--------TYKKVMNWKETLIFPPEV--PISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCCCHHH--------HHHHHHcCcCcccCCCcC--CCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 986433211 1111111 111122111 011236667766443 34446789999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=345.35 Aligned_cols=240 Identities=24% Similarity=0.327 Sum_probs=196.1
Q ss_pred CccccCCceeEEEEEE----CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEec
Q 001494 802 HCIGKGGQGSVYKVEL----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYL 877 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 877 (1067)
+.||+|+||.||+++. .+|+.||+|++...... ......+..|++++++++||||+++++++.+++..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999864 46889999998753222 122345678999999999999999999999999999999999
Q ss_pred cCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCc
Q 001494 878 EMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN 957 (1067)
Q Consensus 878 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 957 (1067)
++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 81 RGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 999999988543 3589999999999999999999999 9999999999999999999999999999876544334
Q ss_pred cccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHH
Q 001494 958 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKL 1037 (1067)
Q Consensus 958 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1067)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+.......+....
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~~~~~~~p~~~~---- 222 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMILKAKLGMPQFLS---- 222 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHHcCCCCCCCCCC----
Confidence 4456789999999999888899999999999999999999999864332 1122223233333333222
Q ss_pred HHHHHHHHhccCCCCCCCCCHHH
Q 001494 1038 ISFVEVAISCLDESPESRPTMQK 1060 (1067)
Q Consensus 1038 ~~l~~li~~cl~~dP~~Rpt~~e 1060 (1067)
..+.+++.+||+.||++||++.+
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCC
Confidence 34789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=343.63 Aligned_cols=240 Identities=24% Similarity=0.315 Sum_probs=192.4
Q ss_pred CccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHH-HHhcCCCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
+.||+|+||+||+|+.. +|+.||+|++...........+++..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999764 78999999986432222222344555554 56889999999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|..++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 9999888543 3588899999999999999999999 999999999999999999999999999976443334445
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+... ..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~----~~~ 222 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNILNKPLRLKPNI----SVS 222 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCCC----CHH
Confidence 56799999999999998999999999999999999999999864322 112222333333333222 234
Q ss_pred HHHHHHhccCCCCCCCCCHH
Q 001494 1040 FVEVAISCLDESPESRPTMQ 1059 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rpt~~ 1059 (1067)
+.+++.+|++.||++||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCC
Confidence 88999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=339.72 Aligned_cols=243 Identities=24% Similarity=0.316 Sum_probs=193.1
Q ss_pred CccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
++||+|+||.||+|+.. +|+.||+|++...........+.+..|..++... +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999764 6889999998753221112234566777777654 899999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|..++... ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 9999888543 3578899999999999999999999 999999999999999999999999999975433333445
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+... ..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~~~~~~~~~----~~~ 222 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVDTPHYPRWI----TKE 222 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCCCC----CHH
Confidence 577999999999999989999999999999999999999998643321 11112222222222222 234
Q ss_pred HHHHHHhccCCCCCCCCCHH-HHH
Q 001494 1040 FVEVAISCLDESPESRPTMQ-KVS 1062 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rpt~~-evl 1062 (1067)
+.+++.+||+.||++||++. ++.
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHH
Confidence 78999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=324.82 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=216.2
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.-|+..+.||+|.|++|-.|++ -+|+.||||++.+..-++.. ...+.+|++.|+.++|||||++|.+.......|+|.
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 4577888999999999998864 58999999999876555433 466889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeC-CCCCeEEeccccceecCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD-FKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~-~~~~~kl~DfG~a~~~~~ 953 (1067)
|.-++|+|++|+-+. .+.+.+..+.+++.||+.|+.|+|.. .+||||+||+||.+- .-|-||++|||++..+.+
T Consensus 97 ELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999433 34588999999999999999999999 999999999998764 558899999999998875
Q ss_pred CCCccccccccccccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcc
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
. ...+..+|+..|-|||.+.+..|+ +++||||+|||+|-+.+|+.||+. .+..+....++|-.+..|.+.
T Consensus 172 G-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe--------ANDSETLTmImDCKYtvPshv 242 (864)
T KOG4717|consen 172 G-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE--------ANDSETLTMIMDCKYTVPSHV 242 (864)
T ss_pred c-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc--------ccchhhhhhhhcccccCchhh
Confidence 4 566788999999999999999885 689999999999999999999873 344566677888888887665
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
..+ ++++|..|+..||++|.+.+|++.
T Consensus 243 S~e----CrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 243 SKE----CRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hHH----HHHHHHHHHhcCchhhccHHHHhc
Confidence 544 899999999999999999999874
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=338.73 Aligned_cols=243 Identities=23% Similarity=0.327 Sum_probs=192.5
Q ss_pred CccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhc-CCCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE-IRHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
+.||+|+||.||+|+.. +++.||+|++...........+.+..|..+++. .+||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 578999999875322111223456677777765 4899999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|.+++... ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 9999988542 3478899999999999999999999 999999999999999999999999999976433333344
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+... ..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~~~~~~~~----~~~ 222 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMDNPCYPRWL----TRE 222 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCccC----CHH
Confidence 567899999999999888999999999999999999999998643321 11111111112222221 234
Q ss_pred HHHHHHhccCCCCCCCCCHH-HHH
Q 001494 1040 FVEVAISCLDESPESRPTMQ-KVS 1062 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rpt~~-evl 1062 (1067)
+.+++.+||+.||++||++. ++.
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHHH
Confidence 78999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=349.75 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=196.1
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
.|+..+.||+|+||+||+|+. .+++.||+|++...........+.+..|+++++.++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999964 5788999999865332233345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999998543 3478889999999999999999999 99999999999999999999999999976431100
Q ss_pred -----------------------------------------------CccccccccccccCccccccCCCCccchhHHHH
Q 001494 956 -----------------------------------------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFG 988 (1067)
Q Consensus 956 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 988 (1067)
......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 001235799999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCccccccccchhhhhhhhhccC--CCCCCCCcchHHHHHHHHHHHHh--ccCCCCCCCCCHHHHHH
Q 001494 989 VLALEVIKGKHPGDFISLISSSSLNLNIALDEILD--PRLPIPSHNVQEKLISFVEVAIS--CLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 989 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rpt~~evl~ 1063 (1067)
|++|||++|+.||....... ....+.. .....+.. .....++.+++.+ |+..+|..||++.|+++
T Consensus 236 ~il~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~--~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTE--------TQLKVINWENTLHIPPQ--VKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHH--------HHHHHHccccccCCCCC--CCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 99999999999986433211 1111111 11111111 0112347788877 55666777999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=343.47 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=201.7
Q ss_pred hcCCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeC
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHA 867 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 867 (1067)
.++|.++++||+|+||.||+|+.. .+..||||++.... .....+.+.+|++++++++ |||||++++++.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 357889999999999999998642 23479999986542 2233567899999999996 99999999999999
Q ss_pred CceeEEEEeccCCCHHHHhcccCc--------------------------------------------------------
Q 001494 868 QHSFIVYEYLEMGSLAMILSNDAA-------------------------------------------------------- 891 (1067)
Q Consensus 868 ~~~~lv~E~~~~g~L~~~l~~~~~-------------------------------------------------------- 891 (1067)
+..|+||||+++|+|.+++.....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999988854210
Q ss_pred -------------------------------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 001494 892 -------------------------------------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLL 934 (1067)
Q Consensus 892 -------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill 934 (1067)
...+++.++.+++.|+++|++|||+. +|+||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEE
Confidence 12478888899999999999999999 99999999999999
Q ss_pred CCCCCeEEeccccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccc
Q 001494 935 DFKNEARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSS 1011 (1067)
Q Consensus 935 ~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~ 1011 (1067)
+.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-- 348 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-- 348 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--
Confidence 9999999999999987643322 1123456788999999988889999999999999999997 9999764321100
Q ss_pred hhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1012 LNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1012 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.......- .....+. .....+.+++.+||+.+|++|||+.+|.++|+
T Consensus 349 --~~~~~~~~--~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 349 --FYNKIKSG--YRMAKPD----HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred --HHHHHhcC--CCCCCCc----cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 00011111 1111122 22345899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=328.21 Aligned_cols=254 Identities=27% Similarity=0.477 Sum_probs=208.5
Q ss_pred HhcCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
...+|+..++||.|+||.||+|...+++.+|+|.+.... .....++..|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 346788999999999999999998889999999987532 22346788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+++++|.+++.... ...+++.++.+++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 81 TELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999996533 34589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CCCCCCc
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLPIPSH 1031 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1031 (1067)
.........++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .....+... ....+..
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~ 228 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------EVYDQITAGYRMPCPAK 228 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHhCCcCCCCCC
Confidence 4333334456778999999988889999999999999999998 89998643321 111111111 1112222
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
...++.+++.+||+.||++|||+.++++.|+
T Consensus 229 ----~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 229 ----CPQEIYKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred ----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 2235889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=330.52 Aligned_cols=255 Identities=26% Similarity=0.452 Sum_probs=204.9
Q ss_pred cCCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 869 (1067)
.+|.+.+.||+|+||.||+|+.. +++.||+|.+..... ....+.+.+|+++++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 46888899999999999999753 347899999875432 2245789999999999999999999999999999
Q ss_pred eeEEEEeccCCCHHHHhcccC-----------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC
Q 001494 870 SFIVYEYLEMGSLAMILSNDA-----------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN 938 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~ 938 (1067)
.++||||+++++|.+++.... ....+++.++..++.|++.|++|||++ +++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence 999999999999999996432 234578999999999999999999999 999999999999999999
Q ss_pred CeEEeccccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhh
Q 001494 939 EARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLN 1015 (1067)
Q Consensus 939 ~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~ 1015 (1067)
.+||+|||+++....... ......+++.|+|||++.+..++.++||||+||++|||++ |+.||......
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------- 231 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------- 231 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------
Confidence 999999999976543221 1123345788999999999999999999999999999998 99997543321
Q ss_pred hhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1016 IALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....+.......+.. .....+.+++.+||+.||++||++.||++.|+
T Consensus 232 ~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 EVIECITQGRLLQRPR---TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1112222222221111 12235889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=348.06 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=200.6
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
.++|+..++||+|+||.||+|+. .+++.||+|++...........+.+.+|+.+++.++||||+++++++.++...|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 45789999999999999999965 47889999998643222222345577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999998542 377888899999999999999999 999999999999999999999999999987653
Q ss_pred CCC-ccccccccccccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC--CC
Q 001494 954 DSS-NWTELAGTYGYVAPELAYTM----KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP--RL 1026 (1067)
Q Consensus 954 ~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 1026 (1067)
... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+... .+
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~~~ 266 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMDHKNSL 266 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCCCcC
Confidence 322 22346799999999988653 3788999999999999999999998643321 111222221 12
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPES--RPTMQKVSQ 1063 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~ 1063 (1067)
..+.. .....++.+++.+|++.+|++ ||++.|+++
T Consensus 267 ~~~~~--~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 267 TFPDD--IEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCCCc--CCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 22211 112345889999999999998 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=349.91 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=199.2
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||+||+|+.. +++.||||++...........+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36889999999999999999764 68999999986432222233456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999998543 3589999999999999999999999 9999999999999999999999999998764321
Q ss_pred CC--------------------------------------ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh
Q 001494 955 SS--------------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK 996 (1067)
Q Consensus 955 ~~--------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt 996 (1067)
.. .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10 0012468999999999998899999999999999999999
Q ss_pred CCCCCCccccccccchhhhhhhhhccC--CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 001494 997 GKHPGDFISLISSSSLNLNIALDEILD--PRLPIPSHNVQEKLISFVEVAISCLDESPESRPT---MQKVSQ 1063 (1067)
Q Consensus 997 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~evl~ 1063 (1067)
|+.||....... ....+.. .....+... ....++.+++.+|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~--~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQE--------TYRKIINWKETLQFPDEV--PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHH--------HHHHHHcCCCccCCCCCC--CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999987443211 1111111 111112111 112347889999996 8999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=325.16 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=202.2
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
++|+..+.||+|+||+||.|+...+..||+|.+..... ..+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 45788899999999999999887777899999864321 24678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++|+|.+++.... ..+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.++......
T Consensus 80 ~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 80 YMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 999999999986432 2589999999999999999999999 99999999999999999999999999998664432
Q ss_pred Cc-cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 956 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 956 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.. .....++..|+|||...+..++.++|||||||++|||++ |+.||...... .....+...........
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~- 225 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVSQGLRLYRPHL- 225 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHhcCCCCCCCCC-
Confidence 21 112335678999999988889999999999999999998 99997643321 11111111111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....+.+++.+||+.+|.+||++.++++.++
T Consensus 226 --~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 --ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2245899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.15 Aligned_cols=248 Identities=35% Similarity=0.566 Sum_probs=192.4
Q ss_pred ccCccccCCceeEEEEEEC-----CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 800 DEHCIGKGGQGSVYKVELA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 800 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
..+.||.|+||.||+|++. .+..|+||++... ......+++.+|++.+++++||||++++|++...+..++||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 4578999999999999776 3578999999643 23334688999999999999999999999999888899999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... ....+++.++.+|+.||++||+|||++ +++|+||+++||+++.++.+||+|||+++.....
T Consensus 81 e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp E--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999999654 234589999999999999999999999 9999999999999999999999999999876322
Q ss_pred CCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCC-CCCCC
Q 001494 955 SSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPR-LPIPS 1030 (1067)
Q Consensus 955 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 1030 (1067)
... .........|+|||.+.+..++.++||||||+++||+++ |+.||...... .....+.+.. ...+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--------~~~~~~~~~~~~~~~~ 228 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--------EIIEKLKQGQRLPIPD 228 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--------HHHHHHHTTEETTSBT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccccccceecc
Confidence 111 123446778999999998889999999999999999999 68887644221 1111111111 11122
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1031 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
.. ...+.+++.+||+.+|++|||+.++++.|
T Consensus 229 ~~----~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 NC----PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TS----BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ch----hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 22 23488999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=329.37 Aligned_cols=256 Identities=22% Similarity=0.354 Sum_probs=202.0
Q ss_pred HhcCCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA 867 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 867 (1067)
..++|+..+.||+|+||.||+|... +++.||+|++... .......++.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3567999999999999999998643 3567999998643 2223356788999999999999999999999999
Q ss_pred CceeEEEEeccCCCHHHHhcccCc-------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCe
Q 001494 868 QHSFIVYEYLEMGSLAMILSNDAA-------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA 940 (1067)
Q Consensus 868 ~~~~lv~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~ 940 (1067)
...++||||+++++|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 999999999999999999864321 23467888999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCcc--ccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhh
Q 001494 941 RVSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIA 1017 (1067)
Q Consensus 941 kl~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 1017 (1067)
+++|||+++......... ....+++.|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------~~ 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------QV 230 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HH
Confidence 999999997654322211 12345678999999988889999999999999999999 68887643221 11
Q ss_pred hhhccCCCC-CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1018 LDEILDPRL-PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1018 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
...+..... ..+.. ....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 231 ~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 LRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHcCCcCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111111111 11111 2235889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=336.87 Aligned_cols=247 Identities=28% Similarity=0.464 Sum_probs=201.7
Q ss_pred CCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
.|...+.||.|+||.||.|+ ..+.+.||||++.-.........+++..|+.++.+++|||+|.+-|+|-.+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 35667889999999999996 45788999999987665666667899999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
||- |+-.|++. ...+++.+..+..|+.+++.||+|||++ +.||||||+.|||+++.|.||++|||.|....+.
T Consensus 107 YCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 996 46666663 2345688889999999999999999999 9999999999999999999999999999766544
Q ss_pred CccccccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcc
Q 001494 956 SNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
..++|||.|||||++. .+.|+-|+||||+|++..|+.-+++|+-.+..+... ..+.+--.| ..+...
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-----YHIAQNesP--tLqs~e 249 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQNESP--TLQSNE 249 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-----HHHHhcCCC--CCCCch
Confidence 4689999999999875 467999999999999999999999995433332111 111111112 222333
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+.+ .++.|+..|+++-|++|||..+++.
T Consensus 250 WS~---~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 250 WSD---YFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred hHH---HHHHHHHHHHhhCcccCCcHHHHhh
Confidence 444 4888999999999999999999875
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=331.29 Aligned_cols=254 Identities=23% Similarity=0.284 Sum_probs=201.4
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
.|+..++||+|+||.||++.. .+++.||+|++.............+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 377889999999999999865 4789999999864322222233557789999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG- 155 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-
Confidence 999999998875432 34589999999999999999999999 9999999999999999999999999999875432
Q ss_pred CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHH
Q 001494 956 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1067)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||....... ........+.......+. .
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~----~ 227 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERRVKEDQEEYSE----K 227 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHHhhhcccccCc----c
Confidence 22234578999999999988889999999999999999999999987432211 001111111111111111 2
Q ss_pred HHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001494 1036 KLISFVEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1036 ~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
....+.+++.+||+.||++|| ++.++++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 334588999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=328.04 Aligned_cols=260 Identities=22% Similarity=0.326 Sum_probs=208.7
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.+|+..+.||+|+||.||+|+. .+++.||||.+......+....+++.+|+.+++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999974 589999999886543334444568899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 875 EYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
||+++++|.+++... .....+++.++..++.|+++|++|||++ +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 2234689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.........++..|+|||++.+..++.++||||||+++|||++|..||...... .......+...... +...
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~--~~~~ 230 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYP--PLPS 230 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhhcCCCC--CCCc
Confidence 433334457889999999998888999999999999999999999997532210 01111111111111 1111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....++.+++.+||+.+|++|||+.+|++.++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~ 263 (267)
T cd08229 231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263 (267)
T ss_pred ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence 123346899999999999999999999988774
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=359.77 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=202.2
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|++.++||+|+||.||+|... +|+.||+|++...........+++.+|++++++++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47899999999999999999754 68999999997654444445677999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccC--------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccc
Q 001494 875 EYLEMGSLAMILSNDA--------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 946 (1067)
||++||+|.+++.... .....++..+++++.||++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 123456778899999999999999999 99999999999999999999999999
Q ss_pred cceecCCCC------------------CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc
Q 001494 947 IAKFLKPDS------------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLIS 1008 (1067)
Q Consensus 947 ~a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~ 1008 (1067)
+++...... ......+||+.|||||++.+..++.++||||+||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998662110 01123468999999999999999999999999999999999999986422110
Q ss_pred ccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHh
Q 001494 1009 SSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRP-TMQKVSQLL 1065 (1067)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~evl~~L 1065 (1067)
. ........+....+ ..+.+..+.+++.+|++.||++|| +++++.+.|
T Consensus 239 i------~~~~~i~~P~~~~p---~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 239 I------SYRDVILSPIEVAP---YREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred h------hhhhhccChhhccc---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0 00011111111111 112234588999999999999997 556666554
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=340.86 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=198.5
Q ss_pred CCCccCccccCCceeEEEEEE----CCCcEEEEEEeCCCCC-CChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCce
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL----ASGEIIAVKKFHSPLP-GEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 870 (1067)
+|++.++||+|+||.||+++. .+++.||+|++..... ......+.+..|+.+++.+ +||+|+++++++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999865 3688999999864321 1222345678899999999 599999999999999999
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999988543 3488999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC-ccccccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCC
Q 001494 951 LKPDSS-NWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028 (1067)
Q Consensus 951 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1067)
+..... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ .......+.......
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~ 230 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSEVSRRILKCDPPF 230 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHHHHHHHhcCCCCC
Confidence 543322 233467999999999987654 78899999999999999999999864322111 111111222222222
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001494 1029 PSHNVQEKLISFVEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1029 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
+... ...+.+++.+||+.||++|| +++++++
T Consensus 231 ~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 231 PSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 2222 23478999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=325.17 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=203.8
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
++|+..++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 5688999999999999999998888899999976421 124678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 82 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 82 YMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred cCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999986432 34578899999999999999999999 99999999999999999999999999998765322
Q ss_pred Cc-cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 956 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 956 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.. .....++..|+|||++.+..++.++|||||||++|||+| |+.||....... ......... ..+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~~~~--~~~~~~--- 227 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-----VMSALQRGY--RMPRME--- 227 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-----HHHHHHcCC--CCCCCC---
Confidence 11 122345678999999988889999999999999999998 999986432111 111111111 111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....++.+++.+|++.+|++||++.++.+.|+
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 228 -NCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred -CCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 12235889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=341.88 Aligned_cols=241 Identities=24% Similarity=0.320 Sum_probs=192.8
Q ss_pred CccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHH-HHhcCCCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
+.||+|+||+||+|+. .+|+.||+|++...........+++..|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999965 578999999986532222233445555654 56789999999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|..++.. ...+++.++..++.||+.|++|||+. ||+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 999988854 33588999999999999999999999 999999999999999999999999999976443334445
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......++.. ..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~~~~~~~~~~~~~----~~~ 222 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDNILHKPLVLRPGA----SLT 222 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHHHHcCCccCCCCC----CHH
Confidence 56799999999999999999999999999999999999999864332 112222222233222222 234
Q ss_pred HHHHHHhccCCCCCCCCCHHH
Q 001494 1040 FVEVAISCLDESPESRPTMQK 1060 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rpt~~e 1060 (1067)
+.+++.+|++.+|.+||++.+
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHHHhccCHHhcCCCCC
Confidence 789999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=338.03 Aligned_cols=247 Identities=24% Similarity=0.335 Sum_probs=196.2
Q ss_pred CccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
+.||+|+||.||+|+. .+++.||+|++...........+.+..|+.++.++ +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999975 46789999999754333333456688899998888 699999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|..++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 9999888543 3589999999999999999999999 999999999999999999999999999976443333445
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||+......... ........+.......|.... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~p~~~~----~~ 229 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKPIRIPRFLS----VK 229 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCCCCCCCCCC----HH
Confidence 5679999999999999999999999999999999999999996432211110 111112222223333333322 24
Q ss_pred HHHHHHhccCCCCCCCCCHH
Q 001494 1040 FVEVAISCLDESPESRPTMQ 1059 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rpt~~ 1059 (1067)
+.+++.+||+.||++|+++.
T Consensus 230 ~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHHHHHHhccCHHHcCCCC
Confidence 78999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=338.29 Aligned_cols=244 Identities=22% Similarity=0.310 Sum_probs=196.7
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCCceeEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 874 (1067)
+|+..+.||+|+||+||+|+. .+|+.||+|++...........+.+..|+.+++.+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467789999999999999965 478999999987532222223456778888888885 678888999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999988543 3589999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~~~~p~~~~- 225 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHNVSYPKSLS- 225 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCccCC-
Confidence 3333456789999999999988899999999999999999999999874332 1122223333333333222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTM 1058 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~ 1058 (1067)
.++.+++.+|++.+|.+|+++
T Consensus 226 ---~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 226 ---KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---HHHHHHHHHHcccCHhhCCCC
Confidence 347899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=341.15 Aligned_cols=241 Identities=23% Similarity=0.285 Sum_probs=190.8
Q ss_pred CccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHH-HHhcCCCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
+.||+|+||+||+|+.. +++.||+|++.............+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 67889999986432211222334444444 56888999999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|.+++... ..+++..+..++.|+++||+|||++ ||+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 9999988543 3477888889999999999999999 999999999999999999999999999986544334445
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......++.. ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~~----~~~ 222 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNKPLQLKPNI----TNS 222 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCCcCCCCCC----CHH
Confidence 567999999999999989999999999999999999999998643321 11122222222222222 234
Q ss_pred HHHHHHhccCCCCCCCCCHHH
Q 001494 1040 FVEVAISCLDESPESRPTMQK 1060 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rpt~~e 1060 (1067)
+.+++.+|++.||.+||++.+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCC
Confidence 889999999999999998874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=318.17 Aligned_cols=256 Identities=24% Similarity=0.315 Sum_probs=193.3
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC-----c
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ-----H 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~ 869 (1067)
-.|...+++|.|+||.||+|... +++.||||++....... -+|+++|+.++|||||++.-+|.... .
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 35777899999999999999654 57999999997543321 26999999999999999998885432 3
Q ss_pred eeEEEEeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC-CCeEEecccc
Q 001494 870 SFIVYEYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK-NEARVSDFGI 947 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~-~~~kl~DfG~ 947 (1067)
..+|||||+. +|.+++++. ..+..++.-.+.-++.||.+|++|||+. +|+||||||+|+|+|.+ |.+||||||.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence 4699999986 888888642 2234577778888999999999999998 99999999999999977 8999999999
Q ss_pred ceecCCCCCccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccc-------chhhhhhhh
Q 001494 948 AKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSS-------SLNLNIALD 1019 (1067)
Q Consensus 948 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~ 1019 (1067)
|+.+.+.... .....|.-|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+..... +....+.+.
T Consensus 173 AK~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 173 AKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred ceeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 9988766554 445678889999988775 5999999999999999999999988764432111 001111111
Q ss_pred -------hccCCCCCCCC--c-chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1020 -------EILDPRLPIPS--H-NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1020 -------~~~~~~~~~~~--~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+...+.+.... . .......+..+++.++++.+|.+|.++.|++.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111111110 0 11122345899999999999999999999875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=346.04 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=199.4
Q ss_pred hcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
.++|+..+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999765 6889999998642222222345678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|+....
T Consensus 122 ~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 9999999999998532 378889999999999999999999 999999999999999999999999999987653
Q ss_pred CCC-ccccccccccccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC--CC
Q 001494 954 DSS-NWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP--RL 1026 (1067)
Q Consensus 954 ~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 1026 (1067)
... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...... .....+... .+
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~~ 266 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--------GTYSKIMDHKNSL 266 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCccc
Confidence 322 223567999999999987543 788999999999999999999998643321 112222221 12
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPES--RPTMQKVSQL 1064 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 1064 (1067)
..+.. ......+.+++..|++.+|.+ ||++.|+++.
T Consensus 267 ~~p~~--~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPED--VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCc--ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 22211 122334788999999865544 8899998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=343.23 Aligned_cols=252 Identities=20% Similarity=0.278 Sum_probs=194.6
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
..|++.+.||+|+||.||+|.. .+++.||+|+.. .+.+.+|++++++++|||||++++++......++||
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 5799999999999999999864 578999999743 234678999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
|++. +++..++... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 163 e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 163 PRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred ecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 9996 6787777433 3478999999999999999999999 9999999999999999999999999999754322
Q ss_pred -CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc---chh-----------------
Q 001494 955 -SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSS---SLN----------------- 1013 (1067)
Q Consensus 955 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~---~~~----------------- 1013 (1067)
........||+.|+|||++.+..++.++||||+||++|||++|+.|+-........ ...
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 22334567999999999999889999999999999999999999885322110000 000
Q ss_pred -hhhhhhhc---------cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1014 -LNIALDEI---------LDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1014 -~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
........ ..+..........+...++.+++.+||+.||.+|||+.|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 000000000111123456889999999999999999999985
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=352.13 Aligned_cols=249 Identities=20% Similarity=0.251 Sum_probs=201.2
Q ss_pred CCCccCccccCCceeEEEEEEC-C-CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-S-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.|...+.||+|+||.||+|... + ++.||+|.+... .......+.+|+.+++.++|||||++++++..++..|+||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 4888999999999999998543 4 678888876432 2333456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 875 EYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
||+++|+|.+++... ....++++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999999887532 2334688999999999999999999999 999999999999999999999999999987653
Q ss_pred CCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC-CCC
Q 001494 954 DSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP-IPS 1030 (1067)
Q Consensus 954 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1030 (1067)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... .+.
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~~~~ 293 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLYGKYDPFPC 293 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCc
Confidence 322 23345799999999999998999999999999999999999999864322 1112222222211 121
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1031 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
. ...++.+++.+||+.||++||++.++++
T Consensus 294 ~----~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 294 P----VSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred c----CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 2 2234889999999999999999999875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=341.65 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=194.2
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC-----ce
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ-----HS 870 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 870 (1067)
+|++.++||+|+||.||+|.. .+++.||||++...... ......+.+|+++++.++||||+++++++.... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 478889999999999999965 47899999998743222 223456889999999999999999999885432 47
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
|+||||++ ++|.+++... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 80 YVVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 99999996 6888887533 3589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC---ccccccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccccccccc-------hhh----
Q 001494 951 LKPDSS---NWTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSS-------LNL---- 1014 (1067)
Q Consensus 951 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~---- 1014 (1067)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ...
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 532211 2244678999999998865 568999999999999999999999986533211000 000
Q ss_pred --------hhhhhhccCCCCCCC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1015 --------NIALDEILDPRLPIP-SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1015 --------~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
......+. ...+.+ ..........+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~i~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMR-KKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhc-ccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000111 000000 0000111235789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=323.61 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=208.9
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||.||+|... +|+.||+|.++..........+.+.+|++++++++|++++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999765 89999999886433333334577899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 875 EYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
||+++++|..++... .....+++.++..++.++++|++|||+. +|+||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988543 2234588999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCC-CCCCcc
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL-PIPSHN 1032 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1032 (1067)
.........+++.|+|||.+.+..++.++|||||||++|||++|+.||..... ........+..... +.+.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~-- 230 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEKCDYPPLPA-- 230 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhhcCCCCCCCh--
Confidence 43333445688899999999888899999999999999999999999753221 00111111111111 1111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
......+.+++.+||+.+|++|||+.++++.++
T Consensus 231 -~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~ 263 (267)
T cd08224 231 -DHYSEELRDLVSRCINPDPEKRPDISYVLQVAK 263 (267)
T ss_pred -hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence 122345889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=327.87 Aligned_cols=249 Identities=24% Similarity=0.294 Sum_probs=195.4
Q ss_pred cccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCCCH
Q 001494 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL 882 (1067)
Q Consensus 804 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 882 (1067)
||+|+||.||+++. .+|+.||+|++...........+.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999865 46899999998643222222334566799999999999999999999999999999999999999
Q ss_pred HHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcccccc
Q 001494 883 AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA 962 (1067)
Q Consensus 883 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 962 (1067)
.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRA 155 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccC
Confidence 88875432 33478999999999999999999999 9999999999999999999999999999876532 2233457
Q ss_pred ccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHH
Q 001494 963 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVE 1042 (1067)
Q Consensus 963 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1042 (1067)
|++.|+|||++.+..++.++||||+||++|||++|+.||....... ................+.. ....++.+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 228 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRRTLEDEVKFEHQ---NFTEESKD 228 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHHhhccccccccc---cCCHHHHH
Confidence 8999999999998889999999999999999999999986432110 1111112222222221111 12335889
Q ss_pred HHHhccCCCCCCCCCHHHHHHH
Q 001494 1043 VAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1043 li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
++.+||+.||++||++.|+++.
T Consensus 229 li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 229 ICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHhccCHhhCCCCccchhh
Confidence 9999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=349.24 Aligned_cols=252 Identities=22% Similarity=0.302 Sum_probs=196.7
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|++.++||+|+||.||+|+. .+++.||||++...........+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999864 578999999986432222233567888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... +.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998543 3578899999999999999999999 9999999999999999999999999999643211
Q ss_pred CC-----------------------------------------------ccccccccccccCccccccCCCCccchhHHH
Q 001494 955 SS-----------------------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSF 987 (1067)
Q Consensus 955 ~~-----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 987 (1067)
.. .....+||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0012468999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCccccccccchhhhhhhhhccC--CCCCCCCcchHHHHHHHHHHHHhccCCCCCCC---CCHHHHH
Q 001494 988 GVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD--PRLPIPSHNVQEKLISFVEVAISCLDESPESR---PTMQKVS 1062 (1067)
Q Consensus 988 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---pt~~evl 1062 (1067)
||++|||++|+.||....... ....+.. ..+..+.. .....++.+++.+|+. +|.+| +++.|++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE--------TYRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH--------HHHHHHccCCccCCCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 999999999999986433211 1111111 11111211 0122347899999997 66665 5999987
Q ss_pred HH
Q 001494 1063 QL 1064 (1067)
Q Consensus 1063 ~~ 1064 (1067)
+.
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 63
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=339.73 Aligned_cols=240 Identities=23% Similarity=0.330 Sum_probs=191.4
Q ss_pred CccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHH-HHhcCCCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
++||+|+||.||+|+.. +++.||+|++............++..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 68899999986432222222344555554 67889999999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
++|...+... ..+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 9998888542 3478888999999999999999999 999999999999999999999999999976433333344
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+.... .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~----~~ 222 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDNILHKPLQLPGGKT----VA 222 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHHHhcCCCCCCCCCC----HH
Confidence 56789999999999988899999999999999999999999864321 1122233333333333322 34
Q ss_pred HHHHHHhccCCCCCCCCCHH
Q 001494 1040 FVEVAISCLDESPESRPTMQ 1059 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rpt~~ 1059 (1067)
+.+++.+|++.||.+||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHccCCHhhcCCCC
Confidence 88999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.83 Aligned_cols=252 Identities=27% Similarity=0.444 Sum_probs=202.8
Q ss_pred cCCCccCccccCCceeEEEEEEC----CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCcee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 871 (1067)
++|+..+.||+|+||+||+|... +...||||++.... .....+++.+|+.++++++||||+++++++.+.+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 56889999999999999999764 24579999986543 2334567899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+||||+++++|.+++.... +.+++.++.+++.|++.|++|||++ +|+||||||+||+++.++.++++|||+++..
T Consensus 82 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 82 IITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999985432 3689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCccc--cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CCC
Q 001494 952 KPDSSNWT--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLP 1027 (1067)
Q Consensus 952 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1027 (1067)
........ ...+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .....+... ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~ 228 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGYRLP 228 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence 52222211 2334678999999988889999999999999999998 99997533211 111111111 111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+. .....+.+++.+||+.+|++||++.|+++.|+
T Consensus 229 ~~~----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~ 263 (266)
T cd05033 229 PPM----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263 (266)
T ss_pred CCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111 12335889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=327.14 Aligned_cols=254 Identities=22% Similarity=0.371 Sum_probs=201.4
Q ss_pred cCCCccCccccCCceeEEEEEE-----CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCce
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 870 (1067)
.+|+..++||+|+||.||+|.. .+++.||+|.+.... .....+++.+|++++++++||||+++++++..++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4578889999999999999864 356789999987432 233446788999999999999999999999999999
Q ss_pred eEEEEeccCCCHHHHhcccCc--------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC
Q 001494 871 FIVYEYLEMGSLAMILSNDAA--------------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF 936 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~ 936 (1067)
|+||||+++++|.+++..... ...+++.++..++.|++.|++|||++ +|+||||||+||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 999999999999999853211 23478899999999999999999999 9999999999999999
Q ss_pred CCCeEEeccccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchh
Q 001494 937 KNEARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLN 1013 (1067)
Q Consensus 937 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~ 1013 (1067)
++.+|++|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~------ 233 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ------ 233 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence 99999999999986543321 1223345678999999988889999999999999999998 88897543211
Q ss_pred hhhhhhhccC-CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1014 LNIALDEILD-PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1014 ~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....+.. .....+.. ...++.+++.+||+.||++||++.++.+.|+
T Consensus 234 --~~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 234 --EVIEMVRKRQLLPCSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred --HHHHHHHcCCcCCCCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 11111111 11111221 1235889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=334.45 Aligned_cols=199 Identities=27% Similarity=0.433 Sum_probs=173.4
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..++||+|+||.||+++.. +++.+|+|++.... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 67999999999999999999765 68889999886542 2233567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++... ..+++..+..++.+++.|++|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999998543 34788899999999999999999752 7999999999999999999999999999765332
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDF 1003 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~ 1003 (1067)
......|++.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 12345689999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=331.16 Aligned_cols=261 Identities=20% Similarity=0.320 Sum_probs=193.9
Q ss_pred cCCCccCccccCCceeEEEEEE-C-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC---CCCeeeeeeEEEe-----
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-A-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI---RHRNIVKFYGFCS----- 865 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~----- 865 (1067)
++|+..+.||+|+||.||+|+. . +++.||+|++......+ .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 3688899999999999999975 3 46889999987543322 1234556677776655 6999999999885
Q ss_pred eCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecc
Q 001494 866 HAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDF 945 (1067)
Q Consensus 866 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~Df 945 (1067)
.....++||||++ +++.+++.... ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 2456899999997 58888885432 34588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh--------hh
Q 001494 946 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN--------IA 1017 (1067)
Q Consensus 946 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~--------~~ 1017 (1067)
|+++..... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.............. ..
T Consensus 155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred cceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 999876533 233456789999999999888899999999999999999999999875432111000000 00
Q ss_pred h------hhccCCCCCCCC-cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1018 L------DEILDPRLPIPS-HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1018 ~------~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
. .....+....+. .........+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000000000000 000112235789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.58 Aligned_cols=251 Identities=26% Similarity=0.470 Sum_probs=203.5
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
++|++.+.||+|++|.||+|...+++.||+|.+..... ..+++.+|+.++++++||||+++++++...+..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 56888999999999999999887788999999864321 24678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999986433 34589999999999999999999999 99999999999999999999999999998765332
Q ss_pred Cc-cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CCCCCCcc
Q 001494 956 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLPIPSHN 1032 (1067)
Q Consensus 956 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1032 (1067)
.. ......+..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+... ....+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~-- 227 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--------EVLQQVDQGYRMPCPP-- 227 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCCCC--
Confidence 11 111223457999999988889999999999999999999 99998643211 111111111 111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....+.+++.+|++.+|++||++.++.+.|+
T Consensus 228 --~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 228 --GCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred --cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 12345899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=347.75 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=194.7
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
.|+..++||+|+||+||+|+. .+++.||+|++...........+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578899999999999999965 5788999999865322223345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++|+|.+++.+. ..+++..+..++.||+.|++|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999988543 3478888999999999999999999 99999999999999999999999999975331100
Q ss_pred -----------------------------------------------CccccccccccccCccccccCCCCccchhHHHH
Q 001494 956 -----------------------------------------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFG 988 (1067)
Q Consensus 956 -----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG 988 (1067)
......+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 001124689999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCccccccccchhhhhhhhhcc--CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 001494 989 VLALEVIKGKHPGDFISLISSSSLNLNIALDEIL--DPRLPIPSHNVQEKLISFVEVAISCLDESPESRPT---MQKVSQ 1063 (1067)
Q Consensus 989 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~evl~ 1063 (1067)
|++|||++|+.||....... ....+. ......+.. .....++.+++.+++ .+|.+|++ +.|+++
T Consensus 236 vil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLE--------TQMKVINWQTSLHIPPQ--AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHH--------HHHHHHccCCCcCCCCc--ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999999987443211 111111 111111211 112234677777765 59999997 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=343.97 Aligned_cols=252 Identities=25% Similarity=0.315 Sum_probs=200.9
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3688899999999999999865 478999999987543323334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999643 24589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc-cccccccccccCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC--C
Q 001494 955 SSN-WTELAGTYGYVAPELAY------TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP--R 1025 (1067)
Q Consensus 955 ~~~-~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~ 1025 (1067)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||....... ....+... .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~ 227 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--------TYNNIMNFQRF 227 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--------HHHHHHcCCCc
Confidence 322 23357899999999886 4557889999999999999999999986433211 11111110 1
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1026 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...+.. .....++.+++..|++ +|++|||+.++++
T Consensus 228 ~~~~~~--~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 LKFPED--PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCCCCC--CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 111111 1122348899999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.79 Aligned_cols=250 Identities=28% Similarity=0.465 Sum_probs=205.6
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.++...++||-|-||.||.|.++ ..-.||||.++.. ....++|+.|+.+|+.++|||+|+++|+|..+..+|||+
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 45677899999999999998654 5678999998753 334689999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
|||..|+|.+|+++.. ...++.-..+.++.||+.|++||..+ .+||||+.++|.|+.++..|||+|||+++.+..+
T Consensus 343 EfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 9999999999997643 33466667789999999999999999 8999999999999999999999999999988755
Q ss_pred CCccccccc---cccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCC
Q 001494 955 SSNWTELAG---TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPS 1030 (1067)
Q Consensus 955 ~~~~~~~~g---t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1067)
.+ +..+| +..|.|||.+....++.|+|||+|||+|||+.| |..||.+++.-..... ... +-++..|.
T Consensus 419 TY--TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L-----LEk--gyRM~~Pe 489 (1157)
T KOG4278|consen 419 TY--TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL-----LEK--GYRMDGPE 489 (1157)
T ss_pred ce--ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH-----Hhc--cccccCCC
Confidence 44 34444 468999999988889999999999999999998 7888876553211111 111 11222222
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1031 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
. ++.+++++|+.||++.|.+||+++|+.+.||
T Consensus 490 G----CPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 490 G----CPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred C----CCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 2 3335899999999999999999999998875
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=349.32 Aligned_cols=253 Identities=22% Similarity=0.283 Sum_probs=195.9
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.+|++.+.||+|+||.||+|+. .+++.||+|++...........+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688999999999999999965 468999999986432212223456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999998543 3478888899999999999999999 9999999999999999999999999998533100
Q ss_pred -------------------------------------------CCccccccccccccCccccccCCCCccchhHHHHHHH
Q 001494 955 -------------------------------------------SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 991 (1067)
Q Consensus 955 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil 991 (1067)
.......+||+.|+|||++.+..++.++||||+||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0001234799999999999998999999999999999
Q ss_pred HHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCC---CHHHHHH
Q 001494 992 LEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRP---TMQKVSQ 1063 (1067)
Q Consensus 992 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---t~~evl~ 1063 (1067)
|||++|+.||......... ...... ......+.. .....++.+++.+|+ .+|.+|+ ++.|+++
T Consensus 235 yell~G~~Pf~~~~~~~~~-----~~i~~~-~~~~~~~~~--~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQ-----LKVINW-ETTLHIPSQ--AKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHH-----HHHhcc-CccccCCCC--CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999998754321110 000000 011111110 112234677888876 5999999 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=336.87 Aligned_cols=256 Identities=25% Similarity=0.434 Sum_probs=199.5
Q ss_pred cCCCccCccccCCceeEEEEEE------CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeC-
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHA- 867 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 867 (1067)
++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+..|+.+++++ +||||++++++|...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4688999999999999999853 235789999987532 223346678899999999 899999999988654
Q ss_pred CceeEEEEeccCCCHHHHhcccCc--------------------------------------------------------
Q 001494 868 QHSFIVYEYLEMGSLAMILSNDAA-------------------------------------------------------- 891 (1067)
Q Consensus 868 ~~~~lv~E~~~~g~L~~~l~~~~~-------------------------------------------------------- 891 (1067)
...+++|||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 578899999999999998853211
Q ss_pred --cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCc--cccccccccc
Q 001494 892 --AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGY 967 (1067)
Q Consensus 892 --~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y 967 (1067)
..++++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||+++.+...... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 13689999999999999999999999 9999999999999999999999999999876433221 2234456789
Q ss_pred cCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHh
Q 001494 968 VAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAIS 1046 (1067)
Q Consensus 968 ~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 1046 (1067)
+|||++.+..++.++|||||||++|||++ |..||........ ......... ....+. ....++.+++.+
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----~~~~~~~~~--~~~~~~----~~~~~~~~l~~~ 311 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----FCRRLKEGT--RMRAPE----YATPEIYSIMLD 311 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----HHHHHhccC--CCCCCc----cCCHHHHHHHHH
Confidence 99999999999999999999999999998 9999864322110 001111111 111111 122358899999
Q ss_pred ccCCCCCCCCCHHHHHHHhc
Q 001494 1047 CLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1047 cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
||+.+|++||++.|+++.|+
T Consensus 312 cl~~~p~~RPs~~ell~~l~ 331 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILG 331 (337)
T ss_pred HccCChhhCcCHHHHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=326.64 Aligned_cols=253 Identities=25% Similarity=0.443 Sum_probs=201.9
Q ss_pred cCCCccCccccCCceeEEEEEE------CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 869 (1067)
.+|.+.+.||+|+||.||++.. .++..+|+|.+... .....+.+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 5788899999999999999864 23456899988643 22345678999999999999999999999999999
Q ss_pred eeEEEEeccCCCHHHHhcccC----------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCC
Q 001494 870 SFIVYEYLEMGSLAMILSNDA----------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNE 939 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~ 939 (1067)
.++||||+++++|.+++.... ....+++.+++.++.|++.|++|||++ +++||||||+||+++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999999986432 123589999999999999999999999 9999999999999999999
Q ss_pred eEEeccccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhh
Q 001494 940 ARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNI 1016 (1067)
Q Consensus 940 ~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 1016 (1067)
+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~ 230 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------E 230 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------H
Confidence 99999999986543221 1122345678999999988889999999999999999998 89997643321 1
Q ss_pred hhhhccCCCC-CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1017 ALDEILDPRL-PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1017 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....+..... ..+.. ...++.+++.+||+.+|.+|||+.|+.+.|+
T Consensus 231 ~~~~i~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 231 VIECITQGRVLQRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred HHHHHHcCCcCCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 1111111111 11111 1234899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=323.42 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=201.1
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.+|++.+.||+|+||.||+|+. .+++.||+|++..... .....+.+|+.++++++||||+++++++..++..|+||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 5789999999999999999975 5788999999864322 22356788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++... ..+++.++..++.|++.|++|||++ +|+|||+||+||+++.++.++|+|||++......
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 86 EYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 999999999988542 3578999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCc
Q 001494 955 SSNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1067)
........|++.|+|||.+. ...++.++||||+||++|||++|+.||.......... .........+....
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~--- 233 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQPPKLKD--- 233 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---eeecCCCCCCCCcc---
Confidence 33334457889999999874 3447889999999999999999999975332211100 00000111111111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
......++.+++.+||+.+|++|||++++++.+
T Consensus 234 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 -KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 112234588999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.80 Aligned_cols=252 Identities=29% Similarity=0.397 Sum_probs=205.9
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|...+.||+|++|.||+|.. .+++.||+|.+...... ....+++..|++++++++|||++++++++.+.+..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 477788999999999999975 47899999998643222 3345678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++... ....+++.++..++.+++.|++|||+. +++||||||+||+++.++.++++|||+++......
T Consensus 80 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 80 YAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred eCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998643 234688999999999999999999999 99999999999999999999999999998776544
Q ss_pred CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHH
Q 001494 956 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1067)
.......|++.|+|||+..+..++.++|||||||++|||++|+.||..... ......+......... ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~---~~ 224 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIRGVFPPVS---QM 224 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCc---cc
Confidence 444456788999999999988899999999999999999999999864432 1111112211111111 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1036 KLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1036 ~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
...++.+++.+||+.+|++||++.++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 23458999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=350.61 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=203.4
Q ss_pred HhcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC----
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ---- 868 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 868 (1067)
..++|++.+.||+|+||+||+|+ ..+|+.||||++...... ......+.+|+..+..++|+|++++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34689999999999999999996 457999999998654322 233566889999999999999999988765432
Q ss_pred ----ceeEEEEeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEe
Q 001494 869 ----HSFIVYEYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVS 943 (1067)
Q Consensus 869 ----~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~ 943 (1067)
..++||||+++|+|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999988643 2335688999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCC--CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhc
Q 001494 944 DFGIAKFLKPDS--SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEI 1021 (1067)
Q Consensus 944 DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1021 (1067)
|||+++.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--------~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--------EVMHKT 257 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHH
Confidence 999998765321 2233467999999999999999999999999999999999999998643321 111122
Q ss_pred cCCCC-CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1022 LDPRL-PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1022 ~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
..... ..+... ..++.+++.+||+.||++||++.++++.
T Consensus 258 ~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 LAGRYDPLPPSI----SPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred hcCCCCCCCCCC----CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 21111 122222 2348899999999999999999998763
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.18 Aligned_cols=251 Identities=27% Similarity=0.430 Sum_probs=200.9
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
.+|+..+.||+|+||.||+|+.+++..+|+|++..... ...++.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 35788899999999999999888788899999864321 13568889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 80 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 80 YMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred cCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 999999999985432 3588999999999999999999999 99999999999999999999999999998654322
Q ss_pred Cc-cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 956 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 956 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.. .....++..|+|||.+.+..++.++||||||+++||+++ |+.||+....... ........ ....+..
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~~~~~~--~~~~~~~-- 225 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-----VESVSAGY--RLYRPKL-- 225 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-----HHHHHcCC--cCCCCCC--
Confidence 11 111223457999999998889999999999999999999 8999864332111 11111111 1111211
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+.++.+++.+||+.+|++|||+.|+++.|.
T Consensus 226 --~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 226 --APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred --CCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 2335899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=327.22 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=202.2
Q ss_pred hcCCCccCccccCCceeEEEEEECC-----------------CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCee
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELAS-----------------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 857 (1067)
..+|++.+.||+|+||.||+|+... +..||+|++..... ....+++.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 3578999999999999999986542 34689999875422 2445788999999999999999
Q ss_pred eeeeEEEeeCCceeEEEEeccCCCHHHHhcccC--------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 001494 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDA--------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISS 929 (1067)
Q Consensus 858 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~ 929 (1067)
+++++++..++..++||||+++++|.+++.... ....+++..++.++.|++.|++|||++ +|+||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence 999999999999999999999999999986433 123589999999999999999999999 999999999
Q ss_pred CceeeCCCCCeEEeccccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCccc
Q 001494 930 KNVLLDFKNEARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPGDFIS 1005 (1067)
Q Consensus 930 ~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~ 1005 (1067)
+||+++.++.++++|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999986543321 1223456778999999988889999999999999999998 677775432
Q ss_pred cccccchhhhhhhhhc-----cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1006 LISSSSLNLNIALDEI-----LDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1006 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.... ....... .......+. ..+.++.+++.+||+.||++|||+.|+++.|+
T Consensus 239 ~~~~-----~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQQV-----IENAGHFFRDDGRQIYLPRPP----NCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hHHH-----HHHHHhccccccccccCCCcc----CCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 2110 0000111 000011111 12235899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=330.86 Aligned_cols=252 Identities=23% Similarity=0.437 Sum_probs=198.9
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCc----EEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCce
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 870 (1067)
.+|+..+.||+|+||.||+|.+. +++ .||+|++.... .....+++.+|+.+++.++||||++++|++... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 46899999999999999999753 343 48999986432 233456789999999999999999999998764 57
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
++|+||+++|++.+++... ...+++..+++++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 84 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 8999999999999998643 23578899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcc--ccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCC
Q 001494 951 LKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 951 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
........ ....++..|+|||++.+..++.++|||||||++|||++ |+.||+...... ....... ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-----~~~~~~~--~~~~~ 231 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----ISSILEK--GERLP 231 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHhC--CCCCC
Confidence 65433222 12234678999999999899999999999999999998 999987543211 0111111 11112
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+... ..++.+++.+||+.+|++||++.++++.+.
T Consensus 232 ~~~~~----~~~~~~li~~cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 232 QPPIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred CCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 22222 234889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=326.87 Aligned_cols=262 Identities=22% Similarity=0.353 Sum_probs=200.3
Q ss_pred cCCCccCccccCCceeEEEEEEC-----------------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-----------------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 858 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 858 (1067)
++|++.++||+|+||.||+++.. ++..||+|++.... .....+++.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 46889999999999999997532 24468999987542 223356789999999999999999
Q ss_pred eeeEEEeeCCceeEEEEeccCCCHHHHhcccCc--------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCC
Q 001494 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAA--------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSK 930 (1067)
Q Consensus 859 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~ 930 (1067)
++++++...+..++||||+++++|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 999999999999999999999999999864321 12477889999999999999999999 9999999999
Q ss_pred ceeeCCCCCeEEeccccceecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCcccc
Q 001494 931 NVLLDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPGDFISL 1006 (1067)
Q Consensus 931 Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~ 1006 (1067)
||+++.++.++++|||+++.+...... .....+++.|+|||...++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999999865433211 122334678999999888889999999999999999998 6778754332
Q ss_pred ccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1007 ISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....................+.+.. ....+.+++.+||+.||++||++.||.+.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVYLPKPAL----CPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHHhhccccccCCCCCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111000000000001111111211 2235889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=326.80 Aligned_cols=261 Identities=22% Similarity=0.349 Sum_probs=199.3
Q ss_pred cCCCccCccccCCceeEEEEEECC---------------CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELAS---------------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 860 (1067)
++|++.++||+|+||.||+++... ...||+|++.... .......+.+|++++++++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 578899999999999999986532 2358999987532 23345678999999999999999999
Q ss_pred eEEEeeCCceeEEEEeccCCCHHHHhcccCc---------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCc
Q 001494 861 YGFCSHAQHSFIVYEYLEMGSLAMILSNDAA---------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKN 931 (1067)
Q Consensus 861 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~N 931 (1067)
++++...+..++||||+++++|.+++..... ...+++..+++++.|++.|++|||++ +++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999998854221 12468889999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEeccccceecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCccccc
Q 001494 932 VLLDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPGDFISLI 1007 (1067)
Q Consensus 932 ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt--g~~p~~~~~~~ 1007 (1067)
|+++.++.+||+|||+++........ .....+++.|+|||++.++.++.++|||||||++|||++ |..||+.....
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999999765432211 122345678999999988889999999999999999998 56676543321
Q ss_pred cccchhhhhhhhhc-cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1008 SSSSLNLNIALDEI-LDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1008 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
........ ..... .......+.. .+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 240 ~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGE-FFRNQGRQIYLSQTPL----CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHH-hhhhccccccCCCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11000000 00000 0000111111 1235899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=326.24 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=201.3
Q ss_pred CCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCce
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 870 (1067)
+|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+..|+.+++.++||||+++++++.+.+..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 4677889999999999999753 35789999987542 223356788999999999999999999999999999
Q ss_pred eEEEEeccCCCHHHHhcccC-------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC
Q 001494 871 FIVYEYLEMGSLAMILSNDA-------------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK 937 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~ 937 (1067)
++++||+++++|.+++.... ....+++..+.+++.|++.|++|+|++ +|+||||||+||+++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 99999999999999984321 123578888999999999999999999 99999999999999999
Q ss_pred CCeEEeccccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhh
Q 001494 938 NEARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNL 1014 (1067)
Q Consensus 938 ~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~ 1014 (1067)
+.+||+|||+++....... ......+++.|+|||.+.+..++.++||||+||++|||++ |..||.....
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------- 232 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------- 232 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 9999999999886543321 1123445778999999988889999999999999999998 7888754322
Q ss_pred hhhhhhccCCCCC-CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1015 NIALDEILDPRLP-IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1015 ~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
......+...... .+.. ....+.+++.+||+.+|++||+++++++.|+
T Consensus 233 ~~~~~~i~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 233 QDVIEMIRNRQVLPCPDD----CPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHHHHHcCCcCCCCCC----CCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 1122222222221 1222 2334889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=317.20 Aligned_cols=247 Identities=27% Similarity=0.438 Sum_probs=196.1
Q ss_pred CccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCC
Q 001494 802 HCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMG 880 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 880 (1067)
++||+|+||.||+|+. .+++.||+|.+.... .......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 4699999999999975 478999999876432 2334567899999999999999999999999999999999999999
Q ss_pred CHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcc--
Q 001494 881 SLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW-- 958 (1067)
Q Consensus 881 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~-- 958 (1067)
+|.+++... ...+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.+|++|||++..........
T Consensus 79 ~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 79 DFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred cHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 999998543 23578999999999999999999999 99999999999999999999999999997644221111
Q ss_pred ccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHH
Q 001494 959 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKL 1037 (1067)
Q Consensus 959 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1067)
.....+..|+|||.+.++.++.++||||+||++|||++ |..||+...... ........ .....+. ...
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-----~~~~~~~~--~~~~~~~----~~~ 222 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-----TREAIEQG--VRLPCPE----LCP 222 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-----HHHHHHcC--CCCCCcc----cCC
Confidence 11123457999999988889999999999999999998 888876432211 11111111 1111111 123
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1038 ISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1038 ~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.++.+++.+|++.+|++|||+.|+.+.|+
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 35889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=319.97 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=201.5
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.+|...++||+|+||.||+|.. ++++.||+|++... ....+++.+|++++++++||||+++++++..++..++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 4578889999999999999864 46889999998642 222467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++.... ...+++..++.++.|+++|++|||++ +++||||||+||+++.++.+||+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 82 EFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999985432 34588999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCcc-ccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcc
Q 001494 955 SSNW-TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 955 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
.... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||........ ........ ....+..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-----~~~~~~~~--~~~~~~~- 229 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YELLEKGY--RMERPEG- 229 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHHCCC--CCCCCCC-
Confidence 2211 12234568999999988889999999999999999998 8999764332110 11111111 1111222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
...++.+++.+||+.+|++||++.++++.|+
T Consensus 230 ---~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 230 ---CPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred ---CCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 2235889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=325.82 Aligned_cols=254 Identities=26% Similarity=0.464 Sum_probs=202.4
Q ss_pred cCCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 869 (1067)
.+|...+.||+|+||.||+|+.. ++..+|+|.+... .....+.+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 45788899999999999998642 4566899988643 23334678899999999999999999999999999
Q ss_pred eeEEEEeccCCCHHHHhcccC-------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC
Q 001494 870 SFIVYEYLEMGSLAMILSNDA-------------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF 936 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~ 936 (1067)
.++||||+++++|.+++.... ....+++..++.++.|++.|++|||++ +|+||||||+||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 999999999999999986432 123588999999999999999999999 9999999999999999
Q ss_pred CCCeEEeccccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchh
Q 001494 937 KNEARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLN 1013 (1067)
Q Consensus 937 ~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~ 1013 (1067)
++.++|+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||.......
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----- 233 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----- 233 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 99999999999976543321 1123446788999999998889999999999999999999 999976433211
Q ss_pred hhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1014 LNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....+.......... ..+..+.+++.+||+.+|++|||+.+|+++|+
T Consensus 234 ---~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 234 ---VIECITQGRVLERPR---VCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred ---HHHHHhCCCCCCCCc---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 111122222111111 12235889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=341.40 Aligned_cols=255 Identities=21% Similarity=0.300 Sum_probs=199.3
Q ss_pred HHhcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCcee
Q 001494 793 RATNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 793 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 871 (1067)
...++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..|
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34578999999999999999999765 68899999986432222233456788999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+||||+++|+|.+++... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 120 lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 999999999999998542 378888899999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-ccccccccccccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC--
Q 001494 952 KPDSS-NWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP-- 1024 (1067)
Q Consensus 952 ~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 1024 (1067)
..... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||...... .....+...
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~ 264 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMNHKN 264 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCC
Confidence 54322 223567999999999987543 788999999999999999999998743321 111222211
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 001494 1025 RLPIPSHNVQEKLISFVEVAISCLDESPES--RPTMQKVSQL 1064 (1067)
Q Consensus 1025 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 1064 (1067)
....+. .......+.+++.+|+..++.+ ||++.|+++.
T Consensus 265 ~~~~~~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 265 SLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred cccCCC--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111121 1122334788999999844443 7899988764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=319.33 Aligned_cols=251 Identities=24% Similarity=0.405 Sum_probs=202.0
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
++|++.++||+|+||.||+|...+++.||+|.+..... ..+++.+|+.++++++|||++++++++. .+..++|||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 56888999999999999999988899999999874322 2467889999999999999999999874 467899999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999885433 34689999999999999999999999 99999999999999999999999999998765322
Q ss_pred C-ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 956 S-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 956 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
. ......++..|+|||++.+..++.++||||||+++||+++ |+.||....... ........ .....+..
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~--~~~~~~~~-- 227 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-----VIQNLERG--YRMPRPDN-- 227 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-----HHHHHHcC--CCCCCCCC--
Confidence 2 1123345678999999988889999999999999999999 999986433211 01111111 11111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
...++.+++.+|++.+|++|||++++.+.|+
T Consensus 228 --~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 228 --CPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred --CCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 2235899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.53 Aligned_cols=245 Identities=27% Similarity=0.370 Sum_probs=199.8
Q ss_pred CccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCC
Q 001494 802 HCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMG 880 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 880 (1067)
-+||+|.||+||.|+.. +...+|||.+.... .+..+-+.+||...++++|.|||+++|.+.+++.+-|.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 46999999999999765 45668999987542 233567889999999999999999999999999999999999999
Q ss_pred CHHHHhcccCccCCC--ChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeC-CCCCeEEeccccceecCCCCCc
Q 001494 881 SLAMILSNDAAAEDL--EWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD-FKNEARVSDFGIAKFLKPDSSN 957 (1067)
Q Consensus 881 ~L~~~l~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~ 957 (1067)
+|...++.. -+++ .+.++-.+.+||++||.|||++ .|||||||-+|||++ ..|.+||+|||-++.+..-...
T Consensus 658 SLSsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 658 SLSSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred cHHHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 999999532 3345 6677778899999999999999 999999999999996 5689999999999988766666
Q ss_pred cccccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHH
Q 001494 958 WTELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035 (1067)
Q Consensus 958 ~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1067)
..++.||..|||||++..++ |+.++|||||||++.||.||++||-........ ...-.+..... +...+
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-----MFkVGmyKvHP----~iPee 803 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-----MFKVGMYKVHP----PIPEE 803 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-----hhhhcceecCC----CCcHH
Confidence 67789999999999998765 889999999999999999999998644321111 11111112222 23345
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1036 KLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1036 ~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...+...+|.+|+.+||.+||+|.++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 5566899999999999999999999875
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=335.18 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=201.2
Q ss_pred cCCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCC
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQ 868 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 868 (1067)
++|...++||+|+||.||+|++. .++.||+|++...... ...+.+..|++++.++. |||||++++++...+
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 46788899999999999999753 3468999999754322 23457889999999997 999999999999999
Q ss_pred ceeEEEEeccCCCHHHHhcccCc---------------------------------------------------------
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAA--------------------------------------------------------- 891 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~--------------------------------------------------------- 891 (1067)
..++||||+++|+|.+++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999864321
Q ss_pred --------------------------------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcee
Q 001494 892 --------------------------------------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVL 933 (1067)
Q Consensus 892 --------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nil 933 (1067)
...+++.++..++.|++.|++|||+. +|+||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 12367788899999999999999998 9999999999999
Q ss_pred eCCCCCeEEeccccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccc
Q 001494 934 LDFKNEARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSS 1010 (1067)
Q Consensus 934 l~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~ 1010 (1067)
++.++.+|++|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999986543221 1123456788999999988889999999999999999998 8899864332110
Q ss_pred chhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1011 SLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....... ..+...+... ..++.+++.+||+.+|.+||+++|+++.|+
T Consensus 351 ---~~~~~~~--~~~~~~p~~~----~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 397 (401)
T cd05107 351 ---FYNAIKR--GYRMAKPAHA----SDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397 (401)
T ss_pred ---HHHHHHc--CCCCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 0000000 0111222222 235899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=317.93 Aligned_cols=250 Identities=26% Similarity=0.460 Sum_probs=201.3
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++||+++++++++. ....++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 46888999999999999999888888999999875322 2357889999999999999999999885 456899999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++.... ...+++.++..++.+++.|++|||+. +|+||||||+||+++.++.++|+|||.+..+....
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 81 YMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999986432 34578999999999999999999999 99999999999999999999999999998765432
Q ss_pred Cc-cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CCCCCCcc
Q 001494 956 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLPIPSHN 1032 (1067)
Q Consensus 956 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1032 (1067)
.. .....++..|+|||...+..++.++||||||+++|||++ |+.||...... .....+... ..+.+.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~-- 226 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--------EVLEQVERGYRMPCPQ-- 226 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCCCC--
Confidence 21 122335668999999988889999999999999999999 88898643221 111111111 111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....++.+++.+|++.+|++|||++++.++|+
T Consensus 227 --~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 227 --DCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred --cCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 22345899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.92 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=203.7
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..++||+|+||.||+++.. +++.||+|.+.... .....+.+..|+.+++.++||||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4778899999999999999654 78899999986432 22335678889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|++++++.+++... ....+++..+..++.|++.|++|||++ +|+|+||||+||+++.++.++++|||.++......
T Consensus 79 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 79 YCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999999888532 234578899999999999999999999 99999999999999999999999999998765444
Q ss_pred CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCC-CCCCcchH
Q 001494 956 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL-PIPSHNVQ 1034 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1034 (1067)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||+..... .....+..... ..+..
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~--- 223 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--------NLILKVCQGSYKPLPSH--- 223 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--------HHHHHHhcCCCCCCCcc---
Confidence 4344567889999999998888999999999999999999999998643321 11111111111 11211
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
....+.+++.+||+.||++|||+.+++..
T Consensus 224 -~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 -YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22348899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=324.99 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=199.4
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..+.||+|++|.||+|+.. +++.||+|++......+ ...+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 4778899999999999999764 78999999986543222 234677889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|++ +++.+++........+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 997 58888876544446689999999999999999999999 99999999999999999999999999998765443
Q ss_pred CccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh----------------hhh
Q 001494 956 SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN----------------IAL 1018 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~----------------~~~ 1018 (1067)
.......+++.|+|||.+.+. .++.++||||+||++|||+||+.||.............. ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 333445678899999987654 478899999999999999999999864322110000000 000
Q ss_pred hhccCCCCCCC--CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1019 DEILDPRLPIP--SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1019 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.... +..... .........++.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTF-PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred Hhhc-cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 000000 0000012235789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=319.34 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=200.7
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
.+|++.++||+|+||+||+|+..++..||+|++..... ..+++.+|++++++++||||+++++++. .+..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 46889999999999999999887777899999874322 2357889999999999999999999875 456899999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++|+|.+++.... ...+++..+..++.|+++|++|+|+. +++||||||+||+++.++.+||+|||.++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 81 YMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred cCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999996432 34578999999999999999999999 99999999999999999999999999998765433
Q ss_pred Ccc-ccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CCCCCCcc
Q 001494 956 SNW-TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLPIPSHN 1032 (1067)
Q Consensus 956 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1032 (1067)
... ....++..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+... ....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~~~---- 224 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRMPC---- 224 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHhcCCCCCC----
Confidence 221 23345678999999988889999999999999999999 88887643221 111111111 1111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
..+...++.+++.+|++.+|++||++.++++.|+
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 1233446889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=320.15 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=198.7
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..++||+|+||.||+|.. .+++.||+|++.... .....+++.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 3678889999999999999964 678999999986432 2234567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||++++++..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 999999997553 367888899999999999999999 9999999999999999999999999999865432
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
......|++.|+|||++.+..++.++||||||+++|||++|+.||.......... ........+......... ..
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~ 223 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDEDPPVLP--VG 223 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccCCCCCC--CC
Confidence 2234578999999999998889999999999999999999999986432211110 001111111111111000 01
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
....++.+++.+|++.+|++||++.|+++.
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 122348899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=328.81 Aligned_cols=260 Identities=17% Similarity=0.281 Sum_probs=197.6
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|...++||+|+||.||+|+.. +++.||+|++....... ....+.+|++++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 56888999999999999999754 68889999987543222 2345778999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++ ++.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 84 EYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred eCCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 99985 777776432 23478899999999999999999999 9999999999999999999999999999865544
Q ss_pred CCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh-------hhhhhh------
Q 001494 955 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL-------NIALDE------ 1020 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------~~~~~~------ 1020 (1067)
........+++.|+|||.+.+ ..++.++||||+||++|||+||+.||............. ......
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 444445578899999998765 457899999999999999999999986433211100000 000000
Q ss_pred ---ccCCCCCC-C-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1021 ---ILDPRLPI-P-SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1021 ---~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...+.... + .........++.+++.+|++.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 0 0000112235789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=316.74 Aligned_cols=245 Identities=26% Similarity=0.423 Sum_probs=194.5
Q ss_pred ccccCCceeEEEEEE---CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 803 CIGKGGQGSVYKVEL---ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 803 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
.||+|+||.||+|.+ .+++.||+|++.... ......+++..|+.+++.++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999854 367889999986443 23345678899999999999999999999885 4567899999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcc-
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW- 958 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~- 958 (1067)
++|.+++... ..+++..+.+++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 80 GPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999998543 3588999999999999999999999 99999999999999999999999999998765433211
Q ss_pred --ccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHH
Q 001494 959 --TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035 (1067)
Q Consensus 959 --~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1067)
....+++.|+|||.+....++.++|||||||++|||++ |+.||....... ........ .....+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~i~~~--~~~~~~~~~--- 223 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-----VTQMIESG--ERMECPQRC--- 223 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHCC--CCCCCCCCC---
Confidence 12234578999999988889999999999999999998 999986433211 11111111 111222222
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1036 KLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1036 ~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
..++.+++.+||+.||++||++++|++.|+
T Consensus 224 -~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~ 253 (257)
T cd05116 224 -PPEMYDLMKLCWTYGVDERPGFAVVELRLR 253 (257)
T ss_pred -CHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence 234889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=322.87 Aligned_cols=255 Identities=23% Similarity=0.353 Sum_probs=200.4
Q ss_pred hcCCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 868 (1067)
.++|++.++||+|+||.||+|..+ .+..||+|.+.... .......+.+|+.++++++||||+++++++.+.+
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 467899999999999999998543 24579999876432 2333456889999999999999999999999999
Q ss_pred ceeEEEEeccCCCHHHHhcccCc-------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeE
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAA-------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEAR 941 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~k 941 (1067)
..++||||+++|+|.+++..... ....++..+..++.|++.|++|||++ +|+||||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999964221 23456778889999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhh
Q 001494 942 VSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIAL 1018 (1067)
Q Consensus 942 l~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1018 (1067)
++|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--------~~~ 231 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------QVL 231 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHH
Confidence 9999999865432221 122345678999999988889999999999999999998 78887543221 111
Q ss_pred hhccCCCC-CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1019 DEILDPRL-PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1019 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
..+..... ..+.. ....+.+++.+|++.+|++|||+.++++.|+
T Consensus 232 ~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 276 (288)
T cd05061 232 KFVMDGGYLDQPDN----CPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276 (288)
T ss_pred HHHHcCCCCCCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11221111 11111 1235899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.11 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=198.0
Q ss_pred CccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCCC
Q 001494 802 HCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGS 881 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 881 (1067)
++||+|+||.||+|...+++.||+|++..... ......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 46999999999999988899999999875432 2334568899999999999999999999999999999999999999
Q ss_pred HHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcc-cc
Q 001494 882 LAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW-TE 960 (1067)
Q Consensus 882 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~ 960 (1067)
|.+++... ...+++..+..++.+++.|+.|+|++ +++||||||+||+++.++.+|++|||++.......... ..
T Consensus 79 L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 79 FLSFLRKK--KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 99988543 23578999999999999999999999 99999999999999999999999999997644322111 12
Q ss_pred ccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 961 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 961 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
..+++.|+|||++.+..++.++||||||+++||+++ |..||........ ........ ....+.. ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-----~~~~~~~~--~~~~~~~----~~~~ 222 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-----REQVEKGY--RMSCPQK----CPDD 222 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-----HHHHHcCC--CCCCCCC----CCHH
Confidence 234567999999988889999999999999999998 9999864332111 01111111 1111221 2235
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1040 FVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
+.+++.+|++.+|++||++.|++++|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=322.90 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=199.7
Q ss_pred CCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|+..+.||+|+||.||++.. .+++.||+|.+...........+.+..|+.++++++|++++.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67778999999999999865 57899999998654333333345677899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+++++|.+++.... ...+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++...... .
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-Q 156 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-c
Confidence 99999998885432 23588999999999999999999999 9999999999999999999999999999765432 2
Q ss_pred ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHH
Q 001494 957 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEK 1036 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1067)
......|++.|+|||++.+..++.++||||+||++|||++|+.||......... ........... ...+.. .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~~~---~~~~~~----~ 228 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKEVQ---EEYSEK----F 228 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhhhh---hhcCcc----C
Confidence 223457899999999999889999999999999999999999998743211000 00000001110 011111 2
Q ss_pred HHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 001494 1037 LISFVEVAISCLDESPESRPT-----MQKVSQ 1063 (1067)
Q Consensus 1037 ~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 1063 (1067)
..++.+++.+||+.||.+||| +.|+++
T Consensus 229 ~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 229 SPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 234789999999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=319.29 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=195.9
Q ss_pred CCccCccccCCceeEEEEEECCC-c--EEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC------C
Q 001494 798 FDDEHCIGKGGQGSVYKVELASG-E--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA------Q 868 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 868 (1067)
|.++++||+|+||.||+|+.... . .||+|.+..... .....+.+..|+++++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 35678899999999999976543 2 589998875432 233457788999999999999999999987432 2
Q ss_pred ceeEEEEeccCCCHHHHhcccC---ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecc
Q 001494 869 HSFIVYEYLEMGSLAMILSNDA---AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDF 945 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~Df 945 (1067)
..++||||+++|+|.+++.... ....+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 5689999999999998874321 223588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhcc
Q 001494 946 GIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEIL 1022 (1067)
Q Consensus 946 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1022 (1067)
|+++.+...... .....+++.|+|||...+..++.++||||||+++|||++ |+.||...... .....+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~ 228 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--------EIYDYLR 228 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHH
Confidence 999876533221 122345678999999998889999999999999999999 78888643221 1111111
Q ss_pred CC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1023 DP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1023 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.. ....+.. ....+.+++.+||+.+|++|||+.++++.|+
T Consensus 229 ~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 269 (272)
T cd05075 229 QGNRLKQPPD----CLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269 (272)
T ss_pred cCCCCCCCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11 1111222 2234889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=323.65 Aligned_cols=249 Identities=27% Similarity=0.460 Sum_probs=202.1
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.+|+..+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 5788899999999999999964 57899999998753322 2466889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++.. ..+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 97 e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred cccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999999853 2478899999999999999999999 9999999999999999999999999998865544
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
........+++.|+|||.+.+..++.++|||||||++|||++|+.||........ ... ......+....+ .
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~----~~~-~~~~~~~~~~~~----~ 240 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----LYL-IATNGTPELQNP----E 240 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh----HHH-HhcCCCCCCCCc----c
Confidence 3333445788999999999888899999999999999999999999864332110 000 000011111111 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.....+.+++.+||..+|++|||+.|+++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 23345889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=319.96 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=200.8
Q ss_pred hcCCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 868 (1067)
.++|...+.||+|+||.||+|... .+..||+|.+.... .......+..|+.++++++||||+++++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 456888999999999999999764 35779999876432 2233467899999999999999999999999999
Q ss_pred ceeEEEEeccCCCHHHHhcccCc----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC---CeE
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAA----AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN---EAR 941 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~---~~k 941 (1067)
..++||||+++++|.+++..... ...+++.++.+++.||+.|++|||++ +++||||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence 99999999999999999865432 23589999999999999999999999 999999999999998765 599
Q ss_pred EeccccceecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhh
Q 001494 942 VSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIAL 1018 (1067)
Q Consensus 942 l~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1018 (1067)
++|||+++........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||+...... .....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-----~~~~~ 234 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-----VMEFV 234 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHH
Confidence 9999999876322211 112233567999999988889999999999999999997 999986433211 01111
Q ss_pred hhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1019 DEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.. ......+... ..++.+++.+|++.+|++||++.+|++.|+
T Consensus 235 ~~--~~~~~~~~~~----~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TG--GGRLDPPKGC----PGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred Hc--CCcCCCCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11 1111122222 235889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=321.51 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=203.3
Q ss_pred cCCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 869 (1067)
++|++.+.||+|+||.||+|... ++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 56888999999999999998654 34689999986432 22335678899999999999999999999999999
Q ss_pred eeEEEEeccCCCHHHHhcccCc-------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEE
Q 001494 870 SFIVYEYLEMGSLAMILSNDAA-------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARV 942 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl 942 (1067)
.++||||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 9999999999999999864322 23478899999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhh
Q 001494 943 SDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALD 1019 (1067)
Q Consensus 943 ~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1019 (1067)
+|||+++....... ......++..|+|||.+.+..++.++|||||||++||+++ |..||....... ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------~~~ 232 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--------VLK 232 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--------HHH
Confidence 99999976543321 1223456788999999988889999999999999999998 899986433211 111
Q ss_pred hccCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1020 EILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1020 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+... ....+... ..++.+++.+||+.+|++|||+.++++.|+
T Consensus 233 ~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 FVIDGGHLDLPENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHhcCCCCCCCCCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111 12222222 335889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=322.03 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=199.7
Q ss_pred CCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|+..+.||+|+||+||+|.. .+++.||+|.+...........+.+.+|++++++++|++++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778899999999999865 57899999998654322223345578899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-E 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-C
Confidence 99999998875432 33589999999999999999999999 9999999999999999999999999999765432 2
Q ss_pred ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHH
Q 001494 957 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEK 1036 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1067)
......|+..|+|||++.+..++.++|+||+||++|||++|+.||........ .......+.......+.. .
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~~~~~~~----~ 228 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETEEVYSAK----F 228 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhccccccCcc----C
Confidence 22345789999999999888899999999999999999999999864322111 111111122222122222 2
Q ss_pred HHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 001494 1037 LISFVEVAISCLDESPESRPT-----MQKVSQ 1063 (1067)
Q Consensus 1037 ~~~l~~li~~cl~~dP~~Rpt-----~~evl~ 1063 (1067)
...+.+++..|++.||++||+ +.++++
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 234789999999999999999 666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=319.73 Aligned_cols=252 Identities=24% Similarity=0.377 Sum_probs=196.5
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCc----EEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCce
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 870 (1067)
.+|+..+.||+|+||+||+|... +++ .||+|.+... .......++..|+..+++++||||+++++++. ....
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence 46888899999999999999753 454 4777777532 12233467888888999999999999999875 4567
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
++++||+++|+|.+++... ...+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 8999999999999999542 23589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCC
Q 001494 951 LKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 951 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
...... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||........ ....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-----~~~~~~~--~~~~ 231 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-----PDLLEKG--ERLA 231 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----HHHHHCC--CcCC
Confidence 643322 2234456778999999988889999999999999999998 9999864332110 0011100 1111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+... ...+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 232 ~~~~~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~ 266 (279)
T cd05111 232 QPQIC----TIDVYMVMVKCWMIDENVRPTFKELANEFT 266 (279)
T ss_pred CCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11111 224788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.87 Aligned_cols=245 Identities=24% Similarity=0.393 Sum_probs=192.8
Q ss_pred ccccCCceeEEEEEEC---CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 803 CIGKGGQGSVYKVELA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 803 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
.||+|+||.||+|... ++..||+|+..... .....+++.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999998653 45579999986542 2334567999999999999999999999885 4578999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcc-
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW- 958 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~- 958 (1067)
++|.+++... ...+++.++.+++.|++.|++|||++ +++||||||+||+++.++.+|++|||+++.........
T Consensus 79 ~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 79 GPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 9999998532 34589999999999999999999999 99999999999999999999999999998654332211
Q ss_pred --ccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHH
Q 001494 959 --TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035 (1067)
Q Consensus 959 --~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1067)
....+++.|+|||.+.+..++.++|||||||++||+++ |+.||........ ....... .....+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~--~~~~~~~~~--- 223 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-----MSFIEQG--KRLDCPAEC--- 223 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-----HHHHHCC--CCCCCCCCC---
Confidence 11223578999999888889999999999999999996 9999864432110 0111111 111122222
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1036 KLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1036 ~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
..++.+++.+||+.+|++||++.+|.+.|+
T Consensus 224 -~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~ 253 (257)
T cd05115 224 -PPEMYALMKDCWIYKWEDRPNFAKVEERMR 253 (257)
T ss_pred -CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 235889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=341.61 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=196.0
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||.||+|+. .+++.||+|++...........+.+..|+.++..++||+|+++++++.+++..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688899999999999999965 468999999986432222334567888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999998543 3488999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCC
Q 001494 955 SS-----------------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 999 (1067)
Q Consensus 955 ~~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~ 999 (1067)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 0113479999999999999999999999999999999999999
Q ss_pred CCCccccccccchhhhhhhhhccC--CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 001494 1000 PGDFISLISSSSLNLNIALDEILD--PRLPIPSHNVQEKLISFVEVAISCLDESPESRPT---MQKVSQ 1063 (1067)
Q Consensus 1000 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~evl~ 1063 (1067)
||....... ....+.. .....+... ....++.+++.+++ .+|.+|++ +.|+++
T Consensus 235 Pf~~~~~~~--------~~~~i~~~~~~~~~p~~~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETPQE--------TYRKVMNWKETLVFPPEV--PISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCHHH--------HHHHHHcCCCceecCCCC--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 986443211 1111111 111122111 11224778888876 49999985 566553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=322.28 Aligned_cols=255 Identities=23% Similarity=0.437 Sum_probs=202.9
Q ss_pred hcCCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 868 (1067)
.++|+..+.||+|+||.||+|... ++..||+|++.... .....+++.+|+.++++++||||+++++++.+++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 357889999999999999999753 46789999987532 2334567899999999999999999999999999
Q ss_pred ceeEEEEeccCCCHHHHhcccC-------------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 001494 869 HSFIVYEYLEMGSLAMILSNDA-------------------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISS 929 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~ 929 (1067)
..++||||+++|+|.+++.... ....+++.+++.++.|++.|++|||++ +++||||||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 9999999999999999986321 123478889999999999999999999 999999999
Q ss_pred CceeeCCCCCeEEeccccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccc
Q 001494 930 KNVLLDFKNEARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISL 1006 (1067)
Q Consensus 930 ~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~ 1006 (1067)
+||+++.++.++|+|||.++.+..... .......++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999976543321 1122334677999999988889999999999999999998 8888753322
Q ss_pred ccccchhhhhhhhhccCCCCC-CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1007 ISSSSLNLNIALDEILDPRLP-IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
. .....+...... .+.. ...++.+++.+||+.+|++|||+.|+++.|+
T Consensus 239 ~--------~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 E--------EVIYYVRDGNVLSCPDN----CPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred H--------HHHHHHhcCCCCCCCCC----CCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1 111222222211 1111 2245899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.49 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=199.3
Q ss_pred CCccCccccCCceeEEEEEEC----CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc----
Q 001494 798 FDDEHCIGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH---- 869 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 869 (1067)
|+..+.||+|+||.||+|... .+..||+|++...... ......+.+|++.++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 567889999999999999754 2467999998754322 3345678999999999999999999998866554
Q ss_pred --eeEEEEeccCCCHHHHhcccC---ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEec
Q 001494 870 --SFIVYEYLEMGSLAMILSNDA---AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSD 944 (1067)
Q Consensus 870 --~~lv~E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~D 944 (1067)
.++||||+++|+|..++.... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 799999999999998884322 234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCcc--ccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhc
Q 001494 945 FGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEI 1021 (1067)
Q Consensus 945 fG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1021 (1067)
||+++......... ....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------~~~~~~ 228 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------EIYDYL 228 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHH
Confidence 99998765432211 12234678999999988889999999999999999999 88887643321 111111
Q ss_pred cCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1022 LDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1022 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
... ....+.. ...++.+++.+||+.||++|||+.|+++.|+
T Consensus 229 ~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 229 RHGNRLKQPED----CLDELYDLMYSCWRADPKDRPTFTKLREVLE 270 (273)
T ss_pred HcCCCCCCCcC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111 1122222 2335899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=320.63 Aligned_cols=253 Identities=25% Similarity=0.440 Sum_probs=201.1
Q ss_pred cCCCccCccccCCceeEEEEEE------CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 869 (1067)
.+|...++||+|+||.||+|+. .++..+|+|.+... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 4678889999999999999853 24567999987643 23345679999999999999999999999999999
Q ss_pred eeEEEEeccCCCHHHHhcccCc------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC
Q 001494 870 SFIVYEYLEMGSLAMILSNDAA------------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK 937 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~ 937 (1067)
.++||||+++++|.+++..... ...+++..++.++.|++.|++|||+. +++||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence 9999999999999999864321 13578999999999999999999999 99999999999999999
Q ss_pred CCeEEeccccceecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhh
Q 001494 938 NEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNL 1014 (1067)
Q Consensus 938 ~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~ 1014 (1067)
+.+||+|||+++........ .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------- 231 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------- 231 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------
Confidence 99999999999765432211 122335678999999998889999999999999999998 89997532221
Q ss_pred hhhhhhccCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1015 NIALDEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1015 ~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....+... ....+... ...+.+++.+||+.||++||++.||.+.|+
T Consensus 232 -~~~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 -EAIECITQGRELERPRTC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHHHHHHcCccCCCCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111111 11112222 234889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=323.50 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=197.4
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCc--EEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCcee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 871 (1067)
++|++.+.||+|+||.||+|... ++. .+|+|.++... .....+.+.+|+++++++ +||||+++++++.+.+..|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 57889999999999999999764 333 47888876422 223346788999999999 7999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccC-------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC
Q 001494 872 IVYEYLEMGSLAMILSNDA-------------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN 938 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~ 938 (1067)
+||||+++++|.+++.... ....+++..+..++.|++.|++|||++ +|+||||||+||+++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence 9999999999999986432 113588899999999999999999999 999999999999999999
Q ss_pred CeEEeccccceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhh
Q 001494 939 EARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIA 1017 (1067)
Q Consensus 939 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 1017 (1067)
.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |+.||....... .
T Consensus 157 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--------~ 227 (297)
T cd05089 157 ASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------L 227 (297)
T ss_pred eEEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------H
Confidence 99999999986432111 1111223557999999988889999999999999999997 999986433211 1
Q ss_pred hhhccCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1018 LDEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1018 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
...+... ....+.. ...++.+++.+||+.+|.+|||+.++++.|+
T Consensus 228 ~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 228 YEKLPQGYRMEKPRN----CDDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred HHHHhcCCCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111 1111211 2235889999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.88 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=201.9
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCC--ChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPG--EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 872 (1067)
++|+..+.||+|++|.||+|.. .+++.||+|.+...... .....+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999965 57899999998644322 12234568899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
||||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988543 3478899999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCc---cccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccC--CCCC
Q 001494 953 PDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD--PRLP 1027 (1067)
Q Consensus 953 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 1027 (1067)
..... .....++..|+|||.+.+..++.++||||+|+++|||++|+.||....... ....... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~ 227 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--------AIFKIATQPTNPQ 227 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--------HHHHHhccCCCCC
Confidence 32211 123467889999999999889999999999999999999999986432211 0011111 1111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
.+.. ....+.+++.+||+.+|++|||+.|+++.
T Consensus 228 ~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 228 LPSH----VSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCcc----CCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 2222 22348899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.13 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=190.2
Q ss_pred CccccCCceeEEEEEEC---CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEecc
Q 001494 802 HCIGKGGQGSVYKVELA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLE 878 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 878 (1067)
+.||+|+||.||+|... ++..+|+|++..... ......+.+|+.++++++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46999999999999754 345799998865432 2334578899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCc--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 879 MGSLAMILSNDAA--AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 879 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+|+|.+++..... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999864322 23456778889999999999999999 999999999999999999999999999975433221
Q ss_pred c--cccccccccccCccccccC-------CCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCC
Q 001494 957 N--WTELAGTYGYVAPELAYTM-------KVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRL 1026 (1067)
Q Consensus 957 ~--~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1067)
. .....+++.|+|||++.+. .++.++||||||+++|||++ |+.||......................+..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRL 235 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCcc
Confidence 1 1234567889999987642 35789999999999999996 999986443211110000000001111111
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
. . .....+.+++.+|| .+|++|||+.||++.|+
T Consensus 236 ~--~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 236 K--L----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred C--C----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 0 11234788999999 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=321.16 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=205.3
Q ss_pred HHhcCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCcee
Q 001494 793 RATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 793 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 871 (1067)
.....|++.++||+||.+.||++...+.+.||+|++.....+ .....-|..|+..+.++ .|.+||++++|-..++..|
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D-~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEAD-NQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcC-HHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 345679999999999999999999988899999988654433 34467899999999999 5999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+||||-+ -+|..+++.... ....| .++.+..|++.|+.+.|.+ ||||.|+||.|+|+- .|.+||+|||+|..+
T Consensus 437 mvmE~Gd-~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECGD-IDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred EEeeccc-ccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 9999875 599999965432 23334 6778899999999999999 999999999999985 689999999999988
Q ss_pred CCCCCc--cccccccccccCccccccCC-----------CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhh
Q 001494 952 KPDSSN--WTELAGTYGYVAPELAYTMK-----------VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIAL 1018 (1067)
Q Consensus 952 ~~~~~~--~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 1018 (1067)
..+... ....+||+.||+||.+.... .++++||||+|||+|+|+.|+.||.... .....+
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~aKl 582 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIAKL 582 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHHHH
Confidence 766543 34578999999999876432 4578999999999999999999986433 234455
Q ss_pred hhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1019 DEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1019 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
..+.+|.-.++.....+. .++.+++..||++||++||+..|+++
T Consensus 583 ~aI~~P~~~Iefp~~~~~-~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 583 HAITDPNHEIEFPDIPEN-DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HhhcCCCccccccCCCCc-hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 666666442222211111 12889999999999999999999986
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=323.92 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=202.1
Q ss_pred hcCCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeC
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHA 867 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 867 (1067)
.++|+..+.||+|+||.||++... ....+|+|++.... ......++.+|+.+++++ +||||+++++++..+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 356888899999999999998653 23679999987532 223346688999999999 899999999999999
Q ss_pred CceeEEEEeccCCCHHHHhccc-------------CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 001494 868 QHSFIVYEYLEMGSLAMILSND-------------AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLL 934 (1067)
Q Consensus 868 ~~~~lv~E~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill 934 (1067)
+..++||||+++|+|..+++.. .....+++..++.++.|++.|++|||+. +|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 9999999999999999998642 2234689999999999999999999999 99999999999999
Q ss_pred CCCCCeEEeccccceecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccc
Q 001494 935 DFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSS 1011 (1067)
Q Consensus 935 ~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~ 1011 (1067)
+.++.+|++|||.++.+...... .....++..|+|||++.+..++.++|||||||++||+++ |..||.......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 99999999999999876543211 122334678999999988889999999999999999998 889976432211
Q ss_pred hhhhhhhhhccCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1012 LNLNIALDEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1012 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....+... ....+.. ....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 243 -----~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 243 -----LFKLLKEGYRMEKPQN----CTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred -----HHHHHHcCCcCCCCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 11111111 1112222 2234889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=335.87 Aligned_cols=243 Identities=24% Similarity=0.277 Sum_probs=188.7
Q ss_pred cccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC---CCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI---RHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 804 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
||+|+||+||+|+. .+++.||+|++.............+..|..++... +||+|+++++++.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999965 46899999998643211122233455566666554 699999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|.+++... ..+++..+..++.||++|++|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 9999888543 3588999999999999999999999 999999999999999999999999999976443333344
Q ss_pred cccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHH
Q 001494 960 ELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLI 1038 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1067)
..+||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+.......+... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~---~~~ 223 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIAFGKVRFPKNV---LSD 223 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHHcCCCCCCCcc---CCH
Confidence 56799999999988764 478999999999999999999999864322 111222222223333221 123
Q ss_pred HHHHHHHhccCCCCCCCC----CHHHHHH
Q 001494 1039 SFVEVAISCLDESPESRP----TMQKVSQ 1063 (1067)
Q Consensus 1039 ~l~~li~~cl~~dP~~Rp----t~~evl~ 1063 (1067)
++.+++.+||+.||++|| ++.++++
T Consensus 224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 478999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.62 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=199.5
Q ss_pred CCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCce
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 870 (1067)
+|++.+.||+|+||.||+|... ....+|+|.+.... .....+++..|+.+++.++||||+++++++...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4778899999999999998643 23568888886432 223346788999999999999999999999999999
Q ss_pred eEEEEeccCCCHHHHhcccC---------------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCC
Q 001494 871 FIVYEYLEMGSLAMILSNDA---------------------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISS 929 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~ 929 (1067)
++||||+++++|.+++.... ....+++.++..++.|++.|++|||++ +|+||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 99999999999999885321 123578999999999999999999999 999999999
Q ss_pred CceeeCCCCCeEEeccccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccc
Q 001494 930 KNVLLDFKNEARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISL 1006 (1067)
Q Consensus 930 ~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~ 1006 (1067)
+||++++++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999986543322 1122345678999999888889999999999999999998 9999864332
Q ss_pred ccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1007 ISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.. ......... ....+.. ...++.+++.+||+.+|++||++.|+++.|+
T Consensus 236 ~~-----~~~~~~~~~--~~~~~~~----~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~ 284 (290)
T cd05045 236 ER-----LFNLLKTGY--RMERPEN----CSEEMYNLMLTCWKQEPDKRPTFADISKELE 284 (290)
T ss_pred HH-----HHHHHhCCC--CCCCCCC----CCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 11 011111111 1111211 2235889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.63 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=201.8
Q ss_pred CccCccccCCceeEEEEEEC--CCc--EEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 799 DDEHCIGKGGQGSVYKVELA--SGE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 799 ~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
...++||+|.||+|++|.+. +|+ .||||.++...... ...+|++|+.+|.+++|||++++||+..+ ....+||
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 44578999999999999654 454 58999998654433 46789999999999999999999999987 7788999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
|+++.|+|.+.++. .....+-......++.|||.|++||.++ +.||||+..+|+++-....|||+|||+.+.++..
T Consensus 190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999976 5667788888999999999999999999 9999999999999999999999999999988765
Q ss_pred CCcccc---ccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhcc-CCCCCCC
Q 001494 955 SSNWTE---LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEIL-DPRLPIP 1029 (1067)
Q Consensus 955 ~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1029 (1067)
...+.. ..-...|+|||.+....++.++|||+|||++|||+| |..||-+.... .....+- ..+++-|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------qIL~~iD~~erLpRP 337 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------QILKNIDAGERLPRP 337 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------HHHHhccccccCCCC
Confidence 544321 122467999999999999999999999999999998 67886544321 1122221 1233333
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
..+ .+.+++++..||..+|++|||+..+.+.
T Consensus 338 k~c----sedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 338 KYC----SEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCC----hHHHHHHHHHhccCCccccccHHHHHHh
Confidence 333 3459999999999999999999999754
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=324.40 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=197.7
Q ss_pred hcCCCccCccccCCceeEEEEEEC-CCc--EEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCce
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA-SGE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 870 (1067)
.++|++.+.||+|+||.||+|+.+ ++. .+|+|.+.... .....+.+.+|++++.++ +||||+++++++.+++..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 357888999999999999999764 454 45777765322 223456788999999999 899999999999999999
Q ss_pred eEEEEeccCCCHHHHhcccCc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC
Q 001494 871 FIVYEYLEMGSLAMILSNDAA-------------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK 937 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~ 937 (1067)
|+||||+++++|.+++..... ...+++.+++.++.|++.|++|||++ +|+||||||+||+++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence 999999999999999864321 23578999999999999999999999 99999999999999999
Q ss_pred CCeEEeccccceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhh
Q 001494 938 NEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNI 1016 (1067)
Q Consensus 938 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 1016 (1067)
+.+||+|||+++...... ......++..|+|||.+.+..++.++|||||||++|||+| |..||.......
T Consensus 161 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------- 231 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------- 231 (303)
T ss_pred CcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--------
Confidence 999999999986432111 1112234667999999988889999999999999999998 999986433211
Q ss_pred hhhhccCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1017 ALDEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1017 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....+... ....+.. ....+.+++.+||+.+|++||++.++++.++
T Consensus 232 ~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 232 LYEKLPQGYRLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred HHHHHhcCCcCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111111 1111111 2235889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.74 Aligned_cols=250 Identities=25% Similarity=0.441 Sum_probs=200.1
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
++|...++||+|+||.||+|....+..||+|++.... ...+.+.+|++++++++|||++++++++. .+..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 4588889999999999999988777789999876432 12467889999999999999999999875 456899999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 81 FMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999996432 34578999999999999999999999 99999999999999999999999999998764332
Q ss_pred Cc-cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CCCCCCcc
Q 001494 956 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLPIPSHN 1032 (1067)
Q Consensus 956 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1032 (1067)
.. .....++..|+|||...+..++.++|||||||++|||++ |+.||...... .....+... ....+.
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~-- 226 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--------EVLEQVERGYRMPCPQ-- 226 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCCc--
Confidence 21 122345678999999988889999999999999999999 89998643221 111111111 111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....+.+++.+||+.+|++||++++++++|+
T Consensus 227 --~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 227 --GCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred --ccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 23345899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.74 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=201.0
Q ss_pred cCCCccCccccCCceeEEEEEEC----CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCcee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 871 (1067)
.+|+..+.||+|+||.||+|+.. .+..+|+|.+..... ....+.+..|+.++++++||||+++++++.+++..|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46888899999999999999653 234799999865432 233567899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+||||+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++...
T Consensus 82 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 82 IVTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999999643 24579999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcc---ccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CC
Q 001494 952 KPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RL 1026 (1067)
Q Consensus 952 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1026 (1067)
....... ....++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ....+... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~~ 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYRL 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCCcC
Confidence 5432211 11223568999999998889999999999999999886 999986433211 11111111 11
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
+.+. ..+..+.+++.+|++.+|.+||++.++++.|+
T Consensus 229 ~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 264 (267)
T cd05066 229 PAPM----DCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264 (267)
T ss_pred CCCC----CCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence 1111 12335889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=341.22 Aligned_cols=256 Identities=21% Similarity=0.276 Sum_probs=189.5
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC------
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA------ 867 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 867 (1067)
..+|+..++||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 35799999999999999999965 478999999885321 2234799999999999999999887432
Q ss_pred --CceeEEEEeccCCCHHHHhcc-cCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC-CeEEe
Q 001494 868 --QHSFIVYEYLEMGSLAMILSN-DAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN-EARVS 943 (1067)
Q Consensus 868 --~~~~lv~E~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~-~~kl~ 943 (1067)
...++||||+++ ++.+++.. ......+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence 246799999986 56555532 23345689999999999999999999999 999999999999999765 69999
Q ss_pred ccccceecCCCCCccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh-------h
Q 001494 944 DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL-------N 1015 (1067)
Q Consensus 944 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------~ 1015 (1067)
|||+|+.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||............. .
T Consensus 214 DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 214 DFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 999998765332 22345789999999987664 68999999999999999999999987543211100000 0
Q ss_pred hhhhhccCC---CCCCCC---cch-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1016 IALDEILDP---RLPIPS---HNV-----QEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1016 ~~~~~~~~~---~~~~~~---~~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
..... ..+ ....+. ... .....++.+++.+||+.||.+|||+.|+++
T Consensus 293 ~~~~~-~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 293 DQLKE-MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHH-hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000 000 000000 000 011235889999999999999999999875
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.32 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=206.9
Q ss_pred CCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..+.||+|+||.||.++ ..+++.+|+|++....... ...+++.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 47888999999999999985 4568899999986543222 335678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999986533 34588999999999999999999999 99999999999999999999999999998765544
Q ss_pred CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHH
Q 001494 956 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1067)
.......+++.|+|||...+..++.++||||+|+++|||++|+.||+.... ......+......... ..
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~---~~ 224 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIVQGNYTPVV---SV 224 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCCc---cc
Confidence 334456789999999999888889999999999999999999999864322 1122222222222111 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1036 KLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1036 ~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
...++.+++.+||+.+|++||++.++++..
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 225 YSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 234588999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=333.12 Aligned_cols=259 Identities=21% Similarity=0.307 Sum_probs=195.8
Q ss_pred HhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC----
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ---- 868 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 868 (1067)
..++|+..+.||+|+||.||++.. .+|+.||+|++...... ....+++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 347899999999999999999965 56899999998754322 233567789999999999999999999986543
Q ss_pred --ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccc
Q 001494 869 --HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 869 --~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 946 (1067)
..|+||||+++ ++...+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999976 4555542 2378888999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchh-------------
Q 001494 947 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN------------- 1013 (1067)
Q Consensus 947 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~------------- 1013 (1067)
+++..... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||............
T Consensus 169 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 169 LARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred CccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 99765432 2234457899999999999989999999999999999999999998654321100000
Q ss_pred -hhhhhhhccCC--C------------CCCCC--cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1014 -LNIALDEILDP--R------------LPIPS--HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1014 -~~~~~~~~~~~--~------------~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
........... . +..+. .........+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000000 0 00000 000111235789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.39 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=201.5
Q ss_pred hcCCCccCccccCCceeEEEEEE--------CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEe
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL--------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 865 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 865 (1067)
..+|.+.+.||+|+||.||+|+. .++..||+|.+.... .....+++.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 35688899999999999999863 134579999986432 223356788999999999 8999999999999
Q ss_pred eCCceeEEEEeccCCCHHHHhcccCc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCce
Q 001494 866 HAQHSFIVYEYLEMGSLAMILSNDAA-------------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNV 932 (1067)
Q Consensus 866 ~~~~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Ni 932 (1067)
..+..|+||||+++|+|.+++..... ...+++.++..++.|++.|++|||++ +|+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999864321 23578889999999999999999999 999999999999
Q ss_pred eeCCCCCeEEeccccceecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccc
Q 001494 933 LLDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISS 1009 (1067)
Q Consensus 933 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~ 1009 (1067)
+++.++.+||+|||.++........ .....+++.|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-- 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence 9999999999999999876543221 122345678999999988889999999999999999998 78887543321
Q ss_pred cchhhhhhhhhccCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1010 SSLNLNIALDEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1010 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....+... ....+. .....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 247 ------~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 247 ------ELFKLLKEGHRMDKPA----NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred ------HHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 111111111 111111 12335889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=325.00 Aligned_cols=254 Identities=30% Similarity=0.452 Sum_probs=200.6
Q ss_pred CCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|+.++.||+|+||+||+++.. +++.||+|++....... .......+|+.++++++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence 567899999999999999765 56789999998653222 1222345699999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+++++|.+++. ....+++..+..++.|+++||+|||++ +|+||||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 80 CPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp ETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred ccccccccccc---ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999996 334579999999999999999999999 999999999999999999999999999987543444
Q ss_pred ccccccccccccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHH
Q 001494 957 NWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1067)
......++..|+|||++. +..++.++||||+|+++|+|++|..||........................ . ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~ 228 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-Q----QSRE 228 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-T----SHTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-c----ccch
Confidence 555677899999999988 788999999999999999999999998754111111111111100110000 0 0000
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1036 KLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1036 ~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...++.+++.+||+.||++||++.++++
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1146899999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.59 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=201.5
Q ss_pred cCCCccCccccCCceeEEEEEE------CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCC
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQ 868 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 868 (1067)
++|...+.||+|+||.||++.. .++..||+|++.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 5688999999999999999863 235579999987542 223346789999999999 7999999999999999
Q ss_pred ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccc
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a 948 (1067)
..|+||||+++|+|.++++... ...+++.++..++.|++.|++|||++ +|+|+||||+||+++.++.++++|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999986432 23489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCC
Q 001494 949 KFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPR 1025 (1067)
Q Consensus 949 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1067)
+........ .....+++.|+|||.+.+..++.++||||+||++|||++ |+.||........ ......... .
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~----~~~~~~~~~--~ 262 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK----FYKLIKEGY--R 262 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH----HHHHHHcCC--c
Confidence 865433211 122345678999999988889999999999999999998 9999764332110 011111111 1
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1026 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
...+.. ...++.+++.+|++.+|++|||+.|+++.|+
T Consensus 263 ~~~~~~----~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~ 299 (302)
T cd05055 263 MAQPEH----APAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299 (302)
T ss_pred CCCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 111111 1235899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.03 Aligned_cols=249 Identities=29% Similarity=0.454 Sum_probs=203.7
Q ss_pred cCCCccCccccCCceeEEEEEECC-CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..++||+|+||.||+|.... ++.||+|.+.... ..+++.+|++++++++||||+++++++.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 578899999999999999997664 7899999986431 1578999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 999999999998532 34689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
........++..|+|||++.+..++.++||||||+++|||++|+.||........ .........+....+ .
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~----~ 223 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----IFMIPNKPPPTLSDP----E 223 (256)
T ss_pred ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----hhhhccCCCCCCCch----h
Confidence 3333445678899999999888899999999999999999999999874332111 000011111111111 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.....+.+++.+||+.+|++|||+.|+++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 22345889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.88 Aligned_cols=252 Identities=27% Similarity=0.495 Sum_probs=204.4
Q ss_pred hcCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.++|.+.++||+|+||.||+|..++++.||||.+..... ..+++.+|+.++++++|||++++++++......++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 367889999999999999999888888999999874322 2467889999999999999999999999989999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++.... ...+++.++..++.+++.|++|||++ +++||||||+||+++.++.+|++|||.++.....
T Consensus 81 e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 81 EYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred eccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999996532 34589999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCc-cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CCCCCCc
Q 001494 955 SSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLPIPSH 1031 (1067)
Q Consensus 955 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1031 (1067)
... .....++..|+|||.+.+..++.++||||+||++||+++ |+.||..... ......+... ....+..
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~ 228 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVERGYRMPRPPN 228 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCCC
Confidence 111 112234568999999998889999999999999999998 9999854321 1111111111 1111211
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
. ..++.+++.+|++.+|++||++.++.+.|+
T Consensus 229 ~----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 229 C----PEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred C----CHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 1 335899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.65 Aligned_cols=256 Identities=23% Similarity=0.423 Sum_probs=198.1
Q ss_pred cCCCccCccccCCceeEEEEEE------CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeC-
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHA- 867 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 867 (1067)
++|++.+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 5789999999999999999853 4578899999975432 22346788999999999 689999999988654
Q ss_pred CceeEEEEeccCCCHHHHhcccCc--------------------------------------------------------
Q 001494 868 QHSFIVYEYLEMGSLAMILSNDAA-------------------------------------------------------- 891 (1067)
Q Consensus 868 ~~~~lv~E~~~~g~L~~~l~~~~~-------------------------------------------------------- 891 (1067)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999998854210
Q ss_pred --------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC--ccccc
Q 001494 892 --------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS--NWTEL 961 (1067)
Q Consensus 892 --------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~ 961 (1067)
...+++.++.+++.|+++|++|||++ +|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 12368888999999999999999999 999999999999999999999999999986543222 11223
Q ss_pred cccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHH
Q 001494 962 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISF 1040 (1067)
Q Consensus 962 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1040 (1067)
.+++.|+|||.+.+..++.++||||||+++|||++ |..||........ ....... ......+... ..++
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~~~--~~~~~~~~~~----~~~~ 311 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLKE--GTRMRAPDYT----TPEM 311 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH----HHHHHhc--cCCCCCCCCC----CHHH
Confidence 45678999999988889999999999999999997 8999864322110 0011111 1111112111 2248
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1041 VEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1041 ~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+++..||+.+|++|||+.|+++.|+
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~ 337 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLG 337 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHH
Confidence 89999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=320.08 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=198.1
Q ss_pred HhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeC----
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHA---- 867 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~---- 867 (1067)
+...|+..+.||+|+||.||+|.. .+++.||+|++..... ...++..|+.+++++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 456788889999999999999965 4688999999864321 235678899999998 799999999998653
Q ss_pred --CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecc
Q 001494 868 --QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDF 945 (1067)
Q Consensus 868 --~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~Df 945 (1067)
...|+||||+++++|.+++.... ...+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 45899999999999999986432 34588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhh
Q 001494 946 GIAKFLKPDSSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDE 1020 (1067)
Q Consensus 946 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1020 (1067)
|+++.............|++.|+|||++. +..++.++||||+||++|||++|+.||+......... ....
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~~~ 230 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LIPR 230 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----HHhc
Confidence 99987654433445567899999999876 3357889999999999999999999986433211110 0001
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1021 ILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...... ... ....++.+++.+||+.+|.+|||+.|+++
T Consensus 231 ~~~~~~--~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPAPRL--KSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCC--CCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 101111 111 12235889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.24 Aligned_cols=245 Identities=27% Similarity=0.433 Sum_probs=194.0
Q ss_pred CccccCCceeEEEEEEC-C---CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEec
Q 001494 802 HCIGKGGQGSVYKVELA-S---GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYL 877 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 877 (1067)
++||+|+||.||+|... . +..||+|.+...... ...+++..|+++++.++||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999998543 2 368999998754322 34577899999999999999999999876 45689999999
Q ss_pred cCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCc
Q 001494 878 EMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN 957 (1067)
Q Consensus 878 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 957 (1067)
++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++........
T Consensus 78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999996433 588999999999999999999999 9999999999999999999999999999876543322
Q ss_pred ccc---ccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 958 WTE---LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 958 ~~~---~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
... ..++..|+|||.+.+..++.++||||||+++|||++ |+.||+...... ........ .....+..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-----~~~~~~~~--~~~~~~~~-- 222 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-----VIAMLESG--ERLPRPEE-- 222 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHHHcC--CcCCCCCC--
Confidence 211 123467999999988889999999999999999998 999986443211 01111111 11112222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
...++.+++.+||+.+|++||++.++++.|+
T Consensus 223 --~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~ 253 (257)
T cd05060 223 --CPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253 (257)
T ss_pred --CCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 2235889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.85 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=197.0
Q ss_pred CCccCccccCCceeEEEEEE-----CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--Cce
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--QHS 870 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 870 (1067)
|+..+.||+|+||+||++.. .+++.||+|.+..... ....+.+.+|++++++++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 37889999999999988542 4678899999875422 22356788999999999999999999988654 357
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
++||||+++++|.+++.. ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence 899999999999999854 2489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc---cccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccc------hhhhhhhhhc
Q 001494 951 LKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSS------LNLNIALDEI 1021 (1067)
Q Consensus 951 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~------~~~~~~~~~~ 1021 (1067)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.......... ........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 6533221 112335667999999988889999999999999999999999975432110000 0000011111
Q ss_pred cCCC--CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1022 LDPR--LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1022 ~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+.. .+.+.. ...++.+++.+||+.+|++|||++++++.|+
T Consensus 237 ~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~ 279 (283)
T cd05080 237 LERGMRLPCPKN----CPQEVYILMKNCWETEAKFRPTFRSLIPILK 279 (283)
T ss_pred hhcCCCCCCCCC----CCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 1111 111111 2245899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=318.74 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=200.1
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
+.|++.++||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 56888999999999999999765 5889999998643 3334577889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||++++++..++... ...+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 89 EFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred ecCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 999999998877432 23588999999999999999999999 9999999999999999999999999998765443
Q ss_pred CCccccccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCC
Q 001494 955 SSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1067)
........+++.|+|||++. ...++.++|||||||++|||++|+.||....... ..........+....+
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~ 238 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSEPPTLSQP 238 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-----HHHHHhcCCCccCCCC
Confidence 33344566888999999875 3446889999999999999999999975432211 0011111111111112
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
. ....++.+++.+||+.+|++||++.|+++
T Consensus 239 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 239 S----KWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred c----ccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1 22235889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.69 Aligned_cols=248 Identities=30% Similarity=0.470 Sum_probs=202.4
Q ss_pred CccccCCceeEEEEEECC----CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEec
Q 001494 802 HCIGKGGQGSVYKVELAS----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYL 877 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 877 (1067)
+.||+|+||.||+|.... +..||+|++....... ..+.+.+|++.++.++|+|++++++++......++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 469999999999997653 7889999987653322 3578899999999999999999999999999999999999
Q ss_pred cCCCHHHHhcccCc------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 878 EMGSLAMILSNDAA------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 878 ~~g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
++++|.+++..... ...+++.++..++.|++.|++|||++ +++||||||+||+++.++.+|++|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence 99999999965421 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC--CccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccC-CCCC
Q 001494 952 KPDS--SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILD-PRLP 1027 (1067)
Q Consensus 952 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1027 (1067)
.... .......+++.|+|||.+....++.++||||+|+++|||++ |..||+..... .....+.. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~ 227 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--------EVLEYLRKGYRLP 227 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence 5432 22234557889999999988889999999999999999999 69998754321 11111111 1112
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+.. ...++.+++.+||+.+|++|||+.|+++.|+
T Consensus 228 ~~~~----~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 KPEY----CPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCcc----CChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 2222 2345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=323.75 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=199.8
Q ss_pred cCCCccCccccCCceeEEEEEEC--------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA--------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH 866 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 866 (1067)
++|.+.+.||+|+||.||+|+.. ++..||+|.+..... .....++..|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 56899999999999999998642 235699999875422 22346788899999999 79999999999999
Q ss_pred CCceeEEEEeccCCCHHHHhcccCc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcee
Q 001494 867 AQHSFIVYEYLEMGSLAMILSNDAA-------------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVL 933 (1067)
Q Consensus 867 ~~~~~lv~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nil 933 (1067)
.+..|+||||+++|+|.+++..... ...+++.++++++.|++.|++|||+. +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 9999999999999999999965321 23588999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeccccceecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccc
Q 001494 934 LDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSS 1010 (1067)
Q Consensus 934 l~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~ 1010 (1067)
++.++.+||+|||.++........ .....+++.|+|||.+.+..++.++||||+||++|||++ |+.||......
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--- 249 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 249 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---
Confidence 999999999999999765432211 112234568999999988889999999999999999998 88887543221
Q ss_pred chhhhhhhhhccCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1011 SLNLNIALDEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1011 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....+... ....+.. ...++.+++.+||+.+|++|||+.++++.|+
T Consensus 250 -----~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 250 -----ELFKLLKEGHRMDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred -----HHHHHHHcCCCCCCCCc----CCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 111111111 1112222 2235889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=314.43 Aligned_cols=240 Identities=22% Similarity=0.417 Sum_probs=188.1
Q ss_pred CccccCCceeEEEEEECC-------------CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC
Q 001494 802 HCIGKGGQGSVYKVELAS-------------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ 868 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 868 (1067)
+.||+|+||.||+|...+ ...||+|.+... .....+.+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999997532 235888887543 2233467888999999999999999999999999
Q ss_pred ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCC-------eE
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNE-------AR 941 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~-------~k 941 (1067)
..++||||+++|++..++... ...+++..+.+++.||++|++|||++ +|+||||||+||+++.++. ++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 999999999999999888532 24588999999999999999999999 9999999999999987664 89
Q ss_pred EeccccceecCCCCCccccccccccccCccccc-cCCCCccchhHHHHHHHHHHH-hCCCCCCccccccccchhhhhhhh
Q 001494 942 VSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALD 1019 (1067)
Q Consensus 942 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 1019 (1067)
++|||.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+........ .
T Consensus 153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---------~ 219 (262)
T cd05077 153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK---------E 219 (262)
T ss_pred eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH---------H
Confidence 9999998755322 2345788899999886 456899999999999999998 58888753321110 0
Q ss_pred hccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1020 EILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
............. ..++.+++.+||+.||++||++.++++.+.
T Consensus 220 ~~~~~~~~~~~~~----~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYEGQCMLVTPS----CKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHhcCccCCCCC----hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1111111111111 234889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=315.65 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=198.0
Q ss_pred HhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeE
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 872 (1067)
+++.+.....||+|+||.||+|+. .+++.||+|.+... .....+.+.+|++++++++||||+++++++..++..++
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 345566667899999999999974 46788999988643 22345678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC-CCCeEEeccccceec
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF-KNEARVSDFGIAKFL 951 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~-~~~~kl~DfG~a~~~ 951 (1067)
||||+++++|.+++.........++..+..++.|++.|++|||++ +|+||||||+||+++. ++.++|+|||.+...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999986432211127788889999999999999999 9999999999999986 678999999999876
Q ss_pred CCCCCccccccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCC
Q 001494 952 KPDSSNWTELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029 (1067)
Q Consensus 952 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1067)
...........+++.|+|||++.+.. ++.++||||+|+++|||++|+.||........ ..............+
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~ 234 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----AMFKVGMFKIHPEIP 234 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----hHhhhhhhccCCCCC
Confidence 54333334456889999999886643 78899999999999999999999864321100 000000111111122
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.. ...++.+++.+||+.+|++|||+.|+++
T Consensus 235 ~~----~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ES----LSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cc----cCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 22 2234889999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.77 Aligned_cols=249 Identities=27% Similarity=0.461 Sum_probs=202.8
Q ss_pred cCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.+|+..+.||.|+||.||+|. ..+++.||+|.+..... ...+.+.+|+.+++.++|||++++++++...+..|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 468899999999999999985 46789999999865322 22467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++.. ..+++.++..++.+++.|++|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 96 EYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999999998853 2478999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
........+++.|+|||.+.+..++.++|||||||++|+|++|+.||......... ........+....+..
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~--- 240 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNGTPELQNPEK--- 240 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhcCCcccCCccc---
Confidence 43334457889999999998888999999999999999999999998654321110 0111111111111221
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+.+++.+||..||++||++.++++
T Consensus 241 -~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 241 -LSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -CCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 2234889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=335.17 Aligned_cols=259 Identities=24% Similarity=0.318 Sum_probs=196.5
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC-----ce
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ-----HS 870 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 870 (1067)
+|+..++||+|+||.||+|.. .+|+.||+|++..... .....+++.+|+++++.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 478889999999999999975 5789999999864322 2223467889999999999999999999998776 78
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
|+||||+. +++...+.. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999997 567776643 23589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC-CccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh--------------
Q 001494 951 LKPDS-SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL-------------- 1014 (1067)
Q Consensus 951 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------------- 1014 (1067)
..... .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||+............
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 54332 223345678999999998774 47899999999999999999999987543221100000
Q ss_pred -hhhhhhccCCCCCCCC-----cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1015 -NIALDEILDPRLPIPS-----HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1015 -~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
......+.......+. ....+...++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000001000000000 000112345889999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=327.49 Aligned_cols=196 Identities=27% Similarity=0.389 Sum_probs=171.4
Q ss_pred cCCCccCccccCCceeEEEE-EECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-C-----CeeeeeeEEEeeCC
Q 001494 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-H-----RNIVKFYGFCSHAQ 868 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~ 868 (1067)
.+|.+.+.||+|+||.|.+| +..+++.||||+++. ...+..+-..|+.++..++ | -|+|+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN----~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN----KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc----ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 38999999999999999999 466899999999974 4455677788999999996 4 48999999999999
Q ss_pred ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC--CeEEeccc
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN--EARVSDFG 946 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~--~~kl~DfG 946 (1067)
+.|||+|.+. -+|+++++.... ..++...+..|+.||+.||.+||+. +|||+||||+|||+...+ .+||+|||
T Consensus 262 HlciVfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 262 HLCIVFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ceeeeehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 9999999986 599999976554 3489999999999999999999999 999999999999997654 59999999
Q ss_pred cceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001494 947 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDF 1003 (1067)
Q Consensus 947 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~ 1003 (1067)
.|+....... ....+.-|+|||++.+.+|+.+.||||||||++||++|.+-|.+
T Consensus 337 SSc~~~q~vy---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 337 SSCFESQRVY---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cccccCCcce---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 9987654332 55678889999999999999999999999999999999766643
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=302.19 Aligned_cols=244 Identities=25% Similarity=0.299 Sum_probs=210.4
Q ss_pred hcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
.++|+..++||+|.||.|-.++ ..+++.+|+|++++...-.......-+.|-++++..+||.+..+--.|+..++.|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4679999999999999999985 568999999999877666655566678899999999999999999899999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+.||.|...+++.+ .+++....-+-..|..||.|||++ +||+||+|.+|.|+|.+|++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999998886543 377788888899999999999999 999999999999999999999999999987666
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.+.....++|||.|.|||++....|+.++|.|.+||++|||++|+.||...+. ...+.-++-..+.+|....
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------~kLFeLIl~ed~kFPr~ls 392 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------EKLFELILMEDLKFPRTLS 392 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--------hHHHHHHHhhhccCCccCC
Confidence 66777889999999999999999999999999999999999999999853332 2333444445566666555
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC
Q 001494 1034 QEKLISFVEVAISCLDESPESRP 1056 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rp 1056 (1067)
++ ...++...+.+||.+|.
T Consensus 393 ~e----AktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 393 PE----AKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HH----HHHHHHHHhhcChHhhc
Confidence 55 78899999999999995
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.82 Aligned_cols=256 Identities=23% Similarity=0.356 Sum_probs=203.2
Q ss_pred hcCCCccCccccCCceeEEEEEECC-----CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee-CC
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELAS-----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH-AQ 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 868 (1067)
.++|+..+.||+|+||.||+|.... +..||+|++... ......+.+.+|+.++++++||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4678889999999999999997665 688999988643 233445778899999999999999999998766 46
Q ss_pred ceeEEEEeccCCCHHHHhcccCcc-----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEe
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAA-----EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVS 943 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~ 943 (1067)
..++++||+++++|.+++...... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998643322 4689999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhh
Q 001494 944 DFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDE 1020 (1067)
Q Consensus 944 DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1020 (1067)
|||+++.+.+.... .....++..|+|||++.+..++.++|||||||++||+++ |+.||....... .......
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~ 234 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-----MAAYLKD 234 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-----HHHHHHc
Confidence 99999866433221 122345678999999988889999999999999999999 999986543211 1111111
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1021 ILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
. .....+. ....++.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~--~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 274 (280)
T cd05043 235 G--YRLAQPI----NCPDELFAVMACCWALDPEERPSFSQLVQCLT 274 (280)
T ss_pred C--CCCCCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 1 1111111 12235889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=325.27 Aligned_cols=194 Identities=22% Similarity=0.377 Sum_probs=159.2
Q ss_pred cCccccCCceeEEEEEEC---CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee--CCceeEEEE
Q 001494 801 EHCIGKGGQGSVYKVELA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH--AQHSFIVYE 875 (1067)
Q Consensus 801 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E 875 (1067)
+++||+|+||+||+|+.. +++.||+|++..... ...+.+|++++++++||||+++++++.. ....|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999754 567899999864321 2456789999999999999999998854 456899999
Q ss_pred eccCCCHHHHhcccC------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee----CCCCCeEEecc
Q 001494 876 YLEMGSLAMILSNDA------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLL----DFKNEARVSDF 945 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill----~~~~~~kl~Df 945 (1067)
|+++ ++.+++.... ....+++..+..++.|++.|++|||++ +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9865 7777764221 123588899999999999999999999 99999999999999 45678999999
Q ss_pred ccceecCCCCC---ccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCc
Q 001494 946 GIAKFLKPDSS---NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDF 1003 (1067)
Q Consensus 946 G~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~ 1003 (1067)
|+++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 99987653321 23346789999999988764 589999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.74 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=197.9
Q ss_pred CCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|++.+.||+|+||.||+|... ++..+|+|.+... .....+.+..|+++++.++|||++++++++..++..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 566788999999999999765 5788899988543 223456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
++++++..++.. ...++++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|++|||++........
T Consensus 84 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 84 CAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred cCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 999999888753 234589999999999999999999999 999999999999999999999999999976544333
Q ss_pred ccccccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCc
Q 001494 957 NWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1067)
......+++.|+|||++. +..++.++||||+||++|||++|+.||........ .........+....+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 233 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKSEPPTLAQPSR 233 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-----HHHHhhcCCCCCCCccc
Confidence 334567899999999874 34577899999999999999999999864332110 00111111111111211
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...++.+++.+||+.+|.+||++.++++
T Consensus 234 ----~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 234 ----WSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ----cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2235889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=313.41 Aligned_cols=248 Identities=26% Similarity=0.440 Sum_probs=198.3
Q ss_pred CccccCCceeEEEEEECC--C--cEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEec
Q 001494 802 HCIGKGGQGSVYKVELAS--G--EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYL 877 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 877 (1067)
++||+|++|.||+|...+ + ..||+|.+...... ...+.+..|+.++++++||||+++++++.+ ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999997643 3 36899998765332 456789999999999999999999999988 8899999999
Q ss_pred cCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCc
Q 001494 878 EMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN 957 (1067)
Q Consensus 878 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 957 (1067)
++++|.+++..... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++.+......
T Consensus 78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999999865432 5689999999999999999999999 9999999999999999999999999999876543221
Q ss_pred c---ccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 958 W---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 958 ~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
+ ....++..|+|||++.+..++.++|||||||++|||++ |+.||+....... ...... .......+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-----~~~~~~-~~~~~~~~~--- 224 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI-----LKKIDK-EGERLERPE--- 224 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHh-cCCcCCCCc---
Confidence 1 12456788999999988889999999999999999999 9999864332110 000110 111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
..+..+.+++.+|++.+|++||++.++++.|.
T Consensus 225 -~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 -ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 12345889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=295.76 Aligned_cols=262 Identities=22% Similarity=0.375 Sum_probs=215.9
Q ss_pred HHHHHHHhcCCCccCccccCCceeEEEE-EECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEe
Q 001494 788 YEEIIRATNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 865 (1067)
Q Consensus 788 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 865 (1067)
++++.+.+. +.||+|+|+.|-.+ ...+|..||||++.+. .+ .....+.+|++++.+. .|+||+.++++|+
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~g--HsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PG--HSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-Cc--hHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 555555443 67999999999986 6789999999999765 22 3357788999999999 5999999999999
Q ss_pred eCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCC---eEE
Q 001494 866 HAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNE---ARV 942 (1067)
Q Consensus 866 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~---~kl 942 (1067)
+++.+|+|||-|.||.+...+++.. .+++.++.+++++|+.||.|||.+ ||.|||+||+|||-..... +||
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence 9999999999999999998886544 488899999999999999999999 9999999999999976654 899
Q ss_pred eccccceecCCC-------CCccccccccccccCccccc---c--CCCCccchhHHHHHHHHHHHhCCCCCCcccc----
Q 001494 943 SDFGIAKFLKPD-------SSNWTELAGTYGYVAPELAY---T--MKVTEKCDVYSFGVLALEVIKGKHPGDFISL---- 1006 (1067)
Q Consensus 943 ~DfG~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DvwslGvil~elltg~~p~~~~~~---- 1006 (1067)
|||.+.....-. .....+.+|+..|||||+.. + ..|+.+.|.||+|||+|-|++|..||.+.=.
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 999987543211 12234578889999999754 2 2478999999999999999999999854211
Q ss_pred ---ccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1007 ---ISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1007 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
-+.-.......+..+.++.+.+|...+...+.+..+++...+..|+.+|-++.++++
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111123445567788899999999999999999999999999999999999998875
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.67 Aligned_cols=252 Identities=28% Similarity=0.491 Sum_probs=200.4
Q ss_pred cCCCccCccccCCceeEEEEEEC-CC---cEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCcee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SG---EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 871 (1067)
++|+..+.||+|+||.||+|... ++ ..+|+|.+.... .....+++..|++++++++|||++++.+++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 46788899999999999999764 33 379999986532 2233567899999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+||||+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 83 IITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999998542 24589999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCcc-c--cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CC
Q 001494 952 KPDSSNW-T--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RL 1026 (1067)
Q Consensus 952 ~~~~~~~-~--~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1026 (1067)
....... . ....++.|+|||++.+..++.++|||||||++|||++ |+.||..... ......+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~~~~~~ 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAINDGFRL 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhcCCCC
Confidence 4322211 1 1223457999999988889999999999999999998 9999854322 1111111111 11
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
+.+. +...++.+++.+||+.+|++||++.+|++.|+
T Consensus 230 ~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~ 265 (268)
T cd05063 230 PAPM----DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265 (268)
T ss_pred CCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1111 22345889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=329.06 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=195.6
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|++.+.||+|+||+||+++. .+++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688999999999999999975 468999999986422222233456888999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++.+. ...+++..+..++.||+.|++|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998542 33588999999999999999999999 9999999999999999999999999999766543
Q ss_pred CC-ccccccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccC--CCC
Q 001494 955 SS-NWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD--PRL 1026 (1067)
Q Consensus 955 ~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 1026 (1067)
.. ......||+.|+|||++.. ..++.++||||+||++|||++|+.||........ ...+.. ...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--------~~~i~~~~~~~ 227 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--------YGKIMNHKEHF 227 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH--------HHHHHcCCCcc
Confidence 22 2223568999999998863 4578899999999999999999999864332111 111111 111
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCC--CCCCHHHHHH
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPE--SRPTMQKVSQ 1063 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~--~Rpt~~evl~ 1063 (1067)
..+.. ......++.+++.+|+..+++ .||++.++++
T Consensus 228 ~~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 228 QFPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred cCCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 11111 011233478888887765443 4789988875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=322.49 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=199.6
Q ss_pred cCCCccCccccCCceeEEEEEEC--------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA--------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH 866 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 866 (1067)
.+|.+.++||+|+||.||+|+.. ....||+|.+.... ......++..|+.+++++ +||||+++++++.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 56888999999999999998642 34568999987432 223356788999999999 69999999999999
Q ss_pred CCceeEEEEeccCCCHHHHhcccC-------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcee
Q 001494 867 AQHSFIVYEYLEMGSLAMILSNDA-------------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVL 933 (1067)
Q Consensus 867 ~~~~~lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nil 933 (1067)
.+..|+||||+++|+|.+++.... ....+++.++.+++.|++.|++|||++ ||+||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence 999999999999999999986432 123588999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeccccceecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccc
Q 001494 934 LDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSS 1010 (1067)
Q Consensus 934 l~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~ 1010 (1067)
++.++.+||+|||.++........ .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-- 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-- 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 999999999999999865432211 112234467999999988889999999999999999999 888876433211
Q ss_pred chhhhhhhhhccCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1011 SLNLNIALDEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1011 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....+... ....+... ..++.+++.+||+.+|++|||+.|+++.|+
T Consensus 245 ------~~~~~~~~~~~~~~~~~----~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 245 ------LFKLLREGHRMDKPSNC----THELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred ------HHHHHHcCCCCCCCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11111111 11112221 234889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.17 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=201.2
Q ss_pred CCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCC---ChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPG---EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
+|+..+.||+|+||+||+|...+++.+|+|.+...... .....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47888999999999999998888999999998654322 122345688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998543 3478899999999999999999999 999999999999999999999999999876532
Q ss_pred C------CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC
Q 001494 954 D------SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 954 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
. ........|+..|+|||++.+..++.++||||+||++|||++|+.||......... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~ 229 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-----FYIGAHRGLMPR 229 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-----HHhhhccCCCCC
Confidence 1 11123356888999999999888999999999999999999999998643321100 000011011111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.+.. ...++.+++.+||+.+|++||++.|+++
T Consensus 230 ~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 LPDS----FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1222 2234889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.62 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=200.7
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
.+|+..+.||+|+||.||+|...+++.+|+|++...... ..++.+|++++++++||+++++++++......++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 467888999999999999998877889999998643221 3568899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++... ...++++.+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||.++......
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 80 FMEHGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred cCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 99999999988542 23578999999999999999999999 99999999999999999999999999998654322
Q ss_pred Cc-cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CCCCCCcc
Q 001494 956 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLPIPSHN 1032 (1067)
Q Consensus 956 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1032 (1067)
.. .....++.+|+|||.+.+..++.++||||+|+++|||++ |+.||...... .....+... ....+..
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~- 225 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------EVVETINAGFRLYKPRL- 225 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHhCCCCCCCCCC-
Confidence 11 122334678999999988889999999999999999998 99998643211 111111111 1111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....+.+++.+||+.+|++|||+.|+++.|.
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1235899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=317.37 Aligned_cols=260 Identities=23% Similarity=0.386 Sum_probs=199.9
Q ss_pred cCCCccCccccCCceeEEEEEE-----CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--C
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--Q 868 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 868 (1067)
..|+..+.||+|+||.||.++. .+++.||+|.+.... .....+.+.+|++++++++|||++++++++.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3467889999999999999863 367889999986442 233356789999999999999999999998775 5
Q ss_pred ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccc
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a 948 (1067)
..++||||+++++|.+++... ...+++.++..++.|++.|++|||++ ||+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 689999999999999998543 23589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc---cccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc-------ccchhhhhhh
Q 001494 949 KFLKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLIS-------SSSLNLNIAL 1018 (1067)
Q Consensus 949 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~-------~~~~~~~~~~ 1018 (1067)
+........ .....++..|+|||++.+..++.++|||||||++|||++++.|+....... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 876543221 123456778999999988889999999999999999999887642211000 0000000011
Q ss_pred hhccCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1019 DEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1019 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
...... ..+.+.. ...++.+++.+||+.+|++|||+.++++.++
T Consensus 237 ~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 237 RVLEEGKRLPRPPN----CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281 (284)
T ss_pred HHHHcCccCCCCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 111111 1111211 2345899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=316.78 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=197.2
Q ss_pred cCCCccCccccCCceeEEEEEE-----CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--C
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--Q 868 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~ 868 (1067)
..|+..+.||+|+||+||++.. .+++.||+|++... .....+.+.+|++++++++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4678889999999999999864 36889999998643 233456789999999999999999999987543 4
Q ss_pred ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccc
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a 948 (1067)
..++||||+++++|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence 689999999999999998543 23589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCcc---ccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc----chh---hhhhh
Q 001494 949 KFLKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSS----SLN---LNIAL 1018 (1067)
Q Consensus 949 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~----~~~---~~~~~ 1018 (1067)
+......... ....++..|+|||++.+..++.++|||||||++|||++|..|+......... ... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 8765332211 1122345699999998888999999999999999999987764322111000 000 00000
Q ss_pred hhccCC--CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1019 DEILDP--RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1019 ~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+.... ..+.+.. ...++.+++.+||+.+|++||||.|+++.|+
T Consensus 236 ~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05081 236 IELLKNNGRLPAPPG----CPAEIYAIMKECWNNDPSQRPSFSELALQVE 281 (284)
T ss_pred HHHHhcCCcCCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 111111 1111111 2235889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.02 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=198.7
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|...+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 4677888999999999999965 5689999999865321 22356788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++... +.+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 86 EFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred eccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 999999999988543 3588999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCc
Q 001494 955 SSNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1067)
........|++.|+|||++. ...++.++||||+||++|||++|+.||........ ...........+.....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~-- 234 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLMTKSNFQPPKLKDK-- 234 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HHhhhccCCCCCccccc--
Confidence 33344567899999999874 44588899999999999999999999743221100 00000001111111100
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
......+.+++.+|++.+|++|||+.++++
T Consensus 235 --~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 235 --MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 012234889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=324.75 Aligned_cols=249 Identities=25% Similarity=0.396 Sum_probs=200.8
Q ss_pred CCccCccccCCceeEEEEEECC-CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVELAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|.+...||.|+||.||+|..+. +-..|.|++... .....++|+-||++++..+||+||++++.|..++.+||+.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3455679999999999986553 444566766432 233467899999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
|.||-.+.++-+ -...+++.++..+++|++.||.|||++ .|||||+|+.|||++-+|.++++|||.+......-.
T Consensus 111 C~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred cCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 999999888743 344689999999999999999999999 999999999999999999999999999876555555
Q ss_pred ccccccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCc
Q 001494 957 NWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1067)
....+.|||.|||||++. ..+|++++||||||+.+.||..+.+|.....++ +.-..+..--.|.+..|.+
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-----RVllKiaKSePPTLlqPS~ 260 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSEPPTLLQPSH 260 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-----HHHHHHhhcCCCcccCcch
Confidence 567789999999999764 467999999999999999999999996544332 1111222222233333333
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
. ...+.+++.+|+.++|..||+++++++
T Consensus 261 W----s~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 261 W----SRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred h----hhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2 235899999999999999999999976
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.97 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=201.7
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|++.++||+|+||.||+|.. .+++.||+|.+... .....+.+..|++++++++||||+++++++.++...|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 4588889999999999999976 46899999998643 3334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 82 EFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 999999999998542 23589999999999999999999999 9999999999999999999999999998766544
Q ss_pred CCccccccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCC
Q 001494 955 SSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1067)
........+++.|+|||.+. +..++.++||||||+++|||++|+.||........ .........+....+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~ 231 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-----LLKILKSEPPTLDQP 231 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-----HHHHhcCCCCCcCCc
Confidence 44444567899999999874 34467899999999999999999999864432110 001111111111112
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.. ...++.+++.+||+.+|++||++.++++
T Consensus 232 ~~----~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 232 SK----WSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred cc----CCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 11 2234889999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.02 Aligned_cols=264 Identities=25% Similarity=0.399 Sum_probs=203.9
Q ss_pred ccHHHHHHHhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEE
Q 001494 786 IVYEEIIRATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGF 863 (1067)
Q Consensus 786 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 863 (1067)
+.++.+.++.++|++.+.||+|+||.||+|.. .+++.+|+|+..... ....++..|+.+++++ +||||++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 33455556778999999999999999999865 468899999875321 1235677899999999 69999999998
Q ss_pred Ee-----eCCceeEEEEeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC
Q 001494 864 CS-----HAQHSFIVYEYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK 937 (1067)
Q Consensus 864 ~~-----~~~~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~ 937 (1067)
+. .++..++||||+++++|.+++... .....+++..+..++.|+++|+.|||+. +|+||||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~ 160 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE 160 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence 74 345689999999999999887532 2334688899999999999999999999 99999999999999999
Q ss_pred CCeEEeccccceecCCCCCccccccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCccccccccch
Q 001494 938 NEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSL 1012 (1067)
Q Consensus 938 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~ 1012 (1067)
+.+|++|||+++.............|++.|+|||++.. ..++.++||||+||++|||++|+.||.........
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-- 238 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-- 238 (286)
T ss_pred CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--
Confidence 99999999999876544333344578999999998753 44788999999999999999999998643321110
Q ss_pred hhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1013 NLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1013 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
........+....+.. ...++.+++.+||+.+|++|||+.|+++..
T Consensus 239 ---~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 ---FKIPRNPPPTLHQPEL----WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ---hhccccCCCcccCCCC----cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0011111111111111 123488999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=319.76 Aligned_cols=250 Identities=25% Similarity=0.442 Sum_probs=202.8
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
..+|+..+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 36789999999999999999975 5799999999865322 2246688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+++++|.+++.+ ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 95 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred ecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 999999999999853 2478899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.........+++.|+|||.+.+..++.++|||||||++|++++|+.||.......... .......+....+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----~~~~~~~~~~~~~---- 238 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGTPELQNP---- 238 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----eeccCCCCCCCCc----
Confidence 4433345578899999999988889999999999999999999999986433211000 0000001111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
......+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122334789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=316.77 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=203.4
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||.|+||.||+|... +++.||+|++.... .......+.+|+++++.++|||++++++++.++...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 36788899999999999999654 68999999986542 2233467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||+++.....
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999998543 689999999999999999999999 9999999999999999999999999999887655
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
........+++.|+|||.+.+..++.++|||||||++|||+||+.||........ .........+.. +..
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-----~~~~~~~~~~~~--~~~--- 221 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-----LFLIPKNNPPSL--EGN--- 221 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-----HHHhhhcCCCCC--ccc---
Confidence 4444456788899999999988899999999999999999999999864332110 000111111111 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....++.+++.+||..+|++|||++++++
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02335889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=316.23 Aligned_cols=253 Identities=24% Similarity=0.405 Sum_probs=198.7
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCc----EEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 869 (1067)
..+|+..++||+|+||+||+|+. .+++ .||+|++.... .....+++.+|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 35788899999999999999964 4454 48999986532 23345678899999999999999999999875 45
Q ss_pred eeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccce
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK 949 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~ 949 (1067)
.+++|||+++|++.+++... ...+++..++.++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 78999999999999998542 23588999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCC
Q 001494 950 FLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRL 1026 (1067)
Q Consensus 950 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1067)
........ .....+++.|+|||...+..++.++|||||||++|||++ |..||+...... ........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~--~~~ 230 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-----IPDLLEKG--ERL 230 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHCC--CcC
Confidence 76533221 112234678999999988889999999999999999998 899986433211 01111111 111
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
..+.. ...++.+++.+||+.||++||++.++++.|+
T Consensus 231 ~~~~~----~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~ 266 (279)
T cd05109 231 PQPPI----CTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266 (279)
T ss_pred CCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111 2335889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=331.75 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=196.7
Q ss_pred HhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC-----
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA----- 867 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 867 (1067)
..++|+..+.||+|+||.||++.. .+++.||||++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 457899999999999999999965 46889999998754332 23346778899999999999999999988643
Q ss_pred -CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccc
Q 001494 868 -QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 868 -~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 946 (1067)
...|+||||+++ ++.+.+. ..+++..+..++.|+++||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999976 5555553 2378889999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh------------
Q 001494 947 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL------------ 1014 (1067)
Q Consensus 947 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~------------ 1014 (1067)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 165 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99865432 22344578999999999998889999999999999999999999986533211100000
Q ss_pred --hhhhhhccCCC----------------CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1015 --NIALDEILDPR----------------LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1015 --~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
........... .............++.+++.+|++.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000000 000000111123457899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=310.98 Aligned_cols=248 Identities=29% Similarity=0.438 Sum_probs=201.8
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
++|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 56888999999999999999776 88899999875422 35778999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++.... ...+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||.++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 81 YMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999986433 23589999999999999999999999 99999999999999999999999999998763221
Q ss_pred CccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 956 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
.....+..|+|||++.+..++.++||||||+++||+++ |+.||....... ........ .....+..
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~--~~~~~~~~--- 223 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPHVEKG--YRMEAPEG--- 223 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHhcC--CCCCCccC---
Confidence 12334567999999988889999999999999999997 999986432211 00111110 11111111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+.++.+++.+||..+|++|||+.|++++|+
T Consensus 224 -~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 224 -CPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254 (256)
T ss_pred -CCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence 2235889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=319.98 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=200.2
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..++||+|+||.||++.. .+++.||+|.+.... ......++.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 3688999999999999999865 468889999886432 2334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++... ..+++..+..++.|+++|++|||+.+ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 79 EHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred eccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999999643 45788999999999999999999732 8999999999999999999999999998765432
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh--------------------
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL-------------------- 1014 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------------------- 1014 (1067)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||.............
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 1234578899999999888889999999999999999999999985332110000000
Q ss_pred --------hhhhhhccCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1015 --------NIALDEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1015 --------~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
.......... ....+.. ....++.+++.+||+.+|++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSG---AFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCc---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 0000100 123358899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=314.34 Aligned_cols=253 Identities=26% Similarity=0.361 Sum_probs=188.3
Q ss_pred CccccCCceeEEEEEECC---CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEecc
Q 001494 802 HCIGKGGQGSVYKVELAS---GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLE 878 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 878 (1067)
+.||+|+||+||+|+..+ ...+|+|.+.... .......+.+|++.++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 359999999999986543 3468888775432 23335678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCc--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 879 MGSLAMILSNDAA--AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 879 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+|+|.+++..... ....++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 9999999865332 22356778889999999999999999 999999999999999999999999999875433221
Q ss_pred --ccccccccccccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCC
Q 001494 957 --NWTELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRL 1026 (1067)
Q Consensus 957 --~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1067)
......+++.|+|||++.. ..++.++|||||||++|||++ |..||........ ....... ....+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~~~-~~~~~ 230 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV----LKQVVRE-QDIKL 230 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH----HHHHhhc-cCccC
Confidence 1123345678999998643 346789999999999999999 7888764322110 0000010 01111
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
+.+ .........+.+++..|| .||++|||+.||++.|.
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 111122344778889999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=312.12 Aligned_cols=250 Identities=32% Similarity=0.492 Sum_probs=200.0
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCCh------hHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEM------TFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 869 (1067)
+|...+.||+|+||.||+|.. .+++.||+|.+........ ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999965 4688999998865433221 223568899999999999999999999999999
Q ss_pred eeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccce
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK 949 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~ 949 (1067)
.++||||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999543 3578899999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC------ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccC
Q 001494 950 FLKPDSS------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD 1023 (1067)
Q Consensus 950 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1023 (1067)
....... ......|+..|+|||.+.+..++.++||||+||++|||++|+.||........ .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~ 229 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-----IFKIGENAS 229 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-----HHHHhccCC
Confidence 7653211 11234578899999999888899999999999999999999999874332110 011111111
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1024 PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1024 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+. .+.. ....+.+++.+||+.||++||++.|+++
T Consensus 230 ~~--~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 230 PE--IPSN----ISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred Cc--CCcc----cCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11 1111 2235889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=319.22 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=201.2
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||.||+|... +++.||+|.+.... .....+++.+|+.++++++||||+++++++...+..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 36888899999999999999765 78999999886432 2223467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|..++........+++..+..++.+++.|++|||+.+ +|+||||||+||+++.++.+||+|||.+..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999998865433456899999999999999999999632 8999999999999999999999999999765432
Q ss_pred CCccccccccccccCccccccCC------CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCC-CC
Q 001494 955 SSNWTELAGTYGYVAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPR-LP 1027 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1027 (1067)
......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||...... ........+.... ..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~ 229 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLSAIVDGDPPT 229 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHHHHhhcCCCC
Confidence 223346788999999885543 478999999999999999999998643211 1111112222211 11
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.+. ....++.+++.+||+.+|++||++.++++
T Consensus 230 ~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 230 LPS----GYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCc----ccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 122 23345889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=313.54 Aligned_cols=253 Identities=29% Similarity=0.436 Sum_probs=204.0
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||.||+|.. .+++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+.+..|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5788899999999999999975 46788999998754322 3577889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||++++++.+++... ...+++.++..++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+......
T Consensus 80 e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 80 EYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred eCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 999999999988543 24588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccccccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCc
Q 001494 955 SSNWTELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1067)
........++..|+|||.+.+. .++.++||||||+++|||++|+.||......... ............. .
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~----~ 227 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL---FLISKSNFPPPKL----K 227 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhccCCCccc----c
Confidence 3333455788899999998776 7889999999999999999999998643321110 0000010111111 1
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.......++.+++.+||+.+|.+|||+.+++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12233456899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=313.88 Aligned_cols=257 Identities=26% Similarity=0.431 Sum_probs=204.5
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|++.+.||.|+||+||+|.. .++..+|+|++....... ..+.+.+|++.++.++|+|++++++.+..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 4688999999999999999975 468899999986543222 4578899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||++++++.+++........+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 9999999999996544445689999999999999999999999 9999999999999999999999999999766543
Q ss_pred CCc----cccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCC
Q 001494 955 SSN----WTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029 (1067)
Q Consensus 955 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1067)
... .....|+..|+|||++... .++.++|||||||++|||++|+.||......... ...... ..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~ 230 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL----MLTLQN-DPPSLETG 230 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH----HHHhcC-CCCCcCCc
Confidence 322 1334688999999988776 7899999999999999999999998644321100 000000 01111110
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
........++.+++.+||+.||++||++.++++
T Consensus 231 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 -ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 001123345889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=347.96 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=198.3
Q ss_pred HhcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--Cce
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--QHS 870 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 870 (1067)
...+|.+.++||+|+||+||+|+.. +++.||+|++...... ......+..|+.++++++|||||+++++|.+. ..+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3468999999999999999999654 6778999998754322 23456789999999999999999999988543 568
Q ss_pred eEEEEeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCC----CCeeecCCCCCceeeCCC--------
Q 001494 871 FIVYEYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCF----PPIVHRDISSKNVLLDFK-------- 937 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivHrDlk~~Nill~~~-------- 937 (1067)
|+||||+++|+|.+++... .....+++..++.|+.||+.||+|||+... .+||||||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999988642 223468999999999999999999998521 259999999999999642
Q ss_pred ---------CCeEEeccccceecCCCCCccccccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcccc
Q 001494 938 ---------NEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPGDFISL 1006 (1067)
Q Consensus 938 ---------~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~ 1006 (1067)
+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 348999999998764332 2234578999999998864 4588999999999999999999999864332
Q ss_pred ccccchhhhhhhhhccC-CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1007 ISSSSLNLNIALDEILD-PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.. .....+.. +.++.+ ....++.++|..||+.+|.+||++.|+++
T Consensus 249 ~~-------qli~~lk~~p~lpi~-----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 FS-------QLISELKRGPDLPIK-----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HH-------HHHHHHhcCCCCCcC-----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 11 11111111 111111 12235889999999999999999999984
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=329.28 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=197.3
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|++.++||+|+||+||+++.. +++.||+|++...........+.+.+|+.++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999754 68889999986422122223455788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999642 23578899999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-ccccccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccC--CCC
Q 001494 955 SS-NWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD--PRL 1026 (1067)
Q Consensus 955 ~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 1026 (1067)
.. ......||+.|+|||++.+ +.++.++||||+||++|||++|+.||...... .....+.. .+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~~ 227 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHEERF 227 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--------HHHHHHHcCCCcc
Confidence 22 2233579999999998875 45788999999999999999999998643321 11111111 111
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPES--RPTMQKVSQ 1063 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~ 1063 (1067)
..+.. ......++.+++.+|+..++++ |++++++++
T Consensus 228 ~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 228 QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 11211 1122345888999999876554 467887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.89 Aligned_cols=239 Identities=21% Similarity=0.385 Sum_probs=186.4
Q ss_pred ccccCCceeEEEEEECC-------------------------CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCee
Q 001494 803 CIGKGGQGSVYKVELAS-------------------------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857 (1067)
Q Consensus 803 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 857 (1067)
.||+|+||.||+|.... ...||+|++... ......++.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 69999999999986421 135888887532 22334678889999999999999
Q ss_pred eeeeEEEeeCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC
Q 001494 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK 937 (1067)
Q Consensus 858 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~ 937 (1067)
+++++++.+....++||||+++|+|..++... ...+++..+..++.|+++|++|||++ +|+||||||+||+++..
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 99999999999999999999999999988542 34578999999999999999999999 99999999999999865
Q ss_pred C-------CeEEeccccceecCCCCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHH-hCCCCCCcccccc
Q 001494 938 N-------EARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVI-KGKHPGDFISLIS 1008 (1067)
Q Consensus 938 ~-------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~ell-tg~~p~~~~~~~~ 1008 (1067)
+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||.......
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 4 3799999988654322 22356788999998865 45899999999999999995 6899986433211
Q ss_pred ccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1009 SSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
. ..........+.... ..+.+++.+||+.+|++|||+.++++.|.
T Consensus 230 ~---------~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 K---------ERFYEKKHRLPEPSC----KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---------HHHHHhccCCCCCCC----hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 011111112222221 24889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=319.84 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=191.6
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC---CCCeeeeeeEEEee-----C
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI---RHRNIVKFYGFCSH-----A 867 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~ 867 (1067)
+|+..+.||+|+||+||+|+.. +++.||+|.+....... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 4788899999999999999654 78999999987543222 1123455677766655 79999999998864 2
Q ss_pred CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccc
Q 001494 868 QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGI 947 (1067)
Q Consensus 868 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~ 947 (1067)
...++||||+++ ++..++.... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 457999999985 7887775432 24589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh--------hhhh
Q 001494 948 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN--------IALD 1019 (1067)
Q Consensus 948 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~--------~~~~ 1019 (1067)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.............. .+..
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 155 ARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 9866432 222345678999999999888899999999999999999999999864322110000000 0000
Q ss_pred hc------cCCCCCCC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1020 EI------LDPRLPIP-SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1020 ~~------~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.. ..+....+ .....+...++.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000000 0001122345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=310.96 Aligned_cols=251 Identities=27% Similarity=0.361 Sum_probs=201.0
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee-CCceeEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH-AQHSFIVY 874 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~ 874 (1067)
.|+..+.||+|++|.||++.. .+++.||+|++...... ....+.+..|++++++++|||++++++.+.. +...++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 478889999999999999865 46789999998643322 2234568899999999999999999998764 44679999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||++++++.+++... ....+++.++..++.+++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999998643 234589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
........+++.|+|||++.+..++.++||||+|+++|||++|+.||+..... .....+.....+... .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~---~ 224 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--------SLVYRIIEGKLPPMP---K 224 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhcCCCCCc---c
Confidence 44444567889999999999988999999999999999999999998643321 111111111111111 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....++.+++.+|++.+|++|||+.++++
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 225 DYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 23345889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=290.06 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=195.3
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
+.+....||.|..|+||+++.+ +|..+|||.+... +.....++++..+.++..- ++|+||+.+|||..+...++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 4455677999999999999765 6899999999865 3344457788888876655 5899999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
|.|.. -.+..+.+ ..+++++.-+-++...+.+||.||.++. +|+|||+||+|||+|+.|++|+||||++..+.+.
T Consensus 171 elMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 171 ELMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 99853 34444432 2345788888889999999999999884 9999999999999999999999999999877643
Q ss_pred CCccccccccccccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC-CCC
Q 001494 955 SSNWTELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP-IPS 1030 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1030 (1067)
...+..+|-+.|||||.+.-. .|+.++||||||+.++|+.||+.||..-.. ..+.+..+.+...+ .+.
T Consensus 246 -kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-------dFe~ltkvln~ePP~L~~ 317 (391)
T KOG0983|consen 246 -KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-------DFEVLTKVLNEEPPLLPG 317 (391)
T ss_pred -cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-------cHHHHHHHHhcCCCCCCc
Confidence 334567899999999988643 588999999999999999999999875332 12222233332111 111
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1031 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+ ...+..+.+++..||++|+.+||.+.++++
T Consensus 318 ~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 H--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred c--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1 113445899999999999999999999886
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=313.43 Aligned_cols=253 Identities=28% Similarity=0.497 Sum_probs=200.2
Q ss_pred cCCCccCccccCCceeEEEEEEC-CC---cEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCcee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SG---EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 871 (1067)
.+|+..+.||+|+||.||+|+.. ++ ..||+|++.... .....++|..|+.+++.++||||+++++++.+++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 35788899999999999999754 33 369999986542 2334578999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+||||+++++|.+++... .+.+++.+++.++.|++.|++|||++ +++||||||+||+++.++.+|++|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 82 IITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence 999999999999998543 34589999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCc--ccc-cc--ccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCC
Q 001494 952 KPDSSN--WTE-LA--GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPR 1025 (1067)
Q Consensus 952 ~~~~~~--~~~-~~--gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1067)
...... ... .. .+..|+|||.+.+..++.++||||+||++||+++ |..||....... ....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-----~~~~i~~--~~~ 229 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-----VINAIEQ--DYR 229 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-----HHHHHHc--CCc
Confidence 432221 111 11 2457999999998889999999999999999986 999986433211 1111111 111
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1026 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+.+.. .+..+.+++.+||+.+|++||++.++++.|+
T Consensus 230 ~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 230 LPPPMD----CPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred CCCccc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 122222 2335889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=318.01 Aligned_cols=260 Identities=21% Similarity=0.355 Sum_probs=200.8
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||.||+|... +|+.||+|++....... ...+.+.+|+.++++++|||++++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 36888899999999999999765 68999999986443221 23456789999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||++++++..+.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 80 EYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred eccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999999888876432 3489999999999999999999999 9999999999999999999999999999877654
Q ss_pred CCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhh---------------
Q 001494 955 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIAL--------------- 1018 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------------- 1018 (1067)
........++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ......
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChHHhhhccccc
Confidence 433445567889999998876 457899999999999999999999986443211100 000000
Q ss_pred --hhccCCCCCCCCc---chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1019 --DEILDPRLPIPSH---NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1019 --~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.....+....... ........+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000000 00112345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=330.12 Aligned_cols=259 Identities=21% Similarity=0.306 Sum_probs=196.2
Q ss_pred HhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC-----
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA----- 867 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 867 (1067)
..++|+..+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-hhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 346899999999999999999864 468899999987543322 3346778999999999999999999987543
Q ss_pred -CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccc
Q 001494 868 -QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 868 -~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 946 (1067)
...|+||||+++ ++.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999976 5666653 2378889999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh-----------
Q 001494 947 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN----------- 1015 (1067)
Q Consensus 947 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~----------- 1015 (1067)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus 172 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 172 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred CccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 99865432 223445789999999999999999999999999999999999999865432111000000
Q ss_pred ---hhhhhccC--------------CCCCCC--CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1016 ---IALDEILD--------------PRLPIP--SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1016 ---~~~~~~~~--------------~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
........ +....+ .........++.+++.+|++.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 000000 0000112235789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=311.81 Aligned_cols=247 Identities=24% Similarity=0.383 Sum_probs=192.0
Q ss_pred CccccCCceeEEEEEEC-CCc--EEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeEEEEec
Q 001494 802 HCIGKGGQGSVYKVELA-SGE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYL 877 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~ 877 (1067)
+.||+|+||.||+|+.. ++. .+|+|.+.... .....+.+..|+++++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 36899999999999765 343 46888876432 223356788999999999 7999999999999999999999999
Q ss_pred cCCCHHHHhcccC-------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEec
Q 001494 878 EMGSLAMILSNDA-------------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSD 944 (1067)
Q Consensus 878 ~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~D 944 (1067)
++|+|.+++.... ....+++.++..++.|++.|++|||++ +++||||||+||+++.++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 9999999986432 123478999999999999999999998 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccC
Q 001494 945 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILD 1023 (1067)
Q Consensus 945 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1023 (1067)
||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||...... .....+..
T Consensus 156 fgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~~~ 226 (270)
T cd05047 156 FGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQ 226 (270)
T ss_pred CCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--------HHHHHHhC
Confidence 99986322111 1111233567999999988889999999999999999997 99998643221 11111111
Q ss_pred C-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1024 P-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1024 ~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
. ....+.. ...++.+++.+||+.+|.+|||+.++++.|+
T Consensus 227 ~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 227 GYRLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred CCCCCCCCc----CCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 1 1111111 2235889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=311.57 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=203.4
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..+.||+|+||.||+++. .+|+.||+|++...... ....+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 478889999999999999864 57899999998653222 2234678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++.... ...+++.++..++.|++.|++|||++ +++|+||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 80 YCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred cCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999885422 23478899999999999999999999 99999999999999999999999999998765443
Q ss_pred CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC-CCCcchH
Q 001494 956 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP-IPSHNVQ 1034 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1034 (1067)
.......|++.|+|||+..+..++.++|||||||++|||++|+.||..... .....++...... .+.
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~~---- 223 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIRGSYPPVSS---- 223 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhcCCCCCCcc----
Confidence 333345688899999999888899999999999999999999999863221 1112222222221 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....++.+++.+||+.+|++||++.+|++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 22335899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=328.03 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=196.4
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|++.++||+|+||+||+++.. +++.||+|++...........+.+..|+.++..++|++|+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999765 57889999985422112223445788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++|+|.+++.+. ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999642 23588899999999999999999999 9999999999999999999999999999765433
Q ss_pred CC-ccccccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC--CC
Q 001494 955 SS-NWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP--RL 1026 (1067)
Q Consensus 955 ~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 1026 (1067)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ....+... +.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~~ 227 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKERF 227 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCccc
Confidence 22 223457999999999886 3457889999999999999999999986443211 11111111 11
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPES--RPTMQKVSQL 1064 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rpt~~evl~~ 1064 (1067)
..+.. ......++.+++.+|+..++++ |+++.|+++.
T Consensus 228 ~~p~~-~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFPAQ-VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCCc-cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111 1122345788999988665444 6889888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=310.09 Aligned_cols=247 Identities=28% Similarity=0.407 Sum_probs=197.1
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEe-eCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCS-HAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~ 874 (1067)
.+|+..+.||+|+||.||++... |+.||+|.+... ...+.+..|+.++++++|++++++++++. +++..++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 46888899999999999999765 788999998642 12467889999999999999999999764 456789999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.++++... ...+++..+..++.|++.|++|||++ +++||||||+||+++.++.+|++|||+++.....
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999986433 23478999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||........ .........+ ..+.
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~-----~~~~~~~~~~--~~~~--- 222 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGYKM--DAPD--- 222 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHhcCCCC--CCCC---
Confidence 2 22344568999999988889999999999999999998 9999764322110 0001110011 1111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....+.+++.+||+.+|++|||+.++++.|+
T Consensus 223 -~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 223 -GCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254 (256)
T ss_pred -CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence 12335889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=324.16 Aligned_cols=259 Identities=18% Similarity=0.267 Sum_probs=192.8
Q ss_pred ccCccccC--CceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 800 DEHCIGKG--GQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 800 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
..++||+| +|++||+++. .+|+.||+|++...... ....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45789999 7899999854 57899999998754322 23345677899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+++|++.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999985432 23488999999999999999999999 999999999999999999999999987644321111
Q ss_pred c-------cccccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccC----
Q 001494 957 N-------WTELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD---- 1023 (1067)
Q Consensus 957 ~-------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 1023 (1067)
. .....++..|+|||++.+ ..++.++|||||||++|||++|+.||+....................+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0 112346778999999876 458899999999999999999999986433211000000000000000
Q ss_pred ---------------C-----------CCCC----CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1024 ---------------P-----------RLPI----PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1024 ---------------~-----------~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
. .... ..........++.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 0000 00011122346889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=312.74 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=203.0
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
..|+..++||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 3577788999999999999975 468899999986432 2234567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++.. .++++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 82 e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 82 EYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred ecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 99999999998853 3478899999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
........++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+.... ++....
T Consensus 155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--------~~~~~~~~---~~~~~~ 223 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--------LFLIPKNN---PPTLTG 223 (277)
T ss_pred ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--------hhhhhcCC---CCCCch
Confidence 3333445678899999999888899999999999999999999999864332110 01110010 111223
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 344568999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=312.96 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=186.2
Q ss_pred ccccCCceeEEEEEECCC---cEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 803 CIGKGGQGSVYKVELASG---EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 803 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
.||+|+||.||+++..++ ..+++|.+.... .....+.+.+|+..++.++||||+++++++.+....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 599999999999865443 345666665432 223457899999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC--C
Q 001494 880 GSLAMILSNDAA-AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS--S 956 (1067)
Q Consensus 880 g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~--~ 956 (1067)
|+|.++++.... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999865332 23466777889999999999999999 99999999999999999999999999986432211 1
Q ss_pred ccccccccccccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCC
Q 001494 957 NWTELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1067)
......++..|+|||++.. ..++.++|||||||++|||++ |..||+....................++....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 1234567889999998753 235789999999999999997 56677543321111100011111112222211
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1029 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
. ....+.+++..|| .+|++||++++|++.|
T Consensus 237 --~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 237 --P----YSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred --C----CcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 1 2234788999999 6799999999999887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=307.38 Aligned_cols=247 Identities=28% Similarity=0.432 Sum_probs=197.5
Q ss_pred CccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCCC
Q 001494 802 HCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGS 881 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 881 (1067)
++||+|+||.||++...+++.||+|++...... ...+.+..|++++++++||||+++++++.+....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 469999999999998777999999998754332 345678999999999999999999999999999999999999999
Q ss_pred HHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcc--c
Q 001494 882 LAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW--T 959 (1067)
Q Consensus 882 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~--~ 959 (1067)
+.+++... ...+++..+..++.+++.|++|||++ +++||||||+||+++.++.+||+|||.+.......... .
T Consensus 79 l~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 79 LLTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 99998543 23578899999999999999999999 99999999999999999999999999997654221111 1
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLI 1038 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1067)
...++..|+|||.+.+..++.++|||||||++|||+| |..||....... ........ .....+. ....
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----~~~~~~~~--~~~~~~~----~~~~ 222 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----TRERIESG--YRMPAPQ----LCPE 222 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----HHHHHhcC--CCCCCCc----cCCH
Confidence 1233567999999988889999999999999999999 888875433211 01111110 1111111 2233
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1039 SFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1039 ~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
++.+++.+|++.+|++|||+.|+++.|+
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 5899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=331.21 Aligned_cols=254 Identities=23% Similarity=0.281 Sum_probs=195.0
Q ss_pred hcCCCccCccccCCceeEEEEEEC---CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCcee
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 871 (1067)
..+|.+.+.||+|+||.||++... +++.||+|.+... +...+|++++++++|||||++++++......+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 357999999999999999998643 4678999987532 23457999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+|||++. +++.+++.. ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 163 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EEehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 9999996 577777732 34589999999999999999999999 9999999999999999999999999999766
Q ss_pred CCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccch-----------------
Q 001494 952 KPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSL----------------- 1012 (1067)
Q Consensus 952 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~----------------- 1012 (1067)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...........
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 54322 12346799999999999988999999999999999999999999854322100000
Q ss_pred ----hhhhhhhhc---cCCCCCCCCcc-hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1013 ----NLNIALDEI---LDPRLPIPSHN-VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1013 ----~~~~~~~~~---~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.......+. ..+....+... ......++.+++.+|++.||++|||+.|+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000 11111111100 0011235788999999999999999999986
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=333.70 Aligned_cols=191 Identities=23% Similarity=0.308 Sum_probs=164.6
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
..|.+.+.||+|+||.||+|... +++.||||.... ..+.+|++++++++|||||++++++..++..++||
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 46888999999999999999654 578899996431 34568999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
|++. +++..++... ...+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 240 e~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 240 PKYR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EccC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 9995 6787777432 23589999999999999999999999 9999999999999999999999999999876432
Q ss_pred CC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 001494 955 SS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPG 1001 (1067)
Q Consensus 955 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~ 1001 (1067)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22 122457999999999999999999999999999999999987663
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=317.35 Aligned_cols=247 Identities=26% Similarity=0.349 Sum_probs=203.2
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||.||++... +++.||+|++...........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999654 68999999986543223334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998543 4588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ......+.......+...
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~-- 221 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEGKVRFPSFF-- 221 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCccCCccC--
Confidence 2345688999999999888889999999999999999999999864331 112222223333333332
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
...+.+++.+||+.+|++|| +++|+++
T Consensus 222 --~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 222 --SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 23488999999999999999 7777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=310.44 Aligned_cols=246 Identities=27% Similarity=0.408 Sum_probs=189.5
Q ss_pred CccccCCceeEEEEEEC----CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEe-eCCceeEEEEe
Q 001494 802 HCIGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCS-HAQHSFIVYEY 876 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~ 876 (1067)
+.||+|+||.||+|... ++..||+|++... ......+.+..|+.+++.++||||+++++++. .++..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 46899999999998653 2457999987532 22334567889999999999999999999775 45568999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+.+++|.+++.... ...++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 79 MKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 99999999985432 3467788899999999999999999 999999999999999999999999999976543211
Q ss_pred ----ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCccccccccchhhhhhhhhccCCC-CCCCC
Q 001494 957 ----NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPGDFISLISSSSLNLNIALDEILDPR-LPIPS 1030 (1067)
Q Consensus 957 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 1030 (1067)
......++..|+|||.+.+..++.++|||||||++|||++| ..||...... .....+.... ...+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 225 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--------DITVYLLQGRRLLQPE 225 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhcCCCCCCCC
Confidence 11223456789999999888899999999999999999995 5555533221 1111111111 11111
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1031 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
. .+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 226 ~----~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~ 257 (262)
T cd05058 226 Y----CPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257 (262)
T ss_pred c----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 1 1235889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.88 Aligned_cols=240 Identities=23% Similarity=0.415 Sum_probs=188.8
Q ss_pred CccccCCceeEEEEEEC-C-------CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 802 HCIGKGGQGSVYKVELA-S-------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
+.||+|+||.||+|... . ...||+|.+... .....+++.+|+.+++.++||||+++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 46999999999998653 2 334888887532 233456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCC--------eEEecc
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNE--------ARVSDF 945 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~--------~kl~Df 945 (1067)
|||+++|+|..++.... ..+++..++.++.|++.|++|||++ +|+||||||+||+++.++. ++++||
T Consensus 78 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999999996432 3578999999999999999999999 9999999999999988765 599999
Q ss_pred ccceecCCCCCccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCC-CCCCccccccccchhhhhhhhhccC
Q 001494 946 GIAKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGK-HPGDFISLISSSSLNLNIALDEILD 1023 (1067)
Q Consensus 946 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 1023 (1067)
|.+...... ....+++.|+|||++.+. .++.++|||||||++|||++|. .|+....... ......
T Consensus 153 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---------~~~~~~ 219 (258)
T cd05078 153 GISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---------KLQFYE 219 (258)
T ss_pred ccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---------HHHHHH
Confidence 998755432 234678899999998764 4789999999999999999985 5554322211 011111
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1024 PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1024 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....+.... .++.+++.+||+.+|++|||++++++.|+
T Consensus 220 ~~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 DRHQLPAPKW----TELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccccCCCCCc----HHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1222222222 34889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=309.56 Aligned_cols=251 Identities=24% Similarity=0.418 Sum_probs=201.1
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
++|+..++||+|+||.||+|+...+..+|+|.+... ....+.+.+|++++++++|+||+++++++.+ ...+++||
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 578899999999999999998888888999987642 1234678899999999999999999999887 78899999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999986532 34578899999999999999999998 99999999999999999999999999997654322
Q ss_pred Cc-cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 956 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 956 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.. .....++..|+|||++....++.++|+|||||++||+++ |+.||....... ........ .....+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~~~--~~~~~~~--- 226 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERG--YRMPRPE--- 226 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHhCC--CCCCCcc---
Confidence 11 122345677999999988889999999999999999999 899986432210 00111111 1111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
....++.+++.+|++.+|++||++.++.+.|+
T Consensus 227 -~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 227 -NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred -cCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 22345889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=320.41 Aligned_cols=254 Identities=23% Similarity=0.295 Sum_probs=204.4
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||.||+|... +++.||+|.+...........+.+..|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999765 58999999997654333334567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+.+++|.+++... ....+++..+..++.|+++|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998643 235689999999999999999999999 9999999999999999999999999998754322
Q ss_pred CC-----------------------------ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 001494 955 SS-----------------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFIS 1005 (1067)
Q Consensus 955 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~ 1005 (1067)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11 1113467889999999998889999999999999999999999986443
Q ss_pred cccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 001494 1006 LISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPT----MQKVSQ 1063 (1067)
Q Consensus 1006 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~evl~ 1063 (1067)
.. .....+.......+... .....+.+++.+||+.+|++||+ +.|+++
T Consensus 237 ~~--------~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD--------ETFSNILKKEVTFPGSP--PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH--------HHHHHHhcCCccCCCcc--ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 21 11222222222222211 13345899999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=321.91 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=200.3
Q ss_pred cCCCccCccccCCceeEEEEEEC--------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA--------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH 866 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 866 (1067)
.+|++.+.||+|+||.||+|+.. .+..||+|.+.... .....+++.+|+++++++ +||||+++++++.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 46888999999999999998642 12368999887432 223356789999999999 79999999999999
Q ss_pred CCceeEEEEeccCCCHHHHhcccC-------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCcee
Q 001494 867 AQHSFIVYEYLEMGSLAMILSNDA-------------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVL 933 (1067)
Q Consensus 867 ~~~~~lv~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nil 933 (1067)
.+..++||||+++|+|.+++.... ....+++.+++.++.|++.|++|||++ +|+||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 999999999999999999986432 223578899999999999999999999 9999999999999
Q ss_pred eCCCCCeEEeccccceecCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccc
Q 001494 934 LDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSS 1010 (1067)
Q Consensus 934 l~~~~~~kl~DfG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~ 1010 (1067)
++.++.+||+|||+++........ .....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 243 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--- 243 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 999999999999999866432211 122234567999999998889999999999999999998 88887643321
Q ss_pred chhhhhhhhhccCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1011 SLNLNIALDEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1011 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....+... ....+.. ...++.+++.+||+.+|++|||+.|+++.|+
T Consensus 244 -----~~~~~~~~~~~~~~~~~----~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 244 -----ELFKLLKEGHRMDKPAN----CTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred -----HHHHHHHcCCCCCCCCC----CCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 111111111 1111221 2235889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.32 Aligned_cols=369 Identities=29% Similarity=0.426 Sum_probs=290.6
Q ss_pred CCCcceEeccCCccc-cCCCCcccccCccceeecCCCcccCCCCcccccccccceecccccccccCCCCccccccccccc
Q 001494 72 FPHLAYLDLWSNQLF-GNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNL 150 (1067)
Q Consensus 72 ~~~l~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 150 (1067)
+|.++-.|+++|.++ +..|..+..++++++|.|...++. .+|..++.|.+|++|.+++|++. .+-.++..|+.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 455666777888887 468888888888888888888887 78888888888888888888887 666777888888888
Q ss_pred cccccccc-cccCCCccCCCcccEEEEeccCCcCccCCccccccccceecccccccccccC-CCCCcccccceeecccCc
Q 001494 151 ALYSNYLE-DIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIP-QSLGNLSNLAMLNLSSNS 228 (1067)
Q Consensus 151 ~L~~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~ 228 (1067)
.+..|++. .-+|..+..+..|+.||||+|+++ ..|..+...+++.+|+|++|+|. .|| .-|-+|+.|-+||||+|+
T Consensus 84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccch
Confidence 88888773 236777778888888888888888 78888888888888888888888 455 456688888888888888
Q ss_pred CCCCCCcccCCcccCCceEecCcccccccCccccCccceeeEEEeccccc-ccCCCccccCCcccEEEeccccccCCccc
Q 001494 229 LFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLS-GLIPSEIGNLKFLSKIALSYNKFSGLIPH 307 (1067)
Q Consensus 229 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 307 (1067)
+. .+|+.+..|..|+.|+|++|.+...--..+..+++|++|.+++.+-+ .-+|..+.++.+|..+|+|.|.+. ..|+
T Consensus 162 Le-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPe 239 (1255)
T KOG0444|consen 162 LE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPE 239 (1255)
T ss_pred hh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchH
Confidence 87 67777888888888888888776443344556677888888877644 346778888888888888888887 5678
Q ss_pred cccCCccccEEeccCCCCcCCCCcccccCCCCCeEEecCccccccCCccccCCCCCCeEEccCCcCc-cccCcccCCCCC
Q 001494 308 SLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLS-GSIPCEIGNLKS 386 (1067)
Q Consensus 308 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~ 386 (1067)
.+.++.+|+.|+|++|+|+... .......+|++|+||.|+++ .+|+++..++.|+.|++.+|+++ .-+|+.++.+..
T Consensus 240 cly~l~~LrrLNLS~N~iteL~-~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~ 317 (1255)
T KOG0444|consen 240 CLYKLRNLRRLNLSGNKITELN-MTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQ 317 (1255)
T ss_pred HHhhhhhhheeccCcCceeeee-ccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhh
Confidence 8888888888888888887653 34455667888888888888 78888888888888888888876 236888888888
Q ss_pred CCEEEccCCcccccCCCccccccCCcEEEcccCcCcccCchhhhCcCCCcEEeCCCCcccCCCC
Q 001494 387 LSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIP 450 (1067)
Q Consensus 387 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 450 (1067)
|+.+..++|++. ..|..++.|..|+.|.|+.|++- ..|+++.-++.|+.||+..|.-...+|
T Consensus 318 Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 318 LEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred hHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 888888888887 78888888888888888888876 678888888888888888886544333
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=317.73 Aligned_cols=257 Identities=27% Similarity=0.436 Sum_probs=202.8
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||+||+++. .+|+.||+|++.... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 5688889999999999999865 468899999886432 2234577899999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++... +.+++..+..++.+++.|+.|||+.. +++||||||+||+++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 83 EFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred ecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999988543 35889999999999999999999732 8999999999999999999999999998754322
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc---chhhhhhhhhccCCC-CCCCC
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSS---SLNLNIALDEILDPR-LPIPS 1030 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~ 1030 (1067)
. .....|+..|+|||++.+..++.++|||||||++||+++|+.||+........ ..........+.... ...+.
T Consensus 158 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 158 I--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred c--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 1 22457899999999998888999999999999999999999998743321100 000111122222111 11111
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1031 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
.+....+.+++.+|++.||++|||+.|+++.
T Consensus 236 ---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 236 ---SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred ---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1233458899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=311.00 Aligned_cols=254 Identities=24% Similarity=0.440 Sum_probs=202.2
Q ss_pred cCCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 869 (1067)
++|+..+.||+|+||.||+|+.+ +.+.||+|.+.... .....+++.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 46888899999999999999754 34679999876432 22245778999999999999999999999999999
Q ss_pred eeEEEEeccCCCHHHHhcccCcc------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEe
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAA------EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVS 943 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~ 943 (1067)
.++||||+++|+|.+++...... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence 99999999999999999654322 2589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCC-CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhc
Q 001494 944 DFGIAKFLKPD-SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEI 1021 (1067)
Q Consensus 944 DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1021 (1067)
|||++...... ........++..|+|||.+.+..++.++||||||+++||+++ |..||...... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--------~~~~~~ 231 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--------EVLNRL 231 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--------HHHHHH
Confidence 99998754322 122334456788999999988888999999999999999998 78887533211 111111
Q ss_pred cCCC--CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1022 LDPR--LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1022 ~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.... +..+.. ....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 232 ~~~~~~~~~~~~----~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGKLELPVPEG----CPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCCcCCCCCCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111 111111 2235889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=320.49 Aligned_cols=260 Identities=18% Similarity=0.272 Sum_probs=197.5
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|...++||+|+||.||+|+.. +++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 57889999999999999999654 6889999998644322 22346778999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||++ +++..++... ...+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 84 EYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred eccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9997 5888877532 33578899999999999999999999 9999999999999999999999999999765443
Q ss_pred CCccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchh-------hhhhhhhccC---
Q 001494 955 SSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN-------LNIALDEILD--- 1023 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~~~--- 1023 (1067)
........+++.|+|||.+.+. .++.++||||+||++|||++|+.||............ .......+..
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 3333445678999999987654 4788999999999999999999998654321100000 0000000000
Q ss_pred -CCCCCCC---cc----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1024 -PRLPIPS---HN----VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1024 -~~~~~~~---~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.....+. .. .......+.+++.+|++.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 00 0112235789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=315.08 Aligned_cols=247 Identities=28% Similarity=0.424 Sum_probs=199.6
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
.|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+.+.+|++++++++||||+++++++......|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 356678899999999999964 4688999999864322 2335678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|++++++.+++.. ..+++..+..++.|+++|++|||++ +++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 83 YLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred ccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 9999999998843 3578899999999999999999999 99999999999999999999999999998765433
Q ss_pred CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHH
Q 001494 956 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1067)
.......++..|+|||++.+..++.++|||||||++|||++|+.|+....... ....+...... .....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~~---~~~~~ 224 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKNSPP---TLEGQ 224 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhcCCCC---CCCcc
Confidence 33334567889999999998889999999999999999999999975332211 00011111110 01112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1036 KLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1036 ~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+.+++.+||+.+|++||++.++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 2345889999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=319.44 Aligned_cols=194 Identities=22% Similarity=0.389 Sum_probs=158.5
Q ss_pred cCccccCCceeEEEEEEC---CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee--CCceeEEEE
Q 001494 801 EHCIGKGGQGSVYKVELA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH--AQHSFIVYE 875 (1067)
Q Consensus 801 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E 875 (1067)
+.+||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 467999999999999765 45789999986432 12457789999999999999999998854 457899999
Q ss_pred eccCCCHHHHhccc------CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee----CCCCCeEEecc
Q 001494 876 YLEMGSLAMILSND------AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLL----DFKNEARVSDF 945 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill----~~~~~~kl~Df 945 (1067)
|+++ ++.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9875 666665321 1223578899999999999999999999 99999999999999 56678999999
Q ss_pred ccceecCCCCC---ccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCc
Q 001494 946 GIAKFLKPDSS---NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDF 1003 (1067)
Q Consensus 946 G~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~ 1003 (1067)
|+++....... ......||+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99987654322 22345789999999988764 578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.83 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=214.7
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
...|.+.+.||+|.|+.|..|++ .++..||+|.+.+....... .+.+.+|+++|+.++|||||+++.+......+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 35688899999999999999854 57999999999877655443 44589999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+.+|.+++++.+... +.+..+..++.|+.+|++|||++ .|||||||++||+++.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec-
Confidence 999999999999966554 44577888999999999999999 99999999999999999999999999999887
Q ss_pred CCCccccccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcc
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
......+++|++.|.|||++.+..| ++++|+||+|+++|-|+.|..|||+... .....+++...+.++...
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------k~Lr~rvl~gk~rIp~~m 278 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------KELRPRVLRGKYRIPFYM 278 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------ccccchheeeeeccccee
Confidence 3455577899999999999998886 6799999999999999999999985432 333445566666666655
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
..+ ..+++++++-.+|.+|++.+++.+
T Consensus 279 s~d----ce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 279 SCD----CEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ech----hHHHHHHhhccCccccCCHHHhhh
Confidence 555 778999999999999999999875
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=317.68 Aligned_cols=261 Identities=22% Similarity=0.358 Sum_probs=201.0
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..++||+|+||.||+|... +++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 36888899999999999999765 68999999986543322 33567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||++++++..+.... ..+++.++..++.|+++|++|||+. +++|||++|+||++++++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 80 EFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred ecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999998876432 3489999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh------hhhh---------
Q 001494 955 SSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL------NIAL--------- 1018 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~------~~~~--------- 1018 (1067)
........++..|+|||++.+. .++.++|||||||++|||++|+.||............. ....
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 4444456688999999988653 47889999999999999999999986433211000000 0000
Q ss_pred -hhccCCCCCCCCc---chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1019 -DEILDPRLPIPSH---NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1019 -~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.....+....... ..+.....+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000011000000 00112345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=317.15 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=199.3
Q ss_pred CCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|.....||+|+||.||++.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 44456799999999999965 468899999986432 22346688999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
++++++.+++.. ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 101 LEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 999999998843 2478899999999999999999999 999999999999999999999999999976544433
Q ss_pred ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHH
Q 001494 957 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEK 1036 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1067)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||........ .........+...... ..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~----~~ 244 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-----MRRIRDNLPPRVKDSH----KV 244 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcCCCcccccc----cc
Confidence 33456788999999999888899999999999999999999999864332111 1111112222221111 12
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1037 LISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1037 ~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
...+.+++.+||+.||.+|||+.|+++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2347899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=315.44 Aligned_cols=258 Identities=27% Similarity=0.413 Sum_probs=200.9
Q ss_pred HHHHHhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeC
Q 001494 790 EIIRATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHA 867 (1067)
Q Consensus 790 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 867 (1067)
++..+.++|+..+.||+|+||.||+|.. .+++.+|+|++.... ....++.+|+.+++++ +|||++++++++...
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3444568899999999999999999865 578899999986421 1245677899999988 799999999998654
Q ss_pred -----CceeEEEEeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeE
Q 001494 868 -----QHSFIVYEYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEAR 941 (1067)
Q Consensus 868 -----~~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~k 941 (1067)
+..|+||||+++++|.++++.. .....+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 3589999999999999988532 2234689999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCccccccccccccCccccccCC-----CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhh
Q 001494 942 VSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMK-----VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNI 1016 (1067)
Q Consensus 942 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 1016 (1067)
|+|||.+..............|+..|+|||.+.... ++.++|||||||++|||++|+.||........ ..
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-----~~ 243 (291)
T cd06639 169 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-----LF 243 (291)
T ss_pred EeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-----HH
Confidence 999999987654433334456889999999876433 67899999999999999999999864332110 00
Q ss_pred hhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1017 ALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1017 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.......+....+. +....+.+++.+||+.+|++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KIPRNPPPTLLHPE----KWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHhcCCCCCCCccc----ccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 01111111111111 22335899999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=317.52 Aligned_cols=262 Identities=22% Similarity=0.293 Sum_probs=200.1
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCC--ChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPG--EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
+|+..+.||+|+||.||+|.. .+++.||+|++...... .......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477788999999999999975 47899999999754332 122345677899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+ +++|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999986433 3589999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh-------hhhh------
Q 001494 954 DSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------IALD------ 1019 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-------~~~~------ 1019 (1067)
.........+++.|+|||.+.+ ..++.++|||||||++|||++|..||.............. ....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 4444444566888999998765 4578899999999999999999877754332110000000 0000
Q ss_pred hccCCCC--CCC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1020 EILDPRL--PIP-SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1020 ~~~~~~~--~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
....... ..+ .........++.+++.+||+.+|++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000 000 00011223568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=314.03 Aligned_cols=262 Identities=24% Similarity=0.395 Sum_probs=202.2
Q ss_pred cCCCccCccccCCceeEEEEEEC-----CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee--CC
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH--AQ 868 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~ 868 (1067)
+.|+..+.||+|+||.||+|+.. +++.||||++...... ...+++..|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 45777899999999999999753 4788999998754332 346789999999999999999999999877 55
Q ss_pred ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccc
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a 948 (1067)
..++||||+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 7899999999999999996432 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccc---cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc------chhhhhhhh
Q 001494 949 KFLKPDSSNWT---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSS------SLNLNIALD 1019 (1067)
Q Consensus 949 ~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~------~~~~~~~~~ 1019 (1067)
........... ...++..|+|||...+..++.++||||||+++|||++|+.|+......... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 87653322111 223456799999998888999999999999999999999997543211100 000011111
Q ss_pred hccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1020 EILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
+.+......+.. .....++.+++.+||+.+|++||||.||+++|+
T Consensus 237 ~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 237 ELLKEGERLPRP--PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred HHHHcCCcCCCC--ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 111111111111 112245889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=312.62 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=202.7
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..+.||+|+||.||+|... +++.||+|++..... ....+++.+|++++++++||||+++++++......++|+|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 5778899999999999999765 689999999875432 2345778999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN-DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
|+++++|.+++.... ..+++..+.+++.|++.|++|||+ . +++||||||+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 80 YMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred ecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 999999999986432 568889999999999999999999 7 9999999999999999999999999998765432
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCC-CCCCCcch
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPR-LPIPSHNV 1033 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1033 (1067)
.. ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||......... .......+.... ...+..
T Consensus 155 ~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~-- 227 (265)
T cd06605 155 LA--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG---IFELLQYIVNEPPPRLPSG-- 227 (265)
T ss_pred Hh--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc---HHHHHHHHhcCCCCCCChh--
Confidence 21 1266888999999998889999999999999999999999998644211111 111112222211 111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....++.+++.+||..+|++|||+.++++
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 -KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 13345889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=310.73 Aligned_cols=257 Identities=25% Similarity=0.423 Sum_probs=201.5
Q ss_pred CCCccCccccCCceeEEEEEECC--CcEEEEEEeCCCCC-------CChhHHHHHHHHHHHHhc-CCCCeeeeeeEEEee
Q 001494 797 DFDDEHCIGKGGQGSVYKVELAS--GEIIAVKKFHSPLP-------GEMTFQQEFLNEVKALTE-IRHRNIVKFYGFCSH 866 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 866 (1067)
.|+..+.||+|+||.||+|.... ++.+|+|.+..... .......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788999999999999997654 78899998753221 122234557788888764 799999999999999
Q ss_pred CCceeEEEEeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecc
Q 001494 867 AQHSFIVYEYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDF 945 (1067)
Q Consensus 867 ~~~~~lv~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~Df 945 (1067)
++..++||||+++++|.+++... .....+++..++.++.|++.|+.|||+.. +++||||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887432 23346889999999999999999999631 8999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCC
Q 001494 946 GIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPR 1025 (1067)
Q Consensus 946 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1067)
|.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .....+....
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------~~~~~~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------SLATKIVEAV 229 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------HHHHHHhhcc
Confidence 9998765443 334567889999999999888999999999999999999999997533221 1111111111
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1026 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
...... .....++.+++.+||+.||++||++.|+.++++
T Consensus 230 ~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPLPE--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcCCc--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111 012235889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=315.29 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=199.7
Q ss_pred HHHHHHhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEee
Q 001494 789 EEIIRATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH 866 (1067)
Q Consensus 789 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 866 (1067)
.+.......|+..+.||+|+||.||+|+. .+++.||+|++.... ....++..|+.+++++ +||||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 34444567889999999999999999975 568899999985431 2245678899999988 69999999999853
Q ss_pred ------CCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCe
Q 001494 867 ------AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA 940 (1067)
Q Consensus 867 ------~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~ 940 (1067)
....|+||||+++|+|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 457899999999999999886432 34578888999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCccccccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh
Q 001494 941 RVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN 1015 (1067)
Q Consensus 941 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 1015 (1067)
+|+|||++..............|++.|+|||.+. ...++.++|||||||++|||++|+.||........
T Consensus 161 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------ 234 (282)
T cd06636 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------ 234 (282)
T ss_pred EEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------
Confidence 9999999876543333344567899999999875 34578899999999999999999999854322111
Q ss_pred hhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1016 IALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1016 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...+..... +..........+.+++.+||+.||.+|||+.|+++
T Consensus 235 --~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 --LFLIPRNPP--PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --hhhHhhCCC--CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 011111110 00001122345899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.35 Aligned_cols=251 Identities=26% Similarity=0.450 Sum_probs=199.6
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCc----EEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCce
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 870 (1067)
.+|+..+.||+|+||.||+|... +|+ .||+|....... .....++.+|+..+++++|||++++++++.. ...
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 56888899999999999998754 333 589998765432 3345678899999999999999999999987 788
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
++||||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999998543 23489999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCCccc--cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CC
Q 001494 951 LKPDSSNWT--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RL 1026 (1067)
Q Consensus 951 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1026 (1067)
......... ...++..|+|||.+....++.++|+||||+++||+++ |+.||+...... ....+... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~ 230 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--------IPDLLEKGERL 230 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHhCCCCC
Confidence 654322211 1223568999999988889999999999999999998 999987543211 11111111 12
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
..+.... ..+.+++.+||..+|.+||++.++++.|+
T Consensus 231 ~~~~~~~----~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~ 266 (279)
T cd05057 231 PQPPICT----IDVYMVLVKCWMIDAESRPTFKELINEFS 266 (279)
T ss_pred CCCCCCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 2222222 24789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=325.95 Aligned_cols=259 Identities=21% Similarity=0.317 Sum_probs=195.1
Q ss_pred HHhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC----
Q 001494 793 RATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA---- 867 (1067)
Q Consensus 793 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---- 867 (1067)
+..++|+..+.||+|+||.||+|.. .+++.||||++...... ....+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 3457899999999999999999964 57889999998754322 22345677899999999999999999987543
Q ss_pred --CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecc
Q 001494 868 --QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDF 945 (1067)
Q Consensus 868 --~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~Df 945 (1067)
...|++||++ ++++.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3568999988 6788887743 3489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchh-------hhhh
Q 001494 946 GIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN-------LNIA 1017 (1067)
Q Consensus 946 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~~~~ 1017 (1067)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||............ ....
T Consensus 163 g~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 163 GLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred ccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999875432 344578999999999876 46889999999999999999999998643321100000 0000
Q ss_pred h--------hhccCCCCCCCCcchH----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1018 L--------DEILDPRLPIPSHNVQ----EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1018 ~--------~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
. ..........+..... .....+.+++.+|++.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0000000000000000 11124789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=312.47 Aligned_cols=260 Identities=27% Similarity=0.362 Sum_probs=200.0
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--CceeEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--QHSFIV 873 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 873 (1067)
+|+..++||.|++|.||+|.. .+++.||+|.+..... .....++.+|++++++++||||+++++++.+. +..++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 577889999999999999976 4688999999875422 23457789999999999999999999988653 478999
Q ss_pred EEeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 874 YEYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
|||+++++|.+++... .....+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999887532 2234578899999999999999999999 99999999999999999999999999987554
Q ss_pred CCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcc
Q 001494 953 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 953 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
.... ....++..|+|||.+.+..++.++||||+||++|||++|+.||+.....................+.+......
T Consensus 157 ~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 157 NSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred cccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 3221 23457888999999988889999999999999999999999987543210011111111111111111111110
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.......+.+++.+||+.+|.+|||+.|+++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1112345889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=309.63 Aligned_cols=238 Identities=25% Similarity=0.445 Sum_probs=187.9
Q ss_pred CccccCCceeEEEEEECCCc-----------EEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCce
Q 001494 802 HCIGKGGQGSVYKVELASGE-----------IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 870 (1067)
+.||+|+||.||+|...+.. .|++|.+.... .. ...+.+|+.++++++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46999999999999765332 47777765332 11 5778899999999999999999999988 788
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC-------CeEEe
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN-------EARVS 943 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~-------~~kl~ 943 (1067)
++||||+++|+|.+++.... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++ .+|++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 99999999999999996433 2588999999999999999999999 999999999999999888 79999
Q ss_pred ccccceecCCCCCccccccccccccCccccccC--CCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhh
Q 001494 944 DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDE 1020 (1067)
Q Consensus 944 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1020 (1067)
|||+++.... .....++..|+|||++.+. .++.++|||||||++|||++ |..|+........ .....
T Consensus 151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-----~~~~~- 220 (259)
T cd05037 151 DPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-----ERFYQ- 220 (259)
T ss_pred CCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-----HHHHh-
Confidence 9999986543 1234567789999998876 78999999999999999999 5777654321100 00000
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1021 ILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....+.+. . ..+.+++.+||+.+|++|||+.++++.|+
T Consensus 221 -~~~~~~~~~--~----~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -DQHRLPMPD--C----AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -cCCCCCCCC--c----hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111111111 1 45889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=337.06 Aligned_cols=259 Identities=18% Similarity=0.207 Sum_probs=189.0
Q ss_pred HHHHhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC------CCeeeeeeEE
Q 001494 791 IIRATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR------HRNIVKFYGF 863 (1067)
Q Consensus 791 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~ 863 (1067)
+.....+|++.++||+|+||+||+|.. .+++.||||++.... ....++..|+++++.++ |++++.++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 334567899999999999999999965 468899999986421 12334556666666654 4568999998
Q ss_pred EeeC-CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeeCCCC---
Q 001494 864 CSHA-QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN-DCFPPIVHRDISSKNVLLDFKN--- 938 (1067)
Q Consensus 864 ~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlk~~Nill~~~~--- 938 (1067)
+..+ ++.|+|||++ ++++.+++... ..+++..+..|+.||+.||+|||+ . +||||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 8765 5789999988 66787777433 358999999999999999999997 5 999999999999998766
Q ss_pred -------------CeEEeccccceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 001494 939 -------------EARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFIS 1005 (1067)
Q Consensus 939 -------------~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~ 1005 (1067)
.+||+|||.+.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999886432 22345689999999999999999999999999999999999999997543
Q ss_pred cccccchhh-------hhh--------hhhccCC--CC--CCCCc-----------chHHHHHHHHHHHHhccCCCCCCC
Q 001494 1006 LISSSSLNL-------NIA--------LDEILDP--RL--PIPSH-----------NVQEKLISFVEVAISCLDESPESR 1055 (1067)
Q Consensus 1006 ~~~~~~~~~-------~~~--------~~~~~~~--~~--~~~~~-----------~~~~~~~~l~~li~~cl~~dP~~R 1055 (1067)
......... ..+ ...+... .+ ...+. ........+.+|+.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 211100000 000 0000000 00 00000 000112357899999999999999
Q ss_pred CCHHHHHH
Q 001494 1056 PTMQKVSQ 1063 (1067)
Q Consensus 1056 pt~~evl~ 1063 (1067)
||+.|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999986
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.96 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=194.8
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCC--ChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--Cce
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPG--EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--QHS 870 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 870 (1067)
.+|+..+.||+|+||.||+|.. .+++.||+|++...... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999965 56899999988643221 223345688899999999999999999988653 577
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
+++|||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999998543 3478899999999999999999999 999999999999999999999999999976
Q ss_pred cCCCC---CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC
Q 001494 951 LKPDS---SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 951 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
..... .......++..|+|||.+.+..++.++||||+||++|||++|+.||........ ..........+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~-- 229 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA----IFKIATQPTNPQ-- 229 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH----HHHHhcCCCCCC--
Confidence 54321 122335578899999999888899999999999999999999999864322110 000000111111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.+. .....+.+++ +||..+|++||++.|+++
T Consensus 230 ~~~----~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 230 LPS----HISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred Cch----hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111 1223366676 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=318.34 Aligned_cols=255 Identities=23% Similarity=0.279 Sum_probs=198.4
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|+||.||++... +++.||+|.+...........+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999654 67899999986543222334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999999543 3588999999999999999999999 9999999999999999999999999998642110
Q ss_pred CC---------------ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhh
Q 001494 955 SS---------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALD 1019 (1067)
Q Consensus 955 ~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1019 (1067)
.. ......++..|+|||.+.+..++.++|+|||||++|||++|+.||..... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~~~~ 226 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELFG 226 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence 00 01123578889999999888899999999999999999999999863321 11111
Q ss_pred hccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1020 EILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
.........+... ......+.+++.+||+.+|++||++.++.+.+
T Consensus 227 ~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 227 QVISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred HHHhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 2211111111110 11233488999999999999999965555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=309.86 Aligned_cols=250 Identities=24% Similarity=0.267 Sum_probs=202.4
Q ss_pred hcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
.+.|..-++||+||||.||.++ ..+|+.||.|++.+........+...+.|-.++.+++.+.||.+--+|+.++.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 4568888999999999999986 457999999887654333333345577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
+..|.||+|..++.+.+. ..+++..+.-++.+|+.||++||+. +||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999988876554 4589999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
. ......+||.+|||||++.++.|+...|.||+||++|||+.|+.||.....- ....+..+.+.... .+..
T Consensus 340 g-~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----vk~eEvdrr~~~~~----~ey~ 410 (591)
T KOG0986|consen 340 G-KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----VKREEVDRRTLEDP----EEYS 410 (591)
T ss_pred C-CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----hhHHHHHHHHhcch----hhcc
Confidence 4 3445569999999999999999999999999999999999999998632211 11111112222222 2222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCC
Q 001494 1034 QEKLISFVEVAISCLDESPESRPT 1057 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt 1057 (1067)
...+.+..++.+..|++||.+|--
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhcc
Confidence 334445788888999999999963
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.92 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=198.1
Q ss_pred cCCCccCccccCCceeEEEEEECC----CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCcee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELAS----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 871 (1067)
.+|...++||+|+||.||+|...+ ...||+|....... ....+.+.+|+.++++++||||+++++++.+ +..|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 457888999999999999997543 24689998865432 3345678999999999999999999998875 5678
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+||||+++++|.+++... ...+++.++..++.+++.|++|||+. +++||||||+||+++.++.+|++|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999999543 23589999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCc-cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCC
Q 001494 952 KPDSSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029 (1067)
Q Consensus 952 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1067)
...... .....++..|+|||.+....++.++||||||+++||+++ |+.||........ ...... ......+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-----~~~~~~--~~~~~~~ 230 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-----IGRIEN--GERLPMP 230 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-----HHHHHc--CCcCCCC
Confidence 543211 122234568999999988889999999999999999996 9999864432110 011111 1122222
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
... ..++.+++.+|+..+|++|||+.++++.|+
T Consensus 231 ~~~----~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~ 263 (270)
T cd05056 231 PNC----PPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263 (270)
T ss_pred CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 222 235889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.80 Aligned_cols=253 Identities=30% Similarity=0.415 Sum_probs=202.6
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee--CCceeEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH--AQHSFIV 873 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 873 (1067)
+|+..+.||.|+||.||+|.. .+++.||+|++..... .....+++..|++++++++||||+++++++.. +...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 477889999999999999864 5788999999865432 23335678899999999999999999998754 4567999
Q ss_pred EEeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHH-----hCCCCCeeecCCCCCceeeCCCCCeEEecccc
Q 001494 874 YEYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLH-----NDCFPPIVHRDISSKNVLLDFKNEARVSDFGI 947 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~ 947 (1067)
|||+++++|.+++... .....+++..++.++.|++.|++||| +. +++||||||+||+++.++.+|++|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence 9999999999998643 22456899999999999999999999 66 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC
Q 001494 948 AKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 948 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
+..............+++.|+|||.+.+..++.++||||||+++|+|++|+.||+..... .....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~ 228 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--------QLASKIKEGKFR 228 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--------HHHHHHhcCCCC
Confidence 987765443344567899999999998888999999999999999999999998743311 111112222111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
..+ ......+.+++.+|++.+|++||++.+|++.
T Consensus 229 ~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 RIP---YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCc---cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 1223458899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=315.38 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=198.2
Q ss_pred CCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|+....||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++|||++++++++..++..|+||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 34456799999999999965 4789999999864322 2246688999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+++++|..++.. ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 100 LQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 999999988743 3478999999999999999999999 999999999999999999999999999976554433
Q ss_pred ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHH
Q 001494 957 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEK 1036 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1067)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......... ........+...... ..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~----~~ 243 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-----KRLRDSPPPKLKNAH----KI 243 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHhccCCCCccccC----CC
Confidence 344567899999999998888999999999999999999999998643321110 011111111111111 12
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1037 LISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1037 ~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...+.+++.+||+.+|++||++.++++
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 234789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=306.97 Aligned_cols=252 Identities=30% Similarity=0.463 Sum_probs=201.9
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+++.+|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 478889999999999999965 47899999998755332 3456789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++... ..+++..+..++.++++|++|||+. +|+|+||+|+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 80 YCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred cCCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999998643 3478889999999999999999999 99999999999999999999999999998765433
Q ss_pred Ccc----ccccccccccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCC
Q 001494 956 SNW----TELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028 (1067)
Q Consensus 956 ~~~----~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1028 (1067)
... ....+++.|+|||++.+.. ++.++||||||+++||+++|+.||....... ........ ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~~~~~~~--~~~~~~ 227 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QIMFHVGA--GHKPPI 227 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HHHHHHhc--CCCCCC
Confidence 322 2356788999999988766 8899999999999999999999986432111 00001111 111112
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1029 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+.. ......+.+++.+||+.+|++|||+.|++.
T Consensus 228 ~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 PDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred Ccc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 211 112335789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=322.53 Aligned_cols=191 Identities=22% Similarity=0.343 Sum_probs=163.5
Q ss_pred HhcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeE
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 872 (1067)
....|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++.+.+..++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 3467999999999999999999764 5788999975421 23468999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
||||+. +++.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.++...
T Consensus 135 v~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 135 VLPHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEEccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 999996 577777743 234589999999999999999999999 99999999999999999999999999997533
Q ss_pred CCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 001494 953 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000 (1067)
Q Consensus 953 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p 1000 (1067)
.. .......||+.|+|||++.+..++.++|||||||++|||+++..|
T Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 209 VA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred cC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 22 223346789999999999999999999999999999999986555
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.80 Aligned_cols=246 Identities=28% Similarity=0.461 Sum_probs=196.7
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
++|++.+.||+|+||.||++.. +++.||+|++.... ..+.+.+|+.++++++|||++++++++... ..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 4588899999999999999864 57889999986431 235788999999999999999999998764 4799999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 79 LMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred CCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 999999999986433 33578999999999999999999999 9999999999999999999999999999764322
Q ss_pred CccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 956 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
......+..|+|||.+.+..++.++|||||||++|||++ |+.||........ ........ ....+.
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~--~~~~~~---- 220 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-----KECVEKGY--RMEPPE---- 220 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-----HHHHhCCC--CCCCCC----
Confidence 122334568999999988889999999999999999998 9999864432110 11111111 111111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
..+.++.+++.+||+.+|++||+++++++.|+
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 22345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=314.49 Aligned_cols=260 Identities=18% Similarity=0.308 Sum_probs=195.5
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|++|.||+|... +++.||+|.+....... ....+.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 67889999999999999999765 68999999987543222 1245678999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++ +|.+++.... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 83 EYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 99985 8888875432 3578999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccc-chh-------hhhhhhhc----
Q 001494 955 SSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSS-SLN-------LNIALDEI---- 1021 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~-------~~~~~~~~---- 1021 (1067)
........++..|+|||++.+ ..++.++||||+||++|||++|+.||......... ... .......+
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 222333456888999998865 45789999999999999999999998643311000 000 00000000
Q ss_pred --cCCCCCC--CCcc-----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1022 --LDPRLPI--PSHN-----VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1022 --~~~~~~~--~~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....... +... .......+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 0000 0001135789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.83 Aligned_cols=254 Identities=30% Similarity=0.459 Sum_probs=207.1
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|++|.||+|+.. +++.||+|++...... ...+.+..|+..+++++|||++++++++...+..++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 36888899999999999999765 5999999998754322 34678999999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN-DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
||+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++++|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999643 458999999999999999999999 8 999999999999999999999999999987765
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.........++..|+|||.+.+..++.++||||||+++|||++|+.||...... ........+...........
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~- 226 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-----SFFELMQAICDGPPPSLPAE- 226 (264)
T ss_pred CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-----CHHHHHHHHhcCCCCCCCcc-
Confidence 444434567889999999998888999999999999999999999998654320 11111222222111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
.....+.+++.+||+.+|++||++.|+++.
T Consensus 227 -~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 -EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 023458999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.80 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=198.5
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCC-------ChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPG-------EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ 868 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 868 (1067)
+|...+.||+|+||.||+|.. .+|+.||+|.+...... .....+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999964 47899999988542111 1112346788999999999999999999999999
Q ss_pred ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccc
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a 948 (1067)
..++||||+++++|.+++... ..+++..+..++.|++.|+.|||++ +++||||+|+||+++.++.++++|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998654 4588899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC--ccccccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC
Q 001494 949 KFLKPDSS--NWTELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP 1024 (1067)
Q Consensus 949 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1024 (1067)
+....... ......|+..|+|||.+.... ++.++||||+|+++||+++|..||......... ...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~--~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM----FKLGNK--RS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH----HHhhcc--cc
Confidence 76543211 123346788999999887654 789999999999999999999998533221100 000000 11
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1025 RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1025 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+.....+...++.+++.+||+.+|++|||+.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111122222223456899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.29 Aligned_cols=248 Identities=26% Similarity=0.444 Sum_probs=195.0
Q ss_pred CccccCCceeEEEEEECC-------CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 802 HCIGKGGQGSVYKVELAS-------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
+.||+|+||.||+|+..+ ++.||+|.+..... .....++.+|+.+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 469999999999987542 25799998764321 233567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccC----ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC-----CeEEecc
Q 001494 875 EYLEMGSLAMILSNDA----AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN-----EARVSDF 945 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~-----~~kl~Df 945 (1067)
||+++++|.+++.... ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .++++||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999986422 223478899999999999999999999 999999999999999887 8999999
Q ss_pred ccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhcc
Q 001494 946 GIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEIL 1022 (1067)
Q Consensus 946 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1022 (1067)
|+++....... ......++..|+|||++.++.++.++|||||||++|||++ |+.||....... ....+.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~ 227 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------VLQHVT 227 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--------HHHHHh
Confidence 99976543221 1122345678999999998899999999999999999998 999986432211 111111
Q ss_pred C-CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1023 D-PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1023 ~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
. .....+. ..+..+.+++.+||..+|++||++.++++.|+
T Consensus 228 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 AGGRLQKPE----NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCCccCCcc----cchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 1111121 12345889999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.32 Aligned_cols=250 Identities=30% Similarity=0.479 Sum_probs=199.1
Q ss_pred CCccCccccCCceeEEEEEECC-----CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeE
Q 001494 798 FDDEHCIGKGGQGSVYKVELAS-----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 872 (1067)
+++.+.||+|+||.||+++... +..||+|++...... ...+.+..|++.++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 3567889999999999997653 488999998654222 245788999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
+|||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.++...
T Consensus 79 i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence 9999999999999854322 1289999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccc-cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCC-CCCCC
Q 001494 953 PDSSNWT-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLPIP 1029 (1067)
Q Consensus 953 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 1029 (1067)
....... ...+++.|+|||.+.+..++.++||||+|+++|||++ |+.||+.... ......+... ....+
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~ 226 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYRLPKP 226 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCCC
Confidence 4422211 2336789999999988889999999999999999998 7888764221 1111111111 11112
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
.. ...++.+++.+|+..+|++|||+.|+++.|
T Consensus 227 ~~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 EN----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred Cc----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 22 233588999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=309.66 Aligned_cols=251 Identities=27% Similarity=0.351 Sum_probs=204.3
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..++||+|+||.||+|+.. +++.||+|++...........+.+.+|++++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999765 689999999975443333456789999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++... ..+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998543 4588999999999999999999999 99999999999999999999999999998765432
Q ss_pred CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHH
Q 001494 956 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1067)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||+...... ...............+..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~---- 224 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQETADVLYPAT---- 224 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhccccccCccc----
Confidence 2334567889999999988889999999999999999999999987544210 111111111122222222
Q ss_pred HHHHHHHHHHhccCCCCCCCCCH--HHHHH
Q 001494 1036 KLISFVEVAISCLDESPESRPTM--QKVSQ 1063 (1067)
Q Consensus 1036 ~~~~l~~li~~cl~~dP~~Rpt~--~evl~ 1063 (1067)
....+.+++.+||+.||++||++ +|+++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 225 WSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred CcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 22458899999999999999999 77653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=313.47 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=196.3
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCc----EEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCce
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 870 (1067)
.+|+..+.||+|+||.||+|.. .+|+ .||+|.+.... ......++.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 5678889999999999999965 3454 47888876432 223345788999999999999999999998754 56
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
++++||+++|++.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence 7999999999999998542 23578899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc--cccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhccCCCCC
Q 001494 951 LKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 951 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
....... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||........ ...... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-----~~~~~~--~~~~~ 231 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-----PDLLEK--GERLP 231 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----HHHHHC--CCCCC
Confidence 6533221 122345678999999988889999999999999999997 8999864322110 001110 11111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+.. ....+.+++.+||..+|++||++.++++.|+
T Consensus 232 ~~~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 232 QPPI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111 1235889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.68 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=200.6
Q ss_pred HhcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCC---
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQ--- 868 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~--- 868 (1067)
.+++|+..+.||+|+||.||+|... +++.||+|++.... ...+++.+|+.+++++ +||||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 4578999999999999999999764 67899999986432 1346788999999999 7999999999997654
Q ss_pred ---ceeEEEEeccCCCHHHHhcccC-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEec
Q 001494 869 ---HSFIVYEYLEMGSLAMILSNDA-AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSD 944 (1067)
Q Consensus 869 ---~~~lv~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~D 944 (1067)
..|+||||+++++|.+++.... ....+++..+..++.|++.|++|||++ +++||||+|+||+++.++.+|++|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 4899999999999999886432 235689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCccccccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhh
Q 001494 945 FGIAKFLKPDSSNWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALD 1019 (1067)
Q Consensus 945 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1019 (1067)
||.+..............|++.|+|||++.. ..++.++||||+||++|||++|+.||....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~ 228 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--------ALF 228 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--------HHH
Confidence 9999876544444445678899999998753 346789999999999999999999986332111 111
Q ss_pred hccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1020 EILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
++...... ..........++.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 KIPRNPPP-TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HhhccCCC-CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111100 00111123346889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.94 Aligned_cols=248 Identities=26% Similarity=0.457 Sum_probs=199.9
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC---CCeeeeeeEEEeeCCceeE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR---HRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l 872 (1067)
.|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+++.+|+.++++++ |||++++++++.++...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 467788999999999999975 5789999999865422 223467888999999886 9999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
||||+++++|.+++... .+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.++++|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999988542 588999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCc
Q 001494 953 PDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031 (1067)
Q Consensus 953 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1067)
..........|+..|+|||.+.++ .++.++|||||||++|+|++|+.||+........ ........+.+ +..
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-----~~~~~~~~~~~--~~~ 225 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-----MLIPKSKPPRL--EDN 225 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-----hccccCCCCCC--Ccc
Confidence 554444556788999999987654 4688999999999999999999998643321110 00011111111 111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....++.+++.+||+.||++||++.|+++
T Consensus 226 ---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 226 ---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 12345889999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=313.30 Aligned_cols=262 Identities=20% Similarity=0.276 Sum_probs=195.5
Q ss_pred HhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeE
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 872 (1067)
++.+|...+.||+|+||.||+|.. .+++.||+|++....... ....+.+|+.+++.++|+||+++++++.+++..|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 356799999999999999999965 578999999986543222 23456789999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
||||++ +++..++... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 v~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 81 VFEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred EEeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 999996 5666555322 23477888899999999999999999 99999999999999999999999999997654
Q ss_pred CCCCccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchh--------hhh-------
Q 001494 953 PDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN--------LNI------- 1016 (1067)
Q Consensus 953 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~--------~~~------- 1016 (1067)
..........+++.|+|||.+.+. .++.++||||+||++|||++|+.||+........... ...
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 433333445678999999988754 4788999999999999999999998754321000000 000
Q ss_pred ---hhhhccCCCCCCCCc---chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1017 ---ALDEILDPRLPIPSH---NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1017 ---~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
............... .......++.+++.+|++.||.+|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 00001235789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=304.64 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=200.3
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCC--ChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPG--EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
+|+..+.||+|+||.||+|... +++.||+|.+...... .....+.+.+|+++++.++||||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999765 7899999998653321 223456789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+++++|.+++... ..+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998543 3478999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCccccccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcc
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
.. ......+++.|+|||.+.... ++.++|+|||||++|+|++|+.||......... ...... ......+..
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~~-~~~~~~~~~- 226 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-----FKIGRS-KELPPIPDH- 226 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-----HHHHhc-ccCCCcCCC-
Confidence 32 234456888999999887766 899999999999999999999998643311100 000000 011111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+.+++.+||+.+|++||++.++++
T Consensus 227 ---~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 227 ---LSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---cCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 2234789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=314.30 Aligned_cols=260 Identities=20% Similarity=0.319 Sum_probs=195.2
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..+.||+|+||.||+|+.. +|+.||+|++...... ......+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 4778899999999999999764 7899999998654222 1223567789999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++ ++.+++... ...+++..+..++.||++|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 80 YCDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred cCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 9975 677666432 24589999999999999999999999 99999999999999999999999999998765443
Q ss_pred CccccccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccccccccchhh--------hh---hhhhccC
Q 001494 956 SNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL--------NI---ALDEILD 1023 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~--------~~---~~~~~~~ 1023 (1067)
.......+++.|+|||.+.+.. ++.++||||+||++|||+||+.|+............. .. ...+..+
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 3344456788999999887654 6899999999999999999998853211110000000 00 0000000
Q ss_pred -CCCCCCCc------chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1024 -PRLPIPSH------NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1024 -~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
........ .......++.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000 00112345789999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=307.37 Aligned_cols=247 Identities=28% Similarity=0.416 Sum_probs=200.5
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
-|+..++||+|+||.||+|.. .+++.||+|...... .....+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 467788999999999999965 578899999876432 22345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|++++++.+++.. ..+++..+..++.+++.|++|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 83 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 9999999998853 3478999999999999999999999 99999999999999999999999999998765443
Q ss_pred CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHH
Q 001494 956 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1067)
.......++..|+|||.+.+..++.++|||||||++|||++|..||....... ....+.....+ .....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~---~~~~~ 224 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--------VLFLIPKNNPP---TLEGN 224 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--------HHHHHhcCCCC---CCCcc
Confidence 33344567889999999988888999999999999999999999986432211 11111111111 01112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1036 KLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1036 ~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...++.+++.+||+.+|.+||++.++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 2345889999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=305.41 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=196.2
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCC--CChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--Cce
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLP--GEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--QHS 870 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 870 (1067)
.+|+..+.||+|+||.||+|.. .+++.||+|.+..... ......+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999965 4689999998854321 1223346788899999999999999999988764 467
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
++||||+++++|.+++... ..+++..+.+++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||.++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998543 3478888999999999999999999 999999999999999999999999999976
Q ss_pred cCCCC---CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC-CC
Q 001494 951 LKPDS---SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP-RL 1026 (1067)
Q Consensus 951 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1026 (1067)
..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||....... ........+ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~ 228 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------AIFKIATQPTNP 228 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------HHHHHhcCCCCC
Confidence 54221 12234568889999999988889999999999999999999999986432211 001111111 11
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
..+ ......+.+++.+|+. +|++||+++|+++
T Consensus 229 ~~~----~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 229 VLP----PHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCc----hhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111 2233457889999994 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=288.22 Aligned_cols=253 Identities=23% Similarity=0.269 Sum_probs=210.3
Q ss_pred HhcCCCc-cCccccCCceeEEEE-EECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEee----
Q 001494 794 ATNDFDD-EHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH---- 866 (1067)
Q Consensus 794 ~~~~~~~-~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---- 866 (1067)
.+++|.+ .++||-|-.|.|..+ ..++++.+|+|++... ....+|++..-.. .|||||.++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 4566765 367999999999987 5668999999998642 3445788875555 69999999999854
Q ss_pred CCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC---CeEEe
Q 001494 867 AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN---EARVS 943 (1067)
Q Consensus 867 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~---~~kl~ 943 (1067)
...+.+|||.|+||.|...++..+ ...+++.++..|++||+.|+.|||+. +|.||||||+|+|...++ .+|++
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 457789999999999999997544 45689999999999999999999999 999999999999997553 59999
Q ss_pred ccccceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccC
Q 001494 944 DFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD 1023 (1067)
Q Consensus 944 DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1023 (1067)
|||+|+.... .....+.+-||.|.|||++...+|+...|+||+||++|-|++|.+||-..... ........++..
T Consensus 207 DfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~----aispgMk~rI~~ 281 (400)
T KOG0604|consen 207 DFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKRRIRT 281 (400)
T ss_pred ccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc----cCChhHHhHhhc
Confidence 9999987553 34556788899999999999999999999999999999999999997532221 112234456677
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1024 PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1024 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+.+.+|.+.+.+.++...++|+.+|..+|.+|.|+.|+++
T Consensus 282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 8888899999999999999999999999999999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=336.01 Aligned_cols=253 Identities=29% Similarity=0.454 Sum_probs=198.1
Q ss_pred HhcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee------
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH------ 866 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------ 866 (1067)
-..+|++.+.||+||||.||+++.+ ||+.||||++.... .......+.+|++.+++++|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 3467888899999999999999865 89999999997654 33345678899999999999999998743210
Q ss_pred --------------------------------------------------------------------------------
Q 001494 867 -------------------------------------------------------------------------------- 866 (1067)
Q Consensus 867 -------------------------------------------------------------------------------- 866 (1067)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHH
Q 001494 867 -------------------------A--------QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913 (1067)
Q Consensus 867 -------------------------~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~ 913 (1067)
+ ..+||-||||+..++.+++++..... ....+++++++|+.|++|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 0 12488999999988888886544322 346778999999999999
Q ss_pred HHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC------------------CCCCccccccccccccCcccccc
Q 001494 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK------------------PDSSNWTELAGTYGYVAPELAYT 975 (1067)
Q Consensus 914 LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~ 975 (1067)
+|+. |||||||||.||++|+++.|||+|||+|+... ......+..+||.-|+|||.+.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 99999999999999999999999999998621 11224567889999999999876
Q ss_pred CC---CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCC
Q 001494 976 MK---VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESP 1052 (1067)
Q Consensus 976 ~~---~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 1052 (1067)
.. |+.|+|+||+|||++||+.. |.. .......+....++.++.+.....+....-.++|+.+++.||
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~yP---F~T-------sMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLYP---FGT-------SMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhcc---CCc-------hHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCC
Confidence 54 99999999999999999874 321 122233344455666665533344444456789999999999
Q ss_pred CCCCCHHHHHH
Q 001494 1053 ESRPTMQKVSQ 1063 (1067)
Q Consensus 1053 ~~Rpt~~evl~ 1063 (1067)
.+||||.|++.
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 99999999985
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=346.70 Aligned_cols=252 Identities=29% Similarity=0.437 Sum_probs=204.6
Q ss_pred cCCCccCccccCCceeEEEE-EECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
-+++.+..||.|.||.||.| ...+|+..|+|-+...... ....+...+|..++..++|||+|+++|+-.+.+..+|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 35677889999999999997 5778999999988754333 344567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
|||++|+|.+.+.+.+. .++.....+..|++.|++|||++ |||||||||.||+++.+|.+|.+|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999966543 45555567889999999999999 9999999999999999999999999999988765
Q ss_pred CCc----cccccccccccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC
Q 001494 955 SSN----WTELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 955 ~~~----~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
... .....||+.|||||++.+.. ...++||||+||++.||+||+.||...+..+...+... ......
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~------~gh~Pq 1461 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA------AGHKPQ 1461 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh------ccCCCC
Confidence 432 34578999999999998654 56789999999999999999999876554332222111 111222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
+|.. ...+-.+++.+|+..||++|.++.|+++.
T Consensus 1462 ~P~~----ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 IPER----LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred Cchh----hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2322 33457899999999999999999988763
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=330.71 Aligned_cols=370 Identities=29% Similarity=0.390 Sum_probs=324.4
Q ss_pred cccCccceeecCCCccc-CCCCcccccccccceecccccccccCCCCccccccccccccccccccccccCCCccCCCccc
Q 001494 94 GNISKLKYLDLSSNLFS-GAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLV 172 (1067)
Q Consensus 94 ~~l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 172 (1067)
+-|+..+-.|+|+|.|+ +.+|..+..+++++.|.|...++. .+|.+++.|.+|+.|.+++|++.. +-..+..|+.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhH
Confidence 44566788999999999 679999999999999999999998 899999999999999999999987 456789999999
Q ss_pred EEEEeccCCcC-ccCCccccccccceecccccccccccCCCCCcccccceeecccCcCCCCCCcc-cCCcccCCceEecC
Q 001494 173 TLCLYNNLLSG-SIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSE-LGNLKYLSDLKLAD 250 (1067)
Q Consensus 173 ~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~ 250 (1067)
.+++..|++.. -+|..+..|+.|..|+|++|+++ ..|..+..-+++-+|+||+|+|. .||.. |-+|+.|-.||||+
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~ 159 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSN 159 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcccc
Confidence 99999999863 58999999999999999999999 89999999999999999999998 56655 67899999999999
Q ss_pred cccccccCccccCccceeeEEEecccccccCCCccccCCcccEEEecccccc-CCccccccCCccccEEeccCCCCcCCC
Q 001494 251 NKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFS-GLIPHSLGNLSNIAFLFLDSNSLFGLI 329 (1067)
Q Consensus 251 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~ 329 (1067)
|++. .+|+.+..|.+|++|+|++|.+....-..+-.+++|+.|.+++.+-+ .-+|.++.++.+|..++++.|.+. ..
T Consensus 160 NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~v 237 (1255)
T KOG0444|consen 160 NRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IV 237 (1255)
T ss_pred chhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cc
Confidence 9998 78889999999999999999987554455667888999999987643 347889999999999999999998 56
Q ss_pred CcccccCCCCCeEEecCccccccCCccccCCCCCCeEEccCCcCccccCcccCCCCCCCEEEccCCcccc-cCCCccccc
Q 001494 330 PSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTS-SIPISLSNL 408 (1067)
Q Consensus 330 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l 408 (1067)
|+.+..+.+|+.|+||+|+|+ .+.-..+...+|++|+++.|+++ ..|..+..+++|+.|++.+|+++- -+|..++.+
T Consensus 238 Pecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL 315 (1255)
T KOG0444|consen 238 PECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKL 315 (1255)
T ss_pred hHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhh
Confidence 889999999999999999998 45556677788999999999999 789999999999999999999873 368889999
Q ss_pred cCCcEEEcccCcCcccCchhhhCcCCCcEEeCCCCcccCCCCCCCCCCcccEEeccCccccccc
Q 001494 409 TNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNI 472 (1067)
Q Consensus 409 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L~~N~l~~~~ 472 (1067)
.+|+++..++|.+. ..|..++.+.+|+.|.|+.|++-+.+..+.-++.|+.|++..|.--..+
T Consensus 316 ~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMP 378 (1255)
T KOG0444|consen 316 IQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMP 378 (1255)
T ss_pred hhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCC
Confidence 99999999999987 7899999999999999999999888887777888888888887644433
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=311.82 Aligned_cols=261 Identities=22% Similarity=0.329 Sum_probs=197.1
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..+.||.|++|.||+|+.. +++.||||++....... ...+.+..|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 4788899999999999999754 78999999986543222 223578899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+. +++..++.... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||+++......
T Consensus 80 ~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 80 FLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred ccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 996 57888775432 34589999999999999999999999 99999999999999999999999999998665443
Q ss_pred CccccccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhh-------------hhhhc
Q 001494 956 SNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNI-------------ALDEI 1021 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-------------~~~~~ 1021 (1067)
.......+++.|+|||.+.+.. ++.++|||||||++|||+||+.||............... ...+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 3334456788999999877654 588999999999999999999998643321100000000 00000
Q ss_pred c--CCCCCCC--CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1022 L--DPRLPIP--SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1022 ~--~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
. .+..... .........++.+++.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0 0000000 0000011234789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=303.10 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=200.6
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..+.||+|+||.||+|.. .+++.+|+|++....... ...+.+..|++++++++|||++++++++..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 478889999999999999865 578899999987543222 335778999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC-CeEEeccccceecCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN-EARVSDFGIAKFLKPD 954 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~-~~kl~DfG~a~~~~~~ 954 (1067)
|+++++|.+++.... ...+++..+.+++.++++|++|||++ +++||||||+||+++.++ .+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999996432 34578999999999999999999999 999999999999998655 5799999999876543
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCC-CCCCCcch
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPR-LPIPSHNV 1033 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1033 (1067)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||+..... .....+.... ...+..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~-- 224 (256)
T cd08220 156 S-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--------ALVLKIMSGTFAPISDR-- 224 (256)
T ss_pred c-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--------HHHHHHHhcCCCCCCCC--
Confidence 2 223356788999999998888899999999999999999999998643321 1111111111 111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+.+++.+||+.+|++|||+.|+++
T Consensus 225 --~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 225 --YSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --cCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 2234889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=313.00 Aligned_cols=261 Identities=22% Similarity=0.293 Sum_probs=197.9
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--CceeE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--QHSFI 872 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 872 (1067)
++|+..+.||+|+||.||+|... +++.||+|.+...... ......+.+|+.++++++||||+++++++... ...|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 46888999999999999999765 6889999998754322 22334567899999999999999999998877 89999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
||||+++ +|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 84 VMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9999974 8888875422 3589999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCccccccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh-------h------hh
Q 001494 953 PDSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------I------AL 1018 (1067)
Q Consensus 953 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-------~------~~ 1018 (1067)
..........+++.|+|||.+.+.. ++.++|+||+|+++|||++|+.||.............. . ..
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 5433344456788999999887644 68899999999999999999999864332111000000 0 00
Q ss_pred hhcc-----CCCCCCCCcchHH--HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1019 DEIL-----DPRLPIPSHNVQE--KLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1019 ~~~~-----~~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.... ...........+. ....+.+++.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 0000000000001 1345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=307.99 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=199.2
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
.|...+.||+|++|.||++.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 355567899999999999965 57889999988542 22234568899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++.. ..+++..+..++.|++.|++|||++ +++||||+|+||+++.++.++++|||.+.......
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 97 FLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 9999999999854 3478899999999999999999999 99999999999999999999999999887655433
Q ss_pred CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHH
Q 001494 956 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1067)
.......|++.|+|||...+..++.++|||||||++|||++|+.||........ .........+....+. .
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~----~ 240 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-----MKRIRDNLPPKLKNLH----K 240 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-----HHHHHhcCCCCCcccc----c
Confidence 333445688999999999888899999999999999999999999864322111 0111111111111111 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1036 KLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1036 ~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 2235899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=310.18 Aligned_cols=250 Identities=25% Similarity=0.423 Sum_probs=202.2
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.+|+..+.||+|+||.||++.. .+++.||+|.+.... ....+.+..|+.++++++||||+++++++...+..|+|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 5788899999999999999864 578899999985432 222467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++++|.+++... .+++.++..++.|++.|++|||++ +++||||||+||+++.++.++|+|||++......
T Consensus 96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999999998532 378889999999999999999999 9999999999999999999999999998876654
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
........+++.|+|||.+.+..++.++|||||||++||+++|+.||.......... .....+....+ ...
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-------~~~~~~~~~~~--~~~ 239 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNGTPELQ--NPE 239 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-------ehhcCCCCCCC--Ccc
Confidence 444445678899999999988889999999999999999999999986433211100 00001111111 111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
.....+.+++.+||+.+|++||++.++++.
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 223458899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=305.37 Aligned_cols=254 Identities=23% Similarity=0.400 Sum_probs=200.5
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCC---hhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGE---MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 872 (1067)
+|+..+.||+|++|.||+|.. .+++.||+|++....... ....+.+..|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999864 678999999987543221 1235678999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC-CeEEeccccceec
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN-EARVSDFGIAKFL 951 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~-~~kl~DfG~a~~~ 951 (1067)
||||+++++|.+++... .++++..+..++.|++.|++|||++ +++||||||+||+++.++ .+||+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998643 3578999999999999999999999 999999999999998876 5999999999876
Q ss_pred CCCCCc----cccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC
Q 001494 952 KPDSSN----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 952 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
...... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||........ .....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~- 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-----LALIFKIASATT- 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-----HHHHHHHhccCC-
Confidence 543211 1234678899999999888899999999999999999999999863322110 011111110000
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
..........++.+++.+|++.+|++||++.|+++
T Consensus 229 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 -APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01111223345889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.67 Aligned_cols=260 Identities=27% Similarity=0.401 Sum_probs=200.3
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 6888999999999999999765 6889999998654322 2335678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|++++.+..+... ...+++.++..++.|++.|++|||+. +++|||++|+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998877766533 23488999999999999999999999 99999999999999999999999999998765443
Q ss_pred C-ccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh------hhhhhc--cCC-
Q 001494 956 S-NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN------IALDEI--LDP- 1024 (1067)
Q Consensus 956 ~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~------~~~~~~--~~~- 1024 (1067)
. ......++..|+|||++.+. .++.++||||||+++|||++|+.||.............. ...... .++
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 2 33446678899999999888 789999999999999999999999864322110000000 000000 000
Q ss_pred ----CCCCCCc-------chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1025 ----RLPIPSH-------NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1025 ----~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....... .......++.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 00012456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=303.86 Aligned_cols=243 Identities=27% Similarity=0.357 Sum_probs=197.9
Q ss_pred cccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCCCH
Q 001494 804 IGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL 882 (1067)
Q Consensus 804 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 882 (1067)
||.|+||.||+|+.. +++.||+|++...........+.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999765 5899999998754433334567799999999999999999999999999999999999999999
Q ss_pred HHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcccccc
Q 001494 883 AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA 962 (1067)
Q Consensus 883 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 962 (1067)
.+++... ..+++..+..++.|++.|++|+|++ +++|+||+|+||+++.++.++++|||.++...... ......
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 9999643 3478899999999999999999998 99999999999999999999999999998765432 223356
Q ss_pred ccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhcc--CCCCCCCCcchHHHHHHH
Q 001494 963 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL--DPRLPIPSHNVQEKLISF 1040 (1067)
Q Consensus 963 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l 1040 (1067)
+++.|+|||.+.+..++.++|+||+|+++|||++|+.||..... ........+. ......+... ..++
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~----~~~~ 223 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNGKLEFPNYI----DKAA 223 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCCCCCCCccc----CHHH
Confidence 78899999998888899999999999999999999999864331 0111122222 1222222222 3458
Q ss_pred HHHHHhccCCCCCCCCC-----HHHHHH
Q 001494 1041 VEVAISCLDESPESRPT-----MQKVSQ 1063 (1067)
Q Consensus 1041 ~~li~~cl~~dP~~Rpt-----~~evl~ 1063 (1067)
.+++.+||+.+|++||+ +.|+++
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 99999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=306.89 Aligned_cols=247 Identities=26% Similarity=0.309 Sum_probs=194.0
Q ss_pred cccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCCCH
Q 001494 804 IGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL 882 (1067)
Q Consensus 804 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 882 (1067)
||+|+||+||+|.. .+|+.||+|.+...........+.+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999864 47899999998653322222345667899999999999999999999999999999999999999
Q ss_pred HHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcccccc
Q 001494 883 AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA 962 (1067)
Q Consensus 883 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 962 (1067)
.+++..... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+|++|||.+...... .......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA 155 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence 998864332 3589999999999999999999999 9999999999999999999999999999765432 2223456
Q ss_pred ccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHH
Q 001494 963 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVE 1042 (1067)
Q Consensus 963 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1042 (1067)
++..|+|||++.+..++.++||||+||++|+|++|+.||........ ...............+.. ....+.+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~----~~~~~~~ 227 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEELKRRTLEMAVEYPDK----FSPEAKD 227 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHHHHhccccccccCCcc----CCHHHHH
Confidence 78899999999888899999999999999999999999864332110 111111111111122222 2335889
Q ss_pred HHHhccCCCCCCCC-----CHHHHHH
Q 001494 1043 VAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1043 li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
++.+||+.+|.+|| ++.++++
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHh
Confidence 99999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=309.41 Aligned_cols=261 Identities=20% Similarity=0.324 Sum_probs=199.2
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..++||+|++|.||+|+.. +|+.||+|++...... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4788899999999999999765 6899999998754322 223567789999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++ ++.+++........+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9985 7888776544445689999999999999999999999 99999999999999999999999999997655433
Q ss_pred CccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh-------hhhhhhcc-----
Q 001494 956 SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL-------NIALDEIL----- 1022 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------~~~~~~~~----- 1022 (1067)
.......+++.|+|||.+.+. .++.++||||+||++|||++|+.||............. ......+.
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 333445678899999987654 46889999999999999999999986543211100000 00000000
Q ss_pred CCCCCCCCc-----chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1023 DPRLPIPSH-----NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1023 ~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+.... ........+.+++.+|++.||.+||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 00112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=307.48 Aligned_cols=252 Identities=28% Similarity=0.470 Sum_probs=204.0
Q ss_pred HhcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeE
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 872 (1067)
..+.|+..+.||+|+||.||+|... +++.||+|++..... ..+.+..|++.+++++|+|++++++++...+..|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 3456888899999999999999765 788999999875322 35678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
|+||+++++|.+++.... ..+++..+..++.+++.|++|||+. |++|+||+|+||+++.++.++|+|||.+....
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999999996533 3689999999999999999999998 99999999999999999999999999987655
Q ss_pred CCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcc
Q 001494 953 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 953 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
..........+++.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+...... +...
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~-~~~~ 238 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--------LFLITTKGIP-PLKN 238 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHhcCCC-CCcc
Confidence 443333445678899999999888899999999999999999999999864332211 0111111110 0001
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.......+.+++.+||+.+|.+|||+.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112345889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=310.45 Aligned_cols=248 Identities=27% Similarity=0.425 Sum_probs=196.1
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
..|+..+.||+|+||.||+|... +++.||+|++...........+++.+|+++++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999754 68999999986543333344567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++ ++.+++... ...+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99974 666655322 23589999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCccccccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccC-CCCCCCC
Q 001494 955 SSNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD-PRLPIPS 1030 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1030 (1067)
....+++.|+|||++. ...++.++||||||+++|||++|+.||........ ...+.. .....+
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--------~~~~~~~~~~~~~- 235 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNDSPTLS- 235 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--------HHHHhcCCCCCCC-
Confidence 2346788999999874 35588899999999999999999999764332110 001110 111111
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1031 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
......++.+++.+||+.+|++||++.++++.
T Consensus 236 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 --SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11233468999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=304.85 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=195.7
Q ss_pred CCccCccccCCceeEEEEEEC----CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC-----
Q 001494 798 FDDEHCIGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ----- 868 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 868 (1067)
|.+.+.||+|+||.||+|... +++.||||++....... ...+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 566788999999999999643 46889999987543332 33567889999999999999999999886532
Q ss_pred -ceeEEEEeccCCCHHHHhcccC---ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEec
Q 001494 869 -HSFIVYEYLEMGSLAMILSNDA---AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSD 944 (1067)
Q Consensus 869 -~~~lv~E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~D 944 (1067)
..++++||+++|++.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 2478999999999988874321 223578899999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhhc
Q 001494 945 FGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEI 1021 (1067)
Q Consensus 945 fG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1021 (1067)
||.++....... ......+++.|++||.+.+..++.++|||||||++|||++ |+.||....... ....+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--------~~~~~ 228 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--------IYNYL 228 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--------HHHHH
Confidence 999986543221 1123345678999999988889999999999999999999 888876432210 11111
Q ss_pred cC-CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1022 LD-PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1022 ~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.. .....+.. ....+.+++.+||+.+|++||++.|+++.|+
T Consensus 229 ~~~~~~~~~~~----~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~ 270 (273)
T cd05074 229 IKGNRLKQPPD----CLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270 (273)
T ss_pred HcCCcCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11 11111111 2235899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=309.65 Aligned_cols=260 Identities=23% Similarity=0.324 Sum_probs=196.7
Q ss_pred CCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|+..+.||.|++|.||+|.. .+|+.||+|++....... ...+.+.+|+++++.++|||++++++++.+++..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 56778999999999999965 479999999987543222 2235678899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
++ +++.+++.... ...+++..+..++.|+++||+|||++ +++||||+|+||+++.++.++|+|||.++.......
T Consensus 80 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 95 68888885433 24589999999999999999999999 999999999999999999999999999976654333
Q ss_pred ccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh-------h------hhhhcc
Q 001494 957 NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------I------ALDEIL 1022 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-------~------~~~~~~ 1022 (1067)
......+++.|+|||++.+. .++.++||||||+++|||++|+.||.............. . ...+..
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 33344568899999987664 468899999999999999999999864332110000000 0 000000
Q ss_pred --CCCCCC--CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1023 --DPRLPI--PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1023 --~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.+.... ..........++.+++.+|++.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 00001112245889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=291.63 Aligned_cols=253 Identities=27% Similarity=0.370 Sum_probs=198.0
Q ss_pred CCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHH-HhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 798 FDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA-LTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
.+....||.|+||+|+|.. .++|+..|||+++.... ...+++++.|.+. ++.-+.||||+++|++-.++..|+.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3445679999999999974 56899999999986543 3346788888886 555589999999999999999999999
Q ss_pred eccCCCHHHHhcc--cCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 876 YLEMGSLAMILSN--DAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 876 ~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
.|+- +++.+.+. ......+++.-.-.|.....+||.||.+.. .|||||+||+|||++..|.+|+||||++.++..
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9964 66544432 223445788888888888999999999874 899999999999999999999999999987653
Q ss_pred CCCccccccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC--CC
Q 001494 954 DSSNWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP--IP 1029 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 1029 (1067)
. ...+.-+|-..|||||.+... .|+.+|||||+|+++||+.||+.||+.+... .+.+.+++.+..+ ..
T Consensus 221 S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-------feql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 221 S-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-------FEQLCQVVIGDPPILLF 292 (361)
T ss_pred H-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-------HHHHHHHHcCCCCeecC
Confidence 3 233455788889999988643 4889999999999999999999998765432 2223333333322 22
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.....+...++..++..|+.+|-..||.+.++.+
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 3333345667999999999999999999999875
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=305.45 Aligned_cols=245 Identities=22% Similarity=0.239 Sum_probs=186.7
Q ss_pred ccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHH---HhcCCCCeeeeeeEEEeeCCceeEEEEecc
Q 001494 803 CIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA---LTEIRHRNIVKFYGFCSHAQHSFIVYEYLE 878 (1067)
Q Consensus 803 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 878 (1067)
.||+|+||.||++.. .+++.||+|.+.............+.+|..+ +...+||+++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999975 4689999999865432222222334444433 334479999999999999999999999999
Q ss_pred CCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcc
Q 001494 879 MGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW 958 (1067)
Q Consensus 879 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 958 (1067)
+++|.+++... +.+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||++....... .
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 152 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence 99999888543 3589999999999999999999999 99999999999999999999999999997654322 2
Q ss_pred ccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHH
Q 001494 959 TELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKL 1037 (1067)
Q Consensus 959 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1067)
....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ..............+.. ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~----~~ 223 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTVNVELPDS----FS 223 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHHHHHhhcCCcCCccc----cC
Confidence 33468999999998764 5588999999999999999999999864322110 00000111111111222 23
Q ss_pred HHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 001494 1038 ISFVEVAISCLDESPESRP-----TMQKVSQL 1064 (1067)
Q Consensus 1038 ~~l~~li~~cl~~dP~~Rp-----t~~evl~~ 1064 (1067)
.++.+++.+||+.||++|| +++|+++.
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 3588999999999999999 59998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=308.89 Aligned_cols=260 Identities=23% Similarity=0.358 Sum_probs=199.6
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|++.+.||+|+||.||+|+. .+|+.||+|++...... ....+.+.+|+.++++++|||++++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 478889999999999999975 47899999998754322 2335678999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+ +++|.+++.... ..+++.++..++.|+++|++|||++ +++|+||||+||+++.++.++++|||.+.......
T Consensus 80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 99 999999885432 4589999999999999999999999 99999999999999999999999999998765433
Q ss_pred C-ccccccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh-------hh---------
Q 001494 956 S-NWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------IA--------- 1017 (1067)
Q Consensus 956 ~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-------~~--------- 1017 (1067)
. ......++..|+|||.+.+.. ++.++||||+|+++|||++|+.||.............. ..
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 2 233456889999999886544 68999999999999999999888754322110000000 00
Q ss_pred hhhccCCCCC-CC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1018 LDEILDPRLP-IP-SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1018 ~~~~~~~~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...+..+... .+ .....+...++.+++.+|++.+|.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 00 0000122356899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=307.46 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=193.3
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHH-HhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKA-LTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
++|++.+.||+|+||.||+|... +|+.||+|++....... ...++..|+.. ++..+||||+++++++..++..|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 36888999999999999998654 79999999987543222 23455566665 6667899999999999999999999
Q ss_pred EEeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 874 YEYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
|||++ |++.+++... .....+++..+..++.|++.|++|||+++ +++||||||+||+++.++.+||+|||+++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99997 5787776432 23356899999999999999999999853 89999999999999999999999999998654
Q ss_pred CCCCccccccccccccCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccC-CCCC
Q 001494 953 PDSSNWTELAGTYGYVAPELAYT----MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD-PRLP 1027 (1067)
Q Consensus 953 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1027 (1067)
... ......++..|+|||.+.+ ..++.++|+||+||++|||++|+.||+..... ......... ....
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~ 227 (283)
T cd06617 156 DSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-------FQQLKQVVEEPSPQ 227 (283)
T ss_pred ccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-------HHHHHHHHhcCCCC
Confidence 321 2233467889999998765 44688999999999999999999998632211 011111111 1111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.+.. ....++.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 12345889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=303.96 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=200.5
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..+.||+|+||.||+|... +|..||+|.+....... ...+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4778899999999999998654 68899999986532221 234567899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCC-eEEeccccceecCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNE-ARVSDFGIAKFLKPD 954 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~-~kl~DfG~a~~~~~~ 954 (1067)
|+++++|.+++.... ...+++..+..++.|+++|++|||+. +++|+||||+||+++.++. +|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 80 YCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred cCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999986432 23578999999999999999999999 9999999999999998865 699999999876544
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
........|++.|+|||+..+..++.++||||||+++|||++|+.||...... ....+.......... .
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---~ 224 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH--------QLVLKICQGYFAPIS---P 224 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHhcccCCCCC---C
Confidence 33333456889999999998888999999999999999999999998643221 111111111111100 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....++.+++.+||+.+|++|||+.|+++
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 12235889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=307.47 Aligned_cols=259 Identities=20% Similarity=0.226 Sum_probs=185.6
Q ss_pred cCCCccCccccCCceeEEEEEECC----CcEEEEEEeCCCCCCChhH--------HHHHHHHHHHHhcCCCCeeeeeeEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELAS----GEIIAVKKFHSPLPGEMTF--------QQEFLNEVKALTEIRHRNIVKFYGF 863 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~ 863 (1067)
++|++.++||+|+||.||+|...+ +..+|+|+........... ......+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999997654 3456666543221111000 0112233445667789999999997
Q ss_pred EeeCC----ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCC
Q 001494 864 CSHAQ----HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNE 939 (1067)
Q Consensus 864 ~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~ 939 (1067)
+.... ..++++|++.. ++.+.+... ...++..+..++.|++.|++|||++ +|+||||||+||+++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 76544 34678887643 555555332 2246788899999999999999999 9999999999999999999
Q ss_pred eEEeccccceecCCCCC-------ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc-c
Q 001494 940 ARVSDFGIAKFLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSS-S 1011 (1067)
Q Consensus 940 ~kl~DfG~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~ 1011 (1067)
++|+|||+|+.+..... ......||+.|+|||+..+..++.++|||||||++|||++|+.||......... .
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999987643221 112346899999999999999999999999999999999999999755321110 0
Q ss_pred hhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1012 LNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1012 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
........++..+....+. ....+.+++..|++.+|++||++.++.+.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDFIKRLHEGKIKIKN-----ANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHHHHHhhhhhhccCC-----CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0111112233222222221 1235889999999999999999999999874
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=303.60 Aligned_cols=246 Identities=22% Similarity=0.272 Sum_probs=188.7
Q ss_pred CccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHH-HhcCCCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 802 HCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA-LTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
+.||+|+||.||+|.. .+|+.||+|++.............+..|..+ ....+|||++++++++.+++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999965 4689999999864322222222334455544 4455899999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 9999998543 3578999999999999999999999 999999999999999999999999999876432 23
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
...+++.|+|||.+.+..++.++||||+|+++|||++|..||...... .....+.......+..........
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--------AVFDNILSRRINWPEEVKEFCSPE 223 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcccCCCCcccccCCHH
Confidence 346788999999998888899999999999999999999998643321 111111111111111111122345
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1040 FVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
+.+++.+||+.+|++||++.++.+.+
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHHHHH
Confidence 89999999999999999876555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=297.60 Aligned_cols=249 Identities=31% Similarity=0.483 Sum_probs=202.8
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..+.||+|++|.||++... +++.|++|++..... ...+.+.+|++.++.++||+++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4778899999999999999765 788999999875432 345788999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 999999999986432 4689999999999999999999998 99999999999999999999999999998766543
Q ss_pred CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHH
Q 001494 956 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1067)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||+......... .......+....+. .
T Consensus 153 ~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~----~ 222 (253)
T cd05122 153 A-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-----KIATNGPPGLRNPE----K 222 (253)
T ss_pred c-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH-----HHHhcCCCCcCccc----c
Confidence 2 345578899999999988889999999999999999999999987443211100 01111111111111 1
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1036 KLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1036 ~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1235889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=310.27 Aligned_cols=263 Identities=19% Similarity=0.274 Sum_probs=196.0
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCCc----
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQH---- 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~---- 869 (1067)
++|+..+.||+|+||.||+|... +++.||+|++....... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 36888999999999999999754 78999999986543222 22456788999999995 6999999999987665
Q ss_pred -eeEEEEeccCCCHHHHhcccCc--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC-CCCeEEecc
Q 001494 870 -SFIVYEYLEMGSLAMILSNDAA--AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF-KNEARVSDF 945 (1067)
Q Consensus 870 -~~lv~E~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~-~~~~kl~Df 945 (1067)
.|+||||+++ ++.+++..... ...+++..+..++.||++||+|||++ +|+||||||+||+++. ++.+||+||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999986 78777753322 34689999999999999999999999 9999999999999998 889999999
Q ss_pred ccceecCCCCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh-------hh
Q 001494 946 GIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------IA 1017 (1067)
Q Consensus 946 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-------~~ 1017 (1067)
|+++.+...........+++.|+|||.+.+ ..++.++||||||+++|||++|..||.............. ..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 999876544333344467889999998765 4578999999999999999999999864332211000000 00
Q ss_pred hhhc-------cCCCCCC--CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1018 LDEI-------LDPRLPI--PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1018 ~~~~-------~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.... ..+.... ..........++.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0000000 00000122345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=313.86 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=194.7
Q ss_pred CCCccCccccCCceeEEEEEEC---CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--Ccee
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--QHSF 871 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 871 (1067)
.|+..++||+|+||.||+|... +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3778889999999999999764 4789999999764322222345678899999999999999999999888 7899
Q ss_pred EEEEeccCCCHHHHhccc-C-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC----CCCeEEecc
Q 001494 872 IVYEYLEMGSLAMILSND-A-AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF----KNEARVSDF 945 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~-~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~----~~~~kl~Df 945 (1067)
+||||+++ ++.+.+... . ....+++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 555555322 2 123688999999999999999999999 9999999999999999 899999999
Q ss_pred ccceecCCCCC---ccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccc-hhhhhhhh-
Q 001494 946 GIAKFLKPDSS---NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSS-LNLNIALD- 1019 (1067)
Q Consensus 946 G~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~- 1019 (1067)
|+++....... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||.......... ........
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986643322 22345678899999987664 57899999999999999999999986433211000 00000000
Q ss_pred --hc-----------------------cCCCCCCCCcchH-------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1020 --EI-----------------------LDPRLPIPSHNVQ-------EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1020 --~~-----------------------~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+. .......+..... ....++.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 0000011100000 12235889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=304.52 Aligned_cols=246 Identities=26% Similarity=0.371 Sum_probs=196.8
Q ss_pred cccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCCCH
Q 001494 804 IGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL 882 (1067)
Q Consensus 804 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 882 (1067)
||+|+||.||+++.. +|+.||+|++...........+.+.+|++++++++|||++++++.+..+...|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999776 5999999998754333334567788999999999999999999999999999999999999999
Q ss_pred HHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC------
Q 001494 883 AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS------ 956 (1067)
Q Consensus 883 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~------ 956 (1067)
.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99986433 589999999999999999999999 999999999999999999999999999875443311
Q ss_pred --ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 957 --NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 957 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
......++..|+|||...+..++.++||||||+++||+++|+.||...... .....+.......+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~-- 224 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNILNGKIEWPEDV-- 224 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCcCCCccc--
Confidence 223456788999999998888999999999999999999999998643321 11112222222222111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
.....+.+++.+||+.+|++|||+.++.+.+
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 1134588999999999999999995555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=308.63 Aligned_cols=254 Identities=27% Similarity=0.378 Sum_probs=193.7
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCCceeEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 874 (1067)
+|...+.||+|+||.||++.. .+++.||+|++...... .....+..|+.++.++. ||||+++++++..++..+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 456678899999999999865 46899999998754322 34567889999999996 999999999999999999999
Q ss_pred EeccCCCHHHHhcc--cCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 875 EYLEMGSLAMILSN--DAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 875 E~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
||++. ++.++... ......+++..+..++.+++.|++|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 99874 44433211 112346899999999999999999999742 89999999999999999999999999997654
Q ss_pred CCCCccccccccccccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCC-CC
Q 001494 953 PDSSNWTELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL-PI 1028 (1067)
Q Consensus 953 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1028 (1067)
.... .....|++.|+|||++.+. .++.++||||+||++|||++|+.||..... ......+...... ..
T Consensus 160 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~ 231 (288)
T cd06616 160 DSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVKGDPPIL 231 (288)
T ss_pred cCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcCCCCCcC
Confidence 3322 2334678899999998776 588999999999999999999999864321 1111122211111 11
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1029 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+.........++.+++.+||+.+|++|||+.+|++
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111223446899999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=314.80 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=191.8
Q ss_pred CccCccccCCceeEEEEE-ECCCcEEE---EEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc--eeE
Q 001494 799 DDEHCIGKGGQGSVYKVE-LASGEIIA---VKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH--SFI 872 (1067)
Q Consensus 799 ~~~~~lG~G~~g~Vy~~~-~~~~~~va---vK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~l 872 (1067)
+...+||+|+|-+||+|- ..+|..|| ||.-... ......+.|..|+.+++.|+|||||++++++.+... .-+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~--q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVT--QSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhh--cChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 445789999999999994 44677776 3322111 223345789999999999999999999999987664 779
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC-CCeEEeccccceec
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK-NEARVSDFGIAKFL 951 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~-~~~kl~DfG~a~~~ 951 (1067)
|+|.+..|+|..|.++.+. +....+..|++||++||.|||++ .|+|+|||||.+||+|+.+ |.|||+|.|+|+..
T Consensus 121 iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 9999999999999966543 77789999999999999999998 5699999999999999755 89999999999876
Q ss_pred CCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCc
Q 001494 952 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031 (1067)
Q Consensus 952 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1067)
... ......|||.|||||++. ..|++.+||||||++++||.|+..||..-. ...+....+..+.-+..
T Consensus 197 r~s--~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-------n~AQIYKKV~SGiKP~s-- 264 (632)
T KOG0584|consen 197 RKS--HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-------NPAQIYKKVTSGIKPAA-- 264 (632)
T ss_pred hcc--ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-------CHHHHHHHHHcCCCHHH--
Confidence 643 334478999999999887 779999999999999999999999986322 22222233332221100
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...-.-.++++||.+|+.. ..+|||+.|+++
T Consensus 265 l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 265 LSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 0000012488999999999 999999999985
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.86 Aligned_cols=253 Identities=28% Similarity=0.421 Sum_probs=199.0
Q ss_pred CCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC------ce
Q 001494 798 FDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ------HS 870 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~ 870 (1067)
+...+.||+||||.||+++ ..+|+.||||.+..... ....+...+|++++++++|||||+++++-++.. ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4556889999999999998 66899999999976432 233567789999999999999999998865544 56
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeC--CCCC--eEEeccc
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD--FKNE--ARVSDFG 946 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~--~~~~--~kl~DfG 946 (1067)
.+|||||.+|+|...+........+++.+.+.+..+++.||.|||++ +||||||||.||++- .+|. .||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 89999999999999998887777899999999999999999999999 999999999999983 4444 7999999
Q ss_pred cceecCCCCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccc------c---chhhhh
Q 001494 947 IAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISS------S---SLNLNI 1016 (1067)
Q Consensus 947 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~------~---~~~~~~ 1016 (1067)
.|+.+..+ ......+||..|.+||.+.. +.|+..+|.|||||++||..||..||.-...... . ......
T Consensus 170 ~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 170 AARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 99987755 46788999999999999884 7899999999999999999999999853221100 0 000000
Q ss_pred hh--------hhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCC
Q 001494 1017 AL--------DEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRP 1056 (1067)
Q Consensus 1017 ~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 1056 (1067)
.. .-.....++.|.+........+-..+..++..+|.+|-
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 00 00111233444444455556677788888888888887
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=329.17 Aligned_cols=266 Identities=18% Similarity=0.225 Sum_probs=185.8
Q ss_pred HhcCCCccCccccCCceeEEEEEEC--CCcEEEEEEe--------------CCCCCCChhHHHHHHHHHHHHhcCCCCee
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELA--SGEIIAVKKF--------------HSPLPGEMTFQQEFLNEVKALTEIRHRNI 857 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~--------------~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 857 (1067)
...+|++.++||+|+||+||++..+ ++..+++|.+ .............+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999997643 2222222211 11111122234568899999999999999
Q ss_pred eeeeEEEeeCCceeEEEEeccCCCHHHHhcccCc--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeC
Q 001494 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAA--AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD 935 (1067)
Q Consensus 858 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~ 935 (1067)
|++++++.+.+..|+|+|++.+ ++..++..... .......++..++.|++.||+|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 9999999999999999999965 56655533211 22234567788999999999999999 999999999999999
Q ss_pred CCCCeEEeccccceecCCCCC-ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCC-CCccccccccchh
Q 001494 936 FKNEARVSDFGIAKFLKPDSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-GDFISLISSSSLN 1013 (1067)
Q Consensus 936 ~~~~~kl~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p-~~~~~~~~~~~~~ 1013 (1067)
.++.+||+|||+++.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.+ +............
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987654322 22346799999999999999999999999999999999998754 3221110000000
Q ss_pred hh----------------hhhhhccCCCCCCCCcchHH------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1014 LN----------------IALDEILDPRLPIPSHNVQE------KLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1014 ~~----------------~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.. .....+....+......... ....+.+++.+|++.||++|||+.|+++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 00000000000000000000 1124677899999999999999999986
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=285.86 Aligned_cols=203 Identities=24% Similarity=0.386 Sum_probs=168.6
Q ss_pred hcCCCccCccccCCceeEEEEE-ECC----CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee-CC
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVE-LAS----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH-AQ 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~-~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 868 (1067)
...|+....||+|.||.||+|. .++ .+.+|+|+++....... .-....+|+..++.++||||+.+..++-+ +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 4568899999999999999983 332 23699999986544322 23556799999999999999999998877 78
Q ss_pred ceeEEEEeccCCCHHHHhcc--cCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC----CCeEE
Q 001494 869 HSFIVYEYLEMGSLAMILSN--DAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK----NEARV 942 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~----~~~kl 942 (1067)
..|+++||.+. +|.++++. ....+.++...+..|..||+.|+.|||++ -|+|||+||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence 99999999987 77777753 23345788999999999999999999999 89999999999999888 88999
Q ss_pred eccccceecCCCCCc---cccccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCC
Q 001494 943 SDFGIAKFLKPDSSN---WTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGD 1002 (1067)
Q Consensus 943 ~DfG~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~ 1002 (1067)
+|||+++.+..+-.. ....+.|.+|+|||.+.+.+ ||++.|||+.|||+.||+|-.+-|.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 999999988755332 23467799999999888765 8999999999999999999776654
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=310.67 Aligned_cols=262 Identities=26% Similarity=0.330 Sum_probs=196.6
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--Ccee
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--QHSF 871 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 871 (1067)
.++|+..+.||+|+||.||+|.. .+|+.||+|++....... .....+.+|+.++++++|+|++++++++.+. +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 46799999999999999999975 468999999986433222 1223466899999999999999999998755 4689
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+||||+++ ++.+++... ...+++.++..++.|+++|++|||+. +++||||||+||+++.++.+||+|||.+...
T Consensus 85 lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999975 787777532 24689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh-------hhhhhcc-
Q 001494 952 KPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------IALDEIL- 1022 (1067)
Q Consensus 952 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~- 1022 (1067)
...........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.............. .......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 654333344456788999998865 4578999999999999999999999864432211000000 0000000
Q ss_pred ---CCCCCC---CCcc----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1023 ---DPRLPI---PSHN----VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1023 ---~~~~~~---~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...... +... ......++.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 0000 0112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=304.34 Aligned_cols=244 Identities=26% Similarity=0.407 Sum_probs=196.6
Q ss_pred cCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 801 EHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 801 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
..+||+|+||.||++.. .+++.||+|++... .....+.+.+|+.+++.++|||++++++++...+..++||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 46799999999999966 57899999997542 222356788999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
+++.+++.. ..+++..+..++.|++.|++|||+. |++||||+|+||+++.++.++|+|||.+...........
T Consensus 102 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 102 GALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 999988743 2478899999999999999999999 999999999999999999999999999876654433334
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHH
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1067)
...|++.|+|||.+.+..++.++||||+||++|||++|+.||........ .........+..... ......
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~----~~~~~~ 245 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-----MKMIRDNLPPKLKNL----HKVSPS 245 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhhCCcccCCc----ccCCHH
Confidence 45688999999998888889999999999999999999999864322111 011111111111111 112234
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1040 FVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1040 l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+.+++.+||+.+|.+||++.++++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=332.58 Aligned_cols=254 Identities=28% Similarity=0.473 Sum_probs=204.6
Q ss_pred CCCccCccccCCceeEEEEEEC--------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeC
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA--------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHA 867 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 867 (1067)
+....+.+|+|+||.||+|... ....||||..+..... ...+.+..|+++|+.+ +||||+.++|+|.++
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3455669999999999998532 1457999999866543 4568899999999999 599999999999999
Q ss_pred CceeEEEEeccCCCHHHHhcccC-----------cc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 001494 868 QHSFIVYEYLEMGSLAMILSNDA-----------AA--EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLL 934 (1067)
Q Consensus 868 ~~~~lv~E~~~~g~L~~~l~~~~-----------~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill 934 (1067)
+..++|+||+..|+|..++++.+ .. ..++..+.+.++.|||.|++||++. ++||||+.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEe
Confidence 99999999999999999997654 01 2388899999999999999999999 99999999999999
Q ss_pred CCCCCeEEeccccceecCCCCCcc-ccccc--cccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccc
Q 001494 935 DFKNEARVSDFGIAKFLKPDSSNW-TELAG--TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSS 1010 (1067)
Q Consensus 935 ~~~~~~kl~DfG~a~~~~~~~~~~-~~~~g--t~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~ 1010 (1067)
+++..+||+|||+|+......... ....| +..|||||.+....|+.|+|||||||++||++| |..||.......
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-- 529 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-- 529 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH--
Confidence 999999999999999755443322 22232 456999999999999999999999999999998 889987533111
Q ss_pred chhhhhhhhhccCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1011 SLNLNIALDEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1011 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.....+.++ ++..|..+.. +++++|+.||+.+|++||++.++++.|+
T Consensus 530 -----~l~~~l~~G~r~~~P~~c~~----eiY~iM~~CW~~~p~~RP~F~~~~~~~~ 577 (609)
T KOG0200|consen 530 -----ELLEFLKEGNRMEQPEHCSD----EIYDLMKSCWNADPEDRPTFSECVEFFE 577 (609)
T ss_pred -----HHHHHHhcCCCCCCCCCCCH----HHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence 111222222 3344444444 4899999999999999999999999875
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=296.20 Aligned_cols=249 Identities=24% Similarity=0.430 Sum_probs=204.1
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..+.||+|++|.||++... +++.||+|.+...... ....+.+.+|++++++++|||++++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 4778899999999999999654 6889999999765432 2345779999999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+++++|.+++... ..+++..+..++.|++.|++|||+. ||+||||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 80 YAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred cCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999998543 4589999999999999999999999 99999999999999999999999999998776554
Q ss_pred CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHH
Q 001494 956 SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1067)
.......++..|+|||...+..++.++||||+|+++|+|++|+.||....... .............+...
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~--- 223 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-------ALFRIVQDDHPPLPEGI--- 223 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHhccCCCCCCCCC---
Confidence 43445678899999999888888999999999999999999999986433211 00011111111222222
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1036 KLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1036 ~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...+.+++.+||+.+|++|||+.+++.
T Consensus 224 -~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 224 -SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 234889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=296.77 Aligned_cols=249 Identities=29% Similarity=0.416 Sum_probs=204.2
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--CceeEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--QHSFIV 873 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 873 (1067)
+|+..+.||+|++|.||+|... +++.|++|++...... ....+.+.+|++.+++++||||+++++++.+. ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 4777899999999999999765 7899999998754332 33467889999999999999999999999988 899999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+++++|.+++.... .+++.++..++.++++|++|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999986433 689999999999999999999998 999999999999999999999999999987765
Q ss_pred CCC--ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccC--CCCCCC
Q 001494 954 DSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD--PRLPIP 1029 (1067)
Q Consensus 954 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 1029 (1067)
... ......++..|+|||...+...+.++||||||+++|+|++|+.||...... ......... .....+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~ 226 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-------MAALYKIGSSGEPPEIP 226 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHhccccCCCcCCC
Confidence 432 134456888999999998888999999999999999999999998754411 111111111 111112
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.. ....+.+++.+|++.+|++||++.|+++
T Consensus 227 ~~----~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 227 EH----LSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cc----cCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11 2345899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=307.63 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=194.9
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+..+.||+|++|+||+|... +|+.||+|++......+ ...+.+.+|++++++++||||+++++++.+....|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 46888999999999999999764 78999999986543222 23456788999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC-CCCeEEeccccceecCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF-KNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~-~~~~kl~DfG~a~~~~~ 953 (1067)
||+++ ++.+++.... ....++..+..++.||+.|++|||++ +++||||+|+||+++. ++.+||+|||++.....
T Consensus 81 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 81 EYLDL-DLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ecccc-cHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 99964 7777664322 23357888889999999999999999 9999999999999985 45699999999986654
Q ss_pred CCCccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh---hhhhhc--------
Q 001494 954 DSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN---IALDEI-------- 1021 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~---~~~~~~-------- 1021 (1067)
.........+++.|+|||++.+. .++.++||||+||++|+|+||+.||.............. ......
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 43333445678899999988664 578899999999999999999999864332111000000 000000
Q ss_pred ----cCCCCCCCC--cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1022 ----LDPRLPIPS--HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1022 ----~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
..+...... ........++.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000 000112235789999999999999999999985
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=297.42 Aligned_cols=251 Identities=29% Similarity=0.443 Sum_probs=205.2
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..+.||.|+||.||++... +++.||+|++...... ....+++.+|+++++.++|||++++++.+...+..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 4778899999999999999654 6899999998754332 2345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccC-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 876 YLEMGSLAMILSNDA-AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
|+++++|.+++.... ....+++.++..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999986532 235689999999999999999999999 9999999999999999999999999999876654
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCC-CCCCcch
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL-PIPSHNV 1033 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1033 (1067)
........|++.|+|||...+..++.++||||+|+++|+|++|+.||+..... ........... ..+..
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~-- 226 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKGQYPPIPSQ-- 226 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcCCCCCCCCC--
Confidence 43334457889999999988888999999999999999999999998644321 11111111111 11211
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+.+++.+||+.+|++|||+.|+++
T Consensus 227 --~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 227 --YSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2234889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=306.10 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=203.8
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCCceeEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 873 (1067)
++|...+.||+|+||.||+|... +++.||+|++...........+.+..|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888999999999999999654 79999999987543333334567889999999998 99999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+++++|.+++... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999999643 3589999999999999999999999 999999999999999999999999999986653
Q ss_pred CCC--------------------ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchh
Q 001494 954 DSS--------------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN 1013 (1067)
Q Consensus 954 ~~~--------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~ 1013 (1067)
... ......++..|+|||...+..++.++||||+|+++|++++|+.||......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------ 228 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------ 228 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------
Confidence 321 122345788999999988888999999999999999999999998744321
Q ss_pred hhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 001494 1014 LNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTM----QKVSQ 1063 (1067)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~----~evl~ 1063 (1067)
.....+.......+... ...+.+++.+||+.+|++||++ .++++
T Consensus 229 --~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 --LTFQKILKLEYSFPPNF----PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHHHHhcCCCCCCcc----CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11122222233333222 2348899999999999999999 88765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=295.57 Aligned_cols=244 Identities=24% Similarity=0.323 Sum_probs=203.2
Q ss_pred hcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 872 (1067)
..+|....+||+|+||.|..|+.+ +.+.+|||++++...-.....+--+.|-++++.. +-|.+++++.+|+..+++|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357889999999999999999654 6778999999876543322233445677777766 57899999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
||||+.||+|-..++..+. +.+..+.-+|.+||-||-+||++ ||++||+|.+|||+|.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999888865443 66778888999999999999999 99999999999999999999999999998655
Q ss_pred CCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcc
Q 001494 953 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 953 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
-+.....+++|||.|+|||.+...+|+..+|.|||||++|||+.|+.||++.+. .+.+..+.+.....|...
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--------~elF~aI~ehnvsyPKsl 573 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQAIMEHNVSYPKSL 573 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHHccCcCcccc
Confidence 555666789999999999999999999999999999999999999999986543 445556666666666554
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCC
Q 001494 1033 VQEKLISFVEVAISCLDESPESRP 1056 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rp 1056 (1067)
..| ..++....+.+.|.+|.
T Consensus 574 SkE----Av~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 574 SKE----AVAICKGLLTKHPGKRL 593 (683)
T ss_pred cHH----HHHHHHHHhhcCCcccc
Confidence 444 67788889999999995
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=307.33 Aligned_cols=246 Identities=28% Similarity=0.433 Sum_probs=195.2
Q ss_pred CCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|...+.||+|+||.||+|+. .+++.||+|++...........+.+..|++++++++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 67788999999999999975 46889999998754333334456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+++ ++.+.+... ...+++.++..++.+++.|+.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 975 676666432 34589999999999999999999999 9999999999999999999999999998754432
Q ss_pred ccccccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCC-CCCCCcc
Q 001494 957 NWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPR-LPIPSHN 1032 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1032 (1067)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||...... .....+.... ...+.
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~-- 246 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNESPTLQS-- 246 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhccCCCCCC--
Confidence 2346788999999874 456889999999999999999999997543211 1111111111 11111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
......+.+++.+||+.+|.+||++.++++.
T Consensus 247 -~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 247 -NEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred -ccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 1223358899999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=311.53 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=196.2
Q ss_pred HhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC-----
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA----- 867 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 867 (1067)
..++|+..+.||+|+||.||+|.. .+++.||+|++...... ....+++.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN-VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC-hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 347899999999999999999965 47899999998654322 22345677899999999999999999988643
Q ss_pred -CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccc
Q 001494 868 -QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 868 -~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 946 (1067)
...|+||||+++ ++.+.+.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999965 77777642 278889999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchh-------------
Q 001494 947 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN------------- 1013 (1067)
Q Consensus 947 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~------------- 1013 (1067)
+++...... ......+++.|+|||.+.+..++.++||||+||++|+|++|+.||...+........
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 164 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred cceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 998765432 223456788999999999989999999999999999999999998643321100000
Q ss_pred -hhhhhhhccCCC--------------CCCCCcc---hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1014 -LNIALDEILDPR--------------LPIPSHN---VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1014 -~~~~~~~~~~~~--------------~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...........+ ...+... ......++.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000000000 0000000 1122345789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=299.69 Aligned_cols=244 Identities=22% Similarity=0.235 Sum_probs=187.4
Q ss_pred ccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHH---HHhcCCCCeeeeeeEEEeeCCceeEEEEecc
Q 001494 803 CIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVK---ALTEIRHRNIVKFYGFCSHAQHSFIVYEYLE 878 (1067)
Q Consensus 803 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 878 (1067)
.||+|+||.||+|.. .+++.||+|.+.............+..|.. .++...||+|+.+++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999865 568999999986543222221222334433 4455689999999999999999999999999
Q ss_pred CCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcc
Q 001494 879 MGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW 958 (1067)
Q Consensus 879 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 958 (1067)
+++|.+++... ..+++.++..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~ 152 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KP 152 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CC
Confidence 99999888543 4589999999999999999999999 9999999999999999999999999999765432 22
Q ss_pred ccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHH
Q 001494 959 TELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKL 1037 (1067)
Q Consensus 959 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1067)
....|+..|+|||.+.++ .++.++||||+||++|||++|+.||........ ..............+... .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~----s 223 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTMAVELPDSF----S 223 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----HHHHHHhhccCCCCCCcC----C
Confidence 345789999999998754 588999999999999999999999864422111 001111111122222222 3
Q ss_pred HHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001494 1038 ISFVEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1038 ~~l~~li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
.++.+++.+|+..+|.+|| ++.++++
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 3588999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=296.27 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=197.2
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCC--CChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--Cce
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLP--GEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--QHS 870 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 870 (1067)
.+|+..+.||+|+||.||+|+. .+++.||+|++..... ......+.+.+|++++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999965 5689999998753221 1223346788999999999999999999998664 468
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
++||||+++++|.+++... ..+++..+.+++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999988543 3478899999999999999999999 999999999999999999999999999986
Q ss_pred cCCC---CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC-CC
Q 001494 951 LKPD---SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP-RL 1026 (1067)
Q Consensus 951 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1026 (1067)
.... ........++..|+|||.+.+..++.++|||||||++|||++|+.||...... .........+ ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~ 228 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTKP 228 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-------HHHHHHHcCCCCC
Confidence 5421 11223456889999999998888899999999999999999999998643221 1111111111 11
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
..+. ....++.+++.+|++ +|.+||++.+++..
T Consensus 229 ~~p~----~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 229 MLPD----GVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCc----ccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1222 223458999999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=302.92 Aligned_cols=259 Identities=23% Similarity=0.330 Sum_probs=200.1
Q ss_pred CCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|+..+.||+|++|.||+|.. .+++.+|+|++....... .....+..|++++++++||||+++++++..++..++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 56678899999999999965 478999999987543322 3356788899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+++ ++.+++... ...+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 80 MDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred cCC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 975 777777542 24689999999999999999999999 999999999999999999999999999987765543
Q ss_pred ccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh-------hhhhhcc------
Q 001494 957 NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------IALDEIL------ 1022 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~------ 1022 (1067)
......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||.............. .......
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 33445678899999998776 689999999999999999999999864332111000000 0000000
Q ss_pred ---CCC--CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1023 ---DPR--LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1023 ---~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.+. .............++.+++.+||++||.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00001111234457899999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=302.10 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=196.6
Q ss_pred CCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC--CceeEEE
Q 001494 798 FDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA--QHSFIVY 874 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 874 (1067)
|+..+.||+|+||.||+|... +++.||+|++.... ......+.+.+|++++++++|||++++++++.+. +..++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 567789999999999999765 58899999998654 2223346788999999999999999999999888 8999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++ ++..++.... ..+++.++..++.|+++|++|||+. +++|+||||+||++++++.+||+|||.+......
T Consensus 80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 99985 7887775432 4689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CC-ccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh-------hhhh------
Q 001494 955 SS-NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------IALD------ 1019 (1067)
Q Consensus 955 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-------~~~~------ 1019 (1067)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+............. ....
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence 21 2233456788999997765 4578999999999999999999999864332111000000 0000
Q ss_pred --hccCCCCCCCCc---chHH-HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1020 --EILDPRLPIPSH---NVQE-KLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1020 --~~~~~~~~~~~~---~~~~-~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+...+....+.. .... ...++.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000000 0001 1446889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=297.75 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=203.0
Q ss_pred CCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..++||+|+||.||+++. .+++.+|+|++....... ....++.+|++++++++||||+++++++.+....++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 477889999999999999854 478899999987543222 335677889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccC-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 876 YLEMGSLAMILSNDA-AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
|+++++|.+++.+.. ....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999885422 235689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchH
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||+...... ....+........ ..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~---~~ 223 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--------LRYKVQRGKYPPI---PP 223 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCCCCC---ch
Confidence 2223457889999999998889999999999999999999999986443211 1111111111111 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
....++.+++.+|++.+|++||++.|+++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 334458999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.72 Aligned_cols=245 Identities=26% Similarity=0.336 Sum_probs=207.1
Q ss_pred cCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 801 EHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 801 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
.++||.|-||+||-|. .++|+.||||++.+..-... ....+.+|+.+++.++||.||.+...|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 5789999999999985 56899999999976544333 247789999999999999999999999999999999999976
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC---CCeEEeccccceecCCCCC
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK---NEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~---~~~kl~DfG~a~~~~~~~~ 956 (1067)
.-|+.++.. ..+.+++.....++.||+.||.|||.+ +|+|+|+||+|||+... ..+||||||+|+.++.. .
T Consensus 648 DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-s 721 (888)
T KOG4236|consen 648 DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-S 721 (888)
T ss_pred hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh-h
Confidence 656666642 345688888888999999999999999 99999999999999755 36999999999988754 4
Q ss_pred ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHH
Q 001494 957 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEK 1036 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1067)
.....+|||.|.|||++..+.|...-|+||.|||+|--++|..||.... ..-+++....+..|+..+.+.
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----------dIndQIQNAaFMyPp~PW~ei 791 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----------DINDQIQNAAFMYPPNPWSEI 791 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----------chhHHhhccccccCCCchhhc
Confidence 4466899999999999999999999999999999999999999986322 223455556666677777888
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHH
Q 001494 1037 LISFVEVAISCLDESPESRPTMQKVS 1062 (1067)
Q Consensus 1037 ~~~l~~li~~cl~~dP~~Rpt~~evl 1062 (1067)
.....++|...++..-.+|.+..+.+
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 88899999999999999999987754
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=310.19 Aligned_cols=261 Identities=24% Similarity=0.336 Sum_probs=195.4
Q ss_pred hcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeC--Cce
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHA--QHS 870 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~ 870 (1067)
.++|+..+.||+|+||.||+|... +++.||+|++...... ......+.+|+.+++++ +||||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 467888999999999999999764 6889999998643222 22345677899999999 999999999998654 368
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
|+||||++ ++|..++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5888887542 578889999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC-----ccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchh-------h---
Q 001494 951 LKPDSS-----NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN-------L--- 1014 (1067)
Q Consensus 951 ~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~--- 1014 (1067)
...... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||............ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643321 2234568899999998765 45788999999999999999999998643321100000 0
Q ss_pred ---------hhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1015 ---------NIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1015 ---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
......+.................++.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000011000001111123458999999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=299.85 Aligned_cols=259 Identities=23% Similarity=0.349 Sum_probs=194.7
Q ss_pred CCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC---CCCeeeeeeEEEeeCCc----
Q 001494 798 FDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI---RHRNIVKFYGFCSHAQH---- 869 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~---- 869 (1067)
|++.+.||+|+||.||+|+.+ +++.||+|++......+ .....+..|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 567889999999999999876 48999999997544322 2234566777776655 69999999999988776
Q ss_pred -eeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccc
Q 001494 870 -SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948 (1067)
Q Consensus 870 -~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a 948 (1067)
.+++|||+++ ++.+++.... ...+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+||+|||.+
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eeEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 9999999975 7888775432 23589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhh-------h-h--
Q 001494 949 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNI-------A-L-- 1018 (1067)
Q Consensus 949 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-------~-~-- 1018 (1067)
..+.... ......++..|+|||.+.+..++.++|||||||++|||++|+.||+.............. . .
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 155 RIYSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eeccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 8764332 223345788999999999888999999999999999999999998653321110000000 0 0
Q ss_pred ----hhccCCCCCC-CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1019 ----DEILDPRLPI-PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1019 ----~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.......... ......+....+.+++.+||+.||++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 01111233456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=311.54 Aligned_cols=260 Identities=24% Similarity=0.361 Sum_probs=194.2
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC-----
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ----- 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 868 (1067)
.++|++.++||+|+||.||+|.. .+|+.||+|++.... .......+..|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 46799999999999999999964 578999999986421 2223466788999999999999999999876543
Q ss_pred ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccc
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a 948 (1067)
..|+||||+++ ++..++.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred eEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 57999999975 77776643 3489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC---ccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccch-------hhhhh
Q 001494 949 KFLKPDSS---NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSL-------NLNIA 1017 (1067)
Q Consensus 949 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~~~~ 1017 (1067)
+....... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||........... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 86543222 1233567899999998654 4588999999999999999999999864332110000 00000
Q ss_pred hhhccCCC-------CCCCCc-----chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1018 LDEILDPR-------LPIPSH-----NVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1018 ~~~~~~~~-------~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
...+.... ...... .......++.+++.+||+.+|++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 000000 001123458899999999999999999999863
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=294.50 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=190.5
Q ss_pred HHHHHhcCCCccCcc--ccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEe
Q 001494 790 EIIRATNDFDDEHCI--GKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 865 (1067)
Q Consensus 790 ~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 865 (1067)
+.....++|++.+.+ |+|+||.||+++. .+++.+|+|.+....... .|+.....+ +|||++++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEe
Confidence 334445667776666 9999999999864 578889999986432111 122222222 7999999999999
Q ss_pred eCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC-CeEEec
Q 001494 866 HAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN-EARVSD 944 (1067)
Q Consensus 866 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~-~~kl~D 944 (1067)
..+..|+||||+++++|.+++.... .+++.++..++.|+++|++|||+. +++||||||+||+++.++ .++|+|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 9999999999999999999996432 689999999999999999999999 999999999999999998 999999
Q ss_pred cccceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC
Q 001494 945 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP 1024 (1067)
Q Consensus 945 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1024 (1067)
||.++..... ....++..|+|||++.+..++.++||||+|+++|||++|+.||....... .......... ..
T Consensus 154 fg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~-~~ 225 (267)
T PHA03390 154 YGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLKRQ-QK 225 (267)
T ss_pred CccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHHHhh-cc
Confidence 9999866432 23467899999999998889999999999999999999999986332211 1111111111 22
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 001494 1025 RLPIPSHNVQEKLISFVEVAISCLDESPESRPT-MQKVSQ 1063 (1067)
Q Consensus 1025 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~evl~ 1063 (1067)
....+. .....+.+++.+||+.+|.+||+ ++|+++
T Consensus 226 ~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 KLPFIK----NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cCCccc----ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 222221 23345899999999999999996 588874
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=304.67 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=190.6
Q ss_pred CccccC--CceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEecc
Q 001494 802 HCIGKG--GQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLE 878 (1067)
Q Consensus 802 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 878 (1067)
..||+| +||+||+++. .+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 9999999976 47999999998754322 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcc
Q 001494 879 MGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW 958 (1067)
Q Consensus 879 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 958 (1067)
++++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+..........
T Consensus 83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999886543 23488999999999999999999999 99999999999999999999999998654332211110
Q ss_pred -------ccccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh-------------h
Q 001494 959 -------TELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------------I 1016 (1067)
Q Consensus 959 -------~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-------------~ 1016 (1067)
....++..|+|||++.+. .++.++||||+||++|||++|+.||.............. .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 112345679999998764 478999999999999999999999864332110000000 0
Q ss_pred hhh------------------------hccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1017 ALD------------------------EILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1017 ~~~------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
... .+..... ..........++.+++++||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL--RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccc--cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 0000000 01112234557899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=310.44 Aligned_cols=262 Identities=21% Similarity=0.286 Sum_probs=196.6
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC-----C
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA-----Q 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 868 (1067)
.++|...+.||+|+||+||+|+. .+++.||||++....... .....+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 35788999999999999999864 578999999987543222 2245677899999999999999999987654 3
Q ss_pred ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccc
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a 948 (1067)
..|+||||+. ++|.+++... ..+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 5799999996 6788887532 4589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccch---------------
Q 001494 949 KFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSL--------------- 1012 (1067)
Q Consensus 949 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~--------------- 1012 (1067)
+.............++..|+|||.+.. ..++.++|||||||++|+|++|+.||...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 876544333344567889999998765 4588999999999999999999999864322100000
Q ss_pred ----hhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1013 ----NLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1013 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
..........................++.+++.+||+.+|++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000000000000011233458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=303.96 Aligned_cols=248 Identities=28% Similarity=0.440 Sum_probs=194.0
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
.|+..+.||+|+||.||+|+.. +++.||+|.+...........+++.+|+++++.++|||++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4667788999999999999754 678899999864333333345678899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+. |++.+.+... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++......
T Consensus 96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 997 5777666422 23578999999999999999999999 9999999999999999999999999999765432
Q ss_pred CccccccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcc
Q 001494 956 SNWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
....+++.|+|||.+. ...++.++|||||||++|||++|+.||....... ....+.....+ ...
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~--~~~ 235 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESP--ALQ 235 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--------HHHHHhhcCCC--CcC
Confidence 2346788999999874 3457889999999999999999999975432211 00111111111 000
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
.......+.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 11223458899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=304.15 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=196.1
Q ss_pred HHhcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC---
Q 001494 793 RATNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ--- 868 (1067)
Q Consensus 793 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 868 (1067)
...++|+..+.||+|+||.||+|... +|+.||+|++...... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 34578999999999999999999765 6889999998754322 223456778999999999999999999987654
Q ss_pred -------ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeE
Q 001494 869 -------HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEAR 941 (1067)
Q Consensus 869 -------~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~k 941 (1067)
..++||||+++ ++...+... ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 666666432 34589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCC-ccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhh---
Q 001494 942 VSDFGIAKFLKPDSS-NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNI--- 1016 (1067)
Q Consensus 942 l~DfG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~--- 1016 (1067)
|+|||.+........ ......++..|+|||.+.+. .++.++||||+||++|||++|+.||...............
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999987654332 22334567889999987653 4788999999999999999999998643321111000000
Q ss_pred ----hhhhcc--------CCCCCCCC---cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1017 ----ALDEIL--------DPRLPIPS---HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1017 ----~~~~~~--------~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+. ++...... .........+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000 00000000 000012345899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=302.51 Aligned_cols=246 Identities=28% Similarity=0.429 Sum_probs=193.1
Q ss_pred CCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|...++||+|+||+||+|+. .+++.||+|++...........+.+.+|+++++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55667899999999999965 47889999998754433444456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
+. |++.+++... ...+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 4666666432 34588999999999999999999999 999999999999999999999999999864332
Q ss_pred ccccccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 957 NWTELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||.......... .......+... .
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~-----~ 242 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HIAQNDSPTLQ-----S 242 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHHhcCCCCCC-----c
Confidence 23456888999999874 3568889999999999999999999976433211110 00000011111 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
......+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112234889999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=309.91 Aligned_cols=261 Identities=24% Similarity=0.345 Sum_probs=196.7
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee----CCc
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH----AQH 869 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~ 869 (1067)
..+|+..+.||+|+||.||+|.. .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 36788999999999999999964 57999999998754322 2234667789999999999999999998753 346
Q ss_pred eeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccce
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK 949 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~ 949 (1067)
.++||||+. +++.+++... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 899999996 5888888533 3489999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCC----ccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccch-------hhh--
Q 001494 950 FLKPDSS----NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSL-------NLN-- 1015 (1067)
Q Consensus 950 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~~-- 1015 (1067)
....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 6543221 1234578899999998765 4588999999999999999999999865432110000 000
Q ss_pred ------hhhhhc---cCCCCCCCC-cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1016 ------IALDEI---LDPRLPIPS-HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1016 ------~~~~~~---~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+. .......+. ........++.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000 011111110 001122456899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=299.94 Aligned_cols=256 Identities=21% Similarity=0.263 Sum_probs=191.0
Q ss_pred CCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeC--CceeEE
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHA--QHSFIV 873 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 873 (1067)
|+..++||+|+||.||+|.. .+++.||+|++........ ......|+..++++. |||++++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 56778999999999999965 4789999999875432221 234457888888885 99999999999887 899999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+++ ++.+.+... ...+++.++..++.|++.|++|||+. +++||||||+||+++. +.+||+|||+++....
T Consensus 79 ~e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 79 FELMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred EecCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 999975 777666432 24589999999999999999999999 9999999999999999 9999999999987643
Q ss_pred CCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchh-------hhhhhhhc---c
Q 001494 954 DSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN-------LNIALDEI---L 1022 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~~~~~~~~---~ 1022 (1067)
.. ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||............ ........ .
T Consensus 152 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 152 KP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred CC-CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 32 2233567889999997644 45788999999999999999999998654321100000 00000000 0
Q ss_pred CCCCCCCCcc-------hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1023 DPRLPIPSHN-------VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1023 ~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
......+... ......++.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0001111100 1123456899999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=304.12 Aligned_cols=258 Identities=18% Similarity=0.230 Sum_probs=190.4
Q ss_pred ccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccC
Q 001494 800 DEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 800 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
+++.+|.|+++.||++.. +++.||||++..... .....+.+..|++++++++||||+++++++.+.+..+++|||+++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 344455555655555544 699999999875422 223456799999999999999999999999999999999999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC---
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS--- 956 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--- 956 (1067)
+++.+++.... ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+|++|||.+........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999986432 23478899999999999999999999 999999999999999999999999999875542211
Q ss_pred ----ccccccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhh----------
Q 001494 957 ----NWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDE---------- 1020 (1067)
Q Consensus 957 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------- 1020 (1067)
......++..|+|||++.+. .++.++|||||||++|||++|+.||...................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 11234567789999988763 57889999999999999999999986543211100000000000
Q ss_pred ----------ccCCCC--CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1021 ----------ILDPRL--PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1021 ----------~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...+.. ..+.........++.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000 0011111223346889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=283.69 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=203.9
Q ss_pred HhcCCCccCccccCCceeEEEEEEC------CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA 867 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 867 (1067)
...+++....+-+|.||.||.|.++ +.+.|-||.++... ..-+...++.|...+..+.|||+.++.+++.++
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 3456777788999999999999443 34456677775432 223356788999999999999999999998655
Q ss_pred -CceeEEEEeccCCCHHHHhc-----ccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeE
Q 001494 868 -QHSFIVYEYLEMGSLAMILS-----NDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEAR 941 (1067)
Q Consensus 868 -~~~~lv~E~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~k 941 (1067)
+.++++|.++.-|+|..++. +......++..+...++.|++.|++|||++ +|||.||.++|.+||+.-++|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEE
Confidence 57899999999999999997 333344577788899999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCCcc--ccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhh
Q 001494 942 VSDFGIAKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIAL 1018 (1067)
Q Consensus 942 l~DfG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1018 (1067)
++|-.+++.+-+.++.. .....+..||+||.+....|+.++|||||||++|||+| |+.||..+++++...+
T Consensus 437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y------ 510 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY------ 510 (563)
T ss_pred eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH------
Confidence 99999999887665432 22345678999999999999999999999999999998 9999987776543221
Q ss_pred hhccCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1019 DEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1019 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
+.++ ++..|..+.+ +++.+|..||..+|++||+++|++.-|
T Consensus 511 --lkdGyRlaQP~NCPD----eLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 511 --LKDGYRLAQPFNCPD----ELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred --HhccceecCCCCCcH----HHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 2222 2223333333 489999999999999999999998765
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=301.25 Aligned_cols=256 Identities=23% Similarity=0.316 Sum_probs=198.7
Q ss_pred CCCccCccccCCceeEEEEEE----CCCcEEEEEEeCCCCC-CChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCce
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL----ASGEIIAVKKFHSPLP-GEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 870 (1067)
+|+..+.||+|+||.||+++. .+++.||||++..... ......+.+..|+++++++ +||+|+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477789999999999999864 3578899999864321 1222345678999999999 599999999999999999
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
++||||+++++|.+++... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.++++|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999988532 3578899999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCc-cccccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC
Q 001494 951 LKPDSSN-WTELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 951 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
....... .....|+..|+|||.+.+.. .+.++||||||+++|||++|+.||........ .......+......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~ 230 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----QSEISRRILKSKPP 230 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----HHHHHHHHHccCCC
Confidence 5443222 22346789999999887655 68899999999999999999999853221110 11111122222222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.+... ...+.+++.+||+.+|++|||+.++.+.++
T Consensus 231 ~~~~~----~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 231 FPKTM----SAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CCccc----CHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 22222 234789999999999999999988877664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=299.58 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=196.0
Q ss_pred CCCccCccccCCceeEEEEEE----CCCcEEEEEEeCCCCC-CChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCce
Q 001494 797 DFDDEHCIGKGGQGSVYKVEL----ASGEIIAVKKFHSPLP-GEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 870 (1067)
+|++.+.||+|+||.||+|+. .+|+.||+|++..... ......+.+..|+++++++ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999875 3789999999864322 1223346678899999999 599999999999999999
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
++||||+++++|.+++... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998543 3578889999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC-CccccccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC
Q 001494 951 LKPDS-SNWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 951 ~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
..... .......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .........+......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~~ 230 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSEPP 230 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----ccHHHHHHHhhccCCC
Confidence 54332 122345688999999988753 3678999999999999999999998632211 0111111222222222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~evl~ 1063 (1067)
.+.. ....+.+++.+||+.+|++|| ++.++++
T Consensus 231 ~~~~----~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 YPQE----MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCcc----CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 2222 223488999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=302.02 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=192.7
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 873 (1067)
++|+..+.||+|+||.||+|... +++.||||++...... ....++..|+.++.+. +||||+++++++.++...|+|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 56888999999999999999876 4899999998754222 2345667787766666 599999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
|||+++ ++....... ...+++..+..++.|++.|++|||+.. +|+||||+|+||+++.++.+||+|||++..+..
T Consensus 93 ~e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eeccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999864 676666432 236899999999999999999999732 899999999999999999999999999976543
Q ss_pred CCCccccccccccccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC-C
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP-I 1028 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 1028 (1067)
.. ......+++.|+|||.+.+.. ++.++||||||+++|||++|+.||...... ......+...... .
T Consensus 168 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~ 239 (296)
T cd06618 168 SK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEEPPSL 239 (296)
T ss_pred CC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCCCCCC
Confidence 22 223345788999999987554 788999999999999999999998642211 1111111111111 1
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1029 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
+.. .....++.+++.+||+.||++||++.++++.
T Consensus 240 ~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 PPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC--CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 1123358999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=292.25 Aligned_cols=242 Identities=27% Similarity=0.354 Sum_probs=198.6
Q ss_pred cccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCCCH
Q 001494 804 IGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL 882 (1067)
Q Consensus 804 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 882 (1067)
||+|+||.||++... +++.||+|++.............+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999765 5899999998765444434566789999999999999999999999999999999999999999
Q ss_pred HHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcccccc
Q 001494 883 AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA 962 (1067)
Q Consensus 883 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 962 (1067)
.+++.... .+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||.+..............
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 99985432 488999999999999999999998 999999999999999999999999999987654433334566
Q ss_pred ccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHH
Q 001494 963 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVE 1042 (1067)
Q Consensus 963 gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1042 (1067)
++..|+|||...+...+.++|+||||+++||+++|+.||+..+. ......+.......+... ...+.+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~l~~ 222 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKDPLRFPEFL----SPEARD 222 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcCCCCCCCCC----CHHHHH
Confidence 78899999999888889999999999999999999999864332 112222222333333332 234889
Q ss_pred HHHhccCCCCCCCCCH---HHHHH
Q 001494 1043 VAISCLDESPESRPTM---QKVSQ 1063 (1067)
Q Consensus 1043 li~~cl~~dP~~Rpt~---~evl~ 1063 (1067)
++.+||..||++||++ .++.+
T Consensus 223 ~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 223 LISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHHHhcCCHhhCCCcccHHHHHh
Confidence 9999999999999999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=280.42 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=208.0
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 872 (1067)
.++|+..++||+|+|+.|..+++ ++.+.||+|++++....+.+...-...|-.+..+. +||.+|.+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46799999999999999999975 46788999999876554443344455666666555 79999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
|.||++||+|-..+++.+ .++++.+..+...|+-||.|||++ ||++||+|.+|||+|..|++|++|||+++.--
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999977775433 489999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcc
Q 001494 953 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 953 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
.+....++++|||.|+|||.+.+..|+..+|.|++||+++||+.|+.|||...............++-++...+.+|...
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl 482 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL 482 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence 66677788999999999999999999999999999999999999999998765322222222334445556666666554
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCC
Q 001494 1033 VQEKLISFVEVAISCLDESPESRP 1056 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rp 1056 (1067)
... ...++..-+++||++|.
T Consensus 483 svk----as~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 483 SVK----ASHVLKGFLNKDPKERL 502 (593)
T ss_pred ehh----hHHHHHHhhcCCcHHhc
Confidence 433 56777888999999985
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=303.59 Aligned_cols=262 Identities=23% Similarity=0.337 Sum_probs=192.1
Q ss_pred hcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC-----
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ----- 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 868 (1067)
.++|+..++||+|+||.||+|... +++.||||++....... .....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 357899999999999999999654 78999999986543222 22345678999999999999999999987654
Q ss_pred ---ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecc
Q 001494 869 ---HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDF 945 (1067)
Q Consensus 869 ---~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~Df 945 (1067)
..++||||+.+ ++.+.+... ...+++.++..++.|++.|++|||++ +++||||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 34999999975 777776432 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCC----ccccccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhh----
Q 001494 946 GIAKFLKPDSS----NWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNI---- 1016 (1067)
Q Consensus 946 G~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~---- 1016 (1067)
|++........ ......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...............
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99986643221 122345778899999876654 688999999999999999999998654321110000000
Q ss_pred ---hhhhcc----CCCCCCCCcc---hH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1017 ---ALDEIL----DPRLPIPSHN---VQ------EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1017 ---~~~~~~----~~~~~~~~~~---~~------~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...... ......+... .. .....+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000 0000000000 00 01134679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=307.07 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=198.8
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC-----ce
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ-----HS 870 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 870 (1067)
+|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 4788899999999999999765 589999999875432 2234567889999999999999999999987775 78
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
|+||||++ +++.+++... ..+++..+..++.+++.|++|||+. ||+||||||+||+++.++.++|+|||.+..
T Consensus 80 ~lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999998 4788887543 2689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC---CccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh-------h---
Q 001494 951 LKPDS---SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------I--- 1016 (1067)
Q Consensus 951 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-------~--- 1016 (1067)
..... .......+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||.............. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 65543 123445678899999999887 789999999999999999999999864432110000000 0
Q ss_pred -----hhhhccC---CCCCCC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1017 -----ALDEILD---PRLPIP-SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1017 -----~~~~~~~---~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....... .....+ ..........+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0000000 000000 0000112345889999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=327.88 Aligned_cols=148 Identities=26% Similarity=0.366 Sum_probs=132.5
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|.+.++||+|+||.||+|... +++.||||++.............+..|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999765 78999999997543334444577889999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccce
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK 949 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~ 949 (1067)
||+++++|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998543 3478889999999999999999999 99999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=254.56 Aligned_cols=260 Identities=22% Similarity=0.340 Sum_probs=199.4
Q ss_pred CCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|+..++||+|.||+||+|+ ..+++.||+|+++....++ .......+|+-+++.++|.|||+++++...+....+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46677899999999999996 4578999999998654433 335667899999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
||+. +|..+. +...+.++.+.+..++.|+++|+.++|++ .+.|||+||+|.+|+.+|+.|++|||+|+.++-+.
T Consensus 82 ~cdq-dlkkyf--dslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 82 FCDQ-DLKKYF--DSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred HhhH-HHHHHH--HhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 9975 676666 23456688899999999999999999999 99999999999999999999999999999988776
Q ss_pred CccccccccccccCccccccCC-CCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhh-------hhhhhccC-CC
Q 001494 956 SNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLN-------IALDEILD-PR 1025 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~-------~~~~~~~~-~~ 1025 (1067)
..++..+.|.+|++|.++.+.+ |+...|+||.|||+.|+.. |++-|.+.+.......... .....+.. +.
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 6677778899999999998876 8999999999999999997 5544544332211110000 00000000 00
Q ss_pred C---CC-C-CcchHHHH----HHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1026 L---PI-P-SHNVQEKL----ISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1026 ~---~~-~-~~~~~~~~----~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
. ++ | ...+.... ..-+++++..+.-+|.+|.++++.++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0 00 0 01111111 23478888899999999999999876
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=293.82 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=196.0
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCC--ChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPG--EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
+|.+.++||+|+||.||++... .+..+++|+++..... ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999998654 3455666665532211 112234566789999999999999999999999999999
Q ss_pred EEeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 874 YEYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
|||++++++.+++... .....+++.+++.++.|++.|++|||+. +++|+||||+||+++. +.++++|||.++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 2345689999999999999999999999 9999999999999975 679999999998765
Q ss_pred CCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcc
Q 001494 953 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 953 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
..........|++.|+|||...+..++.++||||||+++|+|++|..||+..... ...........+..
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~--- 225 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--------SVVLRIVEGPTPSL--- 225 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHcCCCCCC---
Confidence 4443334456788999999988888899999999999999999999998632211 11111111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
......++.+++.+||+.+|++||++.|+++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1123345889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=305.35 Aligned_cols=264 Identities=22% Similarity=0.315 Sum_probs=197.3
Q ss_pred HHHHHHHhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee
Q 001494 788 YEEIIRATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH 866 (1067)
Q Consensus 788 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 866 (1067)
.+++....++|+..+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 455666778999999999999999999964 57899999998754322 2234567889999999999999999998864
Q ss_pred C------CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCe
Q 001494 867 A------QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA 940 (1067)
Q Consensus 867 ~------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~ 940 (1067)
. ...++++|++ ++++.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3 3467888876 7789887743 2488999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchh------
Q 001494 941 RVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN------ 1013 (1067)
Q Consensus 941 kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~------ 1013 (1067)
||+|||+++.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||............
T Consensus 160 kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 160 KILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred EEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999976432 2234567889999998766 46788999999999999999999998543221100000
Q ss_pred -hhhhhhhccCC-------C-CCCCCcch----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1014 -LNIALDEILDP-------R-LPIPSHNV----QEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1014 -~~~~~~~~~~~-------~-~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.......+.+. . ...+.... .....++.+++.+|++.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 00000000000 0 00000000 011235789999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=302.17 Aligned_cols=260 Identities=25% Similarity=0.365 Sum_probs=196.2
Q ss_pred HHHhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee-CCc
Q 001494 792 IRATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH-AQH 869 (1067)
Q Consensus 792 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 869 (1067)
...+++|+..+.||+|+||.||+|.. .+++.||+|++....... ...+.+..|++++++++||||+++.+++.. ...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 44678899999999999999999964 489999999986543222 234667889999999999999999998865 557
Q ss_pred eeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccce
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK 949 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~ 949 (1067)
.++||||+ ++++..+++. ..+++..+..++.|+++|++|||+. +|+||||+|+||+++.++.++|+|||.++
T Consensus 85 ~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 89999998 4688888743 2467888889999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccch-------hhhhhhhhc
Q 001494 950 FLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSL-------NLNIALDEI 1021 (1067)
Q Consensus 950 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~ 1021 (1067)
.... ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||........... .........
T Consensus 157 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 157 IQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred ccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 5432 2233467889999998766 5689999999999999999999999864332110000 000000000
Q ss_pred cC-----------CCCCCCC-cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1022 LD-----------PRLPIPS-HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1022 ~~-----------~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.+ .....+. ........++.+++.+|++.+|++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000010 000112346899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=303.53 Aligned_cols=261 Identities=21% Similarity=0.252 Sum_probs=192.6
Q ss_pred cCCC-ccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCCh-----------hHHHHHHHHHHHHhcCCCCeeeeeeE
Q 001494 796 NDFD-DEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEM-----------TFQQEFLNEVKALTEIRHRNIVKFYG 862 (1067)
Q Consensus 796 ~~~~-~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~niv~l~~ 862 (1067)
++|. ..+.||+|+||+||+|.. .+++.||||++........ .....+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 457799999999999965 4789999999864322110 01125778999999999999999999
Q ss_pred EEeeCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEE
Q 001494 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARV 942 (1067)
Q Consensus 863 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl 942 (1067)
++..++..++||||++ |++.+++.. ...+++..+..++.|++.|++|||+. +|+||||+|+||+++.++.+|+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 588888853 23488999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCC--------------CCCccccccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccccc
Q 001494 943 SDFGIAKFLKP--------------DSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLI 1007 (1067)
Q Consensus 943 ~DfG~a~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~ 1007 (1067)
+|||.++.... .........+++.|+|||.+.+.. ++.++||||+||++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999986651 111222345678899999887643 688999999999999999999998644321
Q ss_pred cccchhhh-------hhhhhcc-----CCCCCCCCcc----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1008 SSSSLNLN-------IALDEIL-----DPRLPIPSHN----VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1008 ~~~~~~~~-------~~~~~~~-----~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
........ ....+.. .+.....+.. ......++.+++.+|++.+|++|||+.|++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11000000 0000000 0000000000 0112345889999999999999999999985
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=296.95 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=198.7
Q ss_pred CCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|+..+.||+|++|.||+|... +++.||+|++..... .....+.+..|+.++++++|||++++++++.+.+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 556788999999999999765 589999999876532 223346778899999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 956 (1067)
++ ++|.+++.... ..+++..+.+++.+++.|++|||++ +|+||||+|+||+++.++.+||+|||.++.......
T Consensus 80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 98 58999886432 3589999999999999999999999 999999999999999999999999999987655443
Q ss_pred ccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh-------hhhh---hhc----
Q 001494 957 NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL-------NIAL---DEI---- 1021 (1067)
Q Consensus 957 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~-------~~~~---~~~---- 1021 (1067)
......++..|+|||.+.+. .++.++|||||||++||+++|+.||............. .... ...
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 34445567889999988766 78999999999999999999999986433211100000 0000 000
Q ss_pred -cCCCCCCCC--cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1022 -LDPRLPIPS--HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1022 -~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
..+...... .........+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000 000111346899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=293.79 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=194.3
Q ss_pred CCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCCceeEEEE
Q 001494 798 FDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 875 (1067)
|++.+.||+|++|+||+|... +++.||+|++....... ......+|+..+++++ |||++++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 567789999999999999875 57899999986543221 1234557899999998 9999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
|+ +|++.+++.... ...+++.++..++.|++.|++|||++ +++|+||+|+||+++.++.++|+|||.++......
T Consensus 79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 99 778988885433 24589999999999999999999999 99999999999999999999999999998765322
Q ss_pred CccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccch-------------hhhhhhhhc
Q 001494 956 SNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSL-------------NLNIALDEI 1021 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~-------------~~~~~~~~~ 1021 (1067)
......++..|+|||++.+ ..++.++|+||||+++|||++|+.||........... .........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 2234567889999998754 4578999999999999999999999854332110000 000000000
Q ss_pred cCCCCCCCC-cc----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1022 LDPRLPIPS-HN----VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1022 ~~~~~~~~~-~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
......... .. .......+.+++.+||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000 00 0011245889999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=303.85 Aligned_cols=256 Identities=21% Similarity=0.351 Sum_probs=191.8
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC-----
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ----- 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 868 (1067)
..+|...+.||+|+||.||+|.. .+|+.||+|++......+ .....+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 36899999999999999999975 578999999987543222 23456789999999999999999999986543
Q ss_pred -ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccc
Q 001494 869 -HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGI 947 (1067)
Q Consensus 869 -~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~ 947 (1067)
..++|+||+.. ++..+.. ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+|++|||+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46999999964 6666542 2478899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh-------hhh-
Q 001494 948 AKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------IAL- 1018 (1067)
Q Consensus 948 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-------~~~- 1018 (1067)
++.... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.............. ...
T Consensus 164 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 164 ARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 976432 2234567889999998876 4588999999999999999999999875332110000000 000
Q ss_pred -------hhccCCCCCCCCcc----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1019 -------DEILDPRLPIPSHN----VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1019 -------~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
..........+... .......+.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000000000 0112235789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=304.10 Aligned_cols=259 Identities=21% Similarity=0.324 Sum_probs=195.2
Q ss_pred HHhcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC---
Q 001494 793 RATNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ--- 868 (1067)
Q Consensus 793 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 868 (1067)
...++|+..+.||+|+||.||+|. ..+++.||||++..... .....+.+.+|++++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 346789999999999999999985 55799999999865322 2233456889999999999999999999987654
Q ss_pred ---ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecc
Q 001494 869 ---HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDF 945 (1067)
Q Consensus 869 ---~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~Df 945 (1067)
..++||||+ ++++.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 6788888743 3588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchh-------hhhh
Q 001494 946 GIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN-------LNIA 1017 (1067)
Q Consensus 946 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~-------~~~~ 1017 (1067)
|++...... .....+++.|+|||.+.+ ..++.++|+||+||++|++++|+.||............ ....
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 163 GLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999865432 234467889999998876 45788999999999999999999998643321100000 0000
Q ss_pred hhhc--------cC--CCCCCC--CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1018 LDEI--------LD--PRLPIP--SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1018 ~~~~--------~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...+ .. +..... .........++.+++.+|++.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00 000000 0000112235889999999999999999999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=302.18 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=191.5
Q ss_pred hcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC-----
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ----- 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 868 (1067)
.++|+..++||+|+||.||+|... +++.||+|++......+. ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 468999999999999999999754 689999999864432221 2345678999999999999999999875433
Q ss_pred ---ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecc
Q 001494 869 ---HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDF 945 (1067)
Q Consensus 869 ---~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~Df 945 (1067)
..++||||+++ ++...+.. ....+++.++..++.|+++|++|||++ +|+||||||+||+++.++.+||+||
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999975 56655533 234589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCc-----------cccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchh
Q 001494 946 GIAKFLKPDSSN-----------WTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN 1013 (1067)
Q Consensus 946 G~a~~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~ 1013 (1067)
|+++........ .+...+++.|+|||.+.+. .++.++|||||||++|||++|+.||............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765432211 1234567889999987654 5789999999999999999999998643321100000
Q ss_pred hhh-------------hhhh----ccCCCCCCC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1014 LNI-------------ALDE----ILDPRLPIP-SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1014 ~~~-------------~~~~----~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
... .... ......+.. ..........+.+++.+|++.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000 0000 000000000 0000111245889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=286.37 Aligned_cols=256 Identities=28% Similarity=0.403 Sum_probs=194.9
Q ss_pred cCCCccCccccCCceeEEEE-EECCCcEEEEEEeCCCCCC----ChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee-CCc
Q 001494 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPG----EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH-AQH 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 869 (1067)
++|-..+.||+|||+.||+| ++...+.||||+-...... ...+.+...+|.++.+.++||.||++++|+.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 45677889999999999998 5666889999986533211 11233457789999999999999999999964 467
Q ss_pred eeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeC---CCCCeEEeccc
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD---FKNEARVSDFG 946 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~---~~~~~kl~DfG 946 (1067)
+|-|+|||+|.+|+.+++..+ -+++.++..|+.||+.||.||.+. .|+|||=|+||.|||+- .-|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 899999999999999996544 489999999999999999999998 45899999999999994 34789999999
Q ss_pred cceecCCCCCc-------cccccccccccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCcccccccc-chhh
Q 001494 947 IAKFLKPDSSN-------WTELAGTYGYVAPELAYTM----KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSS-SLNL 1014 (1067)
Q Consensus 947 ~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-~~~~ 1014 (1067)
+++.+..+++. ....+||.+|.+||.+.-+ ..+.|+||||.|||+|+.+.|+.||......... ..+.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99988766543 2357899999999976543 3678999999999999999999998643221110 0111
Q ss_pred hhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 001494 1015 NIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVS 1062 (1067)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl 1062 (1067)
-....++. ++..+.. ..+...+|++|++.--++|.+..++.
T Consensus 699 IlkAtEVq---FP~KPvV----sseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 699 ILKATEVQ---FPPKPVV----SSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhcceecc---CCCCCcc----CHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11111221 1111222 22478899999999999998887764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-33 Score=320.61 Aligned_cols=252 Identities=24% Similarity=0.295 Sum_probs=201.8
Q ss_pred HhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeE
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 872 (1067)
..++|.+.++||+|+||.|..++. .+++.||.|++.+-.--......-|..|-.+|..-+.+-|+.++-+|.++.++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 357899999999999999999975 5789999999864211111224568899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
|||||+||+|-..+.... .+++..+..++..|+-||.-+|+- |+|||||||+|||+|..|++|++|||.+-.+.
T Consensus 153 VMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 999999999999996544 588999999999999999999999 99999999999999999999999999998877
Q ss_pred CCCC-ccccccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC--
Q 001494 953 PDSS-NWTELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP-- 1024 (1067)
Q Consensus 953 ~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 1024 (1067)
.++. .....+|||.|++||++.. +.|++.+|.||+||++|||+.|..||-..... .....+++-
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv--------eTY~KIm~hk~ 298 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV--------ETYGKIMNHKE 298 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH--------HHHHHHhchhh
Confidence 5543 4556899999999998752 56899999999999999999999998533321 112222222
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 001494 1025 RLPIPSHNVQEKLISFVEVAISCLDESPESRPT---MQKVS 1062 (1067)
Q Consensus 1025 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~evl 1062 (1067)
.+.+|. ..+.+.+..++|.+.+. +|+.|.. +.++.
T Consensus 299 ~l~FP~--~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 299 SLSFPD--ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred hcCCCc--ccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 334441 12244568888888775 6788876 66654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=257.26 Aligned_cols=204 Identities=25% Similarity=0.406 Sum_probs=169.0
Q ss_pred hcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhc-CCCCeeeeeeEEEeeCCceeE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE-IRHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~l 872 (1067)
.++......||+|++|.|-+.++ .+|+..|+|++...... ..+++.+.|+.+..+ ..+|.+|.++|.+.+++..|+
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~--q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS--QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh--HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 34555667899999999998865 58999999999876543 346778889887544 479999999999999999999
Q ss_pred EEEeccCCCHHHHhccc-CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 873 VYEYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
.||.|+. +++.+.++- .....+++.-.-+||..+.+|+.|||++- .|+|||+||+|||++.+|++|+||||++..+
T Consensus 123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999974 776665432 33456888889999999999999999985 8999999999999999999999999999887
Q ss_pred CCCCCccccccccccccCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCcc
Q 001494 952 KPDSSNWTELAGTYGYVAPELAYT----MKVTEKCDVYSFGVLALEVIKGKHPGDFI 1004 (1067)
Q Consensus 952 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGvil~elltg~~p~~~~ 1004 (1067)
.+. -..+-.+|...|||||.+.. ..|+.|+||||+|+.++||.+++.||+.+
T Consensus 200 ~dS-iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 200 VDS-IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhh-hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 643 22233567788999998753 36899999999999999999999998743
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=298.68 Aligned_cols=239 Identities=23% Similarity=0.290 Sum_probs=191.7
Q ss_pred hcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 872 (1067)
++.|.....+|.|+|++|-.+. ..+++..|||++.....+ -.+|+.++... +|||++++.+.+.+..+.|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 4567777789999999998874 567889999999765222 23566565555 79999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee-CCCCCeEEeccccceec
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLL-DFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill-~~~~~~kl~DfG~a~~~ 951 (1067)
|||++.|+-+.+.+..... .. ..+..|+.+|+.|+.|||++ ||||||+||+|||+ +..++++|+|||.++..
T Consensus 394 v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 9999999988776643222 22 66778999999999999999 99999999999999 68999999999999887
Q ss_pred CCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCc
Q 001494 952 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031 (1067)
Q Consensus 952 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1067)
.+. ....+-|..|.|||+.....|++++|+||+|++||+|++|+.||...+.. .+....+..+...
T Consensus 467 ~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s---- 532 (612)
T KOG0603|consen 467 ERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFS---- 532 (612)
T ss_pred chh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCccc----
Confidence 654 33456688899999999889999999999999999999999998744431 2223333333222
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...+..+++++.+||+.||.+||+|.++..
T Consensus 533 --~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 --ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred --cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 234446899999999999999999999864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=302.57 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=206.5
Q ss_pred HhcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEee-----
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH----- 866 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----- 866 (1067)
-+..|++.+.||.|.+|.||+++ .++|+.+|+|+....... .+++..|+.+++.. .|||++.++|+|..
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 34568888999999999999995 567888999998754332 36677899998887 69999999999853
Q ss_pred CCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccc
Q 001494 867 AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 867 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 946 (1067)
++.+|+|||||.+|+..|+++... ...+.|+.+..|++.++.|+.+||.+ .++|||||-.|||++.++.||++|||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeee
Confidence 468999999999999999998766 67799999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhc
Q 001494 947 IAKFLKPDSSNWTELAGTYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEI 1021 (1067)
Q Consensus 947 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1021 (1067)
++.++..........+|||.|||||++... .|+.++|+||+|++..||--|.+|+..+-+. .++-.+
T Consensus 169 vSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------raLF~I 240 (953)
T KOG0587|consen 169 VSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------RALFLI 240 (953)
T ss_pred eeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------hhhccC
Confidence 999988777777889999999999998643 3677999999999999999999996533221 111111
Q ss_pred cCCCCCCCC-cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1022 LDPRLPIPS-HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1022 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
++-+.|. .....-..++.++|..|+.+|-.+||++.++++
T Consensus 241 --pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 --PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111111 112334457999999999999999999998875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=303.77 Aligned_cols=258 Identities=21% Similarity=0.333 Sum_probs=195.3
Q ss_pred HhcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCc---
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQH--- 869 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 869 (1067)
..++|+..+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|+.++++++|||++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3567999999999999999999764 6889999998654322 2234567789999999999999999998766554
Q ss_pred ---eeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccc
Q 001494 870 ---SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 870 ---~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 946 (1067)
.++|+||+ +++|.+++.. ..+++.++..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5689888853 3589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhh-------hhh
Q 001494 947 IAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------IAL 1018 (1067)
Q Consensus 947 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~-------~~~ 1018 (1067)
++...... .....++..|+|||.+.+ ..++.++||||+||++||+++|+.||.............. ...
T Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 164 LARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred cccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 99865432 234467889999998765 3578899999999999999999999864332111000000 000
Q ss_pred hh--------ccCCCCCCCCcch----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1019 DE--------ILDPRLPIPSHNV----QEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1019 ~~--------~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.. .+........... .....++.+++.+|++.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00 0000000000000 012346889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=296.57 Aligned_cols=258 Identities=23% Similarity=0.317 Sum_probs=189.9
Q ss_pred CCCccCccccCCceeEEEEEEC-C--CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeC----C
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-S--GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHA----Q 868 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~ 868 (1067)
+|+..+.||+|+||.||+++.. + ++.||+|++...... ....+.+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 4778889999999999999754 4 778999998643222 22346678899999999 599999999875432 4
Q ss_pred ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccc
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a 948 (1067)
..|+++||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred cEEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 5789999986 588888743 34588999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC----ccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccc-------hhhhh
Q 001494 949 KFLKPDSS----NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSS-------LNLNI 1016 (1067)
Q Consensus 949 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~ 1016 (1067)
+....... ......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.......... .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 86643221 1233568899999998765 458899999999999999999999986433110000 00000
Q ss_pred hhhhccC-------------CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1017 ALDEILD-------------PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1017 ~~~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
....+.. +..... .........+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 000000 000011235889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=300.73 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=189.3
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC-------
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA------- 867 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 867 (1067)
.+|...+.||.|+||.||+|.. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 5788999999999999999965 5789999999865432 2346788999999999999999999776543
Q ss_pred -------CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC-CCC
Q 001494 868 -------QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF-KNE 939 (1067)
Q Consensus 868 -------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~-~~~ 939 (1067)
...|+||||++ +++.+++.. ..+++..+..++.||+.|++|||+. +|+||||||+||+++. ++.
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 35789999997 588877742 3478999999999999999999999 9999999999999985 457
Q ss_pred eEEeccccceecCCCCC---ccccccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh-
Q 001494 940 ARVSDFGIAKFLKPDSS---NWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL- 1014 (1067)
Q Consensus 940 ~kl~DfG~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~- 1014 (1067)
+|++|||.++....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 89999999986543211 1123457889999997654 457889999999999999999999986433211100000
Q ss_pred ------h---h----hhhhccC---CCCCCC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1015 ------N---I----ALDEILD---PRLPIP-SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1015 ------~---~----~~~~~~~---~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
. . ....... .....+ .........++.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 0 0000000 000000 0000112245889999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=268.18 Aligned_cols=261 Identities=23% Similarity=0.360 Sum_probs=191.6
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee--------
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH-------- 866 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 866 (1067)
..|....++|+|.||.||+|+. ++|+.||+|++...... ..+.....+|++++..++|+|++.++..|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4566678899999999999964 46788999887543222 2234556899999999999999999988743
Q ss_pred CCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccc
Q 001494 867 AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 867 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 946 (1067)
...+|+||++|++ +|.-++... ...++..++.++++++..||.|+|.. .|+|||+||.||||+.+|.+||+|||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 2358999999986 777777543 23478899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCC----CCccccccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccc-----------
Q 001494 947 IAKFLKPD----SSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSS----------- 1010 (1067)
Q Consensus 947 ~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~----------- 1010 (1067)
+++.+... ...++..+.|.+|++||.+.+. .|+++.|||+.|||+.||+||.+-+.........
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 99766432 2345677889999999988765 5899999999999999999998876542211000
Q ss_pred ----chhhhhhhhhcc-CCCCCCC-CcchHHHHH------HHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1011 ----SLNLNIALDEIL-DPRLPIP-SHNVQEKLI------SFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1011 ----~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~------~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.........+-+ -+.++.. .....+... ...+++..++..||++|+++++++.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 000000000000 0000000 000111111 4789999999999999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=289.32 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=202.8
Q ss_pred hcCCCccCccccCCceeEEEEEECCCc-EEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELASGE-IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 873 (1067)
..+++....||-||||.|-.++.++.+ .+|+|.+++...-+...++.+..|-.+|...+.|.||++|-.|.+....|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345666778999999999998776444 4899988765555555667788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCC
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
||-|-||.+..+++..+ .++...+..++..+++|++|||++ +||+||+||+|.++|.+|-+|+.|||+|+.+..
T Consensus 499 mEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999996543 477788888999999999999999 999999999999999999999999999999887
Q ss_pred CCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcch
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
....+ +++|||.|.|||.+....++.++|.||+|+++||+++|.+||...+++......... ++.+ .+|..
T Consensus 573 g~KTw-TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-id~i-----~~Pr~-- 643 (732)
T KOG0614|consen 573 GRKTW-TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-IDKI-----EFPRR-- 643 (732)
T ss_pred CCcee-eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-hhhh-----hcccc--
Confidence 65555 479999999999999999999999999999999999999999987765332221111 1111 12221
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCC
Q 001494 1034 QEKLISFVEVAISCLDESPESRPT 1057 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt 1057 (1067)
......+++++....+|.+|--
T Consensus 644 --I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 644 --ITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --cchhHHHHHHHHHhcCcHhhhc
Confidence 2234678888999999999975
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=278.23 Aligned_cols=219 Identities=21% Similarity=0.207 Sum_probs=174.8
Q ss_pred CCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCCCHHHH
Q 001494 807 GGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMI 885 (1067)
Q Consensus 807 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~ 885 (1067)
|.+|.||+++. .+++.||+|++.... .+..|...+....|||++++++++.+.+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 89999999865 578999999986431 223445555566799999999999999999999999999999998
Q ss_pred hcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccccccccc
Q 001494 886 LSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTY 965 (1067)
Q Consensus 886 l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 965 (1067)
+... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||.+...... .....++.
T Consensus 76 l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~ 146 (237)
T cd05576 76 ISKF---LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVEN 146 (237)
T ss_pred HHHh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCc
Confidence 8543 3489999999999999999999999 9999999999999999999999999988665432 12334567
Q ss_pred cccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHH
Q 001494 966 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAI 1045 (1067)
Q Consensus 966 ~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 1045 (1067)
.|+|||...+..++.++||||+|+++|||++|+.|++...... ... .....+.. ....+.+++.
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------~~~--~~~~~~~~----~~~~~~~li~ 210 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------NTH--TTLNIPEW----VSEEARSLLQ 210 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------ccc--cccCCccc----CCHHHHHHHH
Confidence 8999999988889999999999999999999998865322100 000 11112222 1234889999
Q ss_pred hccCCCCCCCCCH
Q 001494 1046 SCLDESPESRPTM 1058 (1067)
Q Consensus 1046 ~cl~~dP~~Rpt~ 1058 (1067)
+|++.||++||++
T Consensus 211 ~~l~~dp~~R~~~ 223 (237)
T cd05576 211 QLLQFNPTERLGA 223 (237)
T ss_pred HHccCCHHHhcCC
Confidence 9999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=308.69 Aligned_cols=259 Identities=20% Similarity=0.226 Sum_probs=168.4
Q ss_pred HhcCCCccCccccCCceeEEEEEEC-C----CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEE-----
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELA-S----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF----- 863 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~----- 863 (1067)
..++|...++||+|+||.||+|+.. + +..||+|++...... +....| .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 4578999999999999999999765 4 689999997643211 111111 1111122222222211
Q ss_pred -EeeCCceeEEEEeccCCCHHHHhcccCcc-----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 001494 864 -CSHAQHSFIVYEYLEMGSLAMILSNDAAA-----------------EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHR 925 (1067)
Q Consensus 864 -~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHr 925 (1067)
...+...++||||+++++|.+++...... .......+..++.|++.||+|||++ +|+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 24566899999999999999988643210 0112334567999999999999999 99999
Q ss_pred CCCCCceeeCC-CCCeEEeccccceecCCCC-CccccccccccccCccccccCC----------------------CCcc
Q 001494 926 DISSKNVLLDF-KNEARVSDFGIAKFLKPDS-SNWTELAGTYGYVAPELAYTMK----------------------VTEK 981 (1067)
Q Consensus 926 Dlk~~Nill~~-~~~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~ 981 (1067)
||||+|||++. ++.+||+|||+|+.+.... .......+++.|||||.+.... ++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999986 5789999999998654322 2234567899999999653221 3346
Q ss_pred chhHHHHHHHHHHHhCCCCCCccccc-----cccchhhhhhhhhccCCCCCCC----CcchHHHHHHHHHHHHhccCCCC
Q 001494 982 CDVYSFGVLALEVIKGKHPGDFISLI-----SSSSLNLNIALDEILDPRLPIP----SHNVQEKLISFVEVAISCLDESP 1052 (1067)
Q Consensus 982 ~DvwslGvil~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP 1052 (1067)
+||||+||++|||+++..|++..... ....... ........+..... .+..........+++.+|++.||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDL-VAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcH-HHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 79999999999999988775432110 0000000 01111111110000 00000011235589999999999
Q ss_pred CCCCCHHHHHH
Q 001494 1053 ESRPTMQKVSQ 1063 (1067)
Q Consensus 1053 ~~Rpt~~evl~ 1063 (1067)
.+|||+.|+++
T Consensus 439 ~kR~ta~e~L~ 449 (566)
T PLN03225 439 RQRISAKAALA 449 (566)
T ss_pred ccCCCHHHHhC
Confidence 99999999986
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=276.00 Aligned_cols=269 Identities=20% Similarity=0.281 Sum_probs=200.9
Q ss_pred cCcccHHHHHHHhcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-C-C----
Q 001494 783 EGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-H-R---- 855 (1067)
Q Consensus 783 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~---- 855 (1067)
+|-+++..-...+.+|.+.+.+|+|.||.|-++. ..++..||||+++.. ....+..+-|+++++++. + |
T Consensus 76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~ 151 (415)
T KOG0671|consen 76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKF 151 (415)
T ss_pred CceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCce
Confidence 3434444434447889999999999999999974 445899999998742 233456678999999993 2 2
Q ss_pred eeeeeeEEEeeCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeC
Q 001494 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD 935 (1067)
Q Consensus 856 niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~ 935 (1067)
-+|.+.+||.-.++.++|+|.+ |.++.+++.... -.+++..++..|+.|++++++|||+. +++|.|+||+||++.
T Consensus 152 rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfv 226 (415)
T KOG0671|consen 152 RCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFV 226 (415)
T ss_pred EEEeeehhhhccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEe
Confidence 4788889999999999999988 458999996543 34588899999999999999999999 999999999999983
Q ss_pred C--------------------CCCeEEeccccceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHH
Q 001494 936 F--------------------KNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 995 (1067)
Q Consensus 936 ~--------------------~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell 995 (1067)
. +..+||+|||.|+.-... .+..+.|..|+|||++.+-..+.++||||+||||+|+.
T Consensus 227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred ccceEEEeccCCccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 1 234899999999875433 25678899999999999999999999999999999999
Q ss_pred hCCCCCCcccccccc-------chhhhhhhhhc------cCCCCCC-----------------C----CcchHHHHHHHH
Q 001494 996 KGKHPGDFISLISSS-------SLNLNIALDEI------LDPRLPI-----------------P----SHNVQEKLISFV 1041 (1067)
Q Consensus 996 tg~~p~~~~~~~~~~-------~~~~~~~~~~~------~~~~~~~-----------------~----~~~~~~~~~~l~ 1041 (1067)
||..-|...+..+.. +......+... ..+++.. | .....++..++.
T Consensus 304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 999887654422100 00000000000 0000000 0 001123445799
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 001494 1042 EVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1042 ~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+++++|+..||.+|+|+.|+++
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHccCccccccHHHHhc
Confidence 9999999999999999999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=290.09 Aligned_cols=243 Identities=27% Similarity=0.412 Sum_probs=185.9
Q ss_pred CCccCccccCCcee-EEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeEEEE
Q 001494 798 FDDEHCIGKGGQGS-VYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
|...+.+|.|+.|+ ||+|... |+.||||++-.. ...-..+|+..++.- +|||||++++.-.+....||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 44557789998876 5788887 889999998532 234456899999888 59999999999999999999999
Q ss_pred eccCCCHHHHhcccCc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC---CC--CeEEeccccce
Q 001494 876 YLEMGSLAMILSNDAA-AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF---KN--EARVSDFGIAK 949 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~---~~--~~kl~DfG~a~ 949 (1067)
.|.. +|.+++..... .........+.+..|+++|+++||+. +|||||+||+||||+. ++ .++|+|||+++
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9964 99999965311 11112244577889999999999998 9999999999999976 34 58999999999
Q ss_pred ecCCCCCc---cccccccccccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCccccccccchhhhhhhhhccCCC
Q 001494 950 FLKPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPGDFISLISSSSLNLNIALDEILDPR 1025 (1067)
Q Consensus 950 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1067)
.+..+... .....||.+|+|||++.....+.++||||+||++|+.++| .+||......+. .++...
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----------NIl~~~ 729 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----------NILTGN 729 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh----------hhhcCc
Confidence 98766443 3456789999999999999889999999999999999986 899863322111 111111
Q ss_pred CCCCC-cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1026 LPIPS-HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1026 ~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...-. ....+. +..++|.+|++++|..||+|.+|+.
T Consensus 730 ~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 730 YTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred cceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11100 000111 4789999999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=268.06 Aligned_cols=239 Identities=28% Similarity=0.446 Sum_probs=192.1
Q ss_pred CceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCCCHHHHh
Q 001494 808 GQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL 886 (1067)
Q Consensus 808 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l 886 (1067)
+||.||+|... +|+.+|+|++........ .+.+.+|++.+++++|+|++++++++......+++|||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999776 589999999875433221 578899999999999999999999999999999999999999999998
Q ss_pred cccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCcccccccccc
Q 001494 887 SNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG 966 (1067)
Q Consensus 887 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 966 (1067)
.... .+++..+..++.+++.+++|||+. +++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus 79 ~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 151 (244)
T smart00220 79 KKRG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE 151 (244)
T ss_pred Hhcc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence 5433 278899999999999999999999 99999999999999999999999999998765432 3344567889
Q ss_pred ccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHh
Q 001494 967 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAIS 1046 (1067)
Q Consensus 967 y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 1046 (1067)
|+|||...+..++.++||||+|+++|++++|..||+.... .................. ......++.+++.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~ 223 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-------LLELFKKIGKPKPPFPPP-EWKISPEAKDLIRK 223 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------HHHHHHHHhccCCCCccc-cccCCHHHHHHHHH
Confidence 9999999888889999999999999999999999864211 111111111111111111 00022358899999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 001494 1047 CLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1047 cl~~dP~~Rpt~~evl~ 1063 (1067)
|+..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=286.01 Aligned_cols=264 Identities=16% Similarity=0.203 Sum_probs=180.7
Q ss_pred hcCCCccCccccCCceeEEEEEE-----------------CCCcEEEEEEeCCCCCCChh-----------HHHHHHHHH
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-----------------ASGEIIAVKKFHSPLPGEMT-----------FQQEFLNEV 846 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~-----------~~~~~~~e~ 846 (1067)
.++|++.++||+|+||+||+|.. ..++.||||++......... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 46899999999999999999853 24567999998643221100 012234567
Q ss_pred HHHhcCCCCee-----eeeeEEEee--------CCceeEEEEeccCCCHHHHhcccCc---------------------c
Q 001494 847 KALTEIRHRNI-----VKFYGFCSH--------AQHSFIVYEYLEMGSLAMILSNDAA---------------------A 892 (1067)
Q Consensus 847 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~---------------------~ 892 (1067)
.++.+++|.++ ++++++|.. ++..|+||||+++++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 677777753 3578999999999999998863210 1
Q ss_pred CCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCc-cccccccccccCcc
Q 001494 893 EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN-WTELAGTYGYVAPE 971 (1067)
Q Consensus 893 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~gt~~y~aPE 971 (1067)
..+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||+++........ .....+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 2356778899999999999999999 9999999999999999999999999999765432211 11223478999999
Q ss_pred ccccCCC----------------------CccchhHHHHHHHHHHHhCCC-CCCccccccccchh---hhhhhhhccCCC
Q 001494 972 LAYTMKV----------------------TEKCDVYSFGVLALEVIKGKH-PGDFISLISSSSLN---LNIALDEILDPR 1025 (1067)
Q Consensus 972 ~~~~~~~----------------------~~~~DvwslGvil~elltg~~-p~~~~~~~~~~~~~---~~~~~~~~~~~~ 1025 (1067)
.+..... ..+.||||+||++|||++|.. |+............ .......+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 8754321 124799999999999999986 66532221111000 000111111112
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCC---CCCCCHHHHHH
Q 001494 1026 LPIPSHNVQEKLISFVEVAISCLDESP---ESRPTMQKVSQ 1063 (1067)
Q Consensus 1026 ~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rpt~~evl~ 1063 (1067)
...+ ..........+++.+++..+| .+|+|++|+++
T Consensus 461 ~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 YDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1111 112233457899999999765 68999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-31 Score=257.85 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=194.3
Q ss_pred CCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCC-----cee
Q 001494 798 FDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ-----HSF 871 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 871 (1067)
.+..+.||.|+||.||.++ -++|+.||.|++..... .....+.+.+|++++..++|.||...++...-.. +.|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq-~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ-NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHH-HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4556889999999999985 56899999999864322 2334577889999999999999999988765443 568
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+|+|.|. .+|..++- ....++...+.-+..||++|+.|||+. +|.||||||.|.|++.+-..||||||+|+..
T Consensus 134 V~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence 8999885 57777763 344588888899999999999999999 9999999999999999999999999999976
Q ss_pred CCC-CCccccccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccccccccch---------------hh
Q 001494 952 KPD-SSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSL---------------NL 1014 (1067)
Q Consensus 952 ~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~---------------~~ 1014 (1067)
..+ ...++..+-|..|+|||.+.+.+ |+.+.||||.|||+.|++.++.-|....+.+.... .-
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 544 34566777899999999988765 89999999999999999998887754433221100 00
Q ss_pred hhhhhhccCCCCCCCCc-------chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1015 NIALDEILDPRLPIPSH-------NVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
+.+...+++.....|.. .....-.+...+...++..||++|.+..+.+..
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 11112222222221110 001122346778889999999999998887653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=274.84 Aligned_cols=201 Identities=24% Similarity=0.340 Sum_probs=168.9
Q ss_pred CCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
-|...+.||-|+||+|.+++ ..+...||.|.+.+...-.......+..|-.|++..+.+-||+++-.|.+++.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 36677889999999999985 45567799998875433333445567889999999999999999999999999999999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec----
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL---- 951 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~---- 951 (1067)
|++||++-.++-+ .+.+.+..+..++.++..|+++.|.. |+|||||||+|||||.+|++|++|||+++-+
T Consensus 710 YIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999887743 34477788888899999999999999 9999999999999999999999999998532
Q ss_pred -----CCCCCc---------------------------------cccccccccccCccccccCCCCccchhHHHHHHHHH
Q 001494 952 -----KPDSSN---------------------------------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 993 (1067)
Q Consensus 952 -----~~~~~~---------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~e 993 (1067)
...+.. ....+||+.|+|||++....|+.-.|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 111000 013479999999999999999999999999999999
Q ss_pred HHhCCCCCCc
Q 001494 994 VIKGKHPGDF 1003 (1067)
Q Consensus 994 lltg~~p~~~ 1003 (1067)
|+.|+.||-.
T Consensus 864 m~~g~~pf~~ 873 (1034)
T KOG0608|consen 864 MLVGQPPFLA 873 (1034)
T ss_pred HhhCCCCccC
Confidence 9999999853
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=260.02 Aligned_cols=131 Identities=24% Similarity=0.448 Sum_probs=109.9
Q ss_pred cCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-----C---CeeeeeeEEEee
Q 001494 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-----H---RNIVKFYGFCSH 866 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~ 866 (1067)
.+|.+.++||.|-|++||++. ....+.||+|+.+.. ..+.+..+.||+++++++ | .+||+++++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 678899999999999999995 567889999999753 345567789999999884 2 489999999975
Q ss_pred C----CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceee
Q 001494 867 A----QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLL 934 (1067)
Q Consensus 867 ~----~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill 934 (1067)
. .+++||+|++ |.+|..++.....+ .++...+.+|++||+.||.|||++| ||||.||||+|||+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4 4899999998 45666666544333 3888999999999999999999998 99999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-29 Score=240.41 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=191.6
Q ss_pred HhcCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCC--c
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQ--H 869 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~ 869 (1067)
..++|++.+++|+|-+++||.|. ..+.+.++||+++.. ..+.+.+|++++..++ ||||++++++..+.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 34678999999999999999985 567888999998743 2467899999999996 999999999987764 6
Q ss_pred eeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC-CeEEeccccc
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN-EARVSDFGIA 948 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~-~~kl~DfG~a 948 (1067)
+.+|+||+.+.+..... ..++..++...+.++++||.|+|+. ||+|||+||.||+||... ..+++|+|+|
T Consensus 110 paLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred chhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence 78999999998877665 2377788889999999999999999 999999999999999765 5999999999
Q ss_pred eecCCCCCccccccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccc-----------chh---
Q 001494 949 KFLKPDSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLISSS-----------SLN--- 1013 (1067)
Q Consensus 949 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~elltg~~p~~~~~~~~~~-----------~~~--- 1013 (1067)
.++.+. ..+...+.+..|.-||.+...+ |+..-|+|||||++.+|+..+.||-......+. ...
T Consensus 181 EFYHp~-~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 181 EFYHPG-KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred hhcCCC-ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 988765 3344456667789999877654 899999999999999999999996321110000 000
Q ss_pred ------hhhhhhhccCCCCCCC------CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1014 ------LNIALDEILDPRLPIP------SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1014 ------~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
.......++......+ ++...-...++.+++.+.+..|-++|+||+|.++
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0000111111111111 1111111245889999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-29 Score=269.73 Aligned_cols=212 Identities=23% Similarity=0.338 Sum_probs=175.1
Q ss_pred cCcccHHHHHHHhcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHH-----HHHHHHHHHhcCC---
Q 001494 783 EGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQ-----EFLNEVKALTEIR--- 853 (1067)
Q Consensus 783 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~-----~~~~e~~~l~~l~--- 853 (1067)
++....+.......+|...+.+|.|+||.|+.|.++ +...|+||.+.+...-...+.+ .+-.||++|+.++
T Consensus 548 e~~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~s 627 (772)
T KOG1152|consen 548 EGNIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHS 627 (772)
T ss_pred cccccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcC
Confidence 333333433445567999999999999999998655 4667889988754322212221 2457999999997
Q ss_pred CCeeeeeeEEEeeCCceeEEEEecc-CCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCce
Q 001494 854 HRNIVKFYGFCSHAQHSFIVYEYLE-MGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNV 932 (1067)
Q Consensus 854 h~niv~l~~~~~~~~~~~lv~E~~~-~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Ni 932 (1067)
|+||++++++|++++.+|++||-.. +-+|.+++.. ...+++..+..|++|++.|+++||+. ||||||||-+||
T Consensus 628 H~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenv 701 (772)
T KOG1152|consen 628 HENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENV 701 (772)
T ss_pred ccchhhhhheeecCCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhcccccccc---CceecccccccE
Confidence 9999999999999999999999874 5588899843 34589999999999999999999999 999999999999
Q ss_pred eeCCCCCeEEeccccceecCCCCCccccccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCC
Q 001494 933 LLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPGD 1002 (1067)
Q Consensus 933 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~elltg~~p~~ 1002 (1067)
.++.+|-+|++|||.|.+... .....++||..|.|||++.+.+| +..-|||++|+++|-++....||-
T Consensus 702 ivd~~g~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 702 IVDSNGFVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEecCCeEEEeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999999977653 34467899999999999999887 667999999999999999888863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-29 Score=272.99 Aligned_cols=250 Identities=28% Similarity=0.417 Sum_probs=201.4
Q ss_pred cCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
++|+...++|.|.+|.|||++ ..+++..|||+++.....+ .+-..+|+.+++..+|||||.++|.+-..+..|+.|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 578888999999999999996 4689999999998654333 345668999999999999999999999999999999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+.+|+|.+..+- .+++++.++..+++...+|++|||+. |-+|||||-.||++++.|.+|++|||.+..+...
T Consensus 92 EycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999998854 34589999999999999999999999 8899999999999999999999999999888776
Q ss_pred CCccccccccccccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCC-CCccccccccchhhhhhhhh-ccCCCCCCC
Q 001494 955 SSNWTELAGTYGYVAPELA---YTMKVTEKCDVYSFGVLALEVIKGKHP-GDFISLISSSSLNLNIALDE-ILDPRLPIP 1029 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1029 (1067)
-.....+.||+.|||||+. ..+.|...+|||+.|+...|+---+.| |+.... ......... ...+.+..+
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-----r~l~LmTkS~~qpp~lkDk 240 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-----RALFLMTKSGFQPPTLKDK 240 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-----HHHHHhhccCCCCCcccCC
Confidence 6677789999999999964 355689999999999999999887777 332111 000111111 111222211
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
..+. ..+-+|++.|+.++|++||++..+++
T Consensus 241 -~kws---~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 -TKWS---EFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -ccch---HHHHHHHHHHhcCCCccCCChhhhee
Confidence 1222 24778999999999999999988764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=245.58 Aligned_cols=256 Identities=22% Similarity=0.331 Sum_probs=192.9
Q ss_pred cCCCccCccccCCceeEEEE-EECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeC------C
Q 001494 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA------Q 868 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 868 (1067)
.+|...+.+|.|+- .|..| ..-.+++||+|++..+... ....+...+|...+..+.|+|+++++.++.-. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 46777888999988 44444 4456889999998877444 33346677899999999999999999998543 3
Q ss_pred ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccc
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a 948 (1067)
..|+|||||.. ++...+. -.++-..+..|..|++.|+.|||+. ||+|||+||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 67999999964 7777764 2367788899999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccch----------------
Q 001494 949 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSL---------------- 1012 (1067)
Q Consensus 949 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~---------------- 1012 (1067)
+..... ..++..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.........
T Consensus 166 r~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 166 RTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred cccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 876544 456778889999999999998899999999999999999999987654332111000
Q ss_pred -----hhh--------hhhhhcc-CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1013 -----NLN--------IALDEIL-DPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1013 -----~~~--------~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
... ..+.+.+ |..++...+...-....+.+++.+||..+|++|.+++++++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000 0001111 11111111111112234789999999999999999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=242.14 Aligned_cols=212 Identities=33% Similarity=0.603 Sum_probs=184.4
Q ss_pred cccCCceeEEEEEECC-CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCCCH
Q 001494 804 IGKGGQGSVYKVELAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL 882 (1067)
Q Consensus 804 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 882 (1067)
||+|++|.||++.... ++.+++|++....... ..+.+.+|++.++.++|++++++++++......+++|||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 6899999999997754 8999999987543221 346789999999999999999999999999999999999999999
Q ss_pred HHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC-CCCeEEeccccceecCCCCCccccc
Q 001494 883 AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF-KNEARVSDFGIAKFLKPDSSNWTEL 961 (1067)
Q Consensus 883 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~ 961 (1067)
.+++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+.............
T Consensus 79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 99985432 3578999999999999999999999 9999999999999999 8999999999998765443223445
Q ss_pred cccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHH
Q 001494 962 AGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISF 1040 (1067)
Q Consensus 962 ~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1040 (1067)
.+...|++||..... .++.++|+|++|++++++ .++
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~ 190 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PEL 190 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHH
Confidence 678889999998877 788999999999999999 248
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1041 VEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1041 ~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
.+++..|++.+|++||++.++++.+
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhCC
Confidence 8999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-27 Score=249.11 Aligned_cols=211 Identities=22% Similarity=0.259 Sum_probs=173.7
Q ss_pred cCcccHHHHHHHhcCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC------CC
Q 001494 783 EGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR------HR 855 (1067)
Q Consensus 783 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~ 855 (1067)
+|.+.+.--.....+|.+..-.|+|-|++|..|.. .-|..||||++... ....+.=+.|++++++|. --
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~~AD~Edk~ 494 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLNDADPEDKF 494 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhhccCchhhh
Confidence 44444333334457899999999999999999954 45789999999742 223455578999999995 35
Q ss_pred eeeeeeEEEeeCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeC
Q 001494 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD 935 (1067)
Q Consensus 856 niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~ 935 (1067)
|+++++..|....++|+|||-+. -+|.++++..+..-.+....+..++.|+.-||..|... +|+|.||||.|||++
T Consensus 495 Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVN 570 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEec
Confidence 89999999999999999999885 58999998877777788999999999999999999988 999999999999999
Q ss_pred CCC-CeEEeccccceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001494 936 FKN-EARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDF 1003 (1067)
Q Consensus 936 ~~~-~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~ 1003 (1067)
+.. .+||||||.|....... .+....+.-|.|||.+.|.+|++..|+||.||+|||+.||+.-|.+
T Consensus 571 E~k~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred cCcceeeeccCcccccccccc--ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 875 48999999997765432 2233344569999999999999999999999999999999977643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=243.32 Aligned_cols=197 Identities=27% Similarity=0.412 Sum_probs=164.4
Q ss_pred HHHHhcCCCccCccccCCceeEEEEEEC----CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEe
Q 001494 791 IIRATNDFDDEHCIGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCS 865 (1067)
Q Consensus 791 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 865 (1067)
+....+.|..+++||+|.|++||++... ..+.||+|.+..... ...+..|++++..+ .+.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhc
Confidence 3345567899999999999999998543 467899999875432 35688999999999 5999999999999
Q ss_pred eCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC-CCCeEEec
Q 001494 866 HAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF-KNEARVSD 944 (1067)
Q Consensus 866 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~-~~~~kl~D 944 (1067)
..+...+|+||+++....++... ++..++..+++.+.+||+++|.. |||||||||.|++.+. .+.-.|+|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence 99999999999999999988843 66788899999999999999999 9999999999999974 47789999
Q ss_pred cccceecCC----------------C--CC--------------c------------cccccccccccCccccccC-CCC
Q 001494 945 FGIAKFLKP----------------D--SS--------------N------------WTELAGTYGYVAPELAYTM-KVT 979 (1067)
Q Consensus 945 fG~a~~~~~----------------~--~~--------------~------------~~~~~gt~~y~aPE~~~~~-~~~ 979 (1067)
||+|..... . +. . ....+||++|+|||++... ..+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 999972110 0 00 0 0124699999999988765 478
Q ss_pred ccchhHHHHHHHHHHHhCCCCC
Q 001494 980 EKCDVYSFGVLALEVIKGKHPG 1001 (1067)
Q Consensus 980 ~~~DvwslGvil~elltg~~p~ 1001 (1067)
+++||||.|||+..+++++.||
T Consensus 257 taiDiws~GVI~Lslls~~~PF 278 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPF 278 (418)
T ss_pred Cccceeeccceeehhhcccccc
Confidence 9999999999999999999997
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=234.44 Aligned_cols=199 Identities=32% Similarity=0.533 Sum_probs=171.2
Q ss_pred CCccCccccCCceeEEEEEECC-CcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVELAS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|+..+.||+|++|.||++.... ++.+|+|.+...... ...+.+..|++.+++++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 5667889999999999997764 899999999754332 2457888999999999999999999999999999999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCC-
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS- 955 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 955 (1067)
+++++|.+++..... .+++..+..++.+++.++++||+. +++|+|++|.||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 79 CEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 999999999864322 178899999999999999999999 99999999999999999999999999998776442
Q ss_pred CccccccccccccCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001494 956 SNWTELAGTYGYVAPELA-YTMKVTEKCDVYSFGVLALEVIKGKHPGDF 1003 (1067)
Q Consensus 956 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGvil~elltg~~p~~~ 1003 (1067)
.......++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122345677889999988 666778899999999999999999999863
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-27 Score=249.04 Aligned_cols=429 Identities=22% Similarity=0.270 Sum_probs=242.6
Q ss_pred ccCCCCCcccccceeecccCcCCCCCCcccCCcccCCceEecCcccccccCccccCccceeeEEEec-ccccccCCCccc
Q 001494 208 SIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYN-NSLSGLIPSEIG 286 (1067)
Q Consensus 208 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~ 286 (1067)
.+|..+. ..-.+++|..|+|+.+.|.+|+.+++|+.|||++|.|+.+-|++|.++.+|..|-+.+ |+|+.+.-..|+
T Consensus 60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~ 137 (498)
T KOG4237|consen 60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG 137 (498)
T ss_pred cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence 4554443 2455667777777766666677777777777777777766666777666666655544 666666555666
Q ss_pred cCCcccEEEeccccccCCccccccCCccccEEeccCCCCcCCCCcccccCCCCCeEEecCccccccCCccccCCCCCCeE
Q 001494 287 NLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVL 366 (1067)
Q Consensus 287 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 366 (1067)
++..|+.|.+.-|++.-...+.|..++++..|.+.+|.+..+....|..+..++.+.+..|.+. ...+++.+..
T Consensus 138 gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~- 211 (498)
T KOG4237|consen 138 GLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLAD- 211 (498)
T ss_pred hHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-----cccccchhhh-
Confidence 6666666666666666666666666666666666666666555556666666666666665531 0111211111
Q ss_pred EccCCcCccccCcccCCCCCCCEEEccCCcccccCCCccccc-cCCcE-EEcccCcCcccCchhhhCcCCCcEEeCCCCc
Q 001494 367 FIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNL-TNLSV-LSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQ 444 (1067)
Q Consensus 367 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 444 (1067)
+....|..++......-..+.++++..+.+..|... .++.. +....+....-....|+.+++|++|+|++|+
T Consensus 212 ------~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~ 285 (498)
T KOG4237|consen 212 ------DLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNK 285 (498)
T ss_pred ------HHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCc
Confidence 011223334444444555555555554444433222 12211 1112222222233467777788888888887
Q ss_pred ccCCCC-CCCCCCcccEEeccCcccccccccccccCCceeEEEcccccccCCCCCCCCCCCCcceEeccCCccCCCCCCc
Q 001494 445 FQGPIP-NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPK 523 (1067)
Q Consensus 445 l~~~~~-~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~ 523 (1067)
++.+.+ .|.+..++++|+|.+|+|..+....|.++..|+.|+|.+|+|+...|.+|.....|..|+|-.|.+. ..
T Consensus 286 i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~-Cn--- 361 (498)
T KOG4237|consen 286 ITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN-CN--- 361 (498)
T ss_pred cchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc-Cc---
Confidence 777544 4777777888888888888888888888888888888888888877888888888888887777653 00
Q ss_pred ccCCCCCcEE--EcCCCcccCcCcccccCCCccceeecccccccC---CccccccccccccEEEccCCCCCCCccccccc
Q 001494 524 IGYSSQLEVL--DLSSNHVVGDIPAELGKLSFLIKLILAQNQLSG---QLSPKLGLLVQLEHLDLSSNNLSNAIPESLGN 598 (1067)
Q Consensus 524 ~~~~~~L~~L--~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 598 (1067)
.+|..| .|..+.-.|.. ..++...++.+.++++.+.. ..++..+. .-++..|. .
T Consensus 362 ----C~l~wl~~Wlr~~~~~~~~--~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~------------~~s~~cP~---~ 420 (498)
T KOG4237|consen 362 ----CRLAWLGEWLRKKSVVGNP--RCQSPGFVRQIPISDVAFGDFRCGGPEELGC------------LTSSPCPP---P 420 (498)
T ss_pred ----cchHHHHHHHhhCCCCCCC--CCCCCchhccccchhccccccccCCccccCC------------CCCCCCCC---C
Confidence 111111 11222211111 12233345555555444331 11111100 00111111 1
Q ss_pred ccccc-eecccCcccccccchhhhhccccceeccccccCCCcchhhhhcccccccccccccccccccccccccCccccEE
Q 001494 599 LVKLH-YLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCI 677 (1067)
Q Consensus 599 l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~l 677 (1067)
++-+. ..-.|++.++ ..|..+. ..-.+|++.+|.++....+ .+.+| .+|+|+|+|+......|.++++|.+|
T Consensus 421 c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~~vp~~---~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tl 493 (498)
T KOG4237|consen 421 CTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAITSVPDE---LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTL 493 (498)
T ss_pred cchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhcccCHH---HHhhh-hcccccCceehhhcccccchhhhhee
Confidence 12222 2334444443 3333332 2345677777777544444 45666 78888888888888888899999999
Q ss_pred EcccC
Q 001494 678 DISYN 682 (1067)
Q Consensus 678 ~l~~N 682 (1067)
-+|||
T Consensus 494 ilsyn 498 (498)
T KOG4237|consen 494 ILSYN 498 (498)
T ss_pred EEecC
Confidence 99887
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=225.44 Aligned_cols=249 Identities=20% Similarity=0.297 Sum_probs=179.5
Q ss_pred hcCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeE-EEeeCCcee
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYG-FCSHAQHSF 871 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~~ 871 (1067)
.+.|.+.+.+|+|.||.+-.++++ +.+.+++|.+..+.. ..++|.+|..---.+ .|.||+..++ .|+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 456888999999999999999765 567899999876543 357888887765555 5999999886 467778888
Q ss_pred EEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeC-CC-CCeEEeccccce
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD-FK-NEARVSDFGIAK 949 (1067)
Q Consensus 872 lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~-~~-~~~kl~DfG~a~ 949 (1067)
+++||++.|+|..-+.. ..+-+....+++.|++.|+.|||++ ++||||||.+||||- .+ .++|+||||..+
T Consensus 99 F~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred EeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence 99999999999887743 3366778889999999999999999 999999999999993 33 469999999998
Q ss_pred ecCCCCCccccccccccccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC
Q 001494 950 FLKPDSSNWTELAGTYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP 1024 (1067)
Q Consensus 950 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1024 (1067)
..+.... ..--+..|.|||..... ...+.+|||.||+++|.++||+.||+... ..+..+...........+
T Consensus 172 k~g~tV~---~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 172 KVGTTVK---YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred ccCceeh---hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccCc
Confidence 7553322 22235569999965432 24678999999999999999999987322 222222222222222222
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 001494 1025 RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061 (1067)
Q Consensus 1025 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev 1061 (1067)
+.+ .........+.++.++-+..+|++|=...++
T Consensus 248 ~~P---~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 248 ALP---KKFNPFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred cCc---hhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence 221 1112222346677778889999998444443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-28 Score=250.06 Aligned_cols=405 Identities=24% Similarity=0.277 Sum_probs=245.5
Q ss_pred CcceEeccCCccccCCCCcccccCccceeecCCCcccCCCCcccccccccceecccc-cccccCCCCccccccccccccc
Q 001494 74 HLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFK-NQLSGSIPLEVGGLSSLNNLAL 152 (1067)
Q Consensus 74 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L 152 (1067)
....++|..|+|+...|.+|+.+.+|+.||||+|+|+.+-|..|.+|.+|..|-+-+ |+|+......|++|.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 467788888888877778888888888888888888888888888888887775555 8888655567888888888888
Q ss_pred cccccccccCCCccCCCcccEEEEeccCCcCccCC-ccccccccceecccccccccccCCCCCcccccceeecccCcCCC
Q 001494 153 YSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPS-EIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFG 231 (1067)
Q Consensus 153 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 231 (1067)
.-|++.-+..+.|..+++|..|.+.+|.+. .++. .|..+..++.+.+..|.+. ...+++.|.. ++.
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~-~~a------ 214 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLAD-DLA------ 214 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccc-----cccccchhhh-HHh------
Confidence 888888888888888888888888888887 5555 7888888888888888743 1222222221 111
Q ss_pred CCCcccCCcccCCceEecCcccccccCcccc-CccceeeEEEecccccccCC-CccccCCcccEEEeccccccCCccccc
Q 001494 232 SIPSELGNLKYLSDLKLADNKLNGSIPHSLC-NLTNLVILYIYNNSLSGLIP-SEIGNLKFLSKIALSYNKFSGLIPHSL 309 (1067)
Q Consensus 232 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~l 309 (1067)
..|.+++......-..+.++++...-+.-|. .+..+..=..+.+...+.-| ..|..+++|++|+|++|+++++-+.+|
T Consensus 215 ~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aF 294 (498)
T KOG4237|consen 215 MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAF 294 (498)
T ss_pred hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhh
Confidence 2233344444445555555555543333332 12222222222232332323 346667777777777777777666777
Q ss_pred cCCccccEEeccCCCCcCCCCcccccCCCCCeEEecCccccccCCccccCCCCCCeEEccCCcCc---------------
Q 001494 310 GNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLS--------------- 374 (1067)
Q Consensus 310 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--------------- 374 (1067)
.++..+++|+|..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+..|.+|++-.|.+.
T Consensus 295 e~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~ 374 (498)
T KOG4237|consen 295 EGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKK 374 (498)
T ss_pred cchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhC
Confidence 77777777777777776666666777777777777777777666777777777777776666543
Q ss_pred ---cccCcccCCCCCCCEEEccCCcccc---cCCCccccccCCcEEEcccCcCcccCchhhhCcCCCcE-EeCCCCcccC
Q 001494 375 ---GSIPCEIGNLKSLSYLNLAFNKLTS---SIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTK-LFLGDNQFQG 447 (1067)
Q Consensus 375 ---~~~p~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~-L~L~~N~l~~ 447 (1067)
|..|.. .-..++.+.++++.+.. ..|+..+-.+ ++.-| ...+.+.+ ..-|+..+..
T Consensus 375 ~~~~~~~Cq--~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~------------s~~cP---~~c~c~~tVvRcSnk~lk~ 437 (498)
T KOG4237|consen 375 SVVGNPRCQ--SPGFVRQIPISDVAFGDFRCGGPEELGCLT------------SSPCP---PPCTCLDTVVRCSNKLLKL 437 (498)
T ss_pred CCCCCCCCC--CCchhccccchhccccccccCCccccCCCC------------CCCCC---CCcchhhhhHhhcccchhh
Confidence 111110 11233444444443321 1111110000 00001 11122221 2233333333
Q ss_pred CCCCCCCCCcccEEeccCcccccccccccccCCceeEEEcccccccCCCCCCCCCCCCcceEeccCC
Q 001494 448 PIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKN 514 (1067)
Q Consensus 448 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N 514 (1067)
.++.+. ....++++.+|.++.++.+ .+..| .+|+|+|+|.......|.++..|.+|-+|+|
T Consensus 438 lp~~iP--~d~telyl~gn~~~~vp~~---~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 438 LPRGIP--VDVTELYLDGNAITSVPDE---LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred cCCCCC--chhHHHhcccchhcccCHH---HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 322221 2345677777777777776 33445 7788888877666667777777777777765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=281.14 Aligned_cols=349 Identities=25% Similarity=0.298 Sum_probs=222.9
Q ss_pred ccCCcCCCCCCcceEeccCCc------cccCCCCcccccC-ccceeecCCCcccCCCCcccccccccceecccccccccC
Q 001494 64 LHDFSFSSFPHLAYLDLWSNQ------LFGNIPPQIGNIS-KLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGS 136 (1067)
Q Consensus 64 l~~~~~~~~~~l~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 136 (1067)
++...|..+.+|+.|.+..+. +...+|..|..++ +|+.|++.++.+. .+|..| .+.+|++|+|++|++. .
T Consensus 549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~ 625 (1153)
T PLN03210 549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-K 625 (1153)
T ss_pred ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-c
Confidence 445567888888888886553 3345677776663 5888888888776 667766 4677888888888876 5
Q ss_pred CCCccccccccccccccccccccccCCCccCCCcccEEEEeccCCcCccCCccccccccceecccccccccccCCCCCcc
Q 001494 137 IPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNL 216 (1067)
Q Consensus 137 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 216 (1067)
+|..+..+++|+.|+|+++.....+| .++.+++|+.|+|++|.....+|..++++++|+.|++++|..-+.+|..+ ++
T Consensus 626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l 703 (1153)
T PLN03210 626 LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL 703 (1153)
T ss_pred cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence 77777778888888887765444455 36777788888887776555777777777778888877765444666655 67
Q ss_pred cccceeecccCcCCCCCCcccCCcccCCceEecCcccccccCccccCccceeeEEEecccccccCCCccccCCcccEEEe
Q 001494 217 SNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIAL 296 (1067)
Q Consensus 217 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 296 (1067)
++|+.|++++|...+.+|.. ..+|+.|++++|.+. .+|..+ .+++|+.|++.++..... +.
T Consensus 704 ~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l-~~------------- 764 (1153)
T PLN03210 704 KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKL-WE------------- 764 (1153)
T ss_pred CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhc-cc-------------
Confidence 77777777777655455543 245667777777765 455544 456666666655432211 00
Q ss_pred ccccccCCccccccCCccccEEeccCCCCcCCCCcccccCCCCCeEEecCccccccCCccccCCCCCCeEEccCCcCccc
Q 001494 297 SYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGS 376 (1067)
Q Consensus 297 s~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 376 (1067)
.+....+..+...++|+.|++++|...+.+|..++++++|+.|++++|...+.+|..+ ++++|+.|++++|.....
T Consensus 765 ---~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~ 840 (1153)
T PLN03210 765 ---RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRT 840 (1153)
T ss_pred ---cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccc
Confidence 0111111122233556666666666666666666666667777776654333555544 566777777776654434
Q ss_pred cCcccCCCCCCCEEEccCCcccccCCCccccccCCcEEEcccCcCcccCchhhhCcCCCcEEeCCCCc
Q 001494 377 IPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQ 444 (1067)
Q Consensus 377 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 444 (1067)
+|.. ..+|++|+|++|.|+ .+|.++..+++|++|++++|+--..+|..+..++.|+.+++++|.
T Consensus 841 ~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 841 FPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 4432 256777777777776 566777777777777777743222455566777777777777764
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=275.68 Aligned_cols=305 Identities=25% Similarity=0.253 Sum_probs=190.0
Q ss_pred cccccccccccccccCCCccCCCcccEEEEeccCCcCccCCccccccccceecccccccccccCCCCCcccccceeeccc
Q 001494 147 LNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSS 226 (1067)
Q Consensus 147 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 226 (1067)
|+.|++.++.+.. +|..| ...+|+.|++++|++. .+|..+..+++|+.|+|+++...+.+|. ++.+++|+.|+|++
T Consensus 591 Lr~L~~~~~~l~~-lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLRC-MPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCCC-CCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecC
Confidence 4444444444433 23333 2345555555555554 3444455555555555554433234442 44455555555555
Q ss_pred CcCCCCCCcccCCcccCCceEecCcccccccCccccCccceeeEEEecccccccCCCccccCCcccEEEeccccccCCcc
Q 001494 227 NSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIP 306 (1067)
Q Consensus 227 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 306 (1067)
|.....+|..++++++|+.|++++|...+.+|..+ ++++|+.|++++|...+.+|.. .++|+.|++++|.+... |
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~l-P 741 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEF-P 741 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccc-c
Confidence 54444455555555555555555543333444433 4555555555555443333332 23455555555555432 3
Q ss_pred ccccCCccccEEeccCCCC-------cCCCCcccccCCCCCeEEecCccccccCCccccCCCCCCeEEccCCcCccccCc
Q 001494 307 HSLGNLSNIAFLFLDSNSL-------FGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPC 379 (1067)
Q Consensus 307 ~~l~~l~~L~~L~L~~N~l-------~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 379 (1067)
..+ .+++|++|.+.++.. ....+..+...++|+.|++++|...+.+|..++++++|+.|++++|...+.+|.
T Consensus 742 ~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~ 820 (1153)
T PLN03210 742 SNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT 820 (1153)
T ss_pred ccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC
Confidence 322 345555555554321 122222334457899999999988888999999999999999999865557887
Q ss_pred ccCCCCCCCEEEccCCcccccCCCccccccCCcEEEcccCcCcccCchhhhCcCCCcEEeCCC-CcccCCCCCCCCCCcc
Q 001494 380 EIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGD-NQFQGPIPNLKNLTSL 458 (1067)
Q Consensus 380 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~l~~l~~L 458 (1067)
.+ .+++|++|++++|.....+|.. .++|+.|+|++|.|+ .+|..+..+++|++|+|++ |.+...+.....+++|
T Consensus 821 ~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L 895 (1153)
T PLN03210 821 GI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHL 895 (1153)
T ss_pred CC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCC
Confidence 66 7899999999998665555543 468999999999998 5788999999999999998 5666666667788889
Q ss_pred cEEeccCc
Q 001494 459 VRVHLDRN 466 (1067)
Q Consensus 459 ~~L~L~~N 466 (1067)
+.++++++
T Consensus 896 ~~L~l~~C 903 (1153)
T PLN03210 896 ETVDFSDC 903 (1153)
T ss_pred CeeecCCC
Confidence 98888765
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=272.12 Aligned_cols=194 Identities=17% Similarity=0.188 Sum_probs=139.7
Q ss_pred cCCC-CeeeeeeEEE-------eeCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 001494 851 EIRH-RNIVKFYGFC-------SHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922 (1067)
Q Consensus 851 ~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 922 (1067)
.++| +||+++++++ .+.+.++.+|||+ +++|.+++... ...+++.+++.++.||++||+|||++ ||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4456 6888888877 2334677889987 56999999532 34589999999999999999999999 99
Q ss_pred eecCCCCCceeeCC-------------------CCCeEEeccccceecCCCC----------------Cccccccccccc
Q 001494 923 VHRDISSKNVLLDF-------------------KNEARVSDFGIAKFLKPDS----------------SNWTELAGTYGY 967 (1067)
Q Consensus 923 vHrDlk~~Nill~~-------------------~~~~kl~DfG~a~~~~~~~----------------~~~~~~~gt~~y 967 (1067)
+||||||+|||++. ++.+|++|||+++...... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456667777665422100 001123578899
Q ss_pred cCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhc
Q 001494 968 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISC 1047 (1067)
Q Consensus 968 ~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 1047 (1067)
||||++.+..++.++|||||||++|||++|..|+...... ..........+.. .....+...++.+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~------~~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 248 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT------MSSLRHRVLPPQI-------LLNWPKEASFCLWL 248 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH------HHHHHHhhcChhh-------hhcCHHHHHHHHHh
Confidence 9999999999999999999999999999998886422110 0000111111110 11122356788899
Q ss_pred cCCCCCCCCCHHHHHH
Q 001494 1048 LDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1048 l~~dP~~Rpt~~evl~ 1063 (1067)
|+++|.+||+|.|+++
T Consensus 249 L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 249 LHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCCChhhCcChHHHhh
Confidence 9999999999999976
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=214.11 Aligned_cols=165 Identities=25% Similarity=0.287 Sum_probs=124.2
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccc
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 959 (1067)
|+|.++++.. ...+++.++..++.|++.||+|||++ + ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888888542 34589999999999999999999999 6 999999999999999 99998765432
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHH-
Q 001494 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLI- 1038 (1067)
Q Consensus 960 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1038 (1067)
..||+.|||||++.+..++.++|||||||++|||+||+.||........ ........... ..............
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~ 138 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA---ILEILLNGMPA-DDPRDRSNLESVSAA 138 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH---HHHHHHHHhcc-CCccccccHHHHHhh
Confidence 2678999999999999999999999999999999999999864332111 11111111111 10100011112222
Q ss_pred -HHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1039 -SFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1039 -~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
++.+++.+||+.+|++||++.|+++.+.
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 5899999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-23 Score=246.46 Aligned_cols=266 Identities=29% Similarity=0.397 Sum_probs=152.6
Q ss_pred cceeecCCCcccCCCCcccccccccceecccccccccCCCCccccccccccccccccccccccCCCccCCCcccEEEEec
Q 001494 99 LKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYN 178 (1067)
Q Consensus 99 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 178 (1067)
-..|||++|+++ .+|+.+. ++|+.|++++|+++ .+|.. +++|++|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---------------------------p~~Lk~LdLs~ 251 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---------------------------PPELRTLEVSG 251 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---------------------------CCCCcEEEecC
Confidence 345556665555 4555443 24555555555555 23321 23455555555
Q ss_pred cCCcCccCCccccccccceecccccccccccCCCCCcccccceeecccCcCCCCCCcccCCcccCCceEecCcccccccC
Q 001494 179 NLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIP 258 (1067)
Q Consensus 179 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 258 (1067)
|+|+ .+|.. .++|+.|+|++|.++ .+|..+ ++|+.|++++|+++ .+|.. .++|+.|+|++|++++ +|
T Consensus 252 N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp 318 (788)
T PRK15387 252 NQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LP 318 (788)
T ss_pred CccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CC
Confidence 5554 33332 234445555555554 333322 23445555555555 23332 2345555555555553 33
Q ss_pred ccccCccceeeEEEecccccccCCCccccCCcccEEEeccccccCCccccccCCccccEEeccCCCCcCCCCcccccCCC
Q 001494 259 HSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKS 338 (1067)
Q Consensus 259 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 338 (1067)
... .+|+.|++++|+++++ |.. ..+|+.|+|++|+|+++ |.. ..+|+.|++++|+|..+ |.. ..+
T Consensus 319 ~lp---~~L~~L~Ls~N~L~~L-P~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~L-P~l---~~~ 383 (788)
T PRK15387 319 ALP---SELCKLWAYNNQLTSL-PTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTSL-PAL---PSG 383 (788)
T ss_pred CCc---ccccccccccCccccc-ccc---ccccceEecCCCccCCC-CCC---CcccceehhhccccccC-ccc---ccc
Confidence 221 2355555666666542 321 13566666666666643 222 23456666777776643 332 246
Q ss_pred CCeEEecCccccccCCccccCCCCCCeEEccCCcCccccCcccCCCCCCCEEEccCCcccccCCCccccccCCcEEEccc
Q 001494 339 LSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYK 418 (1067)
Q Consensus 339 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 418 (1067)
|+.|++++|+|++ +|.. .++|+.|++++|.+++ +|... .+|+.|++++|+|+ .+|..+.++++|+.|+|++
T Consensus 384 L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 384 LKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred cceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 7788888888874 4443 2568888888888884 56432 46788899999988 6788888899999999999
Q ss_pred CcCcccCchhhhCc
Q 001494 419 NSLSGAIPKEYRNL 432 (1067)
Q Consensus 419 N~l~~~~~~~~~~l 432 (1067)
|++++..+..+..+
T Consensus 455 N~Ls~~~~~~L~~l 468 (788)
T PRK15387 455 NPLSERTLQALREI 468 (788)
T ss_pred CCCCchHHHHHHHH
Confidence 99988877776544
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=244.55 Aligned_cols=260 Identities=28% Similarity=0.344 Sum_probs=207.0
Q ss_pred cccccccccccccccCCCccCCCcccEEEEeccCCcCccCCccccccccceecccccccccccCCCCCcccccceeeccc
Q 001494 147 LNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSS 226 (1067)
Q Consensus 147 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 226 (1067)
-..|+|+.|.++. +|..+. ++|+.|++++|+++ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCCc-CCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 4556777777765 555554 47899999999998 57753 578999999999999 56754 35889999999
Q ss_pred CcCCCCCCcccCCcccCCceEecCcccccccCccccCccceeeEEEecccccccCCCccccCCcccEEEeccccccCCcc
Q 001494 227 NSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIP 306 (1067)
Q Consensus 227 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 306 (1067)
|.++ .+|..+ +.|+.|++++|+++ .+|.. +++|+.|+|++|+++++ |... .+|+.|++++|+++++ |
T Consensus 272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~L-p~lp---~~L~~L~Ls~N~L~~L-P 338 (788)
T PRK15387 272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASL-PALP---SELCKLWAYNNQLTSL-P 338 (788)
T ss_pred Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCccccC-CCCc---ccccccccccCccccc-c
Confidence 9998 456543 56889999999999 56653 47899999999999975 5432 4688899999999864 4
Q ss_pred ccccCCccccEEeccCCCCcCCCCcccccCCCCCeEEecCccccccCCccccCCCCCCeEEccCCcCccccCcccCCCCC
Q 001494 307 HSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKS 386 (1067)
Q Consensus 307 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 386 (1067)
.. ..+|++|+|++|+|+++ |.. ..+|+.|++++|+|+. +|.. ..+|+.|++++|.|++ +|.. .++
T Consensus 339 ~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~ 403 (788)
T PRK15387 339 TL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSE 403 (788)
T ss_pred cc---ccccceEecCCCccCCC-CCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccC
Confidence 32 25799999999999975 433 3578899999999995 6653 3579999999999994 5643 368
Q ss_pred CCEEEccCCcccccCCCccccccCCcEEEcccCcCcccCchhhhCcCCCcEEeCCCCcccCCCC
Q 001494 387 LSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIP 450 (1067)
Q Consensus 387 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 450 (1067)
|+.|++++|+|++ +|.. ..+|+.|++++|+|+ .+|..+.++.+|+.|+|++|++++..+
T Consensus 404 L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~ 462 (788)
T PRK15387 404 LKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL 462 (788)
T ss_pred CCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHH
Confidence 9999999999985 6654 357889999999998 678999999999999999999987543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=224.22 Aligned_cols=166 Identities=20% Similarity=0.226 Sum_probs=129.8
Q ss_pred HhcCCCccCccccCCceeEEEEEEC--CCcEEEEEEeCCCCC--CChhHHHHHHHHHHHHhcCCCCeeee-eeEEEeeCC
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELA--SGEIIAVKKFHSPLP--GEMTFQQEFLNEVKALTEIRHRNIVK-FYGFCSHAQ 868 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~ 868 (1067)
....|...+.||+|+||+||+|+.. +++.||||+...... ......+.+.+|++++++++|+|+++ +++ .+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence 4567999999999999999999764 578889998753211 12223567899999999999999985 443 25
Q ss_pred ceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCceeeCCCCCeEEecccc
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDI-SSKNVLLDFKNEARVSDFGI 947 (1067)
Q Consensus 869 ~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDl-k~~Nill~~~~~~kl~DfG~ 947 (1067)
..|+||||++|++|.... ... ...++.++++|++|||++ ||+|||| ||+||+++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 689999999999997321 101 146788999999999999 9999999 99999999999999999999
Q ss_pred ceecCCCCCc--------cccccccccccCccccccC
Q 001494 948 AKFLKPDSSN--------WTELAGTYGYVAPELAYTM 976 (1067)
Q Consensus 948 a~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~ 976 (1067)
|+.+...... .+...+++.|+|||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9977543311 1345678889999987644
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=204.00 Aligned_cols=254 Identities=17% Similarity=0.225 Sum_probs=196.1
Q ss_pred cCCCccCccccCCceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCceeEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 873 (1067)
-.|+++++||+|.||+++.|+ +-++++||||.-.... ...++..|.+..+.| ..++|...+-+..++.+-.+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 468999999999999999985 5689999999865321 235678899999888 479999999888888899999
Q ss_pred EEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCC-----eEEeccccc
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNE-----ARVSDFGIA 948 (1067)
Q Consensus 874 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~-----~kl~DfG~a 948 (1067)
+|.+ |.+|+|... -....++..++..||.|+..-++|+|++ ..|.|||||+|+||...+. +.|+|||+|
T Consensus 103 idLL-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhh-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9988 678988883 3445689999999999999999999999 9999999999999986653 889999999
Q ss_pred eecCCCCC-------ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhc
Q 001494 949 KFLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEI 1021 (1067)
Q Consensus 949 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1021 (1067)
+.+.++.. ......||.+||+-....+.+.+.+.|.-|+|-++++++.|..||.+..... ..+..+.+
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-----nK~kYeKI 251 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-----NKEKYEKI 251 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc-----hHHHHHHh
Confidence 98865432 2346789999999999999999999999999999999999999998765421 11122222
Q ss_pred cCCCCCCCC-cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1022 LDPRLPIPS-HNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1022 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
-+....-+. ......+.++...+.-.-..+-.+-|+++-+...+
T Consensus 252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf 296 (449)
T KOG1165|consen 252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLF 296 (449)
T ss_pred ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 222222121 22223344566666666667777778876655443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=221.64 Aligned_cols=254 Identities=22% Similarity=0.261 Sum_probs=188.3
Q ss_pred CCCccCccccCCceeEEEEEECCC--cEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC----CCeeeeeeEEE-eeCCc
Q 001494 797 DFDDEHCIGKGGQGSVYKVELASG--EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR----HRNIVKFYGFC-SHAQH 869 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~l~~~~-~~~~~ 869 (1067)
+|.+.++||+|+||.||.|..... +.+|+|.......... ..+..|+.++..+. -+++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 799999999999999999976543 5789888765422211 15667888888776 26899999998 57778
Q ss_pred eeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC-----CeEEec
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN-----EARVSD 944 (1067)
Q Consensus 870 ~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~-----~~kl~D 944 (1067)
.|+||+.+ |.+|.++..... ...++..++.+|+.|++.+|+++|+. |++||||||.|+.+.... .+.+.|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 99999987 679999875444 56799999999999999999999999 999999999999998663 589999
Q ss_pred cccce--ecCCCCC--------ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhh
Q 001494 945 FGIAK--FLKPDSS--------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL 1014 (1067)
Q Consensus 945 fG~a~--~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~ 1014 (1067)
||+|+ .+..... ......||..|++++...+...+.+.|+||++.++.|+..|..||.............
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99998 3322211 1234569999999999999999999999999999999999999975444221111111
Q ss_pred hhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001494 1015 NIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1015 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L 1065 (1067)
.......... .....+. ++.++...+-..+..++|.+..+.+.+
T Consensus 251 ~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 251 KDPRKLLTDR----FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred HHhhhhcccc----ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 1111111111 0111112 355555566668999999999888765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=196.81 Aligned_cols=257 Identities=20% Similarity=0.294 Sum_probs=198.6
Q ss_pred hcCCCccCccccCCceeEEEE-EECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCCceeE
Q 001494 795 TNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 872 (1067)
...|..+++||.|+||.+|.| ...+|+.||||+-..... ..++..|.++.+.++ -..|+.+..|..++..-.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 367999999999999999998 467899999999764322 245778999999886 4788888888899999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC---CCeEEeccccce
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK---NEARVSDFGIAK 949 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~---~~~kl~DfG~a~ 949 (1067)
|||.. |.+|++...- ....++..+++-.+-|++.-++|+|.+ +++||||||+|+|+.-+ ..+.++|||+|+
T Consensus 89 VMdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 99988 6799988842 334578889999999999999999999 89999999999999754 358899999998
Q ss_pred ecCCCCC-------ccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhcc
Q 001494 950 FLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL 1022 (1067)
Q Consensus 950 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1022 (1067)
.+.+... .-....||.+|.+-....+...+.+.|+-|+|.++.++-.|..||++...... .+..+.+.
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-----~QKyEkI~ 237 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-----KQKYEKIS 237 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-----HHHHHHHH
Confidence 7754322 22457899999998888888889999999999999999999999987654321 12222222
Q ss_pred CCCCCCCCcc-hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 001494 1023 DPRLPIPSHN-VQEKLISFVEVAISCLDESPESRPTMQKVSQLLKI 1067 (1067)
Q Consensus 1023 ~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~~ 1067 (1067)
...+..+.+. ....+.++.-.+.-|-..--++-|+..-+.+.+++
T Consensus 238 EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 238 EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 2333322221 12233457777788888888888888888777653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-23 Score=203.89 Aligned_cols=247 Identities=21% Similarity=0.315 Sum_probs=186.7
Q ss_pred CCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEec
Q 001494 798 FDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYL 877 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 877 (1067)
.....+|.+...|+.|+|+++.+ .+++|++..... ..+..++|.+|.-.++-+.||||..++|.|.......++..||
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGN-DIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccccccCc-chhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 34456788999999999999844 455676654322 2223467888999999999999999999999999999999999
Q ss_pred cCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCee-ecCCCCCceeeCCCCCeEEe--ccccceecCCC
Q 001494 878 EMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIV-HRDISSKNVLLDFKNEARVS--DFGIAKFLKPD 954 (1067)
Q Consensus 878 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv-HrDlk~~Nill~~~~~~kl~--DfG~a~~~~~~ 954 (1067)
+-|+|+..+++... --.+..++.+++.++|+|++|||+.. +++ ---+.+..|++|++.+++|+ |--++.+.
T Consensus 270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsfqe--- 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--- 343 (448)
T ss_pred cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeeeec---
Confidence 99999999976443 33677899999999999999999983 444 34688999999999988874 33333211
Q ss_pred CCccccccccccccCccccccCCCC---ccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCc
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVT---EKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031 (1067)
Q Consensus 955 ~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1067)
....-.|.||+||.+...+.+ .++|+|||++++||+-|+..||...++.+...... ...-+..+|+.
T Consensus 344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------leglrv~ippg 413 (448)
T KOG0195|consen 344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------LEGLRVHIPPG 413 (448)
T ss_pred ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------hccccccCCCC
Confidence 112336789999999877643 47999999999999999999998777654322111 11123334443
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
... .+.+++.-|+..||.+||.+..++-.||
T Consensus 414 is~----hm~klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 414 ISR----HMNKLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred ccH----HHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence 333 4888999999999999999999987775
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-22 Score=241.88 Aligned_cols=279 Identities=24% Similarity=0.383 Sum_probs=193.3
Q ss_pred CccceeecCCCcccCCCCcccccccccceecccccccccCCCCccccccccccccccccccccccCCCccCCCcccEEEE
Q 001494 97 SKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCL 176 (1067)
Q Consensus 97 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 176 (1067)
.+...|++++++++ .+|..+. +.|+.|+|++|+++ .+|..+. .+|+.|++++|.+++ +|..+. .+|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEEC
Confidence 34677888888777 5676553 46788888888887 5666554 478888888888876 454443 46888888
Q ss_pred eccCCcCccCCccccccccceecccccccccccCCCCCcccccceeecccCcCCCCCCcccCCcccCCceEecCcccccc
Q 001494 177 YNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGS 256 (1067)
Q Consensus 177 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 256 (1067)
++|+++ .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|+|++|+|++ +|..+. ++|+.|++++|+++ .
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt-~ 318 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLT-A 318 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccc-c
Confidence 888887 6777664 47888888888888 5676664 478888888888884 555443 46888888888888 4
Q ss_pred cCccccCccceeeEEEecccccccCCCccccCCcccEEEeccccccCCccccccCCccccEEeccCCCCcCCCCcccccC
Q 001494 257 IPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNL 336 (1067)
Q Consensus 257 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 336 (1067)
+|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+|+. +|..+. ++|+.|++++|+++.+ |..+.
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt~L-P~~l~-- 387 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--PTITTLDVSRNALTNL-PENLP-- 387 (754)
T ss_pred CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--CCcCEEECCCCcCCCC-CHhHH--
Confidence 565443 578888888888886 455443 688888999888874 455543 5788899999988865 44443
Q ss_pred CCCCeEEecCccccccCCcc----ccCCCCCCeEEccCCcCccccCcccCCCCCCCEEEccCCcccc-cCCCccccccCC
Q 001494 337 KSLSILELGNNKLCGSIPHF----LGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTS-SIPISLSNLTNL 411 (1067)
Q Consensus 337 ~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L 411 (1067)
.+|+.|++++|+++ .+|.. ++.++++..|++.+|.++. ..+.+|+.| ++.+.+.| .++...+.+.++
T Consensus 388 ~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l 459 (754)
T PRK15370 388 AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIV 459 (754)
T ss_pred HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCcccccccccccc
Confidence 36888899999988 44543 3445788899999998872 234445555 34454443 233344444544
Q ss_pred cE
Q 001494 412 SV 413 (1067)
Q Consensus 412 ~~ 413 (1067)
+.
T Consensus 460 ~~ 461 (754)
T PRK15370 460 RV 461 (754)
T ss_pred cc
Confidence 44
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-22 Score=238.59 Aligned_cols=255 Identities=19% Similarity=0.253 Sum_probs=188.6
Q ss_pred CccCccccCCceeEEEEE-ECCCcEEEEEEeCC---CCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 799 DDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHS---PLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 799 ~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
...+++|.|++|.|+.+. ....+..+.|.+.. +...+......+..|..+-..++|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 356789999999888764 33444455554431 22223333334777888889999999998888777777666669
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
||+++ +|..++... ..+...++..+++|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999888543 3477888899999999999999999 9999999999999999999999999999876544
Q ss_pred CC----ccccccccccccCccccccCCCCc-cchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCC
Q 001494 955 SS----NWTELAGTYGYVAPELAYTMKVTE-KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029 (1067)
Q Consensus 955 ~~----~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1067)
.. .....+|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||.......... ..............+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSDQRNIFEGP 550 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhccccccccccCh
Confidence 32 345678999999999999999876 6899999999999999999975333211110 000000000011112
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...........+.++.+++++||.+|.|+.+|++
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 2223344456789999999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-20 Score=210.89 Aligned_cols=260 Identities=27% Similarity=0.410 Sum_probs=197.6
Q ss_pred CCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCC-eeeeeeEEEeeCCceeEEEEe
Q 001494 798 FDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR-NIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~ 876 (1067)
|...+.||.|+||.||++... ..+|+|.+.............+.+|+.+++.+.|+ +++++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567788999999999999777 78899999766544433567899999999999988 799999999777778999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCC-CeEEeccccceecCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN-EARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~-~~kl~DfG~a~~~~~~~ 955 (1067)
+.++++.+++........+.......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997775432113578889999999999999999999 999999999999999998 69999999998665443
Q ss_pred C------ccccccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCC--
Q 001494 956 S------NWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP-- 1024 (1067)
Q Consensus 956 ~------~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 1024 (1067)
. ......|+..|+|||.+.+ ..+....|+||+|++++++++|..||........ .............+
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA-TSQTLKIILELPTPSL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc-HHHHHHHHHhcCCccc
Confidence 2 2456789999999999887 5788999999999999999999999654432100 00001111111111
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1025 RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1025 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
...............+.+++..|+..+|..|.++.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 000000000112235788999999999999999887654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=234.81 Aligned_cols=264 Identities=24% Similarity=0.391 Sum_probs=201.7
Q ss_pred cccceecccccccccCCCCccccccccccccccccccccccCCCccCCCcccEEEEeccCCcCccCCccccccccceecc
Q 001494 121 SYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNL 200 (1067)
Q Consensus 121 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 200 (1067)
.+...|+++++.++ .+|..+. ++|+.|+|++|.++. +|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 35678999999988 5777664 579999999999997 455443 58999999999998 6777664 47999999
Q ss_pred cccccccccCCCCCcccccceeecccCcCCCCCCcccCCcccCCceEecCcccccccCccccCccceeeEEEeccccccc
Q 001494 201 YNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGL 280 (1067)
Q Consensus 201 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 280 (1067)
++|+++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|+++.+
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~L 319 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTAL 319 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccC
Confidence 999998 6787665 57999999999998 5777664 47999999999998 4666553 4789999999999864
Q ss_pred CCCccccCCcccEEEeccccccCCccccccCCccccEEeccCCCCcCCCCcccccCCCCCeEEecCccccccCCccccCC
Q 001494 281 IPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNL 360 (1067)
Q Consensus 281 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 360 (1067)
|..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|+++. +|..+.
T Consensus 320 -P~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~-- 387 (754)
T PRK15370 320 -PETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--PTITTLDVSRNALTN-LPENLP-- 387 (754)
T ss_pred -Cccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--CCcCEEECCCCcCCC-CCHhHH--
Confidence 5443 2689999999999987 455553 689999999999985 455553 689999999999984 555554
Q ss_pred CCCCeEEccCCcCccccCccc----CCCCCCCEEEccCCcccccCCCccccccCCcEEEcccCcCc
Q 001494 361 TNLSVLFIYNNSLSGSIPCEI----GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLS 422 (1067)
Q Consensus 361 ~~L~~L~l~~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 422 (1067)
..|+.|++++|+++ .+|..+ ..++++..|++.+|+++. ..+.+|+.| ++.+.+.
T Consensus 388 ~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~ 445 (754)
T PRK15370 388 AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQ 445 (754)
T ss_pred HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhccccc
Confidence 36889999999998 455543 445788999999999873 344455555 3444443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=192.92 Aligned_cols=174 Identities=14% Similarity=0.165 Sum_probs=135.8
Q ss_pred HhcCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHH------HHHHHHHHhcCCCCeeeeeeEEEeeC
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQE------FLNEVKALTEIRHRNIVKFYGFCSHA 867 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~niv~l~~~~~~~ 867 (1067)
...+|+..+++|.|+||.||.++. ++..+|+|.+...........+. +.+|+..+.++.||+|+.+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999866 57789999998665544433333 57899999999999999999886543
Q ss_pred --------CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCC
Q 001494 868 --------QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNE 939 (1067)
Q Consensus 868 --------~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~ 939 (1067)
+..++||||++|.+|.++.. ++. ....+++.+++.+|+. |++|||+||+||+++.+|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 35789999999999987731 222 2456999999999999 999999999999999988
Q ss_pred eEEeccccceecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHH
Q 001494 940 ARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 995 (1067)
Q Consensus 940 ~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ell 995 (1067)
++++|||..+....+... ..+.....+..++|+|+||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988754321110 01333445667999999999877654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.5e-20 Score=188.14 Aligned_cols=143 Identities=17% Similarity=0.203 Sum_probs=109.5
Q ss_pred cCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChh-----------------------HHHHHHHHHHHHhcCCCCee
Q 001494 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMT-----------------------FQQEFLNEVKALTEIRHRNI 857 (1067)
Q Consensus 801 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~ni 857 (1067)
...||+|+||.||+|...+|+.||||+++........ .......|++.++++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999998889999999999754221110 01123459999999988776
Q ss_pred eeeeEEEeeCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHH-HhCCCCCeeecCCCCCceeeCC
Q 001494 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL-HNDCFPPIVHRDISSKNVLLDF 936 (1067)
Q Consensus 858 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivHrDlk~~Nill~~ 936 (1067)
.....+.. ...++||||++++++...... ...+++.++..++.|++.+++|+ |+. ||+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 44333322 234899999998877644322 23578899999999999999999 688 999999999999998
Q ss_pred CCCeEEeccccceecC
Q 001494 937 KNEARVSDFGIAKFLK 952 (1067)
Q Consensus 937 ~~~~kl~DfG~a~~~~ 952 (1067)
++.++++|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 5889999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=192.11 Aligned_cols=236 Identities=21% Similarity=0.256 Sum_probs=152.6
Q ss_pred CCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCC----------CeeeeeeEEEe
Q 001494 797 DFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH----------RNIVKFYGFCS 865 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~ 865 (1067)
.+..++.||.|+++.||.++.. +|+.+|+|++..+........+++.+|.-....+.+ -.++--++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4566789999999999999765 699999999876654444556777777766655432 12222222221
Q ss_pred ---------eC---C-----ceeEEEEeccCCCHHHHhcc---cC-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 001494 866 ---------HA---Q-----HSFIVYEYLEMGSLAMILSN---DA-AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVH 924 (1067)
Q Consensus 866 ---------~~---~-----~~~lv~E~~~~g~L~~~l~~---~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 924 (1067)
.. . ..+++|+-+ .++|.+++.- .. ....+....++.+..|+.+.+++||++ |++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 11 1 235677777 4688777632 11 112234455667779999999999999 9999
Q ss_pred cCCCCCceeeCCCCCeEEeccccceecCCCCCccccccccccccCccccccC--------CCCccchhHHHHHHHHHHHh
Q 001494 925 RDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM--------KVTEKCDVYSFGVLALEVIK 996 (1067)
Q Consensus 925 rDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwslGvil~ellt 996 (1067)
+||||+|++++.+|.++++||+.....+.. ......+..|.|||..... .++++.|.|++|+++|.|++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999999988765432 2213445779999976442 47889999999999999999
Q ss_pred CCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCC
Q 001494 997 GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESR 1055 (1067)
Q Consensus 997 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1055 (1067)
|+.||+.......... . + ..+. +.++.+..+|..+|+.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~----~---f--------~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW----D---F--------SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG----G---G--------TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc----c---c--------hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999875443211111 0 0 1112 344568999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=218.84 Aligned_cols=245 Identities=22% Similarity=0.256 Sum_probs=182.1
Q ss_pred CCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCC-ChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEE
Q 001494 797 DFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPG-EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 797 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 875 (1067)
+|...+.||.+.|=.|.+|+.+.|. |+||++.+..+. ..+..++-..|++ .+.++|||++++.-+-......|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6788899999999999999999888 889998655422 2222333344555 556689999999988888888899999
Q ss_pred eccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec--CC
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL--KP 953 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~--~~ 953 (1067)
|+.+ +|+|.+.-+ .-+...+.+-|+.|++.|+.-+|.. ||+|||||.+|||++.-+-+.++||..-+.. ..
T Consensus 102 yvkh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9865 888888532 2356667778999999999999999 9999999999999999999999999876532 11
Q ss_pred -CCCcccccccc----ccccCccccccC----------C-CCccchhHHHHHHHHHHHh-CCCCCCccccccccch---h
Q 001494 954 -DSSNWTELAGT----YGYVAPELAYTM----------K-VTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSL---N 1013 (1067)
Q Consensus 954 -~~~~~~~~~gt----~~y~aPE~~~~~----------~-~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~---~ 1013 (1067)
+...++.+..| ..|.|||.+... . .+++-||||+||+++|+++ |++||+.-..+..... .
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD 254 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence 12223333333 469999976542 1 4678999999999999998 7888875443322211 1
Q ss_pred hhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1014 LNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1014 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
.+..+.++.+. .+++++..|++.||.+|-+|.+.++.
T Consensus 255 ~e~~Le~Ied~--------------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 255 PEQLLEKIEDV--------------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHhCcCc--------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 22222233222 37899999999999999999999875
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.1e-19 Score=176.30 Aligned_cols=185 Identities=11% Similarity=0.059 Sum_probs=136.6
Q ss_pred CccCccccCCceeEEEEEECCCcEEEEEEeCCCCCC-ChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCCceeEEEEe
Q 001494 799 DDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPG-EMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 799 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
.+...|++|+||+||.+.. .+.+++.+.+.....- .......+.+|+++++++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998766 5777777766532111 1111225789999999995 5889999886 446999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCC-CCCceeeCCCCCeEEeccccceecCCCC
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDI-SSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDl-k~~Nill~~~~~~kl~DfG~a~~~~~~~ 955 (1067)
++|.+|...... ....++.|++++++++|++ ||+|||| ||+||+++.++.++|+|||+|....+..
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998754311 1134778999999999999 9999999 7999999999999999999998655433
Q ss_pred Cc-----c--------ccccccccccCccccccC-CCC-ccchhHHHHHHHHHHHhCCCCC
Q 001494 956 SN-----W--------TELAGTYGYVAPELAYTM-KVT-EKCDVYSFGVLALEVIKGKHPG 1001 (1067)
Q Consensus 956 ~~-----~--------~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslGvil~elltg~~p~ 1001 (1067)
.. . .....++.|++|+...-- ..+ .+.+-++-|..+|.++||+.|.
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 21 0 012246777778743221 223 4677889999999999999984
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-20 Score=209.47 Aligned_cols=227 Identities=25% Similarity=0.328 Sum_probs=181.2
Q ss_pred ccccCCceeEEEEE----ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCCceeEEEEec
Q 001494 803 CIGKGGQGSVYKVE----LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQHSFIVYEYL 877 (1067)
Q Consensus 803 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 877 (1067)
.+|+|+||.|+.++ ...|.-+|.|+.++......... ....|..++...+ ||.+|++.-.+..+...+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 37999999999853 34577789988876544332222 4566788888886 999999999999999999999999
Q ss_pred cCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCc
Q 001494 878 EMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN 957 (1067)
Q Consensus 878 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 957 (1067)
.+|++...+... ...++.........++-|++++|+. +|+|||+|++||+++.+|++++.|||.++........
T Consensus 80 rgg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred ccchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 999998777433 2356666777788999999999999 9999999999999999999999999999876543222
Q ss_pred cccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHH
Q 001494 958 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKL 1037 (1067)
Q Consensus 958 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1067)
+||..|||||++. .+..++|.||||++++||+||..||.. .....+....+..|.. ..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~~~p~~----l~ 211 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAELEMPRE----LS 211 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhccCCchh----hh
Confidence 8999999999987 567899999999999999999999863 3334444444444443 33
Q ss_pred HHHHHHHHhccCCCCCCCCCH
Q 001494 1038 ISFVEVAISCLDESPESRPTM 1058 (1067)
Q Consensus 1038 ~~l~~li~~cl~~dP~~Rpt~ 1058 (1067)
..+.+++.++...+|..|--.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhcc
Confidence 347888899999999999754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.8e-19 Score=180.53 Aligned_cols=143 Identities=19% Similarity=0.243 Sum_probs=111.8
Q ss_pred cCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChh-----------------------HHHHHHHHHHHHhcCCCCee
Q 001494 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMT-----------------------FQQEFLNEVKALTEIRHRNI 857 (1067)
Q Consensus 801 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~ni 857 (1067)
.+.||+|+||.||+|+..+|+.||||++......... ....+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999998779999999998765321000 01224578999999999987
Q ss_pred eeeeEEEeeCCceeEEEEeccCCCHHHH-hcccCccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeeC
Q 001494 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMI-LSNDAAAEDLEWTQRMSVIKGIADALSYLHN-DCFPPIVHRDISSKNVLLD 935 (1067)
Q Consensus 858 v~l~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlk~~Nill~ 935 (1067)
.....+... ..++||||++++++... +.. ..++..++.+++.+++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 554444333 24899999998855433 321 346778899999999999999999 8 999999999999999
Q ss_pred CCCCeEEeccccceecCC
Q 001494 936 FKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 936 ~~~~~kl~DfG~a~~~~~ 953 (1067)
++.++|+|||+|+....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 89999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-21 Score=179.53 Aligned_cols=164 Identities=32% Similarity=0.561 Sum_probs=93.3
Q ss_pred CCCCCcceEeccCCccccCCCCcccccCccceeecCCCcccCCCCcccccccccceecccccccccCCCCcccccccccc
Q 001494 70 SSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNN 149 (1067)
Q Consensus 70 ~~~~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 149 (1067)
..+.+.+.|.||+|.++ .+|+.++.|.+|+.|++++|+++ .+|.+++.+++|+.|+++-|++. .+|
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lp----------- 95 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILP----------- 95 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCc-----------
Confidence 34455555566666654 45555555555555555555555 55555555555555555555554 444
Q ss_pred ccccccccccccCCCccCCCcccEEEEeccCCc-CccCCccccccccceecccccccccccCCCCCcccccceeecccCc
Q 001494 150 LALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLS-GSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNS 228 (1067)
Q Consensus 150 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 228 (1067)
..|+.++.|+.|||..|++. ..+|+.|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.
T Consensus 96 -------------rgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 96 -------------RGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred -------------cccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCc
Confidence 44555555555555555543 245555555666666666666665 555556666666666666666
Q ss_pred CCCCCCcccCCcccCCceEecCcccccccCccccC
Q 001494 229 LFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCN 263 (1067)
Q Consensus 229 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 263 (1067)
+- .+|.+++.++.|++|.+.+|+++ .+|+.+++
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 55 45666666666666666666665 45544443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3e-19 Score=186.26 Aligned_cols=195 Identities=22% Similarity=0.297 Sum_probs=134.9
Q ss_pred CCCeeeeeeEEEee---------------------------CCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHH
Q 001494 853 RHRNIVKFYGFCSH---------------------------AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIK 905 (1067)
Q Consensus 853 ~h~niv~l~~~~~~---------------------------~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 905 (1067)
+|||||++.++|.+ ...+|+||..++. +|..++-. ...+...+.-|..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence 59999999887643 3467999998875 78877732 2345566677889
Q ss_pred HHHHHHHHHHhCCCCCeeecCCCCCceeeC--CCC--CeEEeccccceecCC------CCCccccccccccccCcccccc
Q 001494 906 GIADALSYLHNDCFPPIVHRDISSKNVLLD--FKN--EARVSDFGIAKFLKP------DSSNWTELAGTYGYVAPELAYT 975 (1067)
Q Consensus 906 ~i~~~l~~LH~~~~~~ivHrDlk~~Nill~--~~~--~~kl~DfG~a~~~~~------~~~~~~~~~gt~~y~aPE~~~~ 975 (1067)
|+++|+.|||.+ ||.|||+|++|||+. +|+ ...|+|||.+-.-.. ..+......|.-.-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 999999999999984 333 368899998743211 1122334567788999998765
Q ss_pred CCC------CccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccC
Q 001494 976 MKV------TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLD 1049 (1067)
Q Consensus 976 ~~~------~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 1049 (1067)
.+- -.|+|.|+.|.+.||+++...||-......-.... .....++.-++ .....+++++...++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-------Yqe~qLPalp~---~vpp~~rqlV~~lL~ 495 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-------YQESQLPALPS---RVPPVARQLVFDLLK 495 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh-------hhhhhCCCCcc---cCChHHHHHHHHHhc
Confidence 431 24899999999999999999997532111110111 11111211111 122247889999999
Q ss_pred CCCCCCCCHHHHHHHh
Q 001494 1050 ESPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1050 ~dP~~Rpt~~evl~~L 1065 (1067)
.||.+|++..-....|
T Consensus 496 r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVL 511 (598)
T ss_pred CCccccCCccHHHhHH
Confidence 9999999876655554
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-20 Score=174.82 Aligned_cols=163 Identities=34% Similarity=0.504 Sum_probs=133.2
Q ss_pred ccccceecccccccccCCCCccccccccccccccccccccccCCCccCCCcccEEEEeccCCcCccCCccccccccceec
Q 001494 120 LSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLN 199 (1067)
Q Consensus 120 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 199 (1067)
+++...|-||+|+++ .+|+.+..|.+|+.|++++|+|++ +|.+++.+++|+.|+++-|++. ..|..|+.++.|+.|+
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 334444445555544 444445555555555555555554 6677888999999999999998 8999999999999999
Q ss_pred ccccccc-cccCCCCCcccccceeecccCcCCCCCCcccCCcccCCceEecCcccccccCccccCccceeeEEEeccccc
Q 001494 200 LYNNELN-GSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLS 278 (1067)
Q Consensus 200 L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 278 (1067)
|+.|++. ..+|..|..|+.|+-|+|+.|.+. .+|..++++++|+.|.+.+|.+- .+|..++.++.|++|++.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 9999986 468999999999999999999998 89999999999999999999998 89999999999999999999999
Q ss_pred ccCCCccccC
Q 001494 279 GLIPSEIGNL 288 (1067)
Q Consensus 279 ~~~p~~~~~l 288 (1067)
-+ |..++++
T Consensus 187 vl-ppel~~l 195 (264)
T KOG0617|consen 187 VL-PPELANL 195 (264)
T ss_pred ec-Chhhhhh
Confidence 65 5556554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.4e-18 Score=203.90 Aligned_cols=195 Identities=22% Similarity=0.273 Sum_probs=160.5
Q ss_pred HhcCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC---CCeeeeeeEEEeeCCce
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR---HRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~ 870 (1067)
....|.+.+.+|+|+||+||+|...+|+.||+|+-+.+..-+. ---.+++.+|+ -+.|+.+..++.-.+.-
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf------YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF------YICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee------eehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3467888999999999999999888899999999876644332 22233444444 35566666666667778
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC-------CCCeEEe
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF-------KNEARVS 943 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~-------~~~~kl~ 943 (1067)
++|+||.+.|+|.+++. ..+.++|.-++.++.|+++.+++||.. +|||+||||+|++|.. ...++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 89999999999999996 345589999999999999999999999 9999999999999952 2348999
Q ss_pred ccccceecC--CCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 001494 944 DFGIAKFLK--PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000 (1067)
Q Consensus 944 DfG~a~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p 1000 (1067)
|||.+..+. ++.......++|-.+-.+|+..+.+.++..|.|.++.+++-|+.|+.-
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999997653 445566778889999999999999999999999999999999999864
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.1e-20 Score=205.07 Aligned_cols=279 Identities=24% Similarity=0.222 Sum_probs=169.8
Q ss_pred EEEccCCccc-ccCCCccccccCCcEEEcccCcCccc----CchhhhCcCCCcEEeCCCCcccCCCCCCCCCCcccEEec
Q 001494 389 YLNLAFNKLT-SSIPISLSNLTNLSVLSFYKNSLSGA----IPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHL 463 (1067)
Q Consensus 389 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~L 463 (1067)
.|+|..+.++ ...+..+..+.+|+.|+++++.++.. ++..+...+.|++++++++.+.+....+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~----------- 70 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGL----------- 70 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHH-----------
Confidence 4677888887 33445567777888888888887533 3445556667788888777665311000
Q ss_pred cCcccccccccccccCCceeEEEcccccccCCCCCCCCCCC---CcceEeccCCccCC----CCCCcccCC-CCCcEEEc
Q 001494 464 DRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCP---KLGALDFSKNNITG----NIPPKIGYS-SQLEVLDL 535 (1067)
Q Consensus 464 ~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~---~L~~L~Ls~N~l~~----~~~~~~~~~-~~L~~L~L 535 (1067)
......+..+++|+.|++++|.+.+..+..+..+. +|++|++++|++++ .+...+..+ ++|+.|++
T Consensus 71 ------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L 144 (319)
T cd00116 71 ------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVL 144 (319)
T ss_pred ------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEc
Confidence 00112333455666666666666543333333333 36666666666652 112223344 66777777
Q ss_pred CCCcccCc----CcccccCCCccceeecccccccCCc----cccccccccccEEEccCCCCCCCcc----cccccccccc
Q 001494 536 SSNHVVGD----IPAELGKLSFLIKLILAQNQLSGQL----SPKLGLLVQLEHLDLSSNNLSNAIP----ESLGNLVKLH 603 (1067)
Q Consensus 536 s~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~----~~l~~l~~L~ 603 (1067)
++|.+++. ++..+..+..|++|++++|.+++.. +..+..+++|+.|+|++|.+++... ..+..+++|+
T Consensus 145 ~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~ 224 (319)
T cd00116 145 GRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLE 224 (319)
T ss_pred CCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCC
Confidence 77777632 2234455567777777777776422 2234445678888888887765433 3345567788
Q ss_pred eecccCcccccccchhhhh-----ccccceeccccccCCC----cchhhhhcccccccccccccccccc----ccccccc
Q 001494 604 YLNLSNNQFSWEIPIKLEE-----LIHLSELDLSYNFLGR----AIPSQICIMQSLEKLNLSHNSLSGV----IPRCFEE 670 (1067)
Q Consensus 604 ~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~l~~ 670 (1067)
+|++++|.+++.....+.. .+.|+.|++++|.+++ .....+..+++|+.+++++|+++.. ....+..
T Consensus 225 ~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~ 304 (319)
T cd00116 225 VLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLE 304 (319)
T ss_pred EEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhh
Confidence 8888888887654444432 2678888888888863 2334555667888888888888855 3444445
Q ss_pred C-ccccEEEcccCcC
Q 001494 671 M-HALQCIDISYNEL 684 (1067)
Q Consensus 671 l-~~L~~l~l~~N~l 684 (1067)
. +.|+.+++.+|++
T Consensus 305 ~~~~~~~~~~~~~~~ 319 (319)
T cd00116 305 PGNELESLWVKDDSF 319 (319)
T ss_pred cCCchhhcccCCCCC
Confidence 5 6788888877764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.9e-20 Score=205.57 Aligned_cols=58 Identities=28% Similarity=0.249 Sum_probs=29.8
Q ss_pred cccccccccc-cccCCCccCCCcccEEEEeccCCcCc----cCCccccccccceecccccccc
Q 001494 149 NLALYSNYLE-DIIPHSLGNLTNLVTLCLYNNLLSGS----IPSEIGNLKYLLDLNLYNNELN 206 (1067)
Q Consensus 149 ~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 206 (1067)
.|+|..+.++ +..+..+..+.+|+.|+++++.++.. ++..+...++|++|+++++.+.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~ 64 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETG 64 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccC
Confidence 3555555554 22333444555666666666666421 3334444455555555555544
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=186.84 Aligned_cols=209 Identities=28% Similarity=0.478 Sum_probs=157.1
Q ss_pred HhcCCCCeeeeeeEEEeeCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCe-eecCC
Q 001494 849 LTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI-VHRDI 927 (1067)
Q Consensus 849 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-vHrDl 927 (1067)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ..-.+++.-...++++|++|++|+|+- +| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 4578899999999999999999999999999999999965 234588999999999999999999988 55 99999
Q ss_pred CCCceeeCCCCCeEEeccccceecCCC--CCccccccccccccCccccccCC-------CCccchhHHHHHHHHHHHhCC
Q 001494 928 SSKNVLLDFKNEARVSDFGIAKFLKPD--SSNWTELAGTYGYVAPELAYTMK-------VTEKCDVYSFGVLALEVIKGK 998 (1067)
Q Consensus 928 k~~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslGvil~elltg~ 998 (1067)
++.|.++|....+|++|||+....... ........-..-|.|||.+.... .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998765421 11111222345699999887641 467899999999999999999
Q ss_pred CCCCccccccccchhhhhhhhhccC-CCCCCCCcch-H-HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 001494 999 HPGDFISLISSSSLNLNIALDEILD-PRLPIPSHNV-Q-EKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 999 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~-~~~~~l~~li~~cl~~dP~~Rpt~~evl~~L~ 1066 (1067)
.||+........ .+.+..+.. +.-...+... . +....+..++..||..+|.+||++++|-..++
T Consensus 156 ~~~~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 156 GPFDLRNLVEDP----DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred CccccccccCCh----HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 998764432222 111111111 1111111111 1 22335889999999999999999999977654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.9e-18 Score=187.82 Aligned_cols=175 Identities=24% Similarity=0.374 Sum_probs=138.6
Q ss_pred CceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccc
Q 001494 868 QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGI 947 (1067)
Q Consensus 868 ~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~ 947 (1067)
.++|+.|+++...+|.+++.+.......++.....++.|++.|++| + +.+|||+||.||....+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 4689999999999999999877777788999999999999999999 6 899999999999999999999999999
Q ss_pred ceecCCCC------CccccccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccchhhhhhhhh
Q 001494 948 AKFLKPDS------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDE 1020 (1067)
Q Consensus 948 a~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1020 (1067)
........ ...+...||..||+||.+.+..|+.|+||||+|++++|+++ -..+++ .......
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----------r~~t~~d 471 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----------RIATLTD 471 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----------HHHhhhh
Confidence 98765433 24567789999999999999999999999999999999998 333322 1122233
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 001494 1021 ILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVS 1062 (1067)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl 1062 (1067)
+.+..++ +....+.+. -+.++.+++...|.+||++.++.
T Consensus 472 ~r~g~ip--~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 472 IRDGIIP--PEFLQDYPE-EYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhcCCCC--hHHhhcCcH-HHHHHHHhcCCCcccCchHHHHh
Confidence 3333332 122222222 36889999999999999665543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.9e-17 Score=165.42 Aligned_cols=138 Identities=15% Similarity=0.186 Sum_probs=105.6
Q ss_pred CCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-----CCCeeeeeeEEEeeCC---c
Q 001494 798 FDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-----RHRNIVKFYGFCSHAQ---H 869 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~ 869 (1067)
+...+.||+|+||.||. ...++.. +||++..... ...+++.+|+.+++.+ +||||++++|++.++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 34567899999999996 3334444 7998865322 2346789999999999 5799999999998873 4
Q ss_pred -eeEEEEe--ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHH-HHHHhCCCCCeeecCCCCCceeeCCC----CCeE
Q 001494 870 -SFIVYEY--LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADAL-SYLHNDCFPPIVHRDISSKNVLLDFK----NEAR 941 (1067)
Q Consensus 870 -~~lv~E~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivHrDlk~~Nill~~~----~~~k 941 (1067)
..+|+|| +++++|.+++.+. .+++. ..++.+++.++ +|||++ +|+||||||+||+++.. +.++
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence 3378999 5579999999542 24444 35677888777 999999 99999999999999743 3799
Q ss_pred Eeccccce
Q 001494 942 VSDFGIAK 949 (1067)
Q Consensus 942 l~DfG~a~ 949 (1067)
|+||+-+.
T Consensus 150 LiDg~G~~ 157 (210)
T PRK10345 150 VCDNIGES 157 (210)
T ss_pred EEECCCCc
Confidence 99954443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.8e-17 Score=170.50 Aligned_cols=147 Identities=18% Similarity=0.209 Sum_probs=112.3
Q ss_pred cCCCccCccccCCceeEEEEE--ECCCcEEEEEEeCCCCCCCh-----------------h----HHHHHHHHHHHHhcC
Q 001494 796 NDFDDEHCIGKGGQGSVYKVE--LASGEIIAVKKFHSPLPGEM-----------------T----FQQEFLNEVKALTEI 852 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~~-----------------~----~~~~~~~e~~~l~~l 852 (1067)
.-|.+.+.||+|+||.||+|. ..+|+.||+|++........ . ....+..|+..++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357888999999999999997 57899999999875421100 0 112356899999999
Q ss_pred CCC--eeeeeeEEEeeCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCC-eeecCCCC
Q 001494 853 RHR--NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP-IVHRDISS 929 (1067)
Q Consensus 853 ~h~--niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivHrDlk~ 929 (1067)
.+. .+++++++ ...++||||++++++...... .......++..++.|++.++++||++ + |+||||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 753 33444432 235899999999888665422 12345566788999999999999999 8 99999999
Q ss_pred CceeeCCCCCeEEeccccceecCC
Q 001494 930 KNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 930 ~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
+||+++ ++.++++|||.|.....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCC
Confidence 999999 88999999999976443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=163.88 Aligned_cols=149 Identities=17% Similarity=0.143 Sum_probs=114.0
Q ss_pred HHHHHHhcCCCccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCCh-------------------hHHHHHHHHHHHH
Q 001494 789 EEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEM-------------------TFQQEFLNEVKAL 849 (1067)
Q Consensus 789 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~e~~~l 849 (1067)
.++......|...+.||+|+||.||++...+|+.||||++........ .....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444445888899999999999999888899999998764321100 0112356788888
Q ss_pred hcCCCC--eeeeeeEEEeeCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCC
Q 001494 850 TEIRHR--NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDI 927 (1067)
Q Consensus 850 ~~l~h~--niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDl 927 (1067)
..+.|+ .++..++ ....++||||++++++...... ....+++.+++.++.++|+. +|+||||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 888777 4444443 2455899999999998765421 33467889999999999998 9999999
Q ss_pred CCCceeeCCCCCeEEeccccceecCC
Q 001494 928 SSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 928 k~~Nill~~~~~~kl~DfG~a~~~~~ 953 (1067)
||+||++++++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.5e-16 Score=162.76 Aligned_cols=137 Identities=19% Similarity=0.324 Sum_probs=114.5
Q ss_pred CccccCCceeEEEEEECCCcEEEEEEeCCCCCCCh-----hHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 802 HCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEM-----TFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
+.||+|++|.||+|.. .|..|++|+......... .....+..|++++..++|++++....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 577899998664322211 1224577899999999999998888887778889999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
++|++|.+.+.... + .+..++.+++.+++++|+. +++|||++|.||+++ ++.++++|||.++.
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999885321 2 7788999999999999999 999999999999999 78999999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.5e-17 Score=190.39 Aligned_cols=206 Identities=24% Similarity=0.308 Sum_probs=142.1
Q ss_pred cCCCccCccccCCceeEEEEEEC-CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
.+|+..+.+--|++|.||.++++ +.+.+|.|+-+. .-+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq---------~lilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---------NLILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccccc---------chhhhc--cccccCCccee----------------
Confidence 57888999999999999999766 466788844221 111111 22222334433
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
|+-...++. .++++... +.+++|+|+. ||+|||+||+|.+|+.=|++|++|||+++.....
T Consensus 136 -----gDc~tllk~---~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 -----GDCATLLKN---IGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -----chhhhhccc---CCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 333333322 22344322 7899999999 9999999999999999999999999998743211
Q ss_pred C---------------CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhh
Q 001494 955 S---------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALD 1019 (1067)
Q Consensus 955 ~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1019 (1067)
. ......+|||.|+|||++....|+..+|.|++|+|+||++.|+.||++.-. ++.+.
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp--------eelfg 268 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELFG 268 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH--------HHHHh
Confidence 0 001245899999999999999999999999999999999999999874322 22233
Q ss_pred hccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCC
Q 001494 1020 EILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRP 1056 (1067)
Q Consensus 1020 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 1056 (1067)
+++......++. ......++++++.+.++.+|..|-
T Consensus 269 ~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 269 QVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence 333322222222 222334588999999999999995
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.3e-16 Score=159.71 Aligned_cols=134 Identities=21% Similarity=0.339 Sum_probs=108.1
Q ss_pred ccccCCceeEEEEEECCCcEEEEEEeCCCCCCC-----hhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEec
Q 001494 803 CIGKGGQGSVYKVELASGEIIAVKKFHSPLPGE-----MTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYL 877 (1067)
Q Consensus 803 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 877 (1067)
.||+|+||.||+|.. +|..|++|+........ .....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 57889999865432111 112356778999999999887666666666777789999999
Q ss_pred cCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceec
Q 001494 878 EMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 878 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~ 951 (1067)
+|+++.+.+..... .++.+++.+++++|+. +++|||++|.||+++ ++.++++|||.++..
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999988743210 7889999999999999 999999999999999 899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=181.08 Aligned_cols=140 Identities=21% Similarity=0.319 Sum_probs=113.2
Q ss_pred cCCCccCccccCCceeEEEEEECCCcEEEEEEe-CCCCCC----ChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCce
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKF-HSPLPG----EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 870 (1067)
..|...++||+|+||+||++...... +++|+. ...... .....+.+.+|+++++.++|++++....++.+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44567899999999999999876444 444432 221111 112235688999999999999999888888887888
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
++||||+++++|.+++. ....++.+++++++|||+. +++|||+||+||++ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998883 3467899999999999999 99999999999999 678999999999976
Q ss_pred c
Q 001494 951 L 951 (1067)
Q Consensus 951 ~ 951 (1067)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=2e-15 Score=181.93 Aligned_cols=155 Identities=30% Similarity=0.432 Sum_probs=103.0
Q ss_pred hHHHHHHHHHhhcccCCCCCCCCCCCCCCCCCcCCcceeeEEcCCCCceeeeeeecccccccccCCcCCCCCCcceEecc
Q 001494 2 EEAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLW 81 (1067)
Q Consensus 2 ~~~~all~~k~~~~~~~~~~~l~sW~~~~~~~~~~c~w~gv~C~~~~~v~~l~l~~~~l~g~l~~~~~~~~~~l~~L~L~ 81 (1067)
+|.+||++||+++... ...+|+++. |...+|.|.||+|+.... + ....++.|+|+
T Consensus 372 ~~~~aL~~~k~~~~~~----~~~~W~g~~-C~p~~~~w~Gv~C~~~~~-~-------------------~~~~v~~L~L~ 426 (623)
T PLN03150 372 EEVSALQTLKSSLGLP----LRFGWNGDP-CVPQQHPWSGADCQFDST-K-------------------GKWFIDGLGLD 426 (623)
T ss_pred hHHHHHHHHHHhcCCc----ccCCCCCCC-CCCcccccccceeeccCC-C-------------------CceEEEEEECC
Confidence 5889999999998532 125897532 111224799999963110 0 00124556777
Q ss_pred CCccccCCCCcccccCccceeecCCCcccCCCCcccccccccceecccccccccCCCCcccccccccccccccccccccc
Q 001494 82 SNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDII 161 (1067)
Q Consensus 82 ~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 161 (1067)
+|.+.|.+|+.|+.|++|+.|+|++|.++|.+|..++.+++|++|+|++|+++|.+|..++++++|+.|+|++|.+++.+
T Consensus 427 ~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~i 506 (623)
T PLN03150 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506 (623)
T ss_pred CCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccC
Confidence 77777777777888888888888888887777777777888888888887777777766666666666666666666666
Q ss_pred CCCccCC-CcccEEEEeccCC
Q 001494 162 PHSLGNL-TNLVTLCLYNNLL 181 (1067)
Q Consensus 162 p~~l~~l-~~L~~L~L~~N~l 181 (1067)
|..++.+ .++..+++.+|..
T Consensus 507 P~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 507 PAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred ChHHhhccccCceEEecCCcc
Confidence 6555442 3445556665543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.9e-15 Score=151.68 Aligned_cols=139 Identities=20% Similarity=0.247 Sum_probs=98.7
Q ss_pred cCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHH---------------------HHHHHHHHhcCCCCe--e
Q 001494 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQE---------------------FLNEVKALTEIRHRN--I 857 (1067)
Q Consensus 801 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~e~~~l~~l~h~n--i 857 (1067)
.+.||+|+||+||+|...+|+.||||++............. ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988889999999986543221111111 134555565554332 4
Q ss_pred eeeeEEEeeCCceeEEEEeccCCCHHH-HhcccCccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeeecCCCCCceeeC
Q 001494 858 VKFYGFCSHAQHSFIVYEYLEMGSLAM-ILSNDAAAEDLEWTQRMSVIKGIADALSYLHN-DCFPPIVHRDISSKNVLLD 935 (1067)
Q Consensus 858 v~l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivHrDlk~~Nill~ 935 (1067)
++.+++ ...++||||++++.+.. .+.... .. .++..++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444433 34689999999854321 111100 11 5677899999999999999 7 999999999999999
Q ss_pred CCCCeEEeccccceecC
Q 001494 936 FKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 936 ~~~~~kl~DfG~a~~~~ 952 (1067)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1e-14 Score=144.27 Aligned_cols=135 Identities=19% Similarity=0.205 Sum_probs=113.2
Q ss_pred ccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCC--CeeeeeeEEEeeCCceeEEEEec
Q 001494 800 DEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH--RNIVKFYGFCSHAQHSFIVYEYL 877 (1067)
Q Consensus 800 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~ 877 (1067)
+.+.+|+|.++.||+++..+ ..+++|....... ...+..|+..++.++| +.++++++++...+..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 35779999999999998764 7899999864322 3568899999999976 58999999888888999999999
Q ss_pred cCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 878 EMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 878 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
+++.+..+ +......++.+++++++++|....++++|+|++|+||+++..+.++++|||.++.
T Consensus 76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 98766543 4466677899999999999986444799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.7e-14 Score=148.69 Aligned_cols=140 Identities=16% Similarity=0.253 Sum_probs=107.1
Q ss_pred ccCccc-cCCceeEEEEEECCCcEEEEEEeCCCC------CC----ChhHHHHHHHHHHHHhcCCCCee--eeeeEEEee
Q 001494 800 DEHCIG-KGGQGSVYKVELASGEIIAVKKFHSPL------PG----EMTFQQEFLNEVKALTEIRHRNI--VKFYGFCSH 866 (1067)
Q Consensus 800 ~~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~----~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~ 866 (1067)
....|| .||.|+||+++.. +..++||++.... .. .......+.+|++++.+++|+++ +..+++...
T Consensus 35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 346788 8999999999876 7778999885321 00 11234567889999999998774 677776543
Q ss_pred CC----ceeEEEEeccC-CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeE
Q 001494 867 AQ----HSFIVYEYLEM-GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEAR 941 (1067)
Q Consensus 867 ~~----~~~lv~E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~k 941 (1067)
+. ..++||||+++ .+|.+++... +++.. .+.+++.++++||++ ||+||||||+|||++.++.++
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 32 23599999997 6898887432 24433 357899999999999 999999999999999999999
Q ss_pred Eeccccceec
Q 001494 942 VSDFGIAKFL 951 (1067)
Q Consensus 942 l~DfG~a~~~ 951 (1067)
|+|||.++..
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1e-15 Score=181.35 Aligned_cols=255 Identities=21% Similarity=0.266 Sum_probs=187.9
Q ss_pred cCCCccCccccCCceeEEEEEEC--CCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCC-CCeeeeeeEEEeeCCceeE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA--SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 872 (1067)
..|...+.||+|+|+.|-.+... ....+|+|.+..+. ......+....|..+-+.+. |+|++++++...+.+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 45777788999999999887543 34456777665543 23334555667888888886 9999999999999999999
Q ss_pred EEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHH-hCCCCCeeecCCCCCceeeCCCC-CeEEecccccee
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH-NDCFPPIVHRDISSKNVLLDFKN-EARVSDFGIAKF 950 (1067)
Q Consensus 873 v~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivHrDlk~~Nill~~~~-~~kl~DfG~a~~ 950 (1067)
++||..++++.+...... ....+...+.....|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988773211 113455667788999999999999 77 999999999999999999 999999999988
Q ss_pred cCC-CCC--ccccccc-cccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCC
Q 001494 951 LKP-DSS--NWTELAG-TYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPR 1025 (1067)
Q Consensus 951 ~~~-~~~--~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1067)
+.. .+. .....+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++.......... .+...-....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~---~~~~~~~~~~ 251 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS---SWKSNKGRFT 251 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce---eecccccccc
Confidence 765 322 2334677 9999999998874 456789999999999999999999775443221110 0111100000
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 001494 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVS 1062 (1067)
Q Consensus 1026 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl 1062 (1067)
.. + +........++..+++..+|..|.+..++.
T Consensus 252 ~~-~---~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 QL-P---WNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cC-c---cccCChhhhhcccccccCCchhcccccccc
Confidence 11 1 112222367788889999999999988764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-15 Score=167.02 Aligned_cols=177 Identities=35% Similarity=0.532 Sum_probs=146.2
Q ss_pred cccCccceeecCCCcccCCCCcccccccccceecccccccccCCCCccccccccccccccccccccccCCCccCCCcccE
Q 001494 94 GNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVT 173 (1067)
Q Consensus 94 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 173 (1067)
-.|+.-...||+.|++. ++|..+..+..|+.|.|.+|.+. .+|..+++|..|.+|+|+.|+++. +|..+..|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~-lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSH-LPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhc-CChhhhcCc-cee
Confidence 34666677888899888 88888888888999999998887 788888888888888888888877 566677666 888
Q ss_pred EEEeccCCcCccCCccccccccceecccccccccccCCCCCcccccceeecccCcCCCCCCcccCCcccCCceEecCccc
Q 001494 174 LCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKL 253 (1067)
Q Consensus 174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 253 (1067)
|-+++|+++ .+|..++.+..|..|+.+.|++. .+|..++.+.+|+.|.+..|++. .+|.++..|+ |..||++.|++
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNki 223 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKI 223 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCce
Confidence 889999988 78888888888888888888888 67888888888888888888887 6777777664 77888888888
Q ss_pred ccccCccccCccceeeEEEecccccc
Q 001494 254 NGSIPHSLCNLTNLVILYIYNNSLSG 279 (1067)
Q Consensus 254 ~~~~p~~~~~l~~L~~L~L~~N~l~~ 279 (1067)
+ .+|-.|.+|+.|++|-|.+|.+..
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCCC
Confidence 7 778888888888888888888874
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.1e-13 Score=166.80 Aligned_cols=117 Identities=32% Similarity=0.512 Sum_probs=58.6
Q ss_pred cceecccCcccccccchhhhhccccceeccccccCCCcchhhhhcccccccccccccccccccccccccCccccEEEccc
Q 001494 602 LHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISY 681 (1067)
Q Consensus 602 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~l~l~~ 681 (1067)
++.|+|++|.++|.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.|+|++|+|++.+|..+..+++|+.|++++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 34444444444444444444444444444444444444444444444444455555544444444444555555555555
Q ss_pred CcCCCCCCCCC--cccCCCcccccCCCCccCCCCCCCCcc
Q 001494 682 NELRGPIPNST--AFRDAPIKALQGNKGLCGDFKGLPSCK 719 (1067)
Q Consensus 682 N~l~~~~~~~~--~~~~~~~~~~~~n~~~c~~~~~~~~c~ 719 (1067)
|+++|.+|..- .+.......+.+|+++|+.+ +.+.|.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~l~~C~ 538 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACG 538 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCC-CCCCCc
Confidence 55555444321 11122234577888889864 466785
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.6e-15 Score=161.72 Aligned_cols=196 Identities=30% Similarity=0.447 Sum_probs=174.9
Q ss_pred CCCCcceEeccCCccccCCCCcccccCccceeecCCCcccCCCCcccccccccceecccccccccCCCCccccccccccc
Q 001494 71 SFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNL 150 (1067)
Q Consensus 71 ~~~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 150 (1067)
.+..-...||+.|.+. ++|..+..+..|+.|.|..|.+. .+|..+++|..|.+|||+.|+++ .+|..+..|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 4667788999999996 89999999999999999999999 89999999999999999999999 7888888776 9999
Q ss_pred cccccccccccCCCccCCCcccEEEEeccCCcCccCCccccccccceecccccccccccCCCCCcccccceeecccCcCC
Q 001494 151 ALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLF 230 (1067)
Q Consensus 151 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 230 (1067)
-+++|+++. +|..++.+..|..||.+.|++. .+|..++++.+|+.|.++.|++. .+|+.+..| .|..||+|.|++.
T Consensus 149 i~sNNkl~~-lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLTS-LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EEecCcccc-CCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 999999987 7888999999999999999998 89999999999999999999998 788888865 6999999999999
Q ss_pred CCCCcccCCcccCCceEecCcccccccCccccCccc---eeeEEEeccc
Q 001494 231 GSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTN---LVILYIYNNS 276 (1067)
Q Consensus 231 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~ 276 (1067)
.+|-.|.+|+.|++|-|.+|.+. ..|..++..-. .++|+...++
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 89999999999999999999998 77777764333 3455555553
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.3e-13 Score=159.44 Aligned_cols=197 Identities=38% Similarity=0.539 Sum_probs=113.6
Q ss_pred eeecCCCcccCCCCcccccccccceecccccccccCCCCcccccc-ccccccccccccccccCCCccCCCcccEEEEecc
Q 001494 101 YLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLS-SLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179 (1067)
Q Consensus 101 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N 179 (1067)
.|+++.|.+... +..+..++.++.|++.+|.++ .+|...+.+. +|+.|++++|.+.. +|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhh-hhhhhhccccccccccCCc
Confidence 466666665422 233445566666666666666 5555555553 66666666666665 3344566666666666666
Q ss_pred CCcCccCCccccccccceecccccccccccCCCCCcccccceeecccCcCCCCCCcccCCcccCCceEecCcccccccCc
Q 001494 180 LLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPH 259 (1067)
Q Consensus 180 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 259 (1067)
+++ .+|...+.++.|+.|++++|+++ .+|..+..+..|++|.+++|++. ..+..+.++..+..|.+.+|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 666 55555556666666666666666 55555555555666666666433 34455555666666666666655 2345
Q ss_pred cccCccceeeEEEecccccccCCCccccCCcccEEEeccccccCCcc
Q 001494 260 SLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIP 306 (1067)
Q Consensus 260 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 306 (1067)
.+..+++++.|++++|.++...+ ++.+.+++.|++++|.+...+|
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccch
Confidence 55555556666666666654322 5555555555555555554443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.7e-13 Score=158.54 Aligned_cols=195 Identities=41% Similarity=0.529 Sum_probs=92.5
Q ss_pred eecccccccccCCCCccccccccccccccccccccccCCCccCCC-cccEEEEeccCCcCccCCccccccccceeccccc
Q 001494 125 TLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLT-NLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNN 203 (1067)
Q Consensus 125 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 203 (1067)
.|+++.|.+. .-+..+..++.++.|++.+|.++. +|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4666666653 222333444555555555555555 233334442 5555555555555 44445555555555555555
Q ss_pred ccccccCCCCCcccccceeecccCcCCCCCCcccCCcccCCceEecCcccccccCccccCccceeeEEEecccccccCCC
Q 001494 204 ELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPS 283 (1067)
Q Consensus 204 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 283 (1067)
+++ .+|...+.+++|+.|++++|++. .+|........|++|++++|.+. .++..+.++.++..|.+.+|++... +.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cc
Confidence 555 34444444555555555555554 34444333444555555555322 2334444444455555555544432 33
Q ss_pred ccccCCcccEEEeccccccCCccccccCCccccEEeccCCCCcCC
Q 001494 284 EIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGL 328 (1067)
Q Consensus 284 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 328 (1067)
.++.++.++.|++++|+++...+ ++.+.++++|++++|.+...
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~ 292 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNA 292 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCcccccc
Confidence 44444444444444444443322 44444444444444444433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.4e-12 Score=147.14 Aligned_cols=144 Identities=19% Similarity=0.261 Sum_probs=101.7
Q ss_pred cCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChh-------------------------------------HHHHHH
Q 001494 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMT-------------------------------------FQQEFL 843 (1067)
Q Consensus 801 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------------------------------------~~~~~~ 843 (1067)
.+.||.|++|.||+|++++|+.||||+.+........ .+-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3689999999999999999999999998653211100 001255
Q ss_pred HHHHHHhcCC----CCeeeeeeEEE-eeCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHH-HHHHHHhC
Q 001494 844 NEVKALTEIR----HRNIVKFYGFC-SHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIAD-ALSYLHND 917 (1067)
Q Consensus 844 ~e~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~ 917 (1067)
.|++.+.+++ |..-+.+-.++ ...+..++||||++|+++.++...... .. .+.+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5666655552 32223333333 234567999999999999887643211 11 23456666666 47888988
Q ss_pred CCCCeeecCCCCCceeeCCCCCeEEeccccceecC
Q 001494 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 918 ~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
|++|+|++|.||+++.++.++++|||++..+.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.1e-12 Score=147.55 Aligned_cols=248 Identities=25% Similarity=0.275 Sum_probs=180.7
Q ss_pred CCCccCcccc--CCceeEEEEEE---CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCce
Q 001494 797 DFDDEHCIGK--GGQGSVYKVEL---ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 797 ~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 870 (1067)
.|...+.+|. |.+|.||.++. .++..+|+|+-+.+...... ...-.+|+...+.+ .|++.++....+.+.+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCCcc
Confidence 4566788999 99999999754 57889999986655433221 12334677776677 499999999999999999
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHH----HHHHHHhCCCCCeeecCCCCCceeeCCC-CCeEEecc
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIAD----ALSYLHNDCFPPIVHRDISSKNVLLDFK-NEARVSDF 945 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivHrDlk~~Nill~~~-~~~kl~Df 945 (1067)
++-+|++. .++..+.+.. ...++....+.+..+..+ |+.++|+. +++|-|+||.||+...+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 99999986 5776666432 233566677777788888 99999999 99999999999999999 88999999
Q ss_pred ccceecCCCCCccc-----cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhh
Q 001494 946 GIAKFLKPDSSNWT-----ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDE 1020 (1067)
Q Consensus 946 G~a~~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1020 (1067)
|+...+.+...... ...|...|++||...+ -++.++|+|++|.+..+..++..+...... ....+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~---------~~W~~ 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN---------SSWSQ 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC---------CCccc
Confidence 99998876542222 2357778999998654 478899999999999999988665321100 00001
Q ss_pred ccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 1021 ILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
. ....++.+.......++...+.++++.+|..|++++.++.
T Consensus 338 ~--r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 L--RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c--ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1 1111222322233334666888999999999999988765
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.3e-12 Score=132.50 Aligned_cols=199 Identities=23% Similarity=0.353 Sum_probs=138.8
Q ss_pred HHhcCCCCeeeeeeEEEeeCC-----ceeEEEEeccCCCHHHHhcccCc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCC
Q 001494 848 ALTEIRHRNIVKFYGFCSHAQ-----HSFIVYEYLEMGSLAMILSNDAA-AEDLEWTQRMSVIKGIADALSYLHNDCFPP 921 (1067)
Q Consensus 848 ~l~~l~h~niv~l~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 921 (1067)
-+-++.|.|+|+++.|+.+.. +..++.|||..|++..++++.+. ...+......+++.||..||.|||+- .|+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 344567999999999886543 56889999999999999976443 34577778889999999999999985 779
Q ss_pred eeecCCCCCceeeCCCCCeEEeccccceecCCCC-----CccccccccccccCccccccCCCCccchhHHHHHHHHHHHh
Q 001494 922 IVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS-----SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK 996 (1067)
Q Consensus 922 ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~ellt 996 (1067)
|+|+.+..+-|++..+|-+|+.--. -....+.. .....-.+-++|.|||+=.....+.++|||+||....||..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999989874211 11111100 00112235688999998666667789999999999999988
Q ss_pred CCCC-CCccccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001494 997 GKHP-GDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 997 g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~ 1063 (1067)
+..- ....+ ...........+.. .+... =++++..|++..|..||+|++++.
T Consensus 278 lEiq~tnseS-----~~~~ee~ia~~i~~-----len~l-----qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSES-----KVEVEENIANVIIG-----LENGL-----QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcc-----eeehhhhhhhheee-----ccCcc-----ccCcCcccccCCCCCCcchhhhhc
Confidence 7643 21111 11112222222211 11111 146778999999999999998763
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.1e-13 Score=140.54 Aligned_cols=186 Identities=24% Similarity=0.245 Sum_probs=101.9
Q ss_pred ccccCCceeEEEcccccccCCCCCC----CCCCCCcceEeccCCccCCCCC-------------CcccCCCCCcEEEcCC
Q 001494 475 SFYIYPNLTFIDLSYNNLYGEISSD----WGRCPKLGALDFSKNNITGNIP-------------PKIGYSSQLEVLDLSS 537 (1067)
Q Consensus 475 ~~~~~~~L~~L~Ls~N~l~~~~~~~----~~~~~~L~~L~Ls~N~l~~~~~-------------~~~~~~~~L~~L~Ls~ 537 (1067)
++...|.|++||||+|-|....+.. +..+..|++|.|.+|.+.-..- ...+.-+.|+++..++
T Consensus 87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~r 166 (382)
T KOG1909|consen 87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGR 166 (382)
T ss_pred HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeec
Confidence 4455677888888888776444433 2446778888888877652211 1223345677777777
Q ss_pred CcccCcCc----ccccCCCccceeecccccccCC----ccccccccccccEEEccCCCCCCCcc----ccccccccccee
Q 001494 538 NHVVGDIP----AELGKLSFLIKLILAQNQLSGQ----LSPKLGLLVQLEHLDLSSNNLSNAIP----ESLGNLVKLHYL 605 (1067)
Q Consensus 538 N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~l~~l~~L~~L 605 (1067)
|++..... ..|...+.|+.+.+++|.|... ....|..++.|+.|||..|-++.... ..++.++.|+.|
T Consensus 167 Nrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El 246 (382)
T KOG1909|consen 167 NRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLREL 246 (382)
T ss_pred cccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheee
Confidence 77764322 2344456666677777666522 22345556666666666666653322 233445556666
Q ss_pred cccCcccccccchhhh-----hccccceeccccccCCCc----chhhhhccccccccccccccc
Q 001494 606 NLSNNQFSWEIPIKLE-----ELIHLSELDLSYNFLGRA----IPSQICIMQSLEKLNLSHNSL 660 (1067)
Q Consensus 606 ~Ls~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l 660 (1067)
++++|.+...+..+|. ..+.|++|.|.+|.|+.. +...+...+.|+.|+|++|++
T Consensus 247 ~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 247 NLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 6666666555444442 234555555555555431 222223344555555555555
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.3e-11 Score=140.02 Aligned_cols=146 Identities=17% Similarity=0.245 Sum_probs=96.3
Q ss_pred cCCCccCccccCCceeEEEEEECC-CcEEEEEEeCCCCCCC---------------------------h----hHHH---
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELAS-GEIIAVKKFHSPLPGE---------------------------M----TFQQ--- 840 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---------------------------~----~~~~--- 840 (1067)
.+|+. +.||.|++|+||+|++++ |+.||||+.++..... . +..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 789999999999999887 9999999997542110 0 0111
Q ss_pred ---HHHHHHHHHhcCC----CCeeeeeeEEEee-CCceeEEEEeccCCCHHHHhcccCcc---CCCChHHHHHHHHHHHH
Q 001494 841 ---EFLNEVKALTEIR----HRNIVKFYGFCSH-AQHSFIVYEYLEMGSLAMILSNDAAA---EDLEWTQRMSVIKGIAD 909 (1067)
Q Consensus 841 ---~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~~i~~ 909 (1067)
++.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++-.-.... ..+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 2445555555442 3444444444433 45678999999999997753211111 122222233333333
Q ss_pred HHHHHHhCCCCCeeecCCCCCceeeCCCC----CeEEeccccceecC
Q 001494 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKN----EARVSDFGIAKFLK 952 (1067)
Q Consensus 910 ~l~~LH~~~~~~ivHrDlk~~Nill~~~~----~~kl~DfG~a~~~~ 952 (1067)
... |++|+|++|.||+++.++ .++++|||++..+.
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 345 999999999999999988 89999999998764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.9e-11 Score=134.64 Aligned_cols=168 Identities=20% Similarity=0.276 Sum_probs=127.9
Q ss_pred EECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEeccCCCHHHHhcccCccCCC
Q 001494 816 ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDL 895 (1067)
Q Consensus 816 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l 895 (1067)
+..++.+|.|+....... ...+...+.++.++.+|||||+++++.++.++..|+|+|.+. -|..++++ +
T Consensus 33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------L 101 (690)
T ss_pred eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------h
Confidence 556788888888865432 234556788899999999999999999999999999999984 56666643 2
Q ss_pred ChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCCccccccccccccCcccccc
Q 001494 896 EWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 975 (1067)
Q Consensus 896 ~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~ 975 (1067)
....+...+.||+.||.|||+.| +++|++|....|++++.|+.||++|-++..............--..|..|+.+..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 34556667899999999999876 8999999999999999999999999988654432221111222234667765432
Q ss_pred CCCCccchhHHHHHHHHHHHhCC
Q 001494 976 MKVTEKCDVYSFGVLALEVIKGK 998 (1067)
Q Consensus 976 ~~~~~~~DvwslGvil~elltg~ 998 (1067)
.. -..|.|.||+++||++.|.
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCcc
Confidence 22 3469999999999999993
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.5e-12 Score=135.56 Aligned_cols=186 Identities=25% Similarity=0.279 Sum_probs=142.9
Q ss_pred CCCCCCCcceEeccCCccCCCCCCcc----cCCCCCcEEEcCCCcccCcCccc-------------ccCCCccceeeccc
Q 001494 499 DWGRCPKLGALDFSKNNITGNIPPKI----GYSSQLEVLDLSSNHVVGDIPAE-------------LGKLSFLIKLILAQ 561 (1067)
Q Consensus 499 ~~~~~~~L~~L~Ls~N~l~~~~~~~~----~~~~~L~~L~Ls~N~l~~~~~~~-------------~~~l~~L~~L~L~~ 561 (1067)
++..+++|++||||.|-+....+..| ..+..|+.|.|.+|.+....... .+.-+.|+.+..++
T Consensus 87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~r 166 (382)
T KOG1909|consen 87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGR 166 (382)
T ss_pred HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeec
Confidence 35667899999999999976555544 46789999999999987432222 23357899999999
Q ss_pred ccccCCc----cccccccccccEEEccCCCCCCCcc----cccccccccceecccCcccccccc----hhhhhcccccee
Q 001494 562 NQLSGQL----SPKLGLLVQLEHLDLSSNNLSNAIP----ESLGNLVKLHYLNLSNNQFSWEIP----IKLEELIHLSEL 629 (1067)
Q Consensus 562 N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~----~~l~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L 629 (1067)
|++.... ...|...+.|+.+.++.|.|....- ..|..+++|+.|||..|-++.... ..+..+++|++|
T Consensus 167 Nrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El 246 (382)
T KOG1909|consen 167 NRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLREL 246 (382)
T ss_pred cccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheee
Confidence 9987433 3456677899999999998874332 456778999999999999875544 445678899999
Q ss_pred ccccccCCCcchhhhh-----cccccccccccccccccc----cccccccCccccEEEcccCcC
Q 001494 630 DLSYNFLGRAIPSQIC-----IMQSLEKLNLSHNSLSGV----IPRCFEEMHALQCIDISYNEL 684 (1067)
Q Consensus 630 ~Ls~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~l~l~~N~l 684 (1067)
+++++.+......++. ..++|+.|.+.+|.|+-. +..+....+.|..|+|++|.+
T Consensus 247 ~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 247 NLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred cccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 9999999887666653 468999999999999833 334555689999999999988
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.6e-11 Score=119.96 Aligned_cols=131 Identities=21% Similarity=0.186 Sum_probs=95.6
Q ss_pred cCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCee-eeeeEEEeeCCceeEEEEeccC
Q 001494 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI-VKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 801 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~ 879 (1067)
.+.++.|.++.||+++.. ++.|++|+....... ...+..|+++++.+.+.++ ++++.+. ....++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence 356899999999999876 778999997643211 2345678888888865444 3455443 3345899999999
Q ss_pred CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCC--CCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC--FPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
.++.... . ....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 76 ~~l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Ccccccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 8775420 1 11245678999999999982 12359999999999999 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.8e-12 Score=127.51 Aligned_cols=108 Identities=28% Similarity=0.277 Sum_probs=56.8
Q ss_pred cCCcccCCceEecCcccccccCccccCccceeeEEEecccccccCCCccccCCcccEEEeccccccCCccccccCCcccc
Q 001494 237 LGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIA 316 (1067)
Q Consensus 237 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 316 (1067)
+..++.|++|||++|.|+ .+..++.-++.++.|++|+|.+... +.+..+++|+.||||+|.++.. .++-..+-+++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~-~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAEC-VGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhh-hhhHhhhcCEe
Confidence 334455666666666666 4555555566666666666666543 2355566666666666665532 33333444455
Q ss_pred EEeccCCCCcCCCCcccccCCCCCeEEecCcccc
Q 001494 317 FLFLDSNSLFGLIPSELRNLKSLSILELGNNKLC 350 (1067)
Q Consensus 317 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 350 (1067)
.|.|+.|.|... ..++.+-+|..||+++|+|.
T Consensus 356 tL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 356 TLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred eeehhhhhHhhh--hhhHhhhhheeccccccchh
Confidence 555555544432 23344444444444444443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.9e-11 Score=120.51 Aligned_cols=126 Identities=31% Similarity=0.291 Sum_probs=43.5
Q ss_pred CCCccceeecccccccCCcccccc-ccccccEEEccCCCCCCCcccccccccccceecccCcccccccchhhhhccccce
Q 001494 550 KLSFLIKLILAQNQLSGQLSPKLG-LLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSE 628 (1067)
Q Consensus 550 ~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 628 (1067)
+...+++|+|.+|+|+.+ +.+. .+.+|+.||||+|.|+.. +.+..++.|++|++++|+|+...+.....+++|++
T Consensus 17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE 92 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred cccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence 344556666666666532 2333 456777777777777643 34666777778888888777433322245777777
Q ss_pred eccccccCCCc-chhhhhcccccccccccccccccccc---cccccCccccEEEc
Q 001494 629 LDLSYNFLGRA-IPSQICIMQSLEKLNLSHNSLSGVIP---RCFEEMHALQCIDI 679 (1067)
Q Consensus 629 L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~l~~l~~L~~l~l 679 (1067)
|+|++|+|.+. ....+..+++|+.|+|.+|+++...- ..+..+|+|+.||-
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 88888777652 23556677778888888887774321 23346677776664
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.4e-10 Score=111.19 Aligned_cols=139 Identities=16% Similarity=0.218 Sum_probs=99.7
Q ss_pred CccccCCceeEEEEEECC-------CcEEEEEEeCCCCC----------CC---------hhHHHHHH----HHHHHHhc
Q 001494 802 HCIGKGGQGSVYKVELAS-------GEIIAVKKFHSPLP----------GE---------MTFQQEFL----NEVKALTE 851 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------~~---------~~~~~~~~----~e~~~l~~ 851 (1067)
..||.|--+.||.|...+ +..+|||+.+.... ++ ....+.+. +|++.+++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999986543 57899998753211 01 11123333 79999988
Q ss_pred CCC--CeeeeeeEEEeeCCceeEEEEeccCCCHHH-HhcccCccCCCChHHHHHHHHHHHHHHHHH-HhCCCCCeeecCC
Q 001494 852 IRH--RNIVKFYGFCSHAQHSFIVYEYLEMGSLAM-ILSNDAAAEDLEWTQRMSVIKGIADALSYL-HNDCFPPIVHRDI 927 (1067)
Q Consensus 852 l~h--~niv~l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivHrDl 927 (1067)
+.. -+++..+++ ..-++||||+.++.+.. .++. ..++..+...+..+++.++..+ |.. ++||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 853 456666654 46689999998654321 2211 1244556677889999999999 788 9999999
Q ss_pred CCCceeeCCCCCeEEeccccceecC
Q 001494 928 SSKNVLLDFKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 928 k~~Nill~~~~~~kl~DfG~a~~~~ 952 (1067)
++.||+++ ++.++++|||.|....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 5789999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.7e-12 Score=144.73 Aligned_cols=247 Identities=32% Similarity=0.350 Sum_probs=143.4
Q ss_pred cccCccceeecCCCcccCCCCcccccccccceecccccccccCCCCccccccccccccccccccccccCCCccCCCcccE
Q 001494 94 GNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVT 173 (1067)
Q Consensus 94 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 173 (1067)
..+..++.+++..|.+.. +-..++.+++|+.|++.+|+|. .+...+..+++|++|+|++|.|+.+. .+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhh
Confidence 344555555566666552 2233555666666666666665 33333555666666666666666653 2555666777
Q ss_pred EEEeccCCcCccCCccccccccceecccccccccccCCC-CCcccccceeecccCcCCCCCCcccCCcccCCceEecCcc
Q 001494 174 LCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQS-LGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNK 252 (1067)
Q Consensus 174 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 252 (1067)
|++++|.++ .+ ..+..++.|+.+++++|+++..-+ . ...+.+|+.+++..|.+.. ...+..+..+..+++..|+
T Consensus 145 L~l~~N~i~-~~-~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLIS-DI-SGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcch-hc-cCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchhc--ccchHHHHHHHHhhccccc
Confidence 777777766 22 334456677777777777663322 1 4566667777777776652 2334444555555667776
Q ss_pred cccccCccccCcc--ceeeEEEecccccccCCCccccCCcccEEEeccccccCCccccccCCccccEEeccCCCCcCC--
Q 001494 253 LNGSIPHSLCNLT--NLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGL-- 328 (1067)
Q Consensus 253 l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-- 328 (1067)
++..-+ +..+. .|+.+++++|++... +..+..+..+..|+++.|++... ..+.....+..+....|.+...
T Consensus 220 i~~~~~--l~~~~~~~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 294 (414)
T KOG0531|consen 220 ISKLEG--LNELVMLHLRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEA 294 (414)
T ss_pred ceeccC--cccchhHHHHHHhcccCccccc-cccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhh
Confidence 663222 12222 267777777777632 35566667777777777777654 3344555666667777766522
Q ss_pred -CCcc-cccCCCCCeEEecCccccccCC
Q 001494 329 -IPSE-LRNLKSLSILELGNNKLCGSIP 354 (1067)
Q Consensus 329 -~p~~-~~~l~~L~~L~L~~N~l~~~~~ 354 (1067)
.... .+....++.+.+..|.+....+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 295 ISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hhccccccccccccccccccCccccccc
Confidence 1111 4456677788888888775544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4e-11 Score=135.25 Aligned_cols=246 Identities=21% Similarity=0.186 Sum_probs=176.0
Q ss_pred HhcCCCccCccccCCceeEEEEEE--CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcC-CCCeeeeeeEEEeeCCce
Q 001494 794 ATNDFDDEHCIGKGGQGSVYKVEL--ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 794 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 870 (1067)
...+|..+..||.|.|+.||++.. .++..|++|............ ..-..|+.+...+ .|.++++....+......
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 346788999999999999999743 468889999987665443322 2224566666666 599999988888888888
Q ss_pred eEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCC-CCeEEeccccce
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK-NEARVSDFGIAK 949 (1067)
Q Consensus 871 ~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~-~~~kl~DfG~a~ 949 (1067)
|+--||+++++..... .....+++..++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.++
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 8999999999887665 2233467778889999999999999998 99999999999999886 788999999987
Q ss_pred ecCCCCCcccccccccccc--CccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccchhhhhhhhhccCCCCC
Q 001494 950 FLKPDSSNWTELAGTYGYV--APELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 950 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
.+.- .......+-+++ +|+......+..+.|++|||.-+.|.++|..--... .....+.....+
T Consensus 416 ~~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-----------~~~~~i~~~~~p 481 (524)
T KOG0601|consen 416 RLAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-----------VQSLTIRSGDTP 481 (524)
T ss_pred ccce---ecccccccccccccchhhccccccccccccccccccccccccCcccCccc-----------ccceeeeccccc
Confidence 4221 111122333344 566666677889999999999999999986531100 001111222222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~evl~~ 1064 (1067)
...... .++..+...+...++..||.+.++...
T Consensus 482 ~~~~~~----~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 482 NLPGLK----LQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred CCCchH----HhhhhhhhhhcCCccccchhhhhhccc
Confidence 221111 346777788999999999998877543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1e-11 Score=125.83 Aligned_cols=130 Identities=28% Similarity=0.300 Sum_probs=58.6
Q ss_pred cccccceecccccccccccCCCCCcccccceeecccCcCCCCCCcccCCcccCCceEecCcccccccCccccCccceeeE
Q 001494 191 NLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVIL 270 (1067)
Q Consensus 191 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 270 (1067)
.-+.|++|+|++|.|+ .+.++..-++.++.|++|+|.+.. + +.+..+++|+.|||++|.++ .+.++-..|.+.+.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 3344555555555554 444444444555555555555541 1 12444455555555555554 333333344455555
Q ss_pred EEecccccccCCCccccCCcccEEEeccccccCCc-cccccCCccccEEeccCCCCc
Q 001494 271 YIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLI-PHSLGNLSNIAFLFLDSNSLF 326 (1067)
Q Consensus 271 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~ 326 (1067)
.|+.|.+..+ ..++.+.+|..||+++|+|.... -..+++++.|+++.|.+|.+.
T Consensus 358 ~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 358 KLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred ehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 5555554432 23444444455555555444321 123334444444444444433
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.6e-12 Score=144.78 Aligned_cols=247 Identities=32% Similarity=0.391 Sum_probs=167.6
Q ss_pred ccccccceecccccccccCCCCccccccccccccccccccccccCCCccCCCcccEEEEeccCCcCccCCccccccccce
Q 001494 118 GHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLD 197 (1067)
Q Consensus 118 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 197 (1067)
..+..++.+++..|.+. .+-..+..+.+|+.|++..|.|+.+. ..+..+++|++|++++|.|+.. ..+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhcc-cchhhhhcchheeccccccccc--cchhhccchhh
Confidence 45677777778888776 34445777888888888888887742 2267788888888888888743 23566677888
Q ss_pred ecccccccccccCCCCCcccccceeecccCcCCCCCCcc-cCCcccCCceEecCcccccccCccccCccceeeEEEeccc
Q 001494 198 LNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSE-LGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNS 276 (1067)
Q Consensus 198 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 276 (1067)
|++++|.|+. + ..+..+.+|+.+++++|++...-+ . ...+.+|+.+++.+|.+.. ...+..+..+..+++..|.
T Consensus 145 L~l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchh-c-cCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchhc--ccchHHHHHHHHhhccccc
Confidence 8888888873 2 346667888888888888874433 2 4667778888888888862 3345555666666888888
Q ss_pred ccccCCCccccCCc--ccEEEeccccccCCccccccCCccccEEeccCCCCcCCCCcccccCCCCCeEEecCcccccc--
Q 001494 277 LSGLIPSEIGNLKF--LSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGS-- 352 (1067)
Q Consensus 277 l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-- 352 (1067)
++..- .+..+.. |+.+++++|.+... +..+..+.++..|++.+|++... ..+.....+..+.+..|++...
T Consensus 220 i~~~~--~l~~~~~~~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 294 (414)
T KOG0531|consen 220 ISKLE--GLNELVMLHLRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEA 294 (414)
T ss_pred ceecc--CcccchhHHHHHHhcccCccccc-cccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhh
Confidence 87542 2223333 78888888888743 35667777888888888887765 3344556667777777776522
Q ss_pred -CCcc-ccCCCCCCeEEccCCcCccccC
Q 001494 353 -IPHF-LGNLTNLSVLFIYNNSLSGSIP 378 (1067)
Q Consensus 353 -~~~~-~~~l~~L~~L~l~~N~l~~~~p 378 (1067)
.... ......++...+..|.+....+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 295 ISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hhccccccccccccccccccCccccccc
Confidence 1111 4556677777887777765433
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.9e-09 Score=113.71 Aligned_cols=255 Identities=18% Similarity=0.254 Sum_probs=161.9
Q ss_pred CccCccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhc-CCCCeeeeeeEE------EeeC-Cce
Q 001494 799 DDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE-IRHRNIVKFYGF------CSHA-QHS 870 (1067)
Q Consensus 799 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~------~~~~-~~~ 870 (1067)
..++.||+|+.+.+|...-- +. .+.|++..+.... .. +.+..|.. -.||-+-.-+.| ..++ ...
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~---~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAA---QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecchh-hc-hhheeecCCCchH---HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 45688999999999974222 12 2457777654322 11 12223333 357654442222 1122 236
Q ss_pred eEEEEeccCC-CHHHHhc---ccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccc
Q 001494 871 FIVYEYLEMG-SLAMILS---NDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 871 ~lv~E~~~~g-~L~~~l~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG 946 (1067)
.++|..+++. -..++++ +........|...+++++.++.+.+.||++ |.+-+|+.++|+|+++++.+.+.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 7888888754 2333332 222334578999999999999999999999 99999999999999999999998866
Q ss_pred cceecCCCCCccccccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhC-CCCCCccccccccchhhhhhh--
Q 001494 947 IAKFLKPDSSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKG-KHPGDFISLISSSSLNLNIAL-- 1018 (1067)
Q Consensus 947 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~-- 1018 (1067)
.-.. ...+......+|.+.|.+||.-. +...+...|-|.+||++++++.| ++||.++..........+..+
T Consensus 163 sfqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 163 SFQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ceee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 4432 23444556678899999999644 33457789999999999999986 999987665433222222111
Q ss_pred ------hhccCCCCCCCCcc-hHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHHh
Q 001494 1019 ------DEILDPRLPIPSHN-VQEKLISFVEVAISCLDE--SPESRPTMQKVSQLL 1065 (1067)
Q Consensus 1019 ------~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~--dP~~Rpt~~evl~~L 1065 (1067)
.+...+..+.|... .......+..+..+|+.. .|+-|||++..+..|
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl 297 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL 297 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence 11111111111111 111223466677788865 377999999887655
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.3e-12 Score=133.07 Aligned_cols=137 Identities=28% Similarity=0.237 Sum_probs=58.7
Q ss_pred ccCCceeEEEcccccccCC--CCCCCCCCCCcceEeccCCccCCCCCCcc-cCCCCCcEEEcCCCcccCcCc-ccccCCC
Q 001494 477 YIYPNLTFIDLSYNNLYGE--ISSDWGRCPKLGALDFSKNNITGNIPPKI-GYSSQLEVLDLSSNHVVGDIP-AELGKLS 552 (1067)
Q Consensus 477 ~~~~~L~~L~Ls~N~l~~~--~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~-~~~~~l~ 552 (1067)
..+++++.||||.|-|+.- +..-...+|+|+.|+++.|++.....+.. ..+++|+.|.|+.+.++.... ..+..++
T Consensus 143 k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fP 222 (505)
T KOG3207|consen 143 KILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFP 222 (505)
T ss_pred hhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCC
Confidence 3455555555555544421 11122345555555555555542211111 133455555555555542111 1122345
Q ss_pred ccceeecccccccCCccccccccccccEEEccCCCCCCCc-ccccccccccceecccCcccc
Q 001494 553 FLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAI-PESLGNLVKLHYLNLSNNQFS 613 (1067)
Q Consensus 553 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~Ls~N~l~ 613 (1067)
+|..|+|..|..-.+-......+..|+.|||++|++-+.. -...+.++.|+.|+++.+.++
T Consensus 223 sl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~ 284 (505)
T KOG3207|consen 223 SLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIA 284 (505)
T ss_pred cHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcc
Confidence 5555555555322222223334445555555555443211 122334455555555555443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-11 Score=131.72 Aligned_cols=158 Identities=27% Similarity=0.169 Sum_probs=71.4
Q ss_pred CCceeEEEcccccccCCCC-CCCCCCCCcceEeccCCccCCC--CCCcccCCCCCcEEEcCCCcccCcCccc-ccCCCcc
Q 001494 479 YPNLTFIDLSYNNLYGEIS-SDWGRCPKLGALDFSKNNITGN--IPPKIGYSSQLEVLDLSSNHVVGDIPAE-LGKLSFL 554 (1067)
Q Consensus 479 ~~~L~~L~Ls~N~l~~~~~-~~~~~~~~L~~L~Ls~N~l~~~--~~~~~~~~~~L~~L~Ls~N~l~~~~~~~-~~~l~~L 554 (1067)
+..|+.+.|.+..+..... +....|+.++.||||+|-+... +......+++|+.|+|+.|++....... -..+++|
T Consensus 120 ~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~l 199 (505)
T KOG3207|consen 120 LKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHL 199 (505)
T ss_pred HHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhh
Confidence 4455666666655543222 3445677777777777766521 1222345667777777777765211111 1124455
Q ss_pred ceeecccccccC-CccccccccccccEEEccCCCCCCCcccccccccccceecccCcccccccc-hhhhhccccceeccc
Q 001494 555 IKLILAQNQLSG-QLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIP-IKLEELIHLSELDLS 632 (1067)
Q Consensus 555 ~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls 632 (1067)
+.|.++.|.++. .+...+..+++|+.|+|..|..-..-.....-+..|+.|||++|++..... ...+.++.|+.|+++
T Consensus 200 K~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls 279 (505)
T KOG3207|consen 200 KQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLS 279 (505)
T ss_pred heEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhcc
Confidence 555555555441 111222334455555555543111111122223444444444444432110 122334444444444
Q ss_pred cccC
Q 001494 633 YNFL 636 (1067)
Q Consensus 633 ~N~l 636 (1067)
.+.|
T Consensus 280 ~tgi 283 (505)
T KOG3207|consen 280 STGI 283 (505)
T ss_pred ccCc
Confidence 4444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.9e-09 Score=103.88 Aligned_cols=134 Identities=22% Similarity=0.337 Sum_probs=101.6
Q ss_pred CccccCCceeEEEEEECCCcEEEEEEe-CCCCCC----ChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEEEe
Q 001494 802 HCIGKGGQGSVYKVELASGEIIAVKKF-HSPLPG----EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 876 (1067)
..+++|+-+.+|.+.+. |.++.+|.- .+.... ..-......+|++++.+++--.|..-+-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999775 444555543 222211 112234567899999988766776666677788888999999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEecccccee
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~ 950 (1067)
++|..+.+.+... ...++..+-.-+.-||.. ||+|+|+.++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888433 245677888888999999 999999999999998654 99999999964
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.5e-10 Score=114.14 Aligned_cols=105 Identities=28% Similarity=0.380 Sum_probs=24.0
Q ss_pred CCCCeEEccCCcCccccCcccC-CCCCCCEEEccCCcccccCCCccccccCCcEEEcccCcCcccCchhhhCcCCCcEEe
Q 001494 361 TNLSVLFIYNNSLSGSIPCEIG-NLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLF 439 (1067)
Q Consensus 361 ~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 439 (1067)
..+++|+|++|.|+. + +.++ .+.+|+.|+|++|.|+.. ..+..++.|++|++++|+|+...+.....+++|+.|+
T Consensus 19 ~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 19 VKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 344555555555542 2 1233 345555555555555532 1344555555555555555533222223455566666
Q ss_pred CCCCcccCC--CCCCCCCCcccEEeccCcccc
Q 001494 440 LGDNQFQGP--IPNLKNLTSLVRVHLDRNYLT 469 (1067)
Q Consensus 440 L~~N~l~~~--~~~l~~l~~L~~L~L~~N~l~ 469 (1067)
|++|+|... ...+..+++|+.|+|.+|.++
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 666655432 112333444444444444443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.3e-09 Score=115.36 Aligned_cols=143 Identities=20% Similarity=0.272 Sum_probs=110.2
Q ss_pred CccccCCceeEEEEEECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCC--CeeeeeeEEEeeC---CceeEEEEe
Q 001494 802 HCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH--RNIVKFYGFCSHA---QHSFIVYEY 876 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~E~ 876 (1067)
+.+|.|.++.||+++..+|+.+++|+....... .....+..|+++++.+++ ..+++++.+.... +..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568999999999998877789999997654321 123567889999999865 4467777777654 367899999
Q ss_pred ccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC-------------------------------------- 918 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------- 918 (1067)
++|.++.+.+.. ..++..++..++.++++++++||+..
T Consensus 82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999888765421 24677778888889999999998531
Q ss_pred ---------------CCCeeecCCCCCceeeCC--CCCeEEecccccee
Q 001494 919 ---------------FPPIVHRDISSKNVLLDF--KNEARVSDFGIAKF 950 (1067)
Q Consensus 919 ---------------~~~ivHrDlk~~Nill~~--~~~~kl~DfG~a~~ 950 (1067)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.8e-09 Score=103.18 Aligned_cols=146 Identities=18% Similarity=0.270 Sum_probs=106.3
Q ss_pred ccCccccCCceeEEEEEECCCcEEEEEEeC-----CCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 800 DEHCIGKGGQGSVYKVELASGEIIAVKKFH-----SPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 800 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
....+-||+-+.|+++.+. |+...||.-. .+..+..-..+...+|++.+.+++--.|..-.-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567889999999998877 7766666432 222222223456788999998887555555555566666778999
Q ss_pred EeccC-CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCC---eEEecccccee
Q 001494 875 EYLEM-GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNE---ARVSDFGIAKF 950 (1067)
Q Consensus 875 E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~---~kl~DfG~a~~ 950 (1067)
||++| .++.+++......+. ..+....++..|-+.+.-||.. +|+|+|+..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 477777754433332 2233367889999999999999 9999999999999987764 58999999854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=9.4e-11 Score=138.35 Aligned_cols=249 Identities=21% Similarity=0.251 Sum_probs=167.9
Q ss_pred cCCCccCccccCCceeEEEEEE-CCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEeeCCceeEEE
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 874 (1067)
+.+...+-+-.|+++.++.++- ..|...++|.......-.....+....+-.+.-..++|-++...--+......++|+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 4566667888999999998743 345444555443211111111122222222322334577776555455567889999
Q ss_pred EeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCC
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~ 954 (1067)
+|..++++...++.... .+.+.+......+..+.+|||.. .+.|||++|.|.+..++++.+++|||.....+-.
T Consensus 884 ~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred HHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999988865442 34444555677888999999998 7999999999999999999999999843321100
Q ss_pred ----------C---------------------CccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 001494 955 ----------S---------------------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDF 1003 (1067)
Q Consensus 955 ----------~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p~~~ 1003 (1067)
. .......||+.|.|||...+.....++|.|+.|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 001235689999999999999999999999999999999999999864
Q ss_pred cccccccchhhhhhhhhccCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHH
Q 001494 1004 ISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQ 1059 (1067)
Q Consensus 1004 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 1059 (1067)
... ...++.+.....+.+. ...+....+.+++...+..+|.+|-.|.
T Consensus 1038 ~tp--------q~~f~ni~~~~~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETP--------QQIFENILNRDIPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cch--------hhhhhccccCCCCCCC-CccccChhhhhhhhhhhccCchhccCcc
Confidence 332 2333444433333221 1223334577888889999999997765
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.9e-10 Score=139.84 Aligned_cols=85 Identities=32% Similarity=0.367 Sum_probs=40.7
Q ss_pred ccccCccceeecCCCcccCCCCcccccccccceecccccccccCCCCccccccccccccccccccccccCCCccCCCccc
Q 001494 93 IGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLV 172 (1067)
Q Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 172 (1067)
|..++.|++||||+|.=-+.+|.+|++|-+||+|+|++..++ .+|..+++|..|.+|++..+.-...+|..+..|++|+
T Consensus 567 f~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr 645 (889)
T KOG4658|consen 567 FRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLR 645 (889)
T ss_pred HhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhccccc
Confidence 344555555555544433344555555555555555555444 4455555555555555544443333344444455555
Q ss_pred EEEEec
Q 001494 173 TLCLYN 178 (1067)
Q Consensus 173 ~L~L~~ 178 (1067)
+|.+..
T Consensus 646 ~L~l~~ 651 (889)
T KOG4658|consen 646 VLRLPR 651 (889)
T ss_pred EEEeec
Confidence 555443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.5e-10 Score=139.23 Aligned_cols=205 Identities=26% Similarity=0.295 Sum_probs=141.1
Q ss_pred CCCCCcceEeccCCccccCCCCcccccCccceeecCCCc--ccCCCCcccccccccceecccccccccCCCCcccccccc
Q 001494 70 SSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNL--FSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSL 147 (1067)
Q Consensus 70 ~~~~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~--l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 147 (1067)
.+....+...+-+|.+. .++....+ ++|++|-+.+|. +....+..|..++.|++|||++|.=-+.+|..+++|-+|
T Consensus 520 ~~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L 597 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL 597 (889)
T ss_pred cchhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence 34456677777777775 44444433 379999999986 553444457889999999999988777999999999999
Q ss_pred ccccccccccccccCCCccCCCcccEEEEeccCCcCccCCccccccccceecccccc--cccccCCCCCcccccceeecc
Q 001494 148 NNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNE--LNGSIPQSLGNLSNLAMLNLS 225 (1067)
Q Consensus 148 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~--l~~~~p~~l~~l~~L~~L~Ls 225 (1067)
++|+|+...+.. +|..+++|..|.+|++..+.-...+|..+..|++|++|.+..-. .....-..+.++.+|+.+...
T Consensus 598 ryL~L~~t~I~~-LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 598 RYLDLSDTGISH-LPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred hcccccCCCccc-cchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence 999999999986 88899999999999999987666777777789999999986543 222333445566666666554
Q ss_pred cCcCCCCCCcccCCcccCC----ceEecCcccccccCccccCccceeeEEEeccccccc
Q 001494 226 SNSLFGSIPSELGNLKYLS----DLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGL 280 (1067)
Q Consensus 226 ~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 280 (1067)
.... .+-..+..+..|. .+.+..+... ..+.++..+.+|+.|.+.++.++..
T Consensus 677 ~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~ 732 (889)
T KOG4658|consen 677 ISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEI 732 (889)
T ss_pred cchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchh
Confidence 4332 1111222333332 3333232322 4556677778888888888877643
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.5e-09 Score=79.11 Aligned_cols=41 Identities=37% Similarity=0.814 Sum_probs=29.3
Q ss_pred hHHHHHHHHHhhcccCCCCCCCCCCCCCCCCCcCCcceeeEEcC
Q 001494 2 EEAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCN 45 (1067)
Q Consensus 2 ~~~~all~~k~~~~~~~~~~~l~sW~~~~~~~~~~c~w~gv~C~ 45 (1067)
+|++|||+||+++..++ ...+++|+.+. ..+||.|.||+|+
T Consensus 3 ~d~~aLl~~k~~l~~~~-~~~l~~W~~~~--~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 3 QDRQALLAFKKSLNNDP-SGVLSSWNPSS--DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHCTT-SC--CCCTT--TT----S-CCCSTTEEE-
T ss_pred HHHHHHHHHHHhccccc-CcccccCCCcC--CCCCeeeccEEeC
Confidence 69999999999998654 45899998642 2689999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.1e-08 Score=98.79 Aligned_cols=129 Identities=26% Similarity=0.332 Sum_probs=84.4
Q ss_pred eEEEEEECCCcEEEEEEeCCCCCC-----------------------ChhHHHHHHHHHHHHhcCCCC--eeeeeeEEEe
Q 001494 811 SVYKVELASGEIIAVKKFHSPLPG-----------------------EMTFQQEFLNEVKALTEIRHR--NIVKFYGFCS 865 (1067)
Q Consensus 811 ~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 865 (1067)
.||.|...+|..+|||+.+..... .........+|++.|.++..- ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999889999999988542110 011123467899999999755 466666542
Q ss_pred eCCceeEEEEecc--CCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHH-HHhCCCCCeeecCCCCCceeeCCCCCeEE
Q 001494 866 HAQHSFIVYEYLE--MGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY-LHNDCFPPIVHRDISSKNVLLDFKNEARV 942 (1067)
Q Consensus 866 ~~~~~~lv~E~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivHrDlk~~Nill~~~~~~kl 942 (1067)
.-.+||||++ |..+..+.... ++......++.+++..+.. +|.. ||+|+|+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 3479999998 55554433211 1134456678888886666 4677 99999999999999877 9999
Q ss_pred eccccceecC
Q 001494 943 SDFGIAKFLK 952 (1067)
Q Consensus 943 ~DfG~a~~~~ 952 (1067)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.3e-07 Score=101.13 Aligned_cols=144 Identities=22% Similarity=0.171 Sum_probs=99.2
Q ss_pred CccccCCceeEEEEEECCCcEEEEEEeCCCCCCCh--------hHHHHHHHHHHHHhcCCCCe--eeeeeEEEee-----
Q 001494 802 HCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEM--------TFQQEFLNEVKALTEIRHRN--IVKFYGFCSH----- 866 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~----- 866 (1067)
+.+-......|++++.. |+.|.||+.....-.+. .....+.+|...+.++...+ ++..+++++.
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 44444444556677664 78899997743221000 00113678888888774333 3344555543
Q ss_pred CCceeEEEEeccCC-CHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC-------CC
Q 001494 867 AQHSFIVYEYLEMG-SLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF-------KN 938 (1067)
Q Consensus 867 ~~~~~lv~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~-------~~ 938 (1067)
....++|||++++. ++.+++.... ..+.+...+..++.+++..++-||+. ||+|+|++++|||++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999986 8888874321 23345667778999999999999999 9999999999999985 46
Q ss_pred CeEEecccccee
Q 001494 939 EARVSDFGIAKF 950 (1067)
Q Consensus 939 ~~kl~DfG~a~~ 950 (1067)
.+.++||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 789999998864
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.4e-08 Score=82.38 Aligned_cols=59 Identities=34% Similarity=0.528 Sum_probs=26.8
Q ss_pred ceeeEEEecccccccCCCccccCCcccEEEeccccccCCccccccCCccccEEeccCCC
Q 001494 266 NLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNS 324 (1067)
Q Consensus 266 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 324 (1067)
+|++|++++|+++.+.+..|.++++|++|++++|+++.+.|.+|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444444444444444444444444444444444444444444444444443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.1e-08 Score=81.21 Aligned_cols=60 Identities=38% Similarity=0.516 Sum_probs=37.7
Q ss_pred cCCceEecCcccccccCccccCccceeeEEEecccccccCCCccccCCcccEEEeccccc
Q 001494 242 YLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKF 301 (1067)
Q Consensus 242 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 301 (1067)
+|++|++++|+++...+..|.++++|++|++++|+++.+.|..|.++++|+.|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455666666666644445666666666666666666666666666666666666666654
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.3e-09 Score=123.17 Aligned_cols=203 Identities=23% Similarity=0.152 Sum_probs=124.3
Q ss_pred CCceeEEEcccccccCCC-CCCCCCCCCcceEeccCCccCCCCCCcccCCCCCcEEEcCCCccc---CcCcccccC----
Q 001494 479 YPNLTFIDLSYNNLYGEI-SSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVV---GDIPAELGK---- 550 (1067)
Q Consensus 479 ~~~L~~L~Ls~N~l~~~~-~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~---~~~~~~~~~---- 550 (1067)
++.++.|.+-.-.=.+.- |-.+..+.+|+.|.|.++.|.. .-....--.+|++|-. +|.+. ..+....+.
T Consensus 83 lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~-~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns 160 (1096)
T KOG1859|consen 83 LQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST-AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNS 160 (1096)
T ss_pred HhhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh-hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccc
Confidence 444555554433222221 5556777899999999998863 1111112235665533 23332 111111111
Q ss_pred --CCccceeecccccccCCccccccccccccEEEccCCCCCCCcccccccccccceecccCcccccccchhhhhccccce
Q 001494 551 --LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSE 628 (1067)
Q Consensus 551 --l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 628 (1067)
.-.|...+.++|.+. .....+.-++.|++||||+|+++.. +.+..+++|+.|||++|.++...--...++. |+.
T Consensus 161 ~~Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~ 236 (1096)
T KOG1859|consen 161 PVWNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQL 236 (1096)
T ss_pred hhhhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-hee
Confidence 235667778888876 4455677778888888888888754 3677788888888888888743333334444 888
Q ss_pred eccccccCCCcchhhhhcccccccccccccccccccc-cccccCccccEEEcccCcCCCCCC
Q 001494 629 LDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIP-RCFEEMHALQCIDISYNELRGPIP 689 (1067)
Q Consensus 629 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~l~l~~N~l~~~~~ 689 (1067)
|.|++|.++. ...+.++++|+.||||.|-|++.-- .-+..+..|+.|+|.||++.+..-
T Consensus 237 L~lrnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 237 LNLRNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred eeecccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 8888888754 2345667888888888888764322 234466777888888888876433
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=4.1e-07 Score=93.44 Aligned_cols=139 Identities=22% Similarity=0.214 Sum_probs=98.6
Q ss_pred CCccCccccCCceeEEEEEECCCcEEEEEEeCCCC-----------------CCCh--hHHHHHHHHHHHHhcCCCC--e
Q 001494 798 FDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPL-----------------PGEM--TFQQEFLNEVKALTEIRHR--N 856 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~~--~~~~~~~~e~~~l~~l~h~--n 856 (1067)
..++.+||.|--+.||.|....|.++|||.=+... ..++ .......+|.++|.++.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999999999999643211 0010 1123356788899888544 6
Q ss_pred eeeeeEEEeeCCceeEEEEeccCCCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCC
Q 001494 857 IVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF 936 (1067)
Q Consensus 857 iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~ 936 (1067)
|++.+++ +...+||||++|-.|...- ++.+..-.++..|+.-+...-.. ||||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 7777653 4567999999986554322 12333444555555555555566 9999999999999999
Q ss_pred CCCeEEeccccceec
Q 001494 937 KNEARVSDFGIAKFL 951 (1067)
Q Consensus 937 ~~~~kl~DfG~a~~~ 951 (1067)
+|.+.++||-.+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999877543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.2e-09 Score=121.44 Aligned_cols=128 Identities=34% Similarity=0.364 Sum_probs=92.5
Q ss_pred CCcEEEcCCCcccCcCcccccCCCccceeecccccccCCccccccccccccEEEccCCCCCCCcccccccccccceeccc
Q 001494 529 QLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLS 608 (1067)
Q Consensus 529 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls 608 (1067)
.|.+.+.++|++. ..-.++.-++.++.|+|++|++... ..+..++.|++|||+.|.++.+.--....+ +|..|+++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhh-hheeeeec
Confidence 4666677777776 3344556667778888888877643 367778888999999998874322222233 49999999
Q ss_pred CcccccccchhhhhccccceeccccccCCC-cchhhhhccccccccccccccccc
Q 001494 609 NNQFSWEIPIKLEELIHLSELDLSYNFLGR-AIPSQICIMQSLEKLNLSHNSLSG 662 (1067)
Q Consensus 609 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~ 662 (1067)
||.++. -..+.++++|+.|||++|-|.+ .-..-+..+..|+.|+|.+|++-.
T Consensus 241 nN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 241 NNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred ccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 998862 3457888999999999998866 233445667889999999999873
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.6e-06 Score=94.26 Aligned_cols=170 Identities=21% Similarity=0.271 Sum_probs=126.5
Q ss_pred CceeEEEEE-ECCCcEEEEEEeCCCCCCChhHHHHHHHHHHHHhcCCCCeeeeeeEEEee----CCceeEEEEeccC-CC
Q 001494 808 GQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH----AQHSFIVYEYLEM-GS 881 (1067)
Q Consensus 808 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~~~-g~ 881 (1067)
-..+.|++. ..+|..|++|+++....... ..-..-++.++++.|+|||++.+++.. +-..++||+|+++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 346778885 45899999999954322221 122345778999999999999998863 3467999999984 46
Q ss_pred HHHHhccc------------CccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccce
Q 001494 882 LAMILSND------------AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK 949 (1067)
Q Consensus 882 L~~~l~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~ 949 (1067)
|.+..-.. ......+++..+.++.|+..||.++|+. |..-+-+.+.+|+++.+.+++|+..|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence 65544211 1122467889999999999999999999 99999999999999999999999888887
Q ss_pred ecCCCCCccccccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 001494 950 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000 (1067)
Q Consensus 950 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~elltg~~p 1000 (1067)
.+..+.. |.+.+ -.+-|.=.+|.+++.|.||..-
T Consensus 442 vl~~d~~--------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 442 VLQEDPT--------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eecCCCC--------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 6654430 11111 1367899999999999999644
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.9e-06 Score=87.01 Aligned_cols=141 Identities=18% Similarity=0.170 Sum_probs=101.6
Q ss_pred cccCCceeEEEEEECCCcEEEEEEeCCCCCCC---hhHHHHHHHHHHHHhcCCC--CeeeeeeEEEe-eC----CceeEE
Q 001494 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGE---MTFQQEFLNEVKALTEIRH--RNIVKFYGFCS-HA----QHSFIV 873 (1067)
Q Consensus 804 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~-~~----~~~~lv 873 (1067)
-|+||.+.|+..... |+.+-+|+-..-.... ..-...|.+|...+.++.. -.+++.+ ++. .. -..++|
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 567999999998776 4468888764111111 1124678899998888842 2255555 332 21 246899
Q ss_pred EEeccC-CCHHHHhcccCccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCC--eEEecccccee
Q 001494 874 YEYLEM-GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNE--ARVSDFGIAKF 950 (1067)
Q Consensus 874 ~E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~--~kl~DfG~a~~ 950 (1067)
+|-+++ .+|.+++.... ..+.+...+..+..++++.++-||+. |+.|+|+.+.||+++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997763 48888874432 33567778889999999999999999 9999999999999987777 99999986653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=7.5e-08 Score=110.36 Aligned_cols=147 Identities=18% Similarity=0.295 Sum_probs=100.4
Q ss_pred HHHHHHHHHHHhCCCCCeeecCCCCCceeeCCCCCeEEeccccceecCCCCC----ccc-----cccccccccCcccccc
Q 001494 905 KGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS----NWT-----ELAGTYGYVAPELAYT 975 (1067)
Q Consensus 905 ~~i~~~l~~LH~~~~~~ivHrDlk~~Nill~~~~~~kl~DfG~a~~~~~~~~----~~~-----~~~gt~~y~aPE~~~~ 975 (1067)
.+++.|+.|+|.. +++||+.|.|++|.++..+.+||+.|+.+....++.. .++ -......|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4556999999987 4999999999999999999999999998875544221 111 1123457999999998
Q ss_pred CCCCccchhHHHHHHHHHHHhCCCC-CCccccccccchhhhhhhhhccCC--CCCCCCcchHHHHHHHHHHHHhccCCCC
Q 001494 976 MKVTEKCDVYSFGVLALEVIKGKHP-GDFISLISSSSLNLNIALDEILDP--RLPIPSHNVQEKLISFVEVAISCLDESP 1052 (1067)
Q Consensus 976 ~~~~~~~DvwslGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP 1052 (1067)
...+.++|+||+||.+|-+..|..+ ++...... ........+. ..... .+...++++=+.+++..++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~------~~~~~~~~~~~~~~~~s----~~~p~el~~~l~k~l~~~~ 253 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL------SYSFSRNLLNAGAFGYS----NNLPSELRESLKKLLNGDS 253 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc------hhhhhhccccccccccc----ccCcHHHHHHHHHHhcCCc
Confidence 8889999999999999999855544 33221111 0111111110 01111 1222347778888999999
Q ss_pred CCCCCHHHHHH
Q 001494 1053 ESRPTMQKVSQ 1063 (1067)
Q Consensus 1053 ~~Rpt~~evl~ 1063 (1067)
..||++.++..
T Consensus 254 ~~rp~~~~l~~ 264 (700)
T KOG2137|consen 254 AVRPTLDLLLS 264 (700)
T ss_pred ccCcchhhhhc
Confidence 99998777654
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.8e-08 Score=99.15 Aligned_cols=114 Identities=25% Similarity=0.171 Sum_probs=77.0
Q ss_pred ccccccEEEccCCCCCCCcccc-----cccccccceecccCcccccccch-----hhhhccccceeccccccCCCc----
Q 001494 574 LLVQLEHLDLSSNNLSNAIPES-----LGNLVKLHYLNLSNNQFSWEIPI-----KLEELIHLSELDLSYNFLGRA---- 639 (1067)
Q Consensus 574 ~l~~L~~L~Ls~N~l~~~~~~~-----l~~l~~L~~L~Ls~N~l~~~~~~-----~~~~l~~L~~L~Ls~N~l~~~---- 639 (1067)
.-+.|++.+...|++.. ++.. |..-..|+++.+..|.|.-.+-. .+..+.+|+.|||.+|-++..
T Consensus 155 ~kp~Le~vicgrNRlen-gs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~ 233 (388)
T COG5238 155 DKPKLEVVICGRNRLEN-GSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRY 233 (388)
T ss_pred cCCCceEEEeccchhcc-CcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHH
Confidence 34668888888888763 2222 22224678888888877533222 234567888899999988653
Q ss_pred chhhhhcccccccccccccccccccccccc------cCccccEEEcccCcCCCCC
Q 001494 640 IPSQICIMQSLEKLNLSHNSLSGVIPRCFE------EMHALQCIDISYNELRGPI 688 (1067)
Q Consensus 640 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~------~l~~L~~l~l~~N~l~~~~ 688 (1067)
...+++..+.|+.|++..+-++.....++. ..++|..|-..||...+.+
T Consensus 234 La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~ 288 (388)
T COG5238 234 LADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGI 288 (388)
T ss_pred HHHHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCce
Confidence 445566777889999999988876664443 3577888888888777543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.1e-08 Score=92.48 Aligned_cols=132 Identities=27% Similarity=0.295 Sum_probs=92.3
Q ss_pred CcceEeccCCccccCCCCccccc---CccceeecCCCcccCCCCcccc-cccccceecccccccccCCCCcccccccccc
Q 001494 74 HLAYLDLWSNQLFGNIPPQIGNI---SKLKYLDLSSNLFSGAIPPQIG-HLSYLKTLHLFKNQLSGSIPLEVGGLSSLNN 149 (1067)
Q Consensus 74 ~l~~L~L~~n~l~~~~p~~~~~l---~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 149 (1067)
.+..+||+++++ +.+++....+ .+|+..+|++|.|. .+|+.|. +.+.++.|+|++|.++ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~l-m~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQL-MYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchh-hHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 455688888888 4677665554 45666699999998 5666664 5568899999999998 78888888888888
Q ss_pred ccccccccccccCCCccCCCcccEEEEeccCCcCccCCccccccccceecccccccccccC
Q 001494 150 LALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIP 210 (1067)
Q Consensus 150 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 210 (1067)
|++++|.+.. .|..+..|.+|-.||..+|.+. .+|..+..-+..-...+.++.+.+.-+
T Consensus 105 lNl~~N~l~~-~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 105 LNLRFNPLNA-EPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred cccccCcccc-chHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 8888888876 5666667888888888888876 566543222222223345555554443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.2e-06 Score=88.88 Aligned_cols=106 Identities=21% Similarity=0.311 Sum_probs=81.7
Q ss_pred HHHHHHHHHHhcCCC--CeeeeeeEEEeeCC----ceeEEEEeccCC-CHHHHhcccCccCCCChHHHHHHHHHHHHHHH
Q 001494 840 QEFLNEVKALTEIRH--RNIVKFYGFCSHAQ----HSFIVYEYLEMG-SLAMILSNDAAAEDLEWTQRMSVIKGIADALS 912 (1067)
Q Consensus 840 ~~~~~e~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~ 912 (1067)
....+|...+..+.. =.++..+++..... ..++|+|++++. +|.+++..... .+......++.++++.++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 356677777766642 23455666655532 458999999874 78888854222 456677889999999999
Q ss_pred HHHhCCCCCeeecCCCCCceeeCCCC---CeEEeccccceec
Q 001494 913 YLHNDCFPPIVHRDISSKNVLLDFKN---EARVSDFGIAKFL 951 (1067)
Q Consensus 913 ~LH~~~~~~ivHrDlk~~Nill~~~~---~~kl~DfG~a~~~ 951 (1067)
-||+. ||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 999999999999999887 7999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1067 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-44 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-40 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-44 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-40 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-40 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-39 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-29 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-26 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-21 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-18 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-14 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-11 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-11 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-11 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-11 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 3e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-11 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 5e-11 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-10 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 9e-10 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-09 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-09 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-09 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-08 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 8e-08 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 9e-06 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 9e-08 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-07 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 8e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-07 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 6e-07 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-06 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 7e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 622 bits (1606), Expect = 0.0
Identities = 225/768 (29%), Positives = 334/768 (43%), Gaps = 58/768 (7%)
Query: 2 EEAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLK 61
E H L+ +K L + N L W+ N C + G+ C +V SI+L+S L
Sbjct: 12 REIHQLISFKDVLPDKNL---LPDWSSNK----NPCTFDGVTCRDD-KVTSIDLSSKPLN 63
Query: 62 GTLHDFS-------------------------FSSFPHLAYLDLWSNQLFGNIPP--QIG 94
S F L LDL N L G + +G
Sbjct: 64 VGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLG 123
Query: 95 NISKLKYLDLSSNLFSGAIP-PQIGHLSYLKTLHLFKNQLSGSIPLEV---GGLSSLNNL 150
+ S LK+L++SSN L+ L+ L L N +SG+ + G L +L
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183
Query: 151 ALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIP 210
A+ N + + + NL L + +N S IP +G+ L L++ N+L+G
Sbjct: 184 AISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFS 240
Query: 211 QSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLC-NLTNLVI 269
+++ + L +LN+SSN G IP LK L L LA+NK G IP L L
Sbjct: 241 RAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTG 298
Query: 270 LYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIP-HSLGNLSNIAFLFLDSNSLFGL 328
L + N G +P G+ L +ALS N FSG +P +L + + L L N G
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358
Query: 329 IPSELRNLK-SLSILELGNNKLCGSIPHFLGN--LTNLSVLFIYNNSLSGSIPCEIGNLK 385
+P L NL SL L+L +N G I L L L++ NN +G IP + N
Sbjct: 359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS 418
Query: 386 SLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQF 445
L L+L+FN L+ +IP SL +L+ L L + N L G IP+E + L L L N
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
Query: 446 QGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCP 504
G IP+ L N T+L + L N LT I + NL + LS N+ G I ++ G C
Sbjct: 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCR 538
Query: 505 KLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQN-- 562
L LD + N G IP + S +++N + G + + A N
Sbjct: 539 SLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594
Query: 563 QLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEE 622
+ G S +L L +++S + N + +L++S N S IP ++
Sbjct: 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654
Query: 623 LIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYN 682
+ +L L+L +N + +IP ++ ++ L L+LS N L G IP+ + L ID+S N
Sbjct: 655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714
Query: 683 ELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLPSCKALKSNKQASRK 730
L GPIP F P N GLCG LP C ++ A +
Sbjct: 715 NLSGPIPEMGQFETFPPAKFLNNPGLCG--YPLPRCDPSNADGYAHHQ 760
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 386 bits (994), Expect = e-121
Identities = 158/652 (24%), Positives = 243/652 (37%), Gaps = 53/652 (8%)
Query: 64 LHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYL 123
L ++ L+L NQL S+L LD+ N S P L L
Sbjct: 16 LTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75
Query: 124 KTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG 183
K L+L N+LS ++L L L SN ++ I + NL+TL L +N LS
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 184 SIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSN--LAMLNLSSNSLFGSIPSELGNLK 241
+ L+ L +L L NN++ + L +N L L LSSN + P +
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195
Query: 242 YLSDLKLADNKLNGSIPHSLC---NLTNLVILYIYNNSLSGLIPSEIGNLKF--LSKIAL 296
L L L + +L S+ LC T++ L + N+ LS + LK+ L+ + L
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 297 SYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHF 356
SYN + + S L + + FL+ N++ L L L ++ L L + SI
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL- 314
Query: 357 LGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSF 416
SL LK L +LN+ N + + L NL LS
Sbjct: 315 --------------ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360
Query: 417 YKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESF 476
+ S L + F + L ++L +N ++ S++F
Sbjct: 361 SNSFTSL--------------RTLTNETFVSL-----AHSPLHILNLTKNKISKIESDAF 401
Query: 477 YIYPNLTFIDLSYNNLYGEISSD-WGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDL 535
+L +DL N + E++ W + + S N L+ L L
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461
Query: 536 SSNH--VVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLS---- 589
V P+ L L L L+ N ++ L L +LE LDL NNL+
Sbjct: 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWK 521
Query: 590 ----NAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQIC 645
L L LH LNL +N F ++L L +DL N L S
Sbjct: 522 HANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581
Query: 646 IMQSLEKLNLSHNSLSGVIPRCFEE-MHALQCIDISYNELRGPIPNSTAFRD 696
SL+ LNL N ++ V + F L +D+ +N + F +
Sbjct: 582 NQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-118
Identities = 133/602 (22%), Positives = 233/602 (38%), Gaps = 35/602 (5%)
Query: 122 YLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLL 181
+ +L+ +P ++ +++ L L N L + + + L +L + N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 182 SGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLK 241
S P L L LNL +NEL+ ++ +NL L+L SNS+ + K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 242 YLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKF--LSKIALSYN 299
L L L+ N L+ + + L NL L + NN + L E+ L K+ LS N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 300 KFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELR---NLKSLSILELGNNKLCGSIPHF 356
+ P + + LFL++ L + +L S+ L L N++L +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 357 LGNL--TNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVL 414
L TNL++L + N+L+ L L Y L +N + SL L N+ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 415 SFYKN---------SLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN-LKNLTSLVRVHLD 464
+ ++ SL ++ L L L + DN G N L +L + L
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 465 RNYL--TSNISESFY--IYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNI 520
++ + +E+F + L ++L+ N + S + L LD N I +
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 521 PPK-IGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSG--QLSPKLGLLVQ 577
+ + + LS N + + L +L+L + L L
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481
Query: 578 LEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSW--------EIPIKLEELIHLSEL 629
L LDLS+NN++N + L L KL L+L +N + L+ L HL L
Sbjct: 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541
Query: 630 DLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIP 689
+L N + L+ ++L N+L+ + F +L+ +++ N +
Sbjct: 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
Query: 690 NS 691
Sbjct: 602 KV 603
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 6e-89
Identities = 129/552 (23%), Positives = 198/552 (35%), Gaps = 37/552 (6%)
Query: 54 NLTSIGLKG----TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLF 109
NLT + L + + F +L LDL N L + L+ L LS+N
Sbjct: 98 NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157
Query: 110 SGAIPP--QIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLG- 166
I S LK L L NQ+ P + L L L + L + L
Sbjct: 158 QALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
Query: 167 --NLTNLVTLCLYNNLLSGSIPSEIGNLKY--LLDLNLYNNELNGSIPQSLGNLSNLAML 222
T++ L L N+ LS + + LK+ L L+L N LN S L L
Sbjct: 218 ELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYF 277
Query: 223 NLSSNSLFGSIPSELGNLKYLSDLKLADN---------KLNGSIPHSLCNLTNLVILYIY 273
L N++ L L + L L + L S L L L +
Sbjct: 278 FLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNME 337
Query: 274 NNSLSGLIPSEIGNLKFLSKIALSYNKFS--GLIPHSLGNLSNIA--FLFLDSNSLFGLI 329
+N + G+ + L L ++LS + S L + +L++ L L N + +
Sbjct: 338 DNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE 397
Query: 330 PSELRNLKSLSILELGNNKLCGSIP-HFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLS 388
L L +L+LG N++ + L N+ +++ N + SL
Sbjct: 398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQ 457
Query: 389 YLNLAFNKLTS--SIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ 446
L L L + S P L NL++L N+++ L KL L L N
Sbjct: 458 RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517
Query: 447 ---------GPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEIS 497
GPI LK L+ L ++L+ N E F L IDL NNL +
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 498 SDWGRCPKLGALDFSKNNITGNIPPKIGYS-SQLEVLDLSSNHVVGDIPAELGKLSFLIK 556
S + L +L+ KN IT G + L LD+ N + ++++ +
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINE 637
Query: 557 LILAQNQLSGQL 568
+LS
Sbjct: 638 THTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-63
Identities = 81/442 (18%), Positives = 152/442 (34%), Gaps = 64/442 (14%)
Query: 265 TNLVILYIYNNSLSGLIPSEI-GNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSN 323
+ + + L+ +P ++ N+ L+ L++N+ L + S + L + N
Sbjct: 4 VSHEVADCSHLKLTQ-VPDDLPTNITVLN---LTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 324 SLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGN 383
++ L P + L L +L L +N+L TNL+ L + +NS+
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 384 LKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDN 443
K+L L+L+ N L+S+ + L NL L N + +E
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF----------- 168
Query: 444 QFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRC 503
+SL ++ L N + F+ L + L+ L ++
Sbjct: 169 ----------ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLE 218
Query: 504 PKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSF--LIKLILAQ 561
+ + L LS++ + L + L L L+
Sbjct: 219 LAN---------------------TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY 257
Query: 562 NQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLE 621
N L+ + L QLE+ L NN+ + SL L + YLNL +
Sbjct: 258 NNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS----------- 306
Query: 622 ELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISY 681
++ +S L + ++ LE LN+ N + G+ F + L+ + +S
Sbjct: 307 ----FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362
Query: 682 NELRGPIPNSTAFRDAPIKALQ 703
+ + F L
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLH 384
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 5e-56
Identities = 78/380 (20%), Positives = 130/380 (34%), Gaps = 26/380 (6%)
Query: 63 TLHDFSFSSFPHLAYLDLWSN---------QLFGNIPPQIGNISKLKYLDLSSNLFSGAI 113
L S ++ YL+L + L + L++L++ N G
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345
Query: 114 PPQIGHLSYLKTLHLFKNQLSGSIP----LEVGGLSSLNNLALYSNYLEDIIPHSLGNLT 169
L LK L L + S S L+ L L N + I + L
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405
Query: 170 NLVTLCLYNNLLSGSIP-SEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNS 228
+L L L N + + E L+ + ++ L N+ S + +L L L +
Sbjct: 406 HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465
Query: 229 L--FGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLS-------- 278
L S PS L+ L+ L L++N + L L L IL + +N+L+
Sbjct: 466 LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANP 525
Query: 279 GLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKS 338
G + L L + L N F + +L + + L N+L L S N S
Sbjct: 526 GGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVS 585
Query: 339 LSILELGNNKLCGSIP-HFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKL 397
L L L N + F NL+ L + N + + ++ + +L
Sbjct: 586 LKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPEL 645
Query: 398 TSSIP-ISLSNLTNLSVLSF 416
+S + + V F
Sbjct: 646 SSHYLCNTPPHYHGFPVRLF 665
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-33
Identities = 53/273 (19%), Positives = 93/273 (34%), Gaps = 21/273 (7%)
Query: 27 TFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLF 86
T N ++KI S A+ + + ++L + L + ++ + L N+
Sbjct: 389 TKNKISKIESDAFSWLG-----HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYL 443
Query: 87 GNIPPQIGNISKLKYLDLSSNLFSG--AIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGL 144
+ L+ L L + P L L L L N ++ + GL
Sbjct: 444 QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGL 503
Query: 145 SSLNNLALYSNYLEDI--------IPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLL 196
L L L N L + + L L++L L L +N +L L
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563
Query: 197 DLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELG-NLKYLSDLKLADNKLNG 255
++L N LN N +L LNL N + G + L++L + N +
Sbjct: 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
Query: 256 SIPH-----SLCNLTNLVILYIYNNSLSGLIPS 283
+ + N T+ I + ++ L P
Sbjct: 624 TCESIAWFVNWINETHTNIPELSSHYLCNTPPH 656
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-25
Identities = 43/168 (25%), Positives = 69/168 (41%), Gaps = 3/168 (1%)
Query: 527 SSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSN 586
+ EV D S + +P +L + + L L NQL + QL LD+ N
Sbjct: 3 TVSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 587 NLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICI 646
+S PE L L LNL +N+ S +L+EL L N + + +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 647 MQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAF 694
++L L+LSHN LS ++ LQ + +S N+++
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-11
Identities = 28/158 (17%), Positives = 52/158 (32%), Gaps = 8/158 (5%)
Query: 51 NSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFS 110
N++ + HL L+L SN ++ +LK +DL N +
Sbjct: 514 NNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN 573
Query: 111 GAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVG-GLSSLNNLALYSNYLEDIIPHSLG--- 166
+ LK+L+L KN ++ G +L L + N +
Sbjct: 574 TLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVN 633
Query: 167 --NLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYN 202
N T+ L ++ L + P G + + +
Sbjct: 634 WINETHTNIPELSSHYLCNTPPHYHG--FPVRLFDTSS 669
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 361 bits (929), Expect = e-112
Identities = 93/634 (14%), Positives = 195/634 (30%), Gaps = 101/634 (15%)
Query: 78 LDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSG-- 135
LD+W Q + + ++ L L SG +P IG L+ L+ L L +
Sbjct: 66 LDMWGAQ----PGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNE 121
Query: 136 --SIPLEVGGLSSLNNLALYSNYLEDIIPHSLG--NLTNLVTLCLYNNLLSGSIPSEIGN 191
P + S + + + ++L+ C+ ++ SI
Sbjct: 122 RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181
Query: 192 LKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADN 251
+ +N + + +++ L+ L + ++ E
Sbjct: 182 TLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYA 235
Query: 252 KLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGN 311
+ + NL +L + +YN +P+ + L + I ++ N+
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG------- 288
Query: 312 LSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLC-GSIPHFLGNLTNLSVLFIYN 370
+ ++ + + I+ +G N L + L + L +L
Sbjct: 289 ---------EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLY 339
Query: 371 NSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPK--E 428
N L G +P G+ L+ LNLA+N++T + LSF N L IP +
Sbjct: 340 NQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFD 397
Query: 429 YRNLVKLTKLFLGDNQFQGPIPN--------LKNLTSLVRVHLDRNYLTSNISESFYIYP 480
+++ ++ + N+ ++ ++L N ++ E F
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 481 NLTFIDLSYNNL-------YGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSS--QLE 531
L+ I+L N L + + ++ L ++D N +T + ++ L
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLV 516
Query: 532 VLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNA 591
+DLS N P + S L + D N
Sbjct: 517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ------------------RDAQGNRTLRE 557
Query: 592 IPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLE 651
PE + L L + +N + +I ++
Sbjct: 558 WPEGITLCPSLTQLQIGSNDIR-------------------------KVNEKI--TPNIS 590
Query: 652 KLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
L++ N + + Y++ +
Sbjct: 591 VLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-112
Identities = 102/643 (15%), Positives = 200/643 (31%), Gaps = 81/643 (12%)
Query: 36 SCAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGN 95
+ + G G N + + G S +S + L L G +P IG
Sbjct: 46 NWSQQGFGTQPGANWNF--NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103
Query: 96 ISKLKYLDLSSNLFSG----AIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGL--SSLNN 149
+++L+ L L S+ P I + + + S L
Sbjct: 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163
Query: 150 LALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSI 209
+ S+ + I S + +N ++ + + L L + N+
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAEN 222
Query: 210 PQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVI 269
N + + + NLK L+D+++ + +P L L + +
Sbjct: 223 ICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277
Query: 270 LYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGL- 328
+ + N K I +++ N+L
Sbjct: 278 INVACNRGISGEQ----------------LKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321
Query: 329 IPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLS 388
+ + L+ +K L +LE N+L G +P F G+ L+ L + N ++ G + +
Sbjct: 322 VETSLQKMKKLGMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQITEIPANFCGFTEQVE 380
Query: 389 YLNLAFNKLTS-SIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG 447
L+ A NKL +++ +S + F N + + F
Sbjct: 381 NLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGS----------------VDGKNFDP 424
Query: 448 PIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNL-------YGEISSDW 500
P ++ ++L N ++ E F L+ I+L N L + + ++
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
Query: 501 GRCPKLGALDFSKNNITGNIPPKIGYSS--QLEVLDLSSNHVVGDIPAELGKLSFLIKLI 558
L ++D N +T + ++ L +DLS N P + S L
Sbjct: 485 KNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542
Query: 559 LAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPI 618
+ D N PE + L L + +N ++
Sbjct: 543 IRNQ------------------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNE 583
Query: 619 KLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLS 661
K+ ++S LD+ N S +C L ++
Sbjct: 584 KI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 5e-78
Identities = 76/494 (15%), Positives = 161/494 (32%), Gaps = 69/494 (13%)
Query: 223 NLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSG--- 279
N + L + ++ L L +G +P ++ LT L +L + ++
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 280 -LIPSEIGNLKFLSKIALSYNKFSGLIPHSLG--NLSNIAFLFLDSNSLFGLIPSELRNL 336
P I + + + S++ ++S+ I R
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 337 KSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNK 396
+ + +N + + + LT L ++ N+ CE ++ Y
Sbjct: 183 LKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ---- 237
Query: 397 LTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLT 456
+ + NL +L+ + Y +P + L ++ + + N+ +
Sbjct: 238 -YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296
Query: 457 SLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNI 516
+L + + I + YNNL
Sbjct: 297 AL---------------ADAPVGEKIQIIYIGYNNL-----------------------K 318
Query: 517 TGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLV 576
T + + +L +L+ N + G +P G L L LA NQ++ + G
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 577 QLEHLDLSSNNLSNAIPESL--GNLVKLHYLNLSNNQFS-------WEIPIKLEELIHLS 627
Q+E+L + N L IP ++ + ++ S N+ + + I++S
Sbjct: 378 QVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436
Query: 628 ELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGV-------IPRCFEEMHALQCIDIS 680
++LS N + + L +NL N L+ + F+ + L ID+
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 681 YNELRGPIPNSTAF 694
+N+L + +
Sbjct: 497 FNKLTK-LSDDFRA 509
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 4e-59
Identities = 56/341 (16%), Positives = 111/341 (32%), Gaps = 28/341 (8%)
Query: 68 SFSSFPHLAYLDLWSNQLF-GNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTL 126
+ + + N L + + + KL L+ N G P G L +L
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASL 358
Query: 127 HLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDI-IPHSLGNLTNLVTLCLYNNLLSG-- 183
+L NQ++ G + NL+ N L+ I +++ + + N +
Sbjct: 359 NLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVD 418
Query: 184 -----SIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSL-------FG 231
+ + +NL NN+++ + S L+ +NL N L
Sbjct: 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478
Query: 232 SIPSELGNLKYLSDLKLADNKLNGSIP-HSLCNLTNLVILYIYNNSLSGLIPSEIGNLKF 290
N L+ + L NKL L LV + + NS S P++ N
Sbjct: 479 DENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSST 537
Query: 291 LSKIAL------SYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILEL 344
L + N+ P + ++ L + SN + + N+ L +
Sbjct: 538 LKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLD---I 594
Query: 345 GNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLK 385
+N ++ + ++ + C+ ++K
Sbjct: 595 KDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDALDIK 635
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = 3e-98
Identities = 115/556 (20%), Positives = 186/556 (33%), Gaps = 40/556 (7%)
Query: 72 FPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKN 131
LDL N L + +L+ LDLS LS+L TL L N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 132 QLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCL-YNNLLSGSIPSEIG 190
+ GLSSL L L + +G+L L L + +N + S +P
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 191 NLKYLLDLNLYNNELNGSIPQSLGNLSNLAM----LNLSSNSLFGSIPSELGNLKYLSDL 246
NL L L+L +N++ L L + + L+LS N + P ++ L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKL 205
Query: 247 KLADNKLNGSIPHSLC-NLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLI 305
L +N + ++ + L L + + +
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR------------------NEGNLEKFD 247
Query: 306 PHSLGNLSNIAFLFLDSNSL---FGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTN 362
+L L N+ L I L ++S L + +
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFG 305
Query: 363 LSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLS 422
L + N ++ +LK L++ + S +L +L L +N LS
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGLS 360
Query: 423 --GAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISES-FYIY 479
G + L L L N N L L + + L S F
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 480 PNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKI-GYSSQLEVLDLSSN 538
NL ++D+S+ + + + L L + N+ N P I L LDLS
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480
Query: 539 HVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGN 598
+ P LS L L ++ N + L L+ LD S N++ + + L +
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 540
Query: 599 LVK-LHYLNLSNNQFS 613
L +LNL+ N F+
Sbjct: 541 FPSSLAFLNLTQNDFA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 321 bits (825), Expect = 7e-98
Identities = 122/545 (22%), Positives = 208/545 (38%), Gaps = 33/545 (6%)
Query: 167 NLTNLVTLCLYNNLLSGSIPSEIG-NLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLS 225
+ N+ C+ N IP + + K L +L N L S + L +L+LS
Sbjct: 6 VVPNITYQCMELNFYK--IPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 226 SNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEI 285
+ +L +LS L L N + + L++L L +L+ L I
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 286 GNLKFLSKIALSYNKFSGL-IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSI--- 341
G+LK L ++ +++N +P NL+N+ L L SN + + ++LR L + +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 342 -LELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCE-IGNLKSLSYLNLAFNKLTS 399
L+L N + P + L L + NN S ++ I L L L + +
Sbjct: 181 SLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
Query: 400 SIPI------SLSNLTNLSVLSFYKNSLS---GAIPKEYRNLVKLTKLFLGDNQFQGPIP 450
+ +L L NL++ F L I + L ++ L + +
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VK 298
Query: 451 NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALD 510
+ + L + LTF N + E+ P L LD
Sbjct: 299 DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD-----LPSLEFLD 353
Query: 511 FSKNNIT--GNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQL 568
S+N ++ G ++ L+ LDLS N V+ + + L L L + L
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMS 412
Query: 569 SPK-LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEI-PIKLEELIHL 626
L L +LD+S + A L L L ++ N F P EL +L
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 627 SELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRG 686
+ LDLS L + P+ + SL+ LN+SHN+ + ++ +++LQ +D S N +
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 532
Query: 687 PIPNS 691
Sbjct: 533 SKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 319 bits (820), Expect = 4e-97
Identities = 121/541 (22%), Positives = 196/541 (36%), Gaps = 28/541 (5%)
Query: 145 SSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNE 204
S NL L N L + +S + L L L + +L +L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 205 LNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNG-SIPHSLCN 263
+ + LS+L L +L +G+LK L +L +A N + +P N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 264 LTNLVILYIYNNSLSGLIPSEIGNLKFLSKIA----LSYNKFSGLIPHSLGNLSNIAFLF 319
LTNL L + +N + + +++ L + + LS N + + P + + + L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLT 206
Query: 320 LDSNSLFGLIPSE-LRNLKSLSILELGNNKLCGS------IPHFLGNLTNLSVLFIYNNS 372
L +N + ++ L L + L + L L NL++
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 373 LSGS---IPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEY 429
L I L ++S +L + S L
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPT--- 321
Query: 430 RNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLT--SNISESFYIYPNLTFIDL 487
L L +L N+ + +L SL + L RN L+ S+S + +L ++DL
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 488 SYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKI-GYSSQLEVLDLSSNHVVGDIPA 546
S+N + +SS++ +L LDF +N+ + L LD+S H
Sbjct: 381 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 547 ELGKLSFLIKLILAQNQLSGQLSPK-LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYL 605
LS L L +A N P L L LDLS L P + +L L L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 606 NLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQIC-IMQSLEKLNLSHNSLSGVI 664
N+S+N F + L L LD S N + + ++ SL LNL+ N +
Sbjct: 500 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 559
Query: 665 P 665
Sbjct: 560 E 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-59
Identities = 75/400 (18%), Positives = 126/400 (31%), Gaps = 24/400 (6%)
Query: 49 RVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNI---PPQIGNISKLKYLDLS 105
R++ + L + + L L + + L L +
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 106 SN------LFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLED 159
+ I L+ + + L + +L L +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF--SYNFGWQHLELVNCKFGQ 318
Query: 160 IIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELN--GSIPQSLGNLS 217
L +L L G +L L L+L N L+ G QS +
Sbjct: 319 FPTLKLKSLKR-----LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 218 NLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHS-LCNLTNLVILYIYNNS 276
+L L+LS N + + S L+ L L + L S +L NL+ L I +
Sbjct: 374 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432
Query: 277 LSGLIPSEIGNLKFLSKIALSYNKFSGLI-PHSLGNLSNIAFLFLDSNSLFGLIPSELRN 335
L L + ++ N F P L N+ FL L L L P+ +
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 336 LKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNL-KSLSYLNLAF 394
L SL +L + +N L +L VL N + S E+ + SL++LNL
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552
Query: 395 NKLTSSIPIS--LSNLTNLSVLSFYKNSLSGAIPKEYRNL 432
N + L + + L + A P + + +
Sbjct: 553 NDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM 592
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-47
Identities = 78/440 (17%), Positives = 137/440 (31%), Gaps = 80/440 (18%)
Query: 261 LCNLTNLVILYIYNNSLSGLIPSEIG-NLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLF 319
+ + N+ + N IP + + K L LS+N L +S + + L
Sbjct: 4 VEVVPNITYQCMELNFYK--IPDNLPFSTKNLD---LSFNPLRHLGSYSFFSFPELQVLD 58
Query: 320 LDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPC 379
L + + ++L LS L L N + L++L L +L+
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 380 EIGNLKSLSYLNLAFNKLTS-SIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKL 438
IG+LK+L LN+A N + S +P SNLTNL L N + +
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD---------- 168
Query: 439 FLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISS 498
+ L + L +DLS N + I
Sbjct: 169 ----------LRVLHQMPLL-----------------------NLSLDLSLNPM-NFIQP 194
Query: 499 DWGRCPKLGALDFSKNNITGNIPPKIGYS-SQLEVLDLSSNHVVGDI---PAELGKLSFL 554
+ +L L N + N+ + LEV L + + L L
Sbjct: 195 GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254
Query: 555 IKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSW 614
L + + +L+ +LD ++ I + L + +L +
Sbjct: 255 CNLTIEEFRLA--------------YLDYYLDD----IIDLFNCLTNVSSFSLVSVTIER 296
Query: 615 EIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHAL 674
L+L Q ++ L+ S G ++ +L
Sbjct: 297 VKD--FSYNFGWQHLELVNCKF-----GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSL 349
Query: 675 QCIDISYNELRGPIPNSTAF 694
+ +D+S N L S +
Sbjct: 350 EFLDLSRNGLSFKGCCSQSD 369
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 318 bits (816), Expect = 5e-94
Identities = 92/608 (15%), Positives = 186/608 (30%), Gaps = 75/608 (12%)
Query: 78 LDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSI 137
LD+W +Q + N ++ L L+ G +P IG L+ LK L + + S
Sbjct: 308 LDMWGDQPGV----DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 138 PLEVGGLSSLNNLALYSNYLE-DIIPHSLGNLTNLVTLCLYNNLLS-----GSIPSEIGN 191
L + + + + L L L + ++ I +
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423
Query: 192 LKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADN 251
+ N + I +++ L+ L ++ +++ + D
Sbjct: 424 SLKDTQIGNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYA 477
Query: 252 KLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGN 311
K + S NL +L + +YN +P + +L L + ++ N+ +
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKAD 536
Query: 312 LSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCG-SIPHFLGNLTNLSVLFIYN 370
+ + + + I +G N L L + L +L +
Sbjct: 537 WTR--------------LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVH 582
Query: 371 NSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEY- 429
N + + G L+ L L +N++ + + L F N L IP +
Sbjct: 583 NKVR-HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFN 639
Query: 430 -RNLVKLTKLFLGDNQFQGPIPNL------KNLTSLVRVHLDRNYLTSNISESFYIYPNL 482
+++ + + N+ N+ + V L N + +E F +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699
Query: 483 TFIDLSYNNL-------YGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYS--SQLEVL 533
+ I LS N + ++ L +D N +T + + L +
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNM 758
Query: 534 DLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIP 593
D+S N P + S L + D N + P
Sbjct: 759 DVSYNC-FSSFPTQPLNSSQLKAFGIRHQ------------------RDAEGNRILRQWP 799
Query: 594 ESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKL 653
+ L L + +N ++ KL L LD++ N + +C
Sbjct: 800 TGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMY 856
Query: 654 NLSHNSLS 661
L ++
Sbjct: 857 VLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 260 bits (665), Expect = 3e-73
Identities = 82/514 (15%), Positives = 153/514 (29%), Gaps = 58/514 (11%)
Query: 197 DLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGS 256
+ N + L N + L+L+ G +P +G L L L + S
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 257 IPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIA 316
+ + + + Y K L +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIR-----------------MHYKKMFLDYDQRLNLSDLLQ 405
Query: 317 FLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGS 376
+ + + +LK I L N I + LT L +++ N+ +
Sbjct: 406 DAINRNPEMKPIKKDSRISLKDTQIGNLTNRI--TFISKAIQRLTKLQIIYFANSPFTYD 463
Query: 377 IPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLT 436
+ Y K + +S SNL +L+ + Y +P +L +L
Sbjct: 464 NIAVDWEDANSDY-----AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ 518
Query: 437 KLFLGDNQFQGPI----------PNLKNLTSLVRVHLDRNYLTS-NISESFYIYPNLTFI 485
L + N+ + + ++ N L S S L +
Sbjct: 519 SLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLL 578
Query: 486 DLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGY-SSQLEVLDLSSNHVVGDI 544
D +N + +G KL L N I IP + Q+E L S N + I
Sbjct: 579 DCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNK-LKYI 634
Query: 545 P--AELGKLSFLIKLILAQNQLSGQ-----LSPKLGLLVQLEHLDLSSNNLSNAIPESLG 597
P + + + + N++ + S + + LS N + E
Sbjct: 635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFA 694
Query: 598 NLVKLHYLNLSNNQFS-------WEIPIKLEELIHLSELDLSYNFLGRAIPSQICI--MQ 648
+ + LSNN + + L+ +DL +N L ++ +
Sbjct: 695 TGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLP 753
Query: 649 SLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYN 682
L +++S+N S P L+ I +
Sbjct: 754 YLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ 786
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 4e-59
Identities = 58/393 (14%), Positives = 132/393 (33%), Gaps = 42/393 (10%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSG---------AI 113
+ S+S+ L ++L++ +P + ++ +L+ L+++ N +
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
Query: 114 PPQIGHLSYLKTLHLFKNQLSG-SIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLV 172
++ ++ N L + + L L N + + + G L
Sbjct: 541 ADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLT 598
Query: 173 TLCLYNNLLSGSIPSEIG-NLKYLLDLNLYNNELNGSIPQ--SLGNLSNLAMLNLSSNSL 229
L L N + IP + + L +N+L IP + ++ + ++ S N +
Sbjct: 599 DLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKI 656
Query: 230 FGSIPSELG------NLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGL--- 280
GS + S + L+ N++ + + + + NN ++ +
Sbjct: 657 -GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 281 ----IPSEIGNLKFLSKIALSYNKFSGLIPH-SLGNLSNIAFLFLDSNSLFGLIPSELRN 335
N L+ I L +NK + L L ++ + + N P++ N
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLN 774
Query: 336 LKSLSILEL------GNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSY 389
L + N++ P + +L L I +N + + ++ L
Sbjct: 775 SSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYI 831
Query: 390 LNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLS 422
L++A N S S+ + +
Sbjct: 832 LDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-26
Identities = 34/232 (14%), Positives = 72/232 (31%), Gaps = 34/232 (14%)
Query: 54 NLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFS--- 110
+ S + + + + L N++ S + + LS+NL +
Sbjct: 655 KIGSE-GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIP 713
Query: 111 ----GAIPPQIGHLSYLKTLHLFKNQLSGSIP--LEVGGLSSLNNLALYSNYLEDIIPHS 164
+ L T+ L N+L+ S+ L L+N+ + N P
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQ 771
Query: 165 LGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNL 224
N + L + + + N + P + +L L +
Sbjct: 772 PLNSSQLKAFGIRHQ------------------RDAEGNRILRQWPTGITTCPSLIQLQI 813
Query: 225 SSNSLFGSIPSELGNLKYLSDLKLADNKL-NGSIPHSLCNLTNLVILYIYNN 275
SN + + +L L L +ADN + + + + + +Y+
Sbjct: 814 GSNDI-RKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = 8e-94
Identities = 116/553 (20%), Positives = 199/553 (35%), Gaps = 20/553 (3%)
Query: 124 KTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG 183
KT + L+ IP + +S L N L I + L NL L L +
Sbjct: 15 KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 184 SIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYL 243
+ L L L N L +L L L + L N K L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 244 SDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIAL--SYNKF 301
L L N ++ L +L NN++ L ++ +L+ + ++L + N
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 302 SGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRN--LKSLSILELGNNKLCGSIPHFLGN 359
+G I + + L +I L+N ++SL + + P
Sbjct: 192 AG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 360 LTNLSV--LFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFY 417
L +SV + + + L L+L L+ +P L L+ L L
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 418 KNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTS--NIS 473
N N LT L + N + + L+NL +L + L + + + +
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 474 ESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKI-GYSSQLEV 532
+L ++LSYN + + CP+L LD + + L+V
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429
Query: 533 LDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSG---QLSPKLGLLVQLEHLDLSSNNLS 589
L+LS + + L L L L N Q + L L +LE L LS +LS
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 590 NAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQS 649
+ + +L +++++LS+N+ + L L + L+L+ N + +PS + I+
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQ 548
Query: 650 LEKLNLSHNSLSG 662
+NL N L
Sbjct: 549 QRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = 3e-90
Identities = 110/561 (19%), Positives = 201/561 (35%), Gaps = 35/561 (6%)
Query: 64 LHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYL 123
L++ + L+ N L + L +LDL+ L
Sbjct: 24 LNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 124 KTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG 183
TL L N L + G +L +L + I L N L +L L +N +S
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 184 SIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAM--LNLSSNSLFGSIPSELGNLK 241
+ + L L+ NN ++ + + +L LNL+ N + I +
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSA 202
Query: 242 YLSDLKLADNKLNGSIPHSL--CNLTNLVILYIYNNSLSGLIPSEIGNLKFLS--KIALS 297
L + I L + +L + + + P+ L +S I L
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262
Query: 298 YNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFL 357
+ F + ++ S + L L + L +PS L L +L L L NK
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISA 321
Query: 358 GNLTNLSVLFIYNNSLSGSI-PCEIGNLKSLSYLNLAFNKLTSS--IPISLSNLTNLSVL 414
N +L+ L I N+ + + NL++L L+L+ + + +S + L NL++L L
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381
Query: 415 SFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNI 472
+ N + ++ +L L L + + +NL L ++L + L +
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISS 441
Query: 473 SESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEV 532
+ F P L ++L N+ L +LE+
Sbjct: 442 EQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL---------------------GRLEI 480
Query: 533 LDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAI 592
L LS + L + + L+ N+L+ S + ++ +L+L+SN++S +
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLKGIYLNLASNHISIIL 539
Query: 593 PESLGNLVKLHYLNLSNNQFS 613
P L L + +NL N
Sbjct: 540 PSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 4e-75
Identities = 94/485 (19%), Positives = 175/485 (36%), Gaps = 19/485 (3%)
Query: 221 MLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGL 280
N + L IP L L+ + N L + L NL L + + +
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 281 IPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLS 340
+ L + L+ N + +L + LF + + L N K+L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 341 ILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLS--YLNLAFNKLT 398
L LG+N + L VL NN++ ++ +L+ + LNL N +
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 399 SSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRN--LVKLTKLFLGDNQFQGPIPNLKN-- 454
I + L+F I K +N + L D + P +
Sbjct: 193 G-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 455 -LTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSK 513
S+ ++L ++Y + S +F+ + L +DL+ +L E+ S L L S
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSA 310
Query: 514 NNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAE-LGKLSFLIKLILAQNQL--SGQLSP 570
N L L + N ++ L L L +L L+ + + S +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 571 KLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSW-EIPIKLEELIHLSEL 629
+L L L+ L+LS N + E+ +L L+L+ + + + L L L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430
Query: 630 DLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRC---FEEMHALQCIDISYNELRG 686
+LS++ L + + +L+ LNL N + + + L+ + +S+ +L
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 687 PIPNS 691
++
Sbjct: 491 IDQHA 495
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 5e-47
Identities = 59/359 (16%), Positives = 106/359 (29%), Gaps = 36/359 (10%)
Query: 341 ILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSS 400
N L IP L + L N L L +L++L+L ++
Sbjct: 16 TYNCENLGL-NEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 401 IPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN-LKNLTSLV 459
+ + L L N L L LF L N +L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 460 RVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLG--ALDFSKNNIT 517
++L N+++S + L +D N ++ D + +L+ + N+I
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 518 GNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSF--LIKLILAQNQLSG--QLSPKLG 573
G I P S+ + L+ + I L + L +
Sbjct: 193 G-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 574 LLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSY 633
+ +E ++L + N + L L+L+ S
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-------------------- 291
Query: 634 NFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNST 692
+PS + + +L+KL LS N + +L + I N R +
Sbjct: 292 -----ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC 345
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-22
Identities = 27/161 (16%), Positives = 53/161 (32%), Gaps = 3/161 (1%)
Query: 531 EVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSN 590
+ + + + +IP L + L + N L + L+ L LDL+ +
Sbjct: 15 KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 591 AIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSL 650
++ + +L L L+ N + L L L + + ++L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 651 EKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNS 691
E L L N +S + L+ +D N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 294 bits (756), Expect = 2e-91
Identities = 95/290 (32%), Positives = 157/290 (54%), Gaps = 15/290 (5%)
Query: 788 YEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 847
E+ A+++F +++ +G+GG G VYK LA G ++AVK+ + +F EV+
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE--RTQGGELQFQTEVE 79
Query: 848 ALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL-SNDAAAEDLEWTQRMSVIKG 906
++ HRN+++ GFC +VY Y+ GS+A L + L+W +R + G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN-WTELAGTY 965
A L+YLH+ C P I+HRD+ + N+LLD + EA V DFG+AK + ++ T + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
Query: 966 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL---------NI 1016
G++APE T K +EK DV+ +GV+ LE+I G+ D L + + L
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 1017 ALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
L+ ++D L + E++ ++VA+ C SP RP M +V ++L+
Sbjct: 260 KLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 4e-86
Identities = 85/305 (27%), Positives = 129/305 (42%), Gaps = 27/305 (8%)
Query: 102 LDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDII 161
D + + G + + L L L P I
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP----------------------I 68
Query: 162 PHSLGNLTNLVTLCLYN-NLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLA 220
P SL NL L L + N L G IP I L L L + + ++G+IP L + L
Sbjct: 69 PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128
Query: 221 MLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLV-ILYIYNNSLSG 279
L+ S N+L G++P + +L L + N+++G+IP S + + L + I N L+G
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 280 LIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSL 339
IP NL L+ + LS N G G+ N + L NSL + + K+L
Sbjct: 189 KIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNL 246
Query: 340 SILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTS 399
+ L+L NN++ G++P L L L L + N+L G IP + GNL+ A NK
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLC 305
Query: 400 SIPIS 404
P+
Sbjct: 306 GSPLP 310
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 6e-85
Identities = 96/305 (31%), Positives = 149/305 (48%), Gaps = 14/305 (4%)
Query: 2 EEAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCN---HGGRVNSINLTSI 58
++ ALL+ K L N LSSW T + W+G+ C+ RVN+++L+ +
Sbjct: 6 QDKQALLQIKKDLGNPTT---LSSW--LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGL 60
Query: 59 GLKGTLH-DFSFSSFPHLAYLDLWS-NQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQ 116
L S ++ P+L +L + N L G IPP I +++L YL ++ SGAIP
Sbjct: 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
Query: 117 IGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVT-LC 175
+ + L TL N LSG++P + L +L + N + IP S G+ + L T +
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180
Query: 176 LYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPS 235
+ N L+G IP NL L ++L N L G G+ N ++L+ NSL +
Sbjct: 181 ISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239
Query: 236 ELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIA 295
+G K L+ L L +N++ G++P L L L L + N+L G IP GNL+ A
Sbjct: 240 -VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSA 297
Query: 296 LSYNK 300
+ NK
Sbjct: 298 YANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 1e-70
Identities = 82/318 (25%), Positives = 138/318 (43%), Gaps = 54/318 (16%)
Query: 274 NNSLSGLIPSEIGNLKFLSKIALSYNKFSG--LIPHSLGNLSNIAFLFL-DSNSLFGLIP 330
N + G++ ++ + LS IP SL NL + FL++ N+L G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 331 SELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYL 390
+ L L L + + + G+IP FL + L L N+LSG++P I +L +L +
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 391 NLAFNKLTSSIPISLSNLTNLS-VLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPI 449
N+++ +IP S + + L ++ +N L+G IP + NL
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL----------------- 197
Query: 450 PNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGAL 509
NL F+DLS N L G+ S +G +
Sbjct: 198 -------------------------------NLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 510 DFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLS 569
+KN++ ++ K+G S L LDL +N + G +P L +L FL L ++ N L G++
Sbjct: 227 HLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI- 284
Query: 570 PKLGLLVQLEHLDLSSNN 587
P+ G L + + ++N
Sbjct: 285 PQGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-66
Identities = 75/328 (22%), Positives = 132/328 (40%), Gaps = 37/328 (11%)
Query: 400 SIPISLSNLTNLS----VLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPI---PNL 452
I L N T LS + G + ++ L L P +L
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 453 KNLTSLVRVHL-DRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDF 511
NL L +++ N L I + L ++ +++ N+ G I + L LDF
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 512 SKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIK-LILAQNQLSGQLSP 570
S N ++G +PP I L + N + G IP G S L + +++N+L+G++ P
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
Query: 571 KLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELD 630
L L +DLS N L G+ ++L+ N ++++
Sbjct: 193 TFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG------------- 238
Query: 631 LSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPN 690
++ + ++L L+L +N + G +P+ ++ L +++S+N L G IP
Sbjct: 239 ------------KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 691 STAFRDAPIKALQGNKGLCGDFKGLPSC 718
+ + A NK LCG LP+C
Sbjct: 287 GGNLQRFDVSAYANNKCLCG--SPLPAC 312
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 2e-85
Identities = 113/549 (20%), Positives = 203/549 (36%), Gaps = 30/549 (5%)
Query: 161 IPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLA 220
+ + + N+ C+ L +P +I + +++L N L S N S L
Sbjct: 4 LNPCIEVVPNITYQCMDQKLSK--VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQ 59
Query: 221 MLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGL 280
L+LS + L +LS+L L N + P S LT+L L L+ L
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASL 119
Query: 281 IPSEIGNLKFLSKIALSYNKFSGL-IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSL 339
IG L L K+ +++N +P NL+N+ + L N + + ++L+ L+
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 340 SI----LELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCE-IGNLKSLSYLNLAF 394
L++ N + I L L + N S +I + NL L L
Sbjct: 180 PQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLIL 238
Query: 395 NKLTSSIPIS------LSNLTNLSVLSFY--KNSLSGAIPKEYRNLVKLTKLFLGDNQFQ 446
+ + + L ++++ F + ++ L ++ + L +
Sbjct: 239 GEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298
Query: 447 GPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKL 506
+ ++ + + R L + P L + L+ N IS P L
Sbjct: 299 Y-LEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKG--SISFKKVALPSL 352
Query: 507 GALDFSKNNIT--GNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQL 564
LD S+N ++ G ++ L LDLS N + + A L L L + L
Sbjct: 353 SYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTL 411
Query: 565 SGQLSPK-LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIK-LEE 622
L +L +LD+S N L L+ L ++ N F
Sbjct: 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
Query: 623 LIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYN 682
+L+ LDLS L + + L+ LN+SHN+L + + ++++L +D S+N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531
Query: 683 ELRGPIPNS 691
+
Sbjct: 532 RIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 3e-85
Identities = 124/569 (21%), Positives = 212/569 (37%), Gaps = 30/569 (5%)
Query: 111 GAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTN 170
G++ P I + + T +LS +P ++ SS N+ L N L+ + +S N +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 171 LVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLF 230
L L L + L +L +L L N + P S L++L L L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 231 GSIPSELGNLKYLSDLKLADNKLNG-SIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLK 289
+G L L L +A N ++ +P NLTNLV + + N + + +++ L+
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 290 FLS----KIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSE-LRNLKSLSILEL 344
+ +S N + + + + L L N I L+NL L + L
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 345 ------GNNKLCGSIPHFLGNLTNLSVLFIY--NNSLSGSIPCEIGNLKSLSYLNLAFNK 396
L P + L ++++ + + L ++S ++LA
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 397 LTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLT 456
+ + LS + L P +L L L L N+ L
Sbjct: 297 IKY--LEDVPKHFKWQSLSIIRCQLKQ-FPTL--DLPFLKSLTLTMNKGSI-SFKKVALP 350
Query: 457 SLVRVHLDRNYLTSNISESFYI--YPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKN 514
SL + L RN L+ + S+ +L +DLS+N +S+++ +L LDF +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHS 409
Query: 515 NITGNIPPK-IGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPK-L 572
+ +L LD+S + D L+ L L +A N
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469
Query: 573 GLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLS 632
L LDLS L L +L LN+S+N + +L LS LD S
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529
Query: 633 YNFLGRAIPSQICIMQSLEKLNLSHNSLS 661
+N + + +SL NL++NS++
Sbjct: 530 FNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 5e-84
Identities = 124/554 (22%), Positives = 190/554 (34%), Gaps = 29/554 (5%)
Query: 78 LDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSI 137
+L +P I S K +DLS N + S L+ L L + ++
Sbjct: 16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72
Query: 138 PLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLD 197
GL L+NL L N ++ P S LT+L L L+ IG L L
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKK 132
Query: 198 LNLYNNELNG-SIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSD----LKLADNK 252
LN+ +N ++ +P NL+NL ++LS N + ++L L+ L ++ N
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192
Query: 253 LNGSIPHSLCNLTNLVILYIYNNSLSGLIPSE-IGNLKFLSKIALSYNKFSG------LI 305
++ I L L + N S I + NL L L +F
Sbjct: 193 ID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251
Query: 306 PHSLGNLSNIAFLFLD--SNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNL 363
P + L ++ + F + L ++S + L + +
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKW 309
Query: 364 SVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLS- 422
L I L P +L L L L NK SI L +LS L +N+LS
Sbjct: 310 QSLSIIRCQLK-QFP--TLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSF 364
Query: 423 -GAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISES-FYIYP 480
G L L L N N L L + + L S F
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE 424
Query: 481 NLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKI-GYSSQLEVLDLSSNH 539
L ++D+SY N + + L L + N+ N + ++ L LDLS
Sbjct: 425 KLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 540 VVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNL 599
+ L L L ++ N L S L L LD S N + +
Sbjct: 485 LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFP 544
Query: 600 VKLHYLNLSNNQFS 613
L + NL+NN +
Sbjct: 545 KSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 9e-65
Identities = 98/496 (19%), Positives = 179/496 (36%), Gaps = 39/496 (7%)
Query: 207 GSIPQSLGNLSNLAMLNLSSNSLFGSIPSELG-NLKYLSDLKLADNKLNGSIPHSLCNLT 265
GS+ + + N+ L +P ++ + K + L+ N L +S N +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPSSTKNID---LSFNPLKILKSYSFSNFS 56
Query: 266 NLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSL 325
L L + + + L LS + L+ N P S L+++ L L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 326 FGLIPSELRNLKSLSILELGNNKLCG-SIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNL 384
L + L +L L + +N + +P + NLTNL + + N + ++ L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176
Query: 385 KSLS----YLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKE-YRNLVKLTKLF 439
+ L+++ N + I L L+ N S I K +NL L
Sbjct: 177 RENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235
Query: 440 LGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSD 499
L +F+ NL+ + L + L+Y N + +
Sbjct: 236 LILGEFKD-ERNLEIFEPSIMEGLCDVTIDEF--------------RLTYTNDFSDDIVK 280
Query: 500 WGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLIL 559
+ + A+ + +I + + + L + + P L FL L L
Sbjct: 281 FHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL-KQFPT--LDLPFLKSLTL 335
Query: 560 AQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNL--VKLHYLNLSNNQFSWEIP 617
N+ S +S K L L +LDLS N LS + S +L L +L+LS N +
Sbjct: 336 TMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMS 392
Query: 618 IKLEELIHLSELDLSYNFLGRAIP-SQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQC 676
L L LD ++ L R S ++ L L++S+ + F + +L
Sbjct: 393 ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNT 452
Query: 677 IDISYNELRGPIPNST 692
+ ++ N + ++
Sbjct: 453 LKMAGNSFKDNTLSNV 468
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 2e-62
Identities = 93/474 (19%), Positives = 161/474 (33%), Gaps = 28/474 (5%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGA-IPPQIGHLS 121
+ SFS L L +L IG + LK L+++ N +P +L+
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 122 YLKTLHLFKNQLSGSIPLEVGGLSSLNN----LALYSNYLEDIIPHSLGNLTNLVTLCLY 177
L + L N + ++ L L + N ++ I + + L L L
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLR 212
Query: 178 NNLLSGSIPSE-IGNLKYLLDLNLYNNELNGSI------PQSLGNLSNLAM--LNLSSNS 228
N S +I + NL L L E P + L ++ + L+ +
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 229 LFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNL 288
F + L +S + LA + + L I L ++ L
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFL 330
Query: 289 KFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLK--SLSILELGN 346
K L+ L+ NK S I L ++++L L N+L +L SL L+L
Sbjct: 331 KSLT---LTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSF 385
Query: 347 NKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCE-IGNLKSLSYLNLAFNKLTSSIPISL 405
N + L L L +++L +L+ L YL++++
Sbjct: 386 NGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444
Query: 406 SNLTNLSVLSFYKNSLSGAIPKEY-RNLVKLTKLFLGDNQFQGPIPN-LKNLTSLVRVHL 463
LT+L+ L NS N LT L L Q + L L +++
Sbjct: 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504
Query: 464 DRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNIT 517
N L S + +L+ +D S+N + L + + N++
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-48
Identities = 67/361 (18%), Positives = 116/361 (32%), Gaps = 20/361 (5%)
Query: 52 SINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNIS--------KLKYLD 103
+ L + + L L + +I S +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 104 LSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPH 163
L+ + L+ + + L + + +L++ L+
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP--KHFKWQSLSIIRCQLKQF--- 322
Query: 164 SLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNL--SNLAM 221
+L L +L L N S I + L L L+L N L+ S S +L ++L
Sbjct: 323 PTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380
Query: 222 LNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHS-LCNLTNLVILYIYNNSLSGL 280
L+LS N + + L+ L L + L S +L L+ L I +
Sbjct: 381 LDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439
Query: 281 IPSEIGNLKFLSKIALSYNKFSGLIPHS-LGNLSNIAFLFLDSNSLFGLIPSELRNLKSL 339
L L+ + ++ N F + N +N+ FL L L + L L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499
Query: 340 SILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTS 399
+L + +N L L +LS L N + S KSL++ NL N +
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC 559
Query: 400 S 400
Sbjct: 560 I 560
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-38
Identities = 62/338 (18%), Positives = 104/338 (30%), Gaps = 53/338 (15%)
Query: 16 NHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHL 75
+ N F+ ++
Sbjct: 269 TYTNDFSDDIVKFHC-----------------------------------------LANV 287
Query: 76 AYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSG 135
+ + L + + K + L + P L +LK+L L N+
Sbjct: 288 SAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ-FPTL--DLPFLKSLTLTMNKG-- 340
Query: 136 SIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNL--TNLVTLCLYNNLLSGSIPSEIGNLK 193
SI + L SL+ L L N L S +L +L L L N + + L+
Sbjct: 341 SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLE 399
Query: 194 YLLDLNLYNNELNGSIPQS-LGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNK 252
L L+ ++ L S +L L L++S + L L+ LK+A N
Sbjct: 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNS 459
Query: 253 LNGSIPHS-LCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGN 311
+ + N TNL L + L + L L + +S+N L
Sbjct: 460 FKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQ 519
Query: 312 LSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKL 349
L +++ L N + KSL+ L NN +
Sbjct: 520 LYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 4e-83
Identities = 99/324 (30%), Positives = 150/324 (46%), Gaps = 32/324 (9%)
Query: 760 KNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELAS 819
S+ S + ++ ++ ATN+FD + IG G G VYK L
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 820 GEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYL 877
G +A+K+ + Q +EF E++ L+ RH ++V GFC ++Y+Y+
Sbjct: 63 GAKVALKRRTP-----ESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 878 EMGSLAMILS-NDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF 936
E G+L L +D + W QR+ + G A L YLH I+HRD+ S N+LLD
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDE 174
Query: 937 KNEARVSDFGIAKFLKPDSSNW---TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 993
+++DFGI+K + T + GT GY+ PE ++TEK DVYSFGV+ E
Sbjct: 175 NFVPKITDFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 994 VIKGKHPGDFISLISSSSLNLNIA-----------LDEILDPRLPIPSHNVQEKLISFVE 1042
V+ + S +N+A L++I+DP L E L F +
Sbjct: 234 VLCARSAIVQ----SLPREMVNLAEWAVESHNNGQLEQIVDPNL--ADKIRPESLRKFGD 287
Query: 1043 VAISCLDESPESRPTMQKVSQLLK 1066
A+ CL S E RP+M V L+
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 4e-73
Identities = 91/300 (30%), Positives = 146/300 (48%), Gaps = 35/300 (11%)
Query: 788 YEEIIRATNDFDDEHC------IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQ-- 839
+ E+ TN+FD+ +G+GG G VYK + + +AVKK + + T +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT-TEELK 74
Query: 840 QEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQ 899
Q+F E+K + + +H N+V+ GF S +VY Y+ GSL LS L W
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 900 RMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW- 958
R + +G A+ +++LH + +HRDI S N+LLD A++SDFG+A+ +
Sbjct: 135 RCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQTV 190
Query: 959 --TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL-- 1014
+ + GT Y+APE A ++T K D+YSFGV+ LE+I G D L
Sbjct: 191 MTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE----HREPQLLLD 245
Query: 1015 --------NIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+++ +D ++ + + + VA CL E RP ++KV QLL+
Sbjct: 246 IKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 4e-67
Identities = 72/308 (23%), Positives = 127/308 (41%), Gaps = 38/308 (12%)
Query: 788 YEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 847
E + + +G G V+K +L E +AVK F P+ + ++Q E+ EV
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF--PIQDKQSWQNEY--EVY 70
Query: 848 ALTEIRHRNIVKFYGFCSHAQHS----FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSV 903
+L ++H NI++F G +++ + E GSL+ L + + W + +
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHI 126
Query: 904 IKGIADALSYLHNDCF-------PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956
+ +A L+YLH D P I HRDI SKNVLL A ++DFG+A + S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 957 NW--TELAGTYGYVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGKHPGDFIS---- 1005
GT Y+APE+ + + D+Y+ G++ E+ D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 1006 LISSSSLNLNIALDEILDP------RLPIPSH-NVQEKLISFVEVAISCLDESPESRPTM 1058
L + + +L+++ + R + + + E C D E+R +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 1059 QKVSQLLK 1066
V + +
Sbjct: 307 GCVGERIT 314
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 5e-67
Identities = 120/536 (22%), Positives = 202/536 (37%), Gaps = 33/536 (6%)
Query: 167 NLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSS 226
+ N+ C+ N IP + +L+L N L S + L +L+LS
Sbjct: 6 VVPNITYQCMELNFYK--IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61
Query: 227 NSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIG 286
+ +L +LS L L N + + L++L L +L+ L IG
Sbjct: 62 CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
Query: 287 NLKFLSKIALSYNKFSGL-IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSI---- 341
+LK L ++ +++N +P NL+N+ L L SN + + ++LR L + +
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 342 LELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCE-IGNLKSLSYLNLAFNKLTSS 400
L+L N + I L L + NN S ++ I L L L + +
Sbjct: 182 LDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
Query: 401 IPIS------LSNLTNLSVLSFYKNSLSG---AIPKEYRNLVKLTKLFLGDNQFQGPIPN 451
+ L L NL++ F L I + L ++ L + + +
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKD 299
Query: 452 LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDF 511
+ L + +L + + N S P L LD
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTLKL---KSLKRLTFTSNKGGNAFSEVD--LPSLEFLDL 354
Query: 512 SKNNIT--GNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLS 569
S+N ++ G ++ L+ LDLS N V+ + + L L L + L Q+S
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMS 412
Query: 570 PK--LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIK-LEELIHL 626
L L +LD+S + A L L L ++ N F EL +L
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 627 SELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYN 682
+ LDLS L + P+ + SL+ LN++ N L V F+ + +LQ I + N
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 6e-64
Identities = 114/510 (22%), Positives = 192/510 (37%), Gaps = 29/510 (5%)
Query: 145 SSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNE 204
S NL L N L + +S + L L L + +L +L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 205 LNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLN-GSIPHSLCN 263
+ + LS+L L +L +G+LK L +L +A N + +P N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 264 LTNLVILYIYNNSLSGLIPSEIGNLKFLSKIA----LSYNKFSGLIPHSLGNLSNIAFLF 319
LTNL L + +N + + +++ L + + LS N + + P + + + L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLT 206
Query: 320 LDSNSL-FGLIPSELRNLKSLSILEL------GNNKLCGSIPHFLGNLTNLSVLFIYNNS 372
L +N ++ + ++ L L + L L L L NL++
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 373 LSGSIPCEIG---NLKSLSYLNLAFNKLTSSIPIS-LSNLTNLSVLSFYKNSLSGAIPKE 428
L + I L ++S +L + S +L +++
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT----- 321
Query: 429 YRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLT--SNISESFYIYPNLTFID 486
L L +L N+ + +L SL + L RN L+ S+S + +L ++D
Sbjct: 322 -LKLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 487 LSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYS-SQLEVLDLSSNHVVGDIP 545
LS+N + +SS++ +L LDF +N+ + S L LD+S H
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 546 AELGKLSFLIKLILAQNQLSGQLSPK-LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHY 604
LS L L +A N P L L LDLS L P + +L L
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498
Query: 605 LNLSNNQFSWEIPIKLEELIHLSELDLSYN 634
LN+++NQ + L L ++ L N
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-61
Identities = 125/541 (23%), Positives = 198/541 (36%), Gaps = 47/541 (8%)
Query: 89 IPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLN 148
IP + K LDLS N L+ L L + ++ LS L+
Sbjct: 22 IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 149 NLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELN-G 207
L L N ++ + + L++L L L+ IG+LK L +LN+ +N +
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 208 SIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLS----DLKLADNKLNGSIPHSLCN 263
+P+ NL+NL L+LSSN + ++L L + L L+ N +N I
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
Query: 264 LTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSN 323
L L + NN S + GL L + F +
Sbjct: 199 EIRLHKLTLRNNFDSLNVMK---------------TCIQGL--AGLEVHRLVLGEFRNEG 241
Query: 324 SLFGLIPSELRNLKSLSILELGNNKL---CGSIPHFLGNLTNLSVLFIYNNSLSGSIPCE 380
+L S L L +L+I E L I LTN+S + + ++ +
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDF 300
Query: 381 IG--NLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKL 438
+ L +N F + + L +L L+F N A + +L L L
Sbjct: 301 SYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFL 352
Query: 439 FLGDNQFQG---PIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGE 495
L N + TSL + L N + + +S +F L +D ++NL
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM 411
Query: 496 IS-SDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAE-LGKLSF 553
S + L LD S + S LEVL ++ N + + +L
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471
Query: 554 LIKLILAQNQLSGQLSPK-LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQF 612
L L L+Q QL QLSP L L+ L+++SN L + L L + L N +
Sbjct: 472 LTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
Query: 613 S 613
Sbjct: 531 D 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-58
Identities = 109/502 (21%), Positives = 186/502 (37%), Gaps = 46/502 (9%)
Query: 223 NLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIP 282
+ + IP L +L L+ N L +S + L +L + + +
Sbjct: 13 QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 283 SEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSIL 342
+L LS + L+ N L + LS++ L +L L + +LK+L L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 343 ELGNNKL-CGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSY----LNLAFNKL 397
+ +N + +P + NLTNL L + +N + ++ L + L+L+ N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 398 TSSIPISLSNLTNLSVLSFYKNSLSGAIPKEY-RNLVKLTKLFLGDNQFQG-------PI 449
I L L+ N S + K + L L L +F+
Sbjct: 190 N-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 450 PNLKNLTSLVRVHLDRNYLT---SNISESFYIYPNLTFIDLSYNNLYG--EISSDWG--- 501
L+ L +L YL +I + F N++ L + + S ++G
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH 308
Query: 502 --------------RCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSN--HVVGDIP 545
+ L L F+ N N ++ S LE LDLS N G
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGG-NAFSEVDLPS-LEFLDLSRNGLSFKGCCS 366
Query: 546 AELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPES-LGNLVKLHY 604
+ L L L+ N + +S L QLEHLD +NL S +L L Y
Sbjct: 367 QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 605 LNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQI-CIMQSLEKLNLSHNSLSGV 663
L++S+ L L L ++ N I +++L L+LS L +
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 664 IPRCFEEMHALQCIDISYNELR 685
P F + +LQ ++++ N+L+
Sbjct: 486 SPTAFNSLSSLQVLNMASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-46
Identities = 100/475 (21%), Positives = 165/475 (34%), Gaps = 56/475 (11%)
Query: 261 LCNLTNLVILYIYNNSLSGLIPSEI-GNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLF 319
+ + N+ + N IP + + K L LS+N L +S + + L
Sbjct: 4 VEVVPNITYQCMELNFYK--IPDNLPFSTKNLD---LSFNPLRHLGSYSFFSFPELQVLD 58
Query: 320 LDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPC 379
L + + ++L LS L L N + L++L L +L+
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 380 EIGNLKSLSYLNLAFNKLTS-SIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLT-- 436
IG+LK+L LN+A N + S +P SNLTNL L N + + R L ++
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 437 --KLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISE-----------------SFY 477
L L N P L ++ L N+ + N+ + F
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 478 IYPNLTFI----------------DLSYNNLYG-EISSDWGRCPKLGALDFSKNNITGNI 520
NL L+Y + Y +I + + + I
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-- 296
Query: 521 PPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEH 580
Y+ + L+L + G P KL L +L N+ + L LE
Sbjct: 297 VKDFSYNFGWQHLELVNCK-FGQFPT--LKLKSLKRLTFTSNKGGN--AFSEVDLPSLEF 351
Query: 581 LDLSSNNLS--NAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGR 638
LDLS N LS +S L YL+LS N + L L LD ++ L +
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 639 AIP-SQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNST 692
S +++L L++SH F + +L+ + ++ N +
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-42
Identities = 88/413 (21%), Positives = 156/413 (37%), Gaps = 27/413 (6%)
Query: 68 SFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKY----LDLSSNLFSGAIPPQIGHLSYL 123
FS+ +L +LDL SN++ + + ++ LDLS N + I P L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRL 202
Query: 124 KTLHLFKNQLSGSIPLEV-GGLSSLNNLALY------SNYLEDIIPHSLGNLTNLVTLCL 176
L L N S ++ GL+ L L LE +L L NL
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 177 ---YNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSI 233
Y + I L + +L + + S L L +
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFP 320
Query: 234 PSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLS--GLIPSEIGNLKFL 291
+L +LK L+ NK + S +L +L L + N LS G L
Sbjct: 321 TLKLKSLKRLT---FTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 292 SKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIP-SELRNLKSLSILELGNNKLC 350
+ LS+N + + L + L ++L + S +L++L L++ +
Sbjct: 376 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 351 GSIPHFLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLT 409
+ L++L VL + NS + +I L++L++L+L+ +L P + ++L+
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494
Query: 410 NLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVH 462
+L VL+ N L + L L K++L N + P + L+ + +
Sbjct: 495 SLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 547
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-33
Identities = 67/343 (19%), Positives = 115/343 (33%), Gaps = 21/343 (6%)
Query: 49 RVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGN---IPPQIGNISKLKYLDLS 105
R++ + L + + L L + + L L +
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 106 SN------LFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLED 159
+ I L+ + + L + +L L +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQ 318
Query: 160 IIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELN--GSIPQSLGNLS 217
L +L L +N + SE+ +L L L+L N L+ G QS +
Sbjct: 319 FPTLKLKSLKRLT---FTSNKGG-NAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 218 NLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHS-LCNLTNLVILYIYNNS 276
+L L+LS N + ++ S L+ L L + L S +L NL+ L I +
Sbjct: 374 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432
Query: 277 LSGLIPSEIGNLKFLSKIALSYNKFSGLI-PHSLGNLSNIAFLFLDSNSLFGLIPSELRN 335
L L + ++ N F P L N+ FL L L L P+ +
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 336 LKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIP 378
L SL +L + +N+L LT+L ++++ N S P
Sbjct: 493 LSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 51/197 (25%), Positives = 75/197 (38%), Gaps = 5/197 (2%)
Query: 67 FSFSSFPHLAYLDLWSNQL--FGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLK 124
FS P L +LDL N L G + LKYLDLS N + L L+
Sbjct: 341 FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE 399
Query: 125 TLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG 183
L + L V L +L L + + L++L L + N
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 184 SIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKY 242
+ +I L+ L L+L +L P + +LS+L +LN++SN L L
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS 519
Query: 243 LSDLKLADNKLNGSIPH 259
L + L N + S P
Sbjct: 520 LQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-15
Identities = 27/126 (21%), Positives = 52/126 (41%), Gaps = 1/126 (0%)
Query: 573 GLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLS 632
L ++LDLS N L + S + +L L+LS + + L HLS L L+
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 633 YNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNST 692
N + + SL+KL +L+ + + L+ +++++N ++
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKLPE 143
Query: 693 AFRDAP 698
F +
Sbjct: 144 YFSNLT 149
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-66
Identities = 125/521 (23%), Positives = 206/521 (39%), Gaps = 61/521 (11%)
Query: 145 SSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNE 204
+ + I L + L ++ ++ +L + L
Sbjct: 2 PLGSATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 205 LNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNL 264
+ + L+NL +N S+N L + + L NL L D+ + +N++ P L NL
Sbjct: 58 I--KSIDGVEYLNNLTQINFSNNQL--TDITPLKNLTKLVDILMNNNQIADITP--LANL 111
Query: 265 TNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNS 324
TNL L ++NN ++ + P + NL L+++ LS N S + L L+++ L N
Sbjct: 112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSF-GNQ 166
Query: 325 LFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNL 384
+ L P L NL +L L++ +NK+ S L LTNL L NN +S P +G L
Sbjct: 167 VTDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGIL 220
Query: 385 KSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQ 444
+L L+L N+L +L++LTNL+ L N +S P L KLT+L LG NQ
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQ 276
Query: 445 FQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCP 504
I L LT+L + L+ N L S
Sbjct: 277 ISN-ISPLAGLTALTNLELNENQLED--------------------------ISPISNLK 309
Query: 505 KLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQL 564
L L NNI+ P + ++L+ L +N V + L L+ + L NQ+
Sbjct: 310 NLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQI 365
Query: 565 SGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELI 624
S L+P L L ++ L L+ +NA N+ + + P + +
Sbjct: 366 SD-LTP-LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGG 421
Query: 625 HLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIP 665
+E D+++N + + SG +
Sbjct: 422 SYTEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 4e-65
Identities = 121/454 (26%), Positives = 199/454 (43%), Gaps = 36/454 (7%)
Query: 67 FSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTL 126
F+ ++ L + + ++ ++ L + +L+ L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 127 HLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIP 186
+ NQL+ PL L+ L ++ + +N + DI P L NLTNL L L+NN ++ P
Sbjct: 74 NFSNNQLTDITPL--KNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
Query: 187 SEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDL 246
+ NL L L L +N ++ +L L++L L+ + + L NL L L
Sbjct: 130 --LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQV---TDLKPLANLTTLERL 182
Query: 247 KLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIP 306
++ NK+ S L LTNL L NN +S + P +G L L +++L+ N+ +
Sbjct: 183 DISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGT 238
Query: 307 HSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVL 366
L +L+N+ L L +N + L P L L L+ L+LG N++ P L LT L+ L
Sbjct: 239 --LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 292
Query: 367 FIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIP 426
+ N L P I NLK+L+YL L FN ++ P +S+LT L L FY N +S
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--V 346
Query: 427 KEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFID 486
NL + L G NQ + L NLT + ++ L+ T+ N++ +
Sbjct: 347 SSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAWTNAPVNYK---ANVSIPN 402
Query: 487 LSYNNLYGEIS-SDWGRCPKLGALDFSKNNITGN 519
N I+ + D + N +
Sbjct: 403 TVKNVTGALIAPATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-62
Identities = 110/491 (22%), Positives = 189/491 (38%), Gaps = 37/491 (7%)
Query: 131 NQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIG 190
++ L+ L + D + +L + TL + +
Sbjct: 12 TPINQIFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVE 65
Query: 191 NLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLAD 250
L L +N NN+L P L NL+ L + +++N + + + L NL L+ L L +
Sbjct: 66 YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADITPLANLTNLTGLTLFN 121
Query: 251 NKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLG 310
N++ P L NLTNL L + +N++S + + L L +++ N+ + L P L
Sbjct: 122 NQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG-NQVTDLKP--LA 174
Query: 311 NLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYN 370
NL+ + L + SN + + S L L +L L NN++ P LG LTNL L +
Sbjct: 175 NLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNG 230
Query: 371 NSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYR 430
N L + +L +L+ L+LA N++++ P LS LT L+ L N +S P
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA-- 284
Query: 431 NLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYN 490
L LT L L +NQ + I + NL +L + L N ++ L + N
Sbjct: 285 GLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNN 341
Query: 491 NLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGK 550
+ S + L N I+ P + +++ L L+
Sbjct: 342 KV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN 397
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
+S + L + D++ N S E + +
Sbjct: 398 VSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTT 454
Query: 611 QFSWEIPIKLE 621
FS + L+
Sbjct: 455 TFSGTVTQPLK 465
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-56
Identities = 103/444 (23%), Positives = 180/444 (40%), Gaps = 34/444 (7%)
Query: 248 LADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPH 307
D +N L + + +++ + +L ++ + +
Sbjct: 9 TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSIDG- 63
Query: 308 SLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLF 367
+ L+N+ + +N L + P L+NL L + + NN++ P L NLTNL+ L
Sbjct: 64 -VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118
Query: 368 IYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPK 427
++NN ++ P + NL +L+ L L+ N ++ +LS LT+L LSF K
Sbjct: 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LK 171
Query: 428 EYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDL 487
NL L +L + N+ I L LT+L + N ++ I NL + L
Sbjct: 172 PLANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSL 228
Query: 488 SYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAE 547
+ N L +I + L LD + N I+ P + ++L L L +N + P
Sbjct: 229 NGNQL-KDIGT-LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 282
Query: 548 LGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNL 607
L L+ L L L +NQL + L L +L L NN+S+ P + +L KL L
Sbjct: 283 LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338
Query: 608 SNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRC 667
NN+ S L L +++ L +N + P + + + +L L+ + +
Sbjct: 339 YNNKVS--DVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY 394
Query: 668 FEEMHALQCIDISYNELRGPIPNS 691
+ + L P S
Sbjct: 395 KANVSIPNTVKNVTGALIAPATIS 418
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 5e-52
Identities = 105/383 (27%), Positives = 182/383 (47%), Gaps = 28/383 (7%)
Query: 68 SFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLH 127
++ +L L L++NQ+ +I P + N++ L L+LSSN S + L+ L+ L
Sbjct: 107 PLANLTNLTGLTLFNNQI-TDIDP-LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLS 162
Query: 128 LFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPS 187
NQ++ PL L++L L + SN + DI L LTNL +L NN +S P
Sbjct: 163 F-GNQVTDLKPL--ANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP- 216
Query: 188 EIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLK 247
+G L L +L+L N+L +L +L+NL L+L++N + P L L L++LK
Sbjct: 217 -LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271
Query: 248 LADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPH 307
L N+++ P L LT L L + N L + P I NLK L+ + L +N S + P
Sbjct: 272 LGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP- 326
Query: 308 SLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLF 367
+ +L+ + LF +N + + S L NL +++ L G+N++ P L NLT ++ L
Sbjct: 327 -VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 381
Query: 368 IYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPK 427
+ + + + + N+ + + L + P ++S+ + + N S +
Sbjct: 382 LNDQAWTNAPVNYKANVSIPNTVKNVTGALIA--PATISDGGSYTEPDITWNLPSY-TNE 438
Query: 428 EYRNLVKLTKLFLGDNQFQGPIP 450
+ + G F G +
Sbjct: 439 VSYTFSQPVTIGKGTTTFSGTVT 461
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-62
Identities = 92/313 (29%), Positives = 143/313 (45%), Gaps = 26/313 (8%)
Query: 760 KNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELAS 819
K+ S + P L F+G + +++ D + + IG G G+V++ E
Sbjct: 2 KHHHHHHPMSDYDIPTTE-NLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-H 59
Query: 820 GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879
G +AVK EFL EV + +RH NIV F G + + IV EYL
Sbjct: 60 GSDVAVKILMEQDFHAERVN-EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118
Query: 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNE 939
GSL +L A E L+ +R+S+ +A ++YLHN PPIVHR++ S N+L+D K
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYT 177
Query: 940 ARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI---- 995
+V DFG+++ + AGT ++APE+ EK DVYSFGV+ E+
Sbjct: 178 VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 996 --KGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPE 1053
+P ++ + RL IP N+ ++ + +E C P
Sbjct: 238 PWGNLNPAQVVAAVGFKCK------------RLEIPR-NLNPQVAAIIE---GCWTNEPW 281
Query: 1054 SRPTMQKVSQLLK 1066
RP+ + LL+
Sbjct: 282 KRPSFATIMDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-61
Identities = 71/272 (26%), Positives = 128/272 (47%), Gaps = 21/272 (7%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+ + E +G+G G V K + + +A+K+ S + ++ F+ E++ L+ + H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHP 61
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
NIVK YG C +V EY E GSL +L MS + ++YLH
Sbjct: 62 NIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 916 NDCFPPIVHRDISSKNVLLDFKNE-ARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
+ ++HRD+ N+LL ++ DFG A ++ ++ T G+ ++APE+
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFE 176
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034
+EKCDV+S+G++ EVI + P D I + I R P+ N+
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-----IMWAVHNGTRPPLIK-NLP 230
Query: 1035 EKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ + S + C + P RP+M+++ +++
Sbjct: 231 KPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 4e-60
Identities = 93/356 (26%), Positives = 162/356 (45%), Gaps = 25/356 (7%)
Query: 67 FSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTL 126
F + L + + + + L ++ + I +L+ L+ L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYL 71
Query: 127 HLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIP 186
+L NQ++ PL L L NL + +N + DI L NLTNL L L + +S P
Sbjct: 72 NLNGNQITDISPL--SNLVKLTNLYIGTNKITDISA--LQNLTNLRELYLNEDNISDISP 127
Query: 187 SEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDL 246
+ NL + LNL N S L N++ L L ++ + + + + NL L L
Sbjct: 128 --LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKV--KDVTPIANLTDLYSL 182
Query: 247 KLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIP 306
L N++ P L +LT+L Y N ++ + P + N+ L+ + + NK + L P
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP 238
Query: 307 HSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVL 366
L NLS + +L + +N + + + +++L L +L +G+N++ S L NL+ L+ L
Sbjct: 239 --LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSL 292
Query: 367 FIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLS 422
F+ NN L IG L +L+ L L+ N +T P L++L+ + F +
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-55
Identities = 94/394 (23%), Positives = 160/394 (40%), Gaps = 50/394 (12%)
Query: 243 LSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFS 302
+ L +N P +L + + S++ ++ L+ ++K+ ++ K +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 303 GLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTN 362
+ + L+N+ +L L+ N + + P L NL L+ L +G NK+ + L NLTN
Sbjct: 58 SIQG--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 363 LSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLS 422
L L++ +++S P + NL + LNL N S + LSN+T L+ L+ ++ +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168
Query: 423 GAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNL 482
P NL L L L NQ + I L +LTSL N +T L
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITD--ITPVANMTRL 223
Query: 483 TFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVG 542
+ + N + S +L L+ N I+ + ++L++L++ SN +
Sbjct: 224 NSLKIGNNKI--TDLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI-S 278
Query: 543 DIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKL 602
DI L L QL L L++N L N E +G L L
Sbjct: 279 DISV-------------------------LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313
Query: 603 HYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFL 636
L LS N + P L L + D + +
Sbjct: 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 186 bits (476), Expect = 2e-52
Identities = 83/368 (22%), Positives = 156/368 (42%), Gaps = 26/368 (7%)
Query: 318 LFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSI 377
L + + P +L L + + L +++ L + ++ SI
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SI 59
Query: 378 PCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTK 437
I L +L YLNL N++T P LSNL L+ L N ++ +NL L +
Sbjct: 60 Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRE 114
Query: 438 LFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEIS 497
L+L ++ I L NLT + ++L N+ S++S + L ++ ++ + + +
Sbjct: 115 LYLNEDNISD-ISPLANLTKMYSLNLGANHNLSDLSPLSNM-TGLNYLTVTESKV--KDV 170
Query: 498 SDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKL 557
+ L +L + N I P + + L N + P + ++ L L
Sbjct: 171 TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSL 226
Query: 558 ILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIP 617
+ N+++ L L QL L++ +N +S+ ++ +L KL LN+ +NQ S +I
Sbjct: 227 KIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS-DIS 281
Query: 618 IKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCI 677
+ L L L+ L L+ N LG I + +L L LS N ++ + P + +
Sbjct: 282 V-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSA 338
Query: 678 DISYNELR 685
D + ++
Sbjct: 339 DFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 6e-48
Identities = 79/354 (22%), Positives = 150/354 (42%), Gaps = 27/354 (7%)
Query: 336 LKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFN 395
+L+ L N++ +L + S++ + L+S++ L +A
Sbjct: 2 AATLATLPAPINQIFP-----DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54
Query: 396 KLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNL 455
K+ S I + LTNL L+ N ++ P NLVKLT L++G N+ I L+NL
Sbjct: 55 KVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-ISALQNL 109
Query: 456 TSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNN 515
T+L ++L+ + ++ + ++L N+ ++S L L +++
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESK 166
Query: 516 ITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLL 575
+ P I + L L L+ N + P L L+ L NQ++ + +
Sbjct: 167 VKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANM 220
Query: 576 VQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNF 635
+L L + +N +++ P L NL +L +L + NQ S +I +++L L L++ N
Sbjct: 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQ 276
Query: 636 LGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIP 689
+ S + + L L L++N L + L + +S N + P
Sbjct: 277 ISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-16
Identities = 28/161 (17%), Positives = 64/161 (39%), Gaps = 12/161 (7%)
Query: 530 LEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLS 589
L + I L+ I+ +L + ++ L + L ++ ++
Sbjct: 2 AATLATLPAPI-NQIF-PDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 590 NAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQS 649
+ + + L L YLNL+ NQ + P L L+ L+ L + N + S + + +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 650 LEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPN 690
L +L L+ +++S + P + + +++ N +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 6e-59
Identities = 105/540 (19%), Positives = 199/540 (36%), Gaps = 45/540 (8%)
Query: 78 LDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSI 137
D S +IP + + +K LDLS N + + + L+ L L ++++ +I
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TI 65
Query: 138 PLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG-SIPSEIGNLKYL 195
+ L SL +L L N+L + G L++L L L N + S NL L
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125
Query: 196 LDLNLYNNELNGSIP-QSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLN 254
L + N E I L++L L + + SL L +++ + L L ++
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 255 GSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSN 314
+ L+++ L + + +L+ S + + S + + S L S L
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 315 IAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLS 374
+ L+ + + E + + + ++ + L I L
Sbjct: 246 LLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 375 GSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVK 434
+ L+ + + + +K+ +L +L L +N
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN--------------L 345
Query: 435 LTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTS--NISESFYIYPNLTFIDLSYNNL 492
+ + +L ++ +G P+L+ L L +N+L S E NLT +D+S N
Sbjct: 346 MVEEYLKNSACKGAWPSLQTL------VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399
Query: 493 YGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLS 552
+ K+ L+ S I + LEVLD+S+N++ L +L
Sbjct: 400 -HPMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNL-DSFSLFLPRLQ 454
Query: 553 FLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQF 612
+L +++N+L P L L + +S N L + L L + L N +
Sbjct: 455 ---ELYISRNKLKTL--PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-57
Identities = 99/515 (19%), Positives = 193/515 (37%), Gaps = 26/515 (5%)
Query: 175 CLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIP 234
+ SIPS + + L+L N++ L +NL +L L S+ +
Sbjct: 12 GRSRSF--TSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67
Query: 235 SELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGL-IPSEIGNLKFLSK 293
+L L L L+DN L+ L++L L + N L + S NL L
Sbjct: 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127
Query: 294 IALS-YNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGS 352
+ + FS + L+++ L + + SL L++++ + L L ++
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187
Query: 353 IPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLS 412
+ F L+++ L + + +L+ + + S + + + S + L L
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247
Query: 413 VLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNI 472
+ + + L L ++ + + ++ R+H+ + YL ++
Sbjct: 248 RYILELSEVE----FDDCTLNGLGDFNPSESDVVSELGKV-ETVTIRRLHIPQFYLFYDL 302
Query: 473 SESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPK---IGYSSQ 529
S + + + I + + ++ S L LD S+N + G
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362
Query: 530 LEVLDLSSNHV--VGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNN 587
L+ L LS NH+ + L L L L +++N + ++ L+LSS
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421
Query: 588 LSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIM 647
+ + L L++SNN + L L EL +S N L + +P +
Sbjct: 422 IRV-VKT--CIPQTLEVLDVSNNNLD-SFSLFLP---RLQELYISRNKL-KTLPD-ASLF 472
Query: 648 QSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYN 682
L + +S N L V F+ + +LQ I + N
Sbjct: 473 PVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-53
Identities = 94/457 (20%), Positives = 168/457 (36%), Gaps = 36/457 (7%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQ-IGNISKLKYLDLSSNLFSGAIPPQ-IGHL 120
T+ +F S L +LDL N L ++ G +S LKYL+L N + +L
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHL-SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 121 SYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
+ L+TL + + I GL+SLN L + + L + SL ++ ++ L L+ +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 180 LLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSL-------FGS 232
+ + L + L L + L L + + + F
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 233 IPSELGNLKYLSDLKLADNKLNGSIPHSLC-----------NLTNLVILYIYNNSLSGLI 281
+ L + LS+++ D LNG + + L+I L +
Sbjct: 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302
Query: 282 PSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLI---PSELRNLKS 338
+ L+ + +I + +K + +L ++ FL L N + + S
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362
Query: 339 LSILELGNNKL--CGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNK 396
L L L N L L L NL+ L I N+ +P + + +LNL+
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421
Query: 397 LTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLT 456
+ + L VL N+L + L +L +L++ N+ + +P+
Sbjct: 422 IRV---VKTCIPQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLKT-LPDASLFP 473
Query: 457 SLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLY 493
L+ + + RN L S F +L I L N
Sbjct: 474 VLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-52
Identities = 93/485 (19%), Positives = 173/485 (35%), Gaps = 26/485 (5%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQIGHLS 121
+ + +L L L S+++ I ++ L++LDLS N S G LS
Sbjct: 40 YIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLS 98
Query: 122 YLKTLHLFKNQLSG-SIPLEVGGLSSLNNLALYS-NYLEDIIPHSLGNLTNLVTLCLYNN 179
LK L+L N + L++L L + + +I LT+L L +
Sbjct: 99 SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158
Query: 180 LLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGN 239
L + +++ + L L+ +E + LS++ L L +L S L
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218
Query: 240 LKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYN 299
+ S +K + + S L L+ + + + + + +
Sbjct: 219 DEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPS 272
Query: 300 KFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGN 359
+ + I L + LF + + L+ + + + N+K+ F +
Sbjct: 273 ESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQH 332
Query: 360 LTNLSVLFIYNNSLSGSIPCE---IGNLKSLSYLNLAFNKLTS--SIPISLSNLTNLSVL 414
L +L L + N + G SL L L+ N L S L L NL+ L
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL 392
Query: 415 SFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISE 474
+N+ +P + K+ L L + + +L + + N L S
Sbjct: 393 DISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKT-CIPQTLEVLDVSNNNLDSFSLF 449
Query: 475 SFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKI-GYSSQLEVL 533
P L + +S N L + D P L + S+N + ++P I + L+ +
Sbjct: 450 ----LPRLQELYISRNKL--KTLPDASLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKI 502
Query: 534 DLSSN 538
L +N
Sbjct: 503 WLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-42
Identities = 81/435 (18%), Positives = 163/435 (37%), Gaps = 24/435 (5%)
Query: 262 CNLTNLVILYIYNNSLSGLIPSEI-GNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFL 320
+ + + S + IPS + +K L LS+NK + + L +N+ L L
Sbjct: 2 LSCDASGVCDGRSRSFTS-IPSGLTAAMKSLD---LSFNKITYIGHGDLRACANLQVLIL 57
Query: 321 DSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSG-SIPC 379
S+ + + +L SL L+L +N L + G L++L L + N +
Sbjct: 58 KSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117
Query: 380 EIGNLKSLSYLNLAFNKLTSSIP-ISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKL 438
NL +L L + + S I I + LT+L+ L SL + +++ + L
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177
Query: 439 FLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEIS 497
L ++ + L+S+ + L L + + +
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237
Query: 498 SDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLI-- 555
+ KL + + + + D + + D+ +ELGK+ +
Sbjct: 238 ESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSES--DVVSELGKVETVTIR 289
Query: 556 KLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWE 615
+L + Q L LS LL +++ + + ++ + +L L +L+LS N E
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEE 349
Query: 616 I---PIKLEELIHLSELDLSYNFLG--RAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEE 670
L L LS N L + + +++L L++S N+ +P +
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408
Query: 671 MHALQCIDISYNELR 685
++ +++S +R
Sbjct: 409 PEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 55/396 (13%), Positives = 132/396 (33%), Gaps = 21/396 (5%)
Query: 338 SLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKL 397
+ + + + SIP G + L + N ++ ++ +L L L +++
Sbjct: 6 ASGVCDGRSRSF-TSIPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 398 TSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ--GPIPNLKNL 455
+ + +L +L L N LS + L L L L N +Q G NL
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 456 TSLVRVHLDRNYLTSNISE-SFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKN 514
T+L + + S I F +L +++ +L S + L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 515 NITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGL 574
+ S + L+L ++ + L + + S
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 575 LVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYN 634
L++L L + + + + + ++ + E + + L +
Sbjct: 243 LLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 635 FLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAF 694
+L + + +++ ++++ + ++ + V + + +L+ +D+S N + ++A
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356
Query: 695 RDAPIK----ALQGNK-----GLCGDFKGLPSCKAL 721
+ A L N L + +L
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL 392
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-17
Identities = 45/244 (18%), Positives = 88/244 (36%), Gaps = 35/244 (14%)
Query: 45 NHGGRVNSINLTSIGLKG----TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIG-NISKL 99
+ G+V ++ + + + +S + + + ++++F +P ++ L
Sbjct: 278 SELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSL 336
Query: 100 KYLDLSSNLFSGAIPPQ---IGHLSYLKTLHLFKNQLSGSIPLEVG---GLSSLNNLALY 153
++LDLS NL G L+TL L +N L S+ L +L +L +
Sbjct: 337 EFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDIS 395
Query: 154 SNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI------------------GNLKYL 195
N + P S + L L + + + + I L L
Sbjct: 396 RNTFHPM-PDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRL 453
Query: 196 LDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNG 255
+L + N+L ++P + L ++ +S N L L L + L N +
Sbjct: 454 QELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 511
Query: 256 SIPH 259
S P
Sbjct: 512 SCPR 515
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 9e-59
Identities = 112/514 (21%), Positives = 194/514 (37%), Gaps = 76/514 (14%)
Query: 113 IPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNL---- 168
I P+ ++L+ + L+ +P+E + S + E P G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 169 ---------TNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNL 219
L L N LS S+P +L+ L N L +P+ +L +L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSL 116
Query: 220 AMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSG 279
+ N + +L P L L +++N+L +P L N + L I+ + NNSL
Sbjct: 117 LVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKK 167
Query: 280 LIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSL 339
L P +L+F++ N+ L L NL + ++ D+NSL L P +L+S+
Sbjct: 168 L-PDLPPSLEFIA---AGNNQLEEL--PELQNLPFLTAIYADNNSLKKL-PDLPLSLESI 220
Query: 340 SILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTS 399
GNN L L NL L+ ++ NN L ++P +L++L+ + N LT
Sbjct: 221 V---AGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRD---NYLT- 270
Query: 400 SIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLV 459
+P +LT L V + LS P L L N+ + +L L
Sbjct: 271 DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRSLCDLPPSLEEL- 322
Query: 460 RVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGN 519
++ N L + P L + S+N+L E+ L L N +
Sbjct: 323 --NVSNNKLIE-LPALP---PRLERLIASFNHL-AEVPEL---PQNLKQLHVEYNPLR-E 371
Query: 520 IPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLE 579
P +E L ++S+ + ++P L +L + N L + +E
Sbjct: 372 FPDIPE---SVEDLRMNSH--LAEVPELPQNLK---QLHVETNPLR-EFPDIPE---SVE 419
Query: 580 HLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFS 613
L ++S + + + KL ++
Sbjct: 420 DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-57
Identities = 113/515 (21%), Positives = 192/515 (37%), Gaps = 77/515 (14%)
Query: 160 IIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNL 219
I P ++ N T L +++ L+ +P E N+K + +E + P G +
Sbjct: 3 INPRNVSN-TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 220 AM-------------LNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTN 266
A+ L L++ L S+P +L+ L + N L +P +L +
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGL-SSLPELPPHLESLV---ASCNSLT-ELPELPQSLKS 115
Query: 267 LVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLF 326
L++ +LS L P L + +S N+ L L N S + + +D+NSL
Sbjct: 116 LLVDNNNLKALSDLPPL-------LEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK 166
Query: 327 GLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKS 386
L P +L+ ++ GNN+L L NL L+ ++ NNSL +P +L+S
Sbjct: 167 KL-PDLPPSLEFIA---AGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPLSLES 219
Query: 387 LSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ 446
+ N L L NL L+ + N L +P L L + DN
Sbjct: 220 ---IVAGNNILEE--LPELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLT 270
Query: 447 GPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKL 506
++LT L + L+ PNL +++ S N + + P L
Sbjct: 271 DLPELPQSLTFLDVSENIFSGLSELP-------PNLYYLNASSNEI-RSLCDLP---PSL 319
Query: 507 GALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSG 566
L+ S N + +P +LE L S NH+ ++P L +L + N L
Sbjct: 320 EELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLK---QLHVEYNPLR- 370
Query: 567 QLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHL 626
+ + DL N+ +PE N L L++ N E P + +
Sbjct: 371 EFPDIPESVE-----DLRMNSHLAEVPELPQN---LKQLHVETNPLR-EFP---DIPESV 418
Query: 627 SELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLS 661
+L ++ + LE H+
Sbjct: 419 EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 8e-56
Identities = 108/548 (19%), Positives = 196/548 (35%), Gaps = 98/548 (17%)
Query: 137 IPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLL 196
I + L +S+ L ++ P N+ + + + P G + +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLTEM-PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 197 DLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGS 256
L + L L++ L S+P +L+ L + N L
Sbjct: 62 VSRLRDCLDR-----------QAHELELNNLGL-SSLPELPPHLESLV---ASCNSLT-E 105
Query: 257 IPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIA 316
+P +L +L++ +LS L P L + +S N+ L L N S +
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLEKLP--ELQNSSFLK 156
Query: 317 FLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGS 376
+ +D+NSL L P +L+ ++ GNN+L L NL L+ ++ NNSL
Sbjct: 157 IIDVDNNSLKKL-PDLPPSLEFIA---AGNNQL--EELPELQNLPFLTAIYADNNSLK-K 209
Query: 377 IPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLT 436
+P +L+S+ N L L NL L+ + N L +P L
Sbjct: 210 LPDLPLSLESI---VAGNNILEE--LPELQNLPFLTTIYADNNLLK-TLPDL---PPSLE 260
Query: 437 KLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEI 496
L + DN ++LT L + L+ PNL +++ S N +
Sbjct: 261 ALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP-------PNLYYLNASSNEI---- 309
Query: 497 SSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIK 556
++ LE L++S+N ++ ++PA +L +
Sbjct: 310 ---------------------RSLCDLP---PSLEELNVSNNKLI-ELPALPPRLE---R 341
Query: 557 LILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEI 616
LI + N L+ ++ L+ L + N L P+ ++ L + E+
Sbjct: 342 LIASFNHLA-EVPELPQ---NLKQLHVEYNPLRE-FPDIPESVEDLRMNSHLA-----EV 391
Query: 617 PIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQC 676
P E +L +L + N L R P +S+E L ++ + E L+
Sbjct: 392 P---ELPQNLKQLHVETNPL-REFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLED 444
Query: 677 IDISYNEL 684
++
Sbjct: 445 DVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 5e-52
Identities = 108/498 (21%), Positives = 178/498 (35%), Gaps = 73/498 (14%)
Query: 68 SFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLH 127
+ ++ N PP G ++ L L L
Sbjct: 29 EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQ-----------AHELE 77
Query: 128 LFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPS 187
L LS S+P L SL N L + +P +L +L+ LS P
Sbjct: 78 LNNLGLS-SLPELPPHLESLV---ASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPL 132
Query: 188 EIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLK 247
L L + NN+L +P L N S L ++++ +NSL +P +L++++
Sbjct: 133 -------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSL-KKLPDLPPSLEFIA--- 179
Query: 248 LADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPH 307
+N+L +P L NL L +Y NNSL L P +L+ + N
Sbjct: 180 AGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKL-PDLPLSLESIV---AGNNILE--ELP 231
Query: 308 SLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLF 367
L NL + ++ D+N L +P +L++L++ +N L +P +LT L V
Sbjct: 232 ELQNLPFLTTIYADNNLL-KTLPDLPPSLEALNVR---DNYLT-DLPELPQSLTFLDVSE 286
Query: 368 IYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPK 427
+ LS P +L YLN + N++ S+ +L L+V N L +P
Sbjct: 287 NIFSGLSELPP-------NLYYLNASSNEIR-SLCDLPPSLEELNV---SNNKLI-ELPA 334
Query: 428 EYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDL 487
+L +L N +NL L H++ N L + ++ DL
Sbjct: 335 L---PPRLERLIASFNHLAEVPELPQNLKQL---HVEYNPLRE-FPDIP---ESVE--DL 382
Query: 488 SYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAE 547
N+ E+ L L N + P +E L ++S VV
Sbjct: 383 RMNSHLAEVPE---LPQNLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFA 435
Query: 548 LGKLSFLIKLILAQNQLS 565
L + +
Sbjct: 436 HETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-48
Identities = 104/501 (20%), Positives = 184/501 (36%), Gaps = 94/501 (18%)
Query: 185 IPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLS 244
I + +L + +++ L +P N+ + + + + P G + ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 245 DLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGL 304
+L D C L + N LS L P +L+ L S N + L
Sbjct: 62 VSRLRD-----------CLDRQAHELELNNLGLSSL-PELPPHLESLV---ASCNSLTEL 106
Query: 305 IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLS 364
P +L ++ + +L L P L L + NN+L +P N + L
Sbjct: 107 -PELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLPEL-QNSSFLK 156
Query: 365 VLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGA 424
++ + NNSL +P +L+ ++ N+L +P L NL L+ + NSL
Sbjct: 157 IIDVDNNSLK-KLPDLPPSLE---FIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK-K 209
Query: 425 IPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTF 484
+P + L + G+N + +P L+NL L ++ D N L + + + P+L
Sbjct: 210 LPDL---PLSLESIVAGNNILEE-LPELQNLPFLTTIYADNNLLKT-LPDLP---PSLEA 261
Query: 485 IDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDI 544
+++ N L ++P L LD+S N +
Sbjct: 262 LNVRDNYL-------------------------TDLPELPQ---SLTFLDVSENIF-SGL 292
Query: 545 PAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHY 604
L L + N++ L L LE L++S+N L +P L
Sbjct: 293 SELPPNLY---YLNASSNEIR-SLC---DLPPSLEELNVSNNKLI-ELPALPPRL---ER 341
Query: 605 LNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVI 664
L S N + E+P E +L +L + YN L R P ++ L + +
Sbjct: 342 LIASFNHLA-EVP---ELPQNLKQLHVEYNPL-REFPDIPESVEDLRMNSH--------L 388
Query: 665 PRCFEEMHALQCIDISYNELR 685
E L+ + + N LR
Sbjct: 389 AEVPELPQNLKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 44/257 (17%), Positives = 83/257 (32%), Gaps = 35/257 (13%)
Query: 431 NLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYN 490
+ L + + +N+ S + + N + L
Sbjct: 9 SNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 491 NLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGK 550
+ L+ + ++ ++P LE L S N + ++P
Sbjct: 69 -----------LDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQS 112
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
L L+ LS L LE+L +S+N L +PE L N L +++ NN
Sbjct: 113 LKSLLVDNNNLKALSD-------LPPLLEYLGVSNNQLEK-LPE-LQNSSFLKIIDVDNN 163
Query: 611 QFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEE 670
++P + L + N L +P + + L + +NSL + +
Sbjct: 164 SLK-KLP---DLPPSLEFIAAGNNQL-EELPE-LQNLPFLTAIYADNNSLKKL----PDL 213
Query: 671 MHALQCIDISYNELRGP 687
+L+ I N L
Sbjct: 214 PLSLESIVAGNNILEEL 230
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-11
Identities = 22/140 (15%), Positives = 47/140 (33%), Gaps = 17/140 (12%)
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
+FL + + + L+ ++ + + + + P G ++ L +
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 611 QFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEE 670
EL+L+ L ++P LE L S NSL+ +P +
Sbjct: 69 LDR-----------QAHELELNNLGL-SSLPELP---PHLESLVASCNSLT-ELPELPQS 112
Query: 671 MHALQCIDISYNELRGPIPN 690
+ +L + + L P
Sbjct: 113 LKSLLVDNNNLKALSDLPPL 132
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 8e-58
Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 28/283 (9%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELAS-GEIIAVKKFHSPLPGEMTFQ----QEFLNEVKALT 850
N+ + E IGKGG G V+K L ++A+K T QEF EV ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 851 EIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADA 910
+ H NIVK YG +V E++ G L L + A ++W+ ++ ++ IA
Sbjct: 79 NLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNE-----ARVSDFGIAKFLKPDSSNWTELAGTY 965
+ Y+ N PPIVHRD+ S N+ L +E A+V+DFG+++ S + L G +
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSV--SGLLGNF 190
Query: 966 GYVAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD 1023
++APE A TEK D YSF ++ ++ G+ P D S +N+
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--- 247
Query: 1024 PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
R IP + +L + +E C P+ RP + + L
Sbjct: 248 -RPTIPE-DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-57
Identities = 72/286 (25%), Positives = 121/286 (42%), Gaps = 38/286 (13%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMT-FQQEFLNEVKALTEIRH 854
+ E IG GG G VY+ G+ +AVK +++ + E K ++H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
NI+ G C + +V E+ G L +LS + + ++ IA ++YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYL 121
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEAR--------VSDFGIAKFLKPDSSNWTELAGTYG 966
H++ PI+HRD+ S N+L+ K E ++DFG+A+ + AG Y
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYA 179
Query: 967 YVAPELAYTMKVTEKCDVYSFGVLALEVI------KGKHPGDFISLISSSSLNLNIALDE 1020
++APE+ ++ DV+S+GVL E++ +G ++ + L
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL-------- 231
Query: 1021 ILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
LPIPS E +E C + P SRP+ + L
Sbjct: 232 ----ALPIPS-TCPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-56
Identities = 127/672 (18%), Positives = 228/672 (33%), Gaps = 85/672 (12%)
Query: 44 CNHGGRV---NSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLK 100
C+ GR+ NLT + L L N + + +L+
Sbjct: 2 CSFDGRIAFYRFCNLTQV----------PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQ 51
Query: 101 YLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLE 158
L+L S I + +L L+ L L +++ + + GL L L LY L
Sbjct: 52 LLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLS 110
Query: 159 D--IIPHSLGNLTNLVTLCL-YNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGN 215
D + NL L L L N + S + G L L ++ +N++ L
Sbjct: 111 DAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170
Query: 216 LS--NLAMLNLSSNSLFGSIPSELGNL------KYLSDLKLADNKLNGSIPHSLCN---- 263
L L+ +L++NSL+ + + G L L ++ N I + N
Sbjct: 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISK 230
Query: 264 --------LTNLVILYIYNNSLSGLIPSEIGNLKFLS--KIALSYNKFSGLIPHSLGNLS 313
+++ +++ + L S + LS+ L L
Sbjct: 231 SQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLK 290
Query: 314 NIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSL 373
++ L L N + + L +L +L L N L L ++ + + N +
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 374 SGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLV 433
+ L+ L L+L N LT ++ + ++ + N L +PK
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT-LPKINLT-- 402
Query: 434 KLTKLFLGDNQFQG--PIPNLKNLTSLVRVHLDRNYLTS-NISESFYIYPNLTFIDLSYN 490
+ L +N+ + + L + L + L++N +S + ++ P+L + L N
Sbjct: 403 -ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 491 NLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGK 550
L T S L+VL L+ N++ P
Sbjct: 462 ML-------------------QLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSH 502
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
L+ L L L N+L+ L LE LD+S N L P+ + L L++++N
Sbjct: 503 LTALRGLSLNSNRLTV--LSHNDLPANLEILDISRNQLLAPNPDVFVS---LSVLDITHN 557
Query: 611 QFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEE 670
+F LS N I + + + S SL + +E
Sbjct: 558 KFI--------CECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDE 609
Query: 671 MHALQCIDISYN 682
L+ + S
Sbjct: 610 EEVLKSLKFSLF 621
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-56
Identities = 119/536 (22%), Positives = 198/536 (36%), Gaps = 57/536 (10%)
Query: 167 NLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSI-PQSLGNLSNLAMLNLS 225
L L L N + S L+ L L L + +I ++ NL NL +L+L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 226 SNSLFGSIPSELGNLKYLSDLKLADNKLNGSI--PHSLCNLTNLVILYIYNNSLSGL-IP 282
S+ ++ P L +L +L+L L+ ++ NL L L + N + L +
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 283 SEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIA--FLFLDSNSLFGLIP-SELRNLKSL 339
G L L I S N+ + H L L F L +NSL+ + + +
Sbjct: 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201
Query: 340 SILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTS 399
+ L I GN + + ++N++S S + + F+ +
Sbjct: 202 RNMVL-------EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254
Query: 400 SIPISLSNL--TNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLKNLT 456
+ + L +++ L + + + L L L L N+ L
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLD 314
Query: 457 SLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNI 516
+L ++L N L S +FY P + +IDL N++ + KL LD N +
Sbjct: 315 NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374
Query: 517 TGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLV 576
T I + + + LS N KL L K+ L
Sbjct: 375 T-----TIHFIPSIPDIFLSGN-----------KLVTLPKINL----------------- 401
Query: 577 QLEHLDLSSNNLSN-AIPESLGNLVKLHYLNLSNNQFSW-EIPIKLEELIHLSELDLSYN 634
+ LS N L N I L + L L L+ N+FS E L +L L N
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 635 FLGRAIPSQICI-----MQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
L A +++C + L+ L L+HN L+ + P F + AL+ + ++ N L
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 5e-46
Identities = 86/464 (18%), Positives = 169/464 (36%), Gaps = 33/464 (7%)
Query: 244 SDLKLADNKLNG--SIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKF 301
D ++A + +P L L + N + + S L+ L + L
Sbjct: 4 FDGRIAFYRFCNLTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 302 SGLI-PHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSI--PHFLG 358
I + NL N+ L L S+ ++ L P + L L L L L ++ +
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120
Query: 359 NLTNLSVLFIYNNSLSG-SIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLT--NLSVLS 415
NL L+ L + N + + G L SL ++ + N++ L L LS S
Sbjct: 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFS 180
Query: 416 FYKNSLSGAIPKEYRNLVK-LTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISE 474
NSL + ++ + + L G N ++ N ++ + +
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG------NGWTVDITGNFSNAISKSQAF 234
Query: 475 SFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLG--ALDFSKNNITGNIPPKI-GYSSQLE 531
S + ++ ++N+ + + + LD S + ++ ++ L+
Sbjct: 235 SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLK 293
Query: 532 VLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNA 591
VL+L+ N + L L L L+ N L S L ++ ++DL N+++
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAII 353
Query: 592 IPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLE 651
++ L KL L+L +N + + + + ++ LS N L +P +
Sbjct: 354 QDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL-VTLPKINL---TAN 404
Query: 652 KLNLSHNSLSGV-IPRCFEEMHALQCIDISYNELRGPIPNSTAF 694
++LS N L + I + LQ + ++ N
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRFSS-CSGDQTP 447
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-54
Identities = 79/293 (26%), Positives = 129/293 (44%), Gaps = 33/293 (11%)
Query: 789 EEIIRATNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 847
I R +D +GKG G KV +GE++ +K+ E T Q+ FL EVK
Sbjct: 4 HRIFRP-SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEET-QRTFLKEVK 59
Query: 848 ALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGI 907
+ + H N++KF G + + EY++ G+L I+ + W+QR+S K I
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDI 117
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL--------------KP 953
A ++YLH+ I+HRD++S N L+ V+DFG+A+ + KP
Sbjct: 118 ASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN 1013
D + G ++APE+ EK DV+SFG++ E+I +
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-----LPRT 229
Query: 1014 LNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
++ L+ P + F + + C D PE RP+ K+ L+
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPS----FFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 4e-54
Identities = 58/345 (16%), Positives = 109/345 (31%), Gaps = 29/345 (8%)
Query: 111 GAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTN 170
G+ H S + L+ + + N + N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 171 LVTLCLYNNLLSGSIPSEIGNLKY--LLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNS 228
L + + + + L L + L P LS+L + + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 229 LFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNL 288
L +P + L L LA N L ++P S+ +L L L I +P + +
Sbjct: 116 L-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 289 KFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNK 348
L N+ L L+ + L P+ + NL++L L++ N+
Sbjct: 174 D---------------ASGEHQGLVNLQSLRLEWTGIRSL-PASIANLQNLKSLKIRNSP 217
Query: 349 LCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLA-FNKLTSSIPISLSN 407
L ++ + +L L L + + + P G L L L + L ++P+ +
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHR 275
Query: 408 LTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNL 452
LT L L +P L + + + +
Sbjct: 276 LTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-52
Identities = 53/330 (16%), Positives = 105/330 (31%), Gaps = 25/330 (7%)
Query: 93 IGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLAL 152
+ S + L + + + + + NN +
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-------NSNNPQI 60
Query: 153 YSNYLEDI--IPHSLGNLT--NLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGS 208
+ + L + T V L L + L P + L +L + + L
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 209 IPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCN----- 263
+P ++ + L L L+ N L ++P+ + +L L +L + +P L +
Sbjct: 119 LPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 264 ----LTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLF 319
L NL L + + L P+ I NL+ L + + + S L ++ +L + L
Sbjct: 178 EHQGLVNLQSLRLEWTGIRSL-PASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELD 235
Query: 320 LDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPC 379
L + P L L L + ++P + LT L L + +P
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
Query: 380 EIGNLKSLSYLNLAFNKLTSSIPISLSNLT 409
I L + + + +
Sbjct: 296 LIAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 7e-47
Identities = 54/284 (19%), Positives = 107/284 (37%), Gaps = 19/284 (6%)
Query: 90 PPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSY--LKTLHLFKNQLSGSIPLEVGGLSSL 147
+ N + + + A + + L L L P + LS L
Sbjct: 49 AWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106
Query: 148 NNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNG 207
++ + + L ++ P ++ L TL L N L ++P+ I +L L +L++
Sbjct: 107 QHMTIDAAGLMEL-PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164
Query: 208 SIPQSLGN---------LSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIP 258
+P+ L + L NL L L + S+P+ + NL+ L LK+ ++ L+ ++
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLS-ALG 222
Query: 259 HSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALS-YNKFSGLIPHSLGNLSNIAF 317
++ +L L L + + P G L ++ L + L P + L+ +
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL-PLDIHRLTQLEK 281
Query: 318 LFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLT 361
L L +PS + L + I+ + + H
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-46
Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 14/262 (5%)
Query: 60 LKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGH 119
LK T ++ P L+L S L P Q +S L+++ + + +P +
Sbjct: 68 LKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQ 125
Query: 120 LSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGN---------LTN 170
+ L+TL L +N L ++P + L+ L L++ + +P L + L N
Sbjct: 126 FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVN 184
Query: 171 LVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLF 230
L +L L + S+P+ I NL+ L L + N+ L+ ++ ++ +L L L+L +
Sbjct: 185 LQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL 242
Query: 231 GSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKF 290
+ P G L L L D ++P + LT L L + +PS I L
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
Query: 291 LSKIALSYNKFSGLIPHSLGNL 312
I + + + L H
Sbjct: 303 NCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 6e-43
Identities = 67/361 (18%), Positives = 112/361 (31%), Gaps = 50/361 (13%)
Query: 255 GSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSN 314
GS H + + LY ++ + + + N +N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 315 IAFLFLDSNSLFGLIPSELRNLKS--LSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNS 372
+L L + LEL + L P L++L + I
Sbjct: 58 PQIETRTGRAL-KATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAG 115
Query: 373 LSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNL 432
L +P + L L LA N L + +P S+++L L LS +P+
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEP---- 169
Query: 433 VKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNL 492
L G L NL SL L+ + S + S NL + + + L
Sbjct: 170 -------LASTDASGEHQGLVNLQSL---RLEWTGIRS-LPASIANLQNLKSLKIRNSPL 218
Query: 493 YGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLS 552
+ PKL LD N PP G + L+ L L + +P ++ +L+
Sbjct: 219 -SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277
Query: 553 FLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQF 612
QLE LDL + +P + L + + +
Sbjct: 278 ------------------------QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
Query: 613 S 613
+
Sbjct: 314 A 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-42
Identities = 53/323 (16%), Positives = 102/323 (31%), Gaps = 22/323 (6%)
Query: 351 GSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTN 410
GS H + + L+ ++ + + + +N N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 411 LSVLSFYKNSLSGAIPKEYRNL--VKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYL 468
+ + +L A + L L L+ L + +D L
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGL 116
Query: 469 TSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSS 528
+ ++ + L + L+ N L + + +L L +P + +
Sbjct: 117 ME-LPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTD 174
Query: 529 ---------QLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLE 579
L+ L L + +PA + L L L + + LS L P + L +LE
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232
Query: 580 HLDLSSNNLSNAIPESLGNLVKLHYLNLSN-NQFSWEIPIKLEELIHLSELDLSYNFLGR 638
LDL P G L L L + + +P+ + L L +LDL
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLS 291
Query: 639 AIPSQICIMQSLEKLNLSHNSLS 661
+PS I + + + + + +
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-40
Identities = 50/347 (14%), Positives = 104/347 (29%), Gaps = 24/347 (6%)
Query: 230 FGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLK 289
GS + +L + L N
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSN 56
Query: 290 FLSKIALSYNKFSGLIPHSLGNLSNIAFLFLD-SNSLFGLIPSELRNLKSLSILELGNNK 348
+ L + + + L+ + P + L L + +
Sbjct: 57 NPQIETRTGRALKAT-ADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAG 115
Query: 349 LCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNL 408
L +P + L L + N L ++P I +L L L++ + +P L++
Sbjct: 116 L-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 409 TNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYL 468
E++ LV L L L + ++ NL +L + + + L
Sbjct: 174 D---------------ASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPL 218
Query: 469 TSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSS 528
++ + + + P L +DL +G L L + +P I +
Sbjct: 219 SA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277
Query: 529 QLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLL 575
QLE LDL + +P+ + +L +++ + + +
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 39/207 (18%), Positives = 76/207 (36%), Gaps = 12/207 (5%)
Query: 68 SFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIG--------- 118
+ F L L L N L +P I ++++L+ L + + +P +
Sbjct: 122 TMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180
Query: 119 HLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYN 178
L L++L L + S+P + L +L +L + ++ L + ++ +L L L L
Sbjct: 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRG 238
Query: 179 NLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELG 238
+ P G L L L + ++P + L+ L L+L +PS +
Sbjct: 239 CTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298
Query: 239 NLKYLSDLKLADNKLNGSIPHSLCNLT 265
L + + + H
Sbjct: 299 QLPANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-27
Identities = 41/289 (14%), Positives = 92/289 (31%), Gaps = 48/289 (16%)
Query: 404 SLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHL 463
+ + L F ++ L + + + D N +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDV---LSQWQRHYNADRNRWHSAWRQANSNNPQIETR 63
Query: 464 DRNYLTSNISE-SFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPP 522
L + P ++L L P
Sbjct: 64 TGRALKATADLLEDATQPGRVALELRSVPL-------------------------PQFPD 98
Query: 523 KIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLD 582
+ S L+ + + + ++ ++P + + + L L LA+N L L + L +L L
Sbjct: 99 QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156
Query: 583 LSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPS 642
+ + +PE L + + + + L++L L L + + R++P+
Sbjct: 157 IRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGI-RSLPA 200
Query: 643 QICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNS 691
I +Q+L+ L + ++ LS + + L+ +D+ P
Sbjct: 201 SIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPI 248
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 5e-54
Identities = 53/284 (18%), Positives = 100/284 (35%), Gaps = 40/284 (14%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+ + + G ++K G I VK + +F E L H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSR-DFNEECPRLRIFSHP 67
Query: 856 NIVKFYGFCSH--AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
N++ G C A H ++ ++ GSL +L ++ ++ +Q + +A +++
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL- 972
LH P I ++S++V++D AR+S + + +VAPE
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEAL 180
Query: 973 --AYTMKVTEKCDVYSFGVLALEVI------KGKHPGDFISLISSSSLNLNIALDEILDP 1024
D++SF VL E++ + ++ L
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL------------ 228
Query: 1025 RLPIPSHNVQE--KLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
R IP KL+ C++E P RP + +L+
Sbjct: 229 RPTIPPGISPHVSKLMK------ICMNEDPAKRPKFDMIVPILE 266
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-53
Identities = 71/321 (22%), Positives = 117/321 (36%), Gaps = 53/321 (16%)
Query: 788 YEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 847
E ++ IG+G G+VYK L +AVK F +Q F+NE
Sbjct: 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF------ANRQNFINEKN 57
Query: 848 --ALTEIRHRNIVKFYGFCSHAQHS-----FIVYEYLEMGSLAMILSNDAAAEDLEWTQR 900
+ + H NI +F +V EY GSL LS +W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSS 113
Query: 901 MSVIKGIADALSYLHND------CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954
+ + L+YLH + P I HRD++S+NVL+ +SDFG++ L +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 955 SSNW--------TELAGTYGYVAPE-------LAYTMKVTEKCDVYSFGVLALEVI---K 996
GT Y+APE L ++ D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 997 GKHPGDFIS---LISSSSLNLNIALDEILDP------RLPIPSH--NVQEKLISFVEVAI 1045
PG+ + + + + + +++ R P + S E
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 1046 SCLDESPESRPTMQKVSQLLK 1066
C D+ E+R T Q + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMA 314
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-51
Identities = 65/321 (20%), Positives = 119/321 (37%), Gaps = 40/321 (12%)
Query: 760 KNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELAS 819
N S S S+ E I +E++ + IGKG G VY
Sbjct: 4 MNLSLLSARSFPRKASQTSIFLQEWDIPFEQL-------EIGELIGKGRFGQVYHGRW-H 55
Query: 820 GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEM 879
GE+ A++ E + F EV A + RH N+V F G C H I+ +
Sbjct: 56 GEV-AIRLIDIERDNEDQLK-AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKG 113
Query: 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNE 939
+L ++ + A L+ + + + I + YLH I+H+D+ SKNV D +
Sbjct: 114 RTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGK 167
Query: 940 ARVSDFGIAK-----FLKPDSSNWTELAGTYGYVAPEL---------AYTMKVTEKCDVY 985
++DFG+ G ++APE+ + ++ DV+
Sbjct: 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227
Query: 986 SFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAI 1045
+ G + E+ + P + ++ + + + + +++ +
Sbjct: 228 ALGTIWYELHAREWP---FKTQPAEAIIWQMGTGM----KPNLSQIGMGKEISDILL--- 277
Query: 1046 SCLDESPESRPTMQKVSQLLK 1066
C E RPT K+ +L+
Sbjct: 278 FCWAFEQEERPTFTKLMDMLE 298
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-50
Identities = 70/295 (23%), Positives = 127/295 (43%), Gaps = 38/295 (12%)
Query: 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
C+GKG G V++ GE +AVK F S E ++ +E E+ +RH NI+ F
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRET--ELYNTVMLRHENILGF 67
Query: 861 YGFCSHAQHS----FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
++HS +++ Y EMGSL L L+ + ++ IA L++LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHI 123
Query: 917 DCF-----PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS----NWTELAGTYGY 967
+ F P I HRD+ SKN+L+ + ++D G+A ++ GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 968 VAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLIS---SSSLNLNIAL 1018
+APE+ ++ D+++FG++ EV + + + + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 1019 DEILDP------RLPIPSH-NVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+++ R IP+ L S ++ C ++P +R T ++ + L
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 8e-49
Identities = 69/310 (22%), Positives = 125/310 (40%), Gaps = 41/310 (13%)
Query: 786 IVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNE 845
+V I R + IGKG G V++ + GE +AVK F S E ++ +E E
Sbjct: 35 LVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFRE--AE 86
Query: 846 VKALTEIRHRNIVKFYGFCSHAQHS----FIVYEYLEMGSLAMILSNDAAAEDLEWTQRM 901
+ +RH NI+ F + + ++V +Y E GSL L+ + +
Sbjct: 87 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMI 142
Query: 902 SVIKGIADALSYLHNDCF-----PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956
+ A L++LH + P I HRD+ SKN+L+ ++D G+A +
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 957 ----NWTELAGTYGYVAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFIS- 1005
GT Y+APE+ + ++ D+Y+ G++ E+ + G
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
Query: 1006 --LISSSSLNLNIALDEILDP------RLPIPSH-NVQEKLISFVEVAISCLDESPESRP 1056
L + + +++E+ R IP+ E L ++ C + +R
Sbjct: 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
Query: 1057 TMQKVSQLLK 1066
T ++ + L
Sbjct: 323 TALRIKKTLS 332
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-48
Identities = 71/307 (23%), Positives = 122/307 (39%), Gaps = 40/307 (13%)
Query: 789 EEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA 848
+ I IGKG G V+ + GE +AVK F + E ++ +E E+
Sbjct: 32 QRTI--AKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT--EEASWFRE--TEIYQ 84
Query: 849 LTEIRHRNIVKFYGFCSHAQHS----FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVI 904
+RH NI+ F S +++ +Y E GSL L + L+ + +
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLA 140
Query: 905 KGIADALSYLHNDCF-----PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW- 958
L +LH + F P I HRD+ SKN+L+ ++D G+A D++
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 959 ---TELAGTYGYVAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFIS---L 1006
GT Y+ PE+ + D+YSFG++ EV + G + L
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
Query: 1007 ISSSSLNLNIALDEILDP------RLPIPSH-NVQEKLISFVEVAISCLDESPESRPTMQ 1059
+ + + +++ + R P+ + E L ++ C +P SR T
Sbjct: 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320
Query: 1060 KVSQLLK 1066
+V + L
Sbjct: 321 RVKKTLA 327
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-48
Identities = 75/487 (15%), Positives = 157/487 (32%), Gaps = 29/487 (5%)
Query: 136 SIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYL 195
+I + + + L+ + + N+ L L N LS +++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 196 LDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNG 255
LNL +N L L +LS L L+L++N + EL + L A+N ++
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 256 SIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGL-IPHSLGNLSN 314
+ S +Y+ NN ++ L + G + + L N+ + +
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 315 IAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLS 374
+ L L N ++ + L L+L +NKL + + ++ + + NN L
Sbjct: 171 LEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 375 GSIPCEIGNLKSLSYLNLAFNKL-TSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLV 433
I + ++L + +L N ++ S + ++ K ++ +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECT 284
Query: 434 KLTKLFLGDNQFQG-PIPNLKNLTSLVRVHLDRNYLTSN----ISESFYIYPNLTFIDLS 488
T G + P P L +L R + + ID
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344
Query: 489 YNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLE--VLDLSSNHVVGDIPA 546
I R L+ K + + ++L+ + +
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE 404
Query: 547 ELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPES--LGNLVKLHY 604
E L L ++ ++ + + + D+ + + E+ L L
Sbjct: 405 EQSPLQLLRAIVKRYEEMYVE--QQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEAD 462
Query: 605 LNLSNNQ 611
L L++
Sbjct: 463 LALASAN 469
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 8e-48
Identities = 76/438 (17%), Positives = 137/438 (31%), Gaps = 25/438 (5%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSY 122
S ++ LDL N L + +KL+ L+LSSN+ + LS
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLST 81
Query: 123 LKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLS 182
L+TL L N + E+ S+ L +N + + S + L NN ++
Sbjct: 82 LRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV---SCSRGQGKKNIYLANNKIT 133
Query: 183 GSIPSEIGNLKYLLDLNLYNNELNG-SIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLK 241
+ G + L+L NE++ + + + L LNL N ++ + ++
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFA 191
Query: 242 YLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKF 301
L L L+ NKL + + + + + NN L I + + L L N F
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249
Query: 302 SGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLT 361
N + ++ L ++ G F L
Sbjct: 250 HCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI 308
Query: 362 NLSVLFIYNNSLSGS----IPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFY 417
L S GS + CE N ++ + + I L
Sbjct: 309 ALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQK 368
Query: 418 KNSLSGAIPKEYRNLVKLTKLF---LGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISE 474
K +L + R +L +G + Q L L + + Y + +
Sbjct: 369 KKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLL--RAIVKRYEEMYVEQ 426
Query: 475 SFYIYPNLTFIDLSYNNL 492
+ D+ +
Sbjct: 427 QSVQNNAIRDWDMYQHKE 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-47
Identities = 76/509 (14%), Positives = 165/509 (32%), Gaps = 39/509 (7%)
Query: 161 IPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLA 220
I N + ++ L ++ S + + +L+L N L+ L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 221 MLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGL 280
+LNLSSN L +L +L L L L +N + L ++ L+ NN++S +
Sbjct: 62 LLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV 114
Query: 281 IPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGL-IPSELRNLKSL 339
S K + L+ NK + L G S + +L L N + + + +L
Sbjct: 115 SCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 340 SILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTS 399
L L N + + + L L + +N L+ + E + +++++L NKL
Sbjct: 172 EHLNLQYNFI-YDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 400 SIPISLSNLTNLSVLSFYKNSLS-GAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSL 458
I +L NL N G + + ++ + + + N + T
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVP 286
Query: 459 VRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITG 518
H + L + + + + + T
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSG--------------------QGSETE 326
Query: 519 NIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQL 578
+ + ++ +D I + I L + L Q+S +L
Sbjct: 327 RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAEL 386
Query: 579 EHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWE-IPIKLEELIHLSELDLSYNFLG 637
+ + + + L L ++ + + + + + D+ +
Sbjct: 387 DGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
Query: 638 RAIPSQICIMQSLEKLNLSHNSLSGVIPR 666
+ + + + +L+ S + +
Sbjct: 446 QLAEENARLKKLNGEADLALASANATLQE 474
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 4e-46
Identities = 69/512 (13%), Positives = 158/512 (30%), Gaps = 37/512 (7%)
Query: 93 IGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLAL 152
N ++ K ++ + A+ +K L L N LS ++ + L L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 153 YSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQS 212
SN L + + L +L+ L TL L NN + E+ + L+ NN ++ +
Sbjct: 66 SSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS-- 115
Query: 213 LGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNG-SIPHSLCNLTNLVILY 271
+ L++N + + G + L L N+++ + + L L
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 272 IYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPS 331
+ N + + ++ L + LS NK + + + + + ++ L +N L LI
Sbjct: 176 LQYNFIYD-VKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL-VLIEK 231
Query: 332 ELRNLKSLSILELGNNKL-CGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYL 390
LR ++L +L N CG++ F + + ++ +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV--AKQTVKKLTGQNEEECTVPTLG 289
Query: 391 NLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIP 450
+ L L + L ++ +
Sbjct: 290 HYGAYCCEDLPAPFADRLIAL-------------------KRKEHALLSGQGSETERLEC 330
Query: 451 NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALD 510
+N + + + I + ++ L ++S+ +L
Sbjct: 331 ERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTL 390
Query: 511 FSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSP 570
S + + + + + + + + + Q++ +
Sbjct: 391 QQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEE 450
Query: 571 KLGLLVQLEHLDLSSNNLSNAIPESLGNLVKL 602
L DL+ + + + E + L
Sbjct: 451 NARLKKLNGEADLALASANATLQELVVREQNL 482
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-46
Identities = 65/463 (14%), Positives = 146/463 (31%), Gaps = 27/463 (5%)
Query: 208 SIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNL 267
+I + N + + ++ +SL ++ S + + +L L+ N L+ L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 268 VILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFG 327
+L + +N L ++ +L L + L+ N L +I L +N++
Sbjct: 61 ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 328 LIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSG-SIPCEIGNLKS 386
+ S + K++ L NNK+ G + + L + N + + + +
Sbjct: 114 VSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 387 LSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ 446
L +LNL +N + + L L N L+ + E+++ +T + L +N+
Sbjct: 171 LEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 447 GPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKL 506
L+ +L L N F N ++ + + C
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 507 GALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHV-------VGDIPAELGKLSFLIKLIL 559
+ ++ +L L + + + E + ++
Sbjct: 287 TLGHYGAYCCE---DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDA 343
Query: 560 AQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIK 619
+ Q + L+ L + +L E+
Sbjct: 344 LKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHA 402
Query: 620 LEELIHLSELDLSYN-FLGRAIPSQICIMQSLEKLNLSHNSLS 661
EE L L + + Q ++ ++ + +
Sbjct: 403 TEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-43
Identities = 58/393 (14%), Positives = 126/393 (32%), Gaps = 21/393 (5%)
Query: 305 IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLS 364
I N + + +SL + S ++ ++ L+L N L L T L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 365 VLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGA 424
+L + +N L ++ + +L +L L+L N + L ++ L N++S
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS-R 113
Query: 425 IPKEYRNLVKLTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLTS-NISESFYIYPNL 482
+ ++L +N+ + + + L N + + N +E L
Sbjct: 114 VSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 483 TFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVG 542
++L YN +Y ++ KL LD S N + + P+ ++ + + L +N +V
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 543 DIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKL 602
I L L L N + + ++ + ++
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 603 HYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLG----RAIPSQICIMQSLEKLNLSHN 658
+ + LI L + + + + +++
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346
Query: 659 SLSGVIPRCFEEMHALQCIDISYNELRGPIPNS 691
VI + A ++ L + N
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNG 379
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-32
Identities = 49/284 (17%), Positives = 106/284 (37%), Gaps = 16/284 (5%)
Query: 424 AIPKEYRNLVKLTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIYPNL 482
AI + +N + + D+ + + + ++ ++ + L N L+ + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 483 TFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVG 542
++LS N LY + D L LD + N + ++ +E L ++N++
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112
Query: 543 DIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSN-AIPESLGNLVK 601
+ + LA N+++ G ++++LDL N + E +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 602 LHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLS 661
L +LNL N ++ L LDLS N L + + + ++L +N L
Sbjct: 171 LEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 662 GVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGN 705
+I + L+ D+ N ++ ++ +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 28/279 (10%), Positives = 63/279 (22%), Gaps = 34/279 (12%)
Query: 68 SFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLH 127
F S + ++ L +N+L I + L++ DL N F +
Sbjct: 209 EFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQT 266
Query: 128 LFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDI--------------------------- 160
+ K + + + ED+
Sbjct: 267 VAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE 326
Query: 161 -IPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNL 219
+ N + I + + L L+ + + L
Sbjct: 327 RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAEL 386
Query: 220 AMLNLSSNSL--FGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSL 277
+ E L+ L + + + +Y +
Sbjct: 387 DGTLQQAVGQIELQHATEEQSPLQLLR--AIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444
Query: 278 SGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIA 316
+ L K + L+ + + + N+A
Sbjct: 445 TQLAEENARLKKLNGEADLALASANATLQELVVREQNLA 483
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 4e-48
Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 28/280 (10%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
IG G G+VYK + G++ AVK + P Q F NEV L + RH
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQ-AFKNEVGVLRKTRHV 80
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
NI+ F G+ + Q + IV ++ E SL L E + + + + A + YLH
Sbjct: 81 NILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLH 137
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK--PDSSNWTELAGTYGYVAPEL- 972
I+HRD+ S N+ L N ++ DFG+A S + +L+G+ ++APE+
Sbjct: 138 A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 973 --AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEI----LDPRL 1026
+ + + DVY+FG++ E++ G+ P I+ N + ++ + L P L
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------NRDQIIEMVGRGSLSPDL 247
Query: 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
N +++ + CL + + RP+ ++ ++
Sbjct: 248 SKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIE 284
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-46
Identities = 82/365 (22%), Positives = 138/365 (37%), Gaps = 48/365 (13%)
Query: 97 SKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNY 156
+ L++ + + +P + +++ TL + N L+ S+P L +L + N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQ 92
Query: 157 LEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNL 216
L +P L L +P+ L L ++ N+L S+P L
Sbjct: 93 LTS-LPVLPPGLLELSIFSNPLT----HLPALPSGLCK---LWIFGNQLT-SLPVLPPGL 143
Query: 217 SNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNS 276
L++S N L S+P+ L L +N+L S+P L L + +N
Sbjct: 144 QE---LSVSDNQL-ASLPALPSELCK---LWAYNNQLT-SLPMLPSGLQE---LSVSDNQ 192
Query: 277 LSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNL 336
L+ L P+ L L N+ + L P L L + N L +P L
Sbjct: 193 LASL-PTLPSELYKLW---AYNNRLTSL-PALPSGLKE---LIVSGNRL-TSLPVLPSEL 243
Query: 337 KSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNK 396
K L + N+L S+P L +LSV Y N L+ +P + +L S + +NL N
Sbjct: 244 KELM---VSGNRL-TSLPMLPSGLLSLSV---YRNQLT-RLPESLIHLSSETTVNLEGNP 295
Query: 397 LTSSIPISLSNLTNLSVLS---FYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLK 453
L+ +L +T+ S + + P+E R L +L + P P
Sbjct: 296 LSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAP-AD 354
Query: 454 NLTSL 458
Sbjct: 355 RWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 8e-45
Identities = 83/349 (23%), Positives = 136/349 (38%), Gaps = 45/349 (12%)
Query: 123 LKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLS 182
L++ ++ L+ ++P + + + L + N L + P L L + N L+
Sbjct: 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSL-PALPPELRTLE---VSGNQLT 94
Query: 183 GSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKY 242
S+P L L + L S L L + N L S+P L+
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQL-TSLPVLPPGLQE 145
Query: 243 LSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFS 302
LS ++DN+L S+P L L+ YNN L+ L P L+ LS +S N+ +
Sbjct: 146 LS---VSDNQLA-SLPALPSELCK---LWAYNNQLTSL-PMLPSGLQELS---VSDNQLA 194
Query: 303 GLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTN 362
L P L L+ +N L L P+ LK L + N+L S+P L
Sbjct: 195 SL-PTLPSELYK---LWAYNNRLTSL-PALPSGLKELI---VSGNRL-TSLPVLPSELKE 245
Query: 363 LSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLS 422
L V N L+ S+P L S L++ N+LT +P SL +L++ + ++ N LS
Sbjct: 246 LMV---SGNRLT-SLPMLPSGLLS---LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297
Query: 423 GAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSN 471
+ R + +F + T ++L
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRA-LHLAAADWLVPA 345
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-43
Identities = 82/368 (22%), Positives = 137/368 (37%), Gaps = 47/368 (12%)
Query: 144 LSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNN 203
+ L + + L +P L ++ TL + +N L+ S+P+ L+ L + N
Sbjct: 39 NNGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPALPPELRT---LEVSGN 91
Query: 204 ELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCN 263
+L S+P L L++ + L P+ L L + N+L S+P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCKLW---IFGNQLT-SLPVLPPG 142
Query: 264 LTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSN 323
L L + +N L+ L P+ L L N+ + L P L L + N
Sbjct: 143 LQE---LSVSDNQLASL-PALPSELCKLW---AYNNQLTSL-PMLPSGLQE---LSVSDN 191
Query: 324 SLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGN 383
L L P+ L L NN+L S+P L L V N L+ S+P
Sbjct: 192 QLASL-PTLPSELYKLWAY---NNRLT-SLPALPSGLKELIV---SGNRLT-SLPVLPSE 242
Query: 384 LKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDN 443
LK L ++ N+LT S+P+ S L +LSV N L+ +P+ +L T + L N
Sbjct: 243 LKE---LMVSGNRLT-SLPMLPSGLLSLSVYR---NQLT-RLPESLIHLSSETTVNLEGN 294
Query: 444 QF-QGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGR 502
+ + L+ +TS + + L + + L +
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH--LAAADWLVPAREGEPAP 352
Query: 503 CPKLGALD 510
+
Sbjct: 353 ADRWHMFG 360
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 5e-43
Identities = 84/360 (23%), Positives = 128/360 (35%), Gaps = 48/360 (13%)
Query: 70 SSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLF 129
H+ L + N L ++P L+ L++S N + ++P L L
Sbjct: 58 CLPAHITTLVIPDNNL-TSLPALPPE---LRTLEVSGNQLT-SLPVLPPGLLELSIFSNP 112
Query: 130 KNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI 189
L S L L ++ N L +P L L + +N L+ S+P+
Sbjct: 113 LTHLPAL-------PSGLCKLWIFGNQLTS-LPVLPPGLQELS---VSDNQLA-SLPALP 160
Query: 190 GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLA 249
L L YNN+L S+P L L++S N L S+P+ L L
Sbjct: 161 SELCK---LWAYNNQLT-SLPMLPSGLQE---LSVSDNQL-ASLPTLPSELYKLW---AY 209
Query: 250 DNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSL 309
+N+L S+P L L + N L+ L P LK L +S N+ + L P
Sbjct: 210 NNRLT-SLPALPSGLKE---LIVSGNRLTSL-PVLPSELKELM---VSGNRLTSL-PMLP 260
Query: 310 GNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVL--- 366
L + L + N L L P L +L S + + L N L L +T+
Sbjct: 261 SGLLS---LSVYRNQLTRL-PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGP 316
Query: 367 FIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPI----SLSNLTNLSVLSFYKNSLS 422
I + S P E L + L + P N S + + LS
Sbjct: 317 IIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-39
Identities = 95/443 (21%), Positives = 162/443 (36%), Gaps = 72/443 (16%)
Query: 198 LNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSI 257
LN+ + L ++P L ++ L + N+L S+P+ L+ L ++ N+L S+
Sbjct: 45 LNVGESGLT-TLPDCLPA--HITTLVIPDNNL-TSLPALPPELRTLE---VSGNQLT-SL 96
Query: 258 PHSLCNLTNLVILYIYNNSLSGL----------------IPSEIGNLKFLSKIALSYNKF 301
P L L I L L +P L+ LS +S N+
Sbjct: 97 PVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELS---VSDNQL 153
Query: 302 SGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLT 361
+ L P L L+ +N L L P L+ LS + +N+L S+P L
Sbjct: 154 ASL-PALPSELCK---LWAYNNQLTSL-PMLPSGLQELS---VSDNQLA-SLPTLPSELY 204
Query: 362 NLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL 421
L NN L+ S+P LK L ++ N+LT S+P+ S L L V N L
Sbjct: 205 KLWAY---NNRLT-SLPALPSGLKE---LIVSGNRLT-SLPVLPSELKELMVSG---NRL 253
Query: 422 SGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPN 481
+ ++P L L + NQ +L +L+S V+L+ N L+ +
Sbjct: 254 T-SLPML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS---ERTLQALRE 306
Query: 482 LTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVV 541
+T + + + AL + + +P + G + + +
Sbjct: 307 ITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWL--VPAREGEPAPADRWHM------ 358
Query: 542 GDIPAELGKLSF---LIKLILAQN-----QLSGQLSPKLGLLVQLEHLDLSSNNLSNAIP 593
E +F L +L +N Q+S L L + E L ++ ++
Sbjct: 359 --FGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQLAEDEALRANTFAMATEAT 416
Query: 594 ESLGNLVKLHYLNLSNNQFSWEI 616
S + V + N Q
Sbjct: 417 SSCEDRVTFFLHQMKNVQLVHNA 439
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-38
Identities = 85/458 (18%), Positives = 140/458 (30%), Gaps = 96/458 (20%)
Query: 216 LSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNN 275
+ A+LN+ + L ++P L ++ L + DN L S+P L L + N
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLPAH--ITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 276 SLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRN 335
L+ L P L LS + L S + L++ N L L P
Sbjct: 92 QLTSL-PVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLTSL-PVLPPG 142
Query: 336 LKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFN 395
L+ LS + +N+L S+P L L NN L+ S+P L+ L +++ N
Sbjct: 143 LQELS---VSDNQL-ASLPALPSELCKLWAY---NNQLT-SLPMLPSGLQEL---SVSDN 191
Query: 396 KLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNL 455
+L S +P S L L + N L+ ++P L +L + N+ L
Sbjct: 192 QLAS-LPTLPSELYKLWAYN---NRLT-SLPAL---PSGLKELIVSGNRLTSLPVLPSEL 243
Query: 456 TSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNN 515
L + N LTS
Sbjct: 244 KEL---MVSGNRLTS--------------------------------------------- 255
Query: 516 ITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLL 575
+P L L + N + +P L LS + L N LS L L
Sbjct: 256 ----LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS---ERTLQAL 304
Query: 576 VQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNF 635
++ S + + + + L W +P + E +
Sbjct: 305 REITSAPGYSGPI-IRFDMAGASAPRETR-ALHLAAADWLVPAREGEPAPADRWHMFGQE 362
Query: 636 LGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHA 673
S S + + I ++
Sbjct: 363 DNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQLAE 400
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 9e-38
Identities = 76/397 (19%), Positives = 137/397 (34%), Gaps = 43/397 (10%)
Query: 336 LKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFN 395
++L +G + L ++P L +++ L I +N+L+ S+P L++L ++ N
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 396 KLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNL 455
+LTS +P+ L LS+ S L L KL++ NQ L
Sbjct: 92 QLTS-LPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLTSLPVLPPGL 143
Query: 456 TSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNN 515
L + N L S + L + N L + L L S N
Sbjct: 144 QEL---SVSDNQLAS-LPALP---SELCKLWAYNNQL-TSLPMLPS---GLQELSVSDNQ 192
Query: 516 ITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLL 575
+ ++P +L L +N + +PA L +LI++ N+L+ L
Sbjct: 193 LA-SLPTLPS---ELYKLWAYNNRLT-SLPALPSGLK---ELIVSGNRLT-SLPVLPS-- 241
Query: 576 VQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNF 635
+L+ L +S N L+ ++P L+ L ++ NQ + +P L L + ++L N
Sbjct: 242 -ELKELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNP 295
Query: 636 LGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFR 695
L + + S + E AL + + A R
Sbjct: 296 LSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADR 355
Query: 696 DAPIKALQGNKGLCGDFKGLPSCKALKSNKQASRKIW 732
L + + +I
Sbjct: 356 WHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQIS 392
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-32
Identities = 69/324 (21%), Positives = 115/324 (35%), Gaps = 51/324 (15%)
Query: 54 NLTSIGLKGTLHDFSFSSFP-HLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGA 112
L+ T + P L L ++ NQL ++P L+ L +S N + +
Sbjct: 105 ELSIFSNPLT----HLPALPSGLCKLWIFGNQL-TSLPVLPPG---LQELSVSDNQLA-S 155
Query: 113 IPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLV 172
+P L L + NQL+ S+P+ GL L+ + N L + P L L
Sbjct: 156 LPALPSEL---CKLWAYNNQLT-SLPMLPSGLQELS---VSDNQLASL-PTLPSELYKLW 207
Query: 173 TLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGS 232
YNN L+ S+P+ LK L + N L S+P L L +S N L S
Sbjct: 208 ---AYNNRLT-SLPALPSGLKEL---IVSGNRLT-SLPVLPSELKEL---MVSGNRL-TS 255
Query: 233 IPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLS 292
+P L LS + N+L +P SL +L++ + + N LS + +
Sbjct: 256 LPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAP 311
Query: 293 KIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGS 352
+ +F + L + L+P+ +
Sbjct: 312 GYSGPIIRFDMAGASAPRETRA-----LHLAAADWLVPAREGEPAPADRWHM-------- 358
Query: 353 IPHFLGNLTNLSVLFIYNNSLSGS 376
G N ++ + LS +
Sbjct: 359 ----FGQEDNADAFSLFLDRLSET 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-45
Identities = 76/391 (19%), Positives = 138/391 (35%), Gaps = 19/391 (4%)
Query: 208 SIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNL 267
I +L +++ + E L + ++ + L + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 268 VILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFG 327
+L + + + + + K+ + +N L PH N+ + L L+ N L
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 328 LIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSL 387
L N L+ L + NN L T+L L + +N L+ + + + SL
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSL 188
Query: 388 SYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG 447
+ N+++N L+ +L+ + L NS++ + V+LT L L N
Sbjct: 189 FHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGP--VNVELTILKLQHNNLT- 239
Query: 448 PIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLG 507
L N LV V L N L + F L + +S N L ++ P L
Sbjct: 240 DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLK 298
Query: 508 ALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQ 567
LD S N++ ++ +LE L L N +V + L L L L+ N
Sbjct: 299 VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDC- 353
Query: 568 LSPKLGLLVQLEHLDLSSNNLSNAIPESLGN 598
+ L + + + I L +
Sbjct: 354 -NSLRALFRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-44
Identities = 85/384 (22%), Positives = 149/384 (38%), Gaps = 22/384 (5%)
Query: 230 FGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLK 289
+ I S L D+ + + L N I+ N+++ L + + + +
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 69
Query: 290 FLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKL 349
+ + L+ + + ++ I L++ N++ L P +N+ L++L L N L
Sbjct: 70 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129
Query: 350 CGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNL 408
N L+ L + NN+L I + SL L L+ N+LT + LS +
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLI 185
Query: 409 TNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLKNLTSLVRVHLDRNY 467
+L + N LS + + +L N P LT L L N
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNN 237
Query: 468 LTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYS 527
LT + YP L +DLSYN L + + + +L L S N + +
Sbjct: 238 LTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294
Query: 528 SQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNN 587
L+VLDLS NH++ + + L L L N + + KL L++L LS N+
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHND 350
Query: 588 LS-NAIPESLGNLVKLHYLNLSNN 610
N++ N+ + + +
Sbjct: 351 WDCNSLRALFRNVARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-43
Identities = 70/380 (18%), Positives = 149/380 (39%), Gaps = 31/380 (8%)
Query: 51 NSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLF 109
I++ + + F + + + ++ + +P + + +++ L+L+
Sbjct: 26 VHIDMQTQDV---YFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQVELLNLNDLQI 81
Query: 110 SGAIPPQI-GHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGN 167
I + ++ L++ N + +P V + L L L N L + N
Sbjct: 82 E-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHN 139
Query: 168 LTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSS 226
L TL + NN L I + L +L L +N L + L + +L N+S
Sbjct: 140 TPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSY 195
Query: 227 NSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIG 286
N L S L + +L + N +N + + L IL + +N+L+ + +
Sbjct: 196 NLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLL 245
Query: 287 NLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGN 346
N L ++ LSYN+ ++ H + + L++ +N L + + + +L +L+L +
Sbjct: 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSH 304
Query: 347 NKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLS 406
N L + L L++ +NS+ ++ + +L L L+ N + +L
Sbjct: 305 NHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL- 359
Query: 407 NLTNLSVLSFYKNSLSGAIP 426
N++ + I
Sbjct: 360 -FRNVARPAVDDADQHCKID 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-42
Identities = 69/381 (18%), Positives = 135/381 (35%), Gaps = 25/381 (6%)
Query: 89 IPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEV-GGLSSL 147
I + + + + L+ K + + + +P + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 148 NNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNELN 206
L L +E+I ++ + L + N + +P + N+ L L L N+L+
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
Query: 207 GSIPQSLGNLSNLAMLNLSSNSLFGSIPSE-LGNLKYLSDLKLADNKLNGSIPHSLCNLT 265
N L L++S+N+L I + L +L+L+ N+L + S +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVDLS--LIP 186
Query: 266 NLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSL 325
+L + N L S + + ++ S+N + + L+ L L N+L
Sbjct: 187 SLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELT---ILKLQHNNL 238
Query: 326 FGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLK 385
+ L N L ++L N+L + H + L L+I NN L ++ +
Sbjct: 239 TDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 386 SLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQF 445
+L L+L+ N L + + L L NS+ + L L L N +
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDW 351
Query: 446 QGPIPNLKNLTSLVRVHLDRN 466
++ R +D
Sbjct: 352 D-CNSLRALFRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-42
Identities = 67/391 (17%), Positives = 134/391 (34%), Gaps = 25/391 (6%)
Query: 106 SNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSL 165
I + + +H+ E L++ + ++ + + L
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 166 GNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNL 224
+ + L L + + I + + L + N + P N+ L +L L
Sbjct: 66 DSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124
Query: 225 SSNSLFGSIPSEL-GNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPS 283
N L S+P + N L+ L +++N L + T+L L + +N L+ +
Sbjct: 125 ERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV--- 180
Query: 284 EIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILE 343
++ + L +SYN S +L + L NS+ + L L
Sbjct: 181 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILK--- 232
Query: 344 LGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLTSSIP 402
L +N L N L + + N L I ++ L L ++ N+L ++
Sbjct: 233 LQHNNL-TDTAWL-LNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALN 288
Query: 403 ISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVH 462
+ + L VL N L + + +L L+L N + L +L +
Sbjct: 289 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLT 345
Query: 463 LDRNYLTSNISESFYIYPNLTFIDLSYNNLY 493
L N N + ++ N+ + + +
Sbjct: 346 LSHNDWDCNSLRA--LFRNVARPAVDDADQH 374
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-37
Identities = 79/383 (20%), Positives = 135/383 (35%), Gaps = 32/383 (8%)
Query: 346 NNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISL 405
I L + I + E L + + + + L
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 406 SNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHL 463
+ + +L+ + + + KL++G N + +P +N+ L + L
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVL 124
Query: 464 DRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGR-CPKLGALDFSKNNIT----- 517
+RN L+S F+ P LT + +S NNL I D + L L S N +T
Sbjct: 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLTHVDLS 183
Query: 518 -----------GNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSG 566
N+ + +E LD S N + + + L L L N L+
Sbjct: 184 LIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD 240
Query: 567 QLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHL 626
+ L L +DLS N L + + +L L +SNN+ + + + + L
Sbjct: 241 --TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 297
Query: 627 SELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRG 686
LDLS+N L + LE L L HNS+ + H L+ + +S+N+
Sbjct: 298 KVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD- 352
Query: 687 PIPNSTAFRDAPIKALQGNKGLC 709
FR+ A+ C
Sbjct: 353 CNSLRALFRNVARPAVDDADQHC 375
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-43
Identities = 76/308 (24%), Positives = 132/308 (42%), Gaps = 10/308 (3%)
Query: 72 FPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLF 129
LDL N++ + + L+ L+L+ N+ S A+ P +L L+TL L
Sbjct: 31 PTETRLLDLGKNRI-KTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLR 88
Query: 130 KNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSE 188
N+L IPL V GLS+L L + N + ++ + +L NL +L + +N L I
Sbjct: 89 SNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHR 146
Query: 189 I-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLK 247
L L L L L ++L +L L +L L ++ L L L+
Sbjct: 147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206
Query: 248 LADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPH 307
++ ++ + NL L I + +L+ + + +L +L + LSYN S +
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGS 266
Query: 308 SLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH-FLGNLTNLSVL 366
L L + + L L + P R L L +L + N+L ++ ++ NL L
Sbjct: 267 MLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL-TTLEESVFHSVGNLETL 325
Query: 367 FIYNNSLS 374
+ +N L+
Sbjct: 326 ILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-38
Identities = 73/321 (22%), Positives = 128/321 (39%), Gaps = 12/321 (3%)
Query: 370 NNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEY 429
++P I L+L N++ + ++ +L L +N +S P +
Sbjct: 20 RKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAF 76
Query: 430 RNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDL 487
NL L L L N+ + IP L++L ++ + N + + F NL +++
Sbjct: 77 NNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135
Query: 488 SYNNLYGEISSDW-GRCPKLGALDFSKNNITGNIPPKI-GYSSQLEVLDLSSNHVVGDIP 545
N+L IS L L K N+T +IP + + L VL L ++
Sbjct: 136 GDNDL-VYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRD 193
Query: 546 AELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYL 605
+L L L ++ ++P + L L ++ NL+ ++ +LV L +L
Sbjct: 194 YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFL 253
Query: 606 NLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICI-MQSLEKLNLSHNSLSGVI 664
NLS N S L EL+ L E+ L L + + L LN+S N L+ +
Sbjct: 254 NLSYNPISTIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLTTLE 312
Query: 665 PRCFEEMHALQCIDISYNELR 685
F + L+ + + N L
Sbjct: 313 ESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-37
Identities = 74/324 (22%), Positives = 128/324 (39%), Gaps = 12/324 (3%)
Query: 198 LNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSI 257
+ + ++P+ + + +L+L N + E + +L +L+L +N ++
Sbjct: 16 VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72
Query: 258 PHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAF 317
P + NL NL L + +N L + L L+K+ +S NK L+ + +L N+
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKS 132
Query: 318 LFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIP-HFLGNLTNLSVLFIYNNSLSGS 376
L + N L + L SL L L L SIP L +L L VL + + +++
Sbjct: 133 LEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAI 191
Query: 377 IPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKE-YRNLVKL 435
L L L ++ ++ + NL+ LS +L+ A+P R+LV L
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYL 250
Query: 436 TKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLY 493
L L N I L L L + L L +F L +++S N L
Sbjct: 251 RFLNLSYNPIST-IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL- 308
Query: 494 GEISSD-WGRCPKLGALDFSKNNI 516
+ + L L N +
Sbjct: 309 TTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 67/268 (25%), Positives = 116/268 (43%), Gaps = 10/268 (3%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHL 120
+ +F++ +L L L SN+L IP + +S L LD+S N + + L
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDL 127
Query: 121 SYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
LK+L + N L I GL+SL L L L I +L +L L+ L L +
Sbjct: 128 YNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186
Query: 180 LLSGSIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSE-L 237
++ +I L L L + + ++ + NL L+++ +L ++P +
Sbjct: 187 NIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAV 244
Query: 238 GNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALS 297
+L YL L L+ N ++ L L L + + L+ + P L +L + +S
Sbjct: 245 RHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304
Query: 298 YNKFSGLIPHSLGNLSNIAFLFLDSNSL 325
N+ + L ++ N+ L LDSN L
Sbjct: 305 GNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 16/235 (6%)
Query: 54 NLTSIGLKG----TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNL 108
NLT + + L D+ F +L L++ N L I + ++ L+ L L
Sbjct: 105 NLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCN 163
Query: 109 FSGAIPPQI-GHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLG 166
+ +IP + HL L L L ++ +I L L L + D + +
Sbjct: 164 LT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCL 221
Query: 167 NLTNLVTLCLYNNLLSGSIPSE-IGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLS 225
NL +L + + L+ ++P + +L YL LNL N ++ L L L + L
Sbjct: 222 YGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLV 280
Query: 226 SNSLFGSIPSE-LGNLKYLSDLKLADNKLNGSIPHSLC-NLTNLVILYIYNNSLS 278
L + L YL L ++ N+L ++ S+ ++ NL L + +N L+
Sbjct: 281 GGQL-AVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 43/189 (22%), Positives = 74/189 (39%), Gaps = 10/189 (5%)
Query: 509 LDFSKNNITGNIPPKI-GYSSQLEVLDLSSNHVVGDIPAE-LGKLSFLIKLILAQNQLSG 566
LD KN I + LE L+L+ N V + L L L L N+L
Sbjct: 37 LDLGKNRIK-TLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSNRLK- 93
Query: 567 QLSPK-LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIK-LEELI 624
+ L L LD+S N + + +L L L + +N I + L
Sbjct: 94 LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLN 152
Query: 625 HLSELDLSYNFLGRAIPSQI-CIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNE 683
L +L L L +IP++ + L L L H +++ + F+ ++ L+ ++IS+
Sbjct: 153 SLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP 211
Query: 684 LRGPIPNST 692
+ +
Sbjct: 212 YLDTMTPNC 220
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-43
Identities = 53/305 (17%), Positives = 109/305 (35%), Gaps = 16/305 (5%)
Query: 136 SIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYL 195
+I + + + L+ + + N+ L L N LS +++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 196 LDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNG 255
LNL +N L L +LS L L+L++N + EL + L A+N ++
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 256 SIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGL-IPHSLGNLSN 314
+ S +Y+ NN ++ L + G + + L N+ + +
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 315 IAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLS 374
+ L L N ++ + L L+L +NKL + + ++ + + NN L
Sbjct: 171 LEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 375 GSIPCEIGNLKSLSYLNLAFNKLTS-SIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLV 433
I + ++L + +L N ++ S + ++ +E +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 434 KLTKL 438
L
Sbjct: 287 TLGHY 291
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-42
Identities = 66/329 (20%), Positives = 115/329 (34%), Gaps = 25/329 (7%)
Query: 161 IPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLA 220
I N + ++ L ++ S + + +L+L N L+ L + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 221 MLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGL 280
+LNLSSN L +L +L L L L +N + L ++ L+ NN++S +
Sbjct: 62 LLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV 114
Query: 281 IPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGL-IPSELRNLKSL 339
S K + L+ NK + L G S + +L L N + + + +L
Sbjct: 115 SCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 340 SILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTS 399
L L N + + + L L + +N L+ + E + +++++L NKL
Sbjct: 172 EHLNLQYNFI-YDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 400 SIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLKNLTSL 458
I +L NL N L F + + Q +K LT
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFH---------CGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
Query: 459 VRVHLDRNYLTSNISESFYIYPNLTFIDL 487
L + P L
Sbjct: 279 NEEECTVPTLGHYGAYCCEDLPAPFADRL 307
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 57/335 (17%), Positives = 115/335 (34%), Gaps = 20/335 (5%)
Query: 232 SIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFL 291
+I N K+ D+ L ++ + N+ L + N LS + +++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 292 SKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCG 351
+ LS N + L +LS + L L++N + EL S+ L NN +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-S 112
Query: 352 SIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTS-SIPISLSNLTN 410
+ +++ NN ++ + G + YL+L N++ + + ++
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 411 LSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTS 470
L L+ N + + + KL L L N+ P ++ + + L N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL 228
Query: 471 NISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQL 530
I ++ NL DL N + D+ +K + + + +
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVK-KLTGQNEEECTV 285
Query: 531 EVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLS 565
L + D+P + L +
Sbjct: 286 PTLGHYGAYCCEDLP----APFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 55/336 (16%), Positives = 117/336 (34%), Gaps = 24/336 (7%)
Query: 329 IPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLS 388
I +N I ++ ++ L ++ + N+ L + N LS ++ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 389 YLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG- 447
LNL+ N L ++ + +L+ L L N + + + L +N
Sbjct: 62 LLNLSSNVLYETLDL--ESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNISRV 114
Query: 448 PIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYG-EISSDWGRCPKL 506
+ ++ +L N +T + ++DL N + + L
Sbjct: 115 SCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 507 GALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSG 566
L+ N I ++ ++ ++L+ LDLSSN + + E + + + L N+L
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 567 QLSPKLGLLVQLEHLDLSSNNLS-NAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIH 625
+ L LEH DL N + + ++ + + ++ + EE
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECT 284
Query: 626 LSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLS 661
+ L + +P+ + L H+
Sbjct: 285 VPTLGHYGAYCCEDLPAPFA----DRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 56/334 (16%), Positives = 118/334 (35%), Gaps = 22/334 (6%)
Query: 208 SIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNL 267
+I + N + + ++ +SL ++ S + + +L L+ N L+ L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 268 VILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFG 327
+L + +N L ++ +L L + L+ N L +I L +N++
Sbjct: 61 ELLNLSSNVLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 328 LIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSG-SIPCEIGNLKS 386
+ S + K++ L NNK+ G + + L + N + + + +
Sbjct: 114 VSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 387 LSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ 446
L +LNL +N + + L L N L+ + E+++ +T + L +N+
Sbjct: 171 LEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 447 GPIPNLKNLTSLVRVHLDRNYLTS-NISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPK 505
L+ +L L N + + F + + + + P
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 506 LGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNH 539
LG P ++ L +H
Sbjct: 288 LGHY----GAYCCEDLPA---PFADRLIALGHHH 314
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-39
Identities = 59/331 (17%), Positives = 117/331 (35%), Gaps = 20/331 (6%)
Query: 89 IPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLN 148
I N ++ K ++ + A+ +K L L N LS ++ + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 149 NLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGS 208
L L SN L + + L +L+ L TL L NN + E+ + L+ NN ++
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113
Query: 209 IPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNG-SIPHSLCNLTNL 267
+ + L++N + + G + L L N+++ + + L
Sbjct: 114 VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 268 VILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFG 327
L + N + + ++ L + LS NK + + + + + ++ L +N L
Sbjct: 172 EHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL-V 227
Query: 328 LIPSELRNLKSLSILELGNNKL-CGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKS 386
LI LR ++L +L N CG++ F + + + + +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECT 284
Query: 387 LSYLNLAFNKLTSSIPI-SLSNLTNLSVLSF 416
+ L +P L L
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 58/303 (19%), Positives = 102/303 (33%), Gaps = 16/303 (5%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSY 122
S ++ LDL N L + +KL+ L+LSSN+ + LS
Sbjct: 24 QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESLST 81
Query: 123 LKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLS 182
L+TL L N + E+ S+ L +N + + S + L NN ++
Sbjct: 82 LRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV---SCSRGQGKKNIYLANNKIT 133
Query: 183 GSIPSEIGNLKYLLDLNLYNNELNG-SIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLK 241
+ G + L+L NE++ + + + L LNL N ++ + ++
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFA 191
Query: 242 YLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKF 301
L L L+ NKL + + + + + NN L I + + L L N F
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249
Query: 302 SGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLT 361
N + ++ L ++ G F L
Sbjct: 250 H-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI 308
Query: 362 NLS 364
L
Sbjct: 309 ALG 311
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 55/292 (18%), Positives = 101/292 (34%), Gaps = 38/292 (13%)
Query: 376 SIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKL 435
+I N + + L ++ + N+ L N LS + KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 436 TKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGE 495
L L N +L++L++L + L+ NY+ + P++ + + NN+
Sbjct: 61 ELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNI-SR 113
Query: 496 ISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVG-DIPAELGKLSFL 554
+S G+ + + N IT G S+++ LDL N + + L
Sbjct: 114 VSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 555 IKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSW 614
L L N + + +L+ LDLSSN L+ + + + +++L NN+
Sbjct: 172 EHLNLQYNFIYD--VKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV- 227
Query: 615 EIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPR 666
I + Q+LE +L N R
Sbjct: 228 ------------------------LIEKALRFSQNLEHFDLRGNGFHCGTLR 255
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 49/264 (18%), Positives = 101/264 (38%), Gaps = 16/264 (6%)
Query: 424 AIPKEYRNLVKLTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIYPNL 482
AI + +N + + D+ + + + ++ ++ + L N L+ + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 483 TFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVG 542
++LS N LY + D L LD + N + ++ +E L ++N++
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112
Query: 543 DIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSN-AIPESLGNLVK 601
+ + LA N+++ G ++++LDL N + E +
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 602 LHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLS 661
L +LNL N ++ L LDLS N L + + + ++L +N L
Sbjct: 171 LEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227
Query: 662 GVIPRCFEEMHALQCIDISYNELR 685
+I + L+ D+ N
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 13/67 (19%), Positives = 29/67 (43%)
Query: 623 LIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYN 682
++ + L +A+ S ++++L+LS N LS + L+ +++S N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 683 ELRGPIP 689
L +
Sbjct: 69 VLYETLD 75
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-43
Identities = 90/412 (21%), Positives = 155/412 (37%), Gaps = 23/412 (5%)
Query: 224 LSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPS 283
+ I S L D+ + + L N I+ N+++ L +
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAA 69
Query: 284 EIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILE 343
+ + + + + L+ + + ++ I L++ N++ L P +N+ L++L
Sbjct: 70 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129
Query: 344 LGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLTSSIP 402
L N L N L+ L + NN+L I + SL L L+ N+LT
Sbjct: 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH--- 185
Query: 403 ISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLKNLTSLVRV 461
+ LS + +L + N LS + + +L N P LT L
Sbjct: 186 VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL--- 237
Query: 462 HLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIP 521
L N LT + YP L +DLSYN L + + + +L L S N + +
Sbjct: 238 KLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALN 294
Query: 522 PKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHL 581
L+VLDLS NH++ + + L L L N + + KL L++L
Sbjct: 295 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNL 350
Query: 582 DLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSY 633
LS N+ +L + + + +I +LE + E D Y
Sbjct: 351 TLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPY 400
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-41
Identities = 92/568 (16%), Positives = 181/568 (31%), Gaps = 48/568 (8%)
Query: 97 SKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNY 156
+ +Y I + + +H+ E L++ + ++
Sbjct: 3 GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST 62
Query: 157 LEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGN 215
+ + L + + L L + + I + + L + N + P N
Sbjct: 63 MRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN 121
Query: 216 LSNLAMLNLSSNSLFGSIPSEL-GNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYN 274
+ L +L L N L S+P + N L+ L +++N L + T+L L + +
Sbjct: 122 VPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS 180
Query: 275 NSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELR 334
N L+ + S I +L + +SYN S +L + L NS+ +
Sbjct: 181 NRLTHVDLSLIPSLFHAN---VSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNV 232
Query: 335 NLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAF 394
L L L +N L N L + + N L + ++ L L ++
Sbjct: 233 ELTILK---LQHNNL-TDTAWL-LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287
Query: 395 NKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLK 453
N+L ++ + + L VL N L + + +L L+L N +
Sbjct: 288 NRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHH 345
Query: 454 NLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSK 513
L +L L N N ++ N+ + + + +I +
Sbjct: 346 TLKNL---TLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQ------------LE 388
Query: 514 NNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLG 573
+ + K L+ + L+S VV + G+ S + Q+
Sbjct: 389 HGLCCKESDKPYLDRLLQYIALTS--VVEKVQRAQGRCSATDTINSVQSLSHYITQQGGV 446
Query: 574 LLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSY 633
L E L+ N L + N Q + E +L L
Sbjct: 447 PLQGNEQLEAEVNELRAEVQ---------QLTNEQIQQEQLLQGLHAEIDTNLRRYRLPK 497
Query: 634 NFLGRAIPSQICIMQSLEKLNLSHNSLS 661
+ L R+ + + L++ +
Sbjct: 498 DGLARSSDNLNKVFTHLKERQAFKLRET 525
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-37
Identities = 95/570 (16%), Positives = 181/570 (31%), Gaps = 42/570 (7%)
Query: 50 VNSINLTSIGLKG----TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDL 104
+ N + K L SF + L+L Q+ I ++ L +
Sbjct: 48 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYM 106
Query: 105 SSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIP 162
N +PP + ++ L L L +N LS S+P + L L++ +N LE I
Sbjct: 107 GFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIED 164
Query: 163 HSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAML 222
+ T+L L L +N L+ + + + L N+ N L +L + L
Sbjct: 165 DTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEEL 216
Query: 223 NLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIP 282
+ S NS+ + + L+ LKL N L L N LV + + N L ++
Sbjct: 217 DASHNSI-NVVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMY 271
Query: 283 SEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSIL 342
++ L ++ +S N+ + + + L L N L + L L
Sbjct: 272 HPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENL 329
Query: 343 ELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIP 402
L +N + ++ L L L + +N + ++++ + I
Sbjct: 330 YLDHNSI-VTLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKID 384
Query: 403 ISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSL-VRV 461
L + + LT + + QG + S+
Sbjct: 385 YQLEH-------GLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLS 437
Query: 462 HLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIP 521
H + + + + + L E L A N+
Sbjct: 438 HYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAE--IDTNLRRYRL 495
Query: 522 PKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHL 581
PK G + + L+ H+ +L + + A + + + + L
Sbjct: 496 PKDGLARSSDNLNKVFTHLKERQAFKLRETQ--ARRTEADAKQKETEDLEQENIALEKQL 553
Query: 582 DLSSNNLSNAIPESLGNLVKLHYLNLSNNQ 611
D + E+ K+ L N+
Sbjct: 554 DNKRAKQAELRQETSLKRQKVKQLEAKKNR 583
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-42
Identities = 95/520 (18%), Positives = 178/520 (34%), Gaps = 53/520 (10%)
Query: 102 LDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDII 161
+D S N +P + L++ +N +S ++ LS L L + N ++ +
Sbjct: 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 162 PHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQS--LGNLSNL 219
L L L +N L I L L+L N + ++P GN+S L
Sbjct: 62 ISVFKFNQELEYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFD-ALPICKEFGNMSQL 117
Query: 220 AMLNLSSNSLFGSIPSELGNLKYLS-DLKLADNKLNGSIPHSLCNL--TNLVILYIYNNS 276
L LS+ L S + +L L L + P L + +L I++ N
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKE 177
Query: 277 LSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNL 336
++ + + L + + L L+ + SN I
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNI-----ET 232
Query: 337 KSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNK 396
S + + ++ +F ++S + + +LK+LS + +
Sbjct: 233 TWNSFIRILQLVWHTTVWYF-----SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287
Query: 397 LTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLKNL 455
+N+++ +F + + L +N N +L
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 456 TSLVRVHLDRNYLTS--NISESFYIYPNLTFIDLSYNNL-YGEISSDWGRCPKLGALDFS 512
T L + L N L I+E +L +D+S N++ Y E D L +L+ S
Sbjct: 348 TELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407
Query: 513 KNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKL 572
N +T I + +++VLDL SN ++ + ++
Sbjct: 408 SNILTDTIFRCL--PPRIKVLDLHSN------------------------KIK-SIPKQV 440
Query: 573 GLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQF 612
L L+ L+++SN L + L L + L N +
Sbjct: 441 VKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-42
Identities = 108/498 (21%), Positives = 188/498 (37%), Gaps = 37/498 (7%)
Query: 198 LNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSI 257
++ N L +P+ L +LN+S N + S++ +L L L ++ N++
Sbjct: 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 258 PHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGL-IPHSLGNLSNIA 316
L L + +N L + NLK L LS+N F L I GN+S +
Sbjct: 62 ISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLD---LSFNAFDALPICKEFGNMSQLK 118
Query: 317 FLFLDSNSLFGLIPSELRNLKSLSI-LELGNNKLCGSIPHFLGNL--TNLSVLFIYNNSL 373
FL L + L + +L + L LG P L + +L ++F N
Sbjct: 119 FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF 178
Query: 374 SGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLV 433
+ + + +L N+ + LS L L N +
Sbjct: 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSN-------------L 225
Query: 434 KLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPN-----LTFIDLS 488
L + N F I L T++ + L + + Y L+ +
Sbjct: 226 TLNNIETTWNSFIR-ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284
Query: 489 YNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAEL 548
+ S + + +F+ + S LD S+N + +
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC 344
Query: 549 GKLSFLIKLILAQNQLSGQLSPKLGL---LVQLEHLDLSSNNLSNAIPESL-GNLVKLHY 604
G L+ L LIL NQL +LS + + L+ LD+S N++S + L
Sbjct: 345 GHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403
Query: 605 LNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVI 664
LN+S+N + I L + LDL N + ++IP Q+ +++L++LN++ N L V
Sbjct: 404 LNMSSNILTDTIFRCL--PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLKSVP 460
Query: 665 PRCFEEMHALQCIDISYN 682
F+ + +LQ I + N
Sbjct: 461 DGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 1e-41
Identities = 88/488 (18%), Positives = 177/488 (36%), Gaps = 41/488 (8%)
Query: 78 LDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSI 137
+D N L ++P + K L++S N S I LS L+ L + N++ +
Sbjct: 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YL 60
Query: 138 PLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLL-SGSIPSEIGNLKYL 195
+ V L L L N L I S NL L L N + I E GN+ L
Sbjct: 61 DISVFKFNQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQL 117
Query: 196 LDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNG 255
L L L S + +L+ +L + + + L+ + L
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTN 175
Query: 256 SIPHSLCNLTNLVILYIYNNSLSGL-----------IPSEIGNLKFLSKIALSYNKFSGL 304
H + +++ + + +++ + I +++ LS + L+ + +
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 305 IPHSLGNL---SNIAFLFLDSNSLFGLIPSEL-----RNLKSLSILELGNNKLCGSIPHF 356
+ L + + + + + L G + +LK+LSI ++ ++ +
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295
Query: 357 LGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSF 416
+N+++ + + +L+ + N LT ++ + +LT L L
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355
Query: 417 YKNSLSGAIPKEYR---NLVKLTKLFLGDNQFQ--GPIPNLKNLTSLVRVHLDRNYLTSN 471
N L + K + L +L + N + SL+ +++ N LT
Sbjct: 356 QMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414
Query: 472 ISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKI-GYSSQL 530
I P + +DL N + I + L L+ + N + ++P I + L
Sbjct: 415 IFRCL--PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSL 470
Query: 531 EVLDLSSN 538
+ + L +N
Sbjct: 471 QKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-36
Identities = 88/440 (20%), Positives = 151/440 (34%), Gaps = 28/440 (6%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLF-SGAIPPQIGHLS 121
L F L YLDL N+L I LK+LDLS N F + I + G++S
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKL-VKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMS 115
Query: 122 YLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLL 181
LK L L L S L + L+ L + L + T L+
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFP 173
Query: 182 SGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLK 241
+ I ++ NL + + + + + + L +N ++
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL-------- 225
Query: 242 YLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSY--- 298
L++++ N + L T + I N L G + + S ALS
Sbjct: 226 TLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQV 283
Query: 299 --NKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHF 356
+ F + SN+ + + + L+ NN L ++
Sbjct: 284 VSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFEN 343
Query: 357 LGNLTNLSVLFIYNNSLSGSIPCEIG---NLKSLSYLNLAFNKLTSSIP-ISLSNLTNLS 412
G+LT L L + N L + +KSL L+++ N ++ S +L
Sbjct: 344 CGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402
Query: 413 VLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNI 472
L+ N L+ I + ++ L L N+ + + L +L +++ N L S
Sbjct: 403 SLNMSSNILTDTIFR--CLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVP 460
Query: 473 SESFYIYPNLTFIDLSYNNL 492
F +L I L N
Sbjct: 461 DGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-35
Identities = 92/467 (19%), Positives = 163/467 (34%), Gaps = 42/467 (8%)
Query: 222 LNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLI 281
++ S N L +P +L + + L ++ N ++ + +L+ L IL I +N + L
Sbjct: 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61
Query: 282 PSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGL-IPSELRNLKSLS 340
S + L + LS+NK + H NL L L N+ L I E N+ L
Sbjct: 62 ISVFKFNQELEYLDLSHNKLVKISCHPTVNLK---HLDLSFNAFDALPICKEFGNMSQLK 118
Query: 341 ILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSS 400
L L L S + +L VL + + + L N +
Sbjct: 119 FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED-----PEGLQDFNTESLHIVFP 173
Query: 401 IPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVR 460
+ ++SV + LS N L Q + NL +L
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL----TLNN 229
Query: 461 VHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNI 520
+ N + + + + +S L G+ D+S ++
Sbjct: 230 IETTWNSFIRILQ--LVWHTTVWYFSISNVKLQGQ--------LDFRDFDYSGTSLK--- 276
Query: 521 PPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEH 580
L + + S+ S + + + H
Sbjct: 277 --------ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLH 328
Query: 581 LDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFS--WEIPIKLEELIHLSELDLSYNFLGR 638
LD S+N L++ + E+ G+L +L L L NQ +I ++ L +LD+S N +
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY 388
Query: 639 AIPSQICI-MQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNEL 684
C +SL LN+S N L+ I RC ++ +D+ N++
Sbjct: 389 DEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 70/404 (17%), Positives = 137/404 (33%), Gaps = 34/404 (8%)
Query: 54 NLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAI 113
++ + F + L +L L + L + I +++ K L + +
Sbjct: 101 AFDALPICKE-----FGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE 155
Query: 114 PPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVT 173
P L T L + + +S L L N+ ++
Sbjct: 156 DP--EGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL-----------ELSNIKCVLE 202
Query: 174 LCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNL---SNLAMLNLSSNSLF 230
+ L SI +++ L +L L N E + + L + + ++S+ L
Sbjct: 203 DNKCSYFL--SILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260
Query: 231 GSIPSELG-----NLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEI 285
G + +LK LS ++ + + +N+ I + +
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320
Query: 286 GNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSL--FGLIPSELRNLKSLSILE 343
+ + S N + + + G+L+ + L L N L I +KSL L+
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380
Query: 344 LGNNKLCGSIPH-FLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIP 402
+ N + +L L + +N L+ +I + + L+L NK+ SIP
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIP 437
Query: 403 ISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ 446
+ L L L+ N L + L L K++L N +
Sbjct: 438 KQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-28
Identities = 66/400 (16%), Positives = 126/400 (31%), Gaps = 46/400 (11%)
Query: 313 SNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNS 372
L + N + L S++ +L L IL + +N++ L L + +N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 373 LSGSIPCEIGNLKSLSYLNLAFNKLTS-SIPISLSNLTNLSVLSFYKNSLSGAIPKEYRN 431
L I C +L +L+L+FN + I N++ L L L + +
Sbjct: 81 LV-KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 432 LVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNN 491
L ++K+ L + G + + L L + T+ T +L +N
Sbjct: 138 L-NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 492 LYGEISSD-----------WGRCPKLGALDFSKNNITGNIPPKIG---YSSQLEVLDLSS 537
+ + + PKL L + T N +I + + + +S+
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256
Query: 538 NHVVGDIPAELGKLSF-----LIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAI 592
+ G + S L + + S + + + + +
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316
Query: 593 PESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEK 652
+ +L+ SNN + + L L L L N L + L K
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL-----------KELSK 365
Query: 653 LNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNST 692
+ +M +LQ +DIS N +
Sbjct: 366 I-----------AEMTTQMKSLQQLDISQNSVSYDEKKGD 394
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 3e-19
Identities = 46/314 (14%), Positives = 107/314 (34%), Gaps = 8/314 (2%)
Query: 16 NHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHL 75
+V + + I C S L+ + T S + ++
Sbjct: 171 VFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNI 230
Query: 76 AYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSG 135
++ + + + L L L L + +
Sbjct: 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 136 SIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYL 195
S++N + + ++ + L NNLL+ ++ G+L L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350
Query: 196 LDLNLYNNELNGSIPQSLG---NLSNLAMLNLSSNSL-FGSIPSELGNLKYLSDLKLADN 251
L L N+L + + + +L L++S NS+ + + K L L ++ N
Sbjct: 351 ETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN 409
Query: 252 KLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGN 311
L +I L + +L +++N + + P ++ L+ L ++ ++ N+ +
Sbjct: 410 ILTDTIFRCL--PPRIKVLDLHSNKIKSI-PKQVVKLEALQELNVASNQLKSVPDGIFDR 466
Query: 312 LSNIAFLFLDSNSL 325
L+++ ++L +N
Sbjct: 467 LTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 38/194 (19%), Positives = 71/194 (36%), Gaps = 14/194 (7%)
Query: 532 VLDLSSN---HVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNL 588
++D S N HV D+ + L+ ++QN +S + + L +L L +S N +
Sbjct: 4 LVDRSKNGLIHVPKDLSQKTTILN------ISQNYISELWTSDILSLSKLRILIISHNRI 57
Query: 589 SNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGR-AIPSQICIM 647
+L YL+LS+N+ +I ++L LDLS+N I + M
Sbjct: 58 QYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNM 114
Query: 648 QSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKG 707
L+ L LS L ++ + + + +D ++L
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEG-LQDFNTESLHIVFP 173
Query: 708 LCGDFKGLPSCKAL 721
+F +
Sbjct: 174 TNKEFHFILDVSVK 187
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-42
Identities = 73/425 (17%), Positives = 140/425 (32%), Gaps = 45/425 (10%)
Query: 73 PHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQ 132
+ A + ++ ++ L LD ++ + I L+ L L N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNN 75
Query: 133 LSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNL 192
++ L++ ++L LA SN L ++ + LT L L N L+ ++
Sbjct: 76 ITT---LDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT---KLDVSQN 126
Query: 193 KYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNK 252
L LN N L I + + + L L+ N ++ L+ L + NK
Sbjct: 127 PLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNK 181
Query: 253 LNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNL 312
+ + L L N+++ L ++ L+ + S NK + + + L
Sbjct: 182 ITEL---DVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI---DVTPL 232
Query: 313 SNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNS 372
+ + + N L L S L L+ L L I L + T L
Sbjct: 233 TQLTYFDCSVNPLTELDVS---TLSKLTTLHCIQTDL-LEID--LTHNTQLIYFQAEGCR 286
Query: 373 LSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNL 432
+ ++ + L L+ +T + LS L L L+ + +
Sbjct: 287 KIKEL--DVTHNTQLYLLDCQAAGITE---LDLSQNPKLVYLYLNNTELT-ELD--VSHN 338
Query: 433 VKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESF-----YIYPNLTFIDL 487
KL L + Q ++ + +L + E+ I + +D
Sbjct: 339 TKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQ 397
Query: 488 SYNNL 492
N +
Sbjct: 398 FGNPM 402
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-38
Identities = 81/452 (17%), Positives = 159/452 (35%), Gaps = 45/452 (9%)
Query: 147 LNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELN 206
+ + ++ S L L +L +N+ ++ + I L L L +N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 207 GSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTN 266
++ L +NL L SN L ++ + L L+ L NKL +
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPL 128
Query: 267 LVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLF 326
L L N+L+ + ++ + L+++ NK + + + + L N +
Sbjct: 129 LTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 327 GLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKS 386
L ++ K L+ L N + + L L+ L +N L+ I + L
Sbjct: 184 EL---DVSQNKLLNRLNCDTNNI-TKLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQ 234
Query: 387 LSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ 446
L+Y + + N LT + +S L+ L+ L + L I + +L + +
Sbjct: 235 LTYFDCSVNPLTE---LDVSTLSKLTTLHCIQTDLL-EIDLT--HNTQLIYFQAEGCR-K 287
Query: 447 GPIPNLKNLTSLVRVHLDRNYLTS-NISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPK 505
++ + T L + +T ++S++ P L ++ L+ L D K
Sbjct: 288 IKELDVTHNTQLYLLDCQAAGITELDLSQN----PKLVYLYLNNTEL---TELDVSHNTK 340
Query: 506 LGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLS 565
L +L +I + +G L + + L S I +
Sbjct: 341 LKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQF 398
Query: 566 G---QLSPKLGLLVQLEHLDLSSNNLSNAIPE 594
G + P G + ++ NLS P
Sbjct: 399 GNPMNIEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-38
Identities = 75/424 (17%), Positives = 154/424 (36%), Gaps = 47/424 (11%)
Query: 217 SNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNS 276
N A ++ + + L L+ L ++ + + + LT L L +N+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75
Query: 277 LSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNL 336
++ L ++ L+ +A NK + L + L+ + +L D+N L L S+ L
Sbjct: 76 ITTL---DLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKLDVSQNPLL 129
Query: 337 KSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNK 396
L+ N L I + + T L+ L + N + + L+ L+ +FNK
Sbjct: 130 TYLN---CARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181
Query: 397 LTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLKNL 455
+T + +S L+ L+ N+++ + ++LT L N+ + L L
Sbjct: 182 ITE---LDVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEIDVTPLTQL 235
Query: 456 TSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNN 515
T N LT + LT + +L + D +L
Sbjct: 236 TYF---DCSVNPLTELDVSTL---SKLTTLHCIQTDL---LEIDLTHNTQLIYFQAEGCR 286
Query: 516 ITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLL 575
+ + +++QL +LD + + ++ L + L+ L L +L+ +
Sbjct: 287 KIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT---ELDVSHN 338
Query: 576 VQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPI-----KLEELIHLSELD 630
+L+ L + ++ + +G + L+ + Q L + LD
Sbjct: 339 TKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLD 396
Query: 631 LSYN 634
N
Sbjct: 397 QFGN 400
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-33
Identities = 69/371 (18%), Positives = 133/371 (35%), Gaps = 37/371 (9%)
Query: 54 NLTSIGLKGT-LHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGA 112
LT + + S +L YL SN+L N+ + ++KL YL+ +N +
Sbjct: 65 GLTKLICTSNNITTLDLSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT-K 120
Query: 113 IPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLV 172
+ + L L+ +N L+ ++V + L L + N + + T L
Sbjct: 121 LD--VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLT 173
Query: 173 TLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGS 232
TL N ++ ++ K L LN N + + L L L+ SSN L
Sbjct: 174 TLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL-TE 226
Query: 233 IPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLS 292
I + L L+ + N L + + L+ L L+ L + ++ + L
Sbjct: 227 ID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEI---DLTHNTQLI 278
Query: 293 KIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGS 352
+ + + + + + L + + L +L L L L N +L
Sbjct: 279 YFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-E 332
Query: 353 IPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLS 412
+ + + T L L N + +G + +L+ A + + +L+N +
Sbjct: 333 LD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTI 388
Query: 413 VLSFYKNSLSG 423
+S G
Sbjct: 389 AVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-26
Identities = 63/324 (19%), Positives = 110/324 (33%), Gaps = 34/324 (10%)
Query: 362 NLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL 421
N + + + L +L+ L+ + +T I LT L+ L N++
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGI--EKLTGLTKLICTSNNI 76
Query: 422 SGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLKNLTSLVRVHLDRNYLTSNISESFYIYP 480
+ + LT L N+ + L LT L + D N LT P
Sbjct: 77 TTL---DLSQNTNLTYLACDSNKLTNLDVTPLTKLTYL---NCDTNKLTKL---DVSQNP 127
Query: 481 NLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHV 540
LT+++ + N L D +L LD N + +QL LD S N +
Sbjct: 128 LLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKI 182
Query: 541 VGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLV 600
++ + L +L N ++ L +QL LD SSN L+ + L
Sbjct: 183 TEL---DVSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLTEI---DVTPLT 233
Query: 601 KLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSL 660
+L Y + S N + + + L L+ L L +I + + + +
Sbjct: 234 QLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDL-----LEIDLTHNTQLIYFQAEGC 285
Query: 661 SGVIPRCFEEMHALQCIDISYNEL 684
+ L +D +
Sbjct: 286 RKIKELDVTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 8e-14
Identities = 40/254 (15%), Positives = 76/254 (29%), Gaps = 29/254 (11%)
Query: 51 NSINLTSIGLKGT-LHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLF 109
+I LT + L + + L Y D N L + + +SKL L
Sbjct: 210 QNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNPL-TELD--VSTLSKLTTLHCIQTDL 266
Query: 110 SGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLT 169
I + H + L L+V + L L + + ++ L
Sbjct: 267 L-EID--LTHNTQLIYFQA--EGCRKIKELDVTHNTQLYLLDCQAAGITEL---DLSQNP 318
Query: 170 NLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSL 229
LV L L N L+ + + + L L+ N + S+G + L +
Sbjct: 319 KLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEG-- 371
Query: 230 FGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLT-NLVILYIYNNSLSGLIPSEIGNL 288
+ L +N L ++ L + N + + + + + I
Sbjct: 372 ---------QTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWE 422
Query: 289 KFLSKIALSYNKFS 302
+ F+
Sbjct: 423 NLSTDNPAVTYTFT 436
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 61/302 (20%), Positives = 125/302 (41%), Gaps = 52/302 (17%)
Query: 793 RATNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 851
R DF+ C+G+GG G V++ + A+K+ LP +++ + EVKAL +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR--IRLPNRELAREKVMREVKALAK 59
Query: 852 IRHRNIVKFYGFC------------SHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQ 899
+ H IV+++ S + +I + +L ++ E+ E +
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 900 RMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK------- 952
+ + IA+A+ +LH+ ++HRD+ N+ + +V DFG+ +
Sbjct: 120 CLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 953 -----PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLI 1007
P + T GT Y++PE + + K D++S G++ E++ +P F
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP--F---- 227
Query: 1008 SSSSLNLNIALDEILDPRLP-IPSHNVQE--KLISFVEVAISCLDESPESRPTMQKVSQL 1064
S+ + L ++ + + P + + ++ L SP RP +
Sbjct: 228 -STQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ------DMLSPSPMERPE---AINI 277
Query: 1065 LK 1066
++
Sbjct: 278 IE 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 60/271 (22%), Positives = 111/271 (40%), Gaps = 28/271 (10%)
Query: 803 CIGKGGQGSVYK-VELASGEIIAVKKFH-SPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
IG+G +VYK ++ + +A + L +Q F E + L ++H NIV+F
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE--RQRFKEEAEMLKGLQHPNIVRF 90
Query: 861 YG----FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
Y + +V E + G+L L ++ S + I L +LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH- 146
Query: 917 DCFPPIVHRDISSKNVLLDFKN-EARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 975
PPI+HRD+ N+ + ++ D G+A + + + GT ++APE+ Y
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEM-YE 203
Query: 976 MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE 1035
K E DVY+FG+ LE+ ++P S +++ +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPY---SECQNAAQIYRRVTSGVKPASFD---KVAIP 257
Query: 1036 KLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
++ +E C+ ++ + R + + LL
Sbjct: 258 EVKEIIE---GCIRQNKDERYS---IKDLLN 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 70/282 (24%), Positives = 121/282 (42%), Gaps = 32/282 (11%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI 852
+F E IG+G VY+ L G +A+KK + M + + + E+ L ++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV--QIFDLMDAKARADCIKEIDLLKQL 89
Query: 853 RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAA-----EDLEWTQRMSVIKGI 907
H N++K+Y IV E + G L+ ++ + E W +
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQL 145
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGY 967
AL ++H+ ++HRDI NV + ++ D G+ +F ++ L GT Y
Sbjct: 146 CSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 202
Query: 968 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP--GDFISLISSSSLNLNIALDEILDPR 1025
++PE + K D++S G L E+ + P GD ++L SL I + P
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKIEQCDY--P- 256
Query: 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLKI 1067
P+PS + E+L V C++ PE RP V+ + +
Sbjct: 257 -PLPSDHYSEELRQLVN---MCINPDPEKRPD---VTYVYDV 291
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-40
Identities = 86/398 (21%), Positives = 143/398 (35%), Gaps = 38/398 (9%)
Query: 88 NIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEV-GGLSS 146
+P + Y+DLS N + L L+ L + + I GLSS
Sbjct: 27 ELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 147 LNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLL-SGSIPSEI-GNLKYLLDLNLYNNE 204
L L L N + + L NL L L L + L L L L +N
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 205 LNGSIPQSL-GNLSNLAMLNLSSNSLFGSIPSELGNL--KYLSDLKLADNKL-------- 253
+ P S N+ +L+L+ N + +L N K+ + L+L+ L
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200
Query: 254 NGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLS 313
+ T++ L + N + + +KI + +
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS---NSYNMGSSFG 257
Query: 314 NIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIP-HFLGNLTNLSVLFIYNNS 372
+ F D+ + GL S ++ +L +K+ ++ + T+L L + N
Sbjct: 258 HTNFKDPDNFTFKGLEASGVK------TCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNE 310
Query: 373 LSGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKE-YR 430
++ I L L LNL+ N L S NL L VL N + A+ + +
Sbjct: 311 IN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFL 368
Query: 431 NLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRN 466
L L +L L NQ + +P+ LTSL ++ L N
Sbjct: 369 GLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-38
Identities = 86/393 (21%), Positives = 135/393 (34%), Gaps = 37/393 (9%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHL 120
L++ SFS L +L + I +S L L L N F + L
Sbjct: 44 ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGL 102
Query: 121 SYLKTLHLFKNQL-SGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSL-GNLTNLVTLCLY 177
+ L+ L L + L + L+SL L L N ++ I P S N+ L L
Sbjct: 103 ANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLT 162
Query: 178 NNLLSGSIPSEI---GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIP 234
N + SI E K+ L L + L +++ L
Sbjct: 163 FNKVK-SICEEDLLNFQGKHFTLLRLSSITL----------------QDMNEYWLGWEKC 205
Query: 235 SELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKI 294
++ L L+ N S+ + + S S + S G+ F
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKD-- 263
Query: 295 ALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIP 354
F GL S + L + +F L+ S + L L L N++
Sbjct: 264 -PDNFTFKGL------EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDD 316
Query: 355 HFLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSV 413
+ LT+L L + N L SI + NL L L+L++N + + S L NL
Sbjct: 317 NAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKE 375
Query: 414 LSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ 446
L+ N L + L L K++L N +
Sbjct: 376 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 9e-36
Identities = 92/387 (23%), Positives = 145/387 (37%), Gaps = 38/387 (9%)
Query: 296 LSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSEL-RNLKSLSILELGNNKLCGSIP 354
LS N + L S L ++ FL ++ + +I + R L SL IL+L N+ +
Sbjct: 37 LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLE 95
Query: 355 -HFLGNLTNLSVLFIYNNSL-SGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISL-SNLTN 410
L NL VL + +L + L SL L L N + P S N+
Sbjct: 96 TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRR 155
Query: 411 LSVLSFYKNSLSGAIPKEYRNLVK--LTKLFLGDNQFQ---------GPIPNLKNLTSLV 459
VL N + ++ N T L L Q N TS+
Sbjct: 156 FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215
Query: 460 RVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITG- 518
+ L N ++++ F+ T +I S F N
Sbjct: 216 TLDLSGNGFKESMAKRFFDAIAGT-----------KIQSLILSNSYNMGSSFGHTNFKDP 264
Query: 519 -NIPPKIGYSSQLEVLDLSSNHVVGDIPAEL-GKLSFLIKLILAQNQLSGQLSPK-LGLL 575
N K +S ++ DLS + + + + + L +L LAQN+++ ++ L
Sbjct: 265 DNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGL 322
Query: 576 VQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKL-EELIHLSELDLSYN 634
L L+LS N L + NL KL L+LS N + + L +L EL L N
Sbjct: 323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTN 381
Query: 635 FLGRAIPSQI-CIMQSLEKLNLSHNSL 660
L +++P I + SL+K+ L N
Sbjct: 382 QL-KSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-32
Identities = 75/383 (19%), Positives = 151/383 (39%), Gaps = 38/383 (9%)
Query: 313 SNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH-FLGNLTNLSVLFIYNN 371
+++ ++ L NS+ L + L+ L L++ I + L++L +L + N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 372 SLSGSIPCEI-GNLKSLSYLNLAFNKLTSSI--PISLSNLTNLSVLSFYKNSLSGAIPKE 428
+ L +L L L L ++ LT+L +L N++ P
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 429 Y-RNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDL 487
+ N+ + L L N+ + I ++L + H L+S T D+
Sbjct: 149 FFLNMRRFHVLDLTFNKVKS-ICE-EDLLNFQGKHFTLLRLSSI-----------TLQDM 195
Query: 488 SYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKI---GYSSQLEVLDLSSNHVVGDI 544
+ L E + + + LD S N ++ + ++++ L LS+++ +G
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS- 254
Query: 545 PAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHY 604
G + + + DLS + + + + L
Sbjct: 255 -----SFGHTNFKDPDNFTFKGLEASGV------KTCDLSKSKIFALLKSVFSHFTDLEQ 303
Query: 605 LNLSNNQFSWEIPIK-LEELIHLSELDLSYNFLGRAIPSQICI-MQSLEKLNLSHNSLSG 662
L L+ N+ + +I L HL +L+LS NFLG +I S++ + LE L+LS+N +
Sbjct: 304 LTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA 361
Query: 663 VIPRCFEEMHALQCIDISYNELR 685
+ + F + L+ + + N+L+
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 67/339 (19%), Positives = 116/339 (34%), Gaps = 37/339 (10%)
Query: 54 NLTSIGLKG----TLHDFSFSSFPHLAYLDLWSNQL-FGNIPPQI-GNISKLKYLDLSSN 107
+L + L L +F+ +L L L L + ++ L+ L L N
Sbjct: 80 SLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
Query: 108 LFSGAIPPQI-GHLSYLKTLHLFKNQLS----------GSIPLEVGGLSSLNNLALYSNY 156
P ++ L L N++ + LSS+ + +
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199
Query: 157 LEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGN- 215
L + T++ TL L N S+ + + + ++ S G+
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259
Query: 216 --------------LSNLAMLNLSSNSLFGSIPSEL-GNLKYLSDLKLADNKLNGSIPHS 260
S + +LS + +F ++ + + L L LA N++N ++
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318
Query: 261 LCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFL 320
LT+L+ L + N L + NL L + LSYN L S L N+ L L
Sbjct: 319 FWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELAL 378
Query: 321 DSNSLFGLIPSELRNLKSLSILELGNNKL---CGSIPHF 356
D+N L + L SL + L N C I +
Sbjct: 379 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 417
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 52/220 (23%), Positives = 86/220 (39%), Gaps = 23/220 (10%)
Query: 51 NSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI---GNISKLKYLDLSSN 107
++ + G + + LDL N ++ + +K++ L LS++
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249
Query: 108 LFSGAIPPQIG------------HLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYS 154
G+ S +KT L K+++ ++ V + L L L
Sbjct: 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQ 308
Query: 155 NYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNELNGSIP-QS 212
N + I ++ LT+L+ L L N L SI S + NL L L+L N + ++ QS
Sbjct: 309 NEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RALGDQS 366
Query: 213 LGNLSNLAMLNLSSNSLFGSIPSE-LGNLKYLSDLKLADN 251
L NL L L +N L S+P L L + L N
Sbjct: 367 FLGLPNLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 29/186 (15%), Positives = 52/186 (27%), Gaps = 4/186 (2%)
Query: 528 SQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKL-GLLVQLEHLDLSSN 586
+ + +DLS N + +L L L + Q + L L L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 587 NLSNAIPESLGNLVKLHYLNLSNNQF-SWEIPIKL-EELIHLSELDLSYNFLGRAIPSQI 644
+ L L L L+ + + L L L L N + + P+
Sbjct: 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 645 -CIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQ 703
M+ L+L+ N + + + + + N
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209
Query: 704 GNKGLC 709
N +
Sbjct: 210 KNTSIT 215
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 69/315 (21%), Positives = 119/315 (37%), Gaps = 33/315 (10%)
Query: 759 RKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYK-VEL 817
++ ++ P +LT + K V E + + +G+G G V++ +
Sbjct: 21 SSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDK 80
Query: 818 ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYL 877
+G AVK ++ + + E+ A + IV YG I E L
Sbjct: 81 QTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132
Query: 878 EMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK 937
E GSL ++ L + + + + L YLH I+H D+ + NVLL
Sbjct: 133 EGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSD 186
Query: 938 -NEARVSDFGIAKFLKPDSSNWTE-----LAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 991
+ A + DFG A L+PD + + GT ++APE+ K D++S +
Sbjct: 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246
Query: 992 LEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDES 1051
L ++ G HP + L IA + P IP ++ L +
Sbjct: 247 LHMLNGCHP--WTQYFRGPLC-LKIASEP--PPIREIPPS-CAPLTAQAIQ---EGLRKE 297
Query: 1052 PESRPTMQKVSQLLK 1066
P R + +L +
Sbjct: 298 PVHRAS---AMELRR 309
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 62/293 (21%), Positives = 118/293 (40%), Gaps = 52/293 (17%)
Query: 793 RATNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQ-QEFLNEVKALT 850
R DF + IG GG G V+K + G+ +K + + ++ EVKAL
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK--------RVKYNNEKAEREVKALA 59
Query: 851 EIRHRNIVKFYGF----------------CSHAQHSFIVYEYLEMGSLAMILSNDAAAED 894
++ H NIV + G S + FI E+ + G+L + E
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEK 118
Query: 895 LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954
L+ + + + I + Y+H+ +++RD+ N+ L + ++ DFG+ LK D
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLN 1013
GT Y++PE + ++ D+Y+ G++ E++ + +
Sbjct: 176 GKRTR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT----- 229
Query: 1014 LNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
++ D I +K + ++ L + PE RP S++L+
Sbjct: 230 ------DLRDG--IISDI-FDKKEKTLLQ---KLLSKKPEDRPN---TSEILR 267
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-38
Identities = 65/278 (23%), Positives = 111/278 (39%), Gaps = 32/278 (11%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI 852
+ IG+G G V+ G +K+ + M+ + +E EV L +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI---SRMSSKEREESRREVAVLANM 80
Query: 853 RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAA---EDLEWTQRMSVIKGIAD 909
+H NIV++ +IV +Y E G L ++ ED I
Sbjct: 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL----DWFVQICL 136
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVA 969
AL ++H+ I+HRDI S+N+ L ++ DFGIA+ L GT Y++
Sbjct: 137 ALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 970 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL-DPRLPI 1028
PE+ K D+++ G + E+ KH F + ++ + +I+ P+
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHA--F------EAGSMKNLVLKIISGSFPPV 245
Query: 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
H L S V +P RP+ V+ +L+
Sbjct: 246 SLH-YSYDLRSLVS---QLFKRNPRDRPS---VNSILE 276
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 78/279 (27%), Positives = 124/279 (44%), Gaps = 25/279 (8%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTF--QQEFLNEVKALTEI 852
D++ + IG G G K+ + G+I+ K+ G MT +Q ++EV L E+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAEKQMLVSEVNLLREL 62
Query: 853 RHRNIVKFYG--FCSHAQHSFIVYEYLEMGSLA-MILSNDAAAEDLEWTQRMSVIKGIAD 909
+H NIV++Y +IV EY E G LA +I + L+ + V+ +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 910 ALSYLH--NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGY 967
AL H +D ++HRD+ NV LD K ++ DFG+A+ L D+S GT Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 968 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027
++PE M EK D++S G L E+ P F + S L I +
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTA-FSQKELAGKIREGKF----RR 235
Query: 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
IP ++L + L+ RP+ V ++L+
Sbjct: 236 IPYR-YSDELNEIIT---RMLNLKDYHRPS---VEEILE 267
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 69/279 (24%), Positives = 131/279 (46%), Gaps = 35/279 (12%)
Query: 795 TNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
+ IG+G G+VY +++A+G+ +A+++ L + + +NE+ + E +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKE-LIINEILVMRENK 75
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
+ NIV + ++V EYL GSL +++ E Q +V + AL +
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEF 131
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
LH++ ++HRDI S N+LL +++DFG + P+ S + + GT ++APE+
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGK------HPGDFISLISSSSLNLNIALDEILDPRLP 1027
K D++S G++A+E+I+G+ +P + LI+++ P L
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-----------PELQ 237
Query: 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
P + F+ CL+ E R + +LL+
Sbjct: 238 NP-EKLSAIFRDFLNR---CLEMDVEKRGS---AKELLQ 269
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 74/320 (23%), Positives = 129/320 (40%), Gaps = 40/320 (12%)
Query: 757 QRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATN---DFDDEHCIGKGGQGSVY 813
+ + G + + K ++ + D IG+G G V
Sbjct: 5 HHHSSGVDLGTENLYFQSG--VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVC 62
Query: 814 K-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFI 872
E SG +AVK L + ++ NEV + + +H N+V+ Y + ++
Sbjct: 63 LAREKHSGRQVAVKMM--DLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119
Query: 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNV 932
+ E+L+ G+L I+S E+ Q +V + + AL+YLH ++HRDI S ++
Sbjct: 120 LMEFLQGGALTDIVSQVRLNEE----QIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI 172
Query: 933 LLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLAL 992
LL ++SDFG + D L GT ++APE+ + D++S G++ +
Sbjct: 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232
Query: 993 EVIKGK------HPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAIS 1046
E++ G+ P + + S P+L H V L F+E
Sbjct: 233 EMVDGEPPYFSDSPVQAMKRLRDSPP-----------PKLKNS-HKVSPVLRDFLER--- 277
Query: 1047 CLDESPESRPTMQKVSQLLK 1066
L P+ R T +LL
Sbjct: 278 MLVRDPQERAT---AQELLD 294
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 22/268 (8%)
Query: 803 CIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 861
+GKG G VY +L++ IA+K+ Q E+ ++H+NIV++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHLKHKNIVQYL 85
Query: 862 GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP 921
G S I E + GSL+ +L + K I + L YLH++
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 922 IVHRDISSKNVLLDFKN-EARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE--LAYTMKV 978
IVHRDI NVL++ + ++SDFG +K L + GT Y+APE
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 979 TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLI 1038
+ D++S G +E+ GK P F L + + + ++ P IP + +
Sbjct: 203 GKAADIWSLGCTIIEMATGKPP--FYELGEPQAAMFKVGMFKVH-P--EIPES-MSAEAK 256
Query: 1039 SFVEVAISCLDESPESRPTMQKVSQLLK 1066
+F+ C + P+ R + LL
Sbjct: 257 AFIL---KCFEPDPDKRAC---ANDLLV 278
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 76/276 (27%), Positives = 132/276 (47%), Gaps = 35/276 (12%)
Query: 798 FDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
FD +G+G GSVYK +G+I+A+K+ P+ ++ QE + E+ + + +
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDL---QEIIKEISIMQQCDSPH 85
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
+VK+YG +IV EY GS++ I+ + L + ++++ L YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 976
+HRDI + N+LL+ + A+++DFG+A L + + GT ++APE+ +
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 977 KVTEKCDVYSFGVLALEVIKGK------HPGDFISLISSSSLNLNIALDEILDPRLPIPS 1030
D++S G+ A+E+ +GK HP I +I ++ P P
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-----------PTFRKP- 248
Query: 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ FV+ CL +SPE R T +QLL+
Sbjct: 249 ELWSDNFTDFVKQ---CLVKSPEQRAT---ATQLLQ 278
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 76/277 (27%), Positives = 123/277 (44%), Gaps = 36/277 (12%)
Query: 797 DFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
F IGKG G V+K ++ + +++A+K L ++ E+ L++
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
+ K+YG +I+ EYL GS +L E Q ++++ I L YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET----QIATILREILKGLDYLH 136
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 975
++ +HRDI + NVLL E +++DFG+A L GT ++APE+
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 976 MKVTEKCDVYSFGVLALEVIKGK------HPGDFISLISSSSLNLNIALDEILDPRLPIP 1029
K D++S G+ A+E+ +G+ HP + LI ++ P L
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-----------PPTL--- 239
Query: 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
N + L FVE CL++ P RPT +LLK
Sbjct: 240 EGNYSKPLKEFVEA---CLNKEPSFRPT---AKELLK 270
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-35
Identities = 64/303 (21%), Positives = 115/303 (37%), Gaps = 35/303 (11%)
Query: 136 SIPLEVGGLSSLNNLALYSNYLEDI---IPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNL 192
SI L + SL+ + Y N + + N + +
Sbjct: 2 SIMLPINNNFSLSQNSFY-NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLI 58
Query: 193 KYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNK 252
+L L L+ S+P +L + +L ++ N+L S+P +L+YL DN+
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPASLEYLD---ACDNR 111
Query: 253 LNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNL 312
L+ ++P +L +L + NN L+ L P L++++ N+ + L P +L
Sbjct: 112 LS-TLPELPASLKHL---DVDNNQLTML-PELPALLEYIN---ADNNQLTML-PELPTSL 162
Query: 313 SNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLS----VLFI 368
L + +N L L P +L++L + N L S+P +
Sbjct: 163 EV---LSVRNNQLTFL-PELPESLEALD---VSTNLL-ESLPAVPVRNHHSEETEIFFRC 214
Query: 369 YNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKE 428
N ++ IP I +L + L N L+S I SLS T + S + ++
Sbjct: 215 RENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
Query: 429 YRN 431
Sbjct: 274 NTL 276
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 54/290 (18%), Positives = 100/290 (34%), Gaps = 32/290 (11%)
Query: 42 IHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIP--PQIGNISKL 99
I + + + FS++ L + I++
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENR-NEAVSLLKECLINQF 61
Query: 100 KYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLED 159
L L+ S ++P + + L + +N L S+P L L+ N L
Sbjct: 62 SELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYLD---ACDNRLST 114
Query: 160 IIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNL 219
+P +L + L + NN L+ +P L+Y +N NN+L +P+ +L
Sbjct: 115 -LPELPASLKH---LDVDNNQLT-MLPELPALLEY---INADNNQLT-MLPELPTSLE-- 163
Query: 220 AMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNL----VILYIYNN 275
+L++ +N L +P +L+ L ++ N L S+P + + N
Sbjct: 164 -VLSVRNNQL-TFLPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEETEIFFRCREN 217
Query: 276 SLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSL 325
++ + P I +L I L N S I SL +
Sbjct: 218 RITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-28
Identities = 61/334 (18%), Positives = 111/334 (33%), Gaps = 33/334 (9%)
Query: 72 FPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKN 131
P + L++ N L ++P + L+YLD N S +P L K L + N
Sbjct: 79 PPQITVLEITQNAL-ISLPELPAS---LEYLDACDNRLS-TLPELPASL---KHLDVDNN 130
Query: 132 QLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGN 191
QL+ +P L +N +N L + P +L L + NN L+ +P +
Sbjct: 131 QLT-MLPELPALLEYIN---ADNNQLTML-PELPTSLE---VLSVRNNQLT-FLPELPES 181
Query: 192 LKYLLDLNLYNNELNGSIPQSLGNLSNL----AMLNLSSNSLFGSIPSELGNLKYLSDLK 247
L+ L++ N L S+P + N + IP + +L +
Sbjct: 182 LE---ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI-THIPENILSLDPTCTII 236
Query: 248 LADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPH 307
L DN L+ I SL T + S + N F
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQS 294
Query: 308 SLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLF 367
+ + + +N+ L + S + + +L L+ + L
Sbjct: 295 DVSQIWHAFEHEEHANTFSA-FLDRLSDTVSARNTSGFREQ----VAAWLEKLSASAELR 349
Query: 368 IYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSI 401
+ +++ + +L++ NL L
Sbjct: 350 QQSFAVAADATESCEDRVALTWNNLRKTLLVHQA 383
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-27
Identities = 66/364 (18%), Positives = 121/364 (33%), Gaps = 60/364 (16%)
Query: 305 IPHSLGNLSNIAFLFLDSNSLFGL---IPSELRNLKSLSILELGNNKLCGSIPHFLGNLT 361
I + N +++ N++ G S + ++ N+ + L +
Sbjct: 3 IMLPINNNFSLS-QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--IN 59
Query: 362 NLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL 421
S L + +LS S+P + ++ L + N L S +P ++L L N L
Sbjct: 60 QFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALIS-LPELPASLEYLDACD---NRL 112
Query: 422 SGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPN 481
S +P+ L L + +NQ +P L L ++ D N LT + E +
Sbjct: 113 S-TLPEL---PASLKHLDVDNNQLTM-LPEL--PALLEYINADNNQLTM-LPELP---TS 161
Query: 482 LTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVV 541
L + + N L +P LE LD+S+N +
Sbjct: 162 LEVLSVRNNQL-------------------------TFLPELPE---SLEALDVSTNLLE 193
Query: 542 GDIPAELGKL----SFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLG 597
+PA + I +N+++ + + L + L N LS+ I ESL
Sbjct: 194 -SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS 251
Query: 598 NLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSH 657
+ FS + +H D + S + + +
Sbjct: 252 QQTAQPDYHGPRIYFSMSDGQ--QNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHA 309
Query: 658 NSLS 661
N+ S
Sbjct: 310 NTFS 313
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 66/260 (25%), Positives = 119/260 (45%), Gaps = 25/260 (9%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G GG +VY + +A+K P + + F EV +++ H+NIV
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
++V EY+E +L+ + + L ++ I D + + H+ I
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE---LAGTYGYVAPELAYTMKVT 979
VHRDI +N+L+D ++ DFGIAK L ++ T+ + GT Y +PE A
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 980 EKCDVYSFGVLALEVIKGKHP--GDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKL 1037
E D+YS G++ E++ G+ P G+ + +S IA+ I D +P + +V++ +
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGE--TAVS-------IAIKHIQDS-VPNVTTDVRKDI 240
Query: 1038 -ISFVEVAISCLDESPESRP 1056
S V + ++ +R
Sbjct: 241 PQSLSNVILRATEKDKANRY 260
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 94/545 (17%), Positives = 170/545 (31%), Gaps = 100/545 (18%)
Query: 77 YLDLWSNQLFGNIPPQ-IGNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLS 134
L L N + + I +S+L+ L LS N ++ + L+ L + N+L
Sbjct: 56 ALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ 113
Query: 135 GSIPLEVGGLSSLNNLALYSNYLEDIIPHSL-GNLTNLVTLCLYNNLLSGSIPSEIGNLK 193
+I ++SL +L L N + + GNLT L L L + +L
Sbjct: 114 -NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170
Query: 194 -YLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNK 252
+ L+L + + G +SL N +L+L + ++ L L+L++ K
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229
Query: 253 LNGSIPHSL-----CNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPH 307
LN L +L + + + +F + Y L
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLT-- 287
Query: 308 SLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLF 367
+ LKSL I + N S +++
Sbjct: 288 ------------ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335
Query: 368 IYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPK 427
+ + + S ++LN N T S+ S L L L +N L K
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 428 EYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDL 487
++ L D L +L S ++ ++L
Sbjct: 395 VALMTKNMSSLETLDVS-------LNSLNSHAYDRT------------CAWAESILVLNL 435
Query: 488 SYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAE 547
S N L TG++ + +++VLDL +N
Sbjct: 436 SSNML------------------------TGSVFRCL--PPKVKVLDLHNN--------- 460
Query: 548 LGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNL 607
++ + + L L+ L+++SN L + L L Y+ L
Sbjct: 461 ---------------RIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWL 504
Query: 608 SNNQF 612
+N +
Sbjct: 505 HDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-34
Identities = 94/427 (22%), Positives = 164/427 (38%), Gaps = 32/427 (7%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLF-SGAIPPQIGHLS 121
+L F L YLD+ N+L NI ++ L++LDLS N F + + G+L+
Sbjct: 90 SLDFHVFLFNQDLEYLDVSHNRL-QNISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLT 146
Query: 122 YLKTLHLFKNQLSGSIPLEVGGLSSLNNLALY--SNYLEDIIPHSL--GNLTNLVTLCLY 177
L L L + + L L+ + L S +++ SL N T L +
Sbjct: 147 KLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP 205
Query: 178 NNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSL-------GNLSNLAMLNLSSNSLF 230
N+L S + + L +L N+ N+ N + L N+ + ++ +
Sbjct: 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC 265
Query: 231 GSIPSELGNLKYLSDLKLADNKLNGSIP-----HSLCNLTNLVILYIYNNSLSGLIPSEI 285
+ + + L + + + I +S L +L+I ++ N +
Sbjct: 266 SVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALY 325
Query: 286 GNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELG 345
++ LS + + + S+ FL N + LK L L L
Sbjct: 326 SVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ 385
Query: 346 NNKLCGSIPHFLGNLTNLSVLFIYNNSL----SGSIPCEIGNLKSLSYLNLAFNKLTSSI 401
N L + N+S L + SL S + +S+ LNL+ N LT S+
Sbjct: 386 RNGL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444
Query: 402 PISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN--LKNLTSLV 459
L + VL + N + +IPK+ +L L +L + NQ + +P+ LTSL
Sbjct: 445 FRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQ 500
Query: 460 RVHLDRN 466
+ L N
Sbjct: 501 YIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 83/490 (16%), Positives = 151/490 (30%), Gaps = 62/490 (12%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQI-GHLS 121
L S L L L N++ ++ +
Sbjct: 66 ELRMPDISFLSELRVLRLSHNRI-------------------------RSLDFHVFLFNQ 100
Query: 122 YLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSL-GNLTNLVTLCLYNNL 180
L+ L + N+L +I ++SL +L L N + + GNLT L L L
Sbjct: 101 DLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAK 157
Query: 181 LSGSIPSEIGNLK-YLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGN 239
+ +L + L+L + + G +SL N +L+L + +
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMS 216
Query: 240 LKYLSDLKLADNKLNGSIPHSL-----CNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKI 294
+ L L+L++ KLN L +L + + + +F
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276
Query: 295 ALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIP 354
+ Y L + LKSL I + N S
Sbjct: 277 PVEYLNIYNLT--------------ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 355 HFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVL 414
+++ + + + S ++LN N T S+ S L L L
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382
Query: 415 SFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ----GPIPNLKNL-TSLVRVHLDRNYLT 469
+N L K ++ L D S++ ++L N LT
Sbjct: 383 ILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441
Query: 470 SNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKI-GYSS 528
++ + P + +DL N + I D L L+ + N + ++P + +
Sbjct: 442 GSVFRC--LPPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLT 497
Query: 529 QLEVLDLSSN 538
L+ + L N
Sbjct: 498 SLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-32
Identities = 99/509 (19%), Positives = 184/509 (36%), Gaps = 56/509 (11%)
Query: 184 SIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSE----LG 238
+P ++ K L +L N ++ + LS L +L LS N + S+
Sbjct: 45 HVPKDLPPRTKAL---SLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQ 100
Query: 239 NLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGL-IPSEIGNLKFLSKIALS 297
+L+YL ++ N+L +I + +L L + N L + E GNL L+ + LS
Sbjct: 101 DLEYLD---VSHNRL-QNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLS 154
Query: 298 YNKFSGLIPHSLGNLS-NIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHF 356
KF L + +L + L L S + G L+ + + + + S+
Sbjct: 155 AAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVN 214
Query: 357 LGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSF 416
+ + L L + N L+ + S +T + + F
Sbjct: 215 MS-VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273
Query: 417 YKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESF 476
+ + EY N+ LT + + L SL+ H+ + +
Sbjct: 274 WPRPV------EYLNIYNLT--ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALY 325
Query: 477 YIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLS 536
++ + LS ++ S L+ +
Sbjct: 326 SVFAEMNIKMLSISDT------------------------PFIHMVCPPSPSSFTFLNFT 361
Query: 537 SNHVVGDIPAELGKLSFLIKLILAQNQLS--GQLSPKLGLLVQLEHLDLSSNNLSNAIPE 594
N + L L LIL +N L +++ + LE LD+S N+L++ +
Sbjct: 362 QNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYD 421
Query: 595 SL-GNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKL 653
+ LNLS+N + + L + LDL N + +IP + +Q+L++L
Sbjct: 422 RTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRI-MSIPKDVTHLQALQEL 478
Query: 654 NLSHNSLSGVIPRCFEEMHALQCIDISYN 682
N++ N L V F+ + +LQ I + N
Sbjct: 479 NVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 6e-21
Identities = 66/385 (17%), Positives = 130/385 (33%), Gaps = 52/385 (13%)
Query: 310 GNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH--FLGNLTNLSVLF 367
L L NS+ L ++ L L +L L +N++ S+ F +L L
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVF-LFNQDLEYLD 106
Query: 368 IYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPK 427
+ +N L +I C + SL +L+L+FN +P+ K
Sbjct: 107 VSHNRLQ-NISC--CPMASLRHLDLSFNDFDV-LPVC----------------------K 140
Query: 428 EYRNLVKLTKLFLGDNQFQ-GPIPNLKNL-TSLVRVHLDRNYLTSNISESFYIYPNLTFI 485
E+ NL KLT L L +F+ + + +L S + + L ++ +ES PN T +
Sbjct: 141 EFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL-QIPNTTVL 199
Query: 486 DLSYNNLY-----GEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHV 540
L ++ +S + +L + + N + + +L+++ H+
Sbjct: 200 HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259
Query: 541 VGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLV 600
+ F + + +L ++ S L
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNI--------------YNLTITERIDREEFTYSETALK 305
Query: 601 KLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSL 660
L ++ N F + ++ LS + S LN + N
Sbjct: 306 SLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365
Query: 661 SGVIPRCFEEMHALQCIDISYNELR 685
+ + + + LQ + + N L+
Sbjct: 366 TDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 71/308 (23%), Positives = 112/308 (36%), Gaps = 61/308 (19%)
Query: 793 RATNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 851
R +DF++ +G+G G V K A+KK + L+EV L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK----IRHTEEKLSTILSEVMLLAS 58
Query: 852 IRHRNIVKFYGFCSHAQHS-------------FIVYEYLEMGSLA--MILSNDAAAEDLE 896
+ H+ +V++Y ++ FI EY E G+L + N D
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 897 WTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956
W + + I +ALSY+H+ I+HRD+ N+ +D ++ DFG+AK +
Sbjct: 119 W----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 957 NWTELA--------------GTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPG 1001
+ GT YVA E L T EK D+YS G++ E+I G
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231
Query: 1002 DFISLISSSSLNLNIALDEILDPRLPIPSH---NVQEKLISFVEVAISCLDESPESRPTM 1058
L ++ + P N + + +D P RP
Sbjct: 232 M----------ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPG- 277
Query: 1059 QKVSQLLK 1066
LL
Sbjct: 278 --ARTLLN 283
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 61/285 (21%), Positives = 111/285 (38%), Gaps = 37/285 (12%)
Query: 757 QRRKNKSQTKQSSPRNTPGLRSMLTFEGKIV--YEEIIRATNDFDDEHCIGKGGQGSVYK 814
+ + PR + + + EG Y + R +G+GG G VY+
Sbjct: 3 SSHHHHHHSSGLVPRGSHMDGTAESREGTQFGPYR-LRRL---------VGRGGMGDVYE 52
Query: 815 VE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873
E I+A+K L + F+ E + ++ ++V + F ++
Sbjct: 53 AEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112
Query: 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVL 933
+ LA +L L + +++++ I AL H HRD+ +N+L
Sbjct: 113 MRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENIL 166
Query: 934 LDFKNEARVSDFGIAKFLKPDSSNWTELA---GTYGYVAPELAYTMKVTEKCDVYSFGVL 990
+ + A + DFGIA T+L GT Y+APE T + D+Y+ +
Sbjct: 167 VSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCV 224
Query: 991 ALEVIKGKHP--GDFISLISS---------SSLNLNI--ALDEIL 1022
E + G P GD +S++ + S++ I A D ++
Sbjct: 225 LYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVI 269
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-35
Identities = 68/309 (22%), Positives = 131/309 (42%), Gaps = 22/309 (7%)
Query: 99 LKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYL 157
L+ + S +P + L L N+++ I L +L+ L L +N +
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKI 88
Query: 158 EDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLS 217
I P + L L L L N L +P ++ K L +L ++ NE+ L+
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 218 NLAMLNLSSNSL-FGSIPSE-LGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNN 275
+ ++ L +N L I + +K LS +++AD + +IP L +L L++ N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 202
Query: 276 SLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRN 335
++ + + + L L+K+ LS+N S + SL N ++ L L++N L +P L +
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLAD 261
Query: 336 LKSLSILELGNNKL------CGSIPHFLGNLTNLSVLFIYNNSLS-GSIPCEI-GNLKSL 387
K + ++ L NN + P + + S + +++N + I +
Sbjct: 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321
Query: 388 SYLNLAFNK 396
+ + L K
Sbjct: 322 AAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 67/297 (22%), Positives = 124/297 (41%), Gaps = 43/297 (14%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSY 122
+ D F + +L L L +N++ I P F+ L
Sbjct: 66 EIKDGDFKNLKNLHTLILINNKI-SKISP---------------GAFAP--------LVK 101
Query: 123 LKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLL- 181
L+ L+L KNQL +P ++ +L L ++ N + + L ++ + L N L
Sbjct: 102 LERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158
Query: 182 SGSIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSE-LGN 239
S I + +K L + + + + +IPQ L +L L+L N + + + L
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI-TKVDAASLKG 214
Query: 240 LKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYN 299
L L+ L L+ N ++ SL N +L L++ NN L +P + + K++ + L N
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273
Query: 300 KFSGL------IPHSLGNLSNIAFLFLDSNSL--FGLIPSELRNLKSLSILELGNNK 348
S + P ++ + + L SN + + + PS R + + ++LGN K
Sbjct: 274 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 17/285 (5%)
Query: 169 TNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNS 228
+ L L NN ++ + NLK L L L NN+++ P + L L L LS N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 229 LFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSL-SGLIPSEI-G 286
L +P ++ K L +L++ +N++ L ++++ + N L S I +
Sbjct: 112 L-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 168
Query: 287 NLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGN 346
+K LS I ++ + + +L+ L LD N + + + L+ L +L+ L L
Sbjct: 169 GMKKLSYIRIADTNITTIPQGLPPSLTE---LHLDGNKITKVDAASLKGLNNLAKLGLSF 225
Query: 347 NKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTS------S 400
N + L N +L L + NN L +P + + K + + L N +++
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284
Query: 401 IPISLSNLTNLSVLSFYKNSLS-GAIPKE-YRNLVKLTKLFLGDN 443
P + + S +S + N + I +R + + LG+
Sbjct: 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 67/312 (21%), Positives = 116/312 (37%), Gaps = 34/312 (10%)
Query: 242 YLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKF 301
SDL L +P L + +L + NN ++ + + NLK L + L NK
Sbjct: 37 QCSDLGLE------KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 302 SGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHF-LGNL 360
S + P + L + L+L N L +P ++ K+L L + N++ + L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQL-KELPEKM--PKTLQELRVHENEI-TKVRKSVFNGL 144
Query: 361 TNLSVLFIYNNSL-SGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYK 418
+ V+ + N L S I +K LSY+ +A +T+ I +L+ L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDG 201
Query: 419 NSLSGAIPKEY-RNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNISES 475
N ++ + + L L KL L N + N L N L +HL+ N L +
Sbjct: 202 NKIT-KVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLVK-VPGG 258
Query: 476 FYIYPNLTFIDLSYNNLYGEISSDW-------GRCPKLGALDFSKNNIT-GNIPPKIGYS 527
+ + + L NN+ I S+ + + N + I P
Sbjct: 259 LADHKYIQVVYLHNNNI-SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
Query: 528 -SQLEVLDLSSN 538
+ L +
Sbjct: 318 VYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 76/332 (22%), Positives = 120/332 (36%), Gaps = 45/332 (13%)
Query: 362 NLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL 421
+L V+ + L +P ++ + L+L NK+T NL NL L N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 422 SGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLKNLTSLVRVHLDRNYLTSNISESFYIYP 480
S P + LVKL +L+L NQ + P K L L + N +T F
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL---RVHENEITKVRKSVFNGLN 145
Query: 481 NLTFIDLSYNNLY-GEISSDW-GRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSN 538
+ ++L N L I + KL + + NIT IP G L L L N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGN 202
Query: 539 HVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGN 598
+ + A L G L L L LS N++S SL N
Sbjct: 203 KI-TKVDAAS---------------LKG--------LNNLAKLGLSFNSISAVDNGSLAN 238
Query: 599 LVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGR------AIPSQICIMQSLEK 652
L L+L+NN+ ++P L + ++ + L N + P S
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 297
Query: 653 LNLSHNSL--SGVIPRCFEEMHALQCIDISYN 682
++L N + + P F ++ + +
Sbjct: 298 VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 51/236 (21%), Positives = 99/236 (41%), Gaps = 17/236 (7%)
Query: 456 TSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSD-WGRCPKLGALDFSKN 514
+ L N +T F NL + L N + +IS + KL L SKN
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSKN 110
Query: 515 NITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAE-LGKLSFLIKLILAQNQL-SGQLSPK- 571
+ +P L+ L + N + + L+ +I + L N L S +
Sbjct: 111 QLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 166
Query: 572 LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIK-LEELIHLSELD 630
+ +L ++ ++ N++ IP+ L L L+L N+ + ++ L+ L +L++L
Sbjct: 167 FQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLG 222
Query: 631 LSYNFLGRAIPSQICI-MQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
LS+N + A+ + L +L+L++N L +P + +Q + + N +
Sbjct: 223 LSFNSI-SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 41/194 (21%), Positives = 77/194 (39%), Gaps = 14/194 (7%)
Query: 509 LDFSKNNITGNIPPKI-GYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQ 567
LD N IT I L L L +N + P L L +L L++NQL +
Sbjct: 57 LDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-E 114
Query: 568 LSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIK---LEELI 624
L + L+ L + N ++ L ++ + L N I+ + +
Sbjct: 115 LPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK-SSGIENGAFQGMK 171
Query: 625 HLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNEL 684
LS + ++ + IP + SL +L+L N ++ V + ++ L + +S+N +
Sbjct: 172 KLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228
Query: 685 RGPIPNSTAFRDAP 698
+ N + + P
Sbjct: 229 SA-VDNG-SLANTP 240
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 41/160 (25%), Positives = 64/160 (40%), Gaps = 10/160 (6%)
Query: 529 QLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNL 588
L V+ S + +P +L L L N+++ L L L L +N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 589 SNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQI-CIM 647
S P + LVKL L LS NQ E+P K+ L EL + N + + + +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEI-TKVRKSVFNGL 144
Query: 648 QSLEKLNLSHNSL--SGVIPRCFEEMHALQCIDISYNELR 685
+ + L N L SG+ F+ M L I I+ +
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-35
Identities = 69/293 (23%), Positives = 116/293 (39%), Gaps = 48/293 (16%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVELASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKA 848
+ D IG+G G V+ L + +AVK LP ++ + +FL E +
Sbjct: 110 VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL--KAKFLQEARI 165
Query: 849 LTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIA 908
L + H NIV+ G C+ Q +IV E ++ G L + L + ++ A
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAA 223
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN----------- 957
+ YL + C +HRD++++N L+ KN ++SDFG+++
Sbjct: 224 AGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 958 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP--GDFISLISSSSLNL 1014
WT APE + + + DV+SFG+L E G P L+
Sbjct: 281 WT---------APEALNYGRYSSESDVWSFGILLWETFSLGASPYPN----------LSN 321
Query: 1015 NIALDEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ + RLP P + + + C P RP+ + Q L+
Sbjct: 322 QQTREFVEKGGRLPCP-ELCPDAV---FRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 70/294 (23%), Positives = 130/294 (44%), Gaps = 41/294 (13%)
Query: 788 YEEIIRATN---DFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFL 843
YE + R + ++ +G G G VYK +G + A K E + +++
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELE-DYI 64
Query: 844 NEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSV 903
E++ L H IVK G H +I+ E+ G++ I+ L Q V
Sbjct: 65 VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVV 122
Query: 904 IKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG 963
+ + +AL++LH+ I+HRD+ + NVL+ + + R++DFG++ G
Sbjct: 123 CRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG 179
Query: 964 TYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGK------HPGDFISLISSSSL 1012
T ++APE+ + + K D++S G+ +E+ + + +P + I+ S
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD- 238
Query: 1013 NLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
P L PS + F+++ LD++PE+RP+ +QLL+
Sbjct: 239 ----------PPTLLTPS-KWSVEFRDFLKI---ALDKNPETRPS---AAQLLE 275
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-35
Identities = 60/268 (22%), Positives = 102/268 (38%), Gaps = 51/268 (19%)
Query: 801 EHCIGKGGQGSVYKVELA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+ CI GG G +Y LA +G + +K G+ Q + E + L E+ H
Sbjct: 85 KGCIAHGGLGWIY---LALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHP 139
Query: 856 NIVKFYGFCSHAQHS-----FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADA 910
+IV+ + F H +IV EY+ SL + L + ++ + I A
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPA 194
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAP 970
LSYLH+ +V+ D+ +N++L + + ++ D G + L GT G+ AP
Sbjct: 195 LSYLHSI---GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGY----LYGTPGFQAP 246
Query: 971 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP--GDFISLISSSSLNLNIALDEILDPRLPI 1028
E+ T T D+Y+ G + G ++ + DP L
Sbjct: 247 EIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED------------DPVLKT 293
Query: 1029 PSHNVQEKLISFVEVAISCLDESPESRP 1056
S+ + +D P R
Sbjct: 294 YD--------SYGRLLRRAIDPDPRQRF 313
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 38/280 (13%)
Query: 797 DFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHR 855
F + +G G +G++ + +AVK+ EV+ L E H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP------ECFSFADREVQLLRESDEHP 78
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLA-MILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
N+++++ Q +I E +L + D A LE +++++ L++L
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHL 134
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNE-----ARVSDFGIAKFLKPDSS---NWTELAGTYG 966
H+ IVHRD+ N+L+ N A +SDFG+ K L + + GT G
Sbjct: 135 HSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 967 YVAPEL---AYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEIL 1022
++APE+ T D++S G + VI +G HP F + + L A L
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP--FGKSLQRQANILLGACS--L 247
Query: 1023 DPRLPIPSHNVQEK-LISFVEVAISCLDESPESRPTMQKV 1061
D P +V + LI + P+ RP+ + V
Sbjct: 248 DCLHPEKHEDVIARELIE------KMIAMDPQKRPSAKHV 281
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 65/300 (21%), Positives = 107/300 (35%), Gaps = 54/300 (18%)
Query: 793 RATNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 851
R T +F + IG G GSV+K + G I A+K+ PL G +Q L EV A
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAV 66
Query: 852 I-RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLA-MILSNDAAAEDLEWTQRMSVIKGIAD 909
+ +H ++V+++ + H I EY GSLA I N + + ++ +
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVS-------------------DFGIAKF 950
L Y+H+ +VH DI N+ + + + D G
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 951 LKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHP---GDFISL 1006
+ S+ G ++A E L K D+++ + + + GD
Sbjct: 184 I----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239
Query: 1007 ISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
I L IP QE ++ + PE RP+ L+K
Sbjct: 240 IRQGRLP-------------RIPQVLSQE-FTELLK---VMIHPDPERRPS---AMALVK 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 68/322 (21%), Positives = 115/322 (35%), Gaps = 52/322 (16%)
Query: 755 KFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYK 814
+ Q R+ + + S +PG + +++ F +G G G V+K
Sbjct: 25 QLQPRRVSFRGEASETLQSPGYDPS---RPESFFQQ------SFQRLSRLGHGSYGEVFK 75
Query: 815 V-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSFI 872
V G + AVK+ SP G + L EV + ++ +H V+ ++
Sbjct: 76 VRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134
Query: 873 VYEYLEMGSLAMILSNDAAA--EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSK 930
E SL A+ E W ++ AL++LH+ +VH D+
Sbjct: 135 QTELCG-PSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHLHSQ---GLVHLDVKPA 186
Query: 931 NVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---AYTMKVTEKCDVYSF 987
N+ L + ++ DFG+ L + + G Y+APEL +Y DV+S
Sbjct: 187 NIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELLQGSY----GTAADVFSL 241
Query: 988 GVLALEVIKGKHP---GDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVA 1044
G+ LEV G+ + L P + +L S +
Sbjct: 242 GLTILEVACNMELPHGGEGWQQLRQG----------YLPPEFT---AGLSSELRSVLV-- 286
Query: 1045 ISCLDESPESRPTMQKVSQLLK 1066
L+ P+ R T LL
Sbjct: 287 -MMLEPDPKLRAT---AEALLA 304
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 55/284 (19%), Positives = 106/284 (37%), Gaps = 35/284 (12%)
Query: 797 DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+ +G+GG V VE L G A+K+ E ++E E H
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHP 86
Query: 856 NIVKFYGFCSHAQHS----FIVYEYLEMGSLA-MILSNDAAAEDLEWTQRMSVIKGIADA 910
NI++ +C + + +++ + + G+L I L Q + ++ GI
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA-------- 962
L +H HRD+ N+LL + + + D G +
Sbjct: 147 LEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 963 -GTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIA 1017
T Y APEL ++ + + E+ DV+S G + ++ G+ P + +
Sbjct: 204 RCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVALAV 260
Query: 1018 LDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+++ P+ P S + + L++ S + P RP + +
Sbjct: 261 QNQLSIPQSPRHSSALWQ-LLN------SMMTVDPHQRPHIPLL 297
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 69/263 (26%), Positives = 117/263 (44%), Gaps = 26/263 (9%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY- 861
+G GG V+ +L +AVK + L + +F F E + + H IV Y
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 862 -GF--CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
G +IV EY++ +L I+ + + + + VI AL++ H +
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQN- 135
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE---LAGTYGYVAPELAYT 975
I+HRD+ N+++ N +V DFGIA+ + ++ T+ + GT Y++PE A
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 976 MKVTEKCDVYSFGVLALEVIKGKHP--GDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033
V + DVYS G + EV+ G+ P GD S +S +A + + PS
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGD--SPVS-------VAYQHVRED-PIPPSARH 243
Query: 1034 QEKLISFVEVAISCLDESPESRP 1056
+ V + L ++PE+R
Sbjct: 244 EGLSADLDAVVLKALAKNPENRY 266
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 77/320 (24%), Positives = 137/320 (42%), Gaps = 41/320 (12%)
Query: 759 RKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRA--TNDFDDEHCIGKGGQGSVYK-V 815
++ Q + P + + V E + F D IG G G+VY
Sbjct: 15 PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR 74
Query: 816 ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875
++ + E++A+KK Q+ + EV+ L ++RH N +++ G +++V E
Sbjct: 75 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134
Query: 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD 935
Y GS + +L + + L+ + +V G L+YLH+ ++HRD+ + N+LL
Sbjct: 135 YCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLS 188
Query: 936 FKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE---KCDVYSFGVLAL 992
++ DFG A + P +S GT ++APE+ M + K DV+S G+ +
Sbjct: 189 EPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 244
Query: 993 EVIKGK------HPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAIS 1046
E+ + K + + I+ + P L + E +FV+
Sbjct: 245 ELAERKPPLFNMNAMSALYHIAQNE-----------SPALQSG--HWSEYFRNFVDS--- 288
Query: 1047 CLDESPESRPTMQKVSQLLK 1066
CL + P+ RPT LLK
Sbjct: 289 CLQKIPQDRPT---SEVLLK 305
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 56/300 (18%)
Query: 796 NDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+D++ + IG G V E +A+K+ L T E L E++A+++ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHH 72
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL-----SNDAAAEDLEWTQRMSVIKGIAD 909
NIV +Y ++V + L GS+ I+ + + L+ + ++++ + +
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA------G 963
L YLH + +HRD+ + N+LL +++DFG++ FL + T G
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA-TGGDITRNKVRKTFVG 188
Query: 964 TYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK------HPGDFISLISSSSL 1012
T ++APE+ Y K D++SFG+ A+E+ G P + L +
Sbjct: 189 TPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND- 243
Query: 1013 NLNIALDEILDPRLPIPSHNVQEK------LISFVEVAISCLDESPESRPTMQKVSQLLK 1066
P L + + + CL + PE RPT ++LL+
Sbjct: 244 ----------PPSLETGVQDKEMLKKYGKSFRKMIS---LCLQKDPEKRPT---AAELLR 287
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 40/288 (13%)
Query: 795 TNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI- 852
F+ +G G G VYK + +G++ A+K + G+ ++E E+ L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDE--EEEIKQEINMLKKYS 78
Query: 853 RHRNIVKFYG------FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG 906
HRNI +YG ++V E+ GS+ ++ N L+ + +
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICRE 137
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG 966
I LS+LH ++HRDI +NVLL E ++ DFG++ L GT
Sbjct: 138 ILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 967 YVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEI 1021
++APE+ + + K D++S G+ A+E+ +G P ++ AL I
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP--------LCDMHPMRALFLI 246
Query: 1022 LDPRLPIP---SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
PR P P S +K SF+E CL ++ RP QL+K
Sbjct: 247 --PRNPAPRLKSKKWSKKFQSFIES---CLVKNHSQRPAT---EQLMK 286
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-32
Identities = 59/253 (23%), Positives = 98/253 (38%), Gaps = 8/253 (3%)
Query: 97 SKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNY 156
++ + + S +P I S + L+L +N + L L L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 157 LEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGN 215
+ I + L +L TL L++N L+ IPS L L +L L NN + +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169
Query: 216 LSNLAMLNLSSNSLFGSIPSE-LGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYN 274
+ +L L+L I L L L L + +P+ L L L L +
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSG 227
Query: 275 NSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELR 334
N + P L L K+ + ++ S + ++ L+++ L L N+L L
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT 287
Query: 335 NLKSLSILELGNN 347
L+ L L L +N
Sbjct: 288 PLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-32
Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 16/260 (6%)
Query: 72 FPHLAYLDLWSNQLF---GNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHL 128
+ + L IP +YL+L N HL +L+ L L
Sbjct: 53 SNQFSKVVCTRRGLSEVPQGIPSN------TRYLNLMENNIQMIQADTFRHLHHLEVLQL 106
Query: 129 FKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPS 187
+N + I + GL+SLN L L+ N+L I + L+ L L L NN + SIPS
Sbjct: 107 GRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPS 164
Query: 188 EI-GNLKYLLDLNLYNNELNGSIP-QSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSD 245
+ L+ L+L + I + L NL LNL ++ +P+ L L L +
Sbjct: 165 YAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEE 222
Query: 246 LKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLI 305
L+++ N P S L++L L++ N+ +S + + L L ++ L++N S L
Sbjct: 223 LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLP 282
Query: 306 PHSLGNLSNIAFLFLDSNSL 325
L + L L N
Sbjct: 283 HDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-30
Identities = 53/255 (20%), Positives = 100/255 (39%), Gaps = 10/255 (3%)
Query: 195 LLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLN 254
+ L+ +PQ + SN LNL N++ +L +L L+L N +
Sbjct: 56 FSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 255 GSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSN 314
+ L +L L +++N L+ + L L ++ L N + ++ + +
Sbjct: 113 QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPS 172
Query: 315 IAFLFL-DSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSL 373
+ L L + L + L +L L LG + +P+ L L L + N
Sbjct: 173 LMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI-KDMPNLT-PLVGLEELEMSGNHF 230
Query: 374 SGSIPCE-IGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKE-YRN 431
I L SL L + ++++ + L +L L+ N+LS ++P + +
Sbjct: 231 P-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTP 288
Query: 432 LVKLTKLFLGDNQFQ 446
L L +L L N +
Sbjct: 289 LRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 55/253 (21%), Positives = 98/253 (38%), Gaps = 9/253 (3%)
Query: 217 SNLAMLNLSSNSLFGSIPSEL-GNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNN 275
+ + + + L +P + N +YL+ L +N + + +L +L +L + N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIPSNTRYLN---LMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 276 SLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRN 335
S+ + L L+ + L N + + + LS + L+L +N + +
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169
Query: 336 LKSLSILELGNNKLCGSIPHF-LGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAF 394
+ SL L+LG K I L NL L + ++ +P + L L L ++
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSG 227
Query: 395 NKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLK 453
N P S L++L L + +S + L L +L L N P
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT 287
Query: 454 NLTSLVRVHLDRN 466
L LV +HL N
Sbjct: 288 PLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-28
Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 13/221 (5%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHL 120
+ +F HL L L N + I ++ L L+L N + IP +L
Sbjct: 89 MIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYL 146
Query: 121 SYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYS-NYLEDIIPHSLGNLTNLVTLCLYN 178
S L+ L L N + SIP + SL L L LE I + L NL L L
Sbjct: 147 SKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205
Query: 179 NLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSE-L 237
+ +P+ + L L +L + N P S LS+L L + ++ + I
Sbjct: 206 CNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV-SLIERNAF 262
Query: 238 GNLKYLSDLKLADNKLNGSIPHSLC-NLTNLVILYIYNNSL 277
L L +L LA N L+ S+PH L L LV L++++N
Sbjct: 263 DGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 63/232 (27%), Positives = 92/232 (39%), Gaps = 12/232 (5%)
Query: 435 LTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLY 493
L L +N Q + ++L L + L RN + +F +L ++L N L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL- 135
Query: 494 GEISSDW-GRCPKLGALDFSKNNITGNIPPKI-GYSSQLEVLDLSSNHVVGDIPAE-LGK 550
I S KL L N I +IP L LDL + I
Sbjct: 136 TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
L L L L + P L LV LE L++S N+ P S L L L + N+
Sbjct: 195 LFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 611 QFSWEIPIK-LEELIHLSELDLSYNFLGRAIPSQIC-IMQSLEKLNLSHNSL 660
Q S I + L L EL+L++N L ++P + ++ L +L+L HN
Sbjct: 253 QVS-LIERNAFDGLASLVELNLAHNNL-SSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 18/236 (7%)
Query: 457 SLVRVHLDRNYLTS---NISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSK 513
+V R L+ I N +++L NN+ + + L L +
Sbjct: 55 QFSKVVCTRRGLSEVPQGIP------SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGR 108
Query: 514 NNITGNIPPKI-GYSSQLEVLDLSSNHVVGDIPAE-LGKLSFLIKLILAQNQLSGQLSPK 571
N+I I + L L+L N + IP+ LS L +L L N + +
Sbjct: 109 NSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSY 165
Query: 572 -LGLLVQLEHLDLSSNNLSNAIPE-SLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSEL 629
+ L LDL I E + L L YLNL ++P L L+ L EL
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEEL 223
Query: 630 DLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
++S N P + SL+KL + ++ +S + F+ + +L +++++N L
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 75/304 (24%), Positives = 131/304 (43%), Gaps = 49/304 (16%)
Query: 788 YEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 847
+E+ ++ N E +G G G+V G +AVK+ F L E+K
Sbjct: 9 FEQSLK--NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI------DFCDIALMEIK 60
Query: 848 ALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLA-MILSNDAAAEDLEWTQRM---S 902
LTE H N++++Y + + +I E +L ++ S + + E+L+ + S
Sbjct: 61 LLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 903 VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNE-------------ARVSDFGIAK 949
+++ IA +++LH+ I+HRD+ +N+L+ + +SDFG+ K
Sbjct: 120 LLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 950 FLKPDSSNWT----ELAGTYGYVAPEL-------AYTMKVTEKCDVYSFGVLALEVI-KG 997
L S++ +GT G+ APEL ++T D++S G + ++ KG
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 998 KHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPT 1057
KHP S+ + +LDE+ + LIS +D P RPT
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD-LIS------QMIDHDPLKRPT 289
Query: 1058 MQKV 1061
KV
Sbjct: 290 AMKV 293
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-31
Identities = 69/272 (25%), Positives = 123/272 (45%), Gaps = 30/272 (11%)
Query: 801 EHCIGKGGQGSVYKVELASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
+H +G G G VY+ + +AVK M +EFL E + EI+H N+V+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTME-VEEFLKEAAVMKEIKHPNLVQ 280
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
G C+ +I+ E++ G+L L E + + + I+ A+ YL F
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKKNF 339
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTM 976
+HR+++++N L+ + +V+DFG+++ + D+ +T AG + APE
Sbjct: 340 ---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN 394
Query: 977 KVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP--RLPIPSHNV 1033
K + K DV++FGVL E+ G P I + E+L+ R+ P
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGID---------LSQVYELLEKDYRMERPEGCP 445
Query: 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
++ E+ +C +P RP+ ++ Q
Sbjct: 446 EK----VYELMRACWQWNPSDRPSFAEIHQAF 473
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-31
Identities = 73/283 (25%), Positives = 114/283 (40%), Gaps = 31/283 (10%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIR 853
D D IG+G GSV K+ SG+I+AVK+ + Q++ L ++ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSD 79
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRM--SVIKGIADAL 911
IV+FYG +I E + S + D + + + AL
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 971
++L + I+HRDI N+LLD ++ DFGI+ L DS T AG Y+APE
Sbjct: 139 NHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPE 195
Query: 972 ----LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD---P 1024
A + DV+S G+ E+ G+ P ++ L +++ P
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFP-------YPKWNSVFDQLTQVVKGDPP 248
Query: 1025 RLPIPSHNV-QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+L I+FV CL + RP +LLK
Sbjct: 249 QLSNSEEREFSPSFINFVN---LCLTKDESKRPK---YKELLK 285
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 849
I ++ IG G G V+ + + +A+K G M+ +++F+ E + +
Sbjct: 4 VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMS-EEDFIEEAEVM 57
Query: 850 TEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIAD 909
++ H +V+ YG C +V E++E G L+ L + + + +
Sbjct: 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCE 115
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD----SSN------WT 959
++YL C +HRD++++N L+ +VSDFG+ +F+ D S+ W
Sbjct: 116 GMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 172
Query: 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIAL 1018
+PE+ + + K DV+SFGVL EV +GK P + N +
Sbjct: 173 ---------SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE------------NRSN 211
Query: 1019 DEILDP-----RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
E+++ RL P + ++ C E PE RP ++ + L
Sbjct: 212 SEVVEDISTGFRLYKP-RLASTHV---YQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 6e-31
Identities = 28/291 (9%), Positives = 67/291 (23%), Gaps = 43/291 (14%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+ G + V+ V ++ E A+K F + + A + + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 863 FCSHA--------------------------QHSFIVYEYLEMGSLAMILS----NDAAA 892
+ ++ L ++ S
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 893 EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952
D + + + L + +VH + N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL---W 242
Query: 953 PDSSNWTELAGTYGYVAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSS 1010
+ + Y E A T T + + G+ V P ++
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 1011 SLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
S D + + + + + L+ R +
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEA 350
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 44/289 (15%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 849
E+ R + +G G G V + +AVK G M+ + EF E + +
Sbjct: 4 ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMS-EDEFFQEAQTM 57
Query: 850 TEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIAD 909
++ H +VKFYG CS +IV EY+ G L L + + LE +Q + + + +
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCE 115
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD----SSN------WT 959
+++L + F +HRD++++N L+D +VSDFG+ +++ D S W+
Sbjct: 116 GMAFLESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS 172
Query: 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIAL 1018
APE+ + K + K DV++FG+L EV GK P + +
Sbjct: 173 ---------APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP--------YDLYTNSEVV 215
Query: 1019 DEILDP-RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
++ RL P H + + ++ SC E PE RPT Q++ ++
Sbjct: 216 LKVSQGHRLYRP-HLASDTI---YQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 66/281 (23%), Positives = 109/281 (38%), Gaps = 32/281 (11%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL-TEIR 853
ND ++ +G G G V+K+ +G +IAVK+ G + L ++ +
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNKEENKRILMDLDVVLKSHD 82
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
IV+ +G FI E + + + + + I AL Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK---RMQGPIPERILGKMTVAIVKALYY 139
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
L ++HRD+ N+LLD + + ++ DFGI+ L D AG Y+APE
Sbjct: 140 LKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERI 196
Query: 974 YTMKVTE-----KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD---PR 1025
T+ + DV+S G+ +E+ G+ P + L ++L P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFP-------YKNCKTDFEVLTKVLQEEPPL 249
Query: 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
LP SFV+ CL + RP +LL+
Sbjct: 250 LP-GHMGFSGDFQSFVK---DCLTKDHRKRPKYN---KLLE 283
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 68/334 (20%), Positives = 120/334 (35%), Gaps = 47/334 (14%)
Query: 74 HLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQL 133
HL + L +P +I LDL +N S L +L L L N++
Sbjct: 34 HLRVVQCSDLGL-KAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 134 SGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLK 193
S I + L L L + N L IP +
Sbjct: 91 S------------------------KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PS 123
Query: 194 YLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSI--PSELGNLKYLSDLKLADN 251
L++L +++N + L N+ + + N L S P LK L+ L++++
Sbjct: 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEA 182
Query: 252 KLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGN 311
KL IP L L L++ +N + + ++ L ++ L +N+ + SL
Sbjct: 183 KLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239
Query: 312 LSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIP-------HFLGNLTNLS 364
L + L LD+N L +P+ L +LK L ++ L N + + F +
Sbjct: 240 LPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYN 297
Query: 365 VLFIYNNSLSGSI--PCEIGNLKSLSYLNLAFNK 396
+ ++NN + P + + K
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 18/286 (6%)
Query: 169 TNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNS 228
+ L L NN +S + L++L L L NN+++ ++ L L L +S N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 229 LFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSL--SGLIPSEIG 286
L IP L L +L++ DN++ L N+ + + N L SG P
Sbjct: 114 L-VEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 287 NLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGN 346
LK L+ + +S K +G+ L+ L LD N + + +L L L LG+
Sbjct: 171 GLK-LNYLRISEAKLTGIPKDLPETLNE---LHLDHNKIQAIELEDLLRYSKLYRLGLGH 226
Query: 347 NKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTS------S 400
N++ L L L L + NN LS +P + +LK L + L N +T
Sbjct: 227 NQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285
Query: 401 IPISLSNLTNLSVLSFYKNSLSGAI--PKEYRNLVKLTKLFLGDNQ 444
+ +S + N + P +R + + G+ +
Sbjct: 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 73/330 (22%), Positives = 113/330 (34%), Gaps = 42/330 (12%)
Query: 362 NLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL 421
+L V+ + L ++P EI + L+L N ++ L +L L N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 422 SGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPN 481
S K + L KL KL++ N PNL +SLV + + N + F N
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRN 148
Query: 482 LTFIDLSYNNLY-GEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHV 540
+ I++ N L KL L S+ +T IP L L L N +
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKI 205
Query: 541 VGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLV 600
I E L +L L L N + SL L
Sbjct: 206 Q-AIELED-----------------------LLRYSKLYRLGLGHNQIRMIENGSLSFLP 241
Query: 601 KLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQ------SLEKLN 654
L L+L NN+ S +P L +L L + L N + + + C + ++
Sbjct: 242 TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGIS 300
Query: 655 LSHNSLS--GVIPRCFEEMHALQCIDISYN 682
L +N + V P F + I
Sbjct: 301 LFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 66/296 (22%), Positives = 109/296 (36%), Gaps = 42/296 (14%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSY 122
L F HL L L +N++ I FS L
Sbjct: 68 ELRKDDFKGLQHLYALVLVNNKI-SKIHE---------------KAFSP--------LRK 103
Query: 123 LKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLL- 181
L+ L++ KN L IP + SSL L ++ N + + L N+ + + N L
Sbjct: 104 LQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 182 SGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSE-LGNL 240
+ + L L + +L IP+ L L L+L N + +I E L
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKI-QAIELEDLLRY 216
Query: 241 KYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNK 300
L L L N++ SL L L L++ NN LS +P+ + +LK L + L N
Sbjct: 217 SKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN 275
Query: 301 FSGLIPHS------LGNLSNIAFLFLDSN--SLFGLIPSELRNLKSLSILELGNNK 348
+ + + + + L +N + + P+ R + ++ GN K
Sbjct: 276 ITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 67/310 (21%), Positives = 115/310 (37%), Gaps = 31/310 (10%)
Query: 242 YLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKF 301
SDL L ++P + + +L + NN +S L + L+ L + L NK
Sbjct: 39 QCSDLGLK------AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 302 SGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLT 361
S + + L + L++ N L IP L SL L + +N++ L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHL-VEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 362 NLSVLFIYNNSL-SGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNS 420
N++ + + N L + + L+YL ++ KLT I L+ L N
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG---IPKDLPETLNELHLDHNK 204
Query: 421 LSGAIPKEY-RNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNISESFY 477
+ AI E KL +L LG NQ + I N L L +L +HLD N L+ +
Sbjct: 205 IQ-AIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLSR-VPAGLP 261
Query: 478 IYPNLTFIDLSYNNLYGEISSD-------WGRCPKLGALDFSKNNIT-GNIPPKIGYS-S 528
L + L NN+ ++ + + + N + + P +
Sbjct: 262 DLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT 320
Query: 529 QLEVLDLSSN 538
+ +
Sbjct: 321 DRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 59/303 (19%), Positives = 107/303 (35%), Gaps = 29/303 (9%)
Query: 313 SNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNS 372
+ L L +N + L + + L+ L L L NNK+ L L L+I N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 373 LSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL-SGAIPKEYRN 431
L IP + SL L + N++ S L N++ + N L + +
Sbjct: 114 LV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 432 LVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNN 491
+KL L + + + G +L +L +HLD N + + E Y L + L +N
Sbjct: 171 GLKLNYLRISEAKLTGIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQ 228
Query: 492 LYGEISSD-WGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGK 550
+ I + P L L N ++ +P + L+V+ L +N++ ++G
Sbjct: 229 I-RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI-----TKVGV 281
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAI--PESLGNLVKLHYLNLS 608
F + L +N + P + + +
Sbjct: 282 NDF-------------CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328
Query: 609 NNQ 611
N +
Sbjct: 329 NYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 53/234 (22%), Positives = 96/234 (41%), Gaps = 14/234 (5%)
Query: 456 TSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSD-WGRCPKLGALDFSKN 514
+ L N ++ + F +L + L N + +I + KL L SKN
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI-SKIHEKAFSPLRKLQKLYISKN 112
Query: 515 NITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQL-SGQLSPKLG 573
++ IPP S L L + N + L + + + N L + P
Sbjct: 113 HLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169
Query: 574 LLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIK-LEELIHLSELDLS 632
++L +L +S L+ IP+ L L+ L+L +N+ I ++ L L L L
Sbjct: 170 DGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLG 225
Query: 633 YNFLGRAIPSQICI-MQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
+N + R I + + +L +L+L +N LS +P ++ LQ + + N +
Sbjct: 226 HNQI-RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 22/236 (9%)
Query: 457 SLVRVHLDRNYLTS---NISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSK 513
L V L + IS P+ T +DL N++ D+ L AL
Sbjct: 34 HLRVVQCSDLGLKAVPKEIS------PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87
Query: 514 NNITGNIPPKI-GYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPK- 571
N I+ I K +L+ L +S NH+V +IP L S L++L + N++ ++
Sbjct: 88 NKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGV 142
Query: 572 LGLLVQLEHLDLSSNNLSNA-IPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELD 630
L + +++ N L N+ + +KL+YL +S + + IP L L+EL
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELH 199
Query: 631 LSYNFLGRAIPSQICI-MQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
L +N + +AI + + L +L L HN + + + L+ + + N+L
Sbjct: 200 LDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 66/307 (21%), Positives = 127/307 (41%), Gaps = 20/307 (6%)
Query: 131 NQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIG 190
++ P L++ +A + + D + +L + TL + ++ +I +
Sbjct: 7 TAINVIFPDP--ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQ 60
Query: 191 NLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLAD 250
L L+ L L +N++ + L NL+ + L LS N L S + L+ + L L
Sbjct: 61 YLNNLIGLELKDNQI--TDLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTS 116
Query: 251 NKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLG 310
++ P L L+NL +LY+ N ++ + S + L L +++ + S L P L
Sbjct: 117 TQITDVTP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP--LA 170
Query: 311 NLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYN 370
NLS + L D N + + S L +L +L + L NN++ P L N +NL ++ + N
Sbjct: 171 NLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
Query: 371 NSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYR 430
+++ NL + + + IS + L++ S + +
Sbjct: 227 QTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFN 286
Query: 431 NLVKLTK 437
V
Sbjct: 287 QSVTFKN 293
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 56/246 (22%), Positives = 107/246 (43%), Gaps = 18/246 (7%)
Query: 67 FSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTL 126
F + + + + + + ++ + L + I + +L+ L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68
Query: 127 HLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIP 186
L NQ++ PL+ L+ + L L N L+++ + L ++ TL L + ++ P
Sbjct: 69 ELKDNQITDLAPLK--NLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP 124
Query: 187 SEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDL 246
+ L L L L N++ +I L L+NL L++ + + S + L NL L+ L
Sbjct: 125 --LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQV--SDLTPLANLSKLTTL 178
Query: 247 KLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIP 306
K DNK++ I L +L NL+ +++ NN +S + S + N L + L+ +
Sbjct: 179 KADDNKIS-DIS-PLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPV 234
Query: 307 HSLGNL 312
NL
Sbjct: 235 FYNNNL 240
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 56/280 (20%), Positives = 107/280 (38%), Gaps = 19/280 (6%)
Query: 357 LGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSF 416
L N + ++++ ++ +L ++ L+ +T+ + L NL L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLEL 70
Query: 417 YKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESF 476
N ++ P +NL K+T+L L N + + + L S+ + L +T
Sbjct: 71 KDNQITDLAP--LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITD--VTPL 125
Query: 477 YIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLS 536
NL + L N + S L L ++ ++ P + S+L L
Sbjct: 126 AGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKAD 181
Query: 537 SNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESL 596
N + DI L L LI++ L NQ+S +SP L L + L++ ++N
Sbjct: 182 DNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYN 237
Query: 597 GNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFL 636
NLV + + P + + + +L++N
Sbjct: 238 NNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLT 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 16/231 (6%)
Query: 69 FSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHL 128
+L L+L NQ+ ++ P + N++K+ L+LS N + I L +KTL L
Sbjct: 59 VQYLNNLIGLELKDNQI-TDLAP-LKNLTKITELELSGNPLKN-VSA-IAGLQSIKTLDL 114
Query: 129 FKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSE 188
Q++ PL GLS+L L L N + +I P L LTNL L + N +S + +
Sbjct: 115 TSTQITDVTPLA--GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DL-TP 168
Query: 189 IGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKL 248
+ NL L L +N+++ I L +L NL ++L +N + S S L N L + L
Sbjct: 169 LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTL 224
Query: 249 ADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYN 299
+ + NL + S + + P+ I + + L++N
Sbjct: 225 TNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWN 273
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-22
Identities = 47/236 (19%), Positives = 97/236 (41%), Gaps = 18/236 (7%)
Query: 449 IPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGA 508
I L + +++ ++ +T ++++ +T + + L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVTQADL--DGITTLSAFGTGV--TTIEGVQYLNNLIG 67
Query: 509 LDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQL 568
L+ N IT ++ P + +++ L+LS N + ++ A + L + L L Q++
Sbjct: 68 LELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDV- 122
Query: 569 SPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSE 628
L L L+ L L N ++N L L L YL++ N Q S ++ L L L+
Sbjct: 123 -TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DLT-PLANLSKLTT 177
Query: 629 LDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNEL 684
L N + I + + +L +++L +N +S V P L + ++ +
Sbjct: 178 LKADDNKI-SDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 56/261 (21%), Positives = 103/261 (39%), Gaps = 17/261 (6%)
Query: 431 NLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYN 490
L K+ G + +L + + +T+ E NL ++L N
Sbjct: 17 ALANAIKIAAGKSNVTD-TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDN 73
Query: 491 NLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGK 550
+ +++ K+ L+ S N + N+ I ++ LDL+S + D+ L
Sbjct: 74 QI-TDLAPL-KNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQI-TDVTP-LAG 127
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
LS L L L NQ++ +SP L L L++L + + +S+ L NL KL L +N
Sbjct: 128 LSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDN 183
Query: 611 QFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEE 670
+ S +I L L +L E+ L N + P + +L + L++ +++
Sbjct: 184 KIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNN 239
Query: 671 MHALQCIDISYNELRGPIPNS 691
+ + P S
Sbjct: 240 LVVPNVVKGPSGAPIAPATIS 260
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 21/115 (18%), Positives = 41/115 (35%), Gaps = 6/115 (5%)
Query: 68 SFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLH 127
++ L L N++ +I P + ++ L + L +N S P + + S L +
Sbjct: 168 PLANLSKLTTLKADDNKI-SDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 128 LFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLS 182
L ++ L N + I P ++ + + L NL S
Sbjct: 224 LTNQTITNQPVFYNNNLVVPNV--VKGPSGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 56/258 (21%), Positives = 103/258 (39%), Gaps = 13/258 (5%)
Query: 124 KTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLS- 182
+ L+ S+P + SS L L SN L+ + LT L L L +N LS
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 183 GSIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSE--LGN 239
S+ L L+L N + ++ + L L L+ ++L + +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLS 124
Query: 240 LKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEI-GNLKFLSKIALSY 298
L+ L L ++ + L++L +L + NS +I L+ L+ + LS
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 299 NKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH--F 356
+ L P + +LS++ L + N+ F L + L SL +L+ N + +
Sbjct: 185 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI-MTSKKQEL 243
Query: 357 LGNLTNLSVLFIYNNSLS 374
++L+ L + N +
Sbjct: 244 QHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 62/256 (24%), Positives = 98/256 (38%), Gaps = 11/256 (4%)
Query: 100 KYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLE- 158
+ +S + ++P I S L L N+L L+ L L+L SN L
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 159 -DIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSL-GNL 216
S T+L L L N + ++ S L+ L L+ ++ L S+ +L
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125
Query: 217 SNLAMLNLSSNSLFGSIPSE-LGNLKYLSDLKLADNKLNGSI-PHSLCNLTNLVILYIYN 274
NL L++S + L L LK+A N + P L NL L +
Sbjct: 126 RNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184
Query: 275 NSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELR 334
L L P+ +L L + +S+N F L L+++ L N + EL+
Sbjct: 185 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ 244
Query: 335 NL-KSLSILELGNNKL 349
+ SL+ L L N
Sbjct: 245 HFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 59/243 (24%), Positives = 95/243 (39%), Gaps = 10/243 (4%)
Query: 161 IPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELN--GSIPQSLGNLSN 218
+P + ++ L L +N L L L L+L +N L+ G QS ++
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 219 LAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSL-CNLTNLVILYIYNNSL 277
L L+LS N + ++ S L+ L L + L S+ +L NL+ L I +
Sbjct: 80 LKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 278 SGLIPSEIGNLKFLSKIALSYNKF-SGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNL 336
L L + ++ N F +P L N+ FL L L L P+ +L
Sbjct: 139 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 198
Query: 337 KSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEI--GNLKSLSYLNLAF 394
SL +L + +N L +L VL N + + + SL++LNL
Sbjct: 199 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQ 257
Query: 395 NKL 397
N
Sbjct: 258 NDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 12/239 (5%)
Query: 72 FPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNL--FSGAIPPQIGHLSYLKTLHL 128
L+L SN+L ++P + +++L L LSSN F G + LK L L
Sbjct: 27 PSSATRLELESNKL-QSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 129 FKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSL-GNLTNLVTLCLYNNLLSGSIPS 187
N + ++ GL L +L + L+ + S+ +L NL+ L + + +
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFN 143
Query: 188 EI-GNLKYLLDLNLYNNELNGSI-PQSLGNLSNLAMLNLSSNSLFGSIPSE-LGNLKYLS 244
I L L L + N + P L NL L+LS L + +L L
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQ 202
Query: 245 DLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNL-KFLSKIALSYNKFS 302
L ++ N L +L +L N + E+ + L+ + L+ N F+
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 53/222 (23%), Positives = 83/222 (37%), Gaps = 8/222 (3%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQL-FGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQIGHL 120
+L F L L L SN L F Q + LKYLDLS N + L
Sbjct: 42 SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGL 100
Query: 121 SYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
L+ L + L V L +L L + + L++L L + N
Sbjct: 101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160
Query: 180 LLSGSIPSEI-GNLKYLLDLNLYNNELNGSIPQ-SLGNLSNLAMLNLSSNSLFGSIPSEL 237
+ +I L+ L L+L +L + + +LS+L +LN+S N+ F
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 219
Query: 238 GNLKYLSDLKLADNKLNGSIPHSLCNL-TNLVILYIYNNSLS 278
L L L + N + S L + ++L L + N +
Sbjct: 220 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 55/252 (21%), Positives = 105/252 (41%), Gaps = 12/252 (4%)
Query: 222 LNLSSNSLFGSIPSEL-GNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLS-- 278
+ +S L S+P+ + + L L NKL LT L L + +N LS
Sbjct: 12 IRCNSKGL-TSVPTGIPSSATRLE---LESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 279 GLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSEL-RNLK 337
G L + LS+N + + L + L ++L + + +L+
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 338 SLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNK 396
+L L++ + + L++L VL + NS + +I L++L++L+L+ +
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 397 LTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLKNL 455
L P + ++L++L VL+ N+ Y+ L L L N L++
Sbjct: 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246
Query: 456 -TSLVRVHLDRN 466
+SL ++L +N
Sbjct: 247 PSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 65/234 (27%), Positives = 94/234 (40%), Gaps = 9/234 (3%)
Query: 435 LTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLT--SNISESFYIYPNLTFIDLSYNN 491
T+L L N+ Q LT L ++ L N L+ S+S + +L ++DLS+N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 492 LYGEISSDWGRCPKLGALDFSKNNITGNIPPKI-GYSSQLEVLDLSSNHVVGDIPAELGK 550
+ +SS++ +L LDF +N+ + L LD+S H
Sbjct: 90 V-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148
Query: 551 LSFLIKLILAQNQLSGQLSPK-LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSN 609
LS L L +A N P L L LDLS L P + +L L LN+S+
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSH 208
Query: 610 NQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQI--CIMQSLEKLNLSHNSLS 661
N F + L L LD S N + Q SL LNL+ N +
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHI-MTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 9/212 (4%)
Query: 480 PNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNIT-GNIPPKIGYS-SQLEVLDLSS 537
+ T ++L N L + + +L L S N ++ + + + L+ LDLS
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 538 NHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPK--LGLLVQLEHLDLSSNNLSNAIPES 595
N V+ + + L L L + L Q+S L L +LD+S + A
Sbjct: 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 145
Query: 596 LGNLVKLHYLNLSNNQFSWEIPIK-LEELIHLSELDLSYNFLGRAIPSQI-CIMQSLEKL 653
L L L ++ N F EL +L+ LDLS L + + SL+ L
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVL 204
Query: 654 NLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
N+SHN+ + ++ +++LQ +D S N +
Sbjct: 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 9e-04
Identities = 20/96 (20%), Positives = 36/96 (37%), Gaps = 8/96 (8%)
Query: 627 SELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRG 686
+E+ + L ++P+ I S +L L N L + F+++ L + +S N L
Sbjct: 10 TEIRCNSKGL-TSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 687 PIPNSTAFRDAP---IKALQGNK--GLCGDFKGLPS 717
S + L N + +F GL
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ 102
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 16/260 (6%)
Query: 72 FPHLAYLDLWSNQLF---GNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHL 128
+ + L I + L+L N HL +L+ L L
Sbjct: 42 SNQFSKVICVRKNLREVPDGISTN------TRLLNLHENQIQIIKVNSFKHLRHLEILQL 95
Query: 129 FKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPS 187
+N + +I + GL++LN L L+ N L I + L+ L L L NN + SIPS
Sbjct: 96 SRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPS 153
Query: 188 EI-GNLKYLLDLNLYNNELNGSIP-QSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSD 245
+ L L+L + I + LSNL LNL+ +L IP+ L L L +
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL-REIPN-LTPLIKLDE 211
Query: 246 LKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLI 305
L L+ N L+ P S L +L L++ + + + + NL+ L +I L++N + L
Sbjct: 212 LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLP 271
Query: 306 PHSLGNLSNIAFLFLDSNSL 325
L ++ + L N
Sbjct: 272 HDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 51/254 (20%), Positives = 98/254 (38%), Gaps = 8/254 (3%)
Query: 195 LLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLN 254
+ L +P + +N +LNL N + + +L++L L+L+ N +
Sbjct: 45 FSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101
Query: 255 GSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSN 314
+ L NL L +++N L+ + L L ++ L N + ++ + +
Sbjct: 102 TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPS 161
Query: 315 IAFLFL-DSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSL 373
+ L L + L + L +L L L L IP+ L L L + N L
Sbjct: 162 LRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL-REIPNLT-PLIKLDELDLSGNHL 219
Query: 374 SGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNL 432
S +I L L L + +++ + NL +L ++ N+L+ + L
Sbjct: 220 S-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL 278
Query: 433 VKLTKLFLGDNQFQ 446
L ++ L N +
Sbjct: 279 HHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 13/221 (5%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHL 120
+ SF HL L L N + I ++ L L+L N + IP +L
Sbjct: 78 IIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYL 135
Query: 121 SYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYS-NYLEDIIPHSLGNLTNLVTLCLYN 178
S LK L L N + SIP + SL L L L I + L+NL L L
Sbjct: 136 SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAM 194
Query: 179 NLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSE-L 237
L IP+ + L L +L+L N L+ P S L +L L + + + I
Sbjct: 195 CNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI-QVIERNAF 251
Query: 238 GNLKYLSDLKLADNKLNGSIPHS-LCNLTNLVILYIYNNSL 277
NL+ L ++ LA N L +PH L +L +++++N
Sbjct: 252 DNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-28
Identities = 58/253 (22%), Positives = 104/253 (41%), Gaps = 9/253 (3%)
Query: 217 SNLAMLNLSSNSLFGSIPSEL-GNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNN 275
+ + + +L +P + N + L+ L +N++ +S +L +L IL + N
Sbjct: 43 NQFSKVICVRKNL-REVPDGISTNTRLLN---LHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 276 SLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRN 335
+ + L L+ + L N+ + + + LS + L+L +N + +
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNR 158
Query: 336 LKSLSILELGNNKLCGSIP-HFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAF 394
+ SL L+LG K I L+NL L + +L IP + L L L+L+
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSG 216
Query: 395 NKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLK 453
N L++ P S L +L L ++ + + NL L ++ L N P
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276
Query: 454 NLTSLVRVHLDRN 466
L L R+HL N
Sbjct: 277 PLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 67/231 (29%), Positives = 97/231 (41%), Gaps = 10/231 (4%)
Query: 435 LTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLY 493
L L +NQ Q N K+L L + L RN++ + +F NL ++L N L
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL- 124
Query: 494 GEISSDWGRC-PKLGALDFSKNNITGNIPPKI-GYSSQLEVLDLSSNHVVGDIPAE-LGK 550
I + KL L N I +IP L LDL + I
Sbjct: 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
LS L L LA L P L L++L+ LDLS N+LS P S L+ L L + +
Sbjct: 184 LSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241
Query: 611 QFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQIC-IMQSLEKLNLSHNSL 660
Q + L L E++L++N L +P + + LE+++L HN
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNL-TLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 61/236 (25%), Positives = 92/236 (38%), Gaps = 18/236 (7%)
Query: 457 SLVRVHLDRNYLTS---NISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSK 513
+V R L IS N ++L N + + + L L S+
Sbjct: 44 QFSKVICVRKNLREVPDGIS------TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSR 97
Query: 514 NNITGNIPPKI-GYSSQLEVLDLSSNHVVGDIPAE-LGKLSFLIKLILAQNQLSGQLSPK 571
N+I I + L L+L N + IP LS L +L L N + +
Sbjct: 98 NHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSY 154
Query: 572 L-GLLVQLEHLDLSSNNLSNAIPE-SLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSEL 629
+ L LDL + I E + L L YLNL+ EIP L LI L EL
Sbjct: 155 AFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDEL 212
Query: 630 DLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
DLS N L P + L+KL + + + + F+ + +L I++++N L
Sbjct: 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 63/302 (20%), Positives = 112/302 (37%), Gaps = 30/302 (9%)
Query: 103 DLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDII 161
SS + +IP + +K+L L N+++ I +L L L SN + I
Sbjct: 37 KGSSGSLN-SIPSGL--TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIE 92
Query: 162 PHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNELNGSIPQS--LGNLSN 218
S +L +L L L N LS ++ S L L LNL N ++ ++ +L+
Sbjct: 93 EDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTK 150
Query: 219 LAMLNLSSNSLFGSIPSE-LGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSL 277
L +L + + F I + L +L +L++ + L P SL ++ N+ L ++
Sbjct: 151 LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210
Query: 278 SGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLK 337
L+ + + + L LS + L
Sbjct: 211 ILLLEIFVDVTSSVECLELRDTDLDTF---HFSELSTGET-------------NSLIKKF 254
Query: 338 SLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNK 396
+ +++ + L + L ++ L L N L S+P I L SL + L N
Sbjct: 255 TFRNVKITDESL-FQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNP 312
Query: 397 LT 398
Sbjct: 313 WD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-30
Identities = 69/299 (23%), Positives = 111/299 (37%), Gaps = 17/299 (5%)
Query: 207 GSIPQSLGNLSNLAMLNLSSNSLFGSIPSEL-GNLKYLSDLKLADNKLNGSIPHSLCNLT 265
S Q+ + + SS SL SIPS L +K L L++N++ L
Sbjct: 21 ESSNQASLSCDRNGICKGSSGSL-NSIPSGLTEAVKSLD---LSNNRITYISNSDLQRCV 76
Query: 266 NLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSL 325
NL L + +N ++ + +L L + LSYN S L LS++ FL L N
Sbjct: 77 NLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY 136
Query: 326 FGLIPSEL-RNLKSLSILELGNNKLCGSIPH-FLGNLTNLSVLFIYNNSLSGSIPCEI-G 382
L + L +L L IL +GN I LT L L I + L S +
Sbjct: 137 KTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLK 195
Query: 383 NLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKE--------YRNLVK 434
+++++S+L L + + I + +++ L L E
Sbjct: 196 SIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255
Query: 435 LTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLY 493
+ + D + L ++ L+ + RN L S F +L I L N
Sbjct: 256 FRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 58/287 (20%), Positives = 109/287 (37%), Gaps = 24/287 (8%)
Query: 256 SIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNI 315
SIP L + L + NN ++ + S++ L + L+ N + + S +L ++
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 316 AFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSL 373
L L N L L S + L SL+ L L N ++ +LT L +L + N
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY-KTLGETSLFSHLTKLQILRVGNMDT 161
Query: 374 SGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNL 432
I + L L L + + L S P SL ++ N+S L + +
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT 221
Query: 433 VKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNL 492
+ L L D + L++ + S + ++ +L
Sbjct: 222 SSVECLELRDTDLD---------------TFHFSELSTGETNSLIKKFTFRNVKITDESL 266
Query: 493 YGEISSDWGRCPKLGALDFSKNNITGNIPPKI-GYSSQLEVLDLSSN 538
+ ++ + L L+FS+N + ++P I + L+ + L +N
Sbjct: 267 F-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 51/252 (20%), Positives = 89/252 (35%), Gaps = 17/252 (6%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHL 120
+ + +L L L SN + I ++ L++LDLS N S + L
Sbjct: 66 YISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPL 123
Query: 121 SYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNY-LEDIIPHSLGNLTNLVTLCLYN 178
S L L+L N + L+ L L + + I LT L L +
Sbjct: 124 SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183
Query: 179 NLLSGSIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSL----FGSI 233
+ L S + +++ + L L+ + + + S++ L L L F +
Sbjct: 184 SDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242
Query: 234 PS----ELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLK 289
+ L ++K+ D L + L ++ L+ L N L + L
Sbjct: 243 STGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLT 301
Query: 290 FLSKIALSYNKF 301
L KI L N +
Sbjct: 302 SLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 51/261 (19%), Positives = 97/261 (37%), Gaps = 16/261 (6%)
Query: 435 LTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLY 493
+ L L +N+ + L+ +L + L N + + +SF +L +DLSYN L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL- 112
Query: 494 GEISSDW-GRCPKLGALDFSKNNITGNIPPKIGYS--SQLEVLDLSSNHVVGDIPAE-LG 549
+SS W L L+ N + +S ++L++L + + I +
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 550 KLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSN 609
L+FL +L + + L L + + HL L + + + L L +
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231
Query: 610 NQFSW----EIPI----KLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLS 661
E+ L + + ++ L + + + L +L S N L
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL-FQVMKLLNQISGLLELEFSRNQLK 290
Query: 662 GVIPRCFEEMHALQCIDISYN 682
V F+ + +LQ I + N
Sbjct: 291 SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 53/271 (19%), Positives = 91/271 (33%), Gaps = 16/271 (5%)
Query: 352 SIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNL 411
SIP G + L + NN ++ ++ +L L L N + + S S+L +L
Sbjct: 45 SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 412 SVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ--GPIPNLKNLTSLVRVHLDRNYLT 469
L N LS ++ L LT L L N ++ G +LT L + +
Sbjct: 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 470 SNISE-SFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKI-GYS 527
+ I F L +++ ++L + L + +
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVT 221
Query: 528 SQLEVLDLSSNHVVGDIPAEL--------GKLSFLIKLILAQNQLSGQLSPKLGLLVQLE 579
S +E L+L + +EL K + + L Q+ L + L
Sbjct: 222 SSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLL 280
Query: 580 HLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
L+ S N L + L L + L N
Sbjct: 281 ELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 51/281 (18%), Positives = 108/281 (38%), Gaps = 24/281 (8%)
Query: 313 SNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNS 372
+ L L +N + + S+L+ +L L L +N + +L +L L + N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 373 LSGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISL-SNLTNLSVLSFYKNSLSGAIPKE-Y 429
LS ++ L SL++LNL N + SL S+LT L +L I ++ +
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 430 RNLVKLTKLFLGDNQFQG-PIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLS 488
L L +L + + Q +LK++ ++ + L + + ++ ++L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230
Query: 489 YNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAEL 548
+L F + ++ + + ++ + + L
Sbjct: 231 DTDLDT----------------FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLL 273
Query: 549 GKLSFLIKLILAQNQLSGQLSPK-LGLLVQLEHLDLSSNNL 588
++S L++L ++NQL + L L+ + L +N
Sbjct: 274 NQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 39/152 (25%), Positives = 56/152 (36%), Gaps = 24/152 (15%)
Query: 573 GLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKL-EELIHLSELDL 631
GL ++ LDLS+N ++ L V L L L++N + I L L LDL
Sbjct: 49 GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDL 107
Query: 632 SYNFLGRAIPSQICI-MQSLEKLNLSHNSLSGVIPR-CFEEMHALQCIDISYNELRGPIP 689
SYN+L + S + SL LNL N + F + LQ + + + I
Sbjct: 108 SYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ 166
Query: 690 NSTAFRDAPIKALQGNKGLCGDFKGLPSCKAL 721
DF GL + L
Sbjct: 167 R-------------------KDFAGLTFLEEL 179
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-30
Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 38/275 (13%)
Query: 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
E +G+G G V+ +A+K PG M+ + FL E + + ++RH +V+
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQL 244
Query: 861 YGFCSHAQHSFIVYEYLEMGSLAMIL-SNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
Y S + +IV EY+ GSL L + L Q + + IA ++Y+ +
Sbjct: 245 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTM 976
VHRD+ + N+L+ +V+DFG+A+ ++ + +T G + APE A
Sbjct: 302 ---VHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYG 356
Query: 977 KVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP-----RLPIPS 1030
+ T K DV+SFG+L E+ KG+ P + E+LD R+P P
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCP- 403
Query: 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
E L ++ C + PE RPT + + L
Sbjct: 404 PECPESL---HDLMCQCWRKEPEERPTFEYLQAFL 435
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 10/206 (4%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+DF+ +G G G V+KV SG ++A K H L + + + + E++ L E
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 90
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
IV FYG I E+++ GSL +L A + V + L+YL
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYL 147
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
I+HRD+ N+L++ + E ++ DFG++ L DS + GT Y++PE
Sbjct: 148 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-FVGTRSYMSPERLQ 203
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHP 1000
+ + D++S G+ +E+ G++P
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 72/293 (24%), Positives = 126/293 (43%), Gaps = 52/293 (17%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVELASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKA 848
E+ R D +H +G G G VY+ + +AVK M +EFL E
Sbjct: 9 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTME-VEEFLKEAAV 62
Query: 849 LTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIA 908
+ EI+H N+V+ G C+ +I+ E++ G+L L + +++ + + I+
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQIS 121
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD----SSN------W 958
A+ YL F +HRD++++N L+ + +V+DFG+++ + D + W
Sbjct: 122 SAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 959 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIA 1017
T APE K + K DV++FGVL E+ G P I
Sbjct: 179 T---------APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP------------GID 217
Query: 1018 LDEILDP-----RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
L ++ + R+ P EK+ E+ +C +P RP+ ++ Q
Sbjct: 218 LSQVYELLEKDYRMERP-EGCPEKV---YELMRACWQWNPSDRPSFAEIHQAF 266
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-30
Identities = 66/274 (24%), Positives = 122/274 (44%), Gaps = 36/274 (13%)
Query: 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
E +G G G V+ +AVK PG M+ + FL E + ++H +VK
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMS-VEAFLAEANVMKTLQHDKLVKL 248
Query: 861 YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
+ + + +I+ E++ GSL L +D + + IA+ ++++ +
Sbjct: 249 HAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRNY- 305
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYV---APELAYTMK 977
+HRD+ + N+L+ +++DFG+A+ ++ + +T G + APE
Sbjct: 306 --IHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGS 361
Query: 978 VTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP-----RLPIPSH 1031
T K DV+SFG+L +E++ G+ P +S E++ R+P P
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSN------------PEVIRALERGYRMPRP-E 408
Query: 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
N E+L + + C PE RPT + + +L
Sbjct: 409 NCPEELY---NIMMRCWKNRPEERPTFEYIQSVL 439
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 52/292 (17%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 849
EI D +G G G V + +A+K G M+ + EF+ E K +
Sbjct: 20 EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMS-EDEFIEEAKVM 73
Query: 850 TEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIAD 909
+ H +V+ YG C+ + FI+ EY+ G L L + Q + + K + +
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCE 131
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD----SSN------WT 959
A+ YL + F +HRD++++N L++ + +VSDFG+++++ D S W+
Sbjct: 132 AMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIAL 1018
PE+ K + K D+++FGVL E+ GK P +
Sbjct: 189 ---------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE------------RFTN 227
Query: 1019 DEILDP-----RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
E + RL P H EK+ + SC E + RPT + + +
Sbjct: 228 SETAEHIAQGLRLYRP-HLASEKV---YTIMYSCWHEKADERPTFKILLSNI 275
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 66/282 (23%), Positives = 117/282 (41%), Gaps = 42/282 (14%)
Query: 803 CIGKGGQGSVYKVELASGEIIAVKKFH-SPLPGEMTFQQEFLNEVKALTEIRHRN--IVK 859
IG GG V++V +I A+K + + + NE+ L +++ + I++
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT--LDSYRNEIAYLNKLQQHSDKIIR 92
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
Y + Q+ ++V E L L + ++ +R S K + +A+ +H
Sbjct: 93 LYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG- 147
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW--TELAGTYGYVAPEL----- 972
IVH D+ N L+ ++ DFGIA ++PD+++ GT Y+ PE
Sbjct: 148 --IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 973 ------AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL 1026
K++ K DV+S G + + GK P F +N L I+DP
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISKLHAIIDPNH 257
Query: 1027 PI--PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
I P ++ L ++ CL P+ R ++ +LL
Sbjct: 258 EIEFPDI-PEKDLQDVLK---CCLKRDPKQRISIP---ELLA 292
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 65/287 (22%), Positives = 124/287 (43%), Gaps = 43/287 (14%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVK-ALTEIR 853
+D + +G+G G V K+ + SG+I+AVK+ Q+ L ++ ++ +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISMRTVD 64
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS--VIKGIA--- 908
V FYG +I E ++ SL + ++ Q + ++ IA
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDKFY-----KQVIDKGQTIPEDILGKIAVSI 118
Query: 909 -DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGY 967
AL +LH+ ++HRD+ NVL++ + ++ DFGI+ +L D AG Y
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPY 175
Query: 968 VAPE--------LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALD 1019
+APE Y++ K D++S G+ +E+ + P + S + + +
Sbjct: 176 MAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP--YDSWGTPFQQLKQVVEE 229
Query: 1020 EILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
P+L P+ + + F CL ++ + RPT +L++
Sbjct: 230 P--SPQL--PADKFSAEFVDFTS---QCLKKNSKERPT---YPELMQ 266
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 36/274 (13%)
Query: 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
E +G+G G V+ +A+K PG M+ + FL E + + ++RH +V+
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMS-PEAFLQEAQVMKKLRHEKLVQL 327
Query: 861 YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
Y S + +IV EY+ GSL L + + L Q + + IA ++Y+ +
Sbjct: 328 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY- 384
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMK 977
VHRD+ + N+L+ +V+DFG+A+ ++ + +T G + APE A +
Sbjct: 385 --VHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGR 440
Query: 978 VTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP-----RLPIPSH 1031
T K DV+SFG+L E+ KG+ P + E+LD R+P P
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVP------------YPGMVNREVLDQVERGYRMPCP-P 487
Query: 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
E L ++ C + PE RPT + + L
Sbjct: 488 ECPESL---HDLMCQCWRKEPEERPTFEYLQAFL 518
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 63/281 (22%), Positives = 114/281 (40%), Gaps = 40/281 (14%)
Query: 803 CIGKGGQGSVYKVELASGEIIAVK--KFHSPLPGEMTFQQEFLNEVKALTEIRH--RNIV 858
IG GG V++V +I A+K + + NE+ L +++ I+
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKII 72
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
+ Y + Q+ ++V E L L + ++ +R S K + +A+ +H
Sbjct: 73 RLYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW--TELAGTYGYVAPEL---- 972
IVH D+ N L+ ++ DFGIA ++PD+++ GT Y+ PE
Sbjct: 129 ---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 973 -------AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPR 1025
K++ K DV+S G + + GK P F +I+ S I +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQISKLHAIIDP---NHE 239
Query: 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ P ++ L ++ CL P+ R ++ +LL
Sbjct: 240 IEFPDI-PEKDLQDVLK---CCLKRDPKQRISIP---ELLA 273
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 63/271 (23%), Positives = 111/271 (40%), Gaps = 25/271 (9%)
Query: 797 DFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+ +GKGG +++ + + E+ A K L + +++ E+ + H+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLA-MILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
++V F+GF F+V E SL + A E + ++ I YL
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE--ARYY--LRQIVLGCQYL 131
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
H + ++HRD+ N+ L+ E ++ DFG+A ++ D L GT Y+APE+
Sbjct: 132 HRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 188
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH--N 1032
+ + DV+S G + ++ GK P + + L I IP H
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSCLKETYLRIKKNEYSIPKHINP 240
Query: 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063
V LI L P +RPT+ ++
Sbjct: 241 VAASLIQ------KMLQTDPTARPTINELLN 265
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 4e-29
Identities = 55/322 (17%), Positives = 105/322 (32%), Gaps = 62/322 (19%)
Query: 795 TNDFDDEHCIGKGGQ--GSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFL-NEVKALT 850
++ IGKG + +V +GE + V++ L FL E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSK 81
Query: 851 EIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADA 910
H NIV + ++V ++ GS ++ + + +++G+ A
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVLKA 140
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL-------KPDSSNWTELAG 963
L Y+H+ VHR + + ++L+ + +S + +
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 964 TYGYVAPELAYTMKV--TEKCDVYSFGVLALEVIKGK------HP--------------- 1000
+++PE+ K D+YS G+ A E+ G
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257
Query: 1001 ------------GDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKL----ISFVEVA 1044
+++S L+ ++ PSH FVE
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE-- 315
Query: 1045 ISCLDESPESRPTMQKVSQLLK 1066
CL +P++RP+ S LL
Sbjct: 316 -QCLQRNPDARPS---ASTLLN 333
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 65/311 (20%), Positives = 120/311 (38%), Gaps = 27/311 (8%)
Query: 757 QRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKV- 815
K+ + P +++ + R+ + +GKGG +++
Sbjct: 4 PADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDP--RSRRRYVRGRFLGKGGFAKCFEIS 61
Query: 816 ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875
+ + E+ A K L + +++ E+ + H+++V F+GF F+V E
Sbjct: 62 DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121
Query: 876 YLEMGSLA-MILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLL 934
SL + A E + ++ I YLH + ++HRD+ N+ L
Sbjct: 122 LCRRRSLLELHKRRKALTEPE--ARYY--LRQIVLGCQYLHRNR---VIHRDLKLGNLFL 174
Query: 935 DFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 994
+ E ++ DFG+A ++ D L GT Y+APE+ + + DV+S G + +
Sbjct: 175 NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 234
Query: 995 IKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQE--KLISFVEVAISCLDESP 1052
+ GK P + + L I IP H LI L P
Sbjct: 235 LVGKPPFE--------TSCLKETYLRIKKNEYSIPKHINPVAASLIQ------KMLQTDP 280
Query: 1053 ESRPTMQKVSQ 1063
+RPT+ ++
Sbjct: 281 TARPTINELLN 291
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 37/275 (13%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
DF+ +GKG G+VY E S I+A+K + + + EV+ + +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSL------AMILSNDAAAEDLEWTQRMSVIKGIA 908
NI++ YG+ A +++ EY +G++ A + I +A
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA---------TYITELA 119
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYV 968
+ALSY H+ ++HRDI +N+LL E +++DFG + P S L GT Y+
Sbjct: 120 NALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTD-LCGTLDYL 174
Query: 969 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028
PE+ EK D++S GVL E + GK P + + I
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE--------ANTYQETYKRISRVEFTF 226
Query: 1029 PSHNVQE--KLISFVEVAISCLDESPESRPTMQKV 1061
P + LIS L +P RP +++V
Sbjct: 227 PDFVTEGARDLIS------RLLKHNPSQRPMLREV 255
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-29
Identities = 68/325 (20%), Positives = 124/325 (38%), Gaps = 46/325 (14%)
Query: 760 KNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELAS 819
K + Q S T + + + + + IG GG V++V
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSSANECISVKG----RIYSILKQIGSGGSSKVFQVLNEK 79
Query: 820 GEIIAVK--KFHSPLPGEMTFQQEFLNEVKALTEIRH--RNIVKFYGFCSHAQHSFIVYE 875
+I A+K + + NE+ L +++ I++ Y + Q+ ++V E
Sbjct: 80 KQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136
Query: 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD 935
L L + ++ +R S K + +A+ +H IVH D+ N L+
Sbjct: 137 CGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV 189
Query: 936 FKNEARVSDFGIAKFLKPDSSNWTE--LAGTYGYVAPEL-----------AYTMKVTEKC 982
++ DFGIA ++PD+++ + G Y+ PE K++ K
Sbjct: 190 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 983 DVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP-SHNVQEKLISFV 1041
DV+S G + + GK P F +N L I+DP I ++ L +
Sbjct: 249 DVWSLGCILYYMTYGKTP--F-----QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVL 301
Query: 1042 EVAISCLDESPESRPTMQKVSQLLK 1066
+ CL P+ R ++ +LL
Sbjct: 302 K---CCLKRDPKQRISIP---ELLA 320
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYK---VELASGEI-IAVKKFHSPLPGEMTFQQ-EFLN 844
EI + E IG G G V ++ +A+K G Q+ +FL+
Sbjct: 45 EIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLS 99
Query: 845 EVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVI 904
E + + H NI++ G + + + IV EY+E GSL L Q + ++
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGML 157
Query: 905 KGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN------- 957
+G+ + YL + + VHRD++++NVL+D +VSDFG+++ L+ D
Sbjct: 158 RGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG 214
Query: 958 -----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP 1000
WT APE + DV+SFGV+ EV+ G+ P
Sbjct: 215 KIPIRWT---------APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 73/279 (26%), Positives = 113/279 (40%), Gaps = 48/279 (17%)
Query: 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
IGKG G V + G +AVK Q FL E +T++RH N+V+
Sbjct: 26 LQTIGKGEFGDVMLGD-YRGNKVAVKCIK---NDAT--AQAFLAEASVMTQLRHSNLVQL 79
Query: 861 YGFCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
G + +IV EY+ GSL L + L + + +A+ YL + F
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF 138
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN------WTELAGTYGYVAPELA 973
VHRD++++NVL+ N A+VSDFG+ K WT APE
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEAL 186
Query: 974 YTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP-----RLP 1027
K + K DV+SFG+L E+ G+ P I L +++ ++
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------------LKDVVPRVEKGYKMD 234
Query: 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
P + EV +C RP+ ++ + L+
Sbjct: 235 AP-DGCPPAV---YEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 31/267 (11%), Positives = 67/267 (25%), Gaps = 41/267 (15%)
Query: 801 EHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
G ++ ++ A +A+ QE L+ L+ I + +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
+V E++ GSL + A + ++ +A A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQ-----EVADTSPSPVGAIRAMQSLAAAADAAHRA-- 148
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVT 979
+ V VS G +
Sbjct: 149 -GVALSIDHPSRVR--------VSIDGDVV------------LAYPATMPD-------AN 180
Query: 980 EKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLIS 1039
+ D+ G ++ + P + S L A + + P+ ++
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSG----LAPAERD-TAGQPIEPADIDRDIPFQ 235
Query: 1040 FVEVAISCLDESPESRPTMQKVSQLLK 1066
VA + R ++ + +
Sbjct: 236 ISAVAARSVQGDGGIRSASTLLNLMQQ 262
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 8e-29
Identities = 36/297 (12%), Positives = 84/297 (28%), Gaps = 60/297 (20%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR--------- 853
+G+ + + +GE V + ++ EV L +R
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 854 -------------HRNIVKFYGFCSHAQHSFIVYEYLEM----GSLAM----ILSNDAAA 892
K + +++ + +L +LS+ +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 893 EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952
+ L R+ + + L+ LH+ +VH + +++LD + ++ F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 260
Query: 953 PDSSNWTELAGTYG---YVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPGDFI 1004
+S + + + A + +T D ++ G+ + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--N- 317
Query: 1005 SLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+ + I IP V+ L+ L E R +
Sbjct: 318 -----TDDAALGGSEWIFRSCKNIPQ-PVRA-LLE------GFLRYPKEDRLLPLQA 361
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 65/281 (23%), Positives = 120/281 (42%), Gaps = 50/281 (17%)
Query: 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
+G G G V+ +AVK G M+ FL E + +++H+ +V+
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMS-PDAFLAEANLMKQLQHQRLVRL 73
Query: 861 YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
Y + + +I+ EY+E GSL L + + L + + + IA+ ++++ +
Sbjct: 74 YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY- 130
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD----SSN------WTELAGTYGYVAP 970
+HRD+ + N+L+ +++DFG+A+ ++ + WT AP
Sbjct: 131 --IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT---------AP 179
Query: 971 ELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP----- 1024
E T K DV+SFG+L E++ G+ P ++ E++
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------------NPEVIQNLERGY 227
Query: 1025 RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
R+ P N E+L ++ C E PE RPT + +L
Sbjct: 228 RMVRP-DNCPEEL---YQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 73/279 (26%), Positives = 113/279 (40%), Gaps = 48/279 (17%)
Query: 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
IGKG G V + G +AVK Q FL E +T++RH N+V+
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK---NDAT--AQAFLAEASVMTQLRHSNLVQL 251
Query: 861 YGFCSHAQHSF-IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
G + IV EY+ GSL L + L + + +A+ YL + F
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNF 310
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN------WTELAGTYGYVAPELA 973
VHRD++++NVL+ N A+VSDFG+ K WT APE
Sbjct: 311 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEAL 358
Query: 974 YTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP-----RLP 1027
K + K DV+SFG+L E+ G+ P I L +++ ++
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYP------------RIPLKDVVPRVEKGYKMD 406
Query: 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
P + +V +C +RPT ++ + L+
Sbjct: 407 AP-DGCPPAVY---DVMKNCWHLDAATRPTFLQLREQLE 441
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 66/290 (22%), Positives = 115/290 (39%), Gaps = 49/290 (16%)
Query: 804 IGKGGQGSVYKVEL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 858
+GKG GSV +GE++AVKK ++F E++ L ++H NIV
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 859 KFYGFCSHAQHS--FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
K+ G C A ++ EYL GSL L E ++ + + I + YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT 132
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN------------WTELAGT 964
+ +HRD++++N+L++ +N ++ DFG+ K L D W
Sbjct: 133 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----- 184
Query: 965 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL----NIALDE 1020
APE K + DV+SFGV+ E+ + + +
Sbjct: 185 ----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240
Query: 1021 ILDP-----RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+++ RLP P E + C + + RP+ + ++ +
Sbjct: 241 LIELLKNNGRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 60/289 (20%), Positives = 105/289 (36%), Gaps = 42/289 (14%)
Query: 801 EHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIV 858
+ +GG VY+ + + SG A+K+ S E + + EV + ++ H NIV
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 859 KFYGFCSHAQHS-------FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADAL 911
+F S + F++ L G L L + L + + A+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA--------- 962
++H PPI+HRD+ +N+LL + ++ DFG A +
Sbjct: 150 QHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 963 ---GTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNI 1016
T Y PE+ + EK D+++ G + + +HP + L I
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE-------DGAKLRI 261
Query: 1017 ALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+ P LI + L +PE R ++ +V L
Sbjct: 262 VNGKYSIPPHDTQYTVFH-SLIR------AMLQVNPEERLSIAEVVHQL 303
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 45/237 (18%), Positives = 90/237 (37%), Gaps = 42/237 (17%)
Query: 787 VYEEIIRATNDFDDEHCIGKGGQGSVYK-------VELASGEI-IAVKKFHSPLPGEMTF 838
V+ +I D +G+G ++K E + +K +
Sbjct: 1 VFHKIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KAHRNY 55
Query: 839 QQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWT 898
+ F ++++ H+++V YG C + +V E+++ GSL L + +
Sbjct: 56 SESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINIL 113
Query: 899 QRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEAR--------VSDFGIAKF 950
++ V K +A A+ +L + +H ++ +KN+LL + + + +SD GI+
Sbjct: 114 WKLEVAKQLAAAMHFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
Query: 951 LKPDSS-----NWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHP 1000
+ P W PE + + D +SFG E+ G P
Sbjct: 171 VLPKDILQERIPWV---------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 70/292 (23%), Positives = 111/292 (38%), Gaps = 48/292 (16%)
Query: 801 EHCIGKGGQGSVYKVEL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+GKG GSV +G ++AVK+ Q++F E++ L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSD 84
Query: 856 NIVKFYGFCSHAQHS--FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
IVK+ G +V EYL G L L A L+ ++ + I + Y
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEY 142
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS------------NWTEL 961
L + VHRD++++N+L++ + +++DFG+AK L D W
Sbjct: 143 LGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-- 197
Query: 962 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP--GDFISLISSSSLNLNIAL 1018
APE + + DV+SFGV+ E+ L AL
Sbjct: 198 -------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 1019 DEILDP-----RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+L+ RLP P E E+ C SP+ RP+ + L
Sbjct: 251 SRLLELLEEGQRLPAPPACPAE----VHELMKLCWAPSPQDRPSFSALGPQL 298
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 66/293 (22%), Positives = 115/293 (39%), Gaps = 49/293 (16%)
Query: 801 EHCIGKGGQGSVYKVEL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+GKG GSV +GE++AVKK ++F E++ L ++H
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHD 102
Query: 856 NIVKFYGFCSHAQHS--FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
NIVK+ G C A ++ EYL GSL L E ++ + + I + Y
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEY 160
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN------------WTEL 961
L + +HRD++++N+L++ +N ++ DFG+ K L D W
Sbjct: 161 LGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-- 215
Query: 962 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL----NIA 1017
APE K + DV+SFGV+ E+ + +
Sbjct: 216 -------APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 1018 LDEILDP-----RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+ +++ RLP P E + C + + RP+ + ++ +
Sbjct: 269 VFHLIELLKNNGRLPRPDGCPDE----IYMIMTECWNNNVNQRPSFRDLALRV 317
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 28/272 (10%)
Query: 804 IGKGGQGSVYKVEL--ASGEII--AVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
+G G G V + E SG+ + AVK + + +F+ EV A+ + HRN+++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF 919
YG +V E +GSL L L R +V +A+ + YL + F
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 142
Query: 920 PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTM 976
+HRD++++N+LL ++ ++ DFG+ + L + ++ + + APE T
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 977 KVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP--RLPIPSHNV 1033
+ D + FGV E+ G+ P LN + L +I RLP P
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWI--------GLNGSQILHKIDKEGERLPRP---- 247
Query: 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
++ V + C PE RPT + L
Sbjct: 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 64/292 (21%), Positives = 117/292 (40%), Gaps = 47/292 (16%)
Query: 801 EHCIGKGGQGSVYKVELA-----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+G+G G V +GE +AVK P G + E++ L + H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNH-IADLKKEIEILRNLYHE 83
Query: 856 NIVKFYGFCSHAQHS--FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
NIVK+ G C+ + ++ E+L GSL L + + Q++ I + Y
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDY 141
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN------------WTEL 961
L + + VHRD++++NVL++ +++ ++ DFG+ K ++ D W
Sbjct: 142 LGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-- 196
Query: 962 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNL--NIAL 1018
APE K DV+SFGV E++ ++L + +
Sbjct: 197 -------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249
Query: 1019 DEILDP-----RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+++ RLP P + E ++ C + P +R + Q + +
Sbjct: 250 TRLVNTLKEGKRLPCPPNCPDE----VYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 63/288 (21%), Positives = 109/288 (37%), Gaps = 56/288 (19%)
Query: 801 EHCIGKGGQGSVYKVEL--ASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
+ +G G GSV + +I +A+K +E + E + + ++ + I
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYI 72
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
V+ G C +V E G L L E++ + ++ ++ + YL
Sbjct: 73 VRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN------------WTELAGTY 965
F VHRD++++NVLL ++ A++SDFG++K L D S W
Sbjct: 130 NF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY------ 180
Query: 966 GYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP------GDFISLISSSSLNLNIAL 1018
APE K + + DV+S+GV E + G+ P + ++ I
Sbjct: 181 ---APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--------- 228
Query: 1019 DEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
R+ P E + C E RP V Q ++
Sbjct: 229 ----GKRMECPPECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 59/277 (21%), Positives = 103/277 (37%), Gaps = 57/277 (20%)
Query: 804 IGKGGQGSVYK----VELASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIRHRNI 857
+G G G+VYK E +I +A+K+ +E L+E + + + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
+ G C ++ + + G L + +++ ++ IA ++YL +
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS-----------NWTELAGTYG 966
VHRD++++NVL+ +++DFG+AK L + W
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------- 186
Query: 967 YVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP- 1024
A E T + DV+S+GV E++ G P D I EI
Sbjct: 187 --ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD------------GIPASEISSIL 232
Query: 1025 ----RLPIPSHNVQEKLISFVEVAISCLDESPESRPT 1057
RLP P I + C +SRP
Sbjct: 233 EKGERLPQP----PICTIDVYMIMRKCWMIDADSRPK 265
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 66/286 (23%), Positives = 112/286 (39%), Gaps = 58/286 (20%)
Query: 804 IGKGGQGSVYK--VELASGEI-IAVKKFHSPLPGEM--TFQQEFLNEVKALTEIRHRNIV 858
+G G G+V K ++ +AVK + E L E + ++ + IV
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILK---NEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
+ G C +V E E+G L L + ++ + ++ ++ + YL
Sbjct: 82 RMIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN------------WTELAGTYG 966
F VHRD++++NVLL ++ A++SDFG++K L+ D + W
Sbjct: 138 F---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY------- 187
Query: 967 YVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP- 1024
APE K + K DV+SFGVL E G+ P + E+
Sbjct: 188 --APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR------------GMKGSEVTAML 233
Query: 1025 ----RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
R+ P+ +E ++ C E+RP V L+
Sbjct: 234 EKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 53/236 (22%), Positives = 92/236 (38%), Gaps = 11/236 (4%)
Query: 262 CNLTNLVILYIYNNSLSGLIPSEI-GNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFL 320
C V L +P I + + L N+ S + S N+ L+L
Sbjct: 8 CYNEPKVTTSCPQQGLQA-VPVGIPAASQRIF---LHGNRISHVPAASFRACRNLTILWL 63
Query: 321 DSNSLFGLIPSELRNLKSLSILELGNNKLCGSIP-HFLGNLTNLSVLFIYNNSLSGSIPC 379
SN L + + L L L+L +N S+ L L L + L +
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP 122
Query: 380 EI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKL 438
+ L +L YL L N L + + +L NL+ L + N +S + +R L L +L
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 439 FLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNL 492
L N+ + ++L L+ ++L N L++ +E+ L ++ L+ N
Sbjct: 183 LLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 7/216 (3%)
Query: 161 IPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLA 220
+P + + L+ N +S + + L L L++N L + L+ L
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 221 MLNLSSNSLFGSIPSE-LGNLKYLSDLKLADNKLNGSIPH-SLCNLTNLVILYIYNNSLS 278
L+LS N+ S+ L L L L L + L L LY+ +N+L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
Query: 279 GLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKS 338
L +L L+ + L N+ S + + L ++ L L N + + P R+L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 339 LSILELGNNKLCGSIPH-FLGNLTNLSVLFIYNNSL 373
L L L N L ++P L L L L + +N
Sbjct: 203 LMTLYLFANNL-SALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 60/194 (30%), Positives = 91/194 (46%), Gaps = 9/194 (4%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHL 120
+ SF + +L L L SN L I ++ L+ LDLS N ++ P L
Sbjct: 46 HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGL 104
Query: 121 SYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
L TLHL + L + + GL++L L L N L+ + + +L NL L L+ N
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163
Query: 180 LLSGSIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSE-L 237
+S S+P L L L L+ N + P + +L L L L +N+L ++P+E L
Sbjct: 164 RIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL-SALPTEAL 221
Query: 238 GNLKYLSDLKLADN 251
L+ L L+L DN
Sbjct: 222 APLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 52/217 (23%), Positives = 88/217 (40%), Gaps = 7/217 (3%)
Query: 112 AIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNL 171
A+P I + + + L N++S +L L L+SN L I + L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 172 VTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNELNGSIPQ-SLGNLSNLAMLNLSSNSL 229
L L +N S+ L L L+L L + L+ L L L N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 230 FGSIPSE-LGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNL 288
++P + +L L+ L L N+++ + L +L L ++ N ++ + P +L
Sbjct: 142 -QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 289 KFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSL 325
L + L N S L +L L + +L L+ N
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 59/217 (27%), Positives = 86/217 (39%), Gaps = 15/217 (6%)
Query: 88 NIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEV-GGLSS 146
IP + + L N S L L L N L+ I GL+
Sbjct: 29 GIPAA------SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81
Query: 147 LNNLALYSNY-LEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNE 204
L L L N L + P + L L TL L L + + L L L L +N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 205 LNGSIP-QSLGNLSNLAMLNLSSNSLFGSIPSE-LGNLKYLSDLKLADNKLNGSIPHSLC 262
L ++P + +L NL L L N + S+P L L L L N++ PH+
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 263 NLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYN 299
+L L+ LY++ N+LS L + L+ L + L+ N
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 44/216 (20%), Positives = 93/216 (43%), Gaps = 10/216 (4%)
Query: 256 SIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNI 315
++P + ++++ N +S + + + L+ + L N + + + L+ +
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 316 AFLFLDSNSLFGLIPSE-LRNLKSLSILELGNNKLCGSIPH-FLGNLTNLSVLFIYNNSL 373
L L N+ + L L L L L + L L L++ +N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNAL 141
Query: 374 SGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNL 432
++P + +L +L++L L N+++S + L +L L ++N ++ P +R+L
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 433 VKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRN 466
+L L+L N +P L L +L + L+ N
Sbjct: 201 GRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 10/234 (4%)
Query: 217 SNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNS 276
+ L ++P + + L N+++ S NL IL++++N
Sbjct: 11 EPKVTTSCPQQGL-QAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 277 LSGLIPSEIGNLKFLSKIALSYN-KFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRN 335
L+ + + L L ++ LS N + + P + L + L LD L L P R
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 336 LKSLSILELGNNKLCGSIP-HFLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLA 393
L +L L L +N L ++P +L NL+ LF++ N +S S+P L SL L L
Sbjct: 128 LAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLH 185
Query: 394 FNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKE-YRNLVKLTKLFLGDNQFQ 446
N++ P + +L L L + N+LS A+P E L L L L DN +
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 46/217 (21%), Positives = 83/217 (38%), Gaps = 7/217 (3%)
Query: 208 SIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNL 267
++P + + + L N + + + L+ L L N L + L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 268 VILYIYNNSLSGLIPSEI-GNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLF 326
L + +N+ + L L + L L P L+ + +L+L N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 327 GLIPSELRNLKSLSILELGNNKLCGSIPHF-LGNLTNLSVLFIYNNSLSGSIPCEI-GNL 384
L R+L +L+ L L N++ S+P L +L L ++ N ++ + +L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDL 200
Query: 385 KSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL 421
L L L N L++ +L+ L L L N
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 50/209 (23%), Positives = 76/209 (36%), Gaps = 7/209 (3%)
Query: 478 IYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYS-SQLEVLDLS 536
I I L N + ++ + C L L N + I + LE LDLS
Sbjct: 30 IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLS 88
Query: 537 SNHVVGDIPAE-LGKLSFLIKLILAQNQLSGQLSPK-LGLLVQLEHLDLSSNNLSNAIPE 594
N + + L L L L + L +L P L L++L L N L +
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 595 SLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQI-CIMQSLEKL 653
+ +L L +L L N+ S L L L L N + + + L L
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV-AHVHPHAFRDLGRLMTL 206
Query: 654 NLSHNSLSGVIPRCFEEMHALQCIDISYN 682
L N+LS + + ALQ + ++ N
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 53/210 (25%), Positives = 81/210 (38%), Gaps = 9/210 (4%)
Query: 456 TSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDW-GRCPKLGALDFSKN 514
+ R+ L N ++ + SF NLT + L N L I + L LD S N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDN 90
Query: 515 NITGNIPPKI-GYSSQLEVLDLSSNHVVGDIPAE-LGKLSFLIKLILAQNQLSGQLSPK- 571
++ P +L L L + ++ L+ L L L N L L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148
Query: 572 LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDL 631
L L HL L N +S+ + L L L L N+ + P +L L L L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 632 SYNFLGRAIPSQI-CIMQSLEKLNLSHNSL 660
N L A+P++ +++L+ L L+ N
Sbjct: 209 FANNL-SALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 46/182 (25%), Positives = 75/182 (41%), Gaps = 9/182 (4%)
Query: 509 LDFSKNNITGNIPPKI-GYSSQLEVLDLSSNHVVGDIPAE-LGKLSFLIKLILAQNQLSG 566
+ N I+ ++P L +L L SN + I A L+ L +L L+ N
Sbjct: 37 IFLHGNRIS-HVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 567 QLSPK-LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIK-LEELI 624
+ P L +L L L L P L L YL L +N +P +L
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLG 153
Query: 625 HLSELDLSYNFLGRAIPSQI-CIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNE 683
+L+ L L N + ++P + + SL++L L N ++ V P F ++ L + + N
Sbjct: 154 NLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 684 LR 685
L
Sbjct: 213 LS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 28/114 (24%), Positives = 45/114 (39%), Gaps = 1/114 (0%)
Query: 573 GLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLS 632
G+ + + L N +S+ S L L L +N + L L +LDLS
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 633 YNFLGRAIPSQI-CIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
N R++ + L L+L L + P F + ALQ + + N L+
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 47/304 (15%), Positives = 103/304 (33%), Gaps = 32/304 (10%)
Query: 776 LRSMLTFEGKIVYEEIIRATNDFDDE-HCIGKGGQGSVYKVELASGEIIAVKKFHSPLPG 834
L + K++ E A + + K + EI +
Sbjct: 41 LPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLS 100
Query: 835 EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAED 894
+ +++ + +N V S + +I + +L ++ + ED
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 895 LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954
E + + IA+A+ +LH+ ++HRD+ N+ + +V DFG+ + D
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 955 SS------------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGD 1002
T GT Y++PE + + K D++S G++ E++
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277
Query: 1003 FISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVS 1062
+ ++ + + P+ + V+ L SP RP +
Sbjct: 278 ----------ERVRIITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPE---AT 321
Query: 1063 QLLK 1066
+++
Sbjct: 322 DIIE 325
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 69/334 (20%), Positives = 117/334 (35%), Gaps = 66/334 (19%)
Query: 757 QRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDD----EHCIGKGGQGSV 812
+ S + + M + + + +G G G V
Sbjct: 3 HHHHHSSGRENLYFQGIAINPGMY----------VRKKEGKIGESYFKVRKLGSGAYGEV 52
Query: 813 YKV-ELASGEIIAVK----------KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 861
E A+K ++ F +E NE+ L + H NI+K +
Sbjct: 53 LLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112
Query: 862 GFCSHAQHSFIVYEYLEMGSL------AMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
++ ++V E+ E G L AA ++K I + YLH
Sbjct: 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN---------IMKQILSGICYLH 163
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
IVHRDI +N+LL+ KN ++ DFG++ F D + GT Y+APE
Sbjct: 164 KHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRLGTAYYIAPE- 218
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGKHP--GDFISLISSSSLNLNIALDEILDPRLPIPS 1030
K EKCDV+S GV+ ++ G P G N + ++ +
Sbjct: 219 VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQ----------NDQDIIKKVEKGKYYFDF 268
Query: 1031 H---NVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+ N+ ++ ++ L R T ++
Sbjct: 269 NDWKNISDEAKELIK---LMLTYDYNKRCTAEEA 299
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 38/230 (16%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYK----VELASGEI-IAVKKFHSPLPGEMTFQQ-EFL 843
EI + + IG G G VYK E+ +A+K G Q+ +FL
Sbjct: 40 EIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFL 94
Query: 844 NEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSV 903
E + + H NI++ G S + I+ EY+E G+L L + Q + +
Sbjct: 95 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGM 152
Query: 904 IKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN------ 957
++GIA + YL N + VHRD++++N+L++ +VSDFG+++ L+ D
Sbjct: 153 LRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 209
Query: 958 ------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP 1000
WT APE K T DV+SFG++ EV+ G+ P
Sbjct: 210 GKIPIRWT---------APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 61/248 (24%), Positives = 101/248 (40%), Gaps = 27/248 (10%)
Query: 764 QTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKV-ELASGEI 822
S N + G + + + + +G G G V + +
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 823 IAVKKFH-SPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGS 881
A+K + + + L EV L + H NI+K Y F ++ ++V E + G
Sbjct: 65 RAIKIIRKTSVSTSS--NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 882 L------AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD 935
L M + AA +IK + ++YLH IVHRD+ +N+LL+
Sbjct: 123 LFDEIIHRMKFNEVDAAV---------IIKQVLSGVTYLHKHN---IVHRDLKPENLLLE 170
Query: 936 FKNEA---RVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLAL 992
K + ++ DFG++ + E GT Y+APE+ K EKCDV+S GV+
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKK-MKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILF 228
Query: 993 EVIKGKHP 1000
++ G P
Sbjct: 229 ILLAGYPP 236
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 35/218 (16%)
Query: 801 EHCIGKGGQGSVYKVEL---ASGEI-IAVKKFHSPLPGEMTFQQ-EFLNEVKALTEIRHR 855
+ +G G G V L + EI +A+K G Q+ +FL E + + H
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHP 106
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
NI++ G + ++ IV EY+E GSL L A Q + +++GIA + YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLS 164
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN------------WTELAG 963
+ + VHRD++++N+L++ +VSDFG+ + L+ D WT
Sbjct: 165 DMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT---- 217
Query: 964 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP 1000
+PE K T DV+S+G++ EV+ G+ P
Sbjct: 218 -----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 49/313 (15%), Positives = 92/313 (29%), Gaps = 52/313 (16%)
Query: 789 EEIIRATNDFDDEHCIGKGGQGSVYKVE------LASGEIIAVKKFHSPLPGEMTFQQEF 842
E + H +G+G VY+ + + +K P E
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---YIG 114
Query: 843 LNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL--AMILSNDAAAEDLEWTQR 900
++ L +KFY S +V E G+L A+ L + + +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 901 MSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA-----------RVSDFGIAK 949
+S + + +H+ I+H DI N +L + D G +
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 950 FLK--PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP------- 1000
+K P + +T T G+ E+ + D + ++ G +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291
Query: 1001 -------------GDFISLISSSSLNLN-----IALDEILDPRLPIPSHNVQEKLISFVE 1042
D + LN+ +LD + + + K+ +
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRN 351
Query: 1043 VAISCLDESPESR 1055
I L E SR
Sbjct: 352 RLIVLLLECKRSR 364
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 66/272 (24%), Positives = 117/272 (43%), Gaps = 24/272 (8%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKK-FHSPLPGEMTFQQEFLNEVKALTEIR 853
DF + +GKG VY+ + +G +A+K + Q+ NEVK +++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLK 69
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
H +I++ Y + + + ++V E G + L N E R + I + Y
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEAR-HFMHQIITGMLY 127
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
LH+ I+HRD++ N+LL +++DFG+A LK L GT Y++PE+A
Sbjct: 128 LHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033
+ DV+S G + ++ G+ P D + + L++++ +PS
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFD--------TDTVKNTLNKVVLADYEMPSFLS 236
Query: 1034 QE--KLISFVEVAISCLDESPESRPTMQKVSQ 1063
E LI L +P R ++ V
Sbjct: 237 IEAKDLIH------QLLRRNPADRLSLSSVLD 262
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 66/290 (22%), Positives = 112/290 (38%), Gaps = 49/290 (16%)
Query: 804 IGKGGQGSVYKVEL-----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIV 858
+G+G G V +GE++AVK G + + E+ L + H +I+
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQH-RSGWKQEIDILRTLYHEHII 96
Query: 859 KFYGFCSHAQHS--FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
K+ G C A + +V EY+ +GSL L + Q + + I + ++YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA 152
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN------------WTELAGT 964
+ +HRD++++NVLLD ++ DFG+AK + W
Sbjct: 153 QHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----- 204
Query: 965 YGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLN--LNIALDEI 1021
APE K DV+SFGV E++ + + + +
Sbjct: 205 ----APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260
Query: 1022 LDP-----RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ RLP P E + +C + RPT + + +LK
Sbjct: 261 TELLERGERLPRPDKCPAE----VYHLMKNCWETEASFRPTFENLIPILK 306
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-27
Identities = 67/329 (20%), Positives = 128/329 (38%), Gaps = 37/329 (11%)
Query: 751 GLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEI-IRATNDFDDEHCIGKGGQ 809
+ R + P +T S + ++ +++ ++ N + +G G
Sbjct: 290 DGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNF 349
Query: 810 GSVYKVEL--ASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH 866
GSV + +I +A+K +E + E + + ++ + IV+ G C
Sbjct: 350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--TEEMMREAQIMHQLDNPYIVRLIGVCQA 407
Query: 867 AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRD 926
+V E G L L E++ + ++ ++ + YL F VHR+
Sbjct: 408 EAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNF---VHRN 461
Query: 927 ISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT---YGYVAPELAYTMKVTEKCD 983
++++NVLL ++ A++SDFG++K L D S +T + + APE K + + D
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSD 521
Query: 984 VYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP-----RLPIPSHNVQEKL 1037
V+S+GV E + G+ P + E++ R+ P E
Sbjct: 522 VWSYGVTMWEALSYGQKPYK------------KMKGPEVMAFIEQGKRMECP----PECP 565
Query: 1038 ISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ C E RP V Q ++
Sbjct: 566 PELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-27
Identities = 60/275 (21%), Positives = 104/275 (37%), Gaps = 42/275 (15%)
Query: 147 LNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELN 206
+ S ++ I P + L ++ ++ L + + N+++
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 207 GSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTN 266
S+ Q + L N+ L L+ N L I L NLK L L L +NK+ + SL +L
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKL-TDI-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKK 110
Query: 267 LVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLF 326
L L + +N +S + L +L + L+L +N +
Sbjct: 111 LKSLSLEHNGISDING--------------------------LVHLPQLESLYLGNNKIT 144
Query: 327 GLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKS 386
+ L L L L L +N++ I L LT L L++ N +S + + LK+
Sbjct: 145 DITV--LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKN 198
Query: 387 LSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL 421
L L L + + SNL + + SL
Sbjct: 199 LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 114 bits (285), Expect = 4e-26
Identities = 60/286 (20%), Positives = 114/286 (39%), Gaps = 19/286 (6%)
Query: 390 LNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPI 449
+ P + K S++ A+ + L + ++ ++ + +
Sbjct: 4 TITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-V 58
Query: 450 PNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGAL 509
++ L ++ ++ L+ N LT + NL ++ L N + ++SS KL +L
Sbjct: 59 QGIQYLPNVTKLFLNGNKLTD--IKPLTNLKNLGWLFLDENKI-KDLSSL-KDLKKLKSL 114
Query: 510 DFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLS 569
N I+ +I + + QLE L L +N + DI L +L+ L L L NQ+S +
Sbjct: 115 SLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIV 169
Query: 570 PKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSEL 629
P L L +L++L LS N++S+ +L L L L L + + + L+ + +
Sbjct: 170 P-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226
Query: 630 DLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQ 675
+ L P I EK N+ + F +
Sbjct: 227 KNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVT 270
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-25
Identities = 53/242 (21%), Positives = 98/242 (40%), Gaps = 16/242 (6%)
Query: 67 FSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTL 126
F +F +L + + ++ + + +++ ++ I +L + L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 70
Query: 127 HLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIP 186
L N+L+ PL L +L L L N ++D+ L +L L +L L +N +S I
Sbjct: 71 FLNGNKLTDIKPLT--NLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DIN 125
Query: 187 SEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDL 246
+ +L L L L NN++ + L L+ L L+L N + S L L L +L
Sbjct: 126 G-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNL 180
Query: 247 KLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIP 306
L+ N + S +L L NL +L +++ + NL + + +
Sbjct: 181 YLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 238
Query: 307 HS 308
S
Sbjct: 239 IS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 53/257 (20%), Positives = 100/257 (38%), Gaps = 17/257 (6%)
Query: 435 LTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYG 494
+ + + I ++ +L + +T ++++ ++ I + +++
Sbjct: 1 MGETITVSTPIKQ-IFPDDAFAETIKDNLKKKSVTDAVTQNEL--NSIDQIIANNSDI-- 55
Query: 495 EISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFL 554
+ P + L + N +T +I P + L L L N + D+ + L L L
Sbjct: 56 KSVQGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKL 111
Query: 555 IKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSW 614
L L N +S ++ L L QLE L L +N +++ L L KL L+L +NQ S
Sbjct: 112 KSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS- 166
Query: 615 EIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHAL 674
+I L L L L LS N + + + +++L+ L L +
Sbjct: 167 DIVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVP 223
Query: 675 QCIDISYNELRGPIPNS 691
+ + L P S
Sbjct: 224 NTVKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.2 bits (236), Expect = 3e-20
Identities = 62/266 (23%), Positives = 103/266 (38%), Gaps = 17/266 (6%)
Query: 54 NLTSIGLKGT-LHDFS-FSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSG 111
++ I + + P++ L L N+L +I P + N+ L +L L N
Sbjct: 44 SIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKL-TDIKP-LTNLKNLGWLFLDENKIK- 100
Query: 112 AIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNL 171
+ + L LK+L L N +S L L L +L L +N + DI L LT L
Sbjct: 101 DLSS-LKDLKKLKSLSLEHNGISDINGLV--HLPQLESLYLGNNKITDITV--LSRLTKL 155
Query: 172 VTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFG 231
TL L +N +S I + L L +L L N + S ++L L NL +L L S
Sbjct: 156 DTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLN 211
Query: 232 SIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFL 291
+ NL + +K D L P + + + + + L
Sbjct: 212 KPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWH-LPEFTNEVSFIFYQP 268
Query: 292 SKIALSYNKFSGLIPHSLGNLSNIAF 317
I + +F G + L + +++
Sbjct: 269 VTIGKAKARFHGRVTQPLKEVYTVSY 294
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 33/200 (16%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFH-SPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY 861
+GKG G V K + + + AVK + + + L EV+ L ++ H NI+K +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNIMKLF 87
Query: 862 GFCSHAQHSFIVYEYLEMGSL--AMI----LSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
+ +IV E G L +I S AA +IK + ++Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------IIKQVFSGITYMH 138
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
IVHRD+ +N+LL+ K + ++ DFG++ + ++ + GT Y+APE+
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEV 194
Query: 973 ---AYTMKVTEKCDVYSFGV 989
Y EKCDV+S GV
Sbjct: 195 LRGTY----DEKCDVWSAGV 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 40/287 (13%)
Query: 791 IIRATNDFDD----EHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNE 845
+ +T F D + +GKG G V + +G+ AVK + T ++ L E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 846 VKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL--AMI----LSNDAAAEDLEWTQ 899
V+ L ++ H NI+K Y F + ++V E G L +I S AA
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR------ 130
Query: 900 RMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPDSS 956
+I+ + ++Y+H + IVHRD+ +N+LL+ K++ R+ DFG++ +
Sbjct: 131 ---IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 957 NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP--GDFISLISSSSLNL 1014
+ GT Y+APE+ EKCDV+S GV+ ++ G P G I
Sbjct: 185 -MKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG 242
Query: 1015 NIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+ P+ S + ++ LI L P R + +
Sbjct: 243 KYTFEL---PQWKKVSESAKD-LIR------KMLTYVPSMRISARDA 279
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 24/241 (9%)
Query: 762 KSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDD----EHCIGKGGQGSVYK-VE 816
K + K P+ + K V + + D +G G G V++ VE
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVE 72
Query: 817 LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876
A+G + K ++P P + + NE+ + ++ H ++ + ++ E+
Sbjct: 73 KATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129
Query: 877 LEMGSL-AMILSNDAAAEDLEWTQR--MSVIKGIADALSYLHNDCFPPIVHRDISSKNVL 933
L G L I AED + ++ ++ ++ + L ++H IVH DI +N++
Sbjct: 130 LSGGELFDRIA-----AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIM 181
Query: 934 LDFKNEARV--SDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVL 990
+ K + V DFG+A L PD T + APE + V D+++ GVL
Sbjct: 182 CETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVL 239
Query: 991 A 991
Sbjct: 240 G 240
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 48/212 (22%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G+G +V++ +G++ A+K F++ + E + L ++ H+NIVK +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74
Query: 863 F--CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
+ +H ++ E+ GSL +L + A L ++ + V++ + +++L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 921 PIVHRDISSKNVLLDFKNEAR----VSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 972
IVHR+I N++ + + ++DFG A+ L+ D + L GT Y+ P++
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERA 190
Query: 973 ----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
+ K D++S GV G P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 68/275 (24%), Positives = 117/275 (42%), Gaps = 37/275 (13%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+DFD +GKG G+VY E + I+A+K + + + E++ + +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSL------AMILSNDAAAEDLEWTQRMSVIKGIA 908
NI++ Y + + +++ E+ G L +A + ++ +A
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA---------TFMEELA 124
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYV 968
DAL Y H ++HRDI +N+L+ +K E +++DFG + P T + GT Y+
Sbjct: 125 DALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT-MCGTLDYL 179
Query: 969 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028
PE+ EK D++ GVL E + G P D S + I++ L
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD--------SPSHTETHRRIVNVDLKF 231
Query: 1029 PSH--NVQEKLISFVEVAISCLDESPESRPTMQKV 1061
P + + LIS L P R ++ V
Sbjct: 232 PPFLSDGSKDLIS------KLLRYHPPQRLPLKGV 260
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-26
Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 37/231 (16%)
Query: 771 RNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFH 829
+ R L F+G ++ +GKG G V K + + + AVK +
Sbjct: 5 HHHSSGRENLYFQGTF--------AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN 56
Query: 830 -SPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL-AMILS 887
+ + L EV+ L ++ H NI+K + + +IV E G L I+
Sbjct: 57 KASAKNKD--TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK 114
Query: 888 ------NDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA- 940
+DAA +IK + ++Y+H IVHRD+ +N+LL+ K +
Sbjct: 115 RKRFSEHDAA----------RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDC 161
Query: 941 --RVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGV 989
++ DFG++ + ++ + GT Y+APE+ EKCDV+S GV
Sbjct: 162 DIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEV-LRGTYDEKCDVWSAGV 210
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 795 TNDFDDE----HCIGKGGQGSVYK-VELASGEIIAVKKFH-SPLPGEMTFQQEFLNEVKA 848
+ F D +GKG V + V +G A K + L Q+ E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARI 58
Query: 849 LTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL------AMILSNDAAAEDLEWTQRMS 902
+++H NIV+ + ++V++ + G L S A+
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--------- 109
Query: 903 VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPDSSNWT 959
I+ I ++++Y H++ IVHR++ +N+LL K + +++DFG+A + + W
Sbjct: 110 CIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WH 165
Query: 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGV 989
AGT GY++PE+ ++ D+++ GV
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 52/247 (21%), Positives = 101/247 (40%), Gaps = 26/247 (10%)
Query: 758 RRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDD------EHCIGKGGQGS 811
+ S R + + + + + +G G G
Sbjct: 45 NADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQ 104
Query: 812 VYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870
V+K E A+G +A K + + ++E NE+ + ++ H N+++ Y
Sbjct: 105 VHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161
Query: 871 FIVYEYLEMGSL-AMILSNDAAAEDLEWTQR--MSVIKGIADALSYLHNDCFPPIVHRDI 927
+V EY++ G L I+ E T+ + +K I + + ++H I+H D+
Sbjct: 162 VLVMEYVDGGELFDRII-----DESYNLTELDTILFMKQICEGIRHMHQM---YILHLDL 213
Query: 928 SSKNVLLDFKNEARV--SDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDV 984
+N+L ++ ++ DFG+A+ KP GT ++APE + Y V+ D+
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYD-FVSFPTDM 271
Query: 985 YSFGVLA 991
+S GV+A
Sbjct: 272 WSVGVIA 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 52/197 (26%), Positives = 84/197 (42%), Gaps = 29/197 (14%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G G V+ + +G++ A+K NE+ L +I+H NIV
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLED 73
Query: 863 FCSHAQHSFIVYEYLEMGSL-AMILS------NDAAAEDLEWTQRMSVIKGIADALSYLH 915
H ++V + + G L IL DA+ VI+ + A+ YLH
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS----------LVIQQVLSAVKYLH 123
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
+ IVHRD+ +N+L E ++DFG++K + + GT GYVAPE+
Sbjct: 124 ENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEV 178
Query: 973 AYTMKVTEKCDVYSFGV 989
++ D +S GV
Sbjct: 179 LAQKPYSKAVDCWSIGV 195
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 36/207 (17%)
Query: 804 IGKGGQGSVYK-VELASGE-----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
IGKG V + + +G+ I+ V KF S ++ E ++H +I
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS---PGLSTEDLKREASICHMLKHPHI 88
Query: 858 VKFYGFCSHAQHSFIVYEYL----------EMGSLAMILSNDAAAEDLEWTQRMSVIKGI 907
V+ S ++V+E++ + + S A+ ++ I
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH---------YMRQI 139
Query: 908 ADALSYLH-NDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPDSSNWTELAG 963
+AL Y H N+ I+HRD+ VLL K + ++ FG+A L G
Sbjct: 140 LEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195
Query: 964 TYGYVAPELAYTMKVTEKCDVYSFGVL 990
T ++APE+ + DV+ GV+
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 59/254 (23%), Positives = 98/254 (38%), Gaps = 36/254 (14%)
Query: 759 RKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDE----HCIGKGGQGSVYK 814
K + + G A +F + IG+G V +
Sbjct: 53 NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112
Query: 815 -VELASGEIIAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHA 867
V A+G AVK ++ E L ++ H +I+ +
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172
Query: 868 QHSFIVYEYLEMGSL------AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP 921
F+V++ + G L + LS +++ + +A+S+LH +
Sbjct: 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRS---------IMRSLLEAVSFLHANN--- 220
Query: 922 IVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTMKVTE 980
IVHRD+ +N+LLD + R+SDFG + L+P EL GT GY+APE L +M T
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELCGTPGYLAPEILKCSMDETH 279
Query: 981 K-----CDVYSFGV 989
D+++ GV
Sbjct: 280 PGYGKEVDLWACGV 293
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-26
Identities = 47/240 (19%), Positives = 97/240 (40%), Gaps = 18/240 (7%)
Query: 757 QRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYK-V 815
+ + K + + + + + + D +E +G G G V++
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEE--LGTGAFGVVHRVT 177
Query: 816 ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875
E A+G A K +P + ++ E++ ++ +RH +V + ++YE
Sbjct: 178 ERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 876 YLEMGSLAMILSNDAAAEDLEWTQR--MSVIKGIADALSYLHNDCFPPIVHRDISSKNVL 933
++ G L A E + ++ + ++ + L ++H + VH D+ +N++
Sbjct: 235 FMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIM 287
Query: 934 LDFKNEARV--SDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 991
K + DFG+ L P + GT + APE+A V D++S GVL+
Sbjct: 288 FTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 59/277 (21%), Positives = 104/277 (37%), Gaps = 57/277 (20%)
Query: 804 IGKGGQGSVYK----VELASGEI-IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIRHRNI 857
+G G G+VYK E +I +A+K+ +E L+E + + + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEILDEAYVMASVDNPHV 79
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
+ G C ++ + + G L + +++ ++ IA ++YL +
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS-----------NWTELAGTYG 966
VHRD++++NVL+ +++DFG+AK L + W
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM------- 186
Query: 967 YVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDP- 1024
A E T + DV+S+GV E++ G P D I EI
Sbjct: 187 --ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD------------GIPASEISSIL 232
Query: 1025 ----RLPIPSHNVQEKLISFVEVAISCLDESPESRPT 1057
RLP P I + + C +SRP
Sbjct: 233 EKGERLPQP----PICTIDVYMIMVKCWMIDADSRPK 265
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-26
Identities = 55/278 (19%), Positives = 116/278 (41%), Gaps = 25/278 (8%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G+G +V++ +G++ A+K F++ + E + L ++ H+NIVK +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74
Query: 863 F--CSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
+ +H ++ E+ GSL +L + A L ++ + V++ + +++L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 921 PIVHRDISSKNVLLDFKNEAR----VSDFGIAKFLKPDSSNWTELAGTYGYVAPEL---- 972
IVHR+I N++ + + ++DFG A+ L+ D + L GT Y+ P++
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERA 190
Query: 973 ----AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028
+ K D++S GV G P F + +I+ +
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRP--FEGPRRNKEVMYKIITGKPSG 246
Query: 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
VQ+ ++ + SR ++ +L
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 70/279 (25%), Positives = 109/279 (39%), Gaps = 55/279 (19%)
Query: 801 EHCIGKGGQGSVYK----VELASGEI-IAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+G G G+V+K E S +I + +K G +FQ + + A+ + H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQ-AVTDHMLAIGSLDHA 75
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
+IV+ G C +V +YL +GSL + L ++ IA + YL
Sbjct: 76 HIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLE 132
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS-----------NWTELAGT 964
VHR+++++NVLL ++ +V+DFG+A L PD W
Sbjct: 133 EHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----- 184
Query: 965 YGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILD 1023
A E + K T + DV+S+GV E++ G P + L E+ D
Sbjct: 185 ----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA------------GLRLAEVPD 228
Query: 1024 P-----RLPIPSHNVQEKLISFVEVAISCLDESPESRPT 1057
RL P Q I V + C RPT
Sbjct: 229 LLEKGERLAQP----QICTIDVYMVMVKCWMIDENIRPT 263
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-25
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFY- 861
+G GG G V + + +GE +A+K+ L + ++ + E++ + ++ H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPNVVSARE 79
Query: 862 -----GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
+ + EY E G L L+ L+ +++ I+ AL YLH
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 917 DCFPPIVHRDISSKNVLLDFKNEAR---VSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
+ I+HRD+ +N++L + + D G AK L GT Y+APEL
Sbjct: 140 NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVGTLQYLAPELL 195
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGKHP 1000
K T D +SFG LA E I G P
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 21/199 (10%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
+G G V K + +G+ A K K ++E EV L EIRH NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQR--MSVIKGIADALSYLHND 917
+ + ++ E + G L D AE T+ +K I D + YLH+
Sbjct: 73 LHDIFENKTDVVLILELVSGGELF-----DFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 918 CFPPIVHRDISSKNVLLDFKNEA----RVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-L 972
I H D+ +N++L KN ++ DFGIA ++ + + + GT +VAPE +
Sbjct: 128 R---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIV 183
Query: 973 AYTMKVTEKCDVYSFGVLA 991
Y + + D++S GV+
Sbjct: 184 NYE-PLGLEADMWSIGVIT 201
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 46/197 (23%), Positives = 93/197 (47%), Gaps = 25/197 (12%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+GKG V + V++ +G+ A ++ Q+ E + ++H NIV+ +
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTK-KLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 863 FCSHAQHSFIVYEYLEMGSLA-MILS------NDAAAEDLEWTQRMSVIKGIADALSYLH 915
S H +++++ + G L I++ DA+ I+ I +A+ + H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS----------HCIQQILEAVLHCH 127
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
+VHR++ +N+LL K + +++DFG+A ++ + W AGT GY++PE+
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 973 AYTMKVTEKCDVYSFGV 989
+ D+++ GV
Sbjct: 185 LRKDPYGKPVDLWACGV 201
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 47/216 (21%), Positives = 88/216 (40%), Gaps = 34/216 (15%)
Query: 801 EHCIGKGGQGSVYKVELASGEI----IAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIRHR 855
+G+G G VY+ + + +AVK ++F++E + + H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
+IVK G + ++I+ E G L L + L+ + I A++YL
Sbjct: 74 HIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLE 130
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN----------WTELAGTY 965
+ VHRDI+ +N+L+ ++ DFG++++++ + W
Sbjct: 131 SINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------ 181
Query: 966 GYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP 1000
+PE + T DV+ F V E++ GK P
Sbjct: 182 ---SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 54/204 (26%), Positives = 80/204 (39%), Gaps = 32/204 (15%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
+G G G V E + + +A+K KF E E++ L ++ H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSL------AMILSNDAAAEDLEWTQRMSVIKGIADAL 911
+K F + +IV E +E G L L + A+
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL---------YFYQMLLAV 127
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPDSSNWTELAGTYGYV 968
YLH + I+HRD+ +NVLL + E +++DFG +K L S L GT Y+
Sbjct: 128 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYL 183
Query: 969 APE-LAYTMKV--TEKCDVYSFGV 989
APE L D +S GV
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGV 207
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 34/216 (15%)
Query: 801 EHCIGKGGQGSVYKVELASGE----IIAVKKFHSPLPGEMTFQ-QEFLNEVKALTEIRHR 855
CIG+G G V++ S E +A+K ++FL E + + H
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHP 76
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
+IVK G + +I+ E +G L L L+ + ++ AL+YL
Sbjct: 77 HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE 133
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD----SSN------WTELAGTY 965
+ F VHRDI+++NVL+ + ++ DFG++++++ +S W
Sbjct: 134 SKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------ 184
Query: 966 GYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP 1000
APE + T DV+ FGV E++ G P
Sbjct: 185 ---APESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-25
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 32/205 (15%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
+G G G V E + + +A++ KF E E++ L ++ H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSL------AMILSNDAAAEDLEWTQRMSVIKGIADAL 911
+K F + +IV E +E G L L + A+
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL---------YFYQMLLAV 252
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPDSSNWTELAGTYGYV 968
YLH + I+HRD+ +NVLL + E +++DFG +K L S L GT Y+
Sbjct: 253 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYL 308
Query: 969 APE-LAYTMKV--TEKCDVYSFGVL 990
APE L D +S GV+
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVI 333
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 21/199 (10%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
+G G V K E ++G A K K S ++E EV L ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQR--MSVIKGIADALSYLHND 917
+ + ++ E + G L D A+ ++ S IK I D ++YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELF-----DFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 918 CFPPIVHRDISSKNVLLDFKNEA----RVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-L 972
I H D+ +N++L KN ++ DFG+A ++ + + GT +VAPE +
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIV 190
Query: 973 AYTMKVTEKCDVYSFGVLA 991
Y + + D++S GV+
Sbjct: 191 NYE-PLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 52/199 (26%), Positives = 88/199 (44%), Gaps = 21/199 (10%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
+G G V K E ++G A K K S ++E EV L ++ H NI+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQR--MSVIKGIADALSYLHND 917
+ + ++ E + G L D A+ ++ S IK I D ++YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELF-----DFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 918 CFPPIVHRDISSKNVLLDFKNEA----RVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-L 972
I H D+ +N++L KN ++ DFG+A ++ + + GT +VAPE +
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVAPEIV 190
Query: 973 AYTMKVTEKCDVYSFGVLA 991
Y + + D++S GV+
Sbjct: 191 NYE-PLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 21/199 (10%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
+G G V K E ++G A K K + +++ EV L EI+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 860 FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQR--MSVIKGIADALSYLHND 917
+ + ++ E + G L D AE T+ +K I + + YLH+
Sbjct: 79 LHEVYENKTDVILILELVAGGELF-----DFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 918 CFPPIVHRDISSKNVLLDFKNEA----RVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-L 972
I H D+ +N++L +N ++ DFG+A + + + + GT +VAPE +
Sbjct: 134 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIV 189
Query: 973 AYTMKVTEKCDVYSFGVLA 991
Y + + D++S GV+
Sbjct: 190 NYE-PLGLEADMWSIGVIT 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 30/216 (13%)
Query: 789 EEIIRATNDFDDE----HCIGKGGQGSVYK-VELASGEIIAVKKFH-SPLPGEMTFQQEF 842
E ++ A+ F D +GKG V + V +G A K + L Q+
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKL 75
Query: 843 LNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL------AMILSNDAAAEDLE 896
E + +++H NIV+ + ++V++ + G L S A+
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--- 132
Query: 897 WTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKP 953
I+ I ++++Y H++ IVHR++ +N+LL K + +++DFG+A +
Sbjct: 133 ------CIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGV 989
+ W AGT GY++PE+ ++ D+++ GV
Sbjct: 184 SEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 48/195 (24%), Positives = 87/195 (44%), Gaps = 21/195 (10%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G+G G V++ VE +S + K + + T Q E+ L RHRNI+ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKF----VKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 863 FCSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQR--MSVIKGIADALSYLHNDCF 919
+ +++E++ + I E +R +S + + +AL +LH+
Sbjct: 69 SFESMEELVMIFEFISGLDIFERIN-----TSAFELNEREIVSYVHQVCEALQFLHSH-- 121
Query: 920 PPIVHRDISSKNVLLDFKNEARV--SDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAYTM 976
I H DI +N++ + + + +FG A+ LKP N+ L Y APE + +
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDV 179
Query: 977 KVTEKCDVYSFGVLA 991
V+ D++S G L
Sbjct: 180 -VSTATDMWSLGTLV 193
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 60/279 (21%), Positives = 107/279 (38%), Gaps = 22/279 (7%)
Query: 148 NNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNG 207
+ ++ I + L ++ ++ L + + N+++
Sbjct: 5 SETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK- 59
Query: 208 SIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNL 267
S+ Q + L N+ L L+ N L + L NLK L L L +NK+ + SL +L L
Sbjct: 60 SV-QGIQYLPNVTKLFLNGNKL--TDIKPLANLKNLGWLFLDENKVK-DLS-SLKDLKKL 114
Query: 268 VILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFG 327
L + +N +S + + +L L + L NK + + L L+ + L L+ N +
Sbjct: 115 KSLSLEHNGISDING--LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISD 170
Query: 328 LIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSL 387
+ L L L L L N + S L L NL VL +++ NL
Sbjct: 171 I--VPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVP 226
Query: 388 SYLNLAFNKLTSSIPIS-LSNLTNLSV---LSFYKNSLS 422
+ + L + IS + +V L + N +S
Sbjct: 227 NTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVS 265
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/256 (22%), Positives = 104/256 (40%), Gaps = 18/256 (7%)
Query: 119 HLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYN 178
+ +L K ++ ++ L+S++ + ++ ++ + + L N+ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 179 NLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELG 238
N L+ I + NLK L L L N++ + SL +L L L+L N + S + L
Sbjct: 78 NKLT-DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI--SDINGLV 131
Query: 239 NLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSY 298
+L L L L +NK+ + L LT L L + +N +S + + L L + LS
Sbjct: 132 HLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSK 187
Query: 299 NKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLG 358
N S L L L N+ L L S + NL + ++ + L P +
Sbjct: 188 NHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIIS 243
Query: 359 NLTNLSVLFIYNNSLS 374
+ + + +
Sbjct: 244 DDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 54/249 (21%), Positives = 102/249 (40%), Gaps = 17/249 (6%)
Query: 67 FSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTL 126
FS +F +L + + ++ + + +++ ++ I +L + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 127 HLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIP 186
L N+L+ PL L +L L L N ++D+ L +L L +L L +N +S I
Sbjct: 74 FLNGNKLTDIKPLA--NLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DIN 128
Query: 187 SEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDL 246
+ +L L L L NN++ + L L+ L L+L N + S L L L +L
Sbjct: 129 G-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNL 183
Query: 247 KLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIP 306
L+ N ++ + +L L NL +L +++ + NL + + +
Sbjct: 184 YLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 241
Query: 307 HS-LGNLSN 314
S G+
Sbjct: 242 ISDDGDYEK 250
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 58/257 (22%), Positives = 110/257 (42%), Gaps = 17/257 (6%)
Query: 405 LSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLD 464
+ K S++ A+ + L + ++ ++ + + ++ L ++ ++ L+
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLN 76
Query: 465 RNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKI 524
N LT + NL ++ L N + ++SS KL +L N I+ +I +
Sbjct: 77 GNKLTD--IKPLANLKNLGWLFLDENKV-KDLSSL-KDLKKLKSLSLEHNGIS-DING-L 130
Query: 525 GYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLS 584
+ QLE L L +N + DI L +L+ L L L NQ+S + P L L +L++L LS
Sbjct: 131 VHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLS 186
Query: 585 SNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQI 644
N++S+ +L L L L L + + + L+ + + + L P I
Sbjct: 187 KNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEII 242
Query: 645 CIMQSLEKLNLSHNSLS 661
EK N+ +
Sbjct: 243 SDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 54/243 (22%), Positives = 98/243 (40%), Gaps = 16/243 (6%)
Query: 449 IPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGA 508
I + ++ +L + +T ++++ ++ I + +++ + P +
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVTQNEL--NSIDQIIANNSDI--KSVQGIQYLPNVTK 72
Query: 509 LDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQL 568
L + N +T +I P + L L L N V D+ + L L L L L N +S +
Sbjct: 73 LFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DI 127
Query: 569 SPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSE 628
+ L L QLE L L +N +++ L L KL L+L +NQ S +I L L L
Sbjct: 128 NG-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQN 182
Query: 629 LDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPI 688
L LS N + + + +++L+ L L + + + L P
Sbjct: 183 LYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPE 240
Query: 689 PNS 691
S
Sbjct: 241 IIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 60/235 (25%), Positives = 92/235 (39%), Gaps = 15/235 (6%)
Query: 69 FSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHL 128
P++ L L N+L +I P + N+ L +L L N + + L LK+L L
Sbjct: 64 IQYLPNVTKLFLNGNKL-TDIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSL 119
Query: 129 FKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSE 188
N +S L L L +L L +N + DI L LT L TL L +N +S I
Sbjct: 120 EHNGISDINGLV--HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VP 173
Query: 189 IGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKL 248
+ L L +L L N + S ++L L NL +L L S + NL + +K
Sbjct: 174 LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 231
Query: 249 ADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSG 303
D L P + + + + + L I + +F G
Sbjct: 232 TDGSL--VTPEIISDDGDYEKPNVKWH-LPEFTNEVSFIFYQPVTIGKAKARFHG 283
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 7e-25
Identities = 38/300 (12%), Positives = 85/300 (28%), Gaps = 65/300 (21%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR--------- 853
+G+ + + + +GE V + ++ EV L +R
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 854 -------------HRNIVKFYGFCSHAQHSFIVYEYLEM----GSLAM----ILSNDAAA 892
K + +++ + +L +LS+ +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 893 EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952
+ L R+ + + L+ LH+ +VH + +++LD + ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 953 PDSSNWTELAGTYGYVAPEL-----------AYTMKVTEKCDVYSFGVLALEVIKGKHPG 1001
+ + G+ PEL +T D ++ G++ + P
Sbjct: 257 ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312
Query: 1002 DFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+ + I IP V+ L+ L E R +
Sbjct: 313 -I------TKDAALGGSEWIFRSCKNIPQ-PVRA-LLE------GFLRYPKEDRLLPLQA 357
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 49/221 (22%), Positives = 92/221 (41%), Gaps = 37/221 (16%)
Query: 793 RATNDFDDE----HCIGKGGQGSVYK-VELASGEIIAVKKF------HSPLPGEMTFQQE 841
+T+ F + +G+G V + + + + AVK ++
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 842 FLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEMGSL------AMILSNDAAAED 894
L EV L ++ H NI++ F+V++ ++ G L + LS +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK- 128
Query: 895 LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954
+++ + + + LH IVHRD+ +N+LLD +++DFG + L P
Sbjct: 129 --------IMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 955 SSNWTELAGTYGYVAPE-LAYTMKV-----TEKCDVYSFGV 989
E+ GT Y+APE + +M ++ D++S GV
Sbjct: 178 EK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 788 YEEIIRATNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVK---KFHSPLPGEMTFQQEFL 843
++ I F + +G G G V+ V E +SG +K K S +P E
Sbjct: 16 FQGTIDDLFIFKRK--LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-----IE 68
Query: 844 NEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMS 902
E++ L + H NI+K + + +IV E E G L I+S A + L
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 903 VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPDSSNWT 959
++K + +AL+Y H+ +VH+D+ +N+L + ++ DFG+A+ K D T
Sbjct: 129 LMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-ST 184
Query: 960 ELAGTYGYVAPE-LAYTMKVTEKCDVYSFGV 989
AGT Y+APE VT KCD++S GV
Sbjct: 185 NAAGTALYMAPEVFKR--DVTFKCDIWSAGV 213
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 37/229 (16%)
Query: 779 MLTFEGKIVYEEIIRATNDFDDE----HCIGKGGQGSVYK-VELASGEIIAVKKFHSPLP 833
M T + +++ R + F D IG G + + A+ AVK
Sbjct: 1 MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID---- 56
Query: 834 GEMTFQQEFLNEVKAL-TEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL-AMILS---- 887
+++ E++ L +H NI+ ++ ++V E ++ G L IL
Sbjct: 57 ---KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF 113
Query: 888 --NDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA----R 941
+A+A V+ I + YLH +VHRD+ N+L ++ R
Sbjct: 114 SEREASA----------VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIR 160
Query: 942 VSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 990
+ DFG AK L+ ++ T +VAPE+ CD++S GVL
Sbjct: 161 ICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 31/185 (16%), Positives = 70/185 (37%), Gaps = 10/185 (5%)
Query: 120 LSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
L ++ + + ++SL + L + + D+ + N+ L + N
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNI 76
Query: 180 LLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGN 239
+ + I L L L + ++ +L L++L +L++S ++ SI +++
Sbjct: 77 HATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 240 LKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYN 299
L ++ + L+ N I L L L L I + + I + L+++
Sbjct: 135 LPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
Query: 300 KFSGL 304
G
Sbjct: 192 TIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 27/164 (16%), Positives = 65/164 (39%), Gaps = 7/164 (4%)
Query: 117 IGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCL 176
++ L + L ++ +E ++ +L + + + + P + L+NL L +
Sbjct: 40 EAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHATNYNP--ISGLSNLERLRI 95
Query: 177 YNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSE 236
++ + L L L++ ++ + SI + L + ++LS N I
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MP 154
Query: 237 LGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGL 280
L L L L + + ++ + + L LY ++ ++ G
Sbjct: 155 LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-23
Identities = 30/185 (16%), Positives = 72/185 (38%), Gaps = 10/185 (5%)
Query: 239 NLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSY 298
K + L + +I + + +L + + N +++ L + I + + ++
Sbjct: 21 TFKAYLNGLLGQSS-TANI--TEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINN 75
Query: 299 NKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLG 358
+ P + LSN+ L + + L L SL++L++ ++ SI +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 359 NLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYK 418
L ++ + + N I + L L LN+ F+ + + + L+ L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 419 NSLSG 423
++ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 35/184 (19%), Positives = 70/184 (38%), Gaps = 13/184 (7%)
Query: 311 NLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYN 370
L +S + +++ +L +++ + L G + N+ L I N
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75
Query: 371 NSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYR 430
+ P I L +L L + +TS +LS LT+L++L ++ +I +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 431 NLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLT--SNISESFYIYPNLTFIDLS 488
L K+ + L N I LK L L +++ + + I + +P L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIED----FPKLNQLYAF 189
Query: 489 YNNL 492
+
Sbjct: 190 SQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-21
Identities = 30/183 (16%), Positives = 70/183 (38%), Gaps = 10/183 (5%)
Query: 167 NLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSS 226
+ L + + +++ +L Y+ L N + + + N+ L +++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYI---TLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 227 NSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIG 286
+ + + L L L++ + +L LT+L +L I +++ I ++I
Sbjct: 76 IHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 287 NLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGN 346
L ++ I LSYN I L L + L + + + + + L+ L +
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 347 NKL 349
+
Sbjct: 191 QTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 30/162 (18%), Positives = 63/162 (38%), Gaps = 7/162 (4%)
Query: 66 DFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKT 125
+ + + L Y+ L + + ++ I +K L +++ + P I LS L+
Sbjct: 37 NITEAQMNSLTYITLANINV-TDLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLER 92
Query: 126 LHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSI 185
L + ++ + GL+SL L + + +D I + L + ++ L N I
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 186 PSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSN 227
+ L L LN+ + ++ + + L L S
Sbjct: 153 -MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 29/157 (18%), Positives = 64/157 (40%), Gaps = 7/157 (4%)
Query: 528 SQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNN 587
+ L + L++ +V D+ + + L + + +P + L LE L + +
Sbjct: 44 NSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN-YNP-ISGLSNLERLRIMGKD 99
Query: 588 LSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIM 647
+++ +L L L L++S++ I K+ L ++ +DLSYN I + +
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTL 158
Query: 648 QSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNEL 684
L+ LN+ + + E+ L + +
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-18
Identities = 33/160 (20%), Positives = 69/160 (43%), Gaps = 7/160 (4%)
Query: 504 PKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQ 563
L + + N+T ++ I Y+ ++ L +++ H + + LS L +L +
Sbjct: 44 NSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHA-TNY-NPISGLSNLERLRIMGKD 99
Query: 564 LSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEEL 623
++ P L L L LD+S + ++I + L K++ ++LS N +I L+ L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTL 158
Query: 624 IHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGV 663
L L++ ++ + I L +L ++ G
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-18
Identities = 37/183 (20%), Positives = 64/183 (34%), Gaps = 11/183 (6%)
Query: 359 NLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYK 418
+ +S + + SL+Y+ LA +T + N+ L+
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 419 NSLSGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLKNLTSLVRVHLDRNYLTSNISESFY 477
+ P L L +L + IPNL LTSL + + + +I
Sbjct: 76 IHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 478 IYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSS 537
P + IDLSYN +I P+L +L+ + + + I +L L S
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFS 190
Query: 538 NHV 540
+
Sbjct: 191 QTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-17
Identities = 31/231 (13%), Positives = 71/231 (30%), Gaps = 57/231 (24%)
Query: 383 NLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGD 442
K+ L + I+ + + +L+ ++ +++ EY + L + +
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGIEY--AHNIKDLTINN 75
Query: 443 NQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGR 502
N ++ L NL + + ++ + +
Sbjct: 76 IH----ATNYNPISGL---------------------SNLERLRIMGKDVTSDKIPNLSG 110
Query: 503 CPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQN 562
L LD S + +I KI ++ +DLS N + DI
Sbjct: 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP---------------- 154
Query: 563 QLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFS 613
L L +L+ L++ + + + + + KL+ L +
Sbjct: 155 ---------LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIG 194
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 22/132 (16%), Positives = 52/132 (39%), Gaps = 5/132 (3%)
Query: 54 NLTSIGLKGT-LHDFS-FSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSG 111
N+ + + +++ S +L L + + + P + ++ L LD+S +
Sbjct: 67 NIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 112 AIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNL 171
+I +I L + ++ L N I + L L +L + + + D + + L
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKL 183
Query: 172 VTLCLYNNLLSG 183
L ++ + G
Sbjct: 184 NQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 17/141 (12%), Positives = 46/141 (32%), Gaps = 31/141 (21%)
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
+ +L Q+ + + + L ++ L++ N+++ + + L ++N
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 611 QFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEE 670
+ + LS +LE+L + ++
Sbjct: 77 HAT-----NYNPISGLS---------------------NLERLRIMGKDVTSDKIPNLSG 110
Query: 671 MHALQCIDISYNELRGPIPNS 691
+ +L +DIS++ I
Sbjct: 111 LTSLTLLDISHSAHDDSILTK 131
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-24
Identities = 53/244 (21%), Positives = 98/244 (40%), Gaps = 34/244 (13%)
Query: 757 QRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKV- 815
++ S S+ T L +G + + + + E +G+G VY+
Sbjct: 18 LYFQSMSSVTASAAPGTASLVPDYWIDGS--NRDALSDFFEVESE--LGRGATSIVYRCK 73
Query: 816 ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875
+ + + A+K + ++ E+ L + H NI+K +V E
Sbjct: 74 QKGTQKPYALKVLKKTVDKKI-----VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128
Query: 876 YLEMGSL-AMILS------NDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDIS 928
+ G L I+ DAA +K I +A++YLH + IVHRD+
Sbjct: 129 LVTGGELFDRIVEKGYYSERDAA----------DAVKQILEAVAYLHENG---IVHRDLK 175
Query: 929 SKNVLLDFKNEA---RVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVY 985
+N+L +++DFG++K ++ + GT GY APE+ + D++
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYCAPEILRGCAYGPEVDMW 234
Query: 986 SFGV 989
S G+
Sbjct: 235 SVGI 238
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 41/204 (20%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIR-HRN 856
+G+G K V S + AVK + E+ AL H N
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ-----------KEITALKLCEGHPN 67
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSL-AMILS------NDAAAEDLEWTQRMSVIKGIAD 909
IVK + H+F+V E L G L I +A+ +++ +
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY----------IMRKLVS 117
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPDSSNWTELAGTYG 966
A+S++H+ +VHRD+ +N+L +N+ ++ DFG A+ PD+ T
Sbjct: 118 AVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174
Query: 967 YVAPELAYTMKVTEKCDVYSFGVL 990
Y APEL E CD++S GV+
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVI 198
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 67/318 (21%), Positives = 104/318 (32%), Gaps = 57/318 (17%)
Query: 356 FLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLS---NLTNLS 412
+ G + +L + +I SL L + ++ S I ++ L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 413 VLSFYKNSLSGAIPKEYRNLV--KLTKLFLGDNQFQGPIPNLKNL-----TSLVRVHLDR 465
L+ ++G P L L L + + L L L + + +
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 466 NYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIG 525
+ + E ++P L+ +DLS N GE CP
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP--------------------L 198
Query: 526 YSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSS 585
L+VL L + + SG S VQL+ LDLS
Sbjct: 199 KFPTLQVLALRNAGM---------------------ETPSGVCSALAAARVQLQGLDLSH 237
Query: 586 NNLSNAIPESL-GNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQI 644
N+L +A +L+ LNLS ++P L LS LDLSYN L PS
Sbjct: 238 NSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRL-DRNPS-P 292
Query: 645 CIMQSLEKLNLSHNSLSG 662
+ + L+L N
Sbjct: 293 DELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-21
Identities = 53/269 (19%), Positives = 90/269 (33%), Gaps = 19/269 (7%)
Query: 194 YLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKL 253
L ++ + + +L L + S + + L +L L + ++
Sbjct: 48 LLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEV 107
Query: 254 NGSIPHSLCNLT--NLVILYIYNNSLSGL--IPSEIGNLKF--LSKIALSYNKFSGLIPH 307
G+ P L T +L IL + N S + +E+ L ++++
Sbjct: 108 TGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167
Query: 308 SLGNLSNIAFLFLDSNSLFG-------LIPSELRNLKSLSILELGNNKLCGSIPHFLGNL 360
+ ++ L L N G L P + L+ L++ G G
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227
Query: 361 TNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKN 419
L L + +NSL + L+ LNL+F L +P L LSVL N
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYN 284
Query: 420 SLSGAIPKEYRNLVKLTKLFLGDNQFQGP 448
L P L ++ L L N F
Sbjct: 285 RLDR-NPSP-DELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 4e-20
Identities = 50/221 (22%), Positives = 68/221 (30%), Gaps = 19/221 (8%)
Query: 481 NLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIG--YSSQLEVLDLSSN 538
LT + + L L +TG PP + L +L+L +
Sbjct: 72 RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 539 HVVGDIPAELGKLSFLI-----KLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIP 593
A L +L + L +AQ ++ + L LDLS N
Sbjct: 132 SWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 594 ES----LGNLVKLHYLNLSNNQF---SWEIPIKLEELIHLSELDLSYNFLGRAIPSQIC- 645
L L L N S + L LDLS+N L A + C
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 646 IMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRG 686
L LNLS L V L +D+SYN L
Sbjct: 251 WPSQLNSLNLSFTGLKQVPKGLP---AKLSVLDLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 5e-19
Identities = 50/268 (18%), Positives = 86/268 (32%), Gaps = 25/268 (9%)
Query: 270 LYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHS---LGNLSNIAFLFLDSNSLF 326
L + ++I L ++ + + I + +S + L L++ +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 327 GLIPSELRNL--KSLSILELGNNKLCGSIPHFLGNL-----TNLSVLFIYNNSLSGSIPC 379
G P L L+IL L N +L L L VL I
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167
Query: 380 EIGNLKSLSYLNLAFNKLTSSI-------PISLSNLTNLSVLSFYKNSLSGAIPKEYRNL 432
++ +LS L+L+ N P+ L L++ + + SG
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227
Query: 433 VKLTKLFLGDNQFQGPIPNLK--NLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYN 490
V+L L L N + + L ++L L L+ +DLSYN
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP---AKLSVLDLSYN 284
Query: 491 NLYGEISSDWGRCPKLGALDFSKNNITG 518
L + + P++G L N
Sbjct: 285 RL--DRNPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 52/300 (17%), Positives = 81/300 (27%), Gaps = 22/300 (7%)
Query: 43 HCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYL 102
CN + L + L + I LK L
Sbjct: 14 SCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRL 73
Query: 103 DLSSNLFSGAIPPQIGHL---SYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALY-SNYLE 158
+ + I + S L+ L L +++G+ P + + + L N
Sbjct: 74 TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 159 DIIPHSLGNL-----TNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSI---- 209
L L L L + ++ L L+L +N G
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 210 ---PQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLC-NLT 265
P L LA+ N + G + L L L+ N L + C +
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253
Query: 266 NLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSL 325
L L + L + L L LSYN+ S L + L L N
Sbjct: 254 QLNSLNLSFTGLKQVPKGLPAKLSVLD---LSYNRLDRN--PSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 6e-18
Identities = 54/300 (18%), Positives = 99/300 (33%), Gaps = 47/300 (15%)
Query: 310 GNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH---FLGNLTNLSVL 366
G S L +++ SL L + ++ I + ++ L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 367 FIYNNSLSGSIPCEIG-----NLKSLSYLNLAFNKLTSSIP-ISLSNLTNLSVLSFYKNS 420
+ N ++G+ P + +L L+ N+++ + + + L VLS +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 421 LSGAIPKEYRNLVKLTKLFLGDNQFQGPIP--------NLKNLTSLVRVHLDRNYLTSNI 472
++ R L+ L L DN G L L + +
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 473 SESFYIYPNLTFIDLSYNNLYGEISSDWGRCP-KLGALDFSKNNITGNIPPKIGYSSQLE 531
S L +DLS+N+L + P +L +L+ S + +P + ++L
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLS 277
Query: 532 VLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNA 591
VLDLS N +L P L Q+ +L L N ++
Sbjct: 278 VLDLSYN-----------RLDRN---------------PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 46/225 (20%), Positives = 65/225 (28%), Gaps = 17/225 (7%)
Query: 19 NGSPLSSWTFNNVTKIGSCAWVGIHCNHGG--RVNSINLTSIGLKGTLHDFSFSSFPHLA 76
S L T N+ G+ + +N N++ L + P L
Sbjct: 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152
Query: 77 YLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAI-------PPQIGHLSYLKTLHLF 129
L + Q+ L LDLS N G P + L L +
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 130 KNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSL-GNLTNLVTLCLYNNLLSGSIPSE 188
SG L L L N L D + L +L L L +P
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271
Query: 189 IG-NLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGS 232
+ L L+L N L+ P L + L+L N S
Sbjct: 272 LPAKLSV---LDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 35/208 (16%), Positives = 66/208 (31%), Gaps = 40/208 (19%)
Query: 525 GYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSP---KLGLLVQLEHL 581
G S +L ++ K L +L + ++ ++ ++ + L+ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 582 DLSSNNLSNAIPESLGNLV--KLHYLNLSNNQ----FSWEIPIKLEELIHLSELDLSYNF 635
L + ++ P L L+ LNL N +W ++ L L ++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 636 LGRAIPSQICIMQSLEKLNLSHN-------------------------------SLSGVI 664
Q+ + +L L+LS N + SGV
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 665 PRCFEEMHALQCIDISYNELRGPIPNST 692
LQ +D+S+N LR +
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 28/164 (17%), Positives = 50/164 (30%), Gaps = 9/164 (5%)
Query: 549 GKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPES---LGNLVKLHYL 605
G S L + + + L+ L + + + + I + + L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 606 NLSNNQFSWEIPIKLEELIH--LSELDLSYNFLGRAIPS----QICIMQSLEKLNLSHNS 659
L N + + P L E L+ L+L Q + L+ L+++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 660 LSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQ 703
AL +D+S N G +A LQ
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 54/236 (22%), Positives = 87/236 (36%), Gaps = 51/236 (21%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRHRNIVKF 860
IG+G G V +E + I A+K + ++ + + EV+ + ++ H NI +
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 861 YGFCSHAQHSFIVYEYLEMGSL-----------------------------------AMI 885
Y Q+ +V E G L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 886 LSNDAAAEDLEWTQRM--SVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARV- 942
+ + D +++ ++++ I AL YLHN I HRDI +N L +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 943 -SDFGIAKFLKP----DSSNWTELAGTYGYVAPEL--AYTMKVTEKCDVYSFGVLA 991
DFG++K + T AGT +VAPE+ KCD +S GVL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 63/231 (27%), Positives = 87/231 (37%), Gaps = 36/231 (15%)
Query: 77 YLDLWSNQLFGNIPP-QIGNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLS 134
LDL N L ++ + +L+ LDLS I LS+L TL L N +
Sbjct: 32 NLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 135 GSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLK 193
S+ L GLSSL L L + +G+L L L + +NL+ S
Sbjct: 90 -SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKL------ 141
Query: 194 YLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSE----LGNLKYLS-DLKL 248
P+ NL+NL L+LSSN + SI L + L+ L L
Sbjct: 142 ----------------PEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDL 184
Query: 249 ADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYN 299
+ N +N I L L + N L + L L KI L N
Sbjct: 185 SLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 53/250 (21%), Positives = 89/250 (35%), Gaps = 38/250 (15%)
Query: 369 YNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKE 428
+ IP + S L+L+FN L S + L VL + + I
Sbjct: 15 MELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70
Query: 429 -YRNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFI 485
Y++L L+ L L N Q + L+SL ++ L S + L +
Sbjct: 71 AYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 486 DLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIP 545
++++N + FS + LE LDLSSN + I
Sbjct: 130 NVAHNLI--------QSFKLPEY--FSN-------------LTNLEHLDLSSNKIQ-SIY 165
Query: 546 AE----LGKLSFL-IKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLV 600
L ++ L + L L+ N ++ + P ++L+ L L +N L + L
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLT 224
Query: 601 KLHYLNLSNN 610
L + L N
Sbjct: 225 SLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 52/223 (23%), Positives = 86/223 (38%), Gaps = 14/223 (6%)
Query: 232 SIPSEL-GNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKF 290
IP L + K L L+ N L +S + L +L + + + +L
Sbjct: 21 KIPDNLPFSTKNLD---LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 291 LSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLC 350
LS + L+ N L + LS++ L +L L + +LK+L L + +N +
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 351 GSIPH--FLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSY----LNLAFNKLTSSIPI 403
S + NLTNL L + +N + SI C L + L+L+ N + I
Sbjct: 138 -SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQP 194
Query: 404 SLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ 446
L L+ N L + L L K++L N +
Sbjct: 195 GAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 478 IYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYS-SQLEVLDLS 536
+ + +DLS+N L S + P+L LD S+ I I S S L L L+
Sbjct: 26 LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILT 84
Query: 537 SNHVVGDIPAEL-GKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSN-AIPE 594
N + + LS L KL+ + L+ + +G L L+ L+++ N + + +PE
Sbjct: 85 GNPI-QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 595 SLGNLVKLHYLNLSNNQFSWEIPI----KLEELIHLS-ELDLSYNFLGRAIPSQICIMQS 649
NL L +L+LS+N+ I L ++ L+ LDLS N + I
Sbjct: 144 YFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIR 201
Query: 650 LEKLNLSHNSLSGVIPRCFEEMHALQCIDISYN 682
L++L L N L V F+ + +LQ I + N
Sbjct: 202 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 14/220 (6%)
Query: 208 SIPQSLGNLSNLAMLNLSSNSLFGSIPSE-LGNLKYLSDLKLADNKLNGSIPHSLC-NLT 265
IP +L + L+LS N L + S + L L L+ ++ +I +L+
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76
Query: 266 NLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSL 325
+L L + N + L L L K+ + L +G+L + L + N +
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 326 FGLIPSEL-RNLKSLSILELGNNKLCGSIPH----FLGNLTNLSV-LFIYNNSLSGSIPC 379
E NL +L L+L +NK+ SI L + L++ L + N ++ I
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194
Query: 380 EIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKN 419
L L L N+L S LT+L + + N
Sbjct: 195 GAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 33/173 (19%), Positives = 63/173 (36%), Gaps = 11/173 (6%)
Query: 520 IPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKL-GLLVQL 578
IP + + LDLS N + L L L++ ++ + L L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 579 EHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKL-EELIHLSELDLSYNFLG 637
L L+ N + + + L L L + + L L EL++++N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
Query: 638 RAIPSQICI-MQSLEKLNLSHNSLSGVIPRCFEEMHALQCI----DISYNELR 685
+ + +LE L+LS N + + +H + + D+S N +
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 47/199 (23%), Positives = 77/199 (38%), Gaps = 33/199 (16%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
IG+G G V V+ + A KK + F E++ + + H NI++ Y
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKY---FVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 863 FCSHAQHSFIVYEYLEMGSL------AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
++V E G L + AA ++K + A++Y H
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---------IMKDVLSAVAYCHK 124
Query: 917 DCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL- 972
+ HRD+ +N L + ++ DFG+A KP GT YV+P++
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVL 180
Query: 973 --AYTMKVTEKCDVYSFGV 989
Y +CD +S GV
Sbjct: 181 EGLY----GPECDEWSAGV 195
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 33/219 (15%)
Query: 804 IGKGGQGSVYKVEL------ASGEIIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRHR 855
+G G G VY+ ++ S +AVK LP + Q +FL E +++ H+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL----SNDAAAEDLEWTQRMSVIKGIADAL 911
NIV+ G + FI+ E + G L L + L + V + IA
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARV---SDFGIAKFLKPDSSNWTELAGTYGYV 968
YL + F +HRDI+++N LL RV DFG+A+ + +++ G +
Sbjct: 154 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYR-KGGCAML 207
Query: 969 -----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHP 1000
PE T K D +SFGVL E+ G P
Sbjct: 208 PVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 19/222 (8%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVELASGE----IIAVKKFHSPLPGEMTFQQEFLNE 845
I + IGKG G VY E A+K + + FL E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQ-VEAFLRE 72
Query: 846 VKALTEIRHRNIVKFYGFCSHAQ-HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVI 904
+ + H N++ G + ++ Y+ G L + + + +S
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFG 130
Query: 905 KGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT 964
+A + YL F VHRD++++N +LD +V+DFG+A+ + D ++
Sbjct: 131 LQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHR 186
Query: 965 YGYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHP 1000
+ + A E T + T K DV+SFGVL E++ +G P
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 66/273 (24%), Positives = 111/273 (40%), Gaps = 25/273 (9%)
Query: 741 GIVALLISLIGLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDD 800
GI ++ L+ K Q + + L L + V F++
Sbjct: 36 GICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNE 95
Query: 801 EHCIGKGGQGSVYKVELASGE----IIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRH 854
IG+G G VY L + AVK L + +FL E + + H
Sbjct: 96 V--IGRGHFGCVYHGTLLDNDGKKIHCAVKS----LNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 855 RNIVKFYGFCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
N++ G C ++ S +V Y++ G L + N+ + + +A + +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKF 207
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYV----- 968
L + F VHRD++++N +LD K +V+DFG+A+ + + T +
Sbjct: 208 LASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWM 263
Query: 969 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHP 1000
A E T K T K DV+SFGVL E++ +G P
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 69/293 (23%), Positives = 112/293 (38%), Gaps = 62/293 (21%)
Query: 801 EHCIGKGGQGSVYKVELASGE----IIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRH 854
IG+G G VY L + AVK L + +FL E + + H
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS----LNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 855 RNIVKFYGFCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
N++ G C ++ S +V Y++ G L + N+ + + +A + Y
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKY 143
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL-------KPDSSN------WTE 960
L + F VHRD++++N +LD K +V+DFG+A+ + + + W
Sbjct: 144 LASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM- 199
Query: 961 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP------GDFISLISSSSLN 1013
A E T K T K DV+SFGVL E++ +G P D +
Sbjct: 200 --------ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-- 249
Query: 1014 LNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
RL P + L EV + C E RP+ ++ +
Sbjct: 250 -----------RLLQP-EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 70/300 (23%)
Query: 804 IGKGGQGSVYKVELASGE------IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
+G+G G V+ E + ++AVK + +Q+F E + LT ++H++I
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK---EASESARQDFQREAELLTMLQHQHI 105
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSL------------AMILSNDAAAEDLEWTQRMSVIK 905
V+F+G C+ + +V+EY+ G L + D A L Q ++V
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 906 GIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL------KPDSSN-- 957
+A + YL F VHRD++++N L+ ++ DFG+++ + +
Sbjct: 166 QVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 958 ---WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHP------GDFISL 1006
W PE + Y K T + DV+SFGV+ E+ GK P + I
Sbjct: 223 PIRWM---------PPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272
Query: 1007 ISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
I+ L P ++ + C P+ R +++ V L+
Sbjct: 273 ITQGR-------------ELERP-RACPPEV---YAIMRGCWQREPQQRHSIKDVHARLQ 315
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 52/231 (22%)
Query: 804 IGKGGQGSVYKVELASGE------IIAVK--KFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+G+G G V+ E + ++AVK K + +++F E + LT ++H
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-----DPTLAARKDFQREAELLTNLQHE 77
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSL-------------AMILSNDAAAEDLEWTQRMS 902
+IVKFYG C +V+EY++ G L + A +L +Q +
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 903 VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL------KPDSS 956
+ IA + YL + F VHRD++++N L+ ++ DFG+++ + +
Sbjct: 138 IASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 957 N-----WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHP 1000
W PE + Y K T + DV+SFGV+ E+ GK P
Sbjct: 195 TMLPIRWM---------PPESIMYR-KFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 33/219 (15%)
Query: 804 IGKGGQGSVYKVEL------ASGEIIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRHR 855
+G G G VY+ ++ S +AVK LP + Q +FL E +++ H+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT----LPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL--SNDAAAEDLEWTQR--MSVIKGIADAL 911
NIV+ G + FI+ E + G L L + ++ + V + IA
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARV---SDFGIAKFLKPDSSNWTELAGTYGYV 968
YL + F +HRDI+++N LL RV DFG+A+ + + + G +
Sbjct: 195 QYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYR-KGGCAML 248
Query: 969 -----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHP 1000
PE T K D +SFGVL E+ G P
Sbjct: 249 PVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-23
Identities = 77/363 (21%), Positives = 138/363 (38%), Gaps = 61/363 (16%)
Query: 679 ISYNELRGPIPNSTA-FRDAPIKALQGNKGLCGDFKGLPSCKALKSNKQASRK---IWIV 734
ISY +G P A F ++ +Q + D KG+ K + + + + I
Sbjct: 250 ISYLTDKGANPTHLADFNQ--VQTIQYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSLTIA 307
Query: 735 VLFPLL--GIVALLI----SLIGLFFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVY 788
L G L+ S I K R S K ++ ++ Y
Sbjct: 308 ENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDY 367
Query: 789 EEIIRATNDFDD---------------EHCIGKGGQGSVYK---VELASGEI-IAVKKFH 829
EII + + CIG+G G V++ + + + +A+K
Sbjct: 368 AEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK 427
Query: 830 SPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL-SN 888
+ + +++FL E + + H +IVK G + +I+ E +G L L
Sbjct: 428 NCTSDSV--REKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR 484
Query: 889 DAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948
L+ + ++ AL+YL + F VHRDI+++NVL+ + ++ DFG++
Sbjct: 485 K---FSLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLS 538
Query: 949 KFLKPDS----------SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KG 997
++++ + W APE + T DV+ FGV E++ G
Sbjct: 539 RYMEDSTYYKASKGKLPIKWM---------APESINFRRFTSASDVWMFGVCMWEILMHG 589
Query: 998 KHP 1000
P
Sbjct: 590 VKP 592
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 60/308 (19%), Positives = 115/308 (37%), Gaps = 56/308 (18%)
Query: 796 NDFDDEHCIGKG-GQGSVYKVELA--SGEIIAVK--------------KFHSPLPGEMTF 838
ND+ I + QG K+ L + A+K K ++ +
Sbjct: 31 NDYR----IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86
Query: 839 QQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSL------AMILSNDAAA 892
+F NE++ +T+I++ + G ++ +I+YEY+E S+ +L +
Sbjct: 87 YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 893 EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952
+ +IK + ++ SY+HN I HRD+ N+L+D ++SDFG ++++
Sbjct: 147 FIPIQVIK-CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM- 202
Query: 953 PDSSNWTELAGTYGYVAPELAYTMKVT--EKCDVYSFGVLALEVIKGKHPGDFISLISSS 1010
D GTY ++ PE K D++S G+ + P F S
Sbjct: 203 VDKKIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP--F-----SL 254
Query: 1011 SLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISC---------------LDESPESR 1055
++L + I + P + + L ++P R
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314
Query: 1056 PTMQKVSQ 1063
T + +
Sbjct: 315 ITSEDALK 322
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 46/220 (20%), Positives = 94/220 (42%), Gaps = 34/220 (15%)
Query: 791 IIRATNDFDD-----EHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLN 844
++ +F++ +G+G V + + ++G+ A K G+ + E L+
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-RAEILH 77
Query: 845 EVKALTEIRHR-NIVKFYGFCSHAQHSFIVYEYLEMGSL--------AMILSNDAAAEDL 895
E+ L + ++ + + ++ EY G + A ++S +
Sbjct: 78 EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR-- 135
Query: 896 EWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLK 952
+IK I + + YLH + IVH D+ +N+LL ++ DFG+++ +
Sbjct: 136 -------LIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185
Query: 953 PDSSNWTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLA 991
E+ GT Y+APE L Y +T D+++ G++A
Sbjct: 186 HACE-LREIMGTPEYLAPEILNYD-PITTATDMWNIGIIA 223
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 57/296 (19%), Positives = 111/296 (37%), Gaps = 66/296 (22%)
Query: 804 IGKGGQGSVYKVELASGE------IIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEIRHR 855
+G+G G VY+ +A+K + + ++ EFLNE + E
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKT----VNEAASMRERIEFLNEASVMKEFNCH 88
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL-------SNDAAAEDLEWTQRMSVIKGIA 908
++V+ G S Q + ++ E + G L L +N+ ++ + + IA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL------KPDSSN----- 957
D ++YL+ + F VHRD++++N ++ ++ DFG+ + + +
Sbjct: 149 DGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 958 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP------GDFISLISSS 1010
W +PE T DV+SFGV+ E+ + P + +
Sbjct: 206 WM---------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256
Query: 1011 SLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
L P N + L + C +P+ RP+ ++ +K
Sbjct: 257 G-------------LLDKP-DNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 295
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 8e-22
Identities = 57/308 (18%), Positives = 102/308 (33%), Gaps = 47/308 (15%)
Query: 370 NNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKE- 428
+ ++ IP ++ ++ L KL + S +L + +N + I +
Sbjct: 18 ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 74
Query: 429 YRNLVKLTKLFL-GDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFI 485
+ NL KL ++ + N I +NL +L + + + +
Sbjct: 75 FSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 133
Query: 486 DLSYNNLYGEISSDW--GRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGD 543
D+ N I + G + L +KN I I +QL+ L+LS N
Sbjct: 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN----- 187
Query: 544 IPAELGKLSFLIKLILAQNQLSGQLSPK-LGLLVQLEHLDLSSNNLSNAIPESLGNLVKL 602
N L +L LD+S + + L NL KL
Sbjct: 188 ------------------NNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL 228
Query: 603 HYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSG 662
+ N + ++P LE+L+ L E L+Y PS C + + + +
Sbjct: 229 RARSTYNLK---KLPT-LEKLVALMEASLTY-------PSHCCAFANWRRQISELHPICN 277
Query: 663 VIPRCFEE 670
E
Sbjct: 278 KSILRQEV 285
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 4e-21
Identities = 48/254 (18%), Positives = 87/254 (34%), Gaps = 13/254 (5%)
Query: 124 KTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG 183
+ +++++ IP ++ + L L I + +L + + N +
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 184 SIPSEI-GNLKYLLDLNLYN-NELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSEL-GNL 240
I +++ NL L ++ + N L P++ NL NL L +S+ + +P +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHLPDVHKIHS 127
Query: 241 KYLSDLKLADNKLNGSIPH-SLCNLT-NLVILYIYNNSLSGLIPSEIGNLKFLSKIALSY 298
L + DN +I S L+ VIL++ N + + S +
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDN 187
Query: 299 NKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLG 358
N L S L + + L L NLK L N K +P
Sbjct: 188 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTL-E 243
Query: 359 NLTNLSVLFIYNNS 372
L L + S
Sbjct: 244 KLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 1e-18
Identities = 56/302 (18%), Positives = 93/302 (30%), Gaps = 22/302 (7%)
Query: 102 LDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDI 160
+ + IP + L +L I G L + + N + ++
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 161 IP-HSLGNLTNLVTLCLYN-NLLSGSIPSEI-GNLKYLLDLNLYNNELNGSIPQ-SLGNL 216
I NL L + + N L I E NL L L + N + +P +
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127
Query: 217 SNLAMLNLSSNSLFGSIPSEL--GNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYI-Y 273
+L++ N +I G L L N + I +S N T L L +
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSD 186
Query: 274 NNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSEL 333
NN+L L + +S + L + L NL + + +P+ L
Sbjct: 187 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKK---LPT-L 242
Query: 334 RNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLA 393
L +L L C + F +S L N + +LA
Sbjct: 243 EKLVALMEASLTYPSHCCA---FANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLA 299
Query: 394 FN 395
+
Sbjct: 300 ED 301
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 49/234 (20%), Positives = 85/234 (36%), Gaps = 18/234 (7%)
Query: 54 NLTSIGLKG----TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLS-SN 107
N + + +FS F L +++ N + I + N+ KL + + +N
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 108 LFSGAIPPQI-GHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSN-YLEDIIPHS 164
I P+ +L L+ L + + +P L + N + I +S
Sbjct: 91 NLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 165 LGNLT-NLVTLCLYNNLLSGSIPSEIGNLKYLLDLNL-YNNELNGSIPQSLGNLSNLAML 222
L+ V L L N + I + N L +LNL NN L S +L
Sbjct: 149 FVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207
Query: 223 NLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNS 276
++S + S+PS L+ L L+ +P +L L L+ + S
Sbjct: 208 DISRTRI-HSLPS--YGLENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 46/246 (18%), Positives = 83/246 (33%), Gaps = 14/246 (5%)
Query: 175 CLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIP 234
C + + IPS++ + ++L +L + +L + +S N + I
Sbjct: 16 CQESKVTE--IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 71
Query: 235 SE-LGNLKYLSDLKLADNKLNGSIPHSLC-NLTNLVILYIYNNSLSGLIPSEIGNLKFLS 292
++ NL L ++++ I NL NL L I N + L +
Sbjct: 72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 131
Query: 293 KIALSYNKFSGLIPHSL--GNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLC 350
+ + N I + G L+L+ N + + S + + NN L
Sbjct: 132 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE 191
Query: 351 GSIPHFLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLT 409
+ +L I + S+P NLK L + L +P +L L
Sbjct: 192 ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLK-KLP-TLEKLV 246
Query: 410 NLSVLS 415
L S
Sbjct: 247 ALMEAS 252
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 6e-13
Identities = 35/212 (16%), Positives = 71/212 (33%), Gaps = 8/212 (3%)
Query: 478 IYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKI-GYSSQLEVLDLS 536
+ N + L + L ++ S+N++ I + +L + +
Sbjct: 28 LPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87
Query: 537 SNHVVGDIPAE-LGKLSFLIKLILAQNQLSGQLSPKLGL-LVQLEHLDLSSNNLSNAIPE 594
+ + I E L L L+++ + L + +Q LD+ N + I
Sbjct: 88 KANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146
Query: 595 SL--GNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICI-MQSLE 651
+ G + L L+ N EI L EL+LS N +P+ +
Sbjct: 147 NSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205
Query: 652 KLNLSHNSLSGVIPRCFEEMHALQCIDISYNE 683
L++S + + E + L+ +
Sbjct: 206 ILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 40/188 (21%), Positives = 73/188 (38%), Gaps = 18/188 (9%)
Query: 509 LDFSKNNITGNIPPKI-GYSSQLEVLDLSSNHVVGDIPAE----LGKLSFLIKLILAQNQ 563
L F + I LE +++S N V+ I A+ L KL + I N
Sbjct: 35 LRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI--RIEKANN 91
Query: 564 LSGQLSPK-LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIP----I 618
L ++P+ L L++L +S+ + + + ++ L++ +N I +
Sbjct: 92 LL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 619 KLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSH-NSLSGVIPRCFEEMHALQCI 677
L L L+ N + + I + L++LNLS N+L + F +
Sbjct: 151 GLSFE--SVILWLNKNGI-QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVIL 207
Query: 678 DISYNELR 685
DIS +
Sbjct: 208 DISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 17/112 (15%), Positives = 31/112 (27%), Gaps = 2/112 (1%)
Query: 573 GLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIK-LEELIHLSELDL 631
L L L + L + +S N I L L E+ +
Sbjct: 27 DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86
Query: 632 SYNFLGRAIPSQICI-MQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYN 682
I + + +L+ L +S+ + + +DI N
Sbjct: 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 138
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 61/295 (20%), Positives = 106/295 (35%), Gaps = 60/295 (20%)
Query: 801 EHCIGKGGQGSVYKVELASGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
+G+G GSV + L + +AVK + +EFL+E + + H N
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE-IEEFLSEAACMKDFSHPN 97
Query: 857 IVKFYGFCSHAQ-----HSFIVYEYLEMGSLAMIL---SNDAAAEDLEWTQRMSVIKGIA 908
+++ G C ++ +++ G L L + + + + + IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS-----------N 957
+ YL N F +HRD++++N +L V+DFG++K +
Sbjct: 158 LGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 958 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP------GDFISLISSS 1010
W A E T K DV++FGV E+ +G P + +
Sbjct: 215 WI---------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265
Query: 1011 SLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
RL P + ++L E+ SC P RPT + L
Sbjct: 266 H-------------RLKQP-EDCLDEL---YEIMYSCWRTDPLDRPTFSVLRLQL 303
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 44/218 (20%)
Query: 795 TNDFDD-----EHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKA 848
D + +G G G V + +G+ A+K + + EV
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--------SPKARQEVDH 74
Query: 849 LTEI-RHRNIVKFYGFCSHAQHS----FIVYEYLEMGSL--------AMILSNDAAAEDL 895
+ +IV + H I+ E +E G L + AAE
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE-- 132
Query: 896 EWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLK 952
+++ I A+ +LH+ I HRD+ +N+L K + +++DFG AK
Sbjct: 133 -------IMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 953 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 990
++ T YVAPE+ K + CD++S GV+
Sbjct: 183 QNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 56/294 (19%), Positives = 106/294 (36%), Gaps = 61/294 (20%)
Query: 804 IGKGGQGSVYKVELASGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
+GKG GSV + +L + +AVK + + +EFL E + E H ++ K
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVAK 89
Query: 860 FYGFCSHAQ------HSFIVYEYLEMGSLAMIL---SNDAAAEDLEWTQRMSVIKGIADA 910
G ++ ++ +++ G L L +L + + IA
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS-----------NWT 959
+ YL + F +HRD++++N +L V+DFG+++ + W
Sbjct: 150 MEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-------KGKHPGDFISLISSSSL 1012
A E T DV++FGV E++ G + + + +
Sbjct: 207 ---------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN- 256
Query: 1013 NLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
RL P E++ ++ C P+ RP+ + L+
Sbjct: 257 ------------RLKQP-PECMEEV---YDLMYQCWSADPKQRPSFTCLRMELE 294
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-21
Identities = 71/357 (19%), Positives = 130/357 (36%), Gaps = 76/357 (21%)
Query: 751 GLFFKF-QRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYE-EIIRATNDFDDEHCIGKGG 808
G+ +K+ Q+ K + + K + + + E R F +G G
Sbjct: 1 GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKT--LGAGA 58
Query: 809 QGSVYK---VELASGE---IIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI-RHRNIVK 859
G V + L + +AVK L + ++E+K ++ + +H NIV
Sbjct: 59 FGKVVEATAFGLGKEDAVLKVAVKM----LKSTAHADEKEALMSELKIMSHLGQHENIVN 114
Query: 860 FYGFCSHAQHSFIVYEYLEMGSL-----------AMILSNDAAAEDLEWTQRMSVIKGIA 908
G C+H ++ EY G L + A + +A
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS-----SN------ 957
+++L + +HRD++++NVLL + A++ DFG+A+ + DS N
Sbjct: 175 QGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231
Query: 958 WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP-------GDFISLISS 1009
W APE + T + DV+S+G+L E+ G +P F L+
Sbjct: 232 WM---------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 1010 SSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
++ P+ + + +C P RPT Q++ L+
Sbjct: 283 GY-------------QMAQPAFAPKN----IYSIMQACWALEPTHRPTFQQICSFLQ 322
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 52/228 (22%), Positives = 94/228 (41%), Gaps = 51/228 (22%)
Query: 795 TNDFDD-----EHCIGKGGQGSVYK-VELASGEIIAVK---KFHSPLPGEMTFQQEFLNE 845
+ F+D E +G+G V + L + + AVK K P E
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK--QPGHIR----SRVFRE 60
Query: 846 VKALTEIR-HRNIVKFYGFCSHAQHSFIVYEYLEMGSL-AMILSN------DAAAEDLEW 897
V+ L + + HRN+++ F ++V+E + GS+ + I +A+
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV----- 115
Query: 898 TQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPD 954
V++ +A AL +LHN I HRD+ +N+L + N+ ++ DF + +K +
Sbjct: 116 -----VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 955 SS-------NWTELAGTYGYVAPE-----LAYTMKVTEKCDVYSFGVL 990
G+ Y+APE ++CD++S GV+
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 53/183 (28%), Positives = 69/183 (37%), Gaps = 10/183 (5%)
Query: 72 FPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFK 130
L L N L ++L L+L + + G L L TL L
Sbjct: 30 PKDTTILHLSENLL-YTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSH 86
Query: 131 NQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI- 189
NQL S+PL L +L L + N L + +L L L L L N L ++P +
Sbjct: 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLL 144
Query: 190 GNLKYLLDLNLYNNELNGSIPQSL-GNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKL 248
L L+L NN L +P L L NL L L NSL +IP L L
Sbjct: 145 TPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL-YTIPKGFFGSHLLPFAFL 202
Query: 249 ADN 251
N
Sbjct: 203 HGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 48/167 (28%), Positives = 68/167 (40%), Gaps = 8/167 (4%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSY 122
T + + L L+L +L G + L LDLS N ++P L
Sbjct: 45 TFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPA 101
Query: 123 LKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLL 181
L L + N+L+ S+PL GL L L L N L+ + P L L L L NN L
Sbjct: 102 LTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160
Query: 182 SGSIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSN 227
+ +P+ + L+ L L L N L +IP+ L L N
Sbjct: 161 T-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 7/205 (3%)
Query: 167 NLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSS 226
+ + + + L+ ++P ++ K L+L N L +L + L LNL
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 227 NSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIG 286
L + + G L L L L+ N+L S+P L L +L + N L+ L +
Sbjct: 65 AEL-TKLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 287 NLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGN 346
L L ++ L N+ L P L + L L +N+L L L L++L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 347 NKLCGSIPHFLGNLTNLSVLFIYNN 371
N L +IP L F++ N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 9e-19
Identities = 55/235 (23%), Positives = 94/235 (40%), Gaps = 37/235 (15%)
Query: 215 NLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYN 274
+++ +N +L ++P +P + IL++
Sbjct: 8 KVASHLEVNCDKRNL-TALPP--------------------DLP------KDTTILHLSE 40
Query: 275 NSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELR 334
N L + + L+++ L + + L G L + L L N L +P +
Sbjct: 41 NLLYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQL-QSLPLLGQ 97
Query: 335 NLKSLSILELGNNKLCGSIPH-FLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNL 392
L +L++L++ N+L S+P L L L L++ N L ++P + L L+L
Sbjct: 98 TLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSL 155
Query: 393 AFNKLTSSIPISL-SNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ 446
A N LT +P L + L NL L +NSL IPK + L FL N +
Sbjct: 156 ANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 19/212 (8%)
Query: 453 KNLTSLVRVHLDRNYLTS---NISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGAL 509
+ S + V+ D+ LT+ ++ + T + LS N LY + +L L
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 510 DFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLS 569
+ + +T + L LDLS N + +P L L L ++ N+L+ L
Sbjct: 61 NLDRAELT-KLQVDGT-LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLP 116
Query: 570 PKL-GLLVQLEHLDLSSNNLSNAIPESL-GNLVKLHYLNLSNNQFSWEIPIKL-EELIHL 626
L +L+ L L N L +P L KL L+L+NN + E+P L L +L
Sbjct: 117 LGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENL 174
Query: 627 SELDLSYNFLGRAIPSQICIMQSLEKLNLSHN 658
L L N L IP L L N
Sbjct: 175 DTLLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 9/184 (4%)
Query: 311 NLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYN 370
+++ + D +L +P +L K +IL L N L L T L+ L +
Sbjct: 8 KVASHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 371 NSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYR 430
L+ + G L L L+L+ N+L S+P+ L L+VL N L+ R
Sbjct: 65 AELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 431 NLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLS 488
L +L +L+L N+ + +P L L ++ L N LT + NL + L
Sbjct: 122 GLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 489 YNNL 492
N+L
Sbjct: 181 ENSL 184
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 10/179 (5%)
Query: 509 LDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQL 568
++ K N+T +PP + +L LS N + A L + L +L L + +L
Sbjct: 15 VNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TK 69
Query: 569 SPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKL-EELIHLS 627
G L L LDLS N L ++P L L L++S N+ + +P+ L L
Sbjct: 70 LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQ 127
Query: 628 ELDLSYNFLGRAIPSQICI-MQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
EL L N L + +P + LEKL+L++N+L+ + + L + + N L
Sbjct: 128 ELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 54/256 (21%), Positives = 87/256 (33%), Gaps = 62/256 (24%)
Query: 359 NLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYK 418
+ + + +L+ ++P ++ K + L+L+ N L + +L T L+ L+ +
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 419 NSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNL-KNLTSLVRVHLDRNYLTSNISESFY 477
L+ + L L L L NQ Q +P L + L +L + + N LTS +
Sbjct: 65 AELT-KLQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 478 IYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSS 537
L + L N L +PP +
Sbjct: 122 GLGELQELYLKGNEL-------------------------KTLPPGL------------- 143
Query: 538 NHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGL---LVQLEHLDLSSNNLSNAIPE 594
L L KL LA N L+ GL L L+ L L N+L IP+
Sbjct: 144 ----------LTPTPKLEKLSLANNNLT---ELPAGLLNGLENLDTLLLQENSLYT-IPK 189
Query: 595 SLGNLVKLHYLNLSNN 610
L + L N
Sbjct: 190 GFFGSHLLPFAFLHGN 205
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 7e-21
Identities = 55/247 (22%), Positives = 96/247 (38%), Gaps = 56/247 (22%)
Query: 787 VYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGE---IIAVKKFHSPLPGEMTFQQ--E 841
+Y + F D IG+G G V K + A+K+ + + +
Sbjct: 18 IYPVLDWNDIKFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKR----MKEYASKDDHRD 71
Query: 842 FLNEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEMGSL-------------AMILS 887
F E++ L ++ H NI+ G C H + ++ EY G+L
Sbjct: 72 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 888 NDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGI 947
++ A L Q + +A + YL F +HRD++++N+L+ A+++DFG+
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGL 188
Query: 948 AKFLKPDSSN------------WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEV 994
++ W A E L Y+ T DV+S+GVL E+
Sbjct: 189 SR----GQEVYVKKTMGRLPVRWM---------AIESLNYS-VYTTNSDVWSYGVLLWEI 234
Query: 995 I-KGKHP 1000
+ G P
Sbjct: 235 VSLGGTP 241
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 50/233 (21%), Positives = 87/233 (37%), Gaps = 49/233 (21%)
Query: 801 EHCIGKGGQGSVYKVELASGE------IIAVKKFHSPLPGEMTFQQ--EFLNEVKALTEI 852
+G+ G VYK L +A+K L + EF +E +
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKT----LKDKAEGPLREEFRHEAMLRARL 69
Query: 853 RHRNIVKFYGFCSHAQHSFIVYEYLEMGSL-------------AMILSNDAAAEDLEWTQ 899
+H N+V G + Q +++ Y G L + LE
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 900 RMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL------KP 953
+ ++ IA + YL + VH+D++++NVL+ K ++SD G+ + + K
Sbjct: 130 FVHLVAQIAAGMEYLSSHHV---VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186
Query: 954 DSSN-----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP 1000
++ W APE K + D++S+GV+ EV G P
Sbjct: 187 LGNSLLPIRWM---------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 57/255 (22%), Positives = 94/255 (36%), Gaps = 44/255 (17%)
Query: 757 QRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDD----EHCIGKGGQGSV 812
+ + + P + F K + I+ DD +G G G V
Sbjct: 21 PQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQ--IKKNAIIDDYKVTSQVLGLGINGKV 78
Query: 813 YK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFC----SH 866
+ + E A+K + EV+ + +IV+ +
Sbjct: 79 LQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAG 130
Query: 867 AQHSFIVYEYLEMGSL--------AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
+ IV E L+ G L + A+E ++K I +A+ YLH+
Sbjct: 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE---------IMKSIGEAIQYLHSIN 181
Query: 919 FPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT 975
I HRD+ +N+L K +++DFG AK +S T T YVAPE+
Sbjct: 182 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGP 237
Query: 976 MKVTEKCDVYSFGVL 990
K + CD++S GV+
Sbjct: 238 EKYDKSCDMWSLGVI 252
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 98 KLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNY 156
+D SS + AIP I + K L L N+LS S+P + L+ L L L N
Sbjct: 17 NKNSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNK 72
Query: 157 LEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNELNGSIPQSL-G 214
L+ + L NL TL + +N L ++P + L L +L L N+L S+P +
Sbjct: 73 LQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFD 130
Query: 215 NLSNLAMLNLSSNSLFGSIPS----ELGNLKYLSDLKLADNKLNGSIPHSLC-NLTNLVI 269
+L+ L L+L N L S+P +L +LK L L +N+L +P LT L
Sbjct: 131 SLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELR---LYNNQLK-RVPEGAFDKLTELKT 185
Query: 270 LYIYNNSLSGLIPSEIGNLKFLSKIALSYN 299
L + NN L + +L+ L + L N
Sbjct: 186 LKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 59/215 (27%), Positives = 88/215 (40%), Gaps = 13/215 (6%)
Query: 69 FSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTL 126
F L L L N+L +P I + L+ L ++ N A+P + L L L
Sbjct: 57 FHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAEL 114
Query: 127 HLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSI 185
L +NQL S+P V L+ L L+L N L+ + LT+L L LYNN L +
Sbjct: 115 RLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RV 172
Query: 186 PSEI-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLS 244
P L L L L NN+L + +L L ML L N + + Y++
Sbjct: 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNGII----YMA 228
Query: 245 D-LKLADNKLNGSIPHSLCNLTNLVILYIYNNSLS 278
LK ++ G + + C +L I +
Sbjct: 229 KWLKKKADEGLGGVDTAGCEKGGKAVLEITEKDAA 263
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 53/182 (29%), Positives = 75/182 (41%), Gaps = 6/182 (3%)
Query: 265 TNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNS 324
+ L + +N LS L L L + L+ NK L L N+ L++ N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 325 LFGLIPSELRNLKSLSILELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSLSGSIPCEI- 381
L L L +L+ L L N+L S+P F +LT L+ L + N L S+P +
Sbjct: 97 LQALPIGVFDQLVNLAELRLDRNQL-KSLPPRVF-DSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 382 GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLG 441
L SL L L N+L + LT L L N L + +L KL L L
Sbjct: 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 442 DN 443
+N
Sbjct: 214 EN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 57/186 (30%), Positives = 83/186 (44%), Gaps = 14/186 (7%)
Query: 145 SSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNN 203
+ L L SN L + + LT L L L +N L ++P+ I LK L L + +N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 204 ELNGSIPQSL-GNLSNLAMLNLSSNSLFGSIPS----ELGNLKYLSDLKLADNKLNGSIP 258
+L ++P + L NLA L L N L S+P L L YLS L N+L S+P
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLS---LGYNELQ-SLP 149
Query: 259 HSLC-NLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAF 317
+ LT+L L +YNN L + L L + L N+ + + +L +
Sbjct: 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKM 209
Query: 318 LFLDSN 323
L L N
Sbjct: 210 LQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 65/201 (32%), Positives = 90/201 (44%), Gaps = 11/201 (5%)
Query: 223 NLSSNSLFGSIPSEL-GNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLI 281
+ SS L +IPS + + K L L NKL+ + LT L +LY+ +N L L
Sbjct: 22 DCSSKKL-TAIPSNIPADTKKLD---LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77
Query: 282 PSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSI 341
LK L + ++ NK L L N+A L LD N L L P +L L+
Sbjct: 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY 137
Query: 342 LELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLT 398
L LG N+L S+P F LT+L L +YNN L +P L L L L N+L
Sbjct: 138 LSLGYNEL-QSLPKGVF-DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK 194
Query: 399 SSIPISLSNLTNLSVLSFYKN 419
+ +L L +L +N
Sbjct: 195 RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 58/220 (26%), Positives = 88/220 (40%), Gaps = 34/220 (15%)
Query: 395 NKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN--L 452
KLT+ IP ++ + L N LS K + L KL L+L DN+ Q +P
Sbjct: 26 KKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIF 81
Query: 453 KNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFS 512
K L +L + + N L + P F L L L
Sbjct: 82 KELKNLETLWVTDNKLQA--------LPIGVFDQLV----------------NLAELRLD 117
Query: 513 KNNITGNIPPKIGYS-SQLEVLDLSSNHVVGDIPAEL-GKLSFLIKLILAQNQLSGQLSP 570
+N + ++PP++ S ++L L L N + +P + KL+ L +L L NQL
Sbjct: 118 RNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEG 175
Query: 571 KLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
L +L+ L L +N L + +L KL L L N
Sbjct: 176 AFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 12/180 (6%)
Query: 509 LDFSKNNITGNIPPKIGYS-SQLEVLDLSSNHVVGDIPAEL-GKLSFLIKLILAQNQLSG 566
LD N ++ ++P K + ++L +L L+ N + +PA + +L L L + N+L
Sbjct: 42 LDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ- 98
Query: 567 QLSPKL-GLLVQLEHLDLSSNNLSNAIPESL-GNLVKLHYLNLSNNQFSWEIPIKL-EEL 623
L + LV L L L N L ++P + +L KL YL+L N+ +P + ++L
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDKL 156
Query: 624 IHLSELDLSYNFLGRAIPSQICI-MQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYN 682
L EL L N L + +P + L+ L L +N L V F+ + L+ + + N
Sbjct: 157 TSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 520 IPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKL-GLLVQL 578
IP I + + LDL SN + +L+ L L L N+L L + L L
Sbjct: 31 IPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNL 87
Query: 579 EHLDLSSNNLSNAIPESL-GNLVKLHYLNLSNNQFSWEIPIKL-EELIHLSELDLSYNFL 636
E L ++ N L A+P + LV L L L NQ +P ++ + L L+ L L YN L
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
Query: 637 GRAIPSQICI-MQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
+++P + + SL++L L +N L V F+++ L+ + + N+L+
Sbjct: 146 -QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-19
Identities = 75/348 (21%), Positives = 136/348 (39%), Gaps = 80/348 (22%)
Query: 762 KSQTKQSSPRNTPGLRSMLTFEGKIVYE-EIIRATNDFDDEHCIGKGGQGSVYKVELASG 820
+ T+ SS +TP L + +E + E R +G+G G V E
Sbjct: 48 RITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKP--LGEGCFGQVVMAEAVGI 105
Query: 821 E--------IIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI-RHRNIVKFYGFCSHAQH 869
+ +AVK L + T + + ++E++ + I +H+NI+ G C+
Sbjct: 106 DKDKPKEAVTVAVKM----LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161
Query: 870 SFIVYEYLEMGSL-------------AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
+++ EY G+L N E + + +S +A + YL +
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD-----SSN------WTELAGTY 965
+HRD++++NVL+ N +++DFG+A+ + ++N W
Sbjct: 222 QKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------ 272
Query: 966 GYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP--GDFISLISSSSLNLNIALDEIL 1022
APE + T + DV+SFGVL E+ G P G I ++E+
Sbjct: 273 ---APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG--------------IPVEELF 315
Query: 1023 DP-----RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
R+ P++ E + C P RPT +++ + L
Sbjct: 316 KLLKEGHRMDKPANCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDL 359
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 45/240 (18%), Positives = 85/240 (35%), Gaps = 19/240 (7%)
Query: 187 SEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDL 246
L + NL + + S LS + N ++++ + + L +L
Sbjct: 13 FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKEL 68
Query: 247 KLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIP 306
L+ N+++ + L +LT L L + N L L L L L N+
Sbjct: 69 HLSHNQIS-DLS-PLKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRDTDS 123
Query: 307 HSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVL 366
L +L N+ L + +N L + L L L +L+L N++ + L L ++ +
Sbjct: 124 --LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNWI 177
Query: 367 FIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPIS-LSNLTNLSV---LSFYKNSLS 422
+ L + + + S IS + + V L Y + +S
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDEVS 237
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 50/233 (21%), Positives = 91/233 (39%), Gaps = 17/233 (7%)
Query: 67 FSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTL 126
F + +L + ++ +S ++ + ++ ++ + + LK L
Sbjct: 13 FPDPGLANAVKQNLGKQSV-TDLVS-QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68
Query: 127 HLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIP 186
HL NQ+S PL+ L+ L L++ N L+++ + L L L NN L
Sbjct: 69 HLSHNQISDLSPLK--DLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRD--T 121
Query: 187 SEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDL 246
+ +LK L L++ NN+L SI LG LS L +L+L N + + L LK ++ +
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWI 177
Query: 247 KLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYN 299
L K L + + + P I N + +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLWE 228
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 14/199 (7%)
Query: 431 NLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYN 490
L K LG + + K L+ + + D + + S + NL + LS+N
Sbjct: 17 GLANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHLSHN 73
Query: 491 NLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGK 550
+ ++S KL L ++N + N+ S+ L L L +N + D + L
Sbjct: 74 QI-SDLSP-LKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELR-DTDS-LIH 126
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
L L L + N+L + LG L +LE LDL N ++N L L K+++++L+
Sbjct: 127 LKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQ 182
Query: 611 QFSWEIPIKLEELIHLSEL 629
+ E EL + +
Sbjct: 183 KCVNEPVKYQPELYITNTV 201
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 43/215 (20%), Positives = 79/215 (36%), Gaps = 17/215 (7%)
Query: 309 LGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFI 368
L+N L S+ L+ + L + N+ + + TNL L +
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHL 70
Query: 369 YNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKE 428
+N +S P + +L L L++ N+L + ++ LS L N L
Sbjct: 71 SHNQISDLSP--LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRDTDSLI 125
Query: 429 YRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLS 488
+L L L + +N+ + I L L+ L + L N +T+ + +IDL+
Sbjct: 126 --HLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLT 180
Query: 489 YNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPK 523
++ P+L + K+ I P
Sbjct: 181 GQKC---VNEPVKYQPELYITNTVKDPDGRWISPY 212
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 29/138 (21%), Positives = 58/138 (42%), Gaps = 11/138 (7%)
Query: 548 LGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNL 607
L+ +K L + ++ L L +++ + ++N+ + + L L+L
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHL 70
Query: 608 SNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRC 667
S+NQ S ++ L++L L EL ++ N L L +L L +N L
Sbjct: 71 SHNQIS-DLS-PLKDLTKLEELSVNRNRLKNLNGIPSA---CLSRLFLDNNELRDTDS-- 123
Query: 668 FEEMHALQCIDISYNELR 685
+ L+ + I N+L+
Sbjct: 124 LIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 17/103 (16%), Positives = 41/103 (39%), Gaps = 8/103 (7%)
Query: 583 LSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPS 642
++ P L NL + + +EL + + + +
Sbjct: 4 QRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG- 58
Query: 643 QICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
+ +L++L+LSHN +S + P +++ L+ + ++ N L+
Sbjct: 59 -MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK 98
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 66/305 (21%), Positives = 120/305 (39%), Gaps = 77/305 (25%)
Query: 804 IGKGGQGSVYK--------VELASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI- 852
+G+G G V + +AVK L + T + + ++E++ + I
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM----LKDDATEKDLSDLVSEMEMMKMIG 98
Query: 853 RHRNIVKFYGFCSHAQHSFIVYEYLEMGSL-------------AMILSNDAAAEDLEWTQ 899
+H+NI+ G C+ +++ EY G+L N E + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 900 RMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD----- 954
+S +A + YL + +HRD++++NVL+ N +++DFG+A+ +
Sbjct: 159 LVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 955 SSN------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP--GDFIS 1005
++N W APE + T + DV+SFGVL E+ G P G
Sbjct: 216 TTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG---- 262
Query: 1006 LISSSSLNLNIALDEILDP-----RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQK 1060
I ++E+ R+ P N +L + C P RPT ++
Sbjct: 263 ----------IPVEELFKLLKEGHRMDKP-ANCTNEL---YMMMRDCWHAVPSQRPTFKQ 308
Query: 1061 VSQLL 1065
+ + L
Sbjct: 309 LVEDL 313
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 63/255 (24%), Positives = 103/255 (40%), Gaps = 46/255 (18%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+ F+ IGKG G V V+ + ++ A+K + E + E++ + + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 855 RNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AAEDLEWTQRMSV 903
+V +Y F + F+V + L G L L + E
Sbjct: 75 PFLVNLWYSFQD-EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE---------- 123
Query: 904 IKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG 963
+ AL YL N I+HRD+ N+LLD ++DF IA L ++ T +AG
Sbjct: 124 ---LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAG 176
Query: 964 TYGYVAPEL-------AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNI 1016
T Y+APE+ Y+ V D +S GV A E+++G+ P + SS +
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP--Y---HIRSSTSSKE 227
Query: 1017 ALDEILDPRLPIPSH 1031
+ + PS
Sbjct: 228 IVHTFETTVVTYPSA 242
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 62/277 (22%), Positives = 103/277 (37%), Gaps = 49/277 (17%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVK-------KFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+GKGG G+V+ L +A+K SPL +T E K H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGS--LAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
+++ + + +V E I E ++ + A+ +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP--SRC--FFGQVVAAIQH 154
Query: 914 LHNDCFPPIVHRDISSKNVLLDFK-NEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
H+ +VHRDI +N+L+D + A++ DFG L +T+ GT Y PE
Sbjct: 155 CHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTRVYSPPEW 209
Query: 973 ----AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028
Y V+S G+L +++ G P + EIL+ L
Sbjct: 210 ISRHQYHAL---PATVWSLGILLYDMVCGDIPFERD--------------QEILEAELHF 252
Query: 1029 PSHNVQE--KLISFVEVAISCLDESPESRPTMQKVSQ 1063
P+H + LI CL P SRP+++++
Sbjct: 253 PAHVSPDCCALIR------RCLAPKPSSRPSLEEILL 283
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 65/267 (24%), Positives = 113/267 (42%), Gaps = 37/267 (13%)
Query: 808 GQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
G+G+ KV+LA +G +A+K + Q+ F EV+ + + H NIVK +
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFEV 82
Query: 864 CSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
+ +++ EY G + ++++ E + S + I A+ Y H I
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFRQIVSAVQYCHQKR---I 135
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----AYTMKV 978
VHRD+ ++N+LLD +++DFG + G Y APEL Y
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYAAPELFQGKKYDGP- 193
Query: 979 TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH--NVQEK 1036
+ DV+S GV+ ++ G P D NL + +L + IP + E
Sbjct: 194 --EVDVWSLGVILYTLVSGSLPFD--------GQNLKELRERVLRGKYRIPFYMSTDCEN 243
Query: 1037 LISFVEVAISCLDESPESRPTMQKVSQ 1063
L+ L +P R T++++ +
Sbjct: 244 LLK------RFLVLNPIKRGTLEQIMK 264
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 65/306 (21%), Positives = 119/306 (38%), Gaps = 77/306 (25%)
Query: 804 IGKGGQGSVYK--------VELASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI- 852
+G+G G V + +AVK L + T + + ++E++ + I
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM----LKSDATEKDLSDLISEMEMMKMIG 132
Query: 853 RHRNIVKFYGFCSHAQHSFIVYEYLEMGSL-------------AMILSNDAAAEDLEWTQ 899
+H+NI+ G C+ +++ EY G+L + E L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 900 RMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD----- 954
+S +A + YL + +HRD++++NVL+ N +++DFG+A+ +
Sbjct: 193 LVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 955 SSN------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP--GDFIS 1005
++N W APE + T + DV+SFGVL E+ G P G
Sbjct: 250 TTNGRLPVKWM---------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG---- 296
Query: 1006 LISSSSLNLNIALDEILDP-----RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQK 1060
+ ++E+ R+ PS+ E + C P RPT ++
Sbjct: 297 ----------VPVEELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQ 342
Query: 1061 VSQLLK 1066
+ + L
Sbjct: 343 LVEDLD 348
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 49/231 (21%), Positives = 95/231 (41%), Gaps = 54/231 (23%)
Query: 804 IGKGGQGSVYKVELASGE------IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
IG+G G V++ ++AVK +M Q +F E + E + NI
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALMAEFDNPNI 112
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSL---------------------AMILSNDAAAEDLE 896
VK G C+ + +++EY+ G L + L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 897 WTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL----- 951
+++ + + +A ++YL F VHRD++++N L+ +++DFG+++ +
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 952 -KPDSSN-----WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI 995
K D ++ W PE + Y + T + DV+++GV+ E+
Sbjct: 230 YKADGNDAIPIRWM---------PPESIFYN-RYTTESDVWAYGVVLWEIF 270
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 65/311 (20%), Positives = 116/311 (37%), Gaps = 84/311 (27%)
Query: 804 IGKGGQGSVYKVELASGE------IIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEIRHR 855
+G+G G V K + +AVK L + ++ L+E L ++ H
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKM----LKENASPSELRDLLSEFNVLKQVNHP 86
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSL---------------------AMILSNDAAAED 894
+++K YG CS ++ EY + GSL +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 895 LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954
L +S I+ + YL VHRD++++N+L+ + ++SDFG+++ + +
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKL---VHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 955 -----SSN------WTELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHP- 1000
S W A E L T + DV+SFGVL E++ G +P
Sbjct: 204 DSYVKRSQGRIPVKWM---------AIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 1001 -GDFISLISSSSLNLNIALDEILDP-----RLPIPSHNVQEKLISFVEVAISCLDESPES 1054
G I + + + R+ P + +E + + C + P+
Sbjct: 254 PG--------------IPPERLFNLLKTGHRMERPDNCSEE----MYRLMLQCWKQEPDK 295
Query: 1055 RPTMQKVSQLL 1065
RP +S+ L
Sbjct: 296 RPVFADISKDL 306
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 60/274 (21%), Positives = 105/274 (38%), Gaps = 45/274 (16%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
+G G G V+ V+ + + VK K E + E+ L+ + H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGS--LAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
+K + +V E G A I + E L + + + A+ YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL----ASYIFRQLVSAVGYLR 147
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL--- 972
I+HRDI +N+++ ++ DFG A +L+ +T GT Y APE+
Sbjct: 148 LKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAPEVLMG 203
Query: 973 -AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031
Y + +++S GV ++ ++P L+E ++ + P
Sbjct: 204 NPYRGP---ELEMWSLGVTLYTLVFEENPFC--------------ELEETVEAAIHPPYL 246
Query: 1032 NVQE--KLISFVEVAISCLDESPESRPTMQKVSQ 1063
+E L+S L PE R T++K+
Sbjct: 247 VSKELMSLVS------GLLQPVPERRTTLEKLVT 274
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 64/299 (21%), Positives = 113/299 (37%), Gaps = 65/299 (21%)
Query: 804 IGKGGQGSVYK------VELASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI-RH 854
+G+G G V + + A+ +AVK L T + ++E+K L I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKM----LKEGATHSEHRALMSELKILIHIGHH 90
Query: 855 RNIVKFYGFCSHA-QHSFIVYEYLEMGSL-------------AMILSNDAAAEDLEWTQR 900
N+V G C+ ++ E+ + G+L + D + L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 901 MSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS---- 956
+ +A + +L + +HRD++++N+LL KN ++ DFG+A+ + D
Sbjct: 151 ICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 957 -------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLIS 1008
W APE + T + DV+SFGVL E+ G P
Sbjct: 208 GDARLPLKWM---------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-------- 250
Query: 1009 SSSLNLNIALDEILDP--RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLL 1065
+ ++ L R+ P + E + + C P RPT ++ + L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 305
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 64/304 (21%), Positives = 114/304 (37%), Gaps = 72/304 (23%)
Query: 804 IGKGGQGSVYK---VELASGE---IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRN 856
+G G G V + L + +AVK ++ ++E+K L+ + H N
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSYLGNHMN 88
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSL---------------AMILSNDAAAEDLEWTQRM 901
IV G C+ + ++ EY G L + L+ +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 902 SVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD-----SS 956
S +A +++L + +HRD++++N+LL ++ DFG+A+ +K D
Sbjct: 149 SFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 957 N------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP-------GD 1002
N W APE + T + DV+S+G+ E+ G P
Sbjct: 206 NARLPVKWM---------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 1003 FISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVS 1062
F +I R+ P H E ++ +C D P RPT +++
Sbjct: 257 FYKMIKEGF-------------RMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIV 299
Query: 1063 QLLK 1066
QL++
Sbjct: 300 QLIE 303
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-18
Identities = 58/243 (23%), Positives = 94/243 (38%), Gaps = 28/243 (11%)
Query: 777 RSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGE 835
M E + + F E G+G G+V E ++G +A+KK +
Sbjct: 4 SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ----D 59
Query: 836 MTFQQEFLNEVKALTEIRHRNIVK-FYGFCSHAQHSF------IVYEYLEMGSLAMILSN 888
F+ L ++ L + H NIV+ F + + +V EY+ +
Sbjct: 60 PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY 119
Query: 889 DAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN-EARVSDFGI 947
+ + ++ LH + HRDI NVL++ + ++ DFG
Sbjct: 120 YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGS 178
Query: 948 AKFLKPDSSNWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGKH-- 999
AK L P N + Y Y APEL YT V D++S G + A E++ G+
Sbjct: 179 AKKLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFA-EMMLGEPIF 232
Query: 1000 PGD 1002
GD
Sbjct: 233 RGD 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 43/256 (16%), Positives = 82/256 (32%), Gaps = 35/256 (13%)
Query: 361 TNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNS 420
+ + IP S L L L + + SNL N+S + +
Sbjct: 11 HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 421 LSGAIPKEY-RNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNISESFY 477
+ NL K+T + + + + I LK L L + + L
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM------- 119
Query: 478 IYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKI--GYSSQLEVLDL 535
+P+LT + + L+ + N +IP G ++ L L
Sbjct: 120 -FPDLTKVYST---------------DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163
Query: 536 SSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKL--GLLVQLEHLDLSSNNLSNAIP 593
+N + + L + L +N+ + G+ LD+S +++
Sbjct: 164 YNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPS 222
Query: 594 ESLGNLVKLHYLNLSN 609
+ L +L +L N
Sbjct: 223 KGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 16/203 (7%)
Query: 54 NLTSIGLKG----TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNL 108
+ ++ L T+ +FS+ P+++ + + + + N+SK+ ++++ +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 109 FSGAIPPQI-GHLSYLKTLHLFKNQLSGSIP--LEVGGLSSLNNLALYSN-YLEDIIPHS 164
I P L LK L +F L P +V L + N Y+ I ++
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 165 LGNLTN-LVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSL--GNLSNLAM 221
L N +TL LYNN + S+ N L + L N+ I + G S ++
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209
Query: 222 LNLSSNSLFGSIPSE-LGNLKYL 243
L++S S+ ++PS+ L +LK L
Sbjct: 210 LDVSQTSV-TALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 46/211 (21%), Positives = 80/211 (37%), Gaps = 10/211 (4%)
Query: 142 GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNL 200
S L L +L I H+ NL N+ + + ++ + S NL + + +
Sbjct: 28 SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87
Query: 201 YNNELNGSIPQS-LGNLSNLAMLNLSSNSLFGSIPSE--LGNLKYLSDLKLADNKLNGSI 257
N I L L L L + + L P + + L++ DN SI
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 258 P-HSLCNLTN-LVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKF-SGLIPHSLGNL-S 313
P ++ L N + L +YNN + + N L + L+ NK+ + + + G + S
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205
Query: 314 NIAFLFLDSNSLFGLIPSELRNLKSLSILEL 344
+ L + S+ L L +LK L
Sbjct: 206 GPSLLDVSQTSVTALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 45/226 (19%), Positives = 86/226 (38%), Gaps = 15/226 (6%)
Query: 175 CLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIP 234
++ IPS + + L L L + NL N++ + +S + +
Sbjct: 18 VTCKDIQR--IPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLE 72
Query: 235 SEL-GNLKYLSDLKLADNKLNGSIPHS-LCNLTNLVILYIYNNSLSGLIP-SEIGNLKFL 291
S NL ++ +++ + + I L L L L I+N L +++ +
Sbjct: 73 SHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIF 132
Query: 292 SKIALSYNKFSGLIP-HSLGNLSN-IAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKL 349
+ ++ N + IP ++ L N L L +N + N L + L NK
Sbjct: 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKY 191
Query: 350 CGSIPH--FLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNL 392
I F G + S+L + S++ ++P + +LK L N
Sbjct: 192 LTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 35/204 (17%), Positives = 72/204 (35%), Gaps = 10/204 (4%)
Query: 480 PNLTFIDLSYNNLYGEISSD-WGRCPKLGALDFSKNNITGNIPPKIGYS-SQLEVLDLSS 537
P+ + L +L I S + P + + S + + Y+ S++ +++ +
Sbjct: 31 PSTQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 538 NHVVGDIPAE-LGKLSFLIKLILAQNQLSG-QLSPKLGLLVQLEHLDLSSNNLSNAIPE- 594
+ I + L +L L L + L K+ L+++ N +IP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 595 SLGNLVK-LHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQIC--IMQSLE 651
+ L L L NN F+ + L + L+ N I +
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 652 KLNLSHNSLSGVIPRCFEEMHALQ 675
L++S S++ + + E + L
Sbjct: 209 LLDVSQTSVTALPSKGLEHLKELI 232
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 38/189 (20%), Positives = 72/189 (38%), Gaps = 9/189 (4%)
Query: 312 LSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIP-HFLGNLTNLSVLFIYN 370
+ L L L + NL ++S + + + + H NL+ ++ + I N
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 371 NSLSGSIPCEI-GNLKSLSYLNLAFNKLTSSIP--ISLSNLTNLSVLSFYKNSLSGAIPK 427
I + L L +L + L P + + +L N +IP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 428 E-YRNLVKLTK-LFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISE-SFY-IYPNLT 483
++ L T L L +N F N T L V+L++N + I + +F +Y +
Sbjct: 149 NAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 484 FIDLSYNNL 492
+D+S ++
Sbjct: 209 LLDVSQTSV 217
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 35/184 (19%), Positives = 67/184 (36%), Gaps = 16/184 (8%)
Query: 54 NLTSIGLKG-----TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSN 107
N++ I + L SF + + ++++ + + I P + LK+L + +
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
Query: 108 LFSGAIPPQ--IGHLSYLKTLHLFKNQLSGSIPLEV-GGLSS-LNNLALYSNYLEDIIPH 163
P + L + N SIP+ GL + L LY+N + +
Sbjct: 116 GLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGY 174
Query: 164 SLGNLTNLVTLCLYNNLLSGSIPSEI--GNLKYLLDLNLYNNELNGSIP-QSLGNLSNLA 220
+ N T L + L N I + G L++ + ++P + L +L L
Sbjct: 175 AF-NGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELI 232
Query: 221 MLNL 224
N
Sbjct: 233 ARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 21/115 (18%), Positives = 43/115 (37%), Gaps = 5/115 (4%)
Query: 68 SFSSFPHLAYLDLWSNQLFGNIPPQI--GNISKLKYLDLSSNLFSGAIPPQIGHLSYLKT 125
S L++ N +IP G ++ L L +N F+ ++ + + L
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183
Query: 126 LHLFKNQLSGSIPLEV--GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYN 178
++L KN+ I + G S + L + + + L +L L+ +
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 17/124 (13%), Positives = 40/124 (32%), Gaps = 5/124 (4%)
Query: 573 GLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKL-EELIHLSELDL 631
L + L L +L + NL + + +S + ++ L ++ +++
Sbjct: 28 SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87
Query: 632 SYNFLGRAIPSQICI-MQSLEKLNLSHNSLSGVIP--RCFEEMHALQCIDISYNELRGPI 688
I + L+ L + + L + P ++I+ N I
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 689 PNST 692
P +
Sbjct: 147 PVNA 150
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-17
Identities = 88/441 (19%), Positives = 142/441 (32%), Gaps = 70/441 (15%)
Query: 287 NLKFLSKIALSYNKFSGL-IPHSLGNLSNIAFLFLDSNSL----FGLIPSELRNLKSLSI 341
+++ L + + S L L + LD L I S LR +L+
Sbjct: 4 DIQSLD---IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 342 LELGNNKLCGSIPHFLGNL-----TNLSVLFIYNNSLS----GSIPCEIGNLKSLSYLNL 392
L L +N+L H + + L + N L+ G + + L +L L+L
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120
Query: 393 AFNKLTSS-----IPISLSNLTNLSVLSFYKNSLS----GAIPKEYRNLVKLTKLFLGDN 443
+ N L + L L L SLS + R +L + +N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180
Query: 444 QFQGP-IPNL-----KNLTSLVRVHLDRNYLT----SNISESFYIYPNLTFIDLSYNNLY 493
+ L + L + L+ +T ++ +L + L N L
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240
Query: 494 GE----ISSDWGRC-PKLGALDFSKNNIT----GNIPPKIGYSSQLEVLDLSSNHVVGD- 543
+ +L L + IT G++ + L+ L L+ N + GD
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL-GDE 299
Query: 544 -----IPAELGKLSFLIKLILAQNQLSGQ----LSPKLGLLVQLEHLDLSSNNLSN---- 590
L L L + + S L L L +S+N L +
Sbjct: 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359
Query: 591 AIPESLG-NLVKLHYLNLSNNQFSWE----IPIKLEELIHLSELDLSYNFLGRAIPSQIC 645
+ + LG L L L++ S + L L ELDLS N LG A Q+
Sbjct: 360 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 419
Query: 646 IM-----QSLEKLNLSHNSLS 661
LE+L L S
Sbjct: 420 ESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-17
Identities = 89/493 (18%), Positives = 160/493 (32%), Gaps = 95/493 (19%)
Query: 195 LLDLNLYNNELN-GSIPQSLGNLSNLAMLNLSSNSL----FGSIPSELGNLKYLSDLKLA 249
+ L++ EL+ + L L ++ L L I S L L++L L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 250 DNKLNGSIPHSLCNL-----TNLVILYIYNNSLS----GLIPSEIGNLKFLSKIALSYNK 300
N+L H + + L + N L+ G++ S + L L ++ LS N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 301 FSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKL----CGSIPHF 356
L + LD L L+L L C +
Sbjct: 125 LGD------AGLQLLCEGLLDPQC-------------RLEKLQLEYCSLSAASCEPLASV 165
Query: 357 LGNLTNLSVLFIYNNSLSGSIPCEIG-----NLKSLSYLNLAFNKLT----SSIPISLSN 407
L + L + NN ++ + + + L L L +T + +++
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225
Query: 408 LTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNY 467
+L L+ N L + +L L + + L + +
Sbjct: 226 KASLRELALGSNKLGDV------GMAELCPGLLHPS------------SRLRTLWIWECG 267
Query: 468 LTSN----ISESFYIYPNLTFIDLSYNNLYGE-----ISSDWGRCPKLGALDFSKNNITG 518
+T+ + +L + L+ N L E + +L +L + T
Sbjct: 268 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTA 327
Query: 519 ----NIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKL-----SFLIKLILAQNQLSGQ-- 567
+ + + L L +S+N + EL + S L L LA +S
Sbjct: 328 ACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSC 387
Query: 568 --LSPKLGLLVQLEHLDLSSNNLSN----AIPESL-GNLVKLHYLNLSNNQFSWEIPIKL 620
L+ L L LDLS+N L + + ES+ L L L + +S E+ +L
Sbjct: 388 SSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 447
Query: 621 EELI----HLSEL 629
+ L L +
Sbjct: 448 QALEKDKPSLRVI 460
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-15
Identities = 80/447 (17%), Positives = 139/447 (31%), Gaps = 90/447 (20%)
Query: 97 SKLKYLDLSSNLFS-GAIPPQIGHLSYLKTLHLFKNQLS----GSIPLEVGGLSSLNNLA 151
++ LD+ S + L + + L L+ I + +L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 152 LYSNYLEDIIPHSLGNL-----TNLVTLCLYNNLLS----GSIPSEIGNLKYLLDLNLYN 202
L SN L D+ H + + L L N L+ G + S + L L +L+L +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 203 NELNGSIPQSLG-----NLSNLAMLNLSSNSL----FGSIPSELGNLKYLSDLKLADNKL 253
N L + Q L L L L SL + S L +L +++N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 254 NGSIPHSLC-----NLTNLVILYIYNNSLS----GLIPSEIGNLKFLSKIALSYNKFSGL 304
N + LC + L L + + ++ + + + L ++AL NK
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK---- 238
Query: 305 IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKL----CGSIPHFLGNL 360
L + L P L L L + + CG + L
Sbjct: 239 ---------------LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283
Query: 361 TNLSVLFIYNNSLSGSIPCEIGNL-----KSLSYLNLAFNKLTS----SIPISLSNLTNL 411
+L L + N L + L L + T+ L+ L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 412 SVLSFYKNSL--SGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLT 469
L N L +G R L + + + L + L ++
Sbjct: 344 LELQISNNRLEDAGV-----RELCQGLG---------------QPGSVLRVLWLADCDVS 383
Query: 470 SN----ISESFYIYPNLTFIDLSYNNL 492
+ ++ + +L +DLS N L
Sbjct: 384 DSSCSSLAATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-12
Identities = 82/411 (19%), Positives = 139/411 (33%), Gaps = 79/411 (19%)
Query: 69 FSSFPHLAYLDLWSNQLFGNIPPQIGNI-----SKLKYLDLSSNLFS----GAIPPQIGH 119
P LA L+L SN+L + K++ L L + + G + +
Sbjct: 52 LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111
Query: 120 LSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
L L+ LHL N L + GL L L L L L
Sbjct: 112 LPTLQELHLSDNLLGDA------GLQLLCEGLLDPQ-------------CRLEKLQLEYC 152
Query: 180 LLS----GSIPSEIGNLKYLLDLNLYNNELNGSIPQSLG-----NLSNLAMLNLSSNSL- 229
LS + S + +L + NN++N + + L + L L L S +
Sbjct: 153 SLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212
Query: 230 ---FGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCN-----LTNLVILYIYNNSLS--- 278
+ + + L +L L NKL LC + L L+I+ ++
Sbjct: 213 SDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKG 272
Query: 279 -GLIPSEIGNLKFLSKIALSYNKFS-----GLIPHSLGNLSNIAFLFLDSNSL----FGL 328
G + + + L +++L+ N+ L L + L++ S S
Sbjct: 273 CGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSH 332
Query: 329 IPSELRNLKSLSILELGNNK--------LCGSIPHFLGNLTNLSVLFIYNNSLS----GS 376
S L + L L++ NN+ LC + + L VL++ + +S S
Sbjct: 333 FSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQ---PGSVLRVLWLADCDVSDSSCSS 389
Query: 377 IPCEIGNLKSLSYLNLAFNKLTSSIPISLS-----NLTNLSVLSFYKNSLS 422
+ + SL L+L+ N L + + L L L Y S
Sbjct: 390 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-11
Identities = 49/241 (20%), Positives = 82/241 (34%), Gaps = 42/241 (17%)
Query: 481 NLTFIDLSYNNLYGEISSDWGRC------PKLGALDFSKNNIT----GNIPPKIGYSSQL 530
++ +D+ L SD + + +T +I + + L
Sbjct: 4 DIQSLDIQCEEL-----SDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 58
Query: 531 EVLDLSSNHV----VGDIPAELGKLSF-LIKLILAQNQLSGQ----LSPKLGLLVQLEHL 581
L+L SN + V + L S + KL L L+G LS L L L+ L
Sbjct: 59 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 582 DLSSNNLSNAIPESLGNLV-----KLHYLNLSNNQFSWEIPIKLEELI----HLSELDLS 632
LS N L +A + L + +L L L S L ++ EL +S
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 633 YNFLGRAIPSQICIM-----QSLEKLNLSHNSLS----GVIPRCFEEMHALQCIDISYNE 683
N + A +C LE L L ++ + +L+ + + N+
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238
Query: 684 L 684
L
Sbjct: 239 L 239
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-10
Identities = 42/181 (23%), Positives = 67/181 (37%), Gaps = 23/181 (12%)
Query: 527 SSQLEVLDLSSNHVVGDIPAELGK-LSFLIKLILAQNQLSGQ----LSPKLGLLVQLEHL 581
S ++ LD+ + AEL L + L L+ +S L + L L
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 582 DLSSNNLSNAIPESLGNLVK-----LHYLNLSNNQFSWE----IPIKLEELIHLSELDLS 632
+L SN L + + ++ + L+L N + + L L L EL LS
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 633 YNFLGRAIPSQICIMQ-----SLEKLNLSHNSLS----GVIPRCFEEMHALQCIDISYNE 683
N LG A +C LEKL L + SLS + + + +S N+
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 684 L 684
+
Sbjct: 182 I 182
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-08
Identities = 69/375 (18%), Positives = 122/375 (32%), Gaps = 74/375 (19%)
Query: 69 FSSFPHLAYLDLWSNQLFGNIPPQIGNI-----SKLKYLDLSSNLFS----GAIPPQIGH 119
+ P L L L N L + +L+ L L S + +
Sbjct: 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168
Query: 120 LSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
K L + N ++ + G+ L L+D + L L L +
Sbjct: 169 KPDFKELTVSNNDINEA------GVRVL------CQGLKD-------SPCQLEALKLESC 209
Query: 180 LLS----GSIPSEIGNLKYLLDLNLYNNELNGS-----IPQSLGNLSNLAMLNLSSNSL- 229
++ + + + L +L L +N+L P L S L L + +
Sbjct: 210 GVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGIT 269
Query: 230 ---FGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNL-----TNLVILYIYNNSLSGL- 280
G + L + L +L LA N+L LC L L++ + S +
Sbjct: 270 AKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC 329
Query: 281 ---IPSEIGNLKFLSKIALSYNKF--SGLIPHSLG---NLSNIAFLFLDSNSL----FGL 328
S + +FL ++ +S N+ +G+ G S + L+L +
Sbjct: 330 CSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSS 389
Query: 329 IPSELRNLKSLSILELGNNK--------LCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCE 380
+ + L SL L+L NN L S+ L L +Y+ S +
Sbjct: 390 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ---PGCLLEQLVLYDIYWSEEMEDR 446
Query: 381 IGNL----KSLSYLN 391
+ L SL ++
Sbjct: 447 LQALEKDKPSLRVIS 461
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 40/223 (17%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
N F +GKGG G V ++ A+G++ A KK + + LNE + L ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 855 RNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA------------AAEDLEWTQRM 901
R +V Y + + +V + G L + + AAE
Sbjct: 244 RFVVSLAYAYET-KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-------- 294
Query: 902 SVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTEL 961
I L LH + IV+RD+ +N+LLD R+SD G+A + +
Sbjct: 295 -----ICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-R 345
Query: 962 AGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
GT GY+APE+ YT D ++ G L E+I G+ P
Sbjct: 346 VGTVGYMAPEVVKNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 70/363 (19%), Positives = 128/363 (35%), Gaps = 84/363 (23%)
Query: 753 FFKFQRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYE-EIIRATNDFDDEHCIGKGGQGS 811
+ K R +++ Q Q + + + E + + E R +F +G G G
Sbjct: 3 YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKV--LGSGAFGK 60
Query: 812 VYKVEL------ASGEIIAVKKFHSPLPGEMTFQ--QEFLNEVKALTEI-RHRNIVKFYG 862
V +AVK L + + ++E+K +T++ H NIV G
Sbjct: 61 VMNATAYGISKTGVSIQVAVKM----LKEKADSSEREALMSELKMMTQLGSHENIVNLLG 116
Query: 863 FCSHAQHSFIVYEYLEMGSL--------------------AMILSNDAAAEDLEWTQRMS 902
C+ + ++++EY G L L + L + +
Sbjct: 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176
Query: 903 VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD-----SSN 957
+A + +L VHRD++++NVL+ ++ DFG+A+ + D N
Sbjct: 177 FAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN 233
Query: 958 ------WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHP-------GDF 1003
W APE + T K DV+S+G+L E+ G +P +F
Sbjct: 234 ARLPVKWM---------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284
Query: 1004 ISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063
LI + ++ P + +E + SC RP+ ++
Sbjct: 285 YKLIQNGF-------------KMDQPFYATEE----IYIIMQSCWAFDSRKRPSFPNLTS 327
Query: 1064 LLK 1066
L
Sbjct: 328 FLG 330
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTE 851
+DF+ IG+G V V++ +G++ A+K K+ GE++ F E L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC---FREERDVLVN 117
Query: 852 IRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADA 910
R I + + F + ++V EY G L +LS E + + I A
Sbjct: 118 GDRRWITQLHFAFQD-ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR--FYLAEIVMA 174
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA-GTYGYVA 969
+ +H VHRDI N+LLD R++DFG L+ D + + +A GT Y++
Sbjct: 175 IDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 970 PELAYTMKVTEK-------CDVYSFGVLALEVIKGKHP 1000
PE+ + CD ++ GV A E+ G+ P
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 14/168 (8%)
Query: 72 FPHLAYLDLWSNQLFGNIPPQI--GNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHL 128
+ A LDL N L + + ++ L L LS N + I + + L+ L L
Sbjct: 38 PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDL 95
Query: 129 FKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPS 187
N L ++ + L +L L LY+N++ + ++ ++ L L L N +S P
Sbjct: 96 SSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 188 EI----GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAM--LNLSSNSL 229
E+ L L+ L+L +N+L L L L L +N L
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 44/169 (26%), Positives = 75/169 (44%), Gaps = 14/169 (8%)
Query: 520 IPPKIGYSSQLEVLDLSSNHVVGDIPAE--LGKLSFLIKLILAQNQLSGQLSPK-LGLLV 576
+P + S +LDLS N++ + AE +L+ L L+L+ N L+ +S + +
Sbjct: 33 VPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 577 QLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIK-LEELIHLSELDLSYNF 635
L +LDLSSN+L +L L L L NN + E++ L +L LS N
Sbjct: 89 NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ 147
Query: 636 LGRAIPSQI----CIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDIS 680
+ P ++ + L L+LS N L + +++ A +
Sbjct: 148 I-SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 4e-16
Identities = 49/225 (21%), Positives = 81/225 (36%), Gaps = 22/225 (9%)
Query: 54 NLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGA 112
NL+ + +++ + +L L L N L I + + L+YLDLSSN
Sbjct: 50 NLSRLR-----AEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLH-T 102
Query: 113 IPPQI-GHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIP---HSLGN 167
+ + L L+ L L+ N + + ++ L L L N +
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNK 161
Query: 168 LTNLVTLCLYNNLLSGSIPSEIGNLKYL--LDLNLYNNELNGSIPQSLGNLSNLAMLNLS 225
L L+ L L +N L +++ L L L+NN L + S+ LS
Sbjct: 162 LPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD-CKLYQLFSHWQYRQLS 220
Query: 226 SNSLFG-----SIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLT 265
S F +L N+ L ++ K + H LT
Sbjct: 221 SVMDFQEDLYCMHSKKLHNIFSLDFFNCSEYKESAWEAHLGDTLT 265
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 12/174 (6%)
Query: 208 SIPQSLGNLSNLAMLNLSSNSLFGSIPSE--LGNLKYLSDLKLADNKLNGSIP-HSLCNL 264
++PQSL S A+L+LS N+L + +E L L L L+ N LN I + +
Sbjct: 32 NVPQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 265 TNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNS 324
NL L + +N L L +L+ L + L N + ++ +++ + L+L N
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 325 LFGLIP---SELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSV--LFIYNNSL 373
+ + L L +L+L +NKL L L L+++NN L
Sbjct: 148 ISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 7e-14
Identities = 39/116 (33%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 573 GLLVQLEHLDLSSNNLSNAIPE-SLGNLVKLHYLNLSNNQFSWEIPIK-LEELIHLSELD 630
L LDLS NNLS E + L LH L LS+N + I + + +L LD
Sbjct: 36 SLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLD 94
Query: 631 LSYNFLGRAIPSQICI-MQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
LS N L + + +Q+LE L L +N + V FE+M LQ + +S N++
Sbjct: 95 LSSNHL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 44/167 (26%), Positives = 70/167 (41%), Gaps = 14/167 (8%)
Query: 313 SNIAFLFLDSNSLFGLIPSE-LRNLKSLSILELGNNKLCGSIP-HFLGNLTNLSVLFIYN 370
S A L L N+L L L +L L L +N L I + NL L + +
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSS 97
Query: 371 NSLSGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKE- 428
N L ++ + +L++L L L N + + ++ L L +N +S P E
Sbjct: 98 NHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155
Query: 429 ---YRNLVKLTKLFLGDNQFQG-PIPNLKNLTSLVRVHLDRNYLTSN 471
L KL L L N+ + P+ +L+ L + V+ L YL +N
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL---YLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 54/187 (28%), Positives = 72/187 (38%), Gaps = 35/187 (18%)
Query: 435 LTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNL 492
L L N LT+L + L N+L SE+F PNL ++DLS N+L
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL 100
Query: 493 YGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAE-LGKL 551
L FS LEVL L +NH+V + +
Sbjct: 101 -----------HTLDEFLFSDL-------------QALEVLLLYNNHIV-VVDRNAFEDM 135
Query: 552 SFLIKLILAQNQLSGQLSPK----LGLLVQLEHLDLSSNNLSNAIPESLGNLVKL--HYL 605
+ L KL L+QNQ+S + + L +L LDLSSN L L L + L
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 606 NLSNNQF 612
L NN
Sbjct: 195 YLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 14/164 (8%)
Query: 478 IYPNLTFIDLSYNNLYGEISSDWGRC--PKLGALDFSKNNITGNIPPKIGYS-SQLEVLD 534
+ +DLS+NNL + ++W L +L S N++ I + L LD
Sbjct: 37 LPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLD 94
Query: 535 LSSNHVVGDIPAE-LGKLSFLIKLILAQNQLSGQLSPK-LGLLVQLEHLDLSSNNLSNAI 592
LSSNH+ + L L L+L N + + + QL+ L LS N +S
Sbjct: 95 LSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-F 151
Query: 593 PE----SLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLS 632
P L KL L+LS+N+ L++L + L
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 52/220 (23%), Positives = 84/220 (38%), Gaps = 33/220 (15%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
DF +G+G +V ELA+ A+K + E ++ + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL------SNDAA----AEDLEWTQRMSVI 904
VK Y + + Y + G L + AE
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----------- 138
Query: 905 KGIADALSYLH-NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN---WTE 960
I AL YLH I+HRD+ +N+LL+ +++DFG AK L P+S +
Sbjct: 139 --IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS- 191
Query: 961 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
GT YV+PEL + D+++ G + +++ G P
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-17
Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLN-----EVKALTEIRHRNI 857
+G+G G V K +G I+A+KKF + + + E+K L ++RH N+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
V C + ++V+E+++ ++ L + L++ + I + + + H+
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 972
I+HRDI +N+L+ ++ DFG A+ L + + T Y APEL
Sbjct: 144 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
Y V DV++ G L E+ G+ PGD
Sbjct: 201 KYGKAV----DVWAIGCLVTEMFMGEPLFPGD 228
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 47/275 (17%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTEIRHR--NI 857
+G GG GSVY + ++ +A+K K GE+ EV L ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 858 VKFYGFCSHAQHSFIVYEYLE-MGSL-AMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
++ + ++ E E + L I A E+L R S + +A+ + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL---AR-SFFWQVLEAVRHCH 166
Query: 916 NDCFPPIVHRDISSKNVLLDF-KNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-- 972
N ++HRDI +N+L+D + E ++ DFG LK + +T+ GT Y PE
Sbjct: 167 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIR 221
Query: 973 --AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPS 1030
Y + V+S G+L +++ G P + +EI+ ++
Sbjct: 222 YHRYHGR---SAAVWSLGILLYDMVCGDIPFEHD--------------EEIIRGQVFFRQ 264
Query: 1031 HNVQE--KLISFVEVAISCLDESPESRPTMQKVSQ 1063
E LI CL P RPT +++
Sbjct: 265 RVSSECQHLIR------WCLALRPSDRPTFEEIQN 293
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-16
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 15/212 (7%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+ F D +G+GG G V+ ++ A+G++ A KK + + Q + E K L ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 855 RNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSV-IKGIADALS 912
R IV Y F + +V + G + + N R I L
Sbjct: 245 RFIVSLAYAFET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
+LH I++RD+ +NVLLD R+SD G+A LK + AGT G++APEL
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 973 ----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
Y V D ++ GV E+I + P
Sbjct: 361 LLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 29/212 (13%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLN-----EVKALTEIRHRNI 857
IG+G G V+K +G+I+A+KKF + + E++ L +++H N+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFL------ESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
V + +V+EY + ++ L D + S+ A+++ H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 972
+HRD+ +N+L+ + ++ DFG A+ L S + + T Y +PEL
Sbjct: 122 N---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
Y V DV++ G + E++ G PG
Sbjct: 179 QYGPPV----DVWAIGCVFAELLSGVPLWPGK 206
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 39/224 (17%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQE---FLNEVKALTE 851
D++ IG+G G V V ++ ++ A+K EM + + F E +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF---EMIKRSDSAFFWEERDIMAF 125
Query: 852 IRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA---------AAEDLEWTQRM 901
+V+ FY F ++ ++V EY+ G L ++SN AE
Sbjct: 126 ANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE-------- 176
Query: 902 SVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTEL 961
+ AL +H+ +HRD+ N+LLD +++DFG + + +
Sbjct: 177 -----VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 962 A-GTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
A GT Y++PE+ +CD +S GV E++ G P
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 49/325 (15%), Positives = 94/325 (28%), Gaps = 60/325 (18%)
Query: 385 KSLSYLNLAFNKLTS----SIPISLSNLTNLSVLSFYKNSLSG----AIPKEYRNLVKLT 436
S+ +L + +T+ S+ L ++ + N++ + + + L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 437 KLFLGDNQFQGPIPN-----------LKNLTSLVRVHLDRNYLTSN----ISESFYIYPN 481
D L L V L N + + +
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 482 LTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVV 541
L + L N L G ++ + K + L + N +
Sbjct: 124 LEHLYLHNNGL-GPQ----------AGAKIARALQELAVNKKAKNAPPLRSIICGRNRL- 171
Query: 542 GDIPAE-----LGKLSFLIKLILAQNQLSGQ-----LSPKLGLLVQLEHLDLSSNNLSN- 590
+ + L + + QN + + L L +L+ LDL N ++
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL 231
Query: 591 ---AIPESLGNLVKLHYLNLSNNQFS----WEIPIKLEELIH--LSELDLSYNFLGRAIP 641
A+ +L + L L L++ S + +L + L L L YN +
Sbjct: 232 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 291
Query: 642 SQIC-----IMQSLEKLNLSHNSLS 661
+ M L L L+ N S
Sbjct: 292 RTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 48/349 (13%), Positives = 96/349 (27%), Gaps = 77/349 (22%)
Query: 309 LGNLSNIAFLFLDSNSL----FGLIPSELRNLKSLSILELGNNKL----CGSIPHFLGNL 360
+ S I L +++ + + L S+ + L N + + + +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 361 TNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNS 420
+L + + L+ L +L L + N+
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQ--------------ALLKCPKLHTVRLSDNA 105
Query: 421 LSG----AIPKEYRNLVKLTKLFLGDNQF--------------QGPIPNLKNLTSLVRVH 462
+ L L+L +N KN L +
Sbjct: 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165
Query: 463 LDRNYLTSN----ISESFYIYPNLTFIDLSYNNLYGE-----ISSDWGRCPKLGALDFSK 513
RN L + +++F + L + + N + E + C +L LD
Sbjct: 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225
Query: 514 NNITGN----IPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLS 569
N T + + L L L+ + G + + +N
Sbjct: 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLL-SAR----GAAAVVDAFSKLENI------ 274
Query: 570 PKLGLLVQLEHLDLSSNNLSN----AIPESLG-NLVKLHYLNLSNNQFS 613
L+ L L N + + + + L +L L+ N+FS
Sbjct: 275 -------GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 51/314 (16%), Positives = 97/314 (30%), Gaps = 60/314 (19%)
Query: 405 LSNLTNLSVLSFYKNSLSG----AIPKEYRNLVKLTKLFLGDNQFQGPI------PNLKN 454
++ + + S ++++ ++ + ++ L N G N+ +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIAS 58
Query: 455 LTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKN 514
L + E I L + +CPKL + S N
Sbjct: 59 KKDLEIAEFSDIFTGRVKDE---IPEALRLL-----------LQALLKCPKLHTVRLSDN 104
Query: 515 NITGN----IPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSP 570
+ + + LE L L +N + G +A+ ++
Sbjct: 105 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGL-GPQAGA----------KIARALQELAVNK 153
Query: 571 KLGLLVQLEHLDLSSNNLSN----AIPESLGNLVKLHYLNLSNNQFSWE-IPIKLEELI- 624
K L + N L N ++ + LH + + N E I L E +
Sbjct: 154 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213
Query: 625 ---HLSELDLSYNFLG----RAIPSQICIMQSLEKLNLSHNSLSGV----IPRCFEEMH- 672
L LDL N A+ + +L +L L+ LS + F ++
Sbjct: 214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN 273
Query: 673 -ALQCIDISYNELR 685
LQ + + YNE+
Sbjct: 274 IGLQTLRLQYNEIE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 46/313 (14%), Positives = 88/313 (28%), Gaps = 61/313 (19%)
Query: 146 SLNNLALYSNYLED----IIPHSLGNLTNLVTLCLYNNLLSG----SIPSEIGNLKYLLD 197
S+ +L + + + L ++ + L N + + I + K L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 198 LNLYNNELN----------GSIPQSLGNLSNLAMLNLSSNSL----FGSIPSELGNLKYL 243
+ + Q+L L + LS N+ + L L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 244 SDLKLADNKL-------------NGSIPHSLCNLTNLVILYIYNNSLSG----LIPSEIG 286
L L +N L ++ N L + N L
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184
Query: 287 NLKFLSKIALSYNKF-----SGLIPHSLGNLSNIAFLFLDSNSLFG-----LIPSELRNL 336
+ + L + + N L+ L + L L N+ F + L++
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT-FTHLGSSALAIALKSW 243
Query: 337 KSLSILELGNNKL----CGSIPHFLGNLTN--LSVLFIYNNSLSGSIPCEIG-----NLK 385
+L L L + L ++ L N L L + N + + +
Sbjct: 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP 303
Query: 386 SLSYLNLAFNKLT 398
L +L L N+ +
Sbjct: 304 DLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 46/290 (15%), Positives = 87/290 (30%), Gaps = 59/290 (20%)
Query: 70 SSFPHLAYLDLWSNQLFGN-----IPPQIGNISKLKYLDLSSNLFS----------GAIP 114
+ + L N + G + I + L+ + S +
Sbjct: 29 LEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 87
Query: 115 PQIGHLSYLKTLHLFKNQLS--GSIPLEVG--GLSSLNNLALYSNYLED----------- 159
+ L T+ L N PL + L +L L++N L
Sbjct: 88 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ 147
Query: 160 --IIPHSLGNLTNLVTLCLYNNLLSG----SIPSEIGNLKYLLDLNLYNNELN-----GS 208
+ N L ++ N L + + L + + N +
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL 207
Query: 209 IPQSLGNLSNLAMLNLSSNSLFG-----SIPSELGNLKYLSDLKLADNKLNG----SIPH 259
+ + L L +L+L N+ F ++ L + L +L L D L+ ++
Sbjct: 208 LLEGLAYCQELKVLDLQDNT-FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266
Query: 260 SLCNLTN--LVILYIYNNSLS-----GLIPSEIGNLKFLSKIALSYNKFS 302
+ L N L L + N + L + L + L+ N+FS
Sbjct: 267 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 3e-16
Identities = 58/225 (25%), Positives = 88/225 (39%), Gaps = 43/225 (19%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-- 852
NDF IG+GG G VY +G++ A+K + LNE L+ +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 853 -RHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AAEDLEWTQR 900
IV Y F + + + + G L LS AAE
Sbjct: 249 GDCPFIVCMSYAFHT-PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE------- 300
Query: 901 MSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE 960
I L ++HN +V+RD+ N+LLD R+SD G+A +
Sbjct: 301 ------IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--A 349
Query: 961 LAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
GT+GY+APE+ AY D +S G + ++++G P
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 58/227 (25%), Positives = 91/227 (40%), Gaps = 42/227 (18%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTE 851
DF+ IG+G G V V+L + ++ A+K K+ E F E L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVN 130
Query: 852 IRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA-----------AAEDLEWTQ 899
+ I Y F + ++V +Y G L +LS AE
Sbjct: 131 GDSKWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE------ 183
Query: 900 RMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT 959
+ A+ +H VHRDI N+L+D R++DFG L D + +
Sbjct: 184 -------MVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233
Query: 960 ELA-GTYGYVAPELAYTMKVTEK-----CDVYSFGVLALEVIKGKHP 1000
+A GT Y++PE+ M+ + CD +S GV E++ G+ P
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 6e-16
Identities = 52/299 (17%), Positives = 96/299 (32%), Gaps = 13/299 (4%)
Query: 356 FLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLS 415
+ + LSV + + + + +L + S + I + +L
Sbjct: 276 LMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLK 335
Query: 416 FYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISES 475
++ +L + L + L++ L + + + I
Sbjct: 336 DRPECW----CRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILL 391
Query: 476 FYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDL 535
L + + + D R LD ++ + + VL L
Sbjct: 392 MRALDPLLYEKETLQYFSTLKAVDPMR---AAYLDDLRSKFLLENSVLKMEYADVRVLHL 448
Query: 536 SSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPES 595
+ + + L +L + L L+ N+L L P L L LE L S N L N +
Sbjct: 449 AHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DG 503
Query: 596 LGNLVKLHYLNLSNNQFS-WEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKL 653
+ NL +L L L NN+ L L L+L N L + Q + + L +
Sbjct: 504 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.8 bits (196), Expect = 2e-15
Identities = 45/271 (16%), Positives = 89/271 (32%), Gaps = 18/271 (6%)
Query: 196 LDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNG 255
L N++L + + S+ + + + L +L+ K
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTV 363
Query: 256 --SIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLS 313
S S L L + L+ + L + + ++ + P L
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD 423
Query: 314 NIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSL 373
++ FL N + +L L + L + H L L ++ L + +N L
Sbjct: 424 DLRSKFLLEN------SVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRL 475
Query: 374 SGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSG-AIPKEYRNL 432
++P + L+ L L + N L ++ ++NL L L N L A + +
Sbjct: 476 R-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSC 532
Query: 433 VKLTKLFLGDNQFQGPIPNLKNLTSLVRVHL 463
+L L L N + + + + L
Sbjct: 533 PRLVLLNLQGN----SLCQEEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 77.5 bits (190), Expect = 9e-15
Identities = 43/224 (19%), Positives = 83/224 (37%), Gaps = 11/224 (4%)
Query: 69 FSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHL 128
++ L +L + + ++ + +L+ L+ + I I + L L
Sbjct: 345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLY 400
Query: 129 FKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSE 188
K L L+ L + ++ L L + L+ +
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH- 458
Query: 189 IGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKL 248
+ L + L+L +N L ++P +L L L +L S N+L ++ + NL L +L L
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLL 515
Query: 249 ADNKLNG-SIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFL 291
+N+L + L + LV+L + NSL L +
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.8 bits (183), Expect = 6e-14
Identities = 53/254 (20%), Positives = 84/254 (33%), Gaps = 10/254 (3%)
Query: 409 TNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYL 468
+L S + + L ++ + + L R L
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKS 361
Query: 469 TSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSS 528
T SE + +L N + ++ L L + K + K
Sbjct: 362 TVLQSE---LESCKELQELEPENKWCLLTI-ILLMRALDPLLYEKETLQYFSTLKAVDPM 417
Query: 529 QLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNL 588
+ LD + + + + + + L LA L+ L L L+ + HLDLS N L
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRL 475
Query: 589 SNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGR-AIPSQICIM 647
+P +L L L L S+N + + L L EL L N L + A +
Sbjct: 476 RA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSC 532
Query: 648 QSLEKLNLSHNSLS 661
L LNL NSL
Sbjct: 533 PRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.8 bits (183), Expect = 7e-14
Identities = 43/273 (15%), Positives = 81/273 (29%), Gaps = 12/273 (4%)
Query: 361 TNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNS 420
+L + + + S L + L
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVL-LKDRPECWCRDSATDEQLFRCELSVEK 360
Query: 421 LSGAIPKEYRNLVKLTKLFLGDNQF-QGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIY 479
+ + E + +L +L + I ++ L L+ + + ++
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLL--YEKETLQYFSTLKAVDPM 417
Query: 480 PNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNH 539
DL L + L + ++T + + + LDLS N
Sbjct: 418 RAAYLDDLRSKFLLENSVLKM-EYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNR 474
Query: 540 VVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSN-AIPESLGN 598
+ +P L L L L + N L + + L +L+ L L +N L A + L +
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 599 LVKLHYLNLSNNQFSWEIPIKLEELIHLSELDL 631
+L LNL N E I+ L +
Sbjct: 532 CPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.5 bits (177), Expect = 4e-13
Identities = 39/258 (15%), Positives = 79/258 (30%), Gaps = 32/258 (12%)
Query: 453 KNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDW----GRCPKLGA 508
+ + L L + + + L + W +L
Sbjct: 294 NRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFR 353
Query: 509 LDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSG-- 566
+ S T + ++ +L+ L+ + + I + L L+ S
Sbjct: 354 CELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLK 412
Query: 567 -------------------QLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNL 607
+ S + L L+ +L+ L L+ + +L+L
Sbjct: 413 AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHLEQLLLVTHLDL 470
Query: 608 SNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGV-IPR 666
S+N+ +P L L L L S N L + + + L++L L +N L +
Sbjct: 471 SHNRLR-ALPPALAALRCLEVLQASDNAL-ENVDG-VANLPRLQELLLCNNRLQQSAAIQ 527
Query: 667 CFEEMHALQCIDISYNEL 684
L +++ N L
Sbjct: 528 PLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 1e-07
Identities = 28/129 (21%), Positives = 42/129 (32%), Gaps = 27/129 (20%)
Query: 68 SFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLH 127
+ +LDL N+L +PP + + L+ L S N + + +L L+ L
Sbjct: 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELL 514
Query: 128 LFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPS 187
L N+L I P L + LV L L N L
Sbjct: 515 LCNNRLQQ---------------------SAAIQP--LVSCPRLVLLNLQGNSLC-QEEG 550
Query: 188 EIGNLKYLL 196
L +L
Sbjct: 551 IQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 29/215 (13%), Positives = 63/215 (29%), Gaps = 28/215 (13%)
Query: 496 ISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLI 555
++ L +D + ++ P S + + DL + + +P ++ +
Sbjct: 265 LTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTG 324
Query: 556 KLILAQNQLS----GQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQ 611
+ L QL +LS + L + +L L N
Sbjct: 325 SDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKS-TVLQSELESCKELQELEPENKW 383
Query: 612 FSWEIPIKLEELIHLSELDLSYNFL---------------------GRAIPSQICIMQSL 650
I + + L L + + +
Sbjct: 384 CLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADV 443
Query: 651 EKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
L+L+H L+ + E++ + +D+S+N LR
Sbjct: 444 RVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLR 476
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGE---MTFQQEFLNEVKALTEIRHRNIVKF 860
IG+G G VYK + GE A+KK E T + E+ L E++H NIVK
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT----IREISILKELKHSNIVKL 65
Query: 861 YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
Y + +V+E+L+ L +L D LE S + + + ++Y H+
Sbjct: 66 YDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDRR-- 120
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AYT 975
++HRD+ +N+L++ + E +++DFG+A+ +T T Y AP++ Y+
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 976 MKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
+ D++S G + E++ G PG
Sbjct: 180 TTI----DIWSVGCIFAEMVNGTPLFPGV 204
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 16/201 (7%)
Query: 296 LSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGL--IPSELRNLKSLSILELGNNKLCGSI 353
L + + + L++I + +++ + + I L ++ L LG NKL I
Sbjct: 26 LKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKL-HDI 78
Query: 354 PHFLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLS 412
LTNL+ L + N L S+P + L +L L L N+L S LTNL+
Sbjct: 79 SAL-KELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT 136
Query: 413 VLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTS 470
L+ N L + L LT+L L NQ Q +P LT L + L +N L S
Sbjct: 137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKS 195
Query: 471 NISESFYIYPNLTFIDLSYNN 491
F +L +I L ++N
Sbjct: 196 VPDGVFDRLTSLQYIWL-HDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 77 YLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGS 136
+L + + Q ++ + + +++ I +L ++ L L N+L
Sbjct: 23 KANLKKKSV-TDAVTQNE-LNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLH-D 77
Query: 137 IPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGN-LKYL 195
I + L++L L L N L+ + LTNL L L N L S+P + + L L
Sbjct: 78 ISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNL 135
Query: 196 LDLNLYNNELNGSIPQSL-GNLSNLAMLNLSSNSLFGSIPS----ELGNLKYLSDLKLAD 250
LNL +N+L S+P+ + L+NL L+LS N L S+P +L LK L L
Sbjct: 136 TYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL-QSLPEGVFDKLTQLKDLR---LYQ 190
Query: 251 NKLNGSIPH-SLCNLTNLVILYIYNN 275
N+L S+P LT+L +++++N
Sbjct: 191 NQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 54/167 (32%), Positives = 77/167 (46%), Gaps = 16/167 (9%)
Query: 68 SFSSFPHLAYLDLWSNQLFGNIPPQIG---NISKLKYLDLSSNLFSGAIPPQIGH-LSYL 123
P++ YL L N+L I ++ L YL L+ N ++P + L+ L
Sbjct: 58 GIQYLPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNL 111
Query: 124 KTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLS 182
K L L +NQL S+P V L++L L L N L+ + LTNL L L N L
Sbjct: 112 KELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170
Query: 183 GSIPSEI-GNLKYLLDLNLYNNELNGSIPQ-SLGNLSNLAMLNLSSN 227
S+P + L L DL LY N+L S+P L++L + L N
Sbjct: 171 -SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 58/219 (26%), Positives = 90/219 (41%), Gaps = 22/219 (10%)
Query: 184 SIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSL--FGSIPSELGNLK 241
P + + NL + + L+++ + +++ + I L N++
Sbjct: 12 IFPDDAFA--ETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQGIQY-LPNVR 66
Query: 242 YLSDLKLADNKLNGSIP--HSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYN 299
YL+ L NKL+ I L NLT L + N L L L L ++ L N
Sbjct: 67 YLA---LGGNKLH-DISALKELTNLTYL---ILTGNQLQSLPNGVFDKLTNLKELVLVEN 119
Query: 300 KFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH--FL 357
+ L L+N+ +L L N L L L +L+ L+L N+L S+P F
Sbjct: 120 QLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL-QSLPEGVF- 177
Query: 358 GNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFN 395
LT L L +Y N L S+P + L SL Y+ L N
Sbjct: 178 DKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 245 DLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGL 304
L + + L ++ + N+ + + I L + +AL NK
Sbjct: 23 KANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLH-- 76
Query: 305 IPHSLG---NLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH-FLGNL 360
+ L+N+ +L L N L L L +L L L N+L S+P L
Sbjct: 77 ---DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-QSLPDGVFDKL 132
Query: 361 TNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISL-SNLTNLSVLSFYK 418
TNL+ L + +N L S+P + L +L+ L+L++N+L S +P + LT L L Y+
Sbjct: 133 TNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQ 190
Query: 419 NSLSGAIPKE-YRNLVKLTKLFLGDNQ 444
N L ++P + L L ++L DN
Sbjct: 191 NQLK-SVPDGVFDRLTSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 48/155 (30%), Positives = 63/155 (40%), Gaps = 13/155 (8%)
Query: 342 LELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSI 401
L + L ++ + N+ + S+ I L ++ YL L NKL I
Sbjct: 24 ANLKKKSV-TDAVTQNE-LNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I 78
Query: 402 PISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ----GPIPNLKNLTS 457
L LTNL+ L N L + L L +L L +NQ Q G L NLT
Sbjct: 79 SA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTY 137
Query: 458 LVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNL 492
L +L N L S F NLT +DLSYN L
Sbjct: 138 L---NLAHNQLQSLPKGVFDKLTNLTELDLSYNQL 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 40/188 (21%), Positives = 83/188 (44%), Gaps = 28/188 (14%)
Query: 509 LDFSKNNITGNIPPKIGYSSQLEVLDLSSNHV--VGDIPAELGKLSFLIKLILAQNQLSG 566
+ K ++T + + +S ++ + +++ + V I L + L L N+L
Sbjct: 24 ANLKKKSVT-DAVTQNELNS-IDQIIANNSDIKSVQGIQ----YLPNVRYLALGGNKLH- 76
Query: 567 QLSPKLGL---LVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLE-- 621
+ L L +L L+ N L + L L L L NQ L
Sbjct: 77 ----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-----SLPDG 127
Query: 622 ---ELIHLSELDLSYNFLGRAIPSQIC-IMQSLEKLNLSHNSLSGVIPRCFEEMHALQCI 677
+L +L+ L+L++N L +++P + + +L +L+LS+N L + F+++ L+ +
Sbjct: 128 VFDKLTNLTYLNLAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL 186
Query: 678 DISYNELR 685
+ N+L+
Sbjct: 187 RLYQNQLK 194
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 48/209 (22%), Positives = 83/209 (39%), Gaps = 36/209 (17%)
Query: 436 TKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGE 495
K L L S+ ++ + + + S + PN+ ++ L N L
Sbjct: 22 IKANLKKKSVTD-AVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKL--- 75
Query: 496 ISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLI 555
+ AL +T L L L+ N + KL+ L
Sbjct: 76 --------HDISALK----ELT-----------NLTYLILTGNQLQSLPNGVFDKLTNLK 112
Query: 556 KLILAQNQLSGQLSPKL-GLLVQLEHLDLSSNNLSNAIPESL-GNLVKLHYLNLSNNQFS 613
+L+L +NQL L + L L +L+L+ N L ++P+ + L L L+LS NQ
Sbjct: 113 ELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ 170
Query: 614 WEIPIKL-EELIHLSELDLSYNFLGRAIP 641
+P + ++L L +L L N L +++P
Sbjct: 171 -SLPEGVFDKLTQLKDLRLYQNQL-KSVP 197
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 18/170 (10%)
Query: 520 IPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLE 579
P ++ +L V D + L+ + ++I + + + + L +
Sbjct: 13 FPDDA--FAETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDI--KSVQGIQYLPNVR 66
Query: 580 HLDLSSNNLSNAIPESLG---NLVKLHYLNLSNNQFSWEIPIKL-EELIHLSELDLSYNF 635
+L L N L + L L YL L+ NQ +P + ++L +L EL L N
Sbjct: 67 YLALGGNKLH-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQ 120
Query: 636 LGRAIPSQIC-IMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNEL 684
L +++P + + +L LNL+HN L + F+++ L +D+SYN+L
Sbjct: 121 L-QSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL 169
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 38/220 (17%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+ FD +G G G V V+ SG A+K ++ + LNE + L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AAEDLEWTQRMSVI 904
+VK + ++V EY+ G + L AA+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ----------- 149
Query: 905 KGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT 964
I YLH+ +++RD+ +N+L+D + +V+DFG AK + WT L GT
Sbjct: 150 --IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWT-LCGT 201
Query: 965 YGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
+APE+ Y V D ++ GVL E+ G P
Sbjct: 202 PEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 46/217 (21%), Positives = 82/217 (37%), Gaps = 45/217 (20%)
Query: 808 GQGSVYKVELA----SGEIIAVK-------------------KFHSPLPGEMTFQQEFLN 844
G+GS V+LA A+K + P PG + +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 845 ----EVKALTEIRHRNIVKFYGFCSHA--QHSFIVYEYLEMGSLAMILSNDAAAEDLEWT 898
E+ L ++ H N+VK H ++V+E + G + + + +ED
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARF 141
Query: 899 ---QRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955
+ + YLH I+HRDI N+L+ +++DFG++ K
Sbjct: 142 YFQD-------LIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 956 SNWTELAGTYGYVAPELAYTMKVT---EKCDVYSFGV 989
+ + GT ++APE + + DV++ GV
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 45/153 (29%), Positives = 61/153 (39%), Gaps = 6/153 (3%)
Query: 342 LELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLTSS 400
L+L + L LT L+ L + N L ++ + +L L L LA N+L S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASL 98
Query: 401 IPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN--LKNLTSL 458
+LT L L N L + L KL +L L NQ Q IP LT+L
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNL 157
Query: 459 VRVHLDRNYLTSNISESFYIYPNLTFIDLSYNN 491
+ L N L S +F L I L + N
Sbjct: 158 QTLSLSTNQLQSVPHGAFDRLGKLQTITL-FGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 50/154 (32%), Positives = 69/154 (44%), Gaps = 8/154 (5%)
Query: 78 LDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSGS 136
LDL S L ++KL +L+L N + + L+ L TL L NQL+ S
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 137 IPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKY 194
+PL V L+ L+ L L N L+ + LT L L L N L SIP+ L
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN 156
Query: 195 LLDLNLYNNELNGSIPQ-SLGNLSNLAMLNLSSN 227
L L+L N+L S+P + L L + L N
Sbjct: 157 LQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 49/146 (33%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHL 120
TL D +F L +L+L NQL + + ++++L L L++N + ++P + HL
Sbjct: 49 TLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHL 106
Query: 121 SYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSL-GNLTNLVTLCLYN 178
+ L L+L NQL S+P V L+ L L L +N L+ IP LTNL TL L
Sbjct: 107 TQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLST 164
Query: 179 NLLSGSIPSEI-GNLKYLLDLNLYNN 203
N L S+P L L + L+ N
Sbjct: 165 NQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 14/159 (8%)
Query: 124 KTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG 183
+ L L L+ GL+ L L L N L+ + +LT L TL L NN L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 184 SIPSEI-GNLKYLLDLNLYNNELNGSIPQSL-GNLSNLAMLNLSSNSLFGSIPS----EL 237
S+P + +L L L L N+L S+P + L+ L L L++N L SIP+ +L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKL 154
Query: 238 GNLKYLSDLKLADNKLNGSIPH-SLCNLTNLVILYIYNN 275
NL+ LS L+ N+L S+PH + L L + ++ N
Sbjct: 155 TNLQTLS---LSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 51/159 (32%), Positives = 69/159 (43%), Gaps = 14/159 (8%)
Query: 100 KYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLE 158
+ LDL S + L+ L L+L NQL ++ V L+ L L L +N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 159 DIIPHSLGNLTNLVTLCLYNNLLSGSIPS----EIGNLKYLLDLNLYNNELNGSIPQSL- 213
+ +LT L L L N L S+PS + LK L L N+L SIP
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKE---LRLNTNQLQ-SIPAGAF 151
Query: 214 GNLSNLAMLNLSSNSLFGSIP-SELGNLKYLSDLKLADN 251
L+NL L+LS+N L S+P L L + L N
Sbjct: 152 DKLTNLQTLSLSTNQL-QSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 52/183 (28%), Positives = 71/183 (38%), Gaps = 28/183 (15%)
Query: 265 TNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNS 324
+ L + + L+ L + L L+ + L YN+ L +L+ + L L +N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94
Query: 325 LFGLIPSELRNLKSLSILELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSLSGSIPCEIG 382
L L +L L L LG N+L S+P F LT L L + N L SIP
Sbjct: 95 LASLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVF-DRLTKLKELRLNTNQLQ-SIP---- 147
Query: 383 NLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGD 442
AF+K LTNL LS N L + L KL + L
Sbjct: 148 --------AGAFDK-----------LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188
Query: 443 NQF 445
NQF
Sbjct: 189 NQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 45/156 (28%), Positives = 58/156 (37%), Gaps = 12/156 (7%)
Query: 246 LKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGL- 304
L L L + LT L L + N L L +L L + L+ N+ + L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99
Query: 305 --IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH--FLGNL 360
+ L L L+L N L L L L L L N+L SIP F L
Sbjct: 100 LGVFDHLTQLDK---LYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL-QSIPAGAF-DKL 154
Query: 361 TNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFN 395
TNL L + N L S+P L L + L N
Sbjct: 155 TNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 10/160 (6%)
Query: 169 TNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSL-GNLSNLAMLNLSSN 227
+ L L + L+ + L L LNL N+L ++ + +L+ L L L++N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANN 93
Query: 228 ---SLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLC-NLTNLVILYIYNNSLSGLIPS 283
SL + L L L L N+L S+P + LT L L + N L +
Sbjct: 94 QLASLPLGVFDHLTQLDKLY---LGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAG 149
Query: 284 EIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSN 323
L L ++LS N+ + + L + + L N
Sbjct: 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 6/155 (3%)
Query: 531 EVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSN 590
E LDL S + A L+ L L L NQL + L +L L L++N L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 591 AIPESL-GNLVKLHYLNLSNNQFSWEIPIKL-EELIHLSELDLSYNFLGRAIPSQIC-IM 647
++P + +L +L L L NQ +P + + L L EL L+ N L ++IP+ +
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKL 154
Query: 648 QSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYN 682
+L+ L+LS N L V F+ + LQ I + N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 54/218 (24%), Positives = 71/218 (32%), Gaps = 61/218 (27%)
Query: 399 SSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG-PIPNLKNLTS 457
S IP + L L+ +R L KLT L L NQ Q +LT
Sbjct: 31 SGIP------ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE 84
Query: 458 LVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNIT 517
L + L N L S P F L+ +L L N +
Sbjct: 85 LGTLGLANNQLAS--------LPLGVFDHLT----------------QLDKLYLGGNQLK 120
Query: 518 GNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGL--- 574
+P V D +L+ L +L L NQL S G
Sbjct: 121 S-LPSG--------VFD---------------RLTKLKELRLNTNQLQ---SIPAGAFDK 153
Query: 575 LVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQF 612
L L+ L LS+N L + + L KL + L NQF
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 29/105 (27%), Positives = 45/105 (42%), Gaps = 3/105 (2%)
Query: 390 LNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPI 449
L+L L + + LT L+ L+ N L + +L +L L L +NQ +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS-L 98
Query: 450 PNL--KNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNL 492
P +LT L +++L N L S S F L + L+ N L
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 14/137 (10%)
Query: 556 KLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESL-GNLVKLHYLNLSNNQFSW 614
KL L L+ L +L L+L N L + + +L +L L L+NNQ +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA- 96
Query: 615 EIPIKLEE-----LIHLSELDLSYNFLGRAIPSQIC-IMQSLEKLNLSHNSLSGVIPRCF 668
L L L +L L N L +++PS + + L++L L+ N L + F
Sbjct: 97 ----SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAF 151
Query: 669 EEMHALQCIDISYNELR 685
+++ LQ + +S N+L+
Sbjct: 152 DKLTNLQTLSLSTNQLQ 168
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 4/109 (3%)
Query: 579 EHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKL-EELIHLSELDLSYNFLG 637
E LDL S L+ + L KL +LNL NQ + + ++L L L L+ N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL- 95
Query: 638 RAIPSQI-CIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
++P + + L+KL L N L + F+ + L+ + ++ N+L+
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 18/211 (8%)
Query: 795 TNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
+ + IG G QG V + +A+KK P T + E+ + +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN 82
Query: 854 HRNIVKFY------GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGI 907
H+NI+ Q +IV E ++ +L ++ +L+ + ++ +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQM 136
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGY 967
+ +LH+ I+HRD+ N+++ ++ DFG+A+ T T Y
Sbjct: 137 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYY 192
Query: 968 VAPELAYTMKVTEKCDVYSFGVLALEVIKGK 998
APE+ M E D++S G + E+IKG
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGE---MTFQQEFLNEVKALTEIRHRNIVKF 860
+G+G G VYK + + G I+A+K+ E T + E+ L E+ H NIV
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA----IREISLLKELHHPNIVSL 84
Query: 861 YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
+ +V+E++E L +L D L+ +Q + + +++ H
Sbjct: 85 IDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQHR-- 139
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AYT 975
I+HRD+ +N+L++ +++DFG+A+ ++T T Y AP++ Y+
Sbjct: 140 -ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 976 MKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
V D++S G + E+I GK PG
Sbjct: 199 TSV----DIWSIGCIFAEMITGKPLFPGV 223
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 35/131 (26%), Positives = 60/131 (45%), Gaps = 6/131 (4%)
Query: 318 LFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSLSG 375
+ L+ N++ + P K L ++L NN++ + F G L +L+ L +Y N ++
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQG-LRSLNSLVLYGNKIT- 93
Query: 376 SIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVK 434
+P + L SL L L NK+ + +L NL++LS Y N L + L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 435 LTKLFLGDNQF 445
+ + L N F
Sbjct: 154 IQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 8e-15
Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 8/130 (6%)
Query: 78 LDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSG 135
+ L N + IPP KL+ +DLS+N S + P L L +L L+ N+++
Sbjct: 37 IRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 136 SIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLK 193
+P + GL SL L L +N + + + +L NL L LY+N L +I L+
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLR 152
Query: 194 YLLDLNLYNN 203
+ ++L N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 37/143 (25%), Positives = 62/143 (43%), Gaps = 12/143 (8%)
Query: 88 NIPPQIGNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSGSIPLEV-GGLS 145
N+P I + L N IPP L+ + L NQ+S + + GL
Sbjct: 29 NLPETI------TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 146 SLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNE 204
SLN+L LY N + ++ L +L L L N ++ + + +L L L+LY+N+
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139
Query: 205 LNGSIPQSLGNLSNLAMLNLSSN 227
L + L + ++L+ N
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 31/141 (21%), Positives = 61/141 (43%), Gaps = 10/141 (7%)
Query: 281 IPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLS 340
+P I ++ L N + P + + + L +N + L P + L+SL+
Sbjct: 30 LPETITEIR------LEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83
Query: 341 ILELGNNKLCGSIPH-FLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLT 398
L L NK+ +P L +L +L + N ++ + + +L +L+ L+L NKL
Sbjct: 84 SLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 399 SSIPISLSNLTNLSVLSFYKN 419
+ + S L + + +N
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 8e-13
Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 6/120 (5%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHL 120
+ +FS + L +DL +NQ+ + P + L L L N + +P + L
Sbjct: 46 VIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGL 103
Query: 121 SYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
L+ L L N+++ + ++ L +LN L+LY N L+ I + L + T+ L N
Sbjct: 104 FSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 36/133 (27%), Positives = 62/133 (46%), Gaps = 4/133 (3%)
Query: 265 TNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNS 324
+ + + N++ + P K L +I LS N+ S L P + L ++ L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 325 LFGLIPSELRNLKSLSILELGNNKLCGSIPHFL-GNLTNLSVLFIYNNSLSGSIPCEI-G 382
+ L S L SL +L L NK+ + +L NL++L +Y+N L +I
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFS 149
Query: 383 NLKSLSYLNLAFN 395
L+++ ++LA N
Sbjct: 150 PLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 30/131 (22%), Positives = 53/131 (40%), Gaps = 10/131 (7%)
Query: 198 LNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPS----ELGNLKYLSDLKLADNKL 253
+ L N + P + L ++LS+N + + L +L L L NK+
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLV---LYGNKI 92
Query: 254 NGSIPHSL-CNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNL 312
+P SL L +L +L + N ++ L +L L+ ++L NK + + L
Sbjct: 93 T-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 313 SNIAFLFLDSN 323
I + L N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 29/131 (22%), Positives = 55/131 (41%), Gaps = 10/131 (7%)
Query: 222 LNLSSNSLFGSIPS----ELGNLKYLSDLKLADNKLNGSIPHSLCN-LTNLVILYIYNNS 276
+ L N++ IP L+ + L++N+++ + L +L L +Y N
Sbjct: 37 IRLEQNTI-KVIPPGAFSPYKKLRRID---LSNNQIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 277 LSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNL 336
++ L S L L + L+ NK + L + +L N+ L L N L + L
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 337 KSLSILELGNN 347
+++ + L N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 29/115 (25%), Positives = 54/115 (46%), Gaps = 4/115 (3%)
Query: 573 GLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKL-EELIHLSELDL 631
L + + L N + P + KL ++LSNNQ S E+ + L L+ L L
Sbjct: 29 NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVL 87
Query: 632 SYNFLGRAIPSQI-CIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
N + +P + + SL+ L L+ N ++ + F+++H L + + N+L+
Sbjct: 88 YGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 34/130 (26%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 556 KLILAQNQLSGQLSPK-LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSW 614
++ L QN + + P +L +DLS+N +S P++ L L+ L L N+ +
Sbjct: 36 EIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 615 EIPIKL-EELIHLSELDLSYNFLGRAIPSQI-CIMQSLEKLNLSHNSLSGVIPRCFEEMH 672
E+P L E L L L L+ N + + + +L L+L N L + F +
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 673 ALQCIDISYN 682
A+Q + ++ N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 25/105 (23%), Positives = 41/105 (39%), Gaps = 3/105 (2%)
Query: 390 LNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPI 449
+ L N + P + S L + N +S P ++ L L L L N+ +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE-L 95
Query: 450 PN--LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNL 492
P + L SL + L+ N + ++F NL + L N L
Sbjct: 96 PKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 30/129 (23%), Positives = 59/129 (45%), Gaps = 6/129 (4%)
Query: 509 LDFSKNNITGNIPPKIGYS-SQLEVLDLSSNHVVGDIPAEL-GKLSFLIKLILAQNQLSG 566
+ +N I IPP +L +DLS+N + ++ + L L L+L N+++
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 567 QLSPKL-GLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIH 625
+L L L L+ L L++N ++ ++ +L L+ L+L +N+ L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 626 LSELDLSYN 634
+ + L+ N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 32/159 (20%), Positives = 53/159 (33%), Gaps = 28/159 (17%)
Query: 456 TSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNN 515
++ + L++N + +F Y L IDLS N +
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI----------------------- 68
Query: 516 ITGNIPPKIGYS-SQLEVLDLSSNHVVGDIPAEL-GKLSFLIKLILAQNQLSGQLSPKLG 573
+ P L L L N + ++P L L L L+L N+++
Sbjct: 69 --SELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQ 125
Query: 574 LLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQF 612
L L L L N L + L + ++L+ N F
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 23/103 (22%), Positives = 42/103 (40%), Gaps = 12/103 (11%)
Query: 395 NKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIP---- 450
LT IP +L ++ + +N++ P + KL ++ L +NQ +
Sbjct: 21 KGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAF 76
Query: 451 -NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNL 492
L++L SL L N +T F +L + L+ N +
Sbjct: 77 QGLRSLNSL---VLYGNKITELPKSLFEGLFSLQLLLLNANKI 116
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 8e-15
Identities = 45/211 (21%), Positives = 86/211 (40%), Gaps = 18/211 (8%)
Query: 795 TNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
+ + IG G QG V + +A+KK P T + E+ + +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN 119
Query: 854 HRNIVKFY------GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGI 907
H+NI+ Q ++V E ++ +I +L+ + ++ +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQM 173
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGY 967
+ +LH+ I+HRD+ N+++ ++ DFG+A+ S T T Y
Sbjct: 174 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYY 229
Query: 968 VAPELAYTMKVTEKCDVYSFGVLALEVIKGK 998
APE+ M E D++S G + E+++ K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 45/208 (21%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLN-----EVKALTEIRHRNI 857
IG+G G+V+K + EI+A+K+ + E + E+ L E++H+NI
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHKNI 63
Query: 858 VKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND 917
V+ + + +V+E+ + L D+ DL+ S + + L + H+
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 918 CFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 972
++HRD+ +N+L++ E ++++FG+A+ ++ T Y P++
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
Y+ + D++S G + E+ P
Sbjct: 178 LYSTSI----DMWSAGCIFAELANAGRP 201
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-14
Identities = 52/232 (22%), Positives = 97/232 (41%), Gaps = 45/232 (19%)
Query: 793 RATNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEF-------LN 844
+ ++ IG+G G V+K +G+ +A+KK + E L
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--------MENEKEGFPITALR 65
Query: 845 EVKALTEIRHRNIVKFYGFCSHAQHS--------FIVYEYLEMGSLAMILSNDAAAEDLE 896
E+K L ++H N+V C ++V+++ E LA +LSN
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN--VLVKFT 122
Query: 897 WTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF----LK 952
++ V++ + + L Y+H + I+HRD+ + NVL+ +++DFG+A+
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 953 PDSSNWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 998
+ +T T Y PEL Y + D++ G ++A E+
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMA-EMWTRS 226
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 47/211 (22%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G G +VYK + +G +A+K+ L E + E+ + E++H NIV+ Y
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK--LDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIA----DALSYLHNDC 918
+V+E+++ L + + + ++++K L++ H +
Sbjct: 71 VIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----A 973
I+HRD+ +N+L++ + + ++ DFG+A+ + ++ T Y AP++
Sbjct: 129 ---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRT 185
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
Y+ + D++S G + E+I GK PG
Sbjct: 186 YSTSI----DIWSCGCILAEMITGKPLFPGT 212
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 46/207 (22%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G+G +VYK + ++A+K+ L E + EV L +++H NIV +
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
+ +V+EYL+ L L D + + + L+Y H +
Sbjct: 68 IIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHRQK---V 121
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AYTMK 977
+HRD+ +N+L++ + E +++DFG+A+ + + T Y P++ Y+ +
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQ 181
Query: 978 VTEKCDVYSFGVLALEVIKGK--HPGD 1002
+ D++ G + E+ G+ PG
Sbjct: 182 I----DMWGVGCIFYEMATGRPLFPGS 204
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 51/240 (21%), Positives = 90/240 (37%), Gaps = 25/240 (10%)
Query: 775 GLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPG 834
G+++ + + E+ + + + I G G+V + G +A+K+ + +
Sbjct: 1 GMQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSD 60
Query: 835 EMT---FQQEF-----LNEVKALTEIRHRNIVKFYG-FCSHAQHSF----IVYEYLEMGS 881
T F L E++ L H NI+ F + + +V E +
Sbjct: 61 GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDL 120
Query: 882 LAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH--NDCFPPIVHRDISSKNVLLDFKNE 939
+I + Q + I L LH +VHRD+ N+LL N+
Sbjct: 121 AQVIHDQRIVISP-QHIQ--YFMYHILLGLHVLHEAG-----VVHRDLHPGNILLADNND 172
Query: 940 ARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 998
+ DF +A+ D +N T Y APEL T+ D++S G + E+ K
Sbjct: 173 ITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 65/226 (28%), Positives = 102/226 (45%), Gaps = 42/226 (18%)
Query: 798 FDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIRHR 855
+ D IG G G VY+ SGE++A+KK + + F N E++ + ++ H
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 107
Query: 856 NIVKFYGFCSHAQHSF------IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG--- 906
NIV+ F + +V +Y+ + A + L + +K
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP----VIYVKLYMY 163
Query: 907 -IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA-RVSDFGIAKFLKPDSSNWTELAGT 964
+ +L+Y+H+ I HRDI +N+LLD ++ DFG AK L N + +
Sbjct: 164 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
Query: 965 YGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGKH--PGD 1002
Y Y APEL YT + DV+S G VLA E++ G+ PGD
Sbjct: 221 Y-YRAPELIFGATDYTSSI----DVWSAGCVLA-ELLLGQPIFPGD 260
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEF----LNEVKALTEIRHRNIV 858
+G+G +VYK + + +I+A+KK L + L E+K L E+ H NI+
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIK--LGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 859 KFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
H + +V++++E L +I+ + L + + + L YLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----A 973
I+HRD+ N+LLD +++DFG+AK + +T T Y APEL
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 189
Query: 974 YTMKVTEKCDVYSFG-VLALEVIKGK--HPGD 1002
Y + V D+++ G +LA E++ PGD
Sbjct: 190 YGVGV----DMWAVGCILA-ELLLRVPFLPGD 216
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 63/267 (23%), Positives = 108/267 (40%), Gaps = 36/267 (13%)
Query: 808 GQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
G G+ KV++ +G +AVK + + + E++ L RH +I+K Y
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 864 CSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
S F+V EY+ G L I + E + + + I A+ Y H +
Sbjct: 80 ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EARRLFQQILSAVDYCHRHM---V 132
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----AYTMKV 978
VHRD+ +NVLLD A+++DFG++ + T G+ Y APE+ Y
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYA--- 188
Query: 979 TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH--NVQEK 1036
+ D++S GV+ ++ G P D ++ +I IP +
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFD--------DEHVPTLFKKIRGGVFYIPEYLNRSVAT 240
Query: 1037 LISFVEVAISCLDESPESRPTMQKVSQ 1063
L+ L P R T++ + +
Sbjct: 241 LLM------HMLQVDPLKRATIKDIRE 261
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 62/277 (22%), Positives = 110/277 (39%), Gaps = 48/277 (17%)
Query: 808 GQGSVYKVELA----SGEIIAVKKFH-SPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
G+GS KV+ + AVK L + E++ L +RH+N+++
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 863 FCSHA--QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG------IADALSYL 914
+ Q ++V EY G M+ D+ E +R V + + D L YL
Sbjct: 74 VLYNEEKQKMYMVMEYCVCGMQEML---DSVPE-----KRFPVCQAHGYFCQLIDGLEYL 125
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA----GTYGYVAP 970
H+ IVH+DI N+LL ++S G+A+ L P +++ + G+ + P
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD--DTCRTSQGSPAFQPP 180
Query: 971 ELAYTMKVTE--KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028
E+A + K D++S GV + G +P + N+ + I I
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE--------GDNIYKLFENIGKGSYAI 232
Query: 1029 PSH--NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063
P L+ L+ P R +++++ Q
Sbjct: 233 PGDCGPPLSDLLK------GMLEYEPAKRFSIRQIRQ 263
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 47/208 (22%), Positives = 89/208 (42%), Gaps = 36/208 (17%)
Query: 804 IGKGGQGSVYK---VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
+G+G G VYK + + A+K+ E+ L E++H N++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE-----GTGISMSACREIALLRELKHPNVISL 83
Query: 861 YG-FCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRM--SVIKGIA----DALS 912
F SHA +++++Y E L I+ A++ + ++ ++K + D +
Sbjct: 84 QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEAR----VSDFGIAKFLKPDSSNWTELAG---TY 965
YLH + ++HRD+ N+L+ + R ++D G A+ +L T+
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 966 GYVAPEL-----AYTMKVTEKCDVYSFG 988
Y APEL YT + D+++ G
Sbjct: 200 WYRAPELLLGARHYTKAI----DIWAIG 223
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 36/147 (24%), Positives = 70/147 (47%), Gaps = 19/147 (12%)
Query: 88 NIPPQIGNISKLKYLDLSSNLFSGAIPPQIG--HLSYLKTLHLFKNQLSGSIPLEVG--- 142
+IP L L++N F+ + L L+ ++ N+++ +E G
Sbjct: 29 HIPQYT------AELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD---IEEGAFE 78
Query: 143 GLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLY 201
G S +N + L SN LE++ L +L TL L +N ++ + ++ L + L+LY
Sbjct: 79 GASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLY 137
Query: 202 NNELNGSIPQ-SLGNLSNLAMLNLSSN 227
+N++ ++ + L +L+ LNL +N
Sbjct: 138 DNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 35/134 (26%), Positives = 61/134 (45%), Gaps = 5/134 (3%)
Query: 265 TNLVILYIYNNSLSGLIPSEI-GNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSN 323
L + NN + L + I L L KI S NK + + + S + + L SN
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 324 SLFGLIPSELRNLKSLSILELGNNKLCGSIPHFL-GNLTNLSVLFIYNNSLSGSIPCEI- 381
L + + L+SL L L +N++ + + L+++ +L +Y+N ++ ++
Sbjct: 92 RLENVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAF 149
Query: 382 GNLKSLSYLNLAFN 395
L SLS LNL N
Sbjct: 150 DTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 33/134 (24%), Positives = 61/134 (45%), Gaps = 9/134 (6%)
Query: 318 LFLDSNSLFGLIPS-ELRNLKSLSILELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSLS 374
L L++N L + + L L + NNK+ I F G + ++ + + +N L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEG-ASGVNEILLTSNRLE 94
Query: 375 GSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKE-YRNL 432
++ ++ L+SL L L N++T S L+++ +LS Y N ++ + + L
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTL 152
Query: 433 VKLTKLFLGDNQFQ 446
L+ L L N F
Sbjct: 153 HSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 31/115 (26%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 68 SFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKT 125
F P L ++ +N++ +I S + + L+SN + ++ L LKT
Sbjct: 52 IFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKT 109
Query: 126 LHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
L L N+++ + + GLSS+ L+LY N + + P + L +L TL L N
Sbjct: 110 LMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 28/134 (20%), Positives = 53/134 (39%), Gaps = 5/134 (3%)
Query: 361 TNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKN 419
+ L + NN + I L L +N + NK+T + + ++ + N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 420 SLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNISESFY 477
L K ++ L L L L N+ + N L+S+ + L N +T+ +F
Sbjct: 92 RLENVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFD 150
Query: 478 IYPNLTFIDLSYNN 491
+L+ ++L N
Sbjct: 151 TLHSLSTLNL-LAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 25/128 (19%), Positives = 52/128 (40%), Gaps = 3/128 (2%)
Query: 246 LKLADNKLNGSIPHSL-CNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGL 304
L+L +N+ + L L + NN ++ + +++I L+ N+ +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENV 96
Query: 305 IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH-FLGNLTNL 363
L ++ L L SN + + L S+ +L L +N++ ++ L +L
Sbjct: 97 QHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI-TTVAPGAFDTLHSL 155
Query: 364 SVLFIYNN 371
S L + N
Sbjct: 156 STLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 31/146 (21%), Positives = 60/146 (41%), Gaps = 13/146 (8%)
Query: 184 SIPSEIGNLKYLLDLNLYNNELNGSIPQSL-GNLSNLAMLNLSSNSLFGSIPS----ELG 238
IP I +Y +L L NNE + L L +N S+N + I
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGAS 81
Query: 239 NLKYLSDLKLADNKLNGSIPHSLC-NLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALS 297
+ + L N+L ++ H + L +L L + +N ++ + L + ++L
Sbjct: 82 GVNEIL---LTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLY 137
Query: 298 YNKFSGLIPHSLGNLSNIAFLFLDSN 323
N+ + + P + L +++ L L +N
Sbjct: 138 DNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 7/139 (5%)
Query: 478 IYPNLTFIDLSYNNLYG-EISSDWGRCPKLGALDFSKNNITGNIPPKIGYS-SQLEVLDL 535
I + L+ N E + + + P+L ++FS N IT +I S + + L
Sbjct: 30 IPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILL 88
Query: 536 SSNHVVGDIPAEL-GKLSFLIKLILAQNQLSGQLSPKL-GLLVQLEHLDLSSNNLSNAIP 593
+SN + ++ ++ L L L+L N+++ + L + L L N ++ P
Sbjct: 89 TSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAP 146
Query: 594 ESLGNLVKLHYLNLSNNQF 612
+ L L LNL N F
Sbjct: 147 GAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 26/109 (23%), Positives = 47/109 (43%), Gaps = 10/109 (9%)
Query: 54 NLTSIGLKG----TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNL 108
L I + + +F + + L SN+L N+ ++ + LK L L SN
Sbjct: 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNR 116
Query: 109 FSGAIPPQI-GHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSN 155
+ + LS ++ L L+ NQ++ ++ L SL+ L L +N
Sbjct: 117 IT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 23/108 (21%), Positives = 52/108 (48%), Gaps = 5/108 (4%)
Query: 581 LDLSSNNLSNAIPESL-GNLVKLHYLNLSNNQFSWEIPIK-LEELIHLSELDLSYNFLGR 638
L L++N + + L +L +N SNN+ + +I E ++E+ L+ N L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL-E 94
Query: 639 AIPSQICI-MQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
+ ++ ++SL+ L L N ++ V F + +++ + + N++
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 21/106 (19%), Positives = 43/106 (40%), Gaps = 4/106 (3%)
Query: 390 LNLAFNKLTSSIPISL-SNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGP 448
L L N+ T + L L ++F N ++ + + ++ L N+ +
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN- 95
Query: 449 IPN--LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNL 492
+ + K L SL + L N +T ++SF ++ + L N +
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 28/131 (21%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 556 KLILAQNQLSGQLSPKLGL--LVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFS 613
+L L N+ + L L QL ++ S+N +++ + ++ + L++N+
Sbjct: 36 ELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 614 WEIPIKL-EELIHLSELDLSYNFLGRAIPSQICI-MQSLEKLNLSHNSLSGVIPRCFEEM 671
+ K+ + L L L L N + + + I + S+ L+L N ++ V P F+ +
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL 152
Query: 672 HALQCIDISYN 682
H+L +++ N
Sbjct: 153 HSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 26/109 (23%), Positives = 48/109 (44%), Gaps = 7/109 (6%)
Query: 509 LDFSKNNITGNIPPKIGYS--SQLEVLDLSSNHVVGDIPAE-LGKLSFLIKLILAQNQLS 565
L + N T + + QL ++ S+N + DI S + +++L N+L
Sbjct: 37 LRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE 94
Query: 566 GQLSPKL-GLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFS 613
+ K+ L L+ L L SN ++ +S L + L+L +NQ +
Sbjct: 95 N-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 49/212 (23%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 795 TNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
+ D +G G G+V V+ +G +A+KK + P F + E++ L +R
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMR 82
Query: 854 HRNIVKFY------GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGI 907
H N++ ++V ++ L ++ ++ L + ++ +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE----KLGEDRIQFLVYQM 137
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGY 967
L Y+H I+HRD+ N+ ++ E ++ DFG+A + S T T Y
Sbjct: 138 LKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRWY 191
Query: 968 VAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 998
APE+ M+ T+ D++S G + E+I GK
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 53/230 (23%), Positives = 96/230 (41%), Gaps = 43/230 (18%)
Query: 795 TNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKK--FHSPLPGEMTFQQEFLNEVKALTE 851
+ + D +G GG G V+ V+ + +A+KK P + L E+K +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-----QSVKHALREIKIIRR 64
Query: 852 IRHRNIVKFY----------GFCSHAQHSF----IVYEYLEMGSLAMILSNDAAAEDLEW 897
+ H NIVK + + IV EY+E LA +L L
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE----QGPLLE 119
Query: 898 TQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN-EARVSDFGIAKFLKPDSS 956
+ + L Y+H+ ++HRD+ N+ ++ ++ ++ DFG+A+ + P S
Sbjct: 120 EHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 957 N---WTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 998
+ +E T Y +P L YT + D+++ G + E++ GK
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 9e-14
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 38/222 (17%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
N+F+ +GKG G V V+ A+G A+K + L E + L RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 855 RNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AAEDLEWTQRMSV 903
+ Y F +H V EY G L LS + AE
Sbjct: 208 PFLTALKYSFQTH-DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE---------- 256
Query: 904 IKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNWTELA 962
I AL YLH++ +V+RD+ +N++LD +++DFG+ K +K ++ T
Sbjct: 257 ---IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FC 310
Query: 963 GTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
GT Y+APE+ Y V D + GV+ E++ G+ P
Sbjct: 311 GTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 63/272 (23%), Positives = 104/272 (38%), Gaps = 46/272 (16%)
Query: 808 GQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
G+G+ +V+LA + E +AVK + + E+ + H N+VKFYG
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYGH 73
Query: 864 CSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSVIKG------IADALSYLHN 916
++ EY G L I + M + + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPD----------IGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA---GTYGYVAPEL- 972
I HRDI +N+LLD ++ ++SDFG+A + ++ L GT YVAPEL
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELL 179
Query: 973 ---AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029
+ E DV+S G++ ++ G+ P + S + +
Sbjct: 180 KRREFH---AEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
L+ L E+P +R T+ +
Sbjct: 235 DSAPL-ALLH------KILVENPSARITIPDI 259
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 41/225 (18%)
Query: 798 FDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLN-EVKALTEIRHRN 856
+ + IG G G V++ +L + +A+KK + F N E++ + ++H N
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ--------DKRFKNRELQIMRIVKHPN 93
Query: 857 IVK-FYGFCSHAQHS-----FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKG---- 906
+V F S+ +V EY+ + + M +IK
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP----MLLIKLYMYQ 149
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLD-FKNEARVSDFGIAKFLKPDSSNWTELAGTY 965
+ +L+Y+H+ I HRDI +N+LLD ++ DFG AK L N + + Y
Sbjct: 150 LLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY 206
Query: 966 GYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK--HPGD 1002
Y APEL YT + D++S G V+A E+++G+ PG+
Sbjct: 207 -YRAPELIFGATNYTTNI----DIWSTGCVMA-ELMQGQPLFPGE 245
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 49/219 (22%), Positives = 92/219 (42%), Gaps = 39/219 (17%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEF-------LNEVKALTEIRHR 855
+G+G G VYK ++ + E +A+K+ + E + EV L E++HR
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIR--------LEHEEEGVPGTAIREVSLLKELQHR 93
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
NI++ H +++EY E L + D+ S + + + +++ H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCH 149
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEAR-----VSDFGIAKFLKPDSSNWTELAGTYGYVAP 970
+ +HRD+ +N+LL + + + DFG+A+ +T T Y P
Sbjct: 150 SRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPP 206
Query: 971 EL-----AYTMKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
E+ Y+ V D++S + E++ PGD
Sbjct: 207 EILLGSRHYSTSV----DIWSIACIWAEMLMKTPLFPGD 241
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 46/212 (21%), Positives = 86/212 (40%), Gaps = 20/212 (9%)
Query: 795 TNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
+ + +G G GSV + +G +AVKK P + + E++ L ++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK 86
Query: 854 HRNIVKFY------GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGI 907
H N++ ++V + L I+ + L +I I
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVK----CQKLTDDHVQFLIYQI 141
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGY 967
L Y+H+ I+HRD+ N+ ++ E ++ DFG+A + + T T Y
Sbjct: 142 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWY 195
Query: 968 VAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 998
APE+ M + D++S G + E++ G+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 44/208 (21%), Positives = 84/208 (40%), Gaps = 32/208 (15%)
Query: 804 IGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFY 861
+G+G V++ + + + E + VK +++ E+K L +R NI+
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK------PVKKKKIKREIKILENLRGGPNIITLA 97
Query: 862 GFCSHAQHSFI---VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
S V+E++ + + L + I AL Y H+
Sbjct: 98 D-IVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG 150
Query: 919 FPPIVHRDISSKNVLLDFKN-EARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----- 972
I+HRD+ NV++D ++ + R+ D+G+A+F P + + + PEL
Sbjct: 151 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDYQ 206
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
Y + D++S G + +I K P
Sbjct: 207 MYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 46/220 (20%), Positives = 76/220 (34%), Gaps = 63/220 (28%)
Query: 792 IRATNDFDD----EHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEV 846
I+ DD +G G G V + + E A+K + EV
Sbjct: 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREV 61
Query: 847 KALTEI-RHRNIVKFYGFC----SHAQHSFIVYEYLEMGSL--------AMILSNDAAAE 893
+ + +IV+ + + IV E L+ G L + A+E
Sbjct: 62 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 121
Query: 894 DLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEA---RVSDFGIAKF 950
++K I +A+ YLH+ I HRD+ +N+L K +++DFG AK
Sbjct: 122 ---------IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169
Query: 951 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 990
Y + CD++S GV+
Sbjct: 170 T---------TGEKYD-------------KSCDMWSLGVI 187
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-13
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 40/224 (17%)
Query: 795 TNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKK---FHSPLPGEMTFQQEFLNEVKALT 850
+ + IG+G G V + + +A+KK F T+ Q L E+K L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-----TYCQRTLREIKILL 80
Query: 851 EIRHRNIVKFYG-FCSHAQHSF----IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIK 905
RH NI+ + IV + +E L +L + L +
Sbjct: 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLK----TQHLSNDHICYFLY 135
Query: 906 GIADALSYLH--NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN---WTE 960
I L Y+H N ++HRD+ N+LL+ + ++ DFG+A+ PD + TE
Sbjct: 136 QILRGLKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 961 LAGTYGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 998
T Y APE+ YT + D++S G +LA E++ +
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSI----DIWSVGCILA-EMLSNR 229
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 6e-13
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 793 RATNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKK--FHSPLPGEMTFQQEFLNEVKAL 849
AT+ ++ IG G G+VYK + SG +A+K + G + EV L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 850 TEIR---HRNIVKFYGFCSHAQHS-----FIVYEYLEMGSLAMILSNDAAAEDLEWTQRM 901
+ H N+V+ C+ ++ +V+E+++ L L A L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPGLPAETIK 123
Query: 902 SVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNWTE 960
+++ L +LH +C IVHRD+ +N+L+ +++DFG+A+ + T
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTP 178
Query: 961 LAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
+ T Y APE+ Y V D++S G + E+ + K G+
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPV----DMWSVGCIFAEMFRRKPLFCGN 222
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 53/199 (26%), Positives = 77/199 (38%), Gaps = 38/199 (19%)
Query: 808 GQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
G G+ L + E++AVK + + E+ +RH NIV+F
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKY----IERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 864 CSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSVIKG------IADALSYLHN 916
H I+ EY G L I + R S + + +SY H+
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNA----------GRFSEDEARFFFQQLLSGVSYCHS 134
Query: 917 DCFPPIVHRDISSKNVLLDFKNEAR--VSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-- 972
I HRD+ +N LLD R + DFG +K S + + GT Y+APE+
Sbjct: 135 MQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLL 190
Query: 973 --AYTMKVTEKCDVYSFGV 989
Y K DV+S GV
Sbjct: 191 RQEYDGK---IADVWSCGV 206
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 795 TNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
+ +G G GSV ++ SGE +A+KK P F + E+ L ++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQ 81
Query: 854 HRNIVKFYGFCSHAQHS------FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGI 907
H N++ + A ++V +++ L I+ + ++ +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG-----LKFSEEKIQYLVYQM 135
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGY 967
L Y+H+ +VHRD+ N+ ++ E ++ DFG+A + + T T Y
Sbjct: 136 LKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWY 189
Query: 968 VAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 998
APE+ + M + D++S G + E++ GK
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 25/194 (12%)
Query: 808 GQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
G+G+ +V+LA + E +AVK + + E+ + H N+VKFYG
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYGH 73
Query: 864 CSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
++ EY G L I + E + + YLH I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQLMAGVVYLHGIG---I 126
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELA---GTYGYVAPEL----AYT 975
HRDI +N+LLD ++ ++SDFG+A + ++ L GT YVAPEL +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELLKRREFH 185
Query: 976 MKVTEKCDVYSFGV 989
E DV+S G+
Sbjct: 186 ---AEPVDVWSCGI 196
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 62/267 (23%), Positives = 108/267 (40%), Gaps = 37/267 (13%)
Query: 808 GQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
G+GS KV+LA + + +A+K L + E+ L +RH +I+K Y
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 864 CSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
+ +V EY G L I+ ED + + I A+ Y H I
Sbjct: 78 ITTPTDIVMVIEYAG-GELFDYIVEKKRMTED----EGRRFFQQIICAIEYCHRHK---I 129
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----AYTMKV 978
VHRD+ +N+LLD +++DFG++ + + T G+ Y APE+ Y
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVINGKLYA--- 185
Query: 979 TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH--NVQEK 1036
+ DV+S G++ ++ G+ P D + ++ +P +
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFD--------DEFIPNLFKKVNSCVYVMPDFLSPGAQS 237
Query: 1037 LISFVEVAISCLDESPESRPTMQKVSQ 1063
LI + P R T+Q++ +
Sbjct: 238 LIR------RMIVADPMQRITIQEIRR 258
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 55/230 (23%), Positives = 99/230 (43%), Gaps = 45/230 (19%)
Query: 795 TNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKK---FHSPLPGEMTFQQEFLNEVKALT 850
++DF + +G+G G V +GEI+A+KK F P F L E+K L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP-----LFALRTLREIKILK 64
Query: 851 EIRHRNIVKFYG-FCSHAQHSF----IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIK 905
+H NI+ + + +F I+ E ++ L ++S + L I
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST----QMLSDDHIQYFIY 119
Query: 906 GIADALSYLH--NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG 963
A+ LH N ++HRD+ N+L++ + +V DFG+A+ + +++ +E G
Sbjct: 120 QTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 964 TYG----YV------APEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 998
+V APE+ Y+ + DV+S G + E+ +
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 63/267 (23%), Positives = 107/267 (40%), Gaps = 36/267 (13%)
Query: 808 GQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGF 863
G G+ KV++ +G +AVK + + + E++ L RH +I+K Y
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 864 CSHAQHSFIVYEYLEMGSL-AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
S F+V EY+ G L I N E + + + I + Y H +
Sbjct: 85 ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK----ESRRLFQQILSGVDYCHRHM---V 137
Query: 923 VHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL----AYTMKV 978
VHRD+ +NVLLD A+++DFG++ + T G+ Y APE+ Y
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYA--- 193
Query: 979 TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH--NVQEK 1036
+ D++S GV+ ++ G P D ++ +I D P +
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFD--------DDHVPTLFKKICDGIFYTPQYLNPSVIS 245
Query: 1037 LISFVEVAISCLDESPESRPTMQKVSQ 1063
L+ L P R T++ + +
Sbjct: 246 LLK------HMLQVDPMKRATIKDIRE 266
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 40/221 (18%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
DF +G G G V+ + +G A+K + + + +E L+ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AAEDLEWTQRMSVI 904
I++ +G AQ F++ +Y+E G L +L AAE
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE----------- 114
Query: 905 KGIADALSYLH-NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG 963
+ AL YLH D I++RD+ +N+LLD +++DFG AK +T L G
Sbjct: 115 --VCLALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYT-LCG 165
Query: 964 TYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
T Y+APE+ Y + D +SFG+L E++ G P
Sbjct: 166 TPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 42/130 (32%), Positives = 56/130 (43%), Gaps = 7/130 (5%)
Query: 77 YLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSG 135
L L NQ+ P ++ LK L L SN A+P + L+ L L L NQL+
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 136 SIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLK 193
+P V L L L + N L + +P + LT+L L L N L SIP L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLS 159
Query: 194 YLLDLNLYNN 203
L L+ N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 42/130 (32%), Positives = 65/130 (50%), Gaps = 7/130 (5%)
Query: 318 LFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSLSG 375
L+L N + L P +L +L L LG+N+L G++P F +LT L+VL + N L+
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVF-DSLTQLTVLDLGTNQLT- 101
Query: 376 SIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVK 434
+P + L L L + NKLT +P + LT+L+ L+ +N L + L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 435 LTKLFLGDNQ 444
LT +L N
Sbjct: 161 LTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 38/132 (28%), Positives = 64/132 (48%), Gaps = 3/132 (2%)
Query: 361 TNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNS 420
TN +L++++N ++ P +L +L L L N+L + +LT L+VL N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99
Query: 421 LSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIY 479
L+ + LV L +LF+ N+ +P ++ LT L + LD+N L S +F
Sbjct: 100 LTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRL 158
Query: 480 PNLTFIDLSYNN 491
+LT L + N
Sbjct: 159 SSLTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 41/130 (31%), Positives = 58/130 (44%), Gaps = 5/130 (3%)
Query: 100 KYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLE 158
+ L L N + P L LK L+L NQL ++P+ V L+ L L L +N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 159 DIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQ-SLGNLS 217
+ L +L L + N L+ +P I L +L L L N+L SIP + LS
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLS 159
Query: 218 NLAMLNLSSN 227
+L L N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 39/130 (30%), Positives = 65/130 (50%), Gaps = 7/130 (5%)
Query: 149 NLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNELNG 207
L L+ N + + P +L NL L L +N L ++P + +L L L+L N+L
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 208 SIPQSL-GNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPH-SLCNLT 265
+P ++ L +L L + N L +P + L +L+ L L N+L SIPH + L+
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLS 159
Query: 266 NLVILYIYNN 275
+L Y++ N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 37/119 (31%), Positives = 61/119 (51%), Gaps = 5/119 (4%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHL 120
L F S +L L L SNQL G +P + ++++L LDL +N + +P + L
Sbjct: 54 KLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRL 111
Query: 121 SYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
+LK L + N+L+ +P + L+ L +LAL N L+ I + L++L L+ N
Sbjct: 112 VHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 42/135 (31%), Positives = 63/135 (46%), Gaps = 9/135 (6%)
Query: 265 TNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGL---IPHSLGNLSNIAFLFLD 321
TN ILY+++N ++ L P +L L ++ L N+ L + SL L+ L L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTV---LDLG 96
Query: 322 SNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEI 381
+N L L + L L L + NKL +P + LT+L+ L + N L SIP
Sbjct: 97 TNQLTVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGA 154
Query: 382 -GNLKSLSYLNLAFN 395
L SL++ L N
Sbjct: 155 FDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 11/141 (7%)
Query: 281 IPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLS 340
IP+ L L N+ + L P +L N+ L+L SN L L +L L+
Sbjct: 38 IPTNAQILY------LHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91
Query: 341 ILELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLT 398
+L+LG N+L +P F L +L LF+ N L+ +P I L L++L L N+L
Sbjct: 92 VLDLGTNQL-TVLPSAVF-DRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148
Query: 399 SSIPISLSNLTNLSVLSFYKN 419
S + L++L+ + N
Sbjct: 149 SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 39/140 (27%), Positives = 62/140 (44%), Gaps = 19/140 (13%)
Query: 169 TNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSL-----GNLSNLAMLN 223
TN L L++N ++ P +L L +L L +N+L +L +L+ L +L+
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-----GALPVGVFDSLTQLTVLD 94
Query: 224 LSSNSLFGSIPS----ELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSG 279
L +N L +PS L +LK L + NKL +P + LT+L L + N L
Sbjct: 95 LGTNQL-TVLPSAVFDRLVHLKELF---MCCNKLT-ELPRGIERLTHLTHLALDQNQLKS 149
Query: 280 LIPSEIGNLKFLSKIALSYN 299
+ L L+ L N
Sbjct: 150 IPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 40/144 (27%), Positives = 58/144 (40%), Gaps = 25/144 (17%)
Query: 556 KLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESL-GNLVKLHYLNLSNNQFSW 614
L L NQ++ L+ L+ L L SN L A+P + +L +L L+L NQ +
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 615 EIPIKLEE-----LIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFE 669
L L+HL EL + N L +P I + L L L N L + F+
Sbjct: 102 ----VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156
Query: 670 EMHALQ------------CIDISY 681
+ +L C DI Y
Sbjct: 157 RLSSLTHAYLFGNPWDCECRDIMY 180
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 5/109 (4%)
Query: 579 EHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKL-EELIHLSELDLSYNFLG 637
+ L L N ++ P +L+ L L L +NQ +P+ + + L L+ LDL N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL- 100
Query: 638 RAIPSQIC-IMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
+PS + + L++L + N L+ +PR E + L + + N+L+
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK 148
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 29/102 (28%), Positives = 46/102 (45%), Gaps = 9/102 (8%)
Query: 395 NKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ----GPIP 450
+K +S+P + TN +L + N ++ P + +L+ L +L+LG NQ G
Sbjct: 28 SKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD 85
Query: 451 NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNL 492
+L LT L L N LT S F +L + + N L
Sbjct: 86 SLTQLTVL---DLGTNQLTVLPSAVFDRLVHLKELFMCCNKL 124
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 7e-12
Identities = 61/261 (23%), Positives = 111/261 (42%), Gaps = 61/261 (23%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFL---NEVKA 848
+ F+ +G+G G V+ V+ + ++ A+K ++ L + V+
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMK----------VLKKATLKVRDRVRT 73
Query: 849 LTE------IRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------A 891
E + H IVK Y F + +++ ++L G L LS +
Sbjct: 74 KMERDILVEVNHPFIVKLHYAFQTE-GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 892 AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-F 950
AE +A AL +LH+ I++RD+ +N+LLD + +++DFG++K
Sbjct: 133 AE-------------LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176
Query: 951 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSS 1010
+ + ++ GT Y+APE+ T+ D +SFGVL E++ G P F
Sbjct: 177 IDHEKKAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP--F------Q 227
Query: 1011 SLNLNIALDEILDPRLPIPSH 1031
+ + IL +L +P
Sbjct: 228 GKDRKETMTMILKAKLGMPQF 248
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 64/232 (27%), Positives = 95/232 (40%), Gaps = 59/232 (25%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFL---NEV----- 846
NDFD +GKG G V V A+G A+K ++E + +EV
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMK----------ILRKEVIIAKDEVAHTVT 54
Query: 847 --KALTEIRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AAE 893
+ L RH + Y F +H V EY G L LS + AE
Sbjct: 55 ESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 894 DLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FLK 952
I AL YLH+ +V+RDI +N++LD +++DFG+ K +
Sbjct: 114 -------------IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157
Query: 953 PDSSNWTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
++ T GT Y+APE+ Y V D + GV+ E++ G+ P
Sbjct: 158 DGATMKT-FCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 8e-11
Identities = 28/109 (25%), Positives = 52/109 (47%), Gaps = 6/109 (5%)
Query: 361 TNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNS 420
+++ L++ N + +P E+ N K L+ ++L+ N++++ S SN+T L L N
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 421 LSGAIPKE-YRNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRN 466
L IP + L L L L N +P +L++L + + N
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 7/105 (6%)
Query: 78 LDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSGS 136
L L NQ +P ++ N L +DLS+N S + Q +++ L TL L N+L
Sbjct: 36 LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 137 IPLEV-GGLSSLNNLALYSNYLEDIIPH-SLGNLTNLVTLCLYNN 179
IP GL SL L+L+ N + +P + +L+ L L + N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 27/106 (25%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 100 KYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLE 158
L L N F+ +P ++ + +L + L N++S ++ + ++ L L L N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 159 DIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNN 203
I P + L +L L L+ N +S +P +L L L + N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 5/106 (4%)
Query: 124 KTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG 183
L+L NQ + +P E+ L + L +N + + S N+T L+TL L N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 184 SIPSEI-GNLKYLLDLNLYNNELNGSIPQ-SLGNLSNLAMLNLSSN 227
IP LK L L+L+ N+++ +P+ + +LS L+ L + +N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 29/107 (27%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 341 ILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLTS 399
L L N+ +P L N +L+++ + NN +S ++ + N+ L L L++N+L
Sbjct: 35 ELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 400 SIPISLSNLTNLSVLSFYKNSLSGAIPKE-YRNLVKLTKLFLGDNQF 445
P + L +L +LS + N +S +P+ + +L L+ L +G N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 33/118 (27%), Positives = 55/118 (46%), Gaps = 13/118 (11%)
Query: 281 IPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLS 340
IP ++ L L N+F+ L+P L N ++ + L +N + L N+ L
Sbjct: 29 IPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 341 ILELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFN 395
L L N+L IP F L +L +L ++ N +S +P +L +LS+L + N
Sbjct: 82 TLILSYNRL-RCIPPRTF-DGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 69 FSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTL 126
S++ HL +DL +N++ + Q N+++L L LS N IPP+ L L+ L
Sbjct: 50 LSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLL 107
Query: 127 HLFKNQLSGSIPLEV-GGLSSLNNLALYSN 155
L N +S +P LS+L++LA+ +N
Sbjct: 108 SLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 29/105 (27%), Positives = 55/105 (52%), Gaps = 7/105 (6%)
Query: 198 LNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSEL-GNLKYLSDLKLADNKLNGS 256
L L N+ +P+ L N +L +++LS+N + ++ ++ N+ L L L+ N+L
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLR-C 92
Query: 257 IPHSLCN-LTNLVILYIYNNSLSGLIPSEI-GNLKFLSKIALSYN 299
IP + L +L +L ++ N +S +P +L LS +A+ N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 28/102 (27%), Positives = 47/102 (46%), Gaps = 1/102 (0%)
Query: 246 LKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLI 305
L L N+ +P L N +L ++ + NN +S L N+ L + LSYN+ +
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIP 94
Query: 306 PHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNN 347
P + L ++ L L N + + +L +LS L +G N
Sbjct: 95 PRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 36/111 (32%), Positives = 52/111 (46%), Gaps = 15/111 (13%)
Query: 579 EHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEE-----LIHLSELDLSY 633
L L N + +P+ L N L ++LSNN+ S L + L L LSY
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-----TLSNQSFSNMTQLLTLILSY 87
Query: 634 NFLGRAIPSQIC-IMQSLEKLNLSHNSLSGVIPR-CFEEMHALQCIDISYN 682
N L R IP + ++SL L+L N +S V+P F ++ AL + I N
Sbjct: 88 NRL-RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 26/85 (30%), Positives = 33/85 (38%), Gaps = 9/85 (10%)
Query: 531 EVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGL---LVQLEHLDLSSNN 587
L L N +P EL L + L+ N++S LS + QL L LS N
Sbjct: 34 TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSN--QSFSNMTQLLTLILSYNR 89
Query: 588 LSNAIPESL-GNLVKLHYLNLSNNQ 611
L IP L L L+L N
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGND 113
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 20/88 (22%), Positives = 35/88 (39%), Gaps = 8/88 (9%)
Query: 409 TNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ----GPIPNLKNLTSLVRVHLD 464
+++ L N + +PKE N LT + L +N+ N+ L +L L
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTL---ILS 86
Query: 465 RNYLTSNISESFYIYPNLTFIDLSYNNL 492
N L +F +L + L N++
Sbjct: 87 YNRLRCIPPRTFDGLKSLRLLSLHGNDI 114
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 9e-11
Identities = 49/272 (18%), Positives = 95/272 (34%), Gaps = 57/272 (20%)
Query: 757 QRRKNKSQTKQSSPRNTPGLRSMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYK-V 815
Q + SQ + + + + +I + ++ H IG G G V +
Sbjct: 17 QHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAY 73
Query: 816 ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG-FCSHAQHSF--- 871
+ ++A+KK ++ + L E+ L + H ++VK F
Sbjct: 74 DKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132
Query: 872 -IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH--NDCFPPIVHRDIS 928
+V E + + + L +++ + + Y+H I+HRD+
Sbjct: 133 YVVLEIADSDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSAG-----ILHRDLK 183
Query: 929 SKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTY---------------------GY 967
N L++ +V DFG+A+ + + ++L + G+
Sbjct: 184 PANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243
Query: 968 V------APEL-----AYTMKVTEKCDVYSFG 988
V APEL YT + DV+S G
Sbjct: 244 VVTRWYRAPELILLQENYTEAI----DVWSIG 271
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 52/256 (20%), Positives = 91/256 (35%), Gaps = 64/256 (25%)
Query: 795 TNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
+ + +G G G V + ++ SG+ A+KK + + E+ + +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-------LQDPRYKNRELDIMKVLD 58
Query: 854 HRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS---------- 902
H NI+K F + + + + +N S
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 903 --------VIKGIAD-------------------ALSYLHNDCFPPIVHRDISSKNVLLD 935
V+K A+ ++H+ I HRDI +N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 936 FKN-EARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL-----AYTMKVTEKCDVYSFG- 988
K+ ++ DFG AK L P + + + Y APEL YT + D++S G
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-YRAPELMLGATEYTPSI----DLWSIGC 230
Query: 989 VLALEVIKGKH--PGD 1002
V E+I GK G+
Sbjct: 231 VFG-ELILGKPLFSGE 245
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 63.8 bits (154), Expect = 9e-11
Identities = 25/162 (15%), Positives = 51/162 (31%), Gaps = 21/162 (12%)
Query: 518 GNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLG--LL 575
++ P + L L + + + L L + L + + L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLK---SLEIISGGLPDSVVEDILGSDL 218
Query: 576 VQLEHLDL---SSNNLSNAIPESL------GNLVKLHYLNLSNNQFSWEIPIKLEE---L 623
LE L L + + L +L + + + + E L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 624 IHLSELDLSYNFLG----RAIPSQICIMQSLEKLNLSHNSLS 661
L +D+S L R + + ++ L+ +N+ +N LS
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (131), Expect = 6e-08
Identities = 28/193 (14%), Positives = 66/193 (34%), Gaps = 22/193 (11%)
Query: 463 LDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPP 522
++ ++ F+ + ++S+ ++S P L L N
Sbjct: 132 VENKEKFAHFEGLFWGDIDFEEQEISWIEQ-VDLSPVLDAMPLLNNLKIKGTNNLSIGKK 190
Query: 523 KIGYSSQLEVLDLSSNHVVGDIPAELG--KLSFLIKLIL---AQNQLSG----QLSPKL- 572
L+ L++ S + + ++ L L KL+L ++ P
Sbjct: 191 P---RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247
Query: 573 -GLLVQLEHLDLSSNNLSNAIPESLGN---LVKLHYLNLSNNQFS----WEIPIKLEELI 624
L+ L + N + E L +L +++S + + ++++
Sbjct: 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIK 307
Query: 625 HLSELDLSYNFLG 637
HL +++ YN+L
Sbjct: 308 HLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.3 bits (111), Expect = 2e-05
Identities = 27/184 (14%), Positives = 64/184 (34%), Gaps = 22/184 (11%)
Query: 450 PNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSD--WGRCPKLG 507
P L + L + + T+N+S PNL +++ L + D P L
Sbjct: 166 PVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLE 222
Query: 508 ALD--FSKNNITGNIPPKI-------GYSSQLEVLDLSSNHVVGDIPAELGK---LSFLI 555
L + + + L+ L + + + L L
Sbjct: 223 KLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLE 282
Query: 556 KLILAQNQLSG----QLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQ 611
+ ++ L+ L + + L+ +++ N LS+ + + L + + +++S++Q
Sbjct: 283 TMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK-IDVSDSQ 341
Query: 612 FSWE 615
+
Sbjct: 342 EYDD 345
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 9e-05
Identities = 26/161 (16%), Positives = 54/161 (33%), Gaps = 21/161 (13%)
Query: 87 GNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGG--L 144
++ P + + L L + + + + LK+L + L S+ ++ G L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT--NNLSIGKKPRPN-LKSLEIISGGLPDSVVEDILGSDL 218
Query: 145 SSLNNLALY---SNYLEDIIPHSL------GNLTNLVTLCLYNNLLSGSIPSEIGN---L 192
+L L LY +Y D + NL L + + + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 193 KYLLDLNLYNNELNGS----IPQSLGNLSNLAMLNLSSNSL 229
L +++ L + + + +L +N+ N L
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 3e-04
Identities = 26/184 (14%), Positives = 58/184 (31%), Gaps = 19/184 (10%)
Query: 256 SIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLS-- 313
+ + I +I LS ++ + + L+ + + + NL
Sbjct: 143 GLFWGDIDFEEQEISWIEQVDLSPVLDA----MPLLNNLKIKGTNNLSIGKKPRPNLKSL 198
Query: 314 NIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFL------GNLTNLSVLF 367
I L + + ++ S+L NL+ L + + + NL L
Sbjct: 199 EIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLG 258
Query: 368 IYNNSLSGSIPCEIGN---LKSLSYLNLAFNKLTSS----IPISLSNLTNLSVLSFYKNS 420
I + + L L ++++ LT + + + +L ++ N
Sbjct: 259 IVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318
Query: 421 LSGA 424
LS
Sbjct: 319 LSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 3e-04
Identities = 14/75 (18%), Positives = 34/75 (45%), Gaps = 7/75 (9%)
Query: 67 FSFSSFPHLAYLDLWSNQLFGNIPPQIGN---ISKLKYLDLSSNLFSG----AIPPQIGH 119
FS FP+L +L + + + + +L+ +D+S+ + + + +
Sbjct: 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDK 305
Query: 120 LSYLKTLHLFKNQLS 134
+ +LK +++ N LS
Sbjct: 306 IKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 5e-04
Identities = 23/149 (15%), Positives = 44/149 (29%), Gaps = 33/149 (22%)
Query: 64 LHDFSFSSFPHLAYLDLW---SNQLFGNIPPQI------GNISKLKYLDLSSNLFSGAIP 114
+ D S P+L L L+ + F LK+L + +
Sbjct: 210 VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVV 269
Query: 115 PQIGH---LSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNL 171
L L+T+ + L+ G L + + +L
Sbjct: 270 EMFLESDILPQLETMDISAGVLTDE------GARLL--------------LDHVDKIKHL 309
Query: 172 VTLCLYNNLLSGSIPSEIGN-LKYLLDLN 199
+ + N LS + E+ L +D++
Sbjct: 310 KFINMKYNYLSDEMKKELQKSLPMKIDVS 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 6e-04
Identities = 23/153 (15%), Positives = 46/153 (30%), Gaps = 18/153 (11%)
Query: 144 LSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIG--NLKYLLDLNLY 201
L ++ L + + NL +L + + L S+ +I +L L L LY
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 202 NNELNGSIPQSLGNLS---------NLAMLNLSSNSLFGSIPSELGNLKYLSDLK---LA 249
+ + NL L + + L L+ ++
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287
Query: 250 DNKLNGS----IPHSLCNLTNLVILYIYNNSLS 278
L + + + +L + + N LS
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 46/218 (21%), Positives = 89/218 (40%), Gaps = 33/218 (15%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR--------- 853
+G G +V+ + + + +A+K + + + +E+K L +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 854 --HRNIVKFYGFCSH----AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGI 907
+I+K +H H +V+E L LA+I + L + +++S K +
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS--KQL 140
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLD------FKNEARVSDFGIAKFLKPDSSNWTEL 961
L Y+H C I+H DI +NVL++ + +++D G A + ++T
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYTNS 195
Query: 962 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 999
T Y +PE+ D++S L E+I G
Sbjct: 196 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 76/517 (14%), Positives = 162/517 (31%), Gaps = 72/517 (13%)
Query: 172 VTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFG 231
V + + ++ ++ + EL G + NL +
Sbjct: 48 VFIGNCYAVSPATVIRRFPKVRSV--------ELKGKPHFADFNLVPDGWGGYVYPWI-E 98
Query: 232 SIPSELGNLKYL--SDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLK 289
++ S L+ + + + D+ L I S N LV+ S GL + +
Sbjct: 99 AMSSSYTWLEEIRLKRMVVTDDCL-ELIAKSFKNFKVLVLSSCEGFSTDGLA-AIAATCR 156
Query: 290 FLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKL 349
L ++ L + + H L + + +L SL+I L +
Sbjct: 157 NLKELDLRESDVDDVSGHWLSHFPDT-----------------YTSLVSLNISCLASEVS 199
Query: 350 CGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAF------NKLTSSIPI 403
++ + NL L + + + L L + S + +
Sbjct: 200 FSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSV 259
Query: 404 SLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKL-----FLGDNQFQGPIPNLKNLTSL 458
+LS L LS + +++ +P Y +LT L + + L L
Sbjct: 260 ALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRL 319
Query: 459 VRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEIS----SDWG------RCPKLGA 508
+ + ++ + +L + + + + ++ G CPKL +
Sbjct: 320 WVLDYIEDAGLEVLASTC---KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLES 376
Query: 509 LDFSKNNITGNIPPKIG-YSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQ 567
+ + +T I + L L L I+ +
Sbjct: 377 VLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCK---- 432
Query: 568 LSPKLGLLVQLEHLDLSSNNLSNAIPESLG-NLVKLHYLNLSNNQFSWE-IPIKLEELIH 625
L L LS L++ + E +G K+ L+++ S + L
Sbjct: 433 ---------DLRRLSLS-GLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDS 482
Query: 626 LSELDLSY-NFLGRAIPSQICIMQSLEKLNLSHNSLS 661
L +L++ F +A+ + ++++ L +S S+S
Sbjct: 483 LRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 63/480 (13%), Positives = 139/480 (28%), Gaps = 69/480 (14%)
Query: 54 NLTSIGLKGTLH--DFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSG 111
+ S+ LKG H DF+ Y+ W + + L+ + L + +
Sbjct: 67 KVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYT-------WLEEIRLKRMVVTD 119
Query: 112 AIPPQIG-HLSYLKTLHLFKNQLSGSIPLE--VGGLSSLNNLALYSNYLEDI-------I 161
I K L L + + L +L L L + ++D+
Sbjct: 120 DCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHF 179
Query: 162 PHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAM 221
P + +L +L CL + + ++ + L L L + L L
Sbjct: 180 PDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEE 239
Query: 222 LNLSS------NSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNN 275
L ++ + L K L L + + +P + L L
Sbjct: 240 LGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTL----- 294
Query: 276 SLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRN 335
+LS +K L + L + L ++ ++ S ++
Sbjct: 295 NLSYATVQSYDLVKLLCQ---------------CPKLQRLWVLDYIEDAGLEVLASTCKD 339
Query: 336 LKSLSILELGNNKLCG-------SIPHFLGNLTNLSVLFIYNNSLSGSIPCEIG-NLKSL 387
L+ L + + + L + + ++ + I N ++
Sbjct: 340 LRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNM 399
Query: 388 SYLNLAFNKLTSSIPISLSNLTNLSVLSFYKN-------SLSG-----AIPKEYRNLVKL 435
+ L + + ++L ++ + ++ SLSG K+
Sbjct: 400 TRFRLCIIEPKAPDYLTL-EPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKM 458
Query: 436 TKLFLGDNQF--QGPIPNLKNLTSLVRVHLDRNYLTSN-ISESFYIYPNLTFIDLSYNNL 492
L + G L SL ++ + + + + + +S ++
Sbjct: 459 EMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 52/345 (15%), Positives = 112/345 (32%), Gaps = 41/345 (11%)
Query: 383 NLKSLSYLNLAFNKLTSSIPISL-SNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLG 441
++ + + P ++ + + L G NLV
Sbjct: 39 EIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVE-----LKGKPHFADFNLVPDGWGGYV 93
Query: 442 DNQFQGPIPNLKNLTSLVRVHLDRNYLT----SNISESFYIYPNLTFIDLSYNNLYGE-- 495
+ + L + L R +T I++SF N + LS +
Sbjct: 94 YPWIEAMSSSYTWLEEI---RLKRMVVTDDCLELIAKSF---KNFKVLVLSSCEGFSTDG 147
Query: 496 ISSDWGRCPKLGALDFSKNNITGNIPPKIGY----SSQLEVLDLSSNHV-VGD--IPAEL 548
+++ C L LD ++++ + + + L L++S V + +
Sbjct: 148 LAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLV 207
Query: 549 GKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSS------NNLSNAIPESLGNLVKL 602
+ L L L + +L+ L QLE L ++ + + +L +L
Sbjct: 208 TRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKEL 267
Query: 603 HYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLG-RAIPSQICIMQSLEKLNLSHN--- 658
L+ + +P L+ L+LSY + + +C L++L +
Sbjct: 268 RCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIED 327
Query: 659 -SLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKAL 702
L + C L+ + + +E PN A + + ++
Sbjct: 328 AGLEVLASTC----KDLRELRVFPSEPFVMEPN-VALTEQGLVSV 367
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 42/130 (32%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 77 YLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSG 135
YLDL +N L ++ L L L N ++P + L+ L L+L NQL
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 136 SIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLK 193
S+P V L+ L LAL +N L+ + LT L L LY N L S+P + L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLT 148
Query: 194 YLLDLNLYNN 203
L + L++N
Sbjct: 149 SLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 39/133 (29%), Positives = 57/133 (42%), Gaps = 4/133 (3%)
Query: 361 TNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNS 420
+ L + NSL L SL+ L L NKL S + LT+L+ L+ N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87
Query: 421 LSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNISESFYI 478
L + L +L +L L NQ Q +P+ LT L + L +N L S F
Sbjct: 88 LQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDR 146
Query: 479 YPNLTFIDLSYNN 491
+L +I L ++N
Sbjct: 147 LTSLQYIWL-HDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 44/131 (33%), Positives = 60/131 (45%), Gaps = 6/131 (4%)
Query: 100 KYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLE 158
YLDL +N L+ L L+L N+L S+P V L+SL L L +N L+
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 159 DIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNELNGSIPQ-SLGNL 216
+ LT L L L N L S+P + L L DL LY N+L S+P L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRL 147
Query: 217 SNLAMLNLSSN 227
++L + L N
Sbjct: 148 TSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 39/120 (32%), Positives = 62/120 (51%), Gaps = 6/120 (5%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGN-ISKLKYLDLSSNLFSGAIPPQI-GHL 120
+L + F L L L N+L ++P + N ++ L YL+LS+N ++P + L
Sbjct: 42 SLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKL 99
Query: 121 SYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
+ LK L L NQL S+P V L+ L +L LY N L+ + LT+L + L++N
Sbjct: 100 TQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 41/134 (30%), Positives = 56/134 (41%), Gaps = 6/134 (4%)
Query: 265 TNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNS 324
L + NSL L L L+++ L NK L L+++ +L L +N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87
Query: 325 LFGLIPSELRNLKSLSILELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSLSGSIPCEI- 381
L L L L L L N+L S+P F LT L L +Y N L S+P +
Sbjct: 88 LQSLPNGVFDKLTQLKELALNTNQL-QSLPDGVF-DKLTQLKDLRLYQNQLK-SVPDGVF 144
Query: 382 GNLKSLSYLNLAFN 395
L SL Y+ L N
Sbjct: 145 DRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 37/128 (28%), Positives = 54/128 (42%), Gaps = 4/128 (3%)
Query: 246 LKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLI 305
L L N L LT+L LY+ N L L L L+ + LS N+ L
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLP 92
Query: 306 PHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH--FLGNLTNL 363
L+ + L L++N L L L L L L N+L S+P F LT+L
Sbjct: 93 NGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL-KSVPDGVF-DRLTSL 150
Query: 364 SVLFIYNN 371
+++++N
Sbjct: 151 QYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 45/142 (31%), Positives = 60/142 (42%), Gaps = 22/142 (15%)
Query: 169 TNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSL-----GNLSNLAMLN 223
L L N L L L L L N+L QSL L++L LN
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-----QSLPNGVFNKLTSLTYLN 82
Query: 224 LSSNSLFGSIPS----ELGNLKYLSDLKLADNKLNGSIPHSLCN-LTNLVILYIYNNSLS 278
LS+N L S+P+ +L LK L+ L N+L S+P + + LT L L +Y N L
Sbjct: 83 LSTNQL-QSLPNGVFDKLTQLKELA---LNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK 137
Query: 279 GLIPSEI-GNLKFLSKIALSYN 299
+P + L L I L N
Sbjct: 138 S-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 14/146 (9%)
Query: 184 SIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPS----ELGN 239
S+P+ I LDL N L L++L L L N L S+P+ +L +
Sbjct: 21 SVPTGIPAQTTYLDLE--TNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTS 77
Query: 240 LKYLSDLKLADNKLNGSIPHSLCN-LTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSY 298
L YL+ L+ N+L S+P+ + + LT L L + N L L L L + L
Sbjct: 78 LTYLN---LSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQ 133
Query: 299 NKFSGLIPH-SLGNLSNIAFLFLDSN 323
N+ +P L+++ +++L N
Sbjct: 134 NQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 7/124 (5%)
Query: 520 IPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKL-GLLVQL 578
+P I +Q LDL +N + +L+ L +L L N+L L + L L
Sbjct: 22 VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78
Query: 579 EHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKL-EELIHLSELDLSYNFLG 637
+L+LS+N L + L +L L L+ NQ +P + ++L L +L L N L
Sbjct: 79 TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL- 136
Query: 638 RAIP 641
+++P
Sbjct: 137 KSVP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 39/129 (30%), Positives = 56/129 (43%), Gaps = 4/129 (3%)
Query: 556 KLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWE 615
L L N L + L L L L N L + L L YLNLS NQ
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 616 IPIKL-EELIHLSELDLSYNFLGRAIPSQIC-IMQSLEKLNLSHNSLSGVIPRCFEEMHA 673
+P + ++L L EL L+ N L +++P + + L+ L L N L V F+ + +
Sbjct: 91 LPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 149
Query: 674 LQCIDISYN 682
LQ I + N
Sbjct: 150 LQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 27/108 (25%), Positives = 53/108 (49%), Gaps = 2/108 (1%)
Query: 579 EHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGR 638
+LDL +N+L + L L L L N+ +L L+ L+LS N L +
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL-Q 89
Query: 639 AIPSQIC-IMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
++P+ + + L++L L+ N L + F+++ L+ + + N+L+
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK 137
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 28/102 (27%), Positives = 43/102 (42%), Gaps = 9/102 (8%)
Query: 395 NKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ----GPIP 450
++ +S+P + + L NSL + L LT+L+LG N+ Q G
Sbjct: 16 SQGRTSVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN 73
Query: 451 NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNL 492
L +LT L +L N L S + F L + L+ N L
Sbjct: 74 KLTSLTYL---NLSTNQLQSLPNGVFDKLTQLKELALNTNQL 112
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 49/230 (21%), Positives = 95/230 (41%), Gaps = 35/230 (15%)
Query: 793 RATNDFDDEHCIGKGGQGSVYKV--ELASGEIIAVKKFHSPLPGE---MTFQQEFLNEVK 847
RA ++ IG+G G V+K G +A+K+ E ++ + EV
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST----IREVA 63
Query: 848 ALTEIR---HRNIVK----FYGFCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQ 899
L + H N+V+ + + +V+E+++ L L +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK-VPEPGVPTET 121
Query: 900 RMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNW 958
++ + L +LH+ +VHRD+ +N+L+ + +++DFG+A+ +
Sbjct: 122 IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MAL 176
Query: 959 TELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGK--HPGD 1002
T + T Y APE+ +Y V D++S G + E+ + K G
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRKPLFRGS 222
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 23/100 (23%), Positives = 35/100 (35%), Gaps = 2/100 (2%)
Query: 251 NKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSE-IGNLKFLSKIALSYNKFSGLIPHSL 309
H L NL LYI N + + L L + + + + P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 310 GNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKL 349
++ L L N+L L ++ L SL L L N L
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 22/96 (22%), Positives = 34/96 (35%), Gaps = 2/96 (2%)
Query: 112 AIPPQIGHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTN 170
+ L L++ Q + L GL L NL + + L + P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 171 LVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELN 206
L L L N L S+ + L +L L N L+
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 4e-09
Identities = 18/100 (18%), Positives = 36/100 (36%), Gaps = 4/100 (4%)
Query: 82 SNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQ-IGHLSYLKTLHLFKNQLSGSIPLE 140
+ + + L L + + + + + L L+ L + K+ L + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 141 V-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
L+ L L N LE + ++ L +L L L N
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 6e-09
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 4/95 (4%)
Query: 329 IPSELRNLKSLSILELGNNKLCGSIPHF-LGNLTNLSVLFIYNNSLSGSIPCEI-GNLKS 386
L ++L+ L + N + + L L L L I + L + +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 387 LSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL 421
LS LNL+FN L S ++ L +L L N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 24/95 (25%), Positives = 38/95 (40%), Gaps = 2/95 (2%)
Query: 161 IPHSLGNLTNLVTLCLYNNLLSGSIPSE-IGNLKYLLDLNLYNNELNGSIPQSLGNLSNL 219
H L NL L + N + + L L +L + + L P + L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 220 AMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLN 254
+ LNLS N+L S+ + L +L L+ N L+
Sbjct: 83 SRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 27/175 (15%), Positives = 51/175 (29%), Gaps = 30/175 (17%)
Query: 502 RCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQ 561
L +++ + + + L L + + + +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELR-------------- 50
Query: 562 NQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLE 621
L G L +L +L + + L P++ +L LNLS N + K
Sbjct: 51 -DLRG--------LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTV 100
Query: 622 ELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQC 676
+ + L EL LS N L C ++ L++ L
Sbjct: 101 QGLSLQELVLSGNPL-----HCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAH 150
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 2e-08
Identities = 21/105 (20%), Positives = 37/105 (35%), Gaps = 6/105 (5%)
Query: 175 CLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIP-QSLGNLSNLAMLNLSSNSLFGSI 233
C + L + + L +L + N + + + L L L L + + L +
Sbjct: 15 CTRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFV 71
Query: 234 PSE-LGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSL 277
+ LS L L+ N L S+ +L L + N L
Sbjct: 72 APDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 20/101 (19%), Positives = 33/101 (32%), Gaps = 2/101 (1%)
Query: 202 NNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSE-LGNLKYLSDLKLADNKLNGSIPHS 260
+ L NL L + + + L L L +L + + L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 261 LCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKF 301
L L + N+L L + L L ++ LS N
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 21/102 (20%), Positives = 35/102 (34%), Gaps = 2/102 (1%)
Query: 346 NNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCE-IGNLKSLSYLNLAFNKLTSSIPIS 404
H L NL+ L+I N + + L L L + + L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 405 LSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ 446
LS L+ N+L ++ + + L +L L N
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 20/127 (15%), Positives = 36/127 (28%), Gaps = 27/127 (21%)
Query: 585 SNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQI 644
+ + + L L L + N Q + + G
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLE--------------LRDLRG------- 54
Query: 645 CIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIK--AL 702
+ L L + + L V P F L +++S+N L + ++ L
Sbjct: 55 --LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWK--TVQGLSLQELVL 110
Query: 703 QGNKGLC 709
GN C
Sbjct: 111 SGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 17/102 (16%), Positives = 35/102 (34%), Gaps = 3/102 (2%)
Query: 370 NNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIP-ISLSNLTNLSVLSFYKNSLSGAIPKE 428
+ + ++L+ L + + + L L L L+ K+ L + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 429 -YRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLT 469
+ +L++L L N + SL + L N L
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 5e-06
Identities = 22/112 (19%), Positives = 38/112 (33%), Gaps = 16/112 (14%)
Query: 36 SCAW-VGIHCNHGGRVNSI-------NLTSIGLKG-----TLHDFSFSSFPHLAYLDLWS 82
G+ C G ++S+ NLT + ++ L L L +
Sbjct: 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 83 NQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQL 133
+ L + P +L L+LS N ++ + L+ L L N L
Sbjct: 66 SGL-RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 15/76 (19%), Positives = 33/76 (43%), Gaps = 2/76 (2%)
Query: 419 NSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPN--LKNLTSLVRVHLDRNYLTSNISESF 476
+ LT+L++ + Q + L+ L L + + ++ L ++F
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 477 YIYPNLTFIDLSYNNL 492
+ P L+ ++LS+N L
Sbjct: 77 HFTPRLSRLNLSFNAL 92
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 33/108 (30%), Positives = 46/108 (42%), Gaps = 7/108 (6%)
Query: 100 KYLDLSSNLFSGAIPPQ--IGHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNY 156
L L+ N I G L +L L L +NQL+ I G S + L L N
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENK 89
Query: 157 LEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNN 203
+++I L L TL LY+N +S + +L L LNL +N
Sbjct: 90 IKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 37/119 (31%), Positives = 54/119 (45%), Gaps = 13/119 (10%)
Query: 281 IPSEIGNLKFLSKIALSYNKFSGLIPHSL-GNLSNIAFLFLDSNSLFGLIPSELRNLKSL 339
IP L L+ N+ + L G L ++ L L N L G+ P+ +
Sbjct: 27 IPLHTTELL------LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 340 SILELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFN 395
L+LG NK+ I + FLG L L L +Y+N +S + +L SL+ LNLA N
Sbjct: 81 QELQLGENKI-KEISNKMFLG-LHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 32/90 (35%), Positives = 43/90 (47%), Gaps = 6/90 (6%)
Query: 69 FSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTL 126
F PHL L+L NQL I P S ++ L L N I ++ L LKTL
Sbjct: 50 FGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTL 107
Query: 127 HLFKNQLSGSIPLEV-GGLSSLNNLALYSN 155
+L+ NQ+S + L+SL +L L SN
Sbjct: 108 NLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 29/109 (26%), Positives = 42/109 (38%), Gaps = 7/109 (6%)
Query: 341 ILELGNNKLCGSIPH-FLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLT 398
L L +N+L G L +L L + N L+ I + L L NK+
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 399 SSIPISL-SNLTNLSVLSFYKNSLSGAIPKE-YRNLVKLTKLFLGDNQF 445
I + L L L+ Y N +S + + +L LT L L N F
Sbjct: 92 E-ISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 31/110 (28%), Positives = 50/110 (45%), Gaps = 15/110 (13%)
Query: 174 LCLYNNLLSGSIPSE--IGNLKYLLDLNLYNNELNGSIPQSL-GNLSNLAMLNLSSNSLF 230
L L +N L I S+ G L +L+ L L N+L I + S++ L L N +
Sbjct: 34 LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI- 90
Query: 231 GSIPS----ELGNLKYLSDLKLADNKLNGSIPH-SLCNLTNLVILYIYNN 275
I + L LK L+ L DN+++ + S +L +L L + +N
Sbjct: 91 KEISNKMFLGLHQLKTLN---LYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 28/106 (26%), Positives = 47/106 (44%), Gaps = 5/106 (4%)
Query: 389 YLNLAFNKLTSSIPISL-SNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG 447
L L N+L L L +L L +N L+G P + + +L LG+N+ +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE 92
Query: 448 PIPN--LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNN 491
I N L L ++L N ++ + SF +LT ++L +N
Sbjct: 93 -ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL-ASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 579 EHLDLSSNNLSNAIPESL-GNLVKLHYLNLSNNQFSWEIPIKL-EELIHLSELDLSYNFL 636
L L+ N L + L G L L L L NQ + I E H+ EL L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 637 GRAIPSQICI-MQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYN 682
+ I +++ + + L+ LNL N +S V+P FE +++L ++++ N
Sbjct: 91 -KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 30/107 (28%), Positives = 46/107 (42%), Gaps = 7/107 (6%)
Query: 556 KLILAQNQLSGQLSPK--LGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFS 613
+L+L N+L ++S G L L L+L N L+ P + + L L N+
Sbjct: 33 ELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 614 WEIPIKL-EELIHLSELDLSYNFLGRAIPSQIC-IMQSLEKLNLSHN 658
EI K+ L L L+L N + + + SL LNL+ N
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 1/103 (0%)
Query: 246 LKLADNKLNGSIPHSL-CNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGL 304
L L DN+L L L +LV L + N L+G+ P+ + ++ L NK +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI 93
Query: 305 IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNN 347
L + L L N + ++P +L SL+ L L +N
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 30/108 (27%), Positives = 50/108 (46%), Gaps = 7/108 (6%)
Query: 509 LDFSKNNITGNIPPKIGYSS--QLEVLDLSSNHVVGDIPAEL-GKLSFLIKLILAQNQLS 565
L + N + I + L L+L N + I S + +L L +N++
Sbjct: 34 LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 566 GQLSPKL-GLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQF 612
++S K+ L QL+ L+L N +S +P S +L L LNL++N F
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-10
Identities = 60/233 (25%), Positives = 96/233 (41%), Gaps = 60/233 (25%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFL---NEVK-ALT 850
DF +GKG G V+ E + + A+K +++ + ++V+ +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIK----------ALKKDVVLMDDDVECTMV 66
Query: 851 E-------IRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AA 892
E H + F F + ++ F V EYL G L + + AA
Sbjct: 67 EKRVLSLAWEHPFLTHMFCTFQT-KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA 125
Query: 893 EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FL 951
E I L +LH+ IV+RD+ N+LLD +++DFG+ K +
Sbjct: 126 E-------------IILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169
Query: 952 KPDSSNWTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
D+ T GT Y+APE+ Y V D +SFGVL E++ G+ P
Sbjct: 170 LGDAKTNT-FCGTPDYIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEF-LNEVKALT 850
F+ +GKGG G V++V +G+I A+K + E L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 851 EIRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AAEDLEWTQ 899
E++H IV Y F + +++ EYL G L M L + AE
Sbjct: 77 EVKHPFIVDLIYAFQTG-GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE------ 129
Query: 900 RMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FLKPDSSNW 958
I+ AL +LH I++RD+ +N++L+ + +++DFG+ K + +
Sbjct: 130 -------ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179
Query: 959 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
T GT Y+APE+ D +S G L +++ G P
Sbjct: 180 T-FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 63/240 (26%), Positives = 95/240 (39%), Gaps = 74/240 (30%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+DF IGKG G V A AVK Q++ + + K E +H
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVK----------VLQKKAILKKK---EEKH 84
Query: 855 ----RNIVKFYGFCSHAQHSFIV------------Y---EYLEMGSLAMILSNDA----- 890
RN+ + +H F+V Y +Y+ G L L +
Sbjct: 85 IMSERNV-----LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP 139
Query: 891 -----AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDF 945
AAE IA AL YLH+ IV+RD+ +N+LLD + ++DF
Sbjct: 140 RARFYAAE-------------IASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF 183
Query: 946 GIAK-FLKPDSSNWTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
G+ K ++ +S+ T GT Y+APE+ Y V D + G + E++ G P
Sbjct: 184 GLCKENIEHNSTTST-FCGTPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 61/262 (23%), Positives = 95/262 (36%), Gaps = 53/262 (20%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELA----SGEIIAVK---KFHSPLPGEMTFQQEFLNEVKA 848
+F+ +G G G V+ V +G++ A+K K + T E +
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT--RTERQV 111
Query: 849 LTEIRHRN-IVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AAEDLE 896
L IR +V Y F + ++ +Y+ G L LS E
Sbjct: 112 LEHIRQSPFLVTLHYAFQTE-TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE--- 167
Query: 897 WTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956
I AL +LH I++RDI +N+LLD ++DFG++K D +
Sbjct: 168 ----------IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 214
Query: 957 NWTE-LAGTYGYVAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISS 1009
GT Y+AP++ + V D +S GVL E++ G P F
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP--FTV--DG 266
Query: 1010 SSLNLNIALDEILDPRLPIPSH 1031
+ IL P P
Sbjct: 267 EKNSQAEISRRILKSEPPYPQE 288
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 55/233 (23%), Positives = 94/233 (40%), Gaps = 60/233 (25%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFL---NEVK-ALT 850
DF+ +GKG G V E + E+ AVK +++ + ++V+ +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVK----------ILKKDVVIQDDDVECTMV 390
Query: 851 E-------IRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AA 892
E + + + F + + V EY+ G L + AA
Sbjct: 391 EKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA 449
Query: 893 EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FL 951
E IA L +L + I++RD+ NV+LD + +++DFG+ K +
Sbjct: 450 E-------------IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493
Query: 952 KPDSSNWTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
+ T GT Y+APE+ Y V D ++FGVL E++ G+ P
Sbjct: 494 WDGVTTKT-FCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 68/267 (25%), Positives = 107/267 (40%), Gaps = 65/267 (24%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFL---NEVK-ALT 850
DFD IG+G V V L + I A+K ++E + ++ T
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMK----------VVKKELVNDDEDIDWVQT 58
Query: 851 E-------IRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AA 892
E H +V F + F V EY+ G L + +A
Sbjct: 59 EKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA 117
Query: 893 EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FL 951
E I+ AL+YLH I++RD+ NVLLD + +++D+G+ K L
Sbjct: 118 E-------------ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161
Query: 952 KPDSSNWTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLI 1007
+P + T GT Y+APE+ Y V D ++ GVL E++ G+ P F +
Sbjct: 162 RPGDTTST-FCGTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP--FDIVG 214
Query: 1008 SSSSL---NLNIALDEILDPRLPIPSH 1031
SS + + IL+ ++ IP
Sbjct: 215 SSDNPDQNTEDYLFQVILEKQIRIPRS 241
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-10
Identities = 67/267 (25%), Positives = 107/267 (40%), Gaps = 65/267 (24%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFL---NEVK-ALT 850
DFD IG+G V V L + I A++ ++E + ++ T
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMR----------VVKKELVNDDEDIDWVQT 101
Query: 851 E-------IRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AA 892
E H +V F + F V EY+ G L + +A
Sbjct: 102 EKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA 160
Query: 893 EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FL 951
E I+ AL+YLH I++RD+ NVLLD + +++D+G+ K L
Sbjct: 161 E-------------ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204
Query: 952 KPDSSNWTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLI 1007
+P + T GT Y+APE+ Y V D ++ GVL E++ G+ P F +
Sbjct: 205 RPGDTTST-FCGTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP--FDIVG 257
Query: 1008 SSSSL---NLNIALDEILDPRLPIPSH 1031
SS + + IL+ ++ IP
Sbjct: 258 SSDNPDQNTEDYLFQVILEKQIRIPRS 284
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 39/184 (21%), Positives = 78/184 (42%), Gaps = 46/184 (25%)
Query: 804 IGKGGQGSVYKVELASGEIIAVK---------KFHSPLPGEMTF-----QQEFLNEVKAL 849
IG+GG G +Y ++ S E + + PL E+ F + E + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 850 TEIRHRNIVKFYGFCSH----AQHSFIVYEYLEMG-SLAMILSNDAAAEDL--EWTQRMS 902
++++ + K++G H + F++ + G L + + +R S
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDL----------QKIYEANAKRFS 150
Query: 903 ---VIKGIAD----ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARV--SDFGIAKFLKP 953
V++ ++ L Y+H + VH DI + N+LL++KN +V D+G+A P
Sbjct: 151 RKTVLQ-LSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 954 DSSN 957
+ +
Sbjct: 207 EGVH 210
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 29/208 (13%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR------N 856
IGKG G V K + +A+K + E F ++ E++ L +R + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
++ + H + +E L M +I N L ++ + I L LH
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFA--HSILQCLDALHK 218
Query: 917 DCFPPIVHRDISSKNVLL--DFKNEARVSDFGIAKFLKPDSSNWTELAGTY----GYVAP 970
I+H D+ +N+LL ++ +V DFG + + + TY Y AP
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE-------HQRVYTYIQSRFYRAP 268
Query: 971 ELAYTMKVTEKCDVYSFGVLALEVIKGK 998
E+ + D++S G + E++ G
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 38/180 (21%), Positives = 70/180 (38%), Gaps = 41/180 (22%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVK------KFHSPLPGEMTF-----QQEFLNEVKALTE 851
IG GG G +Y E A + + PL E+ F +++ + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 852 IRHRNIVKFYGFCSHA----QHSFIVYEYLEMG-SLAMILSNDAAAEDL-EWTQRMSV-- 903
+ + I FYG + F+V E L G L + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDL----------QKISGQNGTFKKST 152
Query: 904 IKGIAD----ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARV--SDFGIAKFLKPDSSN 957
+ + L Y+H + + VH DI + N+LL +KN +V +D+G++ P+ ++
Sbjct: 153 VLQLGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 45/239 (18%), Positives = 87/239 (36%), Gaps = 51/239 (21%)
Query: 798 FDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
+ +H IG+G G VY + + + +A+KK + ++ + L E+ L ++
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDY 86
Query: 857 IVKFYG-FCSHAQHSF----IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADAL 911
I++ Y F IV E + + + L +++ +
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI----FLTEEHIKTILYNLLLGE 142
Query: 912 SYLH--NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTY---- 965
+++H I+HRD+ N LL+ +V DFG+A+ + +
Sbjct: 143 NFIHESG-----IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 966 ------------GYV------APEL-----AYTMKVTEKCDVYSFG-VLALEVIKGKHP 1000
+V APEL YT + D++S G + A E++
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFA-ELLNMLQS 251
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 31/134 (23%), Positives = 56/134 (41%), Gaps = 15/134 (11%)
Query: 554 LIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFS 613
++L + + L L +HL LS+NN+ SL + L L+L N
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK 83
Query: 614 WEIPIKLEELIHLS----ELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIP-RCF 668
K+E L ++ EL +SYN + S I + +L L +S+N ++
Sbjct: 84 -----KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKL 136
Query: 669 EEMHALQCIDISYN 682
+ L+ + ++ N
Sbjct: 137 AALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 23/105 (21%), Positives = 48/105 (45%), Gaps = 6/105 (5%)
Query: 580 HLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRA 639
L + + +L L +L LS N +I L + +L L L N + +
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLI-KK 84
Query: 640 IPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNEL 684
I + + +LE+L +S+N ++ + E++ L+ + +S N++
Sbjct: 85 IENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKI 127
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 31/151 (20%), Positives = 55/151 (36%), Gaps = 9/151 (5%)
Query: 128 LFKNQLSGSIPLEVGGLSSLNNLALYSNYLE-DIIPHSLGNLTNLVTLCLYNNLLSGSIP 186
K+ + + + + L+ + + +L L L L N + I
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI- 63
Query: 187 SEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDL 246
S + ++ L L+L N + I L L +S N + + S + L L L
Sbjct: 64 SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVL 120
Query: 247 KLADNKLN--GSIPHSLCNLTNLVILYIYNN 275
+++NK+ G I L L L L + N
Sbjct: 121 YMSNNKITNWGEIDK-LAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 37/175 (21%), Positives = 63/175 (36%), Gaps = 28/175 (16%)
Query: 327 GLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKS 386
++ +E ++ L + + L L L + N++ I + +++
Sbjct: 19 SVVATEAEKVE----LHGMIPPI-EKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMEN 71
Query: 387 LSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKN---SLSGAIPKEYRNLVKLTKLFLGDN 443
L L+L N + I + L L N SLSG LV L L++ +N
Sbjct: 72 LRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSGI-----EKLVNLRVLYMSNN 125
Query: 444 QFQ--GPIPNLKNLTSLVRVHLDRNYLTSNISES----------FYIYPNLTFID 486
+ G I L L L + L N L ++ E+ PNL +D
Sbjct: 126 KITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 29/159 (18%), Positives = 57/159 (35%), Gaps = 19/159 (11%)
Query: 245 DLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGL 304
+L + + +L L L + N++ + S + ++ L ++L N
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIKK- 84
Query: 305 IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHF--LGNLTN 362
I + + L++ N + L S + L +L +L + NNK+ + L L
Sbjct: 85 IENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKI-TNWGEIDKLAALDK 141
Query: 363 LSVLFIYNNSLSGSIPCE----------IGNLKSLSYLN 391
L L + N L + L +L L+
Sbjct: 142 LEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 26/117 (22%), Positives = 47/117 (40%), Gaps = 6/117 (5%)
Query: 88 NIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSL 147
+ + + K+L LS+N I + + L+ L L +N + L+ +L
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIKKIENLD-AVADTL 95
Query: 148 NNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG-SIPSEIGNLKYLLDLNLYNN 203
L + N + + + L NL L + NN ++ ++ L L DL L N
Sbjct: 96 EELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 30/133 (22%), Positives = 50/133 (37%), Gaps = 12/133 (9%)
Query: 66 DFSFSSFPHLAYLDLWSNQLFGNIPPQIGNIS---KLKYLDLSSNLFSGAIPPQIGHLSY 122
D + S+ +L L +N + +I ++S L+ L L NL I
Sbjct: 41 DATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIK-KIENLDAVADT 94
Query: 123 LKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIP-HSLGNLTNLVTLCLYNNLL 181
L+ L + NQ++ +E L +L L + +N + + L L L L L N L
Sbjct: 95 LEELWISYNQIASLSGIE--KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL 152
Query: 182 SGSIPSEIGNLKY 194
+Y
Sbjct: 153 YNDYKENNATSEY 165
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 33/127 (25%), Positives = 51/127 (40%), Gaps = 12/127 (9%)
Query: 495 EISSDWGRCPKLGALDFSKNNITGNIPPKI-GYSS--QLEVLDLSSNHVVGDIPAELGKL 551
++ + L S NNI KI S L +L L N + I
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLIK-KIENLDAVA 92
Query: 552 SFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIP-ESLGNLVKLHYLNLSNN 610
L +L ++ NQ++ LS + LV L L +S+N ++N + L L KL L L+ N
Sbjct: 93 DTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
Query: 611 QFSWEIP 617
+
Sbjct: 151 PLYNDYK 157
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 37/164 (22%), Positives = 59/164 (35%), Gaps = 22/164 (13%)
Query: 433 VKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLT--SNISESFYIYPNLTFIDLSYN 490
+ +L + L L + + L N + S++S NL + L N
Sbjct: 25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSLSG----MENLRILSLGRN 80
Query: 491 NLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHV--VGDIPAEL 548
+ +I + L L S N I ++ I L VL +S+N + G+I +L
Sbjct: 81 LIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEI-DKL 136
Query: 549 GKLSFLIKLILAQNQLSGQLSPK----------LGLLVQLEHLD 582
L L L+LA N L + L L+ LD
Sbjct: 137 AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 39/214 (18%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVK------KFHSPLPGEMTFQQEFLNEVKALTEIRHR- 855
IGKG G V K E +A+K F Q EV+ L +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---------NQA-QIEVRLLELMNKHD 111
Query: 856 -----NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADA 910
IV H +V+E L ++ + + L T++ + + + A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFA--QQMCTA 169
Query: 911 LSYLHNDCFPPIVHRDISSKNVLL--DFKNEARVSDFGIAKFLKPDSSNWTELAGTY--- 965
L +L I+H D+ +N+LL ++ ++ DFG + L + Y
Sbjct: 170 LLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQL-------GQRIYQYIQS 221
Query: 966 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 998
Y +PE+ M D++S G + +E+ G+
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 60/233 (25%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFL---NEVK-ALT 850
++F+ +GKG G V + +G++ AVK +++ + ++V+ +T
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVK----------VLKKDVILQDDDVECTMT 72
Query: 851 E-------IRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AA 892
E H + + F F + F V E++ G L + AA
Sbjct: 73 EKRILSLARNHPFLTQLFCCFQT-PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA 131
Query: 893 EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FL 951
E I AL +LH+ I++RD+ NVLLD + +++DFG+ K +
Sbjct: 132 E-------------IISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175
Query: 952 KPDSSNWTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
+ T GT Y+APE+ Y V D ++ GVL E++ G P
Sbjct: 176 CNGVTTAT-FCGTPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 66/369 (17%), Positives = 119/369 (32%), Gaps = 71/369 (19%)
Query: 344 LGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIG-----NLKSLSYLNLAFNKLT 398
L + + F ++ L + N+L E+ S++ LNL+ N L
Sbjct: 5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG 64
Query: 399 SSIPISL-----SNLTNLSVLSFYKNSLSGAIPKE-----YRNLVKLTKLFLGDNQFQGP 448
L + N++ L+ N LS E +T L LG N F
Sbjct: 65 FKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSK 124
Query: 449 -----IPNLKNL-TSLVRVHLDRNYLT----SNISESFYIYP-NLTFIDLSYNNLYGEIS 497
NL S+ ++L N L + + P N+ ++L NNL +
Sbjct: 125 SSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK-- 182
Query: 498 SDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKL-----S 552
+ +K + + + LDLS+N + AEL + +
Sbjct: 183 ---------NCAELAKFLASIP--------ASVTSLDLSANLLGLKSYAELAYIFSSIPN 225
Query: 553 FLIKLILAQNQLSGQ----LSPKLGLLVQLEHLDLSSNNLSN-------AIPESLGNLVK 601
++ L L N L G L L L+ + L + + N A+ + N+ K
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQK 285
Query: 602 LHYLNLSNNQFSWEIPIKLEELI-----HLSELDLSYN--FLGRAIPSQICIM---QSLE 651
+ ++ + + I + LI L + + I + L
Sbjct: 286 IILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELR 345
Query: 652 KLNLSHNSL 660
+ + L
Sbjct: 346 ESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 46/316 (14%), Positives = 101/316 (31%), Gaps = 75/316 (23%)
Query: 383 NLKSLSYLNLAFNKLTSSIPISL-----SNLTNLSVLSFYKNSLSGAIPKE-----YRNL 432
++ L+L+ N L S + L + +++ L+ NSL E
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79
Query: 433 VKLTKLFLGDNQFQGP-----IPNLKNL-TSLVRVHLDRNYLTSN----ISESF-YIYPN 481
+T L L N + L + ++ + L N +S ++F + +
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 482 LTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVV 541
+T ++L N+L + + + + + + L+L N++
Sbjct: 140 ITSLNLRGNDLGIK-----------SSDELIQILAAIP--------ANVNSLNLRGNNL- 179
Query: 542 GDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSN----AIPESL- 596
L K + + + LDLS+N L +
Sbjct: 180 ASKNCA-----ELAKFLASIPA-------------SVTSLDLSANLLGLKSYAELAYIFS 221
Query: 597 GNLVKLHYLNLSNNQFS----WEIPIKLEELIHLSELDLSYNFLG-------RAIPSQIC 645
+ LNL N + + + L HL + L Y+ + +A+ +
Sbjct: 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFP 281
Query: 646 IMQSLEKLNLSHNSLS 661
+Q + ++ + +
Sbjct: 282 NIQKIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 47/279 (16%), Positives = 103/279 (36%), Gaps = 46/279 (16%)
Query: 452 LKNLTSLVRVHLDRNYLTSN----ISESF-YIYPNLTFIDLSYNNLYGE----ISSDWGR 502
+ + L N L S + ++F ++T ++LS N+L + +
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 503 CP-KLGALDFSKNNITGNIPPKIGY-----SSQLEVLDLSSNHVVGDIPAELGKL----- 551
P + +L+ S N ++ ++ + VLDL N +E +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 552 SFLIKLILAQNQLSGQ----LSPKLGLL-VQLEHLDLSSNNLSN----AIPESLGNL-VK 601
+ + L L N L + L L + + L+L NNL++ + + L ++
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 602 LHYLNLSNNQFSWEIPIKLEELI-----HLSELDLSYNFLGRAIPSQICIM----QSLEK 652
+ L+LS N + +L + H+ L+L N L + ++ + L+
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257
Query: 653 LNLSHNSLSGVIPRC-------FEEMHALQCIDISYNEL 684
+ L ++ + + F + + +D + E+
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 54/339 (15%), Positives = 102/339 (30%), Gaps = 62/339 (18%)
Query: 165 LGNLTNLVTLCLYNNLLSGSIPSEIG-----NLKYLLDLNLYNNELNGSIPQSLG----- 214
+ +L L N L E+ + LNL N L L
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 215 NLSNLAMLNLSSNSLFGSIPSELGNL-----KYLSDLKLADNKLNGSIPHSLCNL----- 264
+N+ LNLS N L EL ++ L L N +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 265 TNLVILYIYNNS--------LSGLIPSEIGNLKFLSKIALSYNKFS----GLIPHSLGNL 312
++ L + N L ++ + N+ L+ L N + + L ++
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLN---LRGNNLASKNCAELAKFLASI 194
Query: 313 -SNIAFLFLDSNSL-----FGLIPSELRNLKSLSILELGNNKL----CGSIPHFLGNLTN 362
+++ L L +N L L + L L N L ++ +L +
Sbjct: 195 PASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKH 254
Query: 363 LSVLFIYNNSLS--GSIPCE-----IGNLKSLSYLNLAFNKLTSSIPISLSNL-----TN 410
L +++ + + C+ N++ + ++ ++ S I +SNL
Sbjct: 255 LQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGK 314
Query: 411 LSVLSFYKNSLSGA-----IPKEYRNLVKLTKLFLGDNQ 444
V S L A ++ +L +
Sbjct: 315 ADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKP 353
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 59/350 (16%), Positives = 108/350 (30%), Gaps = 66/350 (18%)
Query: 97 SKLKYLDLSSNLFSGAIPPQIG-----HLSYLKTLHLFKNQLSGSIPLEVGGL-----SS 146
+ LDLS N ++ + + +L+L N L E+ + ++
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 147 LNNLALYSNYLEDIIPHSLGNL-----TNLVTLCLYNNLLSGSIPSEIGNL-----KYLL 196
+ +L L N+L L + L L N S SE +
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 197 DLNLYNNELNGSIPQSLGNL-----SNLAMLNLSSNSL----FGSIPSELGNL-KYLSDL 246
LNL N+L L + +N+ LNL N+L + L ++ ++ L
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSL 201
Query: 247 KLADNKLNGSIPHSLC-----NLTNLVILYIYNNSLSG----LIPSEIGNLKFLSKIALS 297
L+ N L L ++V L + N L G + +LK L + L
Sbjct: 202 DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLD 261
Query: 298 YNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFL 357
Y+ + L + N++ + +++ ++ S +
Sbjct: 262 YDIVKNMSKEQCKALG-----------------AAFPNIQKIILVDKNGKEIHPSHSIPI 304
Query: 358 GNL-----TNLSVLFIYNNSLS-----GSIPCEIGNLKSLSYLNLAFNKL 397
NL V + N L + ++ L L
Sbjct: 305 SNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 24/130 (18%), Positives = 49/130 (37%), Gaps = 10/130 (7%)
Query: 532 VLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNA 591
++ L++ + + +L L ++ + L Q + +D S N +
Sbjct: 1 MVKLTAELI-EQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL 57
Query: 592 IPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICI---MQ 648
+ L +L L ++NN+ + L L+EL L+ N L + ++
Sbjct: 58 --DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLK 113
Query: 649 SLEKLNLSHN 658
SL L + N
Sbjct: 114 SLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 17/105 (16%), Positives = 41/105 (39%), Gaps = 5/105 (4%)
Query: 581 LDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAI 640
+ L++ + A N V+ L+L + I L +D S N + +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL- 57
Query: 641 PSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
+++ L+ L +++N + + + + L + ++ N L
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 23/108 (21%), Positives = 39/108 (36%), Gaps = 4/108 (3%)
Query: 528 SQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNN 587
+ LDL + I L + + N++ +L LL +L+ L +++N
Sbjct: 19 VRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNR 75
Query: 588 LSNAIPESLGNLVKLHYLNLSNNQFS-WEIPIKLEELIHLSELDLSYN 634
+ L L L L+NN L L L+ L + N
Sbjct: 76 ICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 19/94 (20%), Positives = 36/94 (38%), Gaps = 5/94 (5%)
Query: 569 SPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIK-LEELIHLS 627
+ + V+ LDL + I L + ++ S+N+ + L L
Sbjct: 12 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLK 67
Query: 628 ELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLS 661
L ++ N + R + L +L L++NSL
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 27/127 (21%), Positives = 44/127 (34%), Gaps = 6/127 (4%)
Query: 102 LDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDII 161
+ L++ L A Q + + L L ++ I L + + N + +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL- 57
Query: 162 PHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNG-SIPQSLGNLSNLA 220
L L TL + NN + L L +L L NN L L +L +L
Sbjct: 58 -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 221 MLNLSSN 227
L + N
Sbjct: 117 YLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 22/118 (18%), Positives = 37/118 (31%), Gaps = 10/118 (8%)
Query: 449 IPNLKNLTSLVRVHLDRNYLTS--NISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKL 506
N + L + N+ + ID S N + + +L
Sbjct: 12 AAQYTNAVRDRELDLRGYKIPVIENLGATL---DQFDAIDFSDNEI--RKLDGFPLLRRL 66
Query: 507 GALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHV--VGDIPAELGKLSFLIKLILAQN 562
L + N I L L L++N + +GD+ L L L L + +N
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 21/107 (19%), Positives = 40/107 (37%), Gaps = 5/107 (4%)
Query: 187 SEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDL 246
++ N +L+L ++ I L ++ S N + + L+ L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-RKL-DGFPLLRRLKTL 69
Query: 247 KLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSK 293
+ +N++ L +L L + NNSL L ++ L L
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVEL--GDLDPLASLKS 114
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 21/134 (15%), Positives = 42/134 (31%), Gaps = 15/134 (11%)
Query: 390 LNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPI 449
+ L + + +N L + I L + + DN+ + +
Sbjct: 2 VKLTAELIEQAA--QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57
Query: 450 PNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWG------RC 503
L L + ++ N + P+LT + L+ N+L + G
Sbjct: 58 DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL-----VELGDLDPLASL 112
Query: 504 PKLGALDFSKNNIT 517
L L +N +T
Sbjct: 113 KSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 25/116 (21%), Positives = 38/116 (32%), Gaps = 4/116 (3%)
Query: 91 PQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNL 150
Q N + + LDL I L + N++ L L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 69
Query: 151 ALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG-SIPSEIGNLKYLLDLNLYNNEL 205
+ +N + I L +L L L NN L + +LK L L + N +
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 32/142 (22%), Positives = 56/142 (39%), Gaps = 7/142 (4%)
Query: 283 SEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSIL 342
++ N ++ L K +I + L + N + L L+ L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 69
Query: 343 ELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSG-SIPCEIGNLKSLSYLNLAFNKLTSSI 401
+ NN++C L +L+ L + NNSL + +LKSL+YL + N +T+
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 129
Query: 402 ---PISLSNLTNLSVLSFYKNS 420
+ + + VL F K
Sbjct: 130 HYRLYVIYKVPQVRVLDFQKVK 151
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 23/111 (20%), Positives = 36/111 (32%), Gaps = 27/111 (24%)
Query: 70 SSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLF 129
++ +D N+ I KL L LKTL +
Sbjct: 39 ATLDQFDAIDFSDNE-----------IRKLDGFP---------------LLRRLKTLLVN 72
Query: 130 KNQLSGSIPLEVGGLSSLNNLALYSNYLEDI-IPHSLGNLTNLVTLCLYNN 179
N++ L L L L +N L ++ L +L +L LC+ N
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 39/173 (22%), Positives = 69/173 (39%), Gaps = 36/173 (20%)
Query: 907 IADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYG 966
+A + +L +HRD++++N+LL KN ++ DFG+A+ + D +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---DYVRKGDA 255
Query: 967 YV-----APELAYTMKVTEKCDVYSFGVLALEVIK-GKHP-------GDFISLISSSSLN 1013
+ APE + T + DV+SFGVL E+ G P +F + +
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-- 313
Query: 1014 LNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
R+ P + E + + C P RPT ++ + L
Sbjct: 314 -----------RMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 7e-09
Identities = 55/233 (23%), Positives = 94/233 (40%), Gaps = 60/233 (25%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFL---NEVK-ALT 850
DF+ +GKG G V E + E+ AVK +++ + ++V+ +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVK----------ILKKDVVIQDDDVECTMV 69
Query: 851 E-------IRHRNIVK-FYGFCSHAQHSFIVYEYLEMGSLAMILSNDA----------AA 892
E + + + F + + V EY+ G L + AA
Sbjct: 70 EKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA 128
Query: 893 EDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK-FL 951
E IA L +L + I++RD+ NV+LD + +++DFG+ K +
Sbjct: 129 E-------------IAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172
Query: 952 KPDSSNWTELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 1000
+ T GT Y+APE+ Y V D ++FGVL E++ G+ P
Sbjct: 173 WDGVTTKT-FCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 34/180 (18%), Positives = 68/180 (37%), Gaps = 44/180 (24%)
Query: 804 IGKGGQGSVYKVE---------LASGEIIAVK--KFHSPLPGEMTFQQ-----EFLNEVK 847
+ QG +Y+ + ++K L E F Q +N+ K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 848 ALTEIRHRNIVKFYGFCSH-AQHSFIVYEYLEMG-SLAMILSNDAAAEDL-EWTQR---- 900
L I GF H ++ F+V L G SL + + + +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSL----------QSALDVSPKHVLS 157
Query: 901 MSVIKGIAD----ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARV--SDFGIAKFLKPD 954
+ +A AL +LH + + VH +++++N+ +D +++++V + +G A P
Sbjct: 158 ERSVLQVACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 1e-08
Identities = 75/481 (15%), Positives = 145/481 (30%), Gaps = 83/481 (17%)
Query: 245 DLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIG------------NLKFLS 292
+ L + NL +L + ++ LIP G NL+ L
Sbjct: 56 TMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115
Query: 293 KIALSYNKFS--GLIPHSLGNLSNIAFLFLDSNSLFG--LIPSELRNLKSLSILELGNNK 348
+ S L + ++ L LD S F + S + + + + L + +
Sbjct: 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESS 175
Query: 349 L----CGSIPHFLGNLTNLSVLFIYNNSLSG----SIPCEIGNLKSLSYLNLAFNKLTS- 399
+ + T+L VL Y + + N +SL + + ++
Sbjct: 176 FSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILEL 235
Query: 400 -SIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKL---FLGDNQFQGPIPNLKNL 455
+ +NL S ++ KL +L ++G N+ P +
Sbjct: 236 VGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQI 295
Query: 456 TSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNN 515
L +L + L + I +CP L L+ N
Sbjct: 296 RKL----------------------DLLYALLETEDHCTLIQ----KCPNLEVLETR-NV 328
Query: 516 ITGNIPPKIG-YSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGL 574
I + Y QL+ L + + E G +S + LAQ
Sbjct: 329 IGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG------------ 376
Query: 575 LVQLEHLDLSSNNLSN----AIPESLGNLVKLHYLNLSNNQFSWEIPIK------LEELI 624
+LE++ + ++++N +I L NL + L + ++P+ L
Sbjct: 377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCK 436
Query: 625 HLSELDLSYN--FLGRAIPSQIC-IMQSLEKLNLSHNSLSGV-IPRCFEEMHALQCIDIS 680
L L S I ++ + L + S + LQ +++
Sbjct: 437 KLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMR 496
Query: 681 Y 681
Sbjct: 497 G 497
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 75/515 (14%), Positives = 146/515 (28%), Gaps = 85/515 (16%)
Query: 191 NLKYLLDLNLYNNEL--NGSIPQSLGNLSNLAMLNLSSNSLFG--SIPSELGNLKYLSDL 246
NL+ L ++ + + +L L L S F + S + + + + L
Sbjct: 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTL 169
Query: 247 KLADNKLNGSIPHSLC----NLTNLVILYIYNNSLSGL----IPSEIGNLKFLSKIALSY 298
+ ++ + L + T+L +L Y + + + + N + L + +
Sbjct: 170 LMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGD 229
Query: 299 NKFSGL--IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHF 356
+ L + NL L+ + L + L L L + +P
Sbjct: 230 FEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL-SYMGPNEMPIL 288
Query: 357 LGNLTNLSVLFIYNNSLSGSIPCE-IGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLS 415
+ L + L C I +L L + + L L
Sbjct: 289 FPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLR 348
Query: 416 FYKNSLSGAIPKEY------------RNLVKLTKLFLGDNQ-----FQGPIPNLKNLTSL 458
+ + + E + +L + + + + LKNL
Sbjct: 349 IERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDF 408
Query: 459 VRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKN--NI 516
V LDR DL +N + C KL F +
Sbjct: 409 RLVLLDREER---------------ITDLPLDNGVRSLLI---GCKKLRRFAFYLRQGGL 450
Query: 517 TGNIPPKIG-YSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLL 575
T IG YS + + L + E +
Sbjct: 451 TDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRG-----------------------C 487
Query: 576 VQLEHLDLSSNNLSN-AIPESLGNLVKLHYLNLSNNQFSWEIPIKLEE---LIHLSELDL 631
L+ L++ S AI ++ L L YL + + S ++ ++ +
Sbjct: 488 PNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPS 547
Query: 632 SYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPR 666
+I M+ + L++ SL+G R
Sbjct: 548 RRVPEVN-QQGEIREMEHPAHI-LAYYSLAG--QR 578
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 7e-06
Identities = 46/347 (13%), Positives = 104/347 (29%), Gaps = 49/347 (14%)
Query: 69 FSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHL 128
+ L + + ++ + + L+ S +P + +L + + L
Sbjct: 216 ARNCRSLVSVKVGDFEILELVGF-FKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR 274
Query: 129 --FKNQLSGSIPLEVGGLSSLNNLAL-YSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSI 185
+P+ + + L L Y+ + + NL L N + +
Sbjct: 275 LGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGL 334
Query: 186 PSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSD 245
K L L + + G +S ++ L+ + L
Sbjct: 335 EVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ------------GCQELEY 382
Query: 246 LKLADNKLN----GSIPHSLCNLTNLVILYIYNNSLSGLIPSEIG------NLKFLSKIA 295
+ + + + SI L NL + ++ + +P + G K L + A
Sbjct: 383 MAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFA 442
Query: 296 LSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLC-GSIP 354
+ G L+++ ++ + ++ + LG +
Sbjct: 443 FYLRQ---------GGLTDLGLSYI------------GQYSPNVRWMLLGYVGESDEGLM 481
Query: 355 HFLGNLTNLSVLFIYNNSLS-GSIPCEIGNLKSLSYLNLAFNKLTSS 400
F NL L + S +I + L SL YL + + + +
Sbjct: 482 EFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 35/105 (33%), Positives = 46/105 (43%), Gaps = 4/105 (3%)
Query: 389 YLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGP 448
L L NKL S LT L+ LS +N + + L KLT L+L +N+ Q
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS- 90
Query: 449 IPN--LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNN 491
+PN LT L + LD N L S F +L I L + N
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWL-HTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 4/105 (3%)
Query: 77 YLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSG 135
L+L SN+L +++L L LS N ++P + L+ L L+L +N+L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 136 SIPLEV-GGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
S+P V L+ L LAL +N L+ + LT+L + L+ N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 38/118 (32%), Positives = 48/118 (40%), Gaps = 12/118 (10%)
Query: 281 IPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLS 340
IPS L+ L NK L L+ + L L N + L L L+
Sbjct: 26 IPSSATRLE------LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT 79
Query: 341 ILELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFN 395
IL L NKL S+P+ F LT L L + N L S+P I L SL + L N
Sbjct: 80 ILYLHENKL-QSLPNGVF-DKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 33/105 (31%), Positives = 49/105 (46%), Gaps = 6/105 (5%)
Query: 318 LFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSLSG 375
L L+SN L L L L+ L L N++ S+P F LT L++L+++ N L
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVF-DKLTKLTILYLHENKLQ- 89
Query: 376 SIPCEI-GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKN 419
S+P + L L L L N+L S LT+L + + N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 29/108 (26%), Positives = 47/108 (43%), Gaps = 2/108 (1%)
Query: 265 TNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNS 324
++ L + +N L L L L+K++LS N+ L L+ + L+L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 325 LFGLIPSELRNLKSLSILELGNNKLCGSIPH-FLGNLTNLSVLFIYNN 371
L L L L L L N+L S+P LT+L ++++ N
Sbjct: 88 LQSLPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 33/106 (31%), Positives = 46/106 (43%), Gaps = 6/106 (5%)
Query: 149 NLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNELNG 207
L L SN L+ + LT L L L N + S+P + L L L L+ N+L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 208 SIPQSL-GNLSNLAMLNLSSNSLFGSIPSE-LGNLKYLSDLKLADN 251
S+P + L+ L L L +N L S+P L L + L N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 6/90 (6%)
Query: 69 FSSFPHLAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTL 126
F L L L NQ+ ++P + ++KL L L N ++P + L+ LK L
Sbjct: 48 FDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKEL 105
Query: 127 HLFKNQLSGSIPLEV-GGLSSLNNLALYSN 155
L NQL S+P + L+SL + L++N
Sbjct: 106 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 31/96 (32%), Positives = 43/96 (44%), Gaps = 10/96 (10%)
Query: 520 IPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGL---LV 576
+P I S L+L SN + KL+ L KL L+QNQ+ L G+ L
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPD--GVFDKLT 76
Query: 577 QLEHLDLSSNNLSNAIPESL-GNLVKLHYLNLSNNQ 611
+L L L N L ++P + L +L L L NQ
Sbjct: 77 KLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQ 111
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 28/102 (27%), Positives = 38/102 (37%)
Query: 246 LKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLI 305
L+L NKL LT L L + N + L L L+ + L NK L
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLP 92
Query: 306 PHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNN 347
L+ + L LD+N L + L SL + L N
Sbjct: 93 NGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 2e-08
Identities = 86/572 (15%), Positives = 163/572 (28%), Gaps = 193/572 (33%)
Query: 484 FIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGD 543
F++ Y + S + ++ Y Q + L + N V
Sbjct: 82 FVEEVLRINYKFLMSPIKTEQRQPSMMTRM------------YIEQRDRL-YNDNQVF-- 126
Query: 544 IPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQ---------LEHLDLSSNNLSNAIPE 594
+ +L +KL + L +L P +L+ + S + +
Sbjct: 127 AKYNVSRLQPYLKL---RQALL-ELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDF 182
Query: 595 SLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDL-SYNFLGRAIPSQICIMQS-LEK 652
K+ +LNL N + L++L++ + + S + I +I +Q+ L +
Sbjct: 183 ------KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 653 LNLSH---NSLSGVI------PRCFEEMHALQC-----------IDISYNELRGPIP--- 689
L S N L ++ + + L C D I
Sbjct: 237 LLKSKPYENCL--LVLLNVQNAKAWNAF-NLSCKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 690 NSTAFRDAPIKALQGNKGLCGDFKGLPSCKALKSNKQASRKIWIVVLFPLLGIVALLISL 749
+S +K+L K L + LP + L +N P +S+
Sbjct: 294 HSMTLTPDEVKSLLL-KYLDCRPQDLPR-EVLTTN-------------P------RRLSI 332
Query: 750 IGL----------FFKFQRRKNKSQTKQSS-------------------PRN---TPGLR 777
I +K + +SS P + L
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILL 392
Query: 778 SMLTFEGKIVYEEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMT 837
S++ F+ ++ +++ N + K + S + S
Sbjct: 393 SLIWFD--VIKSDVMVVVNKLHKYSLVEKQPKESTISI-------------PS------- 430
Query: 838 FQQEFLNEVKALTEIRHRNIVKFY----GFCSHAQ---------HSFIVY-----EYLEM 879
E +++ + HR+IV Y F S +S I + E+ E
Sbjct: 431 IYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPER 489
Query: 880 GSL--AMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK 937
+L + L D + ++ K D+ ++ + S N L K
Sbjct: 490 MTLFRMVFL-------DFRFLEQ----KIRHDSTAWNASG----------SILNTLQQLK 528
Query: 938 N------------EARVSDFGIAKFLKPDSSN 957
E V+ I FL N
Sbjct: 529 FYKPYICDNDPKYERLVNA--ILDFLPKIEEN 558
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 1e-07
Identities = 89/558 (15%), Positives = 176/558 (31%), Gaps = 126/558 (22%)
Query: 93 IGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNL-- 150
+ + ++ Y L S + + P + Y++ N V L L
Sbjct: 83 VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ 142
Query: 151 ALYSNYLED---IIPHSLGNL--TNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNEL 205
AL L ++ + T + + + + +I + L+L N+
Sbjct: 143 ALLE--LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKI----FWLNLKNCNSP- 195
Query: 206 NGSIPQSLGNLSNLAMLNLSSNSLFG-SIPSELGNLK-YLSDLKLADNKLNGSIPHSLCN 263
++ + L L N +S S +I + +++ L L L + L
Sbjct: 196 -ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-LKSKPY----ENCL-- 247
Query: 264 LTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSN 323
LV+L + N KI L +F + L + + LD +
Sbjct: 248 ---LVLLNVQN-------AKAWNAFNLSCKI-LLTTRFKQVT-DFLSA-ATTTHISLDHH 294
Query: 324 SLFGLIPSELRNLKSLSILELGNNKL----CGSIPHFLGNLTNLSVLFIYNNSLSGSIPC 379
S+ L P E+++L L L+ L + P L + I +
Sbjct: 295 SM-TLTPDEVKSL-LLKYLDCRPQDLPREVLTTNPRRLS----IIAESIRDG------LA 342
Query: 380 EIGNLKSLSYLNLAFNKLTSSIPISLSNLT---------NLSVLSFYKNSLSGAIP---- 426
N + ++ +KLT+ I SL+ L LSV F ++ IP
Sbjct: 343 TWDN-----WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV--FPPSAH---IPTILL 392
Query: 427 ------KEYRN----LVKLTKLFLGDNQFQGP---IPNL-----KNLTSLVRVH------ 462
+ + KL K L + Q + IP++ L + +H
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH 452
Query: 463 --LDRNYLTSNISESF---YIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFS--KNN 515
+ + + + ++ + Y Y + I ++ E + LDF +
Sbjct: 453 YNIPKTFDSDDLIPPYLDQYFY---SHI--GHHLKNIEHPERMTLFRMV-FLDFRFLEQK 506
Query: 516 ITGNIPPKIGYSSQLEVL-DLS--SNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKL 572
I + S L L L ++ + P ++ ++ + ++
Sbjct: 507 IRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLP-------KIEEN- 558
Query: 573 GLLVQLEHLDLSSNNLSN 590
L+ ++ DL L
Sbjct: 559 --LICSKYTDLLRIALMA 574
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 1e-07
Identities = 43/284 (15%), Positives = 85/284 (29%), Gaps = 67/284 (23%)
Query: 833 PGEMTFQQEFLNEVKALTEIRHRNIVKFYGF------------CS----HAQHSFIVYEY 876
++ Q +L +AL E+R V G C + F ++ +
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-W 186
Query: 877 LEMG------SLAMILSNDAAAEDLEWTQRMSVIKGI-------ADALSYL-----HNDC 918
L + ++ +L D WT R I L L + +C
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 919 FPPIVHRDISSKNVLLDFKNEARV----SDFGIAKFLKPDSSNWTELAG-TYGYVAPELA 973
+V ++ + F ++ + FL ++ L + E
Sbjct: 247 L--LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE-- 302
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033
+ K L EV+ +P +S+I+ S + D H
Sbjct: 303 -VKSLLLKYLDCRPQDLPREVLTT-NP-RRLSIIAESIRDGLATWDNWK--------HVN 351
Query: 1034 QEKLISFVEVAISCLDES------------PESRPTMQKVSQLL 1065
+KL + +E +++ L+ + P S + L+
Sbjct: 352 CDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI 395
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 6e-07
Identities = 57/314 (18%), Positives = 107/314 (34%), Gaps = 76/314 (24%)
Query: 65 HDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLK 124
H + + + L + + ++P ++ + + LS + + +I + K
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRR---LS--IIAESIRDGLATWDNWK 348
Query: 125 TLHLFKNQLSGSIPLEVGGLSSLNNL--ALYSNYLED--IIPHSLGNLTNLVTLCLYNNL 180
H+ ++L+ I SSLN L A Y + + P S ++ + L L
Sbjct: 349 --HVNCDKLTTIIE------SSLNVLEPAEYRKMFDRLSVFPPSA-HIP-TILLSLIWFD 398
Query: 181 LSGSIPSEIGNL--KYLLDLNLYNNELNGSIP----QSLGNLSNLAML------------ 222
+ S + N KY L + E SIP + L N L
Sbjct: 399 VIKSDVMVVVNKLHKYSL-VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPK 457
Query: 223 -----NLSSNSLFGSIPSELG---------------NLKYLSDLKLADNKL-----NGSI 257
+L L S +G + +L D + + K+ +
Sbjct: 458 TFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL-DFRFLEQKIRHDSTAWNA 516
Query: 258 PHSLCNLTNLVILY---IYNNS--LSGLIPSEIGNLKFLSKIA--LSYNKFSGLIPHSLG 310
S+ N + Y I +N L+ + I L FL KI L +K++ L+ +L
Sbjct: 517 SGSILNTLQQLKFYKPYICDNDPKYERLV-NAI--LDFLPKIEENLICSKYTDLLRIALM 573
Query: 311 NLSNIAFLFLDSNS 324
+F +++
Sbjct: 574 AEDE--AIFEEAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 2e-06
Identities = 78/584 (13%), Positives = 169/584 (28%), Gaps = 159/584 (27%)
Query: 582 DLSSNNLSNAIPESLGNLVKLHYLNLSNNQ------FSWEIPIKLEELIHL---SELDLS 632
+ ++ + L H + + F W + K EE++ L ++
Sbjct: 32 NFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLF-WTLLSKQEEMVQKFVEEVLRIN 90
Query: 633 YNFLGRAI------PSQICIMQSLEKLNLSHNSLSGV----IPRCFEEMHALQCIDISYN 682
Y FL I PS + M E+ + +N + R + L+
Sbjct: 91 YKFLMSPIKTEQRQPSMMTRMYI-EQRDRLYNDNQVFAKYNVSR-LQPYLKLR------Q 142
Query: 683 ELRGPIPNSTAFRDAPIKALQGNKGLCGDFK---GLPSCKALKSNKQASRKI-WIVVLFP 738
L R A + G G G K L C + K + KI W+ +
Sbjct: 143 ALLE-------LRPAKNVLIDGVLG-SG--KTWVALDVCLSYKVQCKMDFKIFWLNL--- 189
Query: 739 LLG----IVALLISLIGLFFKF-----QRRKNKSQTKQSSPRNTPGLRSMLTFEGK---- 785
+L L L ++ R + S K LR +L +
Sbjct: 190 --KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 786 IV-----YEEIIRATNDFDDEHC--------------IGKGGQGSVYKVELASG------ 820
+V + A F+ C + + +
Sbjct: 248 LVLLNVQNAKAWNA---FN-LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV 303
Query: 821 -EIIAVKKFHSP---LPGEMT---------FQQEFLNEVKALTEIRHRNIVKFYGFCSHA 867
++ K LP E+ + + + +H N K +
Sbjct: 304 KSLLL-KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL----TTI 358
Query: 868 QHSFI----------VYEYLEM---------GSLAMILSNDAAAEDLEWTQRMS----VI 904
S + +++ L + L++I + ++ + ++ V
Sbjct: 359 IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418
Query: 905 KGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT 964
K ++ + + ++ ++ K +NE + + + P + + +L
Sbjct: 419 KQPKESTISIPS------IYLELKVKL-----ENEYALHRSIVDHYNIPKTFDSDDLIPP 467
Query: 965 Y--GYVAPELAYTMKV---TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALD 1019
Y Y + + +K E+ ++ L ++ K D + +S S+ L+
Sbjct: 468 YLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSI-----LN 522
Query: 1020 EILDPRL----PIPSHNVQEKLIS----FVEVAISCLDESPESR 1055
+ + + E+L++ F+ L S +
Sbjct: 523 TLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTD 566
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 27/109 (24%), Positives = 46/109 (42%), Gaps = 4/109 (3%)
Query: 528 SQLEVLDLSSNHV-VGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSN 586
S ++ L L ++ G + + L L L+ ++ L L +L+ L+LS N
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDN 74
Query: 587 NLSNAIPESLGNLVKLHYLNLSNNQF-SWEIPIKLEELIHLSELDLSYN 634
+S + L +LNLS N+ L++L +L LDL
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 29/119 (24%), Positives = 59/119 (49%), Gaps = 6/119 (5%)
Query: 544 IPAELGKLSF--LIKLILAQNQLS-GQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLV 600
I EL + + +L+L ++ + G+L +LE L + L++ +L L
Sbjct: 7 IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLN 64
Query: 601 KLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGR-AIPSQICIMQSLEKLNLSHN 658
KL L LS+N+ S + + E+ +L+ L+LS N + + + +++L+ L+L +
Sbjct: 65 KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 29/111 (26%), Positives = 45/111 (40%), Gaps = 4/111 (3%)
Query: 119 HLSYLKTLHLFKNQLS-GSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLY 177
S +K L L ++ + G + L L+ + L I +L L L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 178 NNLLSGSIPSEIGNLKYLLDLNLYNNELNG-SIPQSLGNLSNLAMLNLSSN 227
+N +SG + L LNL N++ S + L L NL L+L +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 28/104 (26%), Positives = 43/104 (41%), Gaps = 5/104 (4%)
Query: 191 NLKYLLDLNLYNNELN-GSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLA 249
+ +L L N+ N G + L L+ + L SI + L L L L+L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSI-ANLPKLNKLKKLELS 72
Query: 250 DNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSK 293
DN+++G + NL L + N + L S I LK L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL--STIEPLKKLEN 114
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 21/95 (22%), Positives = 39/95 (41%), Gaps = 3/95 (3%)
Query: 305 IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLS 364
+ + FL + L + + L L L LEL +N++ G + NL+
Sbjct: 34 LEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91
Query: 365 VLFIYNNSLSG-SIPCEIGNLKSLSYLNLAFNKLT 398
L + N + S + L++L L+L ++T
Sbjct: 92 HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 19/89 (21%), Positives = 39/89 (43%), Gaps = 3/89 (3%)
Query: 598 NLVKLHYLNLSNNQFS-WEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLS 656
+ L L N++ + ++ +E L L L + + + L+KL LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 657 HNSLSGVIPRCFEEMHALQCIDISYNELR 685
N +SG + E+ L +++S N+++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 26/113 (23%), Positives = 49/113 (43%), Gaps = 8/113 (7%)
Query: 71 SFPHLAYLDLWSNQLFGNIPPQIGNIS---KLKYLDLSSNLFSGAIPPQIGHLSYLKTLH 127
+ + L L +++ N G +L++L + + + L+ LK L
Sbjct: 15 TPSDVKELVLDNSRS--NEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLE 70
Query: 128 LFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDI-IPHSLGNLTNLVTLCLYNN 179
L N++SG + + +L +L L N ++D+ L L NL +L L+N
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 28/114 (24%), Positives = 45/114 (39%), Gaps = 5/114 (4%)
Query: 211 QSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVIL 270
++ ++ L + N SN G + + L L + L SI + L L L L
Sbjct: 14 RTPSDVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKL 69
Query: 271 YIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGL-IPHSLGNLSNIAFLFLDSN 323
+ +N +SG + L+ + LS NK L L L N+ L L +
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 29/111 (26%), Positives = 43/111 (38%), Gaps = 4/111 (3%)
Query: 526 YSSQLEVLDLSSNH-VVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLS 584
+ + L L + G I + L L L L +S L L +L+ L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 585 SNNLSNAIPESLGNLVKLHYLNLSNNQF-SWEIPIKLEELIHLSELDLSYN 634
N + + L L +LNLS N+ L++L L LDL
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 37/155 (23%), Positives = 55/155 (35%), Gaps = 24/155 (15%)
Query: 334 RNLKSLSILELGNNKLC-GSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNL 392
R ++ L L N K G I NL L + N L S+ + L L L L
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLEL 78
Query: 393 AFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEY-RNLVKLTKLFLGDNQFQGPIPN 451
+ N++ + + L NL+ L+ N L E + L L L L + + N
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC----EVTN 134
Query: 452 LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFID 486
L + V L P LT++D
Sbjct: 135 LNDYRESVFKLL----------------PQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 29/110 (26%), Positives = 53/110 (48%), Gaps = 8/110 (7%)
Query: 556 KLILAQNQLS-GQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSW 614
+L+L + + G++ V LE L L + L + +L L KL L LS N+
Sbjct: 28 ELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFG 85
Query: 615 EIPIKLEELIHLSELDLSYNFLGRAIPSQICI---MQSLEKLNLSHNSLS 661
+ + E+L +L+ L+LS N L S + ++ L+ L+L + ++
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 32/122 (26%), Positives = 47/122 (38%), Gaps = 6/122 (4%)
Query: 303 GLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTN 362
G I N+ FL L + L + S L L L LEL N++ G + L N
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 363 LSVLFIYNNSLSG-SIPCEIGNLKSLSYLNLAFNKLTSSI---PISLSNLTNLSVLSFYK 418
L+ L + N L S + L+ L L+L ++T+ L L+ L Y
Sbjct: 97 LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD 156
Query: 419 NS 420
Sbjct: 157 RE 158
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 29/104 (27%), Positives = 45/104 (43%), Gaps = 5/104 (4%)
Query: 191 NLKYLLDLNLYNNELN-GSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLA 249
+ +L L N + N G I NL L+L + L S+ + L L L L+L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISVSN-LPKLPKLKKLELS 79
Query: 250 DNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSK 293
+N++ G + L NL L + N L + S + LK L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI--STLEPLKKLEC 121
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 28/104 (26%), Positives = 43/104 (41%), Gaps = 4/104 (3%)
Query: 77 YLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGS 136
LD + G I L++L L + + L LK L L +N++ G
Sbjct: 30 VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGG 86
Query: 137 IPLEVGGLSSLNNLALYSNYLEDI-IPHSLGNLTNLVTLCLYNN 179
+ + L +L +L L N L+DI L L L +L L+N
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 28/110 (25%), Positives = 44/110 (40%), Gaps = 4/110 (3%)
Query: 120 LSYLKTLHLFKNQLS-GSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYN 178
+ ++ L L + + G I +L L+L + L + +L L L L L
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSE 80
Query: 179 NLLSGSIPSEIGNLKYLLDLNLYNNELNG-SIPQSLGNLSNLAMLNLSSN 227
N + G + L L LNL N+L S + L L L L+L +
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 598 NLVKLHYLNLSNNQFSW-EIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLS 656
+ L L N + + +I E ++L L L L S + + L+KL LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 657 HNSLSGVIPRCFEEMHALQCIDISYNEL 684
N + G + E++ L +++S N+L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 31/157 (19%), Positives = 52/157 (33%), Gaps = 31/157 (19%)
Query: 215 NLSNLAMLNLSSNSL-FGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIY 273
+ + L L + G I L L L + L S+ +L L L L +
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 274 NNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSEL 333
N + G + L L+ + LS NK + L L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK-----DISTLEP------------------L 116
Query: 334 RNLKSLSILELGNNKLCGSIPHF----LGNLTNLSVL 366
+ L+ L L+L N ++ ++ + L L+ L
Sbjct: 117 KKLECLKSLDLFNCEVT-NLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 30/111 (27%), Positives = 46/111 (41%), Gaps = 10/111 (9%)
Query: 484 FIDLSYNNLYGEISSDWGRCPKLGALDFSKNNIT--GNIPPKIGYSSQLEVLDLSSNHVV 541
+D +N G+I L L + N+P +L+ L+LS N +
Sbjct: 30 VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISVSNLPK----LPKLKKLELSENRIF 84
Query: 542 GDIPAELGKLSFLIKLILAQNQLS--GQLSPKLGLLVQLEHLDLSSNNLSN 590
G + KL L L L+ N+L L P L L L+ LDL + ++N
Sbjct: 85 GGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVTN 134
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 28/116 (24%), Positives = 45/116 (38%), Gaps = 6/116 (5%)
Query: 404 SLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHL 463
+ + + L VL K++ G I V L L L + + NL L L ++ L
Sbjct: 22 TPAAVREL-VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLEL 78
Query: 464 DRNYLTSNISESFYIYPNLTFIDLSYNNL--YGEISSDWGRCPKLGALDFSKNNIT 517
N + + PNLT ++LS N L + + L +LD +T
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVT 133
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 58/253 (22%), Positives = 103/253 (40%), Gaps = 63/253 (24%)
Query: 784 GKIVYEEIIRATNDFDDEHCIGKGGQGSVYK-VELASGEIIAVKKFHSPLPGEMTFQQEF 842
G++ ++ +GKG G V+K ++ +GE++AVKK T Q
Sbjct: 1 GRVDRH----VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRT 55
Query: 843 LNEVKALTEIR-HRNIVKFY------GFCSHAQHSFIVYEYLEMGS-LAMILSNDAAAED 894
E+ LTE+ H NIV + ++V++Y M + L ++ A
Sbjct: 56 FREIMILTELSGHENIVNLLNVLRADND----RDVYLVFDY--METDLHAVIR----ANI 105
Query: 895 LEWTQRMSVIKGIADALSYLH--NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLK 952
LE + V+ + + YLH ++HRD+ N+LL+ + +V+DFG+++
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLHSGG-----LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160
Query: 953 PDSSNWTELAGTY---------------GYV------APEL-----AYTMKVTEKCDVYS 986
+ + YV APE+ YT + D++S
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWS 216
Query: 987 FG-VLALEVIKGK 998
G +L E++ GK
Sbjct: 217 LGCILG-EILCGK 228
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 61/389 (15%), Positives = 109/389 (28%), Gaps = 84/389 (21%)
Query: 317 FLF---LDSN-SLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNS 372
L N ++ + ++NL +L + KL L L LF +
Sbjct: 2 LLVGLLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEF 61
Query: 373 LSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISL-----SNLTNLSVLSFYKNSLSGAIPK 427
+ E+ L SL LNLA ++T + S L ++ L A +
Sbjct: 62 QNQRFSAEV--LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLR 119
Query: 428 E-YRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFID 486
++ KL L N K+L L L + +T +
Sbjct: 120 TLLPVFLRARKLGLQLNSLGP--EACKDLRDL---------LLHDQC-------QITTLR 161
Query: 487 LSYNNLYGE----ISSDWGRCPKLGALDFSKNNITGN----IPPKIGYSSQLEVLDLSSN 538
LS N L + + L + + ++ + QL+ L+++ N
Sbjct: 162 LSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYN 221
Query: 539 HVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSN----AIPE 594
GD A + ++ LE L L N LS+ + +
Sbjct: 222 G-AGDTAAL------ALARAAREHP-------------SLELLHLYFNELSSEGRQVLRD 261
Query: 595 SLG---NLVKLHYLNLSNNQFSWEIPIKLEEL---------------IHLSELDLSYNFL 636
G ++ S + L E+ + L DL +
Sbjct: 262 LGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRG 321
Query: 637 G----RAIPSQICIMQSLEKLNLSHNSLS 661
+ + + L S
Sbjct: 322 ATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 3e-07
Identities = 32/216 (14%), Positives = 57/216 (26%), Gaps = 43/216 (19%)
Query: 792 IRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFH-----SPLPGEMTFQQEFLNEV 846
T IG+G G V++ A +A+K +E L E+
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 847 KALTEI---------RHRNIVKFYGF--CSHAQHSFIVYEYLEMGS-------------- 881
E+ R + + ++ + S
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 882 --LAMILSNDAAAEDLE--------WTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKN 931
L ++L + DLE S++ + +L+ HRD+ N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGN 192
Query: 932 VLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGY 967
VLL + ++ K S Y
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTL 228
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 41/214 (19%), Positives = 78/214 (36%), Gaps = 22/214 (10%)
Query: 480 PNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSK-NNITGNIPPKIG-YSSQLEVLDLSS 537
L + L L I + + L L+ S + + + S+L+ L+LS
Sbjct: 118 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW 177
Query: 538 NHVVGD--IPAELGKLS-FLIKLILAQNQLSGQLSPK-LGLLV----QLEHLDLSS-NNL 588
+ + + +S + +L L+ L L LV L HLDLS L
Sbjct: 178 CFDFTEKHVQVAVAHVSETITQLNLSG--YRKNLQKSDLSTLVRRCPNLVHLDLSDSVML 235
Query: 589 SNAIPESLGNLVKLHYLNLSN-NQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIM 647
N + L L +L+LS E ++L E+ L L + + +
Sbjct: 236 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL---LK 292
Query: 648 QSLEKL-----NLSHNSLSGVIPRCFEEMHALQC 676
++L L + + + + + +E+ ++C
Sbjct: 293 EALPHLQINCSHFTTIARPTIGNKKNQEIWGIKC 326
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 45/274 (16%), Positives = 80/274 (29%), Gaps = 27/274 (9%)
Query: 5 HALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLKGT- 63
L L N ++ + C + + + + L +
Sbjct: 45 DESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSV 104
Query: 64 LHDFSFSSF----PHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLS--SNLFSGAIPPQI 117
+ + L L L +L I + S L L+LS S A+ +
Sbjct: 105 IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 164
Query: 118 GHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLY 177
S L L+L ++ + H +T L
Sbjct: 165 SSCSRLDELNL-------------SWCFDFTEKH-----VQVAVAHVSETITQLNLSGYR 206
Query: 178 NNLLSGSIPSEIGNLKYLLDLNL-YNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSI-PS 235
NL + + + L+ L+L + L Q L+ L L+LS
Sbjct: 207 KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLL 266
Query: 236 ELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVI 269
ELG + L L++ +G++ L +L I
Sbjct: 267 ELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQI 300
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 46/294 (15%), Positives = 96/294 (32%), Gaps = 41/294 (13%)
Query: 318 LFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSI 377
L L +L + L + ++ + + + + + ++
Sbjct: 52 LDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 110
Query: 378 PCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSL--SGAIPKEYRNLVKL 435
+ L L+L +L+ I +L+ +NL L+ S A+ + +L
Sbjct: 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 170
Query: 436 TKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGE 495
+L L ++ ++ +T ++LS Y +
Sbjct: 171 DELNLSWC-----------------FDFTEKHVQVAVAHVS---ETITQLNLSG---YRK 207
Query: 496 ISSDWG------RCPKLGALDFSK-NNITGNIPPKIGYSSQLEVLDLSSNHVVGDI-PAE 547
RCP L LD S + + + + L+ L LS + + E
Sbjct: 208 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLE 267
Query: 548 LGKLSFLIKLILAQNQLSGQLSPK--LGLLVQLEHLDLSSNNLSNAIPESLGNL 599
LG++ L L Q+ G + L L HL ++ ++ + ++GN
Sbjct: 268 LGEIPTLKTL-----QVFGIVPDGTLQLLKEALPHLQINCSHFTTIARPTIGNK 316
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 47/266 (17%), Positives = 86/266 (32%), Gaps = 76/266 (28%)
Query: 802 HCIGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
H I K G G V L+ + +A+K S + + L+E++ L +R+ +
Sbjct: 40 HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSDP 95
Query: 858 V-KFYGFCSHAQHSF-----------IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIK 905
F +V+E L L I+ ++ L +++ I+
Sbjct: 96 NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI--IQ 153
Query: 906 GIADALSYLHNDCFPPIVHRDISSKNVLLDFKN--------------------------- 938
+ L YLH C I+H DI +N+LL
Sbjct: 154 QVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 939 ----------------------EARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 976
+ +++D G A ++ TE T Y + E+
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVLIGS 268
Query: 977 KVTEKCDVYSFGVLALEVIKGKHPGD 1002
D++S +A E+ G + +
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFE 294
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 40/160 (25%), Positives = 64/160 (40%), Gaps = 34/160 (21%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH-RNIVKFY 861
IG G G +Y +A+GE +A+K + Q E K ++ I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKHPQ-LHIESKIYKMMQGGVGIPTIR 71
Query: 862 GFCSHAQHSFIVYEYLEMG-SLAMILSNDAAAEDL-EWTQR---MSVIKGIAD----ALS 912
+ ++ +V E L G SL EDL + R + + +AD +
Sbjct: 72 WCGAEGDYNVMVMELL--GPSL----------EDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 913 YLHNDCFPPIVHRDISSKNVLL---DFKNEARVSDFGIAK 949
Y+H+ F +HRD+ N L+ N + DFG+AK
Sbjct: 120 YIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 36/166 (21%), Positives = 58/166 (34%), Gaps = 44/166 (26%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKK-----FHSPLPGEMTFQQEFLNEVKALTEIRHRNI 857
IG+G G +++ L + + +A+K L E + I
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT---------GI 68
Query: 858 VKFYGFCSHAQHSFIVYEYLEMG-SLAMILSNDAAAEDL-EWTQR---MSVIKGIAD--- 909
Y F H+ +V + L G SL EDL + R + + A
Sbjct: 69 PNVYYFGQEGLHNVLVIDLL--GPSL----------EDLLDLCGRKFSVKTVAMAAKQML 116
Query: 910 -ALSYLHNDCFPPIVHRDISSKNVLL---DFKNEARVS--DFGIAK 949
+ +H V+RDI N L+ + KN + DFG+ K
Sbjct: 117 ARVQSIHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 38/169 (22%), Positives = 64/169 (37%), Gaps = 44/169 (26%)
Query: 801 EHCIGKGGQGSVYKVE-LASGEIIAVK-----KFHSPLPGEMTFQQEFLNEVKALTEIRH 854
IG G G + + L + E +A+K L E F ++ +
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD-------- 65
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMG-SLAMILSNDAAAEDL-EWTQRMSVIK---GIAD 909
I + Y F +++ +V E L G SL EDL + R +K IA
Sbjct: 66 -GIPQVYYFGPCGKYNAMVLELL--GPSL----------EDLFDLCDRTFSLKTVLMIAI 112
Query: 910 ----ALSYLHNDCFPPIVHRDISSKNVLL---DFKNEARV--SDFGIAK 949
+ Y+H+ ++RD+ +N L+ K + + DF +AK
Sbjct: 113 QLISRMEYVHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 14/98 (14%)
Query: 184 SIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPS----ELG 238
S+P+ I + + L L NN++ P +L NL L +SN L +IP+ +L
Sbjct: 26 SVPAGIPTDKQRL---WLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-TAIPTGVFDKLT 81
Query: 239 NLKYLSDLKLADNKLNGSIPH-SLCNLTNLVILYIYNN 275
L L L DN L SIP + NL +L +Y+YNN
Sbjct: 82 QLTQLD---LNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 88 NIPPQIGNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSGSIPLEV-GGLS 145
IP + + L L++N + + P + HL L+ L+ N+L+ +IP V L+
Sbjct: 30 GIP------TDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLT 81
Query: 146 SLNNLALYSNYLEDIIPH-SLGNLTNLVTLCLYNN 179
L L L N+L+ IP + NL +L + LYNN
Sbjct: 82 QLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 30/106 (28%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 124 KTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG 183
++ +L+ S+P G + L L +N + + P +L NL L +N L+
Sbjct: 15 TLVNCQNIRLA-SVP--AGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT- 70
Query: 184 SIPSEI-GNLKYLLDLNLYNNELNGSIPQ-SLGNLSNLAMLNLSSN 227
+IP+ + L L L+L +N L SIP+ + NL +L + L +N
Sbjct: 71 AIPTGVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 9e-04
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 281 IPSEI-GNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSL 339
+P+ I + + L L+ N+ + L P +L N+ L+ +SN L + L L
Sbjct: 27 VPAGIPTDKQRLW---LNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQL 83
Query: 340 SILELGNNKLCGSIPH--FLGNLTNLSVLFIYNN 371
+ L+L +N L SIP F NL +L+ +++YNN
Sbjct: 84 TQLDLNDNHL-KSIPRGAF-DNLKSLTHIYLYNN 115
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 14/98 (14%)
Query: 184 SIPSEI-GNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPS----ELG 238
S+P+ I + L LY+N++ P L+ L L+L +N L +P+ +L
Sbjct: 23 SVPTGIPTTTQVL---YLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPAGVFDKLT 78
Query: 239 NLKYLSDLKLADNKLNGSIPH-SLCNLTNLVILYIYNN 275
L LS L DN+L SIP + NL +L +++ NN
Sbjct: 79 QLTQLS---LNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 29/95 (30%), Positives = 43/95 (45%), Gaps = 12/95 (12%)
Query: 88 NIPPQIGNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSGSIPLEV-GGLS 145
IP + + L L N + + P + L+ L L L NQL+ +P V L+
Sbjct: 27 GIP------TTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLT 78
Query: 146 SLNNLALYSNYLEDIIPH-SLGNLTNLVTLCLYNN 179
L L+L N L+ IP + NL +L + L NN
Sbjct: 79 QLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 30/81 (37%), Positives = 42/81 (51%), Gaps = 6/81 (7%)
Query: 318 LFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH--FLGNLTNLSVLFIYNNSLSG 375
L+L N + L P L L+ L+L NN+L +P F LT L+ L + +N L
Sbjct: 35 LYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPAGVF-DKLTQLTQLSLNDNQLK- 91
Query: 376 SIPCEI-GNLKSLSYLNLAFN 395
SIP NLKSL+++ L N
Sbjct: 92 SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 124 KTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG 183
T+ L+ S+P G ++ L LY N + + P LT L L L NN L+
Sbjct: 12 TTVDCSGKSLA-SVP--TGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT- 67
Query: 184 SIPSEI-GNLKYLLDLNLYNNELNGSIPQ-SLGNLSNLAMLNLSSN 227
+P+ + L L L+L +N+L SIP+ + NL +L + L +N
Sbjct: 68 VLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 34/160 (21%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFY 861
IG G G +Y + + E +A+K + Q L E K ++ I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQ-LLYESKIYRILQGGTGIPNVR 69
Query: 862 GFCSHAQHSFIVYEYLEMG-SLAMILSNDAAAEDL--EWTQRMSV--IKGIAD----ALS 912
F ++ +V + L G SL EDL ++++S+ + +AD +
Sbjct: 70 WFGVEGDYNVLVMDLL--GPSL----------EDLFNFCSRKLSLKTVLMLADQMINRVE 117
Query: 913 YLHNDCFPPIVHRDISSKNVLL---DFKNEARVSDFGIAK 949
++H+ F +HRDI N L+ N+ + DFG+AK
Sbjct: 118 FVHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 18/99 (18%), Positives = 35/99 (35%), Gaps = 14/99 (14%)
Query: 578 LEHLDLSSNNLSNAIPESLGNLVK----LHYLNLSNNQFSWEIPIKLEELIH----LSEL 629
++ + ++ + +L ++K L LN+ +N S + L E + L EL
Sbjct: 67 VKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIEL 126
Query: 630 DLS--YNFLGRAIPSQICIM----QSLEKLNLSHNSLSG 662
+ LG + +I M +L K
Sbjct: 127 RIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP 165
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1067 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-29 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-07 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-13 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 8e-06 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 6e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 5e-60
Identities = 71/282 (25%), Positives = 121/282 (42%), Gaps = 22/282 (7%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 849
EI IG G G+VYK + +AVK + P Q F NEV L
Sbjct: 4 EIPD--GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTP-QQLQAFKNEVGVL 58
Query: 850 TEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIAD 909
+ RH NI+ F G+ + IV ++ E SL L E + + + + A
Sbjct: 59 RKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQ 115
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGY 967
+ YLH I+HRD+ S N+ L ++ DFG+A S + + +L+G+ +
Sbjct: 116 GMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 968 VAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP 1024
+APE+ + + DVY+FG++ E++ G+ P S I++ + + L P
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSP 229
Query: 1025 RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
L N + + + CL + + RP ++ ++
Sbjct: 230 DLSKVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIE 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-58
Identities = 68/271 (25%), Positives = 124/271 (45%), Gaps = 18/271 (6%)
Query: 797 DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
D++ + IG G G K+ + G+I+ K+ E +Q ++EV L E++H
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHP 63
Query: 856 NIVKFYGFCSHAQHS--FIVYEYLEMGSLAMILSNDAAA-EDLEWTQRMSVIKGIADALS 912
NIV++Y ++ +IV EY E G LA +++ + L+ + V+ + AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 913 YLH--NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAP 970
H +D ++HRD+ NV LD K ++ DFG+A+ L D+S GT Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 971 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPS 1030
E M EK D++S G L E+ P ++ + +I + +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPP--------FTAFSQKELAGKIREGKFRRIP 235
Query: 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+ ++L + L+ RP+++++
Sbjct: 236 YRYSDELNEIIT---RMLNLKDYHRPSVEEI 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-58
Identities = 56/272 (20%), Positives = 106/272 (38%), Gaps = 20/272 (7%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+G G G V+ +AVK FL E + +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ----GSMSPDAFLAEANLMKQLQHQ 68
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
+V+ Y + +I+ EY+E GSL L + L + + + IA+ ++++
Sbjct: 69 RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIE 126
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW-TELAGTYGYVAPELAY 974
+HRD+ + N+L+ +++DFG+A+ ++ + + APE
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034
T K DV+SFG+L E++ + + + + N
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRI-------PYPGMTNPEVIQNLERGYRMVRPDNCP 236
Query: 1035 EKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
E+L + C E PE RPT + +L+
Sbjct: 237 EELYQLMR---LCWKERPEDRPTFDYLRSVLE 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-56
Identities = 72/267 (26%), Positives = 117/267 (43%), Gaps = 21/267 (7%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
DF+ +GKG G+VY S I+A+K + + + EV+ + +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
NI++ YG+ A +++ EY +G++ L + + + I +A+ALSY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYC 122
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
H+ ++HRDI +N+LL E +++DFG + SS T L GT Y+ PE+
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIE 177
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034
EK D++S GVL E + GK P + I P V
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP--------FEANTYQETYKRISRVEFTFPDF-VT 228
Query: 1035 EKLISFVEVAISCLDESPESRPTMQKV 1061
E + L +P RP +++V
Sbjct: 229 EGARDLIS---RLLKHNPSQRPMLREV 252
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-55
Identities = 57/273 (20%), Positives = 114/273 (41%), Gaps = 22/273 (8%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
++ IG G G V+ + + +A+K +++F+ E + + ++ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE----GAMSEEDFIEEAEVMMKLSHP 60
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
+V+ YG C +V+E++E G L+ L + + + + ++YL
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLE 118
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE-LAGTYGYVAPELAY 974
++HRD++++N L+ +VSDFG+ +F+ D + + +PE+
Sbjct: 119 E---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL-DPRLPIPSHNV 1033
+ + K DV+SFGVL EV + + + +++I RL P
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKI-------PYENRSNSEVVEDISTGFRLYKPRLAS 228
Query: 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
++ C E PE RP ++ + L
Sbjct: 229 TH----VYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-55
Identities = 68/304 (22%), Positives = 118/304 (38%), Gaps = 48/304 (15%)
Query: 794 ATNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 852
+DF+ +G G G V+KV SG ++A K H L + + + + E++ L E
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHEC 61
Query: 853 RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALS 912
IV FYG I E+++ GSL +L A + V + L+
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLT 118
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
YL I+HRD+ N+L++ + E ++ DFG++ L + GT Y++PE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 174
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGKHP------------------GDFISLISSSSLNL 1014
+ + D++S G+ +E+ G++P GD
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 1015 NIALDEILDPRLP-----------------IPSHNVQEKLISFVEVAISCLDESPESRPT 1057
+D R P +PS + FV CL ++P R
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNPAERAD 291
Query: 1058 MQKV 1061
++++
Sbjct: 292 LKQL 295
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (485), Expect = 5e-55
Identities = 71/299 (23%), Positives = 128/299 (42%), Gaps = 39/299 (13%)
Query: 788 YEEIIRATNDFDDE---------HCIGKGGQGSVYKVELAS----GEIIAVKKFHSPLPG 834
+E+ A +F E IG G G V L +A+K S
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 835 EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAED 894
+ +++FL+E + + H N++ G + + I+ E++E GSL L +
Sbjct: 69 KQ--RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 895 LEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954
Q + +++GIA + YL + VHRD++++N+L++ +VSDFG+++FL+ D
Sbjct: 127 --VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 955 SSNWTELA-----GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLIS 1008
+S+ T + + APE K T DV+S+G++ EV+ G+ P
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-------- 233
Query: 1009 SSSLNLNIALDEIL-DPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ ++ I D RLP P ++ + C + RP ++ L
Sbjct: 234 YWDMTNQDVINAIEQDYRLPPPMDCPSA----LHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 7e-55
Identities = 64/275 (23%), Positives = 118/275 (42%), Gaps = 23/275 (8%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
D +G G G V + +A+K + EF+ E K + + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDEFIEEAKVMMNLSHE 59
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
+V+ YG C+ + FI+ EY+ G L L + Q + + K + +A+ YL
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD-SSNWTELAGTYGYVAPELAY 974
+HRD++++N L++ + +VSDFG+++++ D ++ + PE+
Sbjct: 118 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 975 TMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033
K + K D+++FGVL E+ GK P + + + I H
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYE--------RFTNSETAEHIAQGLRLYRPHLA 226
Query: 1034 QEKLISFVEVAISCLDESPESRPTMQKV-SQLLKI 1067
EK+ + + SC E + RPT + + S +L +
Sbjct: 227 SEKVYTIMY---SCWHEKADERPTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-53
Identities = 69/273 (25%), Positives = 110/273 (40%), Gaps = 26/273 (9%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+ IGKG G V + G +AVK + Q FL E +T++RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60
Query: 856 NIVKFYGFCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
N+V+ G + +IV EY+ GSL L + + L + + +A+ YL
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 119
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
VHRD++++NVL+ N A+VSDFG+ K SS + APE
Sbjct: 120 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALR 173
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL-DPRLPIPSHNV 1033
K + K DV+SFG+L E+ + L + + ++ P
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRV-------PYPRIPLKDVVPRVEKGYKMDAPDGCP 226
Query: 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
EV +C RP+ ++ + L+
Sbjct: 227 PA----VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (472), Expect = 5e-53
Identities = 71/271 (26%), Positives = 128/271 (47%), Gaps = 26/271 (9%)
Query: 798 FDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
F D IG G G+VY + + E++A+KK Q+ + EV+ L ++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
+++ G +++V EY + ++ + + L+ + +V G L+YLH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS 133
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTM 976
++HRD+ + N+LL ++ DFG A + P +S GT ++APE+ M
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAM 186
Query: 977 ---KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL-DPRLPIPSHN 1032
+ K DV+S G+ +E+ + K P ++N AL I + + S +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP--------LFNMNAMSALYHIAQNESPALQSGH 238
Query: 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063
E +FV+ SCL + P+ RPT + + +
Sbjct: 239 WSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 5e-53
Identities = 67/283 (23%), Positives = 125/283 (44%), Gaps = 26/283 (9%)
Query: 788 YEEIIRATN---DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFL 843
YE + R N ++ +G G G VYK + + + A K + E+ ++++
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYM 57
Query: 844 NEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSV 903
E+ L H NIVK + + +I+ E+ G++ ++ L +Q V
Sbjct: 58 VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVV 115
Query: 904 IKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAG 963
K DAL+YLH+ I+HRD+ + N+L + +++DFG++ G
Sbjct: 116 CKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 172
Query: 964 TYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIAL 1018
T ++APE+ K DV+S G+ +E+ + + P ++ + + L IA
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAK 229
Query: 1019 DEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
E P L PS F++ CL+++ ++R T ++
Sbjct: 230 SEP--PTLAQPSR-WSSNFKDFLK---KCLEKNVDARWTTSQL 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-53
Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 28/275 (10%)
Query: 800 DEHCIGKGGQGSVYKVELA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
++ +G G G+V K + +AVK + + + E L E + ++ +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPY 69
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
IV+ G C + +V E E+G L L + ++ + ++ ++ + YL
Sbjct: 70 IVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLE- 124
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW---TELAGTYGYVAPELA 973
VHRD++++NVLL ++ A++SDFG++K L+ D + + T + APE
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 974 YTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEIL-DPRLPIPSH 1031
K + K DV+SFGVL E G+ P + + + R+ P+
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYR--------GMKGSEVTAMLEKGERMGCPAG 234
Query: 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+E ++ C E+RP V L+
Sbjct: 235 CPRE----MYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-53
Identities = 67/279 (24%), Positives = 117/279 (41%), Gaps = 24/279 (8%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 849
EI R E +G+G G V+ +A+K + FL E + +
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----GTMSPEAFLQEAQVM 66
Query: 850 TEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIAD 909
++RH +V+ Y S + +IV EY+ GSL L + + L Q + + IA
Sbjct: 67 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIAS 124
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD-SSNWTELAGTYGYV 968
++Y+ VHRD+ + N+L+ +V+DFG+A+ ++ + + +
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 969 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL-DPRLP 1027
APE A + T K DV+SFG+L E+ + LD++ R+P
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRV-------PYPGMVNREVLDQVERGYRMP 234
Query: 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
P + ++ C + PE RPT + + L+
Sbjct: 235 CPPECPES----LHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 9e-53
Identities = 67/268 (25%), Positives = 129/268 (48%), Gaps = 20/268 (7%)
Query: 795 TNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
+ IG+G G+VY ++A+G+ +A+++ + + ++ +NE+ + E +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENK 75
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
+ NIV + ++V EYL GSL +++ E Q +V + AL +
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEF 131
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
LH++ ++HRDI S N+LL +++DFG + P+ S + + GT ++APE+
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033
K D++S G++A+E+I+G+ P +++ +L L P L P +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGT---PELQNPEK-L 242
Query: 1034 QEKLISFVEVAISCLDESPESRPTMQKV 1061
F+ CLD E R + +++
Sbjct: 243 SAIFRDFLN---RCLDMDVEKRGSAKEL 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 184 bits (467), Expect = 1e-52
Identities = 62/274 (22%), Positives = 120/274 (43%), Gaps = 22/274 (8%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
D +H +G G G VY+ +AVK + +EFL E + EI+H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKH 72
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
N+V+ G C+ +I+ E++ G+L L + +++ + + I+ A+ YL
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN-WTELAGTYGYVAPELA 973
+HRD++++N L+ + +V+DFG+++ + D+ + APE
Sbjct: 132 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL-DPRLPIPSHN 1032
K + K DV++FGVL E+ ++L+ + + D R+ P
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPY-------PGIDLSQVYELLEKDYRMERPEGC 241
Query: 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
++ E+ +C +P RP+ ++ Q +
Sbjct: 242 PEK----VYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 6e-52
Identities = 66/296 (22%), Positives = 119/296 (40%), Gaps = 40/296 (13%)
Query: 801 EHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKF 860
+ IGKG G V++ + GE +AVK F S E ++ +E E+ +RH NI+ F
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENILGF 62
Query: 861 YGFCSHAQHS----FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
+ + ++V +Y E GSL L+ + + + A L++LH
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHM 118
Query: 917 DCF-----PPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW----TELAGTYGY 967
+ P I HRD+ SKN+L+ ++D G+A + GT Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 968 VAPELAYTM------KVTEKCDVYSFGVLALEVIKGKHPG-----------DFISLISSS 1010
+APE+ + ++ D+Y+ G++ E+ + G D + S
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 1011 SLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ ++ L P +P E L ++ C + +R T ++ + L
Sbjct: 239 EEMRKVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 1e-51
Identities = 55/300 (18%), Positives = 117/300 (39%), Gaps = 44/300 (14%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL 849
N+ + IG+G G V++ ++AVK +M Q +F E +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 70
Query: 850 TEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSN--------------------- 888
E + NIVK G C+ + +++EY+ G L L +
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 889 DAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948
L +++ + + +A ++YL VHRD++++N L+ +++DFG++
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 949 KFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISL 1006
+ + A ++ PE + + T + DV+++GV+ E+ +
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY--- 244
Query: 1007 ISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ + + D + N +L + + C + P RP+ + ++L+
Sbjct: 245 ----GMAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFCSIHRILQ 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-51
Identities = 63/287 (21%), Positives = 115/287 (40%), Gaps = 29/287 (10%)
Query: 789 EEIIRATNDFD-DEHCIGKGGQGSVYKVELA---SGEIIAVKKFHSPLPGEMTFQQEFLN 844
+++ ++ + +G G GSV + +A+K E +E +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMR 58
Query: 845 EVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVI 904
E + + ++ + IV+ G C A+ +V E G L L E++ + ++
Sbjct: 59 EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELL 115
Query: 905 KGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE---L 961
++ + YL VHRD++++NVLL ++ A++SDFG++K L D S +T
Sbjct: 116 HQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 962 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDE 1020
+ APE K + + DV+S+GV E + G+ P + +
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK--------KMKGPEVMAF 224
Query: 1021 ILD-PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
I R+ P E + C E RP V Q ++
Sbjct: 225 IEQGKRMECPPECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-51
Identities = 59/270 (21%), Positives = 116/270 (42%), Gaps = 25/270 (9%)
Query: 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN 856
FD E IG+G +VYK + +A + + + +Q F E + L ++H N
Sbjct: 13 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 69
Query: 857 IVKFYGFCSHA----QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALS 912
IV+FY + +V E + G+L L + ++ S + I L
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQ 126
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKN-EARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 971
+LH PPI+HRD+ N+ + ++ D G+A + + + GT ++APE
Sbjct: 127 FLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPE 183
Query: 972 LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031
+ Y K E DVY+FG+ LE+ ++P + +++ + + +
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRV----TSGVKPASFDK 236
Query: 1032 NVQEKLISFVEVAISCLDESPESRPTMQKV 1061
++ +E C+ ++ + R +++ +
Sbjct: 237 VAIPEVKEIIE---GCIRQNKDERYSIKDL 263
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 4e-51
Identities = 64/270 (23%), Positives = 109/270 (40%), Gaps = 21/270 (7%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
D+D +G+G G V + E +AVK + + + E+ + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNH 62
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
N+VKFYG ++ EY G L + D + + + YL
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYL 119
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPEL 972
H I HRDI +N+LLD ++ ++SDFG+A + ++ ++ GT YVAPEL
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 973 AYTMKV-TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031
+ E DV+S G++ ++ G+ P D S + D P
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWD------QPSDSCQEYSDWKEKKTYLNPWK 230
Query: 1032 NVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+ ++ + L E+P +R T+ +
Sbjct: 231 KIDSAPLALLH---KILVENPSARITIPDI 257
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 67/281 (23%), Positives = 111/281 (39%), Gaps = 28/281 (9%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL----ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 851
D +G G G V + E +AVK + + +F+ EV A+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 852 IRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADAL 911
+ HRN+++ YG +V E +GSL L L R +A+ +
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGM 124
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW---TELAGTYGYV 968
YL + +HRD++++N+LL ++ ++ DFG+ + L + ++ + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 969 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEIL--DPR 1025
APE T + D + FGV E+ G+ P LN + L +I R
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGER 233
Query: 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
LP P Q+ V + C PE RPT + L
Sbjct: 234 LPRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-50
Identities = 68/280 (24%), Positives = 119/280 (42%), Gaps = 27/280 (9%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASGE-----IIAVKKFHSPLPGEMTFQQEFLNEVKALT 850
+ + IG G G VYK L + +A+K + + + +FL E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMG 64
Query: 851 EIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADA 910
+ H NI++ G S + I+ EY+E G+L L + Q + +++GIA
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAG 122
Query: 911 LSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW---TELAGTYGY 967
+ YL N VHRD++++N+L++ +VSDFG+++ L+ D + +
Sbjct: 123 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 968 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP-RL 1026
APE K T DV+SFG++ EV+ + L+ + + I D RL
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-------ELSNHEVMKAINDGFRL 232
Query: 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
P P ++ + C + RP + +L
Sbjct: 233 PTPMDCPSA----IYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 4e-50
Identities = 59/309 (19%), Positives = 120/309 (38%), Gaps = 51/309 (16%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKV------ELASGEIIAVKKFHSPLPGEMTFQQEFL 843
E R + + +G G G V + +AVK + + ++ +
Sbjct: 33 EFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALM 88
Query: 844 NEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSN-------------- 888
+E+K +T++ H NIV G C+ + ++++EY G L L +
Sbjct: 89 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 889 ------DAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARV 942
+ L + + +A + +L VHRD++++NVL+ ++
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKI 205
Query: 943 SDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKH 999
DFG+A+ + DS+ ++APE + T K DV+S+G+L E+ G +
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 1000 PGDFISLISSSSLNLNIALDEILD--PRLPIPSHNVQEKLISFVEVAISCLDESPESRPT 1057
P + ++ +++ ++ P + +E + SC RP+
Sbjct: 266 P--------YPGIPVDANFYKLIQNGFKMDQPFYATEE----IYIIMQSCWAFDSRKRPS 313
Query: 1058 MQKVSQLLK 1066
++ L
Sbjct: 314 FPNLTSFLG 322
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-49
Identities = 60/278 (21%), Positives = 102/278 (36%), Gaps = 21/278 (7%)
Query: 793 RATNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE 851
+ DF +G+G +V ELA+ A+K + E ++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 852 IRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADAL 911
+ H VK Y + + Y + G L + + + T I AL
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 121
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW--TELAGTYGYVA 969
YLH I+HRD+ +N+LL+ +++DFG AK L P+S GT YV+
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 970 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029
PEL + D+++ G + +++ G P F + N + +I+ P
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP--F------RAGNEYLIFQKIIKLEYDFP 230
Query: 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLKI 1067
K VE L R +++ +
Sbjct: 231 EK-FFPKARDLVE---KLLVLDATKRLGCEEMEGYGPL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-49
Identities = 63/303 (20%), Positives = 122/303 (40%), Gaps = 44/303 (14%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFL 843
E R N +G G G V + + +AVK +T ++ +
Sbjct: 19 EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTEREALM 74
Query: 844 NEVKALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSN-------------- 888
+E+K L+ + H NIV G C+ + ++ EY G L L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 889 -DAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGI 947
+ L+ +S +A +++L + +HRD++++N+LL ++ DFG+
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 948 AKFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFIS 1005
A+ +K DS+ ++APE + T + DV+S+G+ E+
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-- 249
Query: 1006 LISSSSLNLNIALDEILD--PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063
+ ++ +++ R+ P H E ++ +C D P RPT +++ Q
Sbjct: 250 -----GMPVDSKFYKMIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQ 300
Query: 1064 LLK 1066
L++
Sbjct: 301 LIE 303
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (442), Expect = 1e-48
Identities = 57/283 (20%), Positives = 117/283 (41%), Gaps = 29/283 (10%)
Query: 785 KIVYEEIIRATNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFL 843
+I ++ ++ + +D +G G G V++V E A+G A K +P + ++
Sbjct: 18 EIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVR 71
Query: 844 NEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSV 903
E++ ++ +RH +V + ++YE++ G L +++ + + +
Sbjct: 72 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEY 129
Query: 904 IKGIADALSYLHNDCFPPIVHRDISSKNVLL--DFKNEARVSDFGIAKFLKPDSSNWTEL 961
++ + L ++H + VH D+ +N++ NE ++ DFG+ L P S
Sbjct: 130 MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT- 185
Query: 962 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEI 1021
GT + APE+A V D++S GVL+ ++ G P N + L +
Sbjct: 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG--------GENDDETLRNV 237
Query: 1022 LDPRLPIPSH---NVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+ + E F+ L P +R T+ +
Sbjct: 238 KSCDWNMDDSAFSGISEDGKDFIR---KLLLADPNTRMTIHQA 277
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-48
Identities = 59/289 (20%), Positives = 111/289 (38%), Gaps = 35/289 (12%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASG---EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI 852
ND + IG+G G V K + A+K+ + ++F E++ L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 67
Query: 853 -RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSN-------------DAAAEDLEWT 898
H NI+ G C H + ++ EY G+L L ++ A L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 899 QRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW 958
Q + +A + YL +HRD++++N+L+ A+++DFG+++ +
Sbjct: 128 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 959 TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIAL 1018
++A E T DV+S+GVL E++ +
Sbjct: 185 M-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-------PYCGMTCAELY 236
Query: 1019 DEIL-DPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+++ RL P + E ++ C E P RP+ ++ L
Sbjct: 237 EKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-48
Identities = 64/273 (23%), Positives = 107/273 (39%), Gaps = 28/273 (10%)
Query: 804 IGKGGQGSVYKVELA----SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK 859
IG+G G VY L AVK + ++ +FL E + + H N++
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 860 FYGFCSHAQHS-FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC 918
G C ++ S +V Y++ G L + N+ ++ + +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147
Query: 919 FPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS----SNWTELAGTYGYVAPELAY 974
VHRD++++N +LD K +V+DFG+A+ + N T ++A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL-DPRLPIPSHNV 1033
T K T K DV+SFGVL E++ P +N +L RL P +
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP-------PYPDVNTFDITVYLLQGRRLLQPEYCP 260
Query: 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
EV + C E RP+ ++ +
Sbjct: 261 DP----LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 29/284 (10%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVELAS----GEIIAVKKFHSPLPGEMTFQQEFLNE 845
EI R + CIG+G G V++ S +A+K + + +++FL E
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQE 58
Query: 846 VKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIK 905
+ + H +IVK G + +I+ E +G L L + L+ +
Sbjct: 59 ALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAY 115
Query: 906 GIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS-NWTELAGT 964
++ AL+YL + VHRDI+++NVL+ + ++ DFG++++++ + ++
Sbjct: 116 QLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 965 YGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPGDFISLISSSSLNLNIALDEILD 1023
++APE + T DV+ FGV E++ G P + N + I +
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ--------GVKNNDVIGRIEN 224
Query: 1024 -PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
RLP+P N L S + C P RP ++ L
Sbjct: 225 GERLPMPP-NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLS 264
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 170 bits (432), Expect = 4e-47
Identities = 53/272 (19%), Positives = 108/272 (39%), Gaps = 26/272 (9%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+ +D +G G G V++ E A+G + K ++P P + + NE+ + ++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHH 85
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
++ + ++ E+L G L ++ + + + ++ ++ + L ++
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHM 143
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARV--SDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
H IVH DI +N++ + K + V DFG+A L PD T + APE+
Sbjct: 144 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEI 199
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH- 1031
V D+++ GVL ++ G P + L +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFA--------GEDDLETLQNVKRCDWEFDEDA 251
Query: 1032 --NVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+V + F++ + L + P R T+
Sbjct: 252 FSSVSPEAKDFIK---NLLQKEPRKRLTVHDA 280
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 6e-46
Identities = 57/284 (20%), Positives = 118/284 (41%), Gaps = 26/284 (9%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVE-LASGE----IIAVKKFHSPLPGEMTFQQEFLN 844
I++ T +F +G G G+VYK + GE +A+K+ + +E L+
Sbjct: 4 RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILD 60
Query: 845 EVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVI 904
E + + + ++ + G C + ++ + + G L + +++ ++
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 117
Query: 905 KGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNW--TELA 962
IA ++YL +VHRD++++NVL+ +++DFG+AK L + +
Sbjct: 118 VQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 963 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL 1022
++A E T + DV+S+GV E++ I +S ++ + E
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSILEKGE-- 230
Query: 1023 DPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
RLP P + + + C +SRP +++
Sbjct: 231 --RLPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-45
Identities = 58/292 (19%), Positives = 113/292 (38%), Gaps = 32/292 (10%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKVEL------ASGEIIAVKKFHSPLPGEMTFQQEFL 843
E+ R +G+G G VY+ +A+K + M + EFL
Sbjct: 16 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 71
Query: 844 NEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL-------SNDAAAEDLE 896
NE + E ++V+ G S Q + ++ E + G L L +N+
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 897 WTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956
++ + + IAD ++YL+ VHRD++++N ++ ++ DFG+ + +
Sbjct: 132 LSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188
Query: 957 --NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL 1014
+ +++PE T DV+SFGV+ E+ L+
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-------PYQGLSN 241
Query: 1015 NIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
L +++ L N + L + C +P+ RP+ ++ +K
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 290
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (412), Expect = 2e-45
Identities = 67/283 (23%), Positives = 124/283 (43%), Gaps = 24/283 (8%)
Query: 795 TNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
++ ++ +G GG V+ L +AVK + L + +F F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 854 HRNIVKFYGFCSHAQHS----FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIAD 909
H IV Y + +IV EY++ +L I+ + + + + VI
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQ 122
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTE---LAGTYG 966
AL++ H I+HRD+ N+++ N +V DFGIA+ + ++ T+ + GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 967 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL 1026
Y++PE A V + DVYS G + EV+ G+ P + S S+ ++ + P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPPSA 236
Query: 1027 PIPSHNVQEKLISFVEVAISCLDESPESRP-TMQKVSQ-LLKI 1067
+ L + V L ++PE+R T ++ L+++
Sbjct: 237 RHE--GLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRV 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-45
Identities = 58/273 (21%), Positives = 103/273 (37%), Gaps = 22/273 (8%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT-EIR 853
DF +GKG G V+ E + + A+K + + + E + L+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
H + + ++ F V EYL G L + + + ++ I L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQF 118
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
LH+ IV+RD+ N+LLD +++DFG+ K + GT Y+APE+
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033
K D +SFGVL E++ G+ P F + I P +
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP--F------HGQDEEELFHSIRMDNPFYPRW-L 226
Query: 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+++ + PE R ++ + +
Sbjct: 227 EKEAKDLLV---KLFVREPEKRLGVR--GDIRQ 254
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 9e-45
Identities = 58/271 (21%), Positives = 105/271 (38%), Gaps = 21/271 (7%)
Query: 795 TNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
+ +D +G G V E + +++A+K + NE+ L +I+
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA--KKALEGKEGSMENEIAVLHKIK 65
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
H NIV H +++ + + G L + +I + DA+ Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKY 122
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELA 973
LH+ + + LD ++ +SDFG++K P S T GT GYVAPE+
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAPEVL 181
Query: 974 YTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPS--- 1030
++ D +S GV+A ++ G P N ++IL S
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFY--------DENDAKLFEQILKAEYEFDSPYW 233
Query: 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
++ + F+ +++ PE R T ++
Sbjct: 234 DDISDSAKDFIR---HLMEKDPEKRFTCEQA 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-44
Identities = 54/261 (20%), Positives = 108/261 (41%), Gaps = 21/261 (8%)
Query: 804 IGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYG 862
+G+G G V++ E +S + K + T Q E+ L RHRNI+ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPI 922
+ +++E++ + ++ A +L + +S + + +AL +LH+ I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 923 VHRDISSKNVLLDFKNEARV--SDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTE 980
H DI +N++ + + + +FG A+ LKP + L Y APE+ V+
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQHDVVST 182
Query: 981 KCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISF 1040
D++S G L ++ G +P + ++ I++ +E I
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFL--------AETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 1041 VEVAISCLDESPESRPTMQKV 1061
++ L + +SR T +
Sbjct: 235 MDFVDRLLVKERKSRMTASEA 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (406), Expect = 3e-44
Identities = 62/274 (22%), Positives = 109/274 (39%), Gaps = 24/274 (8%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
DF +G G G V+ + +G A+K + + + +E L+ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
I++ +G AQ F++ +Y+E G L +L + + AL YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYL 120
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
H+ I++RD+ +N+LLD +++DFG AK++ L GT Y+APE+
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVVS 174
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034
T + D +SFG+L E++ G P N ++IL+ L P
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFY--------DSNTMKTYEKILNAELRFPPF-FN 225
Query: 1035 EKLISFVEVAISCLDESPESRPTMQKVS--QLLK 1066
E + + + R + +
Sbjct: 226 EDVKDLLS---RLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 60/296 (20%), Positives = 113/296 (38%), Gaps = 41/296 (13%)
Query: 796 NDFDDEHCIGKGGQGSVYKVEL--------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVK 847
+ +G+G G V E +AVK S + + ++E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70
Query: 848 ALTEI-RHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMIL-------------SNDAAAE 893
+ I +H+NI+ G C+ +++ EY G+L L + E
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 894 DLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953
L +S +A + YL + +HRD++++NVL+ N +++DFG+A+ +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 954 DSSNWT--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSS 1011
++APE + T + DV+SFGVL E+
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-------PG 240
Query: 1012 LNLNIALDEILD-PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ + + + R+ PS+ E + C P RPT +++ + L
Sbjct: 241 VPVEELFKLLKEGHRMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 158 bits (400), Expect = 8e-43
Identities = 58/278 (20%), Positives = 98/278 (35%), Gaps = 24/278 (8%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEV---KALTE 851
NDF IG+GG G VY +G++ A+K + LNE ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 852 IRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADAL 911
IV + + + G L LS I L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGL 120
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 971
++HN +V+RD+ N+LLD R+SD G+A + + GT+GY+APE
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175
Query: 972 -LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPS 1030
L + D +S G + ++++G P + + + L + +P
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR-----QHKTKDKHEIDRMTLTMAVELPD 230
Query: 1031 HNVQEKLISFVEVAISCLDESPESRPTMQK--VSQLLK 1066
+L S +E L R ++ +
Sbjct: 231 S-FSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (389), Expect = 3e-42
Identities = 57/282 (20%), Positives = 111/282 (39%), Gaps = 35/282 (12%)
Query: 797 DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMT------FQQEFLNEVKAL 849
+++ + +G+G V + + + AVK G + ++ L EV L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 850 TEIR-HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIA 908
++ H NI++ F+V++ ++ G L L+ L + +++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALL 120
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYV 968
+ + LH IVHRD+ +N+LLD +++DFG + L P E+ GT Y+
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYL 176
Query: 969 APELAYTM------KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL 1022
APE+ ++ D++S GV+ ++ G P + L I+
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW--------HRKQMLMLRMIM 228
Query: 1023 DPRLPIPS---HNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
S + + + V L P+ R T ++
Sbjct: 229 SGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (389), Expect = 4e-42
Identities = 47/287 (16%), Positives = 99/287 (34%), Gaps = 27/287 (9%)
Query: 792 IRATNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT 850
+R N + IG G G +Y +A+GE +A+K T + E K
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYK 57
Query: 851 EIRHRNIVKFYGFC-SHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIAD 909
++ + +C + ++ +V E L + + + +
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMIS 114
Query: 910 ALSYLHNDCFPPIVHRDISSKNVL---LDFKNEARVSDFGIAKFLKPDSSN-------WT 959
+ Y+H+ +HRD+ N L N + DFG+AK + ++
Sbjct: 115 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 960 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALD 1019
L GT Y + ++ + + D+ S G + + G P + + I+
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231
Query: 1020 EILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
++ P + + +++ C + +P + QL +
Sbjct: 232 KMSTPIEVLCK-GYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-42
Identities = 60/274 (21%), Positives = 113/274 (41%), Gaps = 23/274 (8%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVK---KFHSPLPGEMTFQQEFLNEVKALTE 851
+ +D +G G V K E ++G A K K + +++ EV L E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 852 IRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADAL 911
I+H N++ + + ++ E + G L L+ E L + +K I + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGV 126
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKNEAR----VSDFGIAKFLKPDSSNWTELAGTYGY 967
YLH+ I H D+ +N++L +N + + DFG+A + + + + GT +
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEF 182
Query: 968 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027
VAPE+ + + D++S GV+ ++ G P F+ +L A++ +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEFEDEYF 240
Query: 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
N F+ L + P+ R T+Q
Sbjct: 241 ---SNTSALAKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (386), Expect = 7e-42
Identities = 64/284 (22%), Positives = 118/284 (41%), Gaps = 25/284 (8%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+ IG+G G VYK + GE A+KK E + E+ L E++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
NIVK Y + +V+E+L+ ++ + LE S + + + ++Y H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCH 117
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAY 974
+ ++HRD+ +N+L++ + E +++DFG+A+ +T T Y AP+ L
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHP------GDFISLI------SSSSLNLNIALDEIL 1022
+ K + D++S G + E++ G D + I +S N+
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 1023 DPRLPIPSHNVQEKLI-----SFVEVAISCLDESPESRPTMQKV 1061
DP + E + S +++ L P R T ++
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 6e-41
Identities = 59/281 (20%), Positives = 109/281 (38%), Gaps = 32/281 (11%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEM--TFQQEFLNEVKALTEIRHRNIVKF 860
+G+G +VYK + +I+A+KK E + L E+K L E+ H NI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 861 YGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFP 920
H + +V++++E +I N L + + + L YLH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 921 PIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKV-T 979
I+HRD+ N+LLD +++DFG+AK + +T T Y APEL + ++
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 980 EKCDVYSFGVLALEVIKGKHP-----------------GDFISLISSSSLNLNIALDEIL 1022
D+++ G + E++ G +L +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 1023 DPRLPIPS--HNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
P +P+ + L+ ++ +P +R T +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQA 277
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-40
Identities = 60/274 (21%), Positives = 102/274 (37%), Gaps = 21/274 (7%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
NDFD +GKG G V V A+G A+K + + E + L RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
+ V EY G L LS + + +R A+ +S L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFY--GAEIVSAL 118
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
+V+RDI +N++LD +++DFG+ K D + GT Y+APE+
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034
D + GV+ E++ G+ P + + + IL + P +
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP--------FYNQDHERLFELILMEEIRFPRT-LS 229
Query: 1035 EKLISFVEVAISCLDESPESRPTMQK--VSQLLK 1066
+ S + L + P+ R ++++
Sbjct: 230 PEAKSLLA---GLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 62/302 (20%), Positives = 116/302 (38%), Gaps = 43/302 (14%)
Query: 790 EIIRATNDFDDEHCIGKGGQGSVYKV------ELASGEIIAVKKFHSPLPGEMTFQQEFL 843
E R + +G+G G V + + A+ +AVK + +
Sbjct: 9 EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALM 64
Query: 844 NEVKALTEIRHR-NIVKFYGFCSHAQHS-FIVYEYLEMGSLAMILSN------------- 888
+E+K L I H N+V G C+ ++ E+ + G+L+ L +
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 889 DAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948
D + L + +A + +L + +HRD++++N+LL KN ++ DFG+A
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA 181
Query: 949 KFLKPDSSNW--TELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISL 1006
+ + D + ++APE + T + DV+SFGVL E+
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---- 237
Query: 1007 ISSSSLNLNIALDEIL--DPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064
+ ++ L R+ P + E + + C P RPT ++ +
Sbjct: 238 ---PGVKIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEH 290
Query: 1065 LK 1066
L
Sbjct: 291 LG 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-40
Identities = 57/274 (20%), Positives = 106/274 (38%), Gaps = 33/274 (12%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPL---PGEMTFQQEFLNEVKALTE 851
+ + +G GG GSVY ++ +A+K GE+ EV L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 852 IR--HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIAD 909
+ +++ + ++ E E + A L+ S + +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLE 121
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDF-KNEARVSDFGIAKFLKPDSSNWTELAGTYGYV 968
A+ + HN ++HRDI +N+L+D + E ++ DFG LK + +T+ GT Y
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYS 176
Query: 969 APE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLP 1027
PE + Y V+S G+L +++ G P + +EI+ ++
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------------HDEEIIRGQVF 222
Query: 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
V + + CL P RPT +++
Sbjct: 223 FRQR-VSSECQHLIR---WCLALRPSDRPTFEEI 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-39
Identities = 56/287 (19%), Positives = 107/287 (37%), Gaps = 31/287 (10%)
Query: 797 DFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+F IG+G G VYK +GE++A+KK E + E+ L E+ H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 856 NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLH 915
NIVK ++V+E+L + ++ + S + + L++ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCH 119
Query: 916 NDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE-LAY 974
+ ++HRD+ +N+L++ + +++DFG+A+ +T T Y APE L
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLIS--------------------SSSLNL 1014
+ D++S G + E++ + S I +S +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 1015 NIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+ + + E S + L P R + +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (364), Expect = 7e-39
Identities = 43/277 (15%), Positives = 95/277 (34%), Gaps = 29/277 (10%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN-IVKFY 861
IG+G G +++ L + + +A+K + + +E + + I Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 862 GFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP 921
F H+ +V + L ++ K + + +H
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 922 IVHRDISSKNVLLD-----FKNEARVSDFGIAKFLKPDSSN-------WTELAGTYGYVA 969
+V+RDI N L+ N V DFG+ KF + + L+GT Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 970 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029
+ + + D+ + G + + ++G P + ++ I + P +
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
+ +E F + + + ++ P + L
Sbjct: 242 AGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-38
Identities = 61/270 (22%), Positives = 105/270 (38%), Gaps = 26/270 (9%)
Query: 801 EHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIV 858
+G G G V ++ + E A+K + EV+ + +IV
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 68
Query: 859 KFYGFCSHA----QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
+ + + IV E L+ G L + D + + ++K I +A+ YL
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNE---ARVSDFGIAKFLKPDSSNWTELAGTYGYVAPE 971
H+ I HRD+ +N+L K +++DFG AK +S T T YVAPE
Sbjct: 128 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPE 183
Query: 972 LAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031
+ K + CD++S GV+ ++ G P ++ S + P S
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 1032 NVQEKLISFVEVAISCLDESPESRPTMQKV 1061
V E++ + + L P R T+ +
Sbjct: 244 -VSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-38
Identities = 59/294 (20%), Positives = 106/294 (36%), Gaps = 35/294 (11%)
Query: 795 TNDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
+ + IG+G G V + + +A+KK T+ Q L E+K L R
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFR 64
Query: 854 HRNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSY 913
H NI+ + YL + L + L + I L Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 914 LHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN---WTELAGTYGYVAP 970
+H+ ++HRD+ N+LL+ + ++ DFG+A+ PD + TE T Y AP
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 971 ELAYT-MKVTEKCDVYSFGVLALEVIKGKHP----------------------GDFISLI 1007
E+ T+ D++S G + E++ + D +I
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 1008 SSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+ + N ++L N K + ++ L +P R +++
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQA 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-37
Identities = 57/278 (20%), Positives = 106/278 (38%), Gaps = 26/278 (9%)
Query: 797 DFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHR 855
+ D IG G G VY+ +L SGE++A+KK ++ E++ + ++ H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHC 73
Query: 856 NIVKFYGFCSHA------QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIAD 909
NIV+ F + + +V +Y+ + A + L + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEA-RVSDFGIAKFLKPDSSNWTELAGTYGYV 968
+L+Y+H+ I HRDI +N+LLD ++ DFG AK L N + + Y
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 969 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPI 1028
+ T DV+S G + E++ G+ + L EI+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPI--------FPGDSGVDQLVEIIKVLGTP 242
Query: 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066
++E ++ E + P ++ +
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 8e-37
Identities = 52/295 (17%), Positives = 104/295 (35%), Gaps = 34/295 (11%)
Query: 793 RATNDFDDEHCIGKGGQGSVYKVE--LASGEIIAVKKFHSPLPGEMTFQQEFLNEV---K 847
RA ++ IG+G G V+K G +A+K+ GE + EV +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLR 62
Query: 848 ALTEIRHRNIVKFYGFCSHAQHSFIVYEYLEMGSLA---MILSNDAAAEDLEWTQRMSVI 904
L H N+V+ + C+ ++ L + + + ++
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 905 KGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGT 964
+ L +LH+ +VHRD+ +N+L+ + +++DFG+A+ + + + T
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVT 178
Query: 965 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNI-------- 1016
Y APE+ D++S G + E+ + K S + L++
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 1017 ----------ALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
A + ++ E + CL +P R +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSA 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 5e-36
Identities = 51/286 (17%), Positives = 109/286 (38%), Gaps = 27/286 (9%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
++ IG+G G+V+K + + EI+A+K+ E L E+ L E++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKH 60
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
+NIV+ + + +V+E+ + S + V + L L
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGL 114
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
++HRD+ +N+L++ E ++++FG+A+ ++ T Y P++ +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 975 TMKV-TEKCDVYSFGVLALEVIKGKHP------------------GDFISLISSSSLNLN 1015
K+ + D++S G + E+ P G S L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 1016 IALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
+ P + V + + ++ + L +P R + ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (347), Expect = 5e-36
Identities = 59/274 (21%), Positives = 102/274 (37%), Gaps = 24/274 (8%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+ FD +G G G V V+ SG A+K ++ + LNE + L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 855 RNIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYL 914
+VK + ++V EY+ G + L I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYL 157
Query: 915 HNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAY 974
H+ +++RD+ +N+L+D + +V+DFG AK L GT +APE+
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEIIL 211
Query: 975 TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034
+ + D ++ GVL E+ G P + ++I+ ++ PSH
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP--------FFADQPIQIYEKIVSGKVRFPSH-FS 262
Query: 1035 EKLISFVEVAISCLDESPESRPTMQK--VSQLLK 1066
L + + L R K V+ +
Sbjct: 263 SDLKDLLR---NLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-35
Identities = 54/282 (19%), Positives = 105/282 (37%), Gaps = 25/282 (8%)
Query: 796 NDFDDEHCIGKGGQGSVYKVELA----SGEIIAVKKFH-SPLPGEMTFQQEFLNEVKALT 850
+F+ +G G G V+ V +G++ A+K + + + + E + L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 851 EIRHR-NIVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIAD 909
IR +V + ++ +Y+ G L LS + E + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 910 ALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWT-ELAGTYGYV 968
+ L + I++RDI +N+LLD ++DFG++K D + + GT Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 969 APELAYTMK--VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL 1026
AP++ + D +S GVL E++ G P + + IL
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT----VDGEKNSQAEISRRILKSEP 253
Query: 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQK--VSQLLK 1066
P P + ++ L + P+ R ++ +
Sbjct: 254 PYPQE-MSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKE 291
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-35
Identities = 51/307 (16%), Positives = 108/307 (35%), Gaps = 47/307 (15%)
Query: 792 IRATNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALT 850
+ ++ IG+G G V+K +G+ +A+KK E F L E+K L
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQ 64
Query: 851 EIRHRNIVKFYGFCSHAQ--------HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMS 902
++H N+V C ++V+++ E ++ + ++
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKR 121
Query: 903 VIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS----NW 958
V++ + + L Y+H I+HRD+ + NVL+ +++DFG+A+ + +
Sbjct: 122 VMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 959 TELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHP----------------- 1000
T T Y PEL + D++ G + E+
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 1001 ----GDFISLISSSSLNLNIALDEILDPRLP--IPSHNVQEKLISFVEVAISCLDESPES 1054
+ + + L + L + ++ + ++ + ++ L P
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQ 295
Query: 1055 RPTMQKV 1061
R
Sbjct: 296 RIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-33
Identities = 57/302 (18%), Positives = 109/302 (36%), Gaps = 37/302 (12%)
Query: 788 YEEIIRATNDFDD----EHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEF 842
+E+ + + +G G G+V + +G +A+KK + P E+ F +
Sbjct: 6 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRA 64
Query: 843 LNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE-YLEMGSLAMILSNDAAAEDLEWTQRM 901
E++ L +RH N++ + + + YL M + L E L +
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 124
Query: 902 SVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTEL 961
++ + L Y+H HRD+ N+ ++ E ++ DFG+A+ DS +
Sbjct: 125 FLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQ--ADSEMTGYV 179
Query: 962 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP--------------------- 1000
+ + M+ T+ D++S G + E+I GK
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 1001 GDFISLISSSSL-NLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQ 1059
+F+ + S N L E+ N ++ +E L E R T
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAG 296
Query: 1060 KV 1061
+
Sbjct: 297 EA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 122 bits (307), Expect = 6e-31
Identities = 55/300 (18%), Positives = 105/300 (35%), Gaps = 52/300 (17%)
Query: 796 NDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR- 853
+D+ +G+G V++ + + E + VK +++ E+K L +R
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRG 88
Query: 854 HRNIVKFYGFCSHAQHS--FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADAL 911
NI+ +V+E++ + L + I AL
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKAL 142
Query: 912 SYLHNDCFPPIVHRDISSKNVLLDFKN-EARVSDFGIAKFLKPDSSNWTELAGTYGYVAP 970
Y H+ I+HRD+ NV++D ++ + R+ D+G+A+F P +A Y
Sbjct: 143 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 199
Query: 971 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP--------------------GDFISLISSS 1010
L D++S G + +I K P D I
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 1011 SLNLNIALDEILDPRLPIP---------SHNVQEKLISFVEVAISCLDESPESRPTMQKV 1061
++ L+ ++IL H V + + F++ L +SR T ++
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD---KLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-30
Identities = 55/293 (18%), Positives = 101/293 (34%), Gaps = 30/293 (10%)
Query: 795 TNDFDDEHCIGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR 853
+ + +G G GSV +G +AVKK P + + E++ L ++
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII-HAKRTYRELRLLKHMK 75
Query: 854 HRNIVKFYGFCSHAQHSF-IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALS 912
H N++ + A+ YL + L+N + L +I I L
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 913 YLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYVAPEL 972
Y+H+ HRD+ N+ ++ E ++ DFG+A+ D +A + +
Sbjct: 136 YIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIM 190
Query: 973 AYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNI---------------A 1017
M + D++S G + E++ G+ I L L + +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 1018 LDEILDPRLPIPSHNVQEKLISFVEVAI----SCLDESPESRPTMQKVSQLLK 1066
+ +P N I +A+ L + R T Q L
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA---QALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-29
Identities = 49/306 (16%), Positives = 99/306 (32%), Gaps = 54/306 (17%)
Query: 796 NDFDDEHCIGKGGQGSVYKV-ELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRH 854
+ + IG G QG V + +A+KK P + T + E+ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 75
Query: 855 RNIVKFYGFCSH------AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIA 908
+NI+ + Q ++V E ++ +I + + ++ +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQML 129
Query: 909 DALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSNWTELAGTYGYV 968
+ +LH+ +HRD+ N+++ ++ DFG+A+ S T T Y
Sbjct: 130 CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYR 185
Query: 969 APELAYTMKVTEKCDVYSFGVLALEVIKGKHP---------------------------- 1000
APE+ M E D++S G + E+++ K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 1001 -----GDFISLISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESR 1055
+ + L + L P + + + L P R
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS---KMLVIDPAKR 302
Query: 1056 PTMQKV 1061
++
Sbjct: 303 ISVDDA 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 104 bits (259), Expect = 8e-25
Identities = 83/333 (24%), Positives = 127/333 (38%), Gaps = 34/333 (10%)
Query: 2 EEAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLK 61
++ ALL+ K L N LSSW T + W+G+ C+ +
Sbjct: 6 QDKQALLQIKKDLGNPTT---LSSWLPT--TDCCNRTWLGVLCDTDTQT----------- 49
Query: 62 GTLHDFSFSSFPHLAYLDLWSNQLFGN--IPPQIGNISKLKYLDLSSNL-FSGAIPPQIG 118
+ LDL L IP + N+ L +L + G IPP I
Sbjct: 50 -----------YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 119 HLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYN 178
L+ L L++ +SG+IP + + +L L N L +P S+ +L NLV +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 179 NLLSGSIPSEIGNLKYL-LDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSEL 237
N +SG+IP G+ L + + N L G IP + NL+ S ++ S L
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL--AFVDLSRNMLEGDASVL 216
Query: 238 GNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALS 297
+ + NL L + NN + G +P + LKFL + +S
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 298 YNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIP 330
+N G IP GNL +N P
Sbjct: 277 FNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.8 bits (208), Expect = 3e-18
Identities = 68/266 (25%), Positives = 98/266 (36%), Gaps = 27/266 (10%)
Query: 187 SEIGNLKYLLDLNLYNNELNG--SIPQSLGNLSNLAMLNLSSN-SLFGSIPSELGNLKYL 243
+ +L+L L IP SL NL L L + +L G IP + L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 244 SDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSG 303
L + ++G+IP L + LV L N+LSG +P I +L L I N+ SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 304 LIPHSLGNLSN-----------------------IAFLFLDSNSLFGLIPSELRNLKSLS 340
IP S G+ S S ++ S L +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 341 ILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSS 400
+G NL+ L + NN + G++P + LK L LN++FN L
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 401 IPISLSNLTNLSVLSFYKNSLSGAIP 426
IP NL V ++ N P
Sbjct: 284 IP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 82.9 bits (203), Expect = 1e-17
Identities = 59/292 (20%), Positives = 103/292 (35%), Gaps = 31/292 (10%)
Query: 431 NLVKLTKLFLGDNQFQGPIP---NLKNLTSLVRVHLDRNY-LTSNISESFYIYPNLTFID 486
++ L L P P +L NL L +++ L I + L ++
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 487 LSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPA 546
+++ N+ G I + L LDFS N ++G +PP I L + N + G IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 547 ELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLN 606
G S L + N L+ IP +
Sbjct: 168 SYGSFSKLFTSMTISR-----------------------NRLTGKIPPT--FANLNLAFV 202
Query: 607 LSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPR 666
+ L ++ ++ + ++L L+L +N + G +P+
Sbjct: 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQ 262
Query: 667 CFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGLCGDFKGLPSC 718
++ L +++S+N L G IP + + A NK LCG LP+C
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG--SPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 77.9 bits (190), Expect = 6e-16
Identities = 70/257 (27%), Positives = 102/257 (39%), Gaps = 6/257 (2%)
Query: 214 GNLSNLAMLNLSSNSLFG--SIPSELGNLKYLSDLKLADN-KLNGSIPHSLCNLTNLVIL 270
+ L+LS +L IPS L NL YL+ L + L G IP ++ LT L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 271 YIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIP 330
YI + ++SG IP + +K L + SYN SG +P S+ +L N+ + D N + G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 331 SELRNLKSLSI-LELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSY 389
+ L + + N+L G IP NL V N + + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 390 LNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPI 449
+ + LS N L N + G +P+ L L L + N G I
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRN--NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 450 PNLKNLTSLVRVHLDRN 466
P NL N
Sbjct: 285 PQGGNLQRFDVSAYANN 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 101 bits (252), Expect = 5e-24
Identities = 70/317 (22%), Positives = 118/317 (37%), Gaps = 28/317 (8%)
Query: 36 SCAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGN 95
C + C+ G L P A LDL +N++ N
Sbjct: 9 QCHLRVVQCSDLG---------------LEKVPKDLPPDTALLDLQNNKITEIKDGDFKN 53
Query: 96 ISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSN 155
+ L L L +N S P L L+ L+L KNQL L L
Sbjct: 54 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEIT 113
Query: 156 YLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGN 215
+ + + L N +V L SG +K L + + + + +IPQ L
Sbjct: 114 KVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL-- 169
Query: 216 LSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNN 275
+L L+L N + + L L L+ L L+ N ++ SL N +L L++ NN
Sbjct: 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229
Query: 276 SLSGLIPSEIGNLKFLSKIALSYNKFSGL------IPHSLGNLSNIAFLFLDSNSL--FG 327
L +P + + K++ + L N S + P ++ + + L SN + +
Sbjct: 230 KLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288
Query: 328 LIPSELRNLKSLSILEL 344
+ PS R + + ++L
Sbjct: 289 IQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (249), Expect = 1e-23
Identities = 59/288 (20%), Positives = 105/288 (36%), Gaps = 14/288 (4%)
Query: 352 SIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNL 411
+P L + ++L + NN ++ + NLK+L L L NK++ P + + L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 412 SVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSN 471
L KN L K + L +L + + + N N +V + + +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 472 ISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLE 531
+ +F L++I ++ N+ + G P L L N IT + + L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 532 VLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSN- 590
L LS N + L L +L L N+L ++ + L +NN+S
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD-HKYIQVVYLHNNNISAI 257
Query: 591 -----AIPESLGNLVKLHYLNLSNNQFS-WEIPIK-LEELIHLSELDL 631
P ++L +N WEI + + + L
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 99.3 bits (246), Expect = 3e-23
Identities = 56/274 (20%), Positives = 98/274 (35%), Gaps = 13/274 (4%)
Query: 256 SIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNI 315
+P L + +L + NN ++ + + NLK L + L NK S + P + L +
Sbjct: 24 KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 316 AFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSG 375
L+L N L L + L+ L + E K+ S+ + L + + L SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSG 140
Query: 376 SIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKL 435
+K LSY+ +A +T+ I +L+ L N ++ + L L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 436 TKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGE 495
KL L N T +R N + + + + L NN+
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 257
Query: 496 ISSDW------GRCPKLGALDFSKNNIT-GNIPP 522
S+D+ + + N + I P
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.5 bits (236), Expect = 6e-22
Identities = 53/269 (19%), Positives = 107/269 (39%), Gaps = 13/269 (4%)
Query: 112 AIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNL 171
+P + L L N+++ + L +L+ L L +N + I P + L L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 172 VTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFG 231
L L N L L+ L ++ S+ L + + + + G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSG 140
Query: 232 SIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFL 291
+K LS +++AD + +IP L +L L++ N ++ + + + L L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 292 SKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCG 351
+K+ LS+N S + SL N ++ +N+ +P L + K + ++ L NN +
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRE-LHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 256
Query: 352 ------SIPHFLGNLTNLSVLFIYNNSLS 374
P + + S + +++N +
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.2 bits (217), Expect = 2e-19
Identities = 52/268 (19%), Positives = 95/268 (35%), Gaps = 12/268 (4%)
Query: 435 LTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLY 493
L L +N+ KNL +L + L N ++ +F L + LS N L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 494 GEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSF 553
+L + + ++ + +E L + G +
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKK 151
Query: 554 LIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFS 613
L + +A ++ + GL L L L N ++ SL L L L LS N S
Sbjct: 152 LSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 614 WEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCF----- 668
L HL EL L+ N L + +P + + ++ + L +N++S + F
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 669 -EEMHALQCIDISYNELRGPIPNSTAFR 695
+ + + + N ++ + FR
Sbjct: 268 NTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 71.6 bits (174), Expect = 6e-14
Identities = 43/216 (19%), Positives = 78/216 (36%), Gaps = 8/216 (3%)
Query: 509 LDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQL 568
LD N IT L L L +N + P L L +L L++NQL
Sbjct: 36 LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK--- 92
Query: 569 SPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSN--NQFSWEIPIKLEELIHL 626
+ L+ L + N ++ L ++ + L + S + + L
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152
Query: 627 SELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRG 686
S + ++ + IP + SL +L+L N ++ V + ++ L + +S+N +
Sbjct: 153 SYIRIADTNI-TTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 209
Query: 687 PIPNSTAFRDAPIKALQGNKGLCGDFKGLPSCKALK 722
S A + N L GL K ++
Sbjct: 210 VDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ 245
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 64.7 bits (156), Expect = 1e-11
Identities = 31/172 (18%), Positives = 60/172 (34%), Gaps = 6/172 (3%)
Query: 520 IPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLE 579
+P + +LDL +N + + L L LIL N++S LV+LE
Sbjct: 25 VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 580 HLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRA 639
L LS N L + L +L + + L ++I + G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI- 141
Query: 640 IPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNS 691
M+ L + ++ +++ + +L + + N++ S
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLPP---SLTELHLDGNKITKVDAAS 190
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.6 bits (135), Expect = 5e-09
Identities = 28/149 (18%), Positives = 41/149 (27%)
Query: 573 GLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLS 632
L LDL +N ++ NL LH L L NN+ S P L+ L L LS
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 633 YNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNST 692
N L +Q L + + +M ++
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 693 AFRDAPIKALQGNKGLCGDFKGLPSCKAL 721
+ + PS L
Sbjct: 148 GMKKLSYIRIADTNITTIPQGLPPSLTEL 176
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.4 bits (119), Expect = 5e-07
Identities = 30/158 (18%), Positives = 54/158 (34%), Gaps = 3/158 (1%)
Query: 577 QLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFL 636
L + S L +P+ L L+L NN+ + + L +L L L N +
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPPDTA--LLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 637 GRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRD 696
+ P + LE+L LS N L + + + + L+ + ++R + N
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127
Query: 697 APIKALQGNKGLCGDFKGLPSCKALKSNKQASRKIWIV 734
K + K L + A I +
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI 165
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 8e-24
Identities = 49/251 (19%), Positives = 98/251 (39%), Gaps = 29/251 (11%)
Query: 804 IGKGGQGSVYKVE-LASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVK--- 859
+G G +V+ + + + +A+K + G+ + + +E+K L + + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKI----VRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 860 ------------FYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGI 907
F + H +V+E L LA+I + L + +++ K +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI--SKQL 134
Query: 908 ADALSYLHNDCFPPIVHRDISSKNVLLDFKN-EARVSDFGIAKFLKPDSS--NWTELAGT 964
L Y+H C I+H DI +NVL++ + + IA ++T T
Sbjct: 135 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 965 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP 1024
Y +PE+ D++S L E+I G F S + + +I++
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIEL 250
Query: 1025 RLPIPSHNVQE 1035
+PS+ ++
Sbjct: 251 LGELPSYLLRN 261
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 102 bits (254), Expect = 1e-23
Identities = 88/385 (22%), Positives = 150/385 (38%), Gaps = 34/385 (8%)
Query: 191 NLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLAD 250
L + L + ++ Q+ +L + L + + L L+ + ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 75
Query: 251 NKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPH--- 307
N+L P L NLT LV + + NN ++ + P + + + +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 308 ---------SLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNK-LCGSIPHFL 357
++ ++S ++ L FG ++L+ L +L+ LE + S L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 358 GNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFY 417
LTNL L NN +S P I +L L+L N+L +L++LTNL+ L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 418 KNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFY 477
N +S P L KLT+L LG NQ I L LT+L + L+ N
Sbjct: 250 NNQISNLAPLS--GLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQ--LEDISPIS 304
Query: 478 IYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSS 537
NLT++ L +NN+ KL L F+ N ++ + + + L
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 538 NHVVGDIPAELGKLSFLIKLILAQN 562
N + P L L+ + +L L
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 100 bits (248), Expect = 6e-23
Identities = 77/382 (20%), Positives = 134/382 (35%), Gaps = 52/382 (13%)
Query: 335 NLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAF 394
L LG + ++ +L ++ L + SI + L +L+ +N +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75
Query: 395 NKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIP---- 450
N+LT P L NLT L + N ++ P + LF P+
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 451 ---------NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNN-LYGEISSDW 500
+ ++++L + + N NLT ++ + S
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 501 GRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILA 560
+ L +L + N I+ P I + L+ L L+ N + L L+ L L LA
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 561 QNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIP--------------------ESLGNLV 600
NQ+S L L +L L L +N +SN P + NL
Sbjct: 250 NNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 601 KLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSL 660
L YL L N S P+ L L L + N + S + + ++ L+ HN +
Sbjct: 308 NLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVS--DVSSLANLTNINWLSAGHNQI 363
Query: 661 SGVIPRCFEEMHALQCIDISYN 682
S + P + + + ++
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 100 bits (248), Expect = 6e-23
Identities = 85/365 (23%), Positives = 154/365 (42%), Gaps = 33/365 (9%)
Query: 68 SFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLH 127
S + + L + + ++ L ++ S+N + P + +L+ L +
Sbjct: 39 SQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94
Query: 128 LFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPH------------SLGNLTNLVTLC 175
+ NQ++ PL + L D + + ++ +++ L L
Sbjct: 95 MNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLT 154
Query: 176 LYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSL-GNLSNLAMLNLSSNSLFGSIP 234
L G+ +++ L L L + N S+ L+NL L ++N + P
Sbjct: 155 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP 214
Query: 235 SELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKI 294
L L +L L N+L +L +LTNL L + NN +S L P + L L+++
Sbjct: 215 LG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 268
Query: 295 ALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIP 354
L N+ S + P L L+ + L L+ N L S + NLK+L+ L L N + P
Sbjct: 269 KLGANQISNISP--LAGLTALTNLELNENQLE--DISPISNLKNLTYLTLYFNNISDISP 324
Query: 355 HFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVL 414
+ +LT L LF NN +S + NL ++++L+ N+++ P L+NLT ++ L
Sbjct: 325 --VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 378
Query: 415 SFYKN 419
Sbjct: 379 GLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 100 bits (248), Expect = 6e-23
Identities = 97/392 (24%), Positives = 163/392 (41%), Gaps = 39/392 (9%)
Query: 67 FSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTL 126
F+ ++ L + + ++ ++ L + +L+ L +
Sbjct: 16 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQI 71
Query: 127 HLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIP 186
+ NQL+ PL L+ L ++ + +N + DI P + +TL +
Sbjct: 72 NFSNNQLTDITPL--KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129
Query: 187 SEIGNLKYLLDLNL---------------YNNELNGSIPQSLGNLSNLAMLNLSSNSLFG 231
+ + L N + + + L NL+ L L++SSN
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KV 187
Query: 232 SIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFL 291
S S L L L L +N+++ P LTNL L + N L + +L L
Sbjct: 188 SDISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNL 243
Query: 292 SKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCG 351
+ + L+ N+ S L P L L+ + L L +N + + P L L +L+ LEL N+L
Sbjct: 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED 299
Query: 352 SIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNL 411
P NL NL+ L +Y N++S P + +L L L A NK++ SL+NLTN+
Sbjct: 300 ISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNI 353
Query: 412 SVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDN 443
+ LS N +S P NL ++T+L L D
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 99.7 bits (247), Expect = 7e-23
Identities = 103/385 (26%), Positives = 162/385 (42%), Gaps = 34/385 (8%)
Query: 95 NISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYS 154
+++ L + + L + TL + + SI V L++L + +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75
Query: 155 NYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQ--- 211
N L DI P L NLT LV + + NN ++ P L L +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 212 ---------SLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLC 262
++ ++S L+ L FG+ ++L L L+ L+ D N S+
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 263 -NLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLD 321
LTNL L NN +S + P I L +++L+ N+ +L +L+N+ L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 322 SNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEI 381
+N + L P L L L+ L+LG N++ P L LT L+ L + N I
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN--QLEDISPI 303
Query: 382 GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLG 441
NLK+L+YL L FN ++ P+ S+LT L L F N +S NL + L G
Sbjct: 304 SNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 442 DNQFQGPIPNLKNLTSLVRVHLDRN 466
NQ P L NLT + ++ L+
Sbjct: 360 HNQISDLTP-LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 99.3 bits (246), Expect = 1e-22
Identities = 82/397 (20%), Positives = 145/397 (36%), Gaps = 34/397 (8%)
Query: 215 NLSNLAMLNLSSNSLFGSIP-SELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIY 273
L+ L ++ ++ ++L + L +L ++G + L NL +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 274 NNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSEL 333
NN L+ + P + NL L I ++ N+ + + P + + L + L
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLA----NLTNLTGLTLFNNQITDIDPL 128
Query: 334 RNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLA 393
+NL +L+ LEL +N + + NL +L L+++
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLANLTTLERLDIS 183
Query: 394 FNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLK 453
NK++ + + LTNL L N +S P L +L L NQ + I L
Sbjct: 184 SNKVSDISVL--AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD-IGTLA 238
Query: 454 NLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSK 513
+LT+L + L N +++ LT + L N +
Sbjct: 239 SLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTN----LEL 292
Query: 514 NNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLG 573
N I L L L N++ P + L+ L +L A N++S L
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLA 348
Query: 574 LLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
L + L N +S+ P L NL ++ L L++
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.0 bits (240), Expect = 6e-22
Identities = 73/384 (19%), Positives = 131/384 (34%), Gaps = 32/384 (8%)
Query: 287 NLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGN 346
L K L + + + +L + L D + + + L +L+ + N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 347 NKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPI--- 403
N+L P L NLT L + + NN ++ P + L +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 404 ---------SLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKN 454
++S+++ LS L+ + G + + L LT L D
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 455 LTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKN 514
L + I NL + L+ N L + L LD + N
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANN 251
Query: 515 NITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGL 574
I+ P + ++L L L +N + P L N+ + +
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPLA----GLTALTNLELNENQLEDISPISN 305
Query: 575 LVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYN 634
L L +L L NN+S+ P + +L KL L +NN+ S L L +++ L +N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS--DVSSLANLTNINWLSAGHN 361
Query: 635 FLGRAIPSQICIMQSLEKLNLSHN 658
+ P + + + +L L+
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 89.3 bits (220), Expect = 2e-19
Identities = 61/262 (23%), Positives = 96/262 (36%), Gaps = 32/262 (12%)
Query: 10 WKTSLQNHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSF 69
+ N S +S+ + + S + ++ I
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 70 SSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLF 129
+ +L L +NQ+ P I ++ L L L+ N + L+ L L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 130 KNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIP--------------------HSLGNLT 169
NQ+S PL GL+ L L L +N + +I P + NL
Sbjct: 250 NNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 170 NLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSL 229
NL L LY N +S P + +L L L NN+++ SL NL+N+ L+ N +
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363
Query: 230 FGSIPSELGNLKYLSDLKLADN 251
P L NL ++ L L D
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.3 bits (176), Expect = 7e-14
Identities = 64/364 (17%), Positives = 120/364 (32%), Gaps = 72/364 (19%)
Query: 383 NLKSLSYLNLAFNKLTSSIPIS-LSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLG 441
L L +T ++ + L +T L S+ G L LT++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 442 DNQFQG--PIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSD 499
+NQ P+ NL L ++ + +T + + L ++ + +++
Sbjct: 75 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 500 WGRCPKLGAL-------------------------------DFSKNNITGNIPPKIGYSS 528
+ + +I+ N I +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 529 QLE---VLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSS 585
+L L ++N + P + + L +L L NQL L L L LDL++
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 586 NNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPI--------------------KLEELIH 625
N +SN P L L KL L L NQ S P+ + L +
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308
Query: 626 LSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
L+ L L +N + P + + L++L ++N +S + + + +N++
Sbjct: 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQIS 364
Query: 686 GPIP 689
P
Sbjct: 365 DLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 62.3 bits (150), Expect = 1e-10
Identities = 66/355 (18%), Positives = 117/355 (32%), Gaps = 70/355 (19%)
Query: 392 LAFNKLTSSIPIS----LSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQG 447
L +T PI+ + L K +++ + + +L ++T L +
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS 58
Query: 448 PIPNLKNLTSLVRVHLDRNYLTS-------------NISESFYIYPNLTFIDLSYNNLYG 494
I ++ L +L +++ N LT ++ + + L
Sbjct: 59 -IDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTL 117
Query: 495 EISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELG----- 549
+ P + ++ ++ N I S L L S L
Sbjct: 118 FNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTL 177
Query: 550 -----------------KLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAI 592
KL+ L LI NQ+S + L+ L L+ N L +
Sbjct: 178 ERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD-- 233
Query: 593 PESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIP----------- 641
+L +L L L+L+NNQ S P L L L+EL L N + P
Sbjct: 234 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE 291
Query: 642 ---------SQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGP 687
S I +++L L L N++S + P + LQ + + N++
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV 344
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (224), Expect = 1e-20
Identities = 62/274 (22%), Positives = 105/274 (38%), Gaps = 7/274 (2%)
Query: 222 LNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLI 281
+ L ++P + + L N+++ S NL IL++++N L+ +
Sbjct: 16 TSCPQQGL-QAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 282 PSEIGNLKFLSKIALSYNKFSGLI-PHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLS 340
+ L L ++ LS N + P + L + L LD L L P R L +L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 341 ILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSS 400
L L +N L +L NL+ LF++ N +S L SL L L N++
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 401 IPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVR 460
P + +L L L + N+LS + L L L L DN + L +
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQK 252
Query: 461 VHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYG 494
+ + ++ + L+ N+L G
Sbjct: 253 FRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (222), Expect = 3e-20
Identities = 64/271 (23%), Positives = 96/271 (35%), Gaps = 7/271 (2%)
Query: 82 SNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEV 141
Q +P I + + + L N S L L L N L+
Sbjct: 19 PQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 142 GGLSSLNNLALYSNY-LEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNL 200
GL+ L L L N L + P + L L TL L L P L L L L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 201 YNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHS 260
+N L + +L NL L L N + L L L L N++ PH+
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 261 LCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFL 320
+L L+ LY++ N+LS L + L+ L + L+ N + + + +
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRG 255
Query: 321 DSNSLFGLIPSELRNLKSLSILELGNNKLCG 351
S+ + +P L + L N L G
Sbjct: 256 SSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (218), Expect = 7e-20
Identities = 64/276 (23%), Positives = 110/276 (39%), Gaps = 8/276 (2%)
Query: 124 KTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG 183
T + L ++P+ + ++ + L+ N + + S NL L L++N+L+
Sbjct: 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70
Query: 184 SIPSEIGNLKYLLDLNLYNNELNGSI-PQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKY 242
+ L L L+L +N S+ P + L L L+L L P L
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130
Query: 243 LSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFS 302
L L L DN L + +L NL L+++ N +S + L L ++ L N+ +
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 303 GLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTN 362
+ PH+ +L + L+L +N+L L L L++L L L +N
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAW 249
Query: 363 LSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLT 398
L ++ + S+P L LA N L
Sbjct: 250 LQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.2 bits (209), Expect = 1e-18
Identities = 62/264 (23%), Positives = 95/264 (35%), Gaps = 8/264 (3%)
Query: 305 IPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLS 364
+P + + +FL N + + + R ++L+IL L +N L L L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 365 VLFIYNNSLSGSI-PCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSG 423
L + +N+ S+ P L L L+L L P L L L N+L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 424 AIPKEYRNLVKLTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIYPNL 482
+R+L LT LFL N+ + L SL R+ L +N + +F L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 483 TFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVG 542
+ L NNL + L L + N + + L+ SS+ V
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPC 262
Query: 543 DIPAELGKLSFLIKLILAQNQLSG 566
+P L LA N L G
Sbjct: 263 SLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (200), Expect = 2e-17
Identities = 60/267 (22%), Positives = 93/267 (34%), Gaps = 8/267 (2%)
Query: 370 NNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEY 429
L ++P I + + L N+++ S NL++L + N L+ +
Sbjct: 20 QQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 430 RNLVKLTKLFLGDNQFQGPIP--NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDL 487
L L +L L DN + L L +HLDR L F L ++ L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 488 SYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAE 547
N L + L L N I+ L+ L L N V P
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 548 LGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNL 607
L L+ L L N LS + L L L++L L+ N + L
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW-VCDCRARPLWAWLQKFRG 255
Query: 608 SNNQFSWEIPIKLE--ELIHLSELDLS 632
S+++ +P +L +L L+ DL
Sbjct: 256 SSSEVPCSLPQRLAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (200), Expect = 2e-17
Identities = 58/257 (22%), Positives = 90/257 (35%), Gaps = 5/257 (1%)
Query: 72 FPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKN 131
+ L N++ L L L SN+ + L+ L+ L L N
Sbjct: 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 132 QLSGSI-PLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIG 190
S+ P GL L+ L L L+++ P L L L L +N L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 191 NLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLAD 250
+L L L L+ N ++ ++ L +L L L N + P +L L L L
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 251 NKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLG 310
N L+ +L L L L + +N + +L K S ++ +P L
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269
Query: 311 NLSNIAFLFLDSNSLFG 327
L +N L G
Sbjct: 270 GRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (192), Expect = 2e-16
Identities = 59/251 (23%), Positives = 89/251 (35%), Gaps = 4/251 (1%)
Query: 456 TSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNN 515
+ R+ L N ++ + SF NLT + L N L ++ + L LD S N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 516 ITGNIPP-KIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGL 574
++ P +L L L + P L+ L L L N L
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 575 LVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYN 634
L L HL L N +S+ + L L L L N+ + P +L L L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 635 FLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAF 694
L + +++L+ L L+ N R LQ S +E+ +P
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQR--L 268
Query: 695 RDAPIKALQGN 705
+K L N
Sbjct: 269 AGRDLKRLAAN 279
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (184), Expect = 2e-15
Identities = 46/264 (17%), Positives = 84/264 (31%), Gaps = 20/264 (7%)
Query: 16 NHNNGSPLSSWTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHL 75
+ N S + + +F +
Sbjct: 40 HGNRISHVPAASFRACRNLTILWLHSNVLAR----------------IDAAAFTGLALLE 83
Query: 76 AYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSG 135
+ QL P + +L L L P L+ L+ L+L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 136 SIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYL 195
L +L +L L+ N + + + L +L L L+ N ++ P +L L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 196 LDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNG 255
+ L L+ N L+ ++L L L L L+ N + +L + + +++
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPC 262
Query: 256 SIPHSLCNLTNLVILYIYNNSLSG 279
S+P L + + N L G
Sbjct: 263 SLPQRLAGRD---LKRLAANDLQG 283
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.8 bits (209), Expect = 2e-19
Identities = 29/183 (15%), Positives = 57/183 (31%), Gaps = 27/183 (14%)
Query: 804 IGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQ-------EFLNEVKALTEIRHRN 856
+G+G + +V+ VK ++ F R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 857 IVKFYGFCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN 916
+ K G +++ E ++ M L + + V+ I + ++ ++
Sbjct: 68 LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK---------FLKPDSSNWTE-LAGTYG 966
IVH D+S NVL+ + + DF + L+ D N + TY
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYR 177
Query: 967 YVA 969
Sbjct: 178 TEK 180
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.2 bits (165), Expect = 6e-13
Identities = 50/270 (18%), Positives = 91/270 (33%), Gaps = 19/270 (7%)
Query: 342 LELGNNKLCGSIPHFLGNLTNLSVLFIY-NNSLSGSIPCEIGNLKSLSYLNLAFNKLT-S 399
L+L L P G L + V+ S E + + +++L+ + + S
Sbjct: 5 LDLTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 400 SIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKL---------FLGDNQFQGPIP 450
++ LS + L LS LS I L +L
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 451 NLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALD 510
L L ++ ++ L N ++S+ RCP L LD
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 511 FSKN-NITGNIPPKIGYSSQLEVLDLSS-NHVVGDIPAELGKLSFLIKLILAQNQLSGQL 568
S + + + + + L+ L LS ++ + ELG++ L L + G L
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 569 SPKLGLLVQLEHLDLSSNNLSNAIPESLGN 598
L L HL ++ ++ + ++GN
Sbjct: 242 QL---LKEALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 2e-09
Identities = 31/261 (11%), Positives = 83/261 (31%), Gaps = 13/261 (4%)
Query: 173 TLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSL-FG 231
TL L L + + + ++ + ++ + + + ++LS++ +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVS 61
Query: 232 SIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFL 291
++ L L +L L +L+ I ++L +NLV L + S +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 292 SKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLK---------SLSIL 342
L+ + + + +L G + ++ + +
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 343 ELGNNKLCGSIPHFLGNLTNLSVLFIYN-NSLSGSIPCEIGNLKSLSYLNLAFNKLTSSI 401
+ L L L L + + E+G + +L L + ++
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 402 PISLSNLTNLSVLSFYKNSLS 422
+ L +L + + +++
Sbjct: 242 QLLKEALPHLQINCSHFTTIA 262
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (135), Expect = 4e-09
Identities = 43/294 (14%), Positives = 90/294 (30%), Gaps = 24/294 (8%)
Query: 102 LDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDI- 160
LDL+ + ++ + ++ + + E + ++ L ++ +E
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVST 62
Query: 161 IPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLA 220
+ L + L L L LS I + + L+ LNL
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS---------------- 106
Query: 221 MLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGL 280
+ + S S L L + + ++ H +T L + N
Sbjct: 107 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD 166
Query: 281 IPSEIGNLKFLSKIALSYN-KFSGLIPHSLGNLSNIAFLFL-DSNSLFGLIPSELRNLKS 338
+ + + L + LS + L+ + L L + EL + +
Sbjct: 167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226
Query: 339 LSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNL 392
L L++ G++ L +L I + + IGN K+ +
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQEIWGI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 29/159 (18%), Positives = 58/159 (36%), Gaps = 3/159 (1%)
Query: 533 LDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLS-NA 591
LDL+ ++ D+ L + ++ + L+ +++H+DLS++ + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVST 62
Query: 592 IPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLE 651
+ L KL L+L + S I L + +L L+LS Q +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 652 KLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPN 690
L+ + + + A I+ L G N
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 161
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 5e-08
Identities = 41/244 (16%), Positives = 77/244 (31%), Gaps = 38/244 (15%)
Query: 81 WSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSGSIPL 139
+ + +++++DLS+++ + I S L+ L L +LS I
Sbjct: 30 CPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVN 89
Query: 140 EVGGLSSLNNLALY--SNYLEDIIPHSLGNLTNL-------------------------- 171
+ S+L L L S + E + L + + L
Sbjct: 90 TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 149
Query: 172 -----VTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSS 226
++ N S + + L Q L+ L L+LS
Sbjct: 150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR 209
Query: 227 -NSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEI 285
+ ELG + L L++ +G++ L +L I + + + I
Sbjct: 210 CYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQIN---CSHFTTIARPTI 266
Query: 286 GNLK 289
GN K
Sbjct: 267 GNKK 270
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 3e-07
Identities = 39/271 (14%), Positives = 91/271 (33%), Gaps = 15/271 (5%)
Query: 436 TKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGE 495
L L + ++ R+++ ++E F + +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVS 61
Query: 496 -ISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAE------- 547
+ +C KL L ++ I + +S L L+LS + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 548 -LGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLN 606
L +L+ + + ++ + QL N + + + L +L+
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 607 LSNN-QFSWEIPIKLEELIHLSELDLSY-NFLGRAIPSQICIMQSLEKLNLSHNSLSGVI 664
LS++ + + +L +L L LS + ++ + +L+ L + G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 665 PRCFEEMHALQCIDISYNELRGPIPNSTAFR 695
E AL + I+ + + +
Sbjct: 242 QLLKE---ALPHLQINCSHFTTIARPTIGNK 269
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 60.8 bits (146), Expect = 1e-10
Identities = 36/226 (15%), Positives = 76/226 (33%), Gaps = 18/226 (7%)
Query: 191 NLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLAD 250
L + + + + ++ Q+ +L + L+ + + + L L L+L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKD 72
Query: 251 NKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLG 310
N++ P + L I + +L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 311 NLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYN 370
L + + L GL + + S L NL+ L+ L +
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLS----------IGNAQVSDLTPLANLSKLTTLKADD 182
Query: 371 NSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSF 416
N +S P + +L +L ++L N+++ P L+N +NL +++
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 39/227 (17%), Positives = 81/227 (35%), Gaps = 18/227 (7%)
Query: 120 LSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
L+ + K+ ++ ++ L + L+ + + I + L NL+ L L +N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 180 LLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGN 239
++ P + L+L+ + +I + ++ + S L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 240 LKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYN 299
L I + + Y+ + + + NL L+ + N
Sbjct: 134 LYLD----------LNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 300 KFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGN 346
K S + P L +L N+ + L +N + + P L N +L I+ L N
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 2e-08
Identities = 34/226 (15%), Positives = 66/226 (29%), Gaps = 17/226 (7%)
Query: 407 NLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRN 466
L N ++ K++++ + + +L +T L I ++ L +L+ + L N
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDN 73
Query: 467 YLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGY 526
+T + + I+ + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 527 SSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSN 586
+ I L+ L L +L L N
Sbjct: 134 L----------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 587 NLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLS 632
+S+ P L +L L ++L NNQ S P L +L + L+
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 6e-08
Identities = 42/227 (18%), Positives = 78/227 (34%), Gaps = 17/227 (7%)
Query: 383 NLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGD 442
L + + + +T ++ ++L ++ LS + ++ + + L L L L D
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 443 NQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGR 502
NQ + LKNLT + + L N L + + + + + ++
Sbjct: 73 NQIT-DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 503 CPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQN 562
I + + LS + L LS L L N
Sbjct: 132 QV--------LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 563 QLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSN 609
++S L L L + L +N +S+ P L N L + L+N
Sbjct: 184 KISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 1e-07
Identities = 39/226 (17%), Positives = 75/226 (33%), Gaps = 24/226 (10%)
Query: 159 DIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSN 218
I P L N + + + ++ ++ +L + L+ + + + + L+N
Sbjct: 11 VIFPDP--ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNN 64
Query: 219 LAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLS 278
L L L N + P + +L K +I T + +
Sbjct: 65 LIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 279 GLIPSEIGNLKFLSKIALSYNKF--------------SGLIPHSLGNLSNIAFLFLDSNS 324
S + L + + L NLS + L D N
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 325 LFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYN 370
+ + P L +L +L + L NN++ P L N +NL ++ + N
Sbjct: 185 ISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 37/227 (16%), Positives = 67/227 (29%), Gaps = 17/227 (7%)
Query: 431 NLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYN 490
L K+ G + + +L + + +T+ E NL ++L N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDN 73
Query: 491 NLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGK 550
+ L + I + ++ + L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
L + I + L+ LS N + L NL KL L +N
Sbjct: 134 LYLDLNQITNISPLA----------GLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 611 QFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSH 657
+ S P L L +L E+ L N + P + +L + L++
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 34/225 (15%), Positives = 68/225 (30%), Gaps = 17/225 (7%)
Query: 239 NLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSY 298
L + + + ++ + +L + L + ++ + + L L + L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 299 NKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLG 358
N+ + L P L + I + + L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 359 NLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYK 418
L + L+G + + S L+NL+ L+ L
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLS----------IGNAQVSDLTPLANLSKLTTLKADD 182
Query: 419 NSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHL 463
N +S P +L L ++ L +NQ + L N ++L V L
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 3e-06
Identities = 38/226 (16%), Positives = 75/226 (33%), Gaps = 18/226 (7%)
Query: 95 NISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYS 154
++ + + + + L + TL F ++ ++ L++L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKD 72
Query: 155 NYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLG 214
N + D+ P + L +I L + + +L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 215 NLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYN 274
L + + L G + ++ S L NL+ L L +
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQV----------SDLTPLANLSKLTTLKADD 182
Query: 275 NSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFL 320
N +S + P + +L L ++ L N+ S + P L N SN+ + L
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 8e-06
Identities = 45/229 (19%), Positives = 77/229 (33%), Gaps = 18/229 (7%)
Query: 335 NLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAF 394
L + + G + + ++ +L ++ L + ++ +I + L +L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 395 NKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKN 454
N++T P+ NLT ++ L N L +K L P+ L N
Sbjct: 73 NQITDLAPL--KNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130
Query: 455 LTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKN 514
L L + I+ + LS N + KL L N
Sbjct: 131 LQVL-------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 515 NITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQ 563
I+ P + L + L +N + P L S L + L NQ
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 40/216 (18%), Positives = 68/216 (31%), Gaps = 21/216 (9%)
Query: 287 NLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGN 346
L KIA + + + + +L I L + + ++ L +L LEL +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 347 NKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLS 406
N++ P L +I + + +L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 407 NLTNLSVLSFYKNSLSGAIPKEYR--------------NLVKLTKLFLGDNQFQGPIPNL 452
L + L+G +Y NL KLT L DN+ I L
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPL 191
Query: 453 KNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLS 488
+L +L+ VHL N ++ NL + L+
Sbjct: 192 ASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 7e-05
Identities = 33/226 (14%), Positives = 68/226 (30%), Gaps = 17/226 (7%)
Query: 311 NLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYN 370
L+N + +++ + +L ++ L + +I + L NL L + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 371 NSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYR 430
N ++ P + + L+ K S+I S T + + A +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 431 NLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYN 490
L + G +L + LT + N
Sbjct: 133 VLYLDLNQITNISPLAGLTNL---------QYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 491 NLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLS 536
+ S P L + N I+ P + +S L ++ L+
Sbjct: 184 KISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 9e-05
Identities = 32/232 (13%), Positives = 68/232 (29%), Gaps = 18/232 (7%)
Query: 449 IPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGA 508
I L + +++ ++ +T ++++ +T + + L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVTQADL--DGITTLSAFGTGVTT--IEGVQYLNNLIG 67
Query: 509 LDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQL 568
L+ N IT P K +L+ + L +S + L +
Sbjct: 68 LELKDNQITDLAPLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST 117
Query: 569 SPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSE 628
+ N I + LS L L L+
Sbjct: 118 QITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTT 177
Query: 629 LDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDIS 680
L N + P + + +L +++L +N +S V P L + ++
Sbjct: 178 LKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 5e-04
Identities = 43/231 (18%), Positives = 84/231 (36%), Gaps = 18/231 (7%)
Query: 67 FSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTL 126
F + + + + + + ++ + L + + +L+ L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGL 68
Query: 127 HLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIP 186
L NQ++ PL+ + L+ I T +T ++ +
Sbjct: 69 ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 187 SEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDL 246
S + L L+ + L G + LS + S + L NL L+ L
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTN----------LQYLSIGNAQVSDLTPLANLSKLTTL 178
Query: 247 KLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALS 297
K DNK++ P L +L NL+ +++ NN +S + P + N L + L+
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 21/65 (32%), Positives = 32/65 (49%), Gaps = 4/65 (6%)
Query: 114 PPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVT 173
+ +LS L TL N++S PL L +L + L +N + D+ P L N +NL
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPL--ASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 174 LCLYN 178
+ L N
Sbjct: 222 VTLTN 226
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 62.1 bits (149), Expect = 1e-10
Identities = 71/332 (21%), Positives = 109/332 (32%), Gaps = 29/332 (8%)
Query: 337 KSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNK 396
+ LEL N L S+P +L +L NSL+ +P +LKSL N
Sbjct: 38 RQAHELELNNLGL-SSLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 397 LTSSIP----ISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNL 452
L+ P + +SN + +S I + +L KL L L
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 453 KNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFS 512
+ L L + N S L+ + N E + P L +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 513 KNNITGNIPPK--------IGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQL 564
N + S + LS L + N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 565 SGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELI 624
S ++ L LE L++S+N L +P L L S N + E+P E
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVP---ELPQ 324
Query: 625 HLSELDLSYNFLGRAIPSQICIMQSLEKLNLS 656
+L +L + YN L R P I +S+E L ++
Sbjct: 325 NLKQLHVEYNPL-REFPD---IPESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 6e-08
Identities = 23/92 (25%), Positives = 36/92 (39%), Gaps = 10/92 (10%)
Query: 152 LYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQ 211
Y N + I +L L + NN L +P+ L+ L N L +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPE 321
Query: 212 SLGNLSNLAMLNLSSNSL--FGSIPSELGNLK 241
NL L++ N L F IP + +L+
Sbjct: 322 LPQNLKQ---LHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 8e-08
Identities = 26/93 (27%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 175 CLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIP 234
Y N S I S L +LN+ NN+L +P L L S N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHL-AEVP 320
Query: 235 SELGNLKYLSDLKLADNKLNGSIPHSLCNLTNL 267
NLK L + N L P ++ +L
Sbjct: 321 ELPQNLKQLH---VEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 1e-07
Identities = 26/96 (27%), Positives = 40/96 (41%), Gaps = 9/96 (9%)
Query: 580 HLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRA 639
N SN I L LN+SNN+ E+P L L S+N L
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLAE- 318
Query: 640 IPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQ 675
+P + Q+L++L++ +N L P E + L+
Sbjct: 319 VPE---LPQNLKQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 24/95 (25%), Positives = 36/95 (37%), Gaps = 9/95 (9%)
Query: 319 FLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIP 378
N+ I S SL L + NNKL +P L L N L+ +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVP 320
Query: 379 CEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSV 413
NLK L++ +N L P ++ +L +
Sbjct: 321 ELPQNLK---QLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 21/89 (23%), Positives = 35/89 (39%), Gaps = 10/89 (11%)
Query: 251 NKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLG 310
N + I +L L + NN L +P+ L+ L S+N + +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERLI---ASFNHLAE-VPELPQ 324
Query: 311 NLSNIAFLFLDSNSLFGL--IPSELRNLK 337
NL L ++ N L IP + +L+
Sbjct: 325 NLKQ---LHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 8e-06
Identities = 63/337 (18%), Positives = 107/337 (31%), Gaps = 31/337 (9%)
Query: 262 CNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLS-------N 314
C L + N LS L P +L+ L S N + L P +L N
Sbjct: 35 CLDRQAHELELNNLGLSSL-PELPPHLESLV---ASCNSLTEL-PELPQSLKSLLVDNNN 89
Query: 315 IAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLS 374
+ L L L S + K + K+ + L L +L + +
Sbjct: 90 LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPP-SLEFIAAG 148
Query: 375 GSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVK 434
+ E+ L++L +L + S + L+ S+++ + L
Sbjct: 149 NNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTT 208
Query: 435 LTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISE------SFYIYPNLTFIDLS 488
+ P+L+ L D L +++ F L
Sbjct: 209 IYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYY 268
Query: 489 YNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAEL 548
N EI S P L L+ S N + +P +LE L S NH + ++P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNH-LAEVPELP 323
Query: 549 GKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSS 585
L +L + N L + +E L ++S
Sbjct: 324 QNLK---QLHVEYNPLREFPD----IPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 8e-06
Identities = 65/331 (19%), Positives = 104/331 (31%), Gaps = 26/331 (7%)
Query: 361 TNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNS 420
L + N LS S+P +L+SL + N LT +P +L L N+
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESL---VASCNSLTE-LP---ELPQSLKSLLVDNNN 89
Query: 421 LSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYP 480
L +L L + N +P L+N + L + +D N L + P
Sbjct: 90 LKA-----LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKL----PDLPP 140
Query: 481 NLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHV 540
+L FI N L D + ++P + + +
Sbjct: 141 SLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPEL 200
Query: 541 VGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLV 600
+ L S + + S + L
Sbjct: 201 QNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLS 260
Query: 601 KLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSL 660
+L N S EI + L EL++S N L +P+ LE+L S N L
Sbjct: 261 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPP---RLERLIASFNHL 316
Query: 661 SGVIPRCFEEMHALQCIDISYNELRGPIPNS 691
+ V E L+ + + YN LR P+
Sbjct: 317 AEVP----ELPQNLKQLHVEYNPLRE-FPDI 342
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 8e-06
Identities = 22/135 (16%), Positives = 43/135 (31%), Gaps = 9/135 (6%)
Query: 37 CAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNI 96
+ ++ + L + + FS L + N I
Sbjct: 224 PSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLP 283
Query: 97 SKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNY 156
L+ L++S+N +P L+ L N L+ +P L L+ + N
Sbjct: 284 PSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQNLKQLH---VEYNP 335
Query: 157 LEDIIPHSLGNLTNL 171
L + P ++ +L
Sbjct: 336 LRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 9e-06
Identities = 55/328 (16%), Positives = 100/328 (30%), Gaps = 27/328 (8%)
Query: 291 LSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILEL---GNN 347
++ L+ S L P +L + L NSL L P ++LKSL + +
Sbjct: 40 AHELELNNLGLSSL-PELPPHLES---LVASCNSLTEL-PELPQSLKSLLVDNNNLKALS 94
Query: 348 KLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSN 407
L + + + L L NS I N + ++ L
Sbjct: 95 DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154
Query: 408 LTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNY 467
L L L F + + + L+ + + N
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214
Query: 468 LTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGA---------LDFSKNNITG 518
L + + L D +L S + N +
Sbjct: 215 LLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274
Query: 519 NIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQL 578
I LE L++S+N ++ ++PA +L +LI + N L+ ++ L
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELPQ---NL 326
Query: 579 EHLDLSSNNLSNAIPESLGNLVKLHYLN 606
+ L + N L P+ ++ L +N
Sbjct: 327 KQLHVEYNPLRE-FPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 16/67 (23%), Positives = 28/67 (41%), Gaps = 5/67 (7%)
Query: 217 SNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNS 276
L L++ L S+P +L+ L + N L +P +L +L++ +
Sbjct: 38 RQAHELELNNLGL-SSLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 277 LSGLIPS 283
LS L P
Sbjct: 93 LSDLPPL 99
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 41/234 (17%), Positives = 69/234 (29%), Gaps = 30/234 (12%)
Query: 379 CEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKL 438
CE+ + S +N LT+ +P L + ++L +N L +LT+L
Sbjct: 4 CEVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 439 FLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISS 498
L + + L L + L N L S + N +
Sbjct: 61 NLDRAELTKLQVD-GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV--SFNRLTSLPL 117
Query: 499 DWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLI 558
R + K N +PP + + +
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA--------------------- 156
Query: 559 LAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQF 612
N L+ + L L L+ L L N+L IP+ L + L N +
Sbjct: 157 --NNNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.6 bits (140), Expect = 9e-10
Identities = 49/183 (26%), Positives = 62/183 (33%), Gaps = 4/183 (2%)
Query: 72 FPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKN 131
L L N L+ + ++L L+L G L L TL L N
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR--AELTKLQVDGTLPVLGTLDLSHN 87
Query: 132 QLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGN 191
QL L +L L + N L + +L L L L L N L P +
Sbjct: 88 QLQSLPL-LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146
Query: 192 LKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADN 251
L L+L NN L L L NL L L NSL+ +IP L L N
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
Query: 252 KLN 254
Sbjct: 206 PWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 48/208 (23%), Positives = 72/208 (34%), Gaps = 25/208 (12%)
Query: 448 PIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLG 507
PI + + S + V+ D+ LT+ + + + T + LS N LY + +L
Sbjct: 2 PICEVSKVASHLEVNCDKRNLTALPPD---LPKDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 508 ALDFSKNNITGNIP---------------------PKIGYSSQLEVLDLSSNHVVGDIPA 546
L+ + +T L VLD+S N +
Sbjct: 59 QLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 547 ELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLN 606
L L L +L L N+L L +LE L L++NNL+ L L L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 607 LSNNQFSWEIPIKLEELIHLSELDLSYN 634
L N + IP L L N
Sbjct: 179 LQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.0 bits (123), Expect = 1e-07
Identities = 46/212 (21%), Positives = 74/212 (34%), Gaps = 9/212 (4%)
Query: 236 ELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIA 295
E+ + ++ L ++P L + IL++ N L + + L+++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 296 LSYNK-FSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIP 354
L + + +L L + SL L + N+L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS----FNRLTSLPL 117
Query: 355 HFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVL 414
L L L L++ N L P + L L+LA N LT L+ L NL L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 415 SFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQ 446
+NSL IPK + L FL N +
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.003
Identities = 25/93 (26%), Positives = 37/93 (39%), Gaps = 1/93 (1%)
Query: 63 TLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSY 122
+L + L L L N+L P + KL+ L L++N + + L
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173
Query: 123 LKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSN 155
L TL L +N L +IP G L L+ N
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.2 bits (141), Expect = 1e-09
Identities = 23/117 (19%), Positives = 41/117 (35%), Gaps = 10/117 (8%)
Query: 576 VQLEHLDLSSNNLSNA-IPESLGNLVKLHYLNLSNNQFSWE----IPIKLEELIHLSELD 630
+ ++ LD+ LS+A E L L + + L + + I L L+EL+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 631 LSYNFLGRAIPSQICIM-----QSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYN 682
L N LG + ++KL+L + L+G +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 118
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 3e-07
Identities = 22/94 (23%), Positives = 40/94 (42%), Gaps = 12/94 (12%)
Query: 577 QLEHLDLSSNNLSN----AIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELI-----HLS 627
L L L+ ++S+ ++ +L L L+LSNN ++L E + L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 628 ELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLS 661
+L L + + ++ Q+LEK S +S
Sbjct: 430 QLVLYDIYWSEEMEDRL---QALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 3e-07
Identities = 21/98 (21%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 527 SSQLEVLDLSSNHVVGDIPAEL-GKLSFLIKLILAQNQLSGQ----LSPKLGLLVQLEHL 581
S ++ LD+ + AEL L + L L+ +S L + L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 582 DLSSNNLSNAIPESLG-----NLVKLHYLNLSNNQFSW 614
+L SN L + + K+ L+L N +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 7e-07
Identities = 25/81 (30%), Positives = 35/81 (43%), Gaps = 9/81 (11%)
Query: 552 SFLIKLILAQNQLSGQ----LSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVK-----L 602
S L L LA +S L+ L L LDLS+N L +A L V+ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 603 HYLNLSNNQFSWEIPIKLEEL 623
L L + +S E+ +L+ L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 6e-06
Identities = 21/80 (26%), Positives = 29/80 (36%), Gaps = 9/80 (11%)
Query: 601 KLHYLNLSNNQFSWE----IPIKLEELIHLSELDLSYNFLGRAIPSQIC-----IMQSLE 651
L L L++ S + L L ELDLS N LG A Q+ LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 652 KLNLSHNSLSGVIPRCFEEM 671
+L L S + + +
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 19/99 (19%), Positives = 32/99 (32%), Gaps = 5/99 (5%)
Query: 170 NLVTLCLYNNLLSGSIPSEI-GNLKYLLDLNLYNNELNG----SIPQSLGNLSNLAMLNL 224
++ +L + LS + +E+ L+ + L + L I +L LA LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 225 SSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCN 263
SN L + K+ L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 23/85 (27%), Positives = 31/85 (36%), Gaps = 9/85 (10%)
Query: 528 SQLEVLDLSSNHV----VGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQ-----L 578
S L VL L+ V + A L L +L L+ N L +L V+ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 579 EHLDLSSNNLSNAIPESLGNLVKLH 603
E L L S + + L L K
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 7e-05
Identities = 14/95 (14%), Positives = 29/95 (30%), Gaps = 5/95 (5%)
Query: 218 NLAMLNLSSNSLFGSIPSEL-GNLKYLSDLKLADNKLNG----SIPHSLCNLTNLVILYI 272
++ L++ L + +EL L+ ++L D L I +L L L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 273 YNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPH 307
+N L + + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 7e-05
Identities = 17/84 (20%), Positives = 31/84 (36%), Gaps = 9/84 (10%)
Query: 215 NLSNLAMLNLSSNSL----FGSIPSELGNLKYLSDLKLADNKLNGSIPHSLC-----NLT 265
S L +L L+ + S+ + L L +L L++N L + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 266 NLVILYIYNNSLSGLIPSEIGNLK 289
L L +Y+ S + + L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 18/90 (20%), Positives = 31/90 (34%), Gaps = 9/90 (10%)
Query: 354 PHFLGNLTNLSVLFIYNNSLSG----SIPCEIGNLKSLSYLNLAFNKLTSSIPISLS--- 406
+ L VL++ + +S S+ + SL L+L+ N L + + L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 407 --NLTNLSVLSFYKNSLSGAIPKEYRNLVK 434
L L Y S + + L K
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 16/94 (17%), Positives = 27/94 (28%), Gaps = 9/94 (9%)
Query: 65 HDFSFSSFPHLAYLDLWSNQL----FGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIG-- 118
L L L + ++ + L+ LDLS+N A Q+
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420
Query: 119 ---HLSYLKTLHLFKNQLSGSIPLEVGGLSSLNN 149
L+ L L+ S + + L
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKP 454
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 19/99 (19%), Positives = 33/99 (33%), Gaps = 13/99 (13%)
Query: 330 PSELRNLKSLSILELGNNKL----CGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIG--- 382
+ L +L L + + C S+ L +L L + NN L + ++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 383 --NLKSLSYLNLAFNKLTSSIPISLSNL----TNLSVLS 415
L L L + + L L +L V+S
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 13/66 (19%), Positives = 27/66 (40%), Gaps = 5/66 (7%)
Query: 624 IHLSELDLSYNFLGRAIPSQIC-IMQSLEKLNLSHNSLSGV----IPRCFEEMHALQCID 678
+ + LD+ L A +++ ++Q + + L L+ I AL ++
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 679 ISYNEL 684
+ NEL
Sbjct: 62 LRSNEL 67
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 19/91 (20%), Positives = 32/91 (35%), Gaps = 10/91 (10%)
Query: 99 LKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSG----SIPLEVGGLSSLNNLALY 153
++ LD+ S A ++ L + + L L+ I + +L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 154 SNYLEDIIPHSLG-----NLTNLVTLCLYNN 179
SN L D+ H + + L L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 17/94 (18%), Positives = 33/94 (35%), Gaps = 8/94 (8%)
Query: 335 NLKSLSILELGNNKLCGS-IPHFLGNLTNLSVLFIYNNSLSG----SIPCEIGNLKSLSY 389
+++SL ++ +L + L L V+ + + L+ I + +L+
Sbjct: 3 DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 390 LNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSG 423
LNL N+L + K SL
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 17/84 (20%), Positives = 28/84 (33%), Gaps = 9/84 (10%)
Query: 167 NLTNLVTLCLYNNLLSG----SIPSEIGNLKYLLDLNLYNNELNGSIPQSLG-----NLS 217
+ L L L + +S S+ + + L +L+L NN L + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 218 NLAMLNLSSNSLFGSIPSELGNLK 241
L L L + L L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 18/81 (22%), Positives = 28/81 (34%), Gaps = 9/81 (11%)
Query: 145 SSLNNLALYSNYLEDI----IPHSLGNLTNLVTLCLYNNLLSGSIPSEIG-----NLKYL 195
S L L L + D + +L +L L L NN L + ++ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 196 LDLNLYNNELNGSIPQSLGNL 216
L LY+ + + L L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 19/93 (20%), Positives = 35/93 (37%), Gaps = 13/93 (13%)
Query: 191 NLKYLLDLNLYNNELNG----SIPQSLGNLSNLAMLNLSSNSLFGSIPSELG-----NLK 241
L L L + +++ S+ +L +L L+LS+N L + +L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 242 YLSDLKLADNKLNGSIPHSLCNL----TNLVIL 270
L L L D + + L L +L ++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 5e-04
Identities = 10/92 (10%), Positives = 27/92 (29%), Gaps = 5/92 (5%)
Query: 481 NLTFIDLSYNNLYGE-ISSDWGRCPKLGALDFSKNNITG----NIPPKIGYSSQLEVLDL 535
++ +D+ L + + + +T +I + + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 536 SSNHVVGDIPAELGKLSFLIKLILAQNQLSGQ 567
SN + + + + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 7e-04
Identities = 19/95 (20%), Positives = 30/95 (31%), Gaps = 10/95 (10%)
Query: 362 NLSVLFIYNNSLSGSIPCEI-GNLKSLSYLNLAFNKLT----SSIPISLSNLTNLSVLSF 416
++ L I LS + E+ L+ + L LT I +L L+ L+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 417 YKNSLSGAIPKE-----YRNLVKLTKLFLGDNQFQ 446
N L K+ KL L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 9e-04
Identities = 15/84 (17%), Positives = 27/84 (32%), Gaps = 5/84 (5%)
Query: 314 NIAFLFLDSNSLFGLIPSEL-RNLKSLSILELGNNKL----CGSIPHFLGNLTNLSVLFI 368
+I L + L +EL L+ ++ L + L C I L L+ L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 369 YNNSLSGSIPCEIGNLKSLSYLNL 392
+N L + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 19/94 (20%), Positives = 29/94 (30%), Gaps = 5/94 (5%)
Query: 291 LSKIALSYNKFSGL-IPHSLGNLSNIAFLFLDSNSL----FGLIPSELRNLKSLSILELG 345
+ + + + S L L + LD L I S LR +L+ L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 346 NNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPC 379
+N+L H + I SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 18/83 (21%), Positives = 29/83 (34%), Gaps = 9/83 (10%)
Query: 95 NISKLKYLDLSSNLFSG----AIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGG-----LS 145
S L+ L L+ S ++ + L+ L L N L + L++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 146 SLNNLALYSNYLEDIIPHSLGNL 168
L L LY Y + + L L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 12/94 (12%), Positives = 29/94 (30%), Gaps = 5/94 (5%)
Query: 75 LAYLDLWSNQLFGNIPPQI-GNISKLKYLDLSSNLFSG----AIPPQIGHLSYLKTLHLF 129
+ LD+ +L ++ + + + + L + I + L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 130 KNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPH 163
N+L V + + L++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 17/84 (20%), Positives = 29/84 (34%), Gaps = 9/84 (10%)
Query: 311 NLSNIAFLFLDSNSL----FGLIPSELRNLKSLSILELGNNKLCGSIPHFLG-----NLT 361
S + L+L + + + L SL L+L NN L + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 362 NLSVLFIYNNSLSGSIPCEIGNLK 385
L L +Y+ S + + L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.004
Identities = 12/76 (15%), Positives = 26/76 (34%), Gaps = 9/76 (11%)
Query: 625 HLSELDLSYNFLG----RAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEE-----MHALQ 675
L L L+ + ++ + + SL +L+LS+N L E L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 676 CIDISYNELRGPIPNS 691
+ + + +
Sbjct: 430 QLVLYDIYWSEEMEDR 445
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 54.2 bits (129), Expect = 1e-08
Identities = 32/207 (15%), Positives = 75/207 (36%), Gaps = 15/207 (7%)
Query: 403 ISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVH 462
S + K S++ A+ + L + ++ ++ + + ++ L ++ ++
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQGIQYLPNVTKLF 74
Query: 463 LDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPP 522
L+ N LT + NL + + + + K ++N +I
Sbjct: 75 LNGNKLTDIKPLA-----NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129
Query: 523 KIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLD 582
+ + ++ + + L KL L + + L L +L++L
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAGLTKLQNLY 184
Query: 583 LSSNNLSNAIPESLGNLVKLHYLNLSN 609
LS N++S+ +L L L L L +
Sbjct: 185 LSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 5e-07
Identities = 35/203 (17%), Positives = 71/203 (34%), Gaps = 16/203 (7%)
Query: 215 NLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYN 274
+ NL S+ ++ L + + ++ + + L N+ L++
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77
Query: 275 NSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELR 334
N L+ I L L + + + + S ++ I +
Sbjct: 78 NKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 335 NLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAF 394
+ S+ N + L LT L L + +N +S +P + L L L L+
Sbjct: 133 LPQLESLYLGNN---KITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 395 NKLTSSIPISLSNLTNLSVLSFY 417
N ++ + +L+ L NL VL +
Sbjct: 188 NHIS-DLR-ALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 5e-07
Identities = 32/204 (15%), Positives = 63/204 (30%), Gaps = 16/204 (7%)
Query: 167 NLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSS 226
+ L ++ ++ L + + N+++ + L N+ L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 227 NSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIG 286
N L L++LK + + + I G
Sbjct: 78 NKLTDIK--------PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129
Query: 287 NLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGN 346
+ +L L L+ + L L+ N + ++P L L L L L
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 347 NKLCGSIPHFLGNLTNLSVLFIYN 370
N + + L NL VL +++
Sbjct: 188 NHIS-DLRAL-AGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 46/204 (22%), Positives = 82/204 (40%), Gaps = 18/204 (8%)
Query: 120 LSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179
+ +L K ++ ++ L+S++ + ++ ++ + + L N+ L L N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGN 78
Query: 180 LLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGN 239
L+ P + NLK L + S + L S SL + S++
Sbjct: 79 KLTDIKP--LANLK-------NLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129
Query: 240 LKYLSDLKLADNKLN-GSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSY 298
L +L L+ N + L LT L L + +N +S ++P + L L + LS
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 299 NKFSGLIPHSLGNLSNIAFLFLDS 322
N S L +L L N+ L L S
Sbjct: 188 NHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 44/202 (21%), Positives = 72/202 (35%), Gaps = 15/202 (7%)
Query: 431 NLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYN 490
+ K L + L S+ ++ + + + S + PN+T + L+ N
Sbjct: 22 AFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQGIQYL--PNVTKLFLNGN 78
Query: 491 NLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGK 550
L + LD +K ++ S S H L
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL------SLEHNGISDINGLVH 132
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
L L L L N+++ L +L+ L L N +S+ +P L L KL L LS N
Sbjct: 133 LPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 188
Query: 611 QFSWEIPIKLEELIHLSELDLS 632
S ++ L L +L L+L
Sbjct: 189 HIS-DLR-ALAGLKNLDVLELF 208
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 7e-08
Identities = 24/107 (22%), Positives = 41/107 (38%), Gaps = 6/107 (5%)
Query: 581 LDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAI 640
L L+ +L+ + L L+ + +L+LS+N+ P L L L L S N L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 641 PSQICIMQSLEKLNLSHNSLSGV-IPRCFEEMHALQCIDISYNELRG 686
++L L +N L + L +++ N L
Sbjct: 60 GVANLPRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.6 bits (110), Expect = 1e-06
Identities = 29/122 (23%), Positives = 45/122 (36%), Gaps = 6/122 (4%)
Query: 509 LDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQL 568
L + ++T + + + LDLS N + P L L L L + N L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 569 SPKLGLLVQLEHLDLSSNNLSN-AIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLS 627
+L+ L L +N L A + L + +L LNL N E I+ L
Sbjct: 60 GVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 628 EL 629
+
Sbjct: 118 SV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 3e-06
Identities = 30/121 (24%), Positives = 42/121 (34%), Gaps = 7/121 (5%)
Query: 77 YLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGS 136
L L L + + + + +LDLS N +PP + L L+ L N
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNA--LE 56
Query: 137 IPLEVGGLSSLNNLALYSNYLEDI-IPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYL 195
V L L L L +N L+ L + LV L L N L L +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
Query: 196 L 196
L
Sbjct: 116 L 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 3e-06
Identities = 34/108 (31%), Positives = 42/108 (38%), Gaps = 6/108 (5%)
Query: 557 LILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEI 616
L LA L+ L L+ + HLDLS N L +P +L L L L S+N
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVD 59
Query: 617 PIKLEELIHLSELDLSYNFL-GRAIPSQICIMQSLEKLNLSHNSLSGV 663
+ L EL L N L A + L LNL NSL
Sbjct: 60 GVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 5e-06
Identities = 29/126 (23%), Positives = 45/126 (35%), Gaps = 10/126 (7%)
Query: 124 KTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG 183
+ LHL L+ + + L + +L L N L + P +L L L L +N L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 184 SIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSL------FGSIPSEL 237
L L N + Q L + L +LNL NSL + L
Sbjct: 58 VDGVANLPRLQELLLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 238 GNLKYL 243
++ +
Sbjct: 117 PSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 9e-06
Identities = 28/108 (25%), Positives = 43/108 (39%), Gaps = 6/108 (5%)
Query: 198 LNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSI 257
L+L + +L ++ L L + L+LS N L P+ L L+ L L+ +DN L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 258 PHSLCNLTNLVILYIYNNSLSGL-IPSEIGNLKFLSKIALSYNKFSGL 304
NL L L + NN L + + L + L N
Sbjct: 60 GV--ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 2e-05
Identities = 30/120 (25%), Positives = 48/120 (40%), Gaps = 7/120 (5%)
Query: 173 TLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGS 232
L L + L+ + + L + L+L +N L P +L L L +L S N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALE 56
Query: 233 IPSELGNLKYLSDLKLADNKLNG-SIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFL 291
+ NL L +L L +N+L + L + LV+L + NSL L +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 23/107 (21%), Positives = 36/107 (33%), Gaps = 5/107 (4%)
Query: 413 VLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNI 472
VL L+ + L+ +T L L N+ + P L L L + N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNA--LEN 57
Query: 473 SESFYIYPNLTFIDLSYNNL-YGEISSDWGRCPKLGALDFSKNNITG 518
+ P L + L N L CP+L L+ N++
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 6e-05
Identities = 32/124 (25%), Positives = 49/124 (39%), Gaps = 6/124 (4%)
Query: 532 VLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNA 591
VL L+ + + L +L + L L+ N+L P L L LE L S N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNA--LE 56
Query: 592 IPESLGNLVKLHYLNLSNNQF-SWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSL 650
+ + NL +L L L NN+ L L L+L N L + Q + + L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 651 EKLN 654
++
Sbjct: 117 PSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 1e-04
Identities = 29/107 (27%), Positives = 40/107 (37%), Gaps = 6/107 (5%)
Query: 318 LFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSI 377
L L L L L L ++ L+L +N+L P L L VL +N+L
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQASDNALENVD 59
Query: 378 PCEIGNLKSLSYLNLAFNKLTSSIPI-SLSNLTNLSVLSFYKNSLSG 423
L L N+L S I L + L +L+ NSL
Sbjct: 60 GVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.1 bits (93), Expect = 2e-04
Identities = 26/124 (20%), Positives = 40/124 (32%), Gaps = 11/124 (8%)
Query: 296 LSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPS--ELRNLKSLSILELGNNKLCGSI 353
L++ + L L L + L L N L L P+ LR L+ L + + G
Sbjct: 5 LAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 354 PHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPIS---LSNLTN 410
L N + + + L LNL N L I L +
Sbjct: 63 NLPRLQELLLC----NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 411 LSVL 414
+S +
Sbjct: 119 VSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 6e-04
Identities = 21/119 (17%), Positives = 46/119 (38%), Gaps = 7/119 (5%)
Query: 485 IDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDI 544
+ L++ +L + + + LD S N + P ++ + L ++ +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP---ALAALRCLEVLQASDNALEN 57
Query: 545 PAELGKLSFLIKLILAQNQLSGQLSPK-LGLLVQLEHLDLSSNNLSNAIPESLGNLVKL 602
+ L L +L+L N+L + + L +L L+L N+L L ++
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 0.001
Identities = 26/110 (23%), Positives = 39/110 (35%), Gaps = 9/110 (8%)
Query: 389 YLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGP 448
L+LA LT L L ++ L N L P L L L +
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL 55
Query: 449 --IPNLKNLTSLVRVHLDRNYLTSNIS-ESFYIYPNLTFIDLSYNNLYGE 495
+ + NL L + L N L + + + P L ++L N+L E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (121), Expect = 1e-07
Identities = 36/231 (15%), Positives = 64/231 (27%), Gaps = 8/231 (3%)
Query: 386 SLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQF 445
S +K+T IP L N L F L + L K+ + N
Sbjct: 9 SNRVFLCQESKVTE-IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 446 QGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYG-----EISSDW 500
I + + + + + NL + + G ++
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 501 GRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILA 560
L + + N T +G S + +L L+ N + +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 561 QNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQ 611
N L + LD+S + + L NL KL + N +
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (105), Expect = 2e-05
Identities = 29/227 (12%), Positives = 56/227 (24%), Gaps = 7/227 (3%)
Query: 198 LNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSI 257
+++ IP L N L L L ++++ N + I
Sbjct: 13 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 258 PHSLCNLTNLVILYI----YNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLS 313
+ + + N + I+ + K +
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 314 NIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSL 373
+ + + N S + IL L N + + NN+L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 374 SGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNS 420
L+++ ++ S L NL L S Y
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.3 bits (105), Expect = 2e-05
Identities = 33/235 (14%), Positives = 74/235 (31%), Gaps = 8/235 (3%)
Query: 162 PHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAM 221
H + + +N V LC + + IPS++ + ++L +L + +L
Sbjct: 2 HHRICHCSNRVFLCQESKVTE--IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 222 LNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLS--- 278
+ +S N + I +++ + + N + + Y+ ++
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 279 -GLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLK 337
+ K L I + N + +G L+L+ N + + +
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 338 SLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNL 392
+ NN L + +L I + + NLK L +
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 36/229 (15%), Positives = 69/229 (30%), Gaps = 7/229 (3%)
Query: 124 KTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG 183
+ +++++ IP ++ + L L I + +L + + N +
Sbjct: 11 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 184 SIPSEIGNLKYLLDLNLYNNELNGSI--PQSLGNLSNLAMLNLSSNSLFGSIPSELGNLK 241
I +++ + L N P++ NL NL L +S+ + +
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 242 YLSDLKLAD--NKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYN 299
L + D N + VIL++ N + + + N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 300 KFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNK 348
L S L + + L L NLK L N K
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 9/78 (11%), Positives = 16/78 (20%)
Query: 603 HYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSG 662
L L+ N N L L++S +
Sbjct: 156 VILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215
Query: 663 VIPRCFEEMHALQCIDIS 680
+ E + L+
Sbjct: 216 LPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 29/216 (13%), Positives = 54/216 (25%), Gaps = 6/216 (2%)
Query: 161 IPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLA 220
IP L N + L L L + + N++ I + +
Sbjct: 23 IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80
Query: 221 MLNLSSNSLFGSIPSELGNLKYLSDLKLADNK--LNGSIPHSLCNLTNLVILYIYNNSLS 278
+ + + L + + + V+L I +N
Sbjct: 81 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140
Query: 279 GLIPSEIGNLKFLSKIALS--YNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNL 336
I + L N + + D+N+L L
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200
Query: 337 KSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNS 372
IL++ ++ + L NL L YN
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 15/87 (17%), Positives = 23/87 (26%), Gaps = 3/87 (3%)
Query: 101 YLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDI 160
L L+ N + N L G S L + + +
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216
Query: 161 IPHSLGNLTNLVTLCLYNNLLSGSIPS 187
+ L NL L YN +P+
Sbjct: 217 PSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 49.1 bits (115), Expect = 2e-06
Identities = 42/323 (13%), Positives = 90/323 (27%), Gaps = 26/323 (8%)
Query: 329 IPSELRNLKSLSILELGNNKL----CGSIPHFLGNLTNLSVLFIYNNS---LSGSIPCEI 381
+ + L S+ + L N + + + + +L + + + IP +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 382 GNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLV-KLTKLFL 440
L + + S + K++ + L +
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 441 GDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDW 500
Q KN L + RN L + + + + + + I +
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 501 GRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILA 560
L L + + ++ L ++ L + A
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262
Query: 561 QNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESL-----GNLVKLHYLNLSNNQFSWE 615
+L + L+ L L N + +L + L +L L+ N+FS E
Sbjct: 263 VVDAFSKLE-----NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317
Query: 616 IPI--KLEELI------HLSELD 630
+ ++ E+ L ELD
Sbjct: 318 DDVVDEIREVFSTRGRGELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 44/322 (13%), Positives = 82/322 (25%), Gaps = 34/322 (10%)
Query: 385 KSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSG----AIPKEYRNLVKLTKLFL 440
KSL + S+ L ++ + N++ + + + L
Sbjct: 8 KSLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 441 GDNQFQGPIPNL-----------KNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSY 489
D + L V L N E + +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 490 NNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELG 549
+ G + + N N PP L+ S
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 550 KLSFLIKLILAQNQLSGQ------LSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLH 603
L + + + L+ L V + ++ S+A+ +L + L
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246
Query: 604 YLNLSNNQFSWEIPIKLEE------LIHLSELDLSYNFLGRAIPSQICI-----MQSLEK 652
L L++ S + + I L L L YN + + M L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 653 LNLSHNSLSGVIPRCFEEMHAL 674
L L+ N S +E+ +
Sbjct: 307 LELNGNRFSE-EDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 2e-04
Identities = 17/107 (15%), Positives = 31/107 (28%), Gaps = 8/107 (7%)
Query: 578 LEHLDLSSNNLSN----AIPESLGNLVKLHYLNLSNNQFSWE----IPIKLEELIHLSEL 629
+E L + ++ ++ L + + LS N E + + L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 630 DLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQC 676
+ S F GR ++ L + L L V Q
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 111
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 2e-04
Identities = 39/328 (11%), Positives = 85/328 (25%), Gaps = 33/328 (10%)
Query: 362 NLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLT----SSIPISLSNLTNLSVLSFY 417
+L + I S+ + S+ + L+ N + + ++++ +L + F
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 418 KNS---LSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISE 474
+ IP+ R L++ + + + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 475 SFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLD 534
L + + N N K +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 535 LSSNHVVGDIPAELGKLSFLIKLILAQNQLS--------------GQLSPKLGLLVQLEH 580
L + +V + G L++ + +L L+ L L
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 581 LDLSSNNLSNAIPESLGN------LVKLHYLNLSNNQFSWEIPIKLEELI-----HLSEL 629
L L+ LS ++ + + L L L N+ + L+ +I L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 630 DLSYNFLGRAIPSQICIMQSLEKLNLSH 657
+L+ N I +
Sbjct: 308 ELNGNRFSEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 38/341 (11%), Positives = 92/341 (26%), Gaps = 44/341 (12%)
Query: 281 IPSEIGNLKFLSKIALSYNKFSG----LIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNL 336
+ + + + +I LS N + ++ + ++ + L
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 337 KSLSILELGNNKLC---GSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLA 393
+ L L KL S F + F+ ++ + L + +A
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 394 FNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLK 453
++ N L + +N L KE+ Q + +K
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK----------TFQSHRLLHTVK 192
Query: 454 NLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSK 513
+ + +R + L ++ + + + ++ P L L +
Sbjct: 193 MVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252
Query: 514 NNITGNIPPKIG------YSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQ 567
++ + + L+ L L N + D L +
Sbjct: 253 CLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID-------------- 298
Query: 568 LSPKLGLLVQLEHLDLSSNNLS--NAIPESLGNLVKLHYLN 606
+ L L+L+ N S + + + + +
Sbjct: 299 -----EKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 4e-04
Identities = 43/323 (13%), Positives = 86/323 (26%), Gaps = 34/323 (10%)
Query: 146 SLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSG----SIPSEIGNLKYLLDLNLY 201
SL A+ + + + L ++ + L N + + I + K L
Sbjct: 9 SLKLDAITTEDEKSVFA-VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 202 NN---ELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIP 258
+ + IP++L L + +++ S + + L+ + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 259 HSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFL 318
L I + + N L I N+ L
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 319 FLDSNSLFGLIPSELRNLKSLSILE-------------LGNNKLCGSIPHFLGNLTNLSV 365
+ I E L L + ++ L + NL
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 366 LFIYNNSLSGSIPCEIGN------LKSLSYLNLAFNKLTSSIPISL-----SNLTNLSVL 414
L + + LS + + L L L +N++ +L + +L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 415 SFYKNSLS--GAIPKEYRNLVKL 435
N S + E R +
Sbjct: 308 ELNGNRFSEEDDVVDEIREVFST 330
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 6e-04
Identities = 16/111 (14%), Positives = 35/111 (31%), Gaps = 6/111 (5%)
Query: 26 WTFNNVTKIGSCAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQL 85
+ + + A +N L++ G + FS L L L N++
Sbjct: 226 TFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 285
Query: 86 FGNIPPQI-----GNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKN 131
+ + + L +L+L+ N FS + + + +
Sbjct: 286 ELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 6e-04
Identities = 41/333 (12%), Positives = 91/333 (27%), Gaps = 31/333 (9%)
Query: 245 DLKLADNKLNG--SIPHSLCNLTNLVILYIYNNSLSG----LIPSEIGNLKFLSKIALSY 298
LKL S+ L ++ + + N++ + I + K L S
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 299 N---KFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPH 355
+ IP +L L +++ + + I L + +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128
Query: 356 FLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLS 415
L + I ++ + N L + N+L + + L
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188
Query: 416 FYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISES 475
+ I E + L L + + + + +S ++ +
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD----------NTFTHLGSSALAIA 238
Query: 476 FYIYPNLTFIDLSYNNLYGEISSDWGRC------PKLGALDFSKNNITGNIPPKIGYS-- 527
+PNL + L+ L ++ L L N I + +
Sbjct: 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 298
Query: 528 ---SQLEVLDLSSNHVVGDIPAELGKLSFLIKL 557
L L+L+ N + + ++ +
Sbjct: 299 EKMPDLLFLELNGNR-FSEEDDVVDEIREVFST 330
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 7e-04
Identities = 47/313 (15%), Positives = 102/313 (32%), Gaps = 18/313 (5%)
Query: 196 LDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSL----FGSIPSELGNLKYLSDLKLADN 251
L L+ E S+ L ++ + LS N++ + + + K L + +D
Sbjct: 10 LKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69
Query: 252 ---KLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHS 308
++ IP +L L ++ +++ + + LS + +
Sbjct: 70 FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLH 129
Query: 309 LGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKL-CGSIPHFLGNLTNLSVLF 367
L A + + + +N L + G N+L GS+ + + +L
Sbjct: 130 NNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 189
Query: 368 IYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPK 427
+G P I +L K+ + ++L + ++ K+ +
Sbjct: 190 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 249
Query: 428 EYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISES-----FYIYPNL 482
L+ G L+N L + L N + + + P+L
Sbjct: 250 LNDCLLSAR----GAAAVVDAFSKLEN-IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 483 TFIDLSYNNLYGE 495
F++L+ N E
Sbjct: 305 LFLELNGNRFSEE 317
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 19/137 (13%), Positives = 42/137 (30%), Gaps = 3/137 (2%)
Query: 567 QLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHL 626
+ + + V+ LDL + I L + ++ S+N+ L L
Sbjct: 9 EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRL 65
Query: 627 SELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRG 686
L ++ N + R + L +L L++NSL +
Sbjct: 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125
Query: 687 PIPNSTAFRDAPIKALQ 703
+ + + ++
Sbjct: 126 NKKHYRLYVIYKVPQVR 142
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 7e-05
Identities = 24/139 (17%), Positives = 43/139 (30%), Gaps = 7/139 (5%)
Query: 91 PQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNL 150
Q N + + LDL I L + N++ L L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTL 68
Query: 151 ALYSNYLEDIIPHSLGNLTNLVTLCL-YNNLLSGSIPSEIGNLKYLLDLNLYN---NELN 206
+ +N + I L +L L L N+L+ + +LK L L +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 207 GSIPQSLGNLSNLAMLNLS 225
+ + + +L+
Sbjct: 129 HYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 6e-04
Identities = 22/145 (15%), Positives = 39/145 (26%), Gaps = 9/145 (6%)
Query: 349 LCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNL 408
L + N L + + I L ++ + N++ L
Sbjct: 7 LIEQAAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF--PLL 62
Query: 409 TNLSVLSFYKNSLSGAIPK-----EYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHL 463
L L N + + LT L + P+ +LK+LT L +
Sbjct: 63 RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122
Query: 464 DRNYLTSNISESFYIYPNLTFIDLS 488
Y P + +D
Sbjct: 123 PVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.002
Identities = 26/135 (19%), Positives = 50/135 (37%), Gaps = 5/135 (3%)
Query: 191 NLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLAD 250
N +L+L ++ I L ++ S N + L+ L L + +
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNN 72
Query: 251 NKLNGSIPHSLCNLTNLVILYIYNNSLSGL-IPSEIGNLKFLSKIALSYNKFSGLIPHSL 309
N++ L +L L + NNSL L + +LK L+ + + N + + L
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 310 GNLSNIAFL-FLDSN 323
+ + + LD
Sbjct: 133 YVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.004
Identities = 26/136 (19%), Positives = 46/136 (33%), Gaps = 7/136 (5%)
Query: 68 SFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLH 127
+++ LDL ++ I + + +D S N L LKTL
Sbjct: 13 QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLL 69
Query: 128 LFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDI-IPHSLGNLTNLVTLCLYN---NLLSG 183
+ N++ L L L L +N L ++ L +L +L LC+
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 184 SIPSEIGNLKYLLDLN 199
I + + L+
Sbjct: 130 YRLYVIYKVPQVRVLD 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (110), Expect = 2e-06
Identities = 27/138 (19%), Positives = 47/138 (34%), Gaps = 5/138 (3%)
Query: 567 QLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHL 626
QL + L L + L LN ++ + + I E + L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 627 SELDLSYNFL--GRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNEL 684
L+LS N L + S + +L+ LNLS N L + L+ + + N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 685 RGPIPNSTAFRDAPIKAL 702
+ + + A +
Sbjct: 128 SDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (106), Expect = 6e-06
Identities = 25/139 (17%), Positives = 49/139 (35%), Gaps = 9/139 (6%)
Query: 329 IPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYN--NSLSGSIPCEIGNLKS 386
+ + S L L +L ++ + N +S++ ++ N+
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL-----RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPE 66
Query: 387 LSYLNLAFNKLT--SSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQ 444
L LNL+ N+L + + NL +L+ N L + +KL +L+L N
Sbjct: 67 LLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 445 FQGPIPNLKNLTSLVRVHL 463
+ S +R
Sbjct: 127 LSDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 2e-04
Identities = 31/136 (22%), Positives = 50/136 (36%), Gaps = 5/136 (3%)
Query: 126 LHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSI 185
L+ K + + L + + AL L L V L +++ + ++
Sbjct: 1 LNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSD--PDLVAQNIDVVLNRRSSMAA-TL 57
Query: 186 PSEIGNLKYLLDLNLYNNELNG--SIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYL 243
N+ LL LNL NN L + + NL +LNLS N L + L
Sbjct: 58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117
Query: 244 SDLKLADNKLNGSIPH 259
+L L N L+ +
Sbjct: 118 EELWLDGNSLSDTFRD 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (92), Expect = 5e-04
Identities = 26/145 (17%), Positives = 50/145 (34%), Gaps = 4/145 (2%)
Query: 425 IPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTF 484
+ ++ L + P+L V ++ + + + P L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLRS-DPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLS 69
Query: 485 IDLSYNNLYG--EISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVG 542
++LS N LY ++SS + P L L+ S N + +LE L L N +
Sbjct: 70 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
Query: 543 DIPAELGKLSFLIKLILAQNQLSGQ 567
+ +S + + +L G
Sbjct: 130 TFRDQSTYISAIRERFPKLLRLDGH 154
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.3 bits (108), Expect = 4e-06
Identities = 43/185 (23%), Positives = 73/185 (39%), Gaps = 8/185 (4%)
Query: 509 LDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAEL-GKLSFLIKLILAQNQLSGQ 567
+D + + IP I L L+ N + L G+L L+KL L +NQL+G
Sbjct: 13 VDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 568 LSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLS 627
++ L L N + + L +L LNL +NQ S +P E L L+
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129
Query: 628 ELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGP 687
L+ + + L K +L+ + P ++ +Q D+ ++E +
Sbjct: 130 SLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFKCS 185
Query: 688 IPNST 692
NS
Sbjct: 186 SENSE 190
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.3 bits (100), Expect = 5e-05
Identities = 34/177 (19%), Positives = 67/177 (37%), Gaps = 8/177 (4%)
Query: 198 LNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSEL-GNLKYLSDLKLADNKLNGS 256
++ L IP+ + + L L+ N L L G L +L L+L N+L G
Sbjct: 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 257 IPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIA 316
P++ +++ L + N + + L L + L N+ S ++P S +L+++
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129
Query: 317 FLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSL 373
L L SN G CG+ + ++ + + ++
Sbjct: 130 SLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK----VRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 40/177 (22%), Positives = 69/177 (38%), Gaps = 8/177 (4%)
Query: 102 LDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEV-GGLSSLNNLALYSNYLEDI 160
+D + IP I + L L N+L + G L L L L N L I
Sbjct: 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 161 IPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLA 220
P++ +++ L L N + L L LNLY+N+++ +P S +L++L
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129
Query: 221 MLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSL 277
LNL+SN + ++L L P + ++ I + ++
Sbjct: 130 SLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKVRDVQ---IKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.0 bits (89), Expect = 0.001
Identities = 36/172 (20%), Positives = 63/172 (36%), Gaps = 9/172 (5%)
Query: 370 NNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISL-SNLTNLSVLSFYKNSLSGAIPKE 428
L IP +I + L L N+L L L +L L +N L+G P
Sbjct: 17 GRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA 73
Query: 429 YRNLVKLTKLFLGDNQFQGPIPN-LKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDL 487
+ + +L LG+N+ + L L ++L N ++ + SF +LT ++L
Sbjct: 74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133
Query: 488 SYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNH 539
+ N W L + P K+ +++ DL +
Sbjct: 134 ASNPFNCNCHLAWFAE-WLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSE 181
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 7e-06
Identities = 35/200 (17%), Positives = 67/200 (33%), Gaps = 16/200 (8%)
Query: 215 NLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYN 274
L+ L ++ ++ +L ++ L+ + SI + L NL + N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 71
Query: 275 NSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELR 334
N L+ + L + + + I
Sbjct: 72 NQLTDIT--------PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 335 NLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAF 394
++ L + S L LT+L L +N ++ P + NL +L L+++
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 395 NKLTSSIPISLSNLTNLSVL 414
NK++ L+ LTNL L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 38/200 (19%), Positives = 69/200 (34%), Gaps = 16/200 (8%)
Query: 167 NLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSS 226
L + L ++ ++ +L + L + SI + L+NL +N S+
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 71
Query: 227 NSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIG 286
N L L +L + L + + + + I
Sbjct: 72 NQLTDIT--------PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 287 NLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGN 346
+ L + + +L L+++ L SN + L P L NL +L L++ +
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 347 NKLCGSIPHFLGNLTNLSVL 366
NK+ L LTNL L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 32/200 (16%), Positives = 67/200 (33%), Gaps = 15/200 (7%)
Query: 406 SNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDR 465
+ L K +++ + + +L ++T L + I ++ L +L +++
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSN 71
Query: 466 NYLTSNISESFYIYPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIG 525
N LT ++ + +++ + + +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 526 YSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSS 585
L + + L L+ L +L + NQ++ L L LE LD+SS
Sbjct: 132 R--------LELSSNTISDISALSGLTSLQQLNFSSNQVTD--LKPLANLTTLERLDISS 181
Query: 586 NNLSNAIPESLGNLVKLHYL 605
N +S+ L L L L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 42/199 (21%), Positives = 68/199 (34%), Gaps = 15/199 (7%)
Query: 359 NLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYK 418
L + +++ ++ +L ++ L + S + L NL+ ++F
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVE--YLNNLTQINFSN 71
Query: 419 NSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYI 478
N L+ L LTKL L +
Sbjct: 72 NQLTD-----ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 126
Query: 479 YPNLTFIDLSYNNLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSN 538
NL ++LS N + S L L+FS N +T P + + LE LD+SSN
Sbjct: 127 LTNLNRLELSSNTIS--DISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSN 182
Query: 539 HVVGDIPAELGKLSFLIKL 557
V + L KL+ L L
Sbjct: 183 KVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 31/200 (15%), Positives = 63/200 (31%), Gaps = 16/200 (8%)
Query: 191 NLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLAD 250
L + L + ++ Q+ +L + L + + L L+ + ++
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 71
Query: 251 NKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLG 310
N+L P +++ + + + + +L
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131
Query: 311 NLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYN 370
L + D ++L GL + N S + +L L NLT L L I +
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDL----------KPLANLTTLERLDISS 181
Query: 371 NSLSGSIPCEIGNLKSLSYL 390
N +S + L +L L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 40/199 (20%), Positives = 72/199 (36%), Gaps = 15/199 (7%)
Query: 431 NLVKLTKLFLGDNQFQGPIPNLKNLTSLVRVHLDRNYLTSNISESFYIYPNLTFIDLSYN 490
L + K LG + +L + + DR + S + NLT I+ S N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 72
Query: 491 NLYGEISSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGK 550
L ++ ++ + + + ++ L +
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNN 610
L I + LSG L+ L+ SSN +++ P L NL L L++S+N
Sbjct: 133 LELSSNTISDISALSGL--------TSLQQLNFSSNQVTDLKP--LANLTTLERLDISSN 182
Query: 611 QFSWEIPIKLEELIHLSEL 629
+ S +I + L +L +L L
Sbjct: 183 KVS-DISV-LAKLTNLESL 199
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (104), Expect = 8e-06
Identities = 24/149 (16%), Positives = 49/149 (32%), Gaps = 2/149 (1%)
Query: 217 SNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLC-NLTNLVILYIYNN 275
+ L + + L + L++L + + + + L L L I +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 276 SLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRN 335
L + P LS++ LS+N L ++ LS + + L+
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 336 LKSLSILELGNNKLCGSIPHFLGNLTNLS 364
+ + + KL L ++ N S
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 22/110 (20%), Positives = 39/110 (35%), Gaps = 3/110 (2%)
Query: 577 QLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEE-LIHLSELDLSYNF 635
L + + + L L L + N Q + ++ L L L + +
Sbjct: 9 GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 636 LGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685
L P L +LNLS N+L + + + + Q + +S N L
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL-QELVLSGNPLH 116
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 5e-04
Identities = 21/143 (14%), Positives = 43/143 (30%), Gaps = 2/143 (1%)
Query: 78 LDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQI-GHLSYLKTLHLFKNQLSGS 136
L + + + L L + + + + L L+ L + K+ L
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 137 IPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLL 196
P L+ L L N LE + ++ L+ + N L + +
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEG 131
Query: 197 DLNLYNNELNGSIPQSLGNLSNL 219
+ +L L ++ N
Sbjct: 132 LGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 40.1 bits (92), Expect = 6e-04
Identities = 35/194 (18%), Positives = 62/194 (31%), Gaps = 33/194 (17%)
Query: 331 SELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYL 390
KS+ E +L G IP + + LK+ +L
Sbjct: 12 RIFEERKSVVATEAEKVELHGMIPPIE------------------KMDATLSTLKACKHL 53
Query: 391 NLAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDNQFQGPIP 450
L+ N + I SLS + NL +LS +N + + + +
Sbjct: 54 ALSTNNIE-KIS-SLSGMENLRILSLGRN--LIKKIENLDAVADTLEELWISYNQIASLS 109
Query: 451 NLKNLTSLVRVHLDRNYLTSNISESFYI-YPNLTFIDLSYNNLYGEISSDW--------- 500
++ L +L +++ N +T+ L + L+ N LY + +
Sbjct: 110 GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169
Query: 501 -GRCPKLGALDFSK 513
R P L LD
Sbjct: 170 VKRLPNLKKLDGMP 183
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.7 bits (86), Expect = 0.003
Identities = 24/180 (13%), Positives = 59/180 (32%), Gaps = 10/180 (5%)
Query: 535 LSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSP------KLGLLVQLEHLDLSSNNL 588
++ + D + ++ + +L G + P L L +HL LS+NN+
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI 60
Query: 589 SNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQ 648
SL + L L+ + + L+ + E ++ ++
Sbjct: 61 EK--ISSLSGMENLRILS--LGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVN 116
Query: 649 SLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELRGPIPNSTAFRDAPIKALQGNKGL 708
++ + + L+ + ++ N L + A + I+ ++ L
Sbjct: 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1067 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.96 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.96 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.93 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.92 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.88 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.86 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.85 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.83 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.72 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.63 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.63 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.19 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 99.07 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 99.03 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.81 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.66 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.44 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 98.36 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 98.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.1 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.03 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.72 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.27 Aligned_cols=249 Identities=26% Similarity=0.443 Sum_probs=208.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEE
Q ss_conf 2888557213577645999997-799399999907999998147999999999983289883332248986188015999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 874 (1067)
++|++.+.||+|+||+||+|+. .+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH---HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 0538878981285829999999899989999998430172---7999999999998679998805857798899989999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf 95458988788605675689996879999999999999988189999252688998566489998299502343003899
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~ 954 (1067)
||+++|+|.+++.+ ..+++..+..++.|++.|++|||++ ||+||||||+|||++.++.+||+|||+|+.....
T Consensus 97 Ey~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp ECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EECCCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf 70379808988641----5999999999999999999999987---9722677688868878996864251564132136
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Q ss_conf 99600022234324731223588896213689999999988299999843100000011333331104999999994049
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
.......+||+.|+|||++.+.+++.++||||+||++|||++|+.||........ .........+....+...
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~-- 242 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYLIATNGTPELQNPEKL-- 242 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHHCSCCCSSGGGS--
T ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHHCCCCCCCCCCCC--
T ss_conf 6644444447773682664479988012031372999998048899899799999-----999985799988885537--
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 99999999997612799999999889988
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
...+.+++.+||+.||.+|||+.|+++
T Consensus 243 --s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 --SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp --CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf --999999999986699668909999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.80 Aligned_cols=248 Identities=28% Similarity=0.473 Sum_probs=209.2
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEE
Q ss_conf 2888557213577645999997-799399999907999998147999999999983289883332248986188015999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 874 (1067)
++|++.+.||+|+||+||+|+. .+++.||+|++......+....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf 95458988788605675689996879999999999999988189999252688998566489998299502343003899
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~ 954 (1067)
||+++|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+|.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred EECCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCC-
T ss_conf 504798589887504---8999999999999999999999988---946522023441466899871155563354488-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Q ss_conf 99600022234324731223588896213689999999988299999843100000011333331104999999994049
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......|....+
T Consensus 159 -~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~s~ 229 (263)
T d2j4za1 159 -SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRVEFTFPDFVTE 229 (263)
T ss_dssp -CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCCCCCTTSCH
T ss_pred -CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHCCCCCCCCCCCH
T ss_conf -852355788763499997589989314404675999998329999888999--------99999997189999866899
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 99999999997612799999999889988
Q 001494 1035 EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
++.+++.+||+.||++|||+.|+++
T Consensus 230 ----~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 230 ----GARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ----9999999976479768909999971
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=367.45 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=204.7
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CC---CEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEE
Q ss_conf 28885572135776459999977-99---399999907999998147999999999983289883332248986188015
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SG---EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 871 (1067)
++|++.+.||+|+||+||+|+.+ ++ ..||||++.... .....+.|.+|+.++++++|||||+++|++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 04278569802788299999995799788999999978445--9899999999999998579988861899996288779
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEEC
Q ss_conf 99995458988788605675689996879999999999999988189999252688998566489998299502343003
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~ 951 (1067)
+||||+++|+|.+++.. ..+.+++.++.+++.|++.|++|||++ +++||||||+|||++.++.+||+|||+|+..
T Consensus 104 iv~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEECCCCCCEEEECC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf 99972279853002104--567999999999999999988988527---9835761504489889991998884431575
Q ss_pred CCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCC-C
Q ss_conf 899996-----000222343247312235888962136899999999882-999998431000000113333311049-9
Q 001494 952 KPDSSN-----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILD-P 1024 (1067)
Q Consensus 952 ~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~-~ 1024 (1067)
...... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .....+.. .
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--------~~~~~i~~~~ 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--------DVINAIEQDY 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTC
T ss_pred CCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHCCC
T ss_conf 67777653650256668830038788836997861214453578999986799999999999--------9999997378
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 999999404999999999997612799999999889988820
Q 001494 1025 RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1025 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
.+..+.... .++.+++.+||+.||++|||+.++++.|+
T Consensus 251 ~~~~~~~~~----~~l~~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 251 RLPPPMDCP----SALHQLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp CCCCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCCCCCCH----HHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 899974226----99999999975879768929999999999
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=366.64 Aligned_cols=253 Identities=20% Similarity=0.323 Sum_probs=209.7
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEE
Q ss_conf 52888557213577645999997-79939999990799999814799999999998328988333224898618801599
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 873 (1067)
.++|++.+.||+|+||.||+|+. .+|+.||+|++... .....+.+.+|+.+++.++|||||++++++.+++..|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 65758988984076819999998899989999998452---431699999999999867997999299999989999999
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEECCCCCEEC
Q ss_conf 995458988788605675689996879999999999999988189999252688998566489--998299502343003
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF--KNEARVSDFGIAKFL 951 (1067)
Q Consensus 874 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~--~~~~kl~Dfgla~~~ 951 (1067)
|||++||+|.+++.. ..+.+++..+..++.|++.|+.|||++ +|+||||||+|||++. ++.+||+|||+|+..
T Consensus 102 mE~~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 102 YEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp ECCCCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEEC
T ss_conf 985799889999976--237899999999999999999999756---976000154673641688986999545210442
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 89999600022234324731223588896213689999999988299999843100000011333331104999999994
Q 001494 952 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031 (1067)
Q Consensus 952 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1067)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+..
T Consensus 177 ~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~ 247 (350)
T d1koaa2 177 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCDWNMDDS 247 (350)
T ss_dssp CTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCSCCG
T ss_pred CCC-CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHCCCCCCCC
T ss_conf 565-432000686242188997589987267655465999999859899899799--------99999998478898942
Q ss_pred CHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 049999999999976127999999998899888
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~ 1064 (1067)
.......++.+++.+||..||.+|||+.|+++.
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 235899999999999756896679089998629
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.83 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=204.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEEE
Q ss_conf 28885572135776459999977993999999079999981479999999999832898833322489861880159999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 875 (1067)
++|++.+.||+|+||+||+|+.+ ..||||++....... ...+.|.+|+.++++++|||||++++++.+ ...++|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCH-HHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 51899889830788589999999--989999997346998-999999999999984799878645679715-58999996
Q ss_pred ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCC
Q ss_conf 54589887886056756899968799999999999999881899992526889985664899982995023430038999
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~ 955 (1067)
|+++|+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCCCC
T ss_conf 58998889998523--57899999999999999998887509---99516147899798189978875002213335567
Q ss_pred --CCCCCCCCCCCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf --960002223432473122358---889621368999999998829999984310000001133333110499999999
Q 001494 956 --SNWTELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPS 1030 (1067)
Q Consensus 956 --~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1067)
.......||+.|+|||++.+. +++.++|||||||++|||+||+.||......... ..........+......
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~---~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI---IFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---HHHHHHTSCCCCGGGSC
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHCCCCCCCCHHCC
T ss_conf 763125665574317999995056899995315163599999999788998998969999---99996588898600036
Q ss_pred CCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 404999999999997612799999999889988820
Q 001494 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1031 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
...+.++.+++.+||+.||++|||+.++++.|+
T Consensus 236 ---~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 236 ---SNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf ---555499999999975889768929999999999
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.59 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=206.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEEE
Q ss_conf 28885572135776459999977993999999079999981479999999999832898833322489861880159999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 875 (1067)
++|++.+.||+|+||+||+|++.+++.||||++.... ...+++.+|+.+++.++||||++++|++.+++..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEE
T ss_conf 9958888982088829999998899999999987886----768999999999996689975653524315993379998
Q ss_pred ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCC
Q ss_conf 54589887886056756899968799999999999999881899992526889985664899982995023430038999
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~ 955 (1067)
|+++|+|.+++... ...+++..+..++.|++.|++|+|++ +|+||||||+||+++.++.+||+|||+|+......
T Consensus 81 ~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred ECCCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCC
T ss_conf 36999189975201--34788999999999999987765316---43104431532666688776865532100236887
Q ss_pred CC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Q ss_conf 96-0002223432473122358889621368999999998829-999984310000001133333110499999999404
Q 001494 956 SN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 956 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.. .....||+.|+|||++.+..++.++||||||+++|||+|+ ..||...... ......... .....|....
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----~~~~~i~~~--~~~~~p~~~~ 228 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTG--FRLYKPRLAS 228 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----HHHHHHHHT--CCCCCCTTSC
T ss_pred CEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHHC--CCCCCCCCCC
T ss_conf 335043001766678578607999840332105999999987898887789999-----999999806--8889954367
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 999999999997612799999999889988820
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
. ++.+++.+||+.||++|||++++++.|+
T Consensus 229 ~----~l~~li~~cl~~~p~~Rps~~~il~~L~ 257 (263)
T d1sm2a_ 229 T----HVYQIMNHCWKERPEDRPAFSRLLRQLA 257 (263)
T ss_dssp H----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 9----9999999976579768919999999999
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.60 Aligned_cols=257 Identities=22% Similarity=0.389 Sum_probs=207.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECC-C-----CEEEEEEECCCCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEEECC
Q ss_conf 288855721357764599999779-9-----39999990799999814799999999998328-9883332248986188
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELAS-G-----EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQ 868 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 868 (1067)
++|++.+.||+|+||+||+|+... + ..||+|++..... ......+.+|+.++.++ +|||||++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCC--HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 99397019830788199999985788554204999999663358--7899999999999997158996868778886299
Q ss_pred CEEEEEEECCCCCHHHHHCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 01599995458988788605675--------------------6899968799999999999999881899992526889
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAA--------------------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDIS 928 (1067)
Q Consensus 869 ~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik 928 (1067)
..|+||||+++|+|.+++..... ...+++..++.++.|++.|++|||++ +|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCC
T ss_conf 589999727999599999862577751022100001222001257789999999999999999999739---90505270
Q ss_pred CCCEEECCCCCEEEECCCCCEECCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 98566489998299502343003899996--000222343247312235888962136899999999882-999998431
Q 001494 929 SKNVLLDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFIS 1005 (1067)
Q Consensus 929 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~ 1005 (1067)
|+||+++.++.+||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||+| |..||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 32144345982898514222204577861562343578765783887279999633030003999999838999999989
Q ss_pred CCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHCC
Q ss_conf 00000011333331104999999994049999999999976127999999998899888209
Q 001494 1006 LISSSSLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLKI 1067 (1067)
Q Consensus 1006 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~~ 1067 (1067)
.... ........ .++..|....+ ++.+++.+||+.||++|||++||++.|.+
T Consensus 272 ~~~~----~~~~~~~~--~~~~~p~~~~~----~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VDAN----FYKLIQNG--FKMDQPFYATE----EIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSHH----HHHHHHTT--CCCCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH----HHHHHHCC--CCCCCCCCCCH----HHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 8999----99998569--98998876789----99999999758896689399999999748
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=364.11 Aligned_cols=251 Identities=19% Similarity=0.284 Sum_probs=207.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEE
Q ss_conf 2888557213577645999997-799399999907999998147999999999983289883332248986188015999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 874 (1067)
++|++.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|+.+++.++|||||++++++.+++..|+||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 0359989993177829999999899979999998872---6467999999999998679979891999999899999999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEECCCCCEECC
Q ss_conf 9545898878860567568999687999999999999998818999925268899856648--99982995023430038
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD--FKNEARVSDFGIAKFLK 952 (1067)
Q Consensus 875 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~--~~~~~kl~Dfgla~~~~ 952 (1067)
||++||+|.+.+.. ....+++..+..++.|++.|+.|||++ ||+||||||+|||++ .++.+||+|||+|+...
T Consensus 106 E~~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 106 EFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp ECCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred ECCCCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEECC
T ss_conf 82899808888986--389989999999999999999999977---9265131445531134678848995256303437
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 99996000222343247312235888962136899999999882999998431000000113333311049999999940
Q 001494 953 PDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 953 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
.. .......|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....+.......+...
T Consensus 181 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~ 251 (352)
T d1koba_ 181 PD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQNVKRCDWEFDEDA 251 (352)
T ss_dssp TT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHCCCCCCSST
T ss_pred CC-CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHHCCCCCCCCC
T ss_conf 88-7201004764534899974799897633389899999999688998997999--------99999984788989300
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 4999999999997612799999999889988
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
......++.+++.+||+.||.+|||+.|+++
T Consensus 252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 2479999999999975699668918999960
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.45 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=209.4
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEE--CCCEE
Q ss_conf 52888557213577645999997-7993999999079999981479999999999832898833322489861--88015
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH--AQHSF 871 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~ 871 (1067)
.++|++.+.||+|+||+||+|+. .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+ .+..|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf 33379967983088919999999999979999998746579-79999999999999977899982489999917899899
Q ss_pred EEEEECCCCCHHHHHCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCC--CCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf 999954589887886056-756899968799999999999999881899--99252688998566489998299502343
Q 001494 872 IVYEYLEMGSLAMILSND-AAAEDLEWTQRMSVIKGIADALSYLHNDCF--PPIVHRDISSKNVLLDFKNEARVSDFGIA 948 (1067)
Q Consensus 872 lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--~~i~H~Dik~~Nill~~~~~~kl~Dfgla 948 (1067)
+||||+++|+|.+++... .....+++..++.++.|++.|+.|||++.. .+|+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCE
T ss_conf 99956899938999985154578999999999999999999999971677887885867654257478885798001000
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCC-C
Q ss_conf 003899996000222343247312235888962136899999999882999998431000000113333311049999-9
Q 001494 949 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL-P 1027 (1067)
Q Consensus 949 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 1027 (1067)
+.............||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+..... .
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--------~~~~~i~~~~~~~ 233 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------ELAGKIREGKFRR 233 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCCCC
T ss_pred EECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH--------HHHHHHHCCCCCC
T ss_conf 32245777556677882327999983999993898875278999980188998998999--------9999997189988
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 999404999999999997612799999999889988
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
.+..... ++.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~s~----~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 IPYRYSD----ELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCH----HHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9743599----9999999976799557918999972
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=364.34 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=206.1
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEE
Q ss_conf 528885572135776459999977-9939999990799999814799999999998328988333224898618801599
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 873 (1067)
.++|++.+.||+|+||+||+|.+. +++.||||++..... ..+++.+|+.+++.++|||||++++++.+++..|+|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC----HHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEE
T ss_conf 7993986598208880899999999996999999777610----399999999999867999882677527457854787
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCC
Q ss_conf 99545898878860567568999687999999999999998818999925268899856648999829950234300389
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~ 953 (1067)
|||+++|++.+++... ....+++..+..++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 92 ~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 92 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred EECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf 6314676067775303-554157999999999999978889878---930576045768998999289832445465378
Q ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 9996-000222343247312235888962136899999999882999998431000000113333311049999999940
Q 001494 954 DSSN-WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 954 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
.... .....|++.|+|||++.+..++.++||||+|+++|||++|+.|+....... ........ ...+..+...
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~----~~~~~i~~--~~~~~~~~~~ 241 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEK--DYRMERPEGC 241 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHHT--TCCCCCCTTC
T ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHC--CCCCCCCCCC
T ss_conf 87221035566546669278727999810430217899999986799887742599----99999855--8888887433
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 4999999999997612799999999889988820
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
.. ++.+++.+||+.||++|||+.++++.|+
T Consensus 242 ~~----~l~~li~~cl~~dP~~Rps~~ei~~~L~ 271 (287)
T d1opja_ 242 PE----KVYELMRACWQWNPSDRPSFAEIHQAFE 271 (287)
T ss_dssp CH----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 09----9999999975779768939999999999
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=366.61 Aligned_cols=252 Identities=25% Similarity=0.325 Sum_probs=207.0
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEE
Q ss_conf 528885572135776459999977-9939999990799999814799999999998328988333224898618801599
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 873 (1067)
.+.|++.+.||+|+||+||+|+.. +++.||+|++....... ....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH--HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 666699889940658399999999999899999981577312--899999999999867998999198999989988898
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEECCCCCEE
Q ss_conf 99545898878860567568999687999999999999998818999925268899856648---999829950234300
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLD---FKNEARVSDFGIAKF 950 (1067)
Q Consensus 874 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~---~~~~~kl~Dfgla~~ 950 (1067)
|||++||+|.+++... +.+++..+..++.|++.|++|||++ +|+||||||+||++. .++.+||+|||+|+.
T Consensus 86 mE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp ECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred EECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEEE
T ss_conf 8526898488865303---6788789999999999998752413---055687046300110468882499831543587
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 38999960002223432473122358889621368999999998829999984310000001133333110499999999
Q 001494 951 LKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPS 1030 (1067)
Q Consensus 951 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1067)
.... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+.
T Consensus 160 ~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~~~~~ 230 (307)
T d1a06a_ 160 EDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------AKLFEQILKAEYEFDS 230 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHTTCCCCCT
T ss_pred CCCC-CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHCCCCCCCC
T ss_conf 2589-704400328422591887379998078734515999999859799999899--------9999998616877787
Q ss_pred CCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 404999999999997612799999999889988
Q 001494 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1031 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
......+.++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 666678999999999976089757918999862
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.63 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=204.9
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEE
Q ss_conf 52888557213577645999997-79939999990799999814799999999998328988333224898618801599
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 873 (1067)
.++|++.+.||+|+||+||+|+. .+++.||+|++..... ....+.+.+|+.+++.++|||||++++++.+++..|+|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 5688897897127780999999989996999999875409--78999999999999867999999499999989999999
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCC
Q ss_conf 99545898878860567568999687999999999999998818999925268899856648999829950234300389
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~ 953 (1067)
|||+++|+|.+++.+. +.+++..+..++.|++.|+.|||+++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EECCCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHHC--CEECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 9767998689987424---99999999999999999999999859--997144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHH-------------------
Q ss_conf 9996000222343247312235888962136899999999882999998431000000113-------------------
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL------------------- 1014 (1067)
Q Consensus 954 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~------------------- 1014 (1067)
. .....+||+.|+|||++.+.+|+.++||||+||++|||++|+.||.............
T Consensus 158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C--CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCC
T ss_conf 8--62111377141194687589989488899899999999988899899887899999988751775457742123332
Q ss_pred ---------------HHHHHHCCC-CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf ---------------333311049-9999999404999999999997612799999999889988
Q 001494 1015 ---------------NIALDEILD-PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1015 ---------------~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
......... +....+.. ....++.+++.+||..||++||||.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG---VFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBT---TBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC---CCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 211112223541347788766502687667644---48999999999986899467908999960
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.91 Aligned_cols=251 Identities=25% Similarity=0.311 Sum_probs=211.4
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEE
Q ss_conf 52888557213577645999997-79939999990799999814799999999998328988333224898618801599
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 873 (1067)
.++|++.+.||+|+||.||+|+. .+++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCC
Q ss_conf 99545898878860567568999687999999999999998818999925268899856648999829950234300389
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~ 953 (1067)
|||++||+|..++... ..+++..+..++.|++.|++|||++ +|+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 0035798605555325---6775999999999996521134315---962246477784765899888820565200356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Q ss_conf 99960002223432473122358889621368999999998829999984310000001133333110499999999404
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
........+||+.|+|||++.+.+|+.++||||+||++|||++|+.||..... ......+....+..|....
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~~~~~~p~~~s 229 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEEIRFPRTLS 229 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTTSC
T ss_pred CCCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHCCCCCCCCCCC
T ss_conf 78620551008899666650489888333102230678899878999999699--------9999998528998986689
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 999999999997612799999999-----889988
Q 001494 1034 QEKLISFVEVAISCLDESPESRPT-----MQKVSQ 1063 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt-----~~ev~~ 1063 (1067)
.+ +.+++.+||+.||.+|++ ++++++
T Consensus 230 ~~----~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 230 PE----AKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HH----HHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HH----HHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf 99----99999866638934422565234999972
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.05 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=204.0
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEE
Q ss_conf 52888557213577645999997-79939999990799999814799999999998328988333224898618801599
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 873 (1067)
.++|++.+.||+|+||+||+|+. .+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC--HHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf 74608998972174809999999999979999998456641--2799999999999857998884696540467436798
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCC
Q ss_conf 99545898878860567568999687999999999999998818999925268899856648999829950234300389
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~ 953 (1067)
|||+++|+|.+++... ..+++..+..++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 mEy~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECC
T ss_conf 8645898089997537---9999999999999999999999975---983575468997887899879832314224046
Q ss_pred CC--CCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Q ss_conf 99--96000222343247312235888-9621368999999998829999984310000001133333110499999999
Q 001494 954 DS--SNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPS 1030 (1067)
Q Consensus 954 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1030 (1067)
.. ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||........ ............+.
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-------~~~~~~~~~~~~~~ 228 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKTYLNP 228 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-------HHHHHHTTCTTSTT
T ss_pred CCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHHCCCCCCCC
T ss_conf 88653111325574742872861899999710161737999999829978888985999-------99998638887886
Q ss_pred CCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 404999999999997612799999999889988
Q 001494 1031 HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1031 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
......++.+++.+||+.||++|||+.|+++
T Consensus 229 --~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 --WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf --4469999999999976799668909999961
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.36 Aligned_cols=250 Identities=21% Similarity=0.304 Sum_probs=208.7
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEE
Q ss_conf 2888557213577645999997-799399999907999998147999999999983289883332248986188015999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 874 (1067)
++|++.+.||+|+||+||+|+. .+++.||||++...........+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf 95458988788605675689996879999999999999988189999252688998566489998299502343003899
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~ 954 (1067)
||+++|+|.+++... +.+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 704898777765315---9999999999999999999762165---0884767741236688853886032102422567
Q ss_pred C--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 9--96000222343247312235888962136899999999882999998431000000113333311049999999940
Q 001494 955 S--SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHN 1032 (1067)
Q Consensus 955 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1032 (1067)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+....+.++...
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~ 233 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKLEYDFPEKF 233 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTCCCCCTTC
T ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHCCCCCCCCCC
T ss_conf 764333555677552584400268989666230456999998038899899599--------999999971899998547
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 4999999999997612799999999889988
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
.. ++.+++.+||+.||.+|||+.|+.+
T Consensus 234 s~----~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 234 FP----KARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CH----HHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CH----HHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf 99----9999999985579768919789737
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.46 Aligned_cols=250 Identities=22% Similarity=0.393 Sum_probs=203.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEEE
Q ss_conf 28885572135776459999977993999999079999981479999999999832898833322489861880159999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 875 (1067)
++|++.+.||+|+||.||+|.+++++.||||++..... ..+.+.+|+.++++++|||||+++|++.+ +..|+|||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEE
T ss_conf 99388679810798289999999999999999864768----88999999999986799988578731045-97699999
Q ss_pred ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCC
Q ss_conf 54589887886056756899968799999999999999881899992526889985664899982995023430038999
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~ 955 (1067)
|+++|+|.+++.... ...+++..+.+++.|+++|+.|||++ +|+||||||+||+++.++.+||+|||+|+......
T Consensus 88 y~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred ECCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCC
T ss_conf 578982888875147-89887889999999999999999748---95467564225156202440423410147735886
Q ss_pred C-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCC-CCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCC
Q ss_conf 9-600022234324731223588896213689999999988299999-84310000001133333110499-99999940
Q 001494 956 S-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPG-DFISLISSSSLNLNIALDEILDP-RLPIPSHN 1032 (1067)
Q Consensus 956 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1032 (1067)
. ......|++.|+|||++.+..++.++|||||||++|||+||..|+ ..... ......+..+ ....+...
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--------~~~~~~i~~~~~~~~p~~~ 235 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMVRPDNC 235 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCCTTC
T ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHHCCCCCCCCCC
T ss_conf 44203567744445828983799982456452579999999689888888899--------9999999706888896557
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 4999999999997612799999999889988820
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
.. ++.+++.+||+.||++|||+.+|++.|+
T Consensus 236 ~~----~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 236 PE----ELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp CH----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 19----9999999975889768939999999861
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.32 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=203.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEE
Q ss_conf 2888557213577645999997-799399999907999998147999999999983289883332248986188015999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 874 (1067)
+.|++.+.||+|+||+||+|+. .+++.||+|++..... ...+.+.+|+++++.++|||||++++++.+++..|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 375984799307781999999999993999999872899---99999999999998679999884988980099589999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf 95458988788605675689996879999999999999988189999252688998566489998299502343003899
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~ 954 (1067)
||+++|+|.+++.+. ...+++.++..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 Ey~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp ECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred ECCCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC
T ss_conf 627998188999862--89999999999999999999999988---9887140700314878999899716123035778
Q ss_pred CCCCCCCCCCCCCCCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 99600022234324731223-----5888962136899999999882999998431000000113333311049999999
Q 001494 955 SSNWTELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029 (1067)
Q Consensus 955 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1067)
........||+.|+|||++. +..|+.++||||+||++|||++|+.||......... ........+....+
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~-----~~i~~~~~~~~~~~ 238 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL-----LKIAKSEPPTLAQP 238 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-----HHHHHSCCCCCSSG
T ss_pred CCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-----HHHHCCCCCCCCCC
T ss_conf 6410010256264799998320257888880665787899999982088999998999999-----99970799877765
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 9404999999999997612799999999889988
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
... ..++.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~----s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 239 SRW----SSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GGS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC----CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 669----999999999976699668919999962
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.21 Aligned_cols=250 Identities=25% Similarity=0.428 Sum_probs=209.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEEE
Q ss_conf 28885572135776459999977993999999079999981479999999999832898833322489861880159999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 875 (1067)
++|++.++||+|+||+||+|++++++.||||+++.... ..+++.+|+.+++.++||||++++|++.+++..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
T ss_conf 99799689820788399999988998999999874757----78999999999996689860158899850781699997
Q ss_pred ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCC
Q ss_conf 54589887886056756899968799999999999999881899992526889985664899982995023430038999
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~ 955 (1067)
|+++|++..++.. ....+++..+.+++.|+++|++|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 80 y~~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 80 YMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CCTTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCC
T ss_conf 0489938886410--246776899999999999999987546---84346654135887699847988614420235787
Q ss_pred C-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCC
Q ss_conf 9-6000222343247312235888962136899999999882-9999984310000001133333110499-99999940
Q 001494 956 S-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP-RLPIPSHN 1032 (1067)
Q Consensus 956 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1032 (1067)
. ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+...... ....+..+ ++..|...
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--------~~~~i~~~~~~~~p~~~ 226 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------TAEHIAQGLRLYRPHLA 226 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------HHHHHHTTCCCCCCTTC
T ss_pred CEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHH--------HHHHHHHCCCCCCCCCC
T ss_conf 2252465788775780786379988521033643246739755999988999999--------99999807978996546
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 4999999999997612799999999889988820
Q 001494 1033 VQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1033 ~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
. .++.+++.+||+.||++|||+.++++.|.
T Consensus 227 ~----~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 227 S----EKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp C----HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred C----HHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 5----99999999976689768939999998741
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.52 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=203.3
Q ss_pred CCCCCCC-CCCCCCCEEEEEEEEC---CCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEE
Q ss_conf 2888557-2135776459999977---99399999907999998147999999999983289883332248986188015
Q 001494 796 NDFDDEH-CIGKGGQGSVYKVELA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 796 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 871 (1067)
+++.+.+ +||+|+||+||+|.++ ++..||||++... ......++|.+|+.++++++|||||+++|++.. +..|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEE
T ss_conf 4718878487306080999999960897689999998820--397899999999999986799888068656036-8079
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEEC
Q ss_conf 99995458988788605675689996879999999999999988189999252688998566489998299502343003
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~ 951 (1067)
+||||+++|+|.+++.. ....+++..+.+++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 85 lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCC
T ss_conf 99980789968997521--256999999999999999987899868---8105767646604546885420331342115
Q ss_pred CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCC-CCC
Q ss_conf 899996---000222343247312235888962136899999999882-999998431000000113333311049-999
Q 001494 952 KPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILD-PRL 1026 (1067)
Q Consensus 952 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1026 (1067)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||....... ....+.. .++
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--------~~~~i~~~~~~ 231 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRM 231 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------HHHHHHTTCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHCCCCC
T ss_conf 5434321135621137433586887279999541232201789999938999999979999--------99999818999
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 9999404999999999997612799999999889988820
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
..|..... ++.+++.+||+.+|++|||+.+|.+.|+
T Consensus 232 ~~p~~~~~----~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 232 ECPPECPP----ELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp CCCTTCCH----HHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCH----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 99976789----9999999975779768909999999999
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.98 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=209.0
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCC---CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCE
Q ss_conf 52888557213577645999997-79939999990799999---814799999999998328988333224898618801
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPG---EMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 870 (1067)
.++|++.+.||+|+||+||+|+. .+|+.||+|++...... .....+.+.+|+.+++.++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEECCC
Q ss_conf 59999545898878860567568999687999999999999998818999925268899856648999----82995023
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN----EARVSDFG 946 (1067)
Q Consensus 871 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~----~~kl~Dfg 946 (1067)
|+||||+++|+|.+++... +.+++..+..++.|++.|++|||++ +|+||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEECCCCCCCCCHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 9999867786431001035---6421557899999999998766625---422113330127982589866646964334
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 43003899996000222343247312235888962136899999999882999998431000000113333311049999
Q 001494 947 IAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL 1026 (1067)
Q Consensus 947 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1067)
+|...... .......|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.....
T Consensus 163 ~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVSAVNY 233 (293)
T ss_dssp TCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTCC
T ss_pred HHHHCCCC-CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHHCCC
T ss_conf 42105777-631224777743099998189999766522140999999708899889999--------999999981688
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 9999404999999999997612799999999889988
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
..+.......+..+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8870104788999999999986389668919999961
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=359.66 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=201.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEE
Q ss_conf 2888557213577645999997-799399999907999998147999999999983289883332248986188015999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 874 (1067)
..|+..+.||+|+||.||+|+. .+++.||||++...........+.+.+|+.+++.++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf 95458988788605675689996879999999999999988189999252688998566489998299502343003899
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~ 954 (1067)
||+++|++..+... ...+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCCC
T ss_conf 80699945789973---79999999999999999999999868---9766678842179879997898443653346778
Q ss_pred CCCCCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 996000222343247312235---88896213689999999988299999843100000011333331104999999994
Q 001494 955 SSNWTELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031 (1067)
Q Consensus 955 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1067)
....||+.|+|||++.+ ..|+.++||||+||++|||++|+.||........ .........+... +..
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-----~~~i~~~~~~~~~-~~~ 238 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNESPALQ-SGH 238 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCCCCCS-CTT
T ss_pred ----CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHHCCCCCCC-CCC
T ss_conf ----731347663688998346788867214545589999999878899999799999-----9999828999888-788
Q ss_pred CHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 04999999999997612799999999889988
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
. +.++.+++.+||+.||.+|||+.++++
T Consensus 239 ~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 239 W----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C----CHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 8----999999999977379657918999971
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.12 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=203.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCC-----CEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCE
Q ss_conf 2888557213577645999997799-----39999990799999814799999999998328988333224898618801
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASG-----EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 870 (1067)
++|+..+.||+|+||.||+|.++.. ..||||++.... ......+|.+|+.+++.++|||||+++|++.+.+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 996861598117790999999968998787999999988445--968999999999999856898783236778338803
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEE
Q ss_conf 59999545898878860567568999687999999999999998818999925268899856648999829950234300
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~ 950 (1067)
++||||+.++++.+++... ...+++.++.+++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEECCCCCCHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 8999721357402221023--45420899999999999854121212---342576564427888998499845510300
Q ss_pred CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCC-CC
Q ss_conf 389999---60002223432473122358889621368999999998829999984310000001133333110499-99
Q 001494 951 LKPDSS---NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP-RL 1026 (1067)
Q Consensus 951 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1026 (1067)
...... ......||+.|+|||++.+..++.++||||||+++|||+++..|+...... ......+.++ +.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRL 232 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCC
T ss_pred CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHCCCCC
T ss_conf 357876526742677773434888870499997355634489899999679886556899-------9999998635789
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 9999404999999999997612799999999889988820
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
..+.... .++.+++.+||+.||++|||+.+|++.|+
T Consensus 233 ~~~~~~~----~~l~~li~~cl~~~p~~RPt~~eil~~L~ 268 (283)
T d1mqba_ 233 PTPMDCP----SAIYQLMMQCWQQERARRPKFADIVSILD 268 (283)
T ss_dssp CCCTTCB----HHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCHHHH----HHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 9850457----99999999977679768939999999999
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=357.58 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=206.7
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEE
Q ss_conf 52888557213577645999997-79939999990799999814799999999998328988333224898618801599
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 873 (1067)
.++|++.+.||+|+||+||+|+. .+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf 54708888972076808999999899979999998457754889999999999999863696753303568528800567
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCC
Q ss_conf 99545898878860567568999687999999999999998818999925268899856648999829950234300389
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~ 953 (1067)
|||++||++...+... ..+++..+..++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 mE~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EEECCCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEECC
T ss_conf 6503786322343222---2111007999999998765541247---677055681050386899889831752167124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Q ss_conf 99960002223432473122358889621368999999998829999984310000001133333110499999999404
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
. ....+||+.|+|||++.+.+++.++||||+||++|||++|+.||..... ......+.......+....
T Consensus 157 ~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~s 225 (316)
T d1fota_ 157 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAELRFPPFFN 225 (316)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCCCCCCTTSC
T ss_pred C---CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCH--------HHHHHHHHCCCCCCCCCCC
T ss_conf 5---6434576343599998389998043046533368999759899999699--------9999999708988997789
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 99999999999761279999999-----9889988
Q 001494 1034 QEKLISFVEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rp-----t~~ev~~ 1063 (1067)
. ++.+++.+||..||.+|+ |++++++
T Consensus 226 ~----~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 226 E----DVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp H----HHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred H----HHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf 9----999999999544997666431021999981
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.12 Aligned_cols=245 Identities=26% Similarity=0.406 Sum_probs=199.8
Q ss_pred CCCCCCCCEEEEEEEEC---CCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEEEECC
Q ss_conf 72135776459999977---993999999079999981479999999999832898833322489861880159999545
Q 001494 802 HCIGKGGQGSVYKVELA---SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEYLE 878 (1067)
Q Consensus 802 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 878 (1067)
++||+|+||+||+|.++ +++.||||++..... +....+++.+|+.++++++|||||+++|++.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCC
T ss_conf 78345878299999981697385999999880108-98999999999999986799898527777505-97799997478
Q ss_pred CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCCCC-
Q ss_conf 8988788605675689996879999999999999988189999252688998566489998299502343003899996-
Q 001494 879 MGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSSN- 957 (1067)
Q Consensus 879 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~- 957 (1067)
+|+|.+++... ..+++..+.+++.|++.|++|||++ +|+||||||+||+++.++.+|++|||+|+........
T Consensus 91 ~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 91 LGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp TEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 89689997522---5789999999999999997668747---95567776113102356751234134533134323443
Q ss_pred --CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCH
Q ss_conf --000222343247312235888962136899999999882-999998431000000113333311049-9999999404
Q 001494 958 --WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILD-PRLPIPSHNV 1033 (1067)
Q Consensus 958 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1033 (1067)
.....||+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.. .++..|....
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--------~~~~~i~~~~~~~~p~~~~ 236 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGERMGCPAGCP 236 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCCCTTCC
T ss_pred CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHCCCCCCCCCCCC
T ss_conf 22445677842039166537999843443034031328965899999998999--------9999998289999986567
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 999999999997612799999999889988820
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
. ++.+++.+||+.||++|||+.+|.+.|+
T Consensus 237 ~----~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 237 R----EMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp H----HHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred H----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 9----9999999975889768909899999852
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=357.47 Aligned_cols=247 Identities=23% Similarity=0.291 Sum_probs=206.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEE
Q ss_conf 2888557213577645999997-799399999907999998147999999999983289883332248986188015999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 874 (1067)
++|++.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf 95458988788605675689996879999999999999988189999252688998566489998299502343003899
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~ 954 (1067)
||+.+|++..++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 233466226667515---8989999999999999989999859---9861767999936077897886101033322566
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Q ss_conf 99600022234324731223588896213689999999988299999843100000011333331104999999994049
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNVQ 1034 (1067)
Q Consensus 955 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1067)
.....||+.|||||++.+..++.++||||+||++|||++|+.||..... ......+.......+.....
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~s~ 263 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKVRFPSHFSS 263 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTTCCH
T ss_pred ---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHCCCCCCCCCCCH
T ss_conf ---6433676356788997179988533114500789999758899899599--------99999986179889766899
Q ss_pred HHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 9999999999761279999999-----9889988
Q 001494 1035 EKLISFVEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1035 ~~~~~l~~li~~cl~~dP~~Rp-----t~~ev~~ 1063 (1067)
++.+++.+||..||.+|+ |+.++++
T Consensus 264 ----~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 264 ----DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----HHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf ----999999998340998606553454999971
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=355.24 Aligned_cols=252 Identities=21% Similarity=0.245 Sum_probs=200.6
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHH---HHHHHHHCCCCCEEEEEEEEEEECCCE
Q ss_conf 52888557213577645999997-79939999990799999814799999---999998328988333224898618801
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFL---NEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~ 870 (1067)
.++|++.+.||+|+||.||+|+. .+|+.||+|++.............+. .++.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEE
Q ss_conf 59999545898878860567568999687999999999999998818999925268899856648999829950234300
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~ 950 (1067)
|+||||+++|+|.+++... ..+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEECCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEEE
T ss_conf 9999914898389998732---5532789999999999999999977---962204442216785889679822010233
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 3899996000222343247312235-888962136899999999882999998431000000113333311049999999
Q 001494 951 LKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029 (1067)
Q Consensus 951 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1067)
.... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||....... ...............+
T Consensus 157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~ 229 (364)
T d1omwa3 157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTMAVELP 229 (364)
T ss_dssp CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHHSSSCCCCCC
T ss_pred CCCC--CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHHCCCCCCCCC
T ss_conf 3788--64331134554216876038999844104677899999985999888899899-----9999986046888788
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 9404999999999997612799999999-----889988
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPT-----MQKVSQ 1063 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt-----~~ev~~ 1063 (1067)
....+ ++.+++.+||+.||.+||| |+++++
T Consensus 230 ~~~s~----~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 DSFSP----ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSSCH----HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCH----HHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf 77899----999999998566988808874357999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.28 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=196.1
Q ss_pred CCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEE----CCCEEE
Q ss_conf 88557213577645999997-7993999999079999981479999999999832898833322489861----880159
Q 001494 798 FDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH----AQHSFI 872 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 872 (1067)
|+..++||+|+||+||+|.. .+++.||+|++..... .....+.+.+|++++++++|||||++++++.+ +...|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEE
T ss_conf 8851697008284999999999995999999851227-989999999999999857999850699998403345888999
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCEEEECCCCCE
Q ss_conf 9995458988788605675689996879999999999999988189999--25268899856648-99982995023430
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPP--IVHRDISSKNVLLD-FKNEARVSDFGIAK 949 (1067)
Q Consensus 873 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dik~~Nill~-~~~~~kl~Dfgla~ 949 (1067)
||||+++|+|.+++.+. ..+++..+..++.|++.|++|||++ + |+||||||+|||++ .++.+||+|||+|+
T Consensus 90 vmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECCCCE
T ss_conf 99578989489997513---5546999999999999999999978---99799687674351166799988980057654
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 03899996000222343247312235888962136899999999882999998431000000113333311049999999
Q 001494 950 FLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIP 1029 (1067)
Q Consensus 950 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1029 (1067)
.... .......||+.|+|||++.+ +++.++||||+||++|||++|+.||....... .....+.....+
T Consensus 164 ~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-------~~~~~i~~~~~~-- 231 (270)
T d1t4ha_ 164 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVKP-- 231 (270)
T ss_dssp GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCCC--
T ss_pred ECCC--CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHCCCCC--
T ss_conf 2368--76677553813008988478-99986711007999999987889998765599-------999999738998--
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 9404999999999997612799999999889988
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
.........++.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 6567557899999999976379758929999967
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.50 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=207.6
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEE
Q ss_conf 52888557213577645999997-79939999990799999814799999999998328988333224898618801599
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 873 (1067)
.++|++.+.||+|+||+||+|.. .+++.||+|++... ......+.+|+++++.++||||+++++++.+++..|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 01058878983177839999999899969999997578----66599999999999857997989098999889988999
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCEEEECCCCCEEC
Q ss_conf 9954589887886056756899968799999999999999881899992526889985664899--98299502343003
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK--NEARVSDFGIAKFL 951 (1067)
Q Consensus 874 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~--~~~kl~Dfgla~~~ 951 (1067)
|||++||+|.+++... ...+++.++..++.|++.|+.|||++ +|+||||||+||+++.+ ..+|++|||+++..
T Consensus 80 mE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 80 FEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCC
T ss_conf 9538998088998753--89999999999999999999999876---997513554443443788518997644111003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf 89999600022234324731223588896213689999999988299999843100000011333331104999999994
Q 001494 952 KPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSH 1031 (1067)
Q Consensus 952 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1031 (1067)
... .......+++.|+|||...+..++.++||||+||++|+|++|+.||..... ......+.......+..
T Consensus 155 ~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~ 225 (321)
T d1tkia_ 155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTFDEE 225 (321)
T ss_dssp CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCCCHH
T ss_pred CCC-CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHCCCCCCHH
T ss_conf 467-753212233222340210487778401130279999999828999999899--------99999998389998802
Q ss_pred CHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 04999999999997612799999999889988
Q 001494 1032 NVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1032 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
.......++.+++.+||..||.+|||+.|+++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 23678999999999986699668909999963
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.84 Aligned_cols=251 Identities=26% Similarity=0.418 Sum_probs=204.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEEE
Q ss_conf 28885572135776459999977993999999079999981479999999999832898833322489861880159999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 875 (1067)
++|++.+.||+|+||+||+|+.++++.||||++..... ..+.|.+|+.++++++|||||+++|++.+ +..|+|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEE
T ss_conf 99798469930798099999999999999999880448----88999999999986666788689999823-97599999
Q ss_pred ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCC
Q ss_conf 54589887886056756899968799999999999999881899992526889985664899982995023430038999
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~ 955 (1067)
|+++|++..++.... ...+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||+|+......
T Consensus 92 y~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 92 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred ECCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCC
T ss_conf 447994354200003-55305999999999999999987541---14335312307999899929984425554256887
Q ss_pred -CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCH
Q ss_conf -96000222343247312235888962136899999999882999998431000000113333311049-9999999404
Q 001494 956 -SNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD-PRLPIPSHNV 1033 (1067)
Q Consensus 956 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1033 (1067)
.......|++.|+|||++....++.++||||||+++|||++|+.|+...... ......+.. .....+....
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-------~~~~~~i~~~~~~~~~~~~~ 240 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMPCPPECP 240 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCCCTTSC
T ss_pred CEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHHCCCCCCCCCCC
T ss_conf 33524545566545808983799891774132358999998689999988889-------99999998268999983237
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 999999999997612799999999889988820
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
.++.+++.+||+.||++||++.+|++.|+
T Consensus 241 ----~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 269 (285)
T d1fmka3 241 ----ESLHDLMCQCWRKEPEERPTFEYLQAFLE 269 (285)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----HHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf ----99999999975669758919999999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.16 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=204.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHH-HCCCCCEEEEEEEEEEECCCEEEE
Q ss_conf 2888557213577645999997-79939999990799999814799999999998-328988333224898618801599
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKAL-TEIRHRNIVKFYGFCSHAQHSFIV 873 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv 873 (1067)
++|++.+.||+|+||+||+|+. .+++.||+|++...........+.+..|...+ +.++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCC
Q ss_conf 99545898878860567568999687999999999999998818999925268899856648999829950234300389
Q 001494 874 YEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKP 953 (1067)
Q Consensus 874 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~ 953 (1067)
|||+++|+|.+++... ..+++.++..++.|++.|++|||++ +++||||||+|||++.++.+|++|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 7503798089986404---7899999999999999999999868---934034765404444899630155530232356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Q ss_conf 99960002223432473122358889621368999999998829999984310000001133333110499999999404
Q 001494 954 DSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 954 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+....+..|....
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~~~~p~~~s 227 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDNPFYPRWLE 227 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCTTSC
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHCCCCCCCCCCC
T ss_conf 653345457877768999982799883232011227898987388999998999--------999999718998975679
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 99999999999761279999999988-9988
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQ-KVSQ 1063 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~-ev~~ 1063 (1067)
. ++.+++.+||+.||.+||++. ++++
T Consensus 228 ~----~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 228 K----EAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp H----HHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred H----HHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 9----99999999654489878388999980
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=350.47 Aligned_cols=255 Identities=22% Similarity=0.410 Sum_probs=208.0
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECC
Q ss_conf 528885572135776459999977------99399999907999998147999999999983289883332248986188
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 868 (1067)
.++|++.+.||+|+||.||+|+.+ +++.||||++... ......+++.+|+.+++.++||||+++++++...+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHH--CCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCC
T ss_conf 8893886798207883999999888765778829999998821--08579999999999999668997655246660598
Q ss_pred CEEEEEEECCCCCHHHHHCCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCC
Q ss_conf 0159999545898878860567---------------------5689996879999999999999988189999252688
Q 001494 869 HSFIVYEYLEMGSLAMILSNDA---------------------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDI 927 (1067)
Q Consensus 869 ~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Di 927 (1067)
..++++||+++|+|.+++.... ....+++..++.++.|++.|++|||++ +++||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEEEEEE
T ss_conf 0389998158992999998527554210000111001210346788989999999999999985541357---8685488
Q ss_pred CCCCEEECCCCCEEEECCCCCEECCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCC
Q ss_conf 99856648999829950234300389999--600022234324731223588896213689999999988299-999843
Q 001494 928 SSKNVLLDFKNEARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPGDFI 1004 (1067)
Q Consensus 928 k~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~P~~~~ 1004 (1067)
||+||+++.++.+||+|||+|+....... ......+++.|+|||.+.+..++.++|||||||++|||++|. .||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCC
T ss_conf 40116898999289833144211367764111577776767679899726889805630252362999980689999998
Q ss_pred CCCCCCCHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 100000011333331104999-99999404999999999997612799999999889988820
Q 001494 1005 SLISSSSLNLNIALDEILDPR-LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1005 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
... .....+..+. ...+..... ++.+++.+||+.+|++||||.+|+++|+
T Consensus 247 ~~~--------e~~~~v~~~~~~~~p~~~~~----~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 247 AHE--------EVIYYVRDGNILACPENCPL----ELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp CHH--------HHHHHHHTTCCCCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHH--------HHHHHHHCCCCCCCCCCCHH----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 999--------99999973997888732529----9999999974889657939999999999
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.16 Aligned_cols=252 Identities=23% Similarity=0.412 Sum_probs=203.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCC----EEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCE
Q ss_conf 28885572135776459999977-993----9999990799999814799999999998328988333224898618801
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGE----IIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHS 870 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 870 (1067)
.+|++.+.||+|+||+||+|.+. +++ .||+|++..... ....+++.+|+.++++++|||||+++|++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CE
T ss_conf 9997831982089929999999589988989999999651349--79999999999999867998881589999619-83
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEE
Q ss_conf 59999545898878860567568999687999999999999998818999925268899856648999829950234300
Q 001494 871 FIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 871 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~ 950 (1067)
++++||+.+|+|.+++.. ....+++..+.+++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+|+.
T Consensus 86 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEEEECCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEE
T ss_conf 699984268740101113--345799999999999999999999876---950476212031167998758602552223
Q ss_pred CCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 3899996--000222343247312235888962136899999999882-9999984310000001133333110499999
Q 001494 951 LKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLP 1027 (1067)
Q Consensus 951 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1027 (1067)
....... .....||+.|+|||++.+..++.++||||||+++|||+| |..||+....... ...... ..++.
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-----~~~i~~--~~~~~ 233 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----SSILEK--GERLP 233 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-----HHHHHH--TCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHC--CCCCC
T ss_conf 35444532236510586446708874699983565440799999999779999999998999-----999975--99899
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 999404999999999997612799999999889988820
Q 001494 1028 IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1028 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
.+..... ++.+++.+||+.||.+|||+.++++.|+
T Consensus 234 ~p~~~~~----~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 234 QPPICTI----DVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp CCTTBCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCH----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 9855689----9999999847899346919999999999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=351.28 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=208.9
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECC----C
Q ss_conf 52888557213577645999997-799399999907999998147999999999983289883332248986188----0
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ----H 869 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 869 (1067)
.++|++.+.||+|+||.||+|+. .+++.||+|++......+....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCE
Q ss_conf 15999954589887886056756899968799999999999999881899992526889985664899982995023430
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK 949 (1067)
Q Consensus 870 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~ 949 (1067)
.|+||||++|++|.+++... +.+++..+..++.|++.|++|||++ +|+||||||+||+++.++..+++|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEEHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 99999778898710112035---8999999999999999999999857---95276346755665754320100344432
Q ss_pred ECCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 0389999---6000222343247312235888962136899999999882999998431000000113333311049999
Q 001494 950 FLKPDSS---NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL 1026 (1067)
Q Consensus 950 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1067)
....... ......||+.|+|||++.+..++.++||||+||++|||+||+.||....... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~~~~~~~ 231 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--------VAYQHVREDP 231 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCCC
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHH--------HHHHHHHCCC
T ss_conf 21235443333464257624369999839999966320265289999976979989969999--------9999984699
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHC
Q ss_conf 999940499999999999761279999999-9889988820
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRP-TMQKVSQLLK 1066 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-t~~ev~~~L~ 1066 (1067)
..+.......+.++.+++.+||+.||.+|| |++++.+.|.
T Consensus 232 ~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHH
T ss_conf 99710034789999999999866797677739999999999
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.77 Aligned_cols=252 Identities=23% Similarity=0.282 Sum_probs=202.5
Q ss_pred HCCCCCCC-CCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHC-CCCCEEEEEEEEEEE----C
Q ss_conf 52888557-213577645999997-7993999999079999981479999999999832-898833322489861----8
Q 001494 795 TNDFDDEH-CIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTE-IRHRNIVKFYGFCSH----A 867 (1067)
Q Consensus 795 ~~~~~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~ 867 (1067)
.++|.+.. .||+|+||.||+|+. .+++.||+|++.. ...+.+|+.++.+ .+|||||++++++.+ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC--------CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCC
T ss_conf 14879810796545486999999889998999999897--------4779999999998669999782989995034689
Q ss_pred CCEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEC
Q ss_conf 801599995458988788605675689996879999999999999988189999252688998566489---99829950
Q 001494 868 QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF---KNEARVSD 944 (1067)
Q Consensus 868 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~---~~~~kl~D 944 (1067)
...|+||||++||+|.+++.... ...+++.++..++.|++.|++|||++ +|+||||||+||+++. ++.+||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEECCCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 78999997789984999998627-87757999999999999999999976---986444100220113555566311354
Q ss_pred CCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 23430038999960002223432473122358889621368999999998829999984310000001133333110499
Q 001494 945 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDP 1024 (1067)
Q Consensus 945 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1024 (1067)
||+|+..... .......||+.|+|||++.+..|+.++||||+||++|+|++|+.||........ .......+...
T Consensus 158 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~----~~~~~~~i~~~ 232 (335)
T d2ozaa1 158 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----SPGMKTRIRMG 232 (335)
T ss_dssp CTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSC
T ss_pred CCEEEECCCC-CCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHH----HHHHHHHHHCC
T ss_conf 5512333688-864322677563792777489888888887645167788658899889887788----99999998538
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 999999404999999999997612799999999889988
Q 001494 1025 RLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1025 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
....+.........++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 888898543469999999999975699657909999970
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=344.99 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=206.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCH------HHHHHHHHHHHHHHCCC-CCEEEEEEEEEEEC
Q ss_conf 2888557213577645999997-7993999999079999981------47999999999983289-88333224898618
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEM------TFQQEFLNEVKALTEIR-HRNIVKFYGFCSHA 867 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 867 (1067)
++|++.+.||+|+||+||+|+. .+++.||+|++........ ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred CCEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf 80159999545898878860567568999687999999999999998818999925268899856648999829950234
Q 001494 868 QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGI 947 (1067)
Q Consensus 868 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgl 947 (1067)
+..|+||||+++|+|.+++.. .+.+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEECCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf 605999976898668999986---59999999999999999999999875---994323462548986899838712403
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf 3003899996000222343247312235------8889621368999999998829999984310000001133333110
Q 001494 948 AKFLKPDSSNWTELAGTYGYVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEI 1021 (1067)
Q Consensus 948 a~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 1021 (1067)
++..... .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+
T Consensus 157 a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--------~~~~~i 227 (277)
T d1phka_ 157 SCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--------LMLRMI 227 (277)
T ss_dssp CEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHH
T ss_pred EEECCCC-CCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHH--------HHHHHH
T ss_conf 1672688-7213452467888988860534456788992331856560231032288898899999--------999999
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 4999999994049999999999976127999999998899888
Q 001494 1022 LDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1022 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~ 1064 (1067)
.......+.......+.++.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8189888985434689999999999765896689199999739
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.61 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=199.1
Q ss_pred CCCCCCCCCCEEEEEEEECCC----CEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEE-CCCEEEEE
Q ss_conf 557213577645999997799----3999999079999981479999999999832898833322489861-88015999
Q 001494 800 DEHCIGKGGQGSVYKVELASG----EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH-AQHSFIVY 874 (1067)
Q Consensus 800 ~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 874 (1067)
..++||+|+||+||+|++..+ ..||||++... ......++|.+|++++++++||||++++|++.+ ++..++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred CCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 666981368809999999779987999999998843--697899999999999986789998678678980699438999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf 95458988788605675689996879999999999999988189999252688998566489998299502343003899
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~ 954 (1067)
||+++|++.+++.. .....++..+.+++.|++.|+.|+|+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 109 E~~~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp ECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEEECCCHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCC
T ss_conf 87406741442101--345404899999999988765200336---7625776687576779998899106523225566
Q ss_pred CCC----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCC-CCCCCC
Q ss_conf 996----000222343247312235888962136899999999882999998431000000113333311049-999999
Q 001494 955 SSN----WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILD-PRLPIP 1029 (1067)
Q Consensus 955 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1029 (1067)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .....+.. .++..|
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-------~~~~~i~~g~~~~~p 256 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQP 256 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCCCCC
T ss_pred CCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHCCCCCCCC
T ss_conf 5553100256555645567688743799974574661999999997899998889999-------999999808988996
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 9404999999999997612799999999889988820
Q 001494 1030 SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1030 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
..... ++.+++.+||+.||++||++.||++.|+
T Consensus 257 ~~~~~----~l~~li~~cl~~dP~~RPs~~ei~~~L~ 289 (311)
T d1r0pa_ 257 EYCPD----PLYEVMLKCWHPKAEMRPSFSELVSRIS 289 (311)
T ss_dssp TTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCH----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 44759----9999999976889768939999999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.26 Aligned_cols=253 Identities=25% Similarity=0.415 Sum_probs=205.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC--CC--CEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEE
Q ss_conf 28885572135776459999977--99--399999907999998147999999999983289883332248986188015
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA--SG--EIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 871 (1067)
++|++.+.||+|+||.||+|++. ++ ..||||++...........++|.+|+.+++.++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEEC
Q ss_conf 99995458988788605675689996879999999999999988189999252688998566489998299502343003
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~ 951 (1067)
+||||+++|++.+++.. ....+++..+.+++.|++.|+.|||++ +|+||||||+||+++.++.+|++|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf 14654238612544421--268999999999999999999875217---8752056688815655654332561155530
Q ss_pred CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCCC--C
Q ss_conf 899996---000222343247312235888962136899999999882-9999984310000001133333110499--9
Q 001494 952 KPDSSN---WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDP--R 1025 (1067)
Q Consensus 952 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~ 1025 (1067)
...... .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||....... ....+... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--------~~~~i~~~~~~ 233 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--------ILHKIDKEGER 233 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTSCCC
T ss_pred CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHHCCCC
T ss_conf 3588752654763257310799998379999421566148999999968999999969999--------99999847999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 99999404999999999997612799999999889988820
Q 001494 1026 LPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1026 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
+..+.... .++.+++.+||+.||++|||+.+|.+.|+
T Consensus 234 ~~~~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~ 270 (273)
T d1u46a_ 234 LPRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLL 270 (273)
T ss_dssp CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 99854453----99999999976889667929999999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.79 Aligned_cols=251 Identities=24% Similarity=0.422 Sum_probs=204.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECC----CCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEE
Q ss_conf 288855721357764599999779----9399999907999998147999999999983289883332248986188015
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELAS----GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 871 (1067)
++|++++.||+|+||.||+|.+.. +..||+|++... ......+.+.+|+.+++.++||||+++++++. ++..|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEE
T ss_conf 9969877993078829999999369964499999993656--68799999999999998689999856988995-37479
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEEC
Q ss_conf 99995458988788605675689996879999999999999988189999252688998566489998299502343003
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 872 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~ 951 (1067)
+||||+++|++.+++.. ....+++..++.++.|++.|+.|||++ +++||||||+||+++.++.+|++|||+|+..
T Consensus 84 iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEEC
T ss_conf 99984069807765422--478999999999999998775230226---7441410265532067896787650342133
Q ss_pred CCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCC-CCCCC
Q ss_conf 89999-6000222343247312235888962136899999999882-999998431000000113333311049-99999
Q 001494 952 KPDSS-NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILD-PRLPI 1028 (1067)
Q Consensus 952 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 1028 (1067)
..... ......||+.|+|||++.+..++.++|||||||++|||++ |..||....... ....+.. .....
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--------~~~~i~~~~~~~~ 230 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERLPM 230 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCCCCC
T ss_pred CCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHCCCCCCC
T ss_conf 67762330540058310326675169988745244424789999826999988899999--------9999981899989
Q ss_pred CCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 99404999999999997612799999999889988820
Q 001494 1029 PSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1029 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
+..... ++.+++.+||+.||++|||+.+|++.|+
T Consensus 231 ~~~~~~----~~~~li~~cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 231 PPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp CTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCH----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 877799----9999999976879768929999999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.08 Aligned_cols=257 Identities=23% Similarity=0.404 Sum_probs=202.7
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEEEC
Q ss_conf 528885572135776459999977------9939999990799999814799999999998328-988333224898618
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHA 867 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 867 (1067)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+..|...+.++ +|+||+.+++++.++
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCC
T ss_conf 79979844984167839999998677755578399999986001--7178999999999988614998499741154047
Q ss_pred -CCEEEEEEECCCCCHHHHHCCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf -801599995458988788605675-------------689996879999999999999988189999252688998566
Q 001494 868 -QHSFIVYEYLEMGSLAMILSNDAA-------------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVL 933 (1067)
Q Consensus 868 -~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nil 933 (1067)
...++||||+++|+|.+++..... ...+++..+..++.|++.|+.|||++ +|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEE
T ss_conf 9757999984589929999985366666532220233214689999999999999999988737---9717867731065
Q ss_pred ECCCCCEEEECCCCCEECCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCCCC
Q ss_conf 48999829950234300389999--600022234324731223588896213689999999988299-999843100000
Q 001494 934 LDFKNEARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPGDFISLISSS 1010 (1067)
Q Consensus 934 l~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~P~~~~~~~~~~ 1010 (1067)
++.++.+||+|||+|+....... ......||+.|+|||++.+..++.++||||+||++|||++|. .||.......
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-- 244 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 244 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--
T ss_pred ECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHH--
T ss_conf 779982898457520011356652224751667210203686468899663221367899999868899998999899--
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 01133333110499999999404999999999997612799999999889988820
Q 001494 1011 SLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
.......+. ..+..+....+ ++.+++.+||+.||++|||+.++++.|+
T Consensus 245 --~~~~~~~~~--~~~~~~~~~~~----~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 245 --EFCRRLKEG--TRMRAPDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp --HHHHHHHHT--CCCCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHHHHHHCC--CCCCCCCCCCH----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf --999999638--98888865789----9999999976779667919999999997
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.47 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=204.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCC--EEEEEEECCCCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEEECCCEE
Q ss_conf 28885572135776459999977-993--9999990799999814799999999998328-9883332248986188015
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGE--IIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 871 (1067)
++|++.++||+|+||.||+|+++ ++. .||||++..... ....+.+.+|+.+++.+ +||||++++|++.+++..|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
T ss_conf 99688779820788289999998999699999999782338--5799999999999986228998836788884187369
Q ss_pred EEEEECCCCCHHHHHCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC
Q ss_conf 999954589887886056-------------7568999687999999999999998818999925268899856648999
Q 001494 872 IVYEYLEMGSLAMILSND-------------AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN 938 (1067)
Q Consensus 872 lv~e~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~ 938 (1067)
+||||+++|+|.++++.. .....+++.++.+++.|++.|+.|+|++ +++||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCC
T ss_conf 99980289869999864035555512310123457899999999999999998766308---954555052048986887
Q ss_pred CEEEECCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCCCCCCCCCHHHHHH
Q ss_conf 8299502343003899996000222343247312235888962136899999999882999-998431000000113333
Q 001494 939 EARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH-PGDFISLISSSSLNLNIA 1017 (1067)
Q Consensus 939 ~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-P~~~~~~~~~~~~~~~~~ 1017 (1067)
.+||+|||+|+..... .......||..|+|||.+.+..++.++||||||+++|||++|.. ||...... ..
T Consensus 165 ~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--------~~ 235 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------EL 235 (309)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HH
T ss_pred CEEECCCCCCCCCCCC-CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHH--------HH
T ss_conf 6387434432244422-34553013775555387526999962215313889999983689999999999--------99
Q ss_pred HHHCCC-CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 311049-9999999404999999999997612799999999889988820
Q 001494 1018 LDEILD-PRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1018 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
...+.. .++..+..... ++.+++.+||+.||++||||.+|++.|+
T Consensus 236 ~~~i~~~~~~~~~~~~~~----~~~~li~~cl~~dP~~RPs~~eil~~L~ 281 (309)
T d1fvra_ 236 YEKLPQGYRLEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSLN 281 (309)
T ss_dssp HHHGGGTCCCCCCTTBCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHCCCCCCCCCCCH----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 999982688888766789----9999999976789668949999999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.76 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=207.0
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECC
Q ss_conf 528885572135776459999977------99399999907999998147999999999983289883332248986188
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVELA------SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 868 (1067)
.++|+..+.||+|+||.||+|.+. +++.||||++... ........+.+|+.++++++||||+++++++..+.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 8991883598207881899999878644778968999998701--28689999999999999769998841254784288
Q ss_pred CEEEEEEECCCCCHHHHHCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf 015999954589887886056-------7568999687999999999999998818999925268899856648999829
Q 001494 869 HSFIVYEYLEMGSLAMILSND-------AAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEAR 941 (1067)
Q Consensus 869 ~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~k 941 (1067)
..++||||+++|+|.+++... .....+++..+.+++.|+++|+.|||++ +|+||||||+|||++.++.+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEE
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEEE
T ss_conf 10677760489988999875033211344468879999999999999999987647---965432867754035996499
Q ss_pred EECCCCCEECCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCCCCCHHHHHHH
Q ss_conf 9502343003899996--00022234324731223588896213689999999988299-99984310000001133333
Q 001494 942 VSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPGDFISLISSSSLNLNIAL 1018 (1067)
Q Consensus 942 l~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~P~~~~~~~~~~~~~~~~~~ 1018 (1067)
|+|||+|+........ .....+++.|+|||.+.+..++.++||||||+++|||+||. .||..... ....
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--------~~~~ 245 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVL 245 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------HHHH
T ss_pred EEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH--------HHHH
T ss_conf 94245420235776303134023163237888873699883334443789999999689999999899--------9999
Q ss_pred HHCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 11049999-9999404999999999997612799999999889988820
Q 001494 1019 DEILDPRL-PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1019 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
..+.++.. ..+.... ..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 246 ~~i~~~~~~~~p~~~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~ 290 (308)
T d1p4oa_ 246 RFVMEGGLLDKPDNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIK 290 (308)
T ss_dssp HHHHTTCCCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred HHHHHCCCCCCCCCCH----HHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 9998088888863353----99999999975779658939999999978
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.24 Aligned_cols=247 Identities=28% Similarity=0.417 Sum_probs=202.5
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEE-CCCEEEEE
Q ss_conf 28885572135776459999977993999999079999981479999999999832898833322489861-88015999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH-AQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 874 (1067)
++|++.+.||+|+||.||+|+.+ ++.||||++.... ..+.+.+|++++++++||||++++|++.+ .+..|+||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH-----HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 99488579820798089999999-9099999988577-----79999999999986789898549878872389289999
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf 95458988788605675689996879999999999999988189999252688998566489998299502343003899
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~ 954 (1067)
||+++|+|.+++.... ...+++..+++++.|++.|+.|||+. +++||||||+||+++.++.+|++|||+++....
T Consensus 81 ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp CCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ECCCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCC-
T ss_conf 6369998999987457-88889999999999998523211337---655366656760146899776324560034478-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Q ss_conf 996000222343247312235888962136899999999882-9999984310000001133333110499999999404
Q 001494 955 SSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSSSLNLNIALDEILDPRLPIPSHNV 1033 (1067)
Q Consensus 955 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1067)
......+++.|+|||++.+..++.++||||||+++|||+| |+.||....... ....+... .++..+....
T Consensus 156 --~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-----~~~~i~~~--~~~~~~~~~~ 226 (262)
T d1byga_ 156 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRVEKG--YKMDAPDGCP 226 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----HHHHHTTT--CCCCCCTTCC
T ss_pred --CCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHCC--CCCCCCCCCC
T ss_conf --77655666467781787279888588777579999999978999999999999-----99999808--9999976579
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 999999999997612799999999889988820
Q 001494 1034 QEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1034 ~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
+ ++.+++.+||+.||++|||+.++++.|+
T Consensus 227 ~----~~~~li~~cl~~dP~~Rps~~~l~~~L~ 255 (262)
T d1byga_ 227 P----AVYEVMKNCWHLDAAMRPSFLQLREQLE 255 (262)
T ss_dssp H----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 9----9999999975669768939999999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.47 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=206.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECC--------CCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEEE
Q ss_conf 288855721357764599999779--------939999990799999814799999999998328-98833322489861
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELAS--------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSH 866 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 866 (1067)
++|++++.||+|+||.||+|+... +..||||++.... ......++.+|...+.++ +|||||++++++.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf 996970098516782899999857875556675499999988112--868899999999999981399969734652201
Q ss_pred CCCEEEEEEECCCCCHHHHHCCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 8801599995458988788605675-------------689996879999999999999988189999252688998566
Q 001494 867 AQHSFIVYEYLEMGSLAMILSNDAA-------------AEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVL 933 (1067)
Q Consensus 867 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nil 933 (1067)
++..++||||+++|++.+++..... ...+++.++++++.|++.|++|||++ +++||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEE
T ss_conf 8868999973699909999986067764322233457434679999999999999999876637---9786302210224
Q ss_pred ECCCCCEEEECCCCCEECCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCC
Q ss_conf 48999829950234300389999--6000222343247312235888962136899999999882-99999843100000
Q 001494 934 LDFKNEARVSDFGIAKFLKPDSS--NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPGDFISLISSS 1010 (1067)
Q Consensus 934 l~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~ 1010 (1067)
++.++.+||+|||+++....... ......+++.|+|||.+.+..|+.++||||||+++|||++ |+.||.......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-- 245 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 245 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHH--
T ss_conf 547897676221110113555554314667888466326675179888255547758888874017989899999999--
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 01133333110499999999404999999999997612799999999889988820
Q 001494 1011 SLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
....+.. ...+..+..... ++.+++.+||+.||.+||||.||++.|+
T Consensus 246 ---~~~~i~~--~~~~~~p~~~~~----~l~~li~~cl~~dP~~Rps~~eil~~L~ 292 (299)
T d1fgka_ 246 ---LFKLLKE--GHRMDKPSNCTN----ELYMMMRDCWHAVPSQRPTFKQLVEDLD 292 (299)
T ss_dssp ---HHHHHHT--TCCCCCCSSCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHHHHHC--CCCCCCCCCCHH----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf ---9999972--888898743529----9999999976679767939999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.95 Aligned_cols=256 Identities=24% Similarity=0.420 Sum_probs=206.1
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE------CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCC-CCCEEEEEEEEEEECC
Q ss_conf 2888557213577645999997------79939999990799999814799999999998328-9883332248986188
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL------ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI-RHRNIVKFYGFCSHAQ 868 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 868 (1067)
++|++++.||+|+||.||+|++ .+++.||||++.... ......++.+|+.+++.+ +|||||++++++.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 9969854982068829999998066447788699999987424--87799999999999876269998878998983199
Q ss_pred CEEEEEEECCCCCHHHHHCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 0159999545898878860567---------------5689996879999999999999988189999252688998566
Q 001494 869 HSFIVYEYLEMGSLAMILSNDA---------------AAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVL 933 (1067)
Q Consensus 869 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nil 933 (1067)
..++||||+++|++.+++.... ....+++..+.+++.|++.|++|||++ +++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCC
T ss_conf 7899997379987999998535665444445332223345889999999999999999988757---9266624102100
Q ss_pred ECCCCCEEEECCCCCEECCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCC-CCCCCCCCCC
Q ss_conf 489998299502343003899996--0002223432473122358889621368999999998829999-9843100000
Q 001494 934 LDFKNEARVSDFGIAKFLKPDSSN--WTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-GDFISLISSS 1010 (1067)
Q Consensus 934 l~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P-~~~~~~~~~~ 1010 (1067)
++.++.+|++|||.++........ .....||+.|+|||++.+..++.++||||||+++|||+|++.| |.......
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-- 255 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH--
T ss_conf 002575210234010233678861586201359687677886179999740010258999999858998877899899--
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 01133333110499999999404999999999997612799999999889988820
Q 001494 1011 SLNLNIALDEILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
.......... ....+..... .+.+++.+||+.||.+|||+.++++.|+
T Consensus 256 --~~~~~i~~~~--~~~~~~~~~~----~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 256 --KFYKMIKEGF--RMLSPEHAPA----EMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp --HHHHHHHHTC--CCCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHHHHHHCCC--CCCCCCCCCH----HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf --9999986689--8898543659----9999999975779657929999999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.26 Aligned_cols=263 Identities=21% Similarity=0.326 Sum_probs=203.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEE
Q ss_conf 2888557213577645999997-799399999907999998147999999999983289883332248986188015999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 874 (1067)
++|++.+.||+|+||+||+|.. .+++.||+|++......+ ...+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCH-HHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 99776517723768099999999999799999980222575-89999999999998679983887445332243203788
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf 95458988788605675689996879999999999999988189999252688998566489998299502343003899
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~ 954 (1067)
||+.++.+..... .....+++..+..++.|++.|+.|||++ +|+||||||+||+++.++.+|++|||.|+.....
T Consensus 81 e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 81 EFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp ECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred EECCCCHHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCC
T ss_conf 6237744555442--0256888899999999999999986528---8992135711401134676210357861343688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHH-------HHH---HHHCCC
Q ss_conf 99600022234324731223588-8962136899999999882999998431000000113-------333---311049
Q 001494 955 SSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL-------NIA---LDEILD 1023 (1067)
Q Consensus 955 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~-------~~~---~~~~~~ 1023 (1067)
........|++.|+|||.+.... ++.++||||+||++|+|++|+.||............. ... ......
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred CCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCC
T ss_conf 64100103652154112213665777422103333134279668799898899999999998328983331444222421
Q ss_pred --CCC-CCCCCCH----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf --999-9999404----9999999999976127999999998899888
Q 001494 1024 --PRL-PIPSHNV----QEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1024 --~~~-~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~ 1064 (1067)
... ....... .....++.+++.+||..||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 243454322220444166789999999999763995579189999678
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.84 Aligned_cols=258 Identities=22% Similarity=0.280 Sum_probs=198.3
Q ss_pred CCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEEEE
Q ss_conf 557213577645999997-7993999999079999981--4799999999998328988333224898618801599995
Q 001494 800 DEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEM--TFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYEY 876 (1067)
Q Consensus 800 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 876 (1067)
..++||+|+||+||+|+. .+++.||||++........ ...+.+.+|+.+++.++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCCC
Q ss_conf 45898878860567568999687999999999999998818999925268899856648999829950234300389999
Q 001494 877 LEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDSS 956 (1067)
Q Consensus 877 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~ 956 (1067)
++++++...... ...+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred HCCHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC
T ss_conf 345077655412---66778999999999999999886316---355035776258853778411465761000578755
Q ss_pred CCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHH-------HHHHHHCC----CC
Q ss_conf 60002223432473122358-88962136899999999882999998431000000113-------33331104----99
Q 001494 957 NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL-------NIALDEIL----DP 1024 (1067)
Q Consensus 957 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~-------~~~~~~~~----~~ 1024 (1067)
.....+||+.|+|||++.+. .++.++||||+||++|||++|..||............. ........ ..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHH
T ss_conf 43302047333639997267788805643630428999985969999999999999999851899725452100021344
Q ss_pred CC-CCCCCCH----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 99-9999404----999999999997612799999999889988
Q 001494 1025 RL-PIPSHNV----QEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1025 ~~-~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
.. ..+.... .....++.+++.+||+.||++||||.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 30347898867856568999999999976389456908999967
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.35 Aligned_cols=262 Identities=24% Similarity=0.317 Sum_probs=196.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECC----CEE
Q ss_conf 2888557213577645999997799399999907999998147999999999983289883332248986188----015
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ----HSF 871 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~ 871 (1067)
++|...+.||+|+||.||+|++. |+.||||++... .........|+..+..++||||+++++++.+++ ..|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCC----CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
T ss_conf 68999889820788199999999-989999998720----0467999999999962799868326889983798604899
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf 99995458988788605675689996879999999999999988189-----9992526889985664899982995023
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDC-----FPPIVHRDISSKNVLLDFKNEARVSDFG 946 (1067)
Q Consensus 872 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dik~~Nill~~~~~~kl~Dfg 946 (1067)
+||||+++|+|.+++++. .++|..+++++.+++.|++|+|+.. .++|+||||||+|||++.++.+||+|||
T Consensus 78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEECCCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECC
T ss_conf 999646698989998658----9998999999999999999988766520468986615317313578688776887638
Q ss_pred CCEECCCCCC----CCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCC-----
Q ss_conf 4300389999----600022234324731223588------8962136899999999882999998431000000-----
Q 001494 947 IAKFLKPDSS----NWTELAGTYGYVAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSS----- 1011 (1067)
Q Consensus 947 la~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~----- 1011 (1067)
+++....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+..........
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC
T ss_conf 66234677762001355250354767822105654546777675012201599999996289988766311241012255
Q ss_pred --HHHHHHHHHCCCCCC--CCCCC-CHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf --113333311049999--99994-04999999999997612799999999889988820
Q 001494 1012 --LNLNIALDEILDPRL--PIPSH-NVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1012 --~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
............... ..+.. ...+....+.+++.+||+.||.+|||+.||++.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 643099999987502468887765577689999999999976069858959999999999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=336.67 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=204.9
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEEE
Q ss_conf 28885572135776459999977993999999079999981479999999999832898833322489861880159999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVYE 875 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 875 (1067)
++|++.++||+|+||+||+|+.++++.||||++...... ....+.+.+|+.+++.++||||+++++++..++..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEE
T ss_conf 996343187227781899999689999999998123268-5899999999999986799868766012046773158997
Q ss_pred ECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCCC
Q ss_conf 54589887886056756899968799999999999999881899992526889985664899982995023430038999
Q 001494 876 YLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPDS 955 (1067)
Q Consensus 876 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~ 955 (1067)
++.++.+..+... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.|.......
T Consensus 81 ~~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EEHHHHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf 4004567899860---47751445689999999999986057---48826787750568689978732366430114676
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHH-------H---HHHHC---
Q ss_conf 960002223432473122358-889621368999999998829999984310000001133-------3---33110---
Q 001494 956 SNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------I---ALDEI--- 1021 (1067)
Q Consensus 956 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~-------~---~~~~~--- 1021 (1067)
.......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.............. . .....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 54101024311013788717888884100211175899997797998988989999999986389971104212333221
Q ss_pred ---CCCCCCCCC-CCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf ---499999999-404999999999997612799999999889988
Q 001494 1022 ---LDPRLPIPS-HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1022 ---~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
.......+. .........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 4333335676466651258999999999986689668909999856
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.54 Aligned_cols=262 Identities=19% Similarity=0.307 Sum_probs=193.8
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CC-CCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCC---CCCEEEEEEEEEEE---
Q ss_conf 52888557213577645999997-79-939999990799999814799999999998328---98833322489861---
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-AS-GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEI---RHRNIVKFYGFCSH--- 866 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~--- 866 (1067)
.++|++.+.||+|+||+||+|+. .+ ++.||+|++......+.. ...+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHH-HHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 589798889921558699999998889989999998023245167-9999999999998742589880236632214666
Q ss_pred --CCCEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEC
Q ss_conf --880159999545898878860567568999687999999999999998818999925268899856648999829950
Q 001494 867 --AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSD 944 (1067)
Q Consensus 867 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~D 944 (1067)
....++++||++++.+..... .....+++..+..++.|++.|++|||++ +|+||||||+|||++.++.+|++|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCCEEEEEEEECCCCCHHHHHH--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEECC
T ss_conf 66746999997405871444443--0378999899999999999999999758---898357986278985899754210
Q ss_pred CCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHH-------HH
Q ss_conf 23430038999960002223432473122358889621368999999998829999984310000001133-------33
Q 001494 945 FGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN-------IA 1017 (1067)
Q Consensus 945 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~-------~~ 1017 (1067)
||+++.... ........||+.|+|||++.+.+++.++||||+||++|||++|+.||.............. ..
T Consensus 160 fg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 160 FGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred HHHHHHHCC-CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHC
T ss_conf 001011002-3457776548511483100179888111000328999999878799899898999999998407996110
Q ss_pred H-------HHCCCCCCCCC-CCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 3-------11049999999-9404999999999997612799999999889988
Q 001494 1018 L-------DEILDPRLPIP-SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1018 ~-------~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
. ..........+ ..........+.+++.+||+.||++||||.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 532111103330223456454404458999999999987489667918999966
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.66 Aligned_cols=242 Identities=21% Similarity=0.344 Sum_probs=196.4
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHH---HHHHHHHHHHHHHCCC--CCEEEEEEEEEEECCC
Q ss_conf 2888557213577645999997-79939999990799999814---7999999999983289--8833322489861880
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMT---FQQEFLNEVKALTEIR--HRNIVKFYGFCSHAQH 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 869 (1067)
++|++++.||+|+||+||+|+. .+++.||+|++......+.. ....+.+|+.+++.++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEEECCC-CCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEECCCC
Q ss_conf 1599995458-9887886056756899968799999999999999881899992526889985664899-9829950234
Q 001494 870 SFIVYEYLEM-GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFK-NEARVSDFGI 947 (1067)
Q Consensus 870 ~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~-~~~kl~Dfgl 947 (1067)
.|+||||+.+ +++.+++.. ...+++..+..++.|++.|++|||++ +|+||||||+||+++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEECCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCCCC
T ss_conf 89999833686228999861---58999999999999999999999877---9755667611147744788489775465
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 3003899996000222343247312235888-962136899999999882999998431000000113333311049999
Q 001494 948 AKFLKPDSSNWTELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL 1026 (1067)
Q Consensus 948 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1067)
|+.... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... +.....
T Consensus 158 a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~~~~~ 221 (273)
T d1xwsa_ 158 GALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIRGQV 221 (273)
T ss_dssp CEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHHCCC
T ss_pred CEECCC--CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH--------------HHHCCC
T ss_conf 353244--4556656587747999984899788653325540345367568899887367--------------761544
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 9999404999999999997612799999999889988
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
..+..... ++.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~s~----~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 FFRQRVSS----ECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCSSCCCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCH----HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 77877999----9999999976089758939999853
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.15 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=198.2
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECC-----
Q ss_conf 52888557213577645999997-799399999907999998147999999999983289883332248986188-----
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ----- 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 868 (1067)
.++|++.+.||+|+||+||+|.. .+++.||+|++..... .....+.+.+|+.+++.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 7718998898017781999999999998999999852225-969999999999999866898754799986357655554
Q ss_pred -CEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf -0159999545898878860567568999687999999999999998818999925268899856648999829950234
Q 001494 869 -HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGI 947 (1067)
Q Consensus 869 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgl 947 (1067)
..|+||||+ ++++...... ..+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEECC-CCCHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCCC
T ss_conf 1599998405-5218999874----0226999999999999999998737---876456685111121001221134310
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHH------------
Q ss_conf 30038999960002223432473122358-88962136899999999882999998431000000113------------
Q 001494 948 AKFLKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL------------ 1014 (1067)
Q Consensus 948 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~------------ 1014 (1067)
|+.... ..+...|++.|+|||++.+. .++.++||||+||++|||++|+.||.............
T Consensus 168 a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 168 ARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred EECCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHH
T ss_conf 220687---63102455333588998178789965010300389999997869988897689999998503788488886
Q ss_pred ------HHHHHHCCCCCCCCC-CCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ------333311049999999-94049999999999976127999999998899888
Q 001494 1015 ------NIALDEILDPRLPIP-SHNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1015 ------~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~ 1064 (1067)
............... ..........+.+++.+||..||++||||.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 530003443311578666556677556899999999999772995579299999639
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.59 Aligned_cols=261 Identities=21% Similarity=0.269 Sum_probs=197.3
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECC----C
Q ss_conf 52888557213577645999997-799399999907999998147999999999983289883332248986188----0
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQ----H 869 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 869 (1067)
..+|++.+.||+|+||+||+|.. .+++.||||++... ......+.+.+|+.+++.++||||+++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHH--CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf 89859978994064809999999999949999998031--0958999999999999976898988588899505645541
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCE
Q ss_conf 15999954589887886056756899968799999999999999881899992526889985664899982995023430
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK 949 (1067)
Q Consensus 870 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~ 949 (1067)
.+++++++.+|+|.+++.. ..+++..+..++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 85 ~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEEECCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf 4999996259865664405----8999999999999999999999978---98677787643788799977875457056
Q ss_pred ECCCCCC---CCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHH----------
Q ss_conf 0389999---600022234324731223-58889621368999999998829999984310000001133----------
Q 001494 950 FLKPDSS---NWTELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN---------- 1015 (1067)
Q Consensus 950 ~~~~~~~---~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~---------- 1015 (1067)
....... ......|++.|+|||++. +..++.++||||+||++|||++|+.||..............
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf 50477764101011026520003878604788874101004670133776697997888889999987652069975664
Q ss_pred -------HHHHHCCCCCCCCCC--CCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -------333110499999999--4049999999999976127999999998899888
Q 001494 1016 -------IALDEILDPRLPIPS--HNVQEKLISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1016 -------~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~ 1064 (1067)
........+.....+ ........++.+++.+||+.||++||||.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2343322220244677557787778378999999999999764895679089998619
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.26 Aligned_cols=257 Identities=23% Similarity=0.272 Sum_probs=192.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEEC------C
Q ss_conf 2888557213577645999997-79939999990799999814799999999998328988333224898618------8
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA------Q 868 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 868 (1067)
.+|+..++||+|+||+||+|+. .+++.||||++..... ...+|+.+++.++||||+++++++... .
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 776751698217683999999999997999999881606-------8999999998668989873878997447657731
Q ss_pred CEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEECCCC
Q ss_conf 0159999545898878860567568999687999999999999998818999925268899856648999-829950234
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN-EARVSDFGI 947 (1067)
Q Consensus 869 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~-~~kl~Dfgl 947 (1067)
+.|+||||++++..............+++..+..++.|++.|++|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCC
T ss_conf 8999984168860788886310368999999999999999999999866---8764578860378735897116733660
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHH-------HHHHHH
Q ss_conf 3003899996000222343247312235-88896213689999999988299999843100000011-------333331
Q 001494 948 AKFLKPDSSNWTELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN-------LNIALD 1019 (1067)
Q Consensus 948 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~-------~~~~~~ 1019 (1067)
++..... .......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||............ ......
T Consensus 170 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 170 AKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred HHHCCCC-CCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHH
T ss_conf 5440477-653200255555682776404688821000246527785502879989879999999999974898177654
Q ss_pred ----HCCC---CCCCCCC---CCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf ----1049---9999999---404999999999997612799999999889988
Q 001494 1020 ----EILD---PRLPIPS---HNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1020 ----~~~~---~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
.... +...... ........++.+++.+||..||++||||.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 306210110355445674444315689999999999976589557929999966
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.42 Aligned_cols=263 Identities=19% Similarity=0.292 Sum_probs=198.8
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEE-------
Q ss_conf 52888557213577645999997-7993999999079999981479999999999832898833322489861-------
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSH------- 866 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------- 866 (1067)
.++|++.++||+|+||+||+|+. .+|+.||||++......+ .....+.+|+.+++.++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCH-HHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCC
T ss_conf 279889999722748299999998999799999984222463-7899999999999983599966067654024654444
Q ss_pred -CCCEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf -8801599995458988788605675689996879999999999999988189999252688998566489998299502
Q 001494 867 -AQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDF 945 (1067)
Q Consensus 867 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Df 945 (1067)
++..|+||||++++.+..... ....+++..+..++.|++.|+.|||++ +|+||||||+||+++.++.+|++||
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CCCEEEEEEECCCCCCCCHHHH---CCCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEEC
T ss_conf 5763899985357874101222---034433089999999999999885229---9885676722203668996876313
Q ss_pred CCCEECCCCCC----CCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH---
Q ss_conf 34300389999----60002223432473122358-88962136899999999882999998431000000113333---
Q 001494 946 GIAKFLKPDSS----NWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIA--- 1017 (1067)
Q Consensus 946 gla~~~~~~~~----~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~--- 1017 (1067)
|+++....... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||................
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 50022355444321135660249787428997079998917870067864661744879989989999999999841899
Q ss_pred ----HHHCC-------CCCCCCCCCCHHHH------HHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----31104-------99999999404999------9999999976127999999998899888
Q 001494 1018 ----LDEIL-------DPRLPIPSHNVQEK------LISFVEVAISCLDESPESRPTMQKVSQL 1064 (1067)
Q Consensus 1018 ----~~~~~-------~~~~~~~~~~~~~~------~~~l~~li~~cl~~dP~~Rpt~~ev~~~ 1064 (1067)
..... ............+. ...+.+++.+||+.||++||||.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8255344320344433201334455503340444599899999999873896589099999749
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.42 Aligned_cols=261 Identities=20% Similarity=0.279 Sum_probs=204.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEECCCEEEEE
Q ss_conf 2888557213577645999997-799399999907999998147999999999983289883332248986188015999
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHAQHSFIVY 874 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 874 (1067)
++|++.+.||+|+||+||+|+. .+++.||||+++.... .......+.+|+.+++.++||||+++++++.+....++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 997862697128681999999999996999999803217-8689999999999998567578882135444443115886
Q ss_pred EECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCEECCCC
Q ss_conf 95458988788605675689996879999999999999988189999252688998566489998299502343003899
Q 001494 875 EYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFLKPD 954 (1067)
Q Consensus 875 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~ 954 (1067)
|++.++++..+.... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+|++|||.|+.....
T Consensus 81 ~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 81 EFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred EECCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC
T ss_conf 302332221121235---6540367899999999998774339---9860014676121133782665204601104688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH--------------HHH
Q ss_conf 99600022234324731223588-896213689999999988299999843100000011333--------------331
Q 001494 955 SSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNI--------------ALD 1019 (1067)
Q Consensus 955 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~--------------~~~ 1019 (1067)
........+++.|+|||.+.... ++.++||||+||++|||++|+.||............... ...
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CCCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCC
T ss_conf 75100103443101466750698888044402654188998518999988999999999998611899735513443222
Q ss_pred HC-C---CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 10-4---99999999404999999999997612799999999889988
Q 001494 1020 EI-L---DPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1020 ~~-~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
+. . .+...............+.+++.+|++.||.+||||+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 113344454431043306568999999999986499668909999964
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.99 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=200.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEEC------C
Q ss_conf 28885572135776459999977-9939999990799999814799999999998328988333224898618------8
Q 001494 796 NDFDDEHCIGKGGQGSVYKVELA-SGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA------Q 868 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 868 (1067)
++|++.++||+|+||+||+|+.. +|+.||||++..... .......+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 775998896217585999999999998999999882336-9799999999999998648987648998970256434576
Q ss_pred CEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf 01599995458988788605675689996879999999999999988189999252688998566489998299502343
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948 (1067)
Q Consensus 869 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla 948 (1067)
..|+||||+.++.+.... ..+++..+..++.|++.|+.|||+. ||+||||||+||+++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEEEECCCHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf 269998414467787650------3899999999999999999886522---1124567763211365443132010232
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCC-----------------
Q ss_conf 003899996000222343247312235888962136899999999882999998431000000-----------------
Q 001494 949 KFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSS----------------- 1011 (1067)
Q Consensus 949 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~----------------- 1011 (1067)
+.... ........+|+.|+|||++.+..++.++||||+||++|||++|+.||..........
T Consensus 167 ~~~~~-~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 167 RTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred HCCCC-CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHH
T ss_conf 11466-65533221465555813314777787743335662578986598998889778899999972058987999876
Q ss_pred -HHHHHHHHHC-----------C-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf -1133333110-----------4-99999999404999999999997612799999999889988
Q 001494 1012 -LNLNIALDEI-----------L-DPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1012 -~~~~~~~~~~-----------~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
.......... . .................+.+++.+|+..||++||||+|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 56677776417543566642126433354321013337999999999987699457908999966
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=319.60 Aligned_cols=257 Identities=19% Similarity=0.248 Sum_probs=193.9
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCE-EEEEEEEEEECCCEEE
Q ss_conf 52888557213577645999997-799399999907999998147999999999983289883-3322489861880159
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN-IVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~l 872 (1067)
.++|++.+.||+|+||.||+|+. .+++.||||+...... .+++..|+++++.++|++ |+.+.+++.+.+..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC-----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEE
T ss_conf 8889996898507880999999988998999999721005-----88899999999970389960179999951987789
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEECCCCCE
Q ss_conf 9995458988788605675689996879999999999999988189999252688998566489---9982995023430
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF---KNEARVSDFGIAK 949 (1067)
Q Consensus 873 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~---~~~~kl~Dfgla~ 949 (1067)
||||++ +++.+.+.. ....+++..+..++.|++.|++|||++ +|+||||||+||+++. +..+|++|||+|+
T Consensus 81 vme~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEECCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEECC-CCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCE
T ss_conf 998738-713332443--068876899999999999999999979---94426678766064335777615650467513
Q ss_pred ECCCCCC-------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 0389999-------600022234324731223588896213689999999988299999843100000011333331104
Q 001494 950 FLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEIL 1022 (1067)
Q Consensus 950 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1022 (1067)
....... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred ECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 42554455410001357767873532999991899898321886177899998498766553057799999985235678
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 99999999404999999999997612799999999889988820
Q 001494 1023 DPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1023 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
.+...... ..+.++.+++..||+.+|++||++.++.+.|+
T Consensus 235 ~~~~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 235 TPIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp SCHHHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred CCHHHHCC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 98357534----78899999999984399557919999999999
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=316.14 Aligned_cols=252 Identities=20% Similarity=0.300 Sum_probs=194.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEEEC--CCEE
Q ss_conf 2888557213577645999997-799399999907999998147999999999983289-88333224898618--8015
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHA--QHSF 871 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~ 871 (1067)
++|++.++||+|+||+||+|+. .+++.||+|++... . .+.+.+|+.+++.+. ||||+++++++... ...+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---K---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---C---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---H---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEE
T ss_conf 6718978983174819999998899979999998889---9---999999999998515799876799999816877126
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEECCCCCEE
Q ss_conf 9999545898878860567568999687999999999999998818999925268899856648999-829950234300
Q 001494 872 IVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKN-EARVSDFGIAKF 950 (1067)
Q Consensus 872 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~-~~kl~Dfgla~~ 950 (1067)
+||||+++++|.... ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+|++|||+|+.
T Consensus 109 ~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEEEECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEE
T ss_conf 888631798589974------6899999999999999999887643---3443456441237748998366415654266
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHH---------------
Q ss_conf 38999960002223432473122358-88962136899999999882999998431000000113---------------
Q 001494 951 LKPDSSNWTELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNL--------------- 1014 (1067)
Q Consensus 951 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~--------------- 1014 (1067)
.... .......+|+.|+|||.+.+. .++.++||||+||++||+++|+.||.............
T Consensus 180 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 180 YHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf 4688-744432248642476102688888845232335455587604889998876018999999998788415555542
Q ss_pred -----HHHHHHCCCCCCC------CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf -----3333110499999------999404999999999997612799999999889988
Q 001494 1015 -----NIALDEILDPRLP------IPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1015 -----~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
............. ...........++.+++.+||..||.+|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 254447430000033343311211552112448999999999986699568908999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.10 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=202.2
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE----CCCCEEEEEEECCCCC-CCHHHHHHHHHHHHHHHCCCC-CEEEEEEEEEEECCC
Q ss_conf 2888557213577645999997----7993999999079999-981479999999999832898-833322489861880
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL----ASGEIIAVKKFHSPLP-GEMTFQQEFLNEVKALTEIRH-RNIVKFYGFCSHAQH 869 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 869 (1067)
++|++.+.||+|+||+||+|+. .+|+.||+|++..... .+....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCE
Q ss_conf 15999954589887886056756899968799999999999999881899992526889985664899982995023430
Q 001494 870 SFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIAK 949 (1067)
Q Consensus 870 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~ 949 (1067)
.++++||+.+|+|.+++.... .+.+..+..++.|++.|+.|+|+. +++||||||+||+++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 001231234117999987304---543788888899999999885149---98965477320124699988874132022
Q ss_pred ECCCCC-CCCCCCCCCCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 038999-960002223432473122358--88962136899999999882999998431000000113333311049999
Q 001494 950 FLKPDS-SNWTELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDEILDPRL 1026 (1067)
Q Consensus 950 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1067)
.+.... .......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......... .........+..
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKSEP 253 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHHCCC
T ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHHHCCCCCC
T ss_conf 2034444322122233333106876057768871325177779999997689998888777799----999983356899
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 999940499999999999761279999999-----9889988
Q 001494 1027 PIPSHNVQEKLISFVEVAISCLDESPESRP-----TMQKVSQ 1063 (1067)
Q Consensus 1027 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----t~~ev~~ 1063 (1067)
..+..... ++.+++.+||++||++|| |++|+++
T Consensus 254 ~~~~~~s~----~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 PYPQEMSA----LAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCTTSCH----HHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCCCCH----HHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf 88654799----999999997445898819997450999974
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=314.59 Aligned_cols=257 Identities=17% Similarity=0.220 Sum_probs=198.6
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEEECCCEEE
Q ss_conf 52888557213577645999997-799399999907999998147999999999983289-8833322489861880159
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 872 (1067)
..+|++.+.||+|+||+||+|+. .+++.||+|++..... ...+.+|++.++.+. |++++.+++++......++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEE
T ss_conf 9806997998417882999999988997999999750258-----29999999999996489998779999601881179
Q ss_pred EEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEECCCC
Q ss_conf 9995458988788605675689996879999999999999988189999252688998566489-----99829950234
Q 001494 873 VYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDF-----KNEARVSDFGI 947 (1067)
Q Consensus 873 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~-----~~~~kl~Dfgl 947 (1067)
||||+ +++|.+++... ...+++..+..++.|++.|++|||++ ||+||||||+||+++. ++.+|++|||+
T Consensus 79 vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEEC-CCCHHHHHHHH--CCCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCE
T ss_conf 99964-88879999752--03110689999999999999999977---96626677131523475434479568723660
Q ss_pred CEECCCCCC-------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 300389999-------6000222343247312235888962136899999999882999998431000000113333311
Q 001494 948 AKFLKPDSS-------NWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLNIALDE 1020 (1067)
Q Consensus 948 a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1020 (1067)
|+....... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...................
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred EEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCC
T ss_conf 57714676654111024676277510267989648888869998983199999986987678853021999999997056
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf 0499999999404999999999997612799999999889988820
Q 001494 1021 ILDPRLPIPSHNVQEKLISFVEVAISCLDESPESRPTMQKVSQLLK 1066 (1067)
Q Consensus 1021 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~ev~~~L~ 1066 (1067)
...+...... ..+.++.+++..|+..+|++||+++.+.+.|+
T Consensus 233 ~~~~~~~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 233 QSTPLRELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp HHSCHHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred CCCCHHHHCC----CCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 7999589657----99899999999984399300859999999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.50 Aligned_cols=258 Identities=21% Similarity=0.302 Sum_probs=197.7
Q ss_pred HCCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEEC-----C
Q ss_conf 52888557213577645999997-79939999990799999814799999999998328988333224898618-----8
Q 001494 795 TNDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRNIVKFYGFCSHA-----Q 868 (1067)
Q Consensus 795 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 868 (1067)
.++|++.+.||+|+||+||+|+. .+++.||||++..... .....+.+.+|+.+++.++|||+|++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 9871888898317883999999999997999999882002-868999999999999866898742599999634645668
Q ss_pred CEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf 01599995458988788605675689996879999999999999988189999252688998566489998299502343
Q 001494 869 HSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARVSDFGIA 948 (1067)
Q Consensus 869 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla 948 (1067)
..+++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+|++|||.+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred CEEEEEEEECCCCHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf 64999996258862320022----4530999999999999999999738---8765166776334554322001321000
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHH------------
Q ss_conf 00389999600022234324731223588-89621368999999998829999984310000001133------------
Q 001494 949 KFLKPDSSNWTELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLNLN------------ 1015 (1067)
Q Consensus 949 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~------------ 1015 (1067)
.... .......|++.|+|||...+.. ++.++||||+||++|+|++|+.||..............
T Consensus 169 ~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 169 RHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp -CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred CCCC---CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 1257---5444434543555835533775678551243205899999768899788988999999997307997577320
Q ss_pred ---HHHHHCCCCCCCCCCCCHH----HHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf ---3331104999999994049----99999999997612799999999889988
Q 001494 1016 ---IALDEILDPRLPIPSHNVQ----EKLISFVEVAISCLDESPESRPTMQKVSQ 1063 (1067)
Q Consensus 1016 ---~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~ev~~ 1063 (1067)
.............+..... ....++.+++.+||..||.+||||.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 0102445444303557875556626789999999999977588345938999855
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=314.94 Aligned_cols=290 Identities=32% Similarity=0.538 Sum_probs=175.2
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCC--CEEEEECCCCC---CEEEEEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 679999999861456999998899998999985786--20159819999---5226651013554433687578899756
Q 001494 2 EEAHALLRWKTSLQNHNNGSPLSSWTFNNVTKIGSC--AWVGIHCNHGG---RVNSINLTSIGLKGTLHDFSFSSFPHLA 76 (1067)
Q Consensus 2 ~~~~~ll~~k~~~~~~~~~~~l~sw~~~~~~~~~~c--~w~gv~C~~~~---~v~~l~l~~~~l~~~l~~~~~~~l~~L~ 76 (1067)
+|++|||+||+++.++ ..++||+. +.||| +|.||+|+..+ ||++++|...++.|..
T Consensus 6 ~e~~aLl~~k~~~~~~---~~l~sW~~----~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~------------ 66 (313)
T d1ogqa_ 6 QDKQALLQIKKDLGNP---TTLSSWLP----TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY------------ 66 (313)
T ss_dssp HHHHHHHHHHHHTTCC---GGGTTCCT----TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCE------------
T ss_pred HHHHHHHHHHHHCCCC---CCCCCCCC----CCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCC------------
T ss_conf 9999999999977999---86778899----9999889488969748999479889989899888888------------
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 685359823357897643347664530688-7345889965323233434202342222678876666443332001125
Q 001494 77 YLDLWSNQLFGNIPPQIGNISKLKYLDLSS-NLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSN 155 (1067)
Q Consensus 77 ~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~-n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n 155 (1067)
.+|..+++|++|++|+|++ |.++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.++++.|
T Consensus 67 -----------~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N 135 (313)
T d1ogqa_ 67 -----------PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135 (313)
T ss_dssp -----------ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSS
T ss_pred -----------CCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCC
T ss_conf -----------798478467533520202654333002431145420011020356434433222220111001111224
Q ss_pred CCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCC-CEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 3456568775688865399976358768557765662324-401021454346558887764335523125676779978
Q 001494 156 YLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYL-LDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIP 234 (1067)
Q Consensus 156 ~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L-~~L~l~~n~l~~~~p~~l~~l~~L~~L~ls~n~l~~~~~ 234 (1067)
.+....|..+..++.|+.+++++|.+.+.+|..+..+..+ +.+.++.|++++..|..+..+.. ..++++.+...+.+|
T Consensus 136 ~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~ 214 (313)
T d1ogqa_ 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDAS 214 (313)
T ss_dssp EEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCG
T ss_pred CCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCC
T ss_conf 5555685122067400000023553356203121443112323102246435332433222222-233333343322222
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 54677644781572076466545864347554156887064253248875546786557994123345876664467764
Q 001494 235 SELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSN 314 (1067)
Q Consensus 235 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~ 314 (1067)
..+..+++++.+++++|.+.+.+| .+..+++|+.|++++|++++.+|..|.++++|+.|+|++|+++|.+|. ++.+++
T Consensus 215 ~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~ 292 (313)
T d1ogqa_ 215 VLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQR 292 (313)
T ss_dssp GGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGG
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCC
T ss_conf 222222221112222222222222-222455444444765706660876884799999897958835166898-666799
Q ss_pred CCEEECCCCC
Q ss_conf 3178636877
Q 001494 315 IAFLFLDSNS 324 (1067)
Q Consensus 315 L~~L~l~~n~ 324 (1067)
|+.+++.+|+
T Consensus 293 L~~l~l~~N~ 302 (313)
T d1ogqa_ 293 FDVSAYANNK 302 (313)
T ss_dssp SCGGGTCSSS
T ss_pred CCHHHHCCCC
T ss_conf 8978868895
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=287.10 Aligned_cols=258 Identities=17% Similarity=0.253 Sum_probs=190.6
Q ss_pred CCCCCCCCCCCCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCC-----------CCEEEEEEEE
Q ss_conf 2888557213577645999997-799399999907999998147999999999983289-----------8833322489
Q 001494 796 NDFDDEHCIGKGGQGSVYKVEL-ASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-----------HRNIVKFYGF 863 (1067)
Q Consensus 796 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~ 863 (1067)
.+|++.++||+|+||+||+|+. .+|+.||||++... ....+.+.+|+.+++.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC----CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEE
T ss_conf 8579989975077818999999999979999998343----133689999999999840145555542276764789987
Q ss_pred EEEC--CCEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCC-
Q ss_conf 8618--8015999954589887886056756899968799999999999999881-89999252688998566489998-
Q 001494 864 CSHA--QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHN-DCFPPIVHRDISSKNVLLDFKNE- 939 (1067)
Q Consensus 864 ~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dik~~Nill~~~~~- 939 (1067)
+... ...+.++++...+..............+++..+..++.|++.|++|||+ . +|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred EEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCC
T ss_conf 631256520234320003542000001223467868999999999999988876405---86465677057056305765
Q ss_pred -----EEEECCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCHH-
Q ss_conf -----29950234300389999600022234324731223588896213689999999988299999843100000011-
Q 001494 940 -----ARVSDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPGDFISLISSSSLN- 1013 (1067)
Q Consensus 940 -----~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~- 1013 (1067)
++++|||.|..... ......|++.|+|||++.+..++.++||||+||++++|++|+.||............
T Consensus 166 ~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CCCCEEEEEECCCCCCCCC---CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHH
T ss_conf 6443056753144212344---5422366521057132146677764320123789999987889989875543210268
Q ss_pred -H-----------HHHH------HHCCC--------CCCCC---------CCCCHHHHHHHHHHHHHHCCCCCCCCCCCH
Q ss_conf -3-----------3333------11049--------99999---------994049999999999976127999999998
Q 001494 1014 -L-----------NIAL------DEILD--------PRLPI---------PSHNVQEKLISFVEVAISCLDESPESRPTM 1058 (1067)
Q Consensus 1014 -~-----------~~~~------~~~~~--------~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~ 1058 (1067)
. .... ....+ ..... ...........+.+++.+|+..||.+||||
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 99999998379987886245322000132012202432357764442100015674358999999999877994579089
Q ss_pred HHHHH
Q ss_conf 89988
Q 001494 1059 QKVSQ 1063 (1067)
Q Consensus 1059 ~ev~~ 1063 (1067)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHHC
T ss_conf 99966
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=6.5e-39 Score=228.21 Aligned_cols=341 Identities=31% Similarity=0.398 Sum_probs=0.0
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99756685359823357897643347664530688734588996532323343420234222267887666644333200
Q 001494 72 FPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLA 151 (1067)
Q Consensus 72 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 151 (1067)
+.++++|+++++++... ..+..+++|++|++++|++++..+ ++++++|++|++++|.+++..| ++++++|+.|+
T Consensus 43 l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~ 116 (384)
T d2omza2 43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 116 (384)
T ss_dssp HTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HCCCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCC
T ss_conf 57878998999898776--242458999989681881798863--3477110103013433322221--11233433344
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 11253456568775688865399976358768557765662324401021454346558887764335523125676779
Q 001494 152 LYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFG 231 (1067)
Q Consensus 152 l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~ls~n~l~~ 231 (1067)
++++.+.+..+ ......+..+....|.+....+..................+. .+.............|...
T Consensus 117 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~- 188 (384)
T d2omza2 117 LFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK-----PLANLTTLERLDISSNKVS- 188 (384)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCG-----GGTTCTTCCEEECCSSCCC-
T ss_pred CCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH-----HHCCCCCCCCCCCCCCCCC-
T ss_conf 33222222222--222222211213466313100232222112222212322011-----1124542110112224333-
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 97854677644781572076466545864347554156887064253248875546786557994123345876664467
Q 001494 232 SIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGN 311 (1067)
Q Consensus 232 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~l~~ 311 (1067)
....+..++.+..+++++|.+++..| +...++|+.|++++|.++.. ..+..+++|+.+++++|.+.+..+ +..
T Consensus 189 -~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~ 261 (384)
T d2omza2 189 -DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSG 261 (384)
T ss_dssp -CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred -CCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCCC--CCC
T ss_conf -21100223532333035774478786--44457787888877777896--134325653410044674478775--355
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 76431786368777677872123689888698008502334883432878999388338867655673457999999797
Q 001494 312 LSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLN 391 (1067)
Q Consensus 312 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 391 (1067)
+++|+.|+++++++.+..+ +..+..++.+.+..|.+. ....+..+++++.|++++|.+.+..+ +..+++|++|+
T Consensus 262 ~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~--~~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~ 335 (384)
T d2omza2 262 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE--DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 335 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCS--CCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEE
T ss_pred CCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCC--CCCCCCHHCCCCEEECCCCCCCCCCC--CCCCCCCCEEE
T ss_conf 4668775456744578773--235652222332323333--32210000246767777887789845--36689889898
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCC
Q ss_conf 6478664569974000247767980268376569621107688858968998
Q 001494 392 LAFNKLTSSIPISLSNLTNLSVLSFYKNSLSGAIPKEYRNLVKLTKLFLGDN 443 (1067)
Q Consensus 392 L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 443 (1067)
+++|+++... .+..+++|++|++++|++++..| +.++++|+.|+|++|
T Consensus 336 L~~n~l~~l~--~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 336 FANNKVSDVS--SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCSSCCCCCG--GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCCCCH--HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf 9899899974--67089999989897995899800--003999999639789
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=8.9e-41 Score=238.50 Aligned_cols=249 Identities=33% Similarity=0.501 Sum_probs=114.5
Q ss_pred CCCEEECCCCCCCC--CCCCCCCCCCCCCEECCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 66453068873458--8996532323343420234-22226788766664433320011253456568775688865399
Q 001494 98 KLKYLDLSSNLFSG--AIPPQIGHLSYLKTLHLFK-NQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTL 174 (1067)
Q Consensus 98 ~L~~L~L~~n~~~~--~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L 174 (1067)
+++.|+|++|.+.+ .+|+.++.+++|++|+|++ |.++|.+|..++++++|++|++++|.+.+..+..+..+..|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCC
T ss_conf 98899898998888887984784675335202026543330024311454200110203564344332222201110011
Q ss_pred EEECCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 97635876855776566232440102145434655888776433552312567677997854677644781572076466
Q 001494 175 CLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLN 254 (1067)
Q Consensus 175 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 254 (1067)
++++|.+.+.+|..+.+++.|+.+++++|.+.+.+|..+..+.++ ++.++++.|+++
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l-----------------------~~~l~~~~n~l~ 187 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL-----------------------FTSMTISRNRLT 187 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT-----------------------CCEEECCSSEEE
T ss_pred CCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-----------------------CCCCCCCCCCCC
T ss_conf 112245555685122067400000023553356203121443112-----------------------323102246435
Q ss_pred CCCCCCCCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 54586434755415688706425324887554678655799412334587666446776431786368777677872123
Q 001494 255 GSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELR 334 (1067)
Q Consensus 255 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~ 334 (1067)
+..|..+..+.. ..++++++...+.+|..+..++.++.+++++|.+.+.++ .++.+++|+.|++++|++.+..|..|.
T Consensus 188 ~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~ 265 (313)
T d1ogqa_ 188 GKIPPTFANLNL-AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLT 265 (313)
T ss_dssp EECCGGGGGCCC-SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGG
T ss_pred CCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHH
T ss_conf 332433222222-233333343322222222222221112222222222222-222455444444765706660876884
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 68988869800850233488343287899938833886
Q 001494 335 NLKSLSILELGNNKLCGSIPHFLGNLTNLSVLFIYNNS 372 (1067)
Q Consensus 335 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~l~~n~ 372 (1067)
.+++|++|+|++|+++|.+|. ++.+++|+.+++++|+
T Consensus 266 ~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 266 QLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp GCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred CCCCCCEEECCCCCCCCCCCC-CCCCCCCCHHHHCCCC
T ss_conf 799999897958835166898-6667998978868895
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.4e-36 Score=211.34 Aligned_cols=125 Identities=25% Similarity=0.344 Sum_probs=61.1
Q ss_pred CCEEEEECCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 62015981999952266510135544336875788997566853598233578976433476645306887345889965
Q 001494 37 CAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQ 116 (1067)
Q Consensus 37 c~w~gv~C~~~~~v~~l~l~~~~l~~~l~~~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~ 116 (1067)
|.|.+|.|+..+ .++ +|. .+ .+.+++|+|++|++....+..|.+++.|++|++++|.+....|..
T Consensus 10 c~~~~~~C~~~~-L~~-----------lP~-~l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~ 74 (305)
T d1xkua_ 10 CHLRVVQCSDLG-LEK-----------VPK-DL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74 (305)
T ss_dssp EETTEEECTTSC-CCS-----------CCC-SC--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred ECCCEEEECCCC-CCC-----------CCC-CC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHH
T ss_conf 559999855999-885-----------198-88--999798978499189869657604656523112344344523566
Q ss_pred CCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEECC
Q ss_conf 323233434202342222678876666443332001125345656877568886539997635
Q 001494 117 IGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNN 179 (1067)
Q Consensus 117 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n 179 (1067)
|.++++|++|++++|+++ .+|..+. ..++.|.+..|.+..+.+..+.....++.++...|
T Consensus 75 f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n 134 (305)
T d1xkua_ 75 FAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 134 (305)
T ss_dssp TTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSS
T ss_pred HHCCCCCCEECCCCCCCC-CCCCCHH--HHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 527985578315687567-6764001--11323210246102344445401331100001233
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-34 Score=200.71 Aligned_cols=34 Identities=24% Similarity=0.169 Sum_probs=10.9
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCC
Q ss_conf 4530688734588996532323343420234222
Q 001494 100 KYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQL 133 (1067)
Q Consensus 100 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l 133 (1067)
++|+|++|+++...+..|.++++|++|++++|.+
T Consensus 35 ~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l 68 (284)
T d1ozna_ 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68 (284)
T ss_dssp SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCC
T ss_conf 8897748817987977864142130000134454
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-33 Score=197.11 Aligned_cols=55 Identities=20% Similarity=0.154 Sum_probs=24.6
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECC
Q ss_conf 7566853598233578976433476645306887345889965323233434202
Q 001494 74 HLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHL 128 (1067)
Q Consensus 74 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L 128 (1067)
.+++|+|++|++....+..|.+++.|++|++++|.+....+..+..+..++.+..
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~ 87 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 9888977488179879778641421300001344543321112122222222222
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.6e-29 Score=176.39 Aligned_cols=204 Identities=27% Similarity=0.321 Sum_probs=0.0
Q ss_pred CCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCE
Q ss_conf 65662324401021454346558887764335523125676779978546776447815720764665458643475541
Q 001494 188 EIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNL 267 (1067)
Q Consensus 188 ~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 267 (1067)
...+...+..++.+++.++ .+|..+. ++++.|+|++|.+++..+..|.++++|+.|+|++|+++ .++ .+..+++|
T Consensus 5 ~~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L 79 (266)
T d1p9ag_ 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVL 79 (266)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTC
T ss_pred EECCCCCCEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCC-CCCCCCCC
T ss_conf 7742689869980699988-6196757--68898988499289859778634565522135665444-431-11112232
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf 56887064253248875546786557994123345876664467764317863687776778721236898886980085
Q 001494 268 VILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNN 347 (1067)
Q Consensus 268 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 347 (1067)
+.|++++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.++++|++.+|.+..+.+..+..++.++.+++++|
T Consensus 80 ~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N 158 (266)
T d1p9ag_ 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (266)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCC
T ss_conf 11111222221-11112122222222222223110110011222211112212434210221233322111000000015
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 023348834328789993883388676556734579999997976478664
Q 001494 348 KLCGSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLT 398 (1067)
Q Consensus 348 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 398 (1067)
++++..+..|..+++|++|++++|.++ .+|..+..+++|+.|+|++|.+.
T Consensus 159 ~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCC
T ss_conf 652237200134212423430139785-56866777888999983699987
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.7e-33 Score=194.09 Aligned_cols=88 Identities=32% Similarity=0.141 Sum_probs=39.3
Q ss_pred CCCCEEECCCCCCCCCCCCCC-----CCCCCCCEECCCCCCCCCCCCH----HHHHCCCCCEECCCCCCCCCCCHHHHH-
Q ss_conf 434089912898899863112-----4412244001357533444112----211001236111456547886245431-
Q 001494 576 VQLEHLDLSSNNLSNAIPESL-----GNLVKLHYLNLSNNQFSWEIPI----KLEELIHLSELDLSYNFLGRAIPSQIC- 645 (1067)
Q Consensus 576 ~~L~~L~Ls~N~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~~~~~~- 645 (1067)
++|+.|+|++|.|++.+...+ ...+.|++|+|++|.|+..... .+...+.|++|+|++|.|+..+...+.
T Consensus 340 ~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~ 419 (460)
T d1z7xw1 340 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419 (460)
T ss_dssp SSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHH
T ss_pred CCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHH
T ss_conf 11113201210135766400111220456777889897997975999999999962998898989999698799999999
Q ss_pred ----CCCCCCCCCCCCCCCCCC
Q ss_conf ----144564001246513565
Q 001494 646 ----IMQSLEKLNLSHNSLSGV 663 (1067)
Q Consensus 646 ----~~~~L~~L~ls~N~l~~~ 663 (1067)
....|+.|++++|.+...
T Consensus 420 ~l~~~~~~L~~l~l~~~~~~~~ 441 (460)
T d1z7xw1 420 SVRQPGCLLEQLVLYDIYWSEE 441 (460)
T ss_dssp HHTSTTCCCCEEECTTCCCCHH
T ss_pred HHHHCCCCCCEEECCCCCCCHH
T ss_conf 9974788667898989878989
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=1.4e-25 Score=154.57 Aligned_cols=52 Identities=27% Similarity=0.260 Sum_probs=20.3
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf 566853598233578976433476645306887345889965323233434202342222
Q 001494 75 LAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLS 134 (1067)
Q Consensus 75 L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~ 134 (1067)
+++|||+++.++ .+|+. +++|++|++++|+++ .+|..+ .+|+.|++++|.++
T Consensus 40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~ 91 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK 91 (353)
T ss_dssp CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS
T ss_pred CCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC
T ss_conf 989993799988-78898---789888989999796-336203---32033266551432
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.1e-32 Score=192.20 Aligned_cols=62 Identities=24% Similarity=0.114 Sum_probs=23.2
Q ss_pred CCCEEECCCCCCCCCCC----CCCCCCCCCCEECCCCCCCCCCCCHHHH-----HCCCCCEECCCCCCCCC
Q ss_conf 34089912898899863----1124412244001357533444112211-----00123611145654788
Q 001494 577 QLEHLDLSSNNLSNAIP----ESLGNLVKLHYLNLSNNQFSWEIPIKLE-----ELIHLSELDLSYNFLGR 638 (1067)
Q Consensus 577 ~L~~L~Ls~N~l~~~~~----~~l~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~ 638 (1067)
.|+.|+|++|.|++... ..+..+++|++|+|++|.|+..+...+. ....|+.|++++|.+..
T Consensus 370 ~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred CCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCCH
T ss_conf 77889897997975999999999962998898989999698799999999997478866789898987898
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=3e-25 Score=152.74 Aligned_cols=32 Identities=25% Similarity=0.238 Sum_probs=11.6
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf 645306887345889965323233434202342222
Q 001494 99 LKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLS 134 (1067)
Q Consensus 99 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~ 134 (1067)
+++|||+++.++ .+|+. +++|++|++++|+++
T Consensus 40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~ 71 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT 71 (353)
T ss_dssp CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS
T ss_pred CCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC
T ss_conf 989993799988-78898---789888989999796
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=5.1e-28 Score=168.02 Aligned_cols=174 Identities=17% Similarity=0.144 Sum_probs=122.3
Q ss_pred CCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCC-----------C----HHHHHHHHHHHHHHHCCCCCEEEEEEE
Q ss_conf 8855721357764599999779939999990799999-----------8----147999999999983289883332248
Q 001494 798 FDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPG-----------E----MTFQQEFLNEVKALTEIRHRNIVKFYG 862 (1067)
Q Consensus 798 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~----~~~~~~~~~e~~~l~~l~h~niv~~~~ 862 (1067)
+.++++||+|+||.||+|...+|+.||||+++..... . .........|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred EEEECCCEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 98618801599995458988788605675689996879999999999999988189999252688998566489998299
Q 001494 863 FCSHAQHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCFPPIVHRDISSKNVLLDFKNEARV 942 (1067)
Q Consensus 863 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dik~~Nill~~~~~~kl 942 (1067)
+. ..+++|||++++.... ++......++.|++.+++|||++ +++||||||+|||++++ .+++
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred EC----CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEEE
T ss_conf 62----8889999504565420----------01578999999999999998268---88983689036114289-8999
Q ss_pred ECCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 50234300389999600022234324731223588896213689999999
Q 001494 943 SDFGIAKFLKPDSSNWTELAGTYGYVAPELAYTMKVTEKCDVYSFGVLAL 992 (1067)
Q Consensus 943 ~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ 992 (1067)
+|||.|......... .....+... -.+. ....|+.++|+||..--+.
T Consensus 144 iDFG~a~~~~~~~~~-~~l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 144 IDFPQSVEVGEEGWR-EILERDVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCCTTCEETTSTTHH-HHHHHHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred EECCCCCCCCCCCCH-HHHHHHHHH-HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 877884308998709-999877999-9999-7578998446899999874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=7.3e-25 Score=150.58 Aligned_cols=56 Identities=14% Similarity=0.111 Sum_probs=23.5
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEECCC
Q ss_conf 7566853598233578976433476645306887345889-9653232334342023
Q 001494 74 HLAYLDLWSNQLFGNIPPQIGNISKLKYLDLSSNLFSGAI-PPQIGHLSYLKTLHLF 129 (1067)
Q Consensus 74 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~-p~~~~~l~~L~~L~L~ 129 (1067)
.+++|++++|.+....+..|.++++|++|++++|.+...+ +..|..++.++++.+.
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf 889998769918964966861464323211022112420100112222222221111
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=8.1e-25 Score=150.33 Aligned_cols=86 Identities=19% Similarity=0.173 Sum_probs=43.8
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCC-CCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCEE
Q ss_conf 76645306887345889965323233434202342222678-87666644333200112-53456568775688865399
Q 001494 97 SKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSI-PLEVGGLSSLNNLALYS-NYLEDIIPHSLGNLTNLVTL 174 (1067)
Q Consensus 97 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~l~~-n~~~~~~p~~~~~l~~L~~L 174 (1067)
+.+++|++++|.++...+..|.++++|++|++++|.+...+ +..|.++++++++.+.. |.+....+..|..+++|+++
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 98899987699189649668614643232110221124201001122222222211111234322222212222222222
Q ss_pred EEECCCCC
Q ss_conf 97635876
Q 001494 175 CLYNNLLS 182 (1067)
Q Consensus 175 ~l~~n~l~ 182 (1067)
++++|.+.
T Consensus 109 ~l~~~~l~ 116 (242)
T d1xwdc1 109 LISNTGIK 116 (242)
T ss_dssp EEESCCCC
T ss_pred CCCHHHHC
T ss_conf 34211112
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=7.3e-24 Score=145.04 Aligned_cols=209 Identities=26% Similarity=0.428 Sum_probs=0.0
Q ss_pred CCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEEEEE
Q ss_conf 23244010214543465588877643355231256767799785467764478157207646654586434755415688
Q 001494 192 LKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILY 271 (1067)
Q Consensus 192 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 271 (1067)
++++..++++.+.+++.. .+..+.+|+.|++.+|.++.. ..+..+++|+.|++++|.+.+..| +..+++|+.++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHHCCCCCCCCC--CHHHCCCCCEEECCCCCCCCC--HHHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCC
T ss_conf 999999984888767757--987848868997779999766--457448888376357853202543--11233432012
Q ss_pred EECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 70642532488755467865579941233458766644677643178636877767787212368988869800850233
Q 001494 272 IYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLCG 351 (1067)
Q Consensus 272 L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 351 (1067)
+++|.++.+ ..+..++.|+.+.++.+...+. ..+...+.+..+.+..+.+....+ +..+++|+.|++++|.+..
T Consensus 92 ~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~n~~~~ 165 (227)
T d1h6ua2 92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD 165 (227)
T ss_dssp CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CHHCCCCCHHHHHCHHHHHCHHHH--HCCCCCCCCCCCCCCCCCC
T ss_conf 111222222--2222222221221222443311--000002301222000000000000--0102111002333333331
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 4883432878999388338867655673457999999797647866456997400024776798026
Q 001494 352 SIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAFNKLTSSIPISLSNLTNLSVLSFYK 418 (1067)
Q Consensus 352 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 418 (1067)
..+ +.++++|+.|++++|.+.+..+ +..+++|++|++++|++++..+ +..+++|+.|++++
T Consensus 166 ~~~--l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 166 LTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred CHH--HCCCCCCEECCCCCCCCCCCHH--HCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEEEEC
T ss_conf 001--0564633564458884177853--4479999989795996899802--03699989897129
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.89 E-value=1.8e-23 Score=142.92 Aligned_cols=131 Identities=25% Similarity=0.328 Sum_probs=68.6
Q ss_pred CCEEEEECCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf 6201598199995226651013554433687578899756685359823357-897643347664530688734588996
Q 001494 37 CAWVGIHCNHGGRVNSINLTSIGLKGTLHDFSFSSFPHLAYLDLWSNQLFGN-IPPQIGNISKLKYLDLSSNLFSGAIPP 115 (1067)
Q Consensus 37 c~w~gv~C~~~~~v~~l~l~~~~l~~~l~~~~~~~l~~L~~L~l~~n~~~~~-~p~~~~~l~~L~~L~L~~n~~~~~~p~ 115 (1067)
|.|..|.|+..+ .+ ++|.. + .+++++|+|++|.+... .+..|.++++|+.|+|++|.+....+.
T Consensus 8 C~~~~v~Cs~~~-L~-----------~iP~~-l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~ 72 (192)
T d1w8aa_ 8 CEGTTVDCTGRG-LK-----------EIPRD-I--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72 (192)
T ss_dssp EETTEEECTTSC-CS-----------SCCSC-C--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTT
T ss_pred ECCCEEEEECCC-CC-----------CCCCC-C--CCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCC
T ss_conf 769999970899-67-----------02989-8--978788984898775530200257876272130136322121212
Q ss_pred CCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf 5323233434202342222678876666443332001125345656877568886539997635876
Q 001494 116 QIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLS 182 (1067)
Q Consensus 116 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~ 182 (1067)
.|..+++|++|+|++|+++...|..|.++++|++|+|++|.|..+.++.|..+++|++|+|++|.+.
T Consensus 73 ~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 73 AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp TTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf 2211222210100355344349799807974655245774535359778568753342000364434
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.88 E-value=1.6e-22 Score=137.59 Aligned_cols=85 Identities=32% Similarity=0.393 Sum_probs=27.1
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCEEC
Q ss_conf 87445334044604578531113344340899128988998631124412244001357533444112211001236111
Q 001494 551 LSFLIKLILAQNQLSGQLSPKLGLLVQLEHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELD 630 (1067)
Q Consensus 551 ~~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 630 (1067)
+++|++|++++|.+..+.+..|..+++|+.|+|++|+|+.+.+.+|.++++|++|+|++|+|+.+.+.+|..+++|++|+
T Consensus 53 l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~ 132 (192)
T d1w8aa_ 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
T ss_conf 76272130136322121212221122221010035534434979980797465524577453535977856875334200
Q ss_pred CCCCC
Q ss_conf 45654
Q 001494 631 LSYNF 635 (1067)
Q Consensus 631 Ls~N~ 635 (1067)
|++|.
T Consensus 133 L~~N~ 137 (192)
T d1w8aa_ 133 LASNP 137 (192)
T ss_dssp CTTCC
T ss_pred CCCCC
T ss_conf 03644
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=8.5e-22 Score=133.64 Aligned_cols=188 Identities=26% Similarity=0.408 Sum_probs=0.0
Q ss_pred CCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEEEE
Q ss_conf 62324401021454346558887764335523125676779978546776447815720764665458643475541568
Q 001494 191 NLKYLLDLNLYNNELNGSIPQSLGNLSNLAMLNLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVIL 270 (1067)
Q Consensus 191 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 270 (1067)
.+.++....+..+.+++.++. ..+.+|+.|++++|.+....+ +..+++|+.|++++|++++..+ +..+++|+.|
T Consensus 22 ~l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L 95 (210)
T d1h6ta2 22 AFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWL 95 (210)
T ss_dssp HHHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHHHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCC
T ss_conf 999999998575765775188--795484589782798887444--7648998987698960258601--1358621201
Q ss_pred EEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 87064253248875546786557994123345876664467764317863687776778721236898886980085023
Q 001494 271 YIYNNSLSGLIPSEIGNLKFLSKIALSYNKFSGLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSILELGNNKLC 350 (1067)
Q Consensus 271 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 350 (1067)
++++|+++++. .+..+++|+.|++++|.+... ..+.++++++.+++++|.+... ..+..+++|+.+++++|+++
T Consensus 96 ~l~~n~i~~l~--~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~ 169 (210)
T d1h6ta2 96 FLDENKVKDLS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 169 (210)
T ss_dssp ECCSSCCCCGG--GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred CCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC
T ss_conf 43333321222--121222111223456532211--2201111122211222333454--31000133210013464302
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 34883432878999388338867655673457999999797647
Q 001494 351 GSIPHFLGNLTNLSVLFIYNNSLSGSIPCEIGNLKSLSYLNLAF 394 (1067)
Q Consensus 351 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 394 (1067)
+..+ +.++++|+.|++++|.++ .++ .+.++++|++|++++
T Consensus 170 ~i~~--l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 170 DIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred CCCC--CCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCC
T ss_conf 5645--367898999989799899-872-116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=1e-21 Score=133.17 Aligned_cols=184 Identities=29% Similarity=0.380 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 64433320011253456568775688865399976358768557765662324401021454346558887764335523
Q 001494 143 GLSSLNNLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIPSEIGNLKYLLDLNLYNNELNGSIPQSLGNLSNLAML 222 (1067)
Q Consensus 143 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L 222 (1067)
++.+.....++.+.+.+..+ ...+.+++.|++++|.++.. +.+..+++|++|++++|++++..+ +..+++|+.|
T Consensus 16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L 89 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI 89 (199)
T ss_dssp HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHHHHHHHHCCCCCCCCCC--HHHHCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCC
T ss_conf 99999999967787788559--87946878998999999775--202137886757545655667640--1677522311
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 12567677997854677644781572076466545864347554156887064253248875546786557994123345
Q 001494 223 NLSSNSLFGSIPSELGNLKYLSDLKLADNKLNGSIPHSLCNLTNLVILYIYNNSLSGLIPSEIGNLKFLSKIALSYNKFS 302 (1067)
Q Consensus 223 ~ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~ 302 (1067)
++++|.+....+ +.+++.|+.|++++|......+ +..+++|+.|++++|++... +.+..+++|+.|++++|+++
T Consensus 90 ~l~~n~~~~~~~--l~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~ 163 (199)
T d2omxa2 90 LMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVT 163 (199)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC
T ss_pred CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCHHHHHHHHHHHHHHHCCC--CCCCCCCCCCCCCCCCCCCC
T ss_conf 112222222211--1112232221112222223210--00122367764311110023--43332111111223455556
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 8766644677643178636877767787212368988869
Q 001494 303 GLIPHSLGNLSNIAFLFLDSNSLFGLIPSELRNLKSLSIL 342 (1067)
Q Consensus 303 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 342 (1067)
+..+ ++++++|++|++++|++..+.+ ++.+++|+.|
T Consensus 164 ~l~~--l~~l~~L~~L~ls~N~i~~i~~--l~~L~~L~~L 199 (199)
T d2omxa2 164 DLKP--LANLTTLERLDISSNKVSDISV--LAKLTNLESL 199 (199)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEE
T ss_pred CCCC--CCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCC
T ss_conf 7701--1679989999787997998810--1278998949
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.86 E-value=5.8e-24 Score=145.59 Aligned_cols=12 Identities=33% Similarity=0.346 Sum_probs=4.3
Q ss_pred CCCCCCCCCCCC
Q ss_conf 564001246513
Q 001494 649 SLEKLNLSHNSL 660 (1067)
Q Consensus 649 ~L~~L~ls~N~l 660 (1067)
.|+.|+|++|++
T Consensus 303 ~L~~L~l~~N~~ 314 (344)
T d2ca6a1 303 DLLFLELNGNRF 314 (344)
T ss_dssp TCCEEECTTSBS
T ss_pred CCCEEECCCCCC
T ss_conf 999897879808
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.85 E-value=4.9e-23 Score=140.49 Aligned_cols=38 Identities=26% Similarity=0.301 Sum_probs=15.3
Q ss_pred CCCCEECCCCCCCCCCCCHHH-----HHCCCCCEECCCCCCCC
Q ss_conf 224400135753344411221-----10012361114565478
Q 001494 600 VKLHYLNLSNNQFSWEIPIKL-----EELIHLSELDLSYNFLG 637 (1067)
Q Consensus 600 ~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~Ls~N~l~ 637 (1067)
+.|+.|++++|.|+......+ ...+.|+.|+|++|++.
T Consensus 273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCC
T ss_conf 8889898989869808999999999703899998978798089
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=2.2e-21 Score=131.33 Aligned_cols=60 Identities=30% Similarity=0.233 Sum_probs=21.7
Q ss_pred CCCCCEEECCCC-CCCCCCCCCCCCCCCCCEECCCCC-CCCCCCCHHHHHCCCCCEECCCCC
Q ss_conf 443408991289-889986311244122440013575-334441122110012361114565
Q 001494 575 LVQLEHLDLSSN-NLSNAIPESLGNLVKLHYLNLSNN-QFSWEIPIKLEELIHLSELDLSYN 634 (1067)
Q Consensus 575 ~~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N 634 (1067)
+++|+.|++++| .+++.....+..+++|++|+++++ .+++.....+..+++|+.|+++++
T Consensus 174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf 22212355322347783033332135768779899999787378999726999898964488
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.3e-17 Score=110.48 Aligned_cols=131 Identities=20% Similarity=0.191 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 88878889741674368723898898655788774997689712476730005787445334044604578531113344
Q 001494 497 SSDWGRCPKLGALDFSKNNITGNIPPKIGYSSQLEVLDLSSNHVVGDIPAELGKLSFLIKLILAQNQLSGQLSPKLGLLV 576 (1067)
Q Consensus 497 ~~~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~~~ 576 (1067)
...|..+.++++|++++|+|+ ..+..+..+++|+.|+|++|.|... ..+..+++|+.|++++|+++.+.+..+..++
T Consensus 11 ~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~ 87 (162)
T d1a9na_ 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 87 (162)
T ss_dssp SCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HHHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 175168574848978899788-6576200414599898979978764--7744576130643102134577763223345
Q ss_pred CCCEEECCCCCCCCCCC-CCCCCCCCCCEECCCCCCCCCCC---CHHHHHCCCCCEEC
Q ss_conf 34089912898899863-11244122440013575334441---12211001236111
Q 001494 577 QLEHLDLSSNNLSNAIP-ESLGNLVKLHYLNLSNNQFSWEI---PIKLEELIHLSELD 630 (1067)
Q Consensus 577 ~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~ 630 (1067)
+|+.|++++|.|+.... ..+..+++|++|++++|.++... +..+..+++|++||
T Consensus 88 ~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 88 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred CCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHCCCCCEEC
T ss_conf 3443420300016654211001365320664079963456106999998789958337
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=2.3e-16 Score=103.65 Aligned_cols=73 Identities=25% Similarity=0.234 Sum_probs=24.0
Q ss_pred CCCCCCHHHHHCCCCCEECCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 34441122110012361114565478862454311445640012465135655511235742219981257578
Q 001494 612 FSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIPRCFEEMHALQCIDISYNELR 685 (1067)
Q Consensus 612 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 685 (1067)
|+.+.+.+|.++++|+.|++++|+|+.+.+.+|..+++|+.|+|++|+|..+....+..+ .|+.|++++|++.
T Consensus 44 l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 44 LQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred CCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCCC-CCCCCCCCCCCCC
T ss_conf 443692122566666721620212477420111245543333226787851574563353-2124335798633
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.63 E-value=7.1e-16 Score=100.89 Aligned_cols=111 Identities=23% Similarity=0.231 Sum_probs=0.0
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCEECCCCCCCCCCCHHHHHCCCCCCCCCCCCC
Q ss_conf 08991289889986311244122440013575334441122110012361114565478862454311445640012465
Q 001494 579 EHLDLSSNNLSNAIPESLGNLVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHN 658 (1067)
Q Consensus 579 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~ls~N 658 (1067)
+.|||++|+|+.... +..++.|++|++++|+|+ ..|..+..+++|+.|++++|.|++... +..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~~--~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSS
T ss_pred CEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCC
T ss_conf 989868998988710--105898898979787168-652156554313545324321123574--123355576888898
Q ss_pred CCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 1356555-11235742219981257578989999764
Q 001494 659 SLSGVIP-RCFEEMHALQCIDISYNELRGPIPNSTAF 694 (1067)
Q Consensus 659 ~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~~~~~~ 694 (1067)
+|.+... ..+..+++|+.+++++|+++........+
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l 112 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERL 112 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHH
T ss_pred CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHH
T ss_conf 6588888256537999999989799688682679999
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.62 E-value=3.4e-18 Score=113.75 Aligned_cols=149 Identities=21% Similarity=0.248 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 88997566853598-23357897643347664530688734588996532323343420234222267887666644333
Q 001494 70 SSFPHLAYLDLWSN-QLFGNIPPQIGNISKLKYLDLSSNLFSGAIPPQIGHLSYLKTLHLFKNQLSGSIPLEVGGLSSLN 148 (1067)
Q Consensus 70 ~~l~~L~~L~l~~n-~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 148 (1067)
.....++.+++++. .-...+|.++..+++|++|+|++|+++ .+++ +..+++|++|+|++|.++ .+|..+..+++|+
T Consensus 20 ~~~~~~~~~~l~~~~~~i~~l~~sl~~L~~L~~L~Ls~n~I~-~i~~-l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~ 96 (198)
T d1m9la_ 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCTTCSCEECCBCCTTCCCCHHHHHHTTTCCEEECSEEEES-CCCC-HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCC
T ss_pred CCCCCCCEEEEECCCCCHHHHHHHHHCCCCCCEEECCCCCCC-CCCC-CCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCC
T ss_conf 854533100255556852002467762604615199446899-8644-247825357341353432-1000033221233
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCC-CCCCCCCCCCEECCCCCCCCCCCCCC----------CCCCC
Q ss_conf 20011253456568775688865399976358768557-76566232440102145434655888----------77643
Q 001494 149 NLALYSNYLEDIIPHSLGNLTNLVTLCLYNNLLSGSIP-SEIGNLKYLLDLNLYNNELNGSIPQS----------LGNLS 217 (1067)
Q Consensus 149 ~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~----------l~~l~ 217 (1067)
.|++++|.+..+ ..+..+++|+.|++++|.++.... ..+..+++|+.|++++|.+....+.. +..++
T Consensus 97 ~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp 174 (198)
T d1m9la_ 97 ELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174 (198)
T ss_dssp EEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCS
T ss_pred CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHHHCC
T ss_conf 333333222222--222222234111234102125542212367776302342798434676322220558999998788
Q ss_pred CCCEEE
Q ss_conf 355231
Q 001494 218 NLAMLN 223 (1067)
Q Consensus 218 ~L~~L~ 223 (1067)
+|+.||
T Consensus 175 ~L~~LD 180 (198)
T d1m9la_ 175 NLKKLD 180 (198)
T ss_dssp SCCEES
T ss_pred CCCEEC
T ss_conf 958769
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.19 E-value=1.6e-10 Score=71.29 Aligned_cols=150 Identities=14% Similarity=0.106 Sum_probs=102.0
Q ss_pred HHHHHHHCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEEEC
Q ss_conf 99999852888557213577645999997799399999907999998147999999999983289-88333224898618
Q 001494 789 EEIIRATNDFDDEHCIGKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHA 867 (1067)
Q Consensus 789 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 867 (1067)
.++......|+..+..+.++.+.||++... +..+.+|+........ ...+.+|...+..+. +-.+++++.++..+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCC---HHHHHHHHHHHHHHHCCCCCCCEEEEEECC
T ss_conf 999975135279976789987718999908-9869999848876532---556999999999876069987289997508
Q ss_pred CCEEEEEEECCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC----------------------------
Q ss_conf 8015999954589887886056756899968799999999999999881899----------------------------
Q 001494 868 QHSFIVYEYLEMGSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHNDCF---------------------------- 919 (1067)
Q Consensus 868 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~---------------------------- 919 (1067)
+..++||++++|..+..... +......++.++++.++.||+...
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~--------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTT--------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred CCEEEEEEECCCCCCCCCCC--------CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf 96499998604334354334--------4026999999899999998556842143576446565557789987765555
Q ss_pred ----------------------------CCEEECCCCCCCEEECCCCCEEEECCCCCEE
Q ss_conf ----------------------------9925268899856648999829950234300
Q 001494 920 ----------------------------PPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 920 ----------------------------~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~ 950 (1067)
+.++|+|+.+.||++++++.+.++||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 43033232005799999999844986781789860047642364996599960231441
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.07 E-value=6.6e-12 Score=78.98 Aligned_cols=81 Identities=31% Similarity=0.205 Sum_probs=36.4
Q ss_pred CCCCCCEECCCCCCCCCCC--CHHHHHCCCCCEECCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCC-------CCC
Q ss_conf 4122440013575334441--1221100123611145654788624543114456400124651356555-------112
Q 001494 598 NLVKLHYLNLSNNQFSWEI--PIKLEELIHLSELDLSYNFLGRAIPSQICIMQSLEKLNLSHNSLSGVIP-------RCF 668 (1067)
Q Consensus 598 ~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~~-------~~~ 668 (1067)
.++.|++|+|++|+|+... +..+..+++|+.|+|++|.|++...-.+.....|+.|++++|++..... ..+
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~ 142 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR 142 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred HCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHH
T ss_conf 48787886377766667731588986588561000435721342344222033104266489976767666156999999
Q ss_pred CCCCCCCEEE
Q ss_conf 3574221998
Q 001494 669 EEMHALQCID 678 (1067)
Q Consensus 669 ~~l~~L~~l~ 678 (1067)
..+|+|+.||
T Consensus 143 ~~~P~L~~LD 152 (162)
T d1koha1 143 ERFPKLLRLD 152 (162)
T ss_dssp TTSTTCCEET
T ss_pred HHCCCCCEEC
T ss_conf 9889978799
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.03 E-value=1.9e-11 Score=76.46 Aligned_cols=39 Identities=33% Similarity=0.278 Sum_probs=13.5
Q ss_pred CCCCCEECCCCCCCCCCCCHHHHHCCCCCEECCCCCCCC
Q ss_conf 122440013575334441122110012361114565478
Q 001494 599 LVKLHYLNLSNNQFSWEIPIKLEELIHLSELDLSYNFLG 637 (1067)
Q Consensus 599 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 637 (1067)
+++|+.|+|++|.|+......+....+|+.|++++|.+.
T Consensus 90 l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 90 APNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp STTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred CCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCC
T ss_conf 885610004357213423442220331042664899767
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.81 E-value=2.1e-08 Score=59.64 Aligned_cols=131 Identities=16% Similarity=0.134 Sum_probs=84.9
Q ss_pred CCCCCCC-EEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCC--CCEEEEEEEEEEECCCEEEEEEECCC
Q ss_conf 2135776-45999997799399999907999998147999999999983289--88333224898618801599995458
Q 001494 803 CIGKGGQ-GSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR--HRNIVKFYGFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 803 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~ 879 (1067)
.+..|.. +.||++...++..+.+|....... ..+..|+..++.+. .-.+++++.++.+++..++||++++|
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH------HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEEC
T ss_conf 76786547758999938987899995896677------689999999999986599988613222456615999874413
Q ss_pred CCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------
Q ss_conf 98878860567568999687999999999999998818------------------------------------------
Q 001494 880 GSLAMILSNDAAAEDLEWTQRMSVIKGIADALSYLHND------------------------------------------ 917 (1067)
Q Consensus 880 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------ 917 (1067)
.++.... .. ....+.++++.++.||+.
T Consensus 91 ~~~~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 91 QDLLSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp EETTTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCCCCCC--------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHH
T ss_conf 5543221--------26---899999999999987368854488755412468899999987541101134011213799
Q ss_pred ---------C----CCCEEECCCCCCCEEECCCCCEEEECCCCCEE
Q ss_conf ---------9----99925268899856648999829950234300
Q 001494 918 ---------C----FPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 918 ---------~----~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~ 950 (1067)
. .+.++|+|+.+.||+++.+..+.++||+.+..
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 9999998718765795678678887635773796589998533265
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.66 E-value=7e-09 Score=62.26 Aligned_cols=112 Identities=17% Similarity=0.141 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CCCC----CCCCCCCCCCCCCCEEECCCCCCC----CCCCCCCCCCCCCCEECCCCCCCCCCCCHH
Q ss_conf 5787445334044-6045----785311133443408991289889----986311244122440013575334441122
Q 001494 549 GKLSFLIKLILAQ-NQLS----GQLSPKLGLLVQLEHLDLSSNNLS----NAIPESLGNLVKLHYLNLSNNQFSWEIPIK 619 (1067)
Q Consensus 549 ~~~~~L~~L~l~~-N~l~----~~~~~~~~~~~~L~~L~Ls~N~l~----~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 619 (1067)
...+.|++|++++ +.++ ......+...+.|+.|+|++|.++ ......+...+.|+.|+|++|.++..+...
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf 28999819782799998989999999997637764540120156215679887531000234330033010214599999
Q ss_pred H----HHCCCCCEECCCCCCCCCC-------CHHHHHCCCCCCCCCCCCCCC
Q ss_conf 1----1001236111456547886-------245431144564001246513
Q 001494 620 L----EELIHLSELDLSYNFLGRA-------IPSQICIMQSLEKLNLSHNSL 660 (1067)
Q Consensus 620 ~----~~l~~L~~L~Ls~N~l~~~-------~~~~~~~~~~L~~L~ls~N~l 660 (1067)
+ ...+.|++|++++|.+... ...++...++|+.|+++.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCC
T ss_conf 9999984893898778877688865799999999997299853864868886
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.44 E-value=1.3e-06 Score=49.74 Aligned_cols=79 Identities=18% Similarity=0.126 Sum_probs=47.9
Q ss_pred CCCCCCCCCEEEEEEEECC-CCEEEEEEECCCCC--CC--HHHHHHHHHHHHHHHCCC-C--CEEEEEEEEEEECCCEEE
Q ss_conf 5721357764599999779-93999999079999--98--147999999999983289-8--833322489861880159
Q 001494 801 EHCIGKGGQGSVYKVELAS-GEIIAVKKFHSPLP--GE--MTFQQEFLNEVKALTEIR-H--RNIVKFYGFCSHAQHSFI 872 (1067)
Q Consensus 801 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~--~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l 872 (1067)
.+.+|.|....||+++..+ ++.+.+|....... ++ .........|+..++.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCC
Q ss_conf 999545898
Q 001494 873 VYEYLEMGS 881 (1067)
Q Consensus 873 v~e~~~~g~ 881 (1067)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEECCCCCC
T ss_conf 871357765
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.36 E-value=2.9e-08 Score=58.84 Aligned_cols=13 Identities=31% Similarity=0.347 Sum_probs=4.5
Q ss_pred CCCCEECCCCCCC
Q ss_conf 2244001357533
Q 001494 600 VKLHYLNLSNNQF 612 (1067)
Q Consensus 600 ~~L~~L~L~~N~l 612 (1067)
+.++.+++++|.+
T Consensus 74 ~~l~~l~l~~~~~ 86 (166)
T d1io0a_ 74 NTLKSLNVESNFI 86 (166)
T ss_dssp SSCCEEECCSSCC
T ss_pred CCCHHHHHCCCCC
T ss_conf 2210121025432
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.28 E-value=6.7e-08 Score=56.83 Aligned_cols=14 Identities=36% Similarity=0.451 Sum_probs=5.2
Q ss_pred CCCCEEECCCCCCC
Q ss_conf 43408991289889
Q 001494 576 VQLEHLDLSSNNLS 589 (1067)
Q Consensus 576 ~~L~~L~Ls~N~l~ 589 (1067)
+.++.+++++|.+.
T Consensus 74 ~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 74 NTLKSLNVESNFIS 87 (166)
T ss_dssp SSCCEEECCSSCCC
T ss_pred CCCHHHHHCCCCCC
T ss_conf 22101210254322
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.10 E-value=1.5e-05 Score=43.76 Aligned_cols=139 Identities=12% Similarity=0.092 Sum_probs=76.4
Q ss_pred CCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCE--EEEEE-----EEEEECCCEEEEEEECCC
Q ss_conf 77645999997799399999907999998147999999999983289883--33224-----898618801599995458
Q 001494 807 GGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIRHRN--IVKFY-----GFCSHAQHSFIVYEYLEM 879 (1067)
Q Consensus 807 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~-----~~~~~~~~~~lv~e~~~~ 879 (1067)
+..-.||+++..+|+.|++|+.+... ...+++..|...+..+.... ++..+ .....++..+.++++++|
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCC----CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCC
T ss_conf 61202699983899979999847877----88999999999999998559987875206898056653479999865277
Q ss_pred CCHH-----HHH-------------CCCC--CCCCCC-------------------HH---HHHHHHHHHHHHHHHH-HH
Q ss_conf 9887-----886-------------0567--568999-------------------68---7999999999999998-81
Q 001494 880 GSLA-----MIL-------------SNDA--AAEDLE-------------------WT---QRMSVIKGIADALSYL-HN 916 (1067)
Q Consensus 880 g~L~-----~~l-------------~~~~--~~~~l~-------------------~~---~~~~i~~~i~~~l~~L-H~ 916 (1067)
..+. ... .... .....+ .. .....+..+...+.-. .+
T Consensus 109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 188 (325)
T d1zyla1 109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 188 (325)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 68899999999998999999886303578655677897887665689998747699889899999999999999984545
Q ss_pred CCCCCEEECCCCCCCEEECCCCCEEEECCCCCEEC
Q ss_conf 89999252688998566489998299502343003
Q 001494 917 DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKFL 951 (1067)
Q Consensus 917 ~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~~ 951 (1067)
....+++|+|+.+.||+++.+ ..++||+-+..-
T Consensus 189 ~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 189 DFTVLRLHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp CSCCEECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred CCCCEEECCCCCCCCEEEECC--CEEEECHHCCCC
T ss_conf 687120247888042878389--358865201468
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.03 E-value=1.7e-05 Score=43.50 Aligned_cols=73 Identities=18% Similarity=0.248 Sum_probs=48.5
Q ss_pred CCCCCCCCCEEEEEEEECC--------CCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCC-CCEEEEEEEEEEECCCEE
Q ss_conf 5721357764599999779--------9399999907999998147999999999983289-883332248986188015
Q 001494 801 EHCIGKGGQGSVYKVELAS--------GEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-HRNIVKFYGFCSHAQHSF 871 (1067)
Q Consensus 801 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 871 (1067)
.+.|+.|-.-.+|++...+ .+.|.+++.... .. .....+|..+++.+. +.-.+++++++.+ +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC--CH---HHHHHHHHHHHHHHHHCCCCCEEEEECCC----C
T ss_conf 999178533434899968877544578981799965996--11---65899999999999757999808998189----5
Q ss_pred EEEEECCCCCH
Q ss_conf 99995458988
Q 001494 872 IVYEYLEMGSL 882 (1067)
Q Consensus 872 lv~e~~~~g~L 882 (1067)
+|+||++|..+
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEECCCCC
T ss_conf 69997345548
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.72 E-value=0.0006 Score=34.99 Aligned_cols=159 Identities=13% Similarity=0.070 Sum_probs=83.8
Q ss_pred CCHHHHHHHHCCCCCCCCC-----CCCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHHHCCC-----CC
Q ss_conf 5699999985288855721-----3577645999997799399999907999998147999999999983289-----88
Q 001494 786 IVYEEIIRATNDFDDEHCI-----GKGGQGSVYKVELASGEIIAVKKFHSPLPGEMTFQQEFLNEVKALTEIR-----HR 855 (1067)
Q Consensus 786 ~~~~~~~~~~~~~~~~~~l-----G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~ 855 (1067)
++.+++.....+|.+++.. ..|.--+.|.++..+|+ +++|++..... . +++..|...+..+. .|
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~-~----~~l~~~~~~l~~L~~~g~pvp 76 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE-K----NDLPFFLGLMQHLAAKGLSCP 76 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----C----CHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCC-EEEEECCCCCC-H----HHHHHHHHHHHHHHHCCCCCC
T ss_conf 89999999998679998568523788852673899978972-89998078999-8----899999999875430255545
Q ss_pred EEEEEE-E--EEEECCCEEEEEEECCCCCHHH-----------HH---C---C-CC---CCCC-----------------
Q ss_conf 333224-8--9861880159999545898878-----------86---0---5-67---5689-----------------
Q 001494 856 NIVKFY-G--FCSHAQHSFIVYEYLEMGSLAM-----------IL---S---N-DA---AAED----------------- 894 (1067)
Q Consensus 856 niv~~~-~--~~~~~~~~~lv~e~~~~g~L~~-----------~l---~---~-~~---~~~~----------------- 894 (1067)
..+... | +....+....++.+..+..... .+ + . .. ....
T Consensus 77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred CCCEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHH
T ss_conf 56410489762134125502453114655333204678888899876454443202453101110120024567777653
Q ss_pred CCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEECCCCCEE
Q ss_conf 9968799999999999999881-8999925268899856648999829950234300
Q 001494 895 LEWTQRMSVIKGIADALSYLHN-DCFPPIVHRDISSKNVLLDFKNEARVSDFGIAKF 950 (1067)
Q Consensus 895 l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dik~~Nill~~~~~~kl~Dfgla~~ 950 (1067)
.........+......+...+. ....|++|+|+.+.||+++.+...-+.||+.+..
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 114127999999987642048554545033378636564020454126742221236
|